since first experiment thomas e starzl <NUMBER>s <NUMBER> liver transplants lts revolutionized treatment patients severe liver disease dramatically improving outcomes illustrating success procedure around <NUMBER> transplants performed around world <NUMBER> <NUMBER> however access lt limited stagnant pool donor organs contrasts increasing number candidates france instance overall number newly listed patients increased <NUMBER> <NUMBER> <NUMBER> average <NUMBER> transplant candidates per available graft <NUMBER> regulation regarding allocation system led grafts offered patients highest risk shortterm mortality consequence severely ill patients endstage liver disease esld prioritized lt increasingly admitted intensive care unit icu <NUMBER> outcomes patients esld icu used concern intensivists due outcomes compared general population <NUMBER> <NUMBER> however improved practices led outstanding <NUMBER> point shortterm survival gain <NUMBER> <NUMBER> liverspecific icu <NUMBER> reasons improvements fourfold better identification candidates icu admission based specific prognosis scores <NUMBER> <NUMBER> better understanding pathophysiology complications chronic liver diseases general improvement icu care <NUMBER> <NUMBER> development specific management patients advanced liver disease indeed last decades numerous medical improvements management precipitating events complications esld instance improvement administration antimicrobial therapy bundle care sepsis resulted better outcomes sepsis septic shock <NUMBER> <NUMBER> <NUMBER> among others use vasopressors antibiotic prophylaxis endoscopic management resulted significant improvements prognosis patients admitted context acute variceal bleeding <NUMBER> <NUMBER> <NUMBER> <NUMBER> setting hepatorenal syndrome hrs combination using albumin infusions vasopressors alongside clearer disease definitions led significant improvements terms outcome <NUMBER> <NUMBER> <NUMBER> <NUMBER> despite improvements lt remains lifesaving procedure patients fail recover adequate liver function order illustrate importance urgent lt situation share <NUMBER> policy recently implemented us improve equity access lt based comparable outcomes observed patients high meld scores without lt patients fulminant hepatic failure fhf <NUMBER> <NUMBER> <NUMBER> share <NUMBER> patients esld given geographic access organs patients fhf latter group still granted higher allocation status given region <NUMBER> several unmet medical ethical issues faced clinicians order optimize management patients high meld scores perspective lt patients categorized era dual concepts acuteonchronic liver failure aclf mere acute decompensation prognosis assessment used context permanent scarcity resource priority access lt managed severely ill patients given potential increased risk postlt mortality upper limits sickness identified beyond patient listed lt deal patients already listed less severe disease exposed brutal deterioration liver function death due restricted access lt finally identify manage patients candidates lt recover adequate liver function hereby offer discuss important questions review literature order shed light management patients high meld scores high meld relationship acuteonchronic liver failure acuteonchronic liver failure mere acute decompensation patients high meld scores often admitted context acute decompensation ie ascites gastrointestinal bleeding hepatic encephalopathy andor acute bacterial infections distinctions made mere acute decompensation aclf regarding respective outcomes mere acute decompensation associated acceptable <NUMBER>day <NUMBER>month mortality <NUMBER> <NUMBER> respectively <NUMBER> defined either absence organ failures ofs presence cerebral failure serum creatinine level <NUMBER> mgdl presence <NUMBER> nonkidney serum creatinine level <NUMBER> mgdl encephalopathy table <NUMBER> median meld patients hospitalized setting <NUMBER> <NUMBER> patients high meld scores likely admitted context aclf world gastroenterology organization defined aclf syndrome patients chronic liver disease without previously diagnosed cirrhosis characterized acute hepatic decompensation resulting liver failure jaundice prolongation international normalized ratio <NUMBER> extrahepatic ofs associated increased mortality within period <NUMBER> days <NUMBER> months onset <NUMBER> definition <NUMBER>day <NUMBER>month mortality setting high respectively around <NUMBER> <NUMBER> <NUMBER> <NUMBER> three types aclf defined according absence type presence type b cirrhosis history previous hepatic decompensation type c latter <NUMBER> prevalent western countries <NUMBER> despite agreement definition exact implications concepts acute failure remain debated among different learned societies <NUMBER> <NUMBER> <NUMBER> <NUMBER> prognostic score use use cases aclf standard liver disease prognostic scores underestimate shortterm mortality closely associated number ofs liver failure per se <NUMBER> <NUMBER> <NUMBER> well established patients often hospitalized icu icu scores simplified acute physiology score ii sequential organ failure assessment sofa acute physiology chronic health evaluation score apache evaluating patients high meld scores prioritized access lt therefore increasingly admitted icu bridging option context aclf prognosis patients accurately assessed sequential evaluation aclf grade admission <NUMBER> <NUMBER> days general management patients high meld scores based organ support treatment precipitating events prevention complications particular focus prevention infectious events case recovery liver function patients referred lt centre considering risk liverrelated complications population case nonrecovery lt curative treatment performed good outcome selected patients transplanted within transplantation window withdrawal care suggested patients candidates lt persistent multiorgan failure several days optimal medical management extrahepatic ofs better predictors mortality meld scores <NUMBER> <NUMBER> <NUMBER> <NUMBER> chronic liver failure consortium clifc european association study liver disease easl led european prospective multicentre <NUMBER> centres study involving <NUMBER> patients hospitalized acute deterioration hepatocellular function order establish diagnostic criteria aclf assess natural history syndrome canonic cohort cohort defined clifsofa <NUMBER> adapted sofa <NUMBER> clifc score <NUMBER> authors proposed arbitrarily <NUMBER> thresholds identical <NUMBER> scores define ofs according <NUMBER> organ systems included liver coagulation kidney brain respiration circulation subsequent grading ranging <NUMBER> absence aclf <NUMBER> depending number ofs tables <NUMBER> <NUMBER> classification identifies <NUMBER> populations different prognoses <NUMBER>days illustrated mortality rates <NUMBER> <NUMBER> <NUMBER> patients aclf grade <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> aclf dynamic process rapid evolution first days medical care associated clinical outcome fig <NUMBER> identification early nonsevere course resolution aclf aclf grade <NUMBER> day <NUMBER> <NUMBER> associated low moderate <NUMBER>day transplantfree mortality ranging <NUMBER> contrary early severe course aclf grade <NUMBER> <NUMBER> day <NUMBER> <NUMBER> associated high <NUMBER>day transplantfree mortality ranging <NUMBER> <NUMBER> therefore sequential evaluation first days care required order optimize prediction outcome subsequent medical management population score derived clifc named clifc aclf additionally included age logtransformed whiteblood cell count initially reported best performance predicting shortterm mortality population results confirmed recent study <NUMBER> patients aclf work clifc aclf failed show better perfomance prediction <NUMBER> days mortality compared meld auroc <NUMBER> vs <NUMBER> p<NUMBER> <NUMBER> <NUMBER> moreover daily use seems less convenient evaluation number clifc lactate levels independently associated shortterm mortality critically ill patients liver cirrhosis shown significantly improve performance clifc aclf modified called clifc aclfslact score remains evaluated external cohort <NUMBER> together numerous biomarkers recently associated outcomes population <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> combining available scores biomarkers could optimize prediction events population high shortterm mortality according north american consortium study liver disease nacseld aclf syndrome defined <NUMBER> extrahepatic ofs among following circulatory failure defined shock brain failure grade iiiiv hepatic encephalopathy renal failure requiring renal replacement therapy respiratory failure requiring mechanical ventilation <NUMBER> <NUMBER> main difference definition easlclif consortium stringent definition renal failure restricted requirements renal replacement therapy absence liverrelated variables ie bilirubin international normalized ratio <NUMBER> <NUMBER> patients fulfilled aclf definition easlclif consortium enrolment princeps european study <NUMBER> <NUMBER> <NUMBER> fulfilled nacselds definition large study published recently <NUMBER> latter including large multinational cohort infected noninfected cirrhotic patients nacseldaclf independent prognostic factor <NUMBER>day survival number ofs <NUMBER> <NUMBER> <NUMBER> <NUMBER> also associated <NUMBER>day survival respectively around <NUMBER> <NUMBER> <NUMBER> <NUMBER> substantial proportion patients high meld scores excluded nacseldaclf definition due stringent definition renal failure moreover excluding liverrelated variables could include patients without high meld scores shall therefore hereafter focus patients high meld scores hospitalized context aclf according easlclif consortium classification recommended <NUMBER> published guidelines diagnosis grading aclf based assessment organ function defined clifc score <NUMBER> according data daily practice prognosis patients high meld scores hospitalized context aclf assessed grade aclf admission sequential evaluation day <NUMBER> day <NUMBER> appears critical order characterize course aclf severe vs nonsevere optimize medical management type organ failure precipitating events association outcome prognosis type organ failure kidney failure <NUMBER> patients common failure reported canonic cohort patients submitted mechanical ventilation mv due due respiratory failure considered presenting cerebral failure patients mv considered presenting respiratory failure review followed liver failure <NUMBER> patients coagulation <NUMBER> patients brain <NUMBER> patients circulation <NUMBER> patients lungs <NUMBER> patients impact type failure shortterm outcome remains debated requirements vasopressors mechanical ventilation identified failures associated worst outcomes studies <NUMBER> <NUMBER> <NUMBER> whereas reported large recent international study <NUMBER> liver failure defined total bilirubin ≥ <NUMBER> mgdl canonic study independent predictor severe lifethreatening course aclf suggesting central role trigger perpetuating factor multiorgan failure <NUMBER> precipitating events impact outcome princeps study aclf precipitating events sepsis <NUMBER> alcohol consumption <NUMBER> gastrointestinal bleeding <NUMBER> others <NUMBER> transjugular portosystemic intrahepatic shunt insertion surgery viral hepatitis <NUMBER> multiple precipitating events reported <NUMBER> population whereas precipitating events identified around <NUMBER> patients <NUMBER> absence precipitating event associated different clinical course <NUMBER> <NUMBER> absence precipitating events thought linked either lack sensitivity diagnostic tests bacterial infections spontaneous resolution events bacterial translocation episodes <NUMBER> <NUMBER> <NUMBER> <NUMBER> type distribution precipitating events varies according regions world instance viral hepatitis represented minority identified precipitating events canonic cohort represented <NUMBER> events large chinese study <NUMBER> type precipitating events related <NUMBER>day mortality could related <NUMBER>month mortality divided hepatic extrahepatic events <NUMBER> fig <NUMBER> subset canonic database bacterial infection trigger aclf associated poorer outcome aclf triggered sepsis <NUMBER>month transplantfree mortality <NUMBER> vs <NUMBER> p <NUMBER> study infections multidrug resistant bacteria triggered aclf andor severe sepsisseptic shock diagnosis associated worse prognosis <NUMBER> therefore according recent recommendations easl potential precipitating factors either hepatic ie heavy alcohol intake viral hepatitis druginduced liver injury autoimmune hepatitis andor extrahepatic ie infections haemodynamic changes following haemorrhage surgery investigated early identification treatment particularly bacterial infections recommended <NUMBER> acuteonchronic liver failure association type events outcomes still controversial issue needs exploration aclf acuteonchronic liver failure around <NUMBER> patients initial aclf grade <NUMBER> observe resolution aclf stabilized grade <NUMBER> side small proportion nonnull <NUMBER> patients initial aclf grade <NUMBER> observe final aclf grade <NUMBER> resolution aclf aclf acuteonchronic liver failure general management population patients high meld scores specific treatment available aside antiviral therapy patients aclf due reactivation hbv infection <NUMBER> <NUMBER> <NUMBER> management mainly based organ support together prevention treatment associated complications medical care requires multidisciplinary approach includes intensivists specialists infectious diseases transplant team made hepatologists surgeons anaesthesiologists <NUMBER> severe prognosis particularly observed aclf grade <NUMBER> <NUMBER> corresponding patients high meld scores patients preferably managed icu lt centre recommended easl guidelines early referral patients aclf lt centres immediate evaluation recommended <NUMBER> <NUMBER> major improvements prognosis critically ill cirrhotic patients observed past decades <NUMBER> parallel outcomes patients aclf shown similar patients without liver disease admitted icu sepsis critical conditions <NUMBER> therefore opinion access icu population denied without strong evidence futility care assessed multidisciplinary evaluation among specific bundle care population particular effort made time initial resuscitation order control extension multiorgan failure instance hour delay appropriate antimicrobial therapy associated significantly increased hospital mortality <NUMBER> <NUMBER> moreover prophylactic strategies used prevent bacterial infection considering deleterious influence prognosis setting aclf triggered noninfectious factors <NUMBER> general management patients made accordance recent guidelines expert reviews critically ill cirrhotic patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> review focus different alternative strategies available population liver transplantation transplant absence effective alternative strategies lt remains unique curative treatment available population granted priority access indeed meld score first proposed predict <NUMBER>month mortality cirrhotic patients transjugular portosystemic intrahepatic shunt insertion <NUMBER> later score widely implemented graft allocation scores prioritize patients disclosing highest risk waiting list mortality thus leading sickest first policy <NUMBER> <NUMBER> <NUMBER> <NUMBER> survival benefit conferred recipients lts increases progressively meld score compared candidates lt waiting list lower threshold meld identifying patients benefit lt well established around <NUMBER> could vary according aetiology underlying liver disease <NUMBER> <NUMBER> nevertheless maximum benefit lt constantly observed sickest patients highest meld scores ie ≥ <NUMBER> <NUMBER> <NUMBER> <NUMBER> meld currently capped <NUMBER> waiting list mortality continues increase score penalizing transplant candidates capped score <NUMBER> despite obvious theoretical benefit procedure performing lt patients high meld scores hospitalized context aclf remains controversial indeed studies reported increased mortality morbidity lt recipients high meld scores compared populations lower meld scores <NUMBER> whereas others <NUMBER> <NUMBER> context global organ shortage lt concept utility therefore opposed one equity <NUMBER> raises several unsolved issues linked question results lt patients high meld scores identification sick transplant patients associated upper limits sickest first policy recent years notion futility lt used posttransplant mortality higher waiting list mortality <NUMBER> <NUMBER> case <NUMBER>month inhospital mortality lt <NUMBER> <NUMBER> however authors recent review preferred correct futile lt potentially inappropriate lt thus reducing value judgment inherent term futile <NUMBER> semantic change follows adoption new terms multisociety statement provided guidance clinicians prevent manage disputes regarding patients advanced critical illnesses <NUMBER> change introduces element uncertainty area ie potentially considering fact medicine always evolving upper limits always repelled <NUMBER> terms potentially inappropriate lt therefore preferred futile lt identification variables associated postlt outcomes setting patients high meld help identify clinical situations lt potentially inappropriate pretransplant variables vs posttransplant outcomes meld alone show good enough performance identifying patients high rates shortterm postlt mortality even severe patients using uncapped meld scores <NUMBER> <NUMBER> meld life support pretransplantation retransplantation <NUMBER> donorrelated variables associated <NUMBER>month postlt mortality <NUMBER> score showed similar performance predicting <NUMBER>month postlt mortality cstatistic <NUMBER> aclfscore identified <NUMBER> recipient characteristics age gender esld hepatocellular carcinoma recent infection presence aclf <NUMBER> donor characteristic gender independently associated mortality <NUMBER> months lt <NUMBER> score also showed comparable predictive performance cstatistic test <NUMBER> apart age none scores contain variables evaluating comorbidities various diseases comorbidities associated outcome <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> screening significant extrahepatic comorbid conditions cornerstone health assessment required placement waiting list ucla score developed aim identifying variables associated <NUMBER>month inhospital mortality lt patients high meld scores ≥ <NUMBER> among evaluated variables authors chose charlsoncomorbidity index cci <NUMBER> already proven recalibrated form efficient determining outcome lt population <NUMBER> another score named cardiac risk score defined presence least <NUMBER> following variables severe valvular disease coronary artery disease <NUMBER> stenosis previous revascularization history myocardial infarction history ventricular atrial arrhythmias elevated preorthotopic lt troponin <NUMBER> ngml andor new wall motion abnormalities echocardiography indeed cardiovascular disease shown associated shortterm outcome particularly first month following lt mortality cardiovascular events <NUMBER> <NUMBER> meld score pretransplant septic shock also ageadjusted cci cardiac risk score associated outcomes using multivariate analysis final score named ucla futility risk score uclafrs important weight given comorbidity including cardiac risk index cci uclafrs <NUMBER> × meld score <NUMBER> × <NUMBER> cci ≥<NUMBER> <NUMBER> cci <NUMBER> <NUMBER> × <NUMBER> cardiac risk <NUMBER> cardiac risk <NUMBER> × <NUMBER> septic shock <NUMBER> septic shock <NUMBER> recent study reporting results lt patients ofs score seemed helpful selecting candidates lt considering predicted observed postlt survival rates <NUMBER> another study aimed compare available scores <NUMBER> independent cohorts transplanted patients high meld scores swiss unos cohort prediction scores showed low positive predictive values posttransplant mortality despite good specificity among scores bar score score linearly associated complications <NUMBER> usefulness score designed critically ill patients seems restricted population based performance cohorts <NUMBER> table <NUMBER> emerging concept hepatology frailty frailty corresponds validated geriatric construct increased vulnerability physiologic stressors frailty represents conditions given patient unlikely reverse liver function returns take long reverse patient highly vulnerable postoperative complications <NUMBER> <NUMBER> many tools assessing frailty proposed evaluated esld particularly patients awaiting lt fried frailty index short physical performance battery <NUMBER> <NUMBER> minute walk test <NUMBER> activity daily living <NUMBER> <NUMBER> karnofsky performance statusbased score recently proposed prediction death hospital discharge cirrhosis <NUMBER> subgroup patients low meld scores high frailty may derive greatest benefit implementation measures <NUMBER> however functional tests evaluating frailty could enough discriminant homogeneous population high meld patients moreover may possible perform tests patients clinical condition interesting approach use alternative tests evaluate frailty better adapted icu population require functional assessment <NUMBER> <NUMBER> evaluation surrogate markers frailty sarcopenia assessed imaging represent alternative option associated meld ctscan assessed sarcopenia demonstrated useful identification patients highest risk mortality waiting lists <NUMBER> moreover sarcopenia associated postlt mortality independently meld score <NUMBER> results confirmed recently different thresholds women men <NUMBER> fatfree muscle mass assessed mri decompensated patients associated mortality also development aclf <NUMBER> however data lacking regarding impact sarcopenia posttransplant outcome patients high meld scores context aclf sarcopenia evolving process evaluation readily performed view assessment sarcopenia ultrasonography seems easy reliable option yet evaluated cirrhotic patients <NUMBER> present time identification potentially inappropriate lt candidates based solely available scores considering statistical performance however combination scores well evaluation frailty could improve clinical management patients high meld scores candidates lt outcome aclf transplanted patients data outcomes patients aclf treated liver lt less scarce postlt <NUMBER>month survival recipients <NUMBER> much higher anticipated patients transplanted <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> indeed canonic study patients transplanted aclf grade <NUMBER> <NUMBER> day <NUMBER> day <NUMBER> n <NUMBER> better <NUMBER>month survival nontransplanted patients <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> similarly reported experience <NUMBER> patients transplanted aclf grade <NUMBER> time lt better <NUMBER>year survival matched controls <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> large cohort study unos performed <NUMBER> patients transplanted <NUMBER> ofs good <NUMBER>year survival ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> ofs reported moreover recipients longterm survival <NUMBER>year acceptable ranging <NUMBER> <NUMBER> similar results liver graft survival <NUMBER> regarding impact type ofs postlt outcomes lower postlt survival among intubated patients patients circulatory failure types <NUMBER>year patient survival <NUMBER> vs <NUMBER> <NUMBER> levesque et al recently reported worse outcome following lt patients aclf grade <NUMBER> compared cohort <NUMBER> survival <NUMBER> year <NUMBER> main difference patient characteristics study collaborative work incidence respiratory failure <NUMBER> groups patients alcf grade <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> together data suggest severe uncontrolled respiratory failure may viewed contraindication lt line recent report identified severe acute respiratory distress syndrome independent factor associated posttransplant mortality <NUMBER> improvement stabilization ofs immediate pretransplant period associated favourable postlt outcomes patients aclf suggesting evolution ofs least controlled improved considering lt <NUMBER> <NUMBER> another important point consider timeframe lt studies reporting favourable postlt outcomes severely ill patients early lt performed time placement waiting list lt ranging <NUMBER> days <NUMBER> <NUMBER> <NUMBER> short timeframe required natural history patients indeed around <NUMBER> die first <NUMBER> days <NUMBER> significant proportion patients placed waiting list acute deterioration condition example study <NUMBER> patients transplanted aclf grade <NUMBER> placed waiting lists immediate prelt hospitalization median time lt <NUMBER> days <NUMBER> therefore pretransplant evaluation must performed timely fashion precluding number clinical tests usually required lt programmes knowledge potential impact postlt outcomes truncated evaluation yet studied extensively patients high meld scores <NUMBER> truncated evaluation involving performance necessary screening tests could lead potential contraindications lt active neoplasia severe alcohol dependence still significant coronary artery disease overlooked addition potential impact outcomes raises degree unfairness regard less severe patients undergoing recommended exhaustive evaluation routinely responsible listing patients discovery contraindication <NUMBER> urgent need evaluate various international lt centre practices setting prospective study validating standardized assessment patients high meld scores yet listed put forward order optimize selection candidates decrease inequity lt seems confer favourable survival outcomes sick patients associated longer total stay icu hospital also leads high rate complications observed population therefore require attentive screening complications particularly infectious nature <NUMBER> <NUMBER> <NUMBER> <NUMBER> current knowledge suggests transplant outcomes selected patients aclf could favourable even patients multiorgan failure time lt however order optimize postlt outcomes lt performed timely manner admission within window improvement least stabilization ofs transplant concept transplantation window order identify transplantation window <NUMBER> classes contraindications separated first definitive contraindications responsible immediate irreversible arrest lt process local level contraindications widely accepted might illustrated metastatic solid neoplasia severe cardiac pulmonary insufficiency related liver disease even prehospitalization bedridden states however definitive contraindications definitive specific time specific transplant centre appreciation varies lt centres depending local expertise potential change time within centre <NUMBER> second dynamic contraindications responsible short temporary inability perform liver transplantation dynamic contraindications represented numbers diseases failures could evolve positively appropriate therapeutic management uncontrolled bacterial infection active fungal infection active gastrointestinal bleeding severe acute respiratory distress syndrome severe haemodynamic instability severe coagulopathy dynamic contraindications often represented precipitating events aclf syndrome <NUMBER> <NUMBER> occurrence resolution control dynamic contraindications context stabilization improvement ofs define transplantation window <NUMBER> fig <NUMBER> discussed earlier optimal transplantation window identified soon possible admission patients high meld scores considering poor expected outcome risk developing adverse events dynamic contraindications short timeframe <NUMBER> <NUMBER> due lack data field exact timeframes within lt contraindicated dynamic contraindications often transplant centre local expertise dependant concept transplantation window lt patient without definitive contraindication based absence dynamic contraindications allow lts performed context stabilization improvement ofs transplantation window rapidly identified following admission order optimize postlt outcomes patients transplanted recovery liver function studies reporting outcomes cirrhotic patients icu discharge scarce however recovery critical illness cirrhotic patients higher risk <NUMBER>year mortality <NUMBER> <NUMBER> compared general population <NUMBER> <NUMBER> <NUMBER> <NUMBER> predictors associated <NUMBER>year mortality icu discharge clearly reported could related number type ofs patients experienced icu well severity liver disease admission discharge icu <NUMBER> currently reliable tools identify populations low risk mortality initial effective icu care discharge icu therefore patients referred liver transplant centres hospitalization closely thereafter order evaluated lt fig <NUMBER> illustration transplantation window dynamic contraindication relationship axis illustrates liver function x axis time scenario onset precipitating event bacterial pneumonia example leads rapid deterioration liver function aclf patient chronic liver disease dynamic contraindications red boxes illustrate timeframe lt performed due uncontrolled clinical condition eg severe acute respiratory syndrome hemodynamic instability resolution least controldepending local expertise dynamic contraindications separated transplantation windows green boxes lt indicated often short elapsed time patient already listed health assessment performed order exclude definitive contraindication lt eg metastatic neoplasia severe cardiac insufficiency opportunity transplant taken firsts transplantation windows events eg bacterial infection ventilation associated pneumonia gi bleeding occur lead patient death aclf acuteonchronic liver failure lt liver transplantation gi gastrointestinal even cases recovery liver function patients high meld scores admitted context aclf referred lt centres soon possible considering risk events <NUMBER>year population place extracorporeal liver support bridging therapy lt modalities serve bridge lt confer sufficient clinical improvement enable patients discharged icuhospital positively impact outcomes patients high meld scores modalities aim replace functions failing liver allowing hepatic recovery stabilizing clinical state enable transplantation <NUMBER> <NUMBER> key concepts therapies remove harmful toxins support liver spontaneous regeneration reduce ongoing inflammatory injury <NUMBER> based albumin dialysis molecular adsorbent recirculating system mars® plasma separation absorption system prometheus® studied devices mars therapy reported improve bilirubin levels hepatic encephalopathy haemodynamic parameters kidney function patients decompensated cirrhosis <NUMBER> <NUMBER> without improving survival relief trial including patients aclf improvement transplantfree survival <NUMBER> <NUMBER> days observed <NUMBER> helios study despite welltolerated treatment prometheus therapy reported improve shortterm survival patients aclf <NUMBER> note results interpreted caution due heterogeneous population patients decompensated cirrhosis associated different degrees ofs different definitions aclf <NUMBER> results large prospective multicentre study evaluating bioartificial device extracorporeal cellular therapy patients severe alcoholic hepatitis showed conferred overall survival benefit compared standard care however among limitations patients stratified according response medical treatment definitive conclusions efficacy device cannot date drawn <NUMBER> second study younger patients lower meld scores therefore ongoing nct<NUMBER> currently <NUMBER> trials involving extracorporeal liver support recruiting setting alcf first evaluating efficacy highvolume plasma exchange gcsf vs gcsf alone patients aclf clinicaltrialsgov identifier nct<NUMBER> second multicentre randomized controlled study evaluating safety performance new liver support device called dialive <NUMBER> patients aclf vs standard care nct<NUMBER> based results available rcts easl guidelines state extracorporeal liver support systems improve survival patients aclf therefore recommended indication <NUMBER> medical treatment among medical treatments offered setting gcsf seems promising treatment accumulating evidence potential efficacy albeit small number patients treated date gcsf promotes mobilization hematopoietic stem cells induces proliferation hepatic progenitor cells animal models liver failure also human alcoholic hepatitis <NUMBER> <NUMBER> smallrandomized clinical trials demonstrated improvement liver function gcsf also significant survival benefit compared standard medical therapy aclf <NUMBER> <NUMBER> <NUMBER> <NUMBER> nonetheless time insufficient evidence therapies recommended patients high meld scores decision essentially performed according local expertise beliefs specific point easl guidelines state despite promising results administration gcsf cannot recommended present <NUMBER> management offer patients receive transplant given either poor predicted survival failure receive transplant within target window survival probability patients high meld scores efficiently calculated available scores aclf aclf grade clifc aclf <NUMBER> absence alternative treatments lt due severe course observed population without lt withdrawal care could reasonable option patients presenting definitive contraindication canonic cohort sequential calculation scores reported identify group patients severe outcome <NUMBER> transplantfree mortality <NUMBER> patients identified ≥ <NUMBER> ofs andor clifc aclf ≥ <NUMBER> day <NUMBER> day <NUMBER> based results algorithmic approach proposed withdrawal care patients <NUMBER> retrospective analysis performed kings college cohort <NUMBER> using thresholds reported <NUMBER> patients survived <NUMBER> days <NUMBER> highlights prediction scores perform differently different cohorts medical management related algorithmbased scores cannot adopted widely without caution important recognize decision regarding withdrawal irrevocable small survival probabilities perceived differently caregivers patients families balancing aspects maintaining patient life dignity wishes fraught statistical ethical difficulties single score unlikely final referee <NUMBER> regarding decision withdraw care data literature well data local experience considered alongside potential improvement ofs qualitative factors frailty patients wishes <NUMBER> <NUMBER> <NUMBER> <NUMBER> finally opinion scores useful identifying situations could reasonable initiate discussion around withdrawal care easl guidelines state withdrawal ongoing intensive care support suggested patients candidates lt <NUMBER> ofs <NUMBER> week adequate intensive treatment <NUMBER> accurate identification variables associated mortality patients cirrhosis permanent scarcity liver grafts led lt recommended increasing number severely ill patients consequence physicians lt centres routinely face medical surgical ethical challenges nonetheless data accumulating pretransplant management patients refined disease assessments based variables clinical course determination risk factors poor outcome lt may made help define sick transplant upperlimit however awaiting devices treatment delay avoid lt urgent need based robust data offer consensual definition definitive contraindications transplantation window equivalent form conformity fact dihedral angles regular ideal simplex π<NUMBER> <NUMBER> · π<NUMBER> <NUMBER>π guarantee balllike neighbourhood point simplex edges however relation <NUMBER> <NUMBER> careful computations leads equation general ideal simplex necessarily regular one turn ideal vertex class forming cusp fig <NUMBER> represented gluing corresponding images <NUMBER> vertex domains ∞ side face pairing ofs induces pairing sides <NUMBER>dimensional polygon denoted bys fig <NUMBER> say horosphere centred ∞ represented halfspace model euclidean plane parallel absolute also described absolute c ∞ topologically polygons kleinbottle fundamental group pg group stabilizer g ∞ ∞ determined starting group gz <NUMBER> z <NUMBER> formulae <NUMBER> fig <NUMBER> exactly k <NUMBER> k <NUMBER> respectively shows figure <NUMBER> gieseking regular ideal simplex tiling touching plane ∞ c ∞ general situation g ∞ generated pairing conjugated z <NUMBER> see p translation z <NUMBER>conjugated z <NUMBER> z −<NUMBER> <NUMBER> group g ∞ <NUMBER> pg euclidean plane represented fig <NUMBER> shows exact situation obtained gieseking manifold one cusp z complex parameter makes stabilizer g ∞ conformal group fixed points line v∞ covered g ∞ images simplexs h <NUMBER> model halfspace translations g ∞ <NUMBER> <NUMBER> similarities c ∞ fixed points v ∞ eg z <NUMBER> <NUMBER> z <NUMBER> <NUMBER>  turn critical socalled surgery transform z <NUMBER> z <NUMBER> tricky use <NUMBER> fixing ∞ v course see <NUMBER> z <NUMBER> z <NUMBER> describes rotation model halfspace line ∞v angle ie φ <NUMBER> · α <NUMBER> <NUMBER> · α <NUMBER> mod <NUMBER>π require stabilizer g ∞ act discontinuously model halfspace angle necessarily ±<NUMBER>πk mod <NUMBER>π ie assumed k periodicity rotation z <NUMBER> z <NUMBER> get <NUMBER> root series fundamental simplices called gies<NUMBER>gies<NUMBER> first one chosen data computed <NUMBER> especially face angles ofs equal opposite edges fig <NUMBER>a <NUMBER> b <NUMBER> however computer gives guarantees table <NUMBER> <NUMBER> computed maple volume ofs well values k know <NUMBER> <NUMBER> lobachevski function provides volume ideal simplex angles formal monodromy group gz <NUMBER> z <NUMBER> k unified presentation k <NUMBER> <NUMBER> sketchily indicate fig <NUMBER> b <NUMBER> construct domain compact one introduce edge e line ∞v choose point z <NUMBER> simplexs ∞<NUMBER>z consider segments corresponding curved bent surfaces q −<NUMBER> z −<NUMBER> constructed transversally edges ofs see fig <NUMBER> <NUMBER> <NUMBER> <NUMBER> also <NUMBER> finally fig <NUMBER> get compact fundamental domainf piecewise linear bent faces equipped pairing iz <NUMBER> z <NUMBER> p q defining relations corresponding edge classes <NUMBER> fig <NUMBER> pictured economic presentation combinatorial fundamental domain course <NUMBER> equivalent <NUMBER> <NUMBER> remark <NUMBER> observe compactification procedure works also k <NUMBER> fig <NUMBER> indicates cusp ideal simplexs kleinbottle glued solid kleinbottle k splitting effect occurs cusp ofs cut along kleinbottle surface get boundary glue boundary boundary k considered <NUMBER> ×rmanifold boundary follows k <NUMBER> ×r g g p r → p r <NUMBER> <NUMBER> p r ∈ <NUMBER> ×r <NUMBER> generator g product reflection say equator <NUMBER> combined <NUMBER>translation r boundary kleinbottle obtained cutting one halfsphere say longitudes <NUMBER> π <NUMBER> complete rfibers requirements <NUMBER> provide second root series cone manifold series gies<NUMBER> k <NUMBER> fig <NUMBER> table <NUMBER> <NUMBER> show surprisingly little bit geometrically equivalent gies<NUMBER> halfturn symmetry ideal simplex <NUMBER> ↔ ∞ <NUMBER> ↔ z requirements <NUMBER> provide third root series orbifold series gies<NUMBER> fig <NUMBER> show case k <NUMBER> <NUMBER> table <NUMBER> <NUMBER> gives computer results fourth root series orbifold series gies<NUMBER> last series tend gieseking regular ideal simplex manifold j r weeks predicted us discussions give illustration gies<NUMBER> series equivalent previous one halfturn symmetry see table <NUMBER> <NUMBER> orbifold volumes important half large enough h marshall g j martin <NUMBER> determined exact lower bound ≈ <NUMBER> next ≈ <NUMBER> orientable orbifolds dimension three compare half coxeter orthoscheme <NUMBER> <NUMBER> <NUMBER> ≈ <NUMBER> <NUMBER> <NUMBER> <NUMBER> ≈ <NUMBER> twotimes less optimal one orthoscheme also reflection authors noticed well higher dimensions problem open general summarize results theorem <NUMBER> surgery procedure gieseking manifold leads essentially two different series rotation parameter k <NUMBER> get orbifold k <NUMBER> surgery yields compact nonorientable hyperbolic cone manifolds first case gies<NUMBER> underlying gieseking manifold closed geodesic line exists cone angle <NUMBER>πk − <NUMBER>k realized deformed ideal simplex sk <NUMBER> complex parameter zk <NUMBER> uniquely determines metric data figures tables volume sk tends <NUMBER> k → ∞ theorem <NUMBER> second series cases gies<NUMBER> leads orbifolds also k ≥ <NUMBER> tending original gieseking manifold k goes infinity orientable double cover gieseking manifold known thurston manifold complement figureeightknot manifold surgery volume <NUMBER> known second minimal one construction leads cone manifold surgeries whose volumes tend zero first series tend original manifold second series minimal volume orientable manifold fomenkomatveevweeks volume <NUMBER> also obtained surgery occasionally possible orbifold surgery examined yet found <NUMBER> third nonorientable doubleidealregularsimplexmanifold computer similar surgery phenomena published actuality plan discuss general surgery situations refreshing <NUMBER> well british military hospitals never done nightingale days find <NUMBER> nurses accompany scutari previous experience studying nursing organizational skills germany france england mostly catholic facilities prepared discern type women required journey war zone also work ahead point nurses thought women questionable character best exposure women harsh brutalities war plague death victorian england viewed general public undignified nightingale aimed change negative stigma advertisement nurses went letters interest began pouring makeshift headquarters london nightingale hired <NUMBER> women anglican nursing sisters catholic nuns <NUMBER> nightingale essential include catholic nuns onethird british forces irish catholic end gathered best prepared nurses could find make journey care wounded british soldiers <NUMBER> upon arrival nurses faced many barriers outright resistance career military medical officer dr john hall made mind wouldnt help <NUMBER> dr hall known oppose patient care changes even beneficial confident nurses going ignorant questionable character lessthanwarm reception didnt deter women organizing cleaning preparing hospital wounded <NUMBER> october <NUMBER> <NUMBER> british allies fought russians battle balaclava <NUMBER> days later another battle ensued <NUMBER> vast number wounded soldiers coming scutari battles quickly changed way medical staff viewed nightingale nurses nurses minimal supplies instituted new practices procedures based observations data collected related nightingales teaching <NUMBER> observed conditions soldiers survived attempted replicate spread best practices throughout hospital example nurses found soldiers clean bandages proper hydration exposure clean air better outcomes didnt began sewing proper bandages using bandages washing reusing stitched sacks together stuffed straw make mattresses men lying floor cooked hot kettles broth soldiers relentlessly mopped swept opening windows boarded let fresh air <NUMBER> following war nightingales data collection reports submitted royal commission statistical findings indicated deaths due overcrowding poor sanitation improper ventilation <NUMBER> accomplishments nightingale nurses scutari transformational strongly impacting value evidenceinformed nursing practices redefining image modern nursing well <NUMBER>th century data demonstrated merits quality nursing care survival rates increased <NUMBER> nearly <NUMBER> care nightingale nurses <NUMBER> attention rigorous infection prevention hygiene cleanliness nutrition hydration compassionate care integral interventions revolutionized nursing care practices improved clinical outcomes fastforward <NUMBER> years todays nurses continue face myriad healthcare challenges systems issues perhaps less nurses unique position thread knowledge wisdom human caring creating sustainable solutions severe ways contemporary practice settings work environments remain fraught problems although infectious diseases may appear less prevalent late <NUMBER>th century burgeoning list complex chronic conditions demand evidenceinformed knowledge innovative interventions new skills meet postmodern imperatives efficiency quality affordability care experience gratitude florence nightingale path charted modern nurses become trusted valued members healthcare team employ data evidence daily plan care however systems healthcare delivery characterized chaos complexity despite long list health system inefficiencies make delivering care challenging stressful nurses must maintain balance ensure safe efficient highquality patient care stevens colleagues described nurses encounters operational failures ofs healthcare system hinder timeliness care erode quality patient safety <NUMBER> multisite study collected data <NUMBER> nurses working <NUMBER> hospitals ofs found several categories including equipmentsupplies information communication medication staffingtraining physical unit layout average nurses reported rate <NUMBER> sd <NUMBER> ofs per shift related equipment supplies findings illustrated nurses commonly encounter ofs delivering patient care frontline nurses intimate knowledge ofs inform operational improvements lead better quality care also help reduce wasted nursing time century half passed since nightingale identified need nurses observe assess understand collect data plan nursing care time spent ofs wastes nurses precious time creates moral distress detracts core care responsibilities although nurses effective identifying ofs theyre often illequipped complete indepth systemlevel problem solving instead due nature work environment nurses forced create workarounds unfortunately clinical nurses little time learn employ secondorder problemsolving techniques investigate seek change problems underlying cause tucker colleagues qualitative study examined daily problemsolving skills nurses <NUMBER> researchers collected data related actual situations responses develop theoretical concepts phenomenon problemsolving behavior using observations <NUMBER> nurses three shifts outcome demonstrated nurses whatever takes moment take care patients use trial error find solution involve others closest work friends problem solving rather reporting resource could solve problem finding solutions current perplexing problems healthcare requires nurses develop maintain refine criticalthinking skills <NUMBER> lead nurses deep clinical knowledge experience toward developing solutions systems problems within organizations beyond walls broader healthcare landscape nurse leaders consider implementing proven solutionseeking frameworks problemsolving techniques lean methodology offering opportunities nursing fellowship programs exercise nurses criticalthinking skills numerous examples nurses achieving significant improvements quality safety patient outcomes guidance frameworks improvement lessons florence nightingale relevant today <NUMBER> years ago nurse leaders must embrace importance nurturing highly motivated nurses critical thinkers contemporary form healthcare performance improvement problem solving use lean management techniques lean concepts seek create continuous improvement culture organizations developing management system focuses improving quality safety cost healthcare delivery processes <NUMBER> organization commits developing lean transformation essential assess state nurses improvement thinking attitudes example roszell lynn sought measure success lean management implementation organization nurses perspective developing frontline improvement thinking fit tool <NUMBER> nurses asked provide perceptions leans impact organization unit individual data fit tool used prioritize focus lean management training improvement efforts identify lean mentors coaches change agents nurses elevate level coach afforded opportunities indepth exposure lean management performance improvement techniques extensive training programs equipped tools techniques improvement nurses valuable resource identify solve clinical organizational problems improve patient outcomes sharpe described grantfunded project <NUMBER> hospitals spanning <NUMBER> years empowered frontline nurses leaders implementing evidencebased practices improve quality safety <NUMBER> nurses involved received extensive training improvement concepts like nightingale scutari nurses frontline nurses taught make improvements measure outcomes quality improvements measured included falls injury sepsis mortality central lineassociated bloodstream infections clabsi hospitalacquired pressure injuries ventilatoracquired pneumonia vap medication administration errors acute myocardial infarction mortality fortythree percent hospitals reduced falls injury <NUMBER> improved sepsis mortality <NUMBER> improved clabsi rates <NUMBER> improved vap rates <NUMBER> reduced medication administration errors <NUMBER> reduced acute myocardial infarction mortality <NUMBER> results achieved nurseled quality improvement projects powerful impactful bramley colleagues described chief nurse excellence care junior fellowship initiative provided small cohort nurses opportunity advance skills leadership innovation improvement science change management <NUMBER> early evaluations qualitative study suggested providing program frontline nurses enhances professional development influences positive patient outcomes case studies projects completed nurse fellows conducted based case findings fellowship selfevaluation study concluded fellowship program sustainable clinically driven opportunity enhance nurses professional development patrician colleagues highlighted program put place us veterans affairs va health administration called veterans affairs quality scholars fellowship program <NUMBER> program partnership va robert wood johnson foundations quality safety education nurses project aim expanding fellowship include nurses <NUMBER> including nurses program promoted interprofessional education team development improve healthcare quality safety across va system early indication effectiveness first three nurse fellowship graduates published successful performance improvement work fellowship approaches described examples provided nurses enriched opportunities make difference care quality populations serve reflecting back thats exactly florence nightingale scutari nurses empowered observe assess gather data conduct analysis intervene solve problems got way patient care interventions world health organization designated <NUMBER> international year nurse midwife celebrating <NUMBER> years since florence nightingales birth nurse leaders celebratory year opportunity reflect past looking future nursing profession aligning nurses professional purpose delivering promise caregivers requires special attention strengthen nurses opportunities engage solving difficult challenges critically examining innovative solutions todays healthcare problems nurses unique position thread knowledge wisdom human caring creating sustainable solutions nurse leaders essential continually develop nurses future change agents development extensive true commitment investment advancing nurses knowledge skills improvement science fellowship model allows deeper understanding performance improvement tools paramount qualities courage tenacity skills nightingale searched years ago still foundational addressing myriad problems nurses face today yet emerge formidable army highly competent nurses skilled quality improvement inspired serve change agents frontline transform systems nightingale realized century half ago nm oral fluid sampling testing offers convenient unobtrusive mechanism evaluating health status swine especially grower finisher swine assessment evaluates potential testing oral fluid samples realtime reversetranscriptase polymerase chain reaction rrtpcr detect african swine fever classical swine fever footandmouth disease surveillance disease outbreak early detection diseasefree setting used series logical arguments informed assumptions range parameter values literature industry practices examine cost value information provided oral fluid sampling rrtpcr testing swine foreign animal disease surveillance objectives outlined based evaluation oral fluid testing demonstrated value settings evaluated greatest value outbreak scenario using oral fluids would minimize disruption animal farm activities reduce sample sizes <NUMBER> decrease resource requirements relative current individual animal sampling plans early detection system sampling every <NUMBER> days met designed prevalence detection threshold <NUMBER> probability quite costly implementation oral fluid testing african swine fever classical swine fever footandmouth disease surveillance yet possible due several limitations information plos oral fluid samples aggregate sample composed saliva mucosal transudate may contain pathogens antibodies pathogens circulating herd collecting samples offers convenient unobtrusive mechanism evaluating health status swine especially nearing slaughter movement slaughternamely growing grower market hog finisher herds collection takes advantage natural swine behavior samples collected hanging cotton ropes one pens barn pigs chew <NUMBER> minutes causing minimal disruption animal activities farm operations <NUMBER> <NUMBER> <NUMBER> <NUMBER> ease sample collection ability obtain disease status information entire group single sample combined widespread industry usage endemic diseases positions sampling strong methodology onfarm surveillance swine pathogens producers currently collect submit samples monitor disease status barns premises minimal training without added cost constraints biosecurity concerns associated veterinary animal health technician farm visits diagnostic testing currently performed on<NUMBER> samples per year three highvolume laboratories representing <NUMBER> premises domestic pathogens including swine enteric coronavirus diseases secd porcine reproductive respiratory syndrome prrs influenza virus swine iavs others <NUMBER> <NUMBER> testing methodologies applied samples collected swine including realtime reversetranscription polymerase chain reaction rrtpcr solidphase competitive enzymelinked immunosorbent assay elisa virus isolation sequencing doubleantibody sandwich elisa <NUMBER> much research focused use rrtpcr singleplex multiplex singleplex method considered calculations evaluation diagnostic tests sample types developed diseases including foreign animal diseases considered evaluation african swine fever asf classical swine fever csf footandmouth disease fmd sensitivity rrtpcr testing protocol applied samples dependent matrix target virus found host factors affecting concentration composition target virus nonhost factors sample quality includes sample deterioration due poor handling excessive environmental contamination <NUMBER> matrix target virus may contain inhibitors could prevent assay working abundance concentration target virus sample host factor depends organism concentration individual animals oral fluid transudate number animals chewing rope collection time shedding virus saliva timeliness rope sampling relative virus shedding window field setting diseased animals may represent portion population particular pen animals <NUMBER> <NUMBER> available information study pigs experimentally infected asf csf fmd show infected animals observed chewing ropes severe clinical signs developed concurrent virus detectable samples <NUMBER> regarding timeliness rope sampling relative shedding virus important note three diseases considered evaluation incubation infectious periods vary depending strain virus virulence <NUMBER> laboratory studies asf fmd detectable samples presentation clinical signs often concurrent pyrexia <NUMBER> <NUMBER> <NUMBER> <NUMBER> detectable levels csf virus appear samples time presentation clinical signs <NUMBER> <NUMBER> <NUMBER> mostly described csf persistently infected animals may result vertical transmission inutero infection shortly birth cases distinct clinical signs may present animals continue shed virus without detectable antibody response <NUMBER> <NUMBER> strains asf csf may present mild clinical signs indistinguishable endemic diseases complicating detection clinical signs alone <NUMBER> <NUMBER> since use rrtpcr diagnostics validated officially samples united states detection asf csf fmd paper use series logical arguments informed assumptions range test accuracy parameter values explore four select hypothetical applications sampling rrtpcr testing hypothetical applications used inform sampling modality might applied surveillance outbreak early detection diseasefree setting screening test applications require additional refining fully considering implementation regulatory framework range scenarios direct comparisons current surveillance systems outside scope current study explored projects examined hypothetical application cost costeffectiveness information provided sampling tested rrtpcr asf csf fmd surveillance swine four scenarios scenarios <NUMBER> <NUMBER> encompass surveillance disease outbreak situations scenarios <NUMBER> <NUMBER> encompass surveillance activities absence outbreak first three scenarios <NUMBER> <NUMBER> <NUMBER> designed using example surveillance characteristics scenario <NUMBER> evaluated based current surveillance efforts endemic disease ie prrs scenarios evaluated help understand sample test type could integrate surveillance planning characteristics used inform scenarios outlined assumptions characteristics section based current usda fad preparedness response plan documents fmd csf <NUMBER> <NUMBER> scenarios <NUMBER> <NUMBER> outbreak surveillance assuming prevalence detection thresholds <NUMBER> infected pensbarn <NUMBER> infected barnspremises <NUMBER> premises per zone prevalence evaluated two potential surveillance schemes response asf csf fmd outbreak cases sampling method could applied zones designated around infected premises would vary based location infected premises overlap multiple zones surveillance two zones evaluated separately scenario <NUMBER>outbreak surveillance support classification premises status control area minimum <NUMBER>km area located directly around infected premises scenario <NUMBER> outbreak surveillance within surveillance zone minimum <NUMBER>km area forms ring around control area show evidence infection differences specific surveillance objectives required zones objective evidence premises infected vs monitoring disease spread outside control area animal movement testing evaluated due information limitations complexity different movement scenarios high number movement scenarios scenarios <NUMBER> <NUMBER> early disease detection prior clinical signs diseasefree setting two additional scenarios assessed early disease detection estimate sample size needed meet <NUMBER> probability detection assuming prevalence detection thresholds <NUMBER> pen <NUMBER> barn <NUMBER> premises levels calculated probability detecting disease prior clinical signs using two different testing frequencies representative number samples us swine population scenario <NUMBER> evaluated sampling frequency every <NUMBER> days detection least one infected barn per premises scenario <NUMBER> evaluated sampling weekly basis aligning current industry practices used monitor endemic diseases <NUMBER> <NUMBER> throughout document sample defined collected one rope single pen <NUMBER> animals sampling event compilation samples collected specified unit pen barn geographic region state country predetermined period time early detection defined ability detect disease testing prior detection clinical signs validation refers oie definition chapter <NUMBER> manual diagnostic tests vaccines terrestrial animals validation process determines fitness assay properly developed optimised standardised intended purpose outlined validation pathways <NUMBER> unless otherwise stated remainder assessment testing samples refers three foreign animal diseases listed value information provided sampling measured effectiveness defined document reaching ideal surveillance target <NUMBER> probability detecting disease given specified prevalence detection threshold specified time period premises level surveillance target described probability detection must met scenario considered costeffectiveness evaluation scenarios <NUMBER> <NUMBER> evaluated costeffectiveness determine best applications sampling testing field settings compared currently outlined individual animal testing plans costeffectiveness analysis readily transferrable additional pathogens revised parameter estimates conducted cost analysis four scenarios estimate total cost application sampling testing examined sample size required meet differing surveillance objectives scenarios <NUMBER> <NUMBER> <NUMBER> scenario <NUMBER> calculated detectable prevalence based industrys routine sampling efforts detection endemic diseases prrs secd surveillance sampling requirements influenced several features test performance including diagnostic test sensitivity presuming perfect sample known herd status optimum timing sample collection relative disease detection window optimized test processing external factors pig behavior environmental impacts sample quality sampling protocol initial followup testing determine confirmedpositive results requirements effective testing regime also impacted temporal accuracy temporal accuracy depends <NUMBER> length time pathogen shed ofs detectable levels sample <NUMBER> whether sampling placement frequency timeliness successfully target highrisk populations periods finally sampling requirements function number premises number animals premises population surveillance population interest evaluation depends scenario addition information gaps related test diagnostic sensitivity field factors optimal sampling testing frequency samples asf csf fmd fully determined test validation needed particularly positive cohort study determine test diagnostic sensitivity data extrapolated laboratory studies asf csf fmd along field applications testing endemic diseases validated test performance field settings would help accurately calculate sample size falsepositive rate costs testing frequency dependent incubation period given asf csf fmd strain window detection virus samples additional data become available regarding diagnostic test parameters disease distribution movement patterns similar information sampling design may need refined aid comparison across scenarios made several assumptions prior evaluation determine effectiveness different scenarios disease detection window based literature summarized table <NUMBER> asf may detected samples <NUMBER> days prior clinical signs csf may detected concurrent clinical signs fmd may detected samples <NUMBER> days prior clinical signs note specimen types listed exhaustive list includes samples would currently used asf csf fmd investigation compared ie oral fluids currently evidence persistently infected animals would relate asf csf detection samples presumably asf csf persistently infected animals would detected sampling due viral shedding without clinical signs assumption used evaluation scenarios evaluated <NUMBER> days assumed number days testing could detect disease prior clinical signs value falls within range asf fmd assumption also used estimate frequently samples would need collected detect disease prior presentation clinical signs diagnostic test sensitivity specificity diagnostic sensitivity specificity ranges rrtpcr shown table <NUMBER> <NUMBER> <NUMBER> <NUMBER> simplify calculations followup testing protocol assumed occur initial nonnegative results rule laboratory test inconsistencies wherein nonnegative result detected national animal health laboratory network laboratory would sent usda reference laboratory followup testing <NUMBER> usda reference laboratory assumed run type rrtpcr test referred sample diagnostic specificity initiation full fad investigation run confirmatory testing would occur followup test also give nonnegative result oral fluid diagnostic test sensitivity used determine sample size conservatively assumed range <NUMBER> <NUMBER> based previously published values table <NUMBER> input usda national veterinary services laboratories nvsl near optimal conditions sample collection submission based range values literature input usda nvsl experts diagnostic test specificity used scenarios estimated low <NUMBER> high <NUMBER> premisesanimal characteristics analyzing data national animal health monitoring system national agricultural statistics service consulting industry experts selected two example counties iowa model large mock swine populations used assessment one example highest total swine population eg sioux county <NUMBER> swine one highest density swine per premises eg wright county average <NUMBER> swineoperation <NUMBER> number hogs example counties divided typical barn size <NUMBER> <NUMBER> animals <NUMBER> pens barn <NUMBER> swine per pen arrive estimates <NUMBER> <NUMBER> average number barns per premises pigs per pen number premises control area surveillance zone calculated based characteristics evaluation using informed assumptions population information estimated <NUMBER> <NUMBER> premises would fall within hypothetical control area <NUMBER> premises would fall within boundaries hypothetical surveillance zone based <NUMBER> prevalence detection threshold <NUMBER> animals per barn individual animal sampling would require least <NUMBER> animals sampled per premises <NUMBER> <NUMBER> number ropes per pen held constant one rope per pen <NUMBER> assessment pen size assumed <NUMBER> swine per pen <NUMBER> pens per barn <NUMBER> swine per barn <NUMBER> premises per control area <NUMBER> premises per surveillance zone characteristics summarized table <NUMBER> timing frequency characteristics sampling frequencies scenarios <NUMBER> <NUMBER> taken directly current usda fad preparedness response plan documents csf fmd modeled documents case asf <NUMBER> <NUMBER> documents testing acute highly pathogenic strains control area occur premises every <NUMBER> th day duration area quarantine minimum <NUMBER> days surveillance zone subset premises randomly selected entire population premises within zone sampling achieve <NUMBER> prevalence detection threshold zone level samples selected premises occur first <NUMBER>week period area quarantine additional <NUMBER>week period area quarantine minimum two sample collections per surveillance zone <NUMBER> usda documents outline specific frequency use aggregate samples testing based previous modeling work performed delgado et al <NUMBER> evaluate laboratory response capacity one model suggested largescale fmd outbreak could last <NUMBER> days value used calculate number sampling events required asf csf fmd outbreak scenario one control area surveillance zone sampling frequency nationallevel early detection system estimated every <NUMBER> days ideal frequency detect disease prior clinical signs assessment applied susceptible exposed infected recovered seir modeling <NUMBER> <NUMBER> <NUMBER> characteristics high virulence fmd strain <NUMBER> <NUMBER> models indicated testing samples every <NUMBER> days plus monitoring clinical signs detected disease prior detection clinical signs alone <NUMBER> time weekly testing samples plus monitoring clinical signs found disease prior detection clinical signs alone <NUMBER> time modeling characteristics moderately virulent paderborn strain csf <NUMBER> indicated weekly testing samples csf plus monitoring clinical signs would provide detection advantage compared relying clinical signs alone disease detection likely moderate virulence asf fmd would follow similar pattern since sampling every <NUMBER> days ideal highly intensive sampling frequency scenario <NUMBER> included evaluate level detection could achieved sampling frequency reflected monitoring practices industry currently uses endemic disease typically industry production systems submit weekly samples monitoring <NUMBER> sample size characteristics calculated sample sizes microsoft excel using cannon formula account imperfect diagnostic test sensitivity <NUMBER> scenario <NUMBER> sample size calculated based weekly sampling premisesbarn size characteristics specified determine probability disease detection prior recognition clinical signs evaluated sampling unit barn sampling could potentially reduced alternative designs eg addressing spatial autocorrelation however focused conventional approaches study probability detection prevalence levels probability detection given disease present set <NUMBER> scenarios <NUMBER> <NUMBER> <NUMBER> goal establishing disease detection system equates <NUMBER> certainty surveillance system would found disease present presence defined detection threshold design prevalence wide range penlevel premiseslevel populationlevel prevalence could used design surveillance system project used examples <NUMBER> infected pens per barn <NUMBER> infected barns per premises <NUMBER> premises per zoneregioncountry sampled <NUMBER> premises prevalence <NUMBER> probability detection outlined fad preparation response plan materials <NUMBER> <NUMBER> also used fmd outbreaks united kingdom designing surveillance zone sampling strategies <NUMBER> scenario <NUMBER> detection threshold used evaluate probability detection could achieved scenario cost analysis presents expenses associated surveillance activities performed sampling testing four scenarios cost analysis estimate expenses resulting interruption trade business continuity instead focused cost sample testing surveillance activities additionally calculated costeffectiveness scenarios <NUMBER> <NUMBER> comparison current outbreak surveillance sample testing plan surveillance sample initial followup testing costs cost testing target number samples persample cost multiplied sample size calculated determined objective cost per sample estimated <NUMBER> per collection kit <NUMBER> <NUMBER> shipping handling assumption laboratory pcr testing fees <NUMBER> <NUMBER> per sample including possible accession fees <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> total estimated cost per sample tested ranges <NUMBER> <NUMBER> simplicity evaluation used estimated <NUMBER> per sample tested cover initial test expenses related collection shipping laboratory fees based assumption higher volume testing could result lower persample cost summarized table <NUMBER> samples nonnegative test results shipped nvsl followup test assumed <NUMBER> cost asf csf fmd investigation confirmatory testing costs persample cost <NUMBER> csf confirmatory testing following current testing protocol ab elisa immunoperoxidase immunoperoxidase virus neutralization <NUMBER> <NUMBER> total estimated cost per sample collected tested asf fmd approximately <NUMBER> following current confirmatory testing protocol using rtpcr virus isolation testing costs <NUMBER> <NUMBER> <NUMBER> scenarios paper oral fluids sample nonnegative result followup testing nvsl fad investigation initiated confirmatory testing performed nvsl foreign animal disease diagnostic laboratory estimated value <NUMBER> hours vs employee time <NUMBER> complete fad investigation ship samples laboratories premises result total cost false positive would minimum <NUMBER> csf <NUMBER> asf fmd assuming samples collected one animal epidemiologic investigation costs exclude domestic business trade impacts characteristics summarized table <NUMBER> cost analysis calculations several dimensions contribute calculations overall cost range include differences number oral fluid samples collected test sensitivity specificity ranges number sampling events testing cost individual samples number epidemiologic investigations samples collected confirmatory testing essentially combination lowest values applicable dimensions presented lowest bound overall cost range combination highest values applicable dimensions presented highest bound overall cost range costeffectiveness calculations calculate total cost acquire disease status information scenarios <NUMBER> <NUMBER> following information needed <NUMBER> number oral fluid samples required <NUMBER> number samples required use current testing protocol <NUMBER> respective costs costeffectiveness calculated dividing cost surveillance option associated cost lower costeffectiveness ratio preferred considered costeffective cost savings difference costs two different testing protocols initial testing followup confirmatory testing table <NUMBER> summarizes evaluation results scenario scenarios <NUMBER> <NUMBER> outbreak surveillance assumed prevalence detection thresholds <NUMBER> infected pensbarn <NUMBER> infected barnspremises <NUMBER> premises per zone prevalence control area surveillance zone table <NUMBER> usda fad preparedness response plan documents fmd csf indicate premises designation within control area requires objective information disease status premises may considered different designation ie move atrisk monitored samples provide aggregate information premises whole within either control area surveillance zone number samples required every <NUMBER> days duration outbreak would much lower sampling <NUMBER> samples per premises individual animal sampling <NUMBER> samples per premises achieve <NUMBER> detection probability <NUMBER> prevalence detection threshold difference translates requiring sample levels <NUMBER> <NUMBER> individual animal sampling levels acquire disease status information oral fluid sampling costs per premises three barns per control area scenario <NUMBER> range <NUMBER> <NUMBER> cost savings <NUMBER> <NUMBER> approximately <NUMBER> <NUMBER> lower cost estimates include cost initial testing compared using current testing protocol plus cost epidemiologic investigation proxy cost collect individual samples include followup testing fad investigations started nonnegative test result oral fluid sampling costs per premises <NUMBER> barns per surveillance zone scenario <NUMBER> range <NUMBER> <NUMBER> cost savings <NUMBER> <NUMBER> also approximately <NUMBER> <NUMBER> lower cost applied testing multiple premises within control area surveillance zone additional costs may incurred evaluate nonnegative test results depending strategy handling false positives outbreak table <NUMBER> scenario <NUMBER> achieve goal early detection sampling testing <NUMBER> probability detection premises level sampling would performed approximately every <NUMBER> days diseases asf fmd given short window detection samples prior presentation clinical signs depending test sensitivity number samples required could range <NUMBER> <NUMBER> cost <NUMBER> <NUMBER> test specificity ranging <NUMBER> <NUMBER> number false positives undergo followup testing would expected range <NUMBER> <NUMBER> <NUMBER> <NUMBER> additional tests fad investigations resulting combined cost <NUMBER> <NUMBER> followup confirmatory testing scenario <NUMBER> currently collection samples domestic disease testing generally performed weekly average <NUMBER> samples per premises <NUMBER> average number samples currently submitted two large swine veterinary diagnostic laboratories per year approximately <NUMBER> estimate costs <NUMBER> test specificity ranging <NUMBER> <NUMBER> number false positives needing followup tests would expected range <NUMBER> <NUMBER> <NUMBER> <NUMBER> additional tests fad investigations resulting combined cost <NUMBER> <NUMBER> scenario <NUMBER> requires <NUMBER> <NUMBER> samples required scenario <NUMBER> detect <NUMBER> <NUMBER> prevalence instead target <NUMBER> premiseslevel prevalence every <NUMBER> days cost savings following scenario <NUMBER> range <NUMBER> <NUMBER> approximately <NUMBER> <NUMBER> lower scenario <NUMBER> <NUMBER> lower number samples per barn ability detect infected premises decreased compared scenario <NUMBER> diagnostic test sensitivity low end assumed range <NUMBER> sample size <NUMBER> ropes provides probability <NUMBER> detecting least one infected premises <NUMBER> premises infected <NUMBER> pens infected per premises test sensitivity high end assumed range <NUMBER> sample size <NUMBER> ropes provides probability <NUMBER> detecting least one infected premises <NUMBER> premises infected <NUMBER> pens infected per premises evaluation compared various scenarios swine sampling test asf csf fmd rrtpcr scenarios included assessment premises disease status table <NUMBER> summary results scenarios <NUMBER> <NUMBER> <NUMBER> including sample numbers costs summary results scenario <NUMBER> include prevalence detected using common industry practices <NUMBER> sampling premises control area <NUMBER> alternatively lower level sampling per farm sampling farms could give prevalence detection threshold premises level reduce prevalence detection threshold penlevel <NUMBER> calculated assuming among pen prevalence threshold needs detected premises <NUMBER> within three day period compare results scenario <NUMBER> <NUMBER> sum cost total sample size per scenario initial testing range total costs follow confirmatory testing initial samples nonnegative results httpsdoiorg<NUMBER>journalpone<NUMBER>t<NUMBER> swine oral fluid pcr testing transboundary animal diseases outbreak setting control area surveillance zone early detection active surveillance system understanding cost effective surveillance schemes using sampling testing asf csf fmd swine surveillance assist selecting best use applications prioritizing future test validation surveillance design development needs many characteristics derived available literature data sources used assumptions overcome information gaps scenarios except scenario <NUMBER> prevalence detection threshold detection probabilities set ideal level lower level prevalence detection threshold detection probability using may still provide beneficial information lower total cost current testing protocols note diagnostic test sensitivity values samples could outside range values used evaluation lower published rrtpcr sensitivity values found influenza virus swine <NUMBER> tests used endemic disease monitoring <NUMBER> additionally evaluation include adjustment factor field impacts animal behavior sample dilution degradation handling submission logistics factors could also lead lower test parameter values since hypothetical test characteristics used actual test utility largely depend results test validation studies could guide scenario development comparison drawing conclusions outbreak surveillance assuming prevalence detection thresholds <NUMBER> infected pensbarn <NUMBER> infected barnspremises <NUMBER> premises per zone prevalence control area surveillance zone outbreak response sample testing offers many advantages compared individual animal sampling including minimal disruption animal farm activities reduction number samples required thus reducing testing costs scenarios <NUMBER> <NUMBER> costeffectiveness ratio aggregate samples lower individual animal sampling additionally sample testing could decrease resource utilization given basic training producers collect submit samples emergency response officials premises line separation emergency response officials would need enter farm approach could decrease resource costs associated personal protective equipment waste disposal personnel downtime farms minimizing potential contamination premises eliminating animal contact depending disease sample testing may detect viral presence prior concurrent clinical signs information could assist policymakers incident commanders timely costeffective information upon base decisions poor sample handling technique decrease test sensitivity certificationtraining program proper sample collection packaging implemented farm personnel accredited veterinarians veterinary paraprofessionals response officials program outlined secure pork supply plan active observational surveillance <NUMBER> would assist outbreak preparedness lead higher quality samples beyond logistical considerations using testing asf csf fmd outbreak sampling also naturally targeted spatially temporally duration sampling limited known period exposure foreseeable enddate end quarantine oral fluid sampling may highly efficacious scenario benefit preventing disease spread greater cost short intensive sampling scheme presuming use outbreak assist prioritization incident response activities eg prioritize order formal surveillance inspection visits consequences false negative positive similarly constrained laboratory capacity could limit application novel testing strategy number samples generated outbreak exceeds laboratory capabilities regardless scale actual outbreak collection expected generate fewer samples compared individual animal sampling thus decreasing testing costs making effective use laboratory capacity test validation information known exploration potential animal movement continuity business scenarios would also informative scenario <NUMBER> early detection scenario designed <NUMBER> probability detecting least one infected premises prior clinical signs infection <NUMBER> pen <NUMBER> barn <NUMBER> among premises scenario assumed sample collection occurred approximately every <NUMBER> days detect disease prior clinical signs based window detection samples asf fmd scenario could modified lower levels sampling different goals would still useful potentially detecting disease earlier passive surveillance alone lowering overall cost partially explored scenario <NUMBER> windows detection asf csf fmd extrapolated laboratory experiments using high virulence strains leading rapid clinical progression disease detection window samples progression clinical signs thoroughly documented less virulent strains asf csf fmd studied given currently available data highly virulent csf detection samples unlikely sampling testing scenario fits csf rapid detection purpose clinical signs seen present time detectable virus samples viral shedding ofs occurs detectable clinical signs asf csf fmd observed frequency sampling could decreased moderate low virulence diseases present nonspecific signs ie csf fmd sampling testing may prove valuable seir modelling performed assessment characteristics moderately virulent strain csf paderborn strain indicated may advantage weekly sampling testing csf likely asf fmd would follow similar pattern low virulence strain chronic form disease introduced however given results evaluation potential application sampling active surveillance largescale early detection system would costly scenario <NUMBER> early detection scenario achieve <NUMBER> probability detecting least one infected premises prior clinical signs range test sensitivities evaluated using common industry sample submission practices higher number samples submitted per barn sampling greater number premises could achieve <NUMBER> probability detection scenario presented assumed premises collected samples weekly submissions distributed throughout given week temporally space submissions scenario represents lower level sampling scenario <NUMBER> may still detect disease earlier passive surveillance alone lower overall cost greatest advantage would likely realized diseases moderate mild clinical signs difficult detect differentiate diseases clinical signs alone ie csf fmd costeffectiveness scenarios <NUMBER> <NUMBER> could compared however decreased costs associated scenario <NUMBER> relative <NUMBER> must carefully balanced decreased level detection capability demonstrated two scenarios oral fluids represent potentially valuable sample source many different scenarios related current individual animal asf csf fmd testing benefit common scenarios sample testing surveillance could contribute emergency preparedness response efforts directed toward asf csf fmd swine scenarios evaluated sample testing may valuable outbreak setting use aggregate screening samples would minimize disruption animal farm activities reduce sample sizes decrease resource requirements compared individual animal sampling regimens immediate broad implementation possible due several limitations information gaps include <NUMBER> usda validation sample diagnostics asf csf fmd swine still underway <NUMBER> information test performance field setting lacking <NUMBER> confirmatory testing suspected falsepositive sample findings may demand timeintensive costly followup testing protocols eg repeat onfarm sampling andor next generation sequencing evaluation based current understanding sample testing without usdavalidated test test validation efforts positive negative cohort studies would improve broader understanding sample testing rrtpcr asf csf fmd swine furthermore understanding test characteristics field setting could used refine sample size requirements steps would provide reliable test characteristics fully evaluating use sample testing method asf csf fmd testing response plans swine evaluation revised additional studies provide new updated information asf csf fmd pathogenesis test characteristics industry practices change fad preparedness response plan materials updated streptococcosis regarded leading infectious disease swine industry clinically features meningitis septicemia arthritis annually results significant economic loss worldwide <NUMBER> streptococcus suis suis initially reported <NUMBER> <NUMBER> demonstrated etiological agent kind frequentlyoccurring bacterial infection <NUMBER> <NUMBER> indeed suis complex population consisting heterogeneous strains <NUMBER> classified <NUMBER> serotypes <NUMBER> <NUMBER> based differentiation capsule antigens <NUMBER> <NUMBER> based varied virulence bacteria may categorized highlypathogenic weaklypathogenic hypovirulent nonpathogenic avirulent strains <NUMBER> generally serotype <NUMBER> suis ss<NUMBER> considered virulent frequently isolated clinicallydiseased piglets <NUMBER> fact serotype <NUMBER> suis also one important serotypes several countries particular note ss<NUMBER> seems previously neglected recently emerging human pathogen <NUMBER> whose infection become increasingly potent especially southeast asian countries like thailand <NUMBER> vietnam <NUMBER> china <NUMBER> <NUMBER> primary agent meningitis septicemia arthritis opportunistic pathogen case pneumonia <NUMBER> <NUMBER> suis reported spread <NUMBER> countries regions fig <NUMBER> claimed less <NUMBER> human cases fatal <NUMBER> also similar clinical symptoms including bacterial meningitis septicemia arthritis frequently observed human ss<NUMBER> infections <NUMBER> <NUMBER> occasionally serotypes ss<NUMBER> including ss<NUMBER> <NUMBER> ss<NUMBER> <NUMBER> ss<NUMBER> <NUMBER> <NUMBER> ss<NUMBER> <NUMBER> <NUMBER> ss<NUMBER> <NUMBER> <NUMBER> ss<NUMBER> <NUMBER> also found function causative agents responsible sporadic cases human suis infection <NUMBER> note two big outbreaks human ss<NUMBER> endemics occurred china <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> <NUMBER> raised serious concerns public health challenged conventional opinion human ss<NUMBER> infections present sporadic cases <NUMBER> <NUMBER> <NUMBER> unfortunately specificeffective human therapeutics vaccine ss<NUMBER> infections available thus far considering severity high mortality modality ss<NUMBER> infection humans <NUMBER> <NUMBER> important develop method convenient quick diagnosis applied toward local ss<NUMBER> detection <NUMBER> <NUMBER> past four decades significant progress made toward better understanding highly infectious clones suis time formulating review <NUMBER> articles available pubmed regarding suis httpwwwncbinlmnih govpubmedtermstreptococcussuistotally <NUMBER> bacterial virulenceassociated factors identified include capsular polysaccharides cps <NUMBER> muramidasereleased protein mrp <NUMBER> suilysin sly <NUMBER> date genomic sequences collection suis strains available fig <NUMBER> majority derived ss<NUMBER> species <NUMBER> <NUMBER> except two newlyreleased genomes correspond ss<NUMBER> <NUMBER> ss<NUMBER> <NUMBER> respectively genomic mining combined bacterial genetics elucidated chinese epidemic strains highly pathogenic suis <NUMBER> carry specific <NUMBER>k pai pathogenicity island <NUMBER> <NUMBER> studies suggested <NUMBER>k pai transposonlike essence streptococcus suis suis family pathogenic grampositive bacterial strains represents primary health problem swine industry worldwide suis also emerging zoonotic pathogen causes severe human infections clinically featuring varied diseasessyndromes meningitis septicemia arthritis past decades continued efforts made significant progress toward better understanding zoonotic infectious entity contributing part elucidation molecular mechanism underlying high pathogenicity review aimed presenting updated overview pathogen perspective molecular epidemiology clinical diagnosis typing virulence mechanism protective antigens contributing zoonosis undergo gitype t<NUMBER>ssmediated horizontal transfer epidemic ss<NUMBER> species <NUMBER> systematic elucidation suis pathogenesis omics era illustrated functional definition collection new genes putative orthologs zur zinc uptake regulator <NUMBER> covr orphan response regulator <NUMBER> rgglike transcription factor <NUMBER> following release genome sequence ss<NUMBER> eg <NUMBER>zyh<NUMBER> <NUMBER> although gained partial glimpse molecular mechanism underlying high pathogenicity ss<NUMBER> still lacking insights interface ss<NUMBER> pathogen host infects <NUMBER> <NUMBER> review aim describe updated partial picture ss<NUMBER> emerging infectious agent centers five aspects global epidemiologydistribution clinical diagnostics typing pathogenesis protective antigencandidate vaccine zoonotic potential general microbiology suis suis group heterogeneous grampositive bacteria earlier classified lancefield groups r fig <NUMBER> <NUMBER> bacteria facultative anaerobes sphericalovoid shape exist pairs andor short chains fig <NUMBER>b c generally microorganisms show either αhemolysis growing selective plates horse blood agar <NUMBER> fig <NUMBER>a given variation cps antigens <NUMBER> serotypes proposed suis population <NUMBER> studies pathogenicity done serotypes serotypes <NUMBER> <NUMBER> <NUMBER> <NUMBER> among ss<NUMBER> recognized virulent species frequently associated diseased pigs often causes opportunistic infection adults occupational contact pig carcass porkrelated products <NUMBER> <NUMBER> suis important animal pathogen naturally inhabits upper respiratory particularly tonsils nasal cavities genital alimentary tracts piglets <NUMBER> <NUMBER> addition natural host swine fig <NUMBER>d pathogen suggested isolated wide range animals horses dogs cats <NUMBER> <NUMBER> note variants suis probably evolved highly infectious zoonotic agents cause meningitis septicemia arthritis even streptococcal toxic shocklike syndrome cause rapid death humans <NUMBER> <NUMBER> <NUMBER> <NUMBER> soon big outbreak human ss<NUMBER> infections china <NUMBER> serious concerns public health scientific community raised <NUMBER> toward better understanding preventioncontrol ss<NUMBER> infections multiple lines new bacterial virulence determinants salksalr two component system <NUMBER> feob transporter <NUMBER> rgg regulator <NUMBER> identified fast assays using pcrbased molecular detection <NUMBER> well elisa enzymelinked immunosorbent assayguided diagnostics established <NUMBER> table <NUMBER> recently epidemiological investigations conducted vietnam proposed <NUMBER> pig population slaughterhouses major reservoir ss<NUMBER> capacity cause human infections <NUMBER> <NUMBER> important risk factors human suis infections consecutively eating high risk porkderived dishes occupational exposure pigs porkrelated products preparation pork presence skin lesions <NUMBER> availability epidemiological knowledge human ss<NUMBER> infections critical improve current situation public awareness ss<NUMBER> infections effectively prevent potential occupational infections caused ss<NUMBER> genomicsproteomicsbased glimpse suis genomicsproteomics approaches probe suis yielded unprecedented comprehensive informationknowledge pathogen <NUMBER> <NUMBER> time writing review less <NUMBER> genomes suis strains available pubmed httpwwwncbinlmnihgovsitesentrezdbgen omecmddetailssearchtermstreptococcussuissave searchfalse completed research groups china fig <NUMBER> genomic sequence analyses suis showed <NUMBER> sequenced genomes feature nearly average gc content <NUMBER> indicating slight evolutionary conservation <NUMBER> genome size varies markedly <NUMBER> <NUMBER> <NUMBER> nt <NUMBER>has<NUMBER> nzaard<NUMBER> <NUMBER> <NUMBER> <NUMBER> nt bm<NUMBER> nc<NUMBER> reflecting genomic flexibility present species fig <NUMBER>b <NUMBER> number putative proteinencoding genes dramatically different <NUMBER> <NUMBER>has<NUMBER> <NUMBER> bm<NUMBER> suggesting nearly <NUMBER> total genes essential redundant bacterial viability might confer newunknown functions adapt varied environmental niches functional comparative genomics suis defined series new infectionvirulencerelated determinants argr regulator <NUMBER> sspa subtilisinlike protease <NUMBER> ciarh twocomponent regulatory system <NUMBER> hand proteomics analyses chinese epidemic ss<NUMBER> strain <NUMBER>zyh<NUMBER> identified <NUMBER> proteins total <NUMBER> processed spots <NUMBER> using immuneproteomic approach lus group revealed <NUMBER> membranerelated proteins chinese vaccine strain ss<NUMBER>ha<NUMBER> <NUMBER> <NUMBER> extracellular antigenic proteins virulent chinese ss<NUMBER> strain zy<NUMBER> <NUMBER> respectively using similar strategy wu coauthors group addressed two strains ss<NUMBER> another prevalent serotype suis gz<NUMBER> sh<NUMBER> observed <NUMBER> candidate proteins five virulenceassociated factors <NUMBER> additionally eight immunogenic proteins localized bacterial surface determined strain gz<NUMBER> including extracellular solutebinding protein <NUMBER> findings might provide solidreasonable basis development subunit vaccine candidates <NUMBER> geographic distribution human ss<NUMBER> infections swine pathogen suis first reported vegetarian <NUMBER> <NUMBER> zoonotic role could traced human ss<NUMBER> meningitis case denmark <NUMBER> <NUMBER> light available literature human suis infection recorded thus far expect suis infections involved less <NUMBER> countries andor regions fig <NUMBER> resulted around <NUMBER> cases severe human infections <NUMBER> <NUMBER> <NUMBER> north america united states <NUMBER> <NUMBER> canada <NUMBER> <NUMBER> south american countries argentina <NUMBER> <NUMBER> chile <NUMBER> <NUMBER> belgium <NUMBER> poland <NUMBER> sweden <NUMBER> denmark <NUMBER> germany <NUMBER> hungary <NUMBER> austria <NUMBER> croatia <NUMBER> italy <NUMBER> greece <NUMBER> portugal <NUMBER> asian countries laos <NUMBER> singapore <NUMBER> <NUMBER> india <NUMBER> korea <NUMBER> <NUMBER> <NUMBER> japan <NUMBER> hong kong <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> taiwan <NUMBER> <NUMBER> <NUMBER> philippine <NUMBER> australia <NUMBER> <NUMBER> new zealand <NUMBER> <NUMBER> far endemics human ss<NUMBER> infections observed two asian counties vietnam <NUMBER> thailand <NUMBER> <NUMBER> <NUMBER> <NUMBER> particular note coexistence sporadic cases epidemics human ss<NUMBER> infections present china <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> seemed true majority human ss<NUMBER> infection cases occurred southeast asia especially vietnam thailand china indicating obvious geographic tropism fig <NUMBER> although quite sure mechanism explain kind tropism anticipate following factors probably correlated frequent occurrence human ss<NUMBER> infections countries include <NUMBER> similar local climates andor environments <NUMBER> backyard cultivation pigs <NUMBER> popular consumption raw pork sold wet market past <NUMBER> years around <NUMBER> cases human suis infections estimated european countries among top three countries history human ss<NUMBER> infections recorded netherlands <NUMBER> cases united kingdom <NUMBER> cases denmark <NUMBER> cases <NUMBER> rest european countries france germany less ten sporadic cases human infection <NUMBER> moreover prevalent type clinical disease caused suis infections countries bacterial meningitis although human suis infections considered sporadic cases countries <NUMBER> <NUMBER> <NUMBER> unbelievable zoonotic infectious events rarely reported north america canada usa two huge countries numerous large frequent swine operations <NUMBER> <NUMBER> best knowledge three human ss<NUMBER> meningitis cases confirmed usa <NUMBER> <NUMBER> <NUMBER> three cases diagnosed canada one case due ss<NUMBER> <NUMBER> cases caused ss<NUMBER> <NUMBER> <NUMBER> gottschalk coworkers <NUMBER> believe small number reported cases two huge countries big industry pig cultivation might attributed following two major reasons <NUMBER> clinical underdiagnosis andor misdiagnosis suis infection rather true absence infectious disease <NUMBER> suis isolates north america less virulent relative europe asia pilot study conducted smith et al <NUMBER> recently indicated human infection suis common united states generally thought reason might lie underdiagnosis misdiagnosis rather real lacking disease <NUMBER> <NUMBER> <NUMBER> issue doubt current situation suis infections well though agree good hygiene conditions prevention strategies whole process pork operation eg wearing gloves might secure major route bacterial entry blood small cuts skins greatly decrease incidents suis infections north america therefore believe necessary employ combined specific approaches like multiplex pcr plus elisa reevaluation epidemiological aspects human suis infections north america interestingly schmid et al <NUMBER> recently demonstrated american ss<NUMBER> isolates carry <NUMBER>k pai dna fragment present chinese epidemic strain might helpful development american ss<NUMBER> strainspecific pcr detection assay accumulated epidemiological data suggests <NUMBER> total cases occurred asian countries <NUMBER> cases human ss<NUMBER> infections mainland china vietnam comparable <NUMBER> <NUMBER> <NUMBER> relative <NUMBER> countries human cases clinically infected suis second <NUMBER> <NUMBER> <NUMBER> noteworthy ss<NUMBER> recognized pathogen mostlyrelevance human bacterial meningitis southern vietnam <NUMBER> hongkong specialized administrative region china first human case suis infection recorded <NUMBER> <NUMBER> <NUMBER> accumulated number suis infections estimated <NUMBER> cases <NUMBER> <NUMBER> particular two big outbreaks human ss<NUMBER> infections china <NUMBER> <NUMBER> seriously challenged public health <NUMBER> <NUMBER> <NUMBER> epidemic <NUMBER> <NUMBER> ss<NUMBER>infected persons died along estimated <NUMBER> <NUMBER> pigs <NUMBER> <NUMBER> epidemic totally <NUMBER> patients ss<NUMBER> infections <NUMBER> dead similar scenario also observed <NUMBER> pigs demonstrated infected ss<NUMBER> <NUMBER> <NUMBER> causative agents epidemics subsequently determined highly invasive clones strong virulent ss<NUMBER> strain seemed acquired new pathogenicity island <NUMBER>k <NUMBER> <NUMBER> <NUMBER> additionally sporadic human meningitis cases caused ss<NUMBER> infections observed three cities china shenzhen city chongqing city nanjing city <NUMBER> <NUMBER> <NUMBER> implying situation ss<NUMBER> infection china complicated could due variants suis <NUMBER> identified subsequent investigations might much interest unveil possible evolutionary relationship chinese epidemic strain neighboring country like vietnam comparative genomics fasteffective detection analyses suis critical prevention andor diagnosis endemic suis <NUMBER> infection swine industry well suis infected patients three types experimental approaches available thus far consist <NUMBER> selective mediabased microbiological cultivation <NUMBER> molecular tests <NUMBER> immunological assays table <NUMBER> given advantage sensitivity fastness second method experimentally developed two subgroups pcrbased detection plus typingoriented analyses like pulsedfield gel electrophoresis pfge restriction fragment length polymorphism rflp might potential clinical reconfirmation revaliadtion generally pcr assays classified six kinds among multiplexpcr using sets specific primers including epf mrp gdh appreciablyvalid approach assay ss<NUMBER> applied countries table <NUMBER> major four kinds typing methods include pfge rflp multilocus sequence typing mlst random amplified polymorphic dna rapd derivatives isrrflp table <NUMBER> general three experimental methods pfge rflp rapd return clues genomic differences different strainsserotypes given direct sequencing multiple loci cpn<NUMBER> dpr reca aroa thra gki muts mlst directly capture nucleotide sequence deviation used typing purpose among immunological approaches elisa could popular way address suis infection experimental tests table <NUMBER> fact different versions elisa developed based various capture antigens identified specifically suis <NUMBER> also established two kinds elisa assays one based sao protein <NUMBER> based enolase surface antigen <NUMBER> work well trials field screening clinical detections recently two new derivative methods reported immunochromatographic strip <NUMBER> electrochemiluminescence immunosensor <NUMBER> respectively table <NUMBER> clinical consequence suis infection determined complicated interplay zoonotic pathogen host series bacterial components well collection host cell factors contribute pathogenesisrelated process far almost <NUMBER> bacterial components identified involved infection andor pathogenicity suis table <NUMBER> particular note wilson coworkers <NUMBER> developed powerful signaturetagged mutagenesis stm system suis identified nearly <NUMBER> potential virulence associate elements screening library consisting approximately <NUMBER> mutants table <NUMBER> however exact roles genes needed verification according general roles context bacterial life cycles bacterial virulenceassociated factors temporarily classified following three subgroups note genes probably attributed two different classifications due dual characteristics <NUMBER> surfacesecreted elements <NUMBER> enzymesproteases <NUMBER> transcription factorsregulatory systems <NUMBER> others transporterssecretion systems table <NUMBER> surfacesecreted components subgroup <NUMBER> total <NUMBER> genesgene clusters determined thus far contribute bacterial pathogenicity <NUMBER> <NUMBER> plus implication bacterial meningitis <NUMBER> <NUMBER> members supplemented group include sspa surfaceassociated subtilisinlike serine protease <NUMBER> <NUMBER> <NUMBER> htps novel immunogenic cell surfaceexposed protein <NUMBER> sat surface protein <NUMBER> <NUMBER> table <NUMBER> like fbp <NUMBER> gene ssu<NUMBER> unknown function determined one surface anchored fibronectinbinding protein importantly surface protein functions vivo crossing mucosal epithelia disseminate suggesting novel virulence factor <NUMBER> two independent research groups one canada <NUMBER> another china <NUMBER> identified subtilisinlike protease sspaencoding gene sspa ssu<NUMBER> suis organism screening mutant library genomic expression library respectively sspa proteinase possesses typical cell wall anchoring signal lpxtg cterminus implying cell surfacedisplayed protein <NUMBER> infection assays demonstrated sspa protein plays critical roles ss<NUMBER> pathogenicity <NUMBER> <NUMBER> <NUMBER> subsequent study revealed suis sspa protease might modulate cytokine secretion macrophages thus trigger central nervous system inflammation associated bacterial meningitis frequently observed ss<NUMBER>infected patients well piglets <NUMBER> hp<NUMBER> new surface protective antigen originally identified jins group <NUMBER> immunogenic antigen elicit obvious humoral antibody response confer efficient protection ss<NUMBER> challenge infection models mice pigs <NUMBER> subsequently hp<NUMBER> protein found interact host cell surface glycosaminoglycans gags binding sites proved solving xray structure nterminal gagbinding domain combined sitedirected mutagenesis plus indirect immunofluorescence assay <NUMBER> recently research group reported hp<NUMBER> involved bacterial virulence evaluating performance isogenic mutant δhp<NUMBER> mice pigs <NUMBER> reasonable interpretation would virulence attenuation due easier clearance δhp<NUMBER> mutant host immunological system stage infection fast clearance attributed reduced cps thickness decreased resistance phagocytosis <NUMBER> comparative transcriptomicsbased analyses elucidated expression cps synthetic operon downregulated δhp<NUMBER> mutant relative wildtype strain <NUMBER> also introduction plasmidborne hp<NUMBER> gene δhp<NUMBER> mutant restore decreased expression level cps operon seen wild type strain <NUMBER> observation consistent fact ccpa global carbon catabolite regulator contributes bacterial infectivitypathogenicity <NUMBER> <NUMBER> preliminary evidence pointed hp<NUMBER> might determine ser<NUMBER> phosphorylation level phospho carrier protein hpr<NUMBER> partner protein ccpa binding cataboliteresponsive elements cre target operons together suggested integration posttranslational modification hpr<NUMBER> ccpamediated transcriptional regulation linked regulatory network bacterial virulence serum opacity factor suis ofs putative member belonging family mscramm microbial surface components recognizing adhesive matrix molecules <NUMBER> nterminal region ofs exhibits similarity serum opacity factor streptococcus pyogenes fibronectinbinding protein fnba streptococcus dysgalactiae cterminus harbors repetitive sequence elements crude extract suis recombinant ofs protein possessed serum opacification activity experimental infections demonstrated deletion ofs gene severely impairs suis virulence <NUMBER> sao surface antigen first identified li et al <NUMBER> react convalescentphase sera pigs clinically infected suis type <NUMBER> subsequently recombinant sao formulated quil found induce potent opsonizing antibody responses confer crossprotection mice challenges virulent heterogeneous suis <NUMBER> also discovered three allelic variants sao gene namely saos saom saol present suis population developed efficient elisa method saom protein serves capture antigen <NUMBER> recent genetic study suggested sao protein minor virulence factor <NUMBER> sat hp<NUMBER> another newlyidentified surface protein suis serotype <NUMBER> <NUMBER> two different research groups shown evidence recombinant sat protein confer effective immunoprotection mice ss<NUMBER> infections implying vaccine molecule candidate <NUMBER> <NUMBER> addition htps putative member histidine triad protein family determined cell surfaceassociated protein expressed infection chinese ss<NUMBER> strain <NUMBER>zyh<NUMBER> <NUMBER> moreover recombinant htps protein demonstrated function protective antigen ss<NUMBER> infections <NUMBER> similarly zhang et al <NUMBER> recently defined another new infectionassociated antigen protein trag using vivoinduced antigen technology iviat inactivation trag gene observed attenuate full virulence chinese ss<NUMBER> strain experimental model zebrafish <NUMBER> surface protein papi<NUMBER> found constitute ancillary pilus subunit exhibit ability confer protection mice serious challenge suis <NUMBER> although never reported evidence zur zinc uptake regulator essential suis virulence <NUMBER> aranda et al recently reported zincbinding lipoprotein <NUMBER> structural component zinc uptake system associated infectivity streptococcus suis implying zinc uptake system might involved bacterial pathogenesis <NUMBER> discrepancy may attributed fact deletion zur partially affect expression zinc uptake system genes whereas inactivation <NUMBER> completely impairs zinc uptake system latter could seriously disrupt normal zinc metabolism turn lead virulence attenuation sick bacterium accumulated data suggested less <NUMBER> bacterial enzymes might implicated manifestation suis virulence table <NUMBER> among eight enzymes proposed virulence factors wilson et al <NUMBER> using system signaturetagged mutagenesis table <NUMBER> four generally regarded enzymes central metabolism separately correspond <NUMBER> glna glutamine synthetase <NUMBER> <NUMBER> gdh glutamate dehydrogenase <NUMBER> <NUMBER> enolase catalyzing dehydration <NUMBER>phosphoglycerate phosphorenolpyruvate <NUMBER> <NUMBER> <NUMBER> <NUMBER> impdh inosine <NUMBER>monophosphate dehydrogenase <NUMBER> five enzymes directly indirectly related synthesis modification bacterial surface structure including dlta enzyme catalyzing lipoteichoic dalanylation <NUMBER> pgda peptidoglycan nacetylglucosamine deacetylase <NUMBER> apua bifunctional amylopullulanase <NUMBER> dpp iv dipeptidyl peptidase iv <NUMBER> sortase transpeptidase <NUMBER> <NUMBER> one remaining two enzymes iga<NUMBER> protease highly immunereactive activity convalescent sera <NUMBER> sribosylhomocycteinase luxs catalyzing synthesis autoinducer <NUMBER> ai<NUMBER> utilized interspecies quorum sensing <NUMBER> <NUMBER> follows discuss roles enzymes suis pathogenesis exceptions neub neuc remaining six among eight enzymes proposed wilson <NUMBER> neub sialic acid synthase catalyzes last committed step de novo biosynthetic pathway sialic acid major element bacterial surface structure recently systematically addressed molecular immunological role bacterial virulence claimed altered architecture suis surface attenuates virulence <NUMBER> <NUMBER> similarly neuc encodes udp nacetylglucosamine <NUMBER>epimerase involvement sialic acid biosynthesis also found essential capsule production required virulence mouse infection model <NUMBER> gdh glutamine dehydrogenaseencoding gene originally known virulence factor widely applied <NUMBER> si et al <NUMBER> demonstrated glutamine synthetase glnaencoding product associated suis virulence using mouse model two research groups <NUMBER> <NUMBER> <NUMBER> reported suis enolase acts octamer <NUMBER> exported bacterial surface capability binding host fibronectin indicating possible role crosstalk pathogen host however protective efficiency recombinant enolase different bacterial origins seem consistent <NUMBER> <NUMBER> <NUMBER> similarly gene encoding inosine <NUMBER>monophosphate dehydrogenase nucleotide metabolismrelated enzyme initially cloned lus research group subsequently suggested involved full virulence ss<NUMBER>h chinese strain infection model piglets <NUMBER> modification bacterial surface critical successful invasion entry pathogens host cells gottschalks group systemically evaluated contributions two kinds modification systems suis pathogenicity lipoteichoic acid ltadalanylation peptidoglycan pg ndeacetylation respectively <NUMBER> <NUMBER> δdlta mutant defection lta dalanylation found attenuated virulence correlated diminished adherenceinvasion porcine brain microvascular endothelial cells decreased capacity escape immune clearance killing porcine neutrophils <NUMBER> fittipaldi et al <NUMBER> observed expression level pgda gene induced upon interaction ss<NUMBER> neutrophils vitro infected mice vivo implying pg ndeacetylation tightly involved ss<NUMBER> infections hypothesis validated virulence attenuation δpgda mutant ss<NUMBER> apua behave like bacterial surface protein lpktge cellwallanchoring motif cterminus also functions bifunctional amylopullulanase <NUMBER> genetic study showed multifunctional αglucandegrading enzyme apua promote adhesion porcine epithelium mucus might link bacterial carbohydrate utilization capability colonization invasiveness hosts research group demonstrated sortase srta originally referred transpeptidase staphylococcus aureus essential full virulence ss<NUMBER> <NUMBER> <NUMBER> however sortase paralogs srtbcd associated bacterial virulence <NUMBER> addition reported functional definition dipeptidyl peptidase iv dpp iv suis <NUMBER> also confirmed contribute greatly bacterial virulence <NUMBER> quorum sensing method bacterial cell densitydependent communication using secreted chemical molecules like autoinducer form language luxs gene product synthetase autoinducer <NUMBER> ai<NUMBER> required interspecies communication recently lus group defined functional luxs member present chinese isolates suis <NUMBER> demonstrated relevance bacterial virulence <NUMBER> <NUMBER> zhang et al identified iga<NUMBER> protease immunedominant antigen necessary full virulence suis <NUMBER> <NUMBER> additionally gruening et al <NUMBER> proved arginine deiminase system ads encoded arcabc operon necessary suis survival acidic stress indicating possibility correlating bacterial successful infection recently discovered adenosine synthase functions effector evasion pmnsmediated innate immunity <NUMBER> might suggest possibility cyclic amp campdependent signaling linked streptococcal infectivity given fact cadd enzyme camp deaminase leptospira <NUMBER> quench campdependent signaling would interest test hypothesis vivo expression cadd protein suis modulate bacterial pathogenesis transcriptional factorsregulators less <NUMBER> pleiotropic regulators suggested involved modulation suis virulence consist nine transcription factors five wellstudied ones adcr <NUMBER> ccpa <NUMBER> <NUMBER> ihkihr <NUMBER> virrvirs <NUMBER> nisknisr <NUMBER> three orphan regulators covr <NUMBER> revsc<NUMBER> <NUMBER> revs <NUMBER> <NUMBER> adcr regulator controlling zinc transport suis aranda coauthors observed disruption transcription factor attenuate bacterial virulence mouse model <NUMBER> contrast zur zinc uptake regulator <NUMBER>zyh<NUMBER> strain suis <NUMBER> essential strong pathogenicity porcine models <NUMBER> driven idea host environment critical expression bacterial virulence factors process infection willenborg et al <NUMBER> evaluated effect sugar metabolism regulator catabolite control protein ccpa suis pathogenesis anticipated expression levels several virulence factors arcb sao enolase altered δccpa mutant particular note recent study implied sao protective antigen plays limited role bacterial virulence <NUMBER> moreover deletion ccpa led significant reduction capsule thickness resistance killing porcine neutrophils <NUMBER> impaired bacterial virulence <NUMBER> argr member argrahrc arginine repressor family recently proved regulate expression arcabc operon encoding arginine deiminase system recognized putative virulence factor <NUMBER> <NUMBER> therefore interest test role argr suis virulence similar scenario observed rgg regulators present grampositive pathogen zheng et al defined rgglike ortholog suis <NUMBER>zyh<NUMBER> observed multiple roles bacterial metabolism importantly verified virulence determinant suis <NUMBER> experimental models piglets <NUMBER> interestingly h <NUMBER> <NUMBER> responsive furlike regulator perr confirmed determine bacterial virulence regulating expression dpr dpslike peroxide resistance proteinencoding gene metqin encoding methionine transporter <NUMBER> among <NUMBER> putative twocomponent signal transduction systems chinese virulent strain suis <NUMBER> <NUMBER> five proposed correlated manifestation strong virulence <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> reported salksalr system present <NUMBER>k pathogenicity island deletion tcs system resulted significant downregulation <NUMBER> genes expression level increased susceptibility polymorphonuclear leukocyte pmnmediated killing consequently virulence δsalkr mutant seriously attenuated <NUMBER> shen et al <NUMBER> conducted followup study address regulatory network salksalr tcs system expected proteomicsbased investigation revealed <NUMBER> downregulated proteins <NUMBER> upregulated protein partially agreed former microarray analysis <NUMBER> much surprise zhongs group recently elucidated physiological role salksalr tcs regulating bioactive lantibiotic suicin production thereby replaced suiksuir <NUMBER> li coworkers <NUMBER> reported second tcs system ciakciar required pathogenicity ss<NUMBER> infection models cd<NUMBER> mice piglets han et al showed ihkirr tcs contributes full virulence streptococcus suis serotype <NUMBER> strain <NUMBER>zyh<NUMBER> via regulating bacterial cell metabolism <NUMBER> recently two tcs virrvirs <NUMBER> nisk r <NUMBER> demonstrated essential ss<NUMBER> pathogenicity also orphan response regulator revsc<NUMBER> determined research group <NUMBER> regulator revsc<NUMBER> positively modulates expression levels virulence factors eg mrp sly cps required bacterial pathogenesis <NUMBER> contrast pan et al reported another orphan response regulator covr opposite effect suis pathogenicity <NUMBER> covrdefective δcovr mutant displayed thicker capsules increased hemolytic activity furthermore adherence mutant epithelial cells greatly increased well resistance phagocytosis killing neutrophils monocytes eventually removal covr gene found correlated increased lethality piglets relative inoculated parent virulent strain <NUMBER>zyh<NUMBER> <NUMBER> others vira newlydetermined virulence factor exclusively present virulent ss<NUMBER> strain <NUMBER> trigger factor also virulence determinant acts controlling expression collection known virulence factors cps mrp sly <NUMBER> feoba encoding iron transporter system might represent first example fact machinery transporter involved suis pathogenicity <NUMBER> li et al <NUMBER> defined transposal characteristics <NUMBER>k pai epidemic strain chinese virulent ss<NUMBER> hus group recently obtained insights <NUMBER>k pai addition virulencedetermining element salksalr tcs system <NUMBER>k pai also carried second virulence factor vird<NUMBER>virb<NUMBER> type ivlike secretion system unexpectedly t<NUMBER>sslike system responsible stimulating host immune reaction observed mice infected chinese streptococcal toxic shocklike syndrome stslscausing strain suis <NUMBER> <NUMBER> raising possible relationship <NUMBER>k molecularimmunological machinery nongroup streptococcus gas ss<NUMBER> cause stsls infected patients fig <NUMBER> finally wilson et al also suggested <NUMBER>ssu<NUMBER> uncharacterized protein homologous pneumonia spr<NUMBER> might virulence factor <NUMBER> pathogens evolved capacity recruithijack host cell factors successful infectionsinvasions far majority clinical visualization representative ss<NUMBER>infected patient streptococcal toxic shocklike syndrome clearly shows purpura gangrenous changes patients legs partially adapted reference <NUMBER> permission b genetic evidence <NUMBER>k pathogenicity island carries elements associated bacterial virulence clinical consequence streptococcal toxic shocklike syndrome pfge assay reveals chinese epidemic strain <NUMBER>zyh<NUMBER> distinct international strain s<NUMBER> <NUMBER> two genetic elements transposable <NUMBER>k pathogenicity island <NUMBER> <NUMBER> functionally defined one salksalr renamed suiksuir <NUMBER> tcs requirement full virulence <NUMBER> vird<NUMBER>virb<NUMBER> t<NUMBER>sslike system associated clinical manifestation stsls mouse model <NUMBER> c proposed model twostage hypothesis stsls ss<NUMBER> gets blood vessels stage results early burst proinflammatory factors th<NUMBER> cytokine storms kind inflammatory superresponses lead stsls death early <NUMBER> h ss<NUMBER> infection stage ii ie several days postinfection ss<NUMBER> might use virulence factors like suilysin cause disease particularly meningitis <NUMBER> cns central nervous system integrated modified references <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> permission host cell factors identified involved suis pathogenesis immunologicalapoptoticinflammatory factors nearly ten years ago gottschalk et al <NUMBER> observed cell wall components suis induce releases interleukin<NUMBER> il<NUMBER> il<NUMBER> monocyte chemotactic protein<NUMBER> mcp<NUMBER> human brain microvascular endothelial cells bmec might increase permeability bloodbrain barrier using experimental model cd<NUMBER> mice group observed <NUMBER> <NUMBER> animals sudden death exhibit high levels systemic tnfα il<NUMBER> il<NUMBER> ifnγ ccl<NUMBER> cxcl<NUMBER> ccl<NUMBER> <NUMBER> h infection <NUMBER> infected mice survived early sepsis later developed clinical signs meningitis present transcriptional activation tlr<NUMBER> tlr<NUMBER> cd<NUMBER> nfκb il<NUMBER>β ccl<NUMBER> tnfα mainly myeloid cells located affected cerebral structures <NUMBER> apparently inflammatory response plays important roles suis infection cd<NUMBER> mice similar observation also reported scherk et al <NUMBER> suis infections correlated release proinflammatory cytokines chemokines eg il<NUMBER> il<NUMBER> gottschalk et al found tolllike receptor <NUMBER> tlr<NUMBER>deficient exhibit significantly reduced production astrocytes <NUMBER> proposed bacterial polysaccharides probably modulates tlr<NUMBER>dependent recognition suis entryinvasiveness cd<NUMBER> mice <NUMBER> using transcriptomic approach de greeff et al <NUMBER> identified macrophagespecific genes il<NUMBER>β mip<NUMBER>α tnfα significantly different expression upon suis infection suggesting mapkinase signaling pathway nfκb signaling implicated response porcine alveolar macrophages suis infections additionally wu et al <NUMBER> verified novel murine ribonuclease angiogenin inhibitor <NUMBER> ai<NUMBER> bind suis hyaluronidase hyl hypothesized interaction host ai<NUMBER> partner bacterial hyl protein might contribute suis meningitis development safe efficient vaccine useful strategy combat suis infection contrast conventional killedlive wholebacteria vaccines <NUMBER> <NUMBER> <NUMBER> engineering subunit vaccine exhibits significant advantage safety largescale producibility <NUMBER> identification protective antigens prerequisite identifying candidate vaccine molecules totally less <NUMBER> protective antigens identified thus far table <NUMBER> among four molecules protective antigen wellknown virulence associated factors mrp ef <NUMBER> kda sly table <NUMBER> note remaining <NUMBER> protein antigens elucidated research groups china <NUMBER> addition identification known protective antigen sly lius report verified three new protective antigens rtx family exoprotein rfea epidermal surface antigen esa immunoglobulin g iggbinding protein ibp <NUMBER> two different research groups china confirmed enolase enzyme central metabolism acts protective antigen displayed bacterial surface <NUMBER> <NUMBER> however esgleas coworker <NUMBER> reported opposite result regarding protective efficiency enolase mice discrepancy could due different versions recombinant protein different strains plus deviations animal vaccination protocols particular note three newlyidentified immunogenic antigens <NUMBER>pgd hp<NUMBER> hp<NUMBER> elucidated chens research group china table <NUMBER> interestingly proteomics also facilitated discover three new immunogenic proteins sspepo <NUMBER> sat hp<NUMBER> <NUMBER> <NUMBER> pilus subunit papi<NUMBER>b <NUMBER> table <NUMBER> disagreement former observation <NUMBER> li coworkers <NUMBER> demonstrated sao surface antigen confer efficient protection mice piglets virulent ss<NUMBER> infection table <NUMBER> accepted suis developed significant human pathogen especia southeast asia posing great challenge public health <NUMBER> clinically collection disease types observed patients suis infections including meningitis septicemia pneumonia terms epidemiologicalclinical statistics bacterial meningitis prevalent symptom caused suis infection meningitis meningitis medically defined inflammation lining covers brain spinal cord meninges <NUMBER> <NUMBER> <NUMBER> kind inflammation usually initiates brief influenzalike prodroma results hearing impairment loss <NUMBER> <NUMBER> generally meningitis grouped two types bacterial nonbacterial eg viral fungal meningitis <NUMBER> former less <NUMBER> kinds bacterial pathogens mycobacteria tuberculosis streptococcus pneumonia staphylococcus aureus determined causatives development human meningitis <NUMBER> <NUMBER> although ss<NUMBER> swine pathogen come know ss<NUMBER> also severe agent human bacterial meningitis <NUMBER> <NUMBER> first case human ss<NUMBER> infection worldwide recorded denmark <NUMBER> <NUMBER> hui et al declared ss<NUMBER> would another leading cause socalled communityacquired meningitis inferior tuberculosis pneumonia <NUMBER> systematic survey bacterial meningitis vietnamese adults recently suggested <NUMBER> ss<NUMBER> multiple virulence factors eg epf sly mrp common pathogen <NUMBER> mortality relatively low <NUMBER> hearing loss occurs high percentage <NUMBER> <NUMBER> moreover hoa et al <NUMBER> addressed antimicrobial susceptibility profile suis strains meningitis patients important question using comprehensive approaches analyze bacterial isolates vietnam <NUMBER> <NUMBER> result found <NUMBER> multidrug resistance suis <NUMBER> causing meningitis southern vietnam increased <NUMBER>y period studied <NUMBER> tetl carried bacteria functionally expressed multiple genes probably coexpressed <NUMBER> findings alerted us important minimize abuse antibiotics treatment bacterial infectious diseases development new therapeutics ss<NUMBER> infections great demand fortunately ho et al <NUMBER> reported largest prospective epidemiological survey human ss<NUMBER> meningitis vietnam pointed three important risk factors associated human ss<NUMBER> meningitis included <NUMBER> eating high risk dishes popular southeast asia <NUMBER> occupational exposure pigs andor porkrelated products <NUMBER> preparation pork presence skin lesions investigations research group demonstrated slaughterhouse pigs major reservoir ss<NUMBER> led human infections ss<NUMBER> meningitis southern vietnam <NUMBER> highlighted <NUMBER> importance improved hygiene pork processing facilities <NUMBER> necessity education programs concerning food safety proper handling pork <NUMBER> similar findings also noted netherlands <NUMBER> new zealand <NUMBER> <NUMBER> netherlands researchers clearly indicated risk developing ss<NUMBER> meningitis among abattoir workers butchers pig breeders <NUMBER> times higher among persons without close contact pigs unprocessed pork products <NUMBER> surprise study performed new zealand revealed high ratio farmers meat inspectors markets seropositive ss<NUMBER> suggesting presence human subclinical ss<NUMBER> infections small extent <NUMBER> <NUMBER> septicemia septicemia serious lifethreatening infection large amount bacteria present blood commonly referred blood poisoning bacteremia sepsis <NUMBER> disease often causes multiorgan failure reducing amount blood reaching vital organs liver kidneys <NUMBER> <NUMBER> <NUMBER> addition known bacterial pathogens staphylococcus capability leading septicemia <NUMBER> lethal rate <NUMBER> ss<NUMBER> also causative agent disease <NUMBER> general ss<NUMBER>caused septicemia arises result localized infection body especially cut skin <NUMBER> patients septicemia following symptoms observed fever chills rising heartrespiratory rate cold clammy feeling fallen blood pressure paled petechial skin ultimately even unconsciousness ss<NUMBER> likely releases toxins blood break walls blood vessels allows blood leak skin leaking causes rash petechiae <NUMBER> cases ss<NUMBER> infects bloodstream meninges time causing septicemia meningitis <NUMBER> <NUMBER> due rapidly progressive condition septicemia evolve irreversible toxic shock even acute death sufferers receive urgent treatment <NUMBER> <NUMBER> <NUMBER> certainly antibiotic remedy could altered quickly treat target bacteria agents medical tests identified bacteria cause septicemia antibiotics best effective <NUMBER> <NUMBER> note medical treatments inducers septicemia eg dental treatment longterm use intravenous needles colostomy <NUMBER> <NUMBER> collectively septicemia serious complex deserves lot attention worldwide others addition two major forms ss<NUMBER>caused diseases clinical types occur less frequently cases human ss<NUMBER> infections including arthritis endocarditis streptococcal toxic shocklike syndrome stsls etc since stsls newlydescribed disease form ss<NUMBER> infections fig <NUMBER> discussed detail toxicshock syndrome refers highly invasive infection deep tissues correlated production bacterial superantigens eg staphylococcal streptococcal exotoxins <NUMBER> <NUMBER> tang et al <NUMBER> formally proposed ss<NUMBER> another bacterial nongas agent responsible stsls aware staphylococcus <NUMBER> <NUMBER> streptococcus pyogenes group streptococcus gas <NUMBER> <NUMBER> leading pathogens capability causing stsls clinical criteria diagnosis stsls disease described follows <NUMBER> clear erythematous blanching rash fig <NUMBER> <NUMBER> sudden onset high fever <NUMBER> hypotension diarrhea <NUMBER> blood spots petechiae <NUMBER> dysfunction multiple organs eg disseminated intravascular coagulation acute renal failure <NUMBER> <NUMBER> <NUMBER> according clinical criteria two independent research groups china reported two big outbreaks human ss<NUMBER>caused stsls occurred jiangsu province <NUMBER> sichuan province <NUMBER> respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> two models proposed explain molecular mechanism ss<NUMBER> triggers stsls infected patients one twostage hypothesis <NUMBER> specific <NUMBER>k pai <NUMBER> <NUMBER> although came know similar findings also recorded thailand <NUMBER> france <NUMBER> australia <NUMBER> gain information difference ss<NUMBER> strains abroad comparison chinese stslscausing isolates given two models based evidence studying chinese ss<NUMBER> strains cant conclude presently represent common strainspecific mechanisms two kinds nonss<NUMBER> serotypes determined sporadic cases human suis infections one ss<NUMBER> <NUMBER> ss<NUMBER> <NUMBER> poggenborg coworker <NUMBER> reported pigfarm worker ss<NUMBER> meningitis septicaemia complicated thoracal lumbar spine spondylodiscitis similarly ahmed et al <NUMBER> also documented meningitis case caused ss<NUMBER> infections female patient occupational exposure piglets day particular note totally <NUMBER> cases human ss<NUMBER> infections identified thailand <NUMBER> clinical presentations included meningitis septic arthritis sepsis <NUMBER> analyses demonstrated <NUMBER> <NUMBER> ss<NUMBER> isolates patients belonged multilocus sequence types st <NUMBER> suggesting clonal dissemination st<NUMBER> strains thailand another neighboring asian country vietnam fatal case human ss<NUMBER> infection revealed schultszs research group <NUMBER> indicating multiple serotypes suis developing human pathogens circulating country together nonss<NUMBER> serotypes suis also exhibited zoonotic potential highlighting great demand monitoring epidemiology development relevant approaches applied toward prevention therapeutics zoonotic agent suis gathering increasing accumulated attention public health officials well relevant academic community <NUMBER> <NUMBER> <NUMBER> respect suis epidemiology believe current situation human ss<NUMBER> infections reevaluated using comprehensive approaches minimize occupational infections suis suggested advances made improve public awareness suis infection science education popularization although progress obtained toward understanding suis pathogenicity especially identifying group bacterial virulence factors still sounds fragmentary lacks insightful dissection integrated regulatory networks bacterial virulence future important direction would link posttranscriptional regulation eg ncrna riboswitch modification acetylation deacetylation bacterial virulence streptococcus suis <NUMBER> moreover structural information virulence factors limited table <NUMBER> therefore believe necessary strengthen study pathogenesisrelated structural biology could establish solid basis design small molecule drugs targeting bacterial virulence factors interest search virulencerelated immunological regulatory elements different <NUMBER>k pai recent exciting findings issue <NUMBER> safe effective vaccines used patients still available due lack comprehensive knowledge suis infections description full picture suis surface antigen proteins might helpful screen andor design vaccine molecules candidate fact nonss<NUMBER> serotypes suis affect humans even lead fatal infections put situation suis infection much complicated serious status public health might alternate way decode genome sequences <NUMBER> kinds different serotypes providing new insights evolution diversity heterogeneous species well distinct clues preventing controlling severe infections pathogens <NUMBER> <NUMBER> systematic proteomic approaches also encouraged address question complement genomicsbased explorations <NUMBER> summary understanding response situation suis infections occurring especially southeast asia satisfactory would helpful integrate representative virulentavirulent strains different countriesregions collaborative investigations therefore long way go toward complete conquest suis emerging human pathogen potential conflicts interest disclosed infections predominantly bacterial nature uncommon patients cirrhosis associated high morbidity mortality <NUMBER> patients infections consequence multiple pathophysiological mechanisms gut dysbiosis increased bacterial translocation portosystemic shunting cirrhosisassociated immune dysfunction caid liver dysfunction genetic factors <NUMBER> <NUMBER> frequent infections spontaneous bacterial peritonitis sbp urinary tract infection uti pneumonia cellulitis bacteremia uncommon <NUMBER> communityacquired bacterial infections account <NUMBER> infections followed healthcare acquired approximately <NUMBER> nosocomial infections <NUMBER> <NUMBER> <NUMBER> recent epidemiological data shown incidence multidrugresistant mdr bacteria increasing especially healthcareassociated settings <NUMBER> <NUMBER> mdr bacteriaassociated infections worst prognosis associated higher rates treatment failure septic shock high mortality <NUMBER> <NUMBER> <NUMBER> preventive measures early diagnosis adequate treatment infections potentially decreasing morbidity mortality among hospitalized patients cirrhosis infections account <NUMBER> admissions <NUMBER>fold higher rate infections without cirrhosis <NUMBER> <NUMBER> bacteria remain common pathogens prevalence <NUMBER> patients hospitalized acute decompensated cirrhosis <NUMBER> <NUMBER> <NUMBER> increases probability death approximately <NUMBER>fold reaching <NUMBER> <NUMBER> month <NUMBER> <NUMBER> year <NUMBER> <NUMBER> enterobacteriaceae nonenterococcal streptococci major causes spontaneous infection cirrhosis <NUMBER> <NUMBER> mdr organisms mdros pathogens resistant least one agent ≥ <NUMBER> main antibiotic families including βlactams examples mdros extendedspectrum βlactamaseproducing enterobacteriaceae esbl nonfermentable gramnegative bacilli pseudomonas aeruginosa stenotrophomonas maltophilia acinetobacter baumannii methicillinresistant staphylococcus aureus mrsa vancomycinresistant enterococci vre <NUMBER> nowadays mdr infections increasing hospitals also communities <NUMBER>• prevalence mdros differs among various geographic regions higher rates nosocomial <NUMBER> healthcareassociated settings <NUMBER> rather communityacquired infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> esblproducing enterobacteriaceae predominant isolates south europe asia vre infections frequently encountered usa latin america <NUMBER>• recent multicenter intercontinental prospective study global study <NUMBER> hospitalized patients cirrhosis across world n <NUMBER> common infections sbp <NUMBER> uti <NUMBER> pneumonia <NUMBER> nine hundred fiftynine microorganisms isolated <NUMBER> gramnegative <NUMBER> grampositive <NUMBER> fungi cirrhosis immunomodulatory deficiency state predisposes patients infections multiple mechanisms fig <NUMBER> bacterial overgrowth intestinal barrier dysfunction result bacterial translocation <NUMBER> genetic variants cirrhosis noted associated increased risk severity infections multifactorial pathogenetic mechanisms cause excessive inflammatory response thus induce circulatory dysfunction acute decompensation eventual development acuteonchronic liver failure aclf intestinal bacterial overgrowth ibo common patients cirrhosis could consequence slow intestinal transit due decreased bowel motility low secretion gastric acid bile acids local intestinal immunological <NUMBER> <NUMBER> <NUMBER> <NUMBER> ibo intestinal bacterial overgrowth res reticuloendothelial system nitric oxide aki acute kidney injury aclf acute chronic liver failure hepatic encephalopathy rai relative adrenal insufficiency dic disseminated intravascular coagulation ards acute respiratory distress syndrome defects <NUMBER> high production nitric oxide inducing vasodilatation portal hypertension may facilitate bacterial overgrowth <NUMBER> <NUMBER> <NUMBER> <NUMBER> ibo result bacterial translocation bt liver inflammation <NUMBER> bt defined migration microorganisms bacterial endotoxins intestinal lumen mesenteric lymph nodes systemic circulation common bacteria involved bt derived family enterobacteriaceae e coli klebsiella spp etc enterococci streptococci spp multiple mechanisms cause wide range clinical manifestations including hemodynamic instability high proinflammatory cytokine levels development severe recurrent infections aclf hepatic encephalopathy hepatorenal syndrome hrs associated poor prognosis <NUMBER> data <NUMBER> patients north american consortium study endstage liver disease nacseld cohort showed dysbiosis intestinal microbiota hospitalized patients cirrhosis particularly changes proteobacteria constituents eg enterobacteriaceae campylobacteraceae pasteurellaceae associates increased risk extrahepatic organ failure aclf death <NUMBER> cirrhosis portal hypertension microcirculation intestinal mucosa disturbed loosening tight junctions tj epithelial cells resulting impairment mucosal integrity facilitate bt <NUMBER> <NUMBER> secreted mediators limit direct contact intestinal bacteria epithelial surface shown deficient cirrhosis include immunoglobulin <NUMBER> biliary lipids <NUMBER> antimicrobial peptides <NUMBER> <NUMBER> also results impaired mucus secretion facilitates bacterial penetration <NUMBER> cirrhosis associated immunodeficiency state designated cirrhosisassociated immunodeficiency dysfunction caid concept includes two entities <NUMBER> immunodeficiency affects innate adaptive immune systems <NUMBER> state persistent inadequate activation immune system leading production proinflammatory cytokines systemic inflammation pathogenassociated molecular patterns pamps enteric bacterial organisms damageassociated molecular patterns damps originating host tissue upon injury bring pattern recognition activation immune cells causing systemic inflammation <NUMBER> genetic polymorphisms immunity pathways may lead variation immune responses infection susceptibilities genetic variations coding pattern recognition receptors prr especially nod<NUMBER> tlr<NUMBER> variants causing impairment innate host defense mechanisms associated sbp susceptibility markers impaired intestinal permeability higher systemic inflammation patients cirrhosis <NUMBER> <NUMBER> cirrhosis aclf unique condition evolve following bacterial infections presentation characterized acute hepatic decompensation multiorgan failure large multicenter prospective study <NUMBER> patients hospitalized acute decompensation cirrhosis canonic study context easlclif consortium established definition categorized grading defines shortterm mortality aclf grades <NUMBER> mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> study bacterial infection common identifiable precipitating factor aclf <NUMBER> followed active alcoholism <NUMBER> among bacterial infections sbp pneumonia frequent sites infection associated aclf severity infection sepsis septic shock also correlated aclf presence types precipitating events related mortality prognosis depended numbers organ failures ofs context presence ofs assessed clifsofa clifc scores associated <NUMBER>day <NUMBER>day mortality suggested aclf grading determined assess mortality hospitalized patients cirrhosis aclf hospitalization majority patients noted achieve grade <NUMBER> aclf within first week therefore next assessment since admission aclf grade days <NUMBER> new scoring system clifc aclf score suggested significantly higher predictive accuracy meld meldna childpughturcotte score main time points aclf diagnosis significantly higher area receiver operating curve auroc prediction <NUMBER>day <NUMBER>day mortality <NUMBER> noting spectrum infections prospective multicenter study <NUMBER> patients cirrhosis hospitalized infection across usa canada nacseld consortium database <NUMBER> <NUMBER> noted differences compared easlclif consortium frequently encountered infections uti <NUMBER> sbp <NUMBER> infections included spontaneous bacteremia <NUMBER> skinsoft tissue <NUMBER> respiratory <NUMBER> miscellaneous <NUMBER> c difficile <NUMBER> nosocomial infections often due drugresistant organisms found first infections <NUMBER> frequently related inhospital procedures use medications antibiotics proton pump inhibitor sbp prophylaxis commonly infections due grampositive organisms <NUMBER> followed gramnegative <NUMBER> fungi <NUMBER> organisms isolated <NUMBER> <NUMBER>•• thus current epidemiological pattern majority nonsbp infections domination grampositive organisms large proportion nosocomial infections addition second infections developed hospitalization encountered <NUMBER> patients uti <NUMBER> respiratory infections <NUMBER> sbp <NUMBER> also associated poor survival hospitalized patients bacterial infection developed ofs <NUMBER>of <NUMBER> <NUMBER>ofs <NUMBER> <NUMBER>ofs <NUMBER> poor predictors found associated development aclf nosocomial infections high baseline meld low mean arterial pressure map nonsbp infections independent predictors poor <NUMBER>day survival iaclf simple bedside tool defined ≥ <NUMBER> ofs shock grade iiiiv ventilation renal replacement therapy second infections high admission meld high white blood cell count low albumin <NUMBER>•• similar canonic study numbers ofs found important predictor overall survival aclf liver transplantlisted patients nacseld experience <NUMBER> risk delistingdeath within <NUMBER>month period following episode infection due multiple organ failures making likely main reason delistingdeath among liver transplantlisted patients <NUMBER>• prevalence sbp outpatients <NUMBER> ranges <NUMBER> <NUMBER> hospitalized patients cirrhosis <NUMBER> fifty percent cases evidence sbp time hospital admission rest acquired hospitalization <NUMBER> symptoms include abdominal pain vomiting diarrhea patients may also signs peritonitis signs systemic inflammation fever leukocytosis tachycardia shock sbp asymptomatic third patients <NUMBER> therefore diagnostic paracentesis performed patients cirrhosis ascites without delay hospital admission andor patients gastrointestinal bleeding shock signs systemic inflammation worsening liver renal function hepatic encephalopathy <NUMBER>•• hospital mortality first episode sbp ranged <NUMBER> <NUMBER> <NUMBER>year mortality <NUMBER> <NUMBER> <NUMBER> diagnosis sbp defined ascitic neutrophil count ≥ <NUMBER> cellsmm <NUMBER> positive ascitic fluid bacterial culture without evidence intraabdominal surgically treatable source infection <NUMBER> methods estimating neutrophil count include manual count microscopy automated count flow cytometry leukocyte esterase reagent strips lers although last one recommended rapid screening test due low sensitivity <NUMBER> <NUMBER> <NUMBER> positive ascitic fluid culture essential diagnosis sbp ascitic blood culture still performed starting antibiotics organisms isolated <NUMBER> cases <NUMBER> <NUMBER> levels ascitic fluid lactoferrin aflac noted elevated sbp prospective study conducted tertiary centers <NUMBER> ascites samples<NUMBER> patients using cutoff level <NUMBER> ngml sensitivity specificity diagnosis sbp <NUMBER> <NUMBER> respectively <NUMBER> another prospective study south korea <NUMBER> patients noted sensitivity <NUMBER> specificity <NUMBER> cutoff level <NUMBER> ngml <NUMBER> however validation studies still needed recommended clinical practice another newly established situ hybridization method detecting phagocytized bacterial dna ascites sbp patients n <NUMBER> demonstrated sensitivity <NUMBER> specificity <NUMBER> results provided day <NUMBER> secondary peritonitis another differential diagnosis peritonitis considered multiorganisms encountered ascites culture also growth anaerobes fungi high ascites neutrophil counts inadequate response therapy runyons criteria follows ≥ <NUMBER> ascitic parameters ascitic glucose g <NUMBER> mgdl protein <NUMBER> <NUMBER> gl ldh <NUMBER> normal serum levels helpful considering entity sensitivity <NUMBER> specificity <NUMBER> prompt abdominal ct early surgical consideration pursued <NUMBER> <NUMBER> empirical antibiotic must started immediately diagnosis sbp nephrotoxic drugs avoided choice empirical antibiotics depends type infection individual risk factors bacterial epidemiology particular global region communityacquired sbp recommended firstline antibiotic treatment thirdgeneration cephalosporins given intravenously duration <NUMBER> days <NUMBER>•• healthcareassociated nosocomial sbp piperacillintazobactams recommended areas low prevalence mdros carbapenem antibiotic choice regions high prevalence esblproducing enterobacteriaceae used combination glycopeptides daptomycin linezolid areas high prevalence grampositive mdr bacteria table <NUMBER> extensive drug resistance xdr bacteria defined nonsusceptibility least one agent two fewer antimicrobial categories pandrug resistance pdr bacteria defined nonsusceptibility agents antimicrobial categories <NUMBER> may require combination antibiotics including highly nephrotoxic agents vancomycin aminoglycosides used plasma levels need monitored prompt deescalation based bacterial susceptibility highly recommended order minimize evolution resistant strain <NUMBER>•• failure treatment suspected clinical symptoms worsen inadequate reduction leukocyte response less <NUMBER> ascitic neutrophil count <NUMBER> h intravenous <NUMBER> albumin <NUMBER> gkg diagnosis sbp followed <NUMBER> gkg day <NUMBER> combination antibiotics significantly reduced renal impairment <NUMBER> <NUMBER> reduced mortality <NUMBER> <NUMBER> albumin infusion especially effective patients total bilirubin <NUMBER> <NUMBER> mgdl blood urea nitrogen <NUMBER> <NUMBER> mgdl serum creatinine <NUMBER> <NUMBER> mgdl <NUMBER> <NUMBER> three highrisk groups patients cirrhosis considered use prophylaxis prevent sbp include acute gastrointestinal bleeding advanced cirrhosis low protein ascites primary prophylaxis previous history sbp secondary prophylaxis table <NUMBER> fortyfive <NUMBER> patients cirrhosis upper gastrointestinal bleeding developed bacterial infection within <NUMBER> days bleeding episode <NUMBER> <NUMBER> <NUMBER> antibiotics administration decrease incidence infection <NUMBER> <NUMBER> <NUMBER> also associated reduction rebleeding rate improved survival <NUMBER> oral norfloxacin <NUMBER> mg <NUMBER> h <NUMBER> days gold standard prophylaxis however patients advanced cirrhosis ≥ <NUMBER> following ascites severe malnutrition encephalopathy jaundice receive intravenous ceftriaxone <NUMBER> gday <NUMBER> days randomized controlled trial rct comparing oral norfloxacin intravenous ceftriaxone advanced cirrhosis gastrointestinal hemorrhage showed probability developing possible infections <NUMBER> vs <NUMBER> p <NUMBER> proven infections <NUMBER> vs <NUMBER> p <NUMBER> spontaneous bacteremiasbp <NUMBER> vs <NUMBER> p <NUMBER> significantly higher patients receiving oral norfloxacin <NUMBER> primary prophylaxis norfloxacin <NUMBER> mgday recommended patients advanced cirrhosis childpugh score ≥ <NUMBER> serum bilirubin ≥ <NUMBER> mgdl low ascitic protein g <NUMBER> gdl either impaired renal function serum creatinine ≥ <NUMBER> mgdl blood urea nitrogen ≥ <NUMBER> mg dl hyponatremia serum sodium ≤ <NUMBER> meql rct evaluated norfloxacin prophylaxis versus intervention highrisk patients developing sbp hrs noted norfloxacin demonstrated improvement <NUMBER>month <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER>year survival <NUMBER> vs <NUMBER> p <NUMBER> significantly reduced <NUMBER>year probability developing sbp <NUMBER> vs <NUMBER> p g <NUMBER> hrs <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> addition ciprofloxacin <NUMBER> mgday <NUMBER> months also shown improve <NUMBER>year survival <NUMBER> vs <NUMBER> p g <NUMBER> <NUMBER> secondary prophylaxis norfloxacin <NUMBER> mgday advised patients experienced episode sbp rct study performed patients previous episode sbp longterm use norfloxacin <NUMBER> mgday reduced <NUMBER>year probability sbp recurrence <NUMBER> <NUMBER> <NUMBER> <NUMBER> however clear recommendation duration prophylactic antibiotics ideally continue liver transplantation lt death rifaximin preventive intervention recurrent hepatic encephalopathy recommendation either primary secondary prophylaxis sbp prospective studies necessary evaluate benefits adverse effects combined norfloxacin rifaximin therapy <NUMBER>•• downside longterm use antibiotic prophylaxis emergence resistant bacteria noted prospective study reported higher prevalence quinoloneresistant organisms patients cirrhosis receiving longterm norfloxacin prophylaxis <NUMBER> vs <NUMBER> receiving placebo p <NUMBER> <NUMBER> nonantibiotic prophylaxis eg preprobiotics fecal microbiota transplantation undergoing investigation <NUMBER>• uti common bacterial infection second frequent infection sbp accounts <NUMBER> infectious complications decompensated cirrhosis <NUMBER> isolated organisms <NUMBER> gramnegative bacteria e coli k pneumonia uti asymptomatic asymptomatic bacteriuria also encountered high frequency could possibly related frequently found residual urinary volume vesical dysfunction cirrhosis <NUMBER> <NUMBER> empirical antibiotics communityacquired uti cirrhosis include intravenous thirdgeneration cephalosporins piperacillin tazobactam associated sepsis oral quinolones trimethoprimsulfamethoxazole uncomplicated uti quinolones recommended firstline treatment already longterm norfloxacin prophylaxis <NUMBER> table <NUMBER> several studies found nosocomialacquired utis associated presence urinary catheter around <NUMBER> <NUMBER> <NUMBER> risks performance urological procedure admission also associated catheterassociated urinary tract infections cautis <NUMBER> <NUMBER>ci <NUMBER> p g <NUMBER> <NUMBER> common microorganisms isolated cautis enterococcus spp e coli p aeruginosa multidrugresistant strains <NUMBER> <NUMBER> <NUMBER> additionally patients cirrhosis urinary catheterization admission found associated mdr bacterial infections nonmdr <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> brings concern catheter withdrawal soon possible patients cirrhosis order prevent cautis hospitalized patients cirrhosis pneumonia carries highest risk mortality infections hr <NUMBER> <NUMBER> <NUMBER> development pneumonia associated severe form communityacquired pneumonia cap may associated bacteremia multilobar involvement impaired consciousness renal failure septic shock overall mortality <NUMBER> vs <NUMBER> p g <NUMBER> <NUMBER> risk hospitalacquired pneumonia hap increased setting hepatic encephalopathy tracheal intubations common pathogen cap pneumonia cirrhosis still streptococcus pneumoniae similar patients without cirrhosis predominant pathogens hap pneumonia gramnegative bacilli staphylococci also associated high mortality <NUMBER> <NUMBER> empirical antibiotic use cirrhosis hap pneumonia consists intravenous antipseudomonal cephalosporin carbapenem plus fluoroquinolone andor glycopeptide highrisk patients mrsa organisms table <NUMBER> common causative organisms cellulitis grampositive bacteria group streptococci staphylococcus aureus gramnegative organisms include e coli klebsiella spp p aeruginosa aeromonas spp vibrio spp also frequently reported cirrhosis <NUMBER> necrotizing fasciitis caused gramnegative bacteria tends concurrent bacteremia initially present septic shock <NUMBER> high awareness manifestation necessary early surgical intervention order decrease morbidity mortality empirical treatment highly effective communityacquired skin soft tissue infection ssti one third nosocomial ssti <NUMBER> broadspectrum antibiotics thirdgeneration cephalosporins combination oxacillin piperacillintazobactam promptly initiated table <NUMBER> fungal infections another cause treatment failure patients cirrhosis especially patients hospitalized intensive care units <NUMBER> alcoholic hepatitis <NUMBER> study hospitalized patients cirrhosis culturepositive infection <NUMBER> n <NUMBER> noted approximate <NUMBER> rate fungal infections <NUMBER> <NUMBER> combined bacterial fungal infection <NUMBER> <NUMBER> fungal infection fungal infection group spontaneous fungal peritonitis sfp positive ascitic fluid culture <NUMBER>n <NUMBER> fungemia positive blood culture without sfp <NUMBER> n <NUMBER> fungal infections due candida spp c albicans nearly candida species sensitive amphotericin b fluconazole voriconazole nine <NUMBER> fungal infections nosocomial infections seven <NUMBER> healthcareassociated <NUMBER> mortality rates <NUMBER> month <NUMBER> months <NUMBER> <NUMBER> respectively significantly higher bacterial infections fungal infections may occur without bacterial infections often impaired renal function creatinine <NUMBER> vs <NUMBER> mgdl p <NUMBER> healthcareassociatednosocomial settings <NUMBER> vs <NUMBER> p <NUMBER> ascitic fluid characteristics cannot distinguish sfp sbp therefore hemoculture ascitic fluid culture fungi empiric use antifungal agents may considered patients cirrhosis nosocomial infections responding empirical antibiotics therapy <NUMBER> nacseld cohort n <NUMBER> <NUMBER> patients <NUMBER> infected patients evidence fungal infections nosocomial rate fungal infections correlate etiology cirrhosis multivariable analysis noted diabetes acute kidney injury icu admission admission bacterial infection associated fungal infections auc <NUMBER> fungal infections associated aclf poor <NUMBER>day survival <NUMBER> patients alcoholic hepatitis stopah trial demonstrated higher rate infections prednisolonetreated patients nonprednisolone group <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> recent metaanalysis <NUMBER> patients severe alcoholic hepatitis <NUMBER> steroids treated found difference infection rates treated untreated corticosteroids however fungal infections higher among received corticosteroids <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> invasive aspergillosis another frequent complication seen severe alcoholic hepatitis carries high mortality thus systemic periodic screening opportunistic pathogens patients recommended <NUMBER> immunization influenza pneumococcus hepatitis b recommended patients chronic liver disease inactivated killedtype vaccinations preferable live attenuated vaccinations patients cirrhosis <NUMBER> yearly inactivated influenza vaccination provided every chronic liver disease patient due safety effectiveness protection pneumonia accounts <NUMBER> infections cirrhosis also carries highest <NUMBER>and <NUMBER>day mortality rate among sources infections <NUMBER> higher incidence greater severity pneumonia streptococcus pneumoniae cirrhosis argues administration pneumococcal vaccine adult <NUMBER> <NUMBER> years old patients cirrhosis booster dose <NUMBER> years old table <NUMBER> superimposed infection hepatitis b patients chronic liver disease cirrhosis associated increased morbidity mortality <NUMBER> <NUMBER> immunogenicity vaccinations correlated inversely degree hepatic decompensation <NUMBER> early immunization hepatitis b prior administer <NUMBER> final dose ppsv<NUMBER> ≥ <NUMBER> years old dose given least <NUMBER> year pcv<NUMBER> least <NUMBER> years recent dose ppsv<NUMBER> recommended chronic liver disease patients without serologic marker hav exposure antihav total administer <NUMBER> dose <NUMBER> <NUMBER> months havrix <NUMBER> dose <NUMBER> <NUMBER> months vaqta recommended chronic liver disease patients without serological markers hbv negative hbsag negative antihbs adult ≥ <NUMBER> years old administer <NUMBER> dose <NUMBER> μgml recombivax hb <NUMBER> <NUMBER> <NUMBER> months <NUMBER> dose <NUMBER> μgml engerixb <NUMBER> <NUMBER> <NUMBER> months patients cannot achieve seroconversion especially advanced cirrhosis may benefit highdose doubledose <NUMBER> μg strategy <NUMBER> dose <NUMBER> μgml recombivax hb <NUMBER> <NUMBER> <NUMBER> months <NUMBER> doses <NUMBER> μgml engerixb <NUMBER> <NUMBER> <NUMBER> <NUMBER> months vaccines eg td tdap zoster hpv mmr varicella chronic liver disease recommended general adult populations advanced cirrhosis live attenuated vaccinations eg zoster mmr varicella cannot yet comfortably recommended iv intravenous sbp spontaneous bacterial peritonitis bun blood urea nitrogen hbv hepatitis b virus td tetanusdiphtheria tdap tetanusdiphtheriapertussis hpv human papilloma virus mmr measlesmumpsrubella stage hepatic decompensation optimal strategy hepatitis vaccination patients decompensated cirrhosis low seroconversion rates <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus group patients may benefit postvaccination serologic testing evaluate response similarly hepatitis b vaccination noted safe high seroconversion rates patients mild moderate chronic liver disease reduced efficacy advanced chronic liver disease underwent liver transplantation <NUMBER> <NUMBER> <NUMBER> weight age patients also factors associated response rate thus patients chronic liver disease vaccinated onset advanced fibrosis cirrhosis possible conventional hepatitis b vaccination series although patients cirrhosis may benefit highdose doubledose <NUMBER> μg strategy <NUMBER> response rate <NUMBER> standard doses <NUMBER> response rate <NUMBER> <NUMBER> <NUMBER> remains controversial doubledose vaccination recommended immunocompromised status eg hiv hemodialysis chemotherapy hematopoietic stemcell transplant <NUMBER> however perspective patients cirrhosis achieve seroconversion antihbs <NUMBER> <NUMBER> miuml following vaccination course may benefit second doubledose <NUMBER> μg regimen table <NUMBER> disappointingly vaccination rates patients cirrhosis remain suboptimal retrospective study trends vaccination <NUMBER> <NUMBER> n <NUMBER> found <NUMBER> <NUMBER> <NUMBER> patients receiving pneumococcal hepatitis hepatitis b vaccine respectively following year cirrhosis diagnosis <NUMBER> adherence patients physicians vaccination guidelines paramount importance order reduce morbidity mortality vaccinepreventable diseases patients cirrhosis conflict interest sirina ekpanyapong md declares conflict interest k rajender reddy md declares conflict interest work article contain studies human animal subjects performed authors routine collection testing oral fluid samples facilitates porcine reproductive respiratory syndrome virus prrsv surveillance commercial swine herds costeffective welfarefriendly fashion however ofs often contain environmental contaminants may affect liquid handling test performance traditional processing methods eg filtration centrifugation compatible highthroughput testing burden additional processing costs time clarification using chemical flocculants alternative approach widely explored therefore evaluated effect chitosanbased clarification treatment commercial prrsv elisa serum individual ofs collected vaccinated pigs n <NUMBER> <NUMBER> <NUMBER> postvaccination subdivided <NUMBER> aliquots aliquot clarified treatment b c <NUMBER>th aliquot serving untreated control samples tested prrsv elisa immediately treatment held <NUMBER>°c retested <NUMBER> <NUMBER> <NUMBER> <NUMBER> posttreatment quantitative qualitative treatment effects evaluated kruskalwallis test found significant difference elisa sp responses among treatments days posttreatment difference detected proportion positive prrsv antibody samples among treatments cochran q p <NUMBER> treatment swine ofs using chitosanbased formulations affect performance commercial prrsv elisa chitosan flocculants could improve characteristics could adapted use field highthroughput laboratories effect chemical clarification oral fluids detection porcine reproductive respiratory syndrome virus igg angiotensinconverting enzyme<NUMBER> ace<NUMBER> expression may increase due upregulation patients using angiotensinconverting enzyme inhibitors acei angiotensin receptor blockers arbs reninangiotensin system blockers increase levels ace<NUMBER> protein facilitates coronavirus entry cells concern drugs could increase risk developing severe fatal form covid<NUMBER> impact discontinuing acei arbs patients covid<NUMBER> remains uncertain design brace corona pragmatic multicenter randomized phase iv clinical trial aims enroll around <NUMBER> participants <NUMBER> sites brazil participants identified ongoing national registry suspected confirmed cases covid<NUMBER> eligible patients using reninangiotensin system blockers aceiarbs confirmed diagnosis covid<NUMBER> randomized strategy continued aceiarb treatment versus temporary discontinuation <NUMBER> days primary outcome median days alive hospital <NUMBER> days secondary outcomes include progression covid<NUMBER> disease allcause mortality death cardiovascular causes myocardial infarction stroke transient ischemic attack new worsening heart failure myocarditis pericarditis arrhythmias thromboembolic events hypertensive crisis respiratory failure hemodynamic decompensation sepsis renal failure troponin btype natriuretic peptide bnp nterminalprobnp ddimer levels summary brace corona evaluate whether strategy continued aceiarb therapy compared temporary discontinuation drugs impacts clinical outcomes among patients covid<NUMBER> continuing versus suspending angiotensinconverting enzyme inhibitors angiotensin receptor blockers impact adverse outcomes hospitalized patients severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER>the brace corona trial j u r n l p r e p r f introduction december <NUMBER> first cases novel infectious viral respiratory illness severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> reported wuhan china highly contagious coronavirus disease caused sarscov<NUMBER> spread rapidly <NUMBER> countries declared global pandemic world health organization march <NUMBER> <NUMBER> <NUMBER> new threatening situation led rapid response medical scientific community identify main characteristics disease interventions improve outcomes patients covid<NUMBER> infectious disease emergencies ongoing covid<NUMBER> pandemic trials interventions need implemented part efforts control spread disease improve patient outcomes <NUMBER> randomized clinical trials reliable approach evaluate effects interventions <NUMBER> context public health emergencies conducting randomized clinical trial even challenging <NUMBER> shortfalls contemporary clinical trial system include increasingly prohibitive costs local national regulatory requirements delays approval unnecessary trial processes <NUMBER> past decade innovations trial design deployed facilitate trial conduct attractive solution registrybased randomized clinical trials <NUMBER> including randomization clinical registry unselected consecutive enrolment advantages prospective randomized trial aligned strengths largescale allcomers clinical registry <NUMBER> prospective registrybased randomized trials may powerful tool conducting studies efficiently costeffectively particularly urgent situation like current covid<NUMBER> pandemic patients covid<NUMBER> comorbidities worse prognosis underlying medical issues however wellknown cardiovascular risk factors commonly identified patients could also explain higher risk population <NUMBER> <NUMBER> reninangiotensin system blockers commonly used patients cardiovascular comorbidities since group drugs routinely indicated patients heart failure hypertension coronary heart disease angiotensinconverting j u r n l p r e p r f enzyme<NUMBER> ace<NUMBER> may increase due upregulation patients using angiotensinconverting enzyme inhibitors acei angiotensin receptor blockers arbs since sarscov<NUMBER> human pathogenic coronaviruses binds target cells ace<NUMBER> <NUMBER> worse prognosis patients cardiovascular disease could related interaction drugs commonly used patients may facilitate virus aggression <NUMBER> basis data indicating ace<NUMBER> effective receptor sarscov<NUMBER> healthcare professionals researchers assessing possible impact aceis arbs patients covid<NUMBER> <NUMBER> ace<NUMBER> receptor found surface type ii alveolar epithelial cells lungs well cells heart kidney liver gastrointestinal tract uncertainty surrounding reninangiotensin system inhibition patients covid<NUMBER> hypothesizing aceiarb use may increase propagation virus others hypothesizing may protective effect figure <NUMBER> <NUMBER> sarscov<NUMBER> gains entry cell binding ace<NUMBER> use acei arb could enhance ace<NUMBER> abundance consequently increase susceptibility viral entry theory effect could increase risk severity covid<NUMBER> hand increase expression angiotensin ii drives lung injury activating type <NUMBER> angiotensin receptor at<NUMBER>r producing inflammation fibrosis decreasing production angiotensin ii acei blocking angiotensin iiat<NUMBER>r activity arb enhances production angiotensin <NUMBER> angiotensin ii activates mas receptor attenuates inflammation fibrosis resulting decrease lung damage <NUMBER> indeed use recombinant human ace<NUMBER> tested promising therapy patients severe acute respiratory distress syndrome <NUMBER> finally reninangiotensin system inhibition protects cardiovascular system lowering blood pressure avoiding ventricular remodeling reducing plasminogen activator inhibitor<NUMBER> <NUMBER> thus withdrawal agents could harmful since potential risk disease complications related discontinuation established therapies already proven effective preventing cardiovascular events result j u r n l p r e p r f <NUMBER> data supporting potential benefit also data indicating potential risk maintaining agents covid<NUMBER> infection reinforces need prospective randomized study address clinical question several possible interactions medications commonly prescribed cardiovascular disease covid<NUMBER> might influence prognosis patients totality evidence taken account true equipoise maintenance suspension aceiarb therapy patients covid<NUMBER> date high quality clinical evidence confirm theories question clarified randomized clinical trial <NUMBER> initial hypothesis continuing aceiarbs beneficial overall course covid<NUMBER> infection compared withdrawing agents brace corona clinicaltrialsgov nct<NUMBER> academically led investigatorinitiated pragmatic phase iv multicenter registrybased randomized trial study openlabel blinded endpoint assessment probe include approximately <NUMBER> patients aceiarb therapy confirmed diagnosis covid<NUMBER> brace corona trial embedded registry patients covid<NUMBER> admitted <NUMBER> sites brazil patients first <NUMBER> eligible trial approached randomized maintenance discontinuation reninangiotensin system inhibition data necessary documenting baseline characteristics outcomes including acei arb doses collected already registry figure <NUMBER> study protocol approved national commission research ethics conep brazilian ministry health study conducted compliance protocol adheres fully ethical principles declaration helsinki specifications international j u r n l p r e p r f <NUMBER> council harmonisation good clinical practice protocol requires patient must provide informed consent study procedure initiated primary objective trial determine whether continued use versus discontinuation aceiarb therapy increases days alive hospital <NUMBER> days patients reninangiotensin system inhibition hospitalized covid<NUMBER> secondary objectives compare impact continued use versus discontinuation reninangiotensin system inhibition covid<NUMBER> disease severity allcause mortality cardiovascular death acute myocardial infarction new worsening heart failure hypertensive crisis transient ischemic attack stroke <NUMBER> days addition incidence myocarditis pericarditis arrhythmias requiring treatment thromboembolic phenomena respiratory failure hemodynamic decompensation sepsis renal failure compared groups <NUMBER> days cardiovascular biomarkers related covid<NUMBER> troponin btype natriuretic peptide bnp nterminalpro hormone bnp ddimer also assessed patients hospitalized suspected diagnosis covid<NUMBER> included registry followed diagnosis confirmed refuted patients ≥<NUMBER> years age confirmed diagnosis covid<NUMBER> chronic reninangiotensin system inhibitor aceiarb therapy assessed brace corona trial based international data around <NUMBER> <NUMBER> patients included brace corona diagnosis hypertension <NUMBER> <NUMBER> would diagnosis heart failure <NUMBER> <NUMBER> patients using sacubitrilvalsartan heart failure included trial patients using three antihypertensive agents hospitalized heart failure j u r n l p r e p r f <NUMBER> last <NUMBER> months eligible randomization patients clinical indication stop aceiarb therapy hypotension acute kidney injury andor shock excluded table <NUMBER> eligible patients randomized using <NUMBER> allocation ratio either continue aceiarb therapy group <NUMBER> discontinue aceiarb therapy <NUMBER> days group <NUMBER> patients randomized group <NUMBER> change reninangiotensin system blocker therapy result covid<NUMBER> dose adjustments concomitant therapies discretion treating physician patients randomized group <NUMBER> discontinue acei arb therapy <NUMBER> days agents replaced drugs needed discretion treating physician beta blockers maintained patients already using heart failure study protocol recommend treatment modification beyond reninangiotensin blockers use hydralazine nitrates preferred patients heart failure commonly used preferred treatment cannot tolerate acei arb therapy patients heart failure deteriorate medication withdrawal managed based hemodynamic profile use diuretics vasodilators type b profile among vasodilators preference acute phase short halflife medications possibility using parenteral agents nitrates associated hydralazine reintroduction acei done clinical compensation preferably <NUMBER> days randomization stable renal function patients hypertension study protocol recommends thiazide calcium channel antagonists hydralazine preferred options patients already using one classes antihypertensive agents may used based patient physician preferences eg betablockers commonly used patients ischemic heart disease heart j u r n l p r e p r f <NUMBER> failure thus beta blockers recommended firstline agents unless presence heart failure ischemic heart disease <NUMBER> cases used regardless blood pressure control study team assist treating physicians process drug replacement decisions based current guidelines since brace corona pragmatic study types acei arbs used defined according local practice following international guidelines <NUMBER> <NUMBER> <NUMBER> details around different types reninangiotensin system blockers reported publication results since currently specific intervention proven beneficial treatment covid<NUMBER> patients treated according current local standards supportive care without systematic use experimental therapies study treatment compliance assessed based medical prescription hospitalization discharge data collected systematically patients included covid<NUMBER> registry brace corona trial data collected include demographics cardiovascular risk factors relevant medical surgical histories clinical characteristics concomitant medications laboratory data data collection performed hospitalization discharge phone call <NUMBER> days capture clinical events discharge flowchart including registry clinical trial populations presented figure <NUMBER> detailed information collected study visit provided supplementary appendix j u r n l p r e p r f <NUMBER> primary outcome study days alive outside hospital daoh <NUMBER> days endpoint calculated patient calculation date randomization <NUMBER> days postrandomization daoh endpoint represents followup time <NUMBER> days subtracted hospitalization days andor days death end followup pragmatic endpoint encompasses time death also potential nonfatal complications could lead prolonged hospitalization sensitivity analysis using hierarchical approach death receiving zero daoh length hospitalization also performed main cardiovascular complications could prolong hospitalization lead death assessed individually secondary outcomes independent clinical events committee whose members unaware randomization assignment adjudicate following secondary clinical outcomes death vascular causes myocardial infarction new worsening heart failure stroke transient ischemic attack <NUMBER> days potential events detected electronic case report forms patients included trial generate alert upload source documents adjudication process detailed definitions secondary outcomes described supplementary appendix initial expected sample size brace corona around <NUMBER> patients however number may increase decrease according recruitment rate event rate data safety monitoring board dsmb assessments efficacy safety futility assuming standard deviation <NUMBER> days daoh <NUMBER> days based ongoing coalizao study brazil nct<NUMBER> <NUMBER> patients <NUMBER> power detect mean ration least <NUMBER> estimate full cohort patients enrolled <NUMBER> <NUMBER> months however may extended depending recruitment rate currently randomized studies field reported outcomes event rates inform calculations accurate sample size order maintain benefits randomization primary analysis follow intentiontotreat principle continuous variables described medians <NUMBER>th <NUMBER>th percentiles mean ± standard deviation according distribution medians compared using kruskalwallis test means compared using ttest categorical variables described absolute relative frequencies proportions compared using chisquare test pvalues <NUMBER> considered statistically significant primary outcome measured daoh <NUMBER> days analysis based median outcome analysis distribution daoh <NUMBER> days presented histograms two groups without discontinuation reninangiotensin system inhibitors median <NUMBER>th <NUMBER>th percentiles general population group calculated comparison groups made using quasipoisson model results presented mean ratios study groups respective <NUMBER> confidence intervals interaction tests performed specific subgroups including sex male vs female age <NUMBER> vs ≤<NUMBER> years days symptoms divided tertiles history myocardial infarction vs history stroke vs history heart failure vs history hypertension vs use acei vs use arb length acei arb use prior enrollment secondary endpoints mortality <NUMBER> days cardiovascular events <NUMBER> days compared log binomial models reporting relative risks respective <NUMBER> confidence intervals analyses performed using r software current version investigatorinitiated study financial support dor institute research education idor extramural funding used support work study coordinated idor brazilian clinical research institute bcri institutions coordinate data management idor manage electronic clinical report form database bcri manage clinical events adjudication database executive steering committees together operational teams idor bcri oversee medical scientific operational conduct study executive steering committee members responsible reporting results drafting editing forthcoming manuscripts authors solely responsible design conduct study study analyses drafting editing paper final contents independent dsmb monitor safety efficacy data ongoing basis access unblinded data dsmb review primary outcome study well secondary outcomes weekly evaluations also <NUMBER> formal interim analyses including hf group dsmb use pvalue <NUMBER> interim analyses declare statistically significant difference outcomes study groups guide recommendations <NUMBER> <NUMBER> overall pvalue <NUMBER> used declare statistical significance end study independent clinical events classification committee adjudicate causes death clinical outcomes described secondary outcomes death myocardial infarction stroke hypertensive crisis new worsening heart failure majority patients affected covid<NUMBER> favorable clinical outcomes acute phase infection <NUMBER> nevertheless risk severe forms infection increases significantly according age presence chronic comorbidities <NUMBER> <NUMBER> among comorbidities j u r n l p r e p r f cardiovascular diseases particularly important intrinsic risk adverse outcomes prevalence conditions global population <NUMBER> <NUMBER> hypertension diabetes heart failure coronary heart disease common comorbidities associated worse prognosis among patients covid<NUMBER> however higher risk detected group could also due related factors may facilitate infection increase propagation virus <NUMBER> reninangiotensin system inhibitors routinely used common cardiovascular conditions <NUMBER> <NUMBER> <NUMBER> benefits reducing cardiovascular events well established mainly longterm analyses patients chronic use therapies <NUMBER> <NUMBER> however acute clinical conditions drugs temporarily discontinued due imminent risk higher potential shortterm benefit therapies <NUMBER> currently intense debate suspension maintenance chronic aceiarb therapy patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> brace corona trial designed test impact discontinuation compared maintenance chronic aceiarb therapy patients covid<NUMBER> one several questions facing physicians setting covid<NUMBER> data needed randomized clinical trials like brace corona reninangiotensin system inhibitors increase levels ace<NUMBER> protein facilitates coronavirus entry cells concern drugs could increase risk developing severe fatal form covid<NUMBER> <NUMBER> presence ace<NUMBER> alveolar epithelial cells makes lungs preferred site entry virus explains respiratory manifestations patients covid<NUMBER> hypothesis worse outcomes associated use acei arb patients covid<NUMBER> recently shown observational studies <NUMBER> <NUMBER> however causeeffect relation use acei arb adverse events covid<NUMBER> cannot established since many confounding factors could explain worse better prognosis patients observational analyses recent retrospective study hospitalized covid<NUMBER> patients allcause mortality lower among patients aceiarb therapy compared using aceiarbs <NUMBER> observational analysis singlecenter study showed aceiarb use associated severity covid<NUMBER> infection worse outcomes hospitalized patients hypertension <NUMBER> j u r n l p r e p r f <NUMBER> nonetheless effect reninangiotensin system inhibition ace<NUMBER> uncertain potential harm related mechanism well defined <NUMBER> <NUMBER> addition use acei arbs could beneficial due wellknown cardiovascular protection <NUMBER> also potential respiratory system protection patients affected severe respiratory disease <NUMBER> <NUMBER> considering highrisk patients cardiovascular disease covid<NUMBER> commonly hospitalized decision regarding best approach management reninangiotensin system inhibitors critical scenario apparent equipoise without high quality scientific evidence medical decisions clinical practice heterogeneous thus randomized clinical trial necessary guide practice multicenter randomized clinical trial conducted pandemic follow steps commonly adopted pivotal phase iii trials however critical urgent nature pandemic encourages opportunities create efficient research processes adopted use clinical research conducted nonpandemic times new threatening situation like covid<NUMBER> pandemic specific evidence guide medical therapy yet urgent need quickly answer clinical questions arise order guide treatment hundreds thousands people infected potentially lethal disease collaborative pragmatic studies one best solutions scenario <NUMBER> brace corona took less <NUMBER> weeks protocol development first patient randomized including national ethics board review approval unprecedented brazil figure <NUMBER> covid<NUMBER> registry already collecting key clinical variables outcomes used randomized trial adding randomization structure allows efficient process provide scientific community streamlined approach answer relevant clinical question less bureaucracy lower cost addition clinicians frontline already interested answering medical question highly engaged trial source documents potential events adjudicated clinical events classification committee since many different complications could occur due interaction covid<NUMBER> baseline cardiovascular condition therapies used patients primary study outcome chosen brace corona daoh <NUMBER> days also pragmatic encompasses potential effect j u r n l p r e p r f <NUMBER> relevant medical complication therefore regardless type inhospital complication captured study daoh ultimately represent meaningful outcome net benefit patients perspective efficient model registrybased randomized trial first kind brazil already applied successfully countries <NUMBER> <NUMBER> represents unique opportunity global crisis covid<NUMBER> could serve important legacy medical community brace corona multicenter randomized trial patients hospitalized covid<NUMBER> reninangiotensin system blockers aims determine whether discontinuation compared maintenance drugs increases days alive hospital results study help guide may result alveolar collapse due loss surfactant type li cells acute lung injury reninangiotensinaldosterone system raas angiotensin ang converted angiotensin ii ang ii ace ang ii mediates vasoconstrictive proinflammatory prooxidative prothrombotic effects possibly increasing levels pai<NUMBER> agonism ang ii type <NUMBER> receptor at<NUMBER>r ace<NUMBER> converts ang ii angiotensin <NUMBER> finally binds mas receptor masr mediates many beneficial actions including vasodilation antiinflammatory antioxidant antiapoptotic effects thus ace<NUMBER>ang <NUMBER>masr axis opposite actions aceang iiat<NUMBER>r axis ace<NUMBER> limits adverse vasoconstrictor profibrotic effects ang ii degradation counteracting actions formation ang <NUMBER> sarscov<NUMBER> binding ace<NUMBER> may attenuate residual ace<NUMBER> activity consequence increased internalization shedding ace<NUMBER> cell surface tipping aceace<NUMBER> balance predominant aceang iiat<NUMBER> axis signaling ang ii may foster pulmonary vasoconstriction inflammatory oxidative organ damage ultimately progressing towards acute lung injury different postulated mechanisms inhibition raas acei arb might dangerous protective covid<NUMBER> acei arbs could theoretically increase risk sarscov<NUMBER> infection severe covid<NUMBER> owing role ace<NUMBER> viral binding site although aceis arbs directly affect ace<NUMBER> activity premise based part findings studies aceis arbs may increase ace<NUMBER> levels thus enhance viral entry aceis arbs may mitigate covid<NUMBER> attenuating ang iimediated acute lung impairment decreasing production ang ii acei blocking ang iiat<NUMBER>r actions arb may reduce levels prothrombotic substances pai<NUMBER> intensify formation ang <NUMBER> ace<NUMBER> activation masr attenuates inflammation fibrosis consequently may attenuate lung damage lymphoid tissue gastrointestinal tract central component bodys immune system major site exposure foreign antigenic materials present microorganisms food patterns lymphocyte sensitisation result widespread implications health disease capacity develop protective immunity carries potential coincidental tissue damage occur onset hypersensitivity reactions patients implies presence various predisposing factors include mode presentation antigen competence immune system encountered genetic constitution individual concerned importance factors appreciated context normal physiology immune system gut object paper discuss clinical relevance paediatric practice particularly relation gastrointestinal infections food allergy immune response requires afferent limb present antigen lymphocytes capable recognition proliferation efferent limb disseminate immunocompetent daughter cells able produce specific antibody lymphokine site antigen exposure clear gut uniquely structured promote antigenlymphocyte interaction large proportion bodys lymphocytes reside gastrointestinal tract scattered throughout length lamina propria epithelium aggregations occurring peyers patches appendix tonsils cells present include two distinct populations lymphocytes one passed thymus maturation participates cellmediated reactions cells one first described bone marrow able produce antibodies b cells afferent lymphatics early concepts antigen access mucosa assumed molecules could pass epithelial cells points apparent peyers patches covered specialised epithelium preferentially allows antigen entry <NUMBER> beneath epithelium lies dome area contains large proportion lymphocytes overlies area ceil traffic <NUMBER> <NUMBER> containing postcapillary venules macrophages b lymphocytes <NUMBER> sensitised cells pass efferent lymphatics mesenteric lymph nodes thence thoracic duct circulation b cell proliferation occurs outside patches characteristically taking place draining lymph nodes spleen <NUMBER> efferent limb immune response mediated lymphocytes return populate mucosa several complicated patterns recirculation identified animals <NUMBER> clearly system allows widespread distribution antigenreactive cells throughout mucosa way elegant efficient immunologically mediated changes gut recognised many years include luminal antibody production cellular infiltration mucosa development immunoglobulin producing cells lamina propria changes reflect gut immune responses include presence circulating antibodies food proteins anaphylactic reactions evidence complement activation following oral challenge development mucosal enteropathies related ingested antigen infections correlation observations classical types iiv immune reactions described gell coombs <NUMBER> proved difficult ability gut produce protective antibodies bacillary dysentry regardless serum antibody levels shown besredka <NUMBER> davies <NUMBER> early <NUMBER>s <NUMBER> years later iga recognised predominant immunoglobulin external secretions <NUMBER> lamina propria <NUMBER> synthesised dimer mucosa becomes associated secretory component produced epithelial cells capacity newborn produce iga impaired <NUMBER> establishment normal population immunoglobulinbearing cells mucosa appears closely related intestinal contents <NUMBER> iga antibodies active bacteria viruses toxins also prevent bacterial adherence mucosa <NUMBER> rats shown prevent albumin absorption following intragastric immunisation <NUMBER> modulation antigen access profound implications cells producing immunoglobulin classes also found lower numbers mucosa igg igm ige demonstrated intestinal secretions igm may associated secretory component igg ige thought derived plasma context distribution ige producing lymphocytes body noteable particularly found mucosae <NUMBER> date difficult study cellular immune reactions gut essential histological features human small bowel enteropathies mimiced allograft rejection studies mice <NUMBER> graftversushost disease <NUMBER> common factor situations local cellmediated immune reaction direct evidence functional lymphocytes small intestine come studies lymphokine production ferguson et al <NUMBER> showed migration inhibition factor released jejunal biopsy specimens patients coeliac disease incubated alphagliadin important model study cellmediated immunity gut parasitic worm infection rodents inbred rats subjected neonatal thymectomy significantly greater infection control animals <NUMBER> <NUMBER> system unlikely mechanism concerned confined classical cellmediated reaction parasite n brasiliensis known stimulate remarkable ige production response particularly dependent tb cell interaction partial villous atrophy occurs nematode infection develop thymusdeprived rats <NUMBER> cellular infiltration columnar epithelium lamina propria well documented jejunal enteropathies <NUMBER> <NUMBER> function intraepithelial lymphocytes remains obscure currently thought effector cells <NUMBER> sentinel position mucosal surface suggests important role infrastructure cellular cooperation underlies immune reactions yet identified gut subpopulations suppressor helper lymphocytes eventually recognised vivo evidence cellmediated immunity antibody dependent cellular cytotoxicity doubtless emerge specific immunological unresponsiveness known tolerance induction tolerance parenteral antigen previous oral immunisation originally shown chase <NUMBER> <NUMBER> mechanisms still understood suggested iga binding antigen molecules either reduces uptake renders tolerogenic shown feeding ovalbumin mice reduces subsequent absorption simultaneously inducing state systemic tolerance <NUMBER> introduction minute amounts hapten portal system similarly produces tolerance <NUMBER> mechanism antigen handling may thus crucial development nondevelopment immunity evidence hypersensitivity reactions <NUMBER> occur gut man relevance disease states type immediate hypersensitivity reactions involve ige antibodies combination antigen release histamine vasoactive substances role gastrointestinal disorders man uncertain although symptoms diarrhoea vomiting urticaria asthma may follow ingestion specific proteins rarely obvious correlation circulating ige antibodies <NUMBER> studies ige antibody activity mucosa required animals worm infestations type reactions appear concerned expulsion parasite associated specific antinematode ige antibodies type ii cytotoxic hypersensitivity reactions involve complement fixing antibodies antigens form integral part become attached surface individuals cells reactions usually described affecting red cells white cells platelets circulation demonstration ofautoantibodies conclusive evidence primary secondary significance confirmation type ii mechanisms operate gastrointestinal disease however locally secreted antibodies reacted epithelial cellmembrane constituents would difficult demonstrate unequivocally type iii arthus type hypersensitivity reactions develop antigenantibodycomplement complexes occur tissue damage results generation chemotactic factors local changes capillary permeability aniibody classes capable complement activation igm igg iga unable fix complement classical pathway although aggregated secretory iga activate complement alternate pathway evidenced bacteriolysis <NUMBER> low concentrations complement found intestinal secretions complement components readily inactivated proteolytic enzymes nevertheless complement activation documented serum following cows milk protein challenge sensitive individuals <NUMBER> following gluten challenge coeliac disease <NUMBER> likely changes reflect type iii reaction lamina propria antigen gained access across damaged epithelium type iv delayed hypersensitivity reactions occur antigen antigensensitive lymphocytes exemplified mantoux test although seems likely discussed cellular immune reactions occur mucosa vivo evidence inconclusive peripheral lymphocyte stimulation presence subfraction gluten reported patients coeliac disease <NUMBER> however interpretation controversial significance circulating antibodies dietary antigens individual patients normal bacterial flora gut determined interactions host microorganisms nonimmune factors important include lactoferrin lysozymes proteolytic enzymes integrity glycocalyx contribution immunological mechanisms examined immunodeficiency disorders commonest selective iga deficiency interestingly patients symptomfree increased susceptibility gastrointestinal infection although giardia lamblia infestation enteropathies well recognised occur <NUMBER> giardiasis common hypogammaglobulinaemia <NUMBER> however children cellular immune defects digeorge syndrome severe combined immunodeficiency suffer greatest incidence bacterial fungal viral infections <NUMBER> <NUMBER> pathogenicity strains ofe coli determined ability adhere mucosa capacity produce enterotoxin animals adherence linked presence genetically determined mucosal receptors <NUMBER> mucosa capable producing specific iga antibodies e coli <NUMBER> protective role clear shown neonatal animals fed colostrum passively transferred immunoglobulins protective <NUMBER> man gastroenteritis necrotising enterocolitis less common breastfed infants <NUMBER> <NUMBER> development vaccine complicated changing serotypes organisms immunisation enterotoxin might practical choleratoxin binding microvilli blocked antibody <NUMBER> vivo application awaited recognition rotavirus coronavirus similar particles faeces done much explain high proportion diarrhoeal diseases man animals bacteriological cause found studies piglets shown maternal colostrum protective <NUMBER> preparation specific vaccine practical proposition <NUMBER> aspects mucosal immunology poliovirus well studied development sabin vaccine findings indicated oral live attenuated vaccineprovoked protective immunity principally localised secretory iga despite finding mechanisms implicated work mebus et al <NUMBER> showed immunity calf gastroenteritis virus preceded appearance specific antibody activity association malnutrition increased susceptibility infection <NUMBER> important cause mortality malnutrition may compromise mucosal immunity nutritional status impaired consequences infection anorexia dehydration malabsorption clear discussion abnormalities antigen presentation lymphocyte responsiveness could predispose development hypersensitivity reactions bowel mucosa currently diagnostic investigation unequivocally establishes occurred many screening tests suggested reflect changes remote gut interpretation positive skin tests circulating antibodies food proteins notoriously unreliable clinician must still rely meticulous observation find many childrens symptoms may reproducible patients nonimmunological mechanisms may involvedsuch lactose malabsorption nevertheless food allergy exist commonly found association cows milk egg protein children present gastrointestinal symptoms patients react immediately others symptoms delayed evident clinically experimentally several different types reactions occurring clearer understanding fundamental basis differences distinction primary secondary phenomena blurred current views suggest group infants become sensitised cows milk protein episode gastroenteritis <NUMBER> hypersensitivity relatively shortlived even group presence jejunal enteropathy always associated continuing disturbances suggested infants symptomatic exposure cows milk breast feeding may sensitised neonatal period time mucosal iga production immature <NUMBER> interesting see current upsurge breast feeding use hypoallergenic milks discernible effect gastrointestinal disorders infancy later life balance required gastrointestinal tract selective absorption nutrients mucosal defence thus resulted development complex immune system inaccessibility epithelium vascular drainage examination experimentation heightened obscurity application modern techniques endoscopy tissue culture cell separation lymphocyte identification offer exciting prospects future relevance aberrations gut immune system disease become truly apparent covid<NUMBER> infections breached five million mark yet neither vaccine scalable treatment sight <NUMBER> <NUMBER> furthermore distinctive feature covid<NUMBER> contrast infectious diseases influenza sars presence large fraction asymptomatic patients dont obvious symptoms still capable infecting susceptible individuals contacts however identifying individuals spreading infections via asymptomatic pathway easy unless extensive contact tracing testing performed major challenge uncertainty estimation asymptomatic fraction estimates ranging <NUMBER> <NUMBER> infected <NUMBER> <NUMBER> along symptomatic pathway <NUMBER> infections spread onset symptoms rendering quarantining people symptoms less efficient compared infectious diseases <NUMBER> challenges driven governments implement nonpharmaceutical interventions npis social distancing partial full lockdowns <NUMBER> unsaid posteriori rationale lockdowns provide efficient isolation mechanism asymptomatic however dearth quantitative understanding effects lockdown triggered debate around effectiveness duration mode partial vs full lockdown thus even suggested societies move unhindered manner towards attainment herdimmunity threshold <NUMBER> threshold achieved sufficiently large proportion population becomes immune result disease spread slows covid<NUMBER> estimating onset herd immunity remains elusive indeed ascertaining whether herd immunity exists moreover high case fatality rate <NUMBER> − <NUMBER> vs <NUMBER> seasonal influenza limits practicality herd immunity effective policy tool thus models provide quantitative estimates disease spread impact policy measures expeditiously required similar epidemicspandemic three different kinds models used covid<NUMBER> <NUMBER> statistical extrapolation models fit observed patterns infections make shortterm prediction <NUMBER> <NUMBER> <NUMBER> agent based models qualitative illustration microscopic dynamics spreading infections <NUMBER> <NUMBER> compartment models divide population groups based current different disease state individual model interaction among <NUMBER> <NUMBER> <NUMBER> <NUMBER> since <NUMBER> plague mumbai compartmental models standard guiding tool policy decisions <NUMBER> spread flulike diseases influenza sars covid<NUMBER> etc often modelled using three four compartments susceptibleinfectedrecovered sir susceptibleexposedinfectedrecovered seir variants also consider theoretically simple containment option quarantining infected persons symptoms however models assume contact compartments leads new infections implicit assumption contact e compartments lead infection contrast asymptomatic patient covid<NUMBER> infect susceptible individuals contact thus epidemiological models must consider distinction asymptomatic symptomatic moreover models distinguish lockdown quarantine two qualitatively different policy tools former operating level society latter level individuals letter aim model novel aspects covid<NUMBER> accomplish three goals corporating mentioned unique aspects covid<NUMBER> disease spread associated policies observed epidemiological data sheds light underlying parameters universalities govern dynamics different phases pandemic spread containment <NUMBER> use model address pertinent questions beyond readily measurable estimates hidden asymptomatics fraction symptomatic infections herd immunity would achieved accomplish objectives introducing sair model treats infections asymptomatic infected symptomatic person equally likely dynamical behavior model quite different seir model model takes account lockdown explicit fashion using discontinuous time reproduction rate effective rate susceptible population get converted infected give implicit closedform solution sair model sheds light dynamics sair model also leads methods estimating parameters therein order make parametric form readily computable also introduce approximate explicit representation provide method estimating parameters model based evolution disease extract underlying countryspecific parameters infection data show exists intermediate regime immediately lockdown countryspecific country specific metrics success lockdown extracted analyzed show herd immunity covid<NUMBER> achieved total symptomatic infections around <NUMBER>−<NUMBER> population lower estimated begin emphasizing difference seir sair models <NUMBER> typical seir model assumes framework serial directed transitions across intermediate health states individuals fig<NUMBER> framework infections caused susceptible person comes contact person deemed infected person basis symptoms however contact certain likelihood person remains presymptomatic intermediate state exposed individual e contagious transitioning contagious symptomic state framework acceptable influenza sars epidemiology covid<NUMBER> alternative pathway susceptible recovered states r passes asymptomatic individuals estimated around <NUMBER> <NUMBER> never show symptoms carry enough viral load infect others thus model covid<NUMBER> consider two parallel pathways infection figure <NUMBER>b consider generalized version sair model representation homogenously mixed population segment covid<NUMBER> spreading system obey following sair dynamicṡ variable x time derivative denoted aṡ x dxdt assume αt denotes probability susceptible person meets infected asymptomatic person become part asymptomatics simplicity includes presymptomatics asymptomatics formulation model claim lockdown modeled considering sudden change infection rate constant using heavyside function αt α <NUMBER> ht lock − note passing one model social distancing reduction value α imperfect lockdown minimal model one may assume asymptomatic patients either get converted symptomatic one effective rate δ recovers rate γ term typically absent standard models denotes fact idealized lockdown susceptible person meets infected person thus first order reaction changes zeroorder reaction proceed analyse model wish point one may add complication model introducing parameters compartments example recovery rate γ infection rate α need asymptomatic symptomatic fraction <NUMBER> however biological evidence contrary assume rates equal leads analytically tractable simplified framework however reality large country unrealistic consider homogenously mixed population crisis learnt lockdown announced people migrate across different segments country even qualitatively correct modeling disease spread dynamics important account migration people migration indeed happen many waves however simplicity assume happens short duration lockdown furthermore one would expect among infected population asymptomatic people able travel needs reminded interested influx infected population given population segment details came order model scenario take typical thermodynamic route dividing system two parts system universe finally cou short period time post lockdown population migration allowedpossible migration characteristic system country region consideration parameters β need extracted data rest world also assumed purpose following similar sair dynamicṡ eq<NUMBER> <NUMBER> complete development covid<NUMBER> specific model present work solved phenomenological model wellmixed society everyone interacting everyone else however interactions may structured age local movement population many modelled framework agent based models formulation disease specific interactions developed also integrated models study interactions agent level detail tandem economic consequences <NUMBER> beyond scope present work emphasis mainly spread infections societal level show set equations model sufficient capture available epidemiological data covid<NUMBER> system equations solved prelockdown situation terms reproduction rate r <NUMBER> α <NUMBER> γ defining observing lockdown solved terms ofs ss <NUMBER> r <NUMBER> instant <NUMBER> denotes susceptible population <NUMBER> recovered population <NUMBER> taken <NUMBER> hand idealized lockdown susceptible person meets infected person thus first order reaction changes zero order reaction intermediate time lock lock solution simplifies flux asymptomatic individuals equations yield exponential decay given <NUMBER> substituting expression eq<NUMBER> evolution equation gives us parametric solution implicit form assuming equation converted explicit form fors function possible substitute eq<NUMBER> obtain expression function finally expression disambiguated separate expressions using eq<NUMBER> specifically equation fori̇ substitute − giveṡ define new constant δ <NUMBER> γ δ solution equation therefore key turn eq <NUMBER> explicit expression extent possible purpose use hermitehadamard inequality logarithm <NUMBER> z suggests use approximate form logarithm log z z − <NUMBER>w <NUMBER> z w <NUMBER> constraint w <NUMBER> w <NUMBER> <NUMBER> upon approximating logarithm get solution explicit form <NUMBER> r <NUMBER> − w <NUMBER> r <NUMBER> b r <NUMBER> w <NUMBER> − w <NUMBER> r <NUMBER> w <NUMBER> r <NUMBER> h <NUMBER> <NUMBER> − b − h<NUMBER> − b h h constant h √ b <NUMBER> − <NUMBER>ad evolution equation known closed find evolution remaining variables using eq <NUMBER> table <NUMBER> evolution infections prelockdown early time limit given k r <NUMBER> − <NUMBER> g <NUMBER> r <NUMBER> − <NUMBER> solution post lockdown given  eqs <NUMBER> eq <NUMBER> managed contact tracing quarantine hence addressing solution lockdown arise covid<NUMBER> thus presented unique infection scenarios challenges lockdown mitigation model closed formsolution address uniquene aspects reported infection data different countries three regimes rising intermediate decreasing implemented lockdown easily assumed reported infections symptomatic infections since countries short testing resources result patients tested confirmation onset symptoms equations derived could fit three different regimes process could extract governing parameters parameter α <NUMBER> γ δ <NUMBER> estimated fitting eq <NUMBER> eq<NUMBER> eq<NUMBER> respectively publicly available data pertaining pre post lockdown period various countries see supplemental material <NUMBER> parameters α <NUMBER> representing rise similar many countries reiterating universal pattern initial prelockdown regime understood intrinsic characteristic dynamics covid<NUMBER> exhibits strong similarities across countries see table <NUMBER> supplemental material <NUMBER> much stronger countryspecific disease dynamics intermediate regime described using parameter β <NUMBER> formal solution eq <NUMBER> fit infection rate right lockdown estimate parameter β <NUMBER> α see supplementary figs<NUMBER> expected migration lockdown expected countryspecific event dictated prevalent socialpolitical conditions blue red lines indicate maxima considering symptomatic total infections respectively infection rate slows significantly herdimmunity achieved combined infections reach peak symptomatic infections crossed ≈ <NUMBER> total population peak symptomatic infections achieved around <NUMBER> final saturation value around <NUMBER> validations levels infections observed different countries parameters extracted could estimate number individuals individual compartments r changed time without lockdown fig<NUMBER> impossible test entire population even significant fraction asymptomatics remained missing link epidemiology although certain estimates suggest <NUMBER> ratio sympomatic asymptomatic individuals using model could estimate ratio asymptomatic symptomatic individuals supplementary fig <NUMBER> varies <NUMBER> <NUMBER> depending phase pandemic dynamics results show herdimmunity defined fraction population symptomatic infections reach peak beyond begin decreasing could achieved <NUMBER> population illustrated fig<NUMBER> table <NUMBER> supplementary informationthese estimates herdimmunity single digit percentages seem contradictory estimates <NUMBER> <NUMBER> one realises large fraction infections asymptomatic accounting total infection <NUMBER> population supplementary table <NUMBER> thus model allowed us make estimates hiddenasymptomatics herdimmunity fraction symptomatics burden health care system conclusion part analysis able provide method estimating asymptomatic fraction population finally fitting model data countries pandemic appears peaked also able estimate level herdimmunity able show herdimmunity achieved levels <NUMBER> <NUMBER> far lower levels suggested literature find sair model readily adapted incorporate effects lockdown solution system equations bears striking resemblance realworld data formal solution allows one evaluate effect lockdown policy tool also integrated frameworks study economic consequences lockdowns simply written form solution upon integrating integration variable b <NUMBER> <NUMBER>ad equation rewritten using identity −i arctanix arctanhx using identity arctanhx <NUMBER> <NUMBER> log x<NUMBER> thus using approximation <NUMBER> gives us analytically tractable solution susceptible population section discuss estimation procedure parameters α <NUMBER> γ δ analytical solutions infectedactive recovered populations known prediscussed section post lockdown scenarios analytical solutions fit onto real time data several countries give us estimate parameters relevant covid<NUMBER> begin post lockdown scenarios solutions rather straight forward number days post lockdown recovery rate given bẏ <NUMBER> infection given using eq <NUMBER> k r <NUMBER> − <NUMBER> g <NUMBER> r <NUMBER> − <NUMBER> solution post lockdown given l exp−δ <NUMBER> β <NUMBER> <NUMBER> − ht − <NUMBER> objective present covid<NUMBER>associated gbs prototypic viraltriggered autoimmune disease context emerging covid<NUMBER>triggered autoimmunities discuss potential concerns ongoing neuroimmunotherapies methods eleven gbs cases four key covid<NUMBER> hotspots discussed regarding presenting symptoms response therapies crossreactivity covid spike proteins nerve glycolipids emerging cases covid<NUMBER>triggered autoimmune necrotizing myositis nam encephalopathies also reviewed context viral invasion autoimmunity ongoing immunotherapies results collective data indicate pandemic patient presenting acute paralytic diseaselike gbs encephalomyelitis myositiseven without systemic symptoms may represent first manifestation covid<NUMBER> anosmia ageusia cranial neuropathies lymphocytopenia red flags enhancing early diagnostic suspicion millerfisher syndrome ganglioside antibodies gd<NUMBER>b instead qg<NUMBER>b found covid<NUMBER> spike protein also binds sialic acidcontaining glycoproteins cellentry antigd<NUMBER>b antibodies typically cause ataxic neuropathy crossreactivity covid<NUMBER>bearing gangliosides peripheral nerve glycolipids addressed elevated creatine kinase <NUMBER> reported <NUMBER> covid<NUMBER>infected patients two patients presented painful muscle weakness responding ivig indicating covid<NUMBER>triggered nam overlooked entity cases acute necrotizing brainstem encephalitis cranial neuropathies leptomeningeal enhancement tumefactive postgadoliniumenhanced demyelinating lesions emerging need explore neuroinvasion autoimmunity concerns modificationsif anyof chronic immunotherapies steroids mycophenolate azathioprine ivig antibcell agents addressed role complement innate immunity viral responses anticomplement therapeutics ie eculizumab reviewed conclusions emerging data indicate covid<NUMBER> trigger gbs autoimmune neurological diseases necessitating vigilance early diagnosis therapy initiation although covid<NUMBER> infection like viruses potentially worsen patients preexisting autoimmunity evidence patients autoimmune neurological diseases stable common immunotherapies facing increased risks infection guillainbarré syndrome first documented covid<NUMBER>triggered autoimmune neurologic disease come myositis offing especially significant viral diseases due rapid changes viral genome regardless consists dna rna allows drawing conclusions origin virus lineage andor influence immunologic environmental pressures like introduction vaccination campaigns climate changes latter implicate authors opinion researcher working molecular epidemiology infectious disease knowledge actual situation field certainly help avoid proposal wrong hypotheses equally important aware techniques used eg phylogenetic analysis selection pressure analysis based hypotheses models intrinsic assumptions biases fuzziness furthermore general awareness illusion particularly derived nucleotide sequence information knowledge viral genetics beside quasispecies structure rna virus populations manifold possibilities virushost interactions still understand review gives minimum background information needed understanding molecular epidemiology footandmouth disease virus presents current developments within field first indication footandmouth disease fmd literature found book italian physician hieronymi fracastorii wright <NUMBER> describes cattle disease similar signs fmd since several indications fmd found literature thalmann nockler <NUMBER> second half <NUMBER>th century account increase animal trade due development new transport routes orourke williamson <NUMBER> disease became important started cause severe economic losses germany <NUMBER> commission set prussian ministry culture following request partei der landwirte reichstag set measures fmd control rott siddell <NUMBER> one year later friedrich loeffler paul frosch wrote report causative agent fmd neither known bacterium toxin ultravisible ultrafilterable substance loeffler frosch <NUMBER> described thereby first animal virus footandmouth disease virus fmdv <NUMBER> first fmd research institute built island riems germany followed research institutes europe eg pirbright united kingdom <NUMBER> lindholm island denmark <NUMBER> major milestones early years fmd research introduction guinea pigs research animals waldmann pape <NUMBER> first steps towards development fmd vaccine <NUMBER> waldmann et al <NUMBER> second world war fmd vaccines became available european countries disease controlled systematic vaccination end <NUMBER> european union adopted nonvaccination policy directive <NUMBER>cee du conseil du <NUMBER> novembre <NUMBER> é tablissant des mesures communautaires de lutte contre la fiè vre aphteuse <NUMBER> united kingdom experienced large fmd outbreak <NUMBER> animals slaughtered gloster et al <NUMBER> since fmd occurred sporadically minor outbreaks detected europe eg denmark <NUMBER> <NUMBER> christensen et al <NUMBER> italy <NUMBER> nunez et al <NUMBER> latter shown causative virus closely related viruses circulated previously middle east nunez et al <NUMBER> <NUMBER> large fmd outbreak started united kingdom alexandersen et al <NUMBER>a spread france ireland netherlands losses agriculture united kingdom alone £<NUMBER> billion thompson et al <NUMBER> causative fmdv showed phylogenetic similarity virus outbreak italy <NUMBER> closely related viruses circulated previously asia middle east footandmouth disease acute highly contagious viral disease great potential causing severe economic losses susceptible clovenhoofed animals alexandersen mowat <NUMBER> causative agent fmd footandmouth disease virus fmdv small positive sense ssrna virus approx <NUMBER> kb belongs aphthovirus genus family picornaviridae belsham <NUMBER> fmdv replicates negative strand rna recently used quantitative strand specific real time rtpcr tool determine strain virulence replication patterns horsington zhang <NUMBER> high genetic phenotypic variability fmdv reflected existence seven serotypes c asia <NUMBER> sat <NUMBER> sat <NUMBER> sat <NUMBER> numerous variants lineages described topotypes knowles samuel <NUMBER> antigenic diversity within serotypes crucial consider selecting vaccine strains crossreactivity may variable kitching <NUMBER> virus capsid composed <NUMBER> copies four structural polypeptides designated vp<NUMBER> vp<NUMBER> region gh loop around residues <NUMBER> vp<NUMBER> protein exposed surface viral capsid determined main antigenic site recognized neutralizing antibodies bittle et al <NUMBER> natural fmdv infection initiated rgd motif within gh loop binds certain cellular integrin receptors expressed epithelial cells targeted acute phase infection alexandersen et al <NUMBER>b monaghan et al <NUMBER> process cell culture adaptation fmdv acquire ability use receptors like glycosaminoglycans gags require rgd motif host specificity natural fmdv infection thought depend fmdv binding specific integrins although yet undiscovered mechanisms determine fmdv susceptibility animals affected include cattle swine sheep goats buffaloes wild ruminants alexandersen mowat <NUMBER> fmd bovinae characterized fever often <NUMBER> <NUMBER>c excessive salivation lameness depression decreased milk production mucosa lips dorsum tongue dental plate severely involved mortality rate low mostly young animals affected due myocardial necrosis alexandersen et al <NUMBER>b gulbahar et al <NUMBER> kitching <NUMBER> fmd pigs primarily affects feet dominated rather painful formation vesicles epidermis feet coronary band interdigital clefts bulbs associated severe lameness complications seen detachment hoof secondary infection disrupted aphthae fluidfilled blisters may cause purulent arthritis pedal joint kitching alexandersen <NUMBER> clinical signs fmd sheep goats less severe often lameness aphthae inflammation cloves alexandersen mowat <NUMBER> mechanism spread fmdv primarily form either aerosolized droplets saliva indirect contact personnel contaminated surfaces subsequently back respiratory tract alexandersen mowat <NUMBER> however infection also occur lesion skin mucous membranes inefficient entering route unless abrasions cuts present alexandersen et al <NUMBER>a donaldson et al <NUMBER> site penetration influenced droplet size since smallest inhaled droplets reaching alveoli lungs initial infection occurs predominantly epithelial surface soft palate adjacent nasopharynx subsequent spread virus regional lymph nodes alexandersen et al <NUMBER>a donaldson et al <NUMBER> virus detected oral cavity real time rtpcr <NUMBER> days onset viraemia alexandersen et al <NUMBER>b inapparent infections fmdv divided two types first animals become infected spread virus without showing clinical signs second animals virus persists recovering fmd clinical signs sutmoller casas <NUMBER> fmdv persistently infected animals defined virus positive minimum <NUMBER> days sutmoller et al <NUMBER> usually referred carriers persistently infected animals show lowlevel excretion fmdv pharynx ruminants periods species virus lineage associated salt <NUMBER> maximum duration persistent infection ranges <NUMBER> months goats <NUMBER> years african buffaloes syncerus caffer alexandersen et al <NUMBER>b fmdv persistence pigs could demonstrated information persistence asian buffaloes bubalus bubalis alexandersen et al <NUMBER>b transmission fmdv carrier animals susceptible hosts field conditions far shown african buffaloes cattle impala aepyceros melampus bastos et al <NUMBER> dawe et al <NUMBER> however experimental conditions saliva obtained carrier animals injected cattle pigs caused infection although information whether also happen field conditions alexandersen et al <NUMBER>b closely related species asian buffaloes unlike persistently infected animals subclinically infected animals ie animals developing obvious clinical signs may highly contagious gibbens et al <NUMBER> holzhauer et al <NUMBER> beside immune status host also involved fmdv lineage plays role subclinical course disease bouma dekker <NUMBER> outbreak caused vaccine strains shows reduced virulence sacarvalho et al <NUMBER> subclinical infections also found example fmd outbreak <NUMBER> united kingdom caused vaccine strain enserink <NUMBER> fmdv infected animals showed clinical signs subclinical infection also produced within vaccinated ruminant herds high fmdv challenge animals high immunity low challenge animals low vaccine titer hutber et al <NUMBER> yadin et al <NUMBER> possibility animals becoming carriers authors knowledge examined nevertheless likely animals may play important role maintenance fmd endemic countries kitching <NUMBER> even though common features spread fmd seven serotypes even variations topotypes different way transmission clinical appearance species tropism kitching <NUMBER> large amounts virus found body secretions excretions relatively long time carried contaminated feed donaldson <NUMBER> wijnker et al <NUMBER> tires vehicles shoes clothes people alexandersen et al <NUMBER>a grubman baxt <NUMBER> transmission via aerosols also occur depending weather conditions characteristics virus survival dissemination alexandersen et al <NUMBER>a alexandersen donaldson <NUMBER> donaldson <NUMBER> donaldson et al <NUMBER> sellers gloster <NUMBER> host plays major role transmission route cattle sheep goats may exhale <NUMBER> log<NUMBER> tcid <NUMBER> virus per day pigs produce <NUMBER> log<NUMBER> tcid <NUMBER> per day represent significantly greater source airborne fmdv infections infected ruminants alexandersen et al <NUMBER>ac alexandersen donaldson <NUMBER> however common route introduction fmd country free fmd illegal use contaminated swill feed hartnett et al <NUMBER> reduction ph meat post mortem due accumulation lactic acid usually sufficient kill fmdv change ph glands bone marrow virus persist à<NUMBER> <NUMBER>c <NUMBER> <NUMBER>c kitching <NUMBER> pandemic strain fmdv serotype major threat europe prevalent serotype worldwide although precise genetically explanation higher prevalence mason et al <NUMBER> lineages type restricted host range suidea cheng et al <NUMBER> whereas others like panasia strain restricted specific host great antigenic diversity members serotype also often crossprotection bronsvoort et al <NUMBER> islam et al <NUMBER> klein et al <NUMBER> konig et al <NUMBER> mattion et al <NUMBER> muthuchelvan et al <NUMBER> tosh et al <NUMBER>a also evidence recombination serotype occurs much serotypes carrillo et al <NUMBER> jackson et al <NUMBER> simmonds <NUMBER> however still unclear many new lineages serotype regularly appear disappear kitching <NUMBER> members serotype seem less virulent usually restricted asia biswas et al <NUMBER> chang et al <NUMBER> mohapatra et al <NUMBER> mohapatra et al <NUMBER> sanyal et al <NUMBER> sanyal et al <NUMBER>ab however recent years increase asia <NUMBER> caused outbreaks asia reported well spread viruses type turkey greece <NUMBER> sat southern african territories serotypes usually found africa also sporadic outbreaks saudi arabia kuwait <NUMBER> aidaros <NUMBER> higher sequence variation within three sat types serotype bastos et al <NUMBER> bastos et al <NUMBER>a last <NUMBER> years major outbreaks reported serotype sporadically south america east africa pakistan <NUMBER> oie <NUMBER> explanation apparent disappearance however vaccines containing serotype c still use countries comprising risk vaccine induced serotype c outbreaks kitching <NUMBER> generally field epidemiology practice epidemiology response problems magnitude significant enough require rapid immediate action goodman buehler <NUMBER> ie required consider obtained data sufficient make practical recommendations rather ask additional academic questions might answered data rapid field epidemiological action case fmd outbreaks required trace potential sources infection limit spread disease example <NUMBER> outbreak fmd united kingdom gibbens et al <NUMBER> gibbens wilesmith <NUMBER> animal vehicle personnel movements animal markets traced investigations infected farms performed order identify potential contact farms subsequently apply appropriate control measures disease surveillance hand considered immediate field epidemiological action according office international des é pizooties oié surveillance means investigation given population subpopulation detect presence pathogenic agent disease frequency type surveillance determined epidemiology pathogenic agent disease desired outputs thiermann <NUMBER> fmd surveillance usually following objectives confirmation absence disease defra <NUMBER> b development andor evaluation fmd control programs endemic countries chung et al <NUMBER> c detect occurrence new fmdv lineages del rio vilas et al <NUMBER> sources data fmd surveillance either purely laboratory results biological samples collected participatory information obtained farmers combination key information beside laboratory data like pcr results sequence analysis serology authors opinion <NUMBER> clinical signs <NUMBER> vaccination status date <NUMBER> vaccine used <NUMBER> species age animal <NUMBER> beginning outbreak monthyear <NUMBER> sampling date place <NUMBER> outbreak history <NUMBER> likely source outbreak <NUMBER> morbidity rate <NUMBER> environmental information though strived aim obtain information accepted sometimes due various reasons possible especially true rural areas less developed countries fmdv shares antigenic variability many picornaviruses however extent variation equal picornaviruses eg three polio serotypes hundred rhinovirus serotypes domingo et al <NUMBER> duarte et al <NUMBER> three major forces driving molecular evolution rna viruses <NUMBER> spontaneous mutation rna virus encoded rnadependentrnapolymerase lacks <NUMBER> <NUMBER> <NUMBER> <NUMBER> exonuclease activity proofreading activity leading high mutation rate approx one mutation per genome per replication drake <NUMBER> viruses adapted genome size called error threshold maximum mutation rate tolerable genome size avoid fitness loss eigen <NUMBER> <NUMBER> bull et al <NUMBER> escarmis et al <NUMBER> gonzalezlopez et al <NUMBER> sole et al <NUMBER> <NUMBER> phenomenon spontaneous mutation leads statistical effect called genetic drift extremely large highly diverse population ratio highly fit less fit genotypes may small transmission event particles might transmitted genotypes represent full genetic fitness distribution original population therefore often include highly fit genotypes comparatively small numbers outcome new population established similar environment members small less fit average class viruses knipe et al <NUMBER> fmdv thought evolve mainly genetic drift due high errorprone nature rna polymerase domingo et al <NUMBER>ac fmdv rna transcription error frequencies estimated vary <NUMBER> à<NUMBER> <NUMBER> à<NUMBER> nucleotide misincorporations per site per replication cycle haydon et al <NUMBER> <NUMBER> recombination recombination describes process fragments nucleic acid sequences two genotypically different parental viruses exchanged progeny contain sequences derived parental viruses inter alia picornaviruses coronaviruses togaviruses display efficient recombination probably occurs replication via copy choice enami et al <NUMBER> jarvis kirkegaard <NUMBER> kirkegaard baltimore <NUMBER> kuge et al <NUMBER> meier et al <NUMBER> recombination seems play important role fmdv evolution occurs mainly gene regions coding nonstructural proteins carrillo et al <NUMBER> domingo et al <NUMBER> jackson et al <NUMBER> klein et al <NUMBER> lee et al <NUMBER> also sometimes gene regions coding structural proteins haydon et al <NUMBER> haydon woolhouse <NUMBER> tosh et al <NUMBER>b changes nonstructural proteins may potentially modify virulence virus klein et al <NUMBER> evolution structural proteins especially vp<NUMBER> plays major role virus entry seems mainly shaped genetic drift domingo et al <NUMBER>bc domingo <NUMBER> primarily immigration individuals surrounding populations gene flow genetically effective migration also applies within single infected host different virus variants sometimes isolated different tissues reflecting adaptation quasispecies domingo et al <NUMBER>a domingo et al bc <NUMBER> means single host populations compete new different virus genotypes limited number susceptible host cells may lead increase virulence virus strain higher basic reproductive rate overtake lessvirulent finally end stage equilibrium alexopoulou dourakis <NUMBER> mao et al <NUMBER> miralles et al <NUMBER> sitia et al <NUMBER> evolution experiments vitro domingo et al <NUMBER> domingo et al <NUMBER>abc martinez et al <NUMBER> martinez et al <NUMBER> martinez et al <NUMBER> villaverde et al <NUMBER> demonstrate fmdvs capability survival despite accumulation mutations upon repeated bottleneck events population size greatly reduced catastrophe therefore range mutation rate must evolved ensure continuous heterogeneity find population subsets invade cells bottleneck events staying errorthreshold exemplified rgdlxxl motif highly variable gh loop vp<NUMBER> motif responsible receptor recognition avb<NUMBER> invariant field isolates even bottleneck events like introduction vaccination monaghan et al <NUMBER> consequence high evolutionary rate fmdv strains virus common origin quickly diverge sequence replicate spread new areas therefore greater number differences greater distance strains space time conversely strains homologous sequences must common recent origin bastos et al <NUMBER>b bronsvoort et al <NUMBER> cottam et al <NUMBER> klein et al <NUMBER> knowles samuel <NUMBER> konig et al <NUMBER> malirat et al <NUMBER> martin et al <NUMBER> sahle et al <NUMBER> sangare et al <NUMBER> usage molecular biological methods study distribution determinants infectious disease subject molecular epidemiology thompson <NUMBER> however important recognize study molecular epidemiology certain virus like fmdv knowledge molecular evolution equally important thus knowing genetic factors shaped evolution pathogens improve development vaccines well control strategies chareonsirisuthigul et al <NUMBER> de freitas et al <NUMBER> holmes <NUMBER> holmes drummond <NUMBER> unlike taxonomy describes closely related organisms based evolutionary grouping ancestral traits molecular epidemiology correlates phylogenetic information biological variables classical epidemiological information furthermore develops hypotheses evolutionary changes considering different selection pressures inter alia caused hosts immune system new environmental challenges despite potential important stress limits molecular epidemiology phylogenies based simplified models available sequences likely biased often represent complete spatial temporal random sample majority sequence analysis rna viruses biased despite quasispecies structure rna viruses based single consensus sequence thus mirroring intrahost viral populations addition two types probability error must considered molecular epidemiology thompson <NUMBER> type <NUMBER> probability error subtyping assignment claims epidemiologic relationship strains none type <NUMBER> probability error subtyping assignment concludes epidemiological relationship actuality generally phylogenetic analysis statistical inference relationship using probability model nucleotide aminoacid substitution evolutionary model assuming wrong evolutionary model affect outcome phylogenetic analysis eg incorrectly estimating tree topology bruno halpern <NUMBER> penny et al <NUMBER> influencing branch length estimation posada <NUMBER> posada crandall <NUMBER> biasing statistical support values buckley cunningham <NUMBER> correct evolutionary model becomes powerful tool despite simplified assumptions fit data make accurate predictions minimizing probability error <NUMBER> <NUMBER> correct model help understand linkage among spatial temporal genetic processes taking place virus transmission changed environment thus evolutionary events occur early initial expansion advantageous changes become fixed genetic population structure using hierarchical likelihood ratio tests goldman <NUMBER> posada crandall <NUMBER> rzhetsky nei <NUMBER> akaike information criterion aic tests saffron et al <NUMBER> seghouane amari <NUMBER> possible identify appropriate model sequence analysis hierarchical set evolutionary models arndt <NUMBER> buckley cunningham <NUMBER> fan et al <NUMBER> lemey et al <NUMBER>ab lemey vandamme <NUMBER> lunter hein <NUMBER> salemi et al <NUMBER> van brussel et al <NUMBER> vandamme et al <NUMBER> vandamme et al <NUMBER> vercauteren vandamme <NUMBER> yang <NUMBER> fmd endemic areas world highrisk zones introducing fmd countries free disease origin new fmdv lineages therefore continuing surveillance fmdv needed early recognition understanding emerging risks changes global fmd situation detection characterization new fmdv lineages control possible conformation changes circulating immunorelevant epitopes special interest may indicate change current used vaccine strains needed one promed <NUMBER> <NUMBER> subtype also detected pakistan klein et al <NUMBER> particular fmdv subtype proven highly virulent caused severe disease ages cattle eufmd <NUMBER> serum neutralization assays demonstrated closer relationship a<NUMBER> serotype subtypes paton <NUMBER> world reference laboratory well fao european commission control fmd recommend absence homologous vaccine strain use widely available a<NUMBER> iraq strain vaccine hypothesized airn<NUMBER> sublineage undergone two different paths evolution structural nonstructural genome regions klein et al <NUMBER> structural genome regions may evolutionary starting point a<NUMBER> sublineage assumed due quasispecies structure fmdv populations errorprone replication process advantageous mutations changed environment fixed lead occurrence new airn<NUMBER> sublineage together mechanism recombination within nonstructural genome regions potentially modifying virulence virus may involved success new sublineage possible origin recombinant virus may coinfection asia<NUMBER> serotype precursor airn<NUMBER> sublineage within asian buffaloes another example new fmdv lineage currently described panasia ii lineage described far bhutan nepal malaysia pakistan seems evolve away old panasia lineage klein et al <NUMBER> leading possible decrease used o<NUMBER>manisa vaccine efficiency special situation office international des epizooties oie status fmdfree countries vaccination practiced countries fmdv eradicated still circulates susceptible population leads permanent bottleneck situation virus emergence vaccine escape mutants likely seen serotype outbreaks south america last years konig et al <NUMBER> mattion et al <NUMBER> perez et al <NUMBER> however molecular epidemiology may also helpful detect low vaccine coverage klein et al <NUMBER> malirat et al <NUMBER> ongoing outbreak situation molecular epidemiology useful tool track virus consequently stop transmission also postoutbreak investigation important regard claim damages best examples particular field given work done united kingdom outbreaks <NUMBER> <NUMBER> <NUMBER> great britain experienced epidemic fmdv caused pan asia strain virus alexandersen et al <NUMBER>a cottam et al <NUMBER> disease spread rapidly widely throughout country republic ireland france netherlands due size outbreak possible track transmission route many cases simply attributed local spread however many tissue samples collected sevenmonth lasting outbreak possible study microevolution virus thereby recover particular transmission pathways acting fmdv lineage cottam et al <NUMBER> august <NUMBER> <NUMBER> new outbreak fmd confirmed surrey united kingdom causing fmdv lineage identified ofs <NUMBER>uk<NUMBER> virus isolated circulation animals since <NUMBER> however lineage used nearby pirbright laboratory site houses separate units institute animal health merial animal health ltd soon clear origin virus thus question arose unit virus escaped full length genome sequencing virus isolates obtained infected animals shown typical amino acid adaptations fmdv propagated several passages cell culture systems used vaccine production merial animal health ltd identified source outbreak cottam et al <NUMBER> molecular epidemiology fmd powerful tool applied correctly regard statistical methods supplied classical epidemiological information important stress taxonomical relationship deduction alone enough understand dynamics fmdv furthermore strived aim develop bioinformatics tools able handle complex virushost interactions infection example seen action micrornas viral infection although active surveillance fmd decreased dramatically incidence disease europe fear new outbreaks still exists example last outbreak uk <NUMBER> demonstrates unreasonable cottam et al <NUMBER> moreover fmd remains endemic developing countries asia south america africa new fmdv strains likely evolve solution effective eradication reduction application measures based molecular genetic characterization virus bronsvoort et al <NUMBER> klein et al <NUMBER> klein et al <NUMBER> klein et al <NUMBER> introduction new fast methods real time rtpcr fmd diagnostics together viral sequence analysis allows study viral biodiversity evolution thereby track transmission events sources well assure vaccine coverage corresponding field fmdv lineages potential vector vaccines lies hope vaccine would cheaper safer andor effective existing vaccines pathogen vaccinia virus vector attracted attention date several immunogenes inserted genome without destroying infectivity b immunogens appear produced normally c vaccinia virus used highly successfully eradicate smallpox wide hostrange thus might find veterinary well human medical application experimental vaccines successfully tested animals prepared using immunogenes influenza virus hepatitis b virus herpes simplex viru£ apathogenic enteric bacteria potential vectors probably enteric pathogens although potential viral vectors likely realized firsl parasitic worms protozoa devastate millions people immunogens organisms identified added impetus investigate potential vector vaccines pathogen keywords vectors bacterial vectors viral vectors vaccinia virus immunogens immunogenes many years term vector latin word carrier bearer meant biologist agent transferring parasite host invertebrate vectors come readily mind example mosquitoes tsetse flies transmitting protozoans cause malaria sleepingsickness respectively recently term applied plasmids manipulated biologists transfer selected genes expression bacteria yeast cells papovavirus simian virus <NUMBER> sv<NUMBER> bovine papilloma virus used vectors conjunction eukaryotic cells vectors used transfer genes biological entities foreign genes cells vitro either fundamental research purposes production proteins would subsequently purified prototype vaccines eg hepatitis b virus surface antigen hbsag yeast <NUMBER> foot mouth disease virus vpi protein escherichia coli <NUMBER> logical step produce vectors could used immunize animals directly foreign gene protein product immunogen produced vivo potential advantages approach discussed later paper convenience shall use word qmmunogene denote gene specifies production protein course natural infection pathogen induces protective immune response focus attention moment vector potential vaccinia virus vaccine virus eradicated smallpox viral standards vaccinia virus dna genome enormous comprising <NUMBER> <NUMBER> base pairs vaccinia virus genes essential replication fact raised possibility also demonstrated marker rescue using another deletion mutant vaccinia virus panicali paolettp showed tk gene unrelated herpes simplex virus hsv could inserted genome infectious vaccinia virus functional tk enzyme produced soon afterwards mackett et al <NUMBER> presented similar findings exploiting tk genes vaccinia virus hsv thus shown vaccinia virus useful selectable cloning expression vector potential vector vaccine purposes lost either group subsequent two years several papers published illustrate potential recombinant vaccinia virus formed containing hbsag gene gene expressed vitro rabbits vaccinated intradermally live recombinant produced antibody hbsag ° haemagglutinin ha immunogene influenza virus inserted vaccinia virus genome tissue culture cells infected recombinant produced glycosylated ha transported cell surface <NUMBER>s rabbits hamsters inoculated recombinant produced serum antibody neutralized influenza virus moreover hamsters inoculated intradermally recombinant protected respiratory infection live influenza virus applied intranasally mice inoculated intraperitoneally vaccinia virus recombinant containing gene glycoprotein hsv resisted lethal dose live hsval recently vaccinia virus recombinants containing gene coding circumsporozoite antigen malaria parasite plasmodium knowlesi made <NUMBER> rabbits inoculated intradermally recombinants produced antibody reacted extracts p knowlesi sporozoites authors suggested possible express several antigens different life cycle stages parasite make potent vaccine vaccinia virus virus used vector vaccines several eukaryotic viruses established potential use vectors eg sv<NUMBER> adenovirus bovine papilloma virus herpes virus retroviruses however pointed viruses oncogenic vaccinia virus another advantage vaccinia virus used highly effectively right vaccine eradicate smallpox large genome permits inclusion large amounts dna construction stable infectious recombinants containing <NUMBER> <NUMBER> bases foreign dna claimed american groups thus potential constructing polyvalent vaccines vaccinia virus large host range may make suitable production vaccines animals alternatively pox viruses may used poultry industry would seem suitable one use vectors chickens kept high stocking densities conducive spread infectious diseases vaccines drugs essential intensive poultry keeping however uk poultry industry spends <NUMBER> turnover vaccines profit margins slim indeed much <NUMBER> uk broiler growers sold loss thus vaccines must cheap buy also cheap apply handling birds individual vaccination costly vaccines currently unavoidable live vaccines applied inexpensively drinking water spray generally induce good immunity cause problems thus vaccine strains avian infectious bronchitis virus ibv coronavirus cause damage oviduct kidneys chickens ibv also predispose young chickens secondary infection strains ofe coli causing colisepticaemia multiage sites vaccine virus may spread young chickens deleterious effects inactivated virus vaccines associated problems ie safer costly buy apply case ibv inactivated virus alone induce good protection coccidiosis chickens caused several species protozoan eimeria effective vaccines exist inactivated vaccines prepared induce protection vector approach may solution problems pathogens many parts world fowl pox problem live pox virus vaccine used control pox virus recombinant carrying immunogene say ibv would associated problems current live ibv vaccines ie would safer would still inexpensive successful protection hamsters another respiratory virus influenza virus vaccinia virus recombinant carrying influenza virus ha gene holds promise similarly constructed avian pox vaccine would protect chickens ibv bacteria suggested potential vectors immunogenes connection vaccines poultry <NUMBER> human rotaviruses bacterium chosen probably e coli strain would nonpathogenic capable colonizing gastrointestinal tract time sufficient permit protective immune response mounted immunogen expression immunogen bacterial cell surface would probably induce better immune response immunogen exposed alter death bacterium requirements lot transport proteins surface bacteria study <NUMBER> ii would expected use enteric bacterial vector would effective pathogens gastrointestinal tract protection mucosal surfaces might arise common mucosal immune system effective <NUMBER>° apart isolation suitable bacteria selection plasmids transfer immunogen obtaining expression bacterial surface potential problems overcome include tendency foreign proteins synthesized bacteria hydrolysed rapidly toxic bacterium b lack ot glycosylation may structurally important c possible failure polypeptides normally oligomeric proteins assembled may result decreased antigenicity however proteins several viruses produced coli case fmdv resultant protein inoculated cattle swine protected challenge fmdv <NUMBER> murray et al reported preparations hepatitis b core antigen produced coli protective reduced severity infection chimpanzees hepatitis b virus bacteria vectors potential advantages warrant continued consideration innocuous il coli strains occur naturally many animals technology largescale production bacteria well developed bacteria would expected stable many live virus vaccines stability important attribute vaccine administration would simple inexpensive animals bacterium could added lkod water might vector chosen basis vaccine first must asked whether vaccine pathogen exists new type vaccine warranted recently broomby <NUMBER> listed number advantages product new biological techniques might simplified production increased safety greater stability improved potency reduced allergenicity patentability new product probably developed high cost strong advantages order compete established product recover costs vaccines totally new may commercially attractive eg coccidiosis poultry endoand ectoparasites herpes simplex virus vectorbased vaccine may cheaply produced safer current vaccines example hepatitis b virus ibv respectively new approaches vaccine production currently investigated synthesis proteins peptides bacteria yeast eukaryotic cells chemical synthesis peptides rational manipulation virus genomes development suitable adjuvants although unlikely vector approach suitable diseases several major potential advantages stem experimental observations immunogenes transferred vaccinia virus genes expressed immunogen properties similar immunogen derived parent virus inoculated animals respond protective immune responses especially exciting protection lower respiratory tract hamsters infection influenza virus following intradermal inoculation vaccinia virus recombinant carrying influenza virus ha gene production ofimmunogens infected cells following use live poxvirus vector might stimulate much comprehensive array immune responses would arise tbllowing parenteral administration inactivated virus subunit vaccine transport immunogens surface cell may cases necessary induction efficient protective immune response advantages ofvaccinia virus used vaccine many years experience medical community worldwide little expertise required administration success eliminating smallpox beyond dispute however misgivings expressed number people vaccinated vaccinia virus serious complications led death surveys undertaken <NUMBER>s usa indicated risk death vaccination complications primary vaccinees one per million vaccinees ages b five per million vaccinees <NUMBER> months age c <NUMBER> per million vaccinees <NUMBER> years old <NUMBER> addition combined rate postvaccinial encephalitis vaccinia necrosum <NUMBER> per million infants three per million aged <NUMBER> years <NUMBER> figures must taken account consideration given use vaccinia virus vector however pathogens afflict mankind much greater scale parasitic worms helminths infect <NUMBER> million people <NUMBER> african continent alone <NUMBER> million people affected malaria causing one million deaths per year <NUMBER> estimated <NUMBER> million people affected hepatitis b virus <NUMBER>s terrible figures demand vaccines developed apart safe efficacious must cheap produce administer vector vaccine based vaccinia virus would seem suitable approach challenge especially developing countries vectors immunogenes cavanagh disease problems greatest ability pay least suggested vector approach general use pox viruses particular panacea outstanding vaccine problems nevertheless approach great potential warrants investigation immunogens many pathogens f one human one veterinary vaccine successfully based vectors gain mankind could enormous outbreak covid<NUMBER> epidemic early control essential among control measures efficient safe identification potential patients important part existing researches show human physiological state perceived breathing <NUMBER> means respiratory signals vital signs reflect human health condition certain extent <NUMBER> many clinical literature suggests abnormal respiratory symptoms may important factors diagnosis specific diseases <NUMBER> recent studies found covid<NUMBER> patients obvious respiratory symptoms shortness breath fever tiredness dry cough <NUMBER> <NUMBER> among symptoms atypical irregular breathing considered one early signs many people early mild respiratory symptoms difficult recognized therefore measurement respiration condition potential covid<NUMBER> patients screened extent may play auxiliary diagnostic role thus helping find potential patients early possible traditional respiration measurement requires attachments sensors patients body <NUMBER> monitor respiration measured movement chest abdomen contact measurement equipment bulky expensive timeconsuming important thing contact measurement may increase risk spreading infectious diseases covid<NUMBER> therefore noncontact measurement suitable current situation recent years many noncontact respiration measurement methods developed based imaging sensors doppler radar <NUMBER> depth camera <NUMBER> thermal camera <NUMBER> considering factors safety stability price measurement technology thermal imaging suitable extensive promotion far thermal imaging used monitoring technology wide range medical fields estimations heart rate <NUMBER> breathing rate <NUMBER> <NUMBER> <NUMBER> another important thing many existing respiration measurement devices large immovable given worldwide epdemic partable intelligent screening equipment required meet needs largescale screening application scenarios realtime manner thermal imaging based respiration measurement nostril regions mouth regions focused regions since two parts periodic heat exchange body outside environment however researchers seldom considered measuring thermal respiration data people wearing masks epidemic infectious diseases masks may effectively suppress spread virus according recent studies <NUMBER> <NUMBER> therefore developing respiration measurement method people wearing masks becomes quite practical study develop portable intelligent health screening device uses thermal imaging extract respiration data masked people used health screening classification via deep learning architecture classification tasks deep learning achieved stateoftheart performance research areas compared traditional classifiers classifiers based deep learning automatically identify corresponding features correlations rather extracting features manually breathing tasks algorithms based deep learning also better extract corresponding features breathing rate breathtoexhale ratio make accurate predictions <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently many researchers made use deep learning analyze respiratory process cho et al used convolutional neural network cnn analyze human breathing parameters determine degree nervousness thermal imaging <NUMBER> romero et al applied language model detect acoustic events sleepdisordered breathing related sounds <NUMBER> wang et al utilized deep learning depth camera classify abnormal respiratory patterns real time achieved excellent results <NUMBER> disadvantage research may equipment portable paper propose remote potable intelligent health screening system based respiratory data prescreening auxiliary diagnosis respiratory diseases like covid<NUMBER> order practical situation people often choose wear masks breathing data capture method people wearing masks introduced extracting breathing data video obtained thermal camera deep learning neural network performed work classification healthy abnormal respiration conditions verify robustness algorithm effectiveness proposed equipment analyze influence mask type measurement distance measurement angle breathing data main contributions paper threefold first combine face recognition technology dualmode imaging accomplish respiratory data extraction method people wearing masks quite essential current situation based dualcamera algorithm respiration data successfully obtained masked facial thermal videos subsequently propose classification method judge abnormal respiratory state deep learning framework finally based two contributions mentioned implemented noncontact efficient health screening system respiratory infections using actual measured data hospital may contribute finding possible cases covid<NUMBER> keeping control secondary spread sarscov<NUMBER> brief introduction proposed respiration condition screening method shown first use portable intelligent screening device get thermal corresponding rgb videos data collection also perform simple realtime screening result getting thermal videos first step extract respiration data faces thermal videos extraction process use face detection method capture peoples masked areas region interest roi selection algorithm proposed get region mask stands characteristic breath finally use bidirectional gru neural network attention mechanism bigruat model work classification task input respiration data data collection achieved system shown fig <NUMBER> whole screening system includes flir one thermal camera android smartphone corresponding application written used data acquisition simple instant analysis screening equipment whose main advantage portable easily applied measure abnormal breathing many occasions instant detection shown fig <NUMBER> flir one thermal camera consists two canmeras rgb camera thermal camera collect face videos cameras use face recogition method get nostril area forehead area temperatures two regions calculated time series shown screening result page fig <NUMBER>b red line stands body temprature blue line stands breathing data breathing data predict respiratory pattern testcase simple realtime screening result given directly application fig <NUMBER> overview portable intelligent health screening system respiratory infections device appearance b analysis result application notice system simultaneously collect body temperature signals current work body temperature signal considered model used reference users according extracted features shown fig <NUMBER> use raw face videos collected rgb camera thermal camera data study ensure accuracy higher performance continuous breathing activities performs fact periodic temperature fluctuations occur around nostril due inspiration expiration cycles therefore respiration data obtained analyzing temperature data around nostril based thermal image sequence however people wear masks many facial features blocked merely recognizing face thermal image lose lot geometric textural facial details resulting recognition errors face mask parts order solve problem adopt method based two parallel located rgb infrared cameras face mask region recognition masked region face first captured rgb camera region mapped thermal image related mapping function algorithm masked face detection based pyramidbox model created tang et al <NUMBER> main idea apply tricks like gaussian pyramidbox deep learning get context correlations characteristics face image first used extract features different scales using gaussian pyramid algorithm highlevel contextual features feature pyramid network proposed excavate highlevel contextual features output together lowlevel features combined lowlevel feature pyramid layers finally result obtained another two layers deep neural network faces lot features lost due cover mask contextsensitive structure obtain feature correlations thus improve accuracy face detection experiment use open source model paddlehub detect face area rgb videos next step extract masked area map area rgb video thermal video since position mask human face fixed obtaining position coordinates human face obtain mask area face scaling equal proportions detected face width w height h loaction leftup corner defined <NUMBER> <NUMBER> loaction rightbottom corner w h corresponding coordinate two corners mask region decalred w<NUMBER> h<NUMBER> <NUMBER>w<NUMBER> <NUMBER>h<NUMBER> considering background boundary mask produce large contrast movement easy cause errors choose center area mask division selected area mapped rgb image thermal image obtain masked region thermal videos getting masked region thermal videos need get region interest roi represents breathing features recent studies often characterize breathing data temperature changes around nostril <NUMBER> <NUMBER> however people wear masks exists another problem nostrils also blocked masks people wearing different masks roi may different therefore perform roi tracking method based maximizing variance thermal image sequence extract certain area masked region thermal video stands breath signals due lack texture features masked regions compared human faces judge roi temperature change thermal image sequence main idea traverse masked region thermal images find small block largest temperature change selected roi position certain block fixed masked region among frames since nostril area fixed face region need consider movement block since face recognition algorithm detect mask position frames thermal image certain block height width n define average pixel intensity frame thermal imagesst represents temperature value frame every block obtained calculate st time line block n total variance list average pixel intensity frames σ <NUMBER> n calculated shown eq <NUMBER> µ stands mean value ofst since respiration periodic data spread nostril area consider block largest variance position heat changes frequency value within mask stands breath data masked region adjust corresponding block size according size masked region masked region n blocks final roi selected thermal video traverse possible blocks mask regions frame find rois frame method respiration data defined asst<NUMBER> pixel intensities rois frames apply bigruat neural network classification task judging whether respiration condition healthy shown fig <NUMBER> input network respiration data obtained extraction method since respiratory data time series regarded time series classification problem therefore choose gate recurrent unit gru network bidirection attention layer work sequence prediction task among deep learning structures recurrent neural network rnn type neural network specially used process time series data samples <NUMBER> time step rnn model represented x h stands current input state hidden state output time step respectively v w u parameters obtained training procedure b bias σ φ activation functions final prediction longshort term memory network developed basis rnn <NUMBER> compared rnn memorize analyze shortterm information process relatively longterm information suitable problems shortterm delays long time intervals based lstm many related structures proposed recent years <NUMBER> gru simplified lstm merges three doors lstm forget input output two doors update reset <NUMBER> tasks data gru may achieve better result lstm since includes less parameters task since input neural network respiration data time sequence gru network may perform better result lstm network structure gru expressed following equations r reset gate controls amount information passed new state previous states z stands update gate determines amount information forgotten added w r w z w h trained parameters vary training procedureh candidate hidden layer regarded summary information h t−<NUMBER> input information x time step h output layer time step sent next unit bidirectional rnn widely used natural language processing <NUMBER> advantage network structure strengthen correlation context sequence respiratory data periodic sequence use bidirectional gru obtain information periodic sequence difference bidirectional gru normal gru backfoward sequence data spliced original forward sequence data way hidden layer original ht changed − → h original hidden layer ← − h backfoward sequence − → h analysis respiratory data entire waveform time sequence taken consideration specic breathing pattern sphyxia several paticular features sudden acceleration may occur certain point entire process however use bigru network features may weakened time sequence data input step step may cause larger error prediction therefore add attention layer network ensure certain key point features breathing process maximized attention mechanism choice focus important points among total data <NUMBER> often combined neural networks like rnn rnn model summarizes hidden states output attention layer make estimation outputs find important ones mechanism widely used many research areas structure attention layer h represents bigru layer output time step bidirectional w u b w also parameters vary training process performs softmax fucntion u get weight step finally output attention layer combination steps bigru different weights applying another softmax function output get final prediction classification task structure whole network shown fig <NUMBER> goal distinguish whether epidemic infectious disease covid<NUMBER> according abnormal breathing respiratory system dataset collected patients covid<NUMBER> data obtained inpatients respiratory disease department cardiology department ruijin hospital patients collected data caught basic chronic respiratory disease fever typical respiratory symptoms infectious diseases therefore body temperature taken consideration current screening system ruijin hospital wards use flir one thermal camera connected android phone work data collection collected data <NUMBER> people person collect two <NUMBER>second infrared rgb camera data sampling frequency <NUMBER> hz data cutting oversampling finally obtained <NUMBER> healthy breathing data <NUMBER> abnormal breathing data total <NUMBER> data piece data consists <NUMBER> frames infrared rgb videos <NUMBER> seconds bigruat network hidden cells bigru layer attention layers <NUMBER> <NUMBER> respectively breathing data normalized input neural network use crossentropy loss function training process separate dataset two parts training set includes <NUMBER> healthy breathing data <NUMBER> abnormal breathing data test set contains <NUMBER> healthy breathing data <NUMBER> abnormal breathing data paper accepted release dataset used current work noncommercial users among whole dataset choose <NUMBER> typical respiratory data examples shown fig <NUMBER> fig <NUMBER>a fig <NUMBER> b stand abnormal respiratory patterns extracted patients fig <NUMBER> c fig <NUMBER>d represent normal respiratory pattern called eupnea healthy participants comparison find respiratory normal people strong periodic evenly distributed abnormal respiratory data tend irregular generally speaking abnormal breathing data respiratory infections faster frequency irregular amplitude experimental results shown table <NUMBER> consider four evaluation metrics viz accuracy precision recall f<NUMBER> measure performance model compare result model three models gruat bilstmat lstm respectively result shows method performs better networks evaluation metrics despite precision value gruat comparison experimental result demonstrates attention mechanism wellperformed keeping important node features time series breathing data since networks attention layer perform better result lstm another point gru based networks achieve better result lstm based networks may beacuse data set relatively small cant fill demand lstm based networks gru based networks require less data lstm perform better result respiration condition classification task figure detailed information classification respiratory state plotted confusion matrixs four models demonstrated fig <NUMBER> seen results performance improvement bigruat compared lstm mainly accuracy rate negative class many scatterlike abnormalities time series abnormal breathing better recognized attention mechanism besides misclassification rate four networks relatively high extent may many positive samples typical respiratory infections characteristics since part patients caught lungrelated diseases analysis section give <NUMBER> comparasions different aspects prove robustness algorithm device order measure robustness breathing data acquisition algorithm effectiveness proposed portable device analyze breathing data person wearing different masks design <NUMBER> mask wearing scenarios cover situations wearing one surgical mask blue line wearing one kn<NUMBER> n<NUMBER> mask red line wearing two surgical masks green line results shown fig <NUMBER> seen experimental results matter kind mask worn even two masks respiratory data well recognized proves stability algorithm device however since different masks different thermal insulation capabilities average breathing temperature may vary mask changes minimize error respiratory data normalized input neural network order verify robustness algorithm device different scenarios design experiments collect respiratory data different distances considering limitations handheld devices test collection facial respiration data distance <NUMBER> <NUMBER> meters result demonstrated fig <NUMBER> signal tends periodic position <NUMBER> centimeters start lose regularity <NUMBER> meters distance <NUMBER> centimeters complete face begins appear camera video distance comes <NUMBER> meters face detection algorithm begins fail gradually due distance pixel limitation experiment verifies algorithm device guarantee relatively accurate measurement results distance range <NUMBER> meters <NUMBER> meters considering breath detection applied different scenarios design experiment show actual situation different shooting angles define camera directly towards face <NUMBER> degree design experiment shooting angle gradually changed <NUMBER> degrees <NUMBER> degree consider transformation two angles horizontal vertical respectively represent left right turning nodding results two cases quite different shown fig <NUMBER> algorithm device maintain good results horizontal rotation difficult obtain precise respiratory data vertical rotation means participants trun left turn right measurement cant nod head since may impact measurement result paper propose abnormal breathing detection method based portable dualmode camera reocrd rgb thermal videos detection method first accomplished accurate robust respiratory data detecion algorithm precisely extract breathing data people wearing masks bigruat network applied work screening respiratory infections validation experiments obtained bigruat network achieves realtively good result accuracy <NUMBER> realworld dataset foreseeable patients covid<NUMBER> clinical respiratory symptoms classification method may yield better results current outbreak covid<NUMBER> research work prescan method abnomral breathing many scenarios community campus hospital may contribute distuigishing possible cases keep control virus spread future research basis ensuring portability plan use stable algorithm minimize effect different masks measurement breathing condition besides temperature may taken consideration achieve higher detection accuracy respiratory infections first case atypical pneumonia referred severe acute respiratory syndrome sars identified guangdong province china november <NUMBER> spread several countries regions hong kong vietnam singapore canada taiwan cumulative number reported cases sars <NUMBER> number deaths <NUMBER> world may <NUMBER> <NUMBER> among <NUMBER> reported cases sars <NUMBER> deaths china mortality rate increased <NUMBER> early <NUMBER> estimated world health organization stated efforts <NUMBER> laboratories china germany canada etc novel coronavirus identified causative agent sars april <NUMBER> <NUMBER> virus named sars coronavirus sarscov <NUMBER> <NUMBER> <NUMBER> first completed genome gene special topics map sarscov released scientists canada <NUMBER> april <NUMBER> subsequently scientists china hong kong usa singapore released succession completed sarscov genomes determined <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> items sarscov associated nucleotide sequences deposited genbank database httpwwwncbinlmnihgovl <NUMBER> completed sarscov genomes may <NUMBER> <NUMBER> classification status coronavirus order nidovirales family coronaviridae gnenus coronavirus replicates cytoplasm human animal host cells causes respiratory enteric diseases host coronaviruses contain positivestranded rna approximately <NUMBER> nucleotides feature largest viral rna genome known date coronaviruses known date divided three groups groups <NUMBER> <NUMBER> <NUMBER> according serotype groups <NUMBER> <NUMBER> contain mammalian viruses group <NUMBER> contains avian viruses within group coronaviruses classified distinct species host ranges antigenic relationships genomic organization species coronavirus typically infects one host species fastidious cell culture viruses cause severe disease many animals including avian infectious bronchitis feline infectious peritonitis porcine gastroenteritis etc often cause significant lose stock raising <NUMBER> two known human coronavirus hcov<NUMBER>e hcovoc<NUMBER> belong respectively group <NUMBER> group <NUMBER> responsible <NUMBER> influenza mild upper respiratory tract illness <NUMBER> upon coronavirus entry appropriate host cell <NUMBER> open reading frame orflab virus genome translated large polyprotein cleaved viralencoded proteases release several protein products <NUMBER> including <NUMBER>clike proteinase <NUMBER>cu ro rnadependent rna polymerase rep atpase helicase hel etc rep hel responsible replicating viral genome generating nested transcripts used synthesis viral proteins host cell ribosome four primary structural proteins including nucleocapsid protein n spike protein membrane protein small envelope protein e glycoproteins fulllength replicated rna plus strand first assembles n protein rnaprotein complex associates n proteins embedded membranes er new virus particles formed nucleocapsid complexes bud er virus migrates golgi eventually exits cell likely exocytosis io worth pointing membrane glycoprotein functionally important defining host range tissue tropism virus entry cell requires interaction protein special cumulative number reported cases sars published httpwwwwhointcsrsars article cellular receptor <NUMBER> sequence lengths <NUMBER> completed genomes sarscov deposited ncbi genbank range <NUMBER> <NUMBER> nucleotide difference genomes <NUMBER> gc content <NUMBER> genomic organization typical coronaviruses characteristic gene order <NUMBER> rep e n genes <NUMBER> <NUMBER> sarscov rep gene comprises approximately twothirds genome includes two open reading frames orfla orflb predicted encode two polyproteins undergoing cotranslational proteolytic processing generate many protein products also predicted regions located sand e n encode number nonstructural proteins vary widely among different coronaviruses unknown function <NUMBER> <NUMBER> <NUMBER> study sarscov associated proteins subject bioinformatical analysis physiochemical properties protein molecular weight isoelectric point extinction coefficient calculated transmembrane segments subcellular localization prediction conserved protein motifs search databases employed analyze predict function sarscov protein furthermore evolution distance sarscov proteins corresponding homology proteins coronaviruses calculated analyzed sarscov associated protein sequences searched swissprot database httpwwwebiacuk swissprot keyword sars protein sequences deposited swissprot refer almost corresponding nucleotide sequences genbank protein sequences obtained swissprot typical genbank <NUMBER> sarscov associated protein sequences swissprot may <NUMBER> <NUMBER> including structural proteins e n function unknown proteins xl x<NUMBER> x<NUMBER> x<NUMBER> comparing proteins corresponding orf completed sarscov genome ay<NUMBER> genbank found proteins encoded orf<NUMBER> orf<NUMBER> deposited swissprot sarscov associated proteins including proteins swissprot putative proteins orf listed table <NUMBER> studies coronaviruses revealed orflab occupies twothirds virus genome divided two orfs orfla orflb <NUMBER> sarscoy polyprotein synthesized <NUMBER> ribosomal frameshift predicted slippery site <NUMBER> <NUMBER> <NUMBER> uuuaaac<NUMBER> orfla orflb overlapped translational process orfla orflb translated polyprotein autocatalytically precessed initially yield mature viral proteases plppro papainlike proteinase <NUMBER>cu ro chymotrypsinlike proteinase generated rep rnadependent rna polymerase hel atpasehelicase protein products whose functions well characterized analysis cleavage sites orflab got <NUMBER> putative protein products table <NUMBER> proteins may exist actual life cycle sarscoy <NUMBER> proteins polyprotein corresponding orflab subject bioinformatical calculation analysis first amino acid composition charge distribution possible repetitive sequence motif sarscov protein analyzed program saps <NUMBER> statistical analysis protein sequence isoelectric point pi extinction coefficient <NUMBER> urn hypothetical protein <NUMBER> bp<NUMBER>xx swissprot id ay<NUMBER> genbank id c extcoef denotes molecular extinction coefficient <NUMBER> nm pi denotes isoelectric point e putative function proteins study details see text f protein functions available protein calculated pi extcoef <NUMBER> program respectively tmap<NUMBER> tmhmm <NUMBER> <NUMBER> employed predict transmembrane segments transmembrane helical regions proteins subcellular localizations proteins predicted hmmpfam <NUMBER> blimps <NUMBER> used compare sarscov protein sequence hmm blocks databases search possible matching conserved protein motifs finally psiblast program <NUMBER> bioinformatics platform workbench <NUMBER> used search homology protein sequences sarscov protein comparing databases nonredundant protein database sdsc matrix blosum<NUMBER> maximum number rounds <NUMBER> clustalw program <NUMBER> used performs multiple sequence alignments homology sequences unrooted phylogenetic trees drawn drawtree drawgram program <NUMBER> evolutionary distance matrixes based protein alignments computed protdist program <NUMBER> like proteins coronaviruses sarscov associated proteins divided structural protein nonstructural protein former includes proteins e n responsible making protein envelope virus latter includes <NUMBER>cu ro rep hel etc responsible proteolytic processing polyproteins <NUMBER>cu ro replication translation viral rna rep hel however many putative proteins derivated orfs sarscov genome example proteins xl x<NUMBER> x<NUMBER> x<NUMBER> x<NUMBER> functions proteins unknown sarscov associated proteins subject analysis calculation bioinformatics tools sequence length molecular weight isoelectric point extinction coefficient protein listed tables <NUMBER> <NUMBER> analysis protein products encoded orflab polyprotein encoded orflab generates <NUMBER> protein products table <NUMBER> cotranslational proteolytic processing among leader protein acidic protein molecular weight <NUMBER> kd positivecharged amino acids kr content <NUMBER> negativecharged amino acids ed content <NUMBER> tmap tmhmm predict transmembrane region protein blimps analysis leader protein reveals segment <NUMBER> matches conserved sequence motif ipb<NUMBER>d influenza rnadependent rna polymerase subunit pb <NUMBER> blocks database psiblast search reveals partial segments protein possess <NUMBER> identities partial segments intrinsic factorvitamin b<NUMBER> receptor cubilin cation transporteratpase aminopeptidase n respectively p<NUMBER> weakly acidic protein molecular weight <NUMBER> kd tmap predicts existence two potential transmembrane regions spanning residues <NUMBER> <NUMBER> tmhmm predicts transmembrane helical segment blimps search reveals segment <NUMBER> <NUMBER> program dr luca toldo developed httpwwwemblheidelbergde <NUMBER> felsenstein <NUMBER> phylip phylogeny inference package version <NUMBER>c <NUMBER> distributed author department genetics university washington seattle article matches conserved protein motif ipb<NUMBER> transferrin blocks database hmmpfam search reveals segments <NUMBER> <NUMBER> match pf<NUMBER> uncharacterised protein family pf<NUMBER> snake toxin hmm database respectively psiblast analysis protein exhibits partial segments p<NUMBER> share <NUMBER> sequence identities proteins drosophila melanogaster extracellular matrix protein b mitochondrial ribosomal protein hypothetical <NUMBER> kd protein <NUMBER>s<NUMBER>sdna spacer listeria innocua plppro strongly acidic protein molecular weight <NUMBER> kd comprises abundant cys <NUMBER> sequence region <NUMBER> deeeeddaeceeeeidetceheygteddyqglplefgasaetvrveeeeeedwlddtteqseiepepeptpee high scoring negative charge segments tmap tmhmm analyses indicate presence seven transmembrane helical segments large nterminus <NUMBER> region oriented surface virus particle inside lumen ergolgi cterminus <NUMBER> residues oriented inside virus particle cytoplasm hmmpfam analysis plppro reveals segments <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> regions match separately conserved protein motifs pf<NUMBER> rnapoldelta pfoi<NUMBER>alpp pfol<NUMBER> peptidasecl<NUMBER> pf<NUMBER> upfooi<NUMBER> pfoi<NUMBER>cbim hmm database blimps search results show partial segments plppro match conserved protein sequences ipb<NUMBER> domain unknown function duf<NUMBER> ipbool<NUMBER> nad dependent epimerasedehydratase family ipb<NUMBER> ubiquitin carboxylterminal hydrolase family <NUMBER> ipb<NUMBER> high mobility group proteins hmgl hmg<NUMBER> pr<NUMBER> huntingtin signature blocks database respectively psiblast search indicates sequence identities sarscov plppro corresponding proteins murine hepatitis virus mhv bovine coronavirus bocov avian infectious bronchitis virus albv human coronavirus <NUMBER>e hcov<NUMBER>e transmissible gastroenteritis virus tgev range <NUMBER> <NUMBER> analytical results plppro indicate likely functions hydrolase <NUMBER>cu ro acidic protein molecular weight <NUMBER> kd contains two repetitive segments repeat two times tttln located positions <NUMBER> <NUMBER> agtd located <NUMBER> <NUMBER> tmhhmm fails predict existence transmembrane helical region blimps hmmpfam search yield matching conserved protein motifs psiblast analysis <NUMBER>cu ro shows sequence identities <NUMBER>cu ro sarscov corresponding proteins mhy bocoy aiby hcov<NUMBER>e aibv range <NUMBER> <NUMBER> <NUMBER>cu ro also shares <NUMBER> sequence identity segment <NUMBER> hydrolase in<NUMBER> dicating <NUMBER>cu ro cany function hydrolysis protein rep acidic protein molecular weight <NUMBER> kd tmap tmhmm predict transmembrane region hmmpfam analysis rep yields matching conserved sequence family pf<NUMBER> hmm database pf<NUMBER> derived rna dependent rna polymerase psiblast search results show sequence rep share <NUMBER> identities sequences corresponding reps coronaviruses hel basic protein molecular weight <NUMBER> kd tmap tmhmm predict existence transmembrane segment hmmpfam search yields match pfol<NUMBER> viralhelicasel viral superfamily <NUMBER> rna helicase psiblast search results indicate sequence identities sarscov hel corresponding helicases coronaviruses <NUMBER> bestconserved motif glycinerich region located <NUMBER> typically forms flexible loop astrand ahelix loop interacts one phosphate groups nucleotide sequence motif generally referred ploop <NUMBER> analyses reveal strongly conserved property <NUMBER>cu ro rep hei hd<NUMBER>insp<NUMBER> basic protein molecular weight <NUMBER> kd tmhmm analysis predicts presence seventransmembrane ahelices nterminus residues <NUMBER> oriented inside virus particle cterminus residues <NUMBER> located outside virus particle segment <NUMBER> cimlvycflgyccccyfglfc sequence containing abundant cys psiblast analysis reveals hd<NUMBER>insp<NUMBER> sarscov shares <NUMBER> sequence identities corresponding proteins coronaviruses hmmpfam search reveals segment <NUMBER> <NUMBER> hd<NUMBER>insp<NUMBER> matches conserved protein motif pf<NUMBER> nadhubiquinoneplastoquinone oxidore hmm database blimps search reveals partial segments hd<NUMBER>insp<NUMBER> match conserved sequence motifs ipb<NUMBER> lntegrin beta cterminus ipb<NUMBER> filovirus glycoprotein ipb<NUMBER> gprotein coupled receptors family ipb<NUMBER> aromatic amino acids permease blocks database results imply hd<NUMBER>insp<NUMBER> might member gprotein coupled receptors family inserted envelope virus functions signal transduction nsp<NUMBER> acidic protein molecular weight <NUMBER> kd contains two segments repeat two times vlls positions <NUMBER> <NUMBER> llsvl positions <NUMBER> <NUMBER> nsp<NUMBER> shares <NUMBER> sequence identities corresponding proteins coronaviruses tmhmm prediction yields transmembrane helical region blimps hmmpfam searches fail identify matching conserved sequence motifs nsp<NUMBER> neutral protein molecular weight <NUMBER> kd transmembrane segment predicted hmmpfam search indicates segment <NUMBER> nsp<NUMBER> matches pf<NUMBER> phage mu protein f like protein segment <NUMBER> matches pf<NUMBER> pininlsdkmema protein conserved region hmm database blimps search reveals partial segments nsp<NUMBER> match conserved sequence motifs ipb<NUMBER> ramp domain pr<NUMBER> haemagglutinin ha<NUMBER> chain signature pr<NUMBER> raemagglutinin halha<NUMBER> chain signature blocks database sequence alignments sarscov nsp<NUMBER> corresponding proteins coronaviruses reveal <NUMBER> sequence identities nsp<NUMBER> strongly basic protein molecular weight <NUMBER> kd tmap tmhmm predict transmembrane segment blimps hmmpfam searches fail identify matching conserved sequence motif psiblast analysis indicates sequence identities nsp<NUMBER> sarscov corresponding proteins coronaviruses <NUMBER> gflp growth factor like protein acidic protein molecular weight <NUMBER> kd transmembrane region predicted blimps search reveals segment <NUMBER> gflp matches ipb<NUMBER> bbox zinc finger superfamily segment <NUMBER> matches ipb<NUMBER> gibberellin regulated protein blocks database sequence identities gflps various coronaviruses <NUMBER> transmembrane regions predicted nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> blimps search reveals segments <NUMBER> <NUMBER> nsp<NUMBER> match conserved sequence motifs pr<NUMBER> ribosomal protein l<NUMBER> signature ipb<NUMBER> uncharacterized pyridoxal<NUMBER>phosphate dependent enzyme family blocks database respectively segment <NUMBER> nsp<NUMBER> matches ipb<NUMBER> myristoylcoa protein nmyristoyltransferase hmmpfam search reveals segment <NUMBER> nsp<NUMBER> matches pfol<NUMBER> ftsjlike methyltransferase hmm database nsp<NUMBER> matching conserved sequence motif found hmm blocks databases sequence identities nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> various coronaviruses <NUMBER> <NUMBER> <NUMBER> results indicate protein products encoded sarscov orflab conservative among various coronaviruses matching conserved sequence families searched blimps hmmpfam psiblast mainly protease implies proteins encoded orflab play various catalytic function roles virus life cycle ii analysis structural proteins sarscov protein coronaviruses large membrane glycoprotein mature protein inserted viral envelope majority protein exposed surface viral particles forms primary viral sur face projection believed trimer makes virus family look like corona structure electron microscope proteins majority coronaviruses cleaved s<NUMBER> s<NUMBER> subunits synthesis s<NUMBER> subunit responsible recognizing binding cellular receptors integral membrane s<NUMBER> subunit required mediate fusion viral cellular membrane reasons virulence host cellular specificity coronavirus defined protein <NUMBER> protein sarscov comprises <NUMBER> amino acids strong acidic protein molecular weight <NUMBER> kd pi <NUMBER> repetitive segment fnglt positions <NUMBER> <NUMBER> tmhmm analysis protein predicts transmembrane helical region near cterminus residues <NUMBER> nterminus segment <NUMBER> oriented surface viral particle cterminus hydrophilic region <NUMBER> oriented inside viral particle segment <NUMBER> ccmtsccsclkgacscgscc rich cys hmmpfam search reveals region <NUMBER> <NUMBER> sarscov protein matches conserved coronavirus sl domain pf<NUMBER> hmm database region <NUMBER> matches conserved coronavirus s<NUMBER> domain pf<NUMBER> hmm database feature cleavage site coronavirus protein usually basic amino acid sequence rrxrr rxrr however protein sarscov lacks basic cleavage site implying probably cleaved s<NUMBER> s<NUMBER> subunits forms sl s<NUMBER> domains searching homology sequences coronavirus proteins psiblast aligning clustalw found s<NUMBER> domain sarscov conservative sl domain former shares <NUMBER> sequence identities sl subunits coronaviruses latter shares <NUMBER> <NUMBER> sequence identities s<NUMBER> subunits coronaviruses result interpret well functions protein s<NUMBER> domains responsible identification binding special receptors various coronaviruses use different receptors infect different host cells explain nonconserved property sl domains s<NUMBER> domains responsible mediating fusion viral cellular membrane unique function explains conserved property s<NUMBER> domains current mechanism proteinmediated membrane fusion proposes collapse model first interaction sl subunit special cellular membrane receptor induces conformational change s<NUMBER> succession induces structural changes s<NUMBER>some amphipathic ahelices carboxyl half s<NUMBER> collapse coiledcoils thus bringing fusion peptide toward transmembrane domain resulting cellular viral membrane fusion <NUMBER> predicted secondary structure sarscov protein using eight different secondary structure prediction methods provided bioinfomatics platform workbench prediction results reveal nine successive ahelices residue positions <NUMBER> <NUMBER> fig <NUMBER> furthermore relative hydrophobic hydrophilic character amino acids protein calculated grease program<NUMBER> j • hydropathicity profile <NUMBER> <NUMBER> regions shows distinct property hydrophilic hydrophobic amino acids present alternately suggesting regions may amphipathic ahelices whose conformation could collapse coiledcoils recently shown rcov<NUMBER>e virons residues <NUMBER> required sa binding cellular receptor aminopeptidase n <NUMBER> sequence alignment proteins sarscov hcov<NUMBER>e found residues <NUMBER> sarscov protein correspond residues <NUMBER> hcov<NUMBER>e protein however experiments required identifying residues <NUMBER> sarscov protein necessary receptor binding e protein sarscov small acidic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd tmap tmhmm predict hydrophobic transmembrane helix residues <NUMBER> residues <NUMBER> oriented inside viral particle hydrophilic segment <NUMBER> surface viral particle hmmpfam search reveals complete sequence e protein matches conserved sequence motif pf<NUMBER> ns<NUMBER>small envelope protein e hmm database blimps search also reveals segment <NUMBER> ofe protein matches ipb<NUMBER> conserved coronavirus small envelope protein e blocks however psiblast search reveals two coronaviruses whose e proteins similar sarscov sequence murine hepatitis virus mhv rat sialodacryoadenitis coronavirus rscov sequence identities e protein sarscov two coronaviruses <NUMBER> <NUMBER> respectively suggesting e protein conservative evolution furthermore studies revealed e protein porcine transmissible gastroenteritis coronavirus essential virus replication <NUMBER> mhv shown although deletion gene e reduces virus replication ten thousand fold virus still replicate <NUMBER> studies required ascertaining e protein sarscov plays functional role virus replication addition attaching virus envelope protein basic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd residues <NUMBER> <NUMBER> near nterminus make strongly hydrophobic region repetitive segment lvig presents positions <NUMBER> <NUMBER> psiblast alignment results reveal strongly conserved sequence wsfnpe sarscov protein positions <NUMBER> sequence identities proteins various coronaviruses <NUMBER> tmhmm predicts three transmembrane ahelical segments located residues <NUMBER> <NUMBER> <NUMBER> nterminus residues <NUMBER> <NUMBER> surface virus particle cterminus hydrophilic domain <NUMBER> inside virus particle segment inside virus particle rich positive charged amino acids believed interact nucleocapsid virus rna hmmpfam blimps searches reveal complete sequence e protein sarscov matches conserved protein protein n strongly basic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd repetitive segment srgns found positions <NUMBER> <NUMBER> tmap tmhmm predict transmembrane region psiblast alignment analysis reveal strongly conserved segment prwyfyylgtgp located position <NUMBER> function segment unknown furthermore segment kkkktdeaqplpqrqkkq position <NUMBER> sarscov n protein rich lys matches bipartite nuclear targeting signal qdoc<NUMBER> pfam database responsible nuclear location interaction hydrophilic segment srggsqassrsssrsrgnsrnstpgssrgns rich ser located position <NUMBER> <NUMBER> clear segment interacts nuclear blimps search indicates complete sequence sarscov n protein matches ipbool<NUMBER> coronavirus nucleocapsid protein addition partial sequences n protein match ipb<NUMBER> orbivirus ns<NUMBER> ipb<NUMBER> serum amyloid protein ipbooi<NUMBER> transferrin binding protein ipb<NUMBER> ubih coq<NUMBER> monooxygenase family blocks database sequence identities n proteins sarscov coronaviruses <NUMBER> iii analysis function unknown proteins sarscov putative protein xl sarscov genome acidic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd analysis xl sequence reveals strongly hydrophobic region ficnllllfvtiyshlllvaagmeaqflylyaliyfl located <NUMBER> tmap tmhmm predict three transmembrane helical regions located residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> nterminus residues <NUMBER> surface virus particle cterminus residues <NUMBER> <NUMBER> inside virus particle psiblast search yields corresponding homology sequence coronaviruses hmmpfam analysis fails identify matching conserved sequence family hmm database blimps search reveals segment located <NUMBER> <NUMBER> matches pr<NUMBER> footandmouth disease virus vpl coat protein signature segment <NUMBER> matches conserved protein motif pr<NUMBER> c elegans integral membrane protein srb signature implying xl sarscov may structural protein inserted viral envelope x<NUMBER> strong basic protein comprising <NUMBER> amino acids proportion positivecharged amino acid kr content negative charged amino acid de content <NUMBER> <NUMBER> repetitive small segment sllk positions <NUMBER> <NUMBER> found x<NUMBER> psiblast search fails identify corresponding homology sequences cterminal segment kkvstnlcthsfrkkqvr located residues <NUMBER> found match bipartite nuclear localization signal ps<NUMBER>inlsbp pfam database tmap tmhmm predict transmembrane region results suggest x<NUMBER> may function like n protein details see discussion n protein oriented inside virus particle interacts virus rna essential virus assembly x<NUMBER> small acidic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd psiblast search fails identify matching homology sequence hmmpfam blimps searches yield matching conserved sequence family although tmhmm fails predict transmembrane ahelix tmap analysis predicts transmembrane segment located position <NUMBER> nterminal residues <NUMBER> outside virus particle cannot predict function x<NUMBER> sarscov based analytical results x<NUMBER> basic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd strongly hydrophobic segment lflivaalvflilcf located residues <NUMBER> x<NUMBER> tmap tmhmm predict transmembrane ahelical region position <NUMBER> nterminal residues <NUMBER> outside virus particle cterminal residues <NUMBER> inside virus particle also note three uninterrupted basic amino acids krk cterminal tail <NUMBER>l<NUMBER> may interact virus rna blimps search reveals segment <NUMBER> x<NUMBER> matches tetracycline resistance protein tete signature pr<NUMBER> blocks database psiblast search fails yield homology sequence matching x<NUMBER> analyses suggest x<NUMBER> may structural protein inserted virus envelope plays function role virus assembly x<NUMBER> basic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd psiblast search fails identify corresponding homology sequence coronaviruses matching x<NUMBER> tmap tmhmm predict transmembrane segment blimps search reveals segment <NUMBER> <NUMBER> x<NUMBER> matches conserved sequence family ipbooooo <NUMBER> kringle blocks database analyses suggest x<NUMBER> may oriented inside virus particle strongly positivecharged regions located nand cterminuses may interact virus rna facilitate virus assembly hp<NUMBER> hypothetical protein <NUMBER> strongly acidic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd tmap tmhmm predict transmembrane segment hmmpfam blimps searches yield matching conserved protein motif psiblast search fails identify matching homology sequence cannot predict function hp<NUMBER> analyses orf<NUMBER> encodes predicted small acidic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd negativecharged amino acids located nand cterminuses protein psiblast yields matching homology protein tmap tmhmm predict transmembrane ahelical region residues <NUMBER> nterminal residues <NUMBER> inside virus cterminal residues <NUMBER> surface virus particle blimps search reveals sequence <NUMBER> orf<NUMBER> matches conserved sequence family pr<NUMBER> c elegans sra family integral membrane protein signature blocks database segment <NUMBER> matches ipb<NUMBER> sodiumsulfate symporter family partial sequences match ipb<NUMBER> liactate permease pr<NUMBER> nadhubiquinone oxidoreductase chain <NUMBER> signature pr<NUMBER> vomeronasal type <NUMBER> receptor family signature ipb<NUMBER> mitochondrial atpase subunit <NUMBER> ipb<NUMBER> bacterial sugar transferase pr<NUMBER> potassium channel signature pr<NUMBER> <NUMBER> kd inner membrane protein signature respectively speculate results protein encoded orf<NUMBER> may structural protein oriented virus envelope whose function role involved ion transferring protein encoded orflo small basic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd psiblast search fails get homology sequence matching protein although tmhmm predicts transmembrane helical region tmap predicts transmembrane segment located residues <NUMBER> <NUMBER> blimps search reveals segment <NUMBER> matches ipboololo thionin blocks database segments <NUMBER> <NUMBER> match pr<NUMBER> zetatubulin signature ipb<NUMBER> nterminal set domains respectively protein encoded orf<NUMBER> acidic protein comprising <NUMBER> amino acids molecular weight <NUMBER> kd psiblast search fails identify matching homology sequence tmhmm predicts transmembrane helical region tmap predicts transmembrane segment position <NUMBER> <NUMBER> hmmpfam blimps searches yield matching conserved protein motif cannot predict functions ofofrlo orf<NUMBER> results iv phylogenetic analysis proteins sarscov searched nonredundant protein database sdsc homology sequences protein sarscov using psiblast program homology sequences proteins subject evolutionary distance matrix calculations table <NUMBER> unrooted phylogenetic trees drawn data shown ascertain classification status evolutional relationship sarscov coronavimses topologies resulting phylograms remarkably similar species formed monophyletic clusters consistent established three taxonomic groups protein sarscov possesses homology sequences sarscov sequence segregated fourth wellresolved branch indicates sarscov related three previously characterized groups coronavimses forms distinct group within genus coronavirus result consistent refs <NUMBER> <NUMBER> evolutionary distance matrix analyses reveal sarscov proteins except plp n approximately equidistant corresponding proteins previously characterized coronavimses example evolutional distance sars<NUMBER>cu ro corresponding proteins coronavimses ranges <NUMBER> <NUMBER> average value <NUMBER> standard deviation <NUMBER> rep ranges <NUMBER> <NUMBER> average value <NUMBER> standard deviation <NUMBER> hel ranges <NUMBER> <NUMBER> average value <NUMBER> standard deviation <NUMBER> etc see table <NUMBER> results support conclusion sarscov belong three previously characterized groups within fourth group reported refs <NUMBER> <NUMBER> however evolutional distance analytical results indicate hel rep related closely corresponding proteins coronavimses average distances less <NUMBER> table <NUMBER> proteins hel rep responsible vims rna replication transcription undergo huge evolutional pressure conserved functions sequences structures conservative sarscov proteins furthermore interesting proteins bocov mhv close corresponding proteins sarscov evolutional distance example seven proteins plp nsp<NUMBER> rep hel nspll nsp<NUMBER> bocov possessing closest evolutional distances corresponding proteins sarscov six proteins <NUMBER>cu ro hd<NUMBER> gflp rep n mhv possessing closest evolutional distances corresponding proteins sarscov however evidence prove proteins sarscov come recombination bocov mhv coronavimses phylogenetic evolutional distance analyses sarscov associated proteins indicate previously unknown coronavirus neither come recombination previously characterized coronaviruses arise mutant known human animal coronaviruses conjecture two possible sources sarscov one possibility arises mutant unknown animal coronavirus recombinant two unknown coronaviruses acquired new virulence factors ability infect humans one arises mutant unknown human coronavirus acquired new virulence factors however antibodies sarscov werefound serum samples obtained patients sars convalescence human serum samples people without sars<NUMBER> j indicates existence mild unknown human coronavirus largescale serologic tests wild domestic animals birds region sars outbreak first appeared may identify usual host sources sarscov manuscript completed research team university hong kong stated coronavirus resembling sars virus isolated six masked palm civets paguma larvata wildanimal market shenzhen china five ten civet handlers market antibodies sars virus blood<NUMBER> j • however coronavirus palm civet acquire ability infect human mutant recombinant sarscov arisen palm civets coronavirus still possess ability infect palm civets cause lower respiratory tract infection animal hosts sarscov resolvents questions essential annihilation sars completely predictions molecular weight pi extinction coefficient proteins sarscov helpful separation extraction purification transmembrane region predictions conserved sequence family searches homology sequence alignments provide significant information predicting protein function analytical results indicate protein products encoded orflab mainly playa function role polyprotein cleavage virus rna replication rna transcription xl protein possessed transmembrane segments integral membrane protein srb signature sequence suggesting xl may structural protein oriented virus envelope x<NUMBER> protein strongly basic protein possesses transmembrane segment bipartite nuclear localization signal suggesting may interact bind virus rna facilitate virus assembly secondary structure features hydrophobic hydrophilic character <NUMBER> protein support well collapse model coronavirus membrane fusion mechanism bioinformatical analysis protein provides useful information search antigenic determinant aimed protein study establishes foundations construction structures sarscov associated proteins molecular modeling determination sarscov proteomics experiments long run provides significant information design antisars drugs development antiviral vaccine guillainbarré syndromes gbss comprise spectrum polyneuropathies characterized acute within <NUMBER> weeks ascending motor weakness mild moderate sensory abnormalities occasional cranial nerve involvement muscle radicular pain according degree involvement motor sensory nerves myelin sheath axon cranial nerve predominance common subtypes acute inflammatory demyelinating polyneuropathy aidp acute motor axonal neuropathy aman miller fisher syndrome mfs characterized acute ophthalmoplegia gait ataxia areflexia <NUMBER> gbs one prototypic viraltriggered autoimmune neurologic diseases approximately <NUMBER> patients preceding <NUMBER> weeks flulike viral illness <NUMBER> <NUMBER> <NUMBER> among infectious agents associated triggering sporadic gbs viruses including influenza enteroviruses cytomegalovirus epsteinbarr virus herpes simplex virus hepatitis hiv bacteria campylobacter jejuni mycoplasma pneumoniae haemophilus influenzae <NUMBER> gbs outbreaks also associated viral epidemics pandemics including h<NUMBER>n<NUMBER> swine flu anew jersey influenza strain arthropodborne flaviviruses west nile virus chikungunya zika coronaviruses including middle east respiratory syndrome merscov sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> months peak covid<NUMBER> pandemic <NUMBER> infections <NUMBER> deaths steadily increasingly worldwide although various respiratory cardiac complications reported yet seen covid<NUMBER>related neuroinflammatory neuroautoimmune diseases viral outbreaks including coronaviruses merscov sarscov <NUMBER> identical viral genome sequence whether due covid<NUMBER>inducing severe respiratory compromise soon median <NUMBER>day incubation period <NUMBER> underrecognition neurologic events owing overwhelming urgency focus lifesaving efforts unclear uptodate large published series apart multifactorial acute cerebrovascular events <NUMBER> patients main covid<NUMBER>related neurologic symptoms hypogeusia <NUMBER> hyposmia <NUMBER> high creatine kinase ck levels myalgia <NUMBER> indicating potential cns peripheral nervous system myopathic manifestations <NUMBER> things however rapidly changing last <NUMBER> weeks first covid<NUMBER>triggered neurologic events reported least <NUMBER> cases gbs prototypic viraltriggered autoimmune neurologic disease observed <NUMBER> main covid<NUMBER> hotspots wuhan italy spain france <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases special neuroimmunologic practical interest highlight come first caseand one wuhanrefers woman <NUMBER> days returning shanghai wuhan presented acute lower extremity weakness areflexia progressed <NUMBER> days arms without systemic symptoms <NUMBER> first seen gbs suspected confirmed elevated csf protein electromyographic features demyelinating neuropathy laboratory test results normal except lymphocytopenia thrombocytopenia started intravenous immunoglobulin ivig <NUMBER> days later developed fever cough pneumonia tested covid<NUMBER> positive <NUMBER> weeks strength normalized lymphocytopenia resolved regular neurology ward however <NUMBER> relatives taking care tested covid<NUMBER> positive pneumonia <NUMBER> neurologists <NUMBER> nurses treating gbs put isolation italy reported <NUMBER> patients gbs <NUMBER> <NUMBER> issue <NUMBER> presented subacute onset upper lower extremity weakness distal paresthesias sensory deficits <NUMBER> days experiencing cough anosmia ageusia sore throat admission lymphocytopenia high creactive protein crp led diagnosis covid<NUMBER> one patient facial diplegia sensory ataxia <NUMBER> csf showed elevated protein concentration negative covid<NUMBER> electrophysiology consistent demyelinating axonal gbs mri showed enhancement caudal nerve roots facial nerve symptoms rapidly progressed tetraplegia requiring mechanical ventilation antiganglioside antibodies <NUMBER> tested patients negative received ivig variable recovery <NUMBER> died third series refers <NUMBER> men spain <NUMBER> days experiencing lowgrade fever malaise anosmia ageusia developed mfs polyneuritis cranialis <NUMBER> patient mfs presented oculomotor nerve palsies diplopia perioral paresthesias areflexia ataxia elevated csf protein concentration diplopia bilateral abducens nerve palsy anosmia lymphopenia tested positive covid<NUMBER> scf covid<NUMBER> negative patient mfs positive gd<NUMBER>b ganglioside antibodies improved ivig neurologic features completely resolved except residual anosmia ageusia last <NUMBER> cases france <NUMBER>glossary ace<NUMBER> angiotensinconverting enzyme <NUMBER> aidp acute inflammatory demyelinating polyneuropathy aman acute motor axonal neuropathy ck creatine kinase crp creactive protein gbs guillainbarré syndrome icu intensive care unit ivig intravenous immunoglobulin mers middle east respiratory syndrome mfs miller fisher syndrome nam necrotizing autoimmune myositis yearold man <NUMBER>yearold woman also presented acute anosmia followed rapidly progressive weakness paresthesias ataxia areflexia multiple cranial palsies including iii v vi vii viii mri enhancement cranial nerves roots plexus high csf protein concentration negative covid<NUMBER> typical features acute demyelinating neuropathy electrophysiology clinical improvement ivig <NUMBER> early gbs cases despite incomplete immunologic workup considering enormous difficulties highly stressed inhospital settings provide early clues expect months ahead regarding common acute autoimmune neurologic conditions gbs polyneuritis cranialis encephalitis encephalomyelitis myositis years casually referring postviral seen febrile illnesses first foremost practicing neurologists pandemic aware patient presents acute paralytic diseaselike gbs encephalomyelitis myositiseven without fever dyspnea systemic symptoms may represent first manifestation covid<NUMBER> compelling considering <NUMBER> covid<NUMBER>positive patients admission fever <NUMBER> many present patients gbs covid<NUMBER> symptoms presentation early gbs cases also highlight <NUMBER> clinical laboratory signs anosmiaageusia lymphocytopeniathrombocytopenia red flags suspecting covid<NUMBER> otherwise asymptomatic patients acute neurologic events confirm feared viral pandemics covid<NUMBER> trigger neurologic autoimmunity contrast postviral neurologic diseases however covid<NUMBER> requires high degree suspicion potential hidden trigger prevent inadvertent viral transmission health care personnel patient relatives wuhan case <NUMBER> series also highlights gbs peaks <NUMBER> days first covid<NUMBER> symptoms intensive care unit icu settings helps distinguish gbs critical illness neuropathy usually appears later course sick icu patients early manifestation anosmia ageusia present gbs series often occurred conjunction cranial neuropathies also large worldwide cohorts reporting sudden loss smell taste early infection <NUMBER> covid<NUMBER> carriers <NUMBER> highly informative covid<NUMBER> neurovirulence even possible viral entry brain contrast commonly reversible anosmia nonneural olfactory epithelial cells virally infected often persistent anosmiaageusia covid<NUMBER> suggests neurotropism targeting olfactory neurons sarscov merscov <NUMBER> coronaviruses similar covid<NUMBER> neurovirulent enter brain via olfactory nerves <NUMBER> mice oronasal infection sarscov virus infects epithelial cells respiratory tract also olfactory receptor neurons neuroepithelium gaining access olfactory bulb brainstem <NUMBER> viruses also enter cns via retrograde axonal transport cranial nerves trigeminal possesses nociceptive neuronal receptors nasal cavity sensory fibers glossopharyngeal via peripheral nerves <NUMBER> present gbs series oculomotor trigeminal mrienhanced facial nerves roots concurrently affected strengthens prove notion accordingly unexpected weeks months ahead see covid<NUMBER>infected patients neurologic signs related multiple cranial nerves brainstem peripheral nerves mri enhancement nerves meninges autoimmunity covid<NUMBER>gbs significance sialic acids present coronaviruses peripheral nerve myelin sarscov <NUMBER>a protein contains oligosaccharides direct evidence sialic acids play critical role human coronavirus infection <NUMBER> shown attachment coronaviruses surface respiratory cells mediated spike viral protein binds angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor entry <NUMBER> also sialic acidcontaining glycoproteins gangliosides cell surfaces <NUMBER> dual receptor attachment proposed reason increased transmissibility covid<NUMBER> compared sarscov binds ace<NUMBER> receptor <NUMBER> <NUMBER> relevance gbs various gangliosides commonly containing either disialosyl moiety gd<NUMBER>b gq<NUMBER>b gt<NUMBER>b <NUMBER> gangliosides share epitopes gm<NUMBER> combination gm<NUMBER> gm<NUMBER> gm<NUMBER> gd<NUMBER>b serve antigens patients neuropathies <NUMBER> igm recognizes gal pl<NUMBER> galnac moiety gm<NUMBER> found surface motor neurons clinically motor neuropathy recognizes epitopes containing disialosyl groups gdlb present dorsal root ganglionic neurons sensory ataxic neuropathy <NUMBER> immunization rabbits gdlb also causes sensory ataxic neuropathy mimicking human disease <NUMBER> interest first described patient sensory ataxic neuropathy gdlb antibodies also ophthalmoplegia <NUMBER> seen mfs present series <NUMBER> covid<NUMBER> spike interacts galnac residue gm<NUMBER> ganglioside dimers anchoring cell surface gangliosides <NUMBER> crossreactivity epitopes within covid<NUMBER> spikebearing gangliosides signature sugar residues surface peripheral nerve glycolipids likely possibility typical molecular mimicry shown peripheral nerve glycolipids campylobacter jejuni zika virus also trigger gbs <NUMBER> accordingly gbs subtypes aidp aman mfs expected covid<NUMBER> necessitating screening ganglioside antibodies assess autoimmunity interesting therapeutic component association emerging data chloroquine antimalarial drug investigation treating covid<NUMBER> binds highaffinity sialic acids gm<NUMBER> gangliosides presence chloroquine sarscov viral spike cannot bind gangliosides infect targeted cells <NUMBER> benefit confirmed safety established chloroquine may added therapeutic value future patients covid<NUMBER>triggered gbs conjunction ivig come myositis offing among potential covid<NUMBER>associated autoimmune diseases first alarming concern inflammatory myopathy especially necrotizing autoimmune myositis nam high ck levels <NUMBER> myalgia weakness reported <NUMBER> covid<NUMBER>infected patients <NUMBER> although covid<NUMBER>associated myopathy yet studied characterized skeletal muscle injury rhabdomyolysis <NUMBER> <NUMBER> published cases suggest autoimmune covid<NUMBER>triggered nam one <NUMBER>yearold man new york presented acute bilateral thigh weakness inability get toilet without fever systemic symptoms high ck level <NUMBER> ul <NUMBER> found covid<NUMBER> positive given hydroxychloroquine week later painful weakness improved ck reduction <NUMBER>yearold man wuhan <NUMBER>day history fever cough covid<NUMBER>positive pneumonia normal strength ck <NUMBER> days later although systemically improved crp doubled developed painful muscle weakness high ck <NUMBER> ul <NUMBER> given ivig strength improved became covid<NUMBER> negative myopathic symptoms severe systemic viral disease multifactorial acute onset severe muscle weakness increased inflammatory markers high ck levels thousands described consistent autoimmune inflammatory myopathy within spectrum nam similar first reported hiv early epidemic <NUMBER> <NUMBER> common causes nam chronic statin use overstated autoimmune paraneoplastic postviral <NUMBER> <NUMBER> <NUMBER> <NUMBER> considering high ck level painful muscle weakness seen <NUMBER> covid<NUMBER>positive patients <NUMBER> potentially treatable autoimmune myopathy likely overlooked studies muscle biopsy antibody screening urgently needed patients therapy ivig improve strength reduce morbidity facilitate recovery reported first <NUMBER> cases <NUMBER> covid<NUMBER>associated myositis also highly interesting ace<NUMBER> sarscov receptor reportedly expressed skeletal muscle <NUMBER> confirmed covid<NUMBER> may represent first virus directly capable infecting muscle fibers none viruses implicated viraltriggered myositis far shown infect muscle <NUMBER> <NUMBER> instead viruses induce immune cell clonal expansion viralspecific cells macrophagemediated muscle fiber autoinvasion abundant proinflammatory cytokines <NUMBER> <NUMBER> <NUMBER> emerging postinfectious autoimmune neurologic disorders acute disseminated encephalomyelitis described coronaviruses postinfectious brainstem encephalitis myelitis radiculoneuropathies unexpected atypical case acute necrotizing encephalopathy attributed immunemediated process proinflammatory cytokines another meningoencephalitis leptomeningeal enhancement already noted <NUMBER> picture becoming clear <NUMBER> reports issue journal documented impressive mris one case acute necrotizing brainstem encephalopathy presented epilepsy changes right mesial temporal lobe hippocampus <NUMBER> another altered mental status multiple white matter tumefactive lesions postgadolinium enhancement periventricular areas corpus callosum suggestive demyelination <NUMBER> underestimating overwhelming burden acute covid<NUMBER> medical staff vigilance disorders needed along screening autoimmune encephalitis autoantibodies <NUMBER> cases potentially respond early initiation immunotherapy especially ivig whenever indicated may additionally offer various potentially protective antibodies anticytokine effects residual neurologic deficits covid<NUMBER>recovered patients need systematic study neurologic data yet available discharged patients survived catastrophic effects virus know several people permanently lost smell taste form disability affecting quality life depriving tasting pleasures ability detect danger signals like smelling gas fire many discharged patients require assistance muscle weakness gait unsteadiness arguably multifactorial patients may critical illness neuropathy deconditioning significant muscle atrophy worsened comorbidities others may neurotoxicity myocytotoxicity antiviral therapies like first described antiretrovirals chloroquine <NUMBER> <NUMBER> <NUMBER> still others may residual effects unrecognized primary myopathy neuropathy myelopathy due postviral autoimmunity study exploring patients current causes residual muscle weakness sensory deficits urgently needed using emg muscle nerve biopsies autoantibody screening csf imaging studies determine immediate longterm recovery prospects identify potential reversibility accelerate return normalcy patients autoimmune neurologic diseases covid<NUMBER> changing ongoing immunotherapies role complement patients autoimmune neuropathies especially chronic inflammatory demyelinating polyneuropathy multifocal motor neuropathy also autoimmunities like myasthenia gravis ms inflammatory myopathies justifiably concerned whether disease status adds additional risk placing immunosuppressed immunocompromised category current evidence aforementioned autoimmune disorder makes susceptible covid<NUMBER> immunosuppressive even immunomodulating therapies receiving may potential although validated data autoimmune neuromuscular patients maintained steroids mycophenolate azathioprine chronic inflammatory demyelinating polyneuropathy receive monthly ivig applies patients ms seems safe start continue treatment standard diseasemodifying drugs clinically stable lymphopenic compelling datadriven reasons change anything patients disturb clinical stability patients monthly ivig may even theoretical advantage ivig offers additional protection due natural autoantibodies ivig infused home infusion switching selfadministered subcutaneous igg might option diminish exposure proven effective <NUMBER> patients rituximab infusion intervals prolonged <NUMBER> months bcell reduction clinical benefit persist longer <NUMBER> new emerging data provide credence reassurance regarding issues especially immunomodulating drugs large number patients wuhan published issue journal <NUMBER> shown altered immunity induced diseasemodifying drugs patients ms neuromyelitis optica spectrum disorder appears insufficient enhance susceptibility covid<NUMBER> infection results important unexpected considering therapies target adaptive immune response little effect suppressing innate immunity facilitates infection macrophages viral spread similar data new york city area show incidence hospitalization among patients immunemediated inflammatory diseases therapy steroids biologic agents consistent among patients covid<NUMBER> general population concluding ongoing use biologics associated worse covid<NUMBER> outcomes <NUMBER> also new evidence suggesting possible beneficial effect anticomplement therapies <NUMBER> complement integral component innate immune response viruses instigator proinflammatory responses evidence activation c<NUMBER> exacerbates sarscovassociated acute respiratory distress syndrome c<NUMBER>c<NUMBER> complement deposits abundant lung biopsies patients covid<NUMBER> <NUMBER> proposed complement inhibition may alleviate inflammatory complications covid<NUMBER> infection leading ongoing trials antic<NUMBER> antic<NUMBER> agents <NUMBER> <NUMBER> basis eculizumab antic<NUMBER> monoclonal antibody approved neuromyelitis optica spectrum disorder myasthenia gravis benefits patients gbs may withheld indicated like ivig may theoretically added benefit targeted funding reported vaccine biological preparation intended produce immunity disease stimulating production antibodies dead attenuated organisms purified products derived generally used produce various vaccines past decade scientific advances genetics molecular biology plant biotechnology improved understanding many infectious diseases led development vaccination programs common method administering vaccines injection given mouth nasal spray though immunization safest method combat diseases worldwide many constraints regarding mode production distribution delivery cost lack enough research hence desirable look effectual powerful yet cost effective easy storage distribution yet safe method immunization also readily acceptable sociocultural groups around globe research underway dedicated solving problems finding ways produce edible vaccines form transgenic plants investigated alternative means produce deliver vaccine edible vaccines called several alternative names food vaccines oral vaccines subunit vaccines green vaccines seem viable alternative especially poor developing countries come great boon medicinal science biotechnologists given credit concept edible vaccines lies converting edible food potential vaccines prevent infectious diseases involves introduction selected desired genes plants inducing altered plants manufacture encoded proteins also found application prevention autoimmune diseases birth control cancer therapy etc edible vaccines currently developed number human animal diseases new technology hopefully contribute positively toward global vaccine programs dramatic impact health care developing countries many people developing countries access vaccines need traditional vaccines costly require skilled medical people administration less effective inducing mucosal immune response needs inspired hiatt et al <NUMBER> attempted produce antibodies plants could serve purpose passive immunization first report edible vaccine surface protein streptococcus tobacco <NUMBER> total leaf protein level appeared <NUMBER> form patent application published international patent cooperation treaty conceiving idea edible vaccine dr charles arntzen tried realize arntzen <NUMBER> <NUMBER> arntzen coworkers introduced concept transgenic plants production delivery system subunit vaccines edible tissues transgenic crop plants used mor et al <NUMBER> found concept could overcome limitations traditional vaccines thereby triggering research edible vaccine <NUMBER>s streptococcus mutans surface protein antigen expressed first time tobacco group also pioneered field work hepatitis b heatlabile toxin b subunit tobacco plants potato tubers year successful expression hepatitis b surface antigen hbsag tobacco plants also achieved mason et al <NUMBER> prove plantderived hbsag could stimulate mucosal immune responses via oral route potato tubers used expression system optimized increase accumulation protein plant tubers richter et al <NUMBER> parallel evaluation plantderived hbsag mason arntzen explored plant expression vaccine candidates including labile toxin b subunit ltb enterotoxigenic escherichia coli etec capsid protein norwalk virus plantderived proteins correctly assembled functional oligomers could elicit expected immune responses given orally animals mason et al <NUMBER> <NUMBER> new era opened vaccine delivery researchers supported national institute allergy infectious diseases niaid shown first time edible vaccine safely generate significant immune responses people report collaborators university maryland baltimore boyce thompson institute plant research ithaca ny tulane university new orleans appeared may issue nature medicine according director niaid edible vaccines offer exciting possibilities significantly reducing burden diseases like hepatitis diarrhea particularly developing world storing administering vaccines often major problems mor et al <NUMBER> also discussed rapid increase research ediblevaccine field pointed plants could used create multicomponent vaccines protect several pathogens aspect ediblevaccine approach strengthens impact later <NUMBER> sala research group reported proteins produced plants induced mucosal immune response main aim behind concept research edible vaccine still early stage scientists long way go become major part immunization program world wide date many plant species used vaccine production choice plant species important edible palatable plant necessary vaccine planned raw consumption case vaccine animal use plant preferentially selected among consumed normal component animals diet food vehicles discussed concept edible vaccine got impetus arntzen coworkers expressed hbsag tobacco first edible vaccine produced tobacco <NUMBER> <NUMBER> recombinant protein surface protein streptococcus total soluble leaf proteins found appeared form patent application published international patent cooperation treaty transgenic tobacco successfully engineered production edible vaccines hepatitis b antigen using gene hepatitis b virus hbv optimum level recombinant protein obtained leaves seeds since acute watery diarrhea caused enterotoxigenic e coli vibrio cholerae colonize small intestine produce one enterotoxin attempt made toward production edible vaccine expressing heatlabile enterotoxin ltb tobacco besides antibodies dental caries expressed tobacco already preclinical human trials italian researchers developed immunologically active costefficient vaccine human papilloma viruses hpv hpv causative agents cervical cancer also involved skin head neck tumors cervical cancer one main causes cancerrelated deaths genetically modified potatoes also viable option seem desired vector many first edible vaccines synthesized potato plants serum antibodies point immunization <NUMBER> <NUMBER> <NUMBER> also showed fourfold mount intestinal antibodies potatoes well tolerated one experienced serious adverse side effects vaccine development successfully tested potatobased vaccine combat norwalk virus spread contaminated food water virus causes severe abdominal pain diarrhea research team led william langridge loma linda university california reported transgenic potatoes engineered cholera antigen ctb effectively immunize mice mice fed transgenic potatoes produce choleraspecific antibodies serum intestine iga igg antibodies reach highest levels fourth feeding yet another experiment genetically engineered potatoes containing hepatitis b vaccine successfully boosted immunity first human trials attempts also made boil potatoes raw potatoes appetizing unfortunately cooking process breaks <NUMBER> proteins vaccine proteins tolerant heat proteins necessary amplify amount protein engineered foods cooked consumption tomatoes excellent candidate easy manipulate genetically new crops grown quickly moreover palatable eaten raw tomatoes grow well regions edible vaccines needed engineered tomatoes dried made paste facilitate delivery antimalaria edible vaccines different transgenic tomato plants expressing antigenic types proposed chowdhury bagasara <NUMBER> hypothesized immunizing individuals <NUMBER> antigens stage life cycle multistage parasites would efficient inexpensive safe way vaccination tomatoes varying sizes shapes colors carrying different antigens would make vaccines easily identifiable lay individuals tomatoes serve ideal candidate hiv antigen unlike transgenic plants carry protein edible immune thermal process help retain healing capabilities scientists claimed tomatoes could used vaccine alzheimers disease work progress genetically modify fruit create edible vaccine fires immune system tackle disease attacking toxic betaamyloid protein destroys vital connections brain cells causing alzheimers researchers engineered tomato plants lycopersicon esculentum mill var uc<NUMBER>b express gene glycoprotein gprotein coats outer surface rabies virus recombinant constructs contained gprotein gene era strain rabies virus including signal peptide control <NUMBER>s promoter cauliflower mosaic virus camv common fruitthe bananais currently considered potential vehicle vaccines serious well common diseases advantage bananas eaten raw compared potatoes rice need cooked also consumed pure form furthermore children tend like banana plants grow well tropical areas vaccines needed hence research leaning toward use banana vector since large number thirdworld countries would benefit edible vaccines tropical climates negative side new crop banana plants takes <NUMBER> months bear fruit fruiting plants cut new crop vaccinebearing plants must planted researchers also developed bananas deliver vaccine hbv banana vaccine expected cost <NUMBER> cents dose compared <NUMBER> currently available injectable vaccine maize also used vector various edible vaccines egyptian scientists genetically engineered maize plants produce protein known hbsag elicits immune response hepatitis b virus could used vaccine human trials successful <NUMBER> billion people infected hepatitis b <NUMBER> million high risk serious illness death liver damage liver cancer would benefited researches offing iowa state university aim allow pigs humans get flu vaccination simply eating corn corn products quite likely corn vaccine would work humans eat corn even corn flakes corn chips tortillas anything contains corn genetically modified maize could provide protection chickens highly contagious fatal viral disease affecting species birds mexican researcher octavio guerreroandrade colleagues centre research advanced studies guanajuato central mexico genetically modified maize create edible vaccine newcastle disease virus ndv inserted gene ndv major killer poultry developing countries maize dna found antibodies virus chickens ate genetically modified maize one pig vaccine also produced corn successfully efforts made us company prodigene genetically modify maize contain key protein found surface monkey form hiv according us national institute health development brings edible effective hiv vaccine people step closer transgenic maize expressing rabies virus glycoprotein g vnukovo strain also produced using ubiquitin maize promoter fused whole coding region rabies virus g gene constitutive promoter camv maize embryogenic callus transformed construct biolistics regenerated maize plants recovered grown greenhouse amount gprotein detected grains approximately <NUMBER> total soluble plant protein rice another potential crop used developing vaccines offers several advantages traditional vaccines require refrigeration fact rice proved potent <NUMBER> months storage room temperature vaccine dissolve exposed stomach acids attempt predominant cell epitope peptides derived japanese cedar pollen allergens specifically expressed rice seeds delivered mucosal immune system mis development allergic immune response allergenspecific th<NUMBER> cell suppressed furthermore specific ige production release histamine mast cells suppressed inflammatory symptoms pollinosis sneezing also suppressed results suggest feasibility using oral immunotherapy agent derived transgenic plants accumulate cell epitope peptides allergens allergy treatment transfer genetic material microbe responsible producing cholera toxin rice plant achieved plants produced toxin rice grains fed mice provoked immunity diarrheacausing bacterium genetically modified spinach also considered development edible vaccine spinach investigated plantderived edible vehicle anthrax vaccine well vehicle hiv<NUMBER> tat protein prospective vaccine candidate experiment fragment protective antigen pa represents receptorbinding domain expressed translational fusion capsid protein outer surface tobacco mosaic virus spinach inoculated recombinant virus plantexpressed pa highly immunogenic laboratory animals among food crops potential developed edible vaccine sweet potato peanuts lettuce watermelon carrots top priority development plantbased vaccines protect many diseases hiv<NUMBER> hepatitis b rabies nonhodgkins lymphoma ongoing throughout globe using one edible plants advantages disadvantages various plant host systems given conventional subunit vaccines expensive technologyintensive need purification require refrigeration produce poor mucosal response contrast edible vaccines would enhance compliance especially children oral administration would eliminate need trained medical personnel production highly efficient easily scaled example hepatitis b antigen required vaccinate whole china annually could grown <NUMBER>acre plot babies world year <NUMBER> acres land cheaper sidestepping demands purification single dose hepatitis b vaccine would cost approximately <NUMBER> cents grown locally using standard methods require capitalintensive pharmaceutical manufacturing facilities massindefinite production would also decrease dependence foreign supply fear contamination animal viruseslike mad cow disease threat vaccines manufactured cultured mammalian cells eliminated plant viruses infect humans edible vaccines activate mucosal systemic immunity come contact digestive tract lining possible subunit vaccines provide poor mucosal response dual effect edible vaccines provides firstline defense pathogens invading mucosa mycobacterium tuberculosis agents causing diarrhea pneumonia stds hiv etc specific advantages stated <NUMBER> edible means administration <NUMBER> need medical personnel syringes <NUMBER> sterile injection conditions required <NUMBER> economical mass production breeding compared animal system <NUMBER> easy administration transportation <NUMBER> effective maintenance vaccine activity controlling temperature plant cultivation <NUMBER> therapeutic proteins free pathogens toxins <NUMBER> storage near site use <NUMBER> heat stable thus eliminating need refrigeration potential outcrossing field deep root system problematic cleaning field mason et al <NUMBER> <NUMBER> antigen protection bioencapsulation <NUMBER> subunit vaccine attenuated vaccine means improved safety <NUMBER> seroconversion presence maternal antibodies <NUMBER> generation systemic mucosal immunity <NUMBER> enhanced compliance especially children <NUMBER> delivery multiple antigens <NUMBER> integration vaccine approaches <NUMBER> plantderived antigens assemble spontaneously oligomers virus like particles <NUMBER> serious side effect problems noticed <NUMBER> reduced risk anaphylactic side effects edible vaccine injection system one benefit reported biomedicineorg reported edible vaccine carries part allergen compared injection methods reduce anaphylactic risk <NUMBER> administration edible vaccines mothers immunize fetusin utero transplacental transfer maternal antibodies infant breast milk edible vaccines potential role protecting infants diseases like groupb streptococcus respiratory syncytial virus rsv etc investigation <NUMBER> edible vaccines would also suitable neglectedless common diseases like dengue hookworm rabies etc may integrated vaccine approaches multiple antigens may also delivered advancement come many hurdles problems true edible vaccines like one could develop immunotolerance vaccine peptide protein though little research done one key goals ediblevaccine pioneers reduce immunization costs later many limitations reported given <NUMBER> consistency dosage fruit fruit plant plant lot lot generation generation similar <NUMBER> stability vaccine fruit known <NUMBER> evaluation dosage requirement tedious <NUMBER> selection best plant difficult <NUMBER> certain foods like potatoes generally eaten raw cooking food might weaken medicine present <NUMBER> convenient infants might spit eat part eat throw later concentrating vaccine teaspoon baby food may practical administering whole fruit <NUMBER> always possibility sideeffects due interaction vaccine vehicle <NUMBER> people could ingest much vaccine could toxic little could lead disease outbreaks among populations believed immune <NUMBER> concern oral vaccines degradation protein components stomach due low ph gastric enzymes however degradation compensated repeating exposure antigen immunological tolerance accomplished mason et al <NUMBER> <NUMBER> potential risk spreading disease edible vaccine delivery concern many potential contamination oral delivery system possible danger foreign proteins plants accumulate low amounts <NUMBER> total protein less immunogenic therefore oral dose far exceeds intranasalparenteral dose example oral hepatitis b dose <NUMBER> times parenteral dose <NUMBER> g potato expressing b subunit labile toxin etec ltb required three different doses immunogenic attempts boosting amount antigens often lead stunted growth plants reduced tuberfruit formation much mrna transgene causes gene silencing plant genome techniques overcome limitations given <NUMBER> optimization coding sequence bacterial viral genes expression plant nuclear genes <NUMBER> expression plasmids <NUMBER> plant viruses expressing foreign genes <NUMBER> coatprotein fusions <NUMBER> viralassisted expression transgenic plants <NUMBER> promoter elements bean yellow dwarf virus reporter genes gus b glucuronidase green fluorescent protein gfp substituted later target antigen genes <NUMBER> antigen genes may linked regulatory elements switch genes readily selected times plant nearly fully grown edible regions exposure outside activator molecule may also tried development edible vaccines possible highvolume lowcost delivery system thirdworld countries fight fatal maladies like aids hepatitis diarrhea researches niaid university maryland showed significant side effects small study using genetically engineered potatoes make toxin e coli diarrheacausing bacterium volunteers reported serious adverse reactions genetically altered potatoes used deliver edible vaccine toxin according national institutes health nih nih reported <NUMBER> volunteers ate raw potato bites developed four times antibodies e coli without obvious side effects longterm reactions edible vaccines yet determined possible delayed reactions yet discovered organized large scale study required edible vaccines put large scale production creating edible vaccines involves genetic engineering approach introduction selected desired genes plants inducing altered plants manufacture encoded proteins process known transformation plants altered new characteristics called transgenic plants like conventional subunit vaccines edible vaccines composed antigenic proteins devoid genes responsible pathogenicity thus way establishing infection assuring safety especially immunecompromised patients gene codes active antigenic protein first isolated pathogen incorporated suitable gene vehicle gene vehicle integrated genome plant allowed express corresponding antigen plant parts fed animals humans run course two main strategies used production candidate vaccine antigen plant tissues fig <NUMBER> b <NUMBER> stable genomic integration popular method used published edible vaccine clinical trials date method genetic line produced propagated either vegetative stem cuttings sexual seeds reproduction methods stable expression strategy provides opportunity introduce one gene possible multicomponent vaccine production furthermore choice genetic regulatory elements allows organ tissuespecific expression foreign antigens stable transformation causes desired gene incorporated either nucleus chloroplast agrobacterium mediated gene transfer used transforming plants gene integrated nucleus besides direct delivery dna tissue also applied biolistic popular method however chloroplast engineering also got impetus last decade due various advantages nuclear engineering gramnegative soil bacterium infects wound sites dicot plants causing formation crown gall tumor bacterium capable transferring particular dna segment tdna tumorinducing ti plasmid nucleus infected cells subsequently integrated host genome transcribed tdna usually contains cancercausing oncogenic genes genes synthesize opines excreted infected crown gall cells food source bacterium genetic manipulation ti plasmid engineered carry desired gene vaccine virulent genes cause tumor growth plants deleted transgene integrated expressed inherited mendelian fashion whole plant regenerated individual transformed plant cell studied genes successfully expressed experimental model plants given orally animals extract transgenic plant containing antigen induced serum antibodies thus used produce edible vaccine application agrobacterium mediated transformation present possible species agronomic interest including members family graminae leguminosae opens interesting new aspect development edible vaccines human veterinary uses second approach nuclear transformation based microprojectile bombardment method also known gene gun biolistic method method especially beneficial plants transformed tumefaciens mediated gene transfer method selected dna sequences precipitated onto metal microparticles bombarded particle gun accelerated speed partial vacuum plant tissue placed within acceleration path microparticles penetrate walls release exogenous dna inside cell integrated nuclear genome thus method effectively introduces dna cells take desired dna identified use marker gene plants use gus common cultured replicate gene possibly cloned method various advantages including <NUMBER> thousands particles accelerated time causing multiple hits resulting transferring genes many cells simultaneously <NUMBER> since intact cells used difficulties encountered use protoplast automatically circumvented <NUMBER> method universal application cell type size shape presenceabsence cell wall significantly alter effectiveness another important use gene gun involves transformation organelles chloroplasts yeast mitochondria biolistic particle delivery system shoots adequately processed dna particles penetrate chloroplast integrate genome chloroplasts transformation interesting alternative nuclear transformation come recent past plant cells chloroplasts capture light energy sun produce free energy process called photosynthesis chloroplast genetic engineering recombinant dna plasmid bound small gold nanoparticles injected chloroplasts leaf using gene gun described device uses high pressure insert plasmid coated particles cells plasmids contain multiple genes importance therapeutic gene marker gene may may antibiotic resistance gene enhances translation therapeutic gene two targeting sequences flank foreign gene foreign genes inserted homologous recombination via flanking sequences precise predetermined location organelle genome gene expression level plastids predominately determined promoter <NUMBER> <NUMBER> untranslated regions <NUMBER> <NUMBER> utr elements gruissem tonkyn <NUMBER> therefore suitable <NUMBER> <NUMBER> utrs including ribosomal binding site rbs important elements plastid expression vectors eibl et al <NUMBER> order obtain highlevel protein accumulation expression transgene first requirement strong promoter ensure high levels mrna laboratories use strong plastid rrna operon rrn promoter prrn besides gene gun peg mediated transformation galistan expansion femto syringe microinjection techniques also used gene delivery chloroplast advantages chloroplast transformation technology low cost natural gene containment site specific insertion high level stable expression generation production lines competitive timeline elimination gene silencing high accumulation recombinant protein precise steps given step <NUMBER> heteroplasmic diploid plant cell first round selection homoplasmic diploid plant cell second round selection step <NUMBER> multiple gene expression step <NUMBER> reproductive organs disintegration paternal plastids step <NUMBER> maternal inheritance transgenic traits common entry point pathogens mucosal epithelia lining gastrointestinal respiratory urinoreproductive tracts collectively largest immunologically active tissue body mis first line defense effective site vaccination pathogens nasal oral vaccines effective goal oral vaccine stimulate mucosal humoral immunity pathogens edible vaccines plant parts fed directly outer tough wall plant cell acts protect antigens attack step <NUMBER> single gene step <NUMBER> antigen food vaccine taken cells intestine passed various immune system cells start defensive attack antigen true infectious agent part one response leaves longlasting memory cells able promptly neutralize real infectious agent whole procedure explained two stages fig <NUMBER> b antibodies antibody fragments produced specific antigens given table <NUMBER> <NUMBER> numerous therapeutic diagnostic applications edible vaccines summarized table <NUMBER> <NUMBER> diseases work going described malaria disease humans transmitted bite infected mosquito remains one significant causes human morbidity mortality worldwide according whos <NUMBER> world malaria report <NUMBER> million cases malaria killing around <NUMBER> people three antigens currently investigated development plantbased malaria vaccine merozoite surface protein msp <NUMBER> msp <NUMBER> plasmodium falciparum msp <NUMBER> p yoelli wang et al <NUMBER> demonstrated oral immunization mice recombinant msp <NUMBER> msp <NUMBER> msp <NUMBER> coadministered ctb mucosal adjuvant induces antibody responses effective blood stage parasite measles infection respiratory system caused virus experiment mice fed tobacco expressing mvh measles virus haemagglutinin edmonston strain antibody titers five times level considered protective humans could attained secretory iga found feces prime boost strategy combining parenteral subsequent oral mvh boosters could induce titers <NUMBER> times human protective levels titers significantly greater either vaccine administered alone mvh edible vaccine cause atypical measles may occasionally seen current vaccine thus may prove better achieving eradication success mice prompted similar experiments primates transgenic rice lettuce baby food measles also developed given ctb adjuvant <NUMBER> g mvh lettuce enough however increased dose would required given alone rabies deadly viral infection transmitted humans animals tomato plants expressing rabies antigens could induce antibodies mice alternatively tmv may also used transformed tomato plants using camv glycoprotein gprotein gene rabies virus era strain shown immunogenic animals hepatitis b potentially lifethreatening liver infection caused hepatitis b virus estimated infected <NUMBER> million people throughout globe making virus one common human pathogen first human trials potatobased vaccine hepatitis b reported encouraging results since immunization known method das <NUMBER> prevent disease hepatitis b virus attempt reduce infection requires availability large quantities vaccine hbsag amount hbsag needed one dose could achieved single potato levels specific antibodies significantly exceeded protective level <NUMBER> miuml humans cloned camv pcmvs plasmid encoding hbsag subtype ayw showed higher expression roots compared leaf tissue transgenic potato furthermore expression antigen found higher roots transgenic potato leaf tissues however expression hbsag transgenic potatoes sufficient using oral vaccine studies underway increase level hbsag using different promoters eg patatin promoter different transcription regulating elements cholera infection small intestine causes large amount watery diarrhea causes <NUMBER> million deaths per year developing world primarily among children studies supported demonstrated possibility effective vaccine cholera provides cross protection enterotoxic e coli address limitation plants transformed gene encoding b subunit e coli heat liable enterotoxin ltb transgenic potatoes expressing ltb found induce serum secretory antibodies fed mice antibodies protective bacterial toxin assay vitro first proof concept edible vaccine since people eat cooked potatoes effect boiling properties ctb expressed transgenic potatoes examined boiling <NUMBER> min half vaccine protein survived biologically active form providing evidence cooking always inactivate edible vaccines thus spectrum plants producing edible vaccines may expanded beyond raw food plants fruits coexpression mutant cholera toxin subunit mcta ltb crop seeds shown effective nasal administration extremely practical prevalence diabetes increasing globally india exception <NUMBER> million people affected diabetes worldwide typei diabetes also known insulindependent diabetes mellitus iddm juvenileonset diabetes primarily affects children young adults accounts <NUMBER> diagnosed diabetes north america research hein <NUMBER> university western ontario showed diabetes prevented mice feeding plants engineered produce diabetes relatedprotein idea based oral tolerance autoimmune system selectively turned early teaching body tolerate antigenic proteins pancreatic protein glutamic acid decarboxylase gad<NUMBER> linked onset iddm injected mice known prevent diabetes canadian group developed transgenic potato tobacco plants gene gad<NUMBER> fed nonobese diabetic mice developed insulindependent diabetes spontaneously results intriguing <NUMBER> prediabetic mice fed transgenic plants developed diabetes <NUMBER> nontreated mice developed disease treated mice also showed increased levels ig<NUMBER> antibody associated cytokines suppresses harmful immune responses thus antigen produced plants appears retain immunogenicity prevent diabetes animal model according canadian scientists first proof principle use edible vaccines treatment autoimmune diseases human immunodeficiency virus hiv retroviral causes acquired immunodeficiency syndrome aids condition humans progressive failure immune system allows lifethreatening opportunistic infections cancer thrive order produce edible vaccine initial success splicing hiv protein cpmv achieved two hiv protein genes camv promoter successfully injected tomatoes needle expressed protein demonstrable polymerase chain reaction pcr different parts plant including ripe fruit well second generation plants recently spinach successfully inoculated tat protein expression cloned tmv gram leaf tissue spinach shown contain <NUMBER> lg tat antigen mice fed spinach followed dna vaccinations resulted higher antibody titers controls levels peaking <NUMBER> weeks postvaccination still unclear whether edible vaccines would regulated food drugs agricultural products vaccine component would licensedantigen genetically engineered fruit transgenic seeds would subjected close scrutiny regulatory bodies order ensure never enter food supply would include greenhouse segregation medicinal plants food crops prevent outcrossing would necessitate separate storage processing facilities although edible vaccines fall genetically modified plants hoped vaccines avoid serious controversy intended save lives edible vaccines future vaccines challenges yet overcome become reality like products regulated food drug administration edible vaccines undergo rigorous review laboratory clinical testing conducted get information regarding safety efficacy purity potency products trials take place satisfactory information collected quality nonclinical safety successful expression antigens plants demonstrated past vaccines also checked efficacy humans results primary phase firstever human clinical trial edible vaccine published journal nature medicine <NUMBER> blaine p friedlander boyce thomson institute plant research indicated consumption servings raw potatoes resulted immunity specific diseases human clinical study conducted direction dr carol tacket center vaccine development university maryland school medicine baltimore first phase human testing potatoes eaten volunteers contained vaccine travelers diarrhea common condition resulting intestinal infection bacterium e coli contaminates food water supplies clinical trials approved advance food drug administration encouraged results study scientists started exploring use technique administering antigens <NUMBER> thanavalas group developed potato vaccine booster use conjunction injected hepatitis b vaccine currently phase ii clinical trial phase patients previously vaccinated <NUMBER> tacket team mates studied human immune response norwalk virus capsid protein expressed potatoes overall <NUMBER> <NUMBER> <NUMBER> volunteers developed kind immune response although antibody increase cases modest year pogrebnyaks lab developed effective vaccine coronavirus causes severe acute respiratory syndrome sars tomato tobacco plants used high expression coronavirus spike protein s<NUMBER> first lyophilized tomato fruit fed mice boosting occurred s<NUMBER> protein expressed tobacco roots high igg<NUMBER> immune responses significant igg<NUMBER>a igg<NUMBER>b responses observed sera research also going direction engineer plants produce variety functional monoclonal antibody et al <NUMBER> first human study transgenic plant vaccine designed induce active immunity <NUMBER> adult volunteers given either <NUMBER> g transgenic potato <NUMBER> g transgenic potato <NUMBER> g wild type potato transgenic potatoes containing <NUMBER> <NUMBER> lgg ltb variable dose per gram potato due tissue specificity promoter therefore ltb expressed different degree different tissues potatoes potatoes study ingested raw however subsequent studies shown transgenic potatoes expressing b subunit cholera toxin could boiled <NUMBER> min tissue becomes soft loss <NUMBER> ctb pentameric gm<NUMBER>binding form serologic responses also detected vaccination totally <NUMBER> <NUMBER> volunteers <NUMBER> ingested transgenic potatoes developed igg antilt half responses occurred first dose <NUMBER> <NUMBER> <NUMBER> volunteers developed fourfold rise serum iga antilt researchers supported niaid shown first time edible vaccine safely trigger significant immune responses people goal phase <NUMBER> proofofconcept trial study demonstrate edible vaccine could stimulate immune response humans volunteers ate bitesized pieces raw potato genetically engineered produce part toxin secreted e coli causes diarrhea trial enrolled <NUMBER> healthy adults <NUMBER> chosen random receive genetically engineered potatoes <NUMBER> received pieces ordinary potatoes investigator periodically collected blood stool samples volunteers evaluate vaccines ability stimulate systemic intestinal immune responses potatoes well tolerated one experienced serious adverse side effects niaid supported scientists exploring use technique administering antigens edible vaccines intestinal pathogens already pipeline potatoes bananas might protect norwalk virus common cause diarrhea potatoes tomatoes might protect hepatitis b developed thirty million children throughout world receive even basic immunizations year result least three million children die diseases fully vaccinepreventable solution vaccinate children might seem simple idea large scale production edible vaccines various diseases recent progress first human clinical trials plantbased vaccine performed brings many challenges like optimization expression levels stabilization post harvest storage etc longterm reactions edible vaccines yet determined possible delayed reactions yet discovered may point consideration addition edible vaccines improved oral immunogenicity use specific adjuvant applied either fusion candidate gene independent gene diseases edible vaccines shown promising application may elaborated veterinary well human spectrum studies conclude plantderived vaccines new hope promise immunogenic effective less expensive vaccination strategies respiratory well intestinal mucosal pathogens research field edible vaccines holds immense potential future every advancement made direction bringing dream edible vaccine one step closer hope coming future edible vaccines conquer serious diseases make planet beautiful live kataoka niakido miyata moriwaki k honjo <NUMBER> biol chem <NUMBER> <NUMBER> <NUMBER> clarke c el al nucleic acids res <NUMBER> <NUMBER> <NUMBER> <NUMBER> queen c bltimore cell <NUMBER> <NUMBER> <NUMBER> <NUMBER> banerji j olson l schaffner w cell <NUMBER> <NUMBER> <NUMBER> perry r p er al proc naln acad scl us <NUMBER> <NUMBER> <NUMBER> <NUMBER> repeated miniexon sequence encodes first <NUMBER> base pairs variant surface antigen mrnas trypanosoma brucei directs synthesis discrete i<NUMBER>nucleotide transcript thus seems variant surface antigen mrnas transcribed discontinuously present two alternative models might occur ability african trypanosomes establish chronic infections mammalian hosts depends highly developed system antigenic variation whereby individual members parasite population change composition surface coae<NUMBER> antigenic variation controlled level gene expression <NUMBER> <NUMBER> trypanosome possessing large repertoire genes estimated <NUMBER> refs <NUMBER> <NUMBER> coding antigenically distinct variant surface glycoproteins vsgs comprise coat anyone time anyone trypanosome one species ofvsg detected <NUMBER> suggesting mutual exclusion operates vsg genes activation vsg genes occurs twostep process requiring first duplication transposition silent basic copy bc gene one telomeric expression sites process equivalent gene conversion selection expression site others transcription<NUMBER>ls extra copy gene thus produced called expressionlinked copy elc socalled nonduplicationactivated vsg genes described others probably represent genes already undergone first step activation gene conversion expression site variants isolated study although structure expression sites sequences involved gene conversion event identified variants l <NUMBER> little known second step particularly activation occurs mutual exclusion operates different expression sites recently major clue problem come finding <NUMBER> <NUMBER> nucleotides vsg mrnas contiguously encoded proteincoding portion gene i<NUMBER> spliced leader segment identical different vsg mrnas regardless telomeric expression site occupyl<NUMBER> genomic location <NUMBER>base pair bp miniexon coding spliced leader recently reported <NUMBER>kilobase pair kb segment tandemly repeated <NUMBER> times one clusters unidentified locus enome least <NUMBER> kb upstream active vsg gene <NUMBER> <NUMBER> two important observations concerning spliced leader detected many rna molecules varying size blot analyses using rna several models proposed explain contiguous mrna produced unusual arrangement exons <NUMBER> <NUMBER> <NUMBER> activity different expression sites regulated included chromosome end exchange splicing long transcripts discontinuous transcription whereby miniexon elc flanked initiation termination sites determine vsg mrnas produced processed studied <NUMBER>kb repeats identified transcriptional products enable nucleotide sequence analysis miniexon repeat recombinant plasmids containing individual repeats generated initially done using pvuii digest genomic dna brucei enzyme reported release miniex oncontaining portion repeat discrete band <NUMBER> bp<NUMBER> band excised agarose gel dna purified electroelution <NUMBER> ligated pvuii site plasmid vector pbr<NUMBER> ref <NUMBER> sample excised material radiolabelled nicktranslation <NUMBER> used probe colony hybridization <NUMBER> thereby identifying recombinants containing repetitive dna four plasmids thus identified characterized three found contain indistinguishable inserts least one rsai site miniexon include rsai site nucleotide sequence analysis vicinity site performed one plasmids pmep<NUMBER> strategy sequence obtained shown figs <NUMBER> respectively demonstrated unambiguously pmepi contains portion miniexon repeat obtain recombinant plasmid containing insert representative complete <NUMBER>kb repeat ligation performed using <NUMBER> <NUMBER> pvull insert pmepi preliminary restriction mapping one pmes<NUMBER> characterized found contain apparently complete <NUMBER>kb miniexon repeat using recombinant plasmid pmesi strategy shown fig complete nucleotide sequence one repeat unit containing miniexon determined presented fig <NUMBER> position first nucleotide miniexon region <NUMBER> <NUMBER> also sequenced independently generated plasmid pmepi see fig <NUMBER> results two plasmids identical region although southern blot analysis suggested repeat unit defined single sau<NUMBER>a site refs <NUMBER> <NUMBER> dat jcb unpublished results possibility remained two closely adjacent sau<NUMBER>a sites contained within repeat pmesi therefore lacked small portion repeat test recombinant plasmid contaiing miniexon repeat generated using sphi digest genomic dna cloned bacteriophage recombinant containing several<NUMBER>kb repeats dac unpublished results ligated sphidigested patl<NUMBER> sphi known cut repeat sequence analysis pmesi southern blot analyses dac unpublished results thus give fragment spanning sau<NUMBER>a site question miniexoncontaining plasmids identified pmehl obtained mapped sequenced see fig <NUMBER> plasmid contiguous sequence spanning sau<NUMBER>a site used construct pmesl obtained data shown demonstrating sequence presented fig <NUMBER> represents complete miniexon repeat ensure sequence complete also representative compared restriction map fragment sizes observed southern blots genomic dna cut several enzymes using pvull insert pmepi radiolabelled probe data shown predominant bands obtained digest agreed cases fragment sizes predicted sequence demonstrated miniexon repeats highly conserved pmesi contains typical member testable prediction model proposing discontinuous transcription detectable levels small rna <NUMBER> kb derived miniexon repeat one sensitive methods detecting characterizing particular transcripts stprotection <NUMBER> whereby radiolabelled dna probe region interest denatured renatured presence rna resulting material digested singlestrandspecific nuclease length protected fragments measured gel electrophoresis autoradiography dna substrate used pmesi extending <NUMBER> pjlabelled pvull site position <NUMBER> downstream sau<NUMBER>a site position <NUMBER> ecori site vector see fig fragment mixed total trypanosome bloodstreamform rna sucrosegradient fractions thereof precipitated redissolved denatured renatured conditions favouring rnadna hybridization <NUMBER>o • mixture cooled diluted digested st nuclease electrophoresis <NUMBER> urea polyacrylamide gel resulting autoradiogram fig <NUMBER> shows single major end point protection total rna corresponds nucleotide <NUMBER> sequence presented fig <NUMBER> minor bands immediately flanking protected region may indicative slight heterogeneity <NUMBER> end rna nonspecific digestion nuclease end rnadna duplex result could interpreted protection short rna <NUMBER> nucleotides derived miniexon repeats andor longer transcript discontinuity position rnadna duplex discriminate two alternatives two procedures used first examined stprotection different size fractions rna produced sucrosegradient centrifugation fig <NUMBER>b maximal protection found fractions <NUMBER> possessed rna peak size slightly larger <NUMBER>s rna <NUMBER> nucleotides diminishing detectable protection remaining fractions fig <NUMBER>a strongly suggested protection observed total rna due least part presence small rna protection observed fractions particularly containing larger rna may due contamination small rna alternatively may result protection hybrid transcripts comprising small rna <NUMBER> ends linked rna example elc region mechanisms discussed second method detect size transcripts miniexon repeat used northern blot analysis <NUMBER> • procedure total trypanosome rna resolved polyacrylamide gel electrophoresis page denaturing conditions transferred genescreen membrane <NUMBER> hybridized <NUMBER> <NUMBER> plabelled synthetic oligonucleotide complementary positions <NUMBER> <NUMBER> <NUMBER> mer chosen excluded miniexon known give intense hybridization throughout rna blots used probe <NUMBER> slprotection experiments indicated hybridize miniex onderived transcripts figure <NUMBER>a shows ethidium bromide stain polyacrylamide<NUMBER> urea gel major small rna species readily apparent figure <NUMBER>b presents autoradiogram produced hybridizing genescreen transfer duplicate half gel <NUMBER>mer one band detected track containing trypanosome rna signal observed track containing rna unrelated parasitic protozoan toxoplasma gondii size band <NUMBER> nucleotides based published values small ribosomal rnas trypanosomes <NUMBER> thus confirming miniex repeats transcribed yield short discrete rna termed miniexonderived rna medrna regard precise size result within experimental error consistent medrna <NUMBER> nucleotides long cannot however exclude possibility medrna many <NUMBER> nucleotides longer sl nuclease nonspecifically digested <NUMBER> end rnadna hybrid note however nucleotides positions <NUMBER> <NUMBER> cytosines cg pairs would less susceptible action definite answer awaits <NUMBER>sequence analysis medrna methods <NUMBER> pendlabelled pvull digest pmes<NUMBER> recut ecori generate uniquely endlabelled fragment corresponding positions <NUMBER> <NUMBER> plus <NUMBER> bp vector see fi § protection done essentially described elsewhere <NUMBER> • briefly probe mixed different fractions bloodstreamfonn rna precipitated redissolved denatured <NUMBER> fonnamide <NUMBER>·c <NUMBER> min renaturation rnadna hybrids promoted incubating <NUMBER> ·c <NUMBER> h buffer diluting <NUMBER> vol aqueous buffer cooling <NUMBER>·c adding <NUMBER> units ofs nuclease digestion <NUMBER> min reactions phenolextracted isopropanolprecipitated resuspended fonnamide loading buffer <NUMBER> resolved page <NUMBER> polyacrylamide gel <NUMBER> urea <NUMBER> • b <NUMBER> linear sucrose gradient prepared <NUMBER> naci mm edta <NUMBER> mm trishci ph <NUMBER> <NUMBER> sds mg total trypanosome rna overlaid buffer samples spun sw<NUMBER> rotor beckman <NUMBER> rpm <NUMBER>·c <NUMBER> h fractions collected bottom tube <NUMBER> measured sprotection experiments <NUMBER> sample removed pooled groups three numbered middle fraction results also suggest <NUMBER> terminus medrn position <NUMBER> miniex repeat confirm used synthetic oligonucleotide rna blot analyses primer reverse transcriptase extensions medrna result fig <NUMBER> shows major band comigrating heterologous dna marker <NUMBER> nucleotides using different heterologous marker hindiii digest bacteriophage dna size band estimated <NUMBER> nucleotides slight discrepancy probably due differences base composition allowing variation extension approximate length <NUMBER> ± <NUMBER> nucleotides given <NUMBER>end primer represents position <NUMBER> miniexon repeat result confirms <NUMBER>end medrna corresponds position <NUMBER> found spliced leader mature vsg mrnas i<NUMBER> <NUMBER> minor band fig <NUMBER> <NUMBER>± nucleotides may artefact reverse transcriptase example loopback synthesis may indicative minor rna <NUMBER> nucleotides longer major species minor heterogeneity might due variation miniexon repeat sequences andor site transcriptional initiation major bands observed loadings sample run longer shorter periods data shown cloned sequenced complete copy <NUMBER>kb miniexon repeat brucei identified short rna <NUMBER> nucleotides transcriptional product data indicate repeat typical member highly conserved familythis demonstrated virtually complete agreement sequence presented fig <NUMBER> partial sequence region <NUMBER> <NUMBER> recently published elsewhere <NUMBER> four differences three single base changes one insertion localized <NUMBER> <NUMBER> sequences cases determined two plasmids differences may indicative minor real variation repeats addition region coding medrna <NUMBER>kb miniexon repeat contains <NUMBER> nucleotides whose function clear part region presumably involved regulation medrna expression remainder could involved aspect trypanosome gene expression particular note repetitive nature sequence around sau<NUMBER>a site consisting <NUMBER> <NUMBER> <NUMBER>and <NUMBER>nucleotide repeats ac atttgttt acactc respectively interesting determine whether regions repeat exactly conserved coding medrna predicted sequence medrna drawn several alternative regions intramolecular basepairing data shown suggests medrna might adopt stable conformation substantial secondary structure data rnase sensitivity cannot present reliable structure detection medrna raises questions signals directing transcription noted de lange et <NUMBER>i studies relative drug sensitivities <NUMBER> cap structures needed confirm medrna rna polymerase ii transcript termination site cannot compared general case sequences eukaryotic transcriptional terminators reported enable consensus sequences made recently complete sequence small nuclear rna snr<NUMBER> gene reported yease z <NUMBER> transcription unit shows remarkable similarity miniexon repeat four critical positions fig <NUMBER> remainder two sequences sharing significant homologies first snr<NUMBER> gene also octanucleotide tttttg centred position <NUMBER> relative start site transcription second <NUMBER> articles n<NUMBER>aturevol<NUMBER>september<NUMBER> initiation site transcription lies within heptanucleotide sequence similar two genes six seven bases identical third sequences although different overall length <NUMBER> versus <NUMBER> nucleotides medrna snr<NUMBER> respectively end near beginning extremely trich region finally region containing putative donor splice site medrna also shares <NUMBER>out <NUMBER>residue homology yeast snr<NUMBER> potential significance discussed finding medrn fulfils one predictions model vsg gene expression involving discontinuous transcription however definitive multiplicity miniexon repeats could although majority repeats indeed transcribed give short medrna one repeat used initiation long transcript including vsg coding exon difficult possibility exclude pulsechase experiments traditionally used demonstrate precursorproduct relationships suffer shortcomingit impossible demonstrate given miniexon repeat used one purpose compared another indistinguishable repeat nevertheless together published observations regarding abundance transcripts containing miniexonderived sequences inability detect linkage miniexon sequence vsg coding ex identification short discrete medrna strongly supports model discontinuous transcription model miniex onderived leader segment vsg reinitiation mini exon repeats mrnas transcribed discrete product miniexon repeats one several possible mechanisms ultimately found attached <NUMBER>end vsg precursor rna chimaeric intervening sequence removed splicing bringing together <NUMBER>nucleotide leader coding portion give final mrna <NUMBER> kb two general schemes easily imagined occur first model presented fig <NUMBER> predicts rna polymerase transcribes medrna dissociates miniexon repeat possibly medrnapolymerase complex transcription reinitiates upstream elc using medrna primer second model fig <NUMBER> b proposed medrna codingregion rna independently produced discrete transcripts posttranscriptionally ligated cases splicing ultimately removes intervening sequence generate mature mrna critical difference two alternatives posttranscriptional ligation requires functional promoter sense site de novo initiation transcription upstream elc whereas reinitiation model proposes site position rna polymerase could act presence primer medrna attempting test distinction vitro previously reported sequence upstream expressed copy vsg gene compared silent copy gene <NUMBER> • found upstream region expressed copy consisted multiple tandem repeats <NUMBER> bp flanking unusual sequence aa<NUMBER> although three <NUMBER>bp repeats found upstream ofthe silent copy aa<NUMBER> unique expressed copy geneand therefore candidate reinitiation site upstream expressed vsg genes sequence unique mobile could basis mutual exclusion observed different expression sites equally another yet undetected mobile control element might role critical question raised results reported whether discontinuous transcription involving small rna unique property brucei example special adaptation coevolved antigenic variation argued finding similar miniexon sequences found many rnas unknown coding function bloodstreamforms parasite also procyclic insect forms vsg genes addition miniexon sequence conserved homologue shown present genomes several related species genera lack antigenic variation type observed brucej<NUMBER> could discontinuous transcription operating cases question cannot yet answered precedent exist systems otherwise totally unrelated transcription influenza virus known require <NUMBER>capped primer <NUMBER> nucleotides long derived cleavage host mrnas <NUMBER> <NUMBER> coronavirus transcripts hand known common <NUMBER>leader sequence seemingly joined coding portion rna conventional splicing strongly suggesting discontinuous transcription <NUMBER> <NUMBER> fact cases transcription occurs rnadependent viral transcriptase may important distinction provide mechanistic precedent discontinuity primary transcripts lyttieton hypothesized long ago triton pluto originated adjacent prograde satellites neptune l • presently accepted masses triton plutocharon <NUMBER> however momentum energy exchange would required set triton retrograde trajectory impossible mass triton probably seriously overestimated <NUMBER> <NUMBER> enough relax restriction implausible present angular momentum state plutocharon significantly influenced neptune could acquire angular momentum ejection event unless physical collision involved quite unlikely simplest hypothesis triton pluto independent representatives large outer solar system planetesimals triton simply captured potentially spectacular consequences include runaway melting interior ices release surface clathrated ch <NUMBER> co nl ref <NUMBER> condensed remnants protoatmosphere could account features tritons unique spectrumsh dynamics tritons orbital evolution considerably simplified fact specific dissipation function q tidal frequencies much less neptune qt« qn assume standard solidbody q triton <NUMBER> ref <NUMBER> lower bound qn derived requiring outward orbital eyolution satellite given rapid satellite originated corotation radius neptune <NUMBER> myr ago l<NUMBER> ms satellites mass semimajor axis n rn k<NUMBER>n neptunes mass radius tidaleffective potential love number second degree g gravitational constant k<NUMBER>n estimated <NUMBER> subject uncertainties neptunes rotation rate <NUMBER> coefficient second harmonic gravitational potential see ref <NUMBER> parameter values given table neptunes third satellite l<NUMBER> confirmed proves regular noncommensurate qn <NUMBER> <NUMBER> • lower bound q uranus <NUMBER> x <NUMBER> <NUMBER> set using miranda <NUMBER> kz uranus <NUMBER> qs planets comparable probably much larger accordingly monthly radial tide raised triton neptune dominates tritons orbital evolution except orbits small eccentricity tide transfer angular momentum synchronouslyrotating triton cases interest nonsynchronous spin angular momentum would negligible compared orbital angular momentum present fractional rate change tritons orbital angular momentum due tide raised neptune triton das akutaufchronische leberversagen aclf wird im zusammenschluss der european association study liver easl und der american association study liver diseases aasld als akute verschlechterung einer vorbestehenden chronischen lebererkrankung die üblicherweise im zusammenhang mit einem auslösenden ereignis steht und aufgrund eines multiorganversagens mit erhöhter <NUMBER>monatsletalität verbunden ist definiert <NUMBER> der fokus der definition liegt dabei eindeutig auf dem organversagen das zumeist extrahepatische organe betrifft abb <NUMBER> und die prognose betroffener patienten stärksten beeinflusst <NUMBER> <NUMBER> zur identifizierung risikostratifizierung sowie definition abhängigkeit von klinisch relevanten outcomeparametern wurden <NUMBER> großen prospektiven multizentrischen untersuchungen davon eine europa chronic liver failure consortium acute chronic liver failure cirrhosis canonic und eine kanadaden usa north american consortium study end stage liver disease nacseld risikogruppen p hübener g braun und v fuhrmann repräsentieren die sektion gastroenterologie der deutsche gesellschaft für internistische intensivmedizin und notfallmedizin dgiin mit hoher kurzfristiger mortalität identifiziert gleichzeitig wurde die prognostische wertigkeit klinischer scores für das aclf evaluiert <NUMBER> <NUMBER> hierbei zeigte sich ein der tendenz erwarteter der tatsächlichen ausprägung jedoch alarmierender anstieg der kurzzeitletalität bis hin zu über <NUMBER> <NUMBER> klar abzugrenzen ist das aclf daher vom akuten leberversagen alv das durch den funktionsausfall einer zuvor gesunden leber definiert ist und bei dem durch intensivmedizinische und supportive maßnahmen über <NUMBER> der fälle ein überleben ohne organtransplantation erreicht werden kann <NUMBER> <NUMBER> die identifikation spezifischer auslöser des aclf ist für die diagnosestellung nicht zwingend erforderlich tab <NUMBER> die häufigsten auslöser des aclf sind geographisch unterschiedlich verteilt und oft für den krankheitsverlauf relevant <NUMBER> die häufigsten auslöser des aclf sind geographisch unterschiedlich verteilt und oft für den krankheitsverlauf relevant <NUMBER> <NUMBER> sie beinhalten lokale und generalisierte infektionen neue oder fortgesetzte leberschädigung durch alkohol undoder andere hepatotoxische substanzen operationen zirkulationsstörungen sowie seltenere ursachen wie beispielsweise einen schub einer autoimmunen hepatitis tab <NUMBER> während die varizenblutung traditionell eher als dekompensation einer vorbestehenden leberzirrhose gewertet und ihre mortalität den letzten jahren durch moderne evidenzbasierte behandlungsstrategien einschließlich endoskopischer blutstillung medikamentöser und interventioneller senkung des portosystemischen druckgradienten und vermeidung infektiöser komplikationen gesenkt werden konnte können sowohl hämorrhagischer als auch septischer schock nach einer blutung ein aclf auslösen bis zu <NUMBER> der fälle kann kein auslösendes ereignis identifiziert werden diesen fällen liegen möglicherweise subklinische infektionen passagere störungenderintestinalen barriere oder unerkannte hepatotoxische effekte als mögliche auslöser zugrunde <NUMBER> unabhängig davon ob das aclf durch direkte oder indirekte schädigung der leber ausgelöst wird scheinen <NUMBER> faktoren im zentrum der pathophysiologie der erkrankung zu stehen <NUMBER> hämodynamische veränderungen und <NUMBER> systemische inflammationsreaktionen systemic inflammatory response syndrome sirs <NUMBER> <NUMBER> <NUMBER> zudem wurden auch andere pround antiinflammatorische zytokine stnfα r<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ifnγ stark erhöhten plasmatischen konzentrationen bei patienten mit aclf nachgewiesen <NUMBER> auch routinelaborparameter wie leukozyten und crp sind bei patienten mit aclf erhöht und korrelieren ihrer höhe mit der anzahl von organausfällen und dem aclfgrad <NUMBER> bei patienten die eine erste immunaktivierung im rahmen des auslösenden stimulus überleben wird ähnlich wie bei der sepsis ohne lebererkrankung ein übergang einen immunsupprimierten bzw immundysregulierten zustand immune paralysis <NUMBER> beobachtet der das risiko für weitere infektionen signifikant erhöht angesichts der hohen letalität hospitalisierter zirrhotiker bei infektionen etwa <NUMBER> bzw bei schweren bakteriellen infektionen mit septischem schock <NUMBER> <NUMBER> <NUMBER> <NUMBER> erscheint eine aggressive antiinfektive präventionsund therapiestrategie bei aclfpatienten von zentraler bedeutung die canonicstudie ging der frage nach welcher anteil von zunächst meist auf einer normalstation hospitalisierten zirrhosepatienten ein aclf aufweisen oder im verlauf entwickeln und welche prognostischen parameter sich dieser patientengruppe ausmachen lassen um besonders gefährdete subgruppen frühzeitig zu erkennen das aclf wurde dabei als häufigste indikation für eine aufnahme von zirrhosepatienten auf eine intensivstation identifiziert die anzahl und das jeweilige ausmaß von organversagen wurden mittels eines modifizierten sequentialorganfailureassessmentsofascores erfasst da sich dieses system der vergangenheit zuverlässiger der mortalitätsabschätzung von kritisch kranken zirrhosepatienten erwiesen hatte als die meldoder childpughklassifikation der sofascore wurde für die studie modifiziert tab <NUMBER> und schließlich eine vereinfachte form clif consortium organ failure score clifcofs mit identischen organparametern und ähnlichem prognostischem wert modifiziert der schweregrad des aclf wurde anhand der anzahl der organausfälle stratifiziert aclf <NUMBER> <NUMBER> aclf <NUMBER> <NUMBER> aclf <NUMBER> <NUMBER> die außerordentlich hohe dynamik des krankheitsbilds aclf spiegelt sich auch der tatsache wider dass während der hospitalisierung etwa <NUMBER> eine besserung und <NUMBER> eine verschlechterung auftrat <NUMBER> die heilungsrate sank mit dem aclfgrad von <NUMBER> aclf <NUMBER> über <NUMBER> aclf <NUMBER> bis auf <NUMBER> aclf <NUMBER> da sich der aclfgrad zumeist den ersten beiden bis maximal <NUMBER> tagen änderte wird hier ein goldenes zeitfenster für therapeutische interventionen vermutet abb <NUMBER> für eine risikoabschätzung von patienten mit akuter dekompensation einer leberzirrhose mit oder ohne aclf wurden klinische und laborchemische parameter identifiziert die mit erhöhter mortalität assoziiert waren hier wurden <NUMBER> die anzahl von organversagen nach clifkriterien <NUMBER> das patientenalter sowie <NUMBER> die konzentration zirkulierender leukozyten als unabhängige variablen identifiziert diese resultate gingen wiederum eine erweiterung des clifcofs ein clif consortium aclf score clifc aclfs der einen punktwert von <NUMBER> annehmen kann und eine deutlich bessere vorhersagekraft hinsichtlich der <NUMBER> <NUMBER> <NUMBER>und <NUMBER>tagesmortalität besitzt als meld meldnaund childpughscore <NUMBER> nachteilig ist hierbei dass der score verglichen zum ursprünglichen sofaoder auch clifsofascore nicht ohne eine komplexe formel berechnet werden kann die kalkulation kann jedoch beispielsweise durch einen onlinerechner des clif consortium erfolgen <NUMBER> der weiteren aufarbeitung der canonickohorte zeigte sich eine <NUMBER> ige letalität von patienten mit ≥<NUMBER> organversagen undoder einem clifaclfs score ≥<NUMBER> nach <NUMBER> tagen therapie sofern keine lebertransplantation erfolgte <NUMBER> die zahlen unterstreichen den stellenwert eines frühen und raschen insbesondere intensivmedizinischen therapiebeginns um das fortschreiten des multiorganversagens zu durchbrechen ob eine frühzeitige lebertransplantation bei patienten mit aclf zielführend ist ist derzeit thema kontroverser debatten und wird erst durch zukünftige studien geklärt werden können zusätzlich kann die wiederholte risikostratifizierung mittels scores bei patienten mit aclf dem schwierigen entscheidungsprozess hinsichtlich der art des weiteren therapeutischen vorgehens kurativer oder palliativer therapieansatz helfen wir möchten jedoch betonen dass derartige entscheidungen definitiv ärztliche entscheidungen sind die niemals von einem score übernommen werden dürfen im rahmen dieses ärztlichen entscheidungsprozesses müssen neben der unmittelbaren schwere der erkrankung beispielsweise auch der mutmaßliche patientenwunsch jeweilige lokale und nationale überlebensraten eine potenzielle reversibilität der ordas akutaufchronische leberversagen als diagnostische und therapeutische herausforderung der intensivmedizin zusammenfassung das akutaufchronische leberversagen acuteonchronic liver failure aclf ist ein emergentes krankheitssyndrom das durch einen oder mehrere akute trigger bei vorgeschädigter leber ausgelöst wird und vom progressiven hepatalen und nichthepatalen organversagen einem gravierenden risiko infektiöser komplikationen sowie hoher kurzfristiger letalität gekennzeichnet ist wenngleich pathophysiologisch noch weitgehend unverstanden erfordert das aclf frühzeitige diagnostische und therapeutische maßnahmen die sich auf zugrunde liegende ursachen sowie das verhindern von komplikationen richten um die prognose betroffener patienten zu verbessern leberversagen · zirrhose · infektion · organversagen · transplantation acuteonchronic liver failure diagnostic therapeutic challenge intensive care abstract acuteonchronic liver failure aclf emerging clinical syndrome patients underlying liver disease usually triggered one multiple insults characterized progressive hepatic nonhepatic organ failure significant risk infections high shortterm mortality rates despite incomplete understanding underlying pathophysiology aclf requires timely diagnostic therapeutic measures aiming identification elimination causative factors well prevention complications improve prognosis affected patients liver failure · cirrhosis · infection · organ failure · transplantation introduction oropharyngeal dysphagia frequent hospitalized poststroke patients associated increased mortality comorbidities aim analysis evaluate impact dysphagia length hospital stay los costs hospital perspective used assess costs methods hospital discharge databases comparing hospital stays ischemic stroke associated dysphagia vs stroke without dysphagia france switzerland analyzed french medical information system program pmsi database analysis focused <NUMBER> stays stroke public sector <NUMBER> hospital stays stroke analyzed swiss ofs office fédéral de la statistique statistique des coûts par cas <NUMBER> database diagnosis codes listing procedures used identify dysphagia stroke patients results patients poststroke dysphagia accounted <NUMBER> stroke hospital stays switzerland consistent recently reported prevalence dysphagia hospital discharge arnold et al <NUMBER> french database analysis identified <NUMBER> stays poststroke dysphagia hypothesize difference swiss french datasets may explained limitations analysis based diagnosis procedure coding patients poststroke dysphagia stayed longer hospitals los <NUMBER> vs <NUMBER> days france los <NUMBER> vs <NUMBER> days switzerland compared patients without poststroke dysphagia poststroke dysphagia associated €<NUMBER> chf<NUMBER> cost increase france switzerland respectively discussion study poststroke dysphagia associated increased los higher hospital costs difficult isolate impact dysphagia patients multiple symptoms disabilities impacting rehabilitation recovery adjusting confounding factors matching stays according age sex stroke complications poststroke dysphagia association increased los higher hospital costs found independent sensory motor complications conclusion poststroke dysphagia associated increased length hospital stay higher hospital costs hospital costs impact post ischemic stroke dysphagia database analyses hospital discharges france switzerland coliforms diffusion chamber studies e coli several tropical sites reveal bacterium survive indefinitely freshwaters puerto rico evaluation methods enumeration fecal coliforms showed currently used media poor reliability result large numbers false positive false negative results applied tropical water samples total fecal coliform bacteria reliable indicators recent biological contamination waters tropical areas fecal streptococci coliphages tropical waters violate underlying assumptions indicator assays coliforms anaerobic bacteria like bifidobacterium spp clostridium perfringens show promise terms survival ease enumeration media specificity best course present lies using current techniques direct enumeration pathogens fluorescent staining nucleic acid analysis developing tropical maximum contaminant levels certain resistant pathogens tropical waters <NUMBER> billion people half worlds population suffered diseases due drinking polluted waters barabas <NUMBER> <NUMBER> million new cases waterborne disease reported year resulting <NUMBER> million deaths nearly <NUMBER> waterborne disease cases occur tropical subtropical areas indeed nearly <NUMBER> diarrheal disease deaths <NUMBER> million occur children <NUMBER> years age living tropics snyder merson <NUMBER> bockemuhl <NUMBER> many investigators government administrators assume high morbidity mortality rates simply indicate contaminated nature water tropical areas however determining level biological contamination tropical source water much difficult regulatory agencies perceive even regulatory agencies residing tropical nations yet need accurately determine level biological contamination much greater tropical areas temperate areas tropical areas much greater number waterborne diseases tables <NUMBER> turn diseases exacerbated greater reliance surface water drinking water source lack adequate sewage treatment feachem <NUMBER> esrey et al <NUMBER> literature sparse specific references fecal contamination tropics yet notable exceptions evison james <NUMBER> reviewed literature ceylon egypt india singapore reported densities escherichia coli water seem coincide known sources fecal contamination feachem <NUMBER> working rural areas new guinea found fecal coliform fc densities <NUMBER> <NUMBER> colonyforming units cfu per <NUMBER> ml fecal streptococci fs levels <NUMBER> <NUMBER> cfu per <NUMBER> ml although mean densities indicator bacteria greater <NUMBER> cfu per <NUMBER> ml nearly sites sites totally unacceptable drinking water feachem concluded sites grossly contaminated fecal material high indicator counts yet stated fc fs densities closely correlated number domestic animals watershed number people fact fc fs densities closest highest human population density lowest addition typical many tropical studies feachem complete identification positive isolates sierra leone wright <NUMBER> reported densities fecal coliforms <NUMBER> <NUMBER> probable number mpn per <NUMBER> ml fs densities <NUMBER> <NUMBER> cfu per <NUMBER> ml water sources used <NUMBER> settlements however wright <NUMBER> found correlation fecal indicators measured salmonella spp fujioka shizumura <NUMBER> found streams hawaii densities fecal colifoms fecal streptococci <NUMBER> <NUMBER> cfu per <NUMBER> ml including known receiving contamination fecal source oluwande et al <NUMBER> found rivers nigeria ccfu colonyforming units see hazen et al <NUMBER> dufour <NUMBER> found exclusively tropics hutchinson ridgway <NUMBER> hawkins et al <NUMBER> <NUMBER> dufour <NUMBER> hutchinson ridgway <NUMBER> hawkins et al <NUMBER> total coliform counts <NUMBER> <NUMBER> cfu per <NUMBER> ml oluwande et al <NUMBER> also assumed high densities fecal indicators meant waters heavily contaminated human feces even though data showed densities total coliforms often higher upstream known contamination sources thomson <NUMBER> also found salmonella spp drinking water wells botswana correlated densities total coliforms fecal coliforms e coli observed salmonella spp could found complete absence e coli fecal coliforms either high low densities total coliforms lavoie viens <NUMBER> reported <NUMBER> traditional water sources ivory coast west africa unacceptably high densities fecal coliforms <NUMBER> cfu per <NUMBER> ml yet fewer <NUMBER> positive total coliform isolates actually e coli fewer <NUMBER> fc isolates actually e coli lavoie <NUMBER> however examined feces local inhabitants found <NUMBER> total coliform isolates e coli <NUMBER> fc isolates e coli studies carefully examined tested underlying assumptions fecalpathogen indicator used bonde <NUMBER> eloquently enumerated criteria follows <NUMBER> indicator must present whenever pathogens present must present presence pathogenic organ<NUMBER> must occur much greater numbers pathogens <NUMBER> must resistant disinfectants aqueous envi<NUMBER> must grow readily relatively simple media <NUMBER> must yield characteristic simple reactions enabling far possible unambiguous identification group species preferably randomly distributed sample tested growth artificial media must largely independent organism present late <NUMBER>s houston proposed idea using three groups bacteria ie coliforms fecal streptococci gasproducing clostridia commonly found feces warmblooded animals indicators fecal pollution waters hutchinson ridgway <NUMBER> argued since groups could come fecal sources presence would indicate recent fecal pollution hutchinson ridgway <NUMBER> nearly <NUMBER> years coliform group bacteria used indicators indicator used isms imminent danger ronments pathogens universally access biological contamination water e coli tropical temperate countries barbaras <NUMBER> first drinking water regulation microbial contamination united states published <NUMBER> first public health service drinking water standards regulation subsequently regulation replaced us public service acts <NUMBER> <NUMBER> current us regulation comes safe drinking water act public law <NUMBER> us environmental protection agency proposed changes implemented fed era<NUMBER> register <NUMBER> october <NUMBER> law approved july <NUMBER> currently first phase implementation new regulation requires <NUMBER> coliforms<NUMBER> ml method sampling frequency drinking waters barbaras <NUMBER> allows <NUMBER> coliforms<NUMBER> ml small community water sources tropical nations tropical parts united states even old regulations may unrealistic <NUMBER>s observed botswana thomson <NUMBER> sierra leone wright <NUMBER> perezrosas hazen <NUMBER> yersinia enterocolitica elias et al <NUMBER> aeromonus hydrophila also found unrelated densities e coli source water thus pathogens could present absence e coli tropical source water indeed well demonstrated high densities enteric viruses dominant cause waterborne disease temperate tropical areas may found complete absence fecal coliforms e coli berg metcalf <NUMBER> nigeria oluwande et al <NUMBER> hawaii fujioka shizumura <NUMBER> new guinea feachem <NUMBER> puerto rico carrillo et al <NUMBER> sierra leone wright <NUMBER> ivory coast lavoie <NUMBER> high densities e coli found complete absence known fecal source ie pathogens monitoring puerto rican waters us geological survey reported <NUMBER> <NUMBER> water sampling stations rivers puerto rico exceeded recommended maximum contaminant levels mcl recreational waters ie lo<NUMBER> fecal coliforms per <NUMBER> ml <NUMBER> curtis et al <NUMBER> thus <NUMBER> sites sampled met recommended mcl recreational waters none waters could meet raw source water standards <NUMBER> fecal coliforms per <NUMBER> ml findings resulted condemnation sewage treatment facilities puerto rico source fecal pollution natural waters yet sampling sites upstream sewage treatment plants puerto rico fc densities high downstream sites even temperate waters coliforms shown limitations using viable count media burlingame et al <NUMBER> found bacterial interference coliform colony greenmetallic sheen production membrane filters mendo medium american public health association apha <NUMBER> noncoliform pseudomonas ueruginosa hydrophila well coliform bacteria e coli enterobacter cloacae means olson <NUMBER> reported formation products noncoliforms antagonistic growth biochemical activity coliforms thus high densities background bacteria typical tropical waters could result significant underestimation coliform bacteria recent studies xu et al <NUMBER> colvrell et al <NUMBER> baker et al <NUMBER> roszak et al <NUMBER> shown enumeration complex media like used grow e coli may reliable studies demonstrated e coli pathogens like salmonella enteridis v cholerue may able survive remain pathogenic yet unculturable pagel et al <NUMBER> compared four standard apha <NUMBER> fc assays various types freshwaters southern canada found assays somewhat variable abilities detect fecal coliforms environmental samples acceptable terms specificity selectivity similar studies laboratory hazen et al <NUMBER> using methodology detect fecal coliforms freshwaters puerto rico found specificity media determined ability medium restrict growth organisms target bacterium least <NUMBER> less specificity claimed canadian investigators table <NUMBER> thus methods gave significantly higher false positive false negative errors controls using known strains e coli indicated accuracy methods studies table <NUMBER> identification <NUMBER> fc isolates various freshwater sites around puerto rico showed less <NUMBER> isolates actually e coli hazen et al <NUMBER> similar studies using methods continental united states dufour et al <NUMBER> south africa grabow et al <NUMBER> canada pagel et al <NUMBER> england evison james <NUMBER> demonstrated <NUMBER> fc positive isolates identified e coli wright <NUMBER> found sierra leone waters fewer <NUMBER> positive isolates fecal coliform assays e coli lavoie <NUMBER> found less <NUMBER> fc isolates ivory coast well waters actually e coli surprising thermotolerant e coli encounters mesophilic thermotolerant background flora tropics given higher constant temperatures productivities santiagomercado hazen <NUMBER> puerto rico jen bell <NUMBER> singapore showed high densities mesophilic thermophilic background flora tropical source waters significantly reducing numbers e coli standard fc media general microbial diversity tropical waters greater temperate source water floral faunal communities watershed thus greater array autochthonous microorganisms greater array allochthonous microbes substances entering tropical waters surrounding milieu hill h <NUMBER> barrel<NUMBER> roland <NUMBER> showed rainfall gambia significantly increased bacterial densities well water fujioka shizumura <NUMBER> also found densities bacteria significantly greater hawaiian streams rainfall carrillo et al <NUMBER> demonstrated torrential rainfall even densities total anaerobes puerto rico stream water exceeded polluted temperate waters total anaerobes daily et al <NUMBER> thus tropical background microbial flora environmental characteristics survival activity characteristics allochthonous microbes quite dissimilar temperate waters gordon fliermans <NUMBER> demonstrated e coli could survive much longer periods time temperate lake receiving thermal effluent thus environmental factors tropics might also significantly affect recovery fecal coliforms environmental samples bigger <NUMBER> first reported growth coliforms tropical waters india ragavachari iver <NUMBER> showed coliforms survive several months natural tropical river waters puerto rico carrillo et al <NUMBER> l<NUMBER>peztorres et al <NUMBER> valdkscollazo et al <NUMBER> hazen et al <NUMBER> showed e coli survived rain forest streams also grew table iv introduced e coli could remain andor become part normal flora situ conditions tropical rain forest enterocolitica elias et al <NUMBER> k pneumoniae l<NUMBER>peztorres et al <NUMBER> candida albicans valdkscollazo et al <NUMBER> hydrophila hazen et al <NUMBER> salmonella typhimurium jimenez et al <NUMBER> v cholerae perezrosas <NUMBER> shown different survival rates e coli indicator inability e coli survive manner similar pathogens would impede ability indicate pathogens temperate investigators also suggested coliforms inadequate index water quality temperate waters dutka <NUMBER> evans et al <NUMBER> temperate survival ofe coli source waters shown numerous circumstances matter days densities decreasing <NUMBER> every <NUMBER> min bonde <NUMBER> regrowth e coli extraenterally temperate areas rarely observed bonde <NUMBER> seen table iv e coli always survives significantly longer situ tropical waters compared temperate waters increased survival e coli tropical waters alone suggests temperate mcls based fecal coliforms cannot applied tropical waters recent studies shown e coli isolated pristine areas tropical rain forests puerto rico rivera et al <NUMBER> bermudez hazen <NUMBER> plasmid profiles antibiotic sensitivities coliphage susceptibility physiological biochemical characteristics confirm even e coli isolated epiphytes trees <NUMBER> ground similar clinical isolates e coli rivera et al <NUMBER> environmental isolates identical mol g c isolates dna <NUMBER> dna homology e coli b bermdez hazen <NUMBER> thus tropical source waters may high densities e coli absence pathogens fecal sources e coli may naturally occurring tropical areas observation suggested high densities e coli diverse tropical countries absence identifiable fecal sources escherichia coli indicator used developed nations determining biological contamination source waters fit underlying assumptions good indicator tropical waters fact criteria <NUMBER> bonde <NUMBER> see seems suitable tropical waters surprising therefore developing nations tropical areas finding difficult impossible meet legislated standards biological contamination since problems fc assay part due e coli target organism changes media incubation would correct problems tropical systems coliphages suggested specific subject cultivation problems e coli berg metcalf <NUMBER> however since host organism viruses e coli e coli survives grows tropical source water likewise viruses infect coliforms would also survive grow therefore coliphages would better e coli host tropics several investigations tropical source water looked fs densities feachem <NUMBER> found streams new guinea highlands densities fecal streptococci <NUMBER> <NUMBER> per <NUMBER> ml fcfs ratio ranged <NUMBER> <NUMBER> feachem interpreted results mean waters <NUMBER> times likely contaminated pigs humans based upon studies geldreich kenner <NUMBER> however e coli able survive waters ratio could inflated high densities fecal streptococci would also seem indicating fecal contamination none may present wright <NUMBER> found source water sierra leone densities fecal streptococci <NUMBER> per <NUMBER> ml n order magnitude lower densities either fecal coliforms <NUMBER> per <NUMBER> ml presumptive e coli <NUMBER> per <NUMBER> ml fs positive isolates identified wright <NUMBER> found anywhere <NUMBER> <NUMBER> confirmed streptococcus faecalis target organism assay addition wright <NUMBER> could find correlation incidence salmonella spp source waters densities fecal streptococci fujioka shizumura <NUMBER> also found <NUMBER> cfu per <NUMBER> ml fecal streptococci streams hawaii even though many streams known fecal source contamination densities fecal streptococci hawaiian streams quite similar densities fecal coliforms studies puerto rico demonstrated faecalis survive remain active long periods time diffusion chambers tropical rain forest stream muiiiz et al preparation even tropical marine waters petroleum contamination could support high densities faecalis santo doming<NUMBER> et al press monitoring puerto rican waters us geological survey shown like fecal colifonns fecal streptococci exceeded recommended mcl recreational waters <NUMBER> time curtis et al <NUMBER> yet like fecal coliforms densities fecal streptococci slightly lower occasionally higher sampling stations upstream sewage treatment plants evison james <NUMBER> suggested e coli feces tropical countries much lower proportions faecalis would also invalidate use fcfs ratio determining origin fecal contamination would higher survival rates e coli faecalis tropics although even fewer studies done tropical water fecal streptococci fecal coliforms fecal streptococci also seem satisfy one bondes eight criteria ideal indicator evison james <NUMBER> suggested bifidobacterium spp might appropriate indicator tropics bifidobacteria obligate anaerobes thus could grow extraenteral environments addition always found human gut quite often higher densities e coli yet seldom found animals resnick levin <NUMBER> advent yn<NUMBER> medium resnick levin <NUMBER> bifidobacteria would seem excellent candidate fecal indicator tropical source waters carrillo et al <NUMBER> showed bifidobacterium adolescentis decreased one order magnitude day situ exposure tropical rain forest stream puerto rico gyllenberg et al <NUMBER> evison james <NUMBER> showed densities bifidobacteria always greater densities e coli contaminated waters temperate areas puerto rico rain forest densities bifidobacteria greater e coli sites except sewage outfall carrillo et al <NUMBER> addition identification isolates rain forest stream using yn<NUMBER> medium showed less <NUMBER> actually bifidobacteria bifidobacteria show promise indicator recent fecal contamination terms lack survival situ specificity human fecal indicator unfortunately currently available medium enumeration yn<NUMBER> hampered lack specificity insufficient resolution background bacterial densities high carrillo et al <NUMBER> clostridiurn perfringens also suggested suitable alternative indicator fecal coliforms fecal streptococci tropical source waters fujioka shizumura <NUMBER> found uncontaminated streams densities c perfringens <NUMBER> <NUMBER> cfu per <NUMBER> ml discharge sites <NUMBER> <NUMBER> cfu per <NUMBER> ml fujioka shizumura <NUMBER> found <NUMBER> hawaiian isolates mcp medium confirmed c perfringens compares favorably temperate studies c perfringens bisson cabelli <NUMBER> however densities c perfringens human fecal material tropics much lower previously mentioned indicators wright <NUMBER> raises serious doubts ability easily detect c perfringens pathogens n eminent danger carrillo et al <NUMBER> found sites receiving heavy rainfall high densities total anaerobes <NUMBER> per <NUMBER> ml fujioka shizumura <NUMBER> made observation densities c perfringens increased significantly uncontaminated sites rainfall suggests conditions c perfringens might extraenteral source wright <NUMBER> found source waters sierra leone densities c perfringens <NUMBER> <NUMBER> per <NUMBER> ml compared favorably densities fecal streptococci like fecal streptococci unrelated isolation salmonella spp c perfringens seems satisfy bondes criteria ideal indicator fecal coliforms fecal streptococci yet falls short least three points studies reported use fecal indicators e coli tropical source water objective evaluations efficacy alternate indicators difficult present obligate anaerobes seem best candidates better indicator tropical source water primarily due inability survive extraenterally however indicators inherent difficulty conditions may survive media used enumeration may allow false positive background flora addition viable nonculturable phenomena reported many pathogens temperate tropical waters suggests indicators may rarely correlated disease risk source waters colwell et al <NUMBER> hazen et al <NUMBER> l<NUMBER>peztorres et al <NUMBER> best indicator may indicator ie directly enumerate selected resistant pathogens would allow realistic estimation health risk immunofluorescent staining detect densities pathogenic bacteria low <NUMBER> cells per ml density may give culturable counts colwell et al <NUMBER> nucleic acid probes detect enteric viruses densities low one virus particle per liter dna probes also developed enterotoxigenic e coli bialkowskahabrzanska <NUMBER> hill et al <NUMBER> moseley et al <NUMBER> salmonella spp fitts et al <NUMBER> thus direct enumeration pathogens currently possible common enteric pathogens might enumerated could polio virus salmonella typhimurium detection either one tropical source water would indicate risk human disease instead enumeration mcls could based detection public health people living tropics economic development respect countries world community dependent upon suitable standard developed tropical source waters currently used fc assays unacceptable indicating biological contamination tropical source waters deloitte <NUMBER> oil gas deal values count total oil gas deal values <NUMBER> increased <NUMBER> <NUMBER> bn thanks several upstream downstream megadeals overall deal count declined yearoveryear yoy <NUMBER> companies continue struggle low commodity prices challenging market conditions according new deloitte report activity <NUMBER> little bit different report said <NUMBER> upstream deal values totaled <NUMBER> bn report noted <NUMBER> bn yoy <NUMBER> deals struck <NUMBER> <NUMBER>year trend us hub global upstream last year representing <NUMBER> terms deal volume value midstream significantly increased deal count deal value <NUMBER> striking <NUMBER> deals worth <NUMBER> bn <NUMBER> <NUMBER> yoy increase respectively private equity spending increased sector investors pivoted production infrastructure downstream deal value reached <NUMBER> bn decade high almost double prior year <NUMBER>year average number transactions declined <NUMBER> yoy oilfield services ofs deal making stalled deal values reaching <NUMBER> bn <NUMBER> <NUMBER> bn yoy <NUMBER> <NUMBER>year average volumes decreased <NUMBER> yoy <NUMBER> <NUMBER>year average absent increase commodity prices dampened level deal making activity expected continue <NUMBER> report said however many companies change portfolios match external market conditions shifts strategic priorities evolving trends themes could shape oil gas transactions market year ahead beyond largest driver <NUMBER> divestitures likely massive <NUMBER> <NUMBER> acquisitions report noted upstream companies involved recent deals expected continue realign portfolios strategies also looking divestment opportunities allow focus expanded footprints assets looking existing assets companies considering carbon footprints comes divestitures investor sentiment changed oil companies increased discussion environmental social governance esg issues size esg investment funds grow could oil gas companies interests burnishing environmental credentials end renewables investment likely increase also carbonbased divestitures deloitte said <NUMBER> majors expected primary catalyst global <NUMBER> majors divested wide swath assets across range geographies resource types integrated national oil companies moving onward downward capitalize growing chemicals demand international oil gas companies continuing expand downstream footprints beyond refining assets distribution retail chemicals businesses investment push primarily targeted integrated refining petrochemical assets well fuel natural gas networks middle east asia pacific expected continue high purity alumina market size worth <NUMBER> bn <NUMBER> global high purity alumina market size anticipated reach <NUMBER> bn <NUMBER> expanding cagr <NUMBER> forecast period according new report grand view research inc market majorly driven growing demand led lighting electric vehicles trend led manufacturers set new plants extend target market cater growing demand manufacturers fastmoving consumer goods fmcg setting ambitious goals shift recycled content nestle example investing <NUMBER> bn use <NUMBER> tonnes foodgrade recycled polyolefins obtained via chemical recycling <NUMBER> packaging companies also considering chemical recycling means tackle problem plastic waste achieve circular economy plastics chemical recycling makes possible convert plastic waste new material virginlike properties allows companies get around european food safety authority efsa requirements traceability part foodgrade approval process food packaging approval viable solution recycle back propylene ethylene reprocess material virgin polymer seem problem materials like polyethylene terephthalate pet primarily based postconsumer plastic bottles however polymers polyolefins postconsumer collection comes various types packaging waste including food packaging cosmetics household domestic cleaners chemical recycling presents major challenge fact may take time least <NUMBER> yearsbefore chemical recycling evolve industrial scale technology mainly due constraints collection sorting also possibility competition postconsumer material polyolefins intensify thus restricting availability sparking increase price waste finished products scenario recyclers might shift alternative materials coronavirus outbreak disrupted chemical production china amid extension lunar new year holiday period restrictions travel movement goods chinese government continues implement measures aimed containing spread novel coronavirus chemical companies forced cut delay production due personnel shortages logistical problems increasing inventories result demand sluggish given importance china global chemical market major curtailment manufacturing activity chemical sector would adversely affect domestic export markets according icis china accounts <NUMBER> global capacity chemicals polyester chain polyvinyl chloride pvc purified terephthalic acid pta methyl tertiary butyl ether mtbe methanol due logistics restrictions postholiday production chinas polyolefin plants cut postponed include jiangsu sanmu groups <NUMBER> tonnesy epoxy resins site yixing zhejiang weitai rubber companys <NUMBER> tonnesy styrene butadiene rubber sbr unit zhejiang sanjiang fine chemicals <NUMBER> tonnesy ethylene oxide facility also zhejiang shandong dadi supu chemical super chemicals <NUMBER> tonnesy isopropanol ipa site jiangsu similar cutbacks implemented methyl isobutyl ketone mibk domestic prices styrene monomers dropped sharply methanol pta futures slumping <NUMBER> feb <NUMBER> feb <NUMBER> respectively operating rates chinese refineries polyethylene pe plants also bar graph shows chinas share world production capacity tonnesy petrochemicals product benzene caustic soda chlorine ethylbenzene ethylene ethylene glycols methanol mixed xylenes mtbe paraxylene pet resins polyester fibres polyester polymer polypropylene propylene pta pvc soda ash toluene vcm original source icis chemical business<NUMBER> feb <NUMBER> website httpwwwiciscom reed business information limited <NUMBER> chinas plan roll back <NUMBER> tariffs imposed certain us imports <NUMBER> affect several chemicals polymers polypropylene pp polystyrene ps high density polyethylene hdpe acrylonitrile butadiene styrene abs linear low density pe lldpe ethylene vinyl acetate eva copolymer tariff cuts take effect <NUMBER> feb <NUMBER> cover <NUMBER> bn worth us imports part <NUMBER>th round uschina trade deal original source icis chemical business<NUMBER> feb <NUMBER> websitehttpwwwiciscom reed business information limited <NUMBER> value japanese rare metal exports rose <NUMBER> <NUMBER> necrotizing enterocolitis nec entity mainly affects premature infants described occasionally fullterm neonates <NUMBER> etiologic roles infectious agents condition yet well established although nec reported neonates course bacterial viral mycotic infections <NUMBER> paper describe fullterm neonate developed nec course sepsis caused streptococcus agalactiae knowledge nec previously reported association microorganism female infant weighing <NUMBER> g born forceps delivery uneventful <NUMBER>week gestation amniorrhexis occurred intrapartum amniotic fluid clear apgar scores <NUMBER> <NUMBER> <NUMBER> <NUMBER> min respectively infant respiratory distress started birth transferred hospital <NUMBER> h age examination admission showed illappearing cyanotic poorly perfused newborn blood pressure <NUMBER> mm hg pulse <NUMBER> beatsmin respiratory rate <NUMBER>lmin rectal temperature <NUMBER>°c infant respiratory distress auscultation revealed bilateral hypoventilation tachycardia liver palpated <NUMBER> cm right costal margin hypotonic hypoactive anterior fontanelle flat meningeal signs laboratory investigation included leukocyte count <NUMBER>mm<NUMBER> <NUMBER> neutrophils <NUMBER> band forms <NUMBER> lymphocytes hemoglobin <NUMBER> gdl hematocrit <NUMBER> platelet count <NUMBER>ooomn quick test <NUMBER> partial thromboplastin time <NUMBER> set control <NUMBER> set blood urea <NUMBER> mgdl creatinine <NUMBER> mgdl arterial blood gases showed severe hypoxemia hypercapnia mixed acidosis urine antigen detection test positive group b streptococcus antigen blood culture grew group b streptococcus cerebrospinal fluid analysis normal culture sterile culture vaginal swab mother yielded group b streptococcus chest radiograph revealed micronodular bilateral alveolar pattern bacterial sepsis initially suspected patient treated ampicillin gentamicin dopamine dobutamine plasma therapy mechanical ventilation umbilical artery vein catheterizations performed condition initially improved deteriorated day <NUMBER> developed marked abdominal distention signs paralytic ileus x ray examination abdomen time showed large pneumoperitoneum thrombocytopenia corrected surgical intervention carried laparotomy fecal material found abdominal cavity <NUMBER> cm necrotic small bowel removal loop proximal end distal side anastomosis performed surgical pathology findings showed congested small bowel edema hemorrhage ischemic necrosis wall perforation compatible necrotizing enterocolitis patient complicated postoperative course dehiscence sutures outward fistulation day <NUMBER> underwent surgery resection another <NUMBER> cm necrotic small bowel required procedure patient favorable course mild symptoms short bowel syndrome nec mainly occurs premature infants occasionally reported fullterm neonates cases predisposing factors usually present although understanding pathogenesis nec remains incomplete disease seems multifactorial basis <NUMBER> <NUMBER> <NUMBER> role infectious agents factors cofactors development cases nec proposed albicans glabrata <NUMBER> although <NUMBER> <NUMBER> patients nec may associated bacteremia likely represents bacterial translocation previously injured intestinal mucosa rather primary initiating event <NUMBER> speculation bacterial species primary etiologic factor development nec secondary bacterial translocation fiom bowel lumen resulting septicemia proven patient describe sepsis pneumonia caused group b streptococcus two main factors development nec septic shock umbilical catheterization factors reproduce ischemichypoxic state decreases mesenteric blood flow ultimately causes hypoxic damage enteric mucosa seen previous mention english literature association ofs agalactiae nec therefore report adds new infectious agent list associated devastating gastrointestinal entity development polymerase chain reaction pcr revolutionized field molecular biology technique consists basically enzymatic synthesis millions copies target dna sequence saiki et al <NUMBER> using thermostable dna polymerase saiki et al <NUMBER> succession cycles includes denatnration template dna hybridization specific dna primers template extension primers possible generate multiple copies target region enzymatically thus pcr provides method obtaining large quantities specific dna sequences small amounts dna including degraded dna samples technolo extensively reviewed see example ehrlich <NUMBER> innis el al <NUMBER> griffin grittn <NUMBER> although pcr widely used increasing number applications area microbiolo diagnosis infectious diseases undergone outstanding advances recent ears traditionally strategies identifying <NUMBER>x<NUMBER> microbial pathogens invohe isolation selective agar media cell cultures use phenotypical tests techniques usually slow laborious important cost animal infectious diseases national economies therefore stimulated search faster moe sensitive specific methods identid microbial pathogens many useful nucleic acid probes immunological assays developed diagnostic purposes techniques also deficiencies jones bej <NUMBER> emergence pcr however offers potential improve laboratorybased diagnosis pathogens mahbubani bej <NUMBER> althougla pcr shortcomings problems caused contaminants inhibitors lack suitable sequences designing specific primers outstanding research effort focused tiffs technique together remarkable development molecular biology minimized deficiencies allowed increased general use diagnostic tool footandmouth disectse vires fmdv fmdv one dangerous viruses ruminants speed spread ability change antigenic identip makes fmdv threatening beef dai industries many countries fast accurate detection fmd outbreaks needed limit spread disease virus consists <NUMBER> copies four proteins vp<NUMBER> <NUMBER> vp<NUMBER> main protein determining antigenic identig pcr systems detecting fmdv developed different laboratories meyer et al <NUMBER> laor et al <NUMBER> laor et al <NUMBER> also repots use pcr determine fmdv serotype rodrfguez el al <NUMBER> strata el al <NUMBER> rinderpest rp<NUMBER> animal diseases greatly influence animal production trade diagnosis enable fast implenlentation control measures minimize losses particularly important case highlycontagious pathogens rpv peste des petit ruminants pprv viruses present confined developing countries remain constant threat livestock rpv may infect artiodacls cattle buffaloes susceptihle species pprv specifically causes disease small ruminants field diagnosis classical rinderpest many indicative clinical signs easy signs ahvays clearly seen particularly countries disease endemic diallo et al <NUMBER> moreover mild strains fail produce clinical signs unless infected animals stressed situation complicated small ruminants becanse infected rpv andor pprv disease produced viruses similar laboratory tests commolaly used either expensive animal inoculation slow virus isolation neutralization insensitive agar gel immunodiffusion pcr drastically improve diagnosis chamberlain el al <NUMBER> grouped different isolates rpv combining pcr sequencing studies using procedure barrett el al <NUMBER> identified two different rpv strains clinical sample warmwayi el al <NUMBER> showed cocirculation two different lineages rpv nigeria epizootics <NUMBER>s bvdv another important pathogen cattle causing considerable economic losses throughout world three syndromes caused bvdv described acute gastroenteritis severe diarrhoea mucosal disease chronic infections several weeks dnration calves lyearold persistently infected animals main source infection herdmates continually shed large quantities virus body secretions excretions due obvious impact bqv infections screening animals must carefully made current methods detection virus isolation immunoassays either lack optimal sensitivity rapidity consistent large scale testing animal specimens radwan et al <NUMBER> pcr however readily detect bqv belak ballagipordany <NUMBER> brock <NUMBER> hertig el al <NUMBER> ward misra <NUMBER> hoft van iddekinge et al <NUMBER> gruber el al <NUMBER> pcr analysis hulk tank milk samples provided rapid sensitive method screen herds presence virus sensitive studies using reference strains bvdv fiom persistently infected carriers shown reverse transoiption rtpcr greater sensitivity tests including enzymelinked immunosorbent assay elisa horner el al <NUMBER> unfortunately cost currently makes technique unsuitahle largescale testing valuahle coniirmatm test cases elisa resuhs suspicious range viral titre low batches foetal bovine serum additionally possible discriminate among different bvdv strains using pcr tajima el al <NUMBER> pcrrestriction fiagment length polymorphism rflp tests demonstrated <NUMBER> bqv isolates fiom ruminants four different farms sweden herdspecific rather speciesspecific virus readily transmitted cattle sheep paton et al <NUMBER> bt arthropodborne viral infection rmninants caused bluetongue virus btv clinically bt varies depending factors population density competence cullicoides sp vector distribution susceptible hosts virulence different serotypes btv among ruminants sheep clinically affected cattle usually asymptomatic reservoirs pcrbased procedures developed diagnosis btv gould el al <NUMBER> dangler el al <NUMBER> wadeevans et al <NUMBER> mccoll gould <NUMBER> akita el al <NUMBER> parsonson el al <NUMBER> whole hlood seems convenient clinical sample fractions blood also successfully used pcr detection btv infection sheep mccoll gould <NUMBER> comparison methods tbr isolation btv infected cahes virus detected elnbrionating chicken eggs <NUMBER> weeks whereas pcr detected btv nucleic acid tot <NUMBER> weeks maclachlan et al <NUMBER> sensitivity technique means adapted detected btv cuuicoides sp samples wilson chase <NUMBER> ehdv orbivirus related btv causes tatal haenaorrlaagic disease domestic wild runainants clinical signs pathological changes caused ehdv btv indistinguishable aradaib el al <NUMBER> compared value pcr virus isolation detection ehdv clinical samples taken fiom naturallyinfected deer concluded pcr assays edhv provide diagnostic ahernative superior current cumbersome timeconsunfing x<NUMBER>rus isolation procedures bovine immunodeficien vimts bi<NUMBER> bw structurally genetically related human immunodeficiency virus hiv biv causes lymphoproliferative changes enlargement subcutaneous lymphatic nodules cattle although infection bw widely prevalent beef dai cattle accurate diagnostic test virus using pcr nash et al <NUMBER> detected bivinfected leucocytes blood milk bivseropositive cows data confirmed presence bw milk laighlighted potential lactogenic transmission virus suarez el al <NUMBER> examined blood samples bivexperimentally infected calves virus isolation protein immunoblot nested pcr showed nested pcr test sensitive method <NUMBER>o<NUMBER> detection biv infection cattle bovine hepesvirus bhv<NUMBER> causes infectious bovine rhinotracheitis ibr economically important disease cattle characterized acute respiratory infection reproductive problems abortion infertility vulvovaginitis balanoposthitis latently infected animals reservoirs bhv<NUMBER> herd virus detection often requested laboratot diagnosis cases respiratm reproductive problems cattle several reports described pcr different bhv<NUMBER> genes tissue cultures vilcek <NUMBER> kibenge et al <NUMBER> yason et al <NUMBER> bovine semen wiedman et al <NUMBER> xia et al <NUMBER> spanish sheep encephalitis sse three viruses belong tickborne encephalitis virus group within genus flavivirus viruses produce similar clinical syndrome histological changes produce brains affected sheep indistinguishable moreover animals fiom affected flocks antibodies crossreact viruses gonzalez et al <NUMBER> sequencing pcr products obtained cdna sse permitted location specitic genetic markers flavmrus marin el al <NUMBER> pcr also enabled construction recombinant vaccinia virus expressing prm e glycoproteins loupingill virus venugopal et al <NUMBER> capine arthqtis encephalitis cae cae worldwide multisystemic disease domestic goats characterized progressive arthritis leucoencephalomyelitis mastitis although virus persists life infection goats cae often subclinical isolation cae attempted routinely diagnostic tool pcr recently adapted detection proviral dna caevinfected cells clinical specimens clavijo thorsen <NUMBER> technique sensitivity several orders magnitude higher direct hybridization may represent important alternative procedure identification persistently infected animals rmninalats viruses pcr protocols successfully developed include bovine leukaemia virus naif et al <NUMBER> naif et al <NUMBER> murtaugh et al <NUMBER> ballagipordany et al <NUMBER> sherman et al <NUMBER> agresti et al <NUMBER> kelly et al <NUMBER> bovine coronaxdrus verbeek tijssen <NUMBER> rotavirus xu et al <NUMBER> maedivisna virus staskus et al <NUMBER> zanoni et al <NUMBER> porcine pavo virus ppio role ppv inducing swine reproductive failure characterized embryo fetal deaths extensively described often clinical signs disease lacking sources ppv include contaminated semen female reproductive tract exposure gameteembryo manipulation molitor et al <NUMBER> developed pcr amplification test detection ppv thereby minimizing risk transmission ppv seronegatives recipients embryo transfer gradil et al <NUMBER> swine influenza swine influenza induces high morbidity low mortality pig populations throughout world although disease usually resolves infected pigs represent substantial source economical loss producer weight loss poor weight gain results obtained schorr et al <NUMBER> proved rtpcr nasal swabs specimens pigs significantly sensitive techniques currently used infectivity assay embrionating chicken eggs porcine reproductive respirato <NUMBER> syndrome prrs disease complex known prrs become economically important health problem throughout europe north america pcr used confirm presence prrs genes infected monolayers katz et al <NUMBER> thus providing first steps development pcr test analyze prrs virus clinical samples prv aetiological agent major disease substantial economic impact swine industry disease fatal young pigs adults infection less severe sometimes clinical signs apparent pigs surviving prv infection remain latently infected life pcr become recommended method evaluating prv latency reports several laboratories indicated neuronal tissues especially trigeminal ganglia reliable sources detection latent prv genome belak et al <NUMBER> wheeler osorio <NUMBER> volz et al <NUMBER> brockmeier et al <NUMBER> trigeminal ganglion assay performed death affected animal tonsil biopsy specimens obtained live animals used amplify prv sequences pcr chung <NUMBER> prv also detected semen boars guerin et al <NUMBER> method simple allows detection around <NUMBER> viral dna sequences per microlitre sample prv infects cells lymphatic tissue white blood cells variety mammals cells also present sausages schunk rziha <NUMBER> established pcr method specifically detect prv artificially contaminated sausages showed pcr less affected extreme ph values tissue culture techniques usually employed recover virus important swine virus detected pcr include hog cholera virus boye et al <NUMBER> liu et al <NUMBER> wirz et al <NUMBER> african swine fever virus steiger et al <NUMBER> intensive breeding poultry means high populations often live confined spaces conditions entry virulent virus cause high mortality big economical losses rapid diagnostic tests needed minimize consequences viral outbreaks environmerits compared virus isolation classic techniques pcr method choice diagnosis many poultry viruses including mareks disease virus becket et al <NUMBER> becket et al <NUMBER> silva <NUMBER> zhu et al <NUMBER> davidson et al <NUMBER> zerbes et al <NUMBER> reticuloendotheliosis virus aly el al <NUMBER> davidson et al <NUMBER> avian leucosis virus van woensel et al <NUMBER> infectious bronchitis virus andreasen et al <NUMBER> linet al <NUMBER> jackwood et al <NUMBER> zwaagstra et al <NUMBER> kwon et al <NUMBER>a b newcastle disease virus jestin jestin <NUMBER> lymphoproliferative disease virus sarid et al <NUMBER> infectious bursal disease virus lee et al <NUMBER> wu et al <NUMBER>a b equine viral arteritis eva eva ubiquitous disease present throughout mainland europe variety sevelity clinical signs vary widely inapparence abortion death proportion seropositive stallions shed causal organism equine arteritis virus eav semen play primary role dissemination perpetuation equine population therefore stallion identified eav positive first priority ascertain whether virus shed animal allowed cover mares pcr included among three methods may used establish presence virus semen chirnside spaan <NUMBER> horserace betting levy board <NUMBER> equine herpesvirus pcr successfully applied detect ehv <NUMBER> <NUMBER> aborted equine fetuses ballagipordany el al <NUMBER> nasopharyngeal swab specimens horses respiratory neurological disease sharma el al <NUMBER> wagner et al <NUMBER> equine viral diseases diagnosed pcr include equine infectious anaemia orourke el al <NUMBER> african horse sickness zientara el al <NUMBER> stonemarschat et al <NUMBER> rabies rabies still one lifethreatening zoonosis regions tile world obviously fast accurate detection infected animals vital importance research resuhs shown pcr play remarkable role rapid sensitive specific detection rabies virus ermine et al <NUMBER> sacramento et al <NUMBER> shankar el al <NUMBER> kamolvarin et al <NUMBER> mccoll et al <NUMBER> technique spread among reference laboratories located regions risk canine pavovirus cpi<NUMBER> cpv causative agent haemorrhagic enteritis myocarditis present one common pathogenic viuses causing diarrhoea dogs cpv easily inactivated usual disinfectants survive <NUMBER> months hospital kennel contaminated often leading secondary infections result important rapid specific sensitive method distinguish infected flom uninfected dogs pcr assays based vp<NUMBER> vp<NUMBER> genes used detect cpv paraffinembedded tissues truyen el al <NUMBER> uwatoko el al <NUMBER> faeces diarrhoeic dogs hirasawa et al <NUMBER> additionally pcrrflp analysis practical reliable method differentiating wildand vaccinetype cpvs hirasawa el al <NUMBER> senda et al canine distemper virus cdi cdv induces multifocal demyelinating disease central nervous system dogs virus persistence plays key role pcr essential research tool study viruss nucleocapsid protein provide molecular basis observed differences virus release spread attenuated virulent cdv stettler zurbriggen <NUMBER> feline infectious peritonitis vinls fipv fipv causes severe often fatal disease domestic wild cats despite considerable research routine diagnostic method available detection fipv nested pcr attempted egberink el al <NUMBER> authors concluded value pcr identification sick animals asymptomatic carriers needed studied work positive pcr healthy animals failed provide absolutely definitive diagnosis fip equally negative pcr result sick animal completely exclude fip better results achieved pcr detection active latent feline herpesvirus <NUMBER> nunberg et al <NUMBER> reubel et al <NUMBER> feline immunodeficiency virus rimstad ueland <NUMBER> morbillivius infections marine mammals first reported <NUMBER> known distributed among wide spectrum seals cetaceans atlantic ocean mediterranean sea rtpcr revealed obvious links morbillivirus outbreak ill marine seals northern europe <NUMBER> occurred freshwater seals lake baikal <NUMBER> visser et al <NUMBER> barrett et al <NUMBER> direct sequencing pcr products included haemagluttinin protein gene lake baikal seals isolate pdv<NUMBER> revealed closely related two isolates cdv germany different cdv vaccines currently used lake baikal region mamaev et al <NUMBER> staphylococcal mastitis important problem dairy farms several staphylococci mainly staphylococcus aureus strains cause acute chronic mastiffs lead gangrenous mastitis human handling udder milking machine potential source staphylococci contaminated milk cause foodborne intoxication man rapid detection staphylococci including killed heat treatment suspected food could prevent foodborne staphylococcal gastroenteritis differentiation aureus strains achieved dna amplification fingerprinting saurnier et al <NUMBER> van belkum et al <NUMBER> although listelia monocytogenes infection may produce clinical syndromes abortion neonatal septicaemia encephalitis common adult animals clinical diagnosis listeric encephalitis ruminants difficult existence broad spectrum central nervous system diseases similar clinical symptoms addition listeria rarely cultured cerebrospinal fluid csf affected animals pcr able detect low numbers bacteria may tool increasing sensitivity listeria detection csf ruminants peters et al <NUMBER> also important detect asymptomatic carriers zoonotic nature infection last decade several outbreaks single cases human listeriosis demonstrated disease often transmitted contaminated food jaton et al <NUMBER> developed sensitive nested pcr assay detection l monoctogenes human csf additionally pcr confirmed usefulness detect specific strains epidemiological investigations listeriosis ericsson et al <NUMBER> anthrax fatal infection humans livestock caused grampositive endosporeforming bacterium bacillus anthracis humans infected primarily contact products derived fiom contaminated animals growing need methods detect b anthracis spores vegetative cells prevent largescale livestock destruction also protect humans may come contact pcr amplification b anthracis genes already reported carl el al <NUMBER> turnbull el al <NUMBER> hutson et al <NUMBER> johns et al <NUMBER> reif et al <NUMBER> allowing detection even single spore b anthracis reif et al <NUMBER> henderson et al <NUMBER> examined variation among isolates b anthracis using restriction patterns pcr found b anthracis profiles unique compared closely related species including b cereus b thuringiensis b mycoides results showed isolates b anthrads ahnost completely homogeneous distinct members b cereus group botulism severe foodborne disease caused clostridium botulinum characterized generalized flaccid paralysis botulinal neurotoxins produced seven distinct serological tqoes c botulinum among potent biological substances known neurotoxins b c e f implicated causes human andor animal disease mouse bioassay established method detection neurotoxin alternatives use animals diagnostic purpose ethically desirable encouraged immunological methods proposed use dnabased techniques extensively explored however authors confirmed pcr great potential identification botulism neurotoxinproducing strains szabo et al <NUMBER> szabo et al <NUMBER> fach et al <NUMBER> clearly demonstrated pcr methods used development highly sensitive specific assays organisms harbouring botulismneurotoxin genes closhfdium pfifngens enterotoxin genes also detected stools without isolation tile organism saitoet al <NUMBER> fach et al <NUMBER> although isolates fiom human foodpoisoning outbreaks sporadic diarrhoeal cases c perfringens also wellknown animal pathogen aetiological agent haemorrhagic necrotic enteritis thus application pcr desirable appropriate veterinal laboratories pcr assay fact developed recently rapid detection genes encoding c pefringens enterotoxins buogo et al <NUMBER> successfully applied samples small large intestine infected piglets enterotoxigenic eschenlchia coli etec major cause diarrhoea neonatal postweaned calves lambs piglets several fimbrial adhesins enterotoxins recognized virulence factors etec sequencing enterotoxins fimbrial genes made possible application nucleic acidbased methods detection harel et al <NUMBER> woodward et al <NUMBER> methods advantage readily applicable large number isolates contrast classic methods agglutination infant mouse ligated swine intestine cell culture assays pcr resuhs obtained sweden kennan et al <NUMBER> showed gene major subtmit f<NUMBER> fimbria present approxiinately half strains expressing k<NUMBER> k<NUMBER> <NUMBER>p f<NUMBER> fimbria isolated piglets older <NUMBER> week diarrhoea suggested f<NUMBER> fimbria major importance among etec strains causing postweaning diarrhoea ojeniyi et al <NUMBER> applied two different genotyping methods colony laybridization pcr detect enterotoxin verotoxin fimbrial genes <NUMBER> e coli strains piglets diarrhoea results compared obtained phenotypic methods correlation genotypic phenotypic resuhs <NUMBER> detection fimbrial enterotoxin genes detected pathogenic strains serotyping using set rabbit ok antisera using techniques verotoxin fimbrial f<NUMBER> genes found frequent postweaning neonatal e coli strains genotypic tests becoming valuable tools identification pathogenic e coli together staphylococcal mastitis coliform mastitis major problem dairy farms identification e coli strains cows clinical mastitis accomplished pcr amplification using repetitive extragenic palindromic rep enterobacterial repetitive intergenic consensus eric sequences procedure revealed e coli strains isolated repeated episodes clinical mastitis cow similar genotypes lipman et al <NUMBER> western countries enterohaemorrhagic e coli ehec especially serotype o<NUMBER>h<NUMBER> become major concern human health ehec strains produce verocytotoxins identified causative agents human diarrhoea haemorrhagic colitis hc haemolyticuraemic syndrome hus thrombotic thrombocytopaenic purpura ttp cattle seem important reservoir ehec although ehec produce haemorrhagic colitis calves many healthy animals carriers high levels ehec carriage among young animals concern meat may significant source transmission bovines humans verocytotoxin genes detected pcr smith et al <NUMBER> tyler et al <NUMBER> technique become useful determine prevalence clinical significance ehec isolated cattle herds without calf diarrhoea burnens et al <NUMBER> found <NUMBER> level ehec carriage among cows reassuring ehec detected milk samples enteric disease caused infection salmoneua important cause morbidity animals enteritidis particular associated human foodborne illness resulting consumption contaminated poultry eggs meat salmonellas generally identified microbiological culture faeces tissue body fluids although elisas may used identify salmonellas full identification still requires culture amplification salmonella genes offers specific direct means detection rahn et al <NUMBER> widjojoatmodjo et al <NUMBER> aabo et al <NUMBER> cohen et al <NUMBER> way et al <NUMBER> nguyen et al <NUMBER> wood et al <NUMBER> booster pcr methods genusspecific detection salmonellas equine chicken faeces developed cohen et al <NUMBER>a b detection possible within <NUMBER>h time submission samples although booster pcr highly sensitive cost twice simple pcr reaction cohen et al <NUMBER> described alternative method using enrichment followed simple pcr reaction enabled salmoneua detected faeces within <NUMBER> h submission samples quantitative method using known quantity competitor dna quantify numbers sahnonellas chicken faeces also developed mahon lax <NUMBER> problems inhibitor substances reported comparison pcr microbiological cultures detection salmonellas dragswabs poultry houses revealed pcr significantly sensitive culture environmental monitoring cohen et al <NUMBER>c enterocolitica also causes foodborne human gastroenteritis pigs implicated major reservoir pathogenic serotypes <NUMBER> <NUMBER> <NUMBER> detection enterocolitica often includes enrichment biochemical confirmation whole process take <NUMBER> weeks pcr successfully used recognition pathogenic enterocolitica kapperud et <NUMBER> koeppel et al <NUMBER> rasmussen et al <NUMBER> best results achieved bacteria concentrated immunomagnetic separation ims pcr approach used detect enterocolitica <NUMBER> faecal samples tonsil swabs pigs rasmussen et al <NUMBER> authors concluded imspcr reliable method used preenriched medium enabling detection positive samples recognized traditional methods h pyrlori microaerophilic gramnegative spiral organism received great attention association human gastritis peptic ulcers even gastric cancer species genus isolated gastric mucosa animals mostly associated gastritis host suggested strains helicobacter canis capable zoonotic transmission sensitive methods detection needed pcr already shown useful stanley et al <NUMBER> clinical samples cousins et al <NUMBER> buck et al <NUMBER> yule et al <NUMBER> wards et al <NUMBER> mycobacterium paratuberculosis causes johnes disease commonly diagnosed disease sheep goats ruminants organisms detected pcr intestinal lymph node tissue infected animals ridge et al <NUMBER> ovine loot rot highly contagious economically serious disease sheep worldwide distribution especially temperate farming areas although hot rot results fiom mixed bacterial infection dichelobacter nodosus shown essential pathogen initiation estahlishment disease clinical diagnostic methods currently available foot rot subjective lack precision consequently demand rapid precise tests differentiate virulent strains use pcr based specific regions <NUMBER>s rrna constitutes competent assay foot rot la fontaine et al <NUMBER> pcr assays employing virulentand benignspecific primers capable specific sensitive differentiation ot strains causing virulent intermediate benign foot rot liu webber <NUMBER> bacteria genus bruceua wellknown intracelhflar pathogens cause animal human infections rapid sensitive pcr detection brucellas without extraction dna accomplished fekete et al <NUMBER>a fekete et al <NUMBER>b ouahrani et al <NUMBER> mycobacterium bovis causative agent tuberculosis cattle member tuberculosis complex group related species includes mycobaclerium tuberculosis major cause human tuberculosis histological examinations enable rapid decisions made suspect carcasses meat inspection however agents bovis induce similar lesions additionally microscopic detection acidfast organisms detect bacteria great concentrations laboratory culture bovis sensitive requires viable bacteria growth organism may take <NUMBER> weeks species identification procedures extend reporting time even tests based pcr shown promising mycobacterial detection leptospirosis probably one worlds widespread zoonoses rapid diagnosis leptospirosis important view need adequate early treatment clinically sufficient know whether patient infected pathogenic leptospires epidemiologically would considerable value tile causative leptospira identified strain level serology contribute early diagnosis antibodies become detectable approximately seventh day infection conventional methods detect leptospires blood either unreliable slow give early results pcr promising tool early detection leptospires blood urine csf period first appearance clinical symptoms time antibodies become detectable van eys et al <NUMBER> gerritsen et al <NUMBER> hookey <NUMBER> merien et al <NUMBER> gravekamp et al <NUMBER> genus borrelia contains several human animal pathogens aetiological agent lyme disease boelia burgdorfe primarily transmitted ixodes ticks several authors successfully employed pcr diagnosis lyme disease rosa schwan <NUMBER> marconi garon <NUMBER> kawabata et al <NUMBER> wellknown ticks feed deer species using pcr kimura et al <NUMBER> demonstrated presence b imrgdmfefi skin naturally infected wild sika deer thus confirming potential deer source transmission pcr data also support notion birds partly responsible heterogeneous distribution lyme disease borrelia spirochetes europe ols<NUMBER>n et al <NUMBER> zingg lefebvre <NUMBER> developed highsensitive pcr assay bonelia cm<NUMBER>aceae crossreact closely related spirochetes disease chickens results reduced egg production significant downgrading carcasses slaughter chlamydia psittaci includes heterogeneous group mammalian avian isolates present generally accepted accessible method typing major outermembrane protein momp important antigen cell surface chlamydia recently pcrrflp analysis momp encoding gene used t<NUMBER>qing c psittaci strains denamur et al <NUMBER> kaltenboeck et al <NUMBER> sayada et al <NUMBER> mycoplasmas known produce wide spectrum animal diseases cattle infected <NUMBER>coplasma mycoides subsp mycoides infection either remain apparently healthy develop contagious bovine pleuropneumonia cbpp disease characterized respiratory problems post mortem findings followed bacteriological culture organism affected tissue take <NUMBER> weeks complete serological detection antibodies highly specific asymptomatic animals early stages infection chronicallyinfected animals may detectable levels antibodies bashiruddin et al <NUMBER> described use pcr detect specific dna clinical material isolates outbreaks cbpp cattle buffaloes italy data showed pcr identify aetiological agent within <NUMBER> days extraction clinical material specificity pcr test distinguish lvl subsp nqcoides subspecies confirmed mcoplasma hyopneumoniae identified causative agent mycoplasmal pneumonia pigs effective vaccine currently available efforts control disease focused elimination sick animals unfortunately efforts hampered difficulties differentiating hyopneumoniae fiom crossreacting mycoplasma flocculare mycoplasma hyorhinis stemke et al <NUMBER> developed method differentiation three species basis amplification <NUMBER>s rrna gene sequence pcr methodolog <NUMBER> detection mycoplasma gallisepticum also reported nascimento et al <NUMBER> kempf et al <NUMBER> kempf et al <NUMBER> organism cause chronic respiratory coxiella lntrnetii zoonotic organism aetiological agent q fever humans q fever occurs influenzalike illness pneumonia granulomatous hepatitis chronic endocarditis animals coxiella reach high concentrations female reproductive system infection followed abortion infertility although infection cattle usually latent c imrnetii may shed via milk infected cows one o<NUMBER> several lactation periods organism survive low numbers long time dairy products made nonpasteurized milk infected cows detection milk requires highsensitive method pcr approach primers based repetitive transposonlike sequences established highlysensitive specific detection c lncrnetii cows milk willems et al <NUMBER> leishmaniasis group infestations viscera skin mucous membranes caused protozoa genus leishmania multicopy <NUMBER>s rrna basis pcr assays specifically detects leishmania sp guevara et al <NUMBER> van eys et al <NUMBER> kinetoplast dna kdna target interest maxiand minicircles present cell multiple copies however proved difficult select speciesspecific kdna sequences diagnosis pcr smyth et al <NUMBER> l<NUMBER>pez et al <NUMBER> important investigate small regions minicircles find speciesspecific sequences consmwed among strains species pcr used detect leishmanias conjunctival biopsies roze <NUMBER> showing number cases ocular inflammation attributed parasite tropical countries protozoan parasites genus topanosoma responsible lifethreatening diseases animals humans pcr used evaluate vectorial ability glossina longipalpis western africa solano et al <NUMBER> weiss <NUMBER> cystforming apicomplexan parasite toxoplasma gondii infects broad spectrum vertebrates domestic feral cats definitive hosts humans animal species infested ingestion oocysts tissue cysts overwhelming infestations especially innnunosuppressed individuals may fatal application pcr quickly accurately detect <NUMBER> gondii varieg clinical specimens including formalinfixed paraffin embedded tissues macpherson gajadhar <NUMBER> wastling et al <NUMBER> hyman et al <NUMBER> cryptosporidiosis recognized important cause human animal diarrhoea pcr amplification combined chemiluminescence specifically detect cuptospofidium pavum dna present fixed paraffinembedded tissues laxer et al <NUMBER> laxer et al <NUMBER> species strain differentiation domestic fowl coccidia genus eimeria also achieved pcr procunier et al <NUMBER> echinococcosis disease caused <NUMBER> larval stages different cestode species genus echinococeus especially echinococcus granulosus echinococcus multiloeulafis species widely prevalent may cause severe disease animals humans pcr study including several independent e multilocula<NUMBER>s isolates various cestodes revealed pcr product obtained genomic dna e multilocula<NUMBER>s isolates dna cestode species gottstein mowatt <NUMBER> sensitivity e granulosus pcr evaluated experimentally approached <NUMBER> pg template dna conesponds dna content single ecbinococcus egg rishi mcmanus <NUMBER> random amplified polynaorphic dna rapd method permitted detailed genetic analysis swiss spanish isolates ofe granulosus sileslucas et al <NUMBER> application pcr detect echinococci allow identification biopsy material oltained liver lesions unknown aetiology demonstration adultstage parasite tissue eggs samples derived faeces small intestines anal swabs definitive carnivore hosts gottstein <NUMBER> tapeworms genus taenia cause human animal taeniasis cysticercosis although eggs fiom tnenia solium taenia saginata cannot differentiated morphologically <NUMBER> bp sequence h<NUMBER>bridize specifically singlecopy gene sequence sofium saginata dna may available future rapid pcr diffeentiation rishi mcmanus <NUMBER> lungworms common parasites ruminants lesser extent horses cattle cause considerable economic losses due weight loss deaths rapdpcr proved valuable tool examine genome differences among dictocaulus species fiom cattle sheep fallow deer epe et al <NUMBER> nematode <NUMBER>ichinella spimlis infect nearly meateating animals trichinellosis transmitted within two cycles interact sylvatic cycle wild animals domestic cycle pigs major source human infestation two different sets primers developed specifically discriminate domestic sylvatic isolates dupouycamet et al <NUMBER> dick et al <NUMBER> pcr able detect situ single excysted lmwa well single encysted larva infected mouse muscle following boiling dick et al <NUMBER> rapdpcr also useful identification trichinella species bandi et al <NUMBER> dupouycamet et al <NUMBER> pcr aheady played important role studies epidemiology taxonomy pathogenesis microorganism infections animals yet used routinely diagnosis animal infectigus disease fact pcr become routine tool research laboratories however infectious diseases remain among major areas application pcr detection genotyping offering potential analyse microorganisnas veterinary importance single technique although many systems developed proceeded towards field trials largescale clinical evaluation pcr application routine analysis biological salnples still major diagnostic challenge assays detect microorganisms high sensitit purified dna samples advances sample preparation detection amplified products field clinical laboratol <NUMBER> conditions needed order achieve high sensitivity animal specimens diagnosis viral diseases major target pcr application laboratou tests tbr identification viruses either slow expensive insensitive technique found largescale application routine detection human patlaogens hiv hepatitis viruses among animal viral diseases pseudorabies equine viral arteritis bovine leukaemia bovine viral diarrhoea good candidates early development approach also focused viral diseases deep socioeconomic impact endemic regions african swine fever rinderpest eradication programmes must include diagnosis sick animals asymptomatic carriers vectors often involve rapid screening large number samples pcr would vel useful relation bacterial diseases pcr used rapid detection pathogens whose vitro cultivation difficult timeconsuming unavailable rflp patterns using pcramplified dna excellent method bacterial typing already used identification bacterial strains involved human foodborne outbreaks hill <NUMBER> parasitic infestations probably last field veterinaly clinical diagnosis incorporate pcr techniques partly relative scarcity important parasitic diseases main countries pcr research developed weiss <NUMBER> conclusion pcr likely become standard diagnostic test situations either microorganism level low differentiation morphologically identical organisms required whether immune response infection uninformative happened progressive introduction enzymelinked immunosorbent assays elisa routine diagnostic tools existence strong demand improved diagnosis methods surely lead next decades development pcrbased test kits suitable field application concern terrorist group might attack civilian populations agriculture releasing deadly pathogens grown past decade failed attempts japanese cult aum shinrikyo release botulinum toxin anthrax tokyo several occasions early <NUMBER>s <NUMBER> anthrax letter attacks united states seem confirm fears however five fatalities us case none japanese case question naturally arises serious threat serious strategy states take combat article draws us experience outline strategy combating bioterrorism general enough apply states especially ones well developed public health medical infrastructures nature threat historically attacks using biological agents rare surprising given relative ineffectiveness biological weapons military weapon due difficulty infecting opposing forces availability protective clothing simple mask cases prompt medical treatment troops risk attackers troops may also become infected centuriesold revulsion killing people poison disease codified <NUMBER> hague convention <NUMBER> geneva protocol <NUMBER> biological toxin weapons convention btwc perhaps best explanation witnessed deaths due biological attack norms powerful albeit imperfect influence human behavior finally respect terrorist use traditional view terrorists want lots people watching lots people dead extent true terrorists little incentive attack civilians indiscriminately would loose political support within community attack would likely provoke draconian response state eliminate group question whether trend continue reason concern regarding bioterrorism knowledge materials equipment make biological weapons spreading worldwide incentives states terrorists acquire use weapons may increasing civilians well agricultural sectors remain quite vulnerable attacks knowledge materials equipment manufacture biological weapons spreading due advances biomedical technology dualuse character technology global nature biotechnology pharmaceutical industries pervasive access knowledge rapid global information sharing unlike nuclear weapons <NUMBER> kg fissile material required build rudimentary fission bomb barrier exists biological weapons fact biological weapon proliferation governed spread knowledge spread material equipment traditional biological agents found environment numerous unprotected strain collections around world large batches bacteria virus grown simple fermenters former state biological programs represent another potential source materials equipment especially knowledge remnants former soviet biological weapon program estimated accounts employed <NUMBER> <NUMBER> scientists technicians represents avenue states terrorists might acquire biological weapons without painstaking research development required create ab initio president yeltsin declared <NUMBER> former soviet biological weapon program dismantled biopreparat civilian biomedical research organization conducted much biological weapons research would converted solely peaceful pursuits due lack transparency concerns remain covert biological weapons program may still exist russia cuba iran north korea syria also believed us government biological weapon programs various levels development south africa iraq formerly programs materials expertise could leak addition numerous countries biological weapon defense programs produce small quantities pathogens peaceful purposes eg testing prophylaxis efficacy allowed btwc knowledge materials could also leak biological weapons varying degrees sophistication clearly within states means acquire covertly dualuse nature equipment supplies make biological weapon programs easy hide guise legitimate biomedical activities small quantities pathogens required seed stocks biological agents emit detectable signal making virtually impossible detect remotely fact biological weapon facilities small distinct physical features makes identification difficult even intrusive onsite inspections un special commission charged locating destroying iraqs weapons mass destruction discovered <NUMBER> iraq war took commission <NUMBER> years locate iraqs biological weapon facilities kamel hussein divulged scope secret iraqi program defecting jordan <NUMBER> finally legitimate peaceful activities vaccine biopesticide production converted biological weapon production within weeks months less clear whether terrorists acquire effective biological weapons without state support terrorists operating rudimentary laboratories face challenges obtaining lethal pathogen strains extending pathogen shelf life particular mastering weaponization hurdles agent drying stabilization aerosolization ie creating respirable aerosol viable agent less <NUMBER> mm diameter settle atmosphere close release point penetrate alveolar region lungs pathogens infectious wet pathogen slurries relatively easy produce difficult disseminate <NUMBER>mm aerosol dry powders ground less <NUMBER> mm prior dispersal although clumping electrostatic charge problem dry agent difficult produce handle safe manner thus path hurdles terrorists lack practical knowledge required circumvent hurdles even trained microbiologists ranks unless receive outside help aum shinrikyo failed kill anyone anthrax used nonlethal vaccine stern strain <NUMBER> attempts aerosolize spores failed led cult carry infamous sarin gas attack tokyo subway <NUMBER> course terrorists may strive highly efficient weapons causing panic terror possible even rudimentary biological weapon means acquiring biological weapons spreading incentives acquire possibly use increasing well united states emerged cold war worlds unrivaled conventional military power collapse former soviet union left allies fend consequently opponents united states must search asymmetric means including possibly biological weapons counter us military might suicide bombings iraq afghanistan current example approach terrorists incentives use weapons may changing well <NUMBER> september <NUMBER> attack united states subsequent indiscriminant attacks bali madrid beslan london suggest terrorists may wish inflict mass casualties biological attacks also devastate sectors us world economy attractive goal terrorists still constraints may exist example terrorists may reluctant use contagious agents subsequent contagion might spread home country social group may less access public health may also eschew biological attacks operation likely fail preferring conventional explosives instead divinely inspired perpetrators failure deterrent suggests god support actions vulnerability civilian populations agriculture may encourage bioterrorism modern military forces relatively invulnerable biological attack civilians quite vulnerable protective clothing would know put routinely receive prophylaxis common biological warfare agents agricultural sector countries also vulnerable farms animal pens animal feed even finished agricultural products eg milk typically secure malevolent actors sudden appearance diseases foot mouth disease bovine spongiform encephalitis wheat rust similar plant animal diseases shut agricultural sector quickly preventing exports domestic consumption demonstrated natural outbreaks diseases past bioterrorism threat complex diverse biological weapons may toxins living pathogens may target humans livestock crops hence aimed mass murder economic impact pathogens may lethal nonlethal contagious noncontagious may infect host via contact openings skin animal insect vectors ingestion contaminated food water inhalation giving rise wide range delivery mechanisms attack outcomes vary many orders magnitude terms consequences current threat largely involves naturally occurring pathogens toxins many ways biological attacks similar scourge disease wrought havoc human animal plant populations millennia main difference consequences greatly compressed time scope future genetically altered synthetic pathogens may possible science genetic manipulation dna synthesis evolving rapidly diversity threats makes difficult comprehend bioterrorism singular phenomenon requiring singular strategy complexity bioterrorism threat suggests multifaceted approach simplify remaining discussion article focuses elements strategy combating bioterrorism aimed humans especially airborne releases potential creating greatest number casualties strategy protecting agricultural sector similar elements requires separate analysis strategy coping proliferation problem involves four complementary elements diplomacy deterrence preemption defense diplomatic initiatives may help prevent spread proscribed weapons thereby eliminating problem source weapons proliferate deterrence may dissuade use deterrence fail preemptive attacks may destroy weapons launch preemption viable option active defenses may interdict weapons arrive passive defenses may protect people effects detonation framework applies proliferation problem nuclear biological chemical ballistic missile four elements important different emphasis depending nature proscribed weapon example cold war nuclear threat principally addressed deterrence complemented diplomatic ie arms control efforts circumscribe threat limited efforts preemption defense biological weapons main emphasis defense complemented diplomatic efforts preemption deterrence diplomatic efforts prevent proliferation biological weapons include <NUMBER> geneva protocol bans first use biological chemical weapons <NUMBER> btwc bans development production stockpiling acquisition transfer biological agents types quantities justification prophylactic protective peaceful purposes means delivery australia group coordinates export control policies relating chemical biological weapons materials equipment among <NUMBER> member states un security council resolution <NUMBER> calls upon states refrain providing form support nonstate actors attempt develop acquire manufacture possess transport transfer use nuclear chemical biological weapons means delivery adopt enforce domestic legislation prevent nonstate actors engaging activities establish domestic controls prevent proliferation fundamental problem monitoring biological weapon proliferation biological agents material equipment quintessential dual use items making difficult separate benevolent malevolent applications covert biological weapon facilities unique signatures would allow identification without intrusive inspections even intrusive inspections difficult identify covert facilities reason btwc include monitoring verification provisions common arms control treaties member states could agree inspection provisions difficulty compounded fact btwc allows states acquire small quantities pathogens prophylactic peaceful purposes difference small pathogen sample used test antibiotics vaccines one used seed stock biological weapon production facility solely one intent attempts <NUMBER>s strengthen btwc inspection protocol ended <NUMBER> bush administration withdrew support arguing justification covert biological weapon programs could easily hidden even protocol entered force legitimate facilities could converted produce biological weapons short period time weeks months inspection regime intrusive enough detect covert programs could compromise proprietary information crucial commercial companies similarly australia group faces enormous challenge distinguishing legitimate illegitimate end uses exported biological material equipment best export controls may impede largescale acquisition activities probably cannot thwart smallscale operations future diplomatic efforts extend beyond traditional arms control treaties export control regimes example usrussian cooperative threat reduction program focused principally securing nuclear weapons materials scientists former soviet union expanded cover wider range former soviet biological weapon facilities activities material protection accounting control would help prevent spread pathogens equipment materials funding employ key former soviet personnel peaceful biomedical research would discourage selling expertise foreign bidders latter particularly important biological weapon acquisition largely issue acquiring tacit knowledge opposed equipment materials build weapons international code conduct biomedical researchers could help reinforce norm biological weapons development promulgation international standards shared best practices safety security pathogen collections biocontainment facilities work deadly pathogens example could reduce risks associated accidents diversion would help promote interaction among biomedical practitioners engaged potentially dangerous research international association collaboration among biologists medical professionals public health practitioners would help address emerging infectious diseases transparency produced collaborations would collateral benefit potential detect covert activities soviet biological weapons program would difficult conceal international collaboration soviet biologists medical public health practitioners cold war detecting covert biological weapon activities increasingly matter detecting people involved weapons improving international disease surveillance specifically improving public health laboratories lessdeveloped countries connectivity international health community worthy objective also security benefits attack contagious agent occurs foreign country sooner detected better governments able limit entry state monitoring borders ports entry restricting travel improved international disease surveillance might also detect presence covert biological weapon programs event accident infects local population <NUMBER> accidental anthrax release sverdlovsk russia would readily detected surveillance system place time course hiding covert programs well avoiding political embarrassment natural disease outbreaks precisely states resist disease surveillance control still efforts world health organization implement global outbreak alert response network well placed recently revised international health regulations require reporting disease international public health concern within <NUMBER> hours fully implemented public health security benefits nations efforts need sustained diplomatic financial backing ultimately governments must recognize spread disease respect international boundaries hence public health solely sovereign issue especially age rapid international travel commodity transport however diplomacy alone ultimately cannot prevent spread biological weapons revelations size scope covert soviet biological weapons program cold war much existed guise legitimate biomedical research demonstrates limited utility diplomatic means diplomacys greatest benefit may reinforce widely held norm use disease weapon war terror reinforcing norm important one hopes convince malevolent actors abide norms status quo powers adhere rather deterrence convinces malevolent actors sincerity united states likeminded states abhor biological weapons hence resolve respond attacked despite best diplomatic efforts biological weapons may still spread question becomes whether states dissuade states terrorists using efficacy deterrence rogue states terrorists questioned leaders believed irrational hence cannot dissuaded retaliatory threats argument distorts character regional leaders authoritarian leaders may ruthless unsavory characters little regard civilian population however generally suicidal similarly terrorist groups often clear strategic tactical goals infrastructure supports operations logistically financially carry acts terror may suicidal topand midlevel leadership frequently therefore principle one may able identify targets retribution dissuade terrorist groups acting practice often difficult especially one wants avoid civilian casualties effective deterrence depends upon ability identify perpetrator attack therefore attribution especially terrorists statesponsored terrorists crucial effective deterrence holding states responsible terrorists acquire material states greater incentive secure biological agents might possess reluctant provide terrorist groups sympathize unauthorized acquisition problem obvious cover state contributes terrorists biological weapon capability un security council resolution <NUMBER> notwithstanding deterrence relies upon clearly communicated credible retaliatory threats whose consequences outweigh benefits attacker might hope gain credibility turn depends states capability resolve retaliate public commitment geneva protocol bwtc un resolution <NUMBER> helps convey resolve conjunction statements top government officials however states often lack capability respond part lack biological weapons make tit tat retaliatory threats nuclear threats states make less credible require nuclear first use difficult politicalstrategic decision circumstances united states may alone sufficient conventional military power threaten retaliation example topple regime aided carried attack although nuclear response options cannot ruled united states clearly emphasize conventional military capabilities deter biological attack threats may help deter biological attacks states bound less effective deterrence nuclear attacks cold war deterring terrorists may common elements deterring states assuming one locate enough top leadership infrastructure supports operations however terrorists less lose costbenefit calculus difficult shift deterring states favor perhaps best way dissuade terrorists attacking deny success attack terrorists often risk averse comes success mission preferring tactics techniques targets assure success dissuading opponent convincing chances success slim referred deterrence denial however terminology confounds deterrence defense true defenses may divert attack less well defended targets dissuade terrorist group attacking altogether reduced chance success however objective defense influence terrorist calculations protect defender regardless calculations preemptive attacks thwarting opponents ability strike first threat imminent destroying weapons launched frequently practiced conventional war considered united states former soviet union respect nuclear war preemption play less role biological attacks impractical biological facilities weapons easy conceal even located easy destroy without risk collateral damage whether radioactive fallout nuclear blast dispersal pathogens due incomplete destruction conventional strike terrorist attacks preemption certainly attempted state knows biological weapons located unlikely unless intelligence law enforcement agencies get lucky efforts improve intelligence suspect groups individuals useful however technical fixes offing allow intelligence agencies improve ability detect covert biological weapon programs future better human intelligence imperative therefore states alert opportunity preempt state terrorist attacks impractical rely upon preemption coping biological attacks demands places accurate timely intelligence active defenseinterdiction active defenses interdict weapons reach targets interdiction frequently cited preferred strategy terrorists however interdiction difficult covert biological delivery pathogens signature allows one detect transit person luggage container moreover biological agents released myriad ways complicating surveillance efforts clear fixes allow intelligence agencies improve ability determine biological attack might occur therefore interdiction programs like proliferation security initiative us effort create international agreements partnerships countries allow united states allies board airplanes ships suspected carrying weapons mass destruction components may deterrent role without accurate timely intelligence likely limited effectiveness biological threats unlike chemical nuclear ballistic missile threats cargo easier detect examples efforts improve border transportation security united states either focus identifying potential terrorists eg united states visitor immigrant status indicator technology usvisit program dangerous cargo eg advance electronic cargo manifests container security initiative customstrade partnership terrorism program screening travelers ports entry useful potentially detects malevolent actors weapons screening cargo much less useful biological threats biological agents emit detectable signature surprisingly cargo screening efforts focus detecting nuclear radiological materials traditional forms defense air ballistic missile defense limited use bioterrorism attacks air defenses effective provided air defense networks alerted attack covert air delivery using commercial private airplane difficult detect without prior intelligence ballistic missile defenses limited use terrorists unlikely ballistic missiles disposal except possibly shortrange missiles rockets latter defenses patriot advanced capability<NUMBER> pac<NUMBER> interceptors mobile tactical high energy laser mthel may utility assuming prove effectiveness test range biological weapon attacks state ballistic missile defenses also limited value biological submunitions released early flight technology united states former soviet union mastered <NUMBER>s easily overwhelm missile defenses passive defenses protect population effects weapons detonate biological weapons passive defenses quite effective inhalation infectious method exposure biological agents therefore simple mask provide considerable protection one knows standard inexpensive n<NUMBER> n<NUMBER> masks filter <NUMBER> <NUMBER> respectively submicron particles inhaled air thereby substantially reducing inhaled dose use example would substantially reduce scale epidemic donned immediately contagious disease outbreak detected thus increasing effectiveness medical response could focus smaller infected population principle homes could outfitted highefficiency particle hepa filters although would require substantial modifications home heating ventilation air conditioning hvac systems would require positive overpressure systems prevent infiltration cracks however hermetically sealed office buildings frequently hepa filters positive overpressure hvac systems making easier harden buildings likely targets attack perform critical functions midst emergency despite simplicity relatively low cost associated physical protection schemes suffer fact effective protection must either place times eg hermetically sealed office buildings individuals must know seek shelter masks latter relies upon adequate warning ready availability shelters masks currently available countries <NUMBER> iraq war israeli citizens carried gas masks donned time ballistic missile surveillance system warned incoming iraqi scud missile attack however countries plans provisions case best work war covert bioterror attacks peacetime preattack vaccination conceptually simplest approach preventing disease biological attack approach taken infectious diseases public health concern example almost children united states vaccinated polio measles mumps rubella pertusses varicella large segments population may risk vaccinated pneumococcal infection hepatitus hepatitus b tetanus influenza reason approach widely adopted defense bioterrorism twofold first unlike mother nature terrorists strategic opponents becomes known population vaccinated specific pathogens terrorists choose alternate pathogen sufficiently sophisticated may design pathogen circumvent vaccine second vaccines serious medical side effects small percentage cases vaccinating entire population prior attack could produce several hundred severe reactions possibly including death hence option political leaders chary unless threat attack imminent noted difficult determine postattack medical prophylaxis hand suffer political liability hence preferred strategy assuming effective however postattack medical intervention effective pathogen threat attack particular pathogen clear present danger case made preattack vaccination particular agent assuming vaccine exists otherwise preattack vaccination contraindicated safer vaccines become available biological agents exception toxins incubate hosts period days weeks depending pathogen dose individual exposed moreover medical interventionantibiotics vaccines case bacterial agents antiviral drugs vaccines case viral agentscan effective administered prior development symptoms host shortly thereafter circumstances therefore window exists inside medical intervention effective saving lives basis important element biodefense strategy namely rapid postattack medical response postattack medical response involves three elements biological agent detection identification medical logistics deliver supplies exposed population prophylaxis campaign dispense appropriate medications entire exposed population short period time including potentially large number people believe exposed three steps must occur many people become symptomatic strategy provide high degree protection incubation period given disease sets timescale activities must occur medical efficacy postattack antibiotic treatment inhalation anthrax example illustrated figure <NUMBER> plots percentage hypothetical victims saved function time medical intervention begins airborne anthrax release upon calculation based one exposed population approximately <NUMBER> <NUMBER> people <NUMBER> would become infected absence medical treatment medical intervention posited consists antibiotic distribution <NUMBER> exposed population period <NUMBER> hours possibly followed vaccination antibiotic treatment prior onset symptoms <NUMBER> effective postsymptomatic antibiotic treatment approximately <NUMBER> effective delivered within <NUMBER> days symptom onset assuming intensive medical care available sort provided victims fall <NUMBER> us anthrax letter attacks ie multidrug regimens pleural fluid drainage different curves required different attack sizes different diseases case contagious diseases one must account secondary transmission figure <NUMBER> one observes <NUMBER> exposed population saved treatment begins within <NUMBER> days exposure maximum medical efficacy asymptotes <NUMBER> due assumptions embedded model clearly sooner one provide prophylaxis exposed population better detection identification time reduced time available implement medical response functions overlap time example logistics associated activating strategic national stockpile warehouses united states currently store medical supplies massive infectious outbreak setting staffing points distribution pods people eventually queue receive treatment occur simultaneously immediately attack detected agent identified figure interpreted care based optimistic assumptions given current us preparedness regarding detection time speed medical logistics deliver antibiotics pods within affected area speed queues processed pods effectiveness prophylaxis regime eg certain medications may contraindicated subpopulations children pregnant women immunocompromised individuals victims may comply entire prophylaxis regimen figure <NUMBER> represent level protection principle achieved moreover <NUMBER> effective medical response attack hypothetically infects <NUMBER> people still leaves <NUMBER> people infected case inhalation anthrax implies close <NUMBER> deaths horrific outcome compared bioterrorism witnessed date likely viewed unacceptable outcome thus tendency strive medical effectiveness well <NUMBER> achieve levels protection <NUMBER> important implement policies reduce percentage people receive prophylaxis assumed <NUMBER> exposed population figure <NUMBER> adhere full antibiotic regimen timeboth important social opposed technical challenges prophylaxis campaign finally important note strategy overlaps efforts improve public health consequently cost biodefense benefits even attack never occurs given low albeit uncertain likelihood biological attack emphasizing biodefense programs activities substantial public health benefits prudent way proceed although important biodefense programs meet criterion eg developing improved smallpox vaccine moreover given infectious diseases leading cause death many developing countries strategy coping bioterrorism address legitimate public health concerns developing world gain little sympathy support cooperation contrariwise developed world stands gain tremendous good helps governments developing countries solve public health problems commodity irrelevant global struggle terrorism two issues important respect detecting bioterrorism event low false alarm rate speed false alarms quickly erode confidence detection system mention economic costs consequently infrequent eg order one per decade given facility urban area monitored false positive rate depends detection technology detection threshold lower thresholds give false positives background biological aerosol levels environment cannot readily discriminated agents one wishes detect rule using two different detection technologies uncorrelated noise background signals reduces false alarm rate considerably detection methods sequenced time reduce cost first detector cueing second however increases detection time rapid agent detection identification important medical treatment effective delivered prior victim becoming symptomatic prophylaxis efficacy drops rapidly symptoms appear intensive supportive care required ward death making medical intervention burdensome costly hence less likely reach many people realtime detection required unless physical protectiondonning masks entering protected buildings part defensive strategy detection within <NUMBER> hours reasonable goal rapidly incubating diseases anthrax thus leaving <NUMBER> days conduct effective medical response diseases incubate slowly eg smallpox contagious diseases preventing secondary infections important part preventing widespread epidemic slower detection speeds acceptable finally detailed dna analysis trace element detection important forensic evidence however collected analyzed within days weeks attack us government funded development wide range biological agent detectors fall two categories environmental sampling detecting host response infection environmental sampling involves collecting air water food swab samples analyzing presence pathogens using antibody tests matching dna sequences known pathogens environmental sampling virtue principle rapid order fraction day depending frequently samples taken used identify pathogen though necessarily whether pathogen virulent us biowatch program currently monitors air approximately <NUMBER> american cities range pathogens example approach pathogen plume passes one biowatch air sampling stations sufficient concentration would detected within approximately <NUMBER> day disadvantage environmental sampling large number sensors air collection stations must deployed ensure small releases detected high probability intelligence available mobile sensors deployed area concern however without reliable intelligence system costs become prohibitive one wishes monitor air small releases hundreds cities time finally sensor network provides little benefit public health cannot detect contagious diseases public health concern example severe acute respiratory syndrome sars influenza concentration microorganisms open environment well detection threshold methods detect human response infection currently involve clinical diagnosis syndromic surveillance data would sent nationwide alerting network clinical diagnosis relies upon symptomatic patients visiting physician hospital emergency room symptomatic victims would seek medical care immediately early symptoms diseases caused biological agents frequently similar influenza fever nonspecific cough congestion etc physician aids improve differential diagnosis relatively uncommon diseases caused biological warfare agents thus reducing time detection identification however one must still wait first victims present may take order <NUMBER> days moreover laboratory cultures commonly used confirm infectious agent take additional <NUMBER> days although antibody tests enzyme linked immunosorbent assays elisa reduce fraction day test conducted immediately therefore clinical diagnosis currently cannot warn attack within <NUMBER> hours syndromic surveillance systems monitor clinical reports pharmacy sales school absentee rates data detect abovenormal rate symptoms geographic area systems example biosense united states detected unusual increases local infection levels natural outbreaks however detect events number symptomatic cases rises background level definition late effective medial intervention event biological attack hence syndromic surveillance systems may public health benefits cannot provide sufficient warning ie within <NUMBER> hours biological attack implement highly effective medical response veterinary wild animal disease surveillance may detect disease among animal bird populations become apparent human population case west nile virus natural outbreak <NUMBER> <NUMBER> united states however monitoring animal disease outbreaks benefits public health defense intentional attacks exposure animal human populations would simultaneous incubation period animals birds frequently comparable humans implying animal disease detection unlikely precede detection zoonotic diseases humans case rapid veterinary wild animal disease detection integration human disease surveillance systems occurred united states future research development area attack warning emphasize improving detection time hosts response infection opposed environmental sampling latter expensive limited benefits public health automated laboratory testing example using elisa techniques dna chips reduce detection identification times hours time samples enter laboratory however clinical diagnosis still requires presentation symptomatic patients presymptomatic diagnostic techniques detect early host immune response infection example mrna transcription genes involved hosts immune response begins within approximately <NUMBER> hours exposure would useful assuming research demonstrates gene expression patterns reliable fingerprints presence given pathogen small class pathogens techniques could reduce warning time approximately <NUMBER> day assuming used routinely hospitals medical clinics detecting asymptomatic victims visit reasons presymptomatic diagnostic methods would tremendous benefits routine medical diagnosis common infectious diseases resulting economies scale reduce cost united states currently probably detect correctly identify bioterrorism event within approximately <NUMBER> days initial release clinical diagnosis note however took <NUMBER> days diagnose cases <NUMBER> anthrax letter attacks including time blood culture confirmation diagnosis information would conveyed us center disease control cdc via public health information network matter hours major urban areas although network fully implemented future us national biosurveillance integration system designed provide warning disease outbreaks natural terrorist origin integrating food agriculture public health clinical diagnosis syndromic surveillance environmental sampling data speed system able detect outbreak constrained abovementioned limits associated different detection methodologies realtime detection required twentyfour hour warning sufficient mount effective medical response since medical prophylaxis begin within approximately <NUMBER> hours atmospheric release case anthrax <NUMBER>hour detection capability would leave least one day implement medical logistics begin providing prophylaxis large number exposed worried citizens providing prophylaxis large number people requires delivery large quantities medical supplies exposed population suggestion people keep supplies necessary medications home thus obviating need rapid distribution rejected people take medications inappropriately eg antibiotics flu may take inappropriate doses large selection medications would needed protect possible biological agents selfvaccination would possible consequently current us plans call stockpiling necessary medical supplies antibiotics antiviral drugs vaccines syringes intravenous supplies ventilators etc central warehouses referred collectively strategic national stockpile intent rapidly dispense supplies attack detected palletized push packs medical supplies delivered local staging area united states aircraft truck within <NUMBER> hours decision deploy greater challenge distribute supplies local staging area pods people queue receive medications pods could local schools fire stations shopping malls hospitals hospitals remain free congestion handle acute cases victims passed symptomatic disease phase united states little hospital surge capacity due managed healthcare however hospital surge capability important victims need intensive care principle challenge effective medical response provide prophylaxis prior appearance large number symptomatic cases hospitals become overwhelmed acute cases surge capacity answer rather rapid effective presymptomatic prophylaxis therefore pod surge capacity important particular augmenting personnel capable servicing queues increase pod throughput diagnostic techniques triage noninfected individuals greatly reduce number people requiring prophylaxis number people concerned exposure exceed actual number people become infected factor <NUMBER> <NUMBER> time takes transfer medical supplies local staging area pods depends time required repackage supplies smaller quantities transport individual pods likely via small trucks efforts clearly made minimize extent repackaging necessary helicopter backup may required roads congested people fleeing exposed area depending size urban area several tens several hundred pods required minimize time required treat exposed population local officials must identify suitable pod locations transportation staff pod exercise logistics plans go smoothly emergency beginning occur united states prophylaxis campaign requires medically trained personnel triage individuals according medical status prescribe appropriate prophylaxis regimen paperwork required track individuals mediations receive provide information medications possible side effects security personnel required ensure order detection occurs within <NUMBER> hours takes <NUMBER> hours distribute supplies strategic national stockpile local staging areas <NUMBER> hours distribute supplies pods <NUMBER> hours set pods occur concurrently stockpile dispersal prophylaxis begin within <NUMBER> hours release <NUMBER> urban pods process <NUMBER> people per hour around clock rapid medical response principle provide prophylaxis approximately <NUMBER> million people within <NUMBER> days thereby saving <NUMBER> population exposed anthrax according figure <NUMBER> numbers reflect current capability rather level protection possible sufficient effort effective medical treatment depends stockpiling appropriate medications sufficient quantity antibiotics efficacy approximately <NUMBER> healthy individuals may contraindicated certain subpopulations eg children pregnant women immunosuppressed individuals united states immunosuppressed population growing due cancer treatments human immunodeficiency virus hiv organ transplants medical interventions cause concern highly effective medical response desired significant subpopulations vaccination effective defense many infectious diseases however vaccines often take <NUMBER> weeks primary seroconversion may require one booster shots thereafter achieve full protection consequently generally less effective postattack prophylaxis unless antibiotic antiviral drugs available control disease vaccination takes effect moreover vaccines exist biological agents exist sufficient quantity others routinely stockpiled diseases current public health concerns therefore research development focus new broad spectrum antibiotics antiviral drugs safe effective vaccines known biological agents administered segments population medical research areas also important benefits public health new treatments discovered emerging infectious diseases concern antibiotic antiviral resistant pathogens best addressed limiting overuse drugs multiple medications hand effective given pathogen strain highlighting importance medical research development finally genetically engineered pathogens enhanced effects circumvent detection systems circumvent medical countermeasures may become widespread future however increasing virulence pathogens genetic manipulation trivial notwithstanding australian mousepox experiment would terrorists need go trouble since natural pathogens terrifying enough current time bioterrorism countermeasures focus naturally occurring pathogens however biotechnology infancy powerful discoveries lie ahead hence defensive policy must strike balance developing countermeasures current versus possible future pathogens research new prophylactic drugs vaccines carried largely private biotechnology pharmaceutical companies resources expertise create new drugs government sponsored financial incentives encourage develop countermeasures otherwise would unprofitable us bioshield act <NUMBER> followon bioshield ii legislation currently congressional review illustrate kinds incentives may effective example tax credits patent extension liability limitations debates also surfaced wisdom censorship biomedical publications world lot gain improved public health stands lose bioterrorism allowing unfettered access scientific advances biology medicine thus censorship classification schemes keep certain information malevolent actors carefully scrutinized open access norm unless clear present danger exists best hope medical countermeasures available need arises time providing benefits public health us government established national advisory board biosecurity group <NUMBER> biologists physicians security experts outside government help maintain balance scientific openness preventing bioterrorism addition developing guidelines research publications life sciences helped draft code conduct life science professionals fostered international cooperation help define issues decontamination required prevent bioterrorism becoming threat physical infrastructure rendering buildings unusable months years public officials cannot certify safe occupancy effective decontamination policy must determine safe public exposure levels depend site use individual susceptibility infection little data exists environmental background levels common pathogens moreover scientific debate regarding effects lowlevel exposure pathogens may contentious lowlevel radiation debate therefore seemingly simple question clean site must ensure public safety fact difficult answer existing scientific data answering question first priority decontamination research pathogen levels monitored months years event expensive complicated fact detection techniques eg dna sequence matching distinguish living dead pathogens addition communicating risks associated residual contamination public credible way vital allay public anxiety economic consequences flow fears nontrivial challenge federal state local authorities working conjunction media postattack vaccination local population important adjunct decontamination strategy vaccinated individuals live safely much higher residual contamination however everyone vaccinated due health risks vaccinating visitors contaminated area inconvenient decontamination strategies differ outdoor indoor contamination outdoor contamination partially removed washing surfaces water case decrease time due environmental degradation agent eg ultraviolet light reduces anthrax spore viability <NUMBER>to <NUMBER>fold day locating hot spots important costly possible outdoor locations pathogens might collect quantity must sampled initially monitored thereafter outdoor chemical decontamination expensive therefore feasible areas order square kilometers indoor contamination serious problem absence ultraviolet light thus slowing environmental degradation amount time people spend indoors thus increasing exposure indoor remediation expensive demonstrated experience hart senate office building brentwood postal facility <NUMBER> us anthrax letter attacks latter took <NUMBER> year cost approximately <NUMBER> million clean moreover current decontamination chemicals eg chlorine dioxide methylformaldehyde paraformaldehyde methylbromide hydrogen peroxide household bleach corrosive carcinogenic andor toxic safer effective decontaminants important area research development example gaseous germination agents cause anthrax spores germinate whereupon vegetative bacillus becomes much vulnerable environmental degradation combining advanced decontamination agents highefficiency particulate air hepa vacuuming could reduce indoor decontamination problem manageable level especially combined vaccination local population ultimately mixed decontamination strategy takes advantage environmental degradation washing chemical decontamination vacuuming appropriate able render public areas usable cost may quite high depending extent future decontamination technologies avoid repeat <NUMBER> us anthrax decontamination experience logic behind belief bioterrorism serious emerging threat sound although reasonable people disagree urgency moreover threat multifaceted complex owing range pathogens delivery modes targets attack substantial uncertainties exist predicting outcome hypothetical biological attack implies attack outcomes look bleak relatively benign depending ones assumptions tendency focus worst case scenarios leads one conclusion biological weapons poor mans nuclear weapon originate part exaggerations trying move governments action may unintended consequence convincing defense bioterrorism hard others pathogens ideal weapon terror hence states must develop coherent strategy combating bioterrorism reasonable cost strategy involves diplomacy deterrence preemption defense emphasis defense arms control export controls may constrain largescale biological weapon programs importantly reinforce norm acquisition use pathogens war weapons terror helps reinforce deterrence may effective states less likely effective terrorist groups attribution crucial deter states aiding terrorist groups however neither diplomacy deterrence sufficient alone combination reduce biological weapon threat satisfactory level terms limiting damage threats preemption attractive concept might impractical relies accurate timely intelligence interdiction covert biological attacks also difficult one must detect malevolent actors since one cannot detect biological weapons consequently emphasis placed passive defense involves detecting release pathogens timely manner rapid postattack medical intervention effective decontamination restore contaminated areas usable state principle postattack medical response protect <NUMBER> exposed population pathogens detected within <NUMBER> day release medical logistics deliver appropriate medical supplies exposed population within <NUMBER> day prophylaxis campaign mounted treat exposed population potentially numbering millions within <NUMBER> days state currently claim effective defense place except possibly small outbreaks defense possible moreover extent biodefense overlaps efforts improve public health expenditures may justified resources wasted even biological attack never occurs past five centuries europe veritable centre world first europeans developed modern conceptions statehood international politics actively projected innovations application ‘standard civilisation’ well beyond continent’s boundaries bull watson <NUMBER> process increasingly global international system formed one europeans continued enjoy pride place europeans also one main sources well beneficiaries western international order since end cold war rested us primacy wider western phenomenon resulted liberal rulebased world order ikenberry <NUMBER> europe manifest concentric hegemonic order us global primacy regionally preponderant security role nato complemented european union eu assumed position regional normative hegemon right haukkala <NUMBER> view ordering continent along essentially unipolar lines envisaging europe concentric circles revolving around ‘brussels’ aalto <NUMBER> diez whitman <NUMBER> europe usa eu formed ‘matryoshka hegemony’ deyermond <NUMBER> sorts sought largely succeeded ordering continent largely unified least complementary manner many developments welcome benign unarguably europe never stable secure past three decades yet growing signs era coming end global level usa entered period retrenchment tensions increasing rapidly rising china allison <NUMBER> president donald trump also largely abdicated global leadership role liberal rulebased international order immense growing strain sørensen <NUMBER> china together russia smaller regional powers challenging current international order global level staking claims regional spheres influence visible also europe russia time making case equitable bipolar setting process contestation culminated ukraine conflict <NUMBER> resulted lowsimmering conflict west russia taking cue international relations ir debates effects polarity number great powers evolution international order chronological lineage see waltz <NUMBER> kegley raymond <NUMBER> mearsheimer <NUMBER> brooks wohlforth <NUMBER> monteiro <NUMBER> article poses question whether europe experiencing period ‘normal’ geopolitical contestation could fact transition towards state affairs become void great powers capable effectively ordering continent let alone wider world word europe headed towards period nonpolarity would entail future cooperation stability even security continent article makes three main contributions firstly links european studies ir debates concerning polarity ongoing change structure international politics situates socalled third wave hegemony studies ikenberry nexon <NUMBER> concentrates examining unravelling western hegemony europe secondly seeks conceptually expand understanding great powerhood introducing notion ‘ordering agents’ article seeks add nuance extant literature largely simply assumed great powers always also capable generating order instead article draws attention whole gamut prerequisites successful ordering role contemporary international politics moreover argued requirements particularly salient europe undoubtedly highly institutionalised region world diez whitman <NUMBER> thirdly article presents analytical narrative concerning developments europe postcold war era two stages firstly recounting story western attempts hegemonic ordering europe russia’s growing contestation moving analysing main causes drivers behind potential nonpolarity europe argument developed four stages firstly concepts nonpolarity great powerhood introduced refined view introducing concept ‘ordering agents’ secondly roles usa european union russia played ordering europe postcold war era analysed thirdly causes drivers consequences nonpolarity europe discussed finally article concludes pondering question whether europe indeed headed towards period nonpolarity could entail future continent ends policy relevant point warning possible unintended consequences current contestation institutional atrophy europe article suggests current trajectory best interest party engages normative argumentation contending twentyfirst century great power worthy name held higher standard terms providing building blocks stability order regional global levels currently case often order norm everyday life case domestic societies monopoly legitimate use violence enjoyed states ensures hierarchical least time also orderly conduct national politics anarchical international system lend clearcut hierarchy along domestic lines entirely without order either purposes article defined subsystemwide structures practices—institutions norms values principles—that govern regulate conduct international politics international politics order stems mainly two sources see young <NUMBER> <NUMBER>–<NUMBER> following taken may emerge spontaneously generated ‘hidden hand’ international anarchy oran young called selfgenerated orders classic example principle balance power times rather successful moderating interstate conflict little <NUMBER> yet purposes article indeed increasingly interdependent global international system find rudimentary effect shallow conception order therefore arguably important avenue generating order premeditated design young’s terminology imposed negotiated orders require intentional agency part key actors take lead act concert generating upholding times modifying even undoing orders nothing automatic latter type order generation takes effort use power achieve final analysis requires great power great powers generate uphold international order great power enough one must also able conduct ordering role willing carry associated burden therefore suggested article ordergenerating great powers particular subset category called ordering agents defined great power capacity ability willingness establish uphold project subsystemwide ordering structures practices—institutions norms values principles—and consequence intendeddesired ordering effects essential building blocks successful ordering agent summarised table <NUMBER> let us begin capacity refers power perhaps essential concept study international politics baldwin <NUMBER> <NUMBER> also one contested ones occasion try settle debates suffice say multifaceted conception power called key question pertains quantity quality power well varying effects employed ordering international according waltz <NUMBER> <NUMBER> great powers require whole spectrum attributes size population territory resource endowment economic capability military strength political stability competence traditionally master variable military power anarchic setting ultimate arbiter conflicts states yet possible overstate relevance especially global interdependent world nye <NUMBER> forms power ranging economic ‘soft’ normative play increasingly important role baldwin <NUMBER> nye <NUMBER> manners <NUMBER> also noteworthy military power ensure reliable control outcomes across board relevant issues contemporary international politics states employ strategies offset military power differentials meaningful geopolitical effects despite fully credible peer competitors indeed actor may power affect behaviour others disruptive forms power—power avoid nonpreferred outcomes simply acting spoiler—without necessarily fully able coerce others adopting stance preferred actor also military power hammer every issue consequence contemporary international politics nail contrary plenty perhaps even increasingly issues world today cannot solved necessarily even contained use military power question climate change well systemic risks pandemics case point goldin mariathasan <NUMBER> applies disruptive forms power generate collective capacity problemsolving governance therefore identifying existence great power capacity abstract first step analysis without ability channel translate capacity actual influence remain resources void actual ordering effects see also sørensen <NUMBER> <NUMBER> analysing power differentials imperative yet tell us anything quality interaction nature consequent contestation ordering great powers exercise power always empirical issue outcome interaction cannot deducted power differentials alone regardless significant may arreguintoft <NUMBER> gain nuanced view processes play one turn english school seminal work hedley bull one first theorists argued order merely pattern grows mechanical interaction like units intentional final analysis also inherently social process key actors take lead generating upholding particular conception order rests set shared values norms institutions bull <NUMBER> bull indeed existence shared institutions balance power international law formed basis called ‘international society’ common institutions represented something shared universal halliday <NUMBER> <NUMBER> pointed bull’s international society ‘communitarian’ implying group shared values also address question change adopted rather conservative stance advocating relative perpetuity constitution international society see friedner parrat <NUMBER> bull’s reading norms values institutions static large seen time prerequisites operation beneficial existence international society point bull entirely mark however international order always serves interests wider international society unevenly important bear mind anna leander’s <NUMBER> <NUMBER> insightful words order never neutral always works advantage least potential disadvantage others inviting us ask whose international order talking see also williams <NUMBER> <NUMBER> interpretation international order serve certain useful functions society large also reflects interests ideas certain key players society therefore international order never neutral necessarily entirely voluntary exercise part members certain amount cooptation coercion times perhaps even domination expected stance taken comes question order international politics norms practices institutions viewed sites contestation struggle final analysis content reflects power ideas able affect change wiener <NUMBER> see also ikenberry nexon <NUMBER> wivel paul <NUMBER> reading choice power ideas false dichotomy either ideas power required make sense given international order sørensen <NUMBER> although times single actor—or group actors acting concert—may powerful enough dictate rules game others brute strength alone usually enough recalibrate international order point towards role intentional agency order change changed wilful actors able affect change order sustain requires agents seek uphold refers third variable definition namely willingness act ordering agent carry associated burden ikenberry’s <NUMBER> treatment international order process leading states sought lock states certain set institutionalised practices useful starting point addition order always entailed viable domestic model projection essential elements beyond borders generate order case two different respects firstly viable domestic model prerequisite effective agency function ordering agent internationally first function satisfactory degree internally secondly reconstitution international order must also rely legitimacy actors involved normative foundation promoted cf hoffmann <NUMBER> <NUMBER>–<NUMBER> philpott <NUMBER> <NUMBER>–<NUMBER> words georg sørensen <NUMBER> <NUMBER> ‘a stable legitimate order founded fit among power base… common collective image order expressed values norms appropriate set institutions’ last conceptual issue needs discussed context deals relationship great power politics polarity ie number great powers given international system waltz <NUMBER> <NUMBER> power obviously key consideration deciphering number great power poles count one relative capabilities must roughly commensurate across domains powerful state world according kegley raymond <NUMBER> <NUMBER> bimultipolar system great powers must near necessarily absolute equals number poles varied historically general multipolarity—the existence two poles system—has norm see kegley raymond <NUMBER> indeed postworld war ii eras stand sense witnessed first period intense rivalry two superpowers locked bipolar setting cold war followed period unipolarity usa enjoying unrivalled primacy hegemony postcold war era monteiro <NUMBER> brooks wohlforth <NUMBER> see table <NUMBER> summary great powers europe modern era table <NUMBER> shows although polarity varied historically issue nonpolarity arisen modern era first sight whole notion nonpolarity might seem odd surely anticipating wholesale collapse statecentric international system disappearance great powers it<NUMBER> better understand nonpolarity european context might possible perhaps even likely must examine question polarity light definition ordering agents established usage relationship great powers polarity almost tautological—great powers poles vice versa present purposes analytically useful instead article contends polarity traditional reading bird’seye view international politics based resources potential whereas useful analytical lens would take account aspects agency namely ability willingness act ordering agent sense defined entails count pole agent question must possession host attributes material power base ideational foundation perceived external legitimacy begin also political variable concerning essential competence act ordering agent international politics willingness carry associated burdens light discussion may define nonpolarity lack great powers capable able willing act ordering agents given international system subsystem term nonpolarity introduced richard n haass article written foreign affairs decade ago defined loosely ‘international system… characterised numerous centres meaningful power’ haass <NUMBER> see also bremmer <NUMBER> spoke ‘g<NUMBER> world’ yet use term article differs haass’s conception two respects first regional scope drawing attention europe instead overall global politics second assume power drifted away diffused host nonstate actors degree would account nonpolarity contrary article argues potential period nonpolarity stems changes taking place within key actors play indigenous capacity willingness act ordering agents atrophying addition nonpolarity also outcome generated current interaction growing contestation main contenders ordering role short nonpolarity situation great powers either incapable unwilling either alone concert apply power successfully create uphold international order europe dissolution soviet union end cold war division opened geopolitical space europe rigid bipolar confrontation gave way much fluid setting fresh opportunities challenges rapidly mushroomed called new policies part usa emerging eu usa four main objectives <NUMBER> managing transition new postcold war order peaceful orderly fashion <NUMBER> facilitating emergence russia successor state soviet union responsible constructive player including development cooperative threat reduction russia deal toxic assets left behind soviet union <NUMBER> ensuring primacy nato—and extension also usa—in european security downplaying eu’s potential emerge fully independent security actor <NUMBER> using eu proxy organise political economic integration consequent transition emerging wider europe discussion concerning key tenets us policy see goldgeier mcfaul <NUMBER> talbott <NUMBER> stent <NUMBER> usa took lead ordering postcold war setting along liberal lines first europe increasingly also globally mearsheimer <NUMBER> quarter century usa able secure unrivalled position top international hierarchy also successful stabilising conflicts europe <NUMBER>s locking continent preferred security structure expansion nato mastanduno <NUMBER> even russia made dissatisfied noises time expectation could successfully placated offering moscow privileged forms partnership west usa particular asmus <NUMBER> eu’s rise prominence dovetailed developments early <NUMBER>s started express ambitions develop capacities indigenous views international affairs develop policies actions world stage adoption common foreign security policy cfsp maastricht treaty <NUMBER> particular significance created fresh instruments external action institutionalised cooperative culture time resulted impressive although perhaps needlessly cumbersome finesse complexity today’s eu see keukeleire delreux <NUMBER> process eu effectively thrust assuming leading role responding economic effects dissolving soviet empire objectives nascent ‘european foreign policy’ usa largely compatible even complementary one way characterise role two played ordering europe think ‘matryoshka hegemony’ us global primacy regionally preponderant security role nato set broad liberal framework within eu took lead ordering european continent expansion outward projection policies norms values haukkala <NUMBER> consequently usa eu working tandem met practically requirements successful ordering agent europe enjoyed unrivalled material preponderance portraying competence political willingness act ordering agents also promoted coherent set ideals period leading role enjoyed great deal external legitimacy reflected long queues accession candidates front nato’s eu’s doors established one exercise caution assigning much strategic intentionality part west nato’s eu’s eventual sprung nach osten reactions responses events demands beyond west’s control initial appetite rather preconceived programmes order subjugate whole continent see asmus <NUMBER> smith <NUMBER> hill <NUMBER> hegemonic underpinnings ordering role arrived piecemeal almost haphazard manner gives western unipolar hegemony europe paradoxical quality degree also explains fizzled quickly face growing russian resistance quite time russia remained outlier western attempts ordering europe fully fully trying figure national interests international identity process russia developed increasingly strained relationship usa eu adopted highly belligerent approach towards concentric order propagating russians crux issue lacked voice role would commensurate selfimage great power one way interpret events last quarter century europe view process increasing frictions tensions western natoeucentric attempts ordering continent russia’s growing frustration even hostility towards inability secure place would allowed voice veto marten <NUMBER> words hill <NUMBER> eyes moscow european architecture left ‘no place russia’ related wider russian complaint concerning role usa played globally us postcold war primacy general way washington responded <NUMBER> terrorist strikes <NUMBER> accentuated russian impression rampant usa bent dominating world unilaterally vladimir putin’s resentful words uttered already <NUMBER> usa ‘overstepped national borders every way’ putin <NUMBER> positioning counterforce reckless domineering washington became leitmotif putin’s rhetoric russian foreign policy well dramatic events ukraine although felt keenly time eu enlargement also created frictions russia west particular question ‘commonshared neighbourhood’ created aftermath ‘big bang’ eastern enlargement <NUMBER> proved source tensions ukraine’s <NUMBER> orange revolution—which took west russia equally surprise—changed moscow’s tack concerning eu’s role region moscow’s previous benign neglect subsided began view eu’s growing role western orientation cis countries increasing suspicion gretskiy et al <NUMBER> although appreciated time orange revolution starting gun preparation operations practices witnessed first georgia <NUMBER> crimea eastern ukraine since <NUMBER> franke <NUMBER> time russia’s grudging acquiescence western liberal hegemony morphed outright opposition yet current conflict russia west far inevitable contrary early <NUMBER>s parties still looking ways make relationship work accounts testify effect see forsberg haukkala <NUMBER> stent <NUMBER> repeated attempts ‘resets’ fresh beginnings marred underlying largely irreconcilable tension western unipolarity however well intended ran counter growing russian calls equitable essentially bipolar setting europe end <NUMBER>s russia started take much assertive steps promote preferred vision order beyond borders first instance took form eurasian economic community eurasec soon became eurasian economic union eaeu russia started invest institutionalised bipolar setting europe moscow leading power half continent expectation attracting majority postsoviet states russia’s leadership see dragneva wolczuk <NUMBER> although eaeu gain initial momentum exemplified expansion members original three current five fact russia felt compelled resort open blackmail coercion attract new members eaeu speaks volumes power attraction new regional bloc conflict ukraine culmination unhappy trends haukkala <NUMBER> actions russia made abundantly clear views eastern europe primary sphere interests trenin <NUMBER> eu nato must respect willing use means disposal enforce policy russia also signalled readiness pay high price terms economic hardship international although mainly western opprobrium menon rumer <NUMBER> wilson <NUMBER> reasons myriad main point worth stressing nearexistential nature russian interests eastern europe creates asymmetry unfavourable west matter hard pushes version order east moscow always willing push back little harder—and accept eventual price words russia stable able ruthless enough act spoiler europe apart eaeu contains severe internal tensions contradictions exemplified catastrophic outcome trying coopt ukraine join organisation <NUMBER>–<NUMBER> testified competent capable even willing act ordering agent europe contrary dramatic escalation ukraine <NUMBER> followed pattern russia proved ruthless application power challenge degree overturn current order regional level admittedly compared west russia lacking many key attributes power population stagnating economy weak almost entirely reliant sale hydrocarbons increasingly turbulent world markets yet may suffer aggregate amply makes skill employ wherewithal disposal see baldwin <NUMBER> <NUMBER> factored russia’s record accomplishment indeed short midterm potential looks promising russia also shown great acumen projecting military means achieve political ends beyond borders immediate vicinity ukraine even beyond events syria shown continued contestation also factor feeds potential emergence nonpolarity europe discussed next degree narrative compatible traditional forms ordering international politics possible process currently witnessing merely ‘normal’ turbulence associated period intense contestation followed creation new least amended order europe gilpin <NUMBER> yet recent years myriad factors developments warranted asking question whether notion nonpolarity fact applicable examining factors outlined definition ordering agent see main contenders europe portray varying drivers rapid decline current order augur possible emergence nonpolarity continent begin one must note unified even concentric western hegemony europe rapidly unravelling usa european union portray much less cohesion ability act tandem successful ordering agents previously trump transatlantic partnership experienced growing strains even signs serious erosion process documented brookings <NUMBER> trump administration views eu institutions hostility european allies growing suspicion time europeans started lose faith partnership americans relations eu usa atrophied meaningful dialogue interaction currently taking place brussels washington consequently ability two coordinate activities channel respective energies direction lost result difficult talk western hegemony europe anymore whole idea unified ‘west’ increasingly questioned shores atlantic kimmage <NUMBER> tcherneva <NUMBER> development affects european order negatively major impact evolution relations global level well two former hegemons found hard work together applies roles individually europe us case issue wholesale atrophy capacity act ordering agent one suggesting terms overall capacity competence usa completely lacking lacks economic military power increasingly lacking ability erosion perceived legitimacy lack essential willingness uphold current order globally europe due political variable stems current period soulsearching revolving around perceived need recalibrate us global role posture light new era ‘great power competition’ seen offing trump presidency accentuated aggravated trends root cause behind kagan <NUMBER> might right arguing trump struck stake heart liberal world order problem us role would changing case short term lot depend presidential elections november <NUMBER> even trump unseated probably affect mainly mood atmospherics transatlantic relations significant undo necessarily even repair damage stems deepseated structural factors tensions usa eu polyakova haddad <NUMBER> turning eu find increasingly isolated alone adrift essentially clinging vestiges preferred order globally regionally without necessary means project protect order fact eu seriously register military power would seem exclude list possible poles yet would erroneous discount ordering agent economically eu still strong position even problems governing european common currency cast shadow prospects addition waltz’s <NUMBER> <NUMBER> verdict concerning europeans two decades ago seems hold eu still lacks organisational ability collective political translate sizable power potential credible international actorness moreover mounting signs eu longer acknowledged key player global affairs indeed ever contrary european perspectives increasingly sidelined global politics increasingly eu actor stage upon others act eu’s inability project order least stymie growing instability visible around borders european neighbourhood policy enp meant result ‘ring friends’ around eu effectively collapsed ukraine conflict aftermath socalled arab spring resulted tragic civil war syria completed current outcome economist dubbed ‘ring fire’ around union haukkala <NUMBER> none argue developments primarily eu’s fault—but act successful ordering agent one needs able project stability protest instability around internally eu’s situation equally precarious last decade repeatedly succumbed crises sapped energies legitimacy even eyes citizens wivel wæver <NUMBER> times seems europeans facing growing problems keeping even eu house order exemplified brexit growing internal fissures concerning economic governance rule law europe krastev <NUMBER> zielonka <NUMBER> however pointed talking potential collapse eu yet exists serious doubt whether extent eu keep role ordering agent even among ranks let alone aspire successful ordering role externally final contender russia demonstrates perhaps signs playing constructive ordering role europe moment contrary even aim generate order elsewhere home seems busy wielding geopolitical wrecking ball hasten demise current order considering definition ordering agent russia fallen short postcold war era even exemplified collapse soviet union empire currently economic power base act ordering agent offer coherent alternative order criticising currently moscow’s actions add positive agenda seem aspire one consequently external appeal legitimacy russia’s agenda europe limited taken together none attributes translate capacity act ordering agent european setting discussion tentatively summarised table <NUMBER> tentatively assess findings full confidence would obviously require rigorous analysis said nevertheless hoped thesis enough prima facie plausibility merits taken seriously subjected rigorous research analysis future europe entered period relative decline role heft global politics rapidly shrinking deep structural forces play diminution europe’s importance inevitable time developments compounded fact order undergirding europe’s security stability deteriorating article argues due normal geopolitical contestation sign europe danger losing ordering agents ie great powers capable able willing create sustain order continent main driver behind developments changing us power role europe trump washington lost appetite act bulwark stability europe resulted ongoing collapse ‘matryoshka hegemony’ previously complementary concentric us eu ordering roles europe make matters worse eu task seems final contender ordering role europe russia even interested addition internal trajectories within eu russia point towards decreasing capacity successful ordering agency therefore time put forward question whether conflict west russia contributing relative decline europe world politics large whether unintended consequence contestation could hastening arrival period nonpolarity europe power able necessarily even willing shoulder responsibility ordering providing good stewardship europe historical track record nonpolarity modern era yet surmise possible effects based conceptual empirical understandings international politics argued period nonpolarity would pose serious problems two reasons firstly europe living era high constantly rising interaction capacity creates demands challenges terms coordination cooperation buzan <NUMBER> <NUMBER> trade flows legal illicit well increasingly important cyber space require governance joint management secondly living era high complex interdependence keohane nye <NUMBER> also includes mounting risks challenges potentially catastrophic even global scale ord <NUMBER> handling issues requires order ordering agents order prerequisite governance without risks inherent current world become difficult practically impossible control contain haphazard uneven response covid<NUMBER> coronavirus pandemic case point global trends argued europe issues even pertinent last three decades europe generated web densely institutionalised forms cooperation rules regulations require capable ordering agents continued existence russia might find entanglements close comfort argued along us military overlay instrumental keeping peace continent way read current situation envisage dialectical process western thesis fully countered russian antithesis synthesis remains still seen—but easy one locate arrive due essential incommensurability current positions indeed crux potential nonpolarity europe fact currently one impose order anymore sides deeply divided unable agree new one one avenue forward might return form balance power europe yet discrepancies various forms power probably large allow moreover internal dynamics within main potential ordering agents situation unlikely remain stable enough allow sustainable recalibration european setting contrary safer prognosis seems continued perhaps even expanding turbulence europe time lack good stewardship europe result erosion norms institutions generating growing friction potential conflict means missed economic opportunities increasing inability work successfully together tackle wider problems facing europe world worryingly hardwon gains past <NUMBER> years risk undone open conflict russia west cannot excluded cause concern rallying call responsible policies politics emergence nonpolar europe cannot anyone’s interest twentyfirst century great power worthy name held higher standard terms providing building blocks stability order regional global levels currently case new idea brown <NUMBER> argued great powers simply due virtue size importance always held higher standard powers final analysis advent possible nonpolarity europe depends political choices main protagonists indeed article prognosis nonpolarity europe inevitable three questions particular stand affect future developments <NUMBER> evolution us role globally europe <NUMBER> eu’s ability overcome current crises develop robust forms international actorness <NUMBER> future russia’s conflict west well evolution appetite seek constructive roles openings europe nonpolar europe still avoided political choices responsible policies main actors foster return capable credible committed ordering agents europe multipatch epidemic models used study various infectious diseases example nosocomial infection <NUMBER> vectorborne diseases <NUMBER> hivaids transmission <NUMBER> sars epidemic <NUMBER> often used capture heterogeneity different geographic locations example densely populated city less populated rural area also helps study effect migrations lockdown measures among different population groups locations covid<NUMBER> pandemic observed infectivity different regions may vary impacted various socialdistance lockdown measures <NUMBER> ode models often used study dynamics multipatch epidemic models well known ode dynamics arises markovian assumptions stochastic multipatch epidemic model infection process poisson infectious andor exposedlatent periods exponentially distributed migration processes also markovian <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> odepde models also used study dynamics infection rates agedependent depending long population infected see example <NUMBER> <NUMBER> models also assume exponentially distributed infectious periods markovian migration processes paper study multipatch sir seir models infectious exposedlatent periods general distribution migration processes markovian infection assumed local infection rate depends susceptible infectious population patch individuals may migrate one patch another susceptible exposedlatent infected recovered stages epidemic dynamics evolves manner mixed markovian nonmarkovian components seems challenging directly derive firstorder fluid equations describe evolution dynamics tracking time epochs becoming exposed andor infectious location individual event times specifically multipatch sir model individual tracks time epochs becoming infected recovered associated continuous time markov chain taking values patcheslocations multipatch seir model individual tracks time epochs becoming exposed infected recovered associated two markov chains used track movement starting individual becomes exposed infectious initially exposed andor infected individuals also assume remaining exposing andor infectious periods general distributions may different newly exposedinfected individuals initially exposedinfectious individuals also track movement exposedinfectious given representations time epochs location processes show functional law large numbers flln functional central limit theorem fclt associated counting processes multipatch sir seir models fluid limits determined set volterra integral equations infectious exposedlatent periods deterministic write fluid integral equations set odes delay remarks <NUMBER> <NUMBER> limit processes fclt determined set stochastic volterra integral equations driven sum independent brownian motions continuous gaussian processes certain covariance structure infectious exposedlatent periods deterministic limits become stochastic differential equations linear drifts delay remarks <NUMBER> <NUMBER> also remark approach results extended study multipatch sis sirs models remarks <NUMBER> <NUMBER> proofs results employ poisson random measures prms constructed sums dirac masses time epochs becoming infectious andor exposed infectious exposing periods markov chain starting location individual epochs use martingale properties convergence theorems critical tools proofs single patch sir seir models general infectious exposing periods approach using prms constructed time epochs becoming infectious andor exposed developed <NUMBER> approach developed paper multipatch sir seir models track locations individual event epoch paper contributes limited literature stochastic epidemic models general infectious periods see overview chapter <NUMBER> <NUMBER> common approaches study nonmarkovian epidemic models lln clt final sizes epidemic see also recent method using piecewise markov deterministic processes <NUMBER> <NUMBER> sir model also refer reinert <NUMBER> proves flln empirical measure sir epidemic dynamics using steins method <NUMBER> flln fclt proved epidemic dynamics classical models sir sis seir sirs prm representations dynamics plays fundamental role proofs although volterra integral equations used describe proportion infectious population sis sir seir model without proving flln see <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> volterra integral equations proposed multipatch epidemic models general infectious andor exposing periods work shows flln fclt nonmarkovian multipatch models identify stochastic multidimensional volterra integral equations limits also worth mentioning multitype epidemic models population splits multiple groups individuals group may infect group addition migration different local infection assumption model proportionate mixing taking account control measures like social distance lockdowns also incorporated see chapters <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> different model since infection local setup individuals stages may migrate one group another also highlight fodor et al <NUMBER> argue volterra integral equations effective ode models study covid<NUMBER> pandemic particular show ode models significantly underestimate initial basic reproduction number r <NUMBER> integral equations results accurate epidemic dynamics sharp changes r <NUMBER> due lockdown measures integral equations also used estimate state covid<NUMBER> epidemic <NUMBER> <NUMBER> notation throughout paper n denotes set natural numbers r k r k denotes space kdimensional vectors real nonnegative coordinates rr k <NUMBER> x ∈ r denote x ∧ minx x ∨ maxx let d<NUMBER> r denote space rvalued càdlàg functions defined <NUMBER> throughout paper convergence means convergence skorohod j <NUMBER> topology see chapter <NUMBER> <NUMBER> also k stands kfold product equipped product topology let c subset consisting continuous functions let c <NUMBER> consist differentiable functions whose derivative continuous function x ∈ use x sup t∈<NUMBER>t xt two functions x ∈ use x • yt xyt denote composition random variables processes defined common complete probability space ω f p notation ⇒ means convergence distribution use <NUMBER> · indicator function use smallo notation realvalued functions f nonzero g f x ogx lim sup x→∞ f xgx <NUMBER> <NUMBER> multipatch sir model general infectious periods <NUMBER> model description consider multipatch epidemic model individuals patch experience susceptibleinfectiousrecovered sir process patches may refer populations different locations example densely populated city less populated rural area individuals patch infected locally may migratetravel one susceptible infectious recovered states rate infection different patches differences density population use public transportations law infectious period illness let n total population size l number patches <NUMBER> l let n n r n denote numbers individuals patch susceptible infectious recovered time respectively balance equation assume n <NUMBER> <NUMBER> l i<NUMBER> n <NUMBER> <NUMBER> r n <NUMBER> <NUMBER> <NUMBER> l let λ infection rate patch <NUMBER> l define following processes <NUMBER> l let n cumulative counting process individuals become infectious <NUMBER> give representation process n via standard poisson random measure q iinf equivalently write p ai unitrate poisson process independent <NUMBER> l let susceptible resp infectious resp removed individuals migrate patch patch j rate ν sij resp rate ν iij resp rate ν rij let xt denote location ie patch time ≥ <NUMBER> infected individual xt markov process alternates states <NUMBER> l define p ij pxr jxr j <NUMBER> l r ≥ <NUMBER> probabilities computed see example corollary <NUMBER> chapter <NUMBER> <NUMBER> example <NUMBER> suppose two patches state <NUMBER> resp <NUMBER> stays duration time follows exponential distribution parameter ν resp aν define p <NUMBER> pxr <NUMBER>xr <NUMBER> p <NUMBER> pxr <NUMBER>xr <NUMBER> p <NUMBER> pxr <NUMBER>xr <NUMBER> p <NUMBER> pxr <NUMBER>xr <NUMBER> standard computation based upon eg corollary <NUMBER> chapter <NUMBER> <NUMBER> yields following explicit formulas use x <NUMBER>k x k indicate associated process individual k patch initially newly infected ones respectively note mutually independent law described process xt also note processes x k start time becoming infected τ n ki processes x <NUMBER>k start time <NUMBER> provide representation epidemic evolution dynamics p siℓ p riℓ ℓ <NUMBER> l unitrate poisson processes mutually independent also independent p ai first term n represents number initially infected individuals patch ℓ <NUMBER> l remain infected patch time second term represents number newly infected individuals patch ℓ <NUMBER> l remain infected patch time first term r n represents number initially infected individuals patch ℓ <NUMBER> l recovered time patch time recovery second term represents number newly infected individuals patch ℓ <NUMBER> l recovered time patch time recovery define prm q ℓinf ds du dv dθ r <NUMBER> × <NUMBER> l sum dirac masses points τ n jℓ u n jℓ η ji x j ℓ η jℓ mean measure ds infection occurs time τ n jℓ case u n jℓ ≤ λ ℓ φ n ℓ τ n jℓ write ℓ ℓ ′ <NUMBER> l denote corresponding compensated prm q ℓinf ds du dv dθ define prmq ℓinf ds du dθ r <NUMBER> × <NUMBER> l mean measure ds du µ ℓ dθ µ ℓ ℓ ′ p ℓℓ ′ ℓ ℓ ′ <NUMBER> l represent flln process z n letz n n −<NUMBER> z n fluidscaled process make following assumptions cdf f finite countable number positive numbers corresponding ≤ <NUMBER> <NUMBER> <NUMBER> · · · k f <NUMBER> hölder continuous exponent <NUMBER> <NUMBER> θ θ <NUMBER> f <NUMBER> δ − f <NUMBER> ≤ cδ <NUMBER>θ c <NUMBER> addition assume f <NUMBER> continuous <NUMBER> probability locally uniformly <NUMBER> tī tr <NUMBER> l ∈ c <NUMBER>l unique solution following set deterministic integral equations  <NUMBER> remark <NUMBER> let infectious periods exponentially distributed rates γ η jℓ ∼ expγ <NUMBER> l j ∈ n due memoryless property remaining infectious periods initially infected individuals exponential distribution well known epidemic evolution dynamics described following set odes checked set integral equations theorem <NUMBER> reduces odes special case fclt process z n letẑ n √ n z n −z diffusionscaled process wherē z n fluidscaled process andz limit limits unique solution following set stochastic volterra integral equations driven gaussian processes <NUMBER> b ai b sij b iij b rij mutually independent standard brownian motions deterministic functionss ī r limits theorem <NUMBER> processesî <NUMBER> ij andî ij continuous gaussian processes mean zero covariance functions otherwise additionî <NUMBER> ij andî ij independent also independent brownian terms remark <NUMBER> discussed remark <NUMBER> infectious periods deterministic equal stochastic integral equations become linear stochastic differential equations delay particular term remark <NUMBER> analysis easily extended multipatch sis model population patch susceptible infectious groups infectious individuals recover become susceptible immediately epidemic evolution dynamics described thus flln obtain limitī <NUMBER> multipatch sir model limits similarly fclt obtain limitî <NUMBER> multipatch sir model limitŝ <NUMBER> multipatch seir model general exposing infectious periods <NUMBER> model description multipatch seir model individuals patch experience susceptibleexposing latentinfectiousrecovered seir process may migrate one patch another either four stages sir model infection process local rates infection vary among patches exposing recovery rates among different patches let n total population size l number patches patch let n e n n r n count numbers individuals susceptible exposed latent infectious recovered patch time respectively balance equation cumulative counting process individuals become infectious <NUMBER> represented <NUMBER> <NUMBER> sir model infection rate λ e n <NUMBER> initially exposed individuals experience exposing infectious periods recovery let ζ <NUMBER> ki k <NUMBER> e n remaining exposinglatent periods initially exposed individuals patch exposing period let η −ki k <NUMBER> e n infectious times n <NUMBER> initially infected individuals experience remaining infectious period recovery notation η <NUMBER> ki sir model n newly infected individuals experience exposing infectious periods let ζ ji j ∈ n η ji j ∈ n associated exposing infectious periods assume ζ <NUMBER> ki ζ ji η <NUMBER> ki η ji iid sequences random variables cdfs g <NUMBER> g f <NUMBER> f respectively also mutually independent note η ji defined j ∈ z <NUMBER> ≤ ≤ l j <NUMBER> code infectious periods initially exposed individuals j <NUMBER> code infectious periods newly exposed individuals let g c <NUMBER> <NUMBER> − g <NUMBER> g c <NUMBER> − g f c <NUMBER> <NUMBER> − f <NUMBER> f c <NUMBER> − f individuals may migrate patch j four epidemic stages rates ν sij ν eij ν iij ν rij susceptible exposing infectious recovered ones respectively times migration stages exponentially distributed let markov process denoting location individual k exposed patch time let q ij py r jy r j <NUMBER> l r <NUMBER> use <NUMBER>k j initially newly exposed individuals patch note distribution processes used individual moves exposing stage infectious stage use markov processes x <NUMBER>k x j migration infectious patients sir model multipatch seir epidemic evolution dynamics described follows  p sij p rij j <NUMBER> l unitrate poisson processes mutually independent also independent p ai clear dynamics e n n sir model remark expression n seir model first term counts number initially exposed individuals patches remain exposed patch time second term counts numbers initially exposed individuals patches become infectious patch time tracking purposes location epochs becoming infection recorded since use η kℓ x <NUMBER>k ℓ different patches ℓ also note use markov process x <NUMBER>k ℓ indicate initially exposed individuals third term counts number newly exposed individuals patches become infectious patch time also track patch individual becomes infectious note key components dynamics represented via prms infection process n ℓ representation <NUMBER> using prm q ℓinf define prmq ℓinf ds du dv dϑ r <NUMBER> × <NUMBER> l sum dirac masses points write ℓ ℓ ′ <NUMBER> l l sum dirac masses points z <NUMBER> µ x ℓ z ℓ ′ p ℓℓ ′ z infection occurs time τ n jℓ write ℓ <NUMBER> l denote corresponding compensated prm q ℓinf ds du dy dϑ dz dθ q ℓinf ds du dy dϑ assumption <NUMBER> cdfs g f satisfy conditions f assumption <NUMBER> addition assume g <NUMBER> f <NUMBER> continuous unique solution following set deterministic integral equations  <NUMBER> remark <NUMBER> suppose exposing infectious periods deterministic taking values e <NUMBER> <NUMBER> also assume remaining exposing infectious periods initially exposed infectious uniformly distributed <NUMBER> e <NUMBER> respectively fluid equations easy see obtain set odes delay taking derivative limits unique solution following set stochastic volterra integral equations driven gaussian processes hereφ continuous gaussian processes independent brownian motions mean zero covariance functions independent limits theorem <NUMBER> become stochastic differential equations linear drifts delay particular remark <NUMBER> analysis multipatch seir model easily extended multipatch sirs model patch population grouped susceptible infectious recovered individuals individuals become susceptible experiencing recovery period model infectious recovered processes n r n correspond exposed infectious processes e n n seir model description epidemic dynamics need change dynamics n <NUMBER> adding individuals become susceptible recovery ie first three terms r n <NUMBER> similar susceptible process n <NUMBER> sis model straightforward write limit processes flln fclt processes n n r n corresponding n e n n seir model section prove theorem <NUMBER> first provide representation processes <NUMBER> l predictable quadratic variation stochastically bounded lemma <NUMBER> <NUMBER> thusm proof rewrite processess n processesm n sℓi square integrable martingales respect filtration f n ≥ <NUMBER> defined predictable quadratic variation thus processes assumption <NUMBER> lemma <NUMBER> lemma <NUMBER> j ≡ <NUMBER> map υ applying continuous mapping theorem conclude convergence n <NUMBER> n l next study processes n give following representation lemma <NUMBER> p iij j <NUMBER> l unitrate poisson processes mutually independent also independent p ai p sij p rij proof representation n observe ℓ number initially infected individuals patch patch ℓ time ∧ η <NUMBER> kℓ k <NUMBER> n ℓ <NUMBER>we also observe ℓ thus using identities obtain expression <NUMBER> convenience let ℓ <NUMBER> l ≥ <NUMBER> next treat processes following lemmas proof first focus onī n<NUMBER> <NUMBER> note since η <NUMBER> k<NUMBER> x <NUMBER>k <NUMBER> independent expectation taken condition x <NUMBER>k <NUMBER> <NUMBER> <NUMBER> note pairs η <NUMBER> k<NUMBER> x <NUMBER>k <NUMBER> · independent k distributions thus lln iid variables obtain ≥ <NUMBER> note convergence holds fact probability since limit deterministic extended convergence finite dimensional distributions order establish tightness show lim sup fact implies tightness follows corollary page <NUMBER> <NUMBER> independence pairs convergence processesī n<NUMBER> ℓi follows similarly remains prove joint convergence since initial variables patches migration processes independent suffices prove joint convergence ī n<NUMBER> ℓ<NUMBER> ī n<NUMBER> ℓl different ℓs separately hand joint convergence ī n<NUMBER> ℓ<NUMBER> ī n<NUMBER> ℓl straightforward since count exclusive partition individuals associated pairs η <NUMBER> kℓ x <NUMBER>k ℓ · independent completes proof forī n ℓi first consider conditional expectations lemma <NUMBER> limit ā <NUMBER> ā l convergent subsequence proof first focus onȋ n <NUMBER> observe writȇ dg <NUMBER> − u differential map u → g <NUMBER> − u thus continuous mapping theorem obtainȋ n <NUMBER> ⇒ī <NUMBER> n → ∞ wherē joint convergence shown mapping x <NUMBER> x k ∈ l l <NUMBER> continuous skorohod j <NUMBER> topology apply continuous mapping theorem prove joint convergence processes completes proof show processesī n ℓi andȋ n ℓi asymptotically negligible ℓ <NUMBER> l proof focus case ℓ <NUMBER> havē recall g <NUMBER> <NUMBER> clear j e χ n j<NUMBER> tτ n j<NUMBER> <NUMBER> independence pairs η j<NUMBER> x j <NUMBER> · η j ′ <NUMBER> implies ǫ <NUMBER> observe three terms right hand side nondecreasing u thus obtain p sup using prm q <NUMBER>inf ds du dv dθ compensated prm q <NUMBER>inf ds du dv dθ first term converges zero n → ∞ second term satisfies follows assumption <NUMBER> shown lemma <NUMBER> <NUMBER> second term right hand side <NUMBER> treated similarly second term right third term using <NUMBER> <NUMBER> first term converges zero n → ∞ second term bounded <NUMBER>λ <NUMBER> <NUMBER> δ <NUMBER> <NUMBER> thus combining obtain result follows next lemma proof lemma direct consequence inequality <NUMBER> <NUMBER> repeat readers convenience consequence lemmas <NUMBER> <NUMBER> obtain following ready prove convergence ī n <NUMBER> ī n l withī <NUMBER> ℓi andī ℓi defined <NUMBER> <NUMBER> respectively proof representations n <NUMBER> havē  withī <NUMBER> ij andī ij defined <NUMBER> <NUMBER> respectively proof represent processesr n bȳ <NUMBER> ∆ n iℓi given <NUMBER> ℓ thus lemmas <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> apply continuous mapping theorem mappingυ conclude convergence r n <NUMBER> r n l argument since joint convergence lemmas <NUMBER> <NUMBER> conclude joint convergence n ī n r n <NUMBER> l addition mapping x z ∈ <NUMBER> → xy xyz ∈ lipschitz continuous skorohod topology thus obtain convergenceφ thus therefore limits satisfy integral equations given theorem <NUMBER> finally uniqueness solutions set integral equations theorem <NUMBER> follows lipschitz continuity mapping x z ∈ <NUMBER> → xy xyz ∈ applying gronwalls inequality completes proof theorem <NUMBER> section prove theorem <NUMBER> first provide following representations diffusionscaled processes processâ n decomposed  processesŝ n havê processesî n havê ℓ <NUMBER> l processesr n havê ℓ <NUMBER> l ℓ establish convergence key components representations proof follows standard martingale convergence argument see eg <NUMBER> main steps include proving quadratic variations converge involving convergence fluidscaled processes applying fclt martingales omit details brevity limits given theorem <NUMBER> proof first focus convergence ofî n<NUMBER> <NUMBER> recall observe pairs η k<NUMBER> x <NUMBER>k <NUMBER> · η k ′ <NUMBER> x <NUMBER>k ′ <NUMBER> · independent law thus proof follows similar approach empirical processes see eg theorem <NUMBER> <NUMBER> differences due process x <NUMBER>k <NUMBER> highlight apply theorem <NUMBER> <NUMBER> <NUMBER> ϑ <NUMBER> similarly also shown <NUMBER> n → ∞ thus convergence finite dimensional distributions <NUMBER> <NUMBER> · · · k ϑ ℓ ℓ <NUMBER> k write k ℓ<NUMBER> iϑ ℓî n<NUMBER> <NUMBER> ℓ using incrementsî n<NUMBER> <NUMBER> ℓ −î n<NUMBER> <NUMBER> ℓ−<NUMBER> covariances equal zero disjoint intervals next prove tightness employ theorem<NUMBER> verify condition <NUMBER> <NUMBER> show r ≤ ≤ n ≥ <NUMBER> constant c φt <NUMBER> p <NUMBER> udf <NUMBER> u nonnegative nondecreasing continuous function recall f <NUMBER> continuous enforce condition <NUMBER> <NUMBER> according theorem<NUMBER> implies tightness let direct calculations following similar steps proof <NUMBER> <NUMBER> obtain thus shown convergence processî n<NUMBER> <NUMBER> ⇒î <NUMBER> <NUMBER> joint convergence î n<NUMBER> ℓi ℓ <NUMBER> l since variables processes associated patch ℓ patch ℓ ′ independent suffices show joint convergences î n<NUMBER> ℓi <NUMBER> l different ℓs separately joint convergence î n<NUMBER> ℓi <NUMBER> l obtain tightness process established suffices show joint convergence finite dimensional distributions take ℓ <NUMBER> <NUMBER> <NUMBER> example <NUMBER> <NUMBER> <NUMBER> ϑ <NUMBER> ϑ <NUMBER> <NUMBER> calculation extended computation final dimensional distributions î n<NUMBER> <NUMBER> î n<NUMBER> <NUMBER> therefore conclude joint convergence finally prove limit processes continuous f <NUMBER> continuous since gaussian suffices show continuity quadratic mean <NUMBER> <NUMBER> lim s→t e î n<NUMBER> ℓi −î n<NUMBER> ℓi <NUMBER> <NUMBER> easily checked continuity covariance functions therefore proof lemma complete limits given theorem <NUMBER> proof recall prm q iinf ds du dv dθ compensated prm q iinf ds du dv dθ representation <NUMBER> write ℓ <NUMBER> l prove convergence define auxiliary processes φ ℓ given <NUMBER> deterministic function shown processesĩ n ℓi squareintegrable martingales respect filtration f n ≥ <NUMBER> defined l ∨ σ η jℓ x j ℓ ℓ <NUMBER> l j <NUMBER> n ℓ <NUMBER> ≤ ≤ quadratic variations addition cross quadratic variations ′ ĩ n ℓi ĩ n ℓi ′ <NUMBER> ℓ ℓ ′ ′ ĩ n ℓi ĩ n ℓ ′ ′ <NUMBER> thus fclt martingales see eg <NUMBER> obtain ĩ n ℓi ℓ <NUMBER> l ⇒ î ℓi ℓ <NUMBER> l l <NUMBER> n → ∞ ℓ <NUMBER> l focus processî n <NUMBER> clear convergence holds theorem <NUMBER> dominated convergence theorem next show sequence î n <NUMBER> −ĩ n <NUMBER> n tight observe decompose sign induce process nondecreasing also clear tightness processes implied tightness following processes since two processes nondecreasing suffices show see corollary page <NUMBER> <NUMBER> lemma <NUMBER> ǫ <NUMBER> j <NUMBER> <NUMBER> ≥ <NUMBER> <NUMBER> l representations ofŝ n tî n andr n <NUMBER> respectively following hold exists constant c <NUMBER> n thus taking squares processesŝ n tî n andr n <NUMBER> apply cauchyschwartz inequality gronwalls inequality conclude consider two cases f assumption <NUMBER> case f f <NUMBER> thus cases obtain <NUMBER> process ξ n <NUMBER> argument two terms follow second fourth terms ξ n <NUMBER> completes proof completing proof theorem <NUMBER> note processes associated initial variables lemma <NUMBER> associated newly infected individuals lemma <NUMBER> associated migrations lemma <NUMBER> mutually independent thus processes converge jointly given convergence initial variables assumption <NUMBER> convergence results lemmas <NUMBER> <NUMBER> <NUMBER> apply continuous mapping theorem map ̥ defined lemma <NUMBER> l proof complete ✷ section prove theorem <NUMBER> note seir model tightness result lemma <NUMBER> ofā n convergence ofs n lemma <NUMBER> hold argument analysis processē n follows processī n sir model omit proof give following representation ofē n lemma <NUMBER> similarly obtain following representations process n focus convergence n ℓ <NUMBER> l let first treat components associated initial quantities implies lln iid variables ≥ <NUMBER> n → ∞ convergence finite dimensional distribution straightforward extension tightness use argument lemma <NUMBER> start ī n<NUMBER> newt note two terms right hand side increasing n → ∞ two terms limit vanishes δ → <NUMBER> thus ǫ <NUMBER> thus conclude thatī n<NUMBER> ℓi ⇒ī <NUMBER> ℓi n → ∞ since g <NUMBER> continuous verify continuity covariance function thus continuity limit processesī <NUMBER> ℓi straightforward completes proof proofs lemmas <NUMBER> <NUMBER> sir model obtain convergence processes e n ℓi n ℓi ℓ <NUMBER> l ≥ <NUMBER> h ℓi defined <NUMBER> proof proof convergence ofē n ℓi follows exact argument lemmas <NUMBER> <NUMBER> focus convergence ofī n ℓi main steps similar highlight differences define auxiliary processes ℓ <NUMBER> l first show ȋ n ℓi ℓ <NUMBER> l ⇒ ī ℓi ℓ <NUMBER> l l <NUMBER> n → ∞ <NUMBER> observe recall h ℓi <NUMBER> writȇ apply continuous mapping theorem proof lemma <NUMBER> obtain convergencȇ n ℓi ⇒ī n ℓi n → ∞ joint convergence <NUMBER> using mapping <NUMBER> next show ǫ <NUMBER> ℓ <NUMBER> l p sup follows similar steps proof lemma <NUMBER> highlight main differences  clear e χ n jℓi tτ n jℓ <NUMBER> e χ n jℓi <NUMBER> τ n jℓ h ℓi t−τ n jℓ <NUMBER>−h ℓi t−τ n jℓ h ℓi defined <NUMBER> moreover e χ n jℓi tχ n j ′ ℓi tf n aℓ <NUMBER> due independence pairs ζ jℓ η jℓ ′ j ℓ · x j ℓ ′ · ζ j ′ ℓ η j ′ ℓ ′ j ′ ℓ · x j ′ ℓ ′ · thus obtain observe five terms right hand side increasing thus p sup last term treated way proof lemma <NUMBER> sir model first two terms use prm representation <NUMBER> clear first term converges zero n → ∞ second term satisfies convergence follows argument proof <NUMBER> <NUMBER> assumption <NUMBER> similarly second term right hand side <NUMBER> clear first term converges zero n → ∞ second term satisfies convergence follows similar argument proof <NUMBER> <NUMBER> assumption <NUMBER> third fourth terms right hand side <NUMBER> two terms treated similarly thus shown apply lemma <NUMBER> conclude tightness joint convergence processes ē n ℓi ℓ <NUMBER> l ī n ℓi ℓ <NUMBER> l suffices prove joint convergence processes ȇ n ℓi ℓ <NUMBER> l ȋ n ℓi ℓ <NUMBER> l whereȋ n ℓit given <NUMBER> <NUMBER> easy prove mapping x <NUMBER> continuous skorohod j <NUMBER> topology thus applying continuous mapping theorem obtain convergence ȇ n ℓi ȋ n ℓi ℓ <NUMBER> l ⇒ ē ℓi tī ℓi ℓ <NUMBER> l <NUMBER>l <NUMBER> n → ∞ asymptotic equivalence betweenē n ℓi andȇ n ℓi betweenī n ℓi andȋ n ℓi results joint convergence <NUMBER> completes proof ready prove convergence ī n <NUMBER> ī n l withē <NUMBER> ℓi ī <NUMBER> ℓi andī <NUMBER> ℓi given <NUMBER> <NUMBER> <NUMBER> lemma <NUMBER> withē ℓi andī ℓi defined <NUMBER> <NUMBER> lemma <NUMBER> respectively proof representations n <NUMBER> havē <NUMBER> andm n iℓi given <NUMBER> convergence <NUMBER> holds recall representations e n ℓi andȋ n ℓi integrals respect toā n ℓ <NUMBER> <NUMBER> respectively thus lemmas <NUMBER> <NUMBER> <NUMBER> equation <NUMBER> lemma <NUMBER> apply continuous mapping theorem mapping υ conclude convergence ī n <NUMBER> ī n l next prove convergence r n <NUMBER> r n l similar <NUMBER> obtain following representations process r n withī <NUMBER> ℓi ī <NUMBER> ℓi andī ℓi given <NUMBER> <NUMBER> <NUMBER> respectively proof represent processesr n bȳ <NUMBER> ∆ n iℓi given <NUMBER> andm n rℓi given <NUMBER> convergence <NUMBER> holds recall representation ofȋ n ℓi integral respect toā n ℓ <NUMBER> thus lemmas <NUMBER> <NUMBER> <NUMBER> equation <NUMBER> lemma <NUMBER> apply continuous mapping theorem mappingυ conclude convergence r n <NUMBER> r n l rest proof follows argument sir model completes proof theorem <NUMBER> section prove theorem <NUMBER> first give following representations diffusionscaled processes processâ n decomposition <NUMBER> witĥ representation processŝ n <NUMBER> processê n representation <NUMBER> using definitions e n<NUMBER> ℓi e n ℓi <NUMBER> obtain ℓ <NUMBER> l  processî n obtain <NUMBER> whereê n<NUMBER> ℓi andê n ℓi defined <NUMBER> <NUMBER> respectively andm n iℓi defined <NUMBER> sir model processr n havê wherem n rℓi defined <NUMBER> sir model convergence processesê n follows argument ofî n sir model focus convergence ofî n seir model given <NUMBER> first lemma <NUMBER> joint convergence following martingales whose proof omitted prove convergence components associated initially exposed infected individuals apply theorem <NUMBER> <NUMBER> direct calculations obtain ≥ <NUMBER> ′ ≥ <NUMBER> establish convergence finite dimensional distributions ofî n<NUMBER> ℓi also obtain ′ ≤ ≤ ′′ n ≥ <NUMBER> ℓ <NUMBER> l also follows similarly lemma <NUMBER> finally continuity limit processes suffices show continuity quadratic mean <NUMBER> follows continuity covariance functions next prove convergence components associated newly exposed individuals limits given theorem <NUMBER> proof convergence ê n ℓi î n ℓi ℓ <NUMBER> l follows similar argument î n ℓi î n ℓi ℓ <NUMBER> l sir model lemma <NUMBER> uses prmq ℓinf ds du dv dϑ representation <NUMBER> particular writê define auxiliary process φ ℓ given <NUMBER> proved convergence ofê n ℓi also havê e n ℓi −ẽ n ℓi ⇒ <NUMBER> n → ∞ ℓ <NUMBER> l focus convergence ofî n ℓi recall prm q ℓinf ds du dy dϑ dz dθ representation <NUMBER> writê define auxiliary process φ ℓ given <NUMBER> since φ ℓ deterministic function thenĩ n ℓi squareintegrable martingale respect filtration f n ≥ <NUMBER> defined quadratic variation h ℓi defined <NUMBER> cross quadratic variations processesĩ n ℓi n ℓ ′ ′ satisfy ′ ĩ n ℓi ĩ n ℓi ′ <NUMBER> ℓ ′ ℓ ′ <NUMBER> l ĩ n ℓi ĩ n ℓ ′ ′ <NUMBER> thus fclt martingales see eg <NUMBER> obtain ĩ n ℓi ℓ <NUMBER> l ⇒ î ℓi ℓ <NUMBER> l l <NUMBER> n → ∞ remains show thatî n ℓi −ĩ n ℓi ⇒ <NUMBER> n → ∞ ℓ <NUMBER> l clear convergence holds theorem <NUMBER> dominated convergence theorem next show sequence î n ℓi −ĩ n ℓi tight havê proof lemma <NUMBER> suffices prove tightness following processes monotone property two processes show ǫ <NUMBER> κ <NUMBER> <NUMBER> similar derivation <NUMBER> lemma <NUMBER> obtain <NUMBER> first third terms converge zero n → ∞ convergence e φ n ℓ − φ ℓ → <NUMBER> applying dominated convergence theorem similar argument lemma <NUMBER> also obtain lim sup n sup applying cauchyschwartz inequality gronwalls inequality obtain <NUMBER> together bound forê n thus claim follows last term <NUMBER> bound sum two terms lipschitz continuity condition case g <NUMBER> f <NUMBER> assumption <NUMBER> say lipschitz coefficient θ ′ θ constants c ′ c respectively obtain bounds right hand side suppose functions g f discrete say gt g <NUMBER> k b k <NUMBER> t≥s k finite countable number b k corresponding k k b k ≤ <NUMBER> <NUMBER> <NUMBER> · · · k f f <NUMBER> <NUMBER>t ≥ finite countable number positive numbers corresponding ≤ <NUMBER> <NUMBER> <NUMBER> · · · k first term right hand side <NUMBER> equal similarly second term right hand side <NUMBER> bounded thus cases obtain lim δ→<NUMBER> lim sup cases g resp f discrete f resp g lipschitz continuous treated similarly without difficulty thus <NUMBER> holds ξ n <NUMBER> consider next  first term bounded <NUMBER>λ <NUMBER> ℓ δ <NUMBER> sup s∈<NUMBER>t e φ n ℓ <NUMBER> second term treated <NUMBER> completes proof <NUMBER> thus convergence î n ℓi ℓ <NUMBER> l ⇒ î ℓi ℓ <NUMBER> l l <NUMBER> n → ∞ remains prove joint convergence ê n ℓi î n ℓi suffices prove joint convergence ẽ n ℓi ĩ n ℓi recall representations <NUMBER> <NUMBER> using prmš q ℓinf ds du dv dϑ q ℓinf ds du dy dϑ dz dθ respectively definitions two prms regardq ℓinf projections q ℓinf r <NUMBER> × <NUMBER> l × r × <NUMBER> l onto r <NUMBER> × <NUMBER> l thus straighrforward prove convergence finitedimensional distributions ẽ n ℓi ĩ n ℓi computing extensions multiple time points since tightness ẽ n ℓi ĩ n ℓi follows individual process conclude joint convergence l <NUMBER> completes proof completing proof theorem <NUMBER> observe correspondence processeŝ φ n <NUMBER> andŝ n ê n î n r n <NUMBER> <NUMBER> <NUMBER> <NUMBER> mapping̥ defined lemma <NUMBER> shown convergence components associated initial variables newly exposed individuals migration processes lemmas <NUMBER> <NUMBER> <NUMBER> mutually independent thus given convergence initial variables assumption <NUMBER> apply continuous mapping theorem map̥ l conclude joint convergence processes ŝ n ê n î n r n ✷ section define several integral mappings prove continuity skorohod j <NUMBER> topology define mdimensional integral mapping υ <NUMBER> z <NUMBER> z ∈ <NUMBER>m → x <NUMBER> x ∈ j nondecreasing x x <NUMBER> z given constants ij b ij ∈ r fixed functions φ ij j <NUMBER> letυ mapping without terms integral respect extension mapping section <NUMBER> <NUMBER> whose proof easily extended mapping thus omit proof brevity lemma <NUMBER> given <NUMBER> z <NUMBER> z ∈ <NUMBER>m <NUMBER> nondecreasing ij b ij ∈ r φ ij ∈ j <NUMBER> x <NUMBER> <NUMBER> x <NUMBER> ∈ r exists unique solution x <NUMBER> x ∈ integral mapping υ <NUMBER> z <NUMBER> z ∈ c <NUMBER>m x <NUMBER> x ∈ c map υ continuous skorohod j <NUMBER> topology n <NUMBER> n z n <NUMBER> z n → <NUMBER> z <NUMBER> z <NUMBER>m x n <NUMBER> x n υy n <NUMBER> n z n <NUMBER> z n → x <NUMBER> x addition <NUMBER> z <NUMBER> z ∈ c <NUMBER>m x <NUMBER> x ∈ c convergence holds uniformly compacts conclusions hold mappingυ next define <NUMBER>mdimensional integral mapping ̥ given b c φ ψ ϕ ∈ constants α β γ <NUMBER> functions f ℓi ℓ <NUMBER> let x z solutions following set integral equations next lemma study existence uniqueness solution continuity property lemma <NUMBER> assume f ℓi ℓ <NUMBER> bounded continuous functions satisfying f ℓi <NUMBER> <NUMBER> let constants α β γ <NUMBER> functions φ ψ ϕ given exists unique solution x z <NUMBER> ∈ <NUMBER>m set integrable equations defining mapping ̥ mapping continuous skorohod j <NUMBER> topology n b n c n φ n ψ n ϕ n <NUMBER> → b c φ ψ ϕ <NUMBER> d<NUMBER> r <NUMBER>m n → ∞ x n <NUMBER> n <NUMBER> z n <NUMBER> <NUMBER> → x <NUMBER> <NUMBER> z <NUMBER> <NUMBER> x n n z n <NUMBER> → x z <NUMBER> d<NUMBER> r <NUMBER>m n → ∞ addition φ ψ ϕ continuous x z <NUMBER> ∈ c <NUMBER>m mapping ̥ continuous uniformly compact sets <NUMBER> proof existence uniqueness solutions apply schaudertychonoff fixed point theorem modify proofs theorems <NUMBER> <NUMBER> chapter ii <NUMBER> results shown volterra integral equations continuous functions prove continuity mapping skorohod j <NUMBER> topology note functions necessarily bounded given functions φ ψ ϕ ∈ let common continuity point exists increasing homeomorphisms λ n <NUMBER> λ n − e → <NUMBER> φ n −φ •λ n → <NUMBER> ψ n −ψ •λ n → <NUMBER> ϕ n −ϕ •λ n → <NUMBER> n −a •λ n → <NUMBER> b n −b •λ n → <NUMBER> c n − c • λ n → <NUMBER> n → ∞ et ≥ <NUMBER> also suffices consider homeomorphisms λ n absolutely continuous respect lebesgue measure <NUMBER> derivativesλ n satisfying λ n − <NUMBER> → <NUMBER> n → ∞ let c <NUMBER> constant sup ℓi sup t∈<NUMBER>t f ℓi ≤ c <NUMBER> brevity consider one functions <NUMBER> since others treated similarly n <NUMBER> − <NUMBER> λ n ≤ n <NUMBER> <NUMBER> − <NUMBER> <NUMBER> ψ n <NUMBER> − ψ <NUMBER> • λ n <NUMBER> n <NUMBER> sx n <NUMBER> b n <NUMBER> sy n <NUMBER> c n <NUMBER> sz n <NUMBER> sds − λ n <NUMBER> <NUMBER> sx <NUMBER> b <NUMBER> sy <NUMBER> c <NUMBER> sz <NUMBER> sds ℓ<NUMBER> <NUMBER> f ℓ<NUMBER> − sa n ℓ sx n ℓ b n ℓ sy n ℓ c n ℓ sz n ℓ sds − λ n <NUMBER> f ℓ<NUMBER> λ n − sa ℓ sx ℓ b ℓ sy ℓ c ℓ sz ℓ sds ℓ<NUMBER> <NUMBER> β ℓ<NUMBER> n ℓ − β <NUMBER>ℓ n <NUMBER> sds − λ n <NUMBER> β ℓ<NUMBER> ℓ − β <NUMBER>ℓ <NUMBER> sds change variables second integral boundedness functions x n <NUMBER> n <NUMBER> z n <NUMBER> <NUMBER> λ n b <NUMBER> λ n c <NUMBER> λ n third term right hand side <NUMBER> bounded λ n − <NUMBER> <NUMBER> <NUMBER> sx <NUMBER> b <NUMBER> sy <NUMBER> c <NUMBER> sz <NUMBER> sds <NUMBER> n <NUMBER> − <NUMBER> λ n sx n <NUMBER> b n <NUMBER> − b <NUMBER> λ n sy n <NUMBER> sc n <NUMBER> − c <NUMBER> λ n sz n <NUMBER> ds <NUMBER> <NUMBER> λ n sx <NUMBER> λ n − x <NUMBER> b <NUMBER> λ n sy <NUMBER> λ n − <NUMBER> c <NUMBER> λ n sz <NUMBER> λ n − z <NUMBER> ds ≤ λ n − <NUMBER> <NUMBER> <NUMBER> sx <NUMBER> b <NUMBER> sy <NUMBER> c <NUMBER> sz <NUMBER> sds c <NUMBER> n <NUMBER> − <NUMBER> • λ n b n <NUMBER> − b <NUMBER> • λ n c n <NUMBER> − c <NUMBER> • λ n <NUMBER> x <NUMBER> λ n − x <NUMBER> <NUMBER> λ n − <NUMBER> z <NUMBER> λ n − z <NUMBER> ds <NUMBER> constant c <NUMBER> first term converges zero since λ n − <NUMBER> → <NUMBER> next three terms converge zero convergences n <NUMBER> → <NUMBER> b n <NUMBER> → b <NUMBER> c n <NUMBER> → c <NUMBER> skorohod topology fourth term right hand side <NUMBER> change variables second integrals bound term ℓ <NUMBER> λ n − <NUMBER> <NUMBER> f <NUMBER> λ n − λ n sa <NUMBER> sx <NUMBER> b <NUMBER> sy <NUMBER> c <NUMBER> sz <NUMBER> sds <NUMBER> f <NUMBER> − − f <NUMBER> λ n − λ n n <NUMBER> sx n <NUMBER> b n <NUMBER> sy n <NUMBER> c n <NUMBER> sz n <NUMBER> ds <NUMBER> f <NUMBER> λ n − λ n n <NUMBER> sx n <NUMBER> b n <NUMBER> sy n <NUMBER> c n <NUMBER> sz n <NUMBER> − <NUMBER> λ n sx <NUMBER> λ n − b <NUMBER> λ n sy <NUMBER> λ n − c <NUMBER> λ n sz <NUMBER> λ n ds first two terms converge zero since λ n − <NUMBER> → <NUMBER> f <NUMBER> continuous respectively also functions bounded <NUMBER> third term similar second third terms <NUMBER> bounded c <NUMBER> c <NUMBER> n <NUMBER> − <NUMBER> • λ n b n <NUMBER> − b <NUMBER> • λ n c n <NUMBER> − c <NUMBER> • λ n <NUMBER> x <NUMBER> λ n − x <NUMBER> <NUMBER> λ n − <NUMBER> z <NUMBER> λ n − z <NUMBER> ds last term right hand side <NUMBER> change variables bound ℓcomponent λ n − <NUMBER> <NUMBER> β ℓ<NUMBER> ℓ λ n − β <NUMBER>ℓ <NUMBER> λ n ds β ℓ<NUMBER> <NUMBER> n ℓ − ℓ λ n sds β <NUMBER>ℓ <NUMBER> n <NUMBER> − <NUMBER> λ n ds thus continuity property skorohod j <NUMBER> topology holds applying gronwalls inequality set integral inequalities x z uniform continuity property compacts functions continuous straightforward completes proof finally define <NUMBER>mdimensional integral mapping̥ given b c φ ψ ϕ χ ∈ constants α β γ κ <NUMBER> functions f ℓi g ℓi ℓ <NUMBER> let x z w solutions following integral mapping first began drafting article wanted raise collective dissatisfaction live debate universities disappeared authors paper presented chaired series midlands policy network mhepn debates recently developed hosted education observatory university wolverhampton author also participated higher education institutional research heir conference held university wolverhampton september <NUMBER> theme measuring excellence higher education mhepn debates intended powerful placebased forum hear regional voices seem virtually silenced generic structure national policy frameworks focused measuring excellence publish thoughts necessity live facetoface debate regional universities unprecedented measures resist spread covid<NUMBER> mean virtual literally left whilst arguments share audible placebased debate remain highly relevant layer complexity unfolds us biological work pandemic intermingles technological communications social activities materially emotionally alter lives point time global economy heathcare worldwide reel pressures covid<NUMBER> moving even rapidly away facetoface meetings necessity yet simultaneously crisis reveals crucial role local communities play national global efforts fight spiralling pandemic therefore important time voice essential part regional universities play connecting global technological biological change local social projects citizens industry postdigital theory offers one entirely perfect room discussion route towards understanding also covid<NUMBER> sit apart global local challenges developing creative skills across populations contend automation change unemployment opportunity <NUMBER>th industrial revolution <NUMBER>ir peters et al <NUMBER> peoples lives fusions analogue digital technologies social practices interconnections noticed around example even airlines grounded worldwide unplanned global detox atmosphere purchasing stockpiling perhaps… even making hand… plastic bottles hand sanitiser ever fast seek communicate crucial information virtually also need aware may use little technology simply cannot afford whilst contactless forms payment automated checkouts prioritised time human forms social care never demand thus health social welfare sustainability concerns visibly mingling eyes economic technological ones situation concerns universities many levels least crosses disciplinary boundaries messy postdigital connections many people lead lives simultaneously offline online material virtual omitted national excellence frameworks alongside deeply contextual differences regional universities mind firstly discuss problems attempting capture rich work academia generic static national frameworks set regional universities developed akin beginning research rather unethically stating findings actually approaching participants instead adopting grounded bottomup approach using variety methods make audible regional voices expressing really done universities avoiding assumptions dynamically informing policy perhaps start new uncertain decade time take triple excellence frameworks ref research excellence framework tef teaching excellence student outcomes framework emerging kef knowledge exchange framework departure point rather fixed agenda even write deadline ref suspended buying us time reflect immediate fundamental change amid pandemic perhaps also good time thank exercises contribution revealing many issues national largely quantitative rational interpretation excellence set universities might proceed richer regionally aware agenda excellent practices set universities one really reflects responds contextual locational diversity english policy relatively territorially agnostic many years dislocation place relegation civic interests words commission university policy remains almost wholly national feels precisely wrong approach todays politics downplays institutional history purpose worse betrays lack interest happens people places moment time feels like huge risk westwood <NUMBER> singular generic concept excellence articulated policy played part furthering territorially agnostic policy discourse universities unfortunately somewhat irrationally also written silenced people actually positioned participate developing plural excellent practices teaching research knowledge exchange community hayes <NUMBER>a hayes <NUMBER> therefore secondly point rather ironic contrast national political system universities active debate takes place daily uk parliament yet legislation policy delivering generic excellence frameworks measuring effectively shuts forms exchanges within regional educational institutions whilst much attention focused towards diversity inclusivity national policy level seems considerably less attention placed plays differently institutions locations universities immersed different regional contexts local economies historical backgrounds interlinked communities schools industry local dialects culture demographics deprivation affluence places surround competing simply occupy similar national space risks silencing diverse voices overlooking varying needs talents opportunities region even write note amid escalating covid<NUMBER> pandemic uk government committing distributing researchrelated funding fairly across uk pells inge <NUMBER> yet days since budget announcement chancellor rishi sunak plan invest rd cuttingedge technologies provide support people every nation region uk gain skills need economy evolves governments pledge level opportunity share prosperity across uk also questioned pells inge <NUMBER> graeme reid chair science research policy university college london expressed concern always told cheque post bafflement budget got interesting clearly wellthoughtthrough content place agenda theyve managed display progress whatsoever shared prosperity fund pells inge <NUMBER> announcements unfold postdigital perspective recognises whilst scientific medical knowledge understandably key steps taken also concern humantechnologicalmaterialsocialglobalregional aspects advice enacted across populations future therefore thirdly explain voices believe need audible placebased debate institutions via initiatives like midlands policy network mhepn provide insights balance data evidence dialogue expertise drawn regions needed together suitable investment move beyond empty national excellence frameworks alone implications universities communities individuals policymakers live oppositional argument one way dynamically raise voices regional univerisites otherwise suppressed datadriven nationally focused measures excellence whilst unusual media companies broadcast political debates question time bbc <NUMBER> regional locations concern live events appear starkly absent educational institutions thrived easily changed current circumstances national lockdown altered ways people live however key principles still upheld across online technologies indeed article though voices live heard group participants meeting room still argue would regional context dialogue presented discuss role collective writing debate…to debate lastly certainly least invite others come forward host events mhern future safe also contribute ideas voices extend experimental format developed last year though may currently safe crowd room share noisy friendly arguments enjoyed last year debate still gather opinions together act collective writing long ago <NUMBER> readings pointed today departments university urged strive excellence since general applicability notion direct relation emptiness readings <NUMBER> <NUMBER> fifteen years molesworth et al <NUMBER> amongst many authors since critiqued neoliberal policies discourse marketisation higher education suggested development mission statements attempt mark distinctive space university sees almost universities attempting occupy similar spaces excellence result molesworth et al <NUMBER> <NUMBER> uk set largely datadriven national excellence frameworks tend uphold neoliberal economic values structure society education transmitted across institutions via rational policy logic assumes generic excellent practices automatically applied across different contexts little effort frameworks effectively move university mission statements even closer towards competing similar space rather diversity place endeavour respond generic topic excellence leaves institutions simply repeating dominant patterns rationalisation wider society like noted george ritzer mcdonaldisation thesis also replicated augmented online ritzer et al <NUMBER> yet generic approach brings troubling opportunity cost failing address regional inequalities particularly policymakers discursive tropesfrom needs dynamic knowledge economies benefits excellencedistract distributional conflicts power dynamics sector schulzecleven et al <NUMBER> <NUMBER> peculiar form reason configures aspects existence economic terms brown <NUMBER> <NUMBER> simply reinforces persistent patterns generic rationalisation mcdonaldisation universities hayes <NUMBER> couldry argues neoliberal rationality reinforced explicit discourse also multiple ways discourse workings get embedded daily life social organization couldry <NUMBER> <NUMBER> neoliberalism crowds ways organising labour becomes institutionalised culture thus shaping organisation space certain types spaces become prioritised whilst others space critical debate even staff common room…perish thought fall use unfortunately human voices shared spaces existed simply stop heard hayes <NUMBER>a <NUMBER> reinforced linguistic tone structure policy discourse shape mcpolicy gives impression universities consumer experience hayes <NUMBER>b hayes jandrić <NUMBER> plays crucial part universities need play sites connectivity linking requirements industry technology market forces demands citizenship delanty <NUMBER> also effectively removes authenticity place region jopling johnson <NUMBER> yet precisely civic focus might help rebuild trust universities well restoring local growth tackling deep regional inequality westwood <NUMBER> key concerns realities underinvestment regions well nationally focused assumptions revealed responses covid<NUMBER> <NUMBER>th industrial revolution connor et al <NUMBER> time policy media rhetoric drown diverse regional voices express sense personal investment belonging leads civic engagement creative enterprise need draw upon wider society dangerous culture education developed towards therapy rather autonomous thinking ecclestone hayes <NUMBER> despite appearances article simply excuse reject regulatory frameworks developed evaluate teaching research collaboration community suggestion settle mediocrity rather high quality aim point instead deeply contextual factors personal institutional regional level excellent examples authentic academic practices captured generic scales measurement dark eerily quiet alley somewhere capital due covid<NUMBER> alone seem currently parked he… perhaps even incur congestion charge whilst stall engine livelier productive interconnecting regional routes might actually travel along together high speed <NUMBER> hs<NUMBER> may controversial environmental concerns needing balanced regional connectivity topham <NUMBER> least conversations heard triplicate national excellence frameworks also needs audible dialogue regional networks avoid becoming static products rather authentic processes time review also uk professional standards framework psf advance <NUMBER> questions asked whether occupying dark deserted alley potential infancy inform dynamic diverse regional teaching practices warnes <NUMBER> argues psf become subsumed part generic university fellowship schemes bolster corporate excellence statistics marketing purposes means personal value individual excellence converted via performance management impersonal institutional excellence warnes <NUMBER> definition direct links easily drawn framework aimed improving learning experiences students reflexive teaching practice reappropriated support neoliberal carrot stick performance review policies aimed improving skill level workforce andor rooting underperformers warnes <NUMBER> fawns et al <NUMBER> point many practices adequately captured data relies teachers students activities conforming anticipated model suggest instead balance data evidence dialogue expertise necessary furthermore within ecological view institutions rather considering performance individuals isolation evaluation also look policies systems environments support constrain educational practice goodyear carvalho <NUMBER> fawns et al <NUMBER> hayes <NUMBER>a call analytics part wider ecological view education relationships holistic conceptions practice valued individual variables goodyear carvalho <NUMBER> acknowledged metrics capture everything important fawns et al <NUMBER> suggest audible regional debate integral part play fawns et al <NUMBER> emphasise importance dialogues teachers students make sense formal curriculum intertwines informal extracurricular activity emergent sites learning suggest engaging dialogue workshops interviews events stakeholders including teaching administrative staff students wider community valuesled vision universities furthered fawns et al <NUMBER> even pressing concern postdigital society need encourage wider dialogue issues raised growing influence algorithms big data beyond specialists already immersed within arena edwards fenwick <NUMBER> debate characterised particular technologies fusions technologies capacity redraw lines physical digital biological domains potential scale speed spread changes connor et al <NUMBER> seem paying enough attention places spaces innovative creative dialogue grows develops neoliberal policy refuses take situational factors account jopling <NUMBER> irony national political system encourages active debate uk parliament yet appears delivering excellence frameworks effectively shutting forms exchanges within schools education lost us time viral crisis individual opinions aired households locations across country recent flood devastation uk yet missing means gather live individual collective regional opinions actively facilitated universities locations new biological threat silenced live debate events time necessity human lives risk taking postdigital perspective alarming surreal situation however offer helpful critical route collective discussion analysis even need postpone room together example selfisolation recently become global priority worth reminding new social phenomenon simply social antisocial even selfisolation may involve physical removal humans social contact dialectically linked forms digital communication online offline choices economic political decisionmaking media reporting uk universities array national excellence frameworks structuring activities timescales quite time amid serious global health concerns could healthy time debate alternative approaches first time held regional debate university wolverhampton february <NUMBER> literally accosted next day individuals attended asking events begun hold debates regional institutions reaction evidence may anecdotal enthusiasm engagement warm apparent clearly miss hearing sound others voices active discussion whilst rhetoric excellence policy cannot factor contributing absence live debate generic focus data frameworks overlooks active dialogue exchanges develop improve educational understanding experience knowledge practices though well bring light rich regional differences challenges topics provocations debates far ranged reoccupation policy discourse academic freedom question whether university dead possible futures universities policy drives divisions teachers students undergraduate supervision staff mental health policybased evidence challenging fluentism academy challenge developing creativity needs change topic generated live debate indicates deeply qualitative contextual nature teaching research regional locations cannot easily captured figures isolated metrics alone turn voices explain role understand active debate contribute topic might help us reverse dull dark alley network diverse regional universities debate dennis hayes debate spirit age tyrrell burgess <NUMBER> <NUMBER> midlands home english enlightenment eighteenth century groups like lunar society derby philosophical society met various towns midlands debate challenge conventional thought philosophy science spirit age expressed motto german philosopher immanuel kant sapere aude dare know two hundred years later enlightenment tradition decline challenging debate fashion writing <NUMBER> leading educational thinker professor tyrrell burgess declared spirit age burgess <NUMBER> <NUMBER> gave general personal defence reason debate important charting decline education general defence unlike beasts use language discuss criticise argue rely trial error discover error trail damaging consequences concluded eschew debate inhibit progress personal defence seldom know anything unless explain others defend criticism powerful aid personal understanding improvement burgess <NUMBER> <NUMBER> educational sphere debate vanished two reasons firstly teachers policymakers politicians see education technical matter correctly applying works nothing discuss need work right way things secondly parallel cultural change turned education towards therapy debate consequence therapeutic turn become mere selfexpression focusses feeling first part tyrrells argument second entirely mine hayes <NUMBER> resurrecting debate spirit age needs initiatives may seem artificial inhibitslowlyindulgent even narcissistic selfexpression certainly need debating societies schools universities set debates proposition one educationalist called discussion debate old fashioned sense old fashioned sense debate leave debate students initiatives like sixthform debating competition debating matters academics professionals need new ways getting echochambers groupthink higher education institutions spontaneously midlands almost accident academics begun experiment tradition early enlightenment societies like many ideas midlands policy network mhepn emerged dissatisfaction spaces academics students others interested state future come together talk started first mhepn debate university wolverhampton england <NUMBER> february <NUMBER> four brief provocations much calls action spurs reaction thought might interesting thought others might agree importantly might agree kinds reasons explore brief overview seems found place debate debate pleasingly oldfashioned word hear nowadays tends come politician calling public debate raise profile whatever change proposing policy criticising public debates take place would seem modern marketized university comparing university education public training stefan collini <NUMBER> <NUMBER> makes important distinction education relativizes constantly calls question information training simply transmits precisely calling question thought network could encourage discussion provocation debate striking little concerning many people attended network said relish opportunity talk ideas opportunities increasingly rare contemporary university midlands place matters attachments place become complex uk countries seem increasingly drawn towards welcome simple oppositions northsouth divide england one opposition midlands sit striking even advocates fairly radical forms regionalism eg niven <NUMBER> tend fall old oppositional geographical patterns even whilst ingeniously coopting south west north associated mhepn midlands simultaneously useful regional marker although open borders ambiguous one midlands represents somewhere drawing history debate challenge calling question nowhere space north south midlands resembles modern university caught oppositions excellence enquiry learning delivery student customer mean space debate kinds issues seem make valuable one debate build dialogue action regional inequality andy westwood getting brexit done might dominant theme decembers general election levelling economy across parts uk quickly become important domestic challenge new conservative government westwood <NUMBER> regional inequality uk longstanding deeply entrenchedand growing policy problem gaps best worst performing regions amongst largest europe oecd see industrial strategy commission <NUMBER> mccann <NUMBER> differences productivity wages living standards important driver political dissatisfaction influencing voting patterns <NUMBER> referendum <NUMBER> election conservatives owe much eighty seat majority constituencies left behind towns andor underperforming regions including west east midlands pm promised double government rd funding boost £<NUMBER>bn overall way levelling economic performance across country chief adviser dominic cummings pointed richard jones resurgence regions paper <NUMBER> blueprint approach involve significant shift traditionalas well recent conservative thinking higher education economy black country new conservative mps walsall dudley west bromwich wolverhampton nearest university campuses many places university wolverhampton north east also conservative city region mayor west midlandsandy street north east midlands new conservative mps representing stoke derby lincoln universities places likely benefit much proposals double research funding instead concerned conservative manifesto promise tackle low value courses higher education data graduate salaries tells us weaker regional local labour markets pay less staying working places earn less lifetime universities recruit locally areas black country north staffordshire stand suffer finances already weakened market tends favour established institutions larger wealthier cities also institutions offer best options increasing innovation skills rd growing underperforming local economies traditional conservative view might endorse accelerate market principles offered reform since <NUMBER> powers office students ofs focus value money possibly fewer capped graduate places overall especially lower value courses almost completely place blind approach creates big political problem withdrawing numbers weakening institutions likely undermine new geographical priorities chris skidmore tweeted recently going level every part uk universities anchor institutions part solution skidmore <NUMBER> sign governments acceptance issues perhaps lost job minister universities science recent reshuffle gavin williamson remains education secretary represents south staffordshire constituency borders several new existing tory colleagues across west midlands amanda solloway new minister science innovation represents derby north better understanding areas institutions contradictions traditional policy approaches theyas well universities placesmust understand pressing need rethink higher education achieve encouraging academic dialogue understanding action key well places student learning challenging knowledge universities crucial sites connectivity linking requirements industry technology market forces demands citizenship delanty <NUMBER> postdigital times regional institutions provide places spaces innovative creative dialogue develop even contemplate emerging global effects <NUMBER>th industrial revolution attempt navigate devastating pandemic universal national chant excellence parameters already set uk universities help us creatively meet technological biological social challenges unfolding around us decades neoliberal policy treated technology neutral addon quick fix enhance education automatically generically hayes <NUMBER>a <NUMBER> rather dialectically intertwined human activity logic left institutions considerably unprepared implications arising artificial intelligence ai big data algorithms biometrics neurotechnologies fuse politics human identity ethics law couldry argues neoliberalism literally changes cannot speak heard couldry <NUMBER> <NUMBER> collini suggests language use discussing university plays part understand situate also live relation collini <NUMBER> <NUMBER> regional institutions rich array voices express actually done universities much stronger chance connections made wider policy order develop dialogue need move away approach writing policy effectively writes labour students teachers leaders hayes <NUMBER>a placebased innovations creativity diverse voices contribute towards reducing regional inequalities developing skills varied regions uk universities crucial sites connecting global technological change local social projects citizens new political economy higher education problem research simply remains policyorientated descriptive undertheorised schulzecleven et al <NUMBER> debate across regional institutions therefore provides vehicle connect new modes inquiry surface academic perspectives personal positionality new postdigital political economy hayes <NUMBER> postdigital positionality one way interpret individual contexts appreciate peoples lives fusions analogue digital technologies social practices current excellence frameworks fail take account new personal institutional realities also changing individuals within function communicate innovate authors added individual voices support developing live debate education indeed first set write realise collective article would stepping raise voices… currently cannot convene live debates due pandemic whilst collective writing takes different format live debate types gatherings provides forum knowledge scope collective acts disturb existing systems academic knowledge creation jandrić et al <NUMBER> different ways live debate chair encourages active participation room increases shared understandings collective article look open reviewers comment chairing exchange argument thus helping readers awareness via act publishing however collective writing cannot replicate live discursive event takes place region simultaneously raise local voices article author explained personal position voice place matter together live debate argued positioning neither voice place reduced frameworks measure university excellence purely generic national terms postdigital context people local contexts also lead messy lives simultaneously offline online material virtual therefore postdigital reality omitted either national excellence frameworks alongside deeply contextual differences regional universities dennis argued education cannot simply remain technical matter seeking excellence involves correctly applying works regardless context turn towards therapy simply dilutes debate narcissistic selfexpression rather argument furthers progress mhepn provides local space us test believe know explain others defend criticism seek enable group meetings online real time need aware behaviours usually change virtual context people joining different locations still alter dynamic different levels access technology intervene different backdrops behind people distract us need mute microphones renders conversations intermittent… yet moment have… perhaps learn adapt time goes meanwhile michael pointed mhepn emerged dissatisfaction agreement need reinstate lost spaces might agree importantly disagree rather making special case public debate inherent part daily activities education even debate appears gone fashion postdigital times aware practices need consigned history replaced digital policy texts would often us believe simply reside alongside live debate moves us beyond transmission information form training towards education relativizes constantly calls question collini <NUMBER> <NUMBER> know live debate happens certain place places matter need represent oftenoverlooked places north south modern university need oppositional debate focus spaces excellence enquiry learning delivery student customer mhepn opened valuable forum debate positionings reflecting andys comments getting brexit done may disappeared currently gets little airtime right eyes understandably conservative governments responses covid<NUMBER> crisis pandemic sit apart political economic challenges beyond whilst political economic measures enact brexit continue biological epidemic travelled throughout europe across globe simultaneously grinding human travel halt matter days global lives returned local lives necessity try grapple overwhelming implications postdigital insights thinking responses covid<NUMBER> wrought tragedy huge scale even amid social isolation make collective productive observations look future current health crisis closed universities regional institutions feeding collective effort research covid<NUMBER> tests vaccines manufacture lifesaving equipment across underperforming regions surrounding many universities lowpaid care assistants supermarket workers relied upon much professors doctors predicted automation linked <NUMBER>ir therefore simply replaced human cashiers shelf stockers anticipated simple terms technological change interconnected forms change nothing new situation course black death fourteenth century unskilled labour premium england least pivotal destroying serfdom existed hundreds years thus current circumstances alongside rapid technological changes worthy continuous debate consider levelling economic performance closing gaps regions might achieved going forward regions unite tackle crisis government thinking economy needs recognise anchor institutions skidmore <NUMBER> overlooked communities support research aid graduates stay work regions places spaces live academic dialogue need gain momentum rethink achieve sarah particularly fond ritzers argument concerning irrationality rationality meaning persistent rationality including plays online augmented situations often leads opposite outcomeirrationality ritzer et al <NUMBER> imposed rationalities national contextfree frameworks excellence serve negate personal institutional positionalities postdigital contexts stand risks closing critical locational dialogue yields creative innovative solutions current future crises couldry <NUMBER> argued voice matters policy texts currently devoid regional contextual voices matter needs change many statements inclusivity diversity read national institutional policies upheld mhepn experimented one way restore live audible human argument response yielded powerful response colleagues requesting forums given universities crucial sites connect global technological change local social projects citizens owe debate really means humans reoccupy policy future hayes <NUMBER>a postdigital perspective recognises aspects brought together intertwined dialectically across time space layer complexity biological work pandemic connected technological communications social activities materially emotionally alter lives people planet raised voices suppressed others restricted global freedom mobility requiring people remain local places understanding role place wider national global economy begins debate debate furthered regional universities serve conduit connect local community wider policy contexts argued attempting capture rich work academia across uks regions generic static national excellence frameworks set regional universities developed fraught problems suggested regulatory approach akin beginning research project unethically predicting findings even approaching participants therefore new policy frameworks recognise voices regional universities well complex postdigital contexts needed core article focused role live placebased debate surface real contributions universities communities link national policy used collective writing alternative way raise academic voices topic amid pandemic alongside devastating human tragedy covid<NUMBER> revealed messy ironic postdigital connections whilst physically disrupting global neoliberal mcdonaldised life grand scale whilst scarcely dare imagine future scenario pandemic might actually repeated need go actually voice concern countries across globe national leaders seek solutions rely commitment creativity people across local regions time recognise universities postdigital sites connecting global technological biological change local social projects citizens discussed irony loss debate within regional universities uk parliament debate remains key forum current measures protect public pandemic brought policy surely indicates power live debate confined national government bodies alone author article presented case though live debate placebased regional voices raised neither collective article virtual forum exactly replicate powerful contextual live debate generated mhepn meetings far however collective piece open reviewers acting rather like chairs live debate offered alternative gathering knowledge topic time unprecedented change invite institutions individuals worldwide contribute open forum means safe join open review <NUMBER> regional dialogue within beyond construct collaborative learning culture alan tuckett raymond williams <NUMBER> <NUMBER> described dominant discourse however powerful never manages eradicate ways thinking highlights residual discourse earlier ways seeing world emergent discourse new forms imagined given voice raising regional academic voices reflects reassertion old valuesas dennis hayes celebration debate skill learnedand reassertion emergent forms postdigital exploration collective ways learning together captured central narrative four authors share common clarity things value omitted dominant neoliberal paradigm shaped much public lives last thirty forty years initial modest steps allocate scarce resources major science investment inspired first research assessment exercise worked least big science subsequent explosion centrally determined data captures emergence league tablesand attendant homogenisation higher education perhaps understandable effect corroding academic collegiality done many places topdown managerialist culture institutional leaders trapped fiscal fight quite death struggle respond external demands risk distorting institutional missions taken place name marketization cost ways thinking institutions responsibility locality graphically highlighted nottingham university decimated regional adult learning programmes whilst opening new shiny campus ningbo china tuckett <NUMBER> authors reassert value dialogue argument within collaborative exploration relationship academy places located paper emerges debates generated midlands higher education policy network properly alive bleaching regional responsiveness drivers shaping current higher education yet whilst properly side devolution rather one size fits centralised higher education discourse whilst celebrates diversity difference cooperative dialogue stays comfortably within sectoral boundaries higher education wondered read would different wider discussion sort cape learning region south africa engaged educators struggled explore distinctiveness different institutional forms whilst working create wider learning culture ideas fired resurgence globally interest learning cities learning regions amongst wolverhampton learning city region inevitably educators recognise reconfiguring learning culture academics need allies business industry faith voluntary sector need imagine new forms association involving adults young people sorts surely humus needed politics linking productivity skills learning culture revitalised regions matter dialogue vital universities open also matter neoliberal certainties helped way dialogues like welcome paper open review <NUMBER> count region higher education surely spatial well geographical geographical region open matter geographical region uk somewhat different one usa china two days ago participated webinar thirty participants every part world active event voice software permitted group breakouts placed small groups well hearing distinguished international scholars giving plenary talks discussant drawing together threads debate saw region action event focusthat academic activism happens held within larger territory philosophy theory higher societyand border community voices conversation identity thoseborder community voices conversation identitynot five ingredients indeed conditions region matter geographical region becomes interesting right look intimated border community voices conversation identity surely see elements fascinating dialogue sarah hayes michael jopling dennis hayes andy westwood perhaps though elements clearly visible others need definite border midlands network seems embrace manchester birmingham certainly voices conversation sense builds larger community regional policy network identity cannot sure days fluidity count identity identity ever pinned always making five elementsas making collectivity regional voicesare thrown high relief digital era confess uneasy term postdigital interesting wordprocessor monitor frowns upon single word postdigital single entity unified word implies suspect implication term get beyond digital put digital behind us least move onto higher level temptation must eschewed even access computers often forgotten higher education influenced internet services messages cultural resources information denied postdigital codigital whether like us every level personal institutional national accommodations digital age simultaneously live digital conduct alongside digital try outlaw digital embrace digital hide digital spy digital court digital socially distant socially proximate digital often many postures well one set relationships none us postdigital pick one issue regional identity new identities forged digital regions significant university element facetoface encounters long observed students comfortable online learning shadow presencing neither fully face yet sufficient space one express point view voice perhaps something similar observed academics perhaps digital media helping realize habermas ideal speech situationand advanced ideal contemporary interactive digital media inequalities position fade little formal positions title professor dr student recede replaced name screen academic identifiers equal case rich pickings available codigital academic age scholarship research new possibilities academic citizenship notion academic argument organisation space kinds discursive space conducive intellectual innovation maximisation crossborder disciplinary flows quite new academic ecologies may await still idea region keeps coming back authors writing collective surely hit three key points presence strong states say uk france china regions subjugated potential mismatch debate national level near absence regional level consequently overlooking regional identities sometimes odds central policies imposed upon regions set ingredients recipe dull uniformity also suppression regional difference autonomy vitality ironic authors observe exchange conducted presence virus pandemic shaping uk followed pattern failed attempts centre dominate regions dire consequences assuredly tasks responsibilities geographical regions work forming regional identities hitherto subjugated voice identity community conversation worked process new kinds digital citizenship may emerge shall call new forms happening gatherings purposive gatherings right however geographical borders remain indistinct let borders stay open well reasonably open least animal models necessary development drugs therapeutics demonstrate efficacy safety well providing essential information route administration pharmacokinetics pharmacodynamics identify key mechanisms driving pathology vivo pandemic coronavirus disease <NUMBER> disease manifestation sarscov<NUMBER> infection led rapid development animal models sarscov<NUMBER> infection already provided insights natural history disease together data previous studies permitted identification potential antiviral approaches identified studies viral infections alexander et al <NUMBER> notably time writing late april <NUMBER> studies using animal models already provided evidence immunity might confer protection reinfection bao et al <NUMBER>a convalescent plasma might decrease viral burden animal studies also confirmed susceptibility domestic cats infection provided evidence importance angiotensin converting enzyme <NUMBER> ace<NUMBER> enabling infection bao et al <NUMBER>b animal models well suited proof concept studies efficacy potential vaccines antivirals however model system drawbacks time writing april <NUMBER> reported animal model sarscov<NUMBER> infection fully recapitulates every key feature severe covid<NUMBER> table <NUMBER> figure <NUMBER> deficit preclinical modelling important vaccines widely available particularly urgent need identify potential treatments article protected copyright rights reserved patients already established sarscov<NUMBER> infection risk progressing severe covid<NUMBER> requiring hospitalisation need respiratory support high dependency intensive care unit ideal evidence preclinical efficacy studies potential therapeutic interventions prevent promote resolution severe covid<NUMBER> patients already symptomatic meaningful improvements clinically relevant endpoints models deterministically progress severe disease following infection sarscov<NUMBER> interventions also applied realistic time points models figure <NUMBER> ideal standard evidence course balanced practical ethical considerations sarscov<NUMBER> zoonotic origins andersen et al <NUMBER> several major factors complicate study virus model organisms include lack infectivity clinical isolates sarscov<NUMBER> model species including mice dogs bao et al <NUMBER>b shi et al <NUMBER> absence persistent infection immunopathology severe acute respiratory distress syndrome systemic complications characterise covid<NUMBER> clinically furthermore sarscov<NUMBER> predominately causes severe covid<NUMBER> older people comorbidities presenting construct validity problem attempted use young immunologically naïve laboratory animals covid<NUMBER> testing scientists developing animal models therefore face challenging set tradeoffs well sense urgency despite pressing needs treatments design implementation preclinical studies covid<NUMBER> maintain quality produce meaningful results avoid needless duplicity avoid undue reduction consideration animal welfare issues london kimmelman <NUMBER> review mechanisms involved covid<NUMBER> development reported approaches model sarscov<NUMBER> infection responses identify key areas studies using animal models might improve recapitulation important characteristics human covid<NUMBER> better help identification assessment new therapeutic interventions new modelling approaches needed improve understanding sarscov<NUMBER> covid<NUMBER> virus newly transitioned infecting humans aspects disease different previously described syndromes developing result viral infections including sars fortunately clinical preclinical data related covid<NUMBER> pandemic disseminated neverbeforeseen rate sarscov<NUMBER> positivesense singlestranded rna coronavirus thought descendant bat coronavirus spilled infecting humans infecting intermediate host potentially pangolin andersen et al <NUMBER> zhang et al <NUMBER>b genome sarscov<NUMBER> <NUMBER> homologous sarscov caused severe acute respiratory syndrome sars outbreaks <NUMBER> lu et al <NUMBER> studies indicate sarscov spike glycoprotein expressed sarscov<NUMBER> undergoes activating cleavage host proteases epithelial surfaces permits high affinity interaction spike host epithelial article protected copyright rights reserved ace<NUMBER> bao et al <NUMBER>b hoffmann et al <NUMBER> bound spike cleavage ace<NUMBER> host proteases tmprss<NUMBER> allows viral entry host epithelial cells viral replication hoffmann et al <NUMBER> damas et al <NUMBER> assessed ace<NUMBER> polymorphism similarity human ace<NUMBER> <NUMBER> vertebrates including <NUMBER> mammals based conservation <NUMBER> amino acids essential interaction ace<NUMBER> sarscov<NUMBER> scoring system predicts likelihood infectivity devised although experimental data would required substantiate merit system study provide rationale choice animal species study infectivity pathogenesis treatment covid <NUMBER> suggested species old world monkeys would highly susceptible infectivity rodents less likely infected sarscov<NUMBER> sarscov exhibit similar stability outside body van doremalen et al <NUMBER> differ incubation transmission kinetics compared sarscov sarscov<NUMBER> appears replicate rapidly upper respiratory tract zou et al <NUMBER> achieves transmission asymptomatic carriers factors likely contributed rapid global spread covid<NUMBER> reported clinical symptoms covid<NUMBER> range mild critical mild disease varies symptoms mild pneumonia severe disease characterised moderate severe pneumonia critical covid<NUMBER> involves diagnosis ards septic shock andor multiorgan failure wu mcgoogan <NUMBER> risk factors including advanced age male sex obesity diabetes immunodeficiency predispose towards development severe critical covid<NUMBER> sarscov<NUMBER> appears less likely cause severe disease sarscov factor likely also enabled greater spread sarscov<NUMBER> may also present additional challenge development animal models pathology covid<NUMBER> centered around immunopathology persistent lung infection leading ards clinical progression follows time course characteristic dysregulated viral immune response gattinoni et al <NUMBER> tian et al <NUMBER> xu et al <NUMBER>b figure <NUMBER> clear however critical cases covid<NUMBER> involve damage systems body may result ards may also causative greater lung injury notably covid<NUMBER> associated coagulopathy driven inflammation characterised elevated fibrinogen ddimer levels indicating increased thrombin generation fibrinolysis zhang et al <NUMBER>a patients suffer increased thrombotic risk standard prophylactic anticoagulants appear partially effective llitjos et al <NUMBER> evidence platelets autoantibodies neutrophil extracellular traps may involved pathogenesis barnes et al <NUMBER> bikdeli et al <NUMBER> zhang et al <NUMBER>c zuo et al <NUMBER> ards presentation within covid<NUMBER> heterogenous may involve gas exchange perfusion abnormalities pulmonary dead space extents differ patients gattinoni et al <NUMBER> additionally hyperactivation inflammatory responses result cytokine storm may kill via exacerbation multiorgan failure lung inflammation myositis blancomelo et al <NUMBER> sarziputtini et al <NUMBER> recapitulation key processes driving severe pathology mortality covid<NUMBER> validate animal models severe covid<NUMBER> research nonhuman primates close phylogeny humans makes particularly important use vaccine development time writing nonhuman primate models sarscov<NUMBER> infection reported using rhesus macaques bao et al <NUMBER>a munster et al <NUMBER> yu et al <NUMBER> cynomolgus macaques rockx et al <NUMBER> studies sarscov african green monkeys common marmosets squirrel monkeys moustached tamarins also used gong bao <NUMBER> although nonhuman primate models resemble human systems closely models use phylogenetically distant animals important note studies frequently use limited numbers animals experiments low <NUMBER> <NUMBER> animals per group results interpreted due caution curtis et al <NUMBER> investigators using intelligent animals however limited numbers nonhuman primates available terminal proof concept pathology studies especially many animals soon needed vaccine tests experimental designers forced make tradeoffs group sizes early pathology studies versus later preclinical trials therapeutics convincing demonstration animal model covid<NUMBER> reported munster et al <NUMBER> rhesus macaques inoculated intranasally intratracheally mouth onto eyes pulmonary infiltrates observed radiologically oedema measured gravimetrically although superficial inspection found lesions focal sporadic alveolar flooding presence hyaline membranes rarely seen animal models ards matutebello et al <NUMBER> observed lung histology accompanied irregular breathing pattern increased respiratory rate animals suggestive hypoxemia although readout may also marker pain distress together results suggest degree ards development however gas exchange impairment measured serum cytokine analysis detected consistent evidence systemic inflammation age major risk factor severe covid<NUMBER> response aged rhesus macaques <NUMBER> years old intratracheal inoculation sarscov<NUMBER> also compared younger controls <NUMBER> years old report suggests agerelated increases viral load <NUMBER> days inoculation radiology histology indicative mild interstitial infiltrates younger animals signs severe oedema including alveolar flooding aged macaques although preliminary largely qualitative study suggests aged macaque models may useful modelling severe disease rhesus macaques also used test whether seroconversion provides protective immunity sarscov<NUMBER> one reported study two animals inoculated intratracheally sarscov<NUMBER> challenged <NUMBER> days later bao et al <NUMBER>a lack viral shedding rechallenge macaques suggested development protective immunity study overinterpreted however studies suggests low even undetectable titres neutralizing antibodies previously infected patients korean centre disease control reported reinfection patients previous covid<NUMBER> limited signs lung inflammation pneumonia also demonstrated macaque study rockx et al rockx et al <NUMBER> ferrets useful studies viral transmission pharmacology frequently reported symptom sarscov<NUMBER> infection unlike mice rats exhibit cough reflex also ferret models used study cystic fibrosis sun et al <NUMBER> ferret studies also potential veterinary zoonotic relevance outbreak sarscov<NUMBER> infections respiratory symptoms article protected copyright rights reserved reported minks related ferrets within mustilidae family two farms netherlands dutch parliament report <NUMBER> following inoculation sarscov<NUMBER> ferrets shown develop symptoms similar described human covid<NUMBER> namely elevated body temperature suggestive pyresis reduced activity appetite coughing <NUMBER> <NUMBER> days post infection kim et al <NUMBER> shi et al <NUMBER> histologically sarscov<NUMBER> infected ferret lungs exhibited severe pulmonary lymphoplasmacytic perivasculitis vasculitis <NUMBER> days post infection transmission sarscov<NUMBER> studied placing naïve ferrets direct indirect contact inoculated ferrets kim et al <NUMBER> observed naïve ferrets placed direct contact infected ferrets displayed symptoms infections elevations body temperature reduced activity <NUMBER> days post infection however ferrets placed indirect contact inoculated animals separation partition allowed air move enclosures show symptoms although tested positive viral rna indicative airborne transmission lung histology inoculated ferrets study showed mild signs inflammation <NUMBER> days post infection measurements upper respiratory tract gene transcripts nasal washes blancomelo et al <NUMBER> studies showed lower magnitude upper airway immune responses relative influenza infection induction unique sarscov<NUMBER> gene signature ontologically enriched cell death leukocyte activationassociated transcripts tracheal cell analysis also showed sarscov<NUMBER>unique transcripts also associated hematopoietic progenitors suggestive extramedullary hematopoiesis infection site however importantly study report lower respiratory systemic pathological findings lack demonstrated pulmonary replication edema ferret sarscov<NUMBER> infection models suggests major limitation ferrets study lung pathology although cats widely used study respiratory diseases close association humans domestic cats means investigation sarscov<NUMBER> infection transmission cats important although relationship domestic cats humans turn complicates use laboratory animals notable domestic cats well zoohoused tigers also felidae family reportedly tested positive usa suggesting veterinary zoonotic importance feline sarscov<NUMBER> studies center disease control report <NUMBER> study transmission sarscov<NUMBER> two pairs one inoculated one naïve pair sub adult aged <NUMBER> months <NUMBER> pairs juvenile cats aged <NUMBER> weeks housed together fecal samples analysed presence viral rna confirm successful infection subadult juvenile cats one three naïve cats viral rna detected fecal samples suggestive transmission albeit limited ferrets notable researchers unable perform nasal washes subadult cats due aggression cats also notable reported death one inoculated juvenile cats <NUMBER> days post infection study suggestive provocation severe disease young animal lung histology autopsy showed pronounced alveolar flooding suggesting pulmonary oedema development study whether severe disease reproduced cats may useful severe covid<NUMBER> efficacy testing veterinary medicine development hamsters used range medical research studies importantly show relatively high degree homology humans within region ace<NUMBER> implicated interaction ace<NUMBER>binding domain sarscov<NUMBER> spike chan et al <NUMBER> inoculated golden syrian hamsters intranasally sarscov<NUMBER> viral replication occurred lungs infected hamsters lungs also developed marked lesions pulmonary edema inflammation cell death assessed histologically inoculated hamsters lost weight showed increased respiratory rate could infect cohoused hamsters suggesting utility model studying transmission infected cohoused hamsters showed similar signs lung pathology lose weight suggesting inoculated hamsters greater severity due higher amount virus delivered lungs inflammation also measured study using quantitative pcr lung samples demonstrating early interferon response elevation il<NUMBER> together data suggest hamsters might highly useful modelling mechanisms covid<NUMBER> however inflammation lung pathology resolved <NUMBER> days post infection suggesting hamster responses reflective resolving inflammation successful host defence opposed dysregulated responses associated severe covid<NUMBER> mice widely used studies immunology lung injury highly characterized immune system rapid breeding cycle used range readily available research tools importantly size rapid breeding growth mice useful accelerating completion studies group numbers high enough statistical testing efficacy potential interventions however spike proteins sarscov<NUMBER> relative sarscov thought insufficient affinity murine ace<NUMBER> entry receptor infection mice wan et al <NUMBER> clinical isolates sarscov therefore adapted serial passage respiratory tract mice produce related viruses ma<NUMBER> v<NUMBER> cause lung injury mortality wildtype mice roberts et al <NUMBER> day et al <NUMBER> pathological exacerbation reported aged immunodeficient mice graham <NUMBER> time writing reports mouseadapted sarscov<NUMBER> known whether naturally occurring mutations sarscov<NUMBER> spike ace<NUMBER>binding domain found clinical isolates altered pathogenicity mice ou et al <NUMBER> mouse adaptation sarscov<NUMBER> would useful acceleration mouse testing may prove difficult sarscov<NUMBER> spike appears evolved high affinity human ace<NUMBER> expense lower affinity ace<NUMBER> organisms wan et al <NUMBER> initial studies published preprints show sarscov<NUMBER> also infect k<NUMBER>hace<NUMBER> mice transgenedependent manner bao et al <NUMBER>b mice inoculation sarscov<NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> caused weight loss antibody responses superficial histological evidence lung inflammation k<NUMBER>hace<NUMBER> article protected copyright rights reserved transgenedependent manner although lung injury limited quantified bao <NUMBER> contrast previous sarscov experiments however mortality reported sarscov<NUMBER> infection k<NUMBER>hace<NUMBER> mice perhaps related lower virulence sarscov<NUMBER> observed humans although one dose virus studied adaptations experimental approach infecting transgenic mice may required study lethal lung injury resulting sarscov<NUMBER> infection another issue future studies whether tissue distribution surface expression levels hace<NUMBER> k<NUMBER>hace<NUMBER> mice faithful recapitulate humans murine ace<NUMBER> expression appears highly localised bronchial epithelium mice sodhi et al <NUMBER> sun et al <NUMBER> ace<NUMBER> perhaps generally distributed human lungs hamming et al <NUMBER> transgenic hace<NUMBER> expression mouse lungs bao et al <NUMBER>b also species differences distribution ace<NUMBER> expression outside lungs may implications systemic responses sarscov<NUMBER> infection additionally ace<NUMBER> downregulation may play role disease progression kuba et al <NUMBER> k<NUMBER>hace<NUMBER> human nonspike reactive murine ace<NUMBER> may resistant ace<NUMBER> downregulation related complications targeted insertion human ace<NUMBER> endogenous mouse locus may therefore useful better modelling severe covid<NUMBER> sarscov<NUMBER> likely originated coronavirus infecting bats andersen et al <NUMBER> zhang et al <NUMBER>b although bats commonly used model organisms particular research interest appear originating species many particularly deadly zoonotic viruses b immune systems evolved tolerate persistent infections viruses higher virulence species possibly accelerates viral evolution brook et al <NUMBER> rabi et al <NUMBER> also notable sarscov<NUMBER> isolates shown infectivity rabbit pig cells vitro chu et al <NUMBER> although vitro tropism always mean infection occur vivo model organisms may useful studies related covid<NUMBER> rabbits well suited longitudinal lung function studies organ systems pigs closely resemble scale humans useful studies involving haemodynamic measurements route method used viral inoculation affect severity viral disease models range inoculation routes used reported animal studies table <NUMBER> intranasal delivery widely used delivery method simple inoculum aspirated airways intranasal route potentially reflective realworld route entry viral droplets however method lead limited focal delivery inoculum lungs su et al <NUMBER> viral diseases affecting lower respiratory tract covid<NUMBER> may result inhalation aerosols enter deeper lungs widespread deposition virus lungs due high upper respiratory tract viral load mucociliary escalator disruption aerosolised delivery viral inoculum may therefore useful induction widespread lung injury might sufficient provoke severe disease well standardisation dose inoculum reaches lower airways respiratory lungs evidence aerosolized delivery provoke injury resembling severe ards elevated cytokine release produced cynomolgus macaque models h<NUMBER>n<NUMBER> influenza wonderlich et al <NUMBER> also recent developments quantitative delivery aerosols powders lungs laboratory animals lexmond et al <NUMBER> aerosolized intratracheal administration approaches controlled delivery inoculum may worthy consideration animal models severe covid<NUMBER> histological analysis superficial visual inspection radiological imaging predominate approaches used assess development lung inflammation injury following experimental sarscov<NUMBER> infection however pathological observations far often reported animals study regions lungs animals table <NUMBER> likely due probabilistic provocation injury primary focus pulmonary oedema measured consistently infected animals using index lung weight percentage body weight munster et al <NUMBER> simple method may prove useful terminal approach lung injury article protected copyright rights reserved assessment feasible studies within constraints bsl<NUMBER> conditions later requirement lung homogenate viral load readouts personnel time personal protective equipment requirements biosafety level bsl <NUMBER> laboratories size animals consideration welfare limit measurements feasible sarscov<NUMBER> infection studies however serial measurements blood oxygen saturation arterial blood gases would highly valuable definition time course impairment gas exchange occurs animal models notable covid<NUMBER> patients decreased arterial oxygen saturation reported prior dyspnoea dramatically decreased saturation leads hospitalization pao<NUMBER>fio<NUMBER> fluctuate course clinical covid<NUMBER> progression clinical setting serial close monitoring oxygen saturation ideal cascella et al <NUMBER> points reminders degree hypoxemia pneumonia indicative disease conclusive evidence progression severe covid<NUMBER>like ards possible serial noninvasive imaging approaches reported macaque studies table <NUMBER> also useful tracking time course pulmonary oedema development notable patients covid<NUMBER> ards limited oedema severe hypoxemia gattinoni et al <NUMBER> additional measurements lung perfusion pulmonary dead space fraction ventilation perfusion scans animals may also useful better understanding article protected copyright rights reserved covid<NUMBER> disease subphenotypes may also present within animal models carla et al <NUMBER> planning terminal measurements involve consideration maximum number highvalue measurements made inoculations affect lungs widely relatively evenly involve use different lobes different potentially confounding measurements example bronchoalveolar lavage useful simultaneously measurements viruses inflammatory cells inflammatory mediators protein deposits bronchoalveolar spaces causes artifacts histological analysis prevents later measurement pulmonary oedema likewise formalin inflation useful histological analysis performed outside bsl<NUMBER> conditions prevents direct quantitative methods measurement viral load lungs pulmonary oedema lobes lungs therefore sequentially tied sampled permit functional histological measurements related ards well viral load lungs experimental designs course require appropriate tradeoffs study complexity welfare safety animals laboratory workers serious potentially lethal nature covid<NUMBER> means bsl<NUMBER> laboratories required experiments using sarscov<NUMBER> however insights mechanisms driving covid<NUMBER> may still derived noninfectious models one example directly related sarscov<NUMBER> effects absence ace<NUMBER> function enhancement pulmonary edema response established using mouse acid inhalation model provoke rapid severe pulmonary edema kuba et al <NUMBER> finding led ongoing trials assess whether administration recombinant ace<NUMBER> may address infectionrelated deficiencies lung barrier protective ace<NUMBER>derived angiotensin ii generation addition potential action decoy preventing viral entry cells urgently needed studies putative therapeutic agents covid<NUMBER> particularly targeting host responses may therefore possible supportive using lung injury models higher throughput influenza viruses adapted infect mouse cells used viral induced lethal lung injury experiments mice widely available bsl<NUMBER> laboratories mechanisms study might feasibly shared sarscov<NUMBER> responses however immune responses coronaviruses influenza example knockout complement component <NUMBER> mice detrimental influenza h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> infection models obrien et al <NUMBER> beneficial sarscov infection models gralinski et al <NUMBER> viral pseudotypes expressing sarscov<NUMBER> spike may also useful vivo nonbsl<NUMBER> studies antiviral efficacy hoffmann et al <NUMBER> although model evasion mechanisms immunopathology unique sarscov<NUMBER> related coronaviruses many models used study ards mice model organisms closer phylogenetically anatomically humans matutebello et al <NUMBER> aeffner et al <NUMBER> lung injury caused instillations bacteria endotoxins ventilation antibodies may particularly relevant covid<NUMBER> complicated secondary infections barotrauma antibody reactions associated dysregulated responses additionally may central mechanisms ards progression resolution meaning nonviral models may utility rapid proofofconcept studies outside bsl<NUMBER> conditions although likely many cases efficacy studies sarscov<NUMBER> infection also needed known risk factors severe covid<NUMBER> offer opportunities drive models towards pathological states figure <NUMBER> advanced age obesity diabetes additional risk factors associated high casefatality rates covid<NUMBER> onder et al <NUMBER> petrilli et al <NUMBER> features may predispose towards severe disease complicating medical treatment hypoventilation result low cardiorespiratory fitness dysregulated immunity imbalance inflammation repair mechanisms well propensity underlying cardiovascular disease changes haemostasis influence progression respiratory infection towards ards tzoran et al <NUMBER> sattar et al <NUMBER> use aged animals might allow modelling age risk factor encouraging light early development preclinical models covid<NUMBER> includes influence age rhesus macaques infection sarscov<NUMBER> reportedly led heightened lung pathology viral replication older macaques <NUMBER> years old compared younger animals <NUMBER> years old additionally aged mice previously demonstrated exacerbated inflammation lung injury following sarscov infection rockx et al <NUMBER> animal models require ageing years may permit rapid testing treatments required covid<NUMBER> pandemic models incorporating risk factors induced obesity eg high fat dietinduced diabetes eg leptin receptor deficiency paul et al <NUMBER> impaired immune responses eg stat<NUMBER> knockoutinhibition frieman et al <NUMBER> might made available quickly additionally covid<NUMBER> may progress severe disease status result immune priming secondary infections intravascular sequelae combining sarscov<NUMBER> infection models first second hit immune priming lps additional challenges nonbsl<NUMBER> approaches cause lung injury described ie inoculation pathogenic bacteria injections injurious antibodies might capable driving host responses towards pathological state discussed severe covid<NUMBER> also associated low blood platelet counts thrombosis consumptive coagulopathy hyperinflammatory state involving platelet activation release nets prolonged systemic elevations cytokines il<NUMBER> cxcl<NUMBER> pathological features associated severe disease yet demonstrated animal models table <NUMBER> degree thrombocytopaenia reported potential biomarker severe covid<NUMBER> lippi et al <NUMBER> large retrospective study revealed degree thrombocytopaenia dynamic presentation clinic decreasing platelet numbers predictive mortality later furthermore shift plateletlymphocyte ratio may indicate occurrence acute inflammatory thrombotic event therefore prognostic value qu et al <NUMBER> thus thrombocytopaenia may reflect <NUMBER> alteration thrombopoiesis due bone marrow lungs potentially spleen inflamedreceiving inflammatory traumarelated thrombopoietic cues <NUMBER> localized lung recruitment platelets facet role immune response alveolar coagulation <NUMBER> disseminated intravascular coagulation dic throughout body xu et al <NUMBER>a <NUMBER> plateletviral interaction although remains hypothetical engagement platelets sarscov<NUMBER> described amgalan othman <NUMBER> evidence disease states features covid<NUMBER> pathology indicate potential causative roles platelets worsening disease might therefore provide opportunities adaption severe mechanistic models severe covid<NUMBER> reports animal studies published date included measurements pathological responses detection would useful evidence successful modelling mechanisms severe disease results studies mice modelling influenza agree necessity platelets immune response inflammation conflict whether beneficial guo et al <NUMBER> campbell et al <NUMBER> detrimental boilard et al <NUMBER> lê et al <NUMBER> additionally platelets shown respond influenza virus increase complement availability encourage release nets blood platelets may important integrators linking viral infection neutrophil responses associated coagulopathy venous thrombosis koupenova et al <NUMBER> furthermore platelets complex relationship lung inflammation protective alveolar capillarybarrier promote excessive vascular leak weyrich zimmerman <NUMBER> middleton et al <NUMBER> given importance platelets coagulopathies dic alveolar thrombi innate immune response hyperinflammation influence patency alveolarcapillary unit association low blood platelet counts severe disease manipulation platelets might useful experimental tool reciprocate pathological events animal models sarscov<NUMBER> infection previous findings experimental thrombocytopenia convert mild selfresolving bacterial lung infection severe form systemic infection extrapulmonary organ involvement death amison et al <NUMBER> suggest induction severe experimental thrombocytopenia <NUMBER> depletion animal models sarscov<NUMBER> may allow infection models demonstrate progression mild severe disease phenotype additionally pulmonary platelet retention induced intravenous injections antimhc class antibodies also associated thrombocytopenia release nets looney et al <NUMBER> caudrillier et al <NUMBER> use antibodies combined infection models might useful modelling contributions platelets nets severe covid<NUMBER> associated lung hypoperfusion release nets autoantibody production zhang et al <NUMBER>c involvement fcγriia viral platelet responses suggests transgenic expression human fcγriia platelets may useful driving greater platelet responses murine sarscov<NUMBER> infection models mice lack activating fcγ receptors platelets boilard et al <NUMBER> treatment heparin low molecular weight heparin associated reduced mortality clinical studies covid<NUMBER> yin et al <NUMBER> nebulised delivery heparin associated reduced requirement ventilation patients hospitalised respiratory diseases severe copd dixon et al <NUMBER> shute et al <NUMBER> ashoor et al <NUMBER> although heparin classically used anticoagulant also demonstrated bind reduce activity range cytokines implicated covid<NUMBER>associated cytokine storm mulloy et al <NUMBER> also interacts sarscov<NUMBER> spike protein manner causes structural alteration ace<NUMBER>binding domain likely reduce viral entry mycroftwest et al <NUMBER> potentially useful polypharmacy heparin underlines need integrated vivo sarscov<NUMBER> infection models incorporating simultaneous clinically relevant measurements coagulation cytokines viral load addition platelet number severity covid<NUMBER> disease progression also correlates closely levels proinflammatory mediators cxcl<NUMBER> interferoninducible protein <NUMBER> tnfalpha associated pathology progression associated hyperinflammatory condition associated ards tang et al <NUMBER> bautista et al <NUMBER> yang et al <NUMBER> amelioration lps induced ards following cxcl<NUMBER> neutralisation rats proposition antitnfalpha therapy covid<NUMBER> patients therefore highlights potential combining sarscov<NUMBER> infections tnfalpha cxcl<NUMBER> challenge method development models severe phenotype lang et al <NUMBER> feldman et al <NUMBER> article protected copyright rights reserved persistence infection inflammation due ineffective viral clearance key feature severe covid<NUMBER> although maintenance infection systemic cytokine release yet reported animal models sarscov<NUMBER> infection potential approach model feature severe disease experimental disruption important antiviral host defence pathways key mediator defensive signalling might transcription factor stat<NUMBER> genetic deletion convert mild sarscov mouse infection model one resulting <NUMBER> mortality frieman et al <NUMBER> pharmacologic inhibitors stat<NUMBER> available miklossy et al <NUMBER> may useful rapid development animal models deficiencies protective antiviral responses without requirement multigenerational crosses ageing laboratory animals dysregulated immune responses myeloid leukocytes may also important pathogenesis severe disease barnes et al <NUMBER> although impact covid<NUMBER> cystic fibrosis patients still unclear colombo et al <NUMBER> mouse models cystic fibrosis mutations involve heightened platelet activation hyperinflammatory state increased neutrophil responses models might useful driving increased severity pathology ortizmuñoz et al <NUMBER> efficacy studies using animal models many disease processes criticised overuse prophylactic application interventions ie pretreatment approaches would realistic clinical treatments denayer et al <NUMBER> severe covid<NUMBER> characteristic time course suggests several windows different treatment approaches might useful figure <NUMBER> users animal models covid<NUMBER> research wherever possible assess time course readouts models consider type therapeutic assessed potential risk patients anticipated adverse effects whether intervention likely need take place hospital setting example viral replication increases likelihood transmission persistent infection mediates severe disease antivirals low toxicity might useful diagnosed cases perhaps even prophylactically highrisk populations interventions nebulised heparin may benefit antiviral agents mycroftwest et al <NUMBER> reducing inflammatory response dixon et al <NUMBER> mulloy et al <NUMBER> may need dosed different time points across development covid<NUMBER> severe disease develops interventions aimed resolving ards systemic complications would useful robust preclinical testing might require models include aspects intensive care support invasive ventilation alexander et al <NUMBER> careful model characterization required identify analogous phases pathology development animal models appropriate timing interventions study animal models rapidly mobilised address need greater understanding covid<NUMBER> testing new therapeutic approaches pandemic useful observations already shared important animal studies adapted measure report key readouts relevant clinical covid<NUMBER> evidence lung injury resembling ards physiological gas exchange impairment hyperinflammation platelet responses coagulopathy study designs may need incorporate additional risk factors disease triggers shift modelling protective selfresolving infection inflammation recapitulating severe disease ards multiorgan failure table <NUMBER> development models reproduce hallmarks disease permit better understanding covid<NUMBER> pathogenesis facilitate improved efficacy testing desperately needed drugs therapeutics article protected copyright rights reserved <NUMBER> <NUMBER> tcid<NUMBER> <NUMBER> <NUMBER> pfu <NUMBER> <NUMBER> pfu <NUMBER> <NUMBER> tcid<NUMBER> <NUMBER> <NUMBER> pfu <NUMBER> <NUMBER> pfu <NUMBER> <NUMBER> tcid<NUMBER> yes presidency donald trump whose hyperbolically selfpromoting business style made object public fascination since <NUMBER>s already given rise vast body writing addition two biographies published prior <NUMBER> election kranish fisher <NUMBER> johnston <NUMBER> ever growing literature includes several books published mainstream trade presses wolff <NUMBER> johnston <NUMBER> together myriad newspaper articles essays public affairs magazines growing body academic literature dedicated analyzing psychology personality type hearn <NUMBER> martin krausejensen <NUMBER> fuchsman <NUMBER> allcorn stein <NUMBER> rhetorical style jamieson taussig <NUMBER> political practice agnew shin <NUMBER> siegel <NUMBER> relationship political business career well exploring rise power light broader trends american well global politics papalia <NUMBER> michels <NUMBER> massing <NUMBER> transformations landscape mass media andrejevic <NUMBER> wells et al <NUMBER> werber <NUMBER> johnson <NUMBER> fürst oehmer <NUMBER> dialectic late capitalism hearn <NUMBER> vast range different analytic perspectives cast phenomenon trump prove illuminating nearly register feeling trauma suggests extent phenomenon represents significant perhaps ominous political event offers singular illumination present situation indeed phenomenon trump brings present conjuncture unprecedented focus precisely insofar situation present merely present issues indeed carries contradictions pastcontradictions dialectical sense walter benjamin insofar reveal order emergent temporality time event one might say radically discontinuous continuous order progress indeed emergence nearly every new celebrity phenomenon matter new celebrity filling existing type new type celebrity instantiated utterly singular individual gives rise kind uncanny feeling especially among quite itwho lag behind becoming aware popular culture single moment appeared impossible place world suddenly seems inevitable necessary draws everything else field attraction allowing things appear relation modal logician might course still insist could possible world without lady gaga obama trump world absolutely singular world existand never quite luxury existing another merely possible worldhas become utterly unthinkable without since entire horizon sense come warped around facts existence around black hole trump feeling assumed vastly greater fundamentally traumatic intensity qualitatively distinct part seeming triviality celebrity phenomena indeed everything however enormous impact relegated sphere private life eg personal computer social networking serves function similar stages proscenium creates illusion safe distance distance indeed illusion relation fact threateningly close many inglis <NUMBER> recognized celebrity opposed fame renown characteristically modern indeed rojek <NUMBER> argues ineluctably woven fabric contemporary society perhaps phenomenon celebrity together subsumed within orbit might regarded simply consequence modernity coping mechanism reaction formation made possible survive condition modernity postmodernity way processing historical change insofar already reached feverish traumatic pitch intensity safer less threatening forms cutification historical time continuumbreaking irruption new becomes noveltyan object contemplative pleasure enjoyment intrigue fascination trumps election however single blow world celebrity already begun rub world reality show suddenly become absolutely immanentlydangerouslyreal since trump already celebrity <NUMBER>s indeed celebrity businessman already straddled two worlds unsettled protecting veil illusion instructive way take note two domains claims tasteless mastery television architectureintimately related yet polar opposites ascent politician indeed leader free world involves secondorder shock secondorder event entire order bound phenomenon celebrity become thing never could real enormity event must recognized whatever else happens perhaps still soon tell already happened logic celebrification transforming event noveltythe domestication cutification historical time itselfhaving served principal shock absorber shocks modernity shocking sudden fashion failed celebrity celebrity celebrity become quantitative rather qualitative factor made evident one considers various ranking schemes organizing social media allow hitherto impossible comparison say teenage girl topeka kansas livefeeding videos cat ten followersor even cat itselfand lady gaga millions minions thought celebrities outliers deviations human norm think even failed celebrities monsters little big one perhaps nothingnot even animals one thinks cecil lionthat still able exist exist outside monstrations media hence also realityauthoritative serious securebeyond veil celebrity save perhaps intimate disgusting facets daily life way might make sense recent somewhat hyperbolic talk posttruth correspondence truth suddenly disappeared world even norms guiding forms praxis discourse undermined rather happened previously media interfaced real way strata authorities media figures celebrities nevertheless able set protective barrier mediascape realscape offering authorized authoritybearing opinion regardless opinion whose interests state corporate ideological represented demonstrative authoritativeness buttressed serious gazes steady stentorian tones served keep two worlds apart daytime tv might dominated manner triviality silliness melodrama come evening men returned home work families gathered back together walter cronkite would remind everyone far away war fought neighbors sons dying students protesting world changing shocks real history say tied back comforting continuity authoritative knowledge sound common sense abiding ethical political juridical norms whereas novelty eventalways already corresponding nothing event always already posttruthwas relegated sphere trivial ephemeral however mediating functioncalled question top bottom squeezed sideshas lost much efficacy becoming increasingly clear prophets postmodernity anticipated outside media qualitative texturingthe topographic distinctionswithin mediascape flattened remain mere quantitative signifers qualitative differences akin markings topographic map following paper claim offer exhaustive definitive analysis phenomenon trump rather seeks encounter vertiginous movement eventfull history bringing focus trump dialectical image contradictions present situation perhaps fundamental methodological principle investigation belief grounded remarks previous paragraphs order gain access dialectical torsion work necessary start juxtaposing something seemingly trivial ephemeral brings furtherreaching historical horizon view hence attempt read trump starting might seem like unlikely constellation one hand board games fichtes highly philosophical politicaleconomic treatise closed commercial state text may regarded founding document economic nationalism insofar defends necessity restrictions commerce going far beyond tactics mercantilism terms comparative advantages gained one party another terms absolutely necessary sovereign nation state exist even though economic nationalism trump bannon shares almost nothing concrete fichtes proposals draw least ideological level principles find pure expression fichtes treatise nowhere clear trumps infamous promise build wall make mexico pay expresses essence fichtean closurefichte believes make countries payhollowed purely rhetorical gesture needless say one possible approach complex phenomenon trump trumpism yet seemingly willful arbitrariness precisely methodologically demanded chance point departure offer point access relentlessly undermines resources sound political juridical scientific reasoning among many firsts one suspects donald j trump <NUMBER> th president usa first head state world power hosted reality show also claim distinction one two least three board games consecrated name donald trump game im back fired apprentice board game given first predates reality tv show apprentice <NUMBER> years suggests certain telos driving peculiar phenomenon donald trumpit could even seem though survivalformat reality show existed trump would invent <NUMBER> fulfillment donald trump become gamemaster dealerthe house yet perhaps quite simple might seem house structure system law play game submitted contingency must compete one another exposed moods go ups downs fortune housethe system structureby contrast like divine beings german poet friedrich hölderlin writes feels nothing experiences nothing possible occupy position house becoming inhuman incapable human pleasure trump however seems want ways wants house free risk also free joy wants winner biggest winner wants dealer one deals consummately dealt precisely double desire articulated throughout trumps art deal first pages trump claims animating desirethe ultimate good orienting choices actionsis neither wealth even one might suspect ever certainly fact case power dont money ive got enough much ill ever need deals art form people paint beautifully canvas write wonderful poetry like making deals preferably big deals thats get kicks trump schwartz <NUMBER> <NUMBER> regarding significance trumps career reality tv host see ouellette <NUMBER> hearn <NUMBER> hearn <NUMBER> kavka <NUMBER> general studies reality tv transformative impact american society include hill <NUMBER> deery <NUMBER> well edited collection murray ouellette <NUMBER> perhaps profound trenchant reflection reality tv regard <NUMBER> show american family appears baudrillards simulacra simulation ideal heroine american way life ancient sacrifices chosen order glorified die beneath flames medium modern fatum heavenly fire longer falls corrupted cities camera lens like laser comes pierce living reality order put death <NUMBER> dealmaking end itwhich say following aristotle dealmaking belongs among activities coherently pursued sake merely means end end determines form life fullest sense first book nicomachean ethics aristotle speaks three ways life hold special prominence gathering together illuminating varied paths human beings upon face earth life pleasure political life life honor virtue contemplative life aristotle <NUMBER> lives oriented around good coherently present meaningful meaninggiving end human action contrast life money making type compulsory activity clear wealth good sought since instrumental sake something else aristotle <NUMBER> trump would seem dealmaking fourth kind life worth taking moments consider claim indeed take seriously far seriously might first seem merit dealmaking subsumed species genus one aristotles existing three lives trumps claim dealmaking done sake would amount much yet perhaps things straightforward dealmaking life cannot easily subsumed aristotles rubrics let us suppose begin dealmaking merely part active life political life agora place assembly democratic athens nothing else market place dealmaking political activity even highest sense nevertheless peculiar peculiarly modern kindperhaps almost unrecognizable aristotle must understood terms modern reconception politics terms social contracta social contract merely foundational constantly renegotiated political life continual conflict contracting parties also another possibility aristotle include life artist among three prominent lives cannot imagine moderns creativity artistic production something done sake life claim dignity significance equal perhaps greater politician thinker might say rather life dealmaking version creative life made possible hannah arendt <NUMBER> argued human condition postclassical ascendance homo faber finally drawing together two points could even say dealmaking exemplifies way political life transformed rise homo faber yet conclusion seem quite adequate either since hannah arendt argues modern world characterized rise homo laborans suppression life making well activity cannot discount possibility dealmaking belongs also perhaps principally life pleasure even life contemplation indeed dealmaking kind art kind artistic life characterized fastness looseness openness moment cant imaginative entrepreneurial youve got much structure prefer come work day see develops… theres rarely day fewer fifty calls often runs hundred least dozen meetings majority occur spur moment last longer <NUMBER> min trump schwartz <NUMBER> whereas artist conceived aristotle brings forth form contemplated beforehand working upon material dealmaker master improviser makes goes along open given playing given making best every situation <NUMBER> art become play aristotles technē heidegger <NUMBER> argues kind epistēmē involving knowledge form brought forth presence act making dealmaking involves peculiar knowledge quite different knowledge forms generic universal eternal dealmaker gains knowledge situation essence situation conflict polemos plays every decision gets played every deal words heraclituss famous fragment πόλεμος πάντων μὲν πατήρ ἐστι πάντων δὲ βασιλεύς καὶ τοὺς μὲν θεοὺς ἔδειξε τοὺς δὲ ἀνθρώπους τοὺς μὲν δούλους ἐποίησε τοὺς δὲ ἐλευθέρους war father king shown gods others men made slaves others free heraclitus <NUMBER> translated trump deal leader shows winners losers dealmaker one greatest degree possible experiences deal partakes pleasure dealmaking living close center deal possible perhaps dealmaking constitutes autonomous selfsufficient prominent mode life gathers together possibilities life politics activity generally artistic creation knowledge contemplation pleasure single mode life least seems capable managing dealing modern condition dealmaker claims master fluidity modern life submit pleasurably fluidity experience pleasure first chapter art deal marches us week vertiginous dealmaking second chapter titled trump cards bringing bit order chaos describe elements deal clear dealmaking taught anything else think dealmaking ability youre born genes still dealmaking gambling dealmaker confronts contingency moment submit chance people think im gambler ive never gambled life gambler someone plays slot machines prefer slot machines good business house said believe power positive thinking fact believe power negative thinking happen conservative business always go deal anticipating worst plan worstif live worstthe good always take care trump schwartz <NUMBER> dealmaker submits deal experiencing vertiginous play yet indemnifies risk imagining even living given circumstances would worst deal dealmaker able elevate beyond true risk course ultimately worst deal ultimate trump card death way indemnify dealmaker even risk live sake pleasure moment closing chapter trump writes dont kid life fragile success doesnt change anything success makes fragile anything change without warning thats try take whats happened seriously…the real excitement playing game… ask exactly deals im describe add end im sure good answer except ive good time making trump schwartz <NUMBER> paradoxical nature dealmaking form life manner living reveals fully dealmaster tries experience deal master deal one time tries master deal forethought anticipation risk yet greatest degree forethought brings us risk fragility things cannot surmounted would seem dealmaker must live present life deal life art creativity life pleasure temporal horizon dealmaker collapses present yet also clear dealmaker ever actually experience pleasure moment never stops wouldnt way try learn past plan future focusing exclusively present thats fun cant fun whats point trump schwartz <NUMBER> one live moment moment exists future ultimately fun past life dealmaking lives fully present ever exists future ever knows lived looking back fun fun fact something feel something enjoy something made bought commodity form pleasure last pages tried show trumps dealmaker dealmaking way life exemplifies paradoxical temporality life late capitalism one might speak way psychopathology everyday life though perhaps sense owes much heidegger freud interesting account shows pathology side winner absolute winner usually capitalist pathologies start side losers failed salesmen drug addicts compulsive gamblers neurotics shapes stripes <NUMBER> possible see pathology loser merely special case limiting case pathology winner yet interests way pathology already manifests fichtes thoughtand simply private quirk idiosyncrasy constitutive horizon german idealism even modern philosophy horizon continues play hegel schopenhauer nietzsche even heidegger… meant critique ad hominem speaks greatness thinker bring forth ruling characteristics age even pathological farreaching version argument could sketched follows whereas aristotle luck chance mark limit causal explanation hence rational articulation things said happen chance yet chance cause right modern philosophy clear empiricism begin regard contingency primary positive source knowledge tension necessity contingency also autonomy heteronomy comes fore german idealism regards tension generative productive ultimately seeks systematic reconciliation heidegger turn following schelling nietzsche also hölderlin returns tension makes irreducible fundamental starting existential analysis thrownness projection recent philosophical encomiums radical contingency must seen light current paper restrict addressing one piece puzzle though indeed important piece indeed fichte recognized greater clarity contemporaries experience life game chance constitutive horizon present age yet time rejected hegelian conviction even certain forms marxism would continue hold game stacked direction progress well schellings belief purely ideological mastery game would suffice fichte contrast gaming quality modern life demanded one last gamble could play worldhistorical stage extraordinarily risky play bring game end way master game finish eighth final section third final book closed commercial state fichte presented regards absolutely compelling case proposal carried would bring ills world end turns anticipation question must necessarily come preoccupy whose philanthropic measures rejected mocked ones wish help wont say <NUMBER> observing incapacity great part mankind follow argument presented series deductions first principles proceeds set forth true reason ideas proposed profoundly displeasing many cannot bear think state things aim characteristic feature age standing sharp relief seriousness sobriety ancestors wish play madly swarm fro fantasy since means available satisfy playurge strong inclination turn life game fichte <NUMBER> fichte tendency something blameworthy rather necessary step induced nature alone path leads species forward suggesting like schillers speiltrieb rooted something innate manifestation decisively historical character moreover primary manifestation aesthetic even intellectual rather primary expression tendency effects prove pernicious sphere economics consequence tendency one never wishes obtain anything following rule instead everything cunning ruses luck acquisition human commerce resemble game chance one could allow men keeping straight narrow things hope gain intrigues cheating chance save condition content rest lives would want delights strive things cunningly possess securely people incessantly call freedomfreedom trade acquisition freedom supervision policing freedom order morality whatever aims strict regularity things taking firmly ordered thoroughly uniform course appear infringement natural freedom people must repelled thought arrangement public commerce swindling speculation accidental profits sudden wealth would longer occur fichte <NUMBER> tendency fichte goes claim gives rise frivolity concerned present enjoyment future security whose life wisdom individuals politics states consists art getting present jam care given future difficulties one thrust remedy taken frivolity security future one promises never desires valid substitute unbridled freedom moment alone entices fichte <NUMBER> hard appreciate prescience force fichtes diagnosis least since would seem though even emergence complex apparatus regulative structures welfare state might give appearance progress measures appear end reactive insufficient proven incapable resisting triumphant march neoliberalism especially shape given hayek chicago school turned anarchic power chance elevated scientifically legitimated power spontaneous selforganization ultimate principle things precisely fichte regards fundamental tendency age one countervailing factor among others progressively unfolding historical dialectic extreme horizon possibility sort goaldirected action called question must reject view political given brilliant expression two decades later hegels elements philosophy right reconciliation freedom particularity individual abstract universality state thus closed commercial state proposes social arrangement economic existence every individual completely regulated state grants individual right pursue certain defined economic activity extracting produce piece land pursuing specific trade guarantees return labor able provide necessities life citizens forbidden freely engaging economic activity foreign entities indeed travel abroad permitted scholars artists even though vision state might seem perversely antimodern fichte indeed regards culmination historical process modernity emergence sovereign nation state reveals tendency toward closure yet merely juridical closure westphalian state enough must supplemented complete economic closure powerful prescient analysis global order colonial relations fichte argues fundamentally exploitative must ultimately lead complete destitution weak nations result trade imbalances ultimately compelled sell sovereignty highest bidder closed commercial state consists three books first offers rational deduction ideal arrangement economic relations culminating theory property exclusive right certain kind activity second concerns history present arguing effect europe originally constituted single vast system trade yet process dividing nation states claims mercantilism represented series halfmeasures undertaken pursuit economic closure one consider passage cited view argument pursued first two books fichtes reasoning would seem peculiar altogether bizarre one hand would seem little point offering proposal contrary spirit age tendencies hand tendency present age toward closure would suggest present age serious might first seem case indeed relation playful serious modes existence complex fichtes closing words suggests perhaps indeed playfulness necessary step driving species forward might imply playful wheeling dealing man present fact agent world historys serious intentions whereas fichtes economic philosophy ponderous heavy teutonic seriousness nonstarter considerations would seem must lead us path taken hegel moreover saw great clarity totalitarian tendencies fichtes seemingly consequent liberalism third book closed commercial state however moves altogether different direction fichte proposes nothing less kind trick catalyzing chain commercial closures trick introduced title politics goes follows one dominant economic powers world suddenly carry money operation involves replacing gold currency used within borders national currency made material cheap yet impossible private parties counterfeit whose value fixed whose validity guaranteed state first state reap tremendous benefits instantly nearly doubling wealth since gold freed function domestic means exchange able acquire tremendous military power must use sole purpose claiming natural boundaries needed selfsufficient economic existence states seeing follow though benefit less first eventually states compelled close economically survive hardly escape us fichtes money operation consists enormous seemingly mad geopoliticoeconomic wager first country close reap greatest benefits exposed greatest risk think could escaped fichte money operation might instantly led immediate disastrous political crisis fichte spend much time risks take seriously rather concerned selling proposal position power might say convinced danger present world faces great sort gamble could lead us back abyss fears economic conditions allow noble free truly human existence destroyed best tradition philosophers afraid philosophy dignity contemplative human reason yet precisely characteristic present age love risk gambles tricks cunning makes fichtes worldhistorical wager possible world loves gamble could find statesman crazy enough gamble everything payoff peace earthamong states within states territory abrupt end dynamism history substitution madness history gentle stable progress based peaceful limited interactions nation states welldefined rich national character system become universal eternal peace established among different peoples single state face earth slightest interest keeping discoveries since use needs inside boundaries oppress states provide superiority nothing follows prevent scholars artists nations entering freest commerce one another public papers longer contain stories wars battles peace treaties alliances things vanished world contain news advances science new discoveries progress legislation police state hasten make home inventions fichte <NUMBER> almost two centuries francis fukayama <NUMBER> years kojeve fichte envisions end history yet end history brought forth less accord ruse history driving forward suffering contradiction toward absolute ruse fichte perhaps fichte existed another great thinker would figured money operationyet whoever discovers however long takes always involve event intervenes existing order things catalyzing chain reaction occurrences leave world utterly transformed <NUMBER> event destined necessitated way intervention invention fundamentally new kind currency imposed top introducing new kind numismatic regime new sovereignty beyond sovereignty <NUMBER> fichte true property must issue free activity indeed believes fundamental error existing theories property consists fact one posits first original property exclusive possession thing theory maintains first original property basis others consists exclusive right determinate free activity fichte <NUMBER> take idealistic theory property already developed great consequence seriously might ask human race appropriates history become fully property historical existenceor indeed historical existence could event selfappropriation vital question necessary question since without historical selfappropriation human freedom would amount nothing thought early humanistic marx still operates within horizon question perhaps still even work heideggers ereignisthe propriative event however difference fichte hegel comes striking view hegel history ongoing process absolute spirit appropriates passing dunamis energeia sense indeed hegel could never actually entertained end history simple sense fichte contrast highest appropriative event wager philosopherstatesman wager end wagers hence end history characterized chance way kind platonism work fichte philosopher one owing nothing world born precipitates event conversion first chain liberating actions human beings take ownership historical existence hence humanity acting decisive way riskiness existence enmeshed yet decision need fact happen originate one visionary risky highest degree possible highest wager secret motto fichtes closed commercial state one could almost say hōlderlinian bon mot coined <NUMBER> years later heidegger writing wake devastation second world war draws question concerning technology wo aber gefahr ist wächst das rettende auchwhere danger salvation saving power yet must give us pause fichte offers powerful prescient critique form life ever come prevail conditions capitalism also succumbs conceit would possible play game master game time expose oneself risk indemnifying oneself risk one might claim risktaking essential value fichte think however speculative thought risktaking thought speculative desire philosopher piece characteristic age indeed fichte recognizes much claiming many wrongly blame poetry philosophy frivolousness age remarks poetry philosophy responsible phenomenon merely serve case former divert toward something else life case latter challenge extent concerns life mean proper domainbeyond sphere ordinary lifephilosophy remains playful precisely bad faiththe pathologyof capitalism form life moreover assumes ever complex concrete forms emergence new ever intricate ways monetizing risk capitalism fetishizes risk yet precariousness becomes general condition capitalists able profit risk longer partake paradox pathology however follows relentlessly losers game life find exposed precariousness struggle find perspective lives according become masters risk exposed contemporary forms life characterized dualism functions ideology regardless particular forms assumes let us consider donald trumps reality show apprentice genre reality show thought perverted brechtian drama brechts plays sought present human condition relentless struggle survival way could realize fateful tragic condition condemned historical reality created reality show turns head struggle survival appears one hand purely effect artificial contrivances show forced people together confined space compete contrived challenges yet time elevates artifice law fate says effect must struggle celebrity gamemaster tells us must must submit celebrity gamemaster everyone celebrity everybody nobody way becoming somebody must want celebrity yet watching reality show grants pleasure denied participants perhaps way becoming celebrities even granted little piece celebrity cannot identify gamemaster however watching even participants game bigger losers biggest loser nevertheless identify completely celebrity gamemaster passing judgment winners losers youre firedi knew think apprentice bad job deserved lose theyll know whose boss uniquely american style fascism offing consists heart logic identification fascism words longer depends suppression individual name communitarian collective valuesvalues however cynical deployment propagandists ruling elite nevertheless retain strong rhetorical force among multitude donald trump master game masterplayer offers perfect point new mode identification identify state collective sacrificing claim individual autonomy rights rather identify atomized individuality system governs lives dispenses lives without either demanding sacrifice offering hope rediscovering individuality universal take pleasure system live vicariously system even though inevitably condemns us however much fun along way lose <NUMBER> sense understand trumps economic nationalism one hand opposite fichtes nothing securing economic rights economic justice even limited recognition responsibility state provide citizens possibility livelihood sufficient allow dignified fully human life nothing even altright might cultural integrity nation state rather trumps economic nationalism follows elevation president dealmakerinchief economic relations nations say mere occasions leader show dealmaking prowess turn serves allow popular identification one able play game enjoy game master time keep playing game yet never lose case trump course identification happens various exclusions racial ethnic sexual foreigners liberals women refuse objectification elderly urban poor preexisting conditions whose lives wake covid<NUMBER> pandemic become expendable rush reopen economy aspect trumps political style provoked greatest degree public outrage also suggests point vulnerability logic late capitalism reveals still largely impossible identify system take pleasure system without gestures exclusion might tempting claim logic exclusion structurally necessary system yet may well case capitalism depends gives rise stratifications fall outside strict logic class conflict tendency capitalism remains directed dissolution least level explicit public ideology qualitative distinctions since inevitably stand way maximization profit trump made clear particularly brutal fashion increasingly necessary identify system since forms life become hollowed longer offer path enjoyment happiness also least broad section population impossible identify system outermost purity abstraction become relatable become livable system must become precisely longer nation ethnicity race thus eyes many system become divided two systems one good one evil radically impersonal system capitalism impersonated ethnoracial state ultimately felicitous happy image businessownertrump small businessman grown monstrous proportionsand radically impersonal system deep state impersonated scheming agent journalist culturalmarxist jew need impersonation surge explicitly exclusionary idioms back mainstream national politics results failure project division identification since end second world war conservatism united states england pursued good system lifeaffirming creative entrepreneurial capitalism versus bad system totalitarianism government regulation yet complete failure trump anything beyond adventuresome grandstanding global arena challenge unfettered dominion corporate interests suggests ethnoracial nationalist impersonation capitalism mask neoliberalism remains force circumstance dangerous highest degree also discloses internal structural contradiction within late capitalism may well also offer certain hope reveals ultimate incapacity capitalism reproduce ideological conditions survival funding applicable recent pandemic novel coronavirus already affected thousands people continuing spread around world virus called severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> disease caused called coronavirus disease <NUMBER> <NUMBER> may <NUMBER> total <NUMBER> confirmed clinical episodes covid<NUMBER> <NUMBER> deaths reported worldwide <NUMBER>a sarscov<NUMBER>infected people experience mild moderate respiratory distress generally recover without requiring special treatment however older people generally <NUMBER> years age underlying medical complications like diabetes cardiovascular disease chronic respiratory disease cancer likely develop serious symptoms like acute respiratory disease multiorgan failure ultimately leading death lai et al <NUMBER> sarscov<NUMBER> belongs family sars severe acute respiratory syndrome mers middle east respiratory syndrome viruses responsible epidemics <NUMBER> <NUMBER> respectively lu et al <NUMBER> genomes sarscov<NUMBER> single positivestrand rna codes similar structural protein sars giving rise debate whether laboratory engineered sars virus naturally evolved new virus sequence analysis rna made available china public database showed novel virus originated possibly bats natural evolution andersen et al <NUMBER> however got transmitted bats humans high transmission rates humans humans still ambiguous infection human cells receptorbinding domain spike protein present envelope virus binds ace<NUMBER> protein present human cells initiating entry process binding induces large conformational change protein leads exposure proteolytic site proteolytic site cleaved protease causing fusion viral envelope host cell membrane completing entry virus human cell shown protein sarscov<NUMBER> higher binding affinity ace<NUMBER> compared sars wrapp et al <NUMBER> based results could concluded sarscov<NUMBER> variant sars however sarscov<NUMBER> genome additional features like presence polybasic rrar cleavage site junction s<NUMBER> s<NUMBER> subunits spike protein presence polybasic cleavage site helps effective cleavage furin proteases determines viral infectivity host range andersen et al <NUMBER> interestingly case avian influenza virus gain polybasic site ha performs similar function host receptor binding like spike protein transform virus low virulent high virulent forms along acquisition cleavage site positively selected fast replication transmission rates alexander brown <NUMBER> better understand transmission rates growth rate r <NUMBER> defines natural transmission pathogen needs calculated sars mers sarscov<NUMBER> interesting observe although belong family sarscov<NUMBER> twice transmission rate compared sars along multiplication cycles range <NUMBER> days sars mers <NUMBER> days sarscov<NUMBER> liang <NUMBER> probably reason sars mers far contained whereas covid<NUMBER> highly widespread mortality rate sarscov<NUMBER> early outbreak wuhan china calculated <NUMBER> however late february estimated rate increase <NUMBER> hand south korea registered death rate <NUMBER> less death rate italy seems several folds higher rosenbaum <NUMBER> infection advanced <NUMBER> countries territories average mortality rate <NUMBER> according recent reports rajgor et al <NUMBER> therefore therapeutic vaccine initiatives direction inevitable efforts made drug therapy well vaccine development combat covid<NUMBER> till date us food drug administration fda approved antiviral drug remsdesivir developed gilead inc usa antimalarial drug chloroquine cqhydroxychloroquine hcq treatment covid<NUMBER> array drugs approved diseases also considered potentially useful several investigational drugs study several clinical trials conducted across globe table <NUMBER>a b figure <NUMBER> order clinically manage coronavirus researchers china france team doctors rajasthan india started using antiviral drugs combination chloroquine colson et al <NUMBER> lai et al <NUMBER> recently announced global trial called solidarity investigate whether dangerous respiratory disease could treated available therapeutic aids httpsnewsunorgenstory<NUMBER> <NUMBER> however unprecedented effort includes thousands patients across many countries volunteer clinical trials trials aim test effectiveness four potential candidates <NUMBER> antiviral drug remdesivir known inhibit rna dependent rna polymerase <NUMBER> combination two hiv drugs lopinavir ritonavir <NUMBER> lopinavir ritonavir plus interferon beta <NUMBER> antimalarial drugs chloroquine hydroxychloroquine table <NUMBER>b coronavirus rna virus retroviral drugs could possibly effect treatment however cq hcq successful antimalarial currently considered part treatment strategy covid<NUMBER> colson et al <NUMBER> cq also shown possess antihiv activity posttranscriptional inhibition gp<NUMBER> present viral envelope inhibition tatmediated transactivation jiang et al <NUMBER> savarino et al <NUMBER> chloroquine also increase ph endosomes mauthe et al <NUMBER> since coronavirus encode gp<NUMBER> tat protein low ph essential uncoating virus inside host cell likely chloroquine stops viral spread blocking process uncoating release nucleic acid however current data various small nonrandomized trials show limited effects cq hcq hcqazithromycin combination treatment covid<NUMBER> since cqhcq known cause toxic effects unprescribed use led human deaths largescale randomized trials like solidarity project able convincingly prove effectiveness cqhcq drug covid<NUMBER> recently shown combination lopinavirritonavir causes adverse effects covid<NUMBER>infected adults benefits observed cao et al <NUMBER> therefore drugs used caution mechanisms well understood efficacy well established also known viruses mutate high frequencies give rise different strains thereby easily gaining resistance drugs thus indepth analysis animal models required study mechanism action ability virus gain resistance drugs animal testing also important measure absorbance drug body dissociation chemistry metabolomics mechanism drug clearance principle drugs help treatment humans contract disease longterm protection disease vaccines developed avoid global pandemic vaccines able mount immune response virus generating neutralizing antibodies would protect humans infected sarscov<NUMBER> thus avoid another outbreak virulent virus development vaccine disease combined effort academicians industries normal circumstances final product vaccine use humans takes least <NUMBER> years passing six phases assessment bregu et al <NUMBER> first phase academician identifies target potential vaccine candidate thereafter candidate challenged vaccine potential testing animal models disease safety well immune responses antigen analyzed identification development vaccine candidate bottleneck takes majority time <NUMBER> years required vaccine development steps successful taken clinical trials three phases tested humans safety phase efficacy protect disease phases ii iii take another <NUMBER> years figure <NUMBER> different companies already taken initiatives develop vaccine covid<NUMBER> important note studies sars provided important clues vaccine covid<NUMBER> also fasttracked overall process vaccine development vaccine initiatives various companies covid<NUMBER> broadly based three strategies using dna rna ii weakened virus known vlps iii targeting viral proteins protein <NUMBER>b one important factors antigen considered vaccine candidate ability mount good immune response however practicality one always constrained terms antigen used vaccine candidates thus enhance immune responses kim et al developed microneedle delivery method induces antigenspecific antibody response early week <NUMBER> immunization microneedle injection causes brief mechanical stress induces local innate immune response thus avoids use adjuvant also skin possesses high amount immune cells involved innate immune response even injecting small amount antigen lead significant activation innate immune responses antigen kim et al <NUMBER> making effective strategy antigens immunogenic order establish antigen vaccine candidate animal models profound importance various aspects vaccinology route analyses mechanism transmission disease duration induced protection host immune response infection vaccination griffin <NUMBER> thus testing animals considered important critical parameter proceed clinical trials humans one major problems associated vaccine efforts covid<NUMBER> animal disease models sarscov<NUMBER> testing absence models difficult predict outcome challenge studies humans gralinski menachery <NUMBER> animal model disease pathogen able infect animal using receptor cells used humans multiply inside host successfully additionally provide either similar clinical symptoms humans sometimes mild symptoms also work would help studying immune responses pathogen following sections discuss various animal models tested based pathogenesis infection sarscov<NUMBER> key <NUMBER> amino acid residues present ace<NUMBER> humans conserved ace<NUMBER> macaques well melin et al <NUMBER> macaques closer model system humans hence choice animal studies vaccine testing covid<NUMBER> studies macaques shown get infected pulmonary infiltrates observed radiographs high viral loads swabs nose throat shedding upper lower respiratory tract munster et al <NUMBER> rockx et al <NUMBER> taken together disease symptoms rhesus macaques matches milder symptoms sarscov<NUMBER> infection humans serum analysis demonstrate increase chemokine levels il<NUMBER>ra il<NUMBER> il<NUMBER> mcp<NUMBER> il<NUMBER> decrease tgfa levels days <NUMBER> <NUMBER> postinfection statistical significance munster et al <NUMBER> sarscov<NUMBER> known affect older people compared young ones similarly also observed macaques older ones show higher viral loads nose throat along prolonged viral shedding upper respiratory tract old animals rockx et al <NUMBER> thus rhesus macaques promising animal model challenge studies studying efficacy vaccines immune responses monkeys similar humans allow us understand monkeys challenge coronavirus protect ferrets model organisms influenza virus similar lung morphology humans actually cough sneeze supporting use animal model sarscov<NUMBER> cameron et al <NUMBER> enkirch von messling <NUMBER> team virologists led ss vasan australia already shown animals susceptible coronavirus callaway <NUMBER> virus causes increase body temperature symptoms hallmark sarscov<NUMBER> develop virus cannot replicate high levels interestingly infected ferrets spread virus high transmission rates even adjacent cages direct contact aerosols kim et al <NUMBER> since countries community transmission stage ferrets act valuable animal model study transmission sarscov<NUMBER> compared logistics cost ethical regulations using monkeys ferrets laboratorybred mice always remain convenient choice disease model however coronavirus infect mice rats <NUMBER> <NUMBER> amino acids mice <NUMBER> <NUMBER> amino acids rats differ binding region ace<NUMBER> compared humans chan et al <NUMBER> order solve problem perlman laboratory developed humanized mouse models sars incorporated human ace<NUMBER> mice mccray et al <NUMBER> humanized ace<NUMBER> mice successfully infected sars develop lethal brain disease making obvious choice test infection sarscov<NUMBER> well however due lack funding high cost maintenance mice colony discontinued breeding mice facility submitted sperms hace<NUMBER> mice jackson laboratory mice high demand jackson laboratory facing huge pressure meet demands however recent results china shown hace<NUMBER> mice support sarscov<NUMBER> infection reduce weight <NUMBER> virus replication occur lungs moreover infected hace<NUMBER> mice also suffer interstitial pneumonia bronchioles filled periodic acid schiff pas positive exudation detached bronchial epithelium unable transmit disease also infiltrates enriched macrophages tlymphocytes blymphocytes authors also confirmed mice use hace<NUMBER> entry fulfill kochs postulates indicating mice successful disease model sarscov<NUMBER> bao et al <NUMBER> animals support sars infection show maximum similarity human ace<NUMBER> <NUMBER> amino acids <NUMBER> different critical binding region ace<NUMBER> making testable model sarscov<NUMBER> infection upon infection sarscov<NUMBER> syrian hamsters demonstrate weight loss <NUMBER> along high viral load nasal turbinate lungs trachea lethality rate hamsters <NUMBER> exudative inflammation hemorrhage necrosis alveolae damage visible initial infection period inflammation intestinal mucosal epithelium causative agent diarrohea along myocardial degeneration consistent pathogenesis observed humans importantly syrian hamsters show similar immune responses humans ifnc proinflammatory cytokines induced day <NUMBER> postinfection followed decrease type ii interferon il<NUMBER> increase tgfb day <NUMBER> postinfection animal successful model system perform challenge studies also dependent ability transmit pathogen consistent syrian hamsters able transmit disease naïve hamsters upon challenge sarscov<NUMBER> chan et al <NUMBER> taken data together syrian hamsters show pathogenesis immune responses similar humans capable transmission strengthens use one testable models vaccine studies thus many promising animal models testing vaccine candidates sarscov<NUMBER> still extensive studies required confirm efficiency appropriate model covid<NUMBER> order fight coronavirus infection win race time moderna biotechnological company collaboration national institute allergy infectious disease niaid usa already begun phase clinical trial experimental vaccine mrna<NUMBER> rna vaccine testing begins <NUMBER> <NUMBER>b argument directly going phase clinical trial mrna<NUMBER> raised good antibody response immunization mice lack disease model coronavirus cansino biologics china also developed replicationdefective adenovirus expressing spike protein sarscov<NUMBER> vaccine candidate covid<NUMBER> <NUMBER>b beijing institute biological productswuhan institute biological products sinovac using inactivated method inovio pharmaceuticals using dnabased vaccine approach similarly order fasttrack vaccine development skipped animal trials currently performing phase trials phase clinical trials test safety toxicity vaccine target humans way help protecting humans sarscov<NUMBER> although looks promising fasttracking vaccine development division among scientific community bypassing animal models phase clinical trials addition agencies like peta using animals research purposes question remains vaccine research without animal model history mankind clear viral pandemics common affecting millions people problem due ability multiply inside host produce high numbers infecting single cell accompanied stability nonliving surfaces allows spread fast virus pandemics global high transmission rates thus control viruses extreme steps often needed therefore absence disease model backed antibody responses mice niaid cansino biologics moved ahead phase clinical trials bypassing animal model studies vaccines different biotechnological companies looking forward come vaccine around year year half thus decision fda bypass animal trials taken positively entrepreneurs according flexibility laws fda could avoid delays treating observed case ganciclovir although ganciclovir successful treating patients acquired immunodeficiency syndromerelated cytomegalovirus retinitis due lack animal studies get approval fda delayed <NUMBER> years van norman <NUMBER> besides overcoming time frame vaccine enter market also important note results animal studies may translate humans terms toxicity challenge studies isuprel treatment asthma rendered safe rats guinea pigs dogs monkeys still led deaths humans far less dosages great britain another instance treat human autoimmune disease monoclonal antibody tgn<NUMBER> going animal models processed phase trials introduction tgn<NUMBER> led critical illness within minutes along longterm complications phase volunteers van norman <NUMBER> however tgn<NUMBER> restored rheumatoid arthritis developing better assays studying immune responses lowering dosage monoclonal antibody brown <NUMBER> strengthening fact studies animals may always translate use humans contrast chemicals generally toxic animal studies may safe humans penicillin fatal guinea pigs would failed animal studies due lack regulations perform animal studies time came use presently successful drug similarly aspirin toxic rhesus monkeys paracetamol toxic dogs cats van norman <NUMBER> thus studies indicate animal studies predict outcomes humans although share lot genomic similarities final response disease also depend epigenome environmental differences even transgenic humanized models mimic human system must remember often genes work alone complex higherorder organisms although bypassing animal models save time effort money possible perform safety challenge studies disease humans also animal studies provide foundation study disease difficult study progression disease humans easy animal model sacrificed histopathology order follow course infection although cell lines also used study infection process animal models provide advantage studying viral multiplication respect symptoms physiology organism thus becomes really important newly originated coronavirus studied animal model studying animal models also provide detailed information potential reservoirs sarscov<NUMBER> organism another problem faced vaccine efforts viral diseases especially viruses rna genetic material repair mechanisms work rna thus lot mutations accumulated rna phenomenon known antigenic drift reason influenza shots needed every seasonal flu infection thus sarscov<NUMBER>possessing rna genome also prone antigenic drift hence animal models coronavirus help understanding selection pressure antigenic drift evolution virus vaccine administered one major disadvantages bypassing animal models observed case viral infections sometimes administration vaccines enhances susceptibility subject disease phenomenon known antibodydependent enhancement antigen sin common vaccine candidates hivaids virus dengue virus subject immunized antigen mounts immune response antigen vaccinated individual infected virus different serotype preexisting antibodies able neutralize virus formation antibodyvirus complex helps attachment fcc receptor circulating monocytes resulting efficient infection monocytes virus halstead <NUMBER> thus instead protecting subject leads higher complications death subject case infection pathogen huisman et al <NUMBER> therefore biotech companies bypassed animal models note antibodydependent enhancement also observed feline coronavirus fcov immunization mice spike protein virus mounts overall high antibody response neutralizing antibody levels low however challenge cats results enhanced susceptibility infection along death cats huisman et al <NUMBER> phenomenon especially relevant proteins prone antigenic drift protein sars mers known capable phenomena liu et al <NUMBER> houser et al <NUMBER> protein major vaccine target sarscov<NUMBER> studies animal model really required establishing vaccine candidate global emergency entire scientific community attempting effective treatment prevention disease shorten time larger interest humanity routine yet essetial processes like animal trials bypassed process development vaccine drug development options like drug repurposing already adapted varying degrees success effective targeted drugs vaccines sarscov<NUMBER> infection still awaited moreover agencies like fda already given green signal clinical trials vaccines bypassing regular process animal trials hence important access positive negative effects choosing suitable animal model one main concerns animal testing animal mimic response effects generated introduction drugvaccine humans importantly animal models rhesus macaque ferrets mice syrian hamster proving successful challenge sarscov<NUMBER> one similar symptoms humans however successful animal trial indicator success drugvaccine due physiological barriers hence decision bypassing animal model needs taken utmost caution saving time cost large number human lives failure drugvaccine could devastating consequences spread covid<NUMBER> pandemic seriously challenging scientific community quest find suitable vaccines andor drugs fast possible unlike many diseases medical need also increasing pressure key economic political decisionmakers president european commission ec ursula von der leyen example voiced hopes vaccine would available autumn <NUMBER> wheaton <NUMBER> light similar remarks worth looking tools regulatory mechanisms may allow us overcome unprecedented health crisis viral infections prototypic speciesspecific diseases make animal testing challenging even without time pressures duration costs especially genetically modified strains susceptible disease need bred support ambitious goals modern bioengineered human multiple organ models lend antiviral drug development countries already started human clinical trials minimal safety testing animals example national institutes health nih roberts <NUMBER> boodman <NUMBER> ema provided updates treatments vaccines development covid<NUMBER> last briefing <NUMBER> anticipated timelines market entry <NUMBER> <NUMBER> outline way forward facilitate market access authorization ema <NUMBER>a exceptional funding efforts also made available via electronic supplementary material online version article https doiorg<NUMBER>s<NUMBER> <NUMBER> <NUMBER> contains supplementary material available authorized users publicprivate partnership innovative medicines initiative imi https bitly<NUMBER>adrb boosting development therapeutics diagnostics tackle current future coronavirus outbreaks imi <NUMBER> ec research innovation <NUMBER> explore nam accelerate developments four testing programs drug vaccine discovery may accelerated use nam drug vaccine development differ principle detail meigs et al <NUMBER> go steps preclinical clinical development acceptance postmarket surveillance vaccine developments tend longer <NUMBER> years vs <NUMBER> years drug trials clinical trials often larger longer risk populations need vaccinated often rare events due nature biologicals often produced fermenting types cell culture vaccines frequently need batch release controls public health measures vaccines face even higher pricing pressures makes development vaccines less attractive pharma indeed major pharma companies engaging development support vaccine development governmental players nonprofit foundations cofunding rd sometimes production interestingly <NUMBER> global vaccine producers european <NUMBER> vaccine consumption us meigs et al <NUMBER> altogether drug discovery rd differs many scientific disciplines understanding major components helps us appreciate new tools used accelerate process models also called test systems essential rd process traditional models based experimental animals novel approaches animalfree use tissue cultures computational techniques third type test model must forgotten however complement others healthy diseased humans use tools rd programs need answer four entirely different questions therefore used four different testing strategies approaches particular models providing specific opportunities use nam scopes four approaches <NUMBER> efficacy usually comes mind think drugs vaccines even principles efficacy action clear eg preventing viral replication blocking virus entry cell also particular molecular target known eg viral rna polymerase docking receptor fig <NUMBER> finding drug candidate interacts target also fulfills features essential make drug eg taken body transported target site tedious highly resourceconsuming process <NUMBER> safety entirely different set models tests used evaluate whether drug welltolerated without adverse sideeffects ie toxicity instance needs assured block important functions human body attack important structures within human cells organs <NUMBER> quality safe efficacious vaccine drug found needs produced high importantly constant quality testing program differs fundamentally safety efficacy needs applied lot vaccine drug control impurities contaminants <NUMBER> target discovery last list first rd process testing program designed yield useful drug targets different models strategies required find example key steps virushost cell interaction identify processes human cells could used target decrease hyperinflammation targets may known diseases research may provide one fastest ways find suitable drugs strategy called repurposing typical example may glycosylation inhibitors fig <NUMBER> developed various neurological diseases may also considered viral infections park <NUMBER> parsons et al <NUMBER> tortorici et al <NUMBER> could tested quickly modern nam via metabolic glycoengineering kranaster et al <NUMBER> four approaches covid<NUMBER> research benefit investments made development nam past <NUMBER> years european perspective one two key developments establishment european center validation alternative methods eurlecvam within ec research infrastructure joint research center jrc followed creation network european reference laboratories eunetval coordinated eurlecvam second major push development nam came substantial funding research ec comprising <NUMBER> €year last <NUMBER> years since framework program <NUMBER> fp<NUMBER> also includes imi funding one current project eutoxrisk develops animalfree safety testing approaches budget <NUMBER> € daneshian et al <NUMBER> graepel et al <NUMBER> several national funding programs also contributed substantially development nam particularly netherlands germany uk legislation eu ban animal testing cosmetics strong incentive industry launch successful research programs nam safety quality control beilmann et al <NUMBER> us national academy sciences nas <NUMBER> report future toxicity testing twentyfirst century nrc <NUMBER> leist et al <NUMBER> leist et al <NUMBER> krewski et al <NUMBER> krewski et al <NUMBER> pivotal triggering chain events culminating roadmaps major agencies epa fda reduce ultimately abandon animal testing collins et al <NUMBER> tice et al <NUMBER> bouhifd et al <NUMBER> fda <NUMBER> thomas et al <NUMBER> epa <NUMBER> second notable report committee nas addressed drug efficacy countermeasures terrorism biological weapons nrc <NUMBER> hartung zurlo <NUMBER> clear recommendation given focus solely nam reasons speed predictivity parallel highly visible government activities industry moved largely animalbased efficacy testing <NUMBER>s predominantly <NUMBER> animalfree efficacy research methods today true academia especially industrydriven research target discovery busquet et al <NUMBER> cell culturebased methods combined modern molecular biology stem cell technology play major role use computational research silico models recently increased well pinero et al <NUMBER> vamathevan et al <NUMBER> parallel increasing awareness shortcomings animal models olson et al <NUMBER> hartung leist <NUMBER> leist hartung <NUMBER> use nam four testing programs detailed special sars<NUMBER>cov<NUMBER> covid<NUMBER> first animal disease model seems fig <NUMBER> overview drug repurposing approaches covid<NUMBER> black structures indicate target cell green structures refer host components processes virus elements shown blue drugs presented red drugs lower right corner considered fight inflammation smoothen potential cytokine storm ie act processes directly linked virus target cell type ii pneumocyte lung arrows refer drug targets target processes suggested literature sometimes exact targets respective drug efficacy known selection drugs drug types exemplary good approaches may missing shown may little use intention highlight broad variety approaches many also used clinically case studies compassionate trials initial stages testing programs stage nam would useful determine target structures ii define exact biological effects drug candidates iii investigate quantify efficacy iv close gaps safety knowledge candidates yet approved used clinically settings eg dosing schedule ace<NUMBER> angiotensin converting enzyme<NUMBER> sace<NUMBER> recombinant soluble domain ace<NUMBER> ifn interferon tmprss<NUMBER> transmembrane serine protease subtype<NUMBER> aak<NUMBER> gak enzymes involved endocytosis jak kinase janus kinase family involved cytokine signaling inflammation color figure online closely related coronaviruses asian bats reptiles lend lab animals show far know pathology found humans typical reflex animal model suggest using nonhuman primates nhp even great apes helped us hiv hepatitis c shown us national academy sciences nas <NUMBER> research great apes common response breed genetically modify lab animals mice render susceptible done earlier sars virus mccray et al <NUMBER> however misses obvious opportunity human microphysiological systems mps become available last decade due stem cell technology bioengineering alepee et al <NUMBER> marx et al <NUMBER> marx et al <NUMBER> ewart et al <NUMBER> shown earlier viral infections studied human brainspheres minibrains abreu et al <NUMBER> zika dengue well others including sars<NUMBER>covid<NUMBER> published shortly others also similar research various organs european organovir education network https organ ovircom many groups building models leverage covid<NUMBER> rd important finding based organoids published research group vienna focused soluble viral receptors sace<NUMBER> therapy monteil et al <NUMBER> however limitations research done biosafety level <NUMBER> guidelines virus sophisticated systems pumps sensors microscopes difficulttosterilize equipment specific consideration thus given design simple robust modelstypically organoids organonchip systems respiratory tissue commercial offers currently exist epithelix mattek gordon et al <NUMBER> seems however lifethreatening course covid<NUMBER> occurs cytokine storm acute respiratory distress syndrome multiple organ failures forms septic shock especially resistant drug identification killing drug companies sepsis programs septic patients clinic rather unlikely multiorgan failures covid<NUMBER> disease developed represent different situation cochrane study register covid<NUMBER> listed <NUMBER> april <NUMBER> total <NUMBER> studies launched <NUMBER> interventional <NUMBER> aimed treatment management https covid <NUMBER>cochr aneorg however understood proportionally light <NUMBER> clinical trials listed <NUMBER> world health organization https bitly<NUMBER>y<NUMBER>tz qs still speed getting started impressive shows drug repurposing mainly occurring surprising drugbank lists <NUMBER> drugs available <NUMBER> small molecules <NUMBER> biologicals <NUMBER> approved https wwwdrugb ankcastats rich portfolio typically already undergone safety testing allows move quickly ahead initially focus entirely nam cellular infectivity instance tested cell cultures vero cells organoids molecular viral targets like polymerase initially tested recombinant form biochemical assays methods allow high throughput thousands samples provide much robust exacting data animal experiment could deliver complex questions concern whether potential drug would reach target tissue whether would also act complex disease setting inflammation altered ph variety cell types moreover combinations complex vitro models silico approaches physiologybased pharmacokinetic pbk modelling well established routinely used drug industry academia considering share repurposing drug candidates comes hiv drug research ample opportunity test failed discarded substances well supportive therapies first results established aids therapies however disappointing https bit ly<NUMBER>cmms xe summarized limited evidence far https bitly<NUMBER>s<NUMBER>ni rf discussions hopes continue murphy <NUMBER> fig <NUMBER> case hiv treatments ultimately became successful combining originally four three different treatments known haart highly active antiretroviral therapy however understanding hiv differs covid<NUMBER> two critical aspects extent immune escape persistence body still might necessary combine treatments always challenge drug development approval practical patient care nam may used identify effective combination targets synergy find beneficial combination drugs concentration ratios efforts carried patients already <NUMBER> vaccines covid<NUMBER> development thanh et al <NUMBER> organoids mps devoid immune component lend less substitute though addition immune cells becoming common addition antibodies serum vaccinated animals recovered humans models test efficacy instead infecting animals opportunity promising development artificial lymph nodes reported first suematsu watanabe <NUMBER> giese marx <NUMBER> summarized progress developing optimizing <NUMBER>d human artificial lymph node model mimic interface innate adaptive immune response vitro giese et al <NUMBER> see also cupedo et al <NUMBER> models shown merit evaluation immunogenicity influenza vaccines drake et al <NUMBER> certainly represent prime nonanimal method covid<NUMBER> vaccine development vaccine development usually targets active vaccination ie exposure humans relevant antigens followed active immune response passive vaccinations also envisaged fig <NUMBER> process antibodies viral antigens produced biotechnology methods injected best known emergency vaccines tetanus variant approach isolation antibodies serum covid<NUMBER> survivors use patients jhsph <NUMBER> casadevall pirofski <NUMBER> traditional oldfashioned way antibody generation uses animal models nowadays monoclonal antibodies produced entirely animalfree molecular biology techniques eg phage display use animals also limitations due pronounced speciesspecific differences pathogenesis antigen recognition immune reactivity nonlymphoid lymphoid tissues systemic orchestration immunity organism level first successful attempt rhesus macaques confirmed april <NUMBER>th <NUMBER> gao et al <NUMBER> however concerns raised approach due fact monkeys develop severe symptoms sarscov<NUMBER> causes humans cohen <NUMBER> therefore fast transition initial trials vitro next step humans often taken covid<NUMBER> research us ind investigational new drug application fda food drug administration starts clinical phase describing manufacturing testing processes laboratory reports proposed study well approval institutional review board institution clinical trial conducted fda <NUMBER> days approve application clinical studies human subjects start similar clinical drug development • phase vaccine trials typically <NUMBER> adults may nonblinded assess safety type extent immune response • phase ii vaccine trials typically several hundred individuals often groups risk acquiring disease trials randomized wellcontrolled include placebo group study safety immunogenicity proposed doses schedule immunizations method delivery • phase iii vaccine trials involving thousands tens thousands people randomized doubleblind studies placebo assess safety rare side effects efficacy prevention disease prevention infection pathogen production antibodies types immune responses related pathogen difficult imagine process could shortened year <NUMBER> months recently suggested policymakers nam described thousands articles past large successes toxicological areas also gaps filled basketter et al <NUMBER> leist et al <NUMBER> approaches contributed limit animal use toxicology much less biomedical research busquet et al <NUMBER> use nam animal welfare issue issue timeor precisely time market worldwide pandemic speed drug development carries enormous weight traditional full safety package based animals includes longtime chronic dosing two years followed lengthy histopathology evaluations however shortcuts seem possible understand applicability covid<NUMBER> exact testing needs must reviewed depending type use duration treatment application methods use pregnancy susceptible populations safety data package initial human use rather light speed <NUMBER> clinical trials begun covid<NUMBER> shows shortcuts taken may generate discussions might possible generally common practices pandemic bruckner <NUMBER> case covid<NUMBER> dosing time drug short often <NUMBER> weeks less many cases pregnancies ie reproductive developmental toxicity issues excluded needed situation <NUMBER> drug acutely toxic <NUMBER> trigger cancer <NUMBER> interfere drugs concerning <NUMBER> situation nam favorable accepted methods available acute topical toxicities also acute systemic toxicity may predicted possibly combination limited number animal experiments hamm et al <NUMBER> strickland et al <NUMBER> concerning <NUMBER> one needs distinguish genotoxic nongenotoxic carcinogenicity genotoxicity successful area nam addressed decades drug development available methods fast days highly sensitive corvi madia <NUMBER> corvi et al <NUMBER> nongenotoxic carcinogenicity harder predict animals nam shows pronounced species differences hernandez et al <NUMBER> one fundamental fact nongenotoxic carcinogens require usually long exposure times thus short treatment covid<NUMBER> minimizes issue moreover nam developed identify typical mechanisms contributing nongenotoxic carcinogenicity eg nuclear receptor activation hernandez et al <NUMBER> jacobs et al <NUMBER> cmr carcinogenicity mutagenicity reproductive toxicity endpoints thus typically critical ensure minimum safety requirements entering clinical trials stage specific context covid<NUMBER> mentioned drug repurposing currently focus requirements usually waived since treatment less <NUMBER> months data particularly needed request full contraception pregnancy tests every month cover fertility clinical trials needed repeated dose test maximally onemonth length would great opportunity complete data set mps since cover <NUMBER> days adapted doserepetition mps qualified however therefore difficult use regulatory context although examples platforms ready used vaccine preclinical testing sanchezschmitz et al <NUMBER> recently published ema regulatory strategy <NUMBER> reports one reason hesitancy may concerns part developers well industry use new approach methodologies nams acceptable regulators thus stall approvals possible reasons limited use nams include lack knowledge regarding existence exact functioning models lack model validation high costs associated implementation ema <NUMBER>b mentioned since focus currently drug repurposing submission proposals rich safety information already considerations ill patient group impact treatments applied time critical long standard care proper control difficult define concerning <NUMBER> excellent nam available test drugdrug interactions level transporter drugmetabolizing enzymes wellestablished drug discovery companies therefore methods allow quick transition testing humans major question deciding test methods nam vs animal prevent harm trial participants end patients olson et al <NUMBER> showed quite impressively limits predicting human adverse effects animal testing recently tamaki et al <NUMBER> studied <NUMBER> adverse drug reactions administration <NUMBER> drugs approved japan <NUMBER> <NUMBER> half predicted preclinical animal data even less predictivity found bailey et al <NUMBER> bailey et al <NUMBER> <NUMBER> drugs two industry groups however monticello et al <NUMBER> clark stegerhartmann <NUMBER> positive results noted problem end clinical trials <NUMBER> discontinued withdrawn drugs europe us almost half discontinued due toxicity siramshetty et al <NUMBER> many countries governmental quality control human vaccines longestablished tradition us july <NUMBER> <NUMBER> us congress passed act regulate sale viruses serums toxins analogous products later referred biologics control act first modern federal legislation control quality drugs part response <NUMBER> contamination events st louis camden involving smallpox vaccine diphtheria antitoxin https bitly<NUMBER>conh kl act created hygienic laboratory us public health service oversee manufacture biological drugs eventually became national institutes health vaccine approval us responsibility fda also licensure agency continues monitor production vaccines including inspecting facilities reviewing manufacturers tests lots vaccines potency safety purity fda right conduct testing manufacturers vaccines <NUMBER> europe socalled official control authority batch release network ocabr implemented shortly establishment european union today official medicinal control laboratories omcls part european ocabr network many european countries omcls experimentally test every batch human vaccines enter market influenza example amounted <NUMBER> batches europe <NUMBER> <NUMBER> kretzschmar et al <NUMBER> type batch control testing among animalconsuming regulatory testing especially actual challenge tests infecting animals required constitutes severe suffering inflicted laboratory animals busquet et al <NUMBER> major progress many vaccines made converting serological tests ie animals antibody titers protective value antibodies induced measured infection animals show protection carried genetically otherwise engineered vaccines developed covid<NUMBER> may reduced need batch release control animals alternatively serological nonanimal batch release tests may implemented beginning de mattia et al <NUMBER> field <NUMBER>rs replacement reduction refinement prolific regulation vaccines pharmaceutical drugs goh et al <NUMBER> eskes whelan <NUMBER> sewell et al <NUMBER> thanks constant input regulators academics pharmaceutical companies eu funding bodies stated technical report nonclinical evaluation vaccines <NUMBER> product diversity new approaches technologies methodologies develop time therefore judgment based best science available always form basis deciding type extent nonclinical evaluation products contextartificial intelligence new approach methods nam vitro silico modelshighthroughput screening methods play crucial role technologies methods consistently proved humanrelevant effective allowing safe progression clinical testing shorter amount time compared traditional animal testing using highthroughput screening methods example could rapidly qualify disqualify drugs candidates facilitate repurposing approved therapeutics treating patients covid<NUMBER> past <NUMBER> years animalfree methods developed impressively notably thanks eufunded projects imi could effectively employed especially predicting toxicity potential covid<NUMBER> vaccines readacross developed intensively echa european chemical agency horizon <NUMBER>funded eutoxrisk could also contribute significantly therefore fully exploited ema member states information missing impurities specific context covid<NUMBER> pandemic ema committed making use available tools platforms facilitate research development subsequent rapid assessment medicines covid<NUMBER> reference provided supplementary material additionally agency expressed take part open discussion use nam covid<NUMBER> vaccines treatment development reference provided supplementary material march <NUMBER> first icmra international coalition medicines regulatory authorities regulatory workshop covid<NUMBER> took place experts ec ema fda part debate experts discussed preclinical data required support firstinhuman fih clinical trials including animal studies would needed prior proceeding fih clinical trials summary report indicates efficacy sarscov<NUMBER> vaccine candidate required demonstrated animal challenge models prior proceeding fih clinical trials imcra <NUMBER> safety testing requirements road challenging international council harmonisation technical requirements pharmaceuticals human use ich nam accepted exceptional circumstances described recent update s<NUMBER> guideline detection reproductive developmental toxicity human pharmaceuticals allows use nam preclinical phase specific regulatory condition lifethreatening disease ich <NUMBER> governmental organizations fda usa ema eu specific programs implement use nams safety efficacy assessment proofofconcept program described ema guideline quality nonclinical clinical requirements investigational advanced therapy medicinal products atmps clinical trials use vitro ex vivo cell tissuebased models stated ema <NUMBER> considered supplement substitute vivo animal studies demonstrate proof concept would open possibility use human tissue <NUMBER>d models mps organonchip spheroid models silico approaches allow faster development provide drug within year called several decisionmakers global scientific community conflict interest th named inventor patent johns hopkins university production minibrains also called brainspheres licensed axosim new orleans la usa consults axosim shareholder open access article licensed creative commons attribution <NUMBER> international license permits use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreat iveco mmons orglicen sesby<NUMBER> spread covid<NUMBER> pandemic seriously challenging scientific community quest find suitable vaccines andor drugs fast possible unlike many diseases medical need also increasing pressure key economic political decisionmakers president european commission ec ursula von der leyen example voiced hopes vaccine would available autumn <NUMBER> wheaton <NUMBER> light similar remarks worth looking tools regulatory mechanisms may allow us overcome unprecedented health crisis viral infections prototypic speciesspecific diseases make animal testing challenging even without time pressures duration costs especially genetically modified strains susceptible disease need bred support ambitious goals modern bioengineered human multiple organ models lend antiviral drug development countries already started human clinical trials minimal safety testing animals example national institutes health nih roberts <NUMBER> boodman <NUMBER> ema provided updates treatments vaccines development covid<NUMBER> last briefing <NUMBER> anticipated timelines market entry <NUMBER> <NUMBER> outline way forward facilitate market access authorization ema <NUMBER>a exceptional funding efforts also made available via electronic supplementary material online version article https doiorg<NUMBER>s<NUMBER> <NUMBER> <NUMBER> contains supplementary material available authorized users publicprivate partnership innovative medicines initiative imi https bitly<NUMBER>adrb boosting development therapeutics diagnostics tackle current future coronavirus outbreaks imi <NUMBER> ec research innovation <NUMBER> explore nam accelerate developments four testing programs drug vaccine discovery may accelerated use nam drug vaccine development differ principle detail meigs et al <NUMBER> go steps preclinical clinical development acceptance postmarket surveillance vaccine developments tend longer <NUMBER> years vs <NUMBER> years drug trials clinical trials often larger longer risk populations need vaccinated often rare events due nature biologicals often produced fermenting types cell culture vaccines frequently need batch release controls public health measures vaccines face even higher pricing pressures makes development vaccines less attractive pharma indeed major pharma companies engaging development support vaccine development governmental players nonprofit foundations cofunding rd sometimes production interestingly <NUMBER> global vaccine producers european <NUMBER> vaccine consumption us meigs et al <NUMBER> altogether drug discovery rd differs many scientific disciplines understanding major components helps us appreciate new tools used accelerate process models also called test systems essential rd process traditional models based experimental animals novel approaches animalfree use tissue cultures computational techniques third type test model must forgotten however complement others healthy diseased humans use tools rd programs need answer four entirely different questions therefore used four different testing strategies approaches particular models providing specific opportunities use nam scopes four approaches <NUMBER> efficacy usually comes mind think drugs vaccines even principles efficacy action clear eg preventing viral replication blocking virus entry cell also particular molecular target known eg viral rna polymerase docking receptor fig <NUMBER> finding drug candidate interacts target also fulfills features essential make drug eg taken body transported target site tedious highly resourceconsuming process <NUMBER> safety entirely different set models tests used evaluate whether drug welltolerated without adverse sideeffects ie toxicity instance needs assured block important functions human body attack important structures within human cells organs <NUMBER> quality safe efficacious vaccine drug found needs produced high importantly constant quality testing program differs fundamentally safety efficacy needs applied lot vaccine drug control impurities contaminants <NUMBER> target discovery last list first rd process testing program designed yield useful drug targets different models strategies required find example key steps virushost cell interaction identify processes human cells could used target decrease hyperinflammation targets may known diseases research may provide one fastest ways find suitable drugs strategy called repurposing typical example may glycosylation inhibitors fig <NUMBER> developed various neurological diseases may also considered viral infections park <NUMBER> parsons et al <NUMBER> tortorici et al <NUMBER> could tested quickly modern nam via metabolic glycoengineering kranaster et al <NUMBER> four approaches covid<NUMBER> research benefit investments made development nam past <NUMBER> years european perspective one two key developments establishment european center validation alternative methods eurlecvam within ec research infrastructure joint research center jrc followed creation network european reference laboratories eunetval coordinated eurlecvam second major push development nam came substantial funding research ec comprising <NUMBER> €year last <NUMBER> years since framework program <NUMBER> fp<NUMBER> also includes imi funding one current project eutoxrisk develops animalfree safety testing approaches budget <NUMBER> € daneshian et al <NUMBER> graepel et al <NUMBER> several national funding programs also contributed substantially development nam particularly netherlands germany uk legislation eu ban animal testing cosmetics strong incentive industry launch successful research programs nam safety quality control beilmann et al <NUMBER> us national academy sciences nas <NUMBER> report future toxicity testing twentyfirst century nrc <NUMBER> leist et al <NUMBER> leist et al <NUMBER> krewski et al <NUMBER> krewski et al <NUMBER> pivotal triggering chain events culminating roadmaps major agencies epa fda reduce ultimately abandon animal testing collins et al <NUMBER> tice et al <NUMBER> bouhifd et al <NUMBER> fda <NUMBER> thomas et al <NUMBER> epa <NUMBER> second notable report committee nas addressed drug efficacy countermeasures terrorism biological weapons nrc <NUMBER> hartung zurlo <NUMBER> clear recommendation given focus solely nam reasons speed predictivity parallel highly visible government activities industry moved largely animalbased efficacy testing <NUMBER>s predominantly <NUMBER> animalfree efficacy research methods today true academia especially industrydriven research target discovery busquet et al <NUMBER> cell culturebased methods combined modern molecular biology stem cell technology play major role use computational research silico models recently increased well pinero et al <NUMBER> vamathevan et al <NUMBER> parallel increasing awareness shortcomings animal models olson et al <NUMBER> hartung leist <NUMBER> leist hartung <NUMBER> use nam four testing programs detailed special sars<NUMBER>cov<NUMBER> covid<NUMBER> first animal disease model seems fig <NUMBER> overview drug repurposing approaches covid<NUMBER> black structures indicate target cell green structures refer host components processes virus elements shown blue drugs presented red drugs lower right corner considered fight inflammation smoothen potential cytokine storm ie act processes directly linked virus target cell type ii pneumocyte lung arrows refer drug targets target processes suggested literature sometimes exact targets respective drug efficacy known selection drugs drug types exemplary good approaches may missing shown may little use intention highlight broad variety approaches many also used clinically case studies compassionate trials initial stages testing programs stage nam would useful determine target structures ii define exact biological effects drug candidates iii investigate quantify efficacy iv close gaps safety knowledge candidates yet approved used clinically settings eg dosing schedule ace<NUMBER> angiotensin converting enzyme<NUMBER> sace<NUMBER> recombinant soluble domain ace<NUMBER> ifn interferon tmprss<NUMBER> transmembrane serine protease subtype<NUMBER> aak<NUMBER> gak enzymes involved endocytosis jak kinase janus kinase family involved cytokine signaling inflammation color figure online closely related coronaviruses asian bats reptiles lend lab animals show far know pathology found humans typical reflex animal model suggest using nonhuman primates nhp even great apes helped us hiv hepatitis c shown us national academy sciences nas <NUMBER> research great apes common response breed genetically modify lab animals mice render susceptible done earlier sars virus mccray et al <NUMBER> however misses obvious opportunity human microphysiological systems mps become available last decade due stem cell technology bioengineering alepee et al <NUMBER> marx et al <NUMBER> marx et al <NUMBER> ewart et al <NUMBER> shown earlier viral infections studied human brainspheres minibrains abreu et al <NUMBER> zika dengue well others including sars<NUMBER>covid<NUMBER> published shortly others also similar research various organs european organovir education network https organ ovircom many groups building models leverage covid<NUMBER> rd important finding based organoids published research group vienna focused soluble viral receptors sace<NUMBER> therapy monteil et al <NUMBER> however limitations research done biosafety level <NUMBER> guidelines virus sophisticated systems pumps sensors microscopes difficulttosterilize equipment specific consideration thus given design simple robust modelstypically organoids organonchip systems respiratory tissue commercial offers currently exist epithelix mattek gordon et al <NUMBER> seems however lifethreatening course covid<NUMBER> occurs cytokine storm acute respiratory distress syndrome multiple organ failures forms septic shock especially resistant drug identification killing drug companies sepsis programs septic patients clinic rather unlikely multiorgan failures covid<NUMBER> disease developed represent different situation cochrane study register covid<NUMBER> listed <NUMBER> april <NUMBER> total <NUMBER> studies launched <NUMBER> interventional <NUMBER> aimed treatment management https covid <NUMBER>cochr aneorg however understood proportionally light <NUMBER> clinical trials listed <NUMBER> world health organization https bitly<NUMBER>y<NUMBER>tz qs still speed getting started impressive shows drug repurposing mainly occurring surprising drugbank lists <NUMBER> drugs available <NUMBER> small molecules <NUMBER> biologicals <NUMBER> approved https wwwdrugb ankcastats rich portfolio typically already undergone safety testing allows move quickly ahead initially focus entirely nam cellular infectivity instance tested cell cultures vero cells organoids molecular viral targets like polymerase initially tested recombinant form biochemical assays methods allow high throughput thousands samples provide much robust exacting data animal experiment could deliver complex questions concern whether potential drug would reach target tissue whether would also act complex disease setting inflammation altered ph variety cell types moreover combinations complex vitro models silico approaches physiologybased pharmacokinetic pbk modelling well established routinely used drug industry academia considering share repurposing drug candidates comes hiv drug research ample opportunity test failed discarded substances well supportive therapies first results established aids therapies however disappointing https bit ly<NUMBER>cmms xe summarized limited evidence far https bitly<NUMBER>s<NUMBER>ni rf discussions hopes continue murphy <NUMBER> fig <NUMBER> case hiv treatments ultimately became successful combining originally four three different treatments known haart highly active antiretroviral therapy however understanding hiv differs covid<NUMBER> two critical aspects extent immune escape persistence body still might necessary combine treatments always challenge drug development approval practical patient care nam may used identify effective combination targets synergy find beneficial combination drugs concentration ratios efforts carried patients already <NUMBER> vaccines covid<NUMBER> development thanh et al <NUMBER> organoids mps devoid immune component lend less substitute though addition immune cells becoming common addition antibodies serum vaccinated animals recovered humans models test efficacy instead infecting animals opportunity promising development artificial lymph nodes reported first suematsu watanabe <NUMBER> giese marx <NUMBER> summarized progress developing optimizing <NUMBER>d human artificial lymph node model mimic interface innate adaptive immune response vitro giese et al <NUMBER> see also cupedo et al <NUMBER> models shown merit evaluation immunogenicity influenza vaccines drake et al <NUMBER> certainly represent prime nonanimal method covid<NUMBER> vaccine development vaccine development usually targets active vaccination ie exposure humans relevant antigens followed active immune response passive vaccinations also envisaged fig <NUMBER> process antibodies viral antigens produced biotechnology methods injected best known emergency vaccines tetanus variant approach isolation antibodies serum covid<NUMBER> survivors use patients jhsph <NUMBER> casadevall pirofski <NUMBER> traditional oldfashioned way antibody generation uses animal models nowadays monoclonal antibodies produced entirely animalfree molecular biology techniques eg phage display use animals also limitations due pronounced speciesspecific differences pathogenesis antigen recognition immune reactivity nonlymphoid lymphoid tissues systemic orchestration immunity organism level first successful attempt rhesus macaques confirmed april <NUMBER>th <NUMBER> gao et al <NUMBER> however concerns raised approach due fact monkeys develop severe symptoms sarscov<NUMBER> causes humans cohen <NUMBER> therefore fast transition initial trials vitro next step humans often taken covid<NUMBER> research us ind investigational new drug application fda food drug administration starts clinical phase describing manufacturing testing processes laboratory reports proposed study well approval institutional review board institution clinical trial conducted fda <NUMBER> days approve application clinical studies human subjects start similar clinical drug development • phase vaccine trials typically <NUMBER> adults may nonblinded assess safety type extent immune response • phase ii vaccine trials typically several hundred individuals often groups risk acquiring disease trials randomized wellcontrolled include placebo group study safety immunogenicity proposed doses schedule immunizations method delivery • phase iii vaccine trials involving thousands tens thousands people randomized doubleblind studies placebo assess safety rare side effects efficacy prevention disease prevention infection pathogen production antibodies types immune responses related pathogen difficult imagine process could shortened year <NUMBER> months recently suggested policymakers nam described thousands articles past large successes toxicological areas also gaps filled basketter et al <NUMBER> leist et al <NUMBER> approaches contributed limit animal use toxicology much less biomedical research busquet et al <NUMBER> use nam animal welfare issue issue timeor precisely time market worldwide pandemic speed drug development carries enormous weight traditional full safety package based animals includes longtime chronic dosing two years followed lengthy histopathology evaluations however shortcuts seem possible understand applicability covid<NUMBER> exact testing needs must reviewed depending type use duration treatment application methods use pregnancy susceptible populations safety data package initial human use rather light speed <NUMBER> clinical trials begun covid<NUMBER> shows shortcuts taken may generate discussions might possible generally common practices pandemic bruckner <NUMBER> case covid<NUMBER> dosing time drug short often <NUMBER> weeks less many cases pregnancies ie reproductive developmental toxicity issues excluded needed situation <NUMBER> drug acutely toxic <NUMBER> trigger cancer <NUMBER> interfere drugs concerning <NUMBER> situation nam favorable accepted methods available acute topical toxicities also acute systemic toxicity may predicted possibly combination limited number animal experiments hamm et al <NUMBER> strickland et al <NUMBER> concerning <NUMBER> one needs distinguish genotoxic nongenotoxic carcinogenicity genotoxicity successful area nam addressed decades drug development available methods fast days highly sensitive corvi madia <NUMBER> corvi et al <NUMBER> nongenotoxic carcinogenicity harder predict animals nam shows pronounced species differences hernandez et al <NUMBER> one fundamental fact nongenotoxic carcinogens require usually long exposure times thus short treatment covid<NUMBER> minimizes issue moreover nam developed identify typical mechanisms contributing nongenotoxic carcinogenicity eg nuclear receptor activation hernandez et al <NUMBER> jacobs et al <NUMBER> cmr carcinogenicity mutagenicity reproductive toxicity endpoints thus typically critical ensure minimum safety requirements entering clinical trials stage specific context covid<NUMBER> mentioned drug repurposing currently focus requirements usually waived since treatment less <NUMBER> months data particularly needed request full contraception pregnancy tests every month cover fertility clinical trials needed repeated dose test maximally onemonth length would great opportunity complete data set mps since cover <NUMBER> days adapted doserepetition mps qualified however therefore difficult use regulatory context although examples platforms ready used vaccine preclinical testing sanchezschmitz et al <NUMBER> recently published ema regulatory strategy <NUMBER> reports one reason hesitancy may concerns part developers well industry use new approach methodologies nams acceptable regulators thus stall approvals possible reasons limited use nams include lack knowledge regarding existence exact functioning models lack model validation high costs associated implementation ema <NUMBER>b mentioned since focus currently drug repurposing submission proposals rich safety information already considerations ill patient group impact treatments applied time critical long standard care proper control difficult define concerning <NUMBER> excellent nam available test drugdrug interactions level transporter drugmetabolizing enzymes wellestablished drug discovery companies therefore methods allow quick transition testing humans major question deciding test methods nam vs animal prevent harm trial participants end patients olson et al <NUMBER> showed quite impressively limits predicting human adverse effects animal testing recently tamaki et al <NUMBER> studied <NUMBER> adverse drug reactions administration <NUMBER> drugs approved japan <NUMBER> <NUMBER> half predicted preclinical animal data even less predictivity found bailey et al <NUMBER> bailey et al <NUMBER> <NUMBER> drugs two industry groups however monticello et al <NUMBER> clark stegerhartmann <NUMBER> positive results noted problem end clinical trials <NUMBER> discontinued withdrawn drugs europe us almost half discontinued due toxicity siramshetty et al <NUMBER> many countries governmental quality control human vaccines longestablished tradition us july <NUMBER> <NUMBER> us congress passed act regulate sale viruses serums toxins analogous products later referred biologics control act first modern federal legislation control quality drugs part response <NUMBER> contamination events st louis camden involving smallpox vaccine diphtheria antitoxin https bitly<NUMBER>conh kl act created hygienic laboratory us public health service oversee manufacture biological drugs eventually became national institutes health vaccine approval us responsibility fda also licensure agency continues monitor production vaccines including inspecting facilities reviewing manufacturers tests lots vaccines potency safety purity fda right conduct testing manufacturers vaccines <NUMBER> europe socalled official control authority batch release network ocabr implemented shortly establishment european union today official medicinal control laboratories omcls part european ocabr network many european countries omcls experimentally test every batch human vaccines enter market influenza example amounted <NUMBER> batches europe <NUMBER> <NUMBER> kretzschmar et al <NUMBER> type batch control testing among animalconsuming regulatory testing especially actual challenge tests infecting animals required constitutes severe suffering inflicted laboratory animals busquet et al <NUMBER> major progress many vaccines made converting serological tests ie animals antibody titers protective value antibodies induced measured infection animals show protection carried genetically otherwise engineered vaccines developed covid<NUMBER> may reduced need batch release control animals alternatively serological nonanimal batch release tests may implemented beginning de mattia et al <NUMBER> field <NUMBER>rs replacement reduction refinement prolific regulation vaccines pharmaceutical drugs goh et al <NUMBER> eskes whelan <NUMBER> sewell et al <NUMBER> thanks constant input regulators academics pharmaceutical companies eu funding bodies stated technical report nonclinical evaluation vaccines <NUMBER> product diversity new approaches technologies methodologies develop time therefore judgment based best science available always form basis deciding type extent nonclinical evaluation products contextartificial intelligence new approach methods nam vitro silico modelshighthroughput screening methods play crucial role technologies methods consistently proved humanrelevant effective allowing safe progression clinical testing shorter amount time compared traditional animal testing using highthroughput screening methods example could rapidly qualify disqualify drugs candidates facilitate repurposing approved therapeutics treating patients covid<NUMBER> past <NUMBER> years animalfree methods developed impressively notably thanks eufunded projects imi could effectively employed especially predicting toxicity potential covid<NUMBER> vaccines readacross developed intensively echa european chemical agency horizon <NUMBER>funded eutoxrisk could also contribute significantly therefore fully exploited ema member states information missing impurities specific context covid<NUMBER> pandemic ema committed making use available tools platforms facilitate research development subsequent rapid assessment medicines covid<NUMBER> reference provided supplementary material additionally agency expressed take part open discussion use nam covid<NUMBER> vaccines treatment development reference provided supplementary material march <NUMBER> first icmra international coalition medicines regulatory authorities regulatory workshop covid<NUMBER> took place experts ec ema fda part debate experts discussed preclinical data required support firstinhuman fih clinical trials including animal studies would needed prior proceeding fih clinical trials summary report indicates efficacy sarscov<NUMBER> vaccine candidate required demonstrated animal challenge models prior proceeding fih clinical trials imcra <NUMBER> safety testing requirements road challenging international council harmonisation technical requirements pharmaceuticals human use ich nam accepted exceptional circumstances described recent update s<NUMBER> guideline detection reproductive developmental toxicity human pharmaceuticals allows use nam preclinical phase specific regulatory condition lifethreatening disease ich <NUMBER> governmental organizations fda usa ema eu specific programs implement use nams safety efficacy assessment proofofconcept program described ema guideline quality nonclinical clinical requirements investigational advanced therapy medicinal products atmps clinical trials use vitro ex vivo cell tissuebased models stated ema <NUMBER> considered supplement substitute vivo animal studies demonstrate proof concept would open possibility use human tissue <NUMBER>d models mps organonchip spheroid models silico approaches allow faster development provide drug within year called several decisionmakers global scientific community conflict interest th named inventor patent johns hopkins university production minibrains also called brainspheres licensed axosim new orleans la usa consults axosim shareholder open access article licensed creative commons attribution <NUMBER> international license permits use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreat iveco mmons orglicen sesby<NUMBER> infectious diseases spread media air water direct contact carriers insects flies mosquitoes <NUMBER> <NUMBER> dynamics may well understood modeling causes carriers disease possible time control media carriers involved spread infection sometimes may even beyond determination many time may even recognize presence infection becomes predominant mathematical modeling tool popularly employed prevention control infectious diseases severe acute respiratory syndrome sars <NUMBER> human immunodeficiency virus infectionacquired immune deficiency syndrome hivaids <NUMBER> h<NUMBER>n<NUMBER> avian flu <NUMBER> h<NUMBER>n<NUMBER> swine flu <NUMBER> also useful studying drug resistant strains malaria <NUMBER> tuberculosis <NUMBER> methicillinresistant staphylococcus aureus mrsa <NUMBER> marine bacteriophage infection <NUMBER> simple deterministic models based dividing population compartments susceptible exposed infected recovered susceptibleinfective si model useful understanding diseases feline infectious peritonitis fip <NUMBER> host remain infected till die susceptibleinfectivesusceptible sis model employed studying infections gonorrhea <NUMBER> possibility host becoming susceptible infection susceptibleinfectiverecovered sir model employed understand diseases syphilis <NUMBER> wherein immunity lasts limited period waning individual susceptible dynamics systems httpdxdoiorg<NUMBER>jchaos<NUMBER> <NUMBER>ó <NUMBER> elsevier ltd rights reserved generally studied two perspectives stability diseasefree equilibrium ii stability endemic equilibrium former case conditions pathogens suffer extinction leaving individuals susceptible studied whereas later conditions infective susceptible populations coexist established interactions among populations compartments susceptible ðxþ infected ðyþ key understand rate infection spread population models bilinear interaction among populations ðxyþ tend disease free equilibrium endemic equilibrium <NUMBER> researchers considered various interactions nonlinear type bx p q <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> xy <NUMBER>þax <NUMBER> xy <NUMBER>þy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> understanding dynamics infectious diseases observed solutions periodic nature exist even without periodic forcing term model existence periodic solutions usually attributed presence time delays system even case bilinear incidence delays exist disease transmission known latency period infection inception identifiable state interesting studies infectious disease models readers referred <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hand fluctuations populations may also attributed changes environment especially open systems perturbations influenced environment may treated noise system dynamic models competing species influence noise extensively studied <NUMBER> <NUMBER> <NUMBER> <NUMBER> predictive models based clinical incidence data pertaining infectious diseases epidemics general discussed <NUMBER> <NUMBER> <NUMBER> earlier studies infectious disease models identification basic reproduction number gave idea stability system either terms disease free environment disease prevalence reproduction number represents number secondary cases caused primary case introduced wholly susceptible population also observed reproduction number less unity disease free equilibrium stable otherwise disease prevails <NUMBER> nature interaction known basic reproduction number unity one needs find ways restrict disease minimum manageable level disease free environment cannot provided comes control disease vaccination preventive strategies could good choice early stages disease provided population large enough emergence vaccine resistant strains one drawbacks frequent long term vaccination massive vaccination possible second stage defensive mechanism could medical treatment adds new sub category population called recovered class representing population recovered treatment basing observations consider following three compartmental system present paper x <NUMBER> ¼ à bf ðx yþ à dx à cvðxþ þ az <NUMBER> ¼ b <NUMBER> f xðt à sþ yðtþ ð þ à rpðyþ à <NUMBER> z <NUMBER> ¼ rp yðt à dþ ð þà az wherein xðtþ yðtþ zðtþ denote susceptible infected recovered treatment populations time respectively <NUMBER> ¼ dt denotes time derivative function p <NUMBER> growth rate susceptible population f denotes nonlinear incidence infection function showing susceptibles x converted infected b <NUMBER> denotes rate contact interaction infected susceptible rate removal susceptible individuals system naturally immune infection way get infected vðxþ vaccination function depends susceptible population c <NUMBER> rate successful vaccination <NUMBER> b <NUMBER> <NUMBER> b rate conversion susceptible infected case b <NUMBER> ¼ b may expect infection helm spreading <NUMBER> b <NUMBER> b may infer disease effective missing x <NUMBER> susceptible may removed system time delay <NUMBER> implies x gets contact takes time become infected called temporary immunity parameter parameter <NUMBER> <NUMBER> removaldeath rate infected populationeither treated inadequately treated beyond treatment may also viewed rate infected population kept quarantine away susceptible population avoiding sort contact infected exposed pðyþ recovery treatment function infected r <NUMBER> denotes rate treatment also recovery rate however infected treatment procedure may recover time gap parameter <NUMBER> rate recovered nonvaccinated individual may reexposed infection become susceptible case arises individual appears recovered treatment prone infection basic interactions among various populations shown fig <NUMBER> assume following conditions infection function first condition nonnegativity minimum requirement function representing biological systems dynamics make sense second condition arises situation susceptible ie influence third condition required create diseasefree environment necessity condition described section <NUMBER> addition nonnegativity condition satisfied p represents recovery treatment function thus assume pðyþ p <NUMBER> <NUMBER>y strict inequality holding <NUMBER> interested studying influence treatment spread disease absence infected population pð<NUMBER>þ ¼ <NUMBER> treatment effort required depending reproduction number epidemic availability need initiate vaccination following probable cases uniform constant supply vðxþ ¼ k ii proportional susceptible population vðxþ ¼ x linear iii sublinear vðxþ ¼ x kþx vðxþ ¼ tanh x saturation limit iv vðxþ may periodic function infection fluctuating seasondependent cyclic however case new infectious disease system may ready vaccines prevent spread recent case spread ebola <NUMBER> thus time gap required start vaccination procedure vaccine invented supplied may vðxðtþþ ¼ <NUMBER> <NUMBER>t <NUMBER> <NUMBER> <NUMBER> <NUMBER> v ¼ vðxðtþþ p <NUMBER> <NUMBER>t <NUMBER> delay also warranted section shall discuss final section basic motivation study stems observations <NUMBER> vaccination alone sufficient contain disease effectively treatment plays important role disease management shall analyze model <NUMBER> keeping view following concerns important handling infectious disease <NUMBER> influence treatment recovery rate r <NUMBER> influence vaccination effort v <NUMBER> combined effect vaccination treatment <NUMBER> destabilize equilibrium ðx ã ã z ã þ ã <NUMBER> make <NUMBER> present paper aims provide answers questions organizing content follows section <NUMBER> possible equilibria determined model eqs <NUMBER> section <NUMBER> local stability properties system discussed section <NUMBER> behavior delayfree system discussed influence time delay <NUMBER> stability delayfree system studied section <NUMBER> influence delay recovery <NUMBER> alone studied section <NUMBER> bounds delays conditions change direction stability also discussed section <NUMBER> general case delays <NUMBER> <NUMBER> discussed section <NUMBER> global stability results derived special case delays present examples simulation results presented section <NUMBER> conclusions scope future study deferred section <NUMBER> section <NUMBER> respectively let us consider case system <NUMBER> assumptions made x <NUMBER> ¼ à bf ðx yþ à dx à cvðxþ þ az <NUMBER> ¼ b <NUMBER> f ðxðt à sþ yþ à rpðyþ à <NUMBER> z <NUMBER> ¼ rpðyðt à dþþ à az continuity solutions <NUMBER> definitions functions f v p easy see x z nonnegative domains definition equilibria constant solutions system popular way understand system study behavior equilibria <NUMBER> look two possibilities existence equilibrium type ð x <NUMBER> <NUMBER>þ called diseasefree equilibrium whose stability implies infection little influence ii stable positive equilibrium ðxỹzþ called endemic equilibrium denotes disease prevalence unless specifically stated ðx ã ã z ã þ denotes either equilibria throughout subsequent study equilibria ðx ã ã z ã þ <NUMBER> satisfy bf ðx ã ã þ þ cvðx ã þ þ dx hypothesize <NUMBER> vð þ <NUMBER> holds shall exist point x satisfies condition cvð xþ ¼ à x illustrate hypothesis considered realtime dataset pertaining sars <NUMBER> fitted logistic curve form vðxþ ¼ fig <NUMBER> curve switches increasing rate growth decreasing rate clearly suggesting existence diseasefree equilibrium point ð x <NUMBER> <NUMBER>þ whose stability implies diseasefree environment logistic curve line passing diseasefree equilibrium point x shown fig <NUMBER> provides mechanism design vaccination v methods containing disease linearizing system <NUMBER> around equilibrium characteristic equation <NUMBER> given fðkþ k <NUMBER> à ða þ c à aþk <NUMBER> þ ½ac à aða þ cþk þ aca à bða þ kþde àks à daee àkðsþdþ ¼ <NUMBER> letting l ¼ à ða þ cþ ¼ ac à aða þ cþ n ¼ aca l <NUMBER> ¼ àbd <NUMBER> ¼ àbad n <NUMBER> ¼ àdae denote <NUMBER> fðkþ k <NUMBER> þ lk <NUMBER> þ mk þ n þ l <NUMBER> ke àks þ <NUMBER> e àks þ n <NUMBER> e àkðsþdþ ¼ <NUMBER> <NUMBER> separating real imaginary parts fðl þ imþ real imaginary parts denoted hereafter rðþ iðþ fðkþ rðfðkþþ ¼ l <NUMBER> à <NUMBER>lm <NUMBER> þ lðl <NUMBER> à <NUMBER> þ þ ml þ n þ l <NUMBER> ½l cos ms þ msinmse àls þ <NUMBER> e àls cos ms þ n <NUMBER> cos mðs þ dþe àlðsþdþ iðfðkþþ ¼ àm <NUMBER> þ <NUMBER>l <NUMBER> þ <NUMBER>llm þ mm þ l <NUMBER> ½m cos ms à lsinmse àls à <NUMBER> e àls sin ms à n <NUMBER> sin mðs þ dþe àlðsþdþ <NUMBER> local stability shall first consider case delays contracting disease ¼ <NUMBER> recovery ¼ <NUMBER> eq <NUMBER> reduces elementary algebra says l <NUMBER> l <NUMBER> þ <NUMBER> ii n þ <NUMBER> þ n <NUMBER> <NUMBER> hold roots equation negative real parts thus theorem <NUMBER> needs proof <NUMBER> locally asymptotically stable provided parameters satisfy l <NUMBER> l <NUMBER> þ <NUMBER> n þ <NUMBER> þ n <NUMBER> <NUMBER> remark <NUMBER> particular ¼ <NUMBER> c <NUMBER> <NUMBER> hold v <NUMBER> ðxþ p <NUMBER> f x p <NUMBER> <NUMBER> <NUMBER> characteristic eq <NUMBER> reduces delay free clearly coefficients nonnegative possibility root positive real part thus equilibrium ðx ã ã z ã þ stable ¼ <NUMBER> c <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus need explore possibilities finding diseasefree equilibrium conditions hold implying possibility diseasefree environment choice parameters selection may infer following <NUMBER> case system disease free equilibrium e <NUMBER> endemic equilibrium e <NUMBER> conditions theorem <NUMBER> hold e <NUMBER> may say disease influence <NUMBER> e <NUMBER> either unstable least one roots equation positive real part exist check stability endemic equilibrium e <NUMBER> <NUMBER> e <NUMBER> stable explore possibilities destabilizing increasing vaccination efforts ii treatment rate iii delay process infection <NUMBER> case e <NUMBER> unstable solutions exhibiting dominance disease system e <NUMBER> need study behavior solutions way handle infected population finding <NUMBER> <NUMBER> yðtþ <NUMBER> shall provide answers towards end article shall study influence time delays system first start delay incubation delay recovery treated understand influence time delay converting exposed population infected allow ¼ <NUMBER> eq <NUMBER> get equations type <NUMBER> well studied literature eg <NUMBER> <NUMBER> <NUMBER> letting <NUMBER> ¼ n <NUMBER> à ðm <NUMBER> þ n <NUMBER> þ <NUMBER> <NUMBER> ¼ <NUMBER> à <NUMBER>ln à l <NUMBER> <NUMBER> <NUMBER> ¼ l <NUMBER> à <NUMBER>m straight forward application theorem <NUMBER> <NUMBER> yields theorem <NUMBER> notice theorem <NUMBER> theorem <NUMBER> <NUMBER> ensures preservation stability instability specify values lengths delay holds following result helps us estimating delay cases need following result <NUMBER> utilized <NUMBER> study denotes pseudo delay related ¼ <NUMBER> ½tan à<NUMBER> ðmtþ þ kp <NUMBER>k <NUMBER> z conditions lemma <NUMBER> ensures stability ¼ <NUMBER> ii confirms pure imaginary zeros limiting case condition iii establishes absence imaginary zeros may observed f <NUMBER> f <NUMBER> f <NUMBER> obtained fðk sþ letting e àks ¼ <NUMBER> à<NUMBER> ð<NUMBER> à ktþð<NUMBER> þ ktþ respectively lemma <NUMBER> necessary sufficient condition violation conditions ii iii reflects corresponding change stability characteristic equation <NUMBER> employing lemma <NUMBER> shall present another set conditions preservation change stability system apply lemma shall denote <NUMBER> <NUMBER> let e àks ¼ <NUMBER> <NUMBER> characteristic polynomial becomes clearly f <NUMBER> ðkþ <NUMBER> rðkþ p <NUMBER> theorem <NUMBER> ensures stability ¼ <NUMBER> <NUMBER> let e àks ¼ à<NUMBER> <NUMBER> get f <NUMBER> ðkþ pðkþ à qðkþ ¼ k <NUMBER> þ lk <NUMBER> þ ðm à l <NUMBER> þk þ ðn à <NUMBER> à n <NUMBER> þ holds clearly f <NUMBER> ðkþ <NUMBER> rðkþ ¼ <NUMBER> k <NUMBER> provided following conditions à l <NUMBER> <NUMBER> <NUMBER> b lðn à <NUMBER> à n <NUMBER> þ <NUMBER> <NUMBER> lðm à l <NUMBER> þn à <NUMBER> à n <NUMBER> holds ensuring presence imaginary zeros limiting case <NUMBER> let e àks ¼ <NUMBER>àkt <NUMBER>þkt <NUMBER> <NUMBER> becomes <NUMBER> pure imaginary zeros ensuring change stability ¼ <NUMBER> separating real imaginary parts get real part following cases arise <NUMBER> real satisfies ðl <NUMBER> þmþþðnàm <NUMBER> àn <NUMBER> þt <NUMBER>þlt <NUMBER> holds <NUMBER> rearrangement gives lðn à <NUMBER> à n <NUMBER> þt <NUMBER> þ ½lðl <NUMBER> þ mþ þðn à <NUMBER> à n <NUMBER> þt þ ðl <NUMBER> þ mþ <NUMBER> thus lðn à <NUMBER> à n <NUMBER> þ <NUMBER> ½lðl <NUMBER> þ mþ þ ðn à <NUMBER> à n <NUMBER> þ <NUMBER> ðl <NUMBER> þ mþ <NUMBER> real exists thus establishing change stability p <NUMBER> given earlier <NUMBER> using value <NUMBER> imaginary part real part get rearrangement becomes à lðn à <NUMBER> à n <NUMBER> þðm à l <NUMBER> þt <NUMBER> þ ðn à <NUMBER> à n <NUMBER> þ <NUMBER> h à ðm <NUMBER> à l <NUMBER> <NUMBER> þl þ l <NUMBER> ðn à <NUMBER> à n <NUMBER> þ h may written summarize discussion theorem <NUMBER> þ ¼ <NUMBER> mþ tan à<NUMBER> ðm þ þ þ þ ¼ l <NUMBER> þmþðnàm <NUMBER> àn <NUMBER> þtþ <NUMBER>þltþ þ <NUMBER> solution <NUMBER> shall study influence time delay recovery stability system wish understand clearly whether time delays influence independently introduced mathematical curiosity specific influence system better ignore proceed <NUMBER> case parameters ¼ <NUMBER> <NUMBER> case characteristic eq <NUMBER> reduces shall utilize lemma <NUMBER> analyze stability behavior system case also following cases may arise <NUMBER> let e àkd ¼ <NUMBER> <NUMBER> get f <NUMBER> ðkþ k <NUMBER> þ lk <NUMBER> þ ðl <NUMBER> þ mþk þ n þ <NUMBER> þ n <NUMBER> ¼ <NUMBER> recalling theorem <NUMBER> f <NUMBER> ðkþ <NUMBER> rðkþ p <NUMBER> <NUMBER> let e àkd ¼ à<NUMBER> <NUMBER> get f <NUMBER> ðkþ k <NUMBER> þ lk <NUMBER> þ ðl <NUMBER> þ mþk þ n þ <NUMBER> à n <NUMBER> ¼ <NUMBER> letting k ¼ im separating real imaginary parts get f <NUMBER> ðimþ ¼ n þ <NUMBER> à n <NUMBER> à lm <NUMBER> þ ðl <NUMBER> þ à <NUMBER> þmi easy see f <NUMBER> ðimþ <NUMBER> condition ensures pure imaginary zeros limiting case <NUMBER> consider e àkd ¼ <NUMBER>àkt <NUMBER>þkt <NUMBER> gives pure imaginary zeros let k ¼ im separating real imaginary parts get real part ½m <NUMBER> à ðl <NUMBER> þ mþm <NUMBER> à lm <NUMBER> þ n þ <NUMBER> þ n <NUMBER> ¼ <NUMBER> imaginary part ½àlm <NUMBER> þ ðn þ <NUMBER> à n <NUMBER> þmt þ ½àm <NUMBER> þ ðl <NUMBER> þ mþm ¼ <NUMBER> eliminating rearranging get <NUMBER> <NUMBER> þ ðl <NUMBER> à <NUMBER>ðl <NUMBER> þ mþþm <NUMBER> þ ½ðl <NUMBER> þ mþ <NUMBER> à <NUMBER>lðn þ <NUMBER> þm <NUMBER> þ ðn þ <NUMBER> þ <NUMBER> à n <NUMBER> <NUMBER> ¼ <NUMBER> inequalities l <NUMBER> à <NUMBER>ðl <NUMBER> þ mþ p <NUMBER> ðl <NUMBER> þ mþ <NUMBER> à <NUMBER>lðn þ <NUMBER> þ p <NUMBER> ðn þ <NUMBER> þ <NUMBER> à n <NUMBER> <NUMBER> p <NUMBER> ð<NUMBER>þ hold <NUMBER> yields real solution thus stabilityinstability <NUMBER> preserved length delay following cases may arise <NUMBER> following conditions ðiþ hold change sign indicates <NUMBER> consider characteristic equation system <NUMBER> given <NUMBER> condition change stability occurrence hopf bifurcation indicated zero real part k ¼ l þ im <NUMBER> letting l ¼ <NUMBER> <NUMBER> get rðfðimþþ ¼ àlm <NUMBER> þ n þ n <NUMBER> cos mðs þ dþ þ l <NUMBER> sin ms þ <NUMBER> cosms iðfðimþþ ¼ àm <NUMBER> þ mm à n <NUMBER> sin mðs þ dþ þ l <NUMBER> mcosms þ <NUMBER> sin ms squaring adding get wðmþ <NUMBER> þ ðl <NUMBER> à <NUMBER>mþm <NUMBER> þ ðm <NUMBER> à <NUMBER>ln à l <NUMBER> <NUMBER> þm <NUMBER> þ ðn <NUMBER> þ n <NUMBER> <NUMBER> à <NUMBER> <NUMBER> þ þ <NUMBER>ðn à lm <NUMBER> þ cos mðs þ dþ þ <NUMBER>ðmm à <NUMBER> þ sin mðs þ dþ establish following result show wðm <NUMBER> þ <NUMBER> stabilityinstability preserved without loss generality let <NUMBER> smallest positive root rðfðimþþ ¼ <NUMBER> since n <NUMBER> cos mðs þ dþ <NUMBER> jn <NUMBER> j l <NUMBER> sin ms <NUMBER> jl <NUMBER> jm <NUMBER> cosms <NUMBER> jm <NUMBER> j positive lm <NUMBER> à n <NUMBER> jn <NUMBER> j þ jl <NUMBER> jm þ jm <NUMBER> j rðfðimþþ consider lm <NUMBER> à jl <NUMBER> jm à ðn þ jn <NUMBER> j þ jm <NUMBER> jþ ¼ <NUMBER> clearly two roots bigger one given holds since <NUMBER> <NUMBER> þ inequality satisfied provided <NUMBER> holds thus wðm <NUMBER> þ <NUMBER> hence change stability instability occurs <NUMBER> observe wð<NUMBER>þ <NUMBER> n <NUMBER> þ <NUMBER>n þ n <NUMBER> <NUMBER> <NUMBER> <NUMBER> holds wðmþ <NUMBER> large therefore wðmþ ¼ <NUMBER> real positive solution let þ denote smallest root <NUMBER> may written  value þ obtained <NUMBER> consider important special case <NUMBER> f ðx yþ xy simple interaction term assume pðyþ vðxþ x recovery vaccination linear <NUMBER> takes form equilibrium points given solutions clearly cþd <NUMBER> <NUMBER> always solution <NUMBER> diseasefree equilibrium <NUMBER> ã <NUMBER> <NUMBER> giving rise positive equilibrium solution <NUMBER> provided bx ãr ða à ðc þ dþx ã þðbx ã à rþ <NUMBER> simply holds since b <NUMBER> hence <NUMBER> necessary sufficient condition existence positive endemic equilibrium <NUMBER> entire yz plane becomes equilibria assuming ðx ã ã z ã þ positive equilibrium <NUMBER> formulate theorem <NUMBER> proof theorem <NUMBER> using <NUMBER> <NUMBER> rewrite <NUMBER> x <NUMBER> ¼ àbyðx à x ã þ à bx ã ðy à ã þ à ðc þ dþðx à x ã þ þ aðz à z ã þ <NUMBER> ¼ b <NUMBER> ðxðt à sþ à x ã þy z <NUMBER> ¼ rðyðt à dþ à ã þ à aðz à z ã þ ð<NUMBER>þ consider function vðx zþ jx à x ã j þ j log à log ã j þ jz à z ã jþ b <NUMBER> z tàs jxðuþ à x ã jdu þ r z tàd jyðuþ à ã jdu vðx ã ã z ã þ ¼ <NUMBER> vðx zþ p <NUMBER> x p <NUMBER> p <NUMBER> z p <NUMBER> v <NUMBER> x z <NUMBER> upper dini derivative v along solutions <NUMBER> hypotheses rest argument follows standard arguments proof complete shall provide result global stability diseasefree equilibrium suppose xðtþ <NUMBER> þr b <NUMBER> solving second equation <NUMBER> linear equation get yðtþ ¼ yð<NUMBER>þe ðb <NUMBER> xsàd <NUMBER> àrþt <NUMBER> sufficiently large using third equation <NUMBER> large zðtþ zð<NUMBER>þe àat <NUMBER> first equation <NUMBER> sufficiently large becomes x <NUMBER> ðtþ ¼ à ðc þ dþxðtþ whose solution carried simulations using subroutines developed matlab employed builtin function dde<NUMBER> <NUMBER> variable step size numerical integration routine solving delay differential equations matlab details dde<NUMBER> solver readers may refer wwwmathworkscomddetutorial utilized plot function advanced graphical tools available matlab obtain results figures presented work figures curves drawn dashdot line diamond marker àrà denote exposed populations infected represented dashed line pentagram marker à à à à curves denoted solid line square marker àãà stand recovered populations simulations carried various lengths delays three cases <NUMBER> ¼ <NUMBER> ¼ <NUMBER> <NUMBER> <NUMBER> <NUMBER> figures generated stand cases unless specified whenever change stability particular length delay delay length specified first consider system <NUMBER> <NUMBER> f ðx yþ xy vðxþ x pðyþ illustrate results consider system consider system wherein parameters <NUMBER> except r ¼ <NUMBER> example studies influence higher treatment rate effected people earlier exam ð<NUMBER> <NUMBER> <NUMBER>þ equilibrium solution <NUMBER> characteristic eq <NUMBER> reduces clearly shows <NUMBER> stable behaves delay free system supported observation conditions theorem <NUMBER> global stability ð<NUMBER> <NUMBER> <NUMBER>þ satisfied thus disease influence dynamics system <NUMBER> shown fig <NUMBER> consider system x <NUMBER> ¼ <NUMBER> à xy à <NUMBER>x þ z <NUMBER> ¼ xðt à sþy à <NUMBER>y study influence choosing higher amount vaccination ie set parameter c ¼ <NUMBER> example applying theorem <NUMBER> get stability delayfree system <NUMBER> takes form gðtþ <NUMBER>t <NUMBER> à <NUMBER>t <NUMBER> à <NUMBER>t à <NUMBER> ¼ <NUMBER> equation positive solution þ ¼ <NUMBER>ðapproxþ consider system x <NUMBER> ¼ <NUMBER> à <NUMBER>xy à <NUMBER>x þ z <NUMBER> ¼ <NUMBER>xðt à sþy à <NUMBER>y chosen r ¼ <NUMBER> shall study influence high recovery rate vaccination rate together infection rate doubled compared earlier examples ð<NUMBER> <NUMBER> <NUMBER>þ equilibrium solution <NUMBER> example <NUMBER> characteristic equation fðkþ ¼ k <NUMBER> þ <NUMBER>k <NUMBER> þ <NUMBER>k ¼ <NUMBER> non zero roots certainly negative real parts thus diseasefree equilibrium locally stable subsequent examples choose nonlinear functions f v andor p <NUMBER> example <NUMBER> consider system <NUMBER> example <NUMBER> consider system nonlinearities infection vaccination parameters chosen r ¼ <NUMBER> shall introduce nonlinear recovery function model consider system wherein ¼ <NUMBER> <NUMBER> <NUMBER> locally asymptotically stable delays may seen fig <NUMBER> system <NUMBER> example <NUMBER> provides situation diseasefree equilibrium ð<NUMBER> <NUMBER> <NUMBER>þ endemic equilibrium ð<NUMBER> <NUMBER> <NUMBER>þ exist however conditions conducive local global stability ð<NUMBER> <NUMBER> <NUMBER>þ indicates prevalence infection irrespective time delay provide scope diseasefree environment example <NUMBER> raised treatment rate r ¼ <NUMBER> <NUMBER> r ¼ <NUMBER> <NUMBER> parameters functional relations kept <NUMBER> case diseasefree equilibrium ð<NUMBER> <NUMBER> <NUMBER>þ exists possibility endemic equilibrium theory says ð<NUMBER> <NUMBER> <NUMBER>þ asymptotically stable locally globally creating eventual infectionfree environment notice infected treated possibility infected contacting susceptible comes spread disease considerably reduced susceptible x ã ¼ <NUMBER> remain system compared x ã ¼ <NUMBER> example <NUMBER> order understand influence vaccination effort system example <NUMBER> raised vaccination parameter c ¼ <NUMBER> system <NUMBER> c ¼ <NUMBER> system <NUMBER> example <NUMBER> parameters kept example <NUMBER> system possesses two equilibria ð<NUMBER> <NUMBER> <NUMBER>þ ð<NUMBER> <NUMBER> <NUMBER>þ compared situation example <NUMBER> equilibrium values infected recovered populations considerably reduced ã ¼ <NUMBER> ¼ z ã ã ¼ <NUMBER> ¼ z ã may due increased vaccination efforts small values time delays disease equilibrium ð<NUMBER> <NUMBER> <NUMBER>þ stable delay incubation increases equilibrium becomes unstable predicted theory wild fluctuations populations noticed delay parameter <NUMBER> may seen figs <NUMBER>f indicates time delay incubation influence system even enhanced vaccination example <NUMBER> system <NUMBER> though rate conversion susceptible infected b <NUMBER> doubled b <NUMBER> ¼ <NUMBER> <NUMBER> b <NUMBER> ¼ <NUMBER> <NUMBER> stability disease free equilibrium ð<NUMBER> <NUMBER> <NUMBER>þ influence higher vaccination treatment ðc ¼ <NUMBER> r ¼ <NUMBER>þ <NUMBER> compared c ¼ <NUMBER> r ¼ <NUMBER> <NUMBER> nonlinear function infection chosen example <NUMBER> see system <NUMBER> provides scope existence disease free equilibrium infection prevails cases similarly nonlinear functions vaccination infection treatment considered examples <NUMBER> <NUMBER> cases corresponding disease free equilibrium locally asymptotically stable independent time delays remark <NUMBER> systems examples <NUMBER> <NUMBER> <NUMBER> <NUMBER> notice diseasefree equilibrium exists ¼ <NUMBER> c ¼ <NUMBER> <NUMBER> <NUMBER> equilibrium choice functions made noticed remark <NUMBER> system thus behaving like delayfree system diseasefree equilibrium locally asymptotically stable examples <NUMBER> <NUMBER> <NUMBER> provide disease environment paper proposed mathematical model describing dynamics population consisting susceptible infected recovered treatment categories existence equilibria local stability studied detail attempt made understand influence vaccination treatment populations presence time delays infection recovery results global stability also established special case proposed model situations effect time delays stability equilibria null void identified special case important interesting explore view point general cases <NUMBER> observed vaccination threshold rate admissible beyond infection gets eradicated examples <NUMBER> <NUMBER> illustrate vaccination alone cannot eradicate infection treatment rate playing key role controlling disease system influenced time delays present study raises basic questions <NUMBER> example <NUMBER> noticed equilibrium ð<NUMBER> <NUMBER> <NUMBER>þ locally stable long time delay infection <NUMBER> thereafter equilibrium becomes unstable predicted theory see results sections <NUMBER> <NUMBER> time simulations show <NUMBER> system behaving wild large fluctuations observed infected recovered populations situation vulnerable stable endemic equilibrium situation may much beyond control thus existence stable endemic equilibrium may sometimes better choice behavior system simultaneous influence time delays general case section <NUMBER> needs investigated detail commensurate delays study section <NUMBER> may provide estimate types delays explicit estimates required however need analyze situations <NUMBER> mathematical studies biological models concentrate stability equilibria known identifiable solutions system consider following system x <NUMBER> ¼ <NUMBER> à <NUMBER>xy à <NUMBER>x þ z <NUMBER> ¼ <NUMBER>xðt à sþy à <NUMBER>y disease free ð<NUMBER> <NUMBER> <NUMBER>þ endemic ð <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> þ equilibria neither theorem <NUMBER> theorem <NUMBER> holds case also system <NUMBER> example <NUMBER> allows possibility existence disease free equilibrium hence scope disease free environment comments made section <NUMBER> aimed situations cases study ways controlling infected populations rather stability system raises following questions control find small p <NUMBER> yðtþ <NUMBER> p create inactive state zone activation spreading disease means identify keep infected people quarantine least till vaccination effective treatment available sufficient meet requirements would point contention future exposition observed <NUMBER> diseases like chagas effort vaccination adequate control disease treatment recommended acute chronic stages diseases system <NUMBER> examples <NUMBER> illustrates cases examples conclude treatment rate high diseasefree environment created stability ð<NUMBER> <NUMBER> <NUMBER>þ example <NUMBER> stability ð<NUMBER> <NUMBER> <NUMBER>þ example <NUMBER> presence improved vaccination effort alone infected hence recovered populations lowered stability ð<NUMBER> <NUMBER> <NUMBER>þ example <NUMBER> stability ð<NUMBER> <NUMBER> <NUMBER>þ example <NUMBER> influence better vaccination addition high treatment rate notice considerable decrease susceptible population due increased rate infection stability ð<NUMBER> <NUMBER> <NUMBER>þ example <NUMBER> stability ð<NUMBER> <NUMBER> <NUMBER>þ example <NUMBER> would interesting see far model explains dynamics chagas disease whole common expectations model really come true prompts us analyze model regard applicability understanding various infectious diseases would scope future study need present simpler conditions parameters provide results global asymptotic stability general infection functions f ðx yþ also global stability analysis model general interaction vaccination recovery functions offing infection rate treatment rate vaccination three important parameters essentially decide dynamics spread disease effort made estimation parameters order decide measures control disease investigation lines made open soon discussion open research problems away system isolation measures taken society controlling spread disease course bðt yþ <NUMBER> condition says situation encouraging growth infected population infectious diseases spread media air water direct contact carriers insects flies mosquitoes <NUMBER> <NUMBER> dynamics may well understood modeling causes carriers disease possible time control media carriers involved spread infection sometimes may even beyond determination many time may even recognize presence infection becomes predominant mathematical modeling tool popularly employed prevention control infectious diseases severe acute respiratory syndrome sars <NUMBER> human immunodeficiency virus infectionacquired immune deficiency syndrome hivaids <NUMBER> h<NUMBER>n<NUMBER> avian flu <NUMBER> h<NUMBER>n<NUMBER> swine flu <NUMBER> also useful studying drug resistant strains malaria <NUMBER> tuberculosis <NUMBER> methicillinresistant staphylococcus aureus mrsa <NUMBER> marine bacteriophage infection <NUMBER> simple deterministic models based dividing population compartments susceptible exposed infected recovered susceptibleinfective si model useful understanding diseases feline infectious peritonitis fip <NUMBER> host remain infected till die susceptibleinfectivesusceptible sis model employed studying infections gonorrhea <NUMBER> possibility host becoming susceptible infection susceptibleinfectiverecovered sir model employed understand diseases syphilis <NUMBER> wherein immunity lasts limited period waning individual susceptible dynamics systems generally studied two perspectives stability diseasefree equilibrium ii stability endemic equilibrium former case conditions pathogens suffer extinction leaving individuals susceptible studied whereas later conditions infective susceptible populations coexist established interactions among populations compartments susceptible x infected key understand rate infection spread population models bilinear interaction among populations xy tend disease free equilibrium endemic equilibrium <NUMBER> researchers considered various interactions nonlinear type βx p q <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> xy <NUMBER>ax <NUMBER> xy <NUMBER>y <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> understanding dynamics infectious diseases observed solutions periodic nature exist even without periodic forcing term model existence periodic solutions usually attributed presence time delays system even case bilinear incidence delays exist disease transmission known latency period infection inception identifiable state interesting studies infectious disease models readers referred <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hand fluctuations populations may also attributed changes environment especially open systems perturbations influenced environment may treated noise system dynamic models competing species influence noise extensively studied <NUMBER> <NUMBER> <NUMBER> <NUMBER> predictive models based clinical incidence data pertaining infectious diseases epidemics general discussed <NUMBER> <NUMBER> <NUMBER> earlier studies infectious disease models identification basic reproduction number gave idea stability system either terms disease free environment disease prevalence reproduction number represents number secondary cases caused primary case introduced wholly susceptible population also observed reproduction number less unity disease free equilibrium stable otherwise disease prevails <NUMBER> nature interaction known basic reproduction number unity one needs find ways restrict disease minimum manageable level disease free environment cannot provided comes control disease vaccination preventive strategies could good choice early stages disease provided population large enough emergence vaccine resistant strains one drawbacks frequent long term vaccination massive vaccination possible second stage defensive mechanism could medical treatment adds new sub category population called recovered class representing population recovered treatment basing observations consider following three compartmental system present paper wherein xt yt zt denote susceptible infected recovered treatment populations time respectively ′ dt denotes time derivative function ≥ <NUMBER> growth rate susceptible population f denotes nonlinear incidence infection function showing susceptibles x converted infected b <NUMBER> denotes rate contact interaction infected susceptible rate removal susceptible individuals system naturally immune infection way get infected v x vaccination function depends susceptible population c <NUMBER> rate successful vaccination <NUMBER> b <NUMBER> ≤ b rate conversion susceptible infected case b <NUMBER> b may expect infection helm spreading <NUMBER> b <NUMBER> b may infer disease effective missing x ′ susceptible may removed system time delay τ <NUMBER> implies x gets contact takes time τ become infected called temporary immunity parameter parameter <NUMBER> <NUMBER> removaldeath rate infected populationeither treated inadequately treated beyond treatment may also viewed rate infected population kept quarantine away susceptible population avoiding sort contact infected exposed p recovery treatment function infected r <NUMBER> denotes rate treatment also recovery rate however infected treatment procedure may recover time gap δ parameter α <NUMBER> rate recovered nonvaccinated individual may reexposed infection become susceptible case arises individual appears recovered treatment prone infection basic interactions among various populations shown figure <NUMBER> assume following conditions infection function first condition nonnegativity minimum requirement function representing biological systems dynamics make sense second condition arises situation susceptible ie influence third condition required create diseasefree environment necessity condition described section <NUMBER> addition nonnegativity condition satisfied p represents recovery treatment function thus assume p ≥ <NUMBER> ∀y strict inequality holding <NUMBER> interested studying influence treatment spread disease absence infected population p <NUMBER> <NUMBER> treatment effort required depending reproduction number epidemic availability need initiate vaccination following probable cases uniform constant supply v x k ii fixed constant proportional susceptible population v x x linear iii sublinear v x x kx v x tanh x saturation limit iv v x may periodic function infection fluctuating seasondependent cyclic however case new infectious disease system may ready vaccines prevent spread recent case spread ebola <NUMBER> thus time gap required start vaccination procedure vaccine invented supplied may v xt <NUMBER> ∀t <NUMBER> ≤ ≤ <NUMBER> v v xt ≥ <NUMBER> ∀t <NUMBER> delay also warranted section shall discuss final section basic motivation study stems observations <NUMBER> vaccination alone sufficient contain disease effectively treatment plays important role disease management shall analyze model <NUMBER> keeping view following concerns important handling infectious disease <NUMBER> influence treatment recovery rate r <NUMBER> influence vaccination effort v <NUMBER> combined effect vaccination treatment <NUMBER> destabilize equilibrium x z <NUMBER> make → <NUMBER> present paper aims provide answers questions organizing content follows section <NUMBER> possible equilibria determined model equations <NUMBER> section <NUMBER> local stability properties system discussed subsection <NUMBER> behaviour delayfree system discussed influence time delay τ <NUMBER> stability delayfree system studied subsection <NUMBER> influence delay recovery δ <NUMBER> alone studied subsection <NUMBER> bounds delays conditions change direction stability also discussed subsection <NUMBER> general case delays τ <NUMBER> δ <NUMBER> discussed section <NUMBER> global stability results derived special case delays present examples simulation results presented section <NUMBER> discussions scope future study deferred section <NUMBER> section <NUMBER> respectively let us consider case system <NUMBER> assumptions made continuity solutions <NUMBER> definitions functions f v p easy see x z nonnegative domains definition equilibria constant solutions system popular way understand system study behaviour equilibria <NUMBER> look two possibilities existence equilibrium type x <NUMBER> <NUMBER> called diseasefree equilibrium whose stability implies infection little influence ii stable positive equilibrium xỹz called endemic equilibrium denotes disease prevalence unless specifically stated x z denotes either equilibria throughout subsequent study equilibria x z <NUMBER> satisfy hypothesize <NUMBER> v ∞ holds shall exist point x satisfies condition cv x − dx illustrate hypothesis considered realtime dataset pertaining sars <NUMBER> fitted logistic curve form v x c <NUMBER>a exp −bx number reported sars cases x given time interval estimated parameters logistic curve data c <NUMBER> b <NUMBER> <NUMBER> inflection point logistic curve give ln b c <NUMBER> point <NUMBER> <NUMBER> shown figure <NUMBER> curve switches increasing rate growth decreasing rate clearly suggesting existence diseasefree equilibrium point x <NUMBER> <NUMBER> whose stability implies diseasefree environment logistic curve line passing diseasefree equilibrium pointx shown figure <NUMBER> provides mechanism design vaccination v methods containing disease linearizing system <NUMBER> around equilibrium x z get characteristic equation <NUMBER> given  letting λ µ iν <NUMBER> separating real imaginary parts f µ iν real imaginary parts denoted hereafter r shall first consider case delays contracting disease τ <NUMBER> recovery δ <NUMBER> equation <NUMBER> reduces elementary algebra says l <NUMBER> l <NUMBER> <NUMBER> ii nm <NUMBER> n <NUMBER> <NUMBER> hold roots equation negative real parts thus theorem <NUMBER> needs proof theorem <NUMBER> τ <NUMBER> δ <NUMBER> system <NUMBER> locally asymptotically stable provided parameters satisfy l <NUMBER> l <NUMBER> <NUMBER> nm <NUMBER> n <NUMBER> <NUMBER> ◻ remark <NUMBER> particular <NUMBER> c ≤ <NUMBER> hold v ′ x ≥ <NUMBER> ∂f ∂x ≥ <NUMBER> ≤ <NUMBER>then characteristic equation <NUMBER> reduces delay free clearly coefficients nonnegative possibility root positive real part thus equilibrium x z stable <NUMBER> c ≤ <NUMBER> ≤ <NUMBER> thus need explore possibilities finding diseasefree equilibrium conditions hold implying possibility diseasefree environment choice parameters selection vaccination function identification infection function recovery may render possible ◻ may infer following <NUMBER> case system disease free equilibrium e <NUMBER> endemic equilibrium e <NUMBER> conditions theorem <NUMBER> hold e <NUMBER> may say disease influence <NUMBER> e <NUMBER> either unstable least one roots equation positive real part exist check stability endemic equilibrium e <NUMBER> <NUMBER> e <NUMBER> stable explore possibilities destabilizing increasing vaccination efforts ii treatment rate iii delay process infection <NUMBER> case e <NUMBER> unstable solutions exhibiting dominance disease system e <NUMBER> need study behaviour solutions way handle infected population finding ǫ <NUMBER> <NUMBER> yt ≤ ǫ shall provide answers towards end article shall study influence time delays system first start delay incubation delay recovery treated understand influence time delay converting exposed population infected allow δ <NUMBER> equation <NUMBER> get equations type <NUMBER> well studied literature eg <NUMBER> <NUMBER> <NUMBER> letting <NUMBER> n <NUMBER> − <NUMBER> n <NUMBER> <NUMBER> <NUMBER> <NUMBER> − <NUMBER>ln − l <NUMBER> <NUMBER> <NUMBER> l <NUMBER> − <NUMBER>m straight forward application theorem <NUMBER> <NUMBER> yields theorem <NUMBER> notice theorem <NUMBER> theorem <NUMBER> <NUMBER> ensures preservation stability instability specify values lengths delay holds following result helps us estimating delay cases need following result <NUMBER> utilized <NUMBER> study conditions lemma <NUMBER> ensures stability τ <NUMBER> ii confirms pure imaginary zeros limiting case condition iii establishes absence imaginary zeros may observed lemma <NUMBER> necessary sufficient condition violation conditions ii iii reflects corresponding change stability characteristic equation <NUMBER> employing lemma <NUMBER> shall present another set conditions preservation change stability system apply lemma shall denote <NUMBER> p λ λ <NUMBER> lλ <NUMBER> mλ n qλ l <NUMBER> λ <NUMBER> n <NUMBER> <NUMBER> let e −λτ <NUMBER> <NUMBER> characteristic polynomial becomes clearly f <NUMBER> λ ≠ <NUMBER> rλ ≥ <NUMBER> theorem <NUMBER> ensures stability τ <NUMBER> <NUMBER> let e −λτ −<NUMBER> <NUMBER> get holds ensuring presence imaginary zeros limiting case <NUMBER> let e −λτ <NUMBER>−λt <NUMBER>λt <NUMBER> <NUMBER> becomes <NUMBER> pure imaginary zeros ensuring change stability assume n <NUMBER> n <NUMBER> ≠ <NUMBER> otherwise λ <NUMBER> letting λ iν f <NUMBER> λ <NUMBER> separating real imaginary parts get real part ν <NUMBER> l <NUMBER> − mt − lν <NUMBER> n <NUMBER> n <NUMBER> <NUMBER> imaginary part −lt <NUMBER>ν <NUMBER> nt − <NUMBER> − n <NUMBER> l <NUMBER> ν <NUMBER> imaginary part ν ≠ <NUMBER> ⇒ ν <NUMBER> l <NUMBER> mn−m <NUMBER> −n <NUMBER> following cases arise rearrangement becomes may written summarize discussion theorem <NUMBER> theorem <NUMBER> assume equilibrium solution <NUMBER> stable τ <NUMBER> δ <NUMBER> system preserves stability length delay τ <NUMBER> δ <NUMBER> provided either following cases satisfy <NUMBER> solution <NUMBER> ◻ shall study influence time delay recovery stability system wish understand clearly whether time delays τ δ influence independently introduced mathematical curiosity specific δ influence system better ignore proceed τ case parameters τ <NUMBER> δ <NUMBER> case characteristic equation <NUMBER> reduces shall utilize lemma <NUMBER> analyze stability behaviour system case also following cases may arise <NUMBER> let e −λδ <NUMBER> <NUMBER> get letting λ iν separating real imaginary parts get easy see condition ensures pure imaginary zeros limiting case <NUMBER> consider e −λδ <NUMBER>−λt <NUMBER>λt <NUMBER> gives λ <NUMBER> lλ <NUMBER> l <NUMBER> mλ nm <NUMBER> −n <NUMBER> λt λ <NUMBER> lλ <NUMBER> l <NUMBER> mλ nm <NUMBER> n <NUMBER> <NUMBER> pure imaginary zeros let λ iν separating real imaginary parts get real part eliminating rearranging get ν ≠ <NUMBER> inequalities hold <NUMBER> yields real solution ν thus stabilityinstability <NUMBER> preserved length delay δ following cases may arise <NUMBER> following conditions l <NUMBER> <NUMBER>l <NUMBER> l <NUMBER> <NUMBER> <NUMBER>ln <NUMBER> n <NUMBER> <NUMBER> n <NUMBER> <NUMBER> ii l <NUMBER> <NUMBER>l <NUMBER> l <NUMBER> <NUMBER> <NUMBER>ln <NUMBER> n <NUMBER> <NUMBER> n <NUMBER> <NUMBER> iii l <NUMBER> <NUMBER>l <NUMBER> l <NUMBER> <NUMBER> <NUMBER>ln <NUMBER> n <NUMBER> <NUMBER> n <NUMBER> <NUMBER> iv l <NUMBER> <NUMBER>l <NUMBER> l <NUMBER> <NUMBER> <NUMBER>ln <NUMBER> n <NUMBER> <NUMBER> n <NUMBER> <NUMBER> hold change sign indicates <NUMBER> one ν <NUMBER> <NUMBER> yielding two possibilities ν values ν certainly <NUMBER> exists ν <NUMBER> lies l <NUMBER> nm <NUMBER> −n <NUMBER> l least one terms positive gives rise change stability <NUMBER> conditions l <NUMBER> <NUMBER>l <NUMBER> l <NUMBER> <NUMBER> <NUMBER>ln <NUMBER> n <NUMBER> <NUMBER> n <NUMBER> <NUMBER> <NUMBER> hold <NUMBER> yields two values ν <NUMBER> <NUMBER> four real values ν <NUMBER> get two values say <NUMBER> <NUMBER> δ say δ <NUMBER> δ <NUMBER> <NUMBER> δ <NUMBER> δ <NUMBER> holds change stability occurs first δ <NUMBER> second bifurcation δ <NUMBER> similar arguments extend three values ν <NUMBER> <NUMBER> consolidate discussion theorem <NUMBER> <NUMBER> given <NUMBER> condition change stability occurrence hopf bifurcation indicated zero real part λ µ iν <NUMBER> letting µ <NUMBER> <NUMBER> get rf iν −lν <NUMBER> n n <NUMBER> cos ντ δ l <NUMBER> ν sin ντ <NUMBER> cosντ iν −ν <NUMBER> mν − n <NUMBER> sin ντ δ l <NUMBER> ν cos ντ <NUMBER> sin ντ squaring adding get establish following result theorem <NUMBER> assume equilibrium solution x z <NUMBER> stable unstable τ <NUMBER> δ <NUMBER> stability instability x z preserved τ <NUMBER> δ <NUMBER> provided conditions ⎛ ⎝ l <NUMBER> l <NUMBER> <NUMBER> <NUMBER>ln n <NUMBER> <NUMBER> <NUMBER>l ⎞ ⎠ <NUMBER> ≤ n <NUMBER> <NUMBER> − <NUMBER> <NUMBER> <NUMBER> l <NUMBER> <NUMBER> n <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hold ii change stability instability occurs condition n <NUMBER> <NUMBER>n n <NUMBER> <NUMBER> <NUMBER> <NUMBER> holds proof theorem <NUMBER> conditions preservation stability instability given rf iν <NUMBER> iν <NUMBER> ν ν <NUMBER> µ <NUMBER> equivalently show ψν <NUMBER> <NUMBER> stabilityinstability preserved without loss generality let ν <NUMBER> smallest positive root rf iν <NUMBER> since n <NUMBER> cos ντ δ ≤ n <NUMBER> l <NUMBER> ν sin ντ ≤ l <NUMBER> ν <NUMBER> cosντ ≤ <NUMBER> positive ν lν <NUMBER> − n ≤ n <NUMBER> l <NUMBER> ν <NUMBER> rf iν consider lν <NUMBER> − l <NUMBER> ν − n n <NUMBER> <NUMBER> <NUMBER> clearly two roots bigger one given ν l <NUMBER> l <NUMBER> <NUMBER> <NUMBER>ln n <NUMBER> <NUMBER> <NUMBER>l clearly ν <NUMBER> ≤ ν <NUMBER> ψν <NUMBER> implied left hand side positive quantity inequality clearly holds ν <NUMBER> <NUMBER> n <NUMBER> <NUMBER> −m <NUMBER> <NUMBER> <NUMBER> l <NUMBER> <NUMBER> holds since ν <NUMBER> ≤ ν inequality satisfied provided <NUMBER> holds thus ψν <NUMBER> <NUMBER> hence change stability instability occurs <NUMBER> observe ψ<NUMBER> <NUMBER> n <NUMBER> <NUMBER>n n <NUMBER> <NUMBER> <NUMBER> <NUMBER> holds ψν <NUMBER> large ν therefore ψν <NUMBER> real positive solution let ν denote smallest root <NUMBER> may written <NUMBER>n − lν <NUMBER> n <NUMBER>mν − ν <NUMBER> l ν <NUMBER> l <NUMBER> − <NUMBER>mν <NUMBER> <NUMBER> − <NUMBER>ln − l <NUMBER> <NUMBER> ν <NUMBER> n <NUMBER> n <NUMBER> <NUMBER> − <NUMBER> <NUMBER> θ τ δ value ν obtained <NUMBER> θ ≡ τ δ <NUMBER> ν tan −<NUMBER> mν−ν <NUMBER> n−lν <NUMBER> proof complete ◻ consider important special case <NUMBER> f x ≡ xy simple interaction term assume py ≡ v x ≡ x recovery vaccination linear <NUMBER> takes form equilibrium points given solutions clearly cd <NUMBER> <NUMBER> always solution <NUMBER> diseasefree equilibrium <NUMBER> ≠ <NUMBER>then <NUMBER> giving rise positive equilibrium solution <NUMBER> provided bx ≠ r − c dx bx − r <NUMBER> simply <NUMBER> necessary sufficient condition existence positive endemic equilibrium <NUMBER> case x r b <NUMBER> r b <NUMBER> entire z plane becomes equilibria assuming x z positive equilibrium <NUMBER> formulate theorem <NUMBER> theorem <NUMBER> positive equilibrium solution x z <NUMBER> globally asymptotically stable independent time delays provided parameters satisfy condition b proof theorem <NUMBER> using <NUMBER> <NUMBER> rewrite <NUMBER> consider function clearly v x z <NUMBER> v x z ≥ <NUMBER> x ≥ <NUMBER> ≥ <NUMBER> z ≥ <NUMBER> v → ∞ x z → ∞ upper dini derivative v along solutions <NUMBER> rest argument follows standard arguments proof complete ◻ shall provide result global stability diseasefree equilibrium suppose xt <NUMBER> r b <NUMBER> solving second equation <NUMBER> linear equation get sufficiently large using third equation <NUMBER> large zt → z<NUMBER>e −αt → <NUMBER> first equation <NUMBER> sufficiently large becomes thus formulate theorem <NUMBER> carried simulations using subroutines developed matlab employed builtin function dde<NUMBER> <NUMBER> variable step size numerical integration routine solving delay differential equations matlab details dde<NUMBER> solver readers may refer wwwmathworkscomdde tutorial utilized plot function advanced graphical tools available matlab obtain results figures presented work figures curves drawn dashdot line diamond marker − − denote exposed populations infected represented dashed line pentagram marker − − − − curves denoted solid line square marker − ◻ − stand recovered populations simulations carried various lengths delays three cases τ <NUMBER> δ <NUMBER> τ <NUMBER> δ <NUMBER> τ <NUMBER> δ <NUMBER> figures generated stand cases unless specified whenever change stability particular length delay delay length specified first consider system <NUMBER> <NUMBER> f x ≡ xy v x ≡ x p ≡ illustrate results consider system obtained letting b c <NUMBER> b <NUMBER> α r <NUMBER> <NUMBER> clearly <NUMBER> positive equilibrium <NUMBER> easy see τ <NUMBER> δ <NUMBER> <NUMBER> <NUMBER> stable virtue theorem <NUMBER> values parameters <NUMBER> b <NUMBER>c <NUMBER>d <NUMBER> positive equation <NUMBER> becomes <NUMBER>t <NUMBER> <NUMBER>t <NUMBER> <NUMBER>t <NUMBER> <NUMBER> solution <NUMBER> thus positive equilibrium system <NUMBER> remains stable length delay τ <NUMBER> δ <NUMBER> conditions <NUMBER> satisfied hence theorem <NUMBER> δ <NUMBER> τ <NUMBER> influence stability also may noticed parametric conditions theorem <NUMBER> satisfied hence <NUMBER> <NUMBER> <NUMBER> globally asymptotically stable virtue theorem <NUMBER> showing infection widely prevalent time conditions theorem <NUMBER> violated hence possibility diseasefree environment dynamics may observed figure <NUMBER> consider system wherein parameters <NUMBER> except r <NUMBER> example studies influence higher treatment rate effected people earlier example clearly x <NUMBER> r b <NUMBER> <NUMBER>y a−cdx bx −r <NUMBER> z <NUMBER> thus <NUMBER> <NUMBER> <NUMBER> equilibrium solution <NUMBER> characteristic equation <NUMBER> reduces f λ λ <NUMBER> <NUMBER>λ <NUMBER> <NUMBER>λ <NUMBER> roots λ <NUMBER> −<NUMBER>± clearly shows <NUMBER> stable behaves delay free system supported observation conditions theorem <NUMBER> global stability <NUMBER> <NUMBER> <NUMBER> satisfied thus disease influence dynamics system <NUMBER> shown figure <NUMBER> consider system study influence choosing higher amount vaccination ie set parameter c <NUMBER> example <NUMBER> clearly applying theorem <NUMBER> get stability delayfree system thus <NUMBER> remains unstable τ τ <NUMBER> since <NUMBER> −<NUMBER> <NUMBER> instability <NUMBER> <NUMBER> <NUMBER> prevails τ τ per theorem <NUMBER> condition n <NUMBER> <NUMBER>n n <NUMBER> <NUMBER> <NUMBER> <NUMBER> theorem <NUMBER> satisfied also indicating change stability delay free system general case behaviour consider system chosen r <NUMBER> c <NUMBER> b <NUMBER> b <NUMBER> <NUMBER> <NUMBER> <NUMBER> shall study influence high recovery rate vaccination rate together infection rate doubled compared earlier examples clearly x cd <NUMBER> r b <NUMBER> <NUMBER>y a−cdx bx −r <NUMBER> z <NUMBER> thus <NUMBER> <NUMBER> <NUMBER> equilibrium solution <NUMBER> example <NUMBER> characteristic equation f λ λ <NUMBER> <NUMBER>λ <NUMBER> <NUMBER>λ <NUMBER> non zero roots certainly negative real parts thus diseasefree equilibrium locally stable subsequent examples choose nonlinear functions f v andor p consider system wherein r <NUMBER> c <NUMBER> b <NUMBER> b <NUMBER> <NUMBER> <NUMBER> α <NUMBER> nonlinearity infection clearly system <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> equilibrium locally stable virtue theorem <NUMBER> <NUMBER> example <NUMBER> consider system shall introduce nonlinear recovery function model consider system wherein <NUMBER> b <NUMBER> b <NUMBER> c <NUMBER> <NUMBER> <NUMBER> <NUMBER> r <NUMBER> α <NUMBER> clearly system diseasefree equilibrium given √ <NUMBER>−<NUMBER> <NUMBER> <NUMBER> <NUMBER> locally asymptotically stable delays τ δ may seen figure <NUMBER> system <NUMBER> example <NUMBER> provides situation diseasefree equilibrium <NUMBER> <NUMBER> <NUMBER> endemic equilibrium <NUMBER> <NUMBER> <NUMBER> exist however conditions conducive local global stability <NUMBER> <NUMBER> <NUMBER> indicates prevalence infection irrespective time delay provide scope diseasefree environment example <NUMBER> raised treatment rate r <NUMBER> <NUMBER> r <NUMBER> <NUMBER> parameters functional relations kept <NUMBER> case diseasefree equilibrium <NUMBER> <NUMBER> <NUMBER> exists possibility endemic equilibrium theory says <NUMBER> <NUMBER> <NUMBER> asymptotically stable locally globally creating eventual infectionfree environment notice infected treated possibility infected contacting susceptible comes spread disease considerably reduced susceptible x <NUMBER> remain system compared x <NUMBER> example <NUMBER> order understand influence vaccination effort system example <NUMBER> raised vaccination parameter c <NUMBER> system <NUMBER> c <NUMBER> system <NUMBER> example <NUMBER> parameters kept example <NUMBER> system possesses two equilibria <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> compared situation example <NUMBER> equilibrium values infected recovered populations considerably reduced <NUMBER> z <NUMBER> z may due increased vaccination efforts small values time delays disease equilibrium <NUMBER> <NUMBER> <NUMBER> stable delay incubation increases equilibrium becomes unstable predicted theory wild fluctuations populations noticed delay parameter τ <NUMBER> may seen figures <NUMBER>a<NUMBER>f indicates time delay incubation influence system even enhanced vaccination example <NUMBER> system <NUMBER> though rate conversion susceptible infected b <NUMBER> doubled b <NUMBER> <NUMBER> <NUMBER> b <NUMBER> <NUMBER> <NUMBER> stability disease free equilibrium <NUMBER> <NUMBER> <NUMBER> influence higher vaccination treatment c <NUMBER> r <NUMBER> <NUMBER> compared c <NUMBER> r <NUMBER> <NUMBER> nonlinear function infection chosen example <NUMBER> see system <NUMBER> provides scope existence disease free equilibrium infection prevails cases similarly nonlinear functions vaccination infection treatment considered examples <NUMBER> <NUMBER> cases corresponding disease free equilibrium locally asymptotically stable independent time delays remark <NUMBER> systems examples <NUMBER> <NUMBER> <NUMBER> <NUMBER> notice diseasefree equilibrium exists <NUMBER> c <NUMBER> ≤ <NUMBER> equilibrium choice functions made noticed remark <NUMBER> system thus behaving like delayfree system diseasefree equilibrium locally asymptotically stable examples <NUMBER> <NUMBER> <NUMBER> provide disease environment ◻ paper proposed mathematical model describing dynamics population consisting susceptible infected recovered treatment categories existence equilibria local stability studied detail attempt made understand influence vaccination treatment populations presence time delays infection recovery results global stability also established special case proposed model situations effect time delays stability equilibria null void identified special case important interesting explore view point general cases <NUMBER> observed vaccination threshold rate admissible beyond infection gets eradicated examples <NUMBER> <NUMBER> illustrate vaccination alone cannot eradicate infection treatment rate playing key role controlling disease system influenced time delays present study raises basic questions <NUMBER> example <NUMBER> noticed equilibrium <NUMBER> <NUMBER> <NUMBER> locally stable long time delay infection τ <NUMBER> thereafter equilibrium becomes unstable predicted theory see results sections <NUMBER> <NUMBER> time simulations show τ <NUMBER> system behaving wild large fluctuations observed infected recovered populations situation vulnerable stable endemic equilibrium situation may much beyond control thus existence stable endemic equilibrium may sometimes better choice behaviour system simultaneous influence time delays general case section <NUMBER> needs investigated detail commensurate delays study section <NUMBER> may provide estimate types delays explicit estimates required however need analyze situations <NUMBER> mathematical studies biological models concentrate stability equilibria known identifiable solutions system consider following system x ′ <NUMBER> − <NUMBER>xy − <NUMBER>x z ′ <NUMBER>xt − τ − <NUMBER>y z ′ <NUMBER>yt − δ − z rate vaccination three important parameters essentially decide dynamics spread disease effort made estimation parameters order decide measures control disease investigation lines made open soon shall propose modifications <NUMBER> taking consideration realistic phenomena present following cases open research problems would form part research <NUMBER> assumed growth rate susceptible population <NUMBER> fixed constant assumption holds good susceptible population receives input large society disease visits limited period reproduction susceptible infected andor recovered population significant however case chronic diseases aids chagas etc offspring three populations may make sizeable contribution system thus may consider x ′ aux z − bf x − dx − cv x αz ′ b <NUMBER> f xt − τ yt − rp − <NUMBER> z ′ rp yt − δ − αz aux z denotes growth function susceptible population <NUMBER> vaccination well attack disease rare may possible well prepared society cases vaccine readily available delay preparation supply natural may viewed two directions vaccine takes time γ <NUMBER> develop immunity susceptible population vaccinated time − γ immune time hence population may removed system thus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> etiological agent coronavirus disease <NUMBER> <NUMBER> emerged wuhan china late <NUMBER> rapidly swept globe may <NUMBER> <NUMBER> <NUMBER> <NUMBER> million confirmed cases <NUMBER> deaths reported worldwide <NUMBER> covid<NUMBER> crisis <NUMBER> inflicted immense toll human health causing profound socioeconomic effects linger years <NUMBER> come vaccines treatments sarscov<NUMBER> could drastically reduce covid<NUMBER> transmission saving <NUMBER> lives brightening prospects economic recovery licensed countermeasures currently exist although <NUMBER> number clinical trials underway clinical testing good predictor preventative drug efficacy <NUMBER> caution warranted approach due potential disease enhancement vaccine candidates <NUMBER> sarscov<NUMBER> including inactivated wholevirus recombinant dna subunit viruslike particle live <NUMBER> virus vectorbased vaccines induced immunopathology following immunization experimental infection <NUMBER> mice ferrets nonhuman primates nhps suggesting hypersensitivity virus components <NUMBER> <NUMBER> <NUMBER> <NUMBER> given <NUMBER> strong genetic similarity sarscov<NUMBER> sarscov<NUMBER> <NUMBER> appropriate surrogate human covid<NUMBER> <NUMBER> needed safely evaluate prophylactics careful assessment animal models could reveal possible immune <NUMBER> complications elicited vaccines therapies prior release public moreover animal models <NUMBER> could help shed light important aspects disease ways easily addressed feasible <NUMBER> humans virus spreads interacts host immune system ideal covid<NUMBER> animal model would replicate facets human disease several animal species <NUMBER> including mice hamsters ferrets nhps found support sarscov<NUMBER> replication displayed <NUMBER> varying degrees nonlethal illness virus delivered respiratory tract animals <NUMBER> <NUMBER> models utility study covid<NUMBER> nhps closest physiological <NUMBER> resemblance humans allowing better comparison host responses infection genetic similarity <NUMBER> also contributed increased availability reagents perform indepth analyses immune response recently first studies evaluating pathogenic potential sarscov<NUMBER> cynomolgus rhesus <NUMBER> macaques performed rhesus macaques developed pneumonia clinical signs whereas disease <NUMBER> cynomolgus macaques fairly mild indicating former appears better reflect severe cases <NUMBER> results suggest certain nhp species may serve better models others <NUMBER> ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> coronavirus infections sars disease caused sarscov<NUMBER> african green monkeys agms <NUMBER> found support highest level viral replication followed cynomolgus macaques rhesus macaques <NUMBER> three species challenged parallel <NUMBER> agms notable replication lower <NUMBER> respiratory tract following sarscov<NUMBER> inoculation necropsy animals indicated focal interstitial <NUMBER> mononuclear inflammatory infiltrates edema lung consistent human sars sarscov<NUMBER> <NUMBER> sarscov<NUMBER> share putative host receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> reasoned agms might serve useful model covid<NUMBER> infected agms low passage isolate sarscov<NUMBER> sarscov<NUMBER>inmi<NUMBER> isolate<NUMBER>italy evaluated potential model covid<NUMBER> sarscov<NUMBER>inmi<NUMBER>isolate<NUMBER>italy <NUMBER> isolated first clinical case italy <NUMBER> first v clade virus gisaid experimentally <NUMBER> inoculated nhps demonstrate agms mimic several aspects human disease including high degree <NUMBER> viral replication severe pulmonary lesions model used conduct pathogenesis studies <NUMBER> screen potential vaccines therapeutics challenged six adult agms <NUMBER> x <NUMBER> <NUMBER> pfu italy isolate sarscov<NUMBER> sarscov<NUMBER>inmi<NUMBER> isolate<NUMBER>italy combined intratracheal intranasal routes dose divided equally cohort <NUMBER> three animals euthanized <NUMBER> dpi remaining three animals held indefinitely blood <NUMBER> animals sampled days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> continuing days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> animals held <NUMBER> past <NUMBER> dpi overt clinical signs disease observable animals decreased appetite <NUMBER> compared baseline <NUMBER> days postinfection dpi <NUMBER> animals brief period elevated body temperature <NUMBER> suggestive fever two three animals <NUMBER> dpi supplementary figure <NUMBER> biphasic increase partial <NUMBER> <NUMBER> pressures noted two animals course study overt changes partial co <NUMBER> pressures <NUMBER> animals noted figure <NUMBER>ab transient shifts leukocyte populations mild thrombocytopenia <NUMBER> observed animals prominently days <NUMBER> postinfection supplementary table <NUMBER> figure <NUMBER> <NUMBER>cdef markers renal hepatic function mostly remained unchanged <NUMBER>fold increases alt ast <NUMBER> alp however crp marker acute systemic inflammation elevated two sevenfold animals <NUMBER> <NUMBER> dpi table <NUMBER> figure <NUMBER> ghij thoracic radiographs taken <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> dpi shown <NUMBER> ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> four animals seroconverted sarscov<NUMBER> including three animals held past <NUMBER> dpi <NUMBER> earliest detection antisarscov<NUMBER> igg occurring <NUMBER> dpi agm<NUMBER> agm<NUMBER> agm<NUMBER> figure <NUMBER> igg <NUMBER> titers peaked <NUMBER> dpi agm<NUMBER> exhibiting low titers <NUMBER> <NUMBER> dpi compared agm<NUMBER> agm<NUMBER> neutralizing titers <NUMBER> plaque reduction values ranged <NUMBER> evident beginning day <NUMBER> one <NUMBER> animal three animals followed study endpoint figure <NUMBER> bcde emergence sarscov<NUMBER> astonishingly rapid evolution localized outbreak pandemic threat <NUMBER> emphasized importance coronaviruses regards human health globally particularly <NUMBER> clustering lineage b betacoronaviruses accordingly necessity exists development animal <NUMBER> models sarscov<NUMBER> recapitulate covid<NUMBER> disease phenotype observed humans regard <NUMBER> ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> nhps efforts made using rhesus cynomolgus macaques <NUMBER> <NUMBER> <NUMBER> <NUMBER> agms challenged isolate sarscov<NUMBER> italy develop overt debilitating clinical <NUMBER> illness however changes leukocyte subpopulations thrombocytes serum markers acute inflammatory <NUMBER> processes indicated systemic response infection using surgically implanted temperature data loggers <NUMBER> able detect elevated body temperatures two animals <NUMBER> dpi indicative fever moreover animals <NUMBER> held past <NUMBER> dpi seroconverted two animals achieving high igg titers <NUMBER> third animal held <NUMBER> <NUMBER> dpi never antisarscov<NUMBER> igg titer <NUMBER> suggesting dampened humoral response <NUMBER> animal immune arms humoral immunity may important sarscov<NUMBER> infection additionally potential reinfection humans sarscov<NUMBER> speculated risk factors <NUMBER> actual incidence unknown however antibody titers endemic human coronaviruses eg <NUMBER> reported gradually wane reinfection homologous virus reported <NUMBER> <NUMBER> important aspect agm model sarscov<NUMBER> infection development pronounced viral <NUMBER> pneumonia agms study exhibited pulmonary consolidation hemorrhage varying severity <NUMBER> animals lung lobes performed thoracic radiographs six sarscov<NUMBER>infected agms <NUMBER> however radiographs consistent work sarscov<NUMBER>infected macaques recently published <NUMBER> others <NUMBER> <NUMBER> <NUMBER> reflect degree lesions hemorrhage lungs seen necropsy <NUMBER> opinion radiographs study well covid<NUMBER> nhp studies <NUMBER> convincingly demonstrate sarscov<NUMBER>induced disease specifically opacities changes observed <NUMBER> radiographs could nonspecific due atelectasis poor inspiratory effort bals collection procedures important discussion current recommendation humans even use radiography <NUMBER> primary diagnosis covid<NUMBER> notably recent study <NUMBER> ambulatory patients covid<NUMBER> <NUMBER> detect abnormalities chest x rays almost <NUMBER> cases <NUMBER> use computed tomography ct <NUMBER> scanning even plesmography techniques may informative detailed pulmonary investigations using <NUMBER> animal models ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> evidence gastrointestinal involvement sarscov<NUMBER>infected agms <NUMBER> reported human cases <NUMBER> putative sarcov<NUMBER> entry receptor ace<NUMBER> expressed epithelium <NUMBER> ileum colon <NUMBER> however animals study exhibited abnormalities within small <NUMBER> intestine observe signs gastrointestinal distress study course possible <NUMBER> exception decreased appetite animals data show infection agms sarscov<NUMBER> results release inflammatory mediators <NUMBER> similar immune signatures human cases several groups reported levels il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> correlate disease severity human patients <NUMBER> <NUMBER> study observed increased serum levels <NUMBER> interleukins well proinflammatory cytokines chemokines elevated human cases specified procedure days days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> μl blood added <NUMBER> μl avl viral <NUMBER> lysis buffer qiagen virus inactivation rna extraction following removal high containment <NUMBER> laboratory rna isolated blood swabs using qiaamp viral rna kit qiagen detection sarscov<NUMBER> load <NUMBER> rna isolated blood mucosal swabs assessed using cdc sarscov<NUMBER> n<NUMBER> assay <NUMBER> primersprobe reverse transcriptase quantitative pcr rtqpcr <NUMBER> sarscov<NUMBER> rna detected using <NUMBER> onestep probe rtqpcr kits qiagen run cfx<NUMBER> detection system biorad following cycle <NUMBER> conditions <NUMBER>°c <NUMBER> minutes <NUMBER>°c <NUMBER> seconds <NUMBER> cycles <NUMBER>°c <NUMBER> seconds <NUMBER>°c <NUMBER> <NUMBER> seconds threshold cycle ct values representing sarscov<NUMBER> genomes analyzed cfx manager <NUMBER> ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> software data presented geq generate geq standard curve rna vero e<NUMBER> cells infected <NUMBER> sarscov<NUMBER>inmi<NUMBER>isolate<NUMBER>italy extracted number genomes calculated using <NUMBER> avogadros number molecular weight sarscov<NUMBER> genome virus titration performed plaque assay vero e<NUMBER> cells atcc crl<NUMBER> blood plasma <NUMBER> mucosal swabs bal samples briefly increasing <NUMBER>fold dilutions samples adsorbed <NUMBER> vero e<NUMBER> cell monolayers duplicate wells <NUMBER> μl cells overlaid emem agar medium plus <NUMBER> avicel incubated <NUMBER> days plaques counted staining <NUMBER> crystal violet formalin limit <NUMBER> detection assay <NUMBER> pfuml copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> washes develop colorimetric reaction reaction stopped <NUMBER>m sulfuric acid <NUMBER> minutes <NUMBER> opd addition absorbance values measured wavelength <NUMBER>nm spectrophotometer <NUMBER> molecular devices emax system sunnyvale ca absorbance values normalized subtracting normal <NUMBER> wells antigencoated wells corresponding serum dilution sumod value <NUMBER> required denote positive sample endpoint titers defined reciprocal last adjusted serum dilution <NUMBER> value ≥ <NUMBER> serum neutralization assay <NUMBER> neutralization titers calculated determining dilution serum reduced <NUMBER> plaques prnt<NUMBER> incubated standard <NUMBER> pfu amount sarscov<NUMBER> twofold serial dilutions serum samples <NUMBER> one hour virusserum mixture used inoculate vero e<NUMBER> cells <NUMBER> minutes cells overlaid <NUMBER> emem agar medium plus <NUMBER> avicel incubated <NUMBER> days plaques counted staining <NUMBER> <NUMBER> crystal violet formalin ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint figure <NUMBER> hematological features agms infected sarscov<NUMBER> blood collected agms <NUMBER> procedure days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> partial pressures co<NUMBER> o<NUMBER> obtained using istat igg binding titers determined using traditional elisa methodology antigen whole infected <NUMBER> cell lysate background subtraction performed using virus negative cell lysate titers represented <NUMBER> reciprocal dilutions antibody neutralization titers also determined sera collected <NUMBER> dpi b <NUMBER> dpi <NUMBER> c <NUMBER> dpi <NUMBER> dpi e data plotted represents percent reduction plaque counts average <NUMBER> duplicate wells compared average three independent virus control plates average plaque count across <NUMBER> three plates <NUMBER> dashed lines graph indicate <NUMBER> neutralization compared virus control plates <NUMBER> plaque counts calculated duplicate wells dilution <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> etiological agent coronavirus disease <NUMBER> <NUMBER> emerged wuhan china late <NUMBER> rapidly swept globe may <NUMBER> <NUMBER> <NUMBER> <NUMBER> million confirmed cases <NUMBER> deaths reported worldwide <NUMBER> covid<NUMBER> crisis <NUMBER> inflicted immense toll human health causing profound socioeconomic effects linger years <NUMBER> come vaccines treatments sarscov<NUMBER> could drastically reduce covid<NUMBER> transmission saving ideal covid<NUMBER> animal model would replicate facets human disease several animal species <NUMBER> including mice hamsters ferrets nhps found support sarscov<NUMBER> replication displayed <NUMBER> varying degrees nonlethal illness virus delivered respiratory tract animals <NUMBER> <NUMBER> models utility study covid<NUMBER> nhps closest physiological <NUMBER> resemblance humans allowing better comparison host responses infection genetic similarity <NUMBER> also contributed increased availability reagents perform indepth analyses immune response recently first studies evaluating pathogenic potential sarscov<NUMBER> cynomolgus rhesus <NUMBER> macaques performed rhesus macaques developed pneumonia clinical signs whereas disease <NUMBER> cynomolgus macaques fairly mild indicating former appears better reflect severe cases <NUMBER> results suggest certain nhp species may serve better models others <NUMBER> <NUMBER> coronavirus infections sars disease caused sarscov<NUMBER> african green monkeys agms <NUMBER> found support highest level viral replication followed cynomolgus macaques rhesus macaques <NUMBER> three species challenged parallel <NUMBER> agms notable replication lower <NUMBER> respiratory tract following sarscov<NUMBER> inoculation necropsy animals indicated focal interstitial <NUMBER> mononuclear inflammatory infiltrates edema lung consistent human sars sarscov<NUMBER> <NUMBER> sarscov<NUMBER> share putative host receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> reasoned agms might serve useful model covid<NUMBER> infected agms low passage isolate sarscov<NUMBER> sarscov<NUMBER>inmi<NUMBER> isolate<NUMBER>italy evaluated potential model covid<NUMBER> sarscov<NUMBER>inmi<NUMBER>isolate<NUMBER>italy <NUMBER> isolated first clinical case italy <NUMBER> first v clade virus gisaid experimentally <NUMBER> inoculated nhps demonstrate agms mimic several aspects human disease including high degree <NUMBER> viral replication severe pulmonary lesions model used conduct pathogenesis studies <NUMBER> screen potential vaccines therapeutics challenged six adult agms <NUMBER> x <NUMBER> <NUMBER> pfu italy isolate sarscov<NUMBER> sarscov<NUMBER>inmi<NUMBER> isolate<NUMBER>italy combined intratracheal intranasal routes dose divided equally cohort <NUMBER> three animals euthanized <NUMBER> dpi remaining three animals held indefinitely blood <NUMBER> animals sampled days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> continuing days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> animals held <NUMBER> past <NUMBER> dpi overt clinical signs disease observable animals decreased appetite <NUMBER> compared baseline <NUMBER> days postinfection dpi <NUMBER> animals brief period elevated body temperature <NUMBER> suggestive fever two three animals <NUMBER> dpi supplementary figure <NUMBER> biphasic increase partial <NUMBER> <NUMBER> pressures noted two animals course study overt changes partial co <NUMBER> pressures <NUMBER> animals noted figure <NUMBER>a <NUMBER> thought correlate disease severity hospitalized patients <NUMBER> <NUMBER> also measured levels <NUMBER> clotting factor fibrinogen levels surged <NUMBER> <NUMBER> monkeys indicating potential coagulation abnormalities <NUMBER> animals figure <NUMBER>b increase circulating fibrinogen aligns gross pathology findings substantial <NUMBER> hemorrhage lung monkeys euthanized <NUMBER> dpi collectively results indicate host response <NUMBER> sarscov<NUMBER> infection agms parallels humans four animals seroconverted sarscov<NUMBER> including three animals held past <NUMBER> dpi <NUMBER> earliest detection antisarscov<NUMBER> igg occurring <NUMBER> dpi agm<NUMBER> agm<NUMBER> agm<NUMBER> figure <NUMBER>a igg <NUMBER> titers peaked <NUMBER> dpi agm<NUMBER> exhibiting low titers <NUMBER> <NUMBER> dpi compared agm<NUMBER> agm<NUMBER> neutralizing titers <NUMBER> plaque reduction values ranged <NUMBER> evident beginning day <NUMBER> one <NUMBER> animal three animals followed study endpoint figure <NUMBER> bcde emergence sarscov<NUMBER> astonishingly rapid evolution localized outbreak pandemic threat <NUMBER> emphasized importance coronaviruses regards human health globally particularly <NUMBER> clustering lineage b betacoronaviruses accordingly necessity exists development animal <NUMBER> models sarscov<NUMBER> recapitulate covid<NUMBER> disease phenotype observed humans regard <NUMBER> nhps efforts made using rhesus cynomolgus macaques <NUMBER> <NUMBER> <NUMBER> <NUMBER> agms challenged isolate sarscov<NUMBER> italy develop overt debilitating clinical <NUMBER> illness however changes leukocyte subpopulations thrombocytes serum markers acute inflammatory <NUMBER> processes indicated systemic response infection using surgically implanted temperature data loggers <NUMBER> able detect elevated body temperatures two animals <NUMBER> dpi indicative fever moreover animals <NUMBER> held past <NUMBER> dpi seroconverted two animals achieving high igg titers <NUMBER> third animal held <NUMBER> <NUMBER> dpi never antisarscov<NUMBER> igg titer <NUMBER> suggesting dampened humoral response <NUMBER> animal immune arms humoral immunity may important sarscov<NUMBER> infection additionally potential reinfection humans sarscov<NUMBER> speculated risk factors <NUMBER> actual incidence unknown however antibody titers endemic human coronaviruses eg <NUMBER> reported gradually wane reinfection homologous virus reported <NUMBER> <NUMBER> important aspect agm model sarscov<NUMBER> infection development pronounced viral <NUMBER> pneumonia agms study exhibited pulmonary consolidation hemorrhage varying severity <NUMBER> animals lung lobes performed thoracic radiographs six sarscov<NUMBER>infected agms <NUMBER> however radiographs consistent work sarscov<NUMBER>infected macaques recently published <NUMBER> others <NUMBER> <NUMBER> <NUMBER> reflect degree lesions hemorrhage lungs seen necropsy <NUMBER> opinion radiographs study well covid<NUMBER> nhp studies <NUMBER> convincingly demonstrate sarscov<NUMBER>induced disease specifically opacities changes observed <NUMBER> radiographs could nonspecific due atelectasis poor inspiratory effort bals collection procedures important discussion current recommendation humans even use radiography <NUMBER> primary diagnosis covid<NUMBER> notably recent study <NUMBER> ambulatory patients covid<NUMBER> <NUMBER> detect abnormalities chest x rays almost <NUMBER> cases <NUMBER> use computed tomography ct <NUMBER> scanning even plesmography techniques may informative detailed pulmonary investigations using <NUMBER> animal models evidence gastrointestinal involvement sarscov<NUMBER>infected agms <NUMBER> reported human cases <NUMBER> putative sarcov<NUMBER> entry receptor ace<NUMBER> expressed epithelium <NUMBER> ileum colon <NUMBER> however animals study exhibited abnormalities within small <NUMBER> intestine observe signs gastrointestinal distress study course possible <NUMBER> exception decreased appetite animals data show infection agms sarscov<NUMBER> results release inflammatory mediators <NUMBER> similar immune signatures human cases several groups reported levels il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> correlate disease severity human patients <NUMBER> <NUMBER> study observed increased serum levels <NUMBER> interleukins well proinflammatory cytokines chemokines elevated human cases moreover detected rise fibrinogen majority monkeys another prominent finding human covid<NUMBER> <NUMBER> cases fibrinogen implicated thrombosis vascular injury suggesting discovery warrants <NUMBER> investigation together results indicate agm model used study host response covid specified procedure days days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> μl blood added <NUMBER> μl avl viral <NUMBER> lysis buffer qiagen virus inactivation rna extraction following removal high containment <NUMBER> laboratory rna isolated blood swabs using qiaamp viral rna kit qiagen detection sarscov<NUMBER> load <NUMBER> rna isolated blood mucosal swabs assessed using cdc sarscov<NUMBER> n<NUMBER> assay <NUMBER> primersprobe reverse transcriptase quantitative pcr rtqpcr <NUMBER> sarscov<NUMBER> rna detected using <NUMBER> onestep probe rtqpcr kits qiagen run cfx<NUMBER> detection system biorad following cycle <NUMBER> conditions <NUMBER>°c <NUMBER> minutes <NUMBER>°c <NUMBER> seconds <NUMBER> cycles <NUMBER>°c <NUMBER> seconds <NUMBER>°c <NUMBER> <NUMBER> seconds threshold cycle ct values representing sarscov<NUMBER> genomes analyzed cfx manager <NUMBER> software data presented geq generate geq standard curve rna vero e<NUMBER> cells infected <NUMBER> sarscov<NUMBER>inmi<NUMBER>isolate<NUMBER>italy extracted number genomes calculated using <NUMBER> avogadros number molecular weight sarscov<NUMBER> genome virus titration performed plaque assay vero e<NUMBER> cells atcc crl<NUMBER> blood plasma <NUMBER> mucosal swabs bal samples briefly increasing <NUMBER>fold dilutions samples adsorbed <NUMBER> vero e<NUMBER> cell monolayers duplicate wells <NUMBER> μl cells overlaid emem agar medium plus <NUMBER> avicel incubated <NUMBER> days plaques counted staining <NUMBER> crystal violet formalin limit <NUMBER> detection assay <NUMBER> pfuml incubated standard <NUMBER> pfu amount sarscov<NUMBER> twofold serial dilutions serum samples <NUMBER> one hour virusserum mixture used inoculate vero e<NUMBER> cells <NUMBER> minutes cells overlaid <NUMBER> emem agar medium plus <NUMBER> avicel incubated <NUMBER> days plaques counted staining <NUMBER> <NUMBER> crystal violet formalin operations support galveston national laboratory supported niaidnih grant uc<NUMBER>ai<NUMBER> <NUMBER> <NUMBER> figure <NUMBER> hematological features agms infected sarscov<NUMBER> blood collected agms <NUMBER> procedure days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> partial pressures co<NUMBER> o<NUMBER> obtained using istat igg binding titers determined using traditional elisa methodology antigen whole infected <NUMBER> cell lysate background subtraction performed using virus negative cell lysate titers represented <NUMBER> reciprocal dilutions antibody neutralization titers also determined sera collected <NUMBER> dpi b <NUMBER> dpi <NUMBER> c <NUMBER> dpi <NUMBER> dpi e data plotted represents percent reduction plaque counts average <NUMBER> duplicate wells compared average three independent virus control plates average plaque count across <NUMBER> three plates <NUMBER> dashed lines graph indicate <NUMBER> neutralization compared virus control plates <NUMBER> plaque counts calculated duplicate wells dilution <NUMBER> past two decades two outbreaks coronaviruses covs asian subcontinent middle east increased chances outbreak near future severe acute respiratory syndrome coronavirus sarscov outbreak end <NUMBER> november china <NUMBER> confirmed cases reported <NUMBER> total deaths <NUMBER> ksiazek et al <NUMBER> <NUMBER> another coronavirus ie middle east respiratory syndrome mers occurred <NUMBER> fatality rate around <NUMBER> <NUMBER> bermingham et al <NUMBER> recently new coronavirus called novel severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> outbreak december <NUMBER> china emergence global health threats situation became worse global level rodriguezmorales et al <NUMBER> world health organization termed syndrome caused novel coronavirus covid<NUMBER> <NUMBER>th feb <NUMBER> gralinski menachery <NUMBER> coronaviruses fall coronaviridae family subfamily coronavirinae members infect broad range hosts producing symptoms diseases wide spectrum flu like severe acute respiratory infection sari sarscov<NUMBER> considered one seven members cov family infect humans similar coronaviruses transmission sarscov<NUMBER> among humans occurs droplets direct contact physical objects aerosols <NUMBER>a liu et al <NUMBER> owing rapid transmission sarscov<NUMBER> epidemic become global public health challenge march <NUMBER> covid<NUMBER> outbreak declared pandemic cucinotta vanelli <NUMBER> june <NUMBER> <NUMBER> million people globally affected nearly <NUMBER> fatalities <NUMBER>b due high morbidity mortality rate coronaviruses infection unmet need therapeutic strategies treat diseases sarma et al <NUMBER> currently recommended therapeutic drugs vaccine coronaviruses emphasizes surge suitable animal model explore pathogenesis evaluation countermeasures disease outbreak coronaviruses numerous animal models developed past gralinski baric <NUMBER> current review highlighted animal models coronaviruses summarized strength weaknesses existing animal models along key features nonhuman primate models sarscov<NUMBER> recently recognized novel coronavirus causing symptoms mild critical type sari infected rhesus macaques study pathogenesis covid<NUMBER> observed high viral titers nose swabs throat swabs also lung lesions varying degrees animals table <NUMBER> model recapitulates covid<NUMBER> symptoms used elucidate therapy sarscov<NUMBER> infection munster et al <NUMBER> rockx et al compared pathogenesis sars mers covid<NUMBER> inoculating cynomolgus macaques virus infection rockx et al <NUMBER> virus samples taken throat nose diffuse alveolar damage reported results study thus demonstrated infection sarscov<NUMBER> nonhuman primates induced signs resemble covid<NUMBER> like disease severity virus infection lies mers sars mahase <NUMBER> yu et al studied association virus infection age viral strain inoculated rhesus macaques <NUMBER> years old <NUMBER> years old intratracheal route clinical signs instance viral replication histopathological changes analyzed replication virus lungs nasopharyngeal swabs old rhesus macaque compared young rhesus macaque infection old rhesus macaques also observed diffuse severe interstitial pneumonia comparative study three species nonhuman primates infected sarscov<NUMBER> rhesus macaque macaca fascicularis common marmoset severe gross lesions histopathological changes vital organs animals observed study found rhesus macaque model susceptible sarscov<NUMBER> compared macaca fascicularis common marmoset woolsey et al determined african green monkeys supported high level sarscov<NUMBER> replication developed respiratory tract related illnesses might substantial reported nonhuman primate species like cynomolgus rhesus macaques study also reported high viral loads feces mucosal samples monkeys <NUMBER> days postinfection dpi woolsey et al <NUMBER> table <NUMBER> inoculation balbc mice mouseadapted sarscov<NUMBER> passage <NUMBER> macsp<NUMBER> significantly affected groups mice irrespective ages infection resulted moderate pneumonia inflammation study reported higher viral load lungs along significant histopathological changes like denatured trachea inflammation pulmonary alveoli detection viral antigen trachea bronchiole type ii pneumocytes significant elevation inflammatory chemokine cytokines sera lung macrophages similar clinical symptoms dinnon et al constructed recombinant virus sarscov<NUMBER> could replicate upper well lower airways groups balbc mice irrespective ages results showed severe infection aged mice comparison young mice dinnon et al <NUMBER> study done based human ace<NUMBER> hace<NUMBER> transgenic mice investigate pathogenesis covid<NUMBER> infected mice reported weight loss increased viral titer lungs histopathological changes revealed presence interstitial pneumonia mice model seems promising evaluation therapeutic measures covid<NUMBER> one studies examined infectivity pathological changes sarscov<NUMBER> infected transgenic hace<NUMBER> mice developed using lung ciliated epithelial cellspecific hfh<NUMBER>foxj<NUMBER> promoter <NUMBER> model showed partial simulation human covid<NUMBER> significant decrease body weight interstitial pneumonia fatality along involvement organs like heart brain eye depicted similarity human counterpart study also showed protection reinfection survived mice table <NUMBER> sun sh et al developed hace<NUMBER> mouse model using crisprcas<NUMBER> knock technology study sarscov<NUMBER> infection compared wild type c<NUMBER>bl<NUMBER> mice model high viral titer brain lungs trachea hace<NUMBER> mice wild type mice sarscov<NUMBER> infection hace<NUMBER> mice associated increased cytokine levels interstitial pneumonia mortality moreover intragastric inoculation sarscov<NUMBER> infection altered significant pathological changes lungs compared wild type mice sun et al <NUMBER>b singh et al animal models sarscov<NUMBER> sarscov merscov sun j et al developed transgenic mice model delivery human ace<NUMBER> exogenously replication deficient adenovirus ad<NUMBER>hace<NUMBER> inoculation mice sarscov<NUMBER> infection linked high viral load lungs along weight loss pneumonia role type<NUMBER> interferon signal transducer activator transcription <NUMBER> stat<NUMBER> signaling vital viral clearance virus infection study concluded beneficial role using human convalescent plasma two antiviral agents polyinosinic polycytidylic acid remdesivir sun j et al <NUMBER>a hassan et al developed hace<NUMBER> transduced mice infected mice sarscov<NUMBER> study observed significant weight loss high viral load lungs severe lung pathology infected mice hassan et al <NUMBER> chan et al observed significant binding novel coronavirus spike ace<NUMBER> receptor syrian hamster silico study table <NUMBER> viral load significantly increased hamster leads diffuse alveolar damage initial stage extensive apoptosis later phase infection chan et al <NUMBER> clinical histopathological observations sarscov<NUMBER> hamster model closely resemble clinical condition airway involvement evident nasal turbinate trachea pulmonary alveoli associated changes inflammation cellular viral n protein expression high viral load first week disease progressed increasing respiratory rate decreasing activity progressive weight loss found severe <NUMBER> dpi similar disease course covid<NUMBER> patients sia et al evaluated transmission pathogenesis sarscov<NUMBER> infection golden syrian hamster model animal groups infected sarscov<NUMBER> showed significant weight loss viral replication respiratory tract viral load high <NUMBER> dpi rapid clearance observed <NUMBER> dpi could attributed presence cd<NUMBER> positive tlymphocytes involvement olfactory sensory neurons simulates anosmia covid<NUMBER> cases transmission sarscov<NUMBER> naïve hamsters aerosols helpful studies sia et al <NUMBER> table <NUMBER> kim et al used ferrets study sarscov<NUMBER> infection transmission study reported ferrets susceptible infection transmission virus one ferret naive ferrets direct indirect physical contact showed infected ferrets exhibited replication virus upper respiratory tract recapitulates covid<NUMBER> human conditions used evaluate countermeasures disease kim et al <NUMBER> table <NUMBER> development sarscov infection model many species like old new world primates used significant infection observed cynomolgus rhesus macaques common marmosets greenough et al <NUMBER> african green monkeys virus inoculated within respiratory tract primates however case squirrel monkeys mustached tamarins investigators able induce infection roberts et al <NUMBER> subbarao roberts <NUMBER> significantly high viral replication cynomolgus rhesus african green monkeys marmosets diarrhea pneumonitis fever watery stool hepatitis observed greenough et al <NUMBER> investigators variable findings number factors may affect results including age animal source dose route administration infection inoculation virus history environment subbarao roberts <NUMBER> however results outbred species consistent biological variability therefore important carry large sample sizes study find meaningful conclusions table <NUMBER> different mice models used study infection balbc mice infected intranasally increase viral titer lungs sign morbidity mortality noticed <NUMBER> <NUMBER> dpi virus replication significantly increased respiratory tract started decreasing day <NUMBER> dpi showed young balbc mice failed exhibit clinical signs disease permitted viral replication hand study showed oneyearold balbc mice exhibited critical infection compared younger mice sarscov infection vogel et al <NUMBER> histopathological findings bronchiolitis diffuse alveolar damage patchy interstitial pneumonitis observed balbc mice model sarscov also observed old age balbc mice prone disease similar clinical one studies suggested <NUMBER>s mice infected sarscov exhibited virus replication selflimited bronchiolitis <NUMBER>s mice strain also reported mild weight loss pneumonitis sarscov infection side stat <NUMBER> mice <NUMBER>s background observed sustained replication virus histopathological changes mimicking humans disease however vaccine studies limited targeted mice immune defects frieman et al <NUMBER> moreover c<NUMBER>bl<NUMBER> mice also used sarscov model virus isolates administered intranasal c<NUMBER>bl<NUMBER> mice showed high replication respiratory tract mice peak <NUMBER> rd day clearance <NUMBER> dpi study observed presence transient systemic infection lungs ultimately affects brain glass et al <NUMBER> table <NUMBER> another model used study sarscov infection golden syrian hamster significantly high titer viruses lungs along interstitial pneumonitis roberts et al <NUMBER> clinical signs like pulmonary histopathology high virus load hamster used model study therapeutics immunotherapy immunoprophylaxis observed viruses got cleared <NUMBER>dpi table <NUMBER> singh et al animal models sarscov<NUMBER> sarscov merscov various studies showed domestic cats ferrets prone sarscov infection virus replication well specific antibodies found species indicating drowsiness epiphysitis <NUMBER> <NUMBER> dpi ferrets died martina et al <NUMBER> however domestic cats study conducted inoculation infection via intranasal route replication virus lungs histological changes like pneumonitis reported ter meulen et al <NUMBER> table <NUMBER> difference homology human small animals dpp<NUMBER> molecules main virus receptor merscov therefore mice guinea pig ferrets usually permissive merscov cockrell et al <NUMBER> coleman et al <NUMBER> de wit et al <NUMBER>a b raj et al <NUMBER> however nonhuman primates rabbits pigs dromedary camels naturally permissive virus adney et al studied pathology transmission merscov among dromedary camels animals displayed slight increases body temperature rhinorrhea large quantity nasal shedding virus suggestive animaltoanimal animaltohuman transmission may occur droplets direct contact merscov mainly affects upper respiratory tract mimics mild clinical signs since clinical settings disease shows severe pathology camel model study therapeutics suitable adney et al <NUMBER> table <NUMBER> merscov classified biosafety level <NUMBER> poses difficulty using camels infection study alpaca belonging camelidae family provides alternative camels crameri et al used alpaca prospective substitute camel merscov vaccine testing crameri et al <NUMBER> exposure merscov study observed dissimilarity immune response two species however pathogenesis infection alpaca unknown table <NUMBER> de wit et al used rhesus macaques develop mers model high viral load merscov lower respiratory tract viral strain mainly affected type ii pneumocytes formed architecture alveolar space since high expression merscov present lungs therefore limited virus shedding viral replication kidney study concluded renal failure humans might associated hypoxia viral dissemination due transitory nature model rhesus macaques found exactly mimicking critical clinical yao et al <NUMBER> human exposure merscov leads severe respiratory disease might result fatality easy attain fatality rate nonhuman primate models cockrell et al used infectious clone novel merscov icmers<NUMBER> induce mers rhesus macaque clone strain found higher pathogenicity comparison wild type merscov peaked <NUMBER> <NUMBER> dpi resolved <NUMBER> dpi respiratory disease found placid brief resolves day <NUMBER> dpi model mimics mild infection mers humans cockrell et al <NUMBER> cases fatality associated comorbidities mers affected patients hui et al <NUMBER> saad et al <NUMBER> severity linked immunocompromised state order study immune response disease severity prescott et al used immunosuppressive drugs downregulate immunity rhesus macaques immunosuppressive state found associated high titer merscov supported pathology lung tissues inflammatory cells significantly decreased immunocompromised animals evaluated histopathologically turn shows effect immune status individual shedding viral load study depicted importance considering immune response along using therapy control infection clinical settings prescott et al <NUMBER> table <NUMBER> marmosets prone merscov infection rhesus macaques might suitable screen therapeutic strategies disease marmoset johnson et al <NUMBER> falzarano et al <NUMBER> study falzarano et al displayed increase severity following exposure merscov marmoset rhesus macaque titer almost <NUMBER> times greater marmoset rhesus macaque infection persisted longer duration compared rhesus macaque need euthanasia fact systemic dissemination virus viral dissemination kidney study observed marmoset model recapitulates houser et al studied effect reinfection rabbits model supported replication merscovemc<NUMBER> virus model displayed asymptomatic infection associated significant clinical sign model suitable preclinical screening therapeutics vaccines mers houser et al <NUMBER> table <NUMBER> mice easily available costeffective easy handle suitable initial screening drug therapies vaccines since mice susceptible merscov infection de wit et al <NUMBER>b coleman et al <NUMBER> therefore zhao et al developed mouse model mers using recombinant adenovirus expresses humanized dipeptidyl peptidase<NUMBER> hdpp<NUMBER> receptor zhao et al <NUMBER> study concluded significant weight loss virus dissemination respiratory tract interstitial pneumonia observed mice transient hdpp<NUMBER> expression mild respiratory system involvement fatality drawbacks model zhao et al <NUMBER> though previous study used adenovirus vector develop dpp<NUMBER> receptor mice vulnerable merscov infection mimic closely clinical conditions agrawal et al used tissuespecific inducible promoters derive humanized dpp<NUMBER> transgenic mice exposure merscov model showed high susceptibility virus briefly transgenic model depicted progressive pneumonia fatality agrawal et al developed hcd<NUMBER>dpp<NUMBER> transgenic mice receptors distributed throughout body physiologically relevant pascal et al used veloci gene technology rapidly develop new humanized model model showed active viral replication respiratory tract without cerebral infection pascal et al <NUMBER> tao et al observed constant inflammatory infiltrates brain lungs humanized cd<NUMBER> hcd<NUMBER>dpp<NUMBER> mice high viral titer observed lungs brain mice exposure merscov infection pathological examination found gross microscopic inflammation restricted lungs sign systemic dissemination along fatality <NUMBER> dpi tao et al showed acute severe infection hampers opportunity fully understand pathogenesis zhao et al developed mouse model exhibits codonoptimizedhdpp<NUMBER> receptor exposure viral strain showed severe disease pathology lungs affected brain kidney severe infection aberrant immune response lead mortality exact mechanism severity disease model requires evaluation zhao et al <NUMBER> cockrell et al used crisprcas<NUMBER> technology genetically alter nonpermissive host receptor model showed severe respiratory distress fatality response merscov supported plethysmography showed decreased pulmonary function might due inflammation pneumocytes airway epithelial cells viral titers detected brain thereby nullifying confounding factors could lead fatality cockrell et al <NUMBER> li et al developed transgenic mice inoculated mouse adapted merscov mers viral strain caused weight loss infection airway epithelia pneumocytes macrophages though model rapid develop required prior sensitization pathological changes exclusively associated speciesadapted mutations mers clone hinders model fully mimic clinical conditions li et al <NUMBER> fan et al used crisprcas<NUMBER> geneediting technology develop knockinmodel mice study displayed high level expression hdpp<NUMBER> respiratory tract lesser extent brain clear site infection along acute respiratory distress syndrome ards lungs also dissemination viruses central nervous system cns study observed high repeatability safety model fan et al <NUMBER> iwatayoshikawa et al developed transgenic mouse model using endogenous promoter hdpp<NUMBER> mice model showed high viral titer lower respiratory tract acute multifocal interstitial pneumonia observed <NUMBER> dpi viral titer also observed peripheral blood lymphoid tissues ageassociated immune response exposure viral strain model expressed mild infection pathology moreover infection model shown signs lesions brain kidney iwatayoshikawa et al <NUMBER> table <NUMBER> <NUMBER> coronaviruses pathology associated involvement severe acute respiratory infection sari immune deregulation thus requisite perform study using assay system must involve cell signalling thus using animal model unparallel approach <NUMBER> animal models recapitulate mild moderate pathology however clinical condition related high mortality morbidity therefore animal models mimic critical pathologies much closer clinical conditions <NUMBER> novel coronavirus covid<NUMBER> pathology linked viral respiratory infection hyperimmune response coagulopathy connors levy <NUMBER> therefore understand mechanism evaluate therapeutic countermeasures animal models involve interplays single model since advent technology transgenic mice significant tool transgenic mice lack coagulopathy component indispensable order understand complete mechanism evaluate countermeasures <NUMBER> validation animal model crucial error animal experimental study narrows chances potential drugs repurposing repositioning drugs vaccines translate successfully clinics moreover wastage resources thus need hour validate animal model using different criteria instance face construct predictive validity denayer et al <NUMBER> novel coronavirus disease covid<NUMBER> caused sarscov<NUMBER> infection firstly reported wuhan hubei china december <NUMBER> <NUMBER> one month severe disease attracted international attentions declared public health emergency international concern pheic january <NUMBER> <NUMBER> within <NUMBER> months covid<NUMBER> unexpectedly spread <NUMBER> countries regions led <NUMBER> million confirmed cases world defined pandemic disease believed second largest infectious disease since <NUMBER> flu <NUMBER> clinicians scientists globally collaborating investigate disease pathogen diagnosis prevention treatment covid<NUMBER> <NUMBER> genome structure sarscov<NUMBER> <NUMBER> however still many critical questions remaining hard answered clinic studies example sarscov<NUMBER> transmit viral pathogenesis vaccines drugs sarscov<NUMBER> therefore animal models urgently expected established severe covid<NUMBER> although several models covid<NUMBER> recently reported <NUMBER> <NUMBER> <NUMBER> including nonhuman primate model none model considered best one depending questions going answer animal models <NUMBER> years ago nonhuman primate models recapitulated several important aspects sars <NUMBER> <NUMBER> <NUMBER> <NUMBER> models made great contributions investigation sars pathogenesis evaluation antiviral drugs vaccine <NUMBER> though covid<NUMBER> different sars aspects pathogens two diseases share characters ace<NUMBER> receptor establish covid<NUMBER> model two families including <NUMBER> species nonhuman primates widely used animal models advantages disadvantages experimentally infected sarscov<NUMBER> followed comparisons clinical symptoms hematology biochemical indexes immunology histopathology among <NUMBER> species found given host factors may involved viral pathogenesis designed experiment present study investigate whether host genetics age gender affect sarscov<NUMBER> infection nonhuman primates figure <NUMBER> two families nonhuman primates old world monkeys <NUMBER> mulatta <NUMBER> fascicularis new world monkeys <NUMBER> c jacchus chosen experiment screening randomly grouped based species age gender figure <NUMBER> animals large size <NUMBER> adults <NUMBER> old mulatta <NUMBER> fascicularis inoculated <NUMBER>x<NUMBER> <NUMBER> pfu sarscov<NUMBER> via <NUMBER> routines intratreachuslly <NUMBER>ml intranasally <NUMBER>ml intra <NUMBER>ml half dosage viruses given <NUMBER> young mulatta via <NUMBER> routines <NUMBER> c jacchus inoculated <NUMBER>x<NUMBER> <NUMBER> pfu intranasally animals monitored daily sampled indicated time points viral inoculation figure <NUMBER> increased body temperature bt <NUMBER> ℃ continuously observed <NUMBER> <NUMBER> mulatta <NUMBER> <NUMBER> fascicularis none <NUMBER> c jacchus post inoculation sarscov<NUMBER> bt <NUMBER> mulatta reached first peak day <NUMBER> post inoculation dpi maintained <NUMBER> ℃ several days highest bt <NUMBER> ℃ sarscov<NUMBER> infection fascicularis bt didnt change much mulatta duration bt<NUMBER> ℃ fascicularis shorter mulatta figure <NUMBER>a <NUMBER> <NUMBER> dpi body weight bw experimental animals c jacchus determined checked electronic balance compared bw day <NUMBER> nine <NUMBER> mulatta showed decreased bw declined range <NUMBER> eightythree percent <NUMBER> fascicularis lost bw <NUMBER> table <NUMBER> chest radiographs infected animals mulatta fascicularis c jacchus due small size recorded every day post virus inoculation beginning <NUMBER> dpi abnormalities various degrees appeared lungs mulatta fascicularis texture two lungs increased thickened scattered small patches figure <NUMBER>b overview chest radiograph throughout study showed progressive pulmonary infiltration noted mulatta fascicularis supplemental figure <NUMBER> know dynamics viral replication virus shedding samples nasal swabs throat swabs anal swabs feces blood tissues collected indicated time points sarscov<NUMBER> genomes quantitated rtqpcr swab samples collected <NUMBER> dpi mulatta fascicularis showed surprisingly high levels viral genome rna particularly nasal swabs swab samples saw second peaks viral rna <NUMBER> dpi swab samples old world monkeys viral rna still detectable <NUMBER> dpi figure <NUMBER>a less viral rna detected throat swabs figure <NUMBER>d figure <NUMBER>e tem viral particle observed ultrathin sections lungs tissues determine host response sarscov<NUMBER> infection firstly however animals study screened prior experiments supposed severe complicationscomorbidities relatively healthy normal immunity may explain matter age gender within one species monkeys showed similar susceptibility responses sars monitoring body temperature one critical steps define covid<NUMBER> suspected patients leads conclusion fever common covid<NUMBER> patients counting <NUMBER> inpatients <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> inoculated mulatta increased body temperature time points peak <NUMBER> ℃ onethird fascicularis c jacchus slightly elevated body temperature nevertheless manifestation could defined fever since dont physiological body temperature various species monkeys reference important clinical feature covid<NUMBER> abnormal changes chest radiograph xray ct <NUMBER> generally considered direct evidence pneumonia ground glass opacities ggo seen <NUMBER> covid<NUMBER> patients followed consolidation <NUMBER> abnormal radiographs <NUMBER> <NUMBER> <NUMBER> <NUMBER> study animals c jacchus bloodserum <NUMBER> <NUMBER> samples upper respiratory track nasal swabs higher levels viral rna throat swabs <NUMBER> sarscov<NUMBER> rna nasal swabs detectable onset disease peaked day <NUMBER> post onset disease began decline slowly usually last <NUMBER> weeks <NUMBER> present study dynamics virus shedding nhp similar reported covid<NUMBER> patients although minor disparities existed due differences disease onset patients viral inoculation time animals day <NUMBER> post viral inoculation unusual peak viral genome rna nasal swabs figure <NUMBER>a speculated may leftover viral nucleic acid viral inoculation replicating viruses since sharply declined <NUMBER> dpi real peak detectable rna replicating viruses <NUMBER> dpi <NUMBER> dpi nasal swabs infected animals addition detectable viral rna anal swabs expression ace<NUMBER> digestive tract patients covid<NUMBER> suggest fecaloral routine great potential risk transmission sarscov<NUMBER> <NUMBER> study noticed high level virus shedding via feces lasted long time <NUMBER> monkeys animal model figure <NUMBER>a viral load various tissues indicator tropism correlates viral pathogenesis lung widely considered target organ sarscov<NUMBER> replication since plenty viruses detected bronchoalveolar lavage fluid covid<NUMBER> patients <NUMBER> earlier stage animal models could detect sarscov<NUMBER> viral genomic rna lung respiratory tissues figure <NUMBER>c however sarscov<NUMBER> rna became negative lung <NUMBER> dpi still detectable weasand bronchus possible inflammatory environment lung may push viruses tissues appearance viral rna blood lung correlated severity covid<NUMBER> <NUMBER> could detect viral rna blood samples <NUMBER> monkeys although differences viral load lasting time among individual animals however couldnt find correlation blood viral rna severity disease viral stock sarscov<NUMBER> obtained center diseases control guangdong province china viruses amplified veroe<NUMBER> cells concentrated ultrafilter system via <NUMBER>kda module millipore amplified sarscov<NUMBER> confirmed via rtpcr sequencing transmission electronic microscopy titrated via plaque assay <NUMBER> <NUMBER> pfuml three species monkeys two families primates old world monkeys new world monkey used study detailed information experimental animals shown figure <NUMBER>a animal groups experimental schedules outlined figure <NUMBER>a referring nhp model sars inoculated old world monkeys total <NUMBER>ml <NUMBER> <NUMBER> pfuml sarscov<NUMBER> intratracheally <NUMBER>ml intranasally <NUMBER>ml conjunctiva <NUMBER>ml new world monkeys <NUMBER>ml intranasally animals daily checked clinical sign body temperature indicated time points figure <NUMBER>a anaesthetized animals ketamine performed following experimental procedures every day post inoculation took chest radiography animals harvested peripheral blood prepare samples whole blood serum collected nasal pharyngeal rectal swabs <NUMBER>ul trizol ls solution invitrogen us analysis monkeys severe signs chosen necropsy pathological changes organs recorded evaluated gross histological ultrastructural levels chest xray image anaesthetized monkey taken <NUMBER>v <NUMBER>ma every day using mobile digital medical xray photography system mobilecooper browiner china data evaluated scored doubleblindly independently two radiologists flow cytometric analysis conducted cytoflex backman usa using florescentlabelled antibodies cellular surface marker cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> briefly <NUMBER> ul whole blood incubated proper fluorescentlabelled antibodies <NUMBER>min dark room temperature <NUMBER> ul <NUMBER>x rbc lys solution bd added antibodyblood mixture incubated <NUMBER>min room temperature remove red blood cells ready analysis cytoflex machine paraffinbedded sections tissues collected fixed <NUMBER> neutral novel nucleic acid hybridization technique rnascope performed detect localize viral rna paraffinembedded tissue sections using sarscov<NUMBER> specific probe rnascope® probevncov<NUMBER>s acd cat <NUMBER> targeting region <NUMBER> <NUMBER> nc<NUMBER> sarscov<NUMBER> genome ffpe slides pretreated baking deparaffinizing target retrieval protease treatment sarscov<NUMBER> specific probe applied pretreated slides hybridized viral genome fluorophore added detect hybridization slides followed counterstaining dapi slides scanned via <NUMBER>d histech system analysis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ↓ hhh <NUMBER> <NUMBER> ↓ body weights bw animals measured day <NUMBER> day <NUMBER> post virus inoculation body weight change expressed bw <NUMBER> dpibw <NUMBER> dpibw <NUMBER> dpi heart bottom fixed <NUMBER> glutaraldehyde <NUMBER> osmium tetroxide solution ultrastructural analysis c coronaviruses covs positivesense singlestranded rna viruses family coronaviridae subfamily coronavirinae infect wide host range produce diseases ranging common cold severefatal illnesses novel virus initially named <NUMBER>ncov changed sarscov<NUMBER> coronavirus study group csg international committee taxonomy viruses ictv since found sister virus severe acute respiratory syndrome coronavirus sarscov <NUMBER> ongoing coronavirus threat emerged china rapidly spread countries declared global health emergency world health organization many nations diverting best efforts implementation appropriate preventive control strategies neither vaccines directacting antiviral drugs available treatment human animal coronavirus infections <NUMBER> <NUMBER> <NUMBER> many efforts directed develop vaccines human cov infections recent decades limiting factor degree crossprotection rendered vaccines due extensive sequence diversity <NUMBER> various vaccines immunotherapeutics drug options explored recent threats zika ebola nipah viruses <NUMBER> <NUMBER> <NUMBER> well previous covs including sarsand merscovs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> valuable options exploited potency efficacy safety along expediting ongoing research <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> discover valuable modalities tackling emerging covid<NUMBER> yet effective vaccine therapeutic intense efforts ongoing therapeutic options available managing covid<NUMBER> based previous experiences treating sarsand merscov major reason lack approved commercially available vaccines therapeutic agents covs might relative lack interest among pharmaceutical companies <NUMBER> outbreak scenarios demand drugs vaccines lasts period outbreak lasts number affected people also small proportion global drug vaccine market time new drug vaccine developed might patients clinical trials also meaningful market newly discovered drugs according guidelines infected patients receive supportive care including oxygen therapy fluid therapy antibiotics treating secondary bacterial infections also recommends isolation patients suspected confirmed covid<NUMBER> <NUMBER> major therapeutic drugs might effective managing covid<NUMBER> include remdesivir lopinavirritonavir alone combination interferonβ convalescent plasma mabs <NUMBER> nevertheless utilizing drugs covid<NUMBER> pneumonia patients clinical efficacy safety studies conducted article describes advances designing vaccines therapeutics counter covid<NUMBER> also discussing experiences sarsand merscovs together could pave ways right direction halt emerging virus multiple strategies adopted development cov vaccines target surfaceexposed spike glycoprotein protein major inducer neutralizing antibodies several sproteinbased strategies attempted developing cov vaccines eg use fulllength protein s<NUMBER>receptorbinding domain rbd expression viruslike particles vlp dna viral vectors <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> protein molecule contains two subunits s<NUMBER> s<NUMBER> s<NUMBER> subunit rbd interacts host cell receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> whereas s<NUMBER> subunit mediates fusion virus host cell membranes releasing viral rna cytoplasm replication <NUMBER> hence sproteinbased vaccines induce antibodies block viral receptor binding also virus genome uncoating shown cterminal domain s<NUMBER> subunit porcine deltacoronavirus constitutes immunodominant region immune response region shows potent neutralizing effect <NUMBER> protein major role induction protective immunity infection sarscov eliciting neutralizingantibodies tcell responses <NUMBER> thus fulllength appropriate parts glycoprotein believed promising candidate cov vaccine composition also reported neither absence presence structural proteins affects protein immunogenicity binding ace<NUMBER> receptor critical initial step virus access host cell <NUMBER> <NUMBER> due superior ability rbd induce neutralizing antibody recombinant proteins contain rbd recombinant vectors encode rbd used developing effective sarscov vaccines <NUMBER> recombinant adenovirusbased vaccine expressing merscov protein induces systemic igg secretory iga lungresident memory tcell responses administered intranasally balbc mice provide longlasting neutralizing immunity mers spike pseudotyped virus thereby suggesting vaccine may confer protection merscov <NUMBER> furthermore rabies virus rv viral vector well grampositive enhancer matrix gem bacterial vector used express merscov protein immune responses vaccine candidates evaluated balbc mice cellular humoral immune responses showed rvbased vaccine stimulates significantly higher levels cellular immunity earlier antibody responses comparison gem particle vector <NUMBER> possibility developing universal cov vaccine assessed based similarity tcell epitopes sarsand merscov confirmed potential crossreactivity among covs <NUMBER> sarscov<NUMBER> shares high genetic similarity sarscov <NUMBER> vaccines developed sarscov may exhibit crossreactivity sarscov<NUMBER> comparative evaluation performed fulllength protein sequences sarscov<NUMBER> sarscov identified variable residues located s<NUMBER> subunit protein critical cov vaccine target <NUMBER> findings suggest specific neutralizing antibodies effective sarscov might effective sarscov<NUMBER> even though protein sarscov<NUMBER> key mutations compared sarscov still act viable target vaccine development <NUMBER> likewise close similarity sarscov<NUMBER> sarscov suggests receptor sarscov<NUMBER> might sarscov receptor ace<NUMBER> <NUMBER> immunoinformatics approach used identification epitopes inclusion covid<NUMBER> vaccine candidates recently immunoinformatics used identify significant cytotoxic lymphocyte ctl bcell epitopes sarscov<NUMBER> protein interactions epitopes corresponding mhc class molecules studied using molecular dynamics simulations found ctl epitopes bind mhc class peptidebinding grooves via multiple contacts thus indicating potential generating immune responses <NUMBER> epitopes may possess ideal characteristics become part covid<NUMBER> vaccine candidates nucleocapsid n protein well potential b cell epitopes e protein merscov suggested probable immunoprotective targets induce tcell neutralizing antibody responses <NUMBER> <NUMBER> reverse genetic strategies successfully used liveattenuated vaccines inactivate exonuclease effects nonstructural protein <NUMBER> nsp<NUMBER> delete envelope protein sars <NUMBER> avian infectious bronchitis virus ibv chicken cov suggested avian live virus ibv vaccine strain h might useful sars <NUMBER> given protection provided strain h based neutralizing antibody production well immune responses hence avian ibv vaccine may considered another option covid<NUMBER> evaluating safety monkeys <NUMBER> scientists rocky mountain laboratories collaborating oxford university develop chimpanzee adenovirusvectored covid<NUMBER> vaccine candidate <NUMBER> coalition epidemic preparedness innovations cepi recently announced initiation three programs aimed develop covid<NUMBER> vaccines utilizing established vaccine platforms <NUMBER> among three programs two continuations previously initiated partnerships cepi collaborated inovio <NUMBER> developing dna vaccine candidates mers <NUMBER> funding vaccine development utilizes dna medicines platform delivering synthetic genes cells translation antigenic proteins elicit tcell antibody responses cepi collaborated university queensland <NUMBER> develop molecular clamp vaccine platform multiple viral pathogens including merscov <NUMBER> funding vaccine platform functions synthesizing viral surface proteins get attached host cells clamp shape facilitates easier recognition antigens immune system <NUMBER> ongoing programs cepi announced funding moderna comparing mrna therapeutics vaccines design manufacture mrna vaccine collaboration vaccine research center vrc national institute allergy infectious diseases niaid part national institutes health nih <NUMBER> niaidvrc scientists developing vaccine candidate expressing sarscov<NUMBER> protein mrna vaccine platform technology vaccine expected undergo clinical testing coming months <NUMBER> direct administration monoclonal antibodies mabs may play effective role cov control intervention exposed individuals observed patients recovering sars display potent neutralizing antibody responses <NUMBER> clinical trial proposed use set mabs functionally target specific domains merscov protein mabs bind six specific epitope groups interacting receptor binding membrane fusion sialic acidbinding sites represent three important entry functions merscov protein <NUMBER> <NUMBER> moreover passive immunization poorly potently neutralizing antibodies induces substantial protection mice subjected lethal merscov challenge thus use antibodies may represent novel approach increase humoral protection emerging covs targeting various protein epitopes functions crossneutralization capacity sarscov rbdspecific neutralizing mabs greatly depends similarity rbds sarscov rbdspecific antibodies crossneutralize sarslike sl covs ie batslcov strain wiv<NUMBER> rbd <NUMBER> amino acid differences sarscov batslcov strain shc<NUMBER> <NUMBER> amino acid differences <NUMBER> crossneutralizing sarscov rbdspecific mabs evaluated efficacy sarscov<NUMBER> requires comparative analysis sarscov<NUMBER> rbd sarscov suitable rbdspecific mabs identified evaluated clinical trials regeneron trying identify mabs specific effective covid<NUMBER> combination therapy mabs drug remdesivir could ideal therapeutic option covid<NUMBER> <NUMBER> evaluation required confirming efficacy combination therapy technology available making fully human antibodies human singlechain antibodies huscfvs humanizednanobodies singledomain antibodies sdab vhvhh traverse across membrane virusinfected cells trans bodies bind interfere biological activities replicating virus proteins consequently leads inhibition virus replication examples include trans bodies influenza virus hepatitis c virus ebola virus dengue virus <NUMBER> thus possible generate trans bodies cov intracellular proteins papainlike proteases plpro cysteinelike protease <NUMBER>clpro nonstructural proteins nsps pivotal cov replication transcription safe nonimmunogenic broadly effective passive immunization covexposed subjects treatment infected patients suitable animal models evaluating vaccines sarsand merscov lacking highly limited making process vaccine development highly challenging <NUMBER> <NUMBER> development efficient animal model mimics clinical disease inform pathogenesis well develop vaccines therapeutics covs several animal models evaluated sarsand mers covs including mouse guinea pigs hamsters ferrets rabbits rhesus macaques marmosets cats <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> early effort directed developing animal models sarscov specificity virus ace<NUMBER> receptor sarscov major hindrance efforts later sarscov transgenic mouse model developed introducing hace<NUMBER> gene mouse genome <NUMBER> first animal model used developing merscov vaccine rhesus macaques infected animals showed clinical symptoms increased body temperature piloerection cough hunched posture reduced food intake <NUMBER> another frequently used animal model merscov common marmoset wherein virus caused lethal pneumonia <NUMBER> humoral cellmediated immunity could detected rhesus macaques common marmoset following merscov immunization <NUMBER> <NUMBER> hamsters potential model studying cov pathology pathogenesis vaccine efficacy attenuated nsp<NUMBER> cov vaccine studied mice <NUMBER> attempts develop animal models merscov mice hamsters ferrets face limitations due inability merscov replicate respiratory tracts species small animals mice hamsters resisting natural infection merscovs susceptible sarscov genetically modified humanized structure eg hdpp<NUMBER> human hdpp<NUMBER>transduced hdpp<NUMBER>tg mice transgenic expressing hdpp<NUMBER> ascertained susceptibility merscov infection <NUMBER> alteration mouse genome using crisprcas<NUMBER> geneediting tool could make animals susceptible cov infection virus replication <NUMBER> genetic engineering used generation <NUMBER> merscov mouse model used evaluation novel merscov vaccines drugs <NUMBER> compared large animal models small animals mice rabbits preferred due lower cost ease manipulation readily available efficacy methods <NUMBER> studies needed recognize suitable models emerging sarscov<NUMBER> identifying receptor affinity sarscov<NUMBER> studying disease manifestations pathologiesviral pathogenesis associated experimental inoculation virus mice rats models well examining virusspecific immune responses protection would facilitate preclinical evaluations candidate covid<NUMBER> vaccines drugs several permissive cell lines hcovs including monkey epithelial cell lines llcmk<NUMBER> verob<NUMBER> used neutralization assays assessing neutralization titers antibody preparations goat lung cells alpaca kidney cells dromedary umbilical cord cells found permissive merscov <NUMBER> sarscov protein found mediate entry hepatoma cell lines targeted neutralizing antibodies virusinfected patients <NUMBER> advanced exvivo <NUMBER>d tracheobronchial tissue mimicking epithelium conductive airway used human covs <NUMBER> moreover vlps displaying sarscov protein found competent entry permissive cells transfected cells overexpress virus receptors <NUMBER> sarscov<NUMBER> isolation attempted vero huh<NUMBER> cells human liver cancer cells <NUMBER> pseudotyped virionsvlps encoding reporter systems gfp luciferase used quantification evaluation effectiveness mabs drugs inhibiting cellular entry covs <NUMBER> assays using pseudotyped virionsvlps performed bsl<NUMBER> facility since use infectious virus safety concern passive immunization antibodies possible antibodydependent enhancement ade virus replication antibodies modified fc fragments without fc fragment eg human singlechain antibodies scfv fab fab′ <NUMBER> safe alternatives several mabs fully human humanized target s<NUMBER>rbd nonrbd well s<NUMBER> domain covs generated tested cell cultures virusneutralizing capability well animal models prophylactic postexposure efficacies <NUMBER> antibodies could useful tools also development vaccines therapeutic drugs antiviral inhibitors data animal cov vaccination suggest systemic humoral cellmediated immune responses induced parenteral administration may adequate prevent respiratory tract infection <NUMBER> respiratory mucosa initial site cov infection transmission mucosal immunization using intranasal vaccine <NUMBER> could effective strategy prophylaxis induction mucosal systemic immune responses molecular mechanisms mucosal systemic immunological factors different difficult predict surrogate marker cov efficacy best surrogate assays protection well herd immunity toward different cov infections warrant detailed investigations main measure clinical management focused alleviating clinical symptoms supportive care <NUMBER> <NUMBER> <NUMBER> therapeutic options could evaluated used covid<NUMBER> include molecules binding virus molecules inhibitors target specific enzymes involved viral replication transcription smallmolecule inhibitors targeting helicase essential proteases proteins virus host cell protease inhibitors host cell endocytosis inhibitors sirna antisense rna ribozyme neutralizing antibodies mabs targeting host receptor interfere s<NUMBER> rbd antiviral peptide targeting s<NUMBER> natural products <NUMBER> <NUMBER> long list anticov agents mostly preclinical compounds yet evaluated anticovid<NUMBER> agents agents phase iii trials covid<NUMBER> including remdesivir oseltamivir asc<NUMBER>f hiv protease inhibitor lopinavir ritonavir darunavir cobicistat <NUMBER> many existing mersandor sarscovs inhibitors screened efficacy rnadependent rna polymerase rdrp sequence sarscov<NUMBER> shown <NUMBER> identity sarscov critical finding since drugs developed sarscov rdrp might show similar efficacy sarscov <NUMBER> rdrp <NUMBER> protein considered major target designing cov antiviral therapies protein inhibitors cleavage inhibitors neutralizing antibodies rbdace<NUMBER> blockers sirnas fusion core blockers protease inhibitors <NUMBER> therapeutic strategies shown potential vitro vivo anticov activities comparatively even though vitro studies performed agents shown efficacy lack sufficient support due lack randomized animal human trials hence limited use covid<NUMBER> hence necessary support extensive animal human trials required therapeutics become useful binding covid<NUMBER> ace<NUMBER> affects balance reninangiotensin system ras potentially leading exacerbation severe pneumonia thus speculated acei angiotensin type<NUMBER> receptor at<NUMBER>r inhibitors might able reduce pulmonary inflammatory responses thereby reducing mortality <NUMBER> guidance covid<NUMBER> control might based existing measures mers sars precautions due unknown nature new cov <NUMBER> <NUMBER> main treatments mechanical ventilation icu admission symptomatic supportive care recommended severe cases furthermore rna synthesis inhibitors like <NUMBER>tc tdf remdesivir neuraminidase inhibitors peptide ek<NUMBER> antiinflammatory drugs abidol chinese traditional medicine lianhuaqingwen shufengjiedu capsules could promising covid<NUMBER> treatments <NUMBER> however clinical trials required confirming safety efficacy covid<NUMBER> major limiting factor quest identifying ideal vaccine therapeutic agent time may take months even several years researchers develop produce standardize evaluate approve commercialize therapeutic agents covid<NUMBER> hence current efforts directed toward identifying evaluating drugs immunotherapeutics proven efficacy viruses similar covid<NUMBER> time required drug discovery programs develop evaluate obtain approval new potent anticovid<NUMBER> agent could take <NUMBER> years <NUMBER> present scenario development new therapeutic agent covid<NUMBER> feasible option regard available time another option repurpose broadly acting antiviral drugs used viral infections drugs advantage easy availability known pharmacokinetic pharmacodynamic properties solubility stability side effects also wellestablished dosing regimens <NUMBER> repurposed drugs potential therapeutic options managing cov infections repurposed drugs lopinavir ritonavir interferon<NUMBER>β possess vitro antimerscov activity vivo study conducted common marmosets nonhuman primate model showed animals treated lopinavirritonavir interferon<NUMBER>β better outcomes untreated animals <NUMBER> combination lopinavirritonavir interferon<NUMBER>β evaluated mers miracle trial <NUMBER> two protease inhibitors lopinavir ritonavir combined ribavirin found associated favorable clinical responses sars patients indicating therapeutic efficacy <NUMBER> early attempt evaluate repurposed drugs covid<NUMBER> controlled trial ritonavirboosted lopinavir interferonα <NUMBER>b therapy registered hospitalized patients china chictr<NUMBER> <NUMBER> oral administration neuraminidase inhibitors oseltamivir used empirical drug covid<NUMBER> suspected cases china hospitals even though evidence efficacy <NUMBER> recently vitro antiviral efficacy approved drugs ribavirin penciclovir nitazoxanide nafamostat chloroquine compared two broadspectrum antiviral drugs remdesivir favipiravir covid<NUMBER> among evaluated drugs remdesivir chloroquine found highly effective controlling covid<NUMBER> vitro <NUMBER> study also pointed three nucleoside analogs ribavirin penciclovir favipiravir may significant vivo antiviral effects covid<NUMBER> since higher concentrations required reduce viral infection vitro remdesivir chloroquine used treatment diseases welldefined safety profile hence drugs used evaluating efficacy patients novel cov infections achievements development vaccines therapeutic agents sarsand merscov well recent ongoing progress covid<NUMBER> facilitate development effective vaccines therapeutics emerging virus however present scenario covid<NUMBER> warrants need implementing robust preventive control measures due potential nosocomial infections <NUMBER> need rely exclusively preventive measures since considerable time required efforts develop new vaccine antiviral agent becomes fruitful researchers searching effective suitable vaccine candidates therapeutics controlling deadly covid<NUMBER> effective vaccines specific antiviral drugs covid<NUMBER> hence rely exclusively enforcing strict preventive control measures minimize risk possible disease transmission results obtained recently conducted vitro study covid<NUMBER> promising since drugs remdesivir chloroquine found highly effective controlling infection direct clinical trials conducted among patients infected covid<NUMBER> since drugs used treating diseases wellestablished safety profiles making evaluation drugs much easier protein considered key viral antigen developing cov vaccines shown several preclinical studies although research progress improve prevention treatment control covid<NUMBER> documented clinical data different therapeutic approaches covs scarce research directed toward study sarscov<NUMBER> suitable animal models analyzing replication transmission pathogenesis abstract airborne transmission predicted prevalent route human exposure sarscov<NUMBER> aside african green monkeys nonhuman primate models replicate airborne transmission sarscov<NUMBER> investigated comprehensive comparative evaluation covid<NUMBER> african green monkeys rhesus macaques cynomolgus macaques following airborne exposure sarscov<NUMBER> performed define <NUMBER> parameters critical disease progression extent correlate human covid<NUMBER> respiratory abnormalities viral shedding noted animals indicating successful infection cynomolgus macaques developed fever thrombocytopenia measured african green monkeys rhesus macaques type ii pneumocyte hyperplasia alveolar fibrosis frequently observed lung tissue cynomolgus macaques <NUMBER> african green monkeys data indicate addition african green monkeys macaques successfully infected airborne sarscov<NUMBER> providing viable macaque natural transmission models medical countermeasure evaluation one sentence summary nonhuman primates develop covid<NUMBER> following airborne virus exposure <NUMBER> main text severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> responsible ongoing worldwide pandemic mild severe respiratory disease identified coronavirus disease <NUMBER> clinical signs symptomatic patients ranged mild disease characterized fever cough andor increased respiratory rate severe sometimes fatal disease characterized severe pneumonia respiratory failure sepsisseptic shock <NUMBER> heart failure <NUMBER> early reports transmission sarscov<NUMBER> suggested human spread occurred primarily respiratory droplets particles created coughing sneezing direct <NUMBER> contact <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however recent evidence indicates airborne transmission may actually represent prevalent human infection route <NUMBER> route relies virusladen particles less <NUMBER>µm size travel extended distances air test evaluate novel medical countermeasures sarscov<NUMBER> animal models mimic natural route infection recapitulate human disease required date countermeasure testing <NUMBER> nonhuman primates predominantly utilized combination models wherein high doses virus excess <NUMBER> <NUMBER> tcid<NUMBER> inoculated intratracheal itintranasal itinocularoral <NUMBER> <NUMBER> <NUMBER> although animals experiments develop mild clinical signs respiratory disease routes exposure largely artificial rely direct contact inoculation rather natural transmission herein sought assess nonhuman primate airborne <NUMBER> challenge models sarscov<NUMBER> airborne virus generated using collison nebulizer produce highly respirable target aerosol <NUMBER> <NUMBER>µm mass median aerodynamic diameter healthy sarscov<NUMBER> serologicallynaïve african green monkeys agm n<NUMBER> rhesus macaques rm n<NUMBER> cynomolgus macaques cm n<NUMBER> exposed sarscov<NUMBER> study day <NUMBER> aerosol route mean virus inhaled dose <NUMBER>×<NUMBER> <NUMBER> sign development fever defined reading ≥<NUMBER>°c baseline duration greater <NUMBER> hours telemetry consistently noted cm study days <NUMBER> figure <NUMBER> maximum temperature change cm <NUMBER>°c mean <NUMBER>°c although small transient temperature increases noted agm rm none met studydefined criteria ≥<NUMBER>°c baseline duration greater <NUMBER> hours called fever therefore fever finding exclusive cm infected airborne sarscov<NUMBER> <NUMBER> common clinical findings animals study included increased respiratory sounds auscultation radiographic findings increased lung opacity without presence infiltrates figure <NUMBER> lung opacity noted animals study however lung infiltrates commonly noted agm cm generally radiographic findings noted prior audible lung sounds radiographic findings commonly identified <NUMBER> study days <NUMBER> increased respiratory sounds noted study days <NUMBER> disease severity based clinical signs graded using scoring system found table s<NUMBER> note table based table utilized finch et al <NUMBER> information contained within <NUMBER> certain updates based covid<NUMBER> disease observed <NUMBER> primate species evaluated present study average disease severity scores follows figure s<NUMBER> agm <NUMBER> range <NUMBER> rm <NUMBER> range <NUMBER> <NUMBER> <NUMBER> <NUMBER> cm <NUMBER> range <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> highest severity score study <NUMBER> cm <NUMBER> lowest severity score study <NUMBER> agm <NUMBER> rm <NUMBER> complete blood counts clinical chemistries figure <NUMBER> table s<NUMBER> performed whole blood serum respectively peak change baseline defined data study day <NUMBER> represented table s<NUMBER> depicts parameters changes baseline <NUMBER> greater equal <NUMBER> lymphocyte neutrophil fluctuations noted animals study likely result inflammatory response infection agm rm exhibited decrease platelet counts beginning study days <NUMBER> persisted study days <NUMBER> nadirs reached earlier agm study day <NUMBER> pronounced <NUMBER> compared rm decreases may relate lung injury <NUMBER> subsequent sequestration evidence inflammation chronic lesions noted histologically support assessment increases one liverrelated enzyme activities present animals notable consistent changes occurring agms cms cms elevated levels appeared correlate timing fever response levels approximating <NUMBER> baseline study day <NUMBER> protracted response noted agms elevated levels noted study days <NUMBER> unfortunately necropsy occurred <NUMBER> days enzyme activities returned baseline corresponding histologic changes liver might suggested cause elevations longer present increases glucose concentration noted agm study days <NUMBER> <NUMBER> fold <NUMBER> <NUMBER> <NUMBER> fold similar trend noted cms degree consistency change less pronounced findings may relate corticosteroid epinephrine response changes glucose levels noted rms <NUMBER> significant increases monocytes measured study day <NUMBER> present agm <NUMBER> fold <NUMBER> fold increase baseline noted agm <NUMBER> agm <NUMBER> respectively although physiological relevance finding unclear time monocytosis consistent exclusive finding agm notable changes clinical chemistry parameters measured study <NUMBER> quantitative reverse transcription polymerase chain reaction qrtpcr performed oropharyngeal op nasopharyngeal np rectal swabs assess viral shedding figure <NUMBER> whole blood assess circulating viral load data shown viral rna whole blood samples detected detected study day <NUMBER> typically limit quantification often noted agm viral rna rectal <NUMBER> swabs noted measured study day <NUMBER> finding often noted agm viral rna detected animals study day <NUMBER> op np swabs peak levels np swabs <NUMBER> log<NUMBER> genomic equivalents geml peak levels op swabs <NUMBER> log<NUMBER> geml significant differences peak levels swab types groups observed one exception cm group peak <NUMBER> levels op swabs <NUMBER> logs lower compared op swab peak levels groups majority animals viral rna longer detected study day <NUMBER> viral rna present agm study day <NUMBER> likely represented residual rna nasal cavity actively replicating virus viability virus op np swabs confirmed plaque assay figure <NUMBER> viable <NUMBER> virus detected rectal swabs data shown virus detected animals study day <NUMBER> swab types peak levels typically detected study day <NUMBER> peak levels np swabs <NUMBER> log<NUMBER> pfuml peak levels op swabs <NUMBER> log<NUMBER> pfuml significant differences swab types groups observed majority animals virus longer detected study day <NUMBER> however virus still detected study day <NUMBER> andor <NUMBER> animals agm <NUMBER> op np agm <NUMBER> op rm <NUMBER> np rm <NUMBER> np cm <NUMBER> np gross necropsy findings infrequent observed majority <NUMBER> lesions confined lungs common finding discoloration one lung lobes agm cm two agm agms <NUMBER> <NUMBER> diffuse red mottling lobes noted cm <NUMBER> locally extensive red discoloration lobes observed cm <NUMBER> also multifocal red gray discoloration right caudal lung lobe two animals adhesions within lungs andor thorax cavity agm <NUMBER> thin clear adhesions extended representative images histology shown figure <NUMBER> exception cm <NUMBER> animals degree inflammation chronic lesions alveolar fibrosis type ii pneumocyte hyperplasia one lung lobes alveolar fibrosis type ii pneumocyte hyperplasia indicate previous cellular damage either due viral infection <NUMBER> andor resulting inflammation findings frequently noted agm cm multinucleate cells likely attributed viral infection noted agms <NUMBER> <NUMBER> multinucleate cells possibly related viral infection also found axillary lymph node <NUMBER> agm <NUMBER> inguinal lymph node cm <NUMBER> histologic findings included following inflammation nasal septumturbinates agm <NUMBER> rm <NUMBER> cms <NUMBER> <NUMBER> lymphoid hyperplasia lymph nodes mucosaassociated lymphoid tissue andor gutassociated lymphoid tissue nearly animals representative images ifa shown figure <NUMBER> consistently comparison <NUMBER> historical uninfected cynomolgus macaque lung tissues infiltration inflammatory cells including cd<NUMBER> macrophages ki<NUMBER> proliferating cells cd<NUMBER> leukocytes cd<NUMBER> cells multifocally detected alveolar septum cm <NUMBER> due ongoing pandemic covid<NUMBER> critical relevant animal models <NUMBER> recapitulate human disease characteristics developed facilitate immediate vaccine treatment testing nonhuman primate models key testing data generated combined human clinical data support rapid deployment safe efficacious countermeasures human use herein describe evaluation first airborne sarscov<NUMBER> model macaques compare results previouslydescribed airborne model <NUMBER> agms <NUMBER> <NUMBER> development macaque models critical advance countermeasure testing efforts although prior studies highlighted potential utility agms sarscov<NUMBER> testing certain characteristics might make nonhuman primates less ideal candidates agms generally wildcaught imported use study medical history animals typically available time import addition age <NUMBER> approximated actual birth dates agms generally unavailable finally wildcaught primates represent diverse genetic population resulting inconsistent cohorts may include animals predisposed developing severe disease following viral infection reason agms typically chosen goldstandard models viral disease contrast cms rms represented critical models countermeasure development various pathogens many years population animals uniform acquired breeding colonies health age information generally available time birth decreasing likelihood outliers based genetic medical background <NUMBER> reason sought investigate airborne exposure sarscov<NUMBER> macaque models airborne model mimics predicted natural transmission route <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> compared nonhuman primate models covid<NUMBER> rely direct contact inoculation mucosal respiratory surfaces exposure agm rm cm sarscov<NUMBER> resulted <NUMBER> disease similar mild cases human covid<NUMBER> increased lung sounds auscultation association radiographic findings consistently confirmed presence mild moderate respiratory disease animals study febrile illness achieved cm cm developed consistent disease fever hallmark disease exclusive group lung infiltrates visualized radiographically also common animals <NUMBER> group clinical disease severity score cm <NUMBER> points higher agm <NUMBER> points higher rm elevation one liverrelated enzyme serum glucose also consistently measured cm overall sufficient objective criteria group could easily employed evaluate efficacy future countermeasure efforts cms investigated potential model sarscov<NUMBER> variable disease <NUMBER> findings noted following either itin itinocular inoculation <NUMBER> <NUMBER> importantly fever represents prominent human disease sign consistently noted cm present study noted cms prior studies addition many clinical signs disease observed present study cm reported prior studies aside infiltrates noted radiographically one studies therefore using airborne transmission route able generate model covid<NUMBER> cm representative human disease compared prior work utilizing species agm aerosol model sarscov<NUMBER> infection recently defined <NUMBER> <NUMBER> <NUMBER> <NUMBER> general findings present study similar previously described two key hematologic findings make attractive model thrombocytopenia monocytosis thrombocytopenia noted human disease <NUMBER> following itin inoculation <NUMBER> following aerosol exposure agm <NUMBER> finding consistently noted agm study similarly pronounced elevation monocytes far exceeded <NUMBER> levels species consistently noted agm finding previously reported physiological relevance unknown time warrants investigation blair et al group thus far describe acute respiratory distress syndrome nonhuman primates following sarscov<NUMBER> inoculation observed rm extensively used sarscov<NUMBER> model species itin itinocularoral rm models gold standards use countermeasure efficacy studies <NUMBER> <NUMBER> <NUMBER> clinical disease following airborne virus exposure similar reported following itin itinocularoral inoculation rm developed mild respiratory disease characterized increased respiratory noise auscultation changes lung opacity radiographically similar <NUMBER> agms thrombocytopenia noted animals group erythema around eyes consistent nearly exclusive finding animals group however relatively subjective measurement may result ocular exposure challenge eyes covered airborne challenge rectal bleeding another reliable finding rm however finding likely related repeated swabbing resulting <NUMBER> irritation rectal tissue sarscov<NUMBER>specific finding nearly animals present study degree inflammation chronic lesions one lung lobes time necropsy findings consistent previously reported direct contact inoculation models <NUMBER> <NUMBER> <NUMBER> alveolar fibrosis type ii pneumocyte hyperplasia indicative previous cellular damage frequently <NUMBER> noted agm cm study day <NUMBER> clinical disease signs including radiographic findings either completely resolved resolving virus lung tissue limit detection ish therefore may important investigate whether necropsy performed earlier disease course could beneficial assessing active disease state primates infected sarscov<NUMBER> countermeasure testing delayed disease <NUMBER> possibility decision shorten length study would obviously also need balanced risk missing delayedonset disease elevation serum glucose levels agm cm noted study date specific finding described human cases covid<NUMBER> suggested patients uncontrolled diabetes higher risk developing lifethreatening complications following sarscov<NUMBER> infection however published studies comparing covid<NUMBER> disease diabetics nondiabetics information <NUMBER> limited role comorbidities high blood pressure obesity heart disease may play observation short information currently available directly linking increased morbidity mortality covid<NUMBER> hyperglycemia however could predicted virusinduced elevations glucose levels could catastrophic patient already predisposed hyperglycemia physiological change could lead diabetic ketoacidosis alone <NUMBER> life threatening combination comorbidities could certainly fatal considering elevated glucose finding agm cm infected sarscov<NUMBER> role hyperglycemia sarscov<NUMBER> pathogenesis investigated data materials availability data available main text supplementary materials material transfer agreement would required transfer specimens generated part study materials methods <NUMBER> figure s<NUMBER> tables s<NUMBER>s<NUMBER> elevated temp fever tory infection acute bronchitis pneumonia sinusitis otitis media recognized bacterial origin warrant treatment antibiotics nonetheless many practicing physicians prescribe antibiotics uncomplicated upper respiratory infections <NUMBER> <NUMBER> <NUMBER> adults investigations etiology upper respiratory infection included bacterial culture nasopharyngeal secretions instead researchers focused throat culture group streptococci viruses mycoplasma nasopharyngeal sampling viral detection culture <NUMBER> <NUMBER> <NUMBER> children however investigations etiology upper respiratory infections frequently included bacterial culture nasopharyngeal secretions bacterial nasopharyngitis considered distinct entityt <NUMBER> <NUMBER> contributing factor complications otitis media pneumonia <NUMBER> <NUMBER> prospective case series adult patients upper respiratory infection surprised find increased number leukocytes nasopharyngeal secretions associated presence bacteria considered pathogens lower respiratory tract suggests bacterial infection upper respiratory tract may occur adults march <NUMBER> <NUMBER> february <NUMBER> <NUMBER> patients presented walkin medical clinic university hospital geneva switzerland complaints cold flu symptoms sore throat recent cough eligible study patients excluded study showed clinical radiologic evidence pneumonia twentyone patients recent history upper respiratory infection included control subjects patients gave informed consent participate study thorough history taken physical examination performed study participant one several participating housestaff physicians using specific questionnaire history exposure schoolage preschool children sick people home work cigarette use relevant past medical problems obtained presence duration <NUMBER> symptoms fever headache rhinitis sore throat cough hoarseness myalgias arthralgias photophobia noted general physical status temperature pulse results physical examination oropharynx tympanic membranes sinuses lungs recorded repeat physical examination performed followup visit two weeks later total duration symptoms use medications noted aspiration nasopharynx performed initial clinical visit inserting <NUMBER>mm soft plastic catheter lukens specimen container argyle sherwood medical tullamore ireland posterior nasopharynx using simple wall suction aspirate secretions secretions rinsed plastic catheter using <NUMBER> ml sterile saline processed within one hour laboratory secretions rinse solution vortexed one minute processed outlined throat culture also obtained rubbing culturette ii swab stick marion scientific kansas city mo firmly tonsilar fossa sent microbiology laboratory analysis within six hours two hundred four hundred microliters nasopharyngeal secretions cytocentrifuged stained gram giemsa stains smears analyzed technician nasopharyngeal secretions throat specimens cultured sheep blood agar chocolate agar colistinnalidixic acid agar thayermartin agar <NUMBER> hours aerobic organisms anaerobic organisms cultured centers disease control agar sheep blood agar disk bacitracin trimethoprimsulfamethoxazole primary streaking mycoplasma cultured biphasic medium chlamydia cultured bacteria identified using standard methods two milliliters vortexed nasopharyngeal secretions transferred <NUMBER> ml viral transport medium l <NUMBER> acute convalescent serum specimens obtained initial followup visits complement fixation used test antibodies adenovirus respiratory syncytial virus parainfluenza viruses types <NUMBER> <NUMBER> <NUMBER> influenza viruses types b chlamydiapneumoniae immunofluorescence used test igm antibodies epsteinbarr virus savyon tel aviv israel elisawas used determination igm antibodies cytomegalovirus medac hamburg germany rubella virus abbott laboratories north chicago il microimmunofluorescence used test igg igm antibodies c pneumoniae <NUMBER> statistical comparisons performed using statcalc statistics program available epi info <NUMBER> pvalues reported twosided <NUMBER> patients seen outpatient medical clinics <NUMBER> <NUMBER> met selection criteria enrolled study average age patient time entry <NUMBER> years range <NUMBER> <NUMBER> years <NUMBER> <NUMBER> men one hundred ninetyeight <NUMBER> smokers <NUMBER> <NUMBER> contact preschool schoolage children three hundred thirtyfour <NUMBER> patients came followup visits average <NUMBER> days initial visit <NUMBER> blood samples drawn second visit convalescent serologic study initial clinical visit patients given one clinical diagnoses housestaff physician diagnoses given pharyngitis n <NUMBER> <NUMBER> rhinitis n <NUMBER> <NUMBER> bronchitis n<NUMBER> <NUMBER> laryngitis n <NUMBER> <NUMBER> sinusitis n<NUMBER> <NUMBER> conjunctivitis n<NUMBER> <NUMBER> otitis media n<NUMBER> <NUMBER> mononucleosis n<NUMBER> <NUMBER> one diagnosis given <NUMBER> <NUMBER> cases cytologic examination performed <NUMBER> <NUMBER> nasopharyngeal specimens two hundred thirtyfive patients <NUMBER> ten leukocytes per highpowered field nasopharyngeal secre tions <NUMBER> <NUMBER> fewer ten leukocytes <NUMBER> <NUMBER> leukocyte epithelial cells noted nasopharyngeal secretions <NUMBER> patients <NUMBER> ciliated cells secretions <NUMBER> <NUMBER> patients one kinds cells seen <NUMBER> <NUMBER> specimens epithelial cells present secretions <NUMBER> <NUMBER> patients <NUMBER> ten leukocytes secretions <NUMBER> <NUMBER> patients <NUMBER> fewer ten leukocytes p <NUMBER> ciliated cells present secretions <NUMBER> <NUMBER> patients <NUMBER> ten ieukocytes secretions <NUMBER> <NUMBER> patients <NUMBER> fewer ten leukocytes poo<NUMBER> bacteria present gram stain secretions <NUMBER> <NUMBER> patients <NUMBER> ten leukocytes secretions seven <NUMBER> patients <NUMBER> fewer ten leukocytes p <NUMBER> results nasopharyngeal pharyngeal cultures summarized table <NUMBER> frequently cultured organisms nasopharynx coagulasenegative staphylococci corynebacterium species streptococcus pneumoniae staphylococcus aureus hemophilus influenzae moraxella catarrhalis <NUMBER> patients grew mixed flora mixture light growth corynebacteria streptococci neisseria species anaerobes fortyfour percent cultures sterile contrast frequently cultured organisms pharynx hemophilus parainfluenzae group streptococci h influenzae pneumoniae enterobacteriaceae aureus three cultures sterile <NUMBER> grew mixed flora growth group flhemolytic streptococci pharynx considered indicate streptococcal pharyngitis occurring <NUMBER> <NUMBER> <NUMBER> patients clinical diagnosis pharyngitis one <NUMBER> <NUMBER> patients without clinical diagnosis pharyngitis nine patients pharyngitis positive pharyngeal culture also grew group streptococci nasopharynx one patient pharyngitis grew group streptococci nasopharynx pharynx results virologic studies <NUMBER> patients two serum specimens drawn summarized table <NUMBER> frequent pathogens documented infection c pneumoniae demonstrated fourfold rise igg titer detected complement fixation <NUMBER> patients two serum specimens available addition infection demonstrated microimmunofluorescence igg igm antibodies <NUMBER> patients tested random association culture bacteria nasopharynx streptococcal pharyngitis viral infection influenza influenza b parainfluenza ten leukocytes per highpowered field nasopharyngeal secretions summarized table <NUMBER> analysis performed <NUMBER> patients <NUMBER> patients leukocytes counted <NUMBER> patients already treated antibiotics included streptococcal pharyngitis influenza b parainfluenza infection associated increased leukocytes nasopharyngeal secretions however pneumoniae catarrhahs h influenzae group streptococci aureus associated ten leukocytes per highpowered field nasopharyngeal secretions number colonyforming units organism isolated independent number leukocytes nasopharyngeal secretions data shown difference numbers leukocytes associated bacterial viral infections clearly illustrated figure <NUMBER> increased number leukocytes found <NUMBER> patients bacteria cultured nasopharynx <NUMBER> patients bacteria cultured virus detected nasopharynx contrast <NUMBER> patients viral infection sterile nasopharyngeal secretions ten leukocytes nasopharyngeal secretions statistically different results patients sterile nasopharyngeal secretion viral infection examine association clinical parameters ten leukocytes per highpowered field nasopharyngeal secretions performed univarlate multivariate analysis clinical information obtained <NUMBER> patients already received antibiotic treatment leukocytes counted results summarized table <NUMBER> history runny nose p <NUMBER> rhinitis physical examination p <NUMBER> occurred significantly frequently patients increased number leukocytes nasopharyngeal secretions association several clinical parameters might alter nasopharyngeal flora therefore increase number leukocytes nasopharyngeal secretions include age history tobacco abuse duration illness prior seeking medical attention history sinusitis asthma chronic bronchitis clinical diagnosis sinusitis otitis media multivariate analysis change interpretation data shown nasopharyngeal aspirates <NUMBER> control subjects ten sterile aureus cultured two corynebacterium seven coagulasenegative staphylococci five increased number leukocytes seen two <NUMBER> direct examination study half patients upper respiratory infections increased number leukocytes nasopharyngeal secretions associated culture pneumoniae group streptococci aureus h influenzae catarrhalls nasopharynx increased number leukocytes associated diagnosis viral infection diagnosis streptococcal pharyngitis results raise possibility bacterial infection superinfection nasopharynx bacterial nasopharyngitis univariate analysis clinical signs symptoms revealed rhinitis associated increased number leukocytes nasopharyngeal secretions hand detect clinical parameter might alter nasopharyngeal flora andor inflammatory reaction upper respiratory infection particular association history current diagnosis sinusitis otitis media tobacco abuse chronic respiratory infection methodologically factors may confounded correlation increased leukocytes culture pathogens first nasopharynx may accurately sampled cases however <NUMBER> specimens contained sort cellular material furthermore presence epithe lial cells inversely correlated recovery leukocytes suggesting absence leukocytes bacteria due sampling error presence ciliated cells strongly correlated presence leukocytes possible inflammation reflected increased number leukocytes leads sloughing ciliated cells problems specimen collection handling include difficulty homogenizing nasopharyngeal secretions specimens analyzed microscopically cultured bacteria viruses may comparable however homogenization uniform association bacteria leukocytes would become even stronger another difficulty differing amounts nasopharyngeal secretions aspirated diluted amount saline resulting variable concentrations microorganisms leukocytes addition relatively viral infections diagnosed study almost cases diagnosed serologic means precluding diagnosis <NUMBER> patients second serologic examination infections diagnosed antigen detection viral culture rhinovirus coronavirus infection cultured however rate viral diagnosis patients two sera examined <NUMBER> comparable rate <NUMBER> obtained huovinen et al recent study patients pharyngitis <NUMBER> study bulk diagnoses made serologic means made antigen detection culture overall rate viral diagnosis well rate <NUMBER> obtained eggenberger <NUMBER> recent study upper respiratory infections children using antigen detection viral laboratory similar transport time antigen detection may less successful adults children couple reasons immune response adults may swift effective children neutralizing viral antigen making diagnosis method difficult furthermore adults may wait longer seek medical attention children rendering detection viral antigen nasopharyngeal secretions less likely viral upper respiratory infections felt caused rhinovirus <NUMBER> <NUMBER> rhinovirus successfully cultured cannot eliminate possibility virus associated increased number leukocytes however seems unlikely since none viral infections associated significant number leukocytes chlamydia pneumoniae recently gained recognition cause respiratory tract infection especially lungs <NUMBER> <NUMBER>o study infection c pneumoniae demonstrated may patients pneumonia excluded children purulent bacterial nasopharyngitis recognized studied extensively <NUMBER> felt caused <NUMBER>hemolytic streptococci h infuenzae pneumococci managed antibiotics <NUMBER> hypothesizing existence bacterial nasopharyngitis adults likely bacteria would part normal nasopharyngeal flora known cause infection lower respiratory tract jousimiessomer et al compared nasal swab cultures <NUMBER> healthy military recruits <NUMBER> <NUMBER> military recruits acute maxillary sinusitis <NUMBER> culture pneumoniae increased <NUMBER> <NUMBER> h influenzae increased <NUMBER> <NUMBER> healthy military recruits recruits sinusitis contrast culture corynebacteria decreased <NUMBER> <NUMBER> culture ofs aureusdecreased <NUMBER> <NUMBER> cultures coagulasenegative staphylococci catarrhalis remained groups studied study potentially pathogenic bacteria cultured control subjects hand possible presence pathogenic bacteria increased leukocytes nasopharnx may secondary colonization already inflamed nasal mucosa rather pathogenic bacteria causing inflammation increased number leukocytes nasopharynx also possible certain bacteria aureus may introduced nasopharyngeal aspirate sampling catheter passed anterior nares data suggest pneumoniae catarrhalls h influenzae may cause bacterial infection nasopharynx whereas aureus weakly associated presence leukocytes group streptococci shown pathogenic nasopharynx young children tl far cultured adults investigation required determine whether presence bacteria leukocytes nasopharynx adults really means bacterial nasopharyngitis exists recognition treatment would important bacteria nasopharynx may lead descending infections bronchitis pneumonia antibiotic treatment could shorten duration upper respiratory infections caused exacerbated bacteria possibly prevent serious lower respiratory tract infections although many physicians already treat adults uncomplicated upper respiratory tract infections antibiotics controlled prospective study using placebo antibiotics could resolve issue severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causing looming pandemic coronavirus disease <NUMBER> <NUMBER> newly emerged coronavirus belongs genus betacoronavirus also includes highly pathogenic sarscov middle east respiratory syndrome coronavirus merscov <NUMBER> phylogenetic analysis suggested three coronaviruses likely originated bats <NUMBER> sarscov<NUMBER> first identified patients atypical pneumonia geographically linked wet market wild animal trade wuhan china virus highly transmissible among humans clusters occurring among close contacts family church community cruise ship nursing home hospital settings <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> within three months <NUMBER> cases covid<NUMBER> <NUMBER> deaths reported globally <NUMBER> countriesterritories <NUMBER> readily available suitable experimental animal models lacking major route transmission speculated respiratory droplets direct indirect contact infectious bodily fluids saliva faeces tears blood recent data showed clinical severity covid<NUMBER> ranges widely asymptomatic infection fatal disease children covid<NUMBER> usually asymptomatic mildly symptomatic <NUMBER> <NUMBER> majority immunocompetent adult covid<NUMBER> patients present fever respiratory symptoms radiological groundglass lung opacities <NUMBER> severe cases especially among elderly immunocompromised patients besides respiratory failure extrapulmonary manifestations diarrhoea confusion hepatic renal dysfunction lymphopenia thrombocytopenia elevated inflammatory biomarkers also reported <NUMBER> small animal models recapitulate clinical pathological features covid<NUMBER> human essential tools studying pathogenesis transmission antiviral treatments vaccines emerging global health threat based recent identification <NUMBER> human angiotensinconverting enzyme <NUMBER> ace<NUMBER> cell entry receptor sarscov<NUMBER> transgenic human ace<NUMBER> mouse model preliminarily reported <NUMBER> however expression human ace<NUMBER> transgenic mice physiological mice readily available rhesus macaque model also reported expertise biosafety level<NUMBER> facilities handle nonhuman primates scarce <NUMBER> study established readily available small animal model covid<NUMBER> using golden syrian hamster mesocricetus auratus silico structural analysis predicted hamster ace<NUMBER> bind sarscov<NUMBER> spike glycoprotein receptorbinding domain rbd high binding affinity clinical features viral kinetics histopathological changes immune responses sarscov<NUMBER>infected syrian hamsters closely mimic described many covid<NUMBER> patients using newly established model demonstrated high transmissibility sarscov<NUMBER> among close contact animals multiple sequence alignment generated using human rhesus macaque common marmoset hamster rabbit ferret rat mouse pig bat ace<NUMBER> protein sequences uniprot accession numbers q<NUMBER>byf<NUMBER> b<NUMBER>duf<NUMBER> f<NUMBER>cnj<NUMBER> g<NUMBER>tef<NUMBER> a<NUMBER>a<NUMBER>u<NUMBER>qta<NUMBER> q<NUMBER>wg<NUMBER> q<NUMBER>egz<NUMBER> q<NUMBER>r<NUMBER>i<NUMBER> k<NUMBER>glm<NUMBER> e<NUMBER>dhi<NUMBER> respectively muscle <NUMBER> missing loop residues sarscov<NUMBER> spike protein rbd pdb id<NUMBER>vsb modelled itasser <NUMBER> human ace<NUMBER> sarscovspike complex structure model pdb id<NUMBER>ajf used model ace<NUMBER> sarscov<NUMBER>spike complex superposition sarscov<NUMBER>rbd sarscovrbd ace<NUMBER>spike complexes sarscov<NUMBER> sarscov minimized rosetta <NUMBER> relax application <NUMBER> ace<NUMBER>spike interface binding energy calculated interfaceanalyzer within rosetta interface binding energies species calculated introducing mutations interface according amino acid differences rosetta proteinprotein δδg protocol amino acid residues ace<NUMBER> within <NUMBER>å sarscov<NUMBER> spike rbd considered interacting residues pymol used highlight interacting sites red ace<NUMBER> structure show hydrogen bonds yellow dash lines sarscov<NUMBER> isolated nasopharyngeal aspirate specimen laboratoryconfirmed covid<NUMBER> patient hong kong <NUMBER> plaque purified viral isolate amplified one additional passage veroe<NUMBER> cells make working stocks virus described previously <NUMBER> experiments involving live sarscov<NUMBER> followed approved standard operating procedures hku biosafety level<NUMBER> facility approval obtained hku committee use live animals teaching research male female syrian hamsters aged <NUMBER> weeks old obtained hku laboratory animal unit animals kept biosafety level<NUMBER> housing given access standard pellet feed water ad libitum virus challenge biosafety level<NUMBER> animal facility phosphatebuffered salinepbs used dilute virus stocks desired concentration inocula backtitrated verify dose given dulbeccos modified eagle mediumdmem containing <NUMBER> <NUMBER> plaqueforming units <NUMBER>µl sarscov<NUMBER> intranasally inoculated intraperitoneal ketamine<NUMBER>mgkg xylazine<NUMBER>mgkg <NUMBER> anaesthesia mockinfected animals challenged <NUMBER>ul pbs animals monitored twice daily clinical signs diseasesupplementary figure s<NUMBER> body weight survival monitored <NUMBER> days postinoculationdpi five animals group sacrificed <NUMBER>dpi <NUMBER>dpi <NUMBER>dpi virological histolopathological analyses remaining animals sacrificed <NUMBER>dpi blood major organ tissues necropsy separated two parts one immediately fixed <NUMBER> pbsbuffered formalin immediately frozen <NUMBER>°c use staining microscopy procedures tissue sections performed described previously modificationssupplementary materials <NUMBER> viral load studies qrtpcr assay conducted blood organ tissues table s<NUMBER> <NUMBER> neutralising antibody detection passive immunisation <NUMBER> serum antisarscov<NUMBER> neutralising antibody detection microneutralisation assay passive immunisation performed described previouslysupplementary materials <NUMBER> <NUMBER> transmission study among close contact animals eight hamsters intranasally challenged sarscov<NUMBER> <NUMBER>dpisupplementary figure s<NUMBER> twentyfour hours later<NUMBER>dpi sarscov<NUMBER>challenged hamster transferred new cage cage containing one naïve hamster close contact five viruschallenged five contact hamsters sacrificed viral load histopathological studies <NUMBER>dpi <NUMBER> days postexposure respectively remaining hamsters kept clinical observation <NUMBER>dpi surface spike gene viral isolates hamsters sanger sequenced described previously <NUMBER> data analysed graphpad prism softwaregraphpad softwareinc weight losses compared using twoway anova students ttest used determine significant differences virus titres among different groups <NUMBER> p<NUMBER> considered statistically significant sponsors role study design data collection analysis interpretation writing report corresponding author full access data study final responsibility decision submit publication binding affinity ace<NUMBER> sarscov<NUMBER> surface spike glycoprotein may dictated amino acid composition binding interface structural analysis performed predicted <NUMBER> amino acid residues ace<NUMBER> interface may interact sarscov<NUMBER> spike glycoprotein rbdfigure<NUMBER>a<NUMBER>b comparison <NUMBER> amino acid residues alignment human mammalian species revealed rhesus macaque ace<NUMBER> <NUMBER> identical human ace<NUMBER> interface region syrian hamster common marmoset ace<NUMBER> proteins also highly similar human ace<NUMBER> <NUMBER> mutations interface table s<NUMBER> notably sarscov<NUMBER> spike exhibited higher binding affinity ace<NUMBER> sarscov spike might attributed compact interacting interface hydrogen bonds formed sarscov<NUMBER> spike glycoprotein rbd ace<NUMBER> figure <NUMBER>c investigate tissue tropism sarscov<NUMBER> syrian hamsters performed viral load studies upper respiratory tractnasal turbinate lower respiratory tract trachea lung extrapulmonary organsintestine salivary glands heart liver spleen lymph nodes kidney brain blood harvested viruschallenged animals different time points represented early<NUMBER>dpi severe<NUMBER>dpi start recovery<NUMBER>dpi phases mean viral loadsfigure<NUMBER>b nasal turbinate lung<NUMBER> <NUMBER> <NUMBER> <NUMBER> genome copiesβactin trachea<NUMBER> <NUMBER> genome copiesβactin consistently highest among tested organ tissues <NUMBER>dpi <NUMBER>dpi viral loads progressively decreased airway tissues <NUMBER>dpi<NUMBER>dpi viral culture lung tissues showed high titre <NUMBER> <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER>g <NUMBER>dpi<NUMBER>dpifigure<NUMBER>c extrapulmonary tissues mean viral load intestine also highish especially <NUMBER>dpi organ blood low mean viral loads<NUMBER>genome copyβactin detected <NUMBER>dpi peaked <NUMBER>dpi progressively reduced undetectable levels <NUMBER>dpi samples nasal turbinate epithelium intact submucosal infiltration blood vessel study transmissibility among close contacts housed sarscov clinical histopathological findings sarscov<NUMBER> hamster model closely resemble manifestations upper lower respiratory tract infection humans airway involvement evident nasal turbinate trachea pulmonary alveoli associated changes inflammation cellular viral n protein expression high viral load first week disease progressed increasing respiratory rate decreasing activity progressive weight loss severe <NUMBER>dpi similar disease course covid<NUMBER> patients <NUMBER> histopathology showed progression initial phase exudative inflammation diffuse alveolar damage haemorrhage necrosis finally proliferative phase one week findings agreement human autopsy findings except model also demonstrated extensive tissue apoptosis <NUMBER> none challenged contact hamsters died <NUMBER> human infections lethal <NUMBER> extrapulmonary manifestations though diarrhoea clinically evident challenged hamsters histopathology showed intestinal mucosal inflammation epithelial necrosis viral n protein expression enterocytes finding corroborates clinical manifestation diarrhoea <NUMBER> covid<NUMBER> patients despite <NUMBER> stool samples rtpcr positive <NUMBER> <NUMBER> <NUMBER> myocardial degenerative changes noted infected hamster patient autopsy despite absence viral antigen detection tissues also consistent occasional report heart failure covid<NUMBER> patients <NUMBER> lymphoid atrophy apoptosis spleen observed correlate frequent clinical finding lymphopenia<NUMBER> <NUMBER> lymphoid necrosis largely related marked activation innate immune response infected hamsters high levels fermenters eat faeces feeding behaviour called coprophagy recover nutrients digested hindgut unabsorbed <NUMBER> thus faecaloral route transmission could excluded model well human readily available small animal models resemble clinical pathological features human covid<NUMBER> urgently needed study pathogenesis antiviral treatment vaccination external subdomain spike glycoprotein rbd sarscov<NUMBER> shares <NUMBER> amino acid identity sarscov new virus still utilizes ace<NUMBER> cell entry receptor abundantly found epithelial linings human animals <NUMBER> <NUMBER> molecular docking computation showed rbd sarscov<NUMBER> binds well ace<NUMBER> human macaques also syrian hamsters moreover hamster demonstrated good model studying respiratory viruses including sarscov influenza virus adenovirus <NUMBER> unlike hamster model sarscov<NUMBER> also notable weight loss intestinal involvement absent hamster model infected <NUMBER> sarscov <NUMBER> importantly viral load nasal turbinate<NUMBER>log<NUMBER>tcid<NUMBER>gram sarscov<NUMBER>infected hamsters consistently <NUMBER>log higher lung<NUMBER>log<NUMBER>tcid<NUMBER>gram <NUMBER>dpi <NUMBER>dpi <NUMBER>dpi whereas viral load nasal turbinate <NUMBER> sarscovinfected hamsters generally similar lower <NUMBER> lung <NUMBER> might help explain sarscov<NUMBER> transmissible upper respiratory tract involvement virus less lower respiratory tract whereas sarscov predominantly infects lower respiratory tract study number limitations first virus inocula used study previous report <NUMBER> sarscov hamster model different might contribute differences findings second tested mrna protein expression hamsters chemokinecytokine profiles enzymeimmunoassay hamster chemokinescytokines unavailable finally focused sequencing surface spike gene essential virushost cell entry complete genome sequencing may reveal additional adaptive mutations genome regions nevertheless unlike nonhuman primates ace<NUMBER>transgenic mice hamster model readily available physiological highly resembles covid<NUMBER> thus would important platform studying pathogenesis transmission treatments vaccines covid<NUMBER> author contributions jfwc ajz sy kyy roles study design data collection data analysis data interpretation writing manuscript vkmp ccsc roles study design experiments data collection data analysis data interpretation ace<NUMBER> amino acid residues within <NUMBER>å sarscov<NUMBER> spike glycoprotein s<NUMBER> subunit rbd highlighted red hydrogen bond donors acceptors represented sticks oxygen red sticks nitrogen blue sticks carbon green sticks ace<NUMBER> grey sticks rbds abbreviations fp fusion peptide hr<NUMBER> heptad repeat <NUMBER> hr<NUMBER> heptad repeat <NUMBER> <NUMBER> ntd nterminal domain rbd receptorbinding domain s<NUMBER> spike s<NUMBER> subunit s<NUMBER> spike s<NUMBER> subunit sp signal peptide tm transmembrane domain laboratory culture standing small viruslike particles viruses pathogens unclear careful examination newer particles shows consistent morphologic characteristics permitting preliminary classification based electronmicroscopic appearance thus far two reports made morphologic distinction amongst small viruses• <NUMBER> report investigation nosocomial infantile gastroenteritis carried general infant ward montreal childrens hospital late fall <NUMBER> data support validity morphologic classification enteritis viruses proposed others add information clinical features epidemiology transmissibility infantile gastroenteritis associated minirotavirus calicivirus potential cause clinical enteritis close contacts ward patients studied period october <NUMBER> november <NUMBER> <NUMBER>· accommodation comprised six threecrib rooms one fourcrib room <NUMBER>·<NUMBER> <NUMBER> e <NUMBER> c v mosby co multiple pathogens present <NUMBER> index patients five asymptoma tic room con tacts table bacterial pathogens viruslike particles identified stool infants diarrhea asymptomatic room contacts culture patient diarrhea tested enterotoxin production using infant mouse assay yi adrenal cell assay methods control strains e coli kindly provided dr da sack assays carried triplicate predominant lactosefermenting colony type infant diarrhea tested invasiveness guinea pig eye inoculation sereny test inoculum drop heavy suspension organism muellerhinton broth <NUMBER> x lo cells per ml used one hundred sixtyfive infants aged <NUMBER> days <NUMBER> months median <NUMBER> months studied <NUMBER> diarrhea comprising <NUMBER> <NUMBER> infants resident outset <NUMBER> <NUMBER> newly admitted infants two eight new cases occurred per week <NUMBER> cases considered nosocomial two infants two periods diarrhea one three total <NUMBER> diarrhea episodes eightyone room contacts infants diarrhea remained asymptomatic specimens <NUMBER> available examination putative stool pathogen identified <NUMBER> <NUMBER> case episodes <NUMBER> <NUMBER> <NUMBER> <NUMBER> asymptomatic room contacts table bacterial pathogens isolated seven infants four coincidentally carried virus concurrent infection two agents occurred <NUMBER> patients three agents two without evidence agentagent pattern viruses six morphologic classes viruslike particles present stools <NUMBER> <NUMBER> episodes diarrhea patients pathogens situated either side walkthrough corridor diarrhea defined increase usual daily stool frequency two excessive water loss stool symptoms began <NUMBER> hours admission hospital infections considered nosocomial stool specimens obtained resident infants first second day study newly admitted patients soon available admission study ward possible specimens obtained infants diarrhea daily intervals first three days illness varia ble intervals four days diarrhea ceased specimens also obtained asymptomatic room contacts infants diarrhea usually first fourth days following onset symptoms index case specimens obtained medical nursing staff virus identification stool suspended phosphatebuffered saline <NUMBER> w iv stored <NUMBER>°c specimens subsequently thawed clarified lowspeed centrifugation <NUMBER> g <NUMBER> minutes <NUMBER> ml aliquots concentrated ultracentrifugation <NUMBER> g <NUMBER> hour pellet resuspended drop <NUMBER> ammonium acetate solution examined using philips <NUMBER> <NUMBER> electronmicroscope viruslike particles sought least <NUMBER> grid squares classified described flewett middleton et al specimens containing adenovirus particles inoculated tissue cultures ofhep<NUMBER> human embryonic lung cells cytopathogenic effect confirmed second passage adenovirus isolates typed neutralization tests specimens room contacts adenovirus positive infants diarrhea cultured way specimens containing picornaparvovirus particles inoculated onto primary rhesus monkey kidney cells isolates identified cytopathogenic effect second passage electronmicroscopic appearance particles classified polioviruses nonpolio enteroviruses neutralization tests bacterial identification specimens examined salmonella shigella conventional methods enteropathogenic serotypes escherichia coli slide agglutination using battery <NUMBER> commercially prepared antisera difco predominant e coli colony type early specimen culture infant diarrhea sent laboratory centre disease control ottawa complete serotyping incubation <NUMBER>°c used enhanced recovery yersinia enterocolitica <NUMBER> <NUMBER> <NUMBER> <NUMBER> asymptomatic room contacts table included adenovirus rota virus minirotavirus fig calicivirus fig <NUMBER> picornaparvovirus coronavirus minirotavirus name chosen <NUMBER> nm particle wh ich resembles particles identified toronto rninireovirus glasgow distinguished sm round viruses slightly larger size irregular margin times resembling palisade small ca psomeres caliciviruses tend smaller minirotaviruses dist inguished scalloped coarsely indente surface appearance viruses variation surface detail depending lie grid state preservation picornap arvoviruses small dense particles entire margin detectable surface structure ten <NUMBER> nosocomial cases showed virus particle concordance presumed index source ta ble <NUMBER> eight <NUMBER> virus positive asymptomatic room contacts showed similar concordance exception one asymptomatic acquisition rotavirus viral concordance infants diarrhea room contacts limited minirotavirus calicivirus concordance asymptomatic infants excreting virus respective room contacts also limited minirotavirus found three <NUMBER> contacts none developed diarrhea correlation symptoms virus acqu isition variable <NUMBER> infants either rniniro tavirus caliclvirus developed diarrhea table ii twelve infants dia rrhea id entifia ble pathogen stoo l nine exposed <NUMBER> room contacts twenty five contacts remained asymptomatic negative stool examinations one diarrhea associated picornaparvovirus bacteria two serotypes enteropathogenic e coli identified specimens four infants diarrhea three coincidentally carried virus two enteropathogenic serotypes also identified pathogen seven <NUMBER> asymptomatic contacts evidence spread enteropathogenic serot ypes infants studied complete serot yping <NUMBER> isolates e coli <NUMBER> infants diarrhea also failed show epidemiologic pattern symptomatic population none th e commonly recognized enterotoxigenic serotypes idenrifled also none <NUMBER> isolates e coli invasive evidenced negative sereny tests stools one infant diarrhea consis tently positive strain e coli ok h<NUMBER> producing heat stable labile enterotoxins specimens contained aden ovirus tissue culture negative isolates e coli obtained parents two siblings enterotoxin negative none found carry e coli <NUMBER> kh<NUMBER> salmonella typhimurium enterocolitica pathogens identified one index patient neither elise nosocomial transmission room contacts occur studies nosocomial gastroenteritis concerned epidemics diarrhea closed patient populations often attributed single agents study differs open nature population ward continued accept new patients throughout attempting discharge transfer cohort diarrhea infant history recent loose stools accepted ward half new patients acute respiratory disease respiratory isolation priorities led frequent room changes may part explain high incidence nosocomial diarrhea acquisition viruses one third asymptomatic infants studied however explain variety virus particles identified seems likely large varied reservoir pathogens established continued admission new patients rapid turnover permitted survival individual agents low level endemicity infants followed discharge hospital data probably low estimate prevalence nosocomial diarrhea communicability viruses study population almost half instances diarrhea associated either minirotavirus calicivirus stool claim true viruses potential pathogens su pported temporal ass ociation fecal carriage presence diarrhea evidence communicability infant infant one sequence lateral transmission calicivirus could traced chain seven infants another exceptional instance infant intractable diarrhea several weeks course punctuated two periods vomiting associated fecal shedding minirotavirus calicivirus respectively two infants separate attacks diarrhea vomiting associated minirotavirus calicivirus seven <NUMBER> infants without diarrhea miniro table repeated vomiting coincident presence virus stool two others loose stools without increase daily frequency vomiting frequent association diarrhea patients found carry viruses table iii vomiting also prominent feature rotavirus gastroenteritis lowgrade fever present three <NUMBER> infants diarrhea associated minirotavirus calicivirus unsuccessful attempts cultivate minirotavirus calicivirus using human fetal intestinal organ culture human embryonic kidney cells monkey kidney eells human embryonic lung hep<NUMBER> cell lines adenovirus relatively common finding stool examined electronmicroscopy poor correlation symptoms occurrence agents obscure significance communicability demonstrated either electronmicroscopy tissue culture methods culture using hep<NUMBER> cells successful six eight specimens infants diarrhea sustained five isolates iden tified adenovirus types <NUMBER> two isolates <NUMBER> three isolates rotavirus played smaller role expected transmission could presumed one asymptomatic room contact may reflect bias small numbers doubt rota virus assert presence open infant ward seasonal variations seem affect identification rates enteritisassociated viruses similar manner picomaparvoviruses particles appeared random finding stool shown communicable enteroviruses identified five eight specimens examined tissue culture two identified polioviruses yield bacterial pathogens study meagre data largely negative classical enteropathogenic serotypes e coli occurred sporadically three four affected infants diarrhea carried virus specimen sequential specimens one infant diarrhea contained enterotoxinproducing strain e coli specimen contained adenovirus screening five lactosefermenting organisms <NUMBER> infants diarrhea seen hospital <NUMBER> <NUMBER> yielded one enterotoxin producing strain ofe coli <NUMBER>h <NUMBER> infant acquired diarrhea pakistan unpublished data found multiple putative pathogens operating concurrently independently study population approximately half cases diarrhea associated either minirotavirus calicivirus whose standing etiologic agents strengthened data presented communitybased epidemiologic studies serology virus culture win necessary substantiate pathogenic role viruses coronavirus pangolincov <NUMBER> <NUMBER> identical sarscov<NUMBER> batcovratg<NUMBER> respectively <NUMBER> although batcovratg<NUMBER> sequence closest sarscov<NUMBER> <NUMBER> similarity receptorbinding domain pangolincov protein similar sarscov<NUMBER> batcovratg<NUMBER> five key amino acids essential binding human receptor identical pangolincov sarscov<NUMBER> four five residues mutated batcovratg<NUMBER> indicating batcovratg<NUMBER> may efficiently infect humans <NUMBER> findings suggest sarscov<NUMBER> may evolved pangolincov adapted humans via natural selection fig <NUMBER> studies needed substantiate pangolins intermediate host cats dogs often close contact humans thus important determine susceptibility sarscov<NUMBER> covid<NUMBER> reported two dogs hong kong dogs live covid<NUMBER> patients become infected tested positive one dogs developed specific antibodies sarscov<NUMBER> seroconverted indicating active infection canine cases covid<NUMBER> also reported netherlands us https<NUMBER>abc comcoronavirusdogsdogupdate<NUMBER> family north carolina experienced mild covid<NUMBER> symptoms pug also showed mild symptoms inappetence three family members tested sarscov<NUMBER> positive virus detected dog family owned two dogs cat one dog tested positive netherlands four house pets tested covid<NUMBER> positive covid<NUMBER> patient owned dog three cats dog suffering severe breathing problems bulldog tested sarscov<NUMBER> positive euthanized due illness three cats also developed specific antibodies sarscov<NUMBER> four animals appeared contracted virus covid<NUMBER> owner contrast dogs cats appear highly susceptible virus belgium cat living covid<NUMBER> owner became clinically ill exhibiting respiratory problems accompanied diarrhea vomiting specific viral sequence sarscov<NUMBER> detected feces gastric vomitus cat sequence identical cat owner indicating occurrence reversezoonotic transmission sarscov<NUMBER> human animal wuhan <NUMBER> cats tested <NUMBER> seroconverted indicating sarscov<NUMBER> exposure cats either people cats <NUMBER> additional case covid<NUMBER> cats reported hong kong cat show clinical signs oral nasal fecal samples tested positive us sarscov<NUMBER> positive cats reported two separate areas state new york <NUMBER> veterinarian tested one cat exhibited mild respiratory symptoms cat sarscov<NUMBER> positive one household positive cat may contracted coronavirus outside household person covid<NUMBER> another case cat respiratory symptoms living covid<NUMBER> patient tested positive data clearly show cats susceptible sarscov<NUMBER> may contract covid<NUMBER> fig <NUMBER> controlled experiment conducted support observations showing cats susceptible covid<NUMBER> <NUMBER> results experiment showed cats highly susceptible sarscov viral sequence detected nasal turbinates soft palate tonsils small intestine infections led massive lesions nasal passages trachea lungs indicating efficient replication virus cats interestingly kittens adolescent cats especially vulnerable covid<NUMBER> notably coronavirus spread infected cats uninfected cats via respiratory droplets feline cases covid<NUMBER> additionally reported spain france germany httpswwwoieintscientificexpertisespecificinformationandrecommendationsquestionsandanswerson<NUMBER>novelcoronavirus logical speculate secondary transmission may occur covid<NUMBER> animals humans despite direct evidence showing whether transmission cats humans occur fig <NUMBER> owning pet cat commonplace thus possible transmission sarscov owners cats cats example veterinary hospital setting concern experimental infections varying conditions wideranging surveillance using specific diagnostic tests collection epidemiological data help elucidate role companion animals spread covid<NUMBER> among wildlife lions tigers susceptible sarscov<NUMBER> four tigers two lions bronx zoo new york city developed clinical symptoms associated respiratory illness testing confirmed sarscov<NUMBER> positive <NUMBER> big cats exposed zookeeper covid<NUMBER> positive actively shedding virus indicating occurrences reversezoonotic transmission fig <NUMBER> susceptibility covid<NUMBER> evaluated laboratory animals companion animals farm animals attempts identify animal models sarscov<NUMBER> infection upon infection susceptible animals may show symptoms even exhibit clinical signs symptoms may match covid<NUMBER> humans thus establishment appropriate animal model crucial among laboratory animals ferrets golden syrian hamsters monkeys shown susceptible sarscov<NUMBER> develop clinical symptoms <NUMBER> ferrets good model human influenza particularly sneeze spreading virus air sarscov<NUMBER> infects ferrets fatalities observed <NUMBER> virus detected ferret nasal washes saliva urine feces airborne transmission observed however viral replication organs undetectable lead symptoms increase body temperature monkeybased study conducted using four rhesus macaques <NUMBER> oldworld monkeys successfully infected viral replication occurred nose pharynx lung gut infections caused weight loss moderate level interstitial pneumonia lesions lymphocyte infiltration occurring lung confirmed staining immunohistochemical analysis monkey study also showed presence antibody response virus using monkey model efficacy remdesivir antiviral drug examined <NUMBER> recovery remdesivirtreated animals significantly better control animals one six treated animals mild breathing difficulty whereas animals control group showed breathing difficulty treated monkeys viral load lungs significantly lower lung damage significantly milder control animals regardless animal model used significant challenge studies experimental infection must performed biosafety level <NUMBER> facility high susceptibility felidae family lions tigers jaguars leopards cougars cheetahs particular monkeys covid<NUMBER> implies potential outbreaks great apes chimpanzees gorillas orangutans zoos animalholding facilities primate research centers national wildlife parks risk assessments needed prepare conservation protection animals among farm animals minks two breeding farms netherlands showed various symptoms including respiratory illness found infected sarscov<NUMBER> minks likely contracted virus farm staff mink farms subsequently placed quarantine httpswwwoieintscientificexpertise specificinformationandrecommendationsquestionsandanswerson<NUMBER>novelcoronavirus subsequent study suggested infection took place minks humans cats played role spread virus farms implicating possible occurrence interspecies transmission cat mink secondary zoonotic transmission mink human sarscov<NUMBER> fig <NUMBER> experimental infections pigs chickens ducks remained sarscov<NUMBER> negative develop clinical signs <NUMBER> viral sequences detected swabs collected virusinoculated animals animals remained seronegative two weeks postinfection therefore pigs chickens ducks seem susceptible sarscov<NUMBER> regardless wider range farm animal species needs examined assess risks sarscov<NUMBER> infection identify possible impacts covid<NUMBER> agricultural food supply industries combination ecological disturbances landscape changes human behaviors public health factors contributes frequency contacts humans wildlife contacts pose risk exposure transboundary animal viruses <NUMBER> moreover viruses easily mutate switch hosts adapt new host control infectious diseases animal populations veterinarians typically apply <NUMBER> biosecurity measures prevent introduction viruses populations <NUMBER> surveillance via diagnostic testing identify infected animals <NUMBER> removal infected animals uninfected populations <NUMBER> vaccination longterm control promoting immunity approaches proven effective successful many countries used contain transboundary epizootics footandmouth disease african swine fever newcastle disease name period within covid<NUMBER> pandemic societies human behaviors quickly changing accommodate changes traditional roles veterinarians evolve accordingly veterinarians significant roles maintaining healthy ecosystems protecting animals humans emerging transboundary infections roles based one health framework application reduce economic impacts livestock industry food supply animals biphasic manner first <NUMBER> dpi followed recrudescence <NUMBER> dpi viral rna vrna found throughout respiratory gastrointestinal systems necropsy higher levels vrna found within gi tract tissues animals seroconverted simultaneously igm igg also documented human covid<NUMBER> cases young agm represent excellent species study mildsubclinical covid<NUMBER> disease shed light unknown aspects longterm virus shedding ideally suited preclinical evaluation candidate vaccines therapeutic interventions pandemic caused emerging coronavirus sarscov<NUMBER> calls swift testing vaccine candidates prior initiation human clinical trials safety must prioritized speed considering vaccine likely administered hundreds millions people nonhuman primates nhps serve unique important purpose preclinical testing candidate human vaccines given close genetic relatedness humans studies nhps geared towards identifying appropriate species recapitulates human disease comprehensive dissection longitudinal viral pathogenesis nhp models critical successful evaluation efficacy vaccines antibody therapeutics small molecules preclinical studies several nhp models reported sarscov<NUMBER> using rhesus andor cynomolgus macaques african green monkeys agms <NUMBER> <NUMBER> <NUMBER> <NUMBER> used less frequently biomedical research rhesus cynomolgus macaques agms oldworld nhp species natural host simian immunodeficiency virus siv <NUMBER> addition siv agms used models infectious diseases rift valley fever pneumonic plague human parainfluenza virus sarscov<NUMBER> nipah virus <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> fully understand pathogenesis <NUMBER> human isolates sarscov<NUMBER> agm critical determine differences aerosol mucosal exposure routes assess whether clinicalgrade imaging nhps used detect subclinical infections understand realtime dynamics virus shedding young adult male agms infected lowpassage clinical isolate sarscov<NUMBER> comprehensive longitudinal disease parameters compared either small particle aerosol multiroute mucosalintratracheal infection agms developed mild disease regardless route exposure infectious dose pulmonary lesions detectable petct acute phase subsequently resolved agms exhibited prolonged shedding infectious virus oral nasal conjunctival rectal mucosal surfaces viral rna vrna remained detectable throughout respiratory gi tissues necropsy absence replicationcompetent virus results show multiple routes involved viral shedding shedding occurs protracted period time subclinical animals greatly impact sarscov<NUMBER> transmission covid<NUMBER> patients healthy male agms <NUMBER> years age infected passage <NUMBER> p<NUMBER> human isolate sarscov<NUMBER> munich germany table s<NUMBER> <NUMBER> four animals infected using small particle aerosol designated a<NUMBER>a<NUMBER> two infected multiroute mucosal exposure designated m<NUMBER> m<NUMBER> involving administration virus oral nasal ocular mucosal surfaces intratracheal instillation using bronchoscope aerosol inhaled exposure doses ranged <NUMBER> log<NUMBER> pfu virus due standard <NUMBER> log loss virus nebulization multiroute mucosal exposures <NUMBER> log<NUMBER> pfu infection animals anesthetized blood draws mucosal swabs plethysmography chest radiography regular intervals postinfection clinical disease mild six animals fig s<NUMBER>a respiratory function revealed transient decrease volume air inhaled tidal volume <NUMBER> dpi fig s<NUMBER>b parameters including frequency expiratory time within normal limits two mucosally infected agm one aerosol infected agm several short spikes fever maximum deviation <NUMBER> °c course infection fig s<NUMBER> three animals average significant elevation temperature less <NUMBER> °c either route <NUMBER> infection suggesting overall lowgrade fever three aerosolinfected agms a<NUMBER>a<NUMBER> developed mild hypothermia response around <NUMBER> dpi persisted remainder study fig s<NUMBER> complete blood counts cbc revealed transient decrease lymphocytes platelets increase neutrophils fig s<NUMBER> also seen human covid<NUMBER> patients <NUMBER> <NUMBER> blood chemistry analysis demonstrated decreases amylase blood urea nitrogen bun elevation liver enzyme levels fig s<NUMBER> tracts virus isolations qrtpcr analysis performed oral rectal nasal conjunctival swab samples obtained course infection sarscov<NUMBER> isolations confirmed using indirect immunofluorescence using antispike antibody fig <NUMBER>a syncytia present vitro isolations particularly later time points eg <NUMBER> dpi replicating virus detected nasal oral swabs animals <NUMBER> <NUMBER> dpi fig <NUMBER>b <NUMBER> dpi <NUMBER> rectal swabs <NUMBER> ocular swabs positive infectious virus swabs broadly negative animals <NUMBER> dpi however resurgence presence replication competent virus <NUMBER> <NUMBER> dpi samples respiratory gi tracts fig <NUMBER>a b qrtpcr results confirmed virus isolation results peak vrna detection oral nasal conjunctival swabs <NUMBER> dpi second spike rectal samples <NUMBER> dpi fig <NUMBER>cf consistent detection vrna <NUMBER> dpi although stage infectious virus isolated either swabs necropsy tissues molecular imaging using positron emission tomography pet radiotracer <NUMBER> ffdg provides sensitive measurement metabolic activity within specific anatomical compartments coregistered computed tomography ct petct provide detailed anatomic structure overlaid areas high metabolic activity revealed tracer fdgbased petct used nhps measurement lung granulomas caused infection mycobacteria tuberculosis <NUMBER> determine whether lung infection sarscov<NUMBER> could visualized using fdgmediated petct ct alone imaging performed preinfection <NUMBER> dpi <NUMBER> dpi animals quantify overall disease burden lungs various time points diseaseassociated total lung fdg activity level calculated <NUMBER> measure total lung inflammation analysis maximum suvs thoracic lymph nodes lns also conducted mucosallyinfected animals one aerosol animals a<NUMBER> significant lung inflammation <NUMBER> dpi based fdg uptake lesions resolved <NUMBER> dpi fig <NUMBER>a lns three animals also showed highest fdg uptake <NUMBER> dpi <NUMBER> agm substantial fdg uptake lns either <NUMBER> <NUMBER> dpi fig <NUMBER>b overall extent disease fig <NUMBER>d areas resolved day <NUMBER> new focal area disease present day cyan arrow fig <NUMBER>d chest radiographs taken longitudinal sampling days animal m<NUMBER> detectable radiographic abnormalities mild nonspecific infiltrates present left lower lobe <NUMBER> <NUMBER> dpi resolving <NUMBER> dpi fig s<NUMBER> order evaluate kinetics seroconversion serial plasma samples sarscov<NUMBER> infected agm assayed antibodies sarscov<NUMBER> spike protein receptor binding domain rbd using indirect elisa fig <NUMBER>a animals generated igm igg antibodies sarscov<NUMBER> notably simultaneous seroconversion igm igg contradicts classic immunology paradigm igm proceeding igg response antigen exposure however mirrors precisely occurs covid<NUMBER> patients <NUMBER> validating utility agm model animals seroconverted second week post exposure exposed via mucosal route higher overall titers received virus via aerosol route could reflect fact mucosal infected animals received higher challenge dose aerosol infected animals neutralization sarscov<NUMBER> measured matched samples using plaquereduction neutralization<NUMBER> test prnt<NUMBER> fig <NUMBER>b neutralizing <NUMBER> antibodies present samples collected <NUMBER> dpi differences kinetics activity two exposure routes demonstrating higher dose received multiroute mucosal infection neither affected onset strength humoral immune response pbmc isolated whole blood stained flow cytometry using either myeloid lymphoid panel table s<NUMBER> figs s<NUMBER>s<NUMBER> proportions proliferating ki<NUMBER> cd<NUMBER> cd<NUMBER> cells increased transiently <NUMBER> dpi animals fig s<NUMBER> unlike aerosol infection sustained increases proliferating cd<NUMBER> cells mucosallyinfected animals fig s<NUMBER>d similar occurs human covid<NUMBER> patients <NUMBER> <NUMBER> nk cell frequencies varied course experiment mean fluorescence intensity mfi cd<NUMBER> nk cells clear pattern emerging fig s<NUMBER>ef relevant since covid<NUMBER> patients severe moderate disease demonstrated decreased cd<NUMBER> mfi nk cells <NUMBER> notably increased frequency cd<NUMBER> lo b cells noted animals second week infection accompanied increased expression ki<NUMBER> cells consisted plasmablast phenotype fig s<NUMBER>hi comparison cd<NUMBER> hi b cells saw increase ki<NUMBER> nhpspecific multiplex cytokine chemokine assay used measure levels appearance virus specific antibodies fig <NUMBER> necropsy upon euthanasia animal <NUMBER> dpi <NUMBER> dpi a<NUMBER> a<NUMBER> full necropsies performed tissues tested qrtpcr levels vrna fig <NUMBER> vrna widespread throughout upper lower respiratory tracts including soft palate nasal turbinates overall levels vrna detected comparable two exposure routes doses indicating <NUMBER>fold higher infectious dose mucosally infected animals received translate higher levels tissue vrna necropsy vrna detected <NUMBER> along entire gastrointestinal gi tract compared lower upper respiratory tracts highlighting differential tropism sarscov<NUMBER> vrna detected <NUMBER> olfactory bulbs largely absent cortex cerebellum animals heart liver spleen kidney largely devoid vrna virus isolation attempts lung gastrointestinal tissue obtained necropsy unsuccessful residual histopathology detected necropsy since agms euthanized <NUMBER> <NUMBER> dpi tissue specimens acute histopathology obtained however lung samples lymph nodes animals known positive petct taken necropsy examined boardcertified veterinary pathologist importantly even <NUMBER> weeks infection several animals demonstrated multiple pulmonary foci interstitial infiltration expansion either lymphocytic mixed inflammatory infiltrates fig <NUMBER> specific diagnostic finding common pathological effect many pneumotropic viruses also consistent convalescent stage respiratory infection interestingly multiple syncytiated cells observed germinal follicles peyers patches two animals fig <NUMBER>b given frequent propensity coronaviruses including sarscov<NUMBER> lead fused cells vitro observation isolated virus agms form syncytia veroe<NUMBER> cells fig <NUMBER>a observation multinucleated syncytial cells human cases disease <NUMBER> <NUMBER> finding likely viral cytopathic effect moreover peyers patches <NUMBER> <NUMBER> agms contained highest levels vrna fig <NUMBER> discussion agms used nonhuman primate model sarscov<NUMBER> infection <NUMBER> epidemic compared rhesus macaques agms supported enhanced sarscov<NUMBER> virus replication developed severe lung pathology <NUMBER> <NUMBER> also excellent species model respiratory diseases pneumonic plague human parainfluenza virus <NUMBER> <NUMBER> study covid<NUMBER> disease young agms mild reflecting frequently occurs young healthy humans infected sarscov<NUMBER> <NUMBER> <NUMBER> lowgrade fever observed respiratory symptoms limited transient decrease tidal volume advanced imaging using metabolic pet probe permitted visualization pulmonary lesions undetectable modalities standard chest radiographs petct used clinically managing covid<NUMBER> patients effective visualizing lesions asymptomatic patients <NUMBER> <NUMBER> notable <NUMBER> three agm a<NUMBER> m<NUMBER> m<NUMBER> febrile responses also highest level inflammation lungs lymph nodes detected petct petct imaging also performed crabeating macaques infected intratracheally sarscov<NUMBER> <NUMBER> disease macaques mildsubclinical petct scans showed areas pneumonia consolidation fdg avid importance studies lies demonstrating petct imaging used bridge human animal data particularly respect determining reductions disease burden following vaccination therapeutic interventions key finding virus isolations followed immunofluorescence confirmation demonstrated unequivocally infectious virus shed respiratory gi early followed recrudescence around <NUMBER> dpi majority vivo sarscov<NUMBER> studies use vrna detection surrogate infectious virus biphasic shedding pattern unexpected highlights need study longer term infection animal models vrna still detectable substantial levels throughout entire gi tract <NUMBER> weeks infection gi titers <NUMBER>fold higher found throughout upper lower respiratory tracts demonstrates tropism sarscov<NUMBER> intestinal tissues importance gi replication viral pathogenesis transmission sarscov<NUMBER> fecal matter contributed superspreader events <NUMBER> outbreak <NUMBER> <NUMBER> mechanism underlying remains largely unexplored sarscov<NUMBER> vrna infectious virus detected feces covid<NUMBER> patients without gi symptoms <NUMBER> <NUMBER> <NUMBER> agm model allow understanding sarscov<NUMBER> shed gi tract potentially transmitted via feces recent study cynomolgus macaques sarscov<NUMBER> infection mild subclinical even aged animals shedding vrna mucosal surfaces limited early time points vrna necropsy largely limited respiratory tissues <NUMBER> preprint study rhesus macaques showed transient clinical disease marked brief fever right infection transient weight loss mild respiratory depression pulmonary infiltrates chest radiograph <NUMBER> upon necropsy vrna found primarily lungs upper respiratory tract gi tract another preprint study rhesus macaques found similar limited disease shedding vrna infiltrates chest radiograph <NUMBER> current consensus regardless nhp species viral isolates infection sarscov<NUMBER> leads mild subclinical infection shedding virus respiratory <NUMBER> tract severe disease lethality rarely seen either mucosal aerosol exposure one distinguishing feature agm model appears tropism virus tissues throughout entire gastrointestinal tract found including substantial shedding infectious virus key finding study repeated isolation infectious virus time mucosal swabs including rectum critically important fundamental understanding covid<NUMBER> disease persontoperson transmission <NUMBER> <NUMBER> animals used male <NUMBER> years age age range <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> years captivity making young around age sexual maturity future studies consider using older animals andor directly imported st kitts particularly relevant covid<NUMBER> pandemic agm west indies spontaneously develop hypertension without dietary intervention inbreeding <NUMBER> moreover naturally develop type ii diabetes atherosclerosis making excellent species study pathogenesis sarscov<NUMBER> conditions representative comorbidities associated severe covid<NUMBER> humans <NUMBER> <NUMBER> increasing age genetic variability spontaneous hypertension diabetes cardiovascular disease may lead severe outcomes agms infected sarscov<NUMBER> thus may accurately reflect variation seen human population summary comprehensively evaluated pathogenesis sarscov<NUMBER> agm model study suggests agms excellent models many aspects covid<NUMBER> humans <NUMBER> young healthy agms may represent subclinical mild human disease <NUMBER> consistent shedding infectious virus respiratory gi tracts absence overt disease allows one sentence summary preexposure sarscov<NUMBER> affects biomarker responses animal models highlighting need robust prescreening protocols prior medical countermeasure studies main text longstanding awareness coronavirus infectious disease seasonalcold smaller outbreak clusters severe acute respiratory syndrome sars<NUMBER> middle eastern respiratory syndrome mers informed infectious disease public health community potential current outbreak <NUMBER> <NUMBER> <NUMBER> <NUMBER> onehealth efforts led multiorganizational teams predict highlighted wide range novel coronaviruses circulating animal reservoirs humanenvironmental interface possible outbreak candidates <NUMBER> <NUMBER> previous ebola virus outbreaks west africa drc invigorated discussions pandemic preparedness rapid response disease x however globe faced stark reality late <NUMBER> ongoing sarscov<NUMBER> pandemic exposing critical gaps ability respond <NUMBER> <NUMBER> researchers moving rapid pace fill gaps development diagnostics vaccines therapeutics <NUMBER> <NUMBER> efforts succeed impact spread virus critical need wellcharacterized assays identify virus assess immune response postexposure determine efficacy vaccines therapeutics <NUMBER> despite extensive research animal modeling postsarscov<NUMBER> mers outbreaks well rapid rate research sarscov<NUMBER> little known regarding longevity immune protection vaccine efficacy reinfection potential new coronavirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> globally vaccine therapeutic groups addressing need better understanding pathogenesis appropriate animal models tackling specific questions nonhuman primate species selection potential viral reinfection virus detection immunological profiling <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> specifically haagmans etal found clinical signs disease cynomolgus macaque challenge model noticed viral secretions nose throat challenged monkeys disease severity sars<NUMBER> mers <NUMBER> rhesus macaque reinfection model qin etal nhps challenged postrecovery exhibit evidence reinfection sarscov<NUMBER> <NUMBER> addition many groups detecting virus subsequent immune response asymptomatic mild severe covid patients <NUMBER> <NUMBER> <NUMBER> data studies suggest differential response species selected initial sarscov<NUMBER> versus reinfection models also impacts diagnostic context unanswered questions regarding concordance immunological data correlates protection inhibit efforts instituting immunity passports <NUMBER> diagnostic assay development validation efforts focus diagnosis postexposure screening human population however application diagnostic toolbox across animal models essential therapeutic vaccine efforts complete understanding disease progression treatment efficacy <NUMBER> <NUMBER> diagnostic animal model assays generally parse two bins based target biomolecule nucleic acid protein diagnostics types assays qualitative quantitative context inform animal model countermeasure development table s<NUMBER> instance realtime pcr used pathogen detection qualitative determining viral load quantitative pathogenspecific igm igg antibody immunological assays characterize infectionspecific host response diagnostically commonly used screen recent previous pathogen exposure critical countermeasure development understanding protective response generated exposure characterizing immune response using microneutralization prnt assays adds specificity qualitative data immune response coupled existing animal model data animals used covid<NUMBER> model countermeasure development screened current previous exposure study organism given significant impact previous exposure study results high transmissibility prevalence novel coronavirus presents unique challenge animal model developers prescreening animals past exposure emerging infectious diseases viral hemorrhagic fevers lesserknown arthropod borne viruses often requires simple elisa nhp cohorts risk prior exposure crossreactive antibodies challenge agent low demonstrate need fully developed molecular immunological toolbox prior animal challenge considering animal models disease agent pandemic potential present integrated assay development approach pcr sequencing immunoassays neutralization assays sarscov<NUMBER> species selection study prescreen application toolbox african green agm nonhuman primate nhp showed evidence previous exposure sarscov<NUMBER> prior challenge institute stock fig <NUMBER> additionally use integrated screening approach postchallenge showed immunological viral load significantly impacted preexposure across longitudinal assessments results immunoassay development took multipronged assay developmentimplementation approach order mitigate risk prior animal model development producing inhouse assays well integrating commercial eua approved elisa kit commercial sources academic collaborators provided sarscov<NUMBER> recombinants develop multiplex beadbased immunoassay magpix platform previous efforts used method qualitatively detect igm igg response glycoprotein nucleoprotein targets animal models cchfv rvfv veev thus simplifying platform selection assay optimization matrix testing could leverage successes utilizing platform longitudinal biomarker assessment serum <NUMBER> <NUMBER> newly developed multiplex magpix assay targeted full trimeric spike protein s<NUMBER> subunit receptorbinding domain nucleoprotein sars<NUMBER> spike protein fig s<NUMBER> ordered sarscov<NUMBER> s<NUMBER> igg elisa kit euroimmun run parallel inhouse magpix multiplex substantial validation data assay nt e realtime rtpcr development optimized two realtime qualitative rtpcr assays qn<NUMBER> gp assays used different reagents center disease control cdc emergency use authorization eua reagents due supply shortages thus establishing independent supply chain human eua testing two assays showed similar performance tested serially diluted sarscov<NUMBER> nucleic acid slight increase sensitivity qn<NUMBER> assay compared gp assay fig s<NUMBER>a <NUMBER>b observed crossreactivity across <NUMBER>organism exclusivity panel including eight different coronaviruses clinical matrices contain inhibitors negatively impact nucleic acid extraction realtime pcr performance matrix testing sensitive qn<NUMBER> assays showed similar performance pbs np swab matrix higher virus concentrations however lod lower less complex pbs matrix fig s<NUMBER>c sixty replicate extractions singlet qn<NUMBER> testing resulted replicates testing positive virus concentration <NUMBER> pfuml fig s<NUMBER>d leveraging past successes developing microneutralization assays optimized rapid highthroughput method evaluating therapeutic countermeasures live sarscov<NUMBER> virus screening four commercially available antibodies identified sarscov<NUMBER> npspecific crossreactive antibody capable detecting sarscov<NUMBER> infected cells immunofluorescencebased assay ifa evaluation mean fluorescent intensity serially diluted antibody uninfected sarscov<NUMBER> infected cells determined optimal immunostaining concentration peak intensity began decrease near <NUMBER> dilution primary antibody resulting <NUMBER> dilution primary antibody subsequent immunostaining fig s<NUMBER>a veroe<NUMBER> cells equally permissive sarscov<NUMBER> infection compared vero<NUMBER> cells inoculated equivalent multiplicity infection moi fig s<NUMBER>b <NUMBER> hours percent infection ranged <NUMBER> moi <NUMBER> less <NUMBER> moi <NUMBER> standard deviation <NUMBER> <NUMBER> fig s<NUMBER>c <NUMBER> hours mois <NUMBER> <NUMBER> resulted <NUMBER> infection standard deviations <NUMBER> <NUMBER> percent infection moi <NUMBER> resulted <NUMBER> infection standard deviation <NUMBER> primary focus effort developing assay evaluate virus entry inhibition therefore opted <NUMBER> hour assay order limit rounds virus replication across several independent experiments sarscov<NUMBER>mt<NUMBER> moi <NUMBER> percentage infected cells within assays consistent intraassay coefficient variance cov ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> based viral stock used fig s<NUMBER>d similarly mean percent infection also consistent independent stocks mean <NUMBER> mean <NUMBER> interassay cov <NUMBER> <NUMBER> respectively fig <NUMBER>e data compiled independent experiments cells infected sarscov<NUMBER> moi <NUMBER> <NUMBER> showed intraassay variability across replicate wells consistent moi <NUMBER> compared moi <NUMBER> fig s<NUMBER>f based results performed subsequent experiments <NUMBER>hour assay moi <NUMBER> prestudy nhp baseline screening prior study start screened serum <NUMBER> total nhps <NUMBER> agm <NUMBER> rm <NUMBER> cm euroimmun elisa covid magpix multiplex µnt prnt study coordinators took prebleed samples <NUMBER> <NUMBER> days prechallenge prebleed serum samples negative immunoassay plaque reduction neutralization test prnt assays table s<NUMBER> part reiterative prescreening covid study coordinators also took prestudy np swabs nhps <NUMBER> days prechallenge fig <NUMBER> surprisingly left nare np swab one agm tested positive qn<NUMBER> assay subsequently gp assay table s<NUMBER> sequencing extracted nucleic acid material showed <NUMBER> coverage sarscov<NUMBER> reference genome found separate clade usamriid challenge stock material institution stocks based wa<NUMBER> mt<NUMBER> however agm swab phylogenetically closer isolates circulating us europe fig s<NUMBER> study team swabbed nhps including positive agm immediately prior challenge left nare np swab positive assays almost half right nare np replicates tested positive gp assay nhp study pcr positive np swab prior study start fig <NUMBER> longitudinal assessment immune response viral load screened time points postchallenge elisa magpix pcr assays nhps showed igg response day <NUMBER> postchallenge pc exception previously exposed agm o<NUMBER> fig s<NUMBER>ac measurable igg response euroimmun elisa started day <NUMBER> pc increased terminal bleed interestingly previously exposed agm igg response plateaued day <NUMBER> pc however observed anamnestic response day <NUMBER> pc fig <NUMBER>a analysis immune response using covid igm igg magpix multiplex immunoassay days pc showed specific igm signal sars<NUMBER> glycoprotein antigens assays yielded measurable signal sars<NUMBER> spike sars<NUMBER> nucleoprotein fig <NUMBER>b fig s<NUMBER> igm signal detectable baseline average nhp species day <NUMBER> agm rm day <NUMBER> cm three glycoprotein derivatives igg signal also detectable baseline day <NUMBER> agm rm day <NUMBER> cm fig s<NUMBER> magpix immunoassay showed higher relative sensitivity euroimmun elisa kit detection igg signal nhps <NUMBER> days sooner based assay observed restimulation igm response preexposed agm postchallenge noted igg fig <NUMBER>b igg response preexposed agm statistically significant <NUMBER> nhps day challenge however statistical difference serologically agm rest cohort terminal bleed fig s<NUMBER> screening np swabs pcr cohorts detectable nucleic acid starting d<NUMBER> d<NUMBER> one nhp species cohort detectable nucleic acid np swab day termination fig s<NUMBER>df notably o<NUMBER> measurable nucleic acid d<NUMBER> terminal bleed lower relative levels viral load exhibited members cohort post challenge fig <NUMBER>c serum samples screened commercial euroimmun sarscov<NUMBER> s<NUMBER> igg elisa kit magpix multiplex igm direct elisa kit measures igg response s<NUMBER> subunit spike glycoprotein analogous s<NUMBER> igm assay magpix multiplex shown panel b neutralizing activity serum collected time challenge termination study day <NUMBER> postchallenge prnt nearly animals showed neutralizing activity time challenge prnt<NUMBER> titers less <NUMBER> fig s<NUMBER> sole exception previously exposed agm o<NUMBER> prnt titer <NUMBER> contrast assessment microneutralization assay demonstrated neutralizing activity serum collected time challenge agm serum samples calculated halfmaximal inhibitory concentration ic <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> table s<NUMBER> agreement elisa prnt data previously exposed agm o<NUMBER> highest prechallenge ic <NUMBER> neutralizing activity rm cm prechallenge serum similar human negative control serum fig s<NUMBER> day <NUMBER> postchallenge prnt<NUMBER> titers increased <NUMBER> <NUMBER> fig s<NUMBER> likewise microneutralization assay ic <NUMBER> increased <NUMBER> fold greatest fold difference occurring rm cms table s<NUMBER> neutralizing titer previously exposed agm o<NUMBER> remained largely unchanged time challenge day <NUMBER> assays foldchange log ic<NUMBER> microneutralization response average agm cohort noticeably higher preexposed agm fig <NUMBER> harmony software percent inhibition calculated relative untreated cells foldchange logic<NUMBER> preexposed agm relatively elevated comparison average agm response mapping assay results showed preexposure impact neutralization relevant diagnostic targets fig <NUMBER> data showed dramatic increase d<NUMBER> d<NUMBER> diagnostic targets rtpcr igm igg neutralization prnt microneutralization across entire cohort exception preinfected cohort nhp o<NUMBER> nhp o<NUMBER> observed generally static level neutralization igg titers rose course study interestingly igm levels dropped fig <NUMBER> fig s<NUMBER> comparison agm o<NUMBER> average nhp response screening assay preexposed agm generally consistent foldchange d<NUMBER> gray bars d<NUMBER> black bars whereas measurable positive foldchange assay average nhp cohort key element modern societys fortune weathering disease outbreaks especially pandemics covid<NUMBER> ability coordinate effective scientific societal response earliest recorded pandemic athenian plague <NUMBER> bc killed ng nt n p <NUMBER> nd nd <NUMBER> population athens peloponnesian war theorized caused typhoid fever <NUMBER> devastating fashion <NUMBER> spanish flu spread world middle world war killing <NUMBER> million infecting <NUMBER> worlds population common postpandemic society event associated advancements made public health response infectious disease research <NUMBER> <NUMBER> <NUMBER> mitigate devastating effects disease spread rising mortality rates must rapid response toward isolating disease causing agent diagnosing affected patients treating infected managing spread disease preventing future outbreaks <NUMBER> rapid development animal models critical response efforts order understand disease pathogenesis serve platform testing medical countermeasures high transmissibility rate covid<NUMBER> dire need medical countermeasures necessitates rapid initiation animal studies develop disease models vaccine therapeutic testing <NUMBER> additionally workflow ppe considerations must taken mitigate preexposure risk nhp colonies fomites potentially infectious exposure routes preinfection nhp question occurred spite enhanced absl<NUMBER> usamriid nhp handling procedures represent personal protective equipment ppe stance beyond currently applied premier institutes previous sarscov<NUMBER> sarscov<NUMBER> research shows distinct differences host nhp response challenge based whether animal naïve preexposed virus <NUMBER> therefore initiated first documented thorough prescreening strategy prior species selection study ensure nhps previous exposure markers required development covid<NUMBER> diagnostic toolbox comprised elisa pcr multiplex igmigg immunoassay neutralization assays establish full prechallenge baseline capture postchallenge image sarscov<NUMBER> animal model applying tools prescreening context discovered one agm nhps previously exposed sarscov<NUMBER> communityacquired infection first documented case community acquired nhp infection root cause analysis undertaken however sequencing confirmed different strain isolate used challenge sequence data showing isolate european asian descent strain derivative challenge stock demonstrated potential contamination naïve nhp cohort environment even extraordinary preventive measures taken mitigate risks coupled high transmissibility virus discovery transmission community nhp serious implications future vaccine therapeutic developmental efforts labs moving forward sarscov<NUMBER> countermeasure testing consider prescreening respective animal cohorts implement measures minimize unintentional community cohort virus transfer ultimately responsibility reporting community acquired nhp infections resides united states department agriculture usda reporting better understanding breadth communityacquired infection within nhp colonies demonstrate impact necessity prescreen cohorts prior study initiation analysis preexposed agm cohort average postchallenge showed inversion diagnostic markers fig <NUMBER> detectable nucleic acid present np swab o<NUMBER> d<NUMBER> addition presence antisarscov<NUMBER> igg igm neutralizing antibodies interestingly relative level viral load present consistently lower rest cohort show marked increase across longitudinal evaluations additionally igg igm response o<NUMBER> elevated d<NUMBER> relative baseline signal nhps igg appeared restimulated d<NUMBER> concordance rest cohort however igm response slowly declined course study fig <NUMBER> lastly nhps net positive fold change neutralizing antibody response d<NUMBER> d<NUMBER> o<NUMBER> significant net change fig <NUMBER> data show critical nature rapid rational prescreening response risk prescreening prior animal studies evidenced alterations responses preinfected nhp together discovery preexposed nhp research raises questions regarding larger discussion necessity prescreening midpandemic research community implications reinfection models identification true correlates protection protective quality future vaccines data clearly show sarscov<NUMBER> preexposure dramatic impact evaluation vaccine therapeutic efficacy protective response due countermeasure treatment longitudinal data covid<NUMBER> diagnostic markers could impactful currently implemented diagnostic algorithms human screening prior infection potential successful vaccine efforts <NUMBER> igg igm coinduction seen parallels current research human cohorts nonphasic general increase immunoglobulins <NUMBER> <NUMBER> igm typically early response indicator bodys adaptive immune response first week postinfection however response appears delayed closely monitored sarscov<NUMBER> infections generally increase igg titers reflect neutralizing activity potential indicator protection thus giving measure confidence establishing immunity passports populations seroconvert however recent studies showed infected yield productive detectable immunological response <NUMBER> additionally evidence preinfected nhp anamnestic immunologic response gross symptoms productive sarscov<NUMBER> infection suggest future vaccine efforts may issues producing durable protective immunity sarscov<NUMBER> reinfection model need investigation establish whether data shown gives evidence vaccine production design similar classic vaccination schedules require periodic updates similar flu general investigation required establish impact reinfection covid<NUMBER> diagnostic countermeasures covid<NUMBER> first pandemic last generation experience beyond implications prescreening animals prior study lessons pandemic response learned timetoproduct maturity prioritize research efforts prioritizing assay development meets critical aspects diagnostic countermeasure development needs always need develop diagnostics vaccines therapeutics rapid response efforts however neglecting clarify relationships diagnostic windows matrices therapeutic targets toxicity vaccines correlates protection delay resolution covid<NUMBER> crisis facilitate resolution openly invite collaboration share detailed protocols development processes standup assays locations • review addresses high priority patient clinician concern • given limited evidence subject included human animal models vivo vitro comprehensive review • first systematic review specifically focussed uk prescribed drugs could alter ace<NUMBER> covid<NUMBER> disease • heterogeneity across study designs models meant metaanalysis suitable • given rapidly changing evidence pandemic progresses possible new studies since published ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint coronavirus sarscov<NUMBER> causes covid<NUMBER> disease global public health emergency reported <NUMBER> countries <NUMBER> confirmed cases <NUMBER> deaths <NUMBER> th may <NUMBER> walker colleagues world health organization collaborating centre infectious disease modelling predicted absence mitigation strategies virus would infect seven billion people account <NUMBER> million deaths year alone <NUMBER> efforts shield elderly <NUMBER> reduction social contacts interrupt transmission <NUMBER> reduction social contacts wider population reduced number deaths still expected <NUMBER> urgent need solutions absence vaccination effective treatment growing interest repurposing existing drugs mitigation particular drugs affecting reninangiotensin system ras highlighted potential candidates investigation <NUMBER> <NUMBER> sarscov<NUMBER> virus utilises angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptors within ras entry lung alveolar epithelial cells <NUMBER> ace<NUMBER> previously shown correlate susceptibility sarscov<NUMBER> virus spike glycoprotein new virus binds ace<NUMBER> even higher affinity <NUMBER> <NUMBER> theoretically altered ace<NUMBER> activity could therefore lead greater susceptibility sarscov<NUMBER> could also cause greater severity infection <NUMBER> previous studies suggest dysregulation ace<NUMBER> activity lungs could promote early neutrophil infiltration subsequent uncontrolled activation ras system <NUMBER> mice models acute lung injury observed response sarscov<NUMBER> spike protein plausible similar responses observed sarscov<NUMBER> <NUMBER> particularly problematic organs containing high ace<NUMBER> lungs may contribute cytokine release syndrome cytokine storm subsequent respiratory failure observed died disease <NUMBER> many prescribed drugs common use known mediate effects ras pathway <NUMBER> million prescriptions issued uk last year alone <NUMBER> million angiotensin converting enzyme inhibitors acei angiotensin receptor blockers arbs acting ras pathway drugs may impact ace<NUMBER> regulation role covid<NUMBER> pandemic clear given number people potentially drugs caused substantial public concern clinical uncertainty continuation cessation prescribed medications pandemic accordingly reviewed existing evidence routinely prescribed uk drugs might alter ace<NUMBER> regulation understanding drug effects ace<NUMBER> given role covid<NUMBER> disease could help reassure clinicians public uncertain times direct research drugs might attenuate exacerbate transmission review conducted accordance preferred reporting systematic reviews metaanalyses prisma guidelines protocol submitted openaccess publication prior commencing study press also made available preprint medrxiv manuscript processing system systematic search medline embase cinahl cochrane library web science conducted inception <NUMBER> st april <NUMBER> search strategy shown table <NUMBER> reference lists recent reviews included studies screened also spoke topic experts screened opengrey additional texts language limits study design filters applied ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> covid<NUMBER> disease still relative new limited research drug therapies specific virus interest comprehensive potential drugs acting ace<NUMBER> inclusive possible within study selection included animal human models vivo invitro studies meet following eligibility criteria measures ace<NUMBER> levels activity gene expression ii includes drug currently available uk prescription according british national formulary iii measures effect drug placebo control sham group experimental design review articles excluded reference lists screened conference abstracts included sufficient detail could elicited include studies children <NUMBER> years examining drug effects utero four members team reviewed titles abstracts eligibility aa hdm cw sh fulltext review data extraction quality assessment carried duplicate using piloted sheet disagreement authors resolved discussion data following study characteristics extracted drug class ii drug name iii duration treatment iii effect ace<NUMBER> level upregulation downregulation effect iv model humanrat etc v site ace<NUMBER> reception lung renal cardiac etc vi study design vii study population viii sample size ix country given urgency research question current pandemic extracted information available us published text review includes animal human models therefore quality assessment carried separately studies human studies evaluated using cochrane risk bias tool includes following domains random sequence generation allocation concealment blinding participants personnel blinding outcome assessment incomplete outcome data selective reporting sources bias <NUMBER> domain scored low risk unclear risk high risk bias classified overall risk bias low domains low risk bias high least one domain high risk bias unclear least one domain unclear domain high risk bias although tool specific ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint trials included studies experimental designs therefore felt appropriate use methodological quality animal studies assessed using syrcles risk bias tool based cochrane risk bias tool <NUMBER> syrcles tool includes selection bias performance bias detection bias attrition bias reporting bias biases owing mix study designs models metaanalysis appropriate narrative synthesis methods used reviewed metadata tabulating studies according inclusionexclusion criteria humananimal model drug classes effects ace<NUMBER> consistency number studies direction effects considered inconsistencies identified effect drug studies looked additional data methods quality outcome measurement potential explanatory factors possible involve patients public design conduct work due rapid timelines invited ppi representatives help us drafting lay summary dissemination findings retrieved <NUMBER> studies screened <NUMBER> removing duplicates following title abstract screening <NUMBER> studies screened full text included <NUMBER> studies final review flow studies shown prisma diagram figure <NUMBER> including reasons study exclusion stage table <NUMBER> shows characteristics included studies originated <NUMBER> different countries common china n <NUMBER> usa n <NUMBER> japan n<NUMBER> <NUMBER> studies humans <NUMBER> invitro <NUMBER> invivo table <NUMBER> <NUMBER> animal models <NUMBER> invitro <NUMBER> invivo animal models included rats n<NUMBER> mice n<NUMBER> canines n<NUMBER> sample sizes invivo animal models ranged <NUMBER> <NUMBER> invivo human studies table <NUMBER> sample sizes ranged <NUMBER> <NUMBER> always reported participants predominantly male white hypertension diabetes although condition always stated models examined ace<NUMBER> receptors heart kidneys <NUMBER> <NUMBER> included studies reporting ace<NUMBER> levels lungs animal models shown table <NUMBER> <NUMBER> different drug classes examined included studies shown table <NUMBER> table <NUMBER> tabulates examined human models mean drug exposure period ranged <NUMBER> mins invitro studies <NUMBER> weeks invivo studies common drug classes arbs n <NUMBER> acei n <NUMBER> <NUMBER> studies examined arbs <NUMBER> reported upregulation ace<NUMBER> levels studies rat models n <NUMBER> examined cardiac ace<NUMBER> levels n <NUMBER> acei <NUMBER> <NUMBER> studies reported upregulation ace<NUMBER> also mainly rat models n <NUMBER> measured cardiac ace<NUMBER> levels n <NUMBER> five studies assessed statins within rat models <NUMBER> reported upregulation ace<NUMBER> <NUMBER> reported downregulation <NUMBER> reported effect ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint similarly oestrogens examined <NUMBER> studies <NUMBER> reported upregulation <NUMBER> reported downregulation <NUMBER> reported effects calcium channel blockers <NUMBER> <NUMBER> studies reported upregulation ace<NUMBER> levels invivo rodent models third study invitro human model showed downregulation ace<NUMBER> calcium channel blocker <NUMBER> studies aldosterone antagonists reporting increases renal ace<NUMBER> levels within rat models several diabetes drugs evaluated found increase ace<NUMBER> insulin <NUMBER> <NUMBER> studies reported upregulation ace<NUMBER> mice rat models thiazolidinediones <NUMBER> <NUMBER> studies reported upregulation <NUMBER> micerate models <NUMBER> cerebral human cells invitro glp<NUMBER> agonists included studies reported increases ace<NUMBER> similarly one study examining dpp<NUMBER> inhibitors also reported increase ace<NUMBER> study measuring effect sglt<NUMBER> inhibitors reported decrease ace<NUMBER> figure <NUMBER> shows risk bias across studies using syrcles risk bias tool general studies lacked blind allocation outcome assessor blinding also frequently omitted information needed make thorough judgement risk bias knowledge comprehensive review drugs prescribed uk could act ace<NUMBER> receptors thus potentially affect covid<NUMBER> disease ace<NUMBER> receptor reported essential contributor sarscov<NUMBER> entry nasopharynx lungs subsequent inflammation leads severe acute respiratory distress syndrome <NUMBER> <NUMBER> review examined drugs across human animal models found number studies reporting upregulation ace<NUMBER> levels response acei n<NUMBER> arbs n<NUMBER> insulin n<NUMBER> thiazolidinedione n<NUMBER> aldosterone agonists n<NUMBER> statins n<NUMBER> oestrogens n<NUMBER> calcium channelblockers n<NUMBER> glp<NUMBER> agonists n<NUMBER> nsaids n<NUMBER> however drugs poorly studied vivo within lungs nasopharynx humans likely matter influencing severity outcomes covid<NUMBER> disease observed frequent drugs upregulate ace<NUMBER> also prescribed people diabetes cardiovascular disease mortality rates covid<NUMBER> high group <NUMBER> <NUMBER> <NUMBER> <NUMBER> notably also conditions high prevalence amongst black asian minority ethnic bame groups disproportionally high mortality rates covid<NUMBER> disease <NUMBER> date much evidence limited clinical commentaries case reports larger cohorts emerging yet adequately considered range potential confounders including comorbidities age sex deprivation household numbers might important prescribed medication spread susceptibility severity disease example cohort <NUMBER> people infected virus wuhan <NUMBER> died coronary heart disease <NUMBER> diabetes <NUMBER> conditions associated increased risk death considered covariates analysis irrespective ace<NUMBER> people diabetes susceptible worse infection lowgrade chronic inflammation hyperglycaemia associated condition results impaired immune responses lower il<NUMBER> il<NUMBER> tnfa delayed mobilisation immune cells response pathogens <NUMBER> comorbidity like many confounders highly relevant examining risk death covid<NUMBER> disease ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint lack adequate adjustment existing conditions highlighted sommerstein colleagues editorial acei arbs covid<NUMBER> <NUMBER> also propose existing comorbidities heart failure may independently linked sarscov<NUMBER> transmission severity subsequent poor pulmonary outcomes observed patients indeed mice models arterial hypertension atrial fibrillation type <NUMBER> diabetes shown upregulate ace<NUMBER> levels irrespective medications <NUMBER> moreover ace<NUMBER> levels shown higher men increasing age <NUMBER> published data deaths covid<NUMBER> disease report males increasing age particularly susceptible poor outcomes <NUMBER> <NUMBER> review also highlighted variable ace<NUMBER> levels different parts body existing literature focussing renal cardiac levels responses drugs may vary depending cell type location although lung ace<NUMBER> important covid<NUMBER> unclear overall covid<NUMBER> mortality might attenuated cardiovascular ace<NUMBER> activity levels also observed variations ace<NUMBER> levels drug exposure duration relatively short amongst included studies review uncertain dysregulation might continue starting stopping medications also unclear observed effects amongst included studies would translate invivo humans net effect receptor access covid<NUMBER> virus access receptor virus may competitively inhibited presence drugs also attach receptor whether upregulation key factor practice unclear particularly challenging understand found paucity data demonstrating effect prescribed drugs ace<NUMBER> lungs nasopharynx sarscov<NUMBER> virus appears enact pathogenic effects results therefore provide convincing evidence role currently prescribed uk drugs acting ace<NUMBER> regulation could affect covid<NUMBER> disease finally found disproportionate number studies reporting upregulation positive effects drugs ace<NUMBER> compared studies reporting effect downregulation may reflect publication bias wellestablished literature especially amongst animal models <NUMBER> carried comprehensive systematic search literature knowledge first review subject include language restrictions nonenglish language studies international literature might indexed databases searched given rate new publications covid<NUMBER> also possible search results may date owing limited research novel virus necessary inclusive possible therefore considered animal human models look drugs acting ace<NUMBER> potential affect covid<NUMBER> outcomes inclusive approach may offer insights heterogeneity across models makes hard interpret findings translate directly patients although robust methodological approach review also aware urgency report findings current pandemic therefore contact authors information studies beyond published observed frequent omission information would allowed us carry detailed quality assessment pursued information quality assessment included papers may well higher reviewed evidence routinely prescribed drugs uk could downregulate ace<NUMBER> thus potentially affect covid<NUMBER> disease review indicates currently prescribed drugs poorly studied invivo within lungs humans ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint better evidence cannot recommend starting stopping prescribed medications covid<NUMBER> pandemic would like thank prof julia hippisleycox early contributions project competing interests authors completed icmje uniform disclosure form confirm financial relationships organisations might interest submitted work previous three years relationships activities could appear influenced submitted work author contribution hdm contributed design study wrote analysis plan conducted analysis drafted revised paper aa contributed design study led analysis drafted revised paper cw sh contributed screening studies data extraction revised paper ni revised paper sg pl contributed design study revised paper hdm guarantor lead author affirms manuscript honest accurate transparent account study reported important aspects study omitted opinions results conclusions reported article authors independent funding sources ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> grausnunes f santos f de marinho de miranda cs barbosadasilva souza ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> pressureoverload hypertrophied rat heart blocking angiotensin ii receptor synergic effects upregulation angiotensin converting enzyme <NUMBER> authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint since identification novel coronavirus sarscov<NUMBER> cause pneumonia patients wuhan china pandemic erupted resulting enormous health care social economic disruption global society <NUMBER> may <NUMBER> <NUMBER> <NUMBER> cases <NUMBER> deaths worldwide <NUMBER> rapid response pandemic academic industry scientists around world initiated efforts develop vaccines therapeutics disease prevention patient management coalition epidemic preparedness innovations cepi global partnership public private philanthropic civil organizations funding work develop sarscov<NUMBER> vaccines using variety technology platforms several vaccine candidates already phase <NUMBER> studies others likely enter clinic next months <NUMBER> one challenges facing rapid vaccine development sarscov<NUMBER> need adequately assure safety vaccines one safety concern disease enhancement syndrome occurred <NUMBER>s inactivated rsv measles vaccines vaccinemediated disease enhancement characterized vaccine results increased disease severity subject later infected natural virus early trials inactivated rsv vaccine vaccine prevent infection <NUMBER> infected required hospitalization two children died <NUMBER> lung pathology patients showed unexpected inflammatory response neutrophils eosinophils evidence immune complex formation complement activation small airways <NUMBER> scientists later learned vaccine caused similar disease enhancement animals characterized immunopathology helper cell type <NUMBER> th<NUMBER> biased response antibody responses poor neutralizing activity <NUMBER> <NUMBER> <NUMBER> since time animal models relied upon predict safety new <NUMBER> rsv vaccines developed note pathogenesis rsv disease enhancement distinct antibody disease enhancement ade occurs macrophage tropic viruses demonstrated notably dengue humans coronavirus feline infectious peritonitis virus cats directly caused nonneutralizing subneutralizing antibodies leading efficient viral uptake via fcγ receptor binding <NUMBER> since pathology consistent rsv vaccine enhanced disease perhaps ade demonstrated sarscov<NUMBER> vaccine candidates animal models also concern similar syndrome could occur humans immunized sarscov<NUMBER> candidate vaccines therefore cepi brighton collaboration safety platform emergency vaccines speac convened scientific working meeting httpsbrightoncollaborationusbrightoncollaborationcepicovid<NUMBER>webconference march <NUMBER> <NUMBER> <NUMBER> experts field vaccine immunology coronaviruses discuss current knowledge could form basis assessment risk enhanced disease sarscov<NUMBER> vaccine development consensus report presents considerations vaccine developers serve guide development testing vaccine candidates avoid safety concerns ultimately door clinical trials controlled regulators context riskbenefit entire dataset provided developers within local trial context microbiology immunology pediatrics university iowa reviewed work others animal models developed sarscov<NUMBER> merscov lessons models inform development priorities useful sarscov<NUMBER> animal models address efficacy safety inbred mouse strains sarscov<NUMBER> replicates efficiently respiratory tract cause pneumonitis clinical signs pneumonia observed old balbc mice <NUMBER> subsequent passage sarscov<NUMBER> mouse lungs resulted isolation virus caused severe disease young old mice <NUMBER> <NUMBER> virus used many subsequent studies ferret models sarscov<NUMBER> also demonstrate virus replication respiratory tracts induction neutralizing antibody response also demonstrated little evidence clinical disease <NUMBER> hamsters contrast mice ferrets demonstrate high levels viral replication develop pneumonitis shown clinical signs disease <NUMBER> following identification human ace<NUMBER> receptor sarscov<NUMBER> transgenic murine models expressing human ace<NUMBER> receptor hace<NUMBER> developed shown develop mild pulmonary disease note mice also developed lethal viral encephalitis attributed viral spread olfactory nerve despite relative scarcity hace<NUMBER> expression brain may relevance sarscov<NUMBER> disease <NUMBER> efficacy several sarscov<NUMBER> vaccines evaluated models spike protein based vaccines demonstrating neutralizing antibody protection pulmonary replication challenge virus mice hamsters <NUMBER> dna vaccine studies shown candidate vaccines encoding protein conferred antibody mediated protection challenge mice vaccines encoding n protein induced humoral cellular immunity <NUMBER> <NUMBER> vectored vaccines expressing sarscov<NUMBER> proteins shown <NUMBER> viral proteins expressed mice ferrets hamsters studies neutralizing antibodies elicited bhpiv<NUMBER> vsv rabies mva adeno viruses expressing protein protected sarscov<NUMBER> replication lungs challenged animals however one mva vaccine expressing sprotein protect infection <NUMBER> contrast sarscov<NUMBER> inbred mice found resistant merscov thus infection studied creating models expressed mers receptor human dpp<NUMBER> hdpp<NUMBER> ad<NUMBER>hdpp<NUMBER> transduced mice could infected mers virus infection associated minimal clinical disease except immunocompromised mice developed weight loss infection note hdpp<NUMBER>transgenic mice developed lethal viral encephalitis concurrent inflammatory changes histopathological examination lung similar hace<NUMBER>tg mice sarscov<NUMBER> subsequently investigators developed mice knockedin expression hdpp<NUMBER> virus passage mice identified mouseadapted mers strains caused severe disease increased histopathology pulmonary edema infected original mers strain <NUMBER> importantly mice without functional cells rag<NUMBER>and tcr alpha delayed viral clearance whereas mice could produce antibodies mumt mice show delay clearance similar models developed crisprcas<NUMBER> mutagenesis two residues mouse ace<NUMBER> molecule followed mouse adaptation serial passage leading ards model lethal infection <NUMBER> <NUMBER> taken together evidence supports notion cells important viral clearance mers <NUMBER> nonhuman primate nhp models also established sarscov<NUMBER> merscov evidence upper respiratory lower respiratory tract sarscov<NUMBER> replication african green monkeys greater extent cynomolgus macaques least <NUMBER> rhesus macaques little evidence clinical disease three species <NUMBER> note consistent findings older humans mice increased pathology documented aged cynomolgus macaques sarscov<NUMBER> wild type infection <NUMBER> controversy disease severity mers models different groups seeing different levels pathology resolved <NUMBER> <NUMBER> vaccine efficacy safety studied animal models many sarscov<NUMBER> candidate vaccines group experts discussed vaccine models utilized characterize response specific vaccines examine disease enhancement antibody dependent enhancement ade signals evidence disease enhancement vaccinated animals challenge live virus multiple studies sarscov<NUMBER> vaccine candidates summarized table limiting comments report data animal models discussing vitro data except mention evidence ade human primary monocytes <NUMBER> <NUMBER> different animal models exhibit different pulmonary pathology generally characterized cellular infiltrates including eosinophils summary provide overview consensus opinion vaccine related outcomes animal models concern risk disease enhancement could guide assessments sarscov<NUMBER> vaccine candidates murine models evidence vaccine related disease enhancement demonstrated inactivated whole vaccine without alum vectored vaccine expressing n protein seen vectored vaccine expressing protein report replicon particle platform expressing protein vectored vaccine expressing proteins general pathology described included pulmonary infiltrates often eosinophils observed th<NUMBER> dominant responses documented reports expression th<NUMBER> driven cytokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ferret model hepatitis demonstrated animals vaccinated recombinant modified vaccinia virus ankara vaccine expressing protein challenged virus <NUMBER> although questions raised study <NUMBER> <NUMBER> <NUMBER> nonhuman primate models also produced evidence enhanced disease sarscov<NUMBER> vaccine immunization chinese macaques immunized modified vaccinia virus expressing protein challenged sarscov<NUMBER> develop clinical disease histopathology showed lung injury injury characterized decreased wound healing increased proinflammatory macrophages expressing il<NUMBER> il<NUMBER> ccl<NUMBER> <NUMBER> report also demonstrated passively administered antis antibody associated lung pathology challenge live virus although mechanism may fc receptor thus classic ade note second report similarly demonstrates effect certain antis antibody preparations without fc involvement <NUMBER> <NUMBER> relevance reports remains unclear multiple studies administration neutralizing monoclonal antibodies different models induce disease enhancement investigators reported absence disease enhancement hamsters monkeys immunized whole inactivated vaccine although models differed number ways notably use bpl βpropiolactone instead formalin inactivation virus <NUMBER> <NUMBER> finally note agreed upon positive control applied animal studies thus interpretations hamperedba animal models sarscov<NUMBER> rapidly developed multiple research human ace<NUMBER> transgenic mice hace<NUMBER> tg aged <NUMBER> weeks <NUMBER> months age studied hace<NUMBER> expression observed lung heart kidney intestinal tissues following intranasal inoculation sarscov<NUMBER> weight loss observed viral rna detected lungs well intestine <NUMBER> gross pathology demonstrated swollen enlarged lungs moderate interstitial pneumonia histological studies documented accumulation inflammatory cells including monocytes lymphocytes alveolar interstitium thickening alveolar walls sarscov<NUMBER> protein detected ihc alveolar macrophages epithelia <NUMBER> nhp also infected sarscov<NUMBER> <NUMBER> rhesus macaques aged <NUMBER> years inoculated intratracheally although fever observed weight loss asthenia seen multiple days viral rna detected nasal throat swabs lesser degree anal specimens peaking days <NUMBER> <NUMBER> lasting day <NUMBER> post infection one animal euthanized day <NUMBER> necropsy viral rna detected multiple organs including cns skeletal muscle heart two surviving rhesus macaques positive neutralization titers documented day <NUMBER> post infection radiographic evidence multiple ground glass opacities lungs days <NUMBER> <NUMBER> <NUMBER> post infection microscopically lung lesions represented acute interstitial pneumonia characterized mild moderate thickening alveolar septum increased number macrophages degeneration pneumocytes inflammatory cell infiltration presence viral antigen confirmed predominately alveolar monocytes macrophages <NUMBER> analysis blood samples showed decline counts total white blood cells lymphocytes monocytes observed changes <NUMBER> percentages decrease cd<NUMBER>cd<NUMBER> cd<NUMBER> cd<NUMBER> tcell counts observed importantly hematological findings similar seen sarscov<NUMBER> infected patients model could serve critical tool detailed studies pathogenesis evaluation intervention strategies including vaccines note following meeting another group confirmed sarscov<NUMBER> infection rhesus macaques viral antigen detected type type ii pneumocytes diffuse pulmonary alveolar damage noted <NUMBER> experts agreed models others development utilized evaluate vaccine candidates evidence disease enhancement specified later sections design barney sarscov<NUMBER> protein structure solved shortly emergence shows similar structure mobility sarscov<NUMBER> <NUMBER> timing first knowledge sarscov<NUMBER> beginning phase <NUMBER> study remarkable sixtyfive days advantages mrna vaccines include ability create highly precise type protein elicit correct antibodies elicit cell responses th<NUMBER> predominant rapidity manufacturing course disadvantages include novel nature mrna dna vaccines without licensed vaccine either technology date lack experience mass production therefore multiple platforms sarscov<NUMBER> development mitigate potential disadvantages nucleic acid vaccines although mrna dna vaccines elicit cell responses without adjuvants adjuvants may important subunit whole cell inactivated vaccines increase immunogenicity drive immune response could limit risk disease enhancement multiple sarscov<NUMBER> vaccines development including vectored vaccines whole cell inactivated vaccines recombinant protein vaccines experts discussed choice adjuvants important efficacy safety platforms dr arnaud didierlaurent centre vaccinology university geneva presented background effects different adjuvants animal human immune responses several adjuvants used commercial vaccines clinical development <NUMBER> oilinwater emulsions mf<NUMBER> as<NUMBER> shown increase breadth antibody repertoire binding affinity affinity maturation compared unadjuvanted vaccines <NUMBER> <NUMBER> human studies influenza vaccines h<NUMBER>n<NUMBER> vaccine adjuvanted mf<NUMBER> squalenebased emulsion increased levels h<NUMBER>specific antibody subclasses igg<NUMBER> igg<NUMBER> binding fcγr<NUMBER> fcγr<NUMBER> compared alum adjuvanted vaccines demonstrates use adjuvant skew functionality profile antigenspecific antibodies potential activate different innate effectors based fcγr expression <NUMBER> use squalenebased emulsion vaccines influenza also shown increase cd<NUMBER> cell response frequencies crossreactivity even preexisting crossreactive antibodies present prior immunization adjuvants could activate naïve b cells promote adaptability memory b cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition antibodies adjuvants promote cellular responses human malaria challenge studies provided early evidence choice adjuvantscombined malaria antigen rtss critical achieving optimal protection highlighted importance cellular response <NUMBER> recently studies hepatitis b surface antigen hbs vaccine adjuvanted as<NUMBER> as<NUMBER> as<NUMBER> alum showed vaccines formulated as<NUMBER> as<NUMBER> induced highest antibody levels as<NUMBER> promoted best hbsspecific cd<NUMBER> cell response <NUMBER> differences associated magnitude initial inflammatory <NUMBER> response triggered different adjuvanted formulations <NUMBER> <NUMBER> interestingly although level cd<NUMBER> cell response lower alum group compared as<NUMBER> group adjuvants led similar memory subset profiles cytokine production profiles given unprecedented demand effective vaccine use adjuvants may critical subunit vaccines providing antigendose sparing increased immunogenicity breadth duration response potentially eliciting crossprotection new cov strains minimizing risk enhanced disease following presentations attendees participated discussion suggested consensus statements attendees asked comment draft statements available online comments reviewed discussed second day meeting resulted summary consensus statement follows • sarscov<NUMBER> low affinity murine ace<NUMBER> receptor murine models require use hace<NUMBER> transgenic mice preferably knockin approach preliminary data indicate possibility infecting hace<NUMBER> transgenic mice demonstration viral replication mild lung lesions mouse adaptation sarscov<NUMBER> done sarscov<NUMBER> likely required obtain virus causes severe disease mice models develop acute lung injury lethality mimic human condition important evaluating vaccine safety • previous studies sarscov<NUMBER> merscov indicated vaccines especially using whole inactivated virus could enhance disease induced mice challenged sarscov<NUMBER> merscov lung lesions highly inflammatory dominance eosinophil infiltration occurred animals despite <NUMBER> presence neutralizing antibody response reduced challenge virus replication lungs studies yet completed sarscov<NUMBER> • mice immunopathology considered consequence dominant th<NUMBER> type response vaccine antigens seen including adjuvants eg cpg vaccine vaccine formulations known drive immune responses towards th<NUMBER> timing challenge vaccination may critical would major interest explore outcome following challenge later timepoints antibodies significantly decaying • one aware potential confounding effect cellculture excipients vaccine challenge strain material known impurities fetal calf serum preclinical vaccine preparation may induce eosinophil influx mouse model challenge strain also contains excipients • models characterization immune response candidate vaccine eg igg isotypes th<NUMBER> markers may predictive value • small animal models infected sarscov<NUMBER> considered eg ferret hamster development small animal models severe disease also inform studies vaccineenhanced disease • passive transfer nhps human antibodies generated phase <NUMBER> trials followed viral challenge could considered assess risk disease enhancement • challenge immunized animals closely related heterologous cov strains may assess risk enhancement future outbreaks • case disease enhancement indepth studies animal models may give indications mechanism immunopathology inform human trial designers critical immunological risk markers monitored phase <NUMBER> trials • given unprecedented demand effective vaccine use adjuvants may critical subunit vaccines providing increased immunogenicity breadth response dose sparing duration response potentially crossprotection new cov strains possibly minimize risk enhanced disease preference given th<NUMBER>driving adjuvants established safety profile humans • understanding role crossreacting antibodies prior coronavirus infections may natural disease caused sarscov<NUMBER> influence risk enhanced disease following vaccination may inform vaccine design • data needed whether antibody waning could increase risk enhanced disease exposure virus long term opinion experts animal data support clinical development could address • postvaccination neutralizing antibody responses cell analysis demonstrate th<NUMBER> response • postvaccination challenge data nhps careful evaluation immunopathology quantitative virology animals • small animal data may also provide important supporting evidence safety hamster ferret mouse models likely available developers • possible immunopathology experiments positive control eg formalin inactivated alumadjuvanted sarscov<NUMBER> sarscov<NUMBER> vaccine mockimmunized negative control provide best guidance felt important establish broadly accepted endpoints scoring systems allow comparison various vaccine candidates working issue • vaccine constructs likely induce predominant th<NUMBER> response group felt animal studies considered entering human phase <NUMBER> trials one animal species including nhps possible noted absence th<NUMBER> response eliminate risk enhanced disease • since studies begun begin prescreen determine preimmunization serostatus participants although shall determined retrospectively appropriate baseline blood specimens obtained stored virus spreading rapidly specimens allow assessment <NUMBER> immune response seronegative seropositive persons likely vaccinated • level neutralizing antibodies determination relative ratio binding neutralizing antibodies important assess potential risk enhanced disease also detection initial priming includes cd<NUMBER> cells andor cd<NUMBER> th<NUMBER> biased response likely mitigate risk disease enhancement determination memory responses useful particularly sarscov<NUMBER> continues circulate • consideration given use postvaccination sera vaccinees could used antibody transfer studies animals look enhanced disease evidence crossprotection coronaviruses • monitoring enhanced disease immunized participants may require longer followup usual phase <NUMBER> trials need delay phase <NUMBER> trials • investigators call requested frequent updating preclinical evolving clinical data developed different academic industrial developers help decisionmaking various vaccine clinical trials creation central information hub encouraged purpose • participants call expressed need standardization protocols data collection forms critical assays including reagents biobanking samples initial clinical trials allow future reassay standards agreed enable comparison results across trials <NUMBER> • group experts considers demonstration disease enhancement candidate vaccine viral challenge animal models necessarily represent nogo signal deciding whether progress early trials clinical development covid<NUMBER> vaccine • continuous monitoring risk clinical trials epidemic context needed • observed effect discussed developers regulators ultimately define actual requirements clinical studies considerations document interpreted general scientific remarks based current knowledge inform research agenda could beneficial vaccines development considerations regulatory nature cannot sense replace need proper regulatory consultations requirements vaccines clinical trials vaccine developers therefore encouraged seek individual scientific advice regulatory authorities ongoing pandemic led search animal models faithfully recapitulating salient features human coronavirus disease covid<NUMBER> pathogenesis studies evaluation vaccines therapeutics <NUMBER> early reports indicated syrian hamsters whose ace<NUMBER> highly homologous human ortholog highly susceptible sarscov<NUMBER> infection <NUMBER> develop severe disease <NUMBER> <NUMBER> <NUMBER> administration cyclophosphamide cyp alkylating agent suppresses b cell function used develop severe disease model sarscov syrian hamsters <NUMBER> reasoned similar approach might allow development severe disease model sarscov<NUMBER> moreover clinical findings lymphopenia associated covid<NUMBER> <NUMBER> prominence severe cases <NUMBER> <NUMBER> suggested <NUMBER> immunosuppressed animal model covid<NUMBER> might accurately model aspects human disease used cyptreated rag<NUMBER> ko hamsters investigate transient disruption ablation adaptive immune response affects sarscov<NUMBER> infection addition used immunocompetent immunosuppressed hamster models evaluate whether preexposure virus previous infection neutralizing antibodies <NUMBER> sufficient limit prevent disease wildtype hamsters susceptible sarscov<NUMBER> infection develop weight loss approximately <NUMBER> <NUMBER> days postinfection dpi following <NUMBER> plaque forming units pfu <NUMBER> intranasal challenge dose <NUMBER> confirmed using <NUMBER> <NUMBER> pfu dose fig s<NUMBER>a maximum weight loss hamster plotted <NUMBER> <NUMBER> pfu challenge dose demonstrating high variability wildtype hamsters responses virus infection coefficients variation <NUMBER> <NUMBER> respectively fig s<NUMBER>b hamsters developed robust neutralizing antibody responses measured plaque <NUMBER> reduction neutralization test prnt<NUMBER> virus genome cleared <NUMBER> dpi measured pharyngeal swab real time rtpcr fig s<NUMBER>cd first experiment manipulating adaptive immune response immunosuppressed hamsters using cyp cyptx beginning <NUMBER> dpi suppression lymphocytes confirmed hematology analysis prior challenge fig <NUMBER>a day <NUMBER> groups <NUMBER> hamsters <NUMBER> exposed <NUMBER> <NUMBER> <NUMBER> pfu sarscov<NUMBER> intranasal route disease progression monitored weight loss fig <NUMBER>b detection viral rna pharyngeal swab using rtpcr fig <NUMBER>c weight loss remarkably similar sarscov<NUMBER> exposed groups regardless dose drastic weight loss beginning <NUMBER> dpi weight loss remained significant relative starting weight <NUMBER> dpi table s<NUMBER> contrast mock <NUMBER> pbs challenged hamsters treated cyp steadily gained weight exceptions fig s<NUMBER>c specifically one cage four mock challenged hamsters showed evidence weight loss <NUMBER> dpi fig s<NUMBER> animals mock challenged hamsters positive sarscov<NUMBER> pharyngeal swab rtpcr analysis starting <NUMBER> dpi fig <NUMBER>c fig s<NUMBER>c <NUMBER> sarscov<NUMBER> challenged hamsters detectable viral rna pharyngeal swabs first time point assayed <NUMBER> dpi remained consistent <NUMBER> <NUMBER> <NUMBER> <NUMBER> molecules n<NUMBER> per <NUMBER>ng rna duration cyp treatment fig <NUMBER>c last cyp treatment <NUMBER> dpi hamsters continued lose weight several hamsters began exhibit signs wasting disease ie cachexia extreme weight loss requiring euthanasia fig <NUMBER>bd approximately <NUMBER> days cessation cyp remaining hamsters started gaining weight viral rna levels pharyngeal swabs dropped <NUMBER> <NUMBER> molecules n per <NUMBER> ng rna fig <NUMBER>c viral rna detected lung tissue subset hamsters collected<NUMBER> dpi day euthanasia moribund animals <NUMBER> dpi euthanasia <NUMBER> dpi end study fig <NUMBER>e <NUMBER> statistically significant reduction lung viral burden comparing <NUMBER> dpi <NUMBER> dpi lung homogenates serum collected surviving hamsters <NUMBER> dpi assayed neutralizing antibodies fig <NUMBER>f six ten infected hamsters survived cyp immunosuppression experiment never developed detectable levels neutralizing antibodies interestingly four hamsters develop neutralizing antibodies cyp treatment <NUMBER> cessation rebounded rapidly measured weight gain fig s<NUMBER> together data indicate cyp treatment allowed persistent infection reversed animals cyp treatment stopped adaptive immune response allowed recover second experiment conducted determine <NUMBER>day interval cyp treatment might lead even dramatic weight loss <NUMBER>day interval last day cyp treatment <NUMBER> <NUMBER> dpi rather <NUMBER> dpi comparing weights ten hamsters treated cyp <NUMBER>day versus <NUMBER>day intervals revealed almost identical kinetics weight loss fig s<NUMBER>a cessation cyp treatment<NUMBER> dpi allowed rapid recovery weight loss cyp treatment <NUMBER>day intervals increased amount viral rna detected pharyngeal swab rtpcr approximately <NUMBER> order magnitude relative <NUMBER>day interval <NUMBER> <NUMBER> dpi fig <NUMBER> s<NUMBER>b apparent increase level virus result increased weight loss lethality based findings decided use <NUMBER> pfu intranasal dose cyp <NUMBER>day interval stopping <NUMBER> dpi future antibody passive transfer experiments rag<NUMBER> ko hamsters deficient recombination activation gene <NUMBER> produce functional b cells <NUMBER> whereas cyp treatment allowed transient partial immunosuppression rag<NUMBER> ko hamsters allowed us evaluate outcome sarscov<NUMBER> infection absence functional lymphocytes rag<NUMBER> ko hamsters exposed <NUMBER> pfu sarscov<NUMBER> intranasal route rag<NUMBER> ko hamsters showed significant weight loss starting <NUMBER> dpi fig <NUMBER>a <NUMBER> infection uniformly lethal median daytodeath <NUMBER> days p<NUMBER> logrank test fig <NUMBER>b viral rna detected pharyngeal swabs trended higher cyptreated hamsters statistically significant fig <NUMBER>c <NUMBER> pfu pbs mock groups cyp experiment shown fig <NUMBER> included fig <NUMBER>a c comparison organs rag<NUMBER> ko animals succumbed met euthanasia criteria <NUMBER> homogenized evaluated viral rna rtpcr viral rna present highest levels lung trachea lower levels viral rna also detected extrapulmonary organs including heart liver spleen intestine brain kidney fig <NUMBER>d fig <NUMBER> euthanized <NUMBER> dpi lungs nasal turbinates formalinfixed paraffin embedded evaluated histopathology situ hybridization ish fig <NUMBER> fig s<NUMBER> lung tissue necropsied animals demonstrated focally extensive areas consolidation pulmonary parenchyma admixed dense aggregates inflammatory cells fig <NUMBER>a bronchial lumina multifocally lined hyperplastic respiratory epithelium fig <NUMBER>b sarscov<NUMBER> genomic rna frequently detected alveolar pneumocytes alveolar infiltrates <NUMBER> bronchiolar epithelial cells ish fig <NUMBER>c <NUMBER> dpi immunocompetent hamsters infected sarscov<NUMBER> exhibited mild congestion inflammatory infiltration indicating recovery viral challenge <NUMBER> supporting hypothesis cyp administration disrupt adaptive immunity exacerbates prolongs disease hamsters lung tissue collected time death sarscov<NUMBER>infected rag<NUMBER> ko hamsters contain <NUMBER> areas hemorrhage inflammation expanding interstitium connective tissue surrounding bronchi arteries fig <NUMBER>d seen cyptreated hamsters bronchial lumina rag<NUMBER> ko hamsters lined multiple layers infected epithelial club cells containing infiltrates lymphocytes presumably nonfunctional heterophils macrophages fig <NUMBER>e gh hemorrhage within alveolar lumen consolidation septal <NUMBER> congestion also observed cyptreated hamsters sarscov<NUMBER> genomic rna viral antigen frequently detected alveolar pneumocytes fig <NUMBER>i alveolar infiltrates bronchiolar epithelial cells fig <NUMBER>f together data indicate absence functional b cells rag<NUMBER> ko hamsters allows increased pathology lethality sarscov<NUMBER> infection <NUMBER> electron microscopy studies performed lung sections sarscov<NUMBER> infected cyptreated hamsters varying lung viral loads fig <NUMBER> lungs lack typical morphology wherein distinct alveolar interalveolar septum capillaries type type ii pneumocytes clearly evident animal least viral load <NUMBER> <NUMBER> molecules n<NUMBER> per <NUMBER>ng rna sarscov<NUMBER> reported range diameter <NUMBER>nm surface spikes measuring approximately <NUMBER>nm <NUMBER> low high viral load samples show compartmentalized <NUMBER> vacuoles round viruslike structure vesicles irregular shaped structures resembling multivesicular bodies fig <NUMBER>jl electron dense vesicles suggestive mature virus particles whereas less electron dense particles likely immature virions addition cytoplasmic vacuoles tissue show swollen rough endoplasmic reticulum rer fig <NUMBER>l swollen rer appears result cellular stress andor increased viral protein synthesis <NUMBER> immunogold labeling necessary confirm presence virus particles tracheas sarscov<NUMBER> infected cyptreated hamsters varying lung viral loads analyzed electron microscopy tracheas also exhibit disruption epithelial layer trachea animal lowest lung viral load <NUMBER> <NUMBER> molecules n<NUMBER> per <NUMBER>ng rna showed mostly intact ciliated cells surface fig <NUMBER>a cells show nine previously infected immunocompetent hamsters two separate experiments retained rechallenge sarscov<NUMBER> goal determine prior infection elicited protective immunity ensure hamsters cleared infectious virus <NUMBER> initial challenge hamsters treated <NUMBER> doses cyp weights monitored <NUMBER> days fig <NUMBER>a animals persistently infected predicted hamsters would experience onset disease measured rapid weight loss positive pharyngeal swab rtpcr following cyp administration significant weight loss detected swabs negative viral rna fig <NUMBER>a nine animals positive neutralizing antibodies prior <NUMBER> rechallenge fig <NUMBER>b nine previously exposed hamsters seven naïve hamsters challenged <NUMBER> pfu sarscov<NUMBER> weights monitored daily pharyngeal swabs collected every day viral rna rtpcr control animals lost weight predicted whereas previously exposed animals protected significant weight loss pharyngeal swab rtpcr indicated statistically significant reduction viral rna detected <NUMBER> rechallenged animals compared naïve animals fig <NUMBER>c table s<NUMBER> addition viral load lung homogenates animals euthanized end study indicated statistically significant p<NUMBER> unpaired test reduction viral rna level rechallenged animals fig <NUMBER>d data indicate immunocompetent hamsters recovered prior exposure sarscov<NUMBER> result persistent infection instead elicits protective immunity <NUMBER> human monoclonal antibody mab targeting spike protein sarscov<NUMBER> evaluated passive transfer experiment using immunosuppressed hamster thirty mgkg centif<NUMBER> mab ic<NUMBER> <NUMBER> ngml prnt<NUMBER> control igg normal mab pbs <NUMBER> administered <NUMBER> dpi day <NUMBER> immunosuppressed animals challenged <NUMBER> pfu sarscov<NUMBER> neutralizing antibody levels sera time challenge measured prnt<NUMBER> fig <NUMBER>a detectable levels ranging <NUMBER> ≥<NUMBER> found centif<NUMBER> mab group disease progression monitored weight change fig <NUMBER>b pharyngeal swab rtpcr fig <NUMBER>c hamsters administered normal mab pbs exhibited significant weight loss <NUMBER> starting <NUMBER> dpi ultimately group weights drop <NUMBER> <NUMBER> respectively table s<NUMBER> hamsters treated centif<NUMBER> mab maintained <NUMBER> day <NUMBER> weight conclusion experiment <NUMBER> dpi table s<NUMBER> virus rna detected pharyngeal swabs groups trending lower centif<NUMBER> mabtreated animals day <NUMBER> p<NUMBER> unpaired test table s<NUMBER> similarly lung tissue collected <NUMBER> dpi end study indicate comparable levels <NUMBER> viral rna detected fig <NUMBER>d significantly reduced infectious virus centif<NUMBER> mabtreated animals p<NUMBER> unpaired test fig <NUMBER>e findings demonstrate sarscov<NUMBER> mab limit infection immunosuppressed animals postulated innate immune hyperactivity adaptive immune dysfunction result increased sarscov<NUMBER> dissemination drives severe disease <NUMBER> order develop small animal model severe disease evaluate role adaptive immunity replicate covid<NUMBER> lymphopenia observed human disease treated hamsters cyp immunosuppressed model observe drastic weight loss high levels virus lung viral persistence begin resolve cyp treatment stopped fig <NUMBER> histopathologic findings lungs cyptreated hamsters also demonstrate prolonged pathology ongoing repair hyperplastic changes bronchial epithelium type <NUMBER> ii pneumocytes observed sampled rag<NUMBER> ko hamsters data demonstrate critical role b cells play resolution disease describe animal model severe covid<NUMBER> disease used rigorous testing medical countermeasures recent development immune function ko hamsters combined syrian hamster <NUMBER> susceptibility sarscov<NUMBER> infection allows investigation role specific immune functions covid<NUMBER> pathogenesis protection thus far stat<NUMBER> ko hamsters used demonstrate type interferon plays role restricting viral dissemination promoting lung pathology sarscov<NUMBER> infected animals <NUMBER> herein found unexpectedly sarscov<NUMBER> challenge resulted uniform lethality rag<NUMBER> ko <NUMBER> hamsters interesting onset disease measured weight loss rapid <NUMBER> days rag<NUMBER> ko animals immunocompetent even transiently immunosuppressed hamsters receiving challenge dose indicates absence functional b cells andor cells exacerbates pathogenesis early stage within day two exposure virus importance cells viral clearance noted coronaviruses <NUMBER> sarscov <NUMBER> mers <NUMBER> fact depletion cd<NUMBER> cells correlates severity adverse outcomes <NUMBER> anecdotal accounts suggesting immunity generated initial sarscov<NUMBER> infection humans may protective subsequent infection recent studies using nonhuman primates indicated prior infection results protective immunity <NUMBER> <NUMBER> show immune response initial sarscov<NUMBER> infection including robust neutralizing antibody response protective rechallenge detected reduced levels viral genome pharyngeal swabs lungs however despite circulating neutralizing antibody available time challenge virus genome still detected seven days rechallenge viral genome pharyngeal swabs day <NUMBER> following rechallenge lung tissue day <NUMBER> <NUMBER> could indicate asymptomatic reinfection possible prolonged viral shedding observed human covid<NUMBER> cases detectable neutralizing antibody titers <NUMBER> alternatively genome detected swabs could input virus slowly cleared respiratory system currently convalescent plasma option treat severe cases covid<NUMBER> <NUMBER> another <NUMBER> antibodybased options include manufactured polyclonal mabs represent avenues prevent treat sarscov<NUMBER> infections standardized product several groups reported vitro characterization antisarscov<NUMBER> neutralizing mabs number antibodies shown protect small animal models including syrian hamsters <NUMBER> <NUMBER> pretreatment mab centif<NUMBER> resulted weight maintenance experiment <NUMBER> trending lower levels viral genome detected pharyngeal swabs lung tissues importantly reduced levels infectious virus detected lung lack reduced viral rna detected rtpcr passive transfer experiment f<NUMBER>mab treated animals highlights potential confounding factor determining efficacy mab treatment possible centif<NUMBER> mab able clear genomic rna able prevent shedding infectious virus addition determining infectious viral loads plaque assay rtpcr detect subgenomic rna indicative productive infection would help differentiate persistence input virus productive infection results expand earlier findings syrian hamster model suitable small animal model covid<NUMBER> <NUMBER> transient reversible immunosuppression using cyp <NUMBER> used increase severity duration disease state advantages cyp model wild type hamsters readily available would produce normal immune response vaccination one disadvantage disruption lymphocytes could confound evaluation therapeutics target components immune response vaccines require rapid mobilization adaptive response evaluation types medical countermeasures wild type hamster would preferred first report sarscov<NUMBER> lethal rag<NUMBER> ko hamsters practical purposes uniformly lethal models allow fewer numbers animals detect significant levels protection facilitating rapid screening candidate therapeutics rag<NUMBER> ko hamsters would suitable use active vaccine studies could used antibody passive transfer studies example passive transfer <NUMBER> immune serum nonhuman primate human vaccine studies could approach investigate mechanisms protection overall hamster sarscov<NUMBER> models severe diseases clinically relevant covid<NUMBER> patients provide platform evaluating candidate medical countermeasures combat pandemic dotted lines b c hamsters exposed increasing doses <NUMBER> sarscov<NUMBER> intranally day <NUMBER> b weights monitored <NUMBER> days statistical calculations table s<NUMBER> c viral genome rna copies per pharyngeal swab assayed indicated times postinfection hamsters monitored survival e lung tissue collected either time death scheduled euthanasia <NUMBER> <NUMBER> dpi assessed viral load f blood collected surviving hamsters <NUMBER> dpi assessed prnt groups <NUMBER> hamsters immunosuppressed cyp beginning <NUMBER> dpi indicated vertical lines b c passively transferred <NUMBER> mgkg centif<NUMBER> mab equivalent volume normal mab pbs <NUMBER> dpi exposed <NUMBER> pfu sarscov<NUMBER> <NUMBER> day <NUMBER> levels circulating neutralizing antibody day <NUMBER> serum assayed prnt disease progression monitored b weight c pharyngeal swabs lung tissue collected <NUMBER> dpi assayed viral rna e infectious virus highly pathogenic coronavirus cov infections wellestablished sources previous epidemics humans ie severe acute respiratory syndrome cov sarscov middle east respiratory syndrome cov merscov novel cov named sarscov<NUMBER> shares highly homological sequence sarscov responsible current covid<NUMBER> outbreak <NUMBER> million patients diagnosed <NUMBER> <NUMBER> deaths exceeds far total sars mers <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> <NUMBER> despite short duration current pandemic outbreak several neurological neuroradiological phenotypes reported <NUMBER> <NUMBER> requiring urgent investigation mechanisms etiology underlying interplay sarscov<NUMBER> central nervous system cns translational neuroscience approach mandatory explore possible cns involvement cov infections accelerate scientific knowledge transfer clinical frontline test new diseaseoriented treatments indeed clinical features previous cov epidemics sars mers lessons animal models used study sars mers constitute valuable tools understand viral pathogenesis host characterize mechanisms viral access dissemination cns meanwhile several laboratories rushing study sarscov<NUMBER> number different animals including primates mice rats hamsters ferrets <NUMBER> provide neurological perspective analysing main features models point relevant similarities specificities comparison sarscov<NUMBER> comprehensive systematic search medline scopus web science httpswwwwhointemerge nciesdiseasesnovelcoronavirus<NUMBER>situationreports performed <NUMBER> outbreak sars guangdong province china led discovery sarscov highly pathogenic cov causative pathogen epidemic <NUMBER> although virus primarily respiratory pathogen reports neurological manifestations epileptic seizures encephalitis may suggest cns involvement infection <NUMBER> <NUMBER> table <NUMBER> complementing reports postmortem neuropathological studies detected sarscov n protein rna polymerase gene fragment neurons infected patients pathological changes brain tissue edema vasculitis cerebral veins <NUMBER> compelling evidence demonstrates sarscov attaches cell membrane binding human angiotensinconverting enzyme <NUMBER> hace<NUMBER> also known sarscov<NUMBER> functional receptor <NUMBER> human tissue studies shown abundant presence receptors epithelia lung small intestine also arterial venous endothelial cells arterial smooth muscle cells organs studied including brain <NUMBER> based transgenic mouse expressing hace<NUMBER> possible show angiotensinconverting enzyme <NUMBER> ace<NUMBER> also expressed neuronal level namely cytoplasm cell bodies <NUMBER> distinctive properties structure mouse ace<NUMBER> compared hace<NUMBER> proteins significantly reduce virus tropism mouse tissues hence order overcome speciesrelated difference transgenic model generated vector carrying hace<NUMBER>coding sequence introduced wildtype mice control human cytokeratin <NUMBER> k<NUMBER> promoter <NUMBER> notably k<NUMBER>hace<NUMBER> transgenic mice infected sarscov infection would start respiratory epithelium rapidly spread alveoli importantly neuroinvasive routes later explored using model monitoring kinetic profile viral antigen <NUMBER> strikingly authors showed viral spread started olfactory bulb progressively invaded subcortical cortical regions transneuronal hypothesis could apply infected regions brainstem nuclei directly connected olfactory bulb authors raise possibility virus established brain might spread along specific neurotransmitter pathways via nonneuronal routes blood virchowrobin spaces <NUMBER> overall results showed model sarscov primarily entered brain via olfactory nerve alternatively authors theorize cov primarily use hematogenous route penetrate cns using dendritic white blood cells reservoirs <NUMBER> presumption based pathological studies shown monocytes macrophages infected sarscov <NUMBER> cellline studies revealed dendritic cells regulators immune responses infected impaired virus <NUMBER> table <NUMBER> multiple animal models explored context sars including nonhuman primates hamsters ferrets mice table <NUMBER> comprehensive descriptive review suitable models beyond scope review refer reader number excellent reviews <NUMBER> <NUMBER> <NUMBER> inferred single ideal animal model sars although evidence collected far significantly contributed advancing field particular well established models range virus replication observed young balbc b<NUMBER> mice replication accompanied minimal signs histopathology nonhuman primates ferrets hamsters <NUMBER> curiously old immunodeficient balbc mice exhibit clinical syndrome supporting age risk factor severe clinical phenotypes <NUMBER> transgenic k<NUMBER>hace<NUMBER> mice infected sarscov develop severe pulmonary phenotype starting respiratory epithelium rapid alveolar dysfunction <NUMBER> model massive infiltration macrophages lymphocytes lungs promoting release proinflammatory cytokines pulmonary level also brain relatively short time frame within <NUMBER> days k<NUMBER>hace<NUMBER> mice develop severe phenotype includes lethargiclike state suggesting cns involvement followup studies mouse strain k<NUMBER>hace<NUMBER> <NUMBER> authors demonstrated extensive involvement transgenic mouse brain sarscov produced widespread infection involving vital brainstem nuclei dorsal motor nucleus vagus nucleus tractus solitarii area postrema model also raised questions cause neuronal destruction death animals <NUMBER> pathological evidence inflammation authors considered possibility apoptosis cause neuronal death although confirmed terminal deoxynucleotidyl transferase tdt dutp nickend labeling tunelpositive cells detected proposed dysregulated cytokine response could cause death animals day <NUMBER> postinfection infected k<NUMBER>hace<NUMBER> mice upregulation proinflammatory cytokines interleukin il<NUMBER> tumor necrosis factor alpha il<NUMBER> authors also propose possible direct involvement dorsal vagal complex vital region brain plays important role orchestrating cardiorespiratory function fact animals intracranially inoculated lowdose virus exhibited limited viral spreading succumbed rapidly <NUMBER> overall data show relevance transgenic approach converting mouse response infection mild severe leading cns human neurons infectible <NUMBER> ace<NUMBER> neuronal expression identified human cns <NUMBER> capable infecting human neuronal cells invitro cell lines <NUMBER> ddp<NUMBER> low expression brain <NUMBER> neuropathology sars genome sequences detected brain autopsies also edema scattered red degeneration neurons <NUMBER> samples available investigation <NUMBER> <NUMBER> currently merscov still relevant threat populations middle east high lethality close <NUMBER> <NUMBER> patients exhibit predominantly pulmonary clinical involvement contrast fewer patients presenting neurological manifestations coma ataxia focal motor deficits peripheral nerve symptoms <NUMBER> <NUMBER> unfortunately published data regarding human neuropathological findings table <NUMBER> merscov exvivo models supported clinical tropism pulmonary tract showing virus replicate human lung cultures bronchial bronchiolar alveolar epithelial cells <NUMBER> cell line susceptibility study also revealed although presenting lower viral expression cytopathic effects mers infect human neuronal lines dipeptidyl peptidase<NUMBER> dpp<NUMBER> also known cd<NUMBER> identified functional receptor merscov dpp<NUMBER> generally expressed human bronchiolar epithelial cells bronchial lung tissue <NUMBER> also found intravascular portion vascular endothelial cells cerebrospinal fluid <NUMBER> identification dpp<NUMBER> functional receptor expressed airway epithelia rodents expected rodents would vulnerable infection turned wrong human binding domain differs rodents <NUMBER> limitation overcome developing mice expressing human dpp<NUMBER> exhibited high susceptibility infection displayed features human disease <NUMBER> including lethargic state showing high mortality extrapulmonary involvement table <NUMBER> authors detected severe lung infection brain invasion seen day <NUMBER> infection suggesting substantially different kinetics merscov infection lung brain <NUMBER> different animal model using human dpp<NUMBER> transgenic mice studied differences viral replication animals infected clinical aerosol transmission simulator compared intranasal instillationinoculated mice <NUMBER> found disease onset lung lesion viral replication progression slower merscov aerosolinfected mice merscov instillationinoculated mice furthermore aerosol infection detected high viral loads <NUMBER> days lungs versus <NUMBER> days brain although lungs brain infected timing different later infection brain <NUMBER> different kinetics could suggest hematogenous route infection indeed neuroinvasive routes explored either models addition similarly sarscov merscov shown replicate human dendritic cells macrophages would support hematogenous hypothesis <NUMBER> number models developed discussed detailed review articles <NUMBER> <NUMBER> table <NUMBER> nonhuman primate model mers de wit colleagues inoculated rhesus macaques merscov primarily affected epithelium lower respiratory tract giving rise mildtomoderate interstitial pneumonia <NUMBER> model able replicate virus shedding replication tissues well gene expression cytokine chemokine profiles however despite mild clinical syndrome neurological signs symptoms reported thus selflimiting nature merscov infection transient patterns various levels model suggests model fully resemble lethal infection observed humans <NUMBER> note macaques immunocompromised immunosuppressive agents merscov replicated significantly higher titers disseminated organs cns examined surprisingly histopathological alterations reduced immunosuppressed animals <NUMBER> together data suggest prominent role host response manifestation disease macaque model allowed testing number potential drugs novel therapeutics remdesivir antiviral agent used also covid<NUMBER> able preventtreat histological radiological signatures disease <NUMBER> studies using transgenic mice expressing human dpp<NUMBER> possible induce features human disease animals <NUMBER> studied cells pneumocytes brain microglia astrocytes neuronal cells presented high titers virus regard pathology whereas infected mice presented extensive pulmonary inflammatory infiltrate findings brain mild perivascular cuffing <NUMBER> however different study using human dpp<NUMBER> transgenic mice days appearance pulmonary lesions pathological changes documented brain dilatation congestion cerebral vessels areas cellular necrosis cerebral cortex hippocampus thalamus <NUMBER> sarscov<NUMBER> merscov infection also shown induce profound acute inflammatory response within lungs brain hcd<NUMBER> tg mice upregulation multiple genes related inflammatory response <NUMBER> clinical neuropathological features human patients covid<NUMBER> recent dramatic pandemic caused sarscov<NUMBER> registered lethality varies european countries ranging <NUMBER> germany <NUMBER> italy <NUMBER> sars mers pulmonary clinical involvement prominent however recently neurological phenotypes involving central peripheral nervous system emerged increasingly recognized ie anosmia ageusia necrohemorrhagic encephalitis guillainbarr e syndrome <NUMBER> <NUMBER> <NUMBER> far published human neuropathological findings table <NUMBER> sarscov<NUMBER> ultrastructure recently characterized highresolution cryoelectron microscopy <NUMBER> remarkably cov spike glycoprotein virus binds cell membrane binds ace<NUMBER> higher affinity compared sarscov addition available antibodies sarscov targeting acebinding domain unable bind sarscov<NUMBER> spike protein indicating binding sites differ sarscov sarscov<NUMBER> finding indicates urgent need generating specific antibodies sarscov<NUMBER> binding domain might also explain distinct pathogenic properties sarscov<NUMBER> <NUMBER> addition ace<NUMBER> receptor sarscov<NUMBER> uses serine protease type ii transmembrane serine protease tmprss<NUMBER> spike protein priming <NUMBER> <NUMBER> recently preliminary report brann et al took advantage bulk mouse whole olfactory mucosa wom rna sequence data derived macaque marmoset human found mouse human datasets olfactory sensory neurons express two key genes involved cov<NUMBER> entry ie ace<NUMBER> tmprss<NUMBER> <NUMBER> contrast olfactory epithelial support cells stem cells express genes cells nasal respiratory epithelium taken together findings suggest possible mechanisms cov<NUMBER> infection could lead anosmia forms olfactory dysfunction moreover findings may question olfactory bulb entry route covs cns <NUMBER> knowledge study evaluated far type pathway targeted cns peripheral structures clinical pathological lessons animal models several laboratories worldwide accelerating attempts develop suitable animal model covid<NUMBER> experimental infection sarscov<NUMBER> models provides basic information address number fundamental questions regarding pathogenicity interaction different hosts hopefully establishing criteria prevention care line observations sars models nonhuman primates wildtype mice infected sarscov<NUMBER> exhibit relatively mild clinical disease spite evidence quantitative reverse transcription polymerase chain reaction rtqpcr revealed massive infection respiratory tract <NUMBER> <NUMBER> table <NUMBER> rhesus macaques infected bronchoalveolar lavage fluid obtained affected patient developed histopathologically confirmed interstitial pneumonia associated widespread presence sarscov<NUMBER> respiratory tract clinical signs mild viral rna detectable means rtqpcr blood primates whole course infection <NUMBER> days <NUMBER> findings demonstrate causal relationship sarscov<NUMBER> interstitial pneumonia reminiscent covid<NUMBER> moreover consistent observations sars models bao et al <NUMBER> used hace<NUMBER> transgenic mice infected sarscov<NUMBER> inducing interstitial pneumonia typical histopathological elements accordingly viral antigens found airway epithelia lines experimental evidence relevant demonstrate causal relationship sarscov<NUMBER> pulmonary involvement unlike sars models nervous system involvement documented experiments however unclear brain tissue systematically assessed susceptible brain regions explored direct indirect viral presence overall pathogenicity sarscov<NUMBER> lower compared sarscov mice indeed discussed hace<NUMBER> transgenic mice infected sarscov exhibited widespread organ damage whereas sarscov<NUMBER> least model confined lungs indicating differential pathogenicity <NUMBER> studies reveal important commonalities sarscov<NUMBER> sarscov infection identify potential target antiviral intervention fact recently tmprss<NUMBER> inhibitor approved clinical use camostat mesylate tested blocked sarscov<NUMBER> entry lung cells <NUMBER> finally authors able show sera convalescent patients sars crossneutralized sars<NUMBER>spikedriven entry <NUMBER> effect occurred preclinical models would closer preventive diseaseoriented treatment • major routes cns infection spread via olfactory bulb andor ii synapseconnected route medullary cardiorespiratory center mechanoreceptors chemoreceptors lung lower respiratory airways andor iii hematogenic via brain endothelial ace<NUMBER> receptors • major pathogenic pathways cns involvement direct viral pathogenicity andor ii immunemediated pathogenicity targeting brain tissue iii inflammatory involvement brain blood vessels andor iv intravascular coagulation secondary systemic inflammatory response mayor cause thrombosis hemorrhage stroke • host individual susceptibility factors underlie variable severity disease human patients however relevant issue also represented gender clinical observation specific involvement males might suggest specific protective estrogenic effect unravelling points could clarify cns contributes respiratory failure patients covid<NUMBER> <NUMBER> <NUMBER> may provide rationale preventive therapeutic strategies major neurological events stroke encephalitis reported complications established exvivo animal models cov infection may help dissect pathogenicity infective routes nervous system targets covs manage mimic pathological hallmarks covid<NUMBER> may tools test treatment efficacy evaluate efficacy vaccines therapeutics among limitations following emerge primary importance • neurological subtle clinical phenotypes easily reproducible animal models • neurological severe phenotypes dependent using specific transgenic approaches enhance virulence limit direct translation humans • severity clinical features always parallel either viral replication level histopathological findings hinting indirect disease mechanisms inflammation prothrombotic states attained present models • innate animal characteristics seem influence viral infection kinetics leading faster virus clearance ongoing outbreak sarscov<NUMBER> confirms human covs primarily respiratory pathogens koch postulates already fulfilled regard <NUMBER> previous reports suggest sarscov merscov occasionally cause clinically relevant cns infections fact animal models suggest invasiveness viruses cns either via olfactory bulb blood dissemination infected activated monocytes passing permeable bloodbrain barrier consequence systemic inflammatory response regard pathogenesis immunemediated cns pathology data derive broadly mice infected murine hepatitis virus strains betacov genetically related human covoc<NUMBER> <NUMBER> briefly three mechanisms immunemediated cns lesions recognized excessive host response infection occur resulting systemic inflammatory response syndrome causes multiple organ dysfunction including cns main pathogenic mechanism case includes tissue dysoxia due intravascular coagulation dysfunction microcirculation homeostasis ii direct viral infection immune cells including macrophages microglia astrocytes cns may activate glial cells locally produce proinflammatory cytokines including il<NUMBER> tumor necrosis factor alpha il<NUMBER>b il<NUMBER> <NUMBER> moreover activated immune cells may contribute tissue damage producing toxic agents recruiting activating immune cells inducing apoptosis immunemediated events either tcells means cytokine chemokine pathways may also eventually lead demyelination iii autoimmune reaction generated adaptive immune response directed host epitopes proteins either misrecognized pathogendirected antibodies expressed damaged tissues previously cryptic adaptive immune system <NUMBER> <NUMBER> order speed clinically useful discoveries would desirable follow indications build systematic consecutive prospective registry including epidemiological data patients covid<NUMBER> attention neurological manifestation fully understand sarscov<NUMBER> infections cause cns involvement extent ii measure sarscov<NUMBER> rna cerebrospinal fluid symptomatic vs asymptomatic patients iii perform autoptic investigations patients covid<NUMBER> order find characterize virus distribution across tissues cerebral blood vessels endothelia glia neurons neuropathological consequences antibodybased neuroinflammatory responses gray white matter vasculitis neuroglial death apoptosis ischaemic hemorrhagic events taking account fact covs prone infecting neurons animal models well humans <NUMBER> <NUMBER> must keep open mind regarding mediumto longterm sequelae consequences acute infection therefore despite immunemediated control acute infection attained hostmediated immune regulatory mechanisms may fail clear virus potentially leading chronic infections hence impact chronic neurological diseases parkinsons disease multiple sclerosis <NUMBER> well acute disseminated encephalomyelitis <NUMBER> calls longterm patient followup clinics also exploring effect sarscov<NUMBER> mouse models neurodegenerative disorders anticipate occurrence chronic sarscov<NUMBER> cns infection emergence strain coronavirus sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> impact global health made imperative development effective safe vaccines lethal strain sarscov<NUMBER> adds list coronavirus diseases threatened global health along sars severe acute respiratory syndrome mers middle east respiratory syndrome coronaviruses emerged <NUMBER> <NUMBER> respectively april <NUMBER> vaccine commercially available coronavirus strains nevertheless knowledge obtained vaccine development efforts mers sars high value covid<NUMBER> coronavirus disease <NUMBER> review past ongoing vaccine development efforts clinically relevant coronavirus strains intention information helps development effective safe vaccines covid<NUMBER> addition information naturally exposed individuals animal models coronavirus strains described purpose helping development effective vaccines covid<NUMBER> vaccines sarscov<NUMBER> lessons coronavirus strains coronaviruses group viruses belong family coronaviridae <NUMBER> <NUMBER> enveloped viruses positivesense singlestranded rna genome nucleocapsid helical symmetry genome size relatively large rna viruses <NUMBER> <NUMBER> kb <NUMBER> coronaviruses infect mammals birds causing varied symptoms respiratory tract disease diarrhea humans coronavirus infections shown potentially lethal case severe acute respiratory syndrome sars middle east respiratory syndrome mers coronaviruses <NUMBER> world experienced would become first series lethal coronavirus infections disease denominated severe acute respiratory syndrome sars would characterized high fever eventually developing shortness breath pneumonia <NUMBER> originating southern china disease later would cause <NUMBER> cases resulting <NUMBER> deaths <NUMBER> countries <NUMBER> despite efforts scientific community vaccine became commercially available sars cases ceased reported <NUMBER> <NUMBER> september <NUMBER> world experienced emergence middle east respiratory syndrome mers coronavirus originated saudi arabia infectious disease characterized mild respiratory symptoms could develop acute respiratory distress syndrome death <NUMBER> disease affected <NUMBER> countries resulting <NUMBER> cases <NUMBER> deaths <NUMBER> mers cases still reported major outbreak declared since <NUMBER> <NUMBER> case sars commercial vaccine available mers reasons lack commercial effective vaccines sars mers varied case mers likely vaccine development delayed scarcity suitable costeffective small animal models preclinical experimentation addition probable vaccine delivered low interest investing vaccine disease produced relatively low geographically centralized cases compared global persistent infectious diseases influenza hiv tuberculosis last factor might also contributed lack vaccine sars sense considered pointless continue investing vaccine disease whose cases ceased reported <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> current pandemic caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first cases reported wuhan china december <NUMBER> <NUMBER> <NUMBER> according world health organization disease reported <NUMBER> countries territories april <NUMBER> <NUMBER> evidence ongoing local transmission <NUMBER> according organization <NUMBER> confirmed cases <NUMBER> deaths associated disease symptoms covid<NUMBER> mild include fever cough shortness breath nevertheless disease might progress severe pneumonia multiorgan failure predominantly elders people underlying diseases <NUMBER> <NUMBER> although vaccines commercially available sars mers past current vaccine development efforts diseases might high value development effective vaccine covid<NUMBER> present review aims describe efforts furthermore describe possible implications creating effective vaccine covid<NUMBER> taking starting point results obtained clinically relevant coronavirus strains focused review active immunization approaches offers possibility longerterm prevention diseases article based previously conducted studies contain studies human participants animals performed authors sars epidemic <NUMBER> several laboratories around world started conduct vaccine development studies preventing disease majority subunit vaccines vaccines based specific protein constituting virus <NUMBER> targeted spike glycoprotein virus sarscov uses glycoprotein bind enter host cells <NUMBER> therefore vaccine induces strong immune responses protein significant effect deterrence virus entry host cells natural infection vaccines based liveattenuated inactivated virus recombinant viral vectors dna viruslike particles vlps soluble proteins studied mainly preclinical studies liveattenuated inactivated viruses based use whole sarscov vaccine virus rendered nonreplicating infectivity greatly reduced means deleting components virus genome using physical chemical methods <NUMBER> case recombinant viral vectors viruses different sarscov capable host cell infection genetically engineered express components sarscov <NUMBER> vlps noninfectious multiprotein structures formed viral proteins selfassemble viruslike structures <NUMBER> table <NUMBER> summarizes vaccines outcome preclinical clinical studies knowledge vaccines based inactivated sars virus dna soluble proteins based sars glycoprotein reached clinical stage phase <NUMBER> <NUMBER> <NUMBER> desired field vaccine development know certain vaccine provide protection virus infection clinical signs usually performed exposing challenging vaccinated individuals animal models virus question due virulence sars coronavirus challenge studies humans performed therefore protective efficacy vaccines assessed several vaccines developed mers coronavirus since emergence <NUMBER> case sars vaccines subunit vaccines mers based glycoprotein vaccines based inactivated live attenuated viruses recombinant viral vectors nanoparticles conglomerate antigenic proteins nano size <NUMBER> dna soluble proteins developed tested predominantly animal models fig <NUMBER> table <NUMBER> knowledge dnabased vaccine already tested clinical trials phase <NUMBER> vaccines mva modified vaccinia virus ankara adenoviruses currently study clinical stage <NUMBER> <NUMBER> vaccines covid<NUMBER> preclinical development clinical stage completed recent emergence disease april <NUMBER> <NUMBER> several entities globe declared intentions develop vaccine covid<NUMBER> according <NUMBER> candidate vaccines developed covid<NUMBER> march <NUMBER> <NUMBER> <NUMBER> information nature vaccines development publicly scarce table <NUMBER> summarizes current development efforts information supplemented public sources march <NUMBER> <NUMBER> one vaccine started clinical trials phase vaccine developed moderna usa uses mrnabased vaccine expressing sarscov<NUMBER> glycoprotein <NUMBER> vaccine development efforts sars mers coronavirus help development effective vaccines covid<NUMBER> section aims describe important information obtained experiments explore areas opportunity development effective vaccines clinically relevant coronaviruses development effective vaccines sars mers slowed lack suitable animal models testing vaccines even though animal models develop immunologic responses sars mers coronaviruses animals show limited viral replication clinical manifestations disease fever cough runny nose shortness breath viremia pneumonia usually leading death <NUMBER> produced certain limitations evaluating protection conferred vaccines several studies addressed issue lack suitable animal model using transgenic animal models rendered animals permissive coronavirus infection means animal models allowed systemic virus replication analysis severe clinically relevant symptoms <NUMBER> glycoprotein divided two subunits s<NUMBER> s<NUMBER> subunit s<NUMBER> contains rbd subunit s<NUMBER> contains heptad repeat regions hr<NUMBER> hr<NUMBER> virus uses membrane fusion entry host cell glycoprotein class fusion protein exists trimer depicted dpp<NUMBER> dipeptidyl peptidase <NUMBER> s<NUMBER> s<NUMBER> subunit s<NUMBER> s<NUMBER> subunit rbd receptor binding domain tmd transmembrane domain vaccination case mers rhesus macaques allow virus replication seem develop severe clinical symptoms increased respiratory rate fever cough <NUMBER> <NUMBER> common marmosets shown display severe symptoms disease leading death <NUMBER> <NUMBER> information use active vaccination experiments scarce case sars virus shows varied lung pathologies limited clinical symptoms cynomolgus macaques african green monkeys <NUMBER> <NUMBER> symptomatology although limited allowed analyzing conferring protection vaccine candidates generally accepted neutralizing antibodies sars mers glycoproteins play predominant role protection coronaviruses <NUMBER> <NUMBER> neutralizing antibodies antibodies bind neutralize virus infection host cells <NUMBER> vaccinated animals passive immunization approaches focusing mers sars glycoproteins induced high titers neutralizing antibodies correlated protection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nevertheless still doubt whether adaptive cell responses another arm immune system also play role conferring protection studies addressing issue example group researchers demonstrated specific cd<NUMBER> cd<NUMBER> cell peptides sarscov could exploited provide protection mice <NUMBER> <NUMBER> <NUMBER> another study pointed protection sarscov mice induced dna vaccine due antibody responses depletion cd<NUMBER>cd<NUMBER> cells adoptive cell transfer effect protection <NUMBER> mers vaccination efficacy nonhuman primates correlated induction cd<NUMBER> cell responses addition neutralizing antibodies using dnabased vaccines <NUMBER> likely protection induced vaccination might dependent different factors selected vaccination platform antigens animal models routes vaccination animal experiments addressed question whether certain vaccination regimen could induce longterm protection case sars viral vectors proteinbased vaccines employing glycoprotein shown certain level protection infection least <NUMBER> mice <NUMBER> months vaccination <NUMBER> <NUMBER> <NUMBER> case mers proteinbased vaccines combination dna proteinbased vaccines shown induce certain level longterm protection mice macaques <NUMBER> <NUMBER> general studies focus induction persistent neutralizing antibodies vaccination contribution tcell responses frequently addressed exposure sars mers coronaviruses also shed light possible mechanisms protection humans rapid strong neutralizing antibody responses highly correlated severity disease recovery patient nevertheless cell responses might also play role elimination virus infection therefore also likely supporting recovery patient <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies induction arms immune response likely necessary effective elimination virus recovery disease vaccine development ideal vaccine provides longterm protection whether longterm protection achieved means vaccination exposure coronaviruses debate information needed regard sarscov memory cells b cells could detected <NUMBER> years infection human survivors <NUMBER> nevertheless certain level neutralizing antibodies tracked <NUMBER> months infection opening possibility certain level protection time frame due humoral response <NUMBER> case mers little known generation memory b cells neutralizing antibodies known persist <NUMBER> months <NUMBER> case memory cells cd<NUMBER> cd<NUMBER> cell responses detected <NUMBER> months infection <NUMBER> human coronaviruses offer clues induction longterm protection cases human coronaviruses hcov<NUMBER>e hcovoc<NUMBER> respiratory viruses cause longlived protection challenge experiments suggest even antibody responses detected long run <NUMBER> <NUMBER> studies safety vaccines sars mers relatively scarce concern induction antigendependent enhancement ade adverse effects derived vaccination natural reexposure ade phenomenon occurs nonneutralizing antibodies proteins virus enhance virus entry host cells also enhancing virus infectivity <NUMBER> ade already observed cats vaccinated speciesspecific coronavirus feline infectious peritonitis coronavirus <NUMBER> case sars antibodydependent enhancement adverse effects induced vaccination animal models raised concern found certain vaccine platforms expressing sars glycoprotein using whole inactivated virus induced lung immunopathology hepatitis challenge animal models <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore mers coronavirus vaccination shown induce pulmonary infiltration challenge mice using inactivated merscov vaccine <NUMBER> note sarscovinfected animal models protected merscov vice versa might develop adverse effects secondary infection <NUMBER> <NUMBER> studies concerning passive antibody transfer mice nonhuman primate experimentation found evidence ade pathologic effects <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> induction ade using glycoprotein tackled using truncated versions protein believed use receptorbinding domain rbd s<NUMBER> subunit glycoprotein lead induction neutralizing antibodies avoiding ade idea focus induction antibodies relevant regions efficient virus neutralization avoid induction potential nonneutralizing antibodies targeting regions protein even though seems little direct evidence proving idea vaccines based regions already tested allowing induction high titers neutralizing antibodies certain level protection small animals nonhuman primates <NUMBER> <NUMBER> <NUMBER> <NUMBER> use adjuvants also considered avoiding potential undesired effects coronavirus vaccination adjuvants substances potentiate modify immunogenicity protection efficacy vaccines <NUMBER> group researchers found using chemical adjuvant delta inulinbased polysaccharide lung immunopathology previously observed mice sars challenge experiments longer observed <NUMBER> hypothesized adjuvant helped avoid exacerbated th<NUMBER>polarized response challenge causative adverse effects case adjuvant enhanced vaccineinduced protection also helped minimize adverse effects due coronavirus vaccination experiments directly comparing vaccine platforms approaches coronaviruses scarce group scientists discovered certain dose dna mvabased vaccines encoding glycoprotein mers develop similar levels neutralizing antibodies <NUMBER> another study vaccines based heterologous primeboost vaccination dna followed proteinbased vaccination induced higher neutralizing antibody titers protection homologous primeboost vaccination approaches mice nonhuman primates <NUMBER> nevertheless different number immunizations performed using different subunits glycoprotein therefore difficult determine whether given vaccine platform would immunogenic protective others solely terms vaccine platform used information could potentially lead selection ideal vaccine platforms coronaviruses although inactivated viruses dna viral vectorbased vaccines tested sars mers coronavirus clinical trials vaccine platforms yet tested mrnabased vaccine relatively recent technology tested covid<NUMBER> phase clinical trials <NUMBER> companies starting clinical trials soon april <NUMBER> year publication <NUMBER> due relatively new emergence vaccine platforms performance coronavirus diseases still known different routes vaccination could also help development effective vaccines coronaviruses considering sars merscov respiratory viruses inducing memory responses respiratory tract would advantageous group researchers found inducing cellular antibody responses respiratory tract means intranasal vaccination might induce higher protection levels mice <NUMBER> <NUMBER> even though targeting spike glycoprotein vaccine development could ideal inducing neutralizing antibodies selection antigens might also offer advantages example nucleocapsid n protein conserved sars mers coronavirus strains <NUMBER> addition n protein induces longlived memory tcells humans <NUMBER> peptides derived protein shown induce crossprotection sars mers mouse experiments <NUMBER> therefore n protein could serve potentially viable alternative provide crossprotective longterm tcell immunity coronaviruses vaccine development efforts coronavirus strains sars mers help direct vaccine development efforts covid<NUMBER> development highly effective safe vaccines covid<NUMBER> consider aspects possibility ade adverse effects previously observed sars mers even though features seen animal models vaccination regimens possibility still considered covid<NUMBER> addition vaccine development efforts address possibility shortterm immunogenicity derived neutralizing antibodies also previously observed sars merscov natural infection possibility exploiting cell responses coronavirus vaccination also considered along b cell responses responses shown persistent protective animal models furthermore evidence longterm persistence humans strategies adjuvantation tailoring glycoprotein different routes vaccination use unexplored vaccine platforms enhancing immunogenicity preventing potential undesired effects also considered worth mentioning employing n protein coronavirus vaccination could several benefits previously mentioned potential providing longterm crossprotection employing antigen note evidence shortterm immunogenicity protection coronavirusexposed individuals mean effective vaccine possible vaccines eradicated diseases lack naturally acquired immunity prove point eg smallpox emergence covid<NUMBER> also serve elevating comprehension expertise abatement pathogenic microorganisms global health importance thank eduardo gorron university queensland australia providing useful comments writing present article funding funding sponsorship received study publication article authorship named authors meet international committee medical journal editors icmje criteria authorship article take responsibility integrity work whole given approval version published compliance ethics guidelines article based previously conducted studies contain studies human participants animals performed authors data availability data sharing applicable article datasets generated analyzed current study open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holderto view copy licence past <NUMBER> yr major contributions knowledge infectious processes immune responses dairy cattle troublesome exclusive mastitis given special attention elsewhere series anniversary manuscripts appear afflicting mucous membranes respiratory alimentary genital tracts many manifest similar signs illness differential diagnosis difficult many caused viruses therapeutic agents ineffective immunoglobulin always available site attack despite deficiencies unfolding knowledge molecular characteristics viruses immune systems clairified much mystery infectious diseases body responses invading microorganisms paper deals selected infectious diseases tested cutting edge scientific inquiry past quarter century arranged alphabetically avoid illusion one important another related diseases introduced within discussion major title omissions may concern readers may feel certain diseases overlooked included compiled querying colleagues united states requesting assign priority ratings diseases judged major importance represented regarded contemporary problems advanced incomplete knowledge past quarter century bluetongue virus emerged ubiquitous infectious agent major importance international commerce cattle industry commercial distribution bovine semen bluetongue noncontagious infectious viral disease ruminants especially sheep less extent goats cattle virus transmitted insect vectors particularly gnats culicoides genus sheep disease characterized fever emaciation oral lesions lameness substantial death rate heaviest losses lambs cattle infection usually nonclinical resulting persistent silent infection virusshedding carrier state occasionally cattle sicken however develop erosions mouth encrustations excoriations muzzle nasal discharge laminitis acute dermatitis patchy nature involving flanks groin perineum udder teats necrosis skin interdigital spaces observed signs occur number diseases socalled mucosal diseases differential diagnosis may difficult utero transmission occurs cattle result abortion hydranencephaly congenital malformations immunotolerant calves virus produce pathologic changes reproductive tracts bulls changes include focal degeneration seminiferous tubules inflammation hemorrhage colliculus seminalis relatively minor importance dairy cattle per se fear bluetongue infection causes restrictions international commerce suspected cattle may reservoir virus serving source infection sheep especially areas culicoides gnats abound <NUMBER> twenty serotypes bluetongue virus known addition cattle infected several closely related viruses including viruses epizootic hemorrhagic disease deer ibaraki disease agents cause similar disease wild ruminants resulting diagnostic difficulties ibaraki virus isolated first ibaraki prefecture japan blood <NUMBER>yrold cow bluetonguelike virus producing lesions cattle resemble bluetongue sheep virus little pathogenicity sheep antibody ibaraki virus commonly found cattle regions united states except northwestern states <NUMBER> appears antigenic relationship bluetongue virus ibaraki virus ibaraki virus two types epizootic hemorrhagic disease virus ehdv deer related serologicalty common complementfixing antigen shared two ehdv serotypes bluetongue virus serotypes <NUMBER> significance ibaraki virus disease cattle united states unknown judging ulcerative effects japanese cattle wide distribution antibody virus cattle united states concern must expressed last quarter century new chapter added study virusinduced lesions teats dairy cattle <NUMBER> martin et al <NUMBER> reported bovine ulcerative mammillitis caused herpesvirus <NUMBER> yedloutschnig et al <NUMBER> identified disease united states established recently disease global distribution disease known bovine ulcerative mammillitis well bovine herpes mammillitis manifested two forms milking herd one form name disease derived ulcerative lesions appear teats less frequently udders affected milking cows virus usually causes gross swelling teat wall within <NUMBER> h skin affected areas becomes soft sloughs revealing irregularly shaped painful deeply ulcerated area heals slowly healing accompanied formation brown scabs healing usually occurs within week skin lesions appear scabs begin shed <NUMBER> wk lymph gland swelling occurs mastitis follows approximately <NUMBER> cases causative herpesvirus probably transmitted mechanically milkers milking machines biting flies <NUMBER> form disease must differentiated paravaccinia pseudocowpox another affliction teats sometimes mouths calves slowhealing nonulcerative virus disease manifested vesicle formation second manifestation disease appearance multiple nodules skin known dermopathic bovine herpesvirus disease nodules appear pronounced circular raised areas skin entire body nodules deep undergo tissue destruction formation superficial scabs ultimately fall tufts hair cast desquamation leaving ulcerated lesions resemble lumpy skin disease severe poxvirus infection indigenous parts africa currently exotic united states past <NUMBER> yr group viral infections affecting mucous membranes bovine alimentary tract studied extensively gained prominent place among dairy cattle diseases debilitating effects necrosis ulcers erosions observed oral mucosa cattle differential diagnosis include bovine viral diarrheamucosal disease bvdmd malignant catarrhal fever papular stomatitis rinderpest bluetongue vesicular diseases ingestion caustic substances bovine viral diarrbeamucosal disease bovine viral diarrheamucosal disease described initially <NUMBER> <NUMBER> epizootic diarrhea cattle today known bvdmd virus togavirus causes multiple clinical pathologic manifestations <NUMBER> detection serum antibody much worlds cattle population suggests inapparent infection common natural infection serum antibody frequently persists lifetime animal classic clinical syndrome occurs sporadically characterized elevated temperature leukopenia diarrhea lacrimation nasal discharge erosions oral mucous membranes cases occur cattle aged <NUMBER> <NUMBER> mo many die survivors may develop chronic debilitating disease characterized weight loss intermittent diarrhea inefficient feed utilization erosions oral mucosa occasionally lameness occurs due laminitis necrotic interdigital dermatitis ulcerative coronitis epizootics bvdmd regarded respiratory disease nasal discharge cough rapid respirations prominent clinical signs <NUMBER> cattle infected pregnancy normal pregnancies however abortions malformed calves may seen even inciting infection mild inapparent bovine malignant catarrhal fever mcf resembles bvdmd crusting muzzle oral erosion necrosis occur usually differentiated severe panophthalmia corneal opacities prominent enlarged superficial lymph nodes stertorous labored breathing nervous behavioral changes characteristic mcf signs observed usually associated fatal encephalitis disease seems occur cattle contact sheep wild ruminants nature virus causing mcf africa known studies still underway determine cause disease north america papular stomatitis mild poxvirus infection usually occurring calves causes raised flat lesions oral mucosa lesions frequently contain characteristic streaks various shades brown irregular edges helps distinguish bvdmd mcf erosions rarely papular stomatitis lesions manifested punchedout depressions mucosa papular stomatitis infections usually inapparent lesions noticed oral mucosa examined occasionally however overwhelming infection manifested clinical signs rinderpest enzootic africa parts asia exotic united states acute devastating disease cattle ruminants ulcerative lesions identical bvdmd found except usually severe introduction rinderpest virus highly susceptible bovine populations heretofore rinderpestfree areas presumably result high clinical attack rates high case fatality rates rapid transmissibility animals herds disease problem likely devastatingly drastic enzootic bvdmd rinderpt always must considered diagnosing bvdmd variations virulence rinderpest strains known mild rinderpest strain easily misdiagnosed bvdmd permitting considerable dissemination virus disease diagnosed vesicular stomatitis virus causes vesicles oral mucous membranes teats coronary bands feet cattle indistinguishable lesions footandmouth disease vesicles rupture rapidly healing secondary bacterial invasion occurs lesions may resemble erosions bvdmd especially epithelial flaps sole remnants vesicles completely desquamated vesicular stomatitis virus probably insectborne disease enzootic southern united states occasionally however appears northern united states canada summer months continued studies needed understand epidemiological nuances disease especially since caused rhabdovirus rhabdoviruses frequently wide host spectra bovine bluetongue infection occasionally results clinical syndrome similar bvdmd necrosis oral mucosa crusting muzzle lameness clinical bovine bluetongue diffuse necrosis oral mucosa particularly dental pad serve differentiating feature contrasted usually discrete erosions bvdmd bluetongue occasionally manifested also drying cracking exfoliation skin pityriasis suggestive photosensitization finding rarely associated bvdmd <NUMBER> skin lesions occur bvdmd said resemble moist eczema diarrhea frequently feature bvdmd mcf rinderpest always consistent sign profuse intractable diarrhea cattle also seen salmonellosis johnes disease salmonellosis differentiated mucosal disease lack latters characteristic oral lesions isolation salmonella organisms feces tissues infected animals acute arsenic poisoning poisoning organophosphate insecticides also cause diarrhea must noted differential diagnosis epizootics bvdmd sometimes misdiagnosed one common respiratory diseases shipping fever infectious bovine rhinotracheitis ibr diagnosis usually based elevated rectal temperature nasal discharge increased respiratory rate cough socalled respiratory form bvdmd usually accompanied pneumonia however unless superimposed infection bvdmd manifested respiratory disorder careful examination oral mucosa gums tongue hard palate ill animals apparendy healthy herdmates sometimes reveals oral erosions oral erosions found catde leukopenia diagnosis bvdmd appropriate differential diagnosis nasal mucosa must examined closely evidence white fibrinous plaques found ibr strong immunologic relationship hog cholera virus agent causing bovine virus diarrhea studies instituted determine bvdmd virus could used immunize swine hog cholera immunity could induced unattenuated live bvdmd virus used however learned subsequently bvdmd virus occurs naturally swine herds great concern expressed infected swine virusshedders would serve sources infection susceptible cattle method vaccinating hogs cholera longer advised modifiedlive virus vaccine developed however available commercial firms vaccination cattle bvdmd <NUMBER> recognized bvdmd modified living vaccines quite effective relatively safe cattle field conditions reports indicating cattle vaccine may predisposing factor possibly primary cause severe reactions animals adverse reactions usually involve low morbidity high mortality clearly understood use vaccine pregnant cows illadvised virus cause abortions responsible congenital abnormalities <NUMBER> consideration reactions bvdmd vaccine recommended previous anticipated disease problems sufficient magnitude warrant risk past <NUMBER> yr became painfully obvious national trend toward larger dairy herds increases cattle density probabilities introducing brucellosis persistence brucellosis becoming greater trend also led higher prevalence areas indeed greater difficulty eliminating disease trend led recognition probability disease might eliminated conventional test slaughter methods new awareness reactivated interest brucellosis research renewed enthusiasm engendered scientific explorations disease serious public health economic importance cattle industries bovine brucellosis primarily disease sexually mature cattle inciting organism usually brucella abortus circulates systemically variable periods time invading body believed invasion commonly ingestion source infection usually discharges infected cow <NUMBER> however methods transmission reported including inhalation organism localizes multiplies reticuloendothelial tissues spleen lymph nodes predilection reproductive organs including udder uterus testicle epididymis seminal vesicles less frequently structures bones joints dramatic clinical manifestation brucellosis usually sign infection abortion resulting placentitis <NUMBER> brucella abortus intracellular parasite multiplies especially abundantly placenta high concentration erythritol placental lesions result fetal anoxia death usually last trimester pregnancy initial infections female localization udder supramammary lymph nodes common permanent sites parturition abortion vaginal excretion organism continued first <NUMBER> days diminished became intermittent <NUMBER> morphological features genus brucella remarkably consistent organism shows limited activity conventional biochemical tests used identification recognized however organisms identified members genus brucelta possess range properties clustered species biotypes clearly defined boundaries species exist cases convenience identification recommended strains classified species preferred natural host sensitivity brucella phages oxidative metabolic profiles <NUMBER> nearly brucellosis cattle caused ingestion subsequent infection one biotypes brucella abortus brucella endotoxins possess many structural biological properties common lipopolysaccharide endotoxins enterobacterial pathogens <NUMBER> initial reaction endotoxin shock sensitized vascular damage fever release histamine catecholamines intravascular clotting repeated insults endotoxin may result tolerance vascular damage <NUMBER> however exposure stimulates cellmediated immunity addition humoral antibody production histiocytic granulomas appear manifestations cellmediated immunity chronic brucellosis brucella agglutinins developed response endotoxin antigen crossreact salmonella pasteurella yersinia leptospira genera <NUMBER> complicating diagnosis evaluation brucellosis research committee serving national research council national academy sciences sanford elberg chairman six preeminent committee members stated aspects brucellosis unexplored epidemiology one views volumes literature amassed vaccination procedures serologic tests shedding organism pathogenesis appalling see limited number studies relating routes transmission relative importance various sources survival organism means transmission within herds characteristics highrisk herds management practices reduce transmission dynamics herd immunity danger accepting field observations truths well illustrated brucellosis history questions concerning role bull transmission etiologic agent <NUMBER> nicoletti <NUMBER> commented accepted widely sexually immature cattle quite resistant exposure b abortus susceptibility increases sexual development pregnancy calves may acquire infection utero ingestion contaminated milk small important percentage heifer calves infected early life negative serologic tests abort infected calf first pregnancy referred latent infections latent infections difficult diagnose early course disease may present serious problems elimination brucellosis cattle herds <NUMBER> brucellosis term incubation period usually implies period exposure infection time clinical serological evidence indicates infection occurred period varies considerably affected several factors gestation exposure dose age vaccination unknown hostresistant influences variable incubation period difficulties diagnosing infection transmission among serious technical problems unraveling epidemiologic patterns brucellosis <NUMBER> many years diagnosis based upon isolating organism infected tissues secretions employing agglutination tests serums cattle surveillance serious limitations found agglutination test often ineffective detecting chronic infections could influenced seriously vaccines antigens subsequently battery serologic methods developed including ring test card test rose bengal test complementfixation rivanol mercaptoethanol tests humorai antibody recently lymphocyte stimulation test evaluated evidence cellmediated immunity <NUMBER> varied sensitivity specificity among made obvious single test entirely reliable diagnosis brucellosis wisely selected combination highly effective strain <NUMBER> vaccine remains widely used immunogenic agent control bovine brucellosis five decades research strain proved change virulence immunogenicity <NUMBER> rarely causes permanent infection vaccinated cattle especially administered calfhood apparent pathogenicity human beings except injected reduced dose proposed nicoletti <NUMBER> administered subcutaneously enhanced practicability use vaccine regardless age cattle major progress understanding calf diarrhea resulted isolation characterization late <NUMBER>s reolike virus called rotavirus coronavirus early <NUMBER>s accomplishments resulted largely efforts mebus coworkers nebraska agricultural experiment station rotavirus recent years importance rotaviruses ubiquitous troublesome diarrheal diseases calves become well established bacterial diarrheal diseases rotaviruses propensity infect one species animal human bovine porcine equine strains possibly may produce diarrhea neonatal calves <NUMBER> although rotaviral infection may occur ages including adult cattle neonates disease often severe frequently fatal disease calves usually becomes apparent <NUMBER> days <NUMBER> wk birth likely disease heretofore known pneumoenteritis calves piglets primarily rotaviral disease pneumoenteritis diarrhea usually precedes pneumonia occurring <NUMBER> <NUMBER> days age calves total milk diet feces rotavirus infection usually brilliant yellow white color always putrid resemble classic milk scours calves however feces may watery brown gray light green tinged fresh blood mucus color appears dietary dependent diarrhea prolonged dehydration becomes apparent calf may die within <NUMBER> <NUMBER> days onset showing significant loss body weight severely ill calves recovered administration glucose saline mixtures substituted milk continued feeding milk harmful probably accounts severity epizootics calves maintained cowcalf operations inclement weather may complicate outbreak many calves developed severe pneumonia onset diarrhea especially exposed inclement weather severely affected animals may die <NUMBER> <NUMBER> wk later <NUMBER> pathogenesis rotavirus infection calves similar transmissible gastroenteritis pigs virus infects villous epithelium intestine immature enterocytes migrate crypts tip villus fail differentiate fully migration failure appears major factor produces ultimate electrolyte transport disorientation sodium ions resulting fluid electrolyte loss manifested diarrhea <NUMBER> resistance rotavirus disease appears mediated local immunity epithelial surface small intestine <NUMBER> unfortunately passive protection afforded colostrum limited value calves protected fed colostrum rotavirus antibody high content colostrum must fed continuously likelihood constant exposure virus <NUMBER> duration immunity known period persistence virus feces illness also unknown effectiveness cellmediated immunity apparently influence persistence virus shed feces likely immunity partial longlasting therefore adults become infected infected neonates since incidence disease extremely high since reinfection may occur likely disease perpetuated persistence virus within animal species also possibility interspecies infection may important transmission infectious agent control disease despite limitations cited feeding colostrum newborn calves extremely important colostrum must contain reasonably high antibodies rotavirus must fed every day crucial neonatal age period rotavirus infection threat effective attenuated bovinederived strain rotavirus used production vaccine vaccine currently given dayold calves although question efficacy new vaccine seems show effectiveness used herds serious rotavirus diarrheal problems <NUMBER> virus also isolated dairy calves neonataldiarrhea <NUMBER> coronavirus rotavirus affect absorptive epithelium gut cause similar clinical syndromes contribute significantly calf morbidity mortality viruses studied similar technologic methods combined commercially available modified live virus vaccine therefore frequently discussed together even though slightly different pathogenic mechanisms different virologic characteristics coronavirus infection cannot distinguished clinically causes diarrhea newborn calves laboratory diagnosis made finding virus feces immunofluorescent microscopy electron microscopy prevention coronavirusinduced diarrhea complex requires hygienic calving conditions assurance calf receives colostrum sanitary rearing practices specific diagnosis established use modified live virus pregnant cattle newborn calves may value two common bacterial enteric diseases young cattle especially calves marked severe diarrhea dehydration high death loss colibacillosis salmonellosis colibacillosis associated infection escbericbia coli ubiquitous organism found normally lower bowel warmblooded animals found abundantly carnivora omnivora sparsely horses cattle may may pathogenic pathogenic propensity regulated plasmidmediated determinants addition providing filamentous surface antigens organism facilitate adhesion epithelium intestine thence colonization proliferation cause organism produce path opotentiating diarrheainducing enterotoxin sometimes neurotoxin also vasotoxic produces enterotoxemic systemic disease <NUMBER> third toxin produced coliform bacteria rarely causing diarrhea endotoxin e coli endotoxin responsible systemic colibacillosis immunoglobulindeficient calves occurs even calves ingest absorb protective quantities colostral antibody <NUMBER> <NUMBER> although alimentary tract usually portal entry signs nonenterotoxemic systemic colibacillosis calves may may accompanied diarrhea alimentary tract injury important emphasize ordinarily endotoxin cause fluid loss intestine usually manifestations endotoxin injury associated hyperthermia lethargy complement activation neutrophil degranulation various toxic effects vascular system may culminate irreversible fatal shock signs include fever depression vomiting trembling edema increased respiration hemorrhage <NUMBER> vasotoxic neurotoxin elaborated varieties escbericbia coii produces enterotoxemic colibacillosis edema disease swine brain hemorrhages calves believed induced bloodvesseldamaging neurotoxin common troublesome toxins e coli enterotoxin disease induces enteropathic enterotoxic colibacillosis socalled white scours calf scours enterotoxic colibacillosis form colibacillosis truly enteric disease occurs young adults spared <NUMBER> calves exposed enteropathic enterotoxic e coli <NUMBER>st day life likely develop disease whereas exposed organism <NUMBER> days later may show signs illness gradient anterior small intestine highly sensitive enterotoxin posterior small intestine relatively resistant cholera man enterotoxininduced secretion small intestine calves takes place across intact unaltered mucosa except discharge gobletcell mucus enterotoxic colibacillosis produces profuse watery dehydrating diarrhea hyperperistalsis whiplashing gut biophysical directional alternation water electrolyte flow intestinal membranes baffling enterotoxic colibacillosis organism adheres villus crypt epithelium yet crypt epithelium contains numerous secretory granules responsible diarrhea believed enterotoxin mimics stimulates release villus hormones including prostaglandins regulate adenylcyclase intestinal secretory process secretion water electrolytes <NUMBER> secretion small intestine exceeds colonic absorption diarrhea occurs losses water sodium carbonate result dehydration metabolic acidosis hyperkalemia acidosis leads decreased intracellular potassium increased extracellular potassium effects cardiac arrhythmias myocardial failure immediate cause death cases death frequently occurs less <NUMBER> h acute form white scours calf shows weakness appears sleepy soon dies without signs usual form however calf shows severe diarrhea fecal material often full gas bubbles whitish color lack bile animals may die days protracted cases lameness may appear acute inflammation one joints joints capsule distended cloudy fluid myriads colon bacilli animals almost always eventually die <NUMBER> controlling calf scours essential emphasize colostrum good management prevent environmental stress equally important colostrum containing immunoglobulin interfere adherence colonization enterotoxic coliforms intestinal villi success vaccination cows prevent diarrheal disease calves appears depend upon preparation antigen vaccine stimulate formation appropriate multivalent anticapsular immunoglobulins antitoxin common enterotoxin immunogenic <NUMBER> morgan et al <NUMBER> vaccinated brood sows purified somatic pili clones piliation phase enterotoxigenic escbericbia coli protected neonatal suckling pigs diarrheal disease caused enterotoxigenic e coli strains possessed pili practicality vaccine diminished heterogeneity pathogenic strains unless ways devised produce polyvalent immunoglobulin genetic hapten linkage pilus immunogenic determinants accomplished pigs likely benefit calves foot rot remains troublesome enigmatic disease cattle although careful difficult research continues chip away elusive nature anaerobic fusobacteria produce copious amounts butyric acid bacteroides species produce copious volumes isovaleric isobutyric acids <NUMBER> isolated cases foot rot cattle studied extensively berg <NUMBER> others including thorley et al great britain <NUMBER> disease cattle frequently associated fusobacterium necropborurn also associated bacteroides melaninogenicus <NUMBER> bacteroides nodosus <NUMBER> organisms little capacity invade normal epithelium anaerobic conditions readily enter multiply tissues damaged injury infection caused organisms <NUMBER> species animals suffering foot rot liver abscesses associated f necropborurn pyogenic bacteria typical lesion necrosis putrid odor genesis lesion cattle understood completely thoroughly known sheep early lesions foot rot cattle similar sheep swelling moistness interdigital cleft sheep cattle inflammation sensitive laminae hoof occurs often underrunning sole important bacterium foot rot sheep bacteroides nodosus disease initiated penetration b nodusus epidermis damaged injury <NUMBER> accompanied followed invasion site f necropborum extends tissue damage creating new invasion sites b nodosus <NUMBER> perhaps genesis foot lesion cattle parallels foot rot sheep treponema penortba may pathopotentiator pusproducing bacteria like corynebacterium pyogenes secondary invaders operate synergy primary invaders produce tissue destruction sometimes abscess formation f necropborurn facilitates establishment growth c pyogenes tissues phagocyteinhibiting leucocytedestroying action exotoxin <NUMBER> c pyogenes produces macromolecular substance stimulates growth invasiveness f necropborurn particularly removing oxygen tissue site microbial attack whether liberation exotoxin activated phage species corynebacteria currently unknown <NUMBER> attempts vaccinate animals formolized bacterial cell preparations culture filtrates f necropborum successful although appears animals develop antibody age exposed organism <NUMBER> clear antibody protective disease however prophylactic agents like broadspectrum antibiotics effective preventing f necropborumassociated liver abscesses cattle agents may potential preventing treating bovine infectious pododermatitis twenty five years ago disease newly described <NUMBER> <NUMBER> intervening period elaboration many fcets infectious bovine rhinotracheitis resolved many perplexing questions infectious bovine rhinotracheitis ibr name given respiratory form herpesvirus infection also sometimes manifested genital syndrome called infectious pustular vulvovaginitis ipv coital exanthema close confinement feedlot cattle cattle large dairy herds provides favorable conditions rapid transmission virus <NUMBER> sometimes disease appears simply granular conjunctivitis occasionally meningoencephalitis especially calves <NUMBER> mo age frequently infection manifested solely abortions abortion sequel either respiratory infection ibr virus injection modified live ibr vaccine abortion usually sequel ipv ibr virus like herpesviruses may latent therefore shed intermittently infected animals long periods following recovery clinical disease latent infection activated use corticosteroids studies reported sheffy rodman <NUMBER> <NUMBER> respiratory form ibr infection probably significant economically important form disease feedlots dairy cattle abortion may costly outbreak may mild numerous subclinical cases may fulminating unusual find cattle infected herd appear bright yet markedly elevated body temperature <NUMBER> may noticeable decrease feed consumption signs upper respiratory infection affected animals exhibit rapid rhythmic sometimes dyspneic breathing inappetence elevated temperature coughing nasal discharge foamy salivation catarrhal conjunctivitis loss weight course disease usually runs <NUMBER> <NUMBER> days muzzle nasal mucosa become inflammed giving rise term red nose occasionally respiratory signs evident conjunctivitis ocular discharges initially clear later infrequently become mucopurulent sometimes centripetally originating corneal opacities may appear principal manifestations infection infection may misdiagnosed pinkeye high percentage cattle classic pinkeye caused virus moraxella boris bacterium corneal opacities originating center cornea spreading centrifugally diagnosis ibrassociated conjunctivitis considered opacities herd appear originate corneoscleral junction <NUMBER> another disease wherein corneal opacities occur frequently originate corneoscleral junction malignant catarrhal fever mcf disease associated dyspnea due profuse accumulation tenacious mucopurulent exudate nasal passages extent trachea bronchi partial blockage airways may result forced openmouthed breathing seen ibr mcf white pustules frequently appear coalesce respiratory ocular reproductive tract mucous membranes lesions appear loci sufficiently distinctive ibr suggest disease question fact ibr nasal passages however similar lesions may occur mcf following natural ibr virus infection vaccination modified live virus <NUMBER>br vaccines cellmediated humoral components immune system activated humoral response usually measured serum neutralization tests served traditionally indicator prior infection indirect measure resistance evidence suggests crucial role resistance recovery early ibr involves locally deployed elements cellmediated immune system thus detection neutralizing antibody serum probably accurate indicator immunity may used methods measuring cellmediated immunity ibr come common use <NUMBER> ibr controlled maintaining protective antibody herd reducing number susceptible animals minimum accomplished helping cattle acquire passive active immunity early age calf receives ibr antibody cotostrum within first <NUMBER> h birth quantity calf receives depends upon dams serum antibody amount colostrum ingested dam transfers ibr antibody offspring comparable serum workers suggest maintaining protective antibody titer brood stock accomplished booster vaccinations <NUMBER> <NUMBER> wk prior breeding vaccinating last trimester pregnancy vaccines approved pregnant cattle colostral antibody may persist long <NUMBER> mo may prevent antibody response vaccine given period therefore calves vaccinated <NUMBER> mo age revaccinated age vaccination may provide immunity longer <NUMBER> yr <NUMBER> additional protective measure additions herd isolated observed carefully signs illness every day <NUMBER> days today live modified combined vaccines ibr bovine virus diarrheamucosal disease parainfluenza<NUMBER> available compatibly effective administered <NUMBER> <NUMBER> mo age calves colostrum immediately birth earlier calves deprived colostrum first ibr vaccines modified live virus products developed used intramuscularly disadvantage causing abortion <NUMBER> intranasaladministered modified livevirus ibr vaccine introduced gained widespread acceptance unlike vaccines intramuscular injection intranasal vaccines usually safe use pregnant cattle among advantages ascribed intranasal vaccines rapid protection attributed interferon production rapid induction secretory antibody mucosal surfaces <NUMBER> intranasal vaccines believed induce production humoral antibody titers comparable intramuscular vaccines intranasal vaccine administered cattle ages applied use intramuscular vaccine suggested intranasaladministered vaccine may override low colostrumacquired maternal immunity resulting successful vaccination calves colostrumacquired antibody calves less <NUMBER> mo old vaccinated booster doses recommended animals retained longterm purposes especially breeding animals inactivated ibr vaccine available time time combination bacterin containing organisms pasteurella genus inactivated myxovirus parainfluenza<NUMBER> latter two agents associated shipping fever complex controversy regarding efficacy inactivated vaccine respiratory illnesses however case many inactivated vaccines initial vaccination procedure repeated annual booster doses recommended advantages inactivated vaccine eliminates risk postvaccination abortion associated livevirus vaccine avoids unfavorable postvaccination reactions except anaphylaxis also inactivated vaccine shedding vaccine virus seeding populations otherwise exposed addition eliminates concern vaccine virus may establish latent infection could reactivated later date although research ibr continues past quarter century seen emerge undescribed disease well understood well controlled infection johnes disease chronic granulomatous enteritis ruminants caused acidfast bacterium mycobacteriurn paratuberculosis johne frothingham first described disease <NUMBER> germany <NUMBER> cited unusual case tuberculosis cow wherein found acidfast bacteria thought either avian bovine tubercle bacilli <NUMBER> <NUMBER> bang denmark recognized infection distinct tuberculosis suggested named bovine pseudotuberculosis paratuberculosis <NUMBER> paratuberculosis recognized united states <NUMBER> yr concern expressed increasing incidence disease characterized progressive emaciation cattle recurrent diarrhea thickening corrugation convolution mucosa distal end small intestine granulomatous enteritis occurs expressed infectiondamaged malfunctioning short clubshaped intestinal villi assume wartlike configurations diagnosis extremely difficult variety reasons clinical disease usually occurs small number infected animals infected animals shed organisms inapparent silent carriers showing evidence disease fecal culture isolation techniques recover organism require <NUMBER> <NUMBER> mo completion organism grows extremely slowly laboratory media techniques detect small number infected animals heretofore immunologic tests including complementfixation test agar gel immunodiffusion test used prior development lymphocyte transformation test employs phytohemagglutinin mitogen purified protein derivative organism antigen lacked specificity sensitivity <NUMBER> difficuh diagnosis compounded fact humoral cellmediated immunologic status infected animals varies stage disease however availability assessment lymphocyte transformation test described buergelt <NUMBER> offers encouraging potential diagnosis ultimate eradication troublesome disease test provides vitro evaluation cellmediated immunity offers fairly sensitive method assess extent disease populations cattle surveillance complicate diagnosis close antigenic crossreactivity mycobacteriurn aviurn cause avian tuberculosis mycobacteriurn paratuberculosis however two infections may differentiated lymphocyte transformation test provided appropriate purified proteinderivative antigens agents used parallel given serum specimen <NUMBER> paradoxically even hopefully effective lymphocyte transformation test humoral mitogensuppressor substance found serum fractions containing immunoglobulins lggl igg<NUMBER> notwithstanding difficulties serologic interpretations lymphocyte transformation test shows promise useful diagnosis subclinical clinical cases johnes disease may provide overall impression extent exposure paratuberculosis within herd nonruminant hosts may serve reservoirs organism may shed infect cattle <NUMBER> although johnes disease historically considered disease involves lower end small intestine ileocaecal valve adjacent lymph nodes organism isolated also liver blood udder uterus ovaries milk urine feces fetus therefore evidence disease transmitted fecal contamination also milk transplacental infection fetus <NUMBER> typical clinical case johnes disease characterized intermittent continuous chronic diarrhea young animals especially <NUMBER> <NUMBER>yrold lactating females disease often occurs early part first second lactation feces soft watery passed without straining diarrhea may decrease severity late pregnancy reappear severely parturition valuable highproducing animals may affected suddenly milk production decreases haircoat may become rough loss hair occurs appetite remains good fever usually one two animals show evidence disease herd time initial observation course weeks months unresponsiveness treatment disease terminates death animals showing severe dehydration emaciation weakness decreased absorption amino acids associated increased protein leakage results negative nitrogen balance clinical manifestations wasting disease although paratuberculosis cultured pharyngeal lymph nodes tonsils bronchial lymph nodes spleen lungs kidney reproductive tract mammary gland placenta gross microscopic lesions usually absent organs lymphatic hematogenic spread thoracic portal venous circulation respectively begins early disease process however organisms seem multiply extent give rise distinct lesions except intestine adjacent lymph nodes spread assumed occur passively way circulating macrophages liver bacterialaden macrophages may become trapped sinusoids conjunction lymphocytes possibly antibody may give rise multiple small granulomas <NUMBER> merkal <NUMBER> introduced recent immunologic concepts understanding pathogenesis johnes disease postulated antigenantibody reaction infected intestine causes release histamine immediatetype hypersensitivity reaction resulting mediation diarrhea delayed hypersensitivity also phenomenon disease involving specific antigens organisms specifically sensitized lympbocytes causes release cytotoxins pyrogens mediate emaciation anemia attention called early literature similarity leprosy paratuberculosis <NUMBER> diseases caused acidfast organisms difficult culture characterized long slow growth periods organisms culture granulomatous inflammatory response diseases similar despite involvement different organ systems microscopic lesions dominated epithelioid langhans giant cells advanced leprosy typical inflammatory cells termed leprosy cells enlarged maerophages vacuolated frothy cytoplasma resulting accumulation lipid substances bacillary debris although cells identified clearly johnes disease vacuolation cytoplasm lipid degeneration epithelioid cells noticed <NUMBER> clumping distortion dissolution bacilli within cells adjacent draining lymph nodes large areas lymphoid cells within paracortical zone replaced granulomatous inflammatory infiltrates diseases <NUMBER> similarity histopathologic findings leprosy paratuberculosis attracted pathologists studying paratuberculosis adaptation ridley joplings morphologic classification leprosy paratuberculosis hence inclination among pathologists refer johnes disease cellular morphologic grounds bovine leprosy <NUMBER> vaccination cattle heatkilled live attenuated organisms used claims success france england vaccination practiced one dose <NUMBER>wkold calf recommended <NUMBER> generally agreed vaccine confer absolute immunity animals vaccinated live attenuated cultures excreted organisms major problem using vaccines nature jobnes disease addition questionable reliability vaccinated animals become sensitized react mammalian tuberculin tested tuberculosis immunologic significance antibody johnes disease relationship infectious agent remain unsolved doubts raised protective nature antibody chronic progressive infectious diseases diseases thought antibody may protect etiologic agent rather host <NUMBER> evidence antibody abrogates effective cellular immunity actually enhances dissemination lesions chronic infectious diseases mechanism enhancement disease antibody suspect disease normally controlled cellular immunity suddenly undergoes rapid dissemination lesions seen classically miliary tuberculosis <NUMBER> one must examine question critically johnes disease occur clinical cases johnes disease resulting diarrhea emaciation death distinguished infected animals show inapparent infection value vaccination needs critical reevaluation evaluation however one must sensitive experience vaccines similar modes example appearance miliary tuberculosis young children rare bcg vaccination <NUMBER> bcg strain originally virulent boris attenuated calmette guerin serial passage inhibitory media assumed effectiveness vaccine dependent upon development humoral antibody due lack adequate effective vaccines effective drugs treatment control johnes disease infected herds achieved best strongly enforced management procedures include prompt isolation culling infected animals offspring determined serologic <NUMBER> culturing <NUMBER> methods segregating calfrearing quarters good hygienic procedures past quartercentury brought remarkable progress understanding bovine malignant lymphoma particulary identification virus cause tumors cattle progressive ultimately fatal disease cattle also known bovine lymphosarcoma bovine lymphomatosis bovine leukosis clinically apparent cases manifested enlargement lymph glands glandular enlargements malignant lymphoma cattle may preceded hematologic change usually persistent lymphocytosis many european workers believe cattle may develop hematologic changes without tumor formation <NUMBER> cattle herds afflicted disease show enlarged firm superficial lymph nodes generally disease animals progresses rapidly emaciation develops death usually occurs animals show signs illness sporadic cases appear calves endemics appear adults incidence highest animals <NUMBER> <NUMBER> yr age calves <NUMBER> mo age showing sporadic form usually present generalized enlargement lymph nodes nodular diffuse lesions spleen liver kidneys bone marrow called neonatal multicentric form animals <NUMBER> mo <NUMBER> yr age may show enlargement limited groups lymph nodes usually involvement thymus gland also age group skin may show multiple tumors referred thymic skin forms respectively conditions appear unrelated bovine leukemia virus <NUMBER> animals <NUMBER> yr age multicentric form malignant lymphoma usually observed sometimes eyeball may protrude tumor formation orbit chronic bloating occurs enlargement thoracic nodes interfere normal eructation abomasal lesions may lead digestive disturbances abomasal ulceration lameness paralysis may occur pressure parts spinal cord peripheral nerves tumors lymphocytic infiltration internal organs may seen cases pronounced increase number circulating lymphocytes hence term lymphocytosis leukemia <NUMBER> evidence blymphocytes target cells bovine leukemia virus blv infection bcells lymphocytes immunoglobulinproducing plasma ceils derived also clear agent ctype virus oncogenic rna virus subfamily oncornavirus ctype particles budding forms cell membranes also observed free particles intercellular spaces particles central nucleoids designated ctype btype particles way contrast acentric nucleoids laboratory diagnosis phytomitogen used buffy coat cultures leucocytes cattle persistent lymphocytosis lymphosarcoma enhance appearance ctype particles cell cultures technique ctype particles heretofore demonstrated cattle persistent lymphocytosis lymphosarcoma also found normal cattle <NUMBER> perhaps indicates inapparent silent infection absence antibody skew epidemiologic evidence distribution infection national cattle population nonetheless united states evidence disease becoming prevalent high low incidence areas <NUMBER> evidence emerging blv responsible producing several forms natural disease <NUMBER> bovine lymphosarcomas associated blv seroepidemi<NUMBER>ogic evidence indicates virus cattle transmitted horizontally contact well vertically also transmitted similarly experiments sheep goats <NUMBER> <NUMBER> blv replicates monolayers bovine embryonic spleen cells fetal lamb spleen human diploid embryonic cells production syncytia <NUMBER> observation fact blv produce lymphomatosis inoculated variety species ie sheep goats subhuman primates <NUMBER> <NUMBER> finding blv cows milk <NUMBER> prompted careful studies human risk exposure blv seroepidemiologic study conducted donham et al <NUMBER> attempt identify antibody bovine leukemia virus people exposed cattle lymphosarcoma farm families farm employees veterinarians contact dairy herds documented cases lymphosarcoma tested precipitating antibody blv using agargel immunodiffusion test cattle also tested serologic procedures information collected farm families regarding consumption unpasteurized milk dairy herds twentyone dairy herds documented cases lymphosarcoma identified total <NUMBER> cows herds bled <NUMBER> showed positive serologic tests positive serums found <NUMBER> dairy farmers family members farm employees associated herds lymphosarcoma consumption raw milk reported <NUMBER> farm group addition <NUMBER> veterinarians <NUMBER> leukemia patients <NUMBER> control human serums tested found negative antibody blv <NUMBER> although <NUMBER> farm people group consumed raw milk showed seropositive evidence infection still advisable people drink pasteurized milk inasmuch demonstrated flash pasteurization inactivates virus milk <NUMBER> special attention called studies <NUMBER> neonatal chimpanzees removed mothers birth nursed separately fed either unpasteurized blvcontaining milk prepared infant formula hematologic changes noted days <NUMBER> <NUMBER> two animals fed blvcontaining milk animals died <NUMBER> <NUMBER> wk respectively bone marrow peripheral blood autopsy findings animals indistinguishable leukemia consistent diguglielmo syndrome erythroleukemia <NUMBER> however neither bovine lymphosarcoma virus blv antibody animals whether disease developed direct result blv ingestion remains moot question since none chimpanzees developed illness antibody <NUMBER> symposium bovine leukosis sponsored united states department agriculture may <NUMBER> glyn g caldwell reported results public health serologic studies concluded adequate serologic tests sensitive specific failed demonstrate infection humans despite close contact rawmilk ingestion blvinfected herds consequently blv appear represent public health hazard humans <NUMBER> studies needed understand fully epidemiologic patterns blv details association variety lymphoid tumors affecting dairy cattle unlike emerging enteric viral diseases satmonellosis plagued dairymen years past <NUMBER> yr however brought considerable understanding ubiquitous enterobacterial disease diarrhea severe dehydration prostration death characterize salmonellosis young cattle especially calves nevertheless established young animals herd adult animals tend become infected appears commonly today <NUMBER> yr ago <NUMBER> time restricted primarily young animals <NUMBER> salmonellosis usually enteric disease sometimes though becomes systemic involving organs tissues intestine especially joints clinical cases calves due salmonella typbimuriurn west rocky mountains however cases calves adults due salmonella dublin <NUMBER> cattle contract dublin infection continue recovery excrete bacteria feces many years <NUMBER> <NUMBER> remain shedders lifetimes organism colonizes gall bladder liver contrast ubiquitous typbimurium infection cattle indistinguishable clinically dublin disease recovered cattle remain carriers shedders month two typbimurium colonize gall bladder liver mammalian species except perhaps rodents notwithstanding facts possible eliminate one infections herd virtually impossible eliminate elimination hostadapted dublin accomplished identifying discarding reservoir carrier animals culturing fecal specimens cannot done nonhostadapted typbimurium infection ubiquitous distribution bacterium among many animal species contaminate farm environment although outbreaks typbimurium infection cattle may originate cattle usually opportunities crossinfection species livestock especially swine wild rodents poultry however great britain specific phage types clones peculiar cattle alone <NUMBER> eliminated herd emphasizes importance phagetyping isolates salmonellae dairy herds <NUMBER> detection salmonellae calf shipped one locality another necessarily indicate infection origin calves showing clinical evidence salmonellosis often come clean source hut apparently encountered organism first time transit acute salmonellosis adult cattle means common calves occasionally troublesome <NUMBER> abortion common feature adult infection <NUMBER> diarrhea dehydration adult usually severe occur colonization latter part small intestine colon necessary first step pathogenesis enteric salmonellosis normal intestinal flora may block access attachment sites mucosal cells needed salmonellas also indigenous fusiform bacteria lie mucous layer coating epithelium large intestine normally inhibit growth salmonellas producing volatile organic acids toxic salmonella organisms <NUMBER> factors antibiotic therapy diet water deprivation disrupt normal colonic flora otherwise stress cattle greatly increase hosts susceptibility enteric septicemic salmonellosis <NUMBER> clinical salmonellosis must regarded multifactorial cause invading intestinal epithelial cells salmonellas cause net secretion water electrolytes possibly means lipopolysaccharide bacterial endotoxin causing inflammatory release prostaglandins turn activate adenylcyclase <NUMBER> enzyme acts upon secretory granules crypt cells stimulate water electrolyte secretion bacterial endotoxin also effects elevated body temperature damage capillary endothelium resulting hemorrhage thrombocytopenia depletion liver glycogen prolonged hypoglycemia shock shock often induces severe circulatory collapse resulting sudden death relapses certainly important practical problem salmonellosis number believed physical tissue damage treatment rather firstorder resurgence infection widespread agreement celtmediated immunity important humoral immunity resistance salmonellosis humoral antibody contributes primarily bacterial clearance <NUMBER> chemically inactivated vaccines bacterins prepared immunoprophylaxis salmonella species varying ofttimes questionable effectiveness assessing effectiveness intracellularlylocated organisms affected humoral antibody body must depend upon effectiveness cellmediated immunity effectiveness macrophages activated sensitized lymphocytes phagocytize kill tissueinvading salmonellas live vaccines prepared avirulent cultures ofs typbimurium dublin used widely europe promote cellmediated immunity <NUMBER> macrophages also release cloninginhibiting factor lymphokine like secretory immunoglobulin iga blocks adherence thus prevents colonization multiplication cloning organisms intestinal epithelium salmonella anatum past decade noticeable appearance increase incidence salmonella anatum infection cattle <NUMBER> <NUMBER> vying dublin second place order frequency <NUMBER> next typbimurium widely distributed salmonella type <NUMBER> source infection appears mostly wild birds contaminate pastures hayfields droppings containing organisms <NUMBER> however organism wide distribution among great variety birds mammals feedstuff water addition pasture hayfield may contaminated infected lactating cows marked reduction milk production associated protracted illness <NUMBER> <NUMBER> salmonellosis antimicrobial resistance another problem relating enteric bacteria appeared past decade increasing resistance among members enterobacteriaceae antimicrobial agents noted throughout world <NUMBER> particular interest focused salmonella species <NUMBER> antimicrobial resistance patterns presence plasmidbearing resistance factors isolates human animal sources studied considerable anxiety expressed use antibiotics animal feeds journal dairy science vol <NUMBER> <NUMBER> <NUMBER> growth promoters prophylactics practice suspected major factor increased antimicrobial resistance effective method assessing magnitude risk welfare man devised opinions degree risk highly polarized increase resistance sustained least one instance abrupt decline ampicillin resistance salmonella typbimurium humans reported new york late <NUMBER>s contrast increasing frequency resistant isolates upstate new york calves similar time <NUMBER> sudden unanticipated drop antibiotic resistance reported singular noteworthy urban experience introduces new unanswered questions population typhimurium suddenly lose ampicillin resistance <NUMBER> possible plasmid coded protein salmonella cell surface antigenic host animal thus resulting immunoglobulin ampicillinresistant strain emerging population immunity <NUMBER> genetic control mechanisms continue studied role gut flora support antagonism toward survival rfactorbearing strains versus antibioticsensitive strains clonepreference effectors needs review lifespan benefits incorporating antibiotics feeds growth stimulants understood fully known antibiotics act molecular level growth promoters considerable practical evidence prophylactic benefits antibiotics feed water exist nonetheless always certain diseases protection claimed actually exist areas antibiotics used prophylactic feed additives improved surveillance monitoring methods needed need better understanding ecologic impact different rfactor incompatibility groups enteric genera escbericbia salmonella <NUMBER> fundamental importance sideropbores since serum tissue extracts contain nutrients essential bacterial growth assumed materials required pathogen available utilization potentiality various pathogens survive animal depends upon ability obtain sufficient iron active metabolism <NUMBER> microorganisms possible exception lactic acid bacteria require iron iron used cytochrome system energy production lactic acid bacilli use system derive energy glycolytic system true anaerobes although anaerobes may utilize pathways although iron one prevalent earths elements aerobic environments amount free iron available assimilation microorganisms restricted due proclivity ferric iron form large insoluble aggregates neutral alkaline ph acquire necessary iron aggregates aerobic microorganisms evolved specialized ironsolubilizing transporting ligands chelating agents termed siderophores pathogen contend insolubility ferric iron must obtain iron host although amount iron host fluids adequate microbial growth ironbinding proteins transferrin ferritin serum lactoferrin secretions sequester essentially iron environments likely mechanism whereby bacterial pathogen successfully competes ironbinding proteins via siderophore production enterochelin enterobactin siderophore produced salmonella typbimurium possibly enteric bacteria antagonizes ironrestricting mechanisms host therefore virulence factor one effective defense mechanisms host might develop irondependent parasites would production antibody siderophores perhaps antisiderophore vaccines animals might reduce risk man antibioticresistant enterobacterial pathogens vaccinal antigens rendered siderophorespecific predetermined genera entire aerobic microflora ubiquity salmonellas suggests problem dairymen time fact long dairy cows calves subjected stressful environments hemorrage prominent feature bovine respiratory disease borne name hemorrhagic septicemia shipping fever many years name evolved habit rather description major lesions septicemias show evidence hemorrhagic lesions many however far iess characterize extensive hemorrhagic diatheses <NUMBER> louis pasteur described organisn caused cholera fowls disease characterized enteritis submucous subserous hemorrhages vascular congestionsurely hemorrhagic disease later learned pasteurs fowl cholera bacillus indistinguishable organism rabbit septicemia swine plague two hemorrhagic diseases wherein isolations common generic organism made <NUMBER> hueppa germany grouped organism one name bacterium septicemiae hemorrhagicae hemorrhagic septicemia bacillus even neophytic era microbiology reported bacterium septicemiae hemorrbagicae isolated cases pneumonia sometimes septicemia cattle hemorrhage common lesion septicemia occasionally lesion identified bovine pneumonia view primitive status microbiology day assurance given hemorrhagic lesions fact attributable organism isolated bacterium septicemiae hemorrhagicae subsequently renamed genus pasteurella proposed species name animal organism isolated assigned according classification scheme proposed also <NUMBER> another german scientist flugge pasteurellosis name proposed shortly thereafter group diseases pasteurella species associated fact pasteurellosis cattle identified respiratory syndrome particularly groups confined young cattle exposed crowded stressful conditions associated shipping hemorrhagic diathesis like fowl cholera sufficient cause disassociate firmly established synonym hemorrhagic septicemia disease remained even day pasteurellosis shipping fever cattle attributed pasteurella rnultocida characterized bronchopneumonia thickened pulmonic septae moderate amounts fibrin lung surface contrast pneumonia attributed pasteurella hemolytica amount fibrin much greater lesions represent true fibrinous pleuropneumonia <NUMBER> affected animals show elevated temperatures difficulty breathing pulmonary rries diarrhea pulmonary subcutaneous edema advanced cases cyanosis mucous membranes due oxygen deficit brought diminished area functional lung parenchyma likely primary infections viruses like parainfluenza<NUMBER> virus ibr respiratory syncytial viruses bvdmd virus others mycoplasmas predispose secondary invasion pasteurellas damaging protective mucociliary clearance mechanisms trachea bronchi impairing alveolar macrophage function seems marked tendency toward seasonal incidence pasteurellosis corresponds activity respiratory virus mycoplasma infections particularly fall winter local inflammatory effect produced viruses parainfluenza<NUMBER> ibr leads increased fluidity mucus coating consequent sneezing coughing inevitably form endogenous aerosols respiratory passages result downward vortical carriage bacteria upper parts tract inspiration <NUMBER> researchers riddles pathogenesis immunoprophylaxis remain elusive therefore speculative however many areas country practicing veterinarians becoming increasingly alarmed frequency intractable often fatal shipping fever cases antibioticresistant pasteurellas recovered <NUMBER> <NUMBER> pathopotentiators unknown search virulent clones among nonpathogenic oropharyngeal commensals continues perhaps behavior another oropharyngeal commensal may shed light mechanism pathogenesis corynebacterium dipbtberiae normal inhabitant oropharynx harmless attacked phage releases deadly exotoxin produces serious disease host phage likely incriminating pathopotentiator perhaps role plasmids extrachromasomal genetic elements bearing pathogenic potentiators explored appears evidence number pasteurellae resistant one antibiotics increasing <NUMBER> therefore search effective immunogen becomes increasingly important liveculture vaccines cattle study following earlier experience live pasteurella multocida use poultry <NUMBER> results encouraging relatively short duration studies serological relationship strains pasteurella multocida shigidi mustafa kartoum sudan <NUMBER> confirmed observations considerable serologic heterogeneity strains p multocida heterogeneity somatic antigen may responsible irregular results current system vaccination pasteurellosis even though indirect evidence indicates immunogenicity p multocida might primarily completely dependent upon capsule antigen long cattle exposed stress shipping fever pulmonic pasteurellosis problem knowledge obtained last quarter century brought us partially closer understanding disease winter dysentery acute highly contagious catarrhal hemorrhagic enteritis cattle characterized brief explosive attack diarrhea occurrence abdominal pain profuse watery sometimes bloody diarrhea identifies disease dysentery northern united states occurs usually housed cattle winter results moderate marked drop milk production infected herds attack rate may reach <NUMBER> fatalities rare causative agent unknown suspected virus <NUMBER> <NUMBER> <NUMBER> jones little <NUMBER> described disease attributed cause new species bacterium vibrio jejuni subsequently renamed campylobacter jejuni <NUMBER> macpherson canada challenged vibrionic cause reproduced disease filtered fecal material suggested caused virus <NUMBER> followed period diagnostic confusion differentiating winter dysentery infectious bovine rhinotracheitis bovine viral diarrheamucosal disease <NUMBER> roberts <NUMBER> characterized winter dysentery <NUMBER>yr study <NUMBER> outbreaks kahrs <NUMBER> employing serologic methods compared winter dysentery bvdmd ibr found winter dysentery unrelated infections roberts <NUMBER> reported incidence disease peaks every <NUMBER> yr suggesting immunity develops herds given area holding disease abeyance susceptible herd replacements ultimately make milking herd permitting disease cycle winter dysentery seems affect young dairy cows frequently lactating pregnant recently calved usually affected severely milking cows often first affected followed several days later younger stock <NUMBER> changes feed weather often suspected predisposing factors stress factors might increase incidence severity disease include poor nutrition parturition stressful stabling respiratory disease confined animals disease seen cattle pasture united states <NUMBER> apparently observed cattle pasture australia <NUMBER> winter dysentery manifested noteworthy change body temperature elevated temperature occur usually precedes onset diarrhea <NUMBER> <NUMBER> h <NUMBER> accompanied cough time diarrhea apparent body temperature usually normal onset diarrhea may preceded dullness depression decreased milk production slight marked inappetance extreme thirst cough nasolacrimal discharge excessive salivation drooling abdominal pain manifested kicking abdomen lying getting frequent intervals rumen atony observed sometimes also loss condition dehydration weakness tottering gait occasionally recumbency reluctance inability get probably two common signs preceding onset diarrhea nasolacrimal discharge dry harsh hacking moist cough <NUMBER> diarrhea strikes suddenly swiftly copiously short duration often characterized explosive projectile considerable velocity intestinal contents released another characteristic feature disease moderate severe decrease milk production animals recently calved seem affected <NUMBER> individual animals winter dysentery may last hours often lasts days less week infected herd duration ranges <NUMBER> <NUMBER> wk <NUMBER> wk commonly cited <NUMBER> whether substantial immunity develops winter dysentery known macpherson hypothesized young calves susceptible maternal antibody acquired colostrum perhaps freedom stress <NUMBER> felt susceptibility greater <NUMBER> <NUMBER>yrold animals passive maternal antibody protection disappeared physiologic stresses mounting sudden onset diarrhea adult cattle merits consideration several diseases differential diagnosis among bvdmd dietetic gastroenteritis coccidiosis parasitosis salmonellosis johnes disease rinderpest effective vaccine available disease likely available precise cause determined may distinct disease caused single infectious agent syndrome many treatments advocated merits questioned <NUMBER> abundant drinking water available affected animals fox suggested intravenous blood tranfusions gaunt recumbent animals supported gruels high nutritional value given mouth <NUMBER> winter dysentery known <NUMBER> yr cause remained elusive still enigma needing intensive study opinions may vary relative economic importance diseases arguments point need effective urgent system reporting analyzing morbidity mortality data dairy herds predictors estimators provided immediate feedback continuousflow basis way incidence prevalence assessed population risk predisposing factors hopefully made visible patterns disease movement foretold monitored management wisely attained technology microbiology immunology advances rapidly next quarter century one past undoubtedly answer many questions raised chronicle leuven campus brussels belgium lecturing amongst others engineering risk analysis risk management ☒ authors declare known competing financial interests personal relationships could appeared influence work reported paper ☐the authors declare following financial interestspersonal relationships may considered potential competing interests current predicament covid<NUMBER> pandemic first health crisis however social disruption economic damage becoming visible <NUMBER> months wuhan city outbreak early december <NUMBER> authors wondered could done better prevention repression covid<NUMBER> pandemic safety management risk control point view within case study framework authors gathered literature pandemics country response effectiveness human behaviour face danger results consist safety management oriented narrative current pandemic several critical observations current paradigms shortcomings preparation number opportunities improvements countermeasures many proverbial animals safety zoo representing typical behaviours observed action based well proven risk analysis methods risk management event tree scenarios bowtie authors analyse generic sequence events pandemic starting root causes prevention via outbreak pathogen mitigation long term effects based analysis authors propose integrated pandemics barrier model model core generic pandemic scenario distinguishing five risk controllable sequential steps outbreak authors contend prevention pandemics via safety management based biohazard risk control possible paramount importance since stop pandemic scenarios altogether even outbreak people thinking safety use quite animals representations safety concepts addition paper tigers dekker<NUMBER> dinosaurs cohen <NUMBER> black swans taleb <NUMBER> dragons elahi <NUMBER> elephants srivatsa <NUMBER> michelle wucker <NUMBER> introduced gray rhinos inwhat could called safety zoo michele wucker <NUMBER> issued reader discussion guide complement <NUMBER> book gray rhino wucker <NUMBER> <NUMBER> discussion questions yet animals appear welcome safety zoo nathan jaye <NUMBER> interviews michele wucker october <NUMBER> <NUMBER> asking black swans safety science stand combination unlikely factors suddenly creating big problem wucker explains gray rhino staring face ready cause havoc youd better find responding use opportunity act still jaye continues asking elephant room wucker replies explanation difficult even see nearby group large elephants natural habitat jaye wucker engage discussion china among things recurring influenza viruses comparing recurring gray rhinos reacting charging rhino worst thing even frightened prone freezing spot scared make wrong choice later schleicher <NUMBER> p<NUMBER> writes gray rhino perfect complement black swan concept engaging thoroughly reality recognizing obvious threats biases working overcome animalconcepts address safety problems seem handle well deem problems unknown ignore accept risk regard unlikely dont act even really actually could yes ostrich bird springs mind us feel mankind living anthropocene era crutzen <NUMBER> result natural selection command planet vulnerable hot violent earth beneath us cold outer space surrounding us bad could things actually get wucker <NUMBER> speculates planetary scale gray rhinos referring catastrophic dangers little one would magnetic storm coming sun wiping electrical part society similar carrington event <NUMBER> cliver <NUMBER> another one manifested extinction dinosaurs successive yucatan shiva asteroid impacts <NUMBER> million years ago lerbekmo <NUMBER> prevention disasters currently beyond capabilities nature may throw earthquakes volcanic eruptions enormous firestorms tsunamis us wake impact mitigation would part also beyond possibilities however continuously watching every earth approaching rock see experimenting ways change direction case pose threat wits end comes future development preventive means preparation would possible though like global tsunami warning system demonstrates bernard titov <NUMBER> asteroid impact happen nonetheless part mankind survive would certainly need show resilience early discovery dangerous spacerock could give us time preparation might help us recover damage shorten aftermath midst current predicament covid<NUMBER> pandemic need worry much smaller yet likely major disasters means disposal avoid else fails mitigate control harm damage might looking safety zoo would seem dragons suspected around wild animal market danger deemed unknown grey mouses local governments accepted risks paper tigers looking away fact looking away dinosaur living room rendered powerless many years budget cutting many western countries thought blackswans fareast dealing sars mind decided highly unlikely pathogen would ever reach west turned error judgement since world became quickly aware contagious elephant doctors room presenting great threat global population response observed countries emerging pandemic like moving way path charging gray rhino several countries better taking action immediately however resulting exceptionally low death tolls leaders several countries behaved like ostrich since downplayed denied ignored pandemic consequences ineffective responses exceptionally high death tolls notions raise many questions many people takes choose right strategy health safety vulnerable groups critical functions essential services supplies society economy relation pandemic risk although first glance covid<NUMBER> pandemic first presents health crisis contend health currently getting near attention safety management point view world confronted unwanted event huge adverse consequences june <NUMBER> <NUMBER> growing total death toll <NUMBER> countries passed <NUMBER> <NUMBER>f societal disruption global economic damage continue develop current predicament covid<NUMBER> pandemic anatomy similar major accidents bhopal tsjernobyland seveso disasters multiple causal factors important risks consider prevention measures take case fail well prepared repression system consisting preparation emergency response mitigation put place since several critical observations made originating background would like explore study learning current covid<NUMBER> pandemic possibilities applying improving current safety management risk control concepts potential future pandemics distinguish industrial chemical occupational environmental biological social medical safety security since risk control touches upon many disciplines expertise areas end want look pandemics general point view major accident hazard risk control use eg chemical industry ec <NUMBER> health safety environment management systems hospitals pariès et al <NUMBER> niv et al <NUMBER> live stock breeding farms biosafety biosecurity systems heckert et al<NUMBER> study centres following question could done better prevention repression covid<NUMBER> pandemic safety management risk control perspective overall design study follows case study method yin et al <NUMBER> consists sequence steps follow research process simplified eisenhardt <NUMBER> design data gathering literature observations analysis construction theoretical model critical reflection outcome latitudinal descriptive case study form use requires blueprint provide structure data gathering yin et al <NUMBER> end use shortlist aspects kohn <NUMBER> derived preliminary literature search quality validity findings protected using multiple independent peerreviewed sources available triangulation data originating different stakeholders mays pope <NUMBER> research design consists three main parts requiring different methods techniques since wide range subjects involved explored literature series separate searches using scoping review technique smith et al <NUMBER> started preliminary search derive initial search terms successive literature searches per subject used progressively extended set search terms inclusionexclusion criteria subjects listed case study blueprint see table<NUMBER> table <NUMBER> case study blueprint structure data gathering analysis several inclusion exclusion criteria used protect quality sources  primary peerreviewed scientific sources various databases via reference listings  secondary sources cronin et al <NUMBER> government organisations international institutions  tertiary grey sources wessels <NUMBER> particularly relevant subjects  time period <NUMBER> exceptions essential sources <NUMBER>  excluded publications available languages english dutch  screened sources found means search terms inexclusion criteria  search terms successively derived sources found different subsets terms used subject ensure important sources included  databases used scopus medline google scholar academia research gate associated proprietary databases risk management model use study consists three well proven elements  <NUMBER> steps risk awareness approach oliveira et al <NUMBER> enders <NUMBER> iso <NUMBER>  risk matrix based assessment system iso <NUMBER>  bowtie timelinecausality model léger et al <NUMBER> khakzad et al <NUMBER> elements generally accepted widely used risk management techniques combination enables mapping analysing comparing outcomes safety management risk control approaches time support theoretical model analyse process observed current covid<NUMBER> pandemic unfolding literature findings deduce series generic pandemic scenario events range countermeasures suite supporting activities way follows steps metasynthesis process cronin et al <NUMBER> polit beck <NUMBER> comparing ideals observed practice roots every critical reflection matter belief culture emotion come learning comparison end compare observed practice ideal outcome according reference frame derived theoretical model ideals outcome learning need constantly debated van woerkom <NUMBER> critical reflection sociological methodology often used education also variety disciplines fook et al <NUMBER> practice method simplest form consists introduction followed two stages hickson <NUMBER> <NUMBER> deconstruction reality <NUMBER> reconstruction towards achieving ideal outcome study limited respect number sources used versus number sources available data gathering via literature search started midapril <NUMBER> continued june <NUMBER> <NUMBER> time became clear internet grown considerably reflected astounding <NUMBER> hits google scientific community produced huge number papers indicated <NUMBER> hits google scholar <NUMBER> related research items researchgatenet <NUMBER> related papers academiaedu found searching covid<NUMBER> overwhelming quantity information defies attempt get overview time soon since exploratory work study conducted authors danger subjectivity therefore simply discarded contend study repeatable verifiable reliability observation based multiple sources start current pandemic interpretations clearly identified choice wording chosen research methodology time period searching described ensure findings learning current covid<NUMBER> pandemic relevant framework safety management based risk control pandemics propose findings literature search observation theory analysis described order subjects listed case study blueprint see table <NUMBER> successive literature searches closely following blueprint resulted <NUMBER> sources total among <NUMBER> primary scientific sources <NUMBER> secondary sources mainly governmental international institutions <NUMBER> tertiary sources mainly public media sources compiled description current predicament comparison country responses effects first <NUMBER> months range human behavioural reactions danger increasing threat viral pandemics spanish flu <NUMBER> several others francis et al <NUMBER> kain fowler <NUMBER> jebril <NUMBER> started sense urgency emergency preparedness especially intensive care units icu elderly homes preparation pandemic include <NUMBER>coordinated surveillance order spot new viruses <NUMBER>scalable emergency response <NUMBER>quickly mass produced vaccines <NUMBER>excellent communication <NUMBER>preapproved research plans instead remain largely underprepared kain fowler <NUMBER> p<NUMBER> spotting virus requires detection method testing capability warning system kain fowler <NUMBER> scalability refers surge capacity equipment physical space human resources system sheikhbardsiri et al <NUMBER> p<NUMBER> later part period <NUMBER> years preceding current predicament showed series multiple returning h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> pandemic influenza virus outbreaks francis et al <NUMBER> <NUMBER> completed guidance pandemic influenza emergency risk management <NUMBER> preparing next influenza virus pandemic subject studies since resulted preparedness framework issued <NUMBER> issued <NUMBER> several countries developed national derivatives plans <NUMBER> dutch government finalized latest national safety strategy nvs <NUMBER> mentioning large scale outbreak infectious disease likely influenza pandemic plan revolves around prevention defence reinforcement fits within context integrated foreign countries safety strategy nvs <NUMBER> p<NUMBER> emergency preparedness plans focus influenza viruses returning rather well known viruses francis et al <NUMBER> assumed higher likelihood recent outbreaks <NUMBER> onwards however unexpectedly originating ebola virus mers corona virus current predicament novemberdecember <NUMBER> outbreak sarscov<NUMBER> virus causing coronavirus disease <NUMBER> abbreviated covid<NUMBER> outbreak first detected december <NUMBER> several clusters patients pneumonia unknown cause epidemiologically linked seafood wet animal wholesale market wuhan recognized zhu et al <NUMBER> p<NUMBER> hua shaw <NUMBER> p<NUMBER> timeline established starting first reported case patient <NUMBER> december <NUMBER> <NUMBER> yan et al <NUMBER> several detailed studies onset wu et al <NUMBER> lead certainty virus transferred humans suggest airborne transmission main culprit chinese officials wuhan municipal health commission reported epidemic december <NUMBER> shortly outbreak reported wuhan city major industrial centre hubei province china december <NUMBER> <NUMBER> declaration chinese officials covid<NUMBER> culprit january <NUMBER> <NUMBER> genome sequence published virologicalorg zhang <NUMBER> day later january <NUMBER> international group experts concluded covid<NUMBER> similar sars virus <NUMBER> evidence found humantohuman transmission developed diagnostic protocol tried january <NUMBER> onwards detect virus patients corman et al <NUMBER> virus particles <NUMBER> nanometers size consist rna proteins decomposing <NUMBER> celsius likely originate chrysanthemum bats pangolin jebril <NUMBER> zhou et al <NUMBER> january <NUMBER> assigned public health emergency international concern pheic status outbreak thereby underlining international threat wangwang <NUMBER> rivm <NUMBER> initial average primary reproduction numbers r <NUMBER> <NUMBER> <NUMBER> reported yan et al <NUMBER> experiences severe disease <NUMBER> becomes critically ill one third die <NUMBER>c may <NUMBER> <NUMBER> estimated economic impact exceeded effect <NUMBER> financial crisis large parts society economy put hold <NUMBER>c p<NUMBER> many countries pandemic still rapidly developing countries across globe impact pandemic remained least factor <NUMBER> less magnitude time remote areas solomon islands oceania thanks travel restrictions virus yet arrived <NUMBER> months since onset pandemic beginning december <NUMBER> <NUMBER>b <NUMBER>c end april <NUMBER> china recovering outbreak gradually bringing back wuhan city normal business levels pandemic still skyrocketing countries peak yet countries remote places planet even arrived astounding differences countries observed also spatial variations within countries seem large illustrated covid<NUMBER> hot spots example milan region northern italy new york state usa province noordbrabant netherlands although death count per country heavily depends point reached process following outbreak <NUMBER>c comparison countries indicative referring approximately point provides first glance effect national strategies spread covid<NUMBER> virus chang et al <NUMBER> identify <NUMBER> countries territories struck pandemic march <NUMBER> <NUMBER> eight affected besides eight countries china italy spain iran germany france south korea usa also several countries special relevance since adopted clearly deviating strategies obtaining clearly different results countries new zealand taiwan hong kong finland belgium netherlands dutch national television channel npo<NUMBER> reported <NUMBER> officially tested recorded victims another <NUMBER> suspected covid<NUMBER> victims may <NUMBER> <NUMBER> bringing total estimated death toll <NUMBER> june <NUMBER> <NUMBER> official death toll netherlands reached <NUMBER> <NUMBER>f leading estimated total <NUMBER> dutch covid<NUMBER> victims country used different strategy approach covid<NUMBER> pandemic strategies different outcomes death toll versus time figure <NUMBER> shows quick response mitigation measures makes difference china south korea new zealand hong kong taiwan managed reduce spreading earliest moment leading number local outbreaks resulting mortality counts staying low countries showed prolonged higher growth rates death tolls khafaie rahim <NUMBER> <NUMBER>b moes <NUMBER> vproovt <NUMBER> table <NUMBER> shows elapsed time first covid<NUMBER> related death china january <NUMBER> <NUMBER> first countries <NUMBER> days pheic status reported january <NUMBER> <NUMBER> pandemic status march <NUMBER> <NUMBER> came late effective safety alert countries still unaffected closer look individual countries shows thatapart speed first responsetheir strategies werent different china country started yan et al <NUMBER> wuhan city hubei region period increasing awareness happened virus got control jebril <NUMBER> p<NUMBER> <NUMBER> spring festival period many millions gathering travelling virus rapidly spread china abroad wuhan national international transport hub peeri et al <NUMBER> chang et al <NUMBER> china used <NUMBER> sars epidemic experience mitigate spread wangwang <NUMBER> worldwide spread followed due global travel jebril <NUMBER> wu et al <NUMBER> italy first receive covid<NUMBER> virus china western europe quickly becoming european epicentre jebril <NUMBER> spain experiencing increasing case fatality rate cfr <NUMBER> khafaie rahim <NUMBER> iran early official reporting place suddenly became epicentre middleeast germany reported low death toll among neighbouring european countries compared italy iran france experiencing increasing cfr <NUMBER> khafaie rahim <NUMBER> south korea reported low death toll worldwide comparison likely related countrys high volume testing approach previous experience sars public places disinfection spraying citizens wearing face masks smart phone contact tracing information campaign moes <NUMBER> usa reported worlds highest death toll <NUMBER>b new zealand quickly realized cases brought overseas country quickly closed borders went full lockdown people told stay within bubble maintain safe distance <NUMBER> meters taiwan reactivated national health command center created sars epidemic <NUMBER> country chose early robust quarantine policy based backtracking peoples whereabouts previous <NUMBER> days using previous sars epidemic experience also use face masks general public disinfection spraying public places infrared thermometers key locations eg transportation hubs risky places information campaign lockdown avoided moes <NUMBER> hong kong adopted effective strategy similar taiwan also previous experience sars citizens wearing face masks among measures taken moes <NUMBER> belgium initially reported relatively modest death toll appeared take fastest growing european country data artefact originated nontested suspect covid<NUMBER> cases previously included covid<NUMBER> reports showing total death statistics netherlands chose social distancing strategy named intelligent lockdown rutte <NUMBER> refers keeping critical functions society running general public keeping freedom moving long social distancing rules sufficiently respected like many countries netherlands advantage seeing pandemic coming manage countermeasures materials equipment place pathogen reached country took june <NUMBER> <NUMBER> large scale testing facilities became available nos <NUMBER> quite opposite occurred finland robust emergency preparedness facilitated immediate introduction pandemic countermeasures leading low death toll <NUMBER>f animals safety zoo represent human conduct towards major safety risks immediately recognized occur often notice threats safety practice  suspect presence yet deem unknown world complex dynamic changing place knowledge equally limited like distant past fear dragons elahi <NUMBER> ale et al <NUMBER> part world around us unknown due lacking awareness existence another part know knowledge mysterious part aware knowledge often referred unknownunknown unkunk petersen et al <NUMBER> unknown risk though unknown unknownunknown category sometimes presumed lindhout <NUMBER> unknown always imply foreseeable ramasesh browning <NUMBER> rather often safety improvement action actually taken instead merely settling unknown nothing foreseeable danger lindhout reniers <NUMBER> requires sufficient risk appetite however gjerdrum peter <NUMBER>  fully aware yet accept risk probabilistic approach probability gets closer zero extremely large consequences may become acceptable even without specific measures taken simply following procedures grey mouses get us verhagen <NUMBER> implies large nationwide disaster scenario could regarded acceptable since risk properly controlled hse <NUMBER> p<NUMBER> probability may really zero though hence disaster completely ruled must therefore considered accepted residual risk deem risks unlikely  know specific safety threats yet regard highly unlikely impossible fully aware identified threats safety might lead unwanted events seen complex interacting multiple causal dynamic entropic mol <NUMBER> depending conditions might one day suddenly unexpectedly overwhelmed black swan taleb <NUMBER> murphy conner <NUMBER> ale et al <NUMBER>  obvious safety risks actually cause damage yet act build safety system routines improve safety yet create bureaucracy improving safety management systems industry health care may lead paper tigers dekker <NUMBER> makes safety management focus going required administrative motions rather keep awareness high spot safety threats  everyone sees known feasible opportunity improve yet pretend doesnt exist paradoxical observation done cohen <NUMBER> <NUMBER> wider general area safety management shows managers pretend known major improvement potential exist even though means realize available coined looking away dinosaur living room obvious next thing order make leap forward  recognize big emerging threats safety still dont act pandemic risks example huge threat known created damage past expected future receiving adequate attention prevention activities place mitigation well prepared srivatsa <NUMBER> mentioned elephant doctors room addressing emerging danger antibioticresistant bacterial infections said capable killing <NUMBER> million people year <NUMBER>  watching immediate lethal danger epic proportion hesitate act means enough describe frighteningly unresponsive human condition even deny ignore big rapidly developing global disaster destroy millions us closing us high speed move gray rhino charges wucker <NUMBER> p<NUMBER>  watch threat coming us freeze people believe eyes ears unknown invisible enemy initially met unbelief much like animals nature hesitant scared avoid engaging fight even freeze face approaching danger sagliano et al <NUMBER> people sometimes appear ostrich bird like ways go sudden threats although disaster risk management preparation response mentioned plans next pandemic <NUMBER> approaches presented many countries following guidance showed range problems preparing next influenza virus outbreak rather next new unknown virus pandemic outbreak majority activities deployed influenza outbreak valid virus outbreak kain fowler <NUMBER> madhav et al <NUMBER> however covid<NUMBER> virus differs influenza virus assumptions made emergency preparedness protocols may therefore always applicable render influenza specific preparation activities unusable slow response since new measures need developed spot limited knowledge pathogen recently priority research development placed medical countermeasures including vaccines therapeutics diagnostics cover gap <NUMBER>c p<NUMBER> preparation virus might brought us better position eg detection method preapproved vaccine research vaccine development required hospital space testing commodities icu staff ventilator equipment kain fowler <NUMBER> case fatality rates cfr eg influenzaa <NUMBER> dawood <NUMBER> <NUMBER> anderson et al <NUMBER> viruses may significantly higher cfrs covid<NUMBER> <NUMBER> sars <NUMBER> mers <NUMBER> yan et al <NUMBER> peeri et al <NUMBER> khafaie rahim <NUMBER> also initially observed primary reproduction number r <NUMBER> covid<NUMBER> virus r <NUMBER> <NUMBER> indicates spreads <NUMBER> <NUMBER> times faster influenza viruses r <NUMBER> <NUMBER> khafaie rahim <NUMBER> jebril <NUMBER> anderson et al <NUMBER> cfr clearly higher bats perhaps pangolin southeast asian region reservoir sarslike corona viruses li <NUMBER> preparation pandemic virus would substantial likely would made us cautious keen act preparing robust measures fact many animals reservoirs many pathogens han et al <NUMBER> also argue along lines still much investigate causal tree preceding first confirmed case patient<NUMBER> yan et al <NUMBER> course requires full transparency events wuhan region leading first case also better understanding containment new virus handled december <NUMBER> <NUMBER> january <NUMBER> <NUMBER> record breaking wuhan new year celebration kynge et al <NUMBER> needed time term prevention used applied stopping infections ongoing pandemic safety system point view regarding pandemic entirety would labelled repression mitigation word prevention used safety management refers done avoid first outbreak education would make difference education increases awareness less unsafe behaviour would improve prevention acceptance better adherence social distancing measures repression pandemic would achieved example chang et al <NUMBER> mention home quarantine strategy explained adopted implemented correctly could help reduce spreading virus members household <NUMBER> seeks alignment guidance many member states national disaster management structures example successful approach found fact still ongoing pandemic hivaids virus worldwide information program comprising education empowerment population groups involved onset pandemic groups affected later chin <NUMBER> started <NUMBER> years onset mann kay <NUMBER> <NUMBER> based knowledge acquired particular relevance gender sexual behaviour education citizens prevention spread disease chin <NUMBER> dowsett et al <NUMBER> gupta <NUMBER> also agricultural biosafety biosecurity systems acknowledged need education training among workers heckert et al <NUMBER> hence need education training empowerment pandemics occur increasingly often wef <NUMBER> kain fowler <NUMBER> madhav et al <NUMBER> become part daily lives even hivaids influenza today irrespective specific pathogen potentially causing pandemic several generic countermeasures could already taken identifiable areas world sparkrisk ie onset likely madhav et al <NUMBER> preventive repressive measures necessary prevention would include eg preventive prophylaxis spatialand temporal segregation repressive measures required quickly contain outbreak areas could include investing existing public health methods routine health monitoring regular vaccination detection activities emergency drills also new measures areas may susceptible spread risk ie situation enables spreading elsewhere necessitating supplementary mitigation measures madhav et al <NUMBER> continuous presence routine pandemic prevention activities creates attention awareness caution among general public health care providers especially regions susceptible sparkrisk onset epidemic pandemic madhav et al <NUMBER> compares earthquake shelter fire evacuationand cruise ship safety drills involved educated trained citizen become partner prevention repression pandemics countries would become resilient many citizens take part form volunteer disaster fighting wef <NUMBER> would certainly help satisfy scalability requirement practice shows red cross volunteers formeror retired health care workers many groups spontaneously creatively display plethora activities pandemic creates disruption society economy happen often future presented acknowledged fact <NUMBER> <NUMBER>c wef <NUMBER> since might happen points government responsibility creation safeguarding societal resilience truly daunting task consecutive pandemics might even allow full societal recovery would profound impact long term global economic development social wellbeing social stability many countries affected <NUMBER>c points individual countries take action businesses buildings schools public space transportation systems designed accommodate sustainable steady state time period lowlevel transmission absence safe effective vaccine <NUMBER>c p<NUMBER> pandemics recurrent recovery periods also agreed prepared detailed societal economical ethical postpandemic recovery plan practical preparation resilience missing covid<NUMBER> pandemic earlier economic financial political considerations put priorities elsewhere societies leading slow response major logistical problems little socioeconomic resilience consensus neighbouring countries lacking leading local regional country level differences noticeable social distancing measures emergency preparedness safety management aspects mentioned dutch national safety strategy plan nvs <NUMBER> ie identification prevention proaction preparation response aftercare necessary directly linked pandemic risk control comes risk identification achieved via integrated risk analysis national safety line <NUMBER> <NUMBER> focusing influenza pandemic anv <NUMBER> p<NUMBER> risk control aspects activities implement appropriate measures covered dutch institute public health environment rivm laid concept directive covid<NUMBER> cdc<NUMBER> guidance rivm <NUMBER> word prevention used label protection vulnerable groups individual citizen behaviour prevent spreading influenza virus nvs anv cdc<NUMBER> aiming avoiding pandemic altogether therefore deal prevention safety management sense proaction mentioned preparation detailed range organisational measures cdc<NUMBER> response consists description patient treatment first detection via home care hospital care icu care aftercare described therefore default assumed arranged via regular care  building emergency stockpile scalable local production capacity end april <NUMBER> measures applied practice netherlands consisted personal hygiene hospital staff wearing personal protective equipment public applying social distancing care professionals dealing vulnerable group elderly care institutions access personal protection however health careand infection case contacts tracing staff constraining factor scarcity material equipment supplies led criticality hospital icu capacity jeopardised timely distribution personal protection equipment care institutions testing among general public mainly due privacy concerns contactless temperature monitoring contacts tracing phoneapp introduced many countries netherlands direct response test test test instruction coming directorgeneral ghebreyesus <NUMBER> detect test isolate care quarantine contacts strategy <NUMBER>c p<NUMBER> international press digital media shown presence antispreading measures several countries already shortly onset pandemic eg face masks infrared temperature sensors drive virus testing booths disinfection spraying public places smart phone based contacts tracing methods countries builtup emergency supplies stockpile production capacity locally available supply problems paramount including china logistic problems led health professionals working without adequate personal protection general public contributing reducing r <NUMBER> <NUMBER> much would possible problems explain much death toll differences observed figure <NUMBER> vulnerable groups whether due age physical mental diseases unhealthy overcrowded living conditions eg facilities asylum seekers prisons due social isolation health care facilities poverty low socioeconomic status need special attention <NUMBER>c p<NUMBER> specific guidance available suitable well proven solutions best practices derived previous epidemics previous epidemics overwhelmed healthcare system creates yet another vulnerable group need postponed treatment due higher death rates observed causes anderson et al <NUMBER> underlines need preparedness groups first statistical data different health stages persons diagnosed pathogen infection go zhong <NUMBER> highly uncertain immediately onset pandemic spread grows data provide useful records records would gradually shed light success rates treatment options used various countries accurately kept records also allow detailed analysis vulnerability specific social groups weiss <NUMBER> however health systems various countries overwhelmed records became increasingly incomplete rather accurate countries keep records wang wang <NUMBER> published early systematic analysis strengths weaknesses opportunities threats swot covid<NUMBER> epidemic prevention control strategy end march <NUMBER> four highest priority improvements identify three emergency response one strengthening economic structure furthermore various aspects social security psychological issues economical damage opportunities education relation emergencies infectious diseases mentioned wang wang <NUMBER> p<NUMBER> mention prevention public health emergencies describe emergencies threat human beings practical issues mentioned weak wildlife market supervision basic health security facilities lagging behind hazard risk assessments although early days holistic swot analysis covid<NUMBER> pandemic underline necessity evaluation transactional leadership aimed exchange rewards fulfilling expectations grote <NUMBER> p<NUMBER> seems necessary switching fixed flexible attitudes different safety management modes operation pariès et al <NUMBER> needed restore society economy disaster fully recover disaster putting back damaged systems establish new normal least reliable robust improved needed pettersen schulman <NUMBER> p<NUMBER> <NUMBER> australia <NUMBER> <NUMBER>b managed pandemic rather well contend speed quality action communication determined success rather gender leaders wiig fahlbruch <NUMBER>p<NUMBER> mention range related fields many definitions resilience several challenges ao many theories lack empirical evidence several areas one area lack knowledge role stakeholders moser et al <NUMBER> p<NUMBER> point resilience concept gradually evolved ability bounce back via coping mechanism via capacity adapt impacts prevention strategy towards system change radical transformation pettersen schulman <NUMBER> p<NUMBER> see resilience means cope unexpected events note resilience described many ways eg rebound stretching organisation robustness magnitude disruption caused unwanted event determines effort neutralize adverse effects leading resilience types kinds scales levels macrae wiig <NUMBER> p<NUMBER> pettersen schulman <NUMBER> p<NUMBER> woods <NUMBER> describes resilience sustainable adaptabilitytiernan et al <NUMBER> suggest nuanced exploration concept adaptive resilience woods <NUMBER> defines network architectures sustain ability adapt future surprises conditions evolve relatively short medical emergency phase pandemic onset followed long mitigation phase lasting effective vaccine becomes available many countries society builds resistance constraints imposed personal lives business operations leisure time travelling behaviour individuals respecting temporary distancing hygiene measures individuals engaging criminal activities providing substandard medical supplies selling fake medicines may require specific temporary legislation allow adequate law enforcement governments could tempted hastily introduce new legislation without respecting democratic decisionmaking procedures introduce election driven aspects implementation practice ensure timely end force smits van duijn <NUMBER> jones <NUMBER> major ethical concerns emerge criteria used triage health professionals suddenly facing limited health care capacity medical supplies berlinger et al <NUMBER> <NUMBER> also constraints fundamental rights lack democratic debate proportionality fines imprisonment uncertainty precise behaviour causes pathogen spread treating citizens equal taking away livelihood curtail exertion democratic rights limit access health care even ethical issues arise criminalizing peoples proximity loved ones focusing physical health ignoring mental health police intrusion private life even messing peoples zest life health ethics aims contribute wellbeing avoidance damage respecting autonomy seeks justice inclusive way beauchamp childress <NUMBER> inquisitive approach prevention may lead discovery new preventive barriers placed well onset pandemics since within <NUMBER> months time fullyfledged global covid<NUMBER> pandemic emerged contend practice underlined also opportunities new repressive barriers placed shortly onset need investigation impact pandemic large contend continuous searching new barriers preventive repressive justified found several lines thinking opening possibilities development new barrier types february <NUMBER> <NUMBER> directorgeneral ghebreyesus <NUMBER> mentioned <NUMBER> health threat signals attention covid<NUMBER> one hence pandemic danger big growing experts pointing pandemics occur often future seeing pandemics given madhav et al <NUMBER> continuum pandemic phases <NUMBER> distracts attention away introduction preventive countermeasures treating pandemics medical emergency <NUMBER>c may stimulate emergency preparedness mitigation leaves prevention safety management sense scope placing focus attention repression implies looking less caused event evidently lines thinking result avoidable repeats unwanted event working repression aspect pandemics implies great value prevention part ignored consequence education training people working animals remain underutilized preventive means moreover nobody right mind would knowingly want accidentally start global pandemic much work prepandemic period madhav et al <NUMBER> p<NUMBER> current line thinking prepare society dealing social disruption huge effort needed socioeconomic recovery wef <NUMBER> contend safety management would better paradigm dealing pandemic risk australian mathematical model acemod analysts managed predict school closures contributing much social distancing strategy assuming compliance levels <NUMBER> also acemod analysis results pointing minimum requirement <NUMBER> <NUMBER> adherence social distancing measures order effectively control pandemic chang et al <NUMBER> allowing lower grade schools reopen may <NUMBER> <NUMBER> dutch government took first step path towards bringing society back feet combined temporal segregation measure half kids mornings half kids afternoons extending early morning shop opening hours especially older vulnerable age group another example age segregation another strategy would quickly compartmentalize society case emergency limit traffic compartments introduce robust surveillance would qualify spatial segregation one questions whether spreading covid<NUMBER> virus could also slowed intermediate distances somewhere social distancing short distances <NUMBER> feet <NUMBER>e <NUMBER> meter rivm <NUMBER> <NUMBER> feet cdc <NUMBER> <NUMBER> meters jebril <NUMBER> closed borders neighbouring countries long distances say <NUMBER> kilometres intermediate distances would scale city region depth investigation effects closing perimeter around eg wuhan city singapore hong kong first months <NUMBER> could offer sufficient proof potential measures employers workers close contact animals comply safe work legislation countries united nations safe work branch international labour organisation ilo geneva issues best practice based guidance safe work current guidance ilo <NUMBER> touch upon epidemic pandemic risk upon principles biosafety biosecurity however barker <NUMBER> p<NUMBER> describes case <NUMBER> infected animals crossed paths <NUMBER> animals underway livestock trade uk <NUMBER> foot mouth disease epidemic law <NUMBER> example indicates also animaltoanimal a<NUMBER>a transfer needs minimized livestock production transport fact adoption biosecurity biosafety principles essential successful prevention pandemics countries necessary spark prone regions development countries madhav et al <NUMBER> international community invest long term biosecurity programmes cost programmes dwarfed damage caused global pandemic programmes could set biosecurity plans small producers assess risks implement biosafe working methods put place monitoring warning system using veterinary control animal isolation sanitation transport conan et al <NUMBER> alhaj <NUMBER> kimman et al <NUMBER> barker <NUMBER> cardona <NUMBER> zhou et al <NUMBER> gonzalez <NUMBER> known danger comes biggest threats called select agents viral bacterial fungal prions origins gonzalez <NUMBER> gonzalez p<NUMBER> selectagentsgov <NUMBER> much known related virus families zhu et al <NUMBER> p<NUMBER> yan et al <NUMBER> zhou et al <NUMBER> preapproved research plans kain fowler <NUMBER> even intensified continuous research known sources pandemic risk appropriate justified considering magnitude damage caused global pandemic instead preparing influenza pandemic could initiate worldwide cooperation order extend scope pandemics preparation activities several threats select agents list selectagentsgov <NUMBER> pandemic prevention consisting chain several preventive measures connected series assisted listening weak signals delatour et al <NUMBER> early warning signals paltrinieri et al <NUMBER> signals indicate likelihood outbreak may increased attention action needed ideally procedural technical measure chain fails would detected corrective action would triggered immediately measures chain still prevent onset pandemic failing measure could reinstated whole chain measures fails pathogen emerges end detection system failure could done direct detection pathogen contaminated personal protection equipment indirect detection eg detection infected people symptoms eg elevated temperature become proven alternative covid<NUMBER> virus found waste water jebril <NUMBER> could biosampling sewers way detect localize zoonosis outbreak sniffer dogs trained smell even intentionally hidden well wrapped illegal substances barker <NUMBER> could dogs less vulnerable virus seem trained reliable covid<NUMBER> sniffers nosais trial france countries may provide answer roe <NUMBER> biosensors may offer alternative technical solution covid<NUMBER> qiu et al <NUMBER> development reliable detection method new pathogen takes time however corman et al <NUMBER> hence failure detection earlier prevention part chain events needed practice could done detection failures perform successive measures lined chain learned manmade disasters nuclear power plants highrisk chemical plants also ways go handling animals could made safer extra layers preventive repressive measures vadimovna sergeevich <NUMBER> proven way control risks unacceptably large potential impact may also useful tool control pandemic risk chemical industry similar chain measures often referred concentric layers protection baybutt <NUMBER> vadimovna sergeevich <NUMBER> primary containment fails secondary containment protecting people environment approach used around many industrial high risk locations often combined emergency shut esd provision markowski siuta <NUMBER> failure detection esd even working automatically suitable equipment installed bio facilities could treated much way high risk chemical facilities ec <NUMBER> leads concept quarantine delay circle around bio facility secondary containment measure pandemic characterized sequence events leading adverse effects disruption socioeconomic damage considerable death toll construct theoretical model background safety management methods techniques scenarios faulttrees feedback learning loops safety barriers systems support barriers use recent experiences covid<NUMBER> pandemic risk management model construct study based three well proven elements firstly risk management distinguishes several successive time phases associated increasing awareness moving towards action many ways though oliveira et al <NUMBER> enders <NUMBER> iso <NUMBER> study use <NUMBER> generally applicable risk awareness steps <NUMBER>discovering danger <NUMBER>acknowledge <NUMBER>investigate understand nature <NUMBER>assess effect magnitude evaluate risk <NUMBER>take appropriate preventive repressive countermeasures <NUMBER>evaluate incidents support learning improvement secondly risk management done different ways depending probability effects unwanted event approach shows risk interrelation likelihood adverse effect end event plotted extended risk matrix figure <NUMBER> probability unwanted event close <NUMBER> avoid taking specific strong effective measures using methods prohibition law allowing prescribed safety measures often referred precautionary principle potential effects large uncertainties large well cautionary principle applies aven <NUMBER> two constitute deterministic approach safety making unwanted event impossible event smaller probability often use risk matrix square effect scale versus probability scale unwanted event plotted risk field within framework safety management system tiled centre area risk matrix used show effect probability combinations acceptable need risk reduction measures acceptable dual approach principle risk control widely used industry iso <NUMBER> left top deterministic probabilistic areas figure <NUMBER> zone probability andor effect zero nothing happen lower right zone consider realistic lower left situate possible yet unlikely extreme events risk management applied yet rather little actually corner opportunities better repression certainly also better prevention education since prevention offers attractive perspective want take account explicitly thirdly happens unwanted event follows one many possible scenarios involving several causal factors may occur time term prevention used effect describe risk control happens unwanted event takes place term repression used minimizing negative effects occur event event situated cause effect hence term unwanted central event used central events normally multiple possible causes multiple possible effects unwanted central event therefore preceded causal tree followed consequences tree usually referred bowtie shape see figure <NUMBER> thus far far see bowtie models introduced manage covid<NUMBER> risks health safety worker perspective wajidi <NUMBER> manton johnson miles scanlon cowley <NUMBER> organisation perspective protecht <NUMBER> global pandemic risk management perspective model unwanted central event faulttree terminology also referred topevent either happens happen depending whether preventive barriers causal tree stop one causal factors contributing pandemic scenario unfolding time case central event happens repressive barriers put place stop mitigate minimize adverse effects preventive repressive barriers classified several types behavioural humanhardware hardwarehuman active hardware passive hardware kept place supporting delivery systems resources within safety management system context leadership communication education training monitoring inspection maintenance right attitude people towards safety feedback loop ensures learning unwanted events leads system improvements via education renewed risk assessment since prevention always perfect central event happen preparation needed foreseeable events thereto repressive barriers put place prepare emergency response feedback mitigation avoidance long term effects must done depends risk inventory risk identified neither preparation specific countermeasures prevention activities emergency response needed immediately event thorough preparation allows fast adequate response emergency situation unwanted yet anticipated event occurs ideally effective prevention allow unwanted event happen first place analyses root causes previous incidents feed improvement preventive barriers evaluation aftermath event feeds improvement effectiveness barriers including repressive ones sociotechnical modelling technique used industrial major accident hazard risk control practice enables safety analysts graphically display causality scenarios barriers timelines integrated way léger et al <NUMBER> framework analysis possible using static probability data events barriers causality tree analysis also made dynamic replacing static data model analysis using real time measurements process parameters inputs khakzad et al <NUMBER> purpose mapping analysing effects barriers pandemic unfolding combinations bayesian networks agent based spreading models chang et al <NUMBER> may become powerful tools data pathogen properties could included becoming available model predicting outcome mitigation strategies prevented pathogen coming animal may infect human way one person may get zoonosis single case may lead humantohuman h<NUMBER>h transfer persons may become infected contained case become outbreak quickly stopped may reach stage local epidemic mitigated sufficiently pathogen may cross country borders become global pandemic events together constitute pandemic scenario unfolding time designed generic pandemic scenario used model builtup line sequence events unfolding current covid<NUMBER> pandemic generic scenario starts root causes identified literature even though root causes may part reside political cultural religious traditional economical realms certainly worth closer look risk management point view important trends contributing pandemic risk populationgrowth deforestation living cities <NUMBER> <NUMBER> <NUMBER> travelling across globe wef <NUMBER> kain fowler <NUMBER> limiting animaltohuman a<NUMBER>h contact transfer risk important preventive measure chang et al <NUMBER> <NUMBER>b humantohuman transfer h<NUMBER>h occurs risk epidemic even pandemic spreading becomes manifest necessitating increased epidemiologic surveillance monitoring peeri et al <NUMBER> p<NUMBER> infection continue humantoanimal h<NUMBER>a transfer like recent case two dutch mink farms lnv <NUMBER> minks cats dog infected may <NUMBER> <NUMBER> dutch news media reported case a<NUMBER>h transfer back minks human demonstrating risk creating new pathogen reservoirs animals june <NUMBER> <NUMBER> dutch government started destruct minks infected farms vulnerability several domesticated animals discovered recently shi et al <NUMBER> p<NUMBER> risk infection could even involve plants heckert et al <NUMBER> covid<NUMBER> virus already detected waste water jebril <NUMBER> would seem distancing spread reducing measures applied animalhuman contacts jebril <NUMBER> p<NUMBER> <NUMBER> lists repressive measures four geographical levels global travel restrictions national government border control keep vulnerable population safe infection reduce transmission local quarantine covid<NUMBER> cases <NUMBER> <NUMBER> <NUMBER> days hospital isolate covid<NUMBER> cases safe covid<NUMBER> case burial practice safe covid<NUMBER> contaminated waste disposal personal hand washing safe coughingsneezing wearing face mask public keep <NUMBER> distance keep away covid<NUMBER> cases infected people di gennaro et al <NUMBER> list several personal measures refrain touching eyes nose mouth case symptoms seek medical care early follow advice given healthcare provider first response fast possible jebril <NUMBER> turning back part transfer reduction measures mitigation early may trigger uncontrolled second wave infection cases <NUMBER>c extracted <NUMBER> text fragments literature sources used study fragments describing conditions events required knowledge listing emergency preparedness activities needs mitigation issues concerning current predicament covid<NUMBER> pandemic thematic analysis according metasynthesis process cronin et al <NUMBER> polit beck <NUMBER> used identify supporting systems unwanted events generic pandemic scenario barriers capable stopping scenario particular point progressing combination three model elements metasynthesis integrated pandemic barrier model constructed shown figure <NUMBER> horizontal time scale composed <NUMBER> steps bowtie time scale model integrated merge three safety models use sequence events observed covid<NUMBER> pandemic unfolded starting december <NUMBER> <NUMBER> model also barriers since explicating interrelating countermeasures many different kinds model provides overview may happen root causes long term effects safety management risk control point view pandemic scenario figure <NUMBER> starting position country first outbreak country origin pandemic scenario though inspired current covid<NUMBER> pandemic events limited specific pathogen first central unwanted event consider country pathogen first arrives another one successive country longer time advantage country origin quickly issues international alert unwanted event model therefore placed first local outbreak point pandemic process infection may either come local outbreak country origin shown infected person arriving another country model structure used outbreak pathogen approach complementary mathematical modelling geographical infectious disease spreading time acemod chang et al <NUMBER> based analysis complex human behaviour space time calibration epidemiological case data schoenberg et al <NUMBER> recursive patterns gouyet <NUMBER> observed pathogen spreading hohl et al <NUMBER> complex human behaviour society vazquezprokopec et al <NUMBER> prediction evaluation mitigation strategies requires sophisticated mathematical models alsharawi et al <NUMBER> chang et al <NUMBER> mathematical models show strengths starting detection outbreak onwards mitigation emergence pandemic siettos russo <NUMBER> zamba et al <NUMBER> integrated pandemic model developed study see figure <NUMBER> provides overview possible barriers pandemic scenario shows causal tree opportunities prevention shows safeguarding operational readiness barriers supporting systems pathogen spreading goes mitigation pandemic may cause flares ie local outbreaks may develop second wave even multiple waves new infection case eg first case country travelling abroad comes patient<NUMBER> brings scenario unwanted central event pandemic scenario severe cases <NUMBER>emergency preparedness safety drills <NUMBER>resources stockpile logistics management <NUMBER>outbreak detection alarm systems <NUMBER>emergency response team organisation <NUMBER>contamination testing methods equipment model proposed hickson <NUMBER> text previous sections study introduction two stages stage <NUMBER>deconstruction understanding event came elements happened pandemic come via generic pandemic scenario shown figure <NUMBER> current predicament covid<NUMBER> pandemic used example resulting effect barriers failing series <NUMBER> consecutive events <NUMBER>root causes local traditions unawareness biohazard risks travelling across globe pathogen reservoirs animals lead <NUMBER>causal factors people close animals food hygiene habits people close people lead <NUMBER>transfer fromvia animal human a<NUMBER>a a<NUMBER>h single case zoonosis leads transfer humans h<NUMBER>h local outbreak leads <NUMBER>epidemic infected people pathogen transfer leads <NUMBER>pandemic treatment quarantine unnoticed spreading epidemic reaching countries leads <NUMBER>adverse effects health social economic effects scenario observed vaccine induced immunity observed since vaccine available second wave yet observed although several new local outbreaks status per may <NUMBER> <NUMBER> stage <NUMBER>reconstruction building event altered elements compare outcome reality scenario would subject robust riskcontrol successive scenario events barriers  biosafety education people working animals would create awareness biohazard risks safe behaviour  biosecurity controlled wild animal markets using animalhuman distancing personal protection hygiene measures working animals farms routine animal disease control applied systematically times would prevent animaltohuman transfer quarantine delay circle around biofacilities would prevent escaping pathogen eg via workers daily commute logistic activities  fast detection quarantine health alert single zoonosis case occurs would prevent humantohuman transfer pathogen quarantine delay circle would allow immediate containment zoonosis closing biofacility outside world  preventive prophylaxisvaccination safety distancing frequent health checks hygiene measures disinfection spraying would prevent local outbreak  fast response contain local outbreak would possible via routine detection using sensors sniffers irthermometers swabtests immediate alert direct quarantine travelling originating biofacility must stopped suspect infection cases must quarantined social contacts must traced quarantined safe waste waste water disposal methods must place local hubs long distance travelling must subjected emergency biosecurity detection comparison deconstruction reconstruction pillay <NUMBER> p<NUMBER> argues gap work imagined work performed important aspect comparison deconstruction reconstruction shows gap even <NUMBER> barrier groups reaches <NUMBER> effectivity remaining probability pandemic reduced factor <NUMBER> <NUMBER> effectivity per barrier factor becomes <NUMBER> barrier <NUMBER> effective probability scenario passes barrier p <NUMBER> <NUMBER> probability scenario passes <NUMBER> barriers series p <NUMBER> <NUMBER> <NUMBER> <NUMBER> inverse reduction factor <NUMBER> means <NUMBER> preventive barrier groups connected series effectively stop pandemic first outbreak performances practice countries biosecurity interventions wang artois et al <NUMBER> whether fast emergency response implementation robust travelling restrictions automated contacts tracing stockpile emergency supplies full lockdown illustrate feasibility taking effective measures covid<NUMBER> pandemic shown many countries safety management perspective prevention repression failed hand several countries shown remarkable successes repression prevention sense avoiding pandemic altogether fully exploited two paradigms acceptance pandemic risk given happens deal medical emergency led effective pandemic risk control would seem considering proactive prevention pandemic risk received little attention ignorance lacking biosafety biosecurity measures limited protective means people close animals among causal factors many opportunities improvement tradeoff investment effective country biosecurity programmes prevention systems social economic damage caused global pandemic likely favour prevention education biosafety biosecurity management systems supports sustainability effective pandemic prevention barriers would minimum comprise humananimal distancing personal protection routine monitoring testing proactive preparation outbreak new pathogen requires continuous research detection methods vaccines time lost onset pandemic due failure preventive measures repression covid<NUMBER> pandemic taken force undue delay spreading virus beyond wuhan region could stopped successive methodically differing attempts many countries resulted exemplary relatively successful cases many poor responses global death toll june <NUMBER> <NUMBER> exceeds <NUMBER> still increasing many western countries slow response initially unrestrained travelling preparation influenza viruses rather sars like viruses major logistical problems materials equipment facilities played main role quality leadership became issue several countries paradigm medical emergency addressing needed huge socioeconomic aftermath addressed advance even foreseen specific preparation activities barriers avoid minimize socioeconomic damage place societal resilience currently based huge financial emergency reserve funds new ways needed protect businesses institutions individuals sudden loss income due large scale enforced closure lack protection leads deterioration complex society building many decades pandemics future might fully recover next one hits new solutions needed accommodate social distancing public spaces incapacitated public transport alleviation social deprivation caused unsuitable buildings wide variety services bringing people close proximity course daunting effort required us would take prevention pandemic risk seriously coronaviruses covs group enveloped positivesensed singlestranded rna viruses within subfamily coronavirinae family coronaviridae order nidovirales coronaviruses divided four genera alphacoronaviruses betacoronaviruses gammacoronaviruses deltacoronaviruses past decades two highly transmissible pathogenic covs severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov emerged humans caused global concerns sarscov first recorded guandong china december <NUMBER> rapidly spread five continents peiris et al <NUMBER> sarscov outbreak ultimately caused <NUMBER> infections <NUMBER> deaths worldwide according merscov firstly emerged arabian peninsula <NUMBER> zaki et al <NUMBER> caused <NUMBER> confirmed cases including <NUMBER> deaths middle east countries uk south korea according sarscov merscov likely originated wild animals prone cause lethal pneumonia humans cui et al <NUMBER> currently vaccine specific antiviral drugs prevent treat infections transmission humans december <NUMBER> cluster pneumonia patients link huanan seafood market potential animal contact reported wuhan hubei province china zhou p et al <NUMBER> zhu et al <NUMBER> subsequently disease rapidly spread throughout world become pandemic etiologic agent disease identified novel coronavirus several independent groups named sarscov<NUMBER> due close relationship sarscov disease subsequently termed coronavirus disease <NUMBER> common clinical manifestations patients fever cough shortness breath fatigue patients radiographic groundglass lung changes finally died acute respiratory distress syndrome ards wang et al <NUMBER> declared covid<NUMBER> public health emergency international concern january <NUMBER> <NUMBER> full genome sequencing analysis classified sarscov<NUMBER> new member betacoronavirus genus includes sarscov merscov bat sarsrelated coronaviruses sarsrcov sarscov<NUMBER> <NUMBER> nucleotide identity sarscov <NUMBER> identify bat cov ratg<NUMBER> discovered cave yunnan china <NUMBER> zhou p et al <NUMBER> like covs genome rna sarscov<NUMBER> encodes nonstructural replicase polyprotein structural proteins including spike envelope e membrane nucleocapsid n proteins protein covs constitutes spike virion surface plays vital role viral binding fusion entry well induction neutralizingantibody tcell responses du et al <NUMBER> importantly several pioneering investigations demonstrated sarscov<NUMBER> sarscov utilizes cellular receptor human angiotensinconverting enzyme <NUMBER> hace<NUMBER> enter cells li et al <NUMBER> zhou p et al <NUMBER> crystal structure sarscov<NUMBER> protein receptorbinding domain rbd binding hace<NUMBER> resolved estimated <NUMBER> <NUMBER>fold higher affinity towards hace<NUMBER> sarscov lan et al <NUMBER> shang et al <NUMBER> findings pave way potent intervention strategies targeting rbdhace<NUMBER> interactions exogenous hace<NUMBER> demonstrated inhibit sarscov<NUMBER> infection cell cultures v et al <NUMBER> x et al <NUMBER> several monoclonal antibodies targeting rbd sarscov sarscov<NUMBER> tested using vitro cultures walls et al <NUMBER> present vaccine antiviral drugs tested effectively animal models small animal models reproduce clinical course pathology observed covid<NUMBER> patients highly needed present study generated stable humanized ace<NUMBER> mice using crisprcas<NUMBER> knockin technology replacing endogenous mouse ace<NUMBER> mace<NUMBER> human ace<NUMBER> characterization demonstrated humanized mice highly susceptible sarscov<NUMBER> infection via intranasal inoculation viral kinetics pathological outcomes seen sarscov<NUMBER> infected animals recapitulated major finding covid<NUMBER> patients additionally intragastric injection sarscov<NUMBER> could also establish infection caused lung injury humanized ace<NUMBER> mice unique mouse model described provides useful tool studying sarscov<NUMBER> infection transmission well evaluating sarscov<NUMBER> vaccines therapeutics previous studies demonstrated transgenic mice expressing human ace<NUMBER> became highly susceptible sarscov infection mccray et al <NUMBER> menachery et al <NUMBER> netland et al <NUMBER> tseng et al <NUMBER> yang et al <NUMBER> aimed establish humanized ace<NUMBER> mouse using crisprcas<NUMBER> knockin technology shown figure <NUMBER>a <NUMBER> full cdnas hace<NUMBER> inserted exon <NUMBER> fig<NUMBER>a first coding exon mace<NUMBER> gene located grc m<NUMBER>p<NUMBER> sites chromosome x disrupted mace<NUMBER> gene terminated expression tdtomato gene inserted downstream hace<NUMBER> internal ribosome entry site ires allowing coexpression hace<NUMBER> tdtomato woodchuck hepatitis virus posttranscriptional regulatory element wpre poly sequence added enhance mrna stability translation efficiency targeting strategy allowed intrinsic expression profile hace<NUMBER> control mace<NUMBER> promoter along subgenomic rna sgrna cas<NUMBER> mrna targeting construct injected <NUMBER> zygotes c<NUMBER>bl<NUMBER> mice successful insertion <NUMBER> <NUMBER> offspring <NUMBER> confirmed pcr screen figure <NUMBER>b three founders backcrossed c<NUMBER>bl<NUMBER> mice <NUMBER> f<NUMBER>positive offspring screened targeting results <NUMBER> positive f<NUMBER> mice confirmed sequencing figure <NUMBER>c southern blotting figure <NUMBER>d expected animals random insertion demonstrated wpre internal probe figure <NUMBER>d importantly western blotting results showed hace<NUMBER> expression strong lung kidney weak spleen liver displayed similar expression pattern mace<NUMBER> protein wildtype wt animals figure <NUMBER>e importantly mace<NUMBER> gene detected pcr homozygous hace<NUMBER> mice decreased largely heterozygous mice figure <NUMBER>f significant hace<NUMBER> expression detected lung small intestine spleen kidney hace<NUMBER> heterozygous homozygous mice wt mice figure <NUMBER>g profiting coexpression design rough global expression patterns hace<NUMBER> examined visually via bioluminescent imaging hace<NUMBER> mice figure <NUMBER>h furthermore immunofluorescence staining lung sections homozygous mice showed hace<NUMBER> well tdtomato predominantly expressed cc<NUMBER> clara cells along airway well small population surfactant protein c positive spc alveolar type ii cells figure <NUMBER>i thus established homozygous mouse model stably expresses hace<NUMBER> control mace<NUMBER> promoter termed hace<NUMBER>kinifdc mice abbreviated hace<NUMBER> mice accordingly characterize susceptibility hace<NUMBER> mice sarscov<NUMBER> infection groups young <NUMBER>weekold aged <NUMBER>weekold hace<NUMBER> mice intranasally infected <NUMBER> <NUMBER>×<NUMBER> <NUMBER> pfu sarscov<NUMBER> wildtype wt c<NUMBER>bl<NUMBER> mice received dose viral challenge set control figure <NUMBER>a animals monitored daily clinical symptoms body weight changes sacrificed day <NUMBER> post infection dpi none inoculated animals displayed obvious clinical symptoms aged hace<NUMBER> mice lost <NUMBER> weight <NUMBER> dpi recovered figure s<NUMBER> shown figure <NUMBER>b robust viral rna replication seen lung trachea brain tissues young aged hace<NUMBER> mice detectable viral rna seen spleen kidney liver intestine serum especially infectious sarscov<NUMBER> successfully rescued lung samples using plaque assay expected viral rnas detected tested tissues serum wt c<NUMBER>bl<NUMBER> mice figure <NUMBER> interestingly also detected high level viral rnas <NUMBER>×<NUMBER> <NUMBER> copiesg feces aged hace<NUMBER> mice immunostaining mouse lung section showed robust viral protein detected along airway young aged hace<NUMBER> mice bare viral protein detected sarscov<NUMBER>inoculated wt mice figure <NUMBER>c confirm major target cells sarscov<NUMBER> model stained lung section infected hace<NUMBER> mice different cell markers including clara cells marked clara cell <NUMBER> kda proteincc<NUMBER> ciliated cells marked βivtubulin alveolar type <NUMBER> cells at<NUMBER> marked podoplaninpdpn alveolar type <NUMBER> cells at<NUMBER> marked surfactant protein cspc well viral protein hace<NUMBER> shown figure <NUMBER>d sarscov<NUMBER> protein predominantly colocalized cc<NUMBER> hace<NUMBER> indicating cc<NUMBER>postive clara cells major target cells sarscov<NUMBER> along airway model additionally immunostaining brain sections infected hace<NUMBER> mice showed robust viral protein expression could also detected neuron astrocyte microglial cells figure s<NUMBER> together results indicate hace<NUMBER> mice highly susceptible intranasal infection sarscov<NUMBER> compared wt mice sustained robust viral rna replication lung clara cells well trachea brain check whether sarscov<NUMBER> infected hace<NUMBER> mice produced similar pathological features observed covid<NUMBER> patients histopathological examination immunohistochemistry ihc immunofluorescence staining performed lung sections sarscov<NUMBER> infected animals compared sarscov<NUMBER> infected wt <NUMBER> mice staining showed young aged hace<NUMBER> mice developed interstitial pneumonia characterized inflammatory cell infiltration alveolar septal thickening distinctive vascular system injury lesions alveolar epithelial cells focal hemorrhage observed aged mice figure <NUMBER>a compared wt mice ihc staining analysis showed sarscov<NUMBER> infection induced neutrophils neu macrophages cd<NUMBER> infiltration aged hace<NUMBER> mice figure <NUMBER>bc additionally immunofluorescence costaining showed sarscov<NUMBER> directly infected cd<NUMBER>positive macrophages lung resulting significant apoptosis ccasp<NUMBER> aged hace<NUMBER> mice figure <NUMBER>d importantly luminex cytokine analysis showed sarscov<NUMBER> infection led elevated cytokine production including eotaxin gcsf ifnγ il<NUMBER> mip<NUMBER>β aged hace<NUMBER> mice weaker response young mice figure <NUMBER>e table s<NUMBER> thus hace<NUMBER> mice sustained viral replication also developed pulmonary pathology upon sarscov<NUMBER> infection sarscov<NUMBER> mainly transmits via droplets close contact among humans however patients covid<NUMBER> infection gastrointestinal symptoms diarrhea abdominal pain vomiting lin et al <NUMBER> wang et al <NUMBER> viral rnas detected feces covid<NUMBER> patients xu et al <NUMBER> highlighting possibility fecaloral transmission sarscov<NUMBER> yeo et al <NUMBER> sought investigate whether sarscov<NUMBER> could establish productive infection via intragastric route hace<NUMBER> mice following intragastric administration sarscov<NUMBER> animals subjected daily monitoring tissue processing <NUMBER> dpi figure <NUMBER>a albeit clinical signs seen three inoculated hace<NUMBER> mice high level viral rna detected trachea <NUMBER>×<NUMBER> <NUMBER> copiesg lung <NUMBER>×<NUMBER> <NUMBER> copiesg two animals figure <NUMBER>b comparable animals infected via intranasal route importantly expression sarscov<NUMBER> protein also detected along lung airway infected hace<NUMBER> mice figure <NUMBER>c addition interstitial inflammation observed alveolar septal thickening intagastric sarscov<NUMBER> infected hace<NUMBER> mice figure <NUMBER>d overall results demonstrated intragastric administration sarscov<NUMBER> could also establish productive infection lead pulmonary pathological changes hace<NUMBER> mice present study generated stable humanized mouse strain hace<NUMBER> expression control ires fusion tdtomato reporter gene characterization demonstrated expression mace<NUMBER> completely replaced hace<NUMBER> homozygous mice peak hace<NUMBER> expression lung small intestine figure <NUMBER> previously several hace<NUMBER> transgenic mice generated different strategies used modeling sarscov infection mccray et al <NUMBER> tseng et al <NUMBER> generally pulmonary pathology caused sarscov transgenic mice correlated level hace<NUMBER> expression lung thus transgenic mouse explored mimic sarscov<NUMBER> infection bao et al <NUMBER> compared transgenic mouse model hace<NUMBER> mouse model several advantages first hace<NUMBER> gene inserted grc m<NUMBER>p<NUMBER> sites chromosome x replace mace<NUMBER> endogenous mace<NUMBER> expression homozygous hace<NUMBER> mice since transgene insertion occurs randomly integrity landing genes would probably affected second tissue distribution hace<NUMBER> mouse model matches clinical findings covid<NUMBER> patients high level hace<NUMBER> expression detected lung figure <NUMBER>e interestingly recent analysis based singlecell sequencing results human tissues showed kidney heart esophagus bladder ileum also represent tissues high abundance zou et al <NUMBER> liver spleen small intestine ovary brain hace<NUMBER> abundant tissues model figure <NUMBER>h inconsistency human mice deserves investigation third introduction tdtomato gene allows realtime monitoring hace<NUMBER> expression ideal physiological features stable inheritance phenotype hace<NUMBER> mice prompted us test application reproducing sarscov<NUMBER> infection surprisingly challenge experiment sarscov<NUMBER> clearly demonstrated hace<NUMBER> mice highly susceptible sarscov<NUMBER> infection via intranasal inoculation <NUMBER>×<NUMBER> <NUMBER> pfu sarscov<NUMBER> readily led robust viral replication respiratory tracts lung trachea well brain peaked viral rna loads lung reached <NUMBER> <NUMBER> copiesg much higher hace<NUMBER> transgenic mice bao et al <NUMBER> presence viral rnas brain somewhat unexpected covid<NUMBER> patients developed neurological systems previous findings sarscov <NUMBER> infected transgenic model also confirmed viral tropism brain mccray et al <NUMBER> consistent findings underlying mechanism sarscov sarscov<NUMBER> invades brain correlation disease severity remain determined characterization demonstrated cc<NUMBER> clara cells along airway major target cells sarscov<NUMBER> figure <NUMBER>d model specific protease clara cells like tryptase clara might contribute efficient cleavage protein enhance viral entry cells additionally cd<NUMBER> macrophages pulmonary alveolus also infected sarscov<NUMBER> resulting severe cell apoptosis figure <NUMBER>d interestingly significant population cells express hace<NUMBER> also infected sarscov<NUMBER> figure <NUMBER>d sarscov<NUMBER> invades cells also deserves investigation overall result provides first line evidence showing specific major target cells sarscov<NUMBER> mouse lung importantly hace<NUMBER> mice intranasal challenged sarscov<NUMBER> developed interstitial pneumonia characterized inflammatory cell infiltration alveolar septal thickening distinctive vascular system injury recapitulated clinical features covid<NUMBER> patients early epidemiological findings suggested advanced age resulted increased mortality covid<NUMBER> patients yang et al <NUMBER> zhou f et al <NUMBER> results hace<NUMBER> model well reflect finding aged hace<NUMBER> mice <NUMBER>weekold lost weight upon sarscov<NUMBER> infection young hace<NUMBER> mice <NUMBER>weekold well wt mice maintained body weight increase observation period figure s<NUMBER> remarkably although young aged mice sustained similar viral replication lung severe pathological changes well increased cytokine response seen aged hace<NUMBER> mice figure <NUMBER> unique features aged hace<NUMBER> mice resembling clinical findings highlight potential application different settings noted clinical symptoms mortality observed model animal models recapitulate severe lethal disease covid<NUMBER> warranted future several lines evidence support potential fecaloral transmission sarscov<NUMBER> first gastrointestinal symptoms seen many covid<NUMBER> patients jin et al <NUMBER> lin et al <NUMBER> viral shedding feces well reported second ace<NUMBER> found highly expressed gastrointestinal epithelial cells vitro studies also indicated sarscov<NUMBER> infect multiple cells gastrointestinal tracts third experience sars mers supported human covs maintained <NUMBER> viability environmental conditions essential fecaloral transmission chan et al <NUMBER> van doremalen et al <NUMBER> recent data sarscov<NUMBER> revealed similar stability sarscov suggesting similar transmission routes plausible van doremalen et al <NUMBER> results hace<NUMBER> mouse model provide evidence supporting hypothesis upon intranasal infection viral rna shading also confirmed feces hace<NUMBER> mice data shown due facility limitation able collect quantitate feces sample individual animal importantly sarscov<NUMBER> given authors declare competing interests <NUMBER> star★ ★ ★ ★methods information requests resources reagents directed fulfilled lead contact youchun wang wangycnifdcorgcn uniquestable reagents generated study available lead contact completed materials transfer agreement study generate unique datasets code groups <NUMBER> weeks <NUMBER> weeks old hace<NUMBER> wildtype c<NUMBER>bl<NUMBER> female mice sarscov<NUMBER> infection maintained animal biosafety level <NUMBER> absl<NUMBER> containment laboratory amms <NUMBER>°c animals allowed free access water diet provided <NUMBER> h lightdark cycle animal experiments approved experimental animal committee nifdc approval number <NUMBER>b<NUMBER> laboratory animal center amms approval number iacucdwzx<NUMBER> vero cells sarscov<NUMBER> propagation titeration maintained dmem medium gibco supplemented <NUMBER> fbs pan biotech <NUMBER> penecillin streptomycin gibco <NUMBER> hepes gibco <NUMBER>℃ sarscov<NUMBER> strain betacovwuhanamms<NUMBER> originally isolated cfqs lab amms patient returning wuhan virus amplified vero cells titerated standard plaque forming assay briefly vero cells <NUMBER>well plates infected <NUMBER>fold serial dilution viruses plates incubated <NUMBER> °c <NUMBER> h cells overlaid <NUMBER> lowmelting point agarose promega dmem containing <NUMBER> fbs incubation <NUMBER> °c <NUMBER> days cells fixed <NUMBER> formaldehyde stained <NUMBER> crystal violet visualize plaques experiments involving infectious sarscov<NUMBER> performed biosafety level <NUMBER> bsl<NUMBER> containment laboratory amms construct targeting vector cdnas encoding hace<NUMBER> linked red fluorescent protein tdtomato ires sequence flowed wpre ploya inserted first coding exon mace<NUMBER> homologous recombination expression inserted hace<NUMBER> tdtomato gene driven mouse mace<NUMBER> promoter specific targeting sgrna <NUMBER>gaaagatgtccagctcctcctgg<NUMBER> cas<NUMBER> mrna microinjected c<NUMBER>bl<NUMBER> zygotes subsequently implanted pseudopregnant mice f<NUMBER> offspring genotyped using two pairs primers lgtf<NUMBER> lgtr<NUMBER> rgtf<NUMBER> rgtr<NUMBER> table s<NUMBER> expected size amplicons <NUMBER> bp <NUMBER> bp respectively genotypepositive founders backcrossed c<NUMBER>bl<NUMBER> mice produce generation f<NUMBER> dna samples f<NUMBER>positive mice subjected southern blotting confirm offtargeting wpre <NUMBER> probe correct insertion <NUMBER> probe two endonucleases ncoi thermo stui thermo used digest dna identifying right insertion random recombinant confirm expression hace<NUMBER> mace<NUMBER> humanized mice tissues <NUMBER> weeks old <NUMBER> weeks old mice dissected immediately immersed rnalater invitrogen stabilization reagent stored <NUMBER>℃ total rna extracted individual tissues using trizol quantified using spectrophotometer realtime quantitative pcr <NUMBER> rtqpcr performed using reverse transcription rtpcr kit takara containing sybr green dye reaction performed triplicate relative expression level hace<NUMBER> mace<NUMBER> determined using primer pairs ehace<NUMBER> f<NUMBER> ehace<NUMBER> r<NUMBER> emace<NUMBER>f<NUMBER> emace<NUMBER>r<NUMBER> table s<NUMBER> amplicons normalized expression gapdh glyceraldehyde <NUMBER>phosphate dehydrogenase mouse tissues homogenized cell lysis buffer western ip <NUMBER> mm trishcl ph <NUMBER> containing <NUMBER> mm nacl <NUMBER> mm edta <NUMBER> triton x<NUMBER> supplemented phenylmethanesulfonyl fluoride pmsf beyotime denatured protein lysates separated using <NUMBER> sdspage gels transfer ace<NUMBER> antibody huabio <NUMBER> gapdh antibody abcam <NUMBER> added followed horseradish peroxidase hrpconjugated antimouse rabbit igg abcam <NUMBER> pierce ecl western blotting substrate thermo used development bioluminescence imaging bli mice anesthetized intraperitoneal injection pelltobarbitalum natricum sigma <NUMBER> mgkg body weight tdtomato bioluminescence imaging performed ivislumina ii imaging systemxenogen relative intensities presented pseudocolored images photon flux photon pscm <NUMBER> sr intranasal infection wildtype c<NUMBER>bl<NUMBER> mice young <NUMBER> weeks old aged <NUMBER> weeks old hace<NUMBER> mice anesthetized sodium pentobarbital dose <NUMBER> mgkg though intraperitoneal route intranasally infected <NUMBER>×<NUMBER> <NUMBER> pfu sarscov<NUMBER> respectively intragastric infection animals fed <NUMBER>×<NUMBER> <NUMBER> pfu sarscov<NUMBER> <NUMBER> μl via intragastric gavage using balltipped <NUMBER>gauge feeding needle mice weighed monitored daily sacrificed day <NUMBER> <NUMBER> post infection serum collection tissue processing viral rna sample extracted rneasy mini kit qiagen according protocols viral rna quantification performed rtqpcr targeting gene sarscov<NUMBER> rtqpcr performed using one step primescript rtpcr kit takara following primers probes covf<NUMBER> covr<NUMBER> covp<NUMBER> table s<NUMBER> mouse tissues excised fixed <NUMBER> neutral buffered formaline dehydrated embedded paraffin embedded tissue sectioned <NUMBER> μm thickness longitudinal sections three tissue sections derived different parts tissue stained hematoxylin eosin according standard procedures examination light microscopy degree lung damage light microscopy assessed degeneration alveolar epithelial cells expansion parenchymal wall edema hemorrhage inflammatory cells infiltration semiquantitative assessment performed reported previously described briefly following haagmans et al <NUMBER> van den brand et al <NUMBER> degree degeneration alveolar epithelial cells scored <NUMBER> alveolar epithelial cells degeneration observed scored <NUMBER> alveolar epithelial cells degeneration less <NUMBER> scored <NUMBER> degeneration <NUMBER> degree parenchymal wall expansion scored <NUMBER> parenchymal wall expanded scored <NUMBER> area expanded parenchymal wall less <NUMBER> focal fusion observed scored <NUMBER> area <NUMBER> focal fusion observed degree edema scored <NUMBER> edema observed scored <NUMBER> area edema less <NUMBER> scored <NUMBER> area <NUMBER> degree inflammatory cells infiltration scored <NUMBER> inflammatory cell infiltration scored <NUMBER> occasional infiltration single inflammatory cell visible scored <NUMBER> focal infiltration inflammatory cells visible lesion lung observed experienced experimental pathologist focuses pathogenesis study virus infection cumulative scores severity three sections provided total score per animal average three animals taken total score group <NUMBER> μm paraffin sections deparaffinised xylene rehydrated series graded alcohols antigen retrievals performed citrate buffer ph<NUMBER> microwave <NUMBER> min <NUMBER>°c followed <NUMBER> min cool room temperature multiplex fluorescence labeling performed using tsadendronfluorophores neon <NUMBER>color allround discovery kit ffpe histova biotechnology briefly endogenous peroxidase quenched <NUMBER> h <NUMBER> <NUMBER> <NUMBER> min followed blocking reagent <NUMBER> min room temperature primary antibody incubated <NUMBER>h humidified chamber <NUMBER>°c followed detection using hrpconjugated secondary antibody tsadendronfluorophores afterwards primary secondary antibodies thoroughly eliminated heating slides retrievalelution buffer abcracker <NUMBER> sec <NUMBER>°c using microwave serial fashion antigen labeled distinct fluorophores multiplex antibody panels applied study ace<NUMBER> paraffinembedded tissues sectioned thickness <NUMBER> μm immunohistochemistry staining sections deparaffinized rehydrated endogenous peroxidases inactivated methanol containing <NUMBER> hydrogen peroxide <NUMBER> min antigen retrieval performed citrate buffer ph<NUMBER> <NUMBER>°c <NUMBER> min incubation blocking solution <NUMBER> normal goat serum <NUMBER> min room temperature slides incubated neutrophil marker antibody santa cruz biotechnology <NUMBER> rabbit anticd<NUMBER> polyclonal antibody abcam <NUMBER> overnight <NUMBER>°c three washes sections incubated biotinylated antiigg <NUMBER>°c <NUMBER>h followed streptavidinperoxidase conjugate zhongshan biotechnology immunoreactivity detected using <NUMBER> <NUMBER> diaminobenzidine sections counterstained hematoxylin observation microscopy measure macrophage neutrophil infiltration semiquantitatively <NUMBER> arbitrarily chosen <NUMBER>× neutrophil <NUMBER> × macrophage objective fields lung parenchyma lung section examined light microscopy presence neutrophils macrophages assessment performed blinded fashion cumulative scores animal expressed number positive fields per <NUMBER> fields total <NUMBER> μl serum mouse adopt cytokine analysis bioplex pro mouse cytokine grp panel <NUMBER>plex biorad according manufacturers instructions data collected luminex <NUMBER> analyzed luminex ponent thermo fisher statistical analyses carried using prism software graphpad prism <NUMBER> data semiquantitative analysis hestained lung sections presented mean statistical significance wt hace<NUMBER> mice assessed mann whitney test students tests data presented mean ± sem statistical significance ihc staining analysis wt hace<NUMBER> mice assessed unpaired students tests statistical significance assessed shapirowilk normality test used determine whether data met normal distribution statistical details experiments animal replication numbers n stated relevant figure legends method details p value less <NUMBER> considered statistically significant human ace<NUMBER> knockin mice generated using crisprcas<NUMBER> technology sarscov<NUMBER> leads robust replication lung trachea brain sarscov<NUMBER> causes interstitial pneumonia elevated cytokine aged hace<NUMBER> mice high dose sarscov<NUMBER> establish infection via intragastric route hace<NUMBER> mice covid<NUMBER> pandemic brought urgent need small animal models sun current pandemic coronavirus sarscov<NUMBER> recently identified patients acute respiratory syndrome covid<NUMBER> compare pathogenesis previously emerging coronaviruses inoculated cynomolgus macaques sarscov<NUMBER> merscov compared pathology virology historical reports sarscov infections sarscov<NUMBER>infected macaques virus excreted nose throat absence clinical signs detected type ii pneumocytes foci diffuse alveolar damage ciliated epithelial cells nasal bronchial bronchiolar mucosae sarscovinfection lung lesions typically severe milder merscov infection virus detected mainly type ii pneumocytes data show sarscov<NUMBER> causes covid<NUMBER>like disease macaques provides new model test preventive therapeutic strategies swabs aged animals compared young animals sarscov<NUMBER> rna detection throat swabs peaked day <NUMBER> pi young day <NUMBER> pi aged animals decreased rapidly time comparison nasal swabs could still detected intermittently day <NUMBER> pi fig <NUMBER>b low levels infectious virus cultured throat nasal swabs day <NUMBER> <NUMBER> respectively table s<NUMBER> support virus shedding animals environmental sampling performed determine potential contamination surfaces environmental sampling indicated presence low levels sarscov<NUMBER> rna surfaces direct contact hands indirect contamination within isolator table s<NUMBER> sarscov<NUMBER> rna detected rectal swab one animal day <NUMBER> pi viral rna detected whole blood time point throughout study autopsy four macaques day <NUMBER> pi two foci pulmonary consolidation lungs fig <NUMBER>a one animal aged <NUMBER> years showed consolidation right middle lobe representing less <NUMBER> lung tissue second animal young <NUMBER> years two foci left lower lobe representing <NUMBER> lung tissue fig <NUMBER>a consolidated lung tissue wellcircumscribed redpurple level less buoyant normal organs two macaques well respiratory tract organs two animals normal virus replication assessed rtqpcr day <NUMBER> pi tissues respiratory digestive urinary cardiovascular tracts endocrine central nervous systems well various lymphoid tissues virus replication primarily restricted respiratory tract nasal cavity trachea bronchi lung lobes highest levels sarscov<NUMBER> rna lungs fig <NUMBER>c interestingly three four animals sarscov<NUMBER> rna also detected ileum tracheobronchial lymph nodes fig <NUMBER>c main histological lesion consolidated pulmonary tissues young aged animals involved alveoli bronchioles consisted areas acute advanced dad fig <NUMBER>b areas lumina alveoli bronchioles variably filled proteinrich edema fluid fibrin cellular debris alveolar macrophages fewer neutrophils lymphocytes fig <NUMBER>ce epithelial necrosis extensive loss epithelium alveolar bronchiolar walls hyaline membranes present damaged alveoli areas advanced lesions alveolar walls moderately thickened lined cuboidal epithelial cells type ii pneumocyte hyperplasia alveolar lumina empty alveolar bronchiolar walls thickened edema fluid mononuclear cells neutrophils aggregates lymphocytes around small pulmonary vessels moderate numbers lymphocytes macrophages present lamina propria submucosa bronchial walls neutrophils bronchial epithelium regeneration epithelium seen bronchioles visible irregular layer squamous high cuboidal epithelial cells hyperchromatic nuclei occasional multinucleated giant cells syncytia free lumina bronchioles alveoli fig <NUMBER>f based positive pankeratin staining negative cd<NUMBER> staining appeared originate epithelial cells fig <NUMBER>f inset sarscov<NUMBER> antigen expression detected moderate numbers type pneumocytes type ii pneumocytes within foci dad fig <NUMBER>g fig <NUMBER>h fig s<NUMBER> pattern staining similar lung tissue sarscovinfected macaques positive control sarscov<NUMBER> antigen expression observed syncytia addition sarscov<NUMBER> antigen expression detected nonlesional tissues lung lobes three four macaques young one aged type ii pneumocytes bronchial ciliated epithelial cells bronchiolar ciliated epithelial cells aged macaque without virological pathological evidence sarscov<NUMBER> infection lungs sarscov<NUMBER> antigen expression ciliated epithelial cells nasal septum fig <NUMBER>i nasal concha palatum molle absence associated histopathological changes sarscovantigen expression detected sampled tissues including brain intestine assess severity infection sarscov<NUMBER> compared merscov young cynomolgus macaques <NUMBER> years age inoculated merscov via route animals remained free clinical signs day <NUMBER> pi remaining animals n<NUMBER> seroconverted revealed presence merscov specific antibodies sera elisa fig s<NUMBER> merscov rna detected nasal fig <NUMBER>a throat swabs fig <NUMBER>b days <NUMBER> pi peaks days <NUMBER> <NUMBER> pi respectively low levels <NUMBER> tcid<NUMBER> equivalentml merscov rna detected rectal swabs days <NUMBER> <NUMBER> pi autopsy four macaques day <NUMBER> pi three animals foci pulmonary consolidation characterized slightly depressed areas lungs representing less <NUMBER> lung tissue table <NUMBER> similar sarscov<NUMBER> infection young aged animals day <NUMBER> pi merscov rna primarily detected respiratory tract inoculated animals fig <NUMBER>c infectious virus titers comparable sarscov<NUMBER> lower compared sarscov infection young macaques table <NUMBER> addition merscov rna detected spleen table <NUMBER> consistent presence virus lower respiratory tract day <NUMBER> pi histopathological changes characteristic dad observed lungs inoculated animals fig <NUMBER>d alveolar septa thickened owing infiltration neutrophils macrophages moderate type ii pneumocyte hyperplasia hypertrophy alveolar lumina elevated alveolar macrophages edema fluid containing fibrin neutrophils fig <NUMBER>d syncytial cells seen alveolar lumina interestingly merscov antigen detected tissues day <NUMBER> pi part respiratory tract therefore sampled four young macaques day <NUMBER> pi time observed multifocal expression viral antigen predominantly type ii pneumocytes occasionally type pneumocytes bronchiolar bronchial epithelial cells macrophages fig <NUMBER>d summary inoculated young aged cynomolgus macaques low passage clinical isolate sarscov<NUMBER> resulted productive infection absence overt clinical signs recent studies human cases shown presymptomatic asymptomatic cases also shed virus <NUMBER> <NUMBER> increased age affect disease outcome prolonged viral shedding upper respiratory tract aged animals prolonged shedding observed sarscov<NUMBER> sarscov patients <NUMBER> <NUMBER> interestingly sarscov<NUMBER> shedding asymptomatic model peaked early course infection similar seen symptomatic patients <NUMBER> also sarscov<NUMBER> antigen detected ciliated epithelial cells nasal mucosae day <NUMBER> pi seen sarscov <NUMBER> merscov infections manuscript animal model viral tropism nasal mucosa fits efficient respiratory transmission seen influenza virus <NUMBER> early peak virus shedding sarscov<NUMBER> similar influenza virus shedding <NUMBER> may explain case detection isolation may effective sarscov<NUMBER> control sarscov <NUMBER> sarscov<NUMBER> primarily detected tissues respiratory tract however sarscov<NUMBER> rna also detectable tissues intestines line recent report <NUMBER> similar results regarding viral shedding tissue cell tropism recently also reported following sarscov<NUMBER> inoculation rhesus macaques however unlike model sarscov<NUMBER> infection rhesus macaques result transient respiratory disease weight loss <NUMBER> <NUMBER> two four animals foci dad day <NUMBER> pi colocalisation sarscov<NUMBER>antigen expression dad provides strong evidence sarscov<NUMBER> infection caused lesion histological character dad including alveolar bronchiolar epithelial necrosis alveolar edema hyaline membrane formation accumulation neutrophils macrophages lymphocytes corresponds limited pathological analyses human covid<NUMBER> cases <NUMBER> <NUMBER> particular presence syncytia lung lesions characteristic respiratory coronavirus infections whereas merscov primarily infects type ii pneumocytes cynomolgus macaques sarscov sarscov<NUMBER> also infect type pneumocytes injury type pneumocytes result pulmonary edema formation hyaline membranes <NUMBER> may explain hyaline membrane formation hallmark sars covid<NUMBER> <NUMBER> <NUMBER> frequently reported mers <NUMBER> <NUMBER> data show cynomolgus macaques permissive sarscov<NUMBER> infection shed virus prolonged period time display covid<NUMBER>like disease nonhuman primate model sarscov<NUMBER> replicates efficiently respiratory epithelial cells throughout respiratory tract including nasal cavity bronchi bronchioles alveoli replication upper respiratory tract fits efficient transmission hosts replication lower respiratory tract fits development lung disease indepth comparison infection sarscov merscov sarscov<NUMBER> model may identify key pathways pathogenesis emerging viruses study provides novel infection model critical evaluation licensure preventive therapeutic strategies sarscov<NUMBER> infection use humans well evaluating efficacy repurposing species specific existing treatments pegylated interferon <NUMBER> intratracheal <NUMBER> ml intranasal <NUMBER> ml per nostril routes suspension containing <NUMBER>x<NUMBER>e<NUMBER> tcid<NUMBER> per ml pbs total infectious dose <NUMBER>e<NUMBER> tcid<NUMBER> animals anesthetized challenge blood collection swabs nasal throat rectal mucosa days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi one group four animals two young <NUMBER> aged euthanized autopsied day <NUMBER> pi collection tissue specimens respiratory digestive urinary cardiovascular tracts endocrine central nervous systems well various lymphoid organs group euthanized day <NUMBER> pi collection tissue specimens respiratory digestive urinary cardiovascular tracts endocrine central nervous systems well various lymphoid organs ten female young adult cynomolgus macaques <NUMBER> years weighing <NUMBER> kg distributed evenly regarding age two groups four animals one group two animals animals inoculated merscov anesthesia combination intratracheal <NUMBER> ml intranasal <NUMBER> ml per nostril inoculation suspension containing <NUMBER>x<NUMBER>e<NUMBER> tcid<NUMBER> per ml pbs total infectious dose <NUMBER>e<NUMBER> tcid<NUMBER> animals anesthetized challenge blood collections taking nasal throat rectal swabs days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi groups four animals euthanized autopsied days <NUMBER> <NUMBER> pi collection tissue specimens respiratory digestive urinary cardiovascular tracts endocrine central nervous systems well various lymphoid organs one group <NUMBER> animals euthanized day <NUMBER> pi isolator two animals following surfaces swabbed drinking nipple wall inside animal cage often touched <NUMBER>x ceiling area outside animal cage never touched animals <NUMBER>x two control swabs handled way environmental samples including opening package removing swab tube without sampling surfaces plastic sterile swabs wetted viral transport medium surface area swabbed two different directions total swab surface <NUMBER> cm<NUMBER> <NUMBER>x<NUMBER> cm possible test sarscov<NUMBER> antibodies serum samples collected days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> serum samples tested sarscov<NUMBER> antibodies using spike s<NUMBER> nucleocapsid n elisas <NUMBER> briefly elisa plates coated overnight either sarscov<NUMBER> s<NUMBER> sarscov n proteins blocking serum samples added incubated <NUMBER>h <NUMBER> c bound antibodies detected using hrplabeled rabbit antihuman igg dako tmb life technologies substrate absorbance sample measured <NUMBER> nm samples nasal septum trachea right primary bronchus right upper middle lower lung lobe bronchoalveolar lavage right upper lung lobe heart liver pancreas stomach duodenum jejunum ileum colon kidney urinary bladder uterus ovary cerebrum cerebellum brain stem olfactory bulb tracheobronchial mesenteric lymphnodes tonsil spleen collected post mortem virus detection rtqpcr virus isolation previously described merscov sarscov <NUMBER> <NUMBER> <NUMBER> briefly tissues homogenized <NUMBER> wv viral transport medium using polytron pt<NUMBER> tissue grinders kinematica lowspeed centrifugation homogenates frozen −<NUMBER>°c inoculated vero e<NUMBER> cell cultures <NUMBER>fold serial dilutions sarscov<NUMBER> rtqpcr performed previously published <NUMBER> merscov rtqpcr performed previously published <NUMBER> autopsies animals performed according standard protocol histological examination following tissues collected adrenal gland aorta axillary lymph node brachial biceps muscle brain stem caecum cerebellum cerebrum colon duodenum eye eyelid femoral bone marrow heart muscle left right ileum inguinal lymph node jejunum kidney lung inflated <NUMBER> neutralbuffered formalin liver mandibular lymph node mesenteric lymph node nasal concha nasal septum oesophagus palatum molle pancreas primary bronchus ovary salivary gland spleen stomach thymus thyroid gland tongue tonsil trachea tracheobronchial lymph node urinary bladder uterus tissues lightmicroscope examination fixed <NUMBER> neutralbuffered formalin embedded paraffin <NUMBER> µm sections stained haematoxylin eosin immunohistochemistry sarscov<NUMBER> merscov antigens detected immunohistochemistry duplicate sections tissue samples paraffin removed sections rehydrated pretreated citric acid buffer ph <NUMBER> <NUMBER> min <NUMBER>°c endogenous peroxidase blocked <NUMBER> hydrogen peroxide slides briefly washed <NUMBER> phosphatebuffered saline tween <NUMBER> fluka buchs switzerland blocked <NUMBER> goat serum x<NUMBER> dako agilent technologies netherlands bv amstelveen netherlands <NUMBER> min room temperature slides incubated rabbit polyclonal antibody sarscovnucleoprotein <NUMBER>t<NUMBER> sino biological chesterbrook pa usa rabbit igg isotypecontrol ab<NUMBER>c rd minneapolis mn usa diluted <NUMBER> phosphatebuffered saline <NUMBER> bovine serum albumin <NUMBER> h room temperature washing sections incubated horseradish peroxidase labeled goatantirabbit igg p<NUMBER> dako agilent technologies netherlands bv amstelveen netherlands diluted <NUMBER> phosphatebuffered saline <NUMBER> bovine serum albumin <NUMBER>h room temperature horseradish peroxidase activity revealed incubating slides <NUMBER>amino<NUMBER>ethylcarbazole sigma st louis mo usa solution <NUMBER> min resulting bright red precipitate sections counterstained haematoxylin <NUMBER> historical tissue sections cynomolgus macaques infected sarscov<NUMBER> included negative controls historical tissue sections cynomolgus macaques infected sarscov included positive controls staining epithelial cells slides processed incubated mouseantihuman pankeratin ae<NUMBER>ae<NUMBER> igg<NUMBER> ms<NUMBER>p thermo fisher scientificwaltham usa <NUMBER> μgml phosphatebuffered saline <NUMBER> bovine serum albumin <NUMBER>h room temperature detect macrophages slides incubated mouseantihuman cd<NUMBER> igg<NUMBER> m<NUMBER> clone kp<NUMBER> dako <NUMBER> phosphatebuffered saline <NUMBER> bovine serum albumin <NUMBER>h room temperature negative control mouse igg<NUMBER> isotype control mab<NUMBER> rd systems europe abingdon uk <NUMBER> μgml included washing sections incubated horseradish peroxidase labeled goatantimouse igg<NUMBER> <NUMBER> southern biotech birmingham al usa phosphatebuffered saline <NUMBER> bovine serum albumin <NUMBER> h room temperature horseradish peroxidase activity revealed incubating slides <NUMBER>amino<NUMBER>ethylcarbazole sigma solution <NUMBER> min resulting bright red precipitate followed counterstaining haematoxylin merscov specific antibody responses inoculated cynomolgus macaques serum collected two merscov inoculated cynomolgus macaques igg responses evaluated using merscov recombinant spike protein domain <NUMBER> s<NUMBER> sera assayed days <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi optical density <NUMBER> nm shown axis data shown individual animals philippines singapore represented conference delegations accounting <NUMBER> attendees terms outcomes <NUMBER>day conference created scientific evidencebased framework inform discussions global health stakeholders participating cepis joint coordination group jcg <NUMBER> december <NUMBER> <NUMBER> ii discuss creation nipahfocused regulatory working group facilitate data sharing joint review nipah vaccine candidates iii identify multidisciplinary actions needed respond pandemic threat posed nipah virus proceedings conference publicly available may consulted using link reference <NUMBER> highlights commentaries members international organising committee follow emphasis lessons learned nipah could applied understanding current covid<NUMBER> pandemic preparedness future emerging infectious diseases eids pandemic potential lesson <NUMBER> make sound investment case preparedness nipah<NUMBER> brought together community scientists past <NUMBER> years passionately studied epidemiology virology pathogenesis therapeutics viruses pandemic potential many invited speakers involved understanding responding <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> outbreak surprise scientists currently involved responding covid<NUMBER> pandemic past <NUMBER> years scientific community heavily involved warning governments possible emergence pathogen x need invest preparedness pathogen terms policy implementation however prior emergence sarscov<NUMBER> scientific community struggled convince policy makers benefits invest research development vaccine manufacturing preparedness pandemics example even though nipah disease known <NUMBER> years investment nipah vaccine development limited development sound businessinvestment case remains priority conduct advocacy move forward development effective nipah countermeasures cepi estimated bring four nipah vaccine candidates successful phase <NUMBER>a clinical trials investment <NUMBER> million us dollars usd would required assuming risk failure <NUMBER> figure may seem high pales comparison economic nonfinancial impact pandemic create currently demonstrated covid<NUMBER> studies estimating economic impact past present henipavirus outbreaks could provide valuable data model sound investment case medical countermeasures nipah virus hendra virus henipaviruses pandemic potential maximize investments possibility panhenipavirus vaccine also considered similar programs considering development pansarbecovirus vaccines <NUMBER> lesson <NUMBER> articulate transform surveillance animals impact humans regarding progress challenges surveillance scientists several countries presented research nipah henipaviruslike sequences found bat samples throughout asia africa addition indian council medical research icmr found several new viruses among bats exploring eid potential opinions may vary translate bat surveillance policy prevention disease however clear international collaboration investment surveillance research needed propose policy prepare potential new pathogens continue emerge bats animals areas high biodiversity <NUMBER> lesson <NUMBER> articulate diagnostics use cases target product profiles terms nipah diagnostics need international reference standards highlighted organizing coordinating collection sera virus isolates midst epidemic great importance timely establishment standard material international standards needed assay validation calibration comparison quality controls costeffective diagnostic kits devices also needed example mobile nucleic acidbased nipah diagnostic system used validated india bangladesh potential applications clinical trials outbreak response eids methods nipah diagnostics presented conference together draft nipah diagnostics target product profile tpp developed rd blueprint team <NUMBER> absence effective nipahspecific treatment could argued clinical justification direct clinical benefit individual patient testing however may benefit individual patient undoubtedly benefit public health large thus save lives two use cases nipah diagnostics include rapid detection nipah virus infections peripheral health center hospital confirmation active nipah virus infection centralized laboratory former tpp would envision nearpatientpointofcare nptpoc test rapid screening latter tpp would envision nptpoc rapid confirmation settings higher infrastructures <NUMBER> nptpoc testing contact tracing proactive quarantine suspected cases indicated onset outbreak quickly halt spread evidenced nipah outbreaks successfully contained indian authorities kerala <NUMBER> <NUMBER> <NUMBER> outbreak situation involving novel pathogen pandemic potential referring previously developed diagnostics use cases tpps help quickly articulate diagnostics strategies early stages pandemic widespread nptpoc diagnostics may need prioritize sensitivity expense specificity needed widespread sensitive diagnostic testing combined appropriate prevention control measures far fastest way bring covid<NUMBER> reproduction number r <NUMBER> less <NUMBER> countries lesson <NUMBER> diversify preclinical testing portfolio create direct dialogue lab scientists pathologists health workers field two conference sessions dedicated nipah pathogenesis animal models transmission case management humans data presented aerosol intranasal challenges african green monkeys agm intratracheal challenge cynomolgus macaques intranasal challenge ferrets although models vary recapitulating specific aspects nipah disease observed humans specific mention myocarditis observed heart tissue myocarditis consistent observation among nipah virusinfected patients india bangladesh yet reported animal models possible difference may due early humane endpoints allowing heart tissue infected animals reach level myocarditis deterioration observed nipah virusinfected humans also mention relapse late onset infection observed malaysian patients several years acute infection evidence renewed viremia relapsed encephalitis humans currently animal model relapsing nipah disease although many investigators proposed research importance nipah henipaviral diseases conceivable animal rule similar regulatory pathway may necessary achieve licensure vaccines countermeasures direct dialogue preclinical scientists pathologists health workers better inform design animal models suitable eid countermeasure development importantly henipavirus research benefited diverse preclinical testing portfolio many different animal species susceptible disease means preclinical studies limited use nonhuman primates nhps also proving important sarscov<NUMBER> research nhps hamsters mice ferrets ensures covid<NUMBER> vaccines tested simultaneously according model wider range biosafety level <NUMBER> bsl<NUMBER> laboratory facilities large small animals across world <NUMBER> conceivable different animal models different endpoints infection disease transmission addition use human organoids also explored model better understand sarscov<NUMBER> biology human tissue <NUMBER> three sessions dedicated epidemiological needs clinical trials review progress development nipah medical countermeasures several therapeutics development including following lipidanchored peptides prevent viral fusion lowcost compounds heparin nasal spray compounds potential prophylactic use also two monoclonal antibodies neutralize virus protect henipavirus infection disease vivo one monoclonal antibody m<NUMBER> completed phase trial australia approved compassionate use humans <NUMBER> since antibodies cross bloodbrain barrier monoclonal antibodybased therapeutics effective virus neutralization likely occur respiratory tract blood tissues virus disseminates brain however multiple nipah challenge models including nhps indicate passive immunization nipah neutralizing antibodies also prevent central nervous system cns involvement administered first signs nipah disease discussion optimal nipah clinical trial design would context eid low incidence ie absence feasible randomized controlled trials rcts observational studies casecontrol studies could still provide valuable evidence relevant clinical trials nipah countermeasures require engagement local regulatory authorities bangladesh directorate general drug administration dgda india drug controller general india dcgi partnerships built locally focus equitable access lowcost interventions recognizing pathways nipah vaccine licensure likely vary across countries early dialogue regulators asia europe north america facilitated conference international nipahfocused regulatory group created similarly bringing regulators together early covid<NUMBER> medical countermeasure development could result identification actions harmonized accelerated meet common requirements convergences along pathway licensure across multiple national regulatory agencies lesson <NUMBER> invest diversified platform technologies harnessed speed scale access pandemic one nipah<NUMBER> session devoted nipah vaccine pipeline least <NUMBER> vaccine candidates confirmed development preclinical stages <NUMBER> five active vaccine developers presented latest preclinical data two speakers presenting platform technologies used development covid<NUMBER> vaccines keith chappell paul young university queensland brisbane australia presented molecular clamp approach produce highly stable prefusion form nipah virus f glycoprotein responsible membrane fusion could additional target neutralizing antibodies molecular clamp novel way locking synthetic versions viral surface proteins shape appears virus surface technology designed platform approach generate vaccines range human animal viruses shown promising results laboratory targeting viruses influenza virus ebola virus nipah virus middle east respiratory syndrome mers coronavirus principle also supported cepi develop recombinant spike proteinbased covid<NUMBER> vaccine phase trials expected begin july <NUMBER> sarah gilbert jenner institute oxford university united kingdom presented chadox<NUMBER> nipah vaccine simian adenovirusbased vaccine encoding nipah virus niv glycoprotein g bangladesh chadox<NUMBER> replicationdeficient simian adenoviral vector used development vaccines many pathogens preclinical clinical studies safe use ages patients immunocompromised inducing strong wellmaintained humoral cell responses encoded antigen without requirement adjuvant single dose chadox<NUMBER>vectored nipah vaccine protects homologous bangladesh strain heterologous malaysia strain challenge intraperitoneal syrian golden hamster challenge model <NUMBER> sarah gilberts team using chimpanzee adenoviral platform technology develop covid<NUMBER> vaccine candidate supported part cepi single dose vaccine encodes spike protein sarscov<NUMBER> may confer protection disease rhesus macaque pneumonia model <NUMBER> covid<NUMBER> vaccine candidate entered phase iii trials united kingdom eu clinical trials register httpswww clinicaltrialsregistereuctrsearchtrial<NUMBER>gb thus becoming first cepisupported vaccine technology platform move pathogen sequence availability phase trials less <NUMBER> weeks investment many vaccine platform technologies resulted unprecedented speed moving quickly pathogen sequence availability early <NUMBER> diverse portfolio <NUMBER> vaccine candidates less <NUMBER> months <NUMBER> although regulatory agencies adapting keep rapidly evolving vaccine pipeline preparedness future pandemics may necessitate regulatory frameworks preapprove specific platforms consistent safety data order save precious time plugging novel pathogen sequence vaccine platform technology many covid<NUMBER> platform technologies dialogue ongoing articulate strategies largescale manufacturing <NUMBER> access <NUMBER> lesson <NUMBER> engage regionally locally globally final conference session dedicated collaboration synergy zhengli shi wuhan institute virologychinese academy sciences cas described sinofrench agreement collaborate eids established <NUMBER> following sarscov outbreak bsl<NUMBER> labs established wuhan institute virology result sarscov outbreak prior covid<NUMBER> pandemic institute annual call launched around april year external organizations wanting access facility test samples access samples inhouse repositories many years research experience international collaborations built cas since <NUMBER> provided preparedness framework chinese scientists responded continue respond sarscov<NUMBER> epidemic <NUMBER> years later nivedita gupta indian council medical research icmr described regional enabler southeast asia research collaboration health research platform research platform established <NUMBER> august <NUMBER> icmr secretariat goal platform facilitate clinical research across region leveraging unique capabilities country sharing expertise <NUMBER> member states southeast asia region <NUMBER> participated second research platform meeting platform place easier mount rapid responses new outbreaks conduct clinical trialsnot nipah virus also eids epilogue unbeknownst scientists attending nipah<NUMBER> conference singapore december <NUMBER> covid<NUMBER> outbreak already begun started year <NUMBER> confronted new eid required rapid mobilization vaccine development nipah<NUMBER> scientific drill timely dialogue need invest development vaccines medical countermeasures eids pandemic potential cepi since mobilized early investment several covid<NUMBER> vaccine candidates stated earlier two awardees builds work already undertaken nipah virus vaccine projects showcased nipah<NUMBER> conference transparency collaborative spirit underpinned nipah<NUMBER> conference although nipah virus may seem like priority current covid<NUMBER> context hope scientific momentum continue highvalue eidrelated research undertaken published henipavirus experts next meet unofficial suggestion commemorate <NUMBER>th anniversary discovery hendra virus founding member henipavirus genus sometime <NUMBER> pleomorphic enveloped coronaviruses genus coronaviridae family contain ∼<NUMBER> kb positivesense rna genome <NUMBER> viral envelop contains envelope e protein transmembrane spike glycoprotein surrounds disordered flexible nucleocapsid n <NUMBER> coronaviruses infect wild animals narrow host range cause selflimiting diseases <NUMBER> human coronaviruses oc<NUMBER> <NUMBER>e nl<NUMBER> hku<NUMBER> associated selflimiting respiratory tract infections <NUMBER> however two zoonotic coronaviruses severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov cross species barrier infect humans caused severe acute respiratory disease sard thousands deaths <NUMBER> <NUMBER> since december <NUMBER> new sarslike coronavirus named sarscov<NUMBER> raised intense concerns within china also internationally <NUMBER> importantly sarscov<NUMBER> showed approximately <NUMBER>∼<NUMBER> genome sequence homology previously identified sarscov strains suggesting evolving similarity virological properties <NUMBER> receptormediated entry first step viral infection host cell receptor binding domain rbd viral protein sarscov merscov attaches human angiotensin converting enzyme <NUMBER> hace<NUMBER> dipeptidyl peptidase <NUMBER> hdpp<NUMBER> proteins respectively hace<NUMBER> also believed receptor sarscov<NUMBER> <NUMBER> entry cells three coronaviruses sarscov merscov sarscov<NUMBER> replicate efficiently produce progeny viruses give rise cytopathogenesis establish productive infection sarscov <NUMBER> caused <NUMBER> cases <NUMBER> deaths <NUMBER> countries merscov <NUMBER> resulted <NUMBER> cases <NUMBER> deaths <NUMBER> countries sarscov<NUMBER> caused two million cases <NUMBER> countries areas territories <NUMBER> deaths date <NUMBER> april <NUMBER> therefore highly emergent obtain effective clinical medication vaccines prevent treat coronavirus infection animal models critical us understand viral infection pathogenesis moreover animal models essential development preclinical evaluation vaccine antiviral agent ideal animal model one mimics viral infection diseases humans multiple aspects including morbidity viral load typical clinical symptoms host immune responses mortality therefore urgent need preventing controlling coronavirus infection necessitates search optimal sarscov<NUMBER> animal model based published studies animal models sarscov merscov include civet cats camelidaes monkeys mice hamsters ferrets rabbits potential hosts figure <NUMBER> aim summarize discuss ability mimic disease symptoms natural history coronavirus disease <NUMBER> humans well usage development vaccine antiviral drugs furthermore humanized animal models available support coronavirus infection pathogenesis might provide new options overcome limitations traditional coronavirus animal models additionally animal models pseudovirus also prospected avoid concern biosafety clinical symptoms sarscovand merscovinfected patients early time include fever chills coughing malaise myalgia headache diarrhoea vomiting nausea <NUMBER> furthermore immunohistochemistry ihc detection demonstrated presence viral antigens lung tissues covid<NUMBER> patients present similar symptoms sarscovor merscovinfected patients patients may show typical clinical symptom early stage infection <NUMBER> typical pathological features severe cases include prolonged inflammation destruction desquamation alveolar pneumocytes hyalinemembrane formation interstitial inflammatory infiltration interalveolar hemorrhage multinucleated giant cells also observed tissues covid<NUMBER> patients <NUMBER> <NUMBER> covid<NUMBER> patients diagnosed pneumonia chest computed tomography ct admitted hospital ct images showed typical features groundglass opacity bilateral patchy shadowing lungs <NUMBER> recent clinical experimental studies demonstrated sarscov<NUMBER> caused nosocomial infection fecaloral transmission infection results immune abnormality multiple organ failures covid<NUMBER> patients moreover long incubation period <NUMBER> days observed covid<NUMBER> cases <NUMBER> suggesting risk occult chronic infection although sarscov<NUMBER> displays lower rate severe cases case fatality coronaviruses high infectivity pathogenicity break species barrier infect human past two decades besides nhp mice hamsters ferrets rabbits possible natural hosts might able support studies coronavirus infection pathogenesis drug discovery sarscov merscov high infectivity widely spreading huge infection population become catastrophic medical burden critical social problem viral entry intracellular replication two essential steps virus establish successful infection specific receptor proteins anchored cell membrane mediate viral entry intranuclear transcriptional factors regulate viral replication therefore hostrange virus depends two steps summarized table <NUMBER> nonhuman primates nhps ferrets hamsters demonstrated support sarscov infection pathogenesis nhps fully permissive merscov infection civet cats demonstrated permissive sarscov infection serological antibody detection camelidaes demonstrated permissive merscov infection specific antibodies merscov protein detected high rate respiratory infections administration merscov immunocompetent young inbred mice support transient sarscov infection without clinical signs disease <NUMBER> permissive merscov due lack functional receptor <NUMBER> careful review illness virological histological immunological characteristics post infection nhps ferrets hamsters presumed potential natural hosts sarscov<NUMBER> meanwhile experimental animal models tree shrew woodchuck pangolin rat guinea pig cotton mouse well domesticated animals cats <NUMBER> dogs might potential hosts support sarscov<NUMBER> infection studies coronavirus greatly benefited using nhps infection disease models oldand newworld monkeys include rhesus macaques macaca mulatta cynomolgus macaques macaca fascicularis african green monkeys chlorocebus sabaeus common marmosets callithrix jacchus squirrel monkeys saimiri mustached tamarins saguinus mystax demonstrated permissive sarscov infection cause symptoms fever diarrhea clinical manifestations pneumonitis <NUMBER> <NUMBER> african green monkeys cynomolgus rhesus macaques showed mild symptoms infection sarscov urbani strain produced neutralizing antibodies nabs might help clear virus <NUMBER> another study rhesus macaques challenged sarscov pumc<NUMBER> strain transient severe pneumonia observed <NUMBER> meanwhile greenough et al reported sard fever diarrhea hepatitis multiorgan failure common marmosets around four seven days post sarscov infection <NUMBER> studies rhesus macaques common marmosets used model merscov infection however merscov infections two nhps caused different levels consequences first symptoms common marmoset model much severe viral yield approximately thousandfold higher rhesus macaque model secondly viral replication common marmosets reached peak level viral infection caused severe pneumonia within four six days post merscov infection <NUMBER> however merscov infection rhesus macaques produce high viral load didnt cause severe symptoms <NUMBER> rhesus macaque demonstrated permissive sarscov<NUMBER> infection via ocular conjunctival route <NUMBER> sarscov<NUMBER> induced transient infection mild pneumonia rhesus macaques however severe pneumonia death observed meanwhile infected rhesus macaques pounced nabs effectively prevent rechallenge sarscov<NUMBER> <NUMBER> recently cynomolgus macaques common marmosets also demonstrated available support sarscov<NUMBER> infection <NUMBER> study rhesus macaques demonstrated susceptible sarscov<NUMBER> infection compared cynomolgus macaques common marmosets ferrets used model studies respiratory pathogens including influenza virus ifv respiratory syncytial virus rsv adenovirus coronavirus infection sarscov ferret presented fever sneezing associated detectable viral titres upper respiratory tract <NUMBER> however severe symptoms deaths caused viral infection observed ferrets support replication merscov <NUMBER> recently ferrets demonstrated available support sarscov<NUMBER> infection two different groups <NUMBER> <NUMBER> reported sarscov infects golden syrian hamster <NUMBER> viruses seeded upper lower respiratory tract reached peak level three days post sarscov infection declined cleared within seven ten days infection sarscov resulted mild transient pneumonia contrast similar infection course symptoms recently observed hamsters infected sarscov<NUMBER> <NUMBER> hamsters demonstrated susceptible merscov infection <NUMBER> interestingly primary sarscov sarscov<NUMBER> infection ferrets hamsters elicited strong nab response protected hosts subsequent infections abovementioned information implies sarscov<NUMBER> infection might induce mild severe pulmonary diseases ferrets hamsters severities symptom might depend viral strains ability merscov infect small animal species may defected lack viral entry replication surprisingly rabbits susceptible merscov infection <NUMBER> although viral nucleic acid infectious progeny virus detectable lung tissues neither significant histopathological changes clinical symptoms observed findings indicate potential route merscov transmission common animal species however reported investigation sarscov sarscov<NUMBER> infection rabbits therefore important experimentally investigate whether ferret hamster rabbit susceptible infection able used animal model sarscov<NUMBER> mouse model widely used many different viral investigations considered best small animal model hepatitis b virus hbv hepatitis c virus hcv cytomegalovirus cmv zika virus among others due low cost small size easy operation high reproducibility mouse model suitable large scale studies viruses pathogenesis also antivirals contrast nhps mice convenient handled higher level biosafety laboratory due relatively small size less operation difficulties importantly mouse easily manipulated genetic level precision research instance lot genetically mutated mice available studies antiviral immunity viral pathogenesis viral infection transmission restriction furthermore current murine immunological reagents available study viral pathogenesis host immune responses several strains mice tried intranasally infected sarscov urbani strain found virus poorly replicated several young adult inbred strains mice balbc c<NUMBER>bl<NUMBER> <NUMBER>s low viral yield clinical illness observed virus cleared within nine days meanwhile mice naturally susceptible merscov infection later revealed mouse dpp<NUMBER> receptor differs human counterpart crucial domains critical bind protein <NUMBER> overcome speciesspecificity barrier sarscov merscov human receptor protein hace<NUMBER> hdpp<NUMBER> expressed mice knocking transfecting human receptor gene mouse studies hace<NUMBER>transgenic mice performed almost time <NUMBER> independently three groups <NUMBER> sarscov infection two transgenepositive mice ac<NUMBER> ac<NUMBER> showed high viral load clinical illness tissue pathology lethal lineage mice ac<NUMBER> displayed higher hace<NUMBER> expressions several organs wider spectrum clinical illness including wasting symptom severe pneumonia death rather nonlethal lineage mice ac<NUMBER> lower hace<NUMBER> expressions yang et al generated another nonlethal lineage mouse expresses hace<NUMBER> mouse ace<NUMBER> promoter <NUMBER> another study revealed differential virological immunological outcomes among different hace<NUMBER> transgenic lineages <NUMBER> rapidly generate merscov infecting mouse model zhao et al transduced common adult balbc c<NUMBER>bl<NUMBER> mice adenoviral vector expressing hdpp<NUMBER> ad<NUMBER>hdpp<NUMBER> merscov infection mice showed interstitial pneumonia expressed viral antigen lungs lost weight deaths observed later hdpp<NUMBER>transgenic mice generated mimic severe merscov infection lethal pathogenesis agrawal et al developed transgenic mouse expresses hdpp<NUMBER> control cag promoter <NUMBER> hdpp<NUMBER>transgenic mouse fully permissive merscov infection cause severe respiratory illness led death within six days infection remarkably high viral load detected multiple organs pathological changes consistent extensive inflammation throughout infection course addition merscov infection induced profound acute innate inflammatory responses within lungs model <NUMBER> li et al developed another hdpp<NUMBER>transgenic mouse demonstrated merscov infection induced lethal lung disease viral load dependent <NUMBER> similar model agrawal et al activated innate immune cells accumulated lungs merscov infection recently yoshikawa et al observed cytokine storm newly generated hdpp<NUMBER>transgenic mouse <NUMBER> receptortransgenic transduced mice widely used study pathogenesis mechanism evaluate vaccines therapeutics table <NUMBER> hace<NUMBER> recently demonstrated receptor sarscov<NUMBER> cell infectious model <NUMBER> hace<NUMBER> transgenic mice supposed option study sarscov<NUMBER> infection pathogenesis recently bao et al demonstrated hace<NUMBER>transgenic mice able support sarscov<NUMBER> infection <NUMBER> observed mice presented weight loss virus replication infiltration lymphocytes monocytes alveolar interstitium accumulation macrophages alveolar cavities three five days post sarscov<NUMBER> infection however significant histopathological lesions viral antigens observed organs including myocardium liver spleen kidney cerebrum intestine testis furthermore pneumonia became mild focal lesion areas seven days post infection suggesting nonlethal selflimiting infection course lineage hace<NUMBER>transgenic mouse cannot mimic severe lethal cases covid<NUMBER> necessity attempts lineages different hace<NUMBER> promotors alternatively transduction adhace<NUMBER> young adult balbc c<NUMBER>bl<NUMBER> mice might provide avenue rapid robust generation sarscov<NUMBER> infectious mouse model order promote replication sarscov young adult immunocompetent mouse three mouseadapted viral strains developed serial passage sarscov urbani strain mouse respiratory tract contrast original urbani strain sarscov sars strains ma<NUMBER> ma<NUMBER> v<NUMBER> replicated lungs mice higher titre proportionally associated pathological changes dissemination virus extrapulmonary sites mortality table <NUMBER> shown figure <NUMBER>a several mutations occurred orf<NUMBER>a nsp<NUMBER> nsp<NUMBER> orf<NUMBER>b nsp<NUMBER> protein believed combination genetic changes enhanced viral virulence <NUMBER> implying importance proteins viral pathogenesis brief three sars strains induced sard mice similar clinical symptoms observed human cases sarscov infection ferrets hamsters mice naturally susceptible merscov infection merscov protein cannot bind dpp<NUMBER> animals thus progeny infectious virus could isolated animals initial infection merscov adaptation unlikely carried mentioned merscov successfully infect hdpp<NUMBER>transgenic mouse interestingly vivo serial passage emc<NUMBER> strain merscov hdpp<NUMBER> knockin mice resulted virus strain mers causes fatal pulmonary disease phenotype associated severe inflammatory responses <NUMBER> furthermore reported passages mouse caused severe diseases example <NUMBER> moreover different mutations merscov s<NUMBER> receptor binding domain s<NUMBER> fusion domain occur different plaques clones passaged emcp<NUMBER> strain implying gene diversity impacts viral entry figure <NUMBER>b protein coronaviruses needs cleaved host proteases functional proteases include endosomal cathepsins cell surface transmembrane proteaseserine tmprss proteases furin trypsin <NUMBER> example sarscov<NUMBER> uses serine protease tmprss<NUMBER> host cell cleave protein activate entry process <NUMBER> protein mutations enhanced infectivity mers strains promoting early entry broadening tissue tropism <NUMBER> comparing mers strain uncleaved protein mers strain protein precleaved furin infected cells hence achieves nonendosome cellular entry thus mutations protease cleaving site protein might alter infectivity sarscov<NUMBER> considering similarity receptor highly gene sequence homology sarscov sarscov<NUMBER> adaptive viral strain novel coronavirus might obtained <NUMBER>∼<NUMBER> serial passage hace<NUMBER> transfected cells animal models overall generating adaptive viral strains might become another approach enhance infectivity establish effective lethal sarscov<NUMBER> infection experimental animals several studies attempted use immunecompromised mice determine role immune effectors coronavirus infection first following knockout mice applied infection sarscov beige lacking functional nk cells cd<NUMBER> − − lacking nkt cells rag −− lacking b cells <NUMBER> however immunecompromised mice failed allow infection sarscov viral kinetics significantly different among <NUMBER>bl<NUMBER> wild type beige cd<NUMBER> −− rag<NUMBER> −− mice histopathological detection showed similar selflimiting bronchiolitis mild pneumonia among mice interestingly prolonged viral replication illness observed stat<NUMBER> −− mice <NUMBER>s background <NUMBER> model viral replication detectable day <NUMBER> post infection indicating stat<NUMBER> mediated type interferon response required control sarscov infection <NUMBER> stat<NUMBER> −− mice also challenged merscov emc<NUMBER> strain lack receptor hdpp<NUMBER> clinical illness observed viral replication undetectable <NUMBER> however hdpp<NUMBER>transfected mice additional deficiency interferonα receptor myd<NUMBER> mvas still cannot prolong viral replication cause severe cause throughout merscov infection course <NUMBER> generally mice targeted immune deficiency useful tools investigate interaction host immunity coronavirus besides relatively low viral load mild illness immunodeficient mice limited value studies vaccine immunotherapy important know risk factors affect clinical outcomes coronavirus infection <NUMBER> first age play important role disease severity know aged mouse model used sarscov infection found sarscov infection aged mice resulted increased mortality younger mice studies <NUMBER> month old balbc c<NUMBER>bl<NUMBER> mice developed severe disease include viral replication weight loss ruffled fur dehydration <NUMBER>∼<NUMBER> weekold ones <NUMBER> however aged <NUMBER>svev mice support prolonged pulmonary viral replication cleared virus within five days <NUMBER> interestingly sars strain ma<NUMBER> showed higher mortality <NUMBER>∼<NUMBER> month aged balbc c<NUMBER>bl<NUMBER> mice <NUMBER>∼<NUMBER> month ones <NUMBER> recently yoshikawa et al demonstrated immunopathology degree merscov infection hdpp<NUMBER>transgenic mouse age dependent <NUMBER> mechanistic studies demonstrated agedependent increases phospholipase pla <NUMBER> g<NUMBER>d dysfunction cd<NUMBER> positive cell could reasons enhanced sarscov infection <NUMBER> <NUMBER> according epidemiology data sarscov<NUMBER> likely cause severe causes high mortality elder people <NUMBER> overall aged mouse model provided opportunity study agedependent susceptibility humans coronavirus second gender impact infection outcomes generally males generate mild immune responses females mount stronger innate adaptive immune responses relatively resistant virus infections explains males females showed different response patterns infection viruses recent studies showed higher expression hace<NUMBER> asian males females <NUMBER> epidemiological data showed genderspecific differences sarscov infection males experiencing higher mortality compared females <NUMBER> genderdependent increase disease severity pathogenic sarscov infection pronounced advancing age <NUMBER> male c<NUMBER>bl<NUMBER> balbc mice showed susceptible higher mortality sarscov ma<NUMBER> infection female mice <NUMBER> addition male mice displayed higher proinflammatory cytokine levels female ones independent b cell responses throughout sarscov infection course clinical experimental findings imply higher risk sarscov sarscov<NUMBER> infection elder asian males however merscov infection showed difference male female hdpp<NUMBER>transgenic mice mortality weight loss epidemiological data merscov infection human different gender conflict study showed high incidence mortality among males <NUMBER> others showed gender may impact infection outcome merscov <NUMBER> thus necessary clarify conflicting results gender impacts clinical experimental studies merscov infection overall gender might interesting topic investigation mechanism sarscov<NUMBER> infection pathogenesis addition infection routes inoculation doses might also impact characteristics virus shedding pathogenesis disease outcomes experimental animals presumptively animal models sarscov might fit study sarscov<NUMBER> due similarities two viruses pathogenesis replication viral characteristics host receptor viral entry therefore combination hace<NUMBER> transgenicor transducemice sarscov<NUMBER> strains might result enhanced infection severe pathogenesis higher mortality resembling clinical illness comparing sarscov merscov sarscov<NUMBER> might complicated transmission pathogenesis makes animal studies difficult example sarscov<NUMBER> infection long incubation time <NUMBER> rapid transmission among populations <NUMBER> severe multiple organ failure <NUMBER> appropriate animal model important evaluate vaccine medical safety protective efficacy comprehensive immune activation although many attempts developing vaccines tried currently approved vaccine sarscov merscov several approaches develop sarscov merscov vaccines evaluated indicated animal models summarized table <NUMBER> traditional inactivated virus vaccines use chemicals radiation render viral genome noninfectious maintaining virion structure thus preserving antigenicity eliminating potential cause productive infection animal studies assessed inactivated sarscov vaccines found elicit production nabs inhibit viral replication nhps mice ferrets hamsters however cases inactivated vaccine may arouse enough nabs cover damage dominant epitopes <NUMBER> moreover inactivated vaccines might lack adequate crossprotection among different viral strains especially unknown newly identified strains liveattenuated vaccines produced reducing eliminating virulence live virus typically using chemicaldriven site mutation gene deletion although liveattenuated vaccine elicit innate adaptive immune responses mice hamsters risk phenotypic genotypic reversion disseminated infection immunocompromised patients limit translation <NUMBER> among functional structural proteins coronavirus protein important antigen might effectively inducing nabs block viral binding entry well stimulating robust host immune responses <NUMBER> therefore protein designed main target development sars vaccines different strategies including developing subunit using expression vector packaging viruslike particle delivering dna plasmid nanoparticle <NUMBER> vaccine strategies showed protection effects different animals table <NUMBER> however limited possibilities incomplete protection risk antibody dependent enhancement ade include expanded infection tissue destruction cytokine storm multiple organ failure <NUMBER> mechanism ade effect complicated yet clearly clarified serum inactivated sarscov protein immunized mice well protein specific antibodies demonstrated promote viral infection cytopathogenesis human immune cells macrophage b lymphocytes via phand cysteine proteaseindependent fcγ receptor pathway <NUMBER> moreover protein specific antibodies treatment caused fatal acute lung injury sarscov infected nhps skewing macrophage mediated inflammationresolving responses <NUMBER> addition prior immunization n protein might also cause severe pneumonia mice infected live sarscov <NUMBER> indeed many studies showed viruslike particle inactivated virus vaccine rdnaproduced protein vaccine led occurrence pulmonary th<NUMBER>type immunopathology challenge live sarscov mice suggesting hypersensitivity sarscov components induced <NUMBER> <NUMBER> similar lung immunopathology also observed mice immunized inactivated merscov vaccine <NUMBER> findings suggested potential pathogenic effect antibodies targeted sarscov<NUMBER> would major concern vaccine development antibodybased therapies although nhps supposed closer human different mouse models viral strains occupied large proportion coronavirus vaccine studies advantages convent largescale draw robust conclusion due genetic differences results animals necessarily going humans contrary many vaccines effective animal experiments showed inadequate protective effects humans rsv <NUMBER> hiv <NUMBER> nevertheless animal experiments essential step trials human vaccines dozen anticov drugs tested vitro vivo targeting protease rnadependent rna polymerase rdrp two effective approaches inhibition viral replication mycophenolic acid inhibitor inosinemonophosphate dehydrogenase guanine monophosphate synthesis displayed potential antimerscov activity cell culture <NUMBER> however animal study merscov infected common marmosets treated mycophenolate mofetil presented worse outcome severe disease higher viral loads necropsied lung without treatment <NUMBER> ribavirin targeting rdrp lopinavirritonavir targeting <NUMBER>clpro protease approved treat sarscov merscov patients respectively nevertheless drugs showed limited antiviral effects upon monotherapy severe side effects patients animals including rhesus macaques common marmosets mice recent studies remdesivir broad spectrum antiviral nucleotide prodrug showed better antimerscov activity lopinavir ritonavir cell culture study animal studies hdpp<NUMBER> transgenic mice nhps <NUMBER> <NUMBER> notably vitro antisarscov<NUMBER> activity remdesivir demonstrated cell culture study <NUMBER> rbd site protein important target development nabs <NUMBER> nabs well evaluated animal models including rhesus macaques common marmoset mice rabbits ferrets hamster however like vaccines abnormal immune responses ade effects induced antibodies remain serious issue <NUMBER> interferon signalling doubleedged sword therapy coronavirus infection one hand recombinant interferons showed preventive antiviral effects animal models include cynomolgus rhesus macaques common marmosets mice ferrets early stage sarscov merscov infection combined action type type iii interferon restricts initial replication sarscov lung fails inhibit systemic virus spreading mice <NUMBER> another hand delayed administration interferons induce dysregulated interferon signalling inflammatory monocyte macrophages responses cause severe transformation lethal pneumonia sarscov infected mice <NUMBER> experimental findings suggested precision intervention time important interferon therapy coronavirus infection hormones used restore cytokine storm host signalling pathways involved viral replication might also considered options treat coronavirus infection evaluated mice <NUMBER> moreover old new drugs associated host endosomal surface proteases utilized viral entry host receptors mediated viral entry endocytosis endosomal acidification also showed ability inhibit coronavirus infection cell models respectively nevertheless unknown vivo antiviral effects risk toxicity adverse effects might limit translation example chloroquine demonstrated able inhibit viral replication sarscov sarscov<NUMBER> vitro showed significant therapeutic effect sarscov mice model <NUMBER> therapy strategies convalescentphase plasma still lack mechanism study detailed vivo evaluation lack adequate appropriate animal models additionally testing antiviral ability old drugs metformin atorvastin glitazones fibrates sartans might another option urgent moment <NUMBER> clinically combined use several antiviral drugs host target agents may effective using either modality alone example sarscov patients received ribavirin lopinavirritonavir corticosteroid lower <NUMBER>day sard death rates received ribavirin corticosteroid <NUMBER> regards patients severe merscov infection viremia resolved within two days combined treatment ribavirin lopinavirritonavir interferonα <NUMBER> sum learn lessons many previous animal experiments firstly drug antiviral effects vitro necessarily antiviral effects vivo secondly combination two drugs different antiviral mechanisms might achieve synergistic enhanced therapeutic effect thirdly know advantages disadvantages drugs need systematically evaluated several different animal models clinical study prevention recovery coronavirus infection usually associated adaptive innate immunity outcomes coronavirus infection depend humoral immune responses subtype titre antibody although nhps mice experimental animals effectively mimic coronavirus infection genetic diversity might disturb interpretation possibly different results human nonhuman species directly study coronavirus infection human organ tissue humanized animal models method choice also used evaluation coronavirus vaccines host target agents past decades mice one several human tissues cells engraftment widely used investigate pathogenesis hiv hbv hcv cmv varicellazoster virus vzv important pathogens lung main target organ coronavirus infection <NUMBER> maidji et al grafted human fetal lung tissues kidney capsule immunodeficient scid mice <NUMBER> lung tissues rapidly grew developed mature structures resembling normal human lung demonstrated support cmv infection pathogenesis <NUMBER> wang et al established human lungxenografted mouse model vzv infection <NUMBER> vzv infection viral replication lung pathogenies proinflammatory cytokine responses detected human lung xenografts recently wahl et al reported humanized mouse mono human lung engraftment lom incorporated human bone marrow liver thymus bltl <NUMBER> lom bltl mice supports infection replication human pathogens merscov rsv cmv zika virus <NUMBER> antigenspecific humoral tcell responses observed bltl mice suggesting human lung immune cell dual chimeric mice might ideal humanized animal model pathogenesis immune study sarscov<NUMBER> due abundant expression hace<NUMBER> multiple organs human multiple organs tissues including liver heart intestine kidney bladder immune cells susceptible infection sarscov<NUMBER> suggesting reason causes multiorgan failures therefore mice engraftment human somatic progenitor stem cells well varied human tissues organoids might useful investigate tropism sarscov<NUMBER> comparing traditional animal models humanized mice provide new options investigators directly study viral infection human tissues adequate delineate tissue tropism hostvirus interactions development humanized mice important improve fundamental understanding mechanisms coronavirus infection immunopathophysiology future humanized mice might become unique tool obtain insights strategies developing coronavirus vaccine early intervention antiviral therapy coronaviruses one important pathogens causing robust respiratory infection severe cases deaths humans input key words including coronavirus animal model sarscov merscov sarscov<NUMBER> also named <NUMBER>ncov early stage sard covid<NUMBER> screen published articles pubmed related articles cited review recent proceedings important data coronavirus studies summarized suggested rapid animal test sarscov<NUMBER> important assess efficiencies vaccines antivirals sensitivity diagnostic tests also debated rapid generation viral strains mice carrying human receptor good option urgent effective animal studies addition development humanized animal model might provide direct infection coronavirus human tissue taken together animal models fundamental tolls investigate viral pathogenesis develop vaccines antiviral drugs work supported national science technology major projects major new drugs innovation development <NUMBER>zx<NUMBER> national science technology major project infectious diseases <NUMBER>zx<NUMBER> key research program ministry science technology <NUMBER>yfc<NUMBER> science technology project fujian province <NUMBER>yz<NUMBER> funders role study design data collection analysis decision publish preparation manuscript potential conflict interest reported author qiyi tang httporcidorg<NUMBER> tong cheng httporcidorg<NUMBER> ningshao xia httporcidorg<NUMBER> outbreak coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> rapidly spreads leading pandemic infection kim et al show ferrets highly susceptible sarscov<NUMBER> infection effectively transmit virus direct indirect contact recapitulating human infection transmission outbreak coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> emerged china rapidly spread worldwide prevent sarscov<NUMBER> dissemination understanding vivo characteristics sarscov<NUMBER> high priority report ferret model sarscov<NUMBER> infection transmission recapitulates aspects human disease sarscov<NUMBER>infected ferrets exhibit elevated body temperatures virus replication although fatalities observed sarscov<NUMBER>infected ferrets shed virus nasal washes saliva urine feces <NUMBER> days postinfection <NUMBER> days postcontact sarscov<NUMBER> detected naive direct contact ferrets furthermore naive indirect contact ferrets positive viral rna suggesting airborne transmission viral antigens detected nasal turbinate trachea lungs intestine acute bronchiolitis present infected lungs thus ferrets represent infection transmission animal model covid<NUMBER> may facilitate development sarscov<NUMBER> therapeutics vaccines coronaviruses covs large family viruses cause respiratory intestinal infections animals humans masters perlman <NUMBER> four generaalphacoronavirus betacoronavirus gammacoronavirus deltacoronavirusalphacoronavirus betacoronavirus commonly associated respiratory illness humans gastroenteritis animals cui et al <NUMBER> covs typically considered highly pathogenic humans outbreaks severe acute respiratory syndrome cov sarscov zhong et al <NUMBER> middle east respiratory syndrome cov merscov zaki et al <NUMBER> recently severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> late december <NUMBER> novel coronavirus disease covid<NUMBER> identified wuhan city hubei province china patients severe pneumonia deep sequencing analysis lower respiratory tract samples revealed identity causative agent newly emerged strain betacoronavirus temporarily named <NUMBER> novel coronavirus <NUMBER>ncov later renamed severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> international committee taxonomy viruses ictv ictv <NUMBER> march <NUMBER> approximately <NUMBER> confirmed cases covid<NUMBER> china <NUMBER> deaths <NUMBER>b sarscov<NUMBER> found high humantohuman transmission close contact infected patients leading rapid global spread infected travelers china march <NUMBER> <NUMBER> sarscov<NUMBER> cases confirmed least <NUMBER> countries steady increase number laboratory confirmed cases <NUMBER> cases outside china suggesting nonpharmaceutical intervention strategies ultimately successful limiting spread therefore animal model recapitulates covid<NUMBER> clinical symptoms human infection urgently needed order decipher transmission routes pathobiology virus allow testing pharmaceutical interventions given sarscov<NUMBER> shares higher sequence homology sarscov <NUMBER> homology merscov <NUMBER> homology entry receptor sarscov human angiotensinconverting enzyme <NUMBER> hace<NUMBER> considered receptor candidate sarscov<NUMBER> correspondingly bao et al <NUMBER> reported weight loss virus replication lungs hace<NUMBER> transgenic mice following sarscov<NUMBER> infection however clinical symptoms cough fever observed order understand rapid spreading characteristics sarscov<NUMBER> additional animal models mimic high humantohuman transmission sarscov<NUMBER> infections warranted given ferret ace<NUMBER> shown contain critical sarscov binding residues wan et al <NUMBER> performed infection direct indirect contact transmission studies using ferret model previously developed influenza virus infections park et al <NUMBER> bouvier <NUMBER> demonstrate ferrettoferret transmission experimental setting ferrets n <NUMBER> inoculated via intranasal route <NUMBER> <NUMBER> tcid <NUMBER> nmcncov<NUMBER> strain isolated covid<NUMBER>confirmed patient south korea february <NUMBER> evaluate transmission mode virus naive ferrets n <NUMBER>group placed direct contact dc cohoused indirect contact ic housed cages permeable partition separating infected ferrets infected ferrets two days primary infection clinical features sarscov<NUMBER> infections recorded study repeated three independent trials total n <NUMBER> direct infection n <NUMBER> dc n <NUMBER> ic n <NUMBER> pbs control n <NUMBER> ferrets nmcncov<NUMBER>infected ferrets elevated body temperatures <NUMBER> c <NUMBER> c <NUMBER> <NUMBER> dpi returned normal <NUMBER> dpi figure <NUMBER>a reduced activity observed nmcncov<NUMBER>infected ferrets <NUMBER> <NUMBER> dpi occasional coughs detectable body weight loss fatalities experimental period interestingly six dc ferrets showed increased body temperatures <NUMBER> c reduced activity <NUMBER> <NUMBER> days post contact dpc detectable body weight loss figures s<NUMBER>a s<NUMBER>b however none ic ferrets showed increased body temperature weight loss <NUMBER> days studies figures s<NUMBER>c s<NUMBER>d data indicate efficient establishment covid<NUMBER> clinical features ferrets exposed infected animals requires direct contact recapitulating humantohuman transmission investigate sarscov<NUMBER> replication shedding group ferrets collected blood nasal washes saliva urine measured tissues nmcncov<NUMBER>infected ferrets n <NUMBER>group tissue n <NUMBER> per group collected <NUMBER> <NUMBER> <NUMBER> dpi viral loads nasal turbinate trachea lung kidney intestine titered using quantitative realtime pcr tcid <NUMBER> data presented mean ± sem serum neutralizing sn antibody titers gmt nmcncov<NUMBER> <NUMBER> tcid <NUMBER> measured onto vero cells <NUMBER> days experiment n <NUMBER> per group data presented geometric mean ± sd tissues harvested day <NUMBER> inoculation immunohistochemistry performed mouse polyclonal antibody presence nmcncov<NUMBER> antigen determined ihc mouse polyclonal antibody magnification <NUMBER> asterisks indicate statistical significance compared pbs control group twoway anova sidaks multiple comparisons test two way anova dunnetts multiple comparisons test b c oneway anova dunnetts multiple comparisons test indicates p <NUMBER> indicates p <NUMBER> indicates p <NUMBER> fecal specimens every day <NUMBER> days collected ferret secretions resuspended cold phosphatebuffered saline pbs containing antibiotics <NUMBER> penicillinstreptomycin gibco virus titration total rna extracted collected samples using rneasy mini kit qiagen hilden germany according manufacturers instructions qiagen <NUMBER> cdna synthesized cdna synthesis kit omniscript reverse transcriptase qiagen hilden germany quantitate viral rna copy number quantitative realtime rtpcr qrtpcr performed targeting spike table <NUMBER> orf<NUMBER>a table s<NUMBER> genes previously described using sybr green kit iq tm sybr green supermix kit biorad hercules ca usa number viral rna copies calculated comparison number copies standard control nmcncov<NUMBER> infected group viral spike rna detected specimens <NUMBER> dpi highest amount viral rna detected nasal washes peaked <NUMBER> dpi <NUMBER> log <NUMBER> copiesml persisting <NUMBER> dpi dropping detection limits <NUMBER> dpi table <NUMBER> virus also detected saliva specimens <NUMBER> dpi <NUMBER> log <NUMBER> copiesml <NUMBER> dpi although viral spike rna detected sera infected ferrets viral copy number low peaked titer <NUMBER> log <NUMBER> copiesml dropped detection limits earlier nasal wash saliva specimens evaluate infectious virus titer specimen collected nasal washes saliva specimens inoculated onto vero cells virus isolation infected ferret group nmcncov<NUMBER> isolated saliva nasal washes specimens early <NUMBER> dpi persisted <NUMBER> <NUMBER> dpi respectively table <NUMBER> nasal washes specimens showed higher virus titers <NUMBER> log <NUMBER> tcid <NUMBER> ml saliva specimens <NUMBER> log <NUMBER> tcid <NUMBER> ml dc ferret group virus isolated nasal washes <NUMBER> dpc <NUMBER> log <NUMBER> tcid <NUMBER> ml <NUMBER> dpc <NUMBER> log <NUMBER> tcid <NUMBER> ml saliva specimens table <NUMBER> gastrointestinal involvement characteristic coronavirus infections animals humans leung et al <NUMBER> also collected fecal urine specimens viral rna detected majority collected specimens ininfected dc groups early <NUMBER> dpc table <NUMBER> similarly infected group dc group highest virus copy numbers <NUMBER> log <NUMBER> copiesml nasal washes rna detected <NUMBER> dpc addition viral rna detected saliva fecal specimens dc group <NUMBER> days whereas urine specimens contained detectable viral rna <NUMBER> dpc ic group <NUMBER> <NUMBER> ferrets positive viral rna nasal washes fecal specimens <NUMBER> dpc although viral rna copy numbers lower <NUMBER> <NUMBER> log <NUMBER> copiesml respectively dc ferrets due cytotoxicity urine fecal virus spike rna gene detection limit viral titer limit <NUMBER> log <NUMBER> copiesml <NUMBER> log <NUMBER> tcid <NUMBER> ml respectively b isolated viruses nasal wash samples inoculated ferrets cell host microbe <NUMBER> <NUMBER> may <NUMBER> <NUMBER> <NUMBER> specimens ferrets could assess virus isolation titer vero cells evaluate presence infectious nmcncov<NUMBER> urine fecal specimens urine fecal specimens <NUMBER> dpi ininfected dc ic ferrets centrifuged remove debris supernatants inoculated naive ferrets n <NUMBER> per specimen nasal washes specimeninoculated ferrets collected <NUMBER> <NUMBER> <NUMBER> dpi infected onto vero cells virus isolation noticeably nmcncov<NUMBER> isolated nasal wash specimens <NUMBER> <NUMBER> urinespecimentreated fecalspecimentreated ferrets table <NUMBER> however failed reisolate virus ferrets infected fecal specimens ic ferrets results indicate ferret highly susceptible infection sarscov<NUMBER> derived body fluids infectious sarscov<NUMBER> sheds urine fecal specimens infected ferrets assess replication sarscov<NUMBER> ferret organs additional <NUMBER> ferrets infected nmcncov<NUMBER> pbs via route <NUMBER> ferrets sacrificed <NUMBER> <NUMBER> <NUMBER> dpi nasal turbinate trachea lung kidney intestine tissues collected using individual scissors avoid cross contamination highest viral rna levels detected nasal turbinate <NUMBER> log <NUMBER> copiesg lung tissue <NUMBER> log <NUMBER> copiesg <NUMBER> dpi viral rna also detected intestine <NUMBER> log <NUMBER> copiesg kidney <NUMBER> log <NUMBER> copiesg <NUMBER> dpi <NUMBER> dpi viral rna still detected nasal turbinate trachea lungs kidney intestine figure <NUMBER>b correlation viral rna copy numbers figure <NUMBER>b highest infectious virus titer detected nasal turbinate <NUMBER> log <NUMBER> tcid <NUMBER> g lung tissue <NUMBER> log <NUMBER> tcid <NUMBER> g <NUMBER> dpi whereas infectious virus recovery failed trachea kidney intestine tissues carried less <NUMBER> log <NUMBER> viral rna copiesg figure <NUMBER>c finally infectious nmcncov<NUMBER> isolated nasal turbinate <NUMBER> log <NUMBER> tcid <NUMBER> g trachea <NUMBER> log <NUMBER> tcid <NUMBER> g <NUMBER> dpi tissues <NUMBER> dpi figure <NUMBER>c however viral rna detection virus recovery failed tested tissues <NUMBER> dpi results suggest virus isolation infected tissues closely related viral rna copy number confirm viral replication infected ferrets immunohistochemistry ihc histopathological examinations conducted figure <NUMBER> figure s<NUMBER> briefly tissue samples collected nmcncov<NUMBER> infected pbstreated ferrets <NUMBER> dpi incubated <NUMBER> neutralbuffered formalin virus inactivation tissue fixation embedded paraffin embedded tissues sectioned dried <NUMBER> days room temperature detect viral antigens ihc mouse polyclonal antibody raised immunization mice inactivated nmcncov<NUMBER> virions used primary antibody slides viewed using olympus bx<NUMBER> olympus tokyo japan microscope dp controller software capture images ihc analyses showed number cells nasal turbinate trachea lung intestine sections nmcncov<NUMBER>infected ferrets figures <NUMBER>i<NUMBER>l pbstreated control ferrets figures <NUMBER>e<NUMBER>h positive sarscov<NUMBER> antigen lung histopathology showed compared pbstreated ferrets nmcncov<NUMBER>infected ferrets <NUMBER> dpi showed increased immune infiltration cell debris alveolar wall bronchial epithelium bronchial lumen figure s<NUMBER> evidencing acute bronchiolitis nmcncov<NUMBER> infection <NUMBER> days infection remaining ferrets including infection n <NUMBER> dc n <NUMBER> ic n <NUMBER> returned normal ranges body temperature body weight specimens negative viral rna evaluate seroconversion rate group sera collected remaining ferrets serumneutralizing sn antibody assay nmcncov<NUMBER> <NUMBER> tcid <NUMBER> conducted vero cells although infection group showed highest mean sn titers compared groups sn titers infection dc groups ranged <NUMBER> and<NUMBER> figure <NUMBER>d hand <NUMBER> <NUMBER> ic ferrets showed positive sn titer <NUMBER> taken together demonstrates presence sarscov<NUMBER> multiple sources infected ferrets potentially explaining rapid transmission naive hosts close contact infected hosts given rapid geographical spread covid<NUMBER> declared sarscov<NUMBER> outbreak public health emergency international concern pheic <NUMBER> th january <NUMBER> <NUMBER>a labeled covid<NUMBER> outbreak pandemic <NUMBER> th march <NUMBER> <NUMBER> confirmed covid<NUMBER> patients time reported close epidemiological association direct indirect covid<NUMBER> patients interestingly growing number individuals travel history china direct contact infected patients become infected lim et al <NUMBER> understand virus rapidly spreads within community inform infection control messaging essential develop experimental animal model support active infection shedding transmission sarscov<NUMBER> sentinel animals study established infection transmission ferret animal model covid<NUMBER> sarscov<NUMBER> found efficiently infect ferrets induce moderate increases body temperature <NUMBER> c moreover able detect viral rna blood <NUMBER> dpi nasal washes <NUMBER> dpi urine <NUMBER> dpi fecal <NUMBER> dpi specimens findings suggest sarscov<NUMBER> shed multiple routes body discharge specimens potentially serving sources viral transmission close contact infected individuals interestingly ferrets direct contact sarscov<NUMBER>infected ferrets positive sarscov<NUMBER> infection early <NUMBER> dpc suggesting rapid transmission occurred even prior infected ferrets reaching highest viral rna copy numbers nasal washes <NUMBER> dpi transmission also occurred prior peak body temperature body weight loss infected animals consistent infectiousness individuals asymptomatic periods regard potential airborne transmission sarscov<NUMBER> viral rna detected nasal washes fecal specimens ic ferrets persisted <NUMBER> days indirect contact one two positive animals seroconverted data show airborne transmission likely considerably less robust direct contact transmission following fortuitous discovery natural susceptibility ferrets human influenza viruses ferret models found highly reproduce human disease manifestation several respiratory viruses including respiratory syncytial virus parainfluenzaviruses sarscov<NUMBER> capraro et al <NUMBER> chan et al <NUMBER> enkirch von messling <NUMBER> park et al <NUMBER> addition presence respective viral receptors anatomic proportions ferret upper lower respiratory tracts density submucosal glands bronchial wall number generations terminal bronchioles reproduce condition human respiratory tract enkirch von messling <NUMBER> supports significance ferrets animal model human respiratory viral infection demonstrated sarscov<NUMBER>infected ferrets showed high virus titers upper respiratory tracts nasal washes consequently transmitted naive ferrets direct contact high efficiency suggesting sarscov<NUMBER> ferret model recapitulates aspects human infection transmission suspected recent covid<NUMBER> patients xu et al <NUMBER> detected infectious viruses urine fecal specimens virusinfected ferrets however also limitations sarscov<NUMBER> ferret model sarscov<NUMBER> infected ferrets showed mild clinical symptoms relatively lower virus titers lungs infected animals sarscov<NUMBER>infected merscovinfected hace<NUMBER> hdpp<NUMBER> transgenic mice glass et al <NUMBER> li et al <NUMBER> hand also possible sarscov<NUMBER> replicates weaker persists longer vivo sarscov<NUMBER> ultimately leading asymptomatic carrier persistent infection effectively spread virus therefore given rapid spreading characteristics sasrscov<NUMBER> humans ferret model would useful tool evaluate efficacy prophylactic antivirals preventive vaccines detailed methods provided online version paper include following jae u jung scientific advisor vaccine stabilization institute california corporation outbreak coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> rapidly spreads leading pandemic infection kim et al show ferrets highly susceptible sarscov<NUMBER> infection effectively transmit virus direct indirect contact recapitulating human infection transmission outbreak coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> emerged china rapidly spread worldwide prevent sarscov<NUMBER> dissemination understanding vivo characteristics sarscov<NUMBER> high priority report ferret model sarscov<NUMBER> infection transmission recapitulates aspects human disease sarscov<NUMBER>infected ferrets exhibit elevated body temperatures virus replication although fatalities observed sarscov<NUMBER>infected ferrets shed virus nasal washes saliva urine feces <NUMBER> days postinfection <NUMBER> days postcontact sarscov<NUMBER> detected naive direct contact ferrets furthermore naive indirect contact ferrets positive viral rna suggesting airborne transmission viral antigens detected nasal turbinate trachea lungs intestine acute bronchiolitis present infected lungs thus ferrets represent infection transmission animal model covid<NUMBER> may facilitate development sarscov<NUMBER> therapeutics vaccines coronaviruses covs large family viruses cause respiratory intestinal infections animals humans masters perlman <NUMBER> four generaalphacoronavirus betacoronavirus gammacoronavirus deltacoronavirusalphacoronavirus betacoronavirus commonly associated respiratory illness humans gastroenteritis animals cui et al <NUMBER> covs typically considered highly pathogenic humans outbreaks severe acute respiratory syndrome cov sarscov zhong et al <NUMBER> middle east respiratory syndrome cov merscov zaki et al <NUMBER> recently severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> late december <NUMBER> novel coronavirus disease identified wuhan city hubei province china patients severe pneumonia deep sequencing analysis lower respiratory tract samples revealed identity causative agent newly emerged strain betacoronavirus temporarily named <NUMBER> novel coronavirus <NUMBER>ncov later renamed severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> international committee taxonomy viruses ictv ictv <NUMBER> march <NUMBER> approximately <NUMBER> confirmed cases covid<NUMBER> china <NUMBER> deaths <NUMBER>b sarscov<NUMBER> found high humantohuman transmission close contact infected patients leading rapid global spread infected travelers china march <NUMBER> <NUMBER> sarscov<NUMBER> cases confirmed least <NUMBER> countries steady increase number laboratory confirmed cases <NUMBER> cases outside china suggesting nonpharmaceutical intervention strategies ultimately successful limiting spread therefore animal model recapitulates covid<NUMBER> clinical symptoms human infection urgently needed order decipher transmission routes pathobiology virus allow testing pharmaceutical interventions given sarscov<NUMBER> shares higher sequence homology sarscov <NUMBER> homology merscov <NUMBER> homology entry receptor sarscov human angiotensinconverting enzyme <NUMBER> hace<NUMBER> considered receptor candidate sarscov<NUMBER> correspondingly bao et al <NUMBER> reported weight loss virus replication lungs hace<NUMBER> transgenic mice following sarscov<NUMBER> infection however clinical symptoms cough fever observed order understand rapid spreading characteristics sarscov<NUMBER> additional animal models mimic high humantohuman transmission sarscov<NUMBER> infections warranted given ferret ace<NUMBER> shown contain critical sarscov binding residues wan et al <NUMBER> performed infection direct indirect contact transmission studies using ferret model previously developed influenza virus infections park et al <NUMBER> bouvier <NUMBER> demonstrate ferrettoferret transmission experimental setting ferrets n <NUMBER> inoculated via intranasal route <NUMBER> <NUMBER> tcid <NUMBER> nmcncov<NUMBER> strain isolated covid<NUMBER>confirmed patient south korea february <NUMBER> evaluate transmission mode virus naive ferrets n <NUMBER>group placed direct contact dc cohoused indirect contact ic housed cages permeable partition separating infected ferrets infected ferrets two days primary infection clinical features sarscov<NUMBER> infections recorded study repeated three independent trials total n <NUMBER> direct infection n <NUMBER> dc n <NUMBER> ic n <NUMBER> pbs control n <NUMBER> ferrets nmcncov<NUMBER>infected ferrets elevated body temperatures <NUMBER> c <NUMBER> c <NUMBER> <NUMBER> dpi returned normal <NUMBER> dpi figure <NUMBER>a reduced activity observed nmcncov<NUMBER>infected ferrets <NUMBER> <NUMBER> dpi occasional coughs detectable body weight loss fatalities experimental period interestingly six dc ferrets showed increased body temperatures <NUMBER> c reduced activity <NUMBER> <NUMBER> days post contact dpc detectable body weight loss figures s<NUMBER>a s<NUMBER>b however none ic ferrets showed increased body temperature weight loss <NUMBER> days studies figures s<NUMBER>c s<NUMBER>d data indicate efficient establishment covid<NUMBER> clinical features ferrets exposed infected animals requires direct contact recapitulating humantohuman transmission investigate sarscov<NUMBER> replication shedding group ferrets collected blood nasal washes saliva urine measured tissues nmcncov<NUMBER>infected ferrets n <NUMBER>group tissue n <NUMBER> per group collected <NUMBER> <NUMBER> <NUMBER> dpi viral loads nasal turbinate trachea lung kidney intestine titered using quantitative realtime pcr tcid <NUMBER> data presented mean ± sem serum neutralizing sn antibody titers gmt nmcncov<NUMBER> <NUMBER> tcid <NUMBER> measured onto vero cells <NUMBER> days experiment n <NUMBER> per group data presented geometric mean ± sd tissues harvested day <NUMBER> inoculation immunohistochemistry performed mouse polyclonal antibody presence nmcncov<NUMBER> antigen determined ihc mouse polyclonal antibody magnification <NUMBER> asterisks indicate statistical significance compared pbs control group twoway anova sidaks multiple comparisons test two way anova dunnetts multiple comparisons test b c oneway anova dunnetts multiple comparisons test indicates p <NUMBER> indicates p <NUMBER> indicates p <NUMBER> fecal specimens every day <NUMBER> days collected ferret secretions resuspended cold phosphatebuffered saline pbs containing antibiotics <NUMBER> penicillinstreptomycin gibco virus titration total rna extracted collected samples using rneasy mini kit qiagen hilden germany according manufacturers instructions qiagen <NUMBER> cdna synthesized cdna synthesis kit omniscript reverse transcriptase qiagen hilden germany quantitate viral rna copy number quantitative realtime rtpcr qrtpcr performed targeting spike table <NUMBER> orf<NUMBER>a table s<NUMBER> genes previously described using sybr green kit iq tm sybr green supermix kit biorad hercules ca usa number viral rna copies calculated comparison number copies standard control nmcncov<NUMBER> infected group viral spike rna detected specimens <NUMBER> dpi highest amount viral rna detected nasal washes peaked <NUMBER> dpi <NUMBER> log <NUMBER> copiesml persisting <NUMBER> dpi dropping detection limits <NUMBER> dpi table <NUMBER> virus also detected saliva specimens <NUMBER> dpi <NUMBER> log <NUMBER> copiesml <NUMBER> dpi although viral spike rna detected sera infected ferrets viral copy number low peaked titer <NUMBER> log <NUMBER> copiesml dropped detection limits earlier nasal wash saliva specimens evaluate infectious virus titer specimen collected nasal washes saliva specimens inoculated onto vero cells virus isolation infected ferret group nmcncov<NUMBER> isolated saliva nasal washes specimens early <NUMBER> dpi persisted <NUMBER> <NUMBER> dpi respectively table <NUMBER> nasal washes specimens showed higher virus titers <NUMBER> log <NUMBER> tcid <NUMBER> ml saliva specimens <NUMBER> log <NUMBER> tcid <NUMBER> ml dc ferret group virus isolated nasal washes <NUMBER> dpc <NUMBER> log <NUMBER> tcid <NUMBER> ml <NUMBER> dpc <NUMBER> log <NUMBER> tcid <NUMBER> ml saliva specimens table <NUMBER> gastrointestinal involvement characteristic coronavirus infections animals humans leung et al <NUMBER> also collected fecal urine specimens viral rna detected majority collected specimens ininfected dc groups early <NUMBER> dpc table <NUMBER> similarly infected group dc group highest virus copy numbers <NUMBER> log <NUMBER> copiesml nasal washes rna detected <NUMBER> dpc addition viral rna detected saliva fecal specimens dc group <NUMBER> days whereas urine specimens contained detectable viral rna <NUMBER> dpc ic group <NUMBER> <NUMBER> ferrets positive viral rna nasal washes fecal specimens <NUMBER> dpc although viral rna copy numbers lower <NUMBER> <NUMBER> log <NUMBER> copiesml respectively dc ferrets due cytotoxicity urine fecal ferret groups days post treatment log <NUMBER> copiesml log <NUMBER> tcid <NUMBER> ml <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> infected nmcncov<NUMBER> infected group dc directly contacted group ic indirectly infected group asterisks indicate statistical significance compared naive sample ordinary oneway anova dunnetts multiple comparisons test indicates p <NUMBER> indicates p <NUMBER> indicates p <NUMBER> virus spike rna gene detection limit viral titer limit <NUMBER> log <NUMBER> copiesml <NUMBER> log <NUMBER> tcid <NUMBER> ml respectively b isolated viruses nasal wash samples inoculated ferrets cell host microbe <NUMBER> <NUMBER> may <NUMBER> <NUMBER> <NUMBER> specimens ferrets could assess virus isolation titer vero cells evaluate presence infectious nmcncov<NUMBER> urine fecal specimens urine fecal specimens <NUMBER> dpi ininfected dc ic ferrets centrifuged remove debris supernatants inoculated naive ferrets n <NUMBER> per specimen nasal washes specimeninoculated ferrets collected <NUMBER> <NUMBER> <NUMBER> dpi infected onto vero cells virus isolation noticeably nmcncov<NUMBER> isolated nasal wash specimens <NUMBER> <NUMBER> urinespecimentreated fecalspecimentreated ferrets table <NUMBER> however failed reisolate virus ferrets infected fecal specimens ic ferrets results indicate ferret highly susceptible infection sarscov<NUMBER> derived body fluids infectious sarscov<NUMBER> sheds urine fecal specimens infected ferrets assess replication sarscov<NUMBER> ferret organs additional <NUMBER> ferrets infected nmcncov<NUMBER> pbs via route <NUMBER> ferrets sacrificed <NUMBER> <NUMBER> <NUMBER> dpi nasal turbinate trachea lung kidney intestine tissues collected using individual scissors avoid cross contamination highest viral rna levels detected nasal turbinate <NUMBER> log <NUMBER> copiesg lung tissue <NUMBER> log <NUMBER> copiesg <NUMBER> dpi viral rna also detected intestine <NUMBER> log <NUMBER> copiesg kidney <NUMBER> log <NUMBER> copiesg <NUMBER> dpi <NUMBER> dpi viral rna still detected nasal turbinate trachea lungs kidney intestine figure <NUMBER>b correlation viral rna copy numbers figure <NUMBER>b highest infectious virus titer detected nasal turbinate <NUMBER> log <NUMBER> tcid <NUMBER> g lung tissue <NUMBER> log <NUMBER> tcid <NUMBER> g <NUMBER> dpi whereas infectious virus recovery failed trachea kidney intestine tissues carried less <NUMBER> log <NUMBER> viral rna copiesg figure <NUMBER>c finally infectious nmcncov<NUMBER> isolated nasal turbinate <NUMBER> log <NUMBER> tcid <NUMBER> g trachea <NUMBER> log <NUMBER> tcid <NUMBER> g <NUMBER> dpi tissues <NUMBER> dpi figure <NUMBER>c however viral rna detection virus recovery failed tested tissues <NUMBER> dpi results suggest virus isolation infected tissues closely related viral rna copy number confirm viral replication infected ferrets immunohistochemistry ihc histopathological examinations conducted figure <NUMBER> figure s<NUMBER> briefly tissue samples collected nmcncov<NUMBER> infected pbstreated ferrets <NUMBER> dpi incubated <NUMBER> neutralbuffered formalin virus inactivation tissue fixation embedded paraffin embedded tissues sectioned dried <NUMBER> days room temperature detect viral antigens ihc mouse polyclonal antibody raised immunization mice inactivated nmcncov<NUMBER> virions used primary antibody slides viewed using olympus bx<NUMBER> olympus tokyo japan microscope dp controller software capture images ihc analyses showed number cells nasal turbinate trachea lung intestine sections nmcncov<NUMBER>infected ferrets figures <NUMBER>i<NUMBER>l pbstreated control ferrets figures <NUMBER>e<NUMBER>h positive sarscov<NUMBER> antigen lung histopathology showed compared pbstreated ferrets nmcncov<NUMBER>infected ferrets <NUMBER> dpi showed increased immune infiltration cell debris alveolar wall bronchial epithelium bronchial lumen figure s<NUMBER> evidencing acute bronchiolitis nmcncov<NUMBER> infection <NUMBER> days infection remaining ferrets including infection n <NUMBER> dc n <NUMBER> ic n <NUMBER> returned normal ranges body temperature body weight specimens negative viral rna evaluate seroconversion rate group sera collected remaining ferrets serumneutralizing sn antibody assay nmcncov<NUMBER> <NUMBER> tcid <NUMBER> conducted vero cells although infection group showed highest mean sn titers compared groups sn titers infection dc groups ranged <NUMBER> and<NUMBER> figure <NUMBER>d hand <NUMBER> <NUMBER> ic ferrets showed positive sn titer <NUMBER> taken together demonstrates presence sarscov<NUMBER> multiple sources infected ferrets potentially explaining rapid transmission naive hosts close contact infected hosts given rapid geographical spread covid<NUMBER> declared sarscov<NUMBER> outbreak public health emergency international concern pheic <NUMBER> th january <NUMBER> <NUMBER>a labeled covid<NUMBER> outbreak pandemic <NUMBER> th march <NUMBER> <NUMBER> confirmed covid<NUMBER> patients time reported close epidemiological association direct indirect covid<NUMBER> patients interestingly growing number individuals travel history china direct contact infected patients become infected lim et al <NUMBER> understand virus rapidly spreads within community inform infection control messaging essential develop experimental animal model support active infection shedding transmission sarscov<NUMBER> sentinel animals study established infection transmission ferret animal model covid<NUMBER> sarscov<NUMBER> found efficiently infect ferrets induce moderate increases body temperature <NUMBER> c moreover able detect viral rna blood <NUMBER> dpi nasal washes <NUMBER> dpi urine <NUMBER> dpi fecal <NUMBER> dpi specimens findings suggest sarscov<NUMBER> shed multiple routes body discharge specimens potentially serving sources viral transmission close contact infected individuals interestingly ferrets direct contact sarscov<NUMBER>infected ferrets positive sarscov<NUMBER> infection early <NUMBER> dpc suggesting rapid transmission occurred even prior infected ferrets reaching highest viral rna copy numbers nasal washes <NUMBER> dpi transmission also occurred prior peak body temperature body weight loss infected animals consistent infectiousness individuals asymptomatic periods regard potential airborne transmission sarscov<NUMBER> viral rna detected nasal washes fecal specimens ic ferrets persisted <NUMBER> days indirect contact one two positive animals seroconverted data show airborne transmission likely considerably less robust direct contact transmission following fortuitous discovery natural susceptibility ferrets human influenza viruses ferret models found highly reproduce human disease manifestation several respiratory viruses including respiratory syncytial virus parainfluenzaviruses sarscov<NUMBER> capraro et al <NUMBER> chan et al <NUMBER> enkirch von messling <NUMBER> park et al <NUMBER> addition presence respective viral receptors anatomic proportions ferret upper lower respiratory tracts density submucosal glands bronchial wall number generations terminal bronchioles reproduce condition human respiratory tract enkirch von messling <NUMBER> supports significance ferrets animal model human respiratory viral infection demonstrated sarscov<NUMBER>infected ferrets showed high virus titers upper respiratory tracts nasal washes consequently transmitted naive ferrets direct contact high efficiency suggesting sarscov<NUMBER> ferret model recapitulates aspects human infection transmission suspected recent covid<NUMBER> patients xu et al <NUMBER> detected infectious viruses urine fecal specimens virusinfected ferrets however also limitations sarscov<NUMBER> ferret model sarscov<NUMBER> infected ferrets showed mild clinical symptoms relatively lower virus titers lungs infected animals sarscov<NUMBER>infected merscovinfected hace<NUMBER> hdpp<NUMBER> transgenic mice glass et al <NUMBER> li et al <NUMBER> hand also possible sarscov<NUMBER> replicates weaker persists longer vivo sarscov<NUMBER> ultimately leading asymptomatic carrier persistent infection effectively spread virus therefore given rapid spreading characteristics sasrscov<NUMBER> humans ferret model would useful tool evaluate efficacy prophylactic antivirals preventive vaccines detailed methods provided online version paper include following information requests resources reagents directed fulfilled lead contact young ki choi choiki<NUMBER>chungbukackr uniquestable reagents generated study available lead contact completed materials transfer agreement study generate unique datasets code reagent table s<NUMBER> sarscov<NUMBER> orf<NUMBER>a r tcagctgatgcacaatcgt study see table s<NUMBER> software algorithms male female ferrets <NUMBER>to <NUMBER>month old seronegative influenza viruses merscov sarscov id bio corporation maintained isolator woori ib corporation bsl<NUMBER> chungbuk national university ferrets group hosed <NUMBER> h lightdark cycle allowed access diet water animal studies carried accordance protocols approved institutional animal care use committee iacuc chungbuk national university virus isolated isolate sarscov<NUMBER> covid<NUMBER> confirmed patient korea infect animal viruses propagated vero cells dmem medium gibco supplemented <NUMBER>penecillinstreptomycin gibco tpck trypsin <NUMBER>ugml worthington biochemical <NUMBER> c <NUMBER> h propagated viruses stored à<NUMBER> c freezer future usage study design animaltoanimal transmission <NUMBER> à<NUMBER> month old male female ferrets confirmed influenza h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> merscov sarscov antibody free ferrets standard enzymelinked immunosorbent assay elisa previously described elsewhere elduah et al <NUMBER> park et al <NUMBER> woo et al <NUMBER> infected intranasal route nmc<NUMBER>ncov<NUMBER> virus isolate sarscov<NUMBER> covid<NUMBER> confirmed patient korea <NUMBER> february dose <NUMBER> <NUMBER> tcid <NUMBER> per ferrets n <NUMBER> oneday postinfection one naive direct contact dc indirect contact ic ferrets introduced cage ic ferrets separated inoculated animals partition allowed air move without direct contact animals study conducted three independent trials blood fecal nasal wash saliva urine specimens collected every day <NUMBER> days group ferrets detect sarscov<NUMBER> investigate whether collected specimen contained infectious live virus inoculated onto vero cells access replication virus ferrets following sarscov<NUMBER> infection various organs additional <NUMBER> ferrets infected sarscov<NUMBER> route three ferrets sacrificed <NUMBER> <NUMBER> <NUMBER> dpi lung liver spleen kidney intestinal tissues collected individual scissors avoid cross contamination may <NUMBER> <NUMBER> <NUMBER> novel coronavirus sarscov<NUMBER> responsible <NUMBER> countries <NUMBER> infections <NUMBER> deaths related disease defined coronavirus disease <NUMBER> covid <NUMBER> <NUMBER> human population immunity sarscov<NUMBER> virus never previously infected humans initial outbreak december <NUMBER> drugs biologics proven effective prevention treatment covid<NUMBER> deal pandemic apart nonpharmaceutical containment measures including quarantine maintenance social distance possible interventions consist repurposing existing pharmaceutical products along development new products vaccines <NUMBER> <NUMBER> <NUMBER> development radically new pharmaceutical product either traditional biological antibody targeting sarscov<NUMBER> receptor subject regulatory approval use humans based three steps <NUMBER> lab discovery vitro cell cultures <NUMBER> preclinical testing vivo animals confirm mechanism action measure range effective dosages ivyspring international publisher tolerability <NUMBER> clinical testing patients define safe dosage confirm efficacy possible interactions process involves serious challenges related efficiency example development human vaccine concept licensing takes least <NUMBER> years <NUMBER> also effectiveness drug development currently involves <NUMBER> overall failure rate <NUMBER> due failure preclinical testing phase meaning drug efficacy measured vitro almost never confirmed animals <NUMBER> main issue widespread technology currently used test therapeutic agents vitro obsolete often consists twodimensional <NUMBER>d polystyrene culture dish single cell population cultured bottom drug tested added culture medium expected modulation specific processes targets measured however simplified vitro culture conditions drug elicits cell response representative vivo response based cell interactions occur threedimensional <NUMBER>d nonflat environments b within heterogeneous cell population never limited cell population primarily addressed drug another serious issue unethical slaughter lab animals effective vitro methods would replace least part moreover methods adopted monitoring drug effects animals also obsolete whereas new miniaturized intravital imaging techniques available could greatly refine vivo observations even terms temporal evolution animal thus reducing number animals sacrificed <NUMBER> many ongoing clinical trials evaluating potential vaccines treatments covid<NUMBER> cannot accelerated without putting safety patients risk instead vitro vivo preclinical phases drug development could accelerated replacing current unrepresentative obsolete study models new ones based improved modeling tools example many groups developed <NUMBER>d static microfluidic intravital imaging models viral infection relevant therapeutics using new highperformance experimental devices userfriendly operators enable live organoids cultured examined <NUMBER>d highresolution imaging review published work based modeling tools specific fields virology pharmacology silico discovery drug targets sarscov<NUMBER> prediction pathogenic mechanisms sarscov<NUMBER> infection lead covid<NUMBER> infection causes massive damage pulmonary cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> due cytokine storm ie acute secretion inflammatory signals innate monocytes response infection causes hyper inflammation <NUMBER> clinicaltrialsgov database currently report many active trials covid<NUMBER> patients drugs already licensed infectious inflammatory diseases include antimalarial drugs chloroquine derivative hydroxychloroquine large spectrum antivirals inhibitors endonucleases nucleosides protease inhibitors antiretrovirals interferons corticosteroids immune suppressants anticoagulants parallel many groups repurposing known compounds developing new vaccines <NUMBER> therapeutic solutions <NUMBER> specifically target sarscov<NUMBER> virus drug targets primarily viral proteins resolved available protein data bank pdb much progress made structural biology sarscov<NUMBER> many structural nonstructural proteins determined experimentally cryoelectron microscopy cryoem xray crystallography proteins specific sarscov<NUMBER> already determined experimentally shown figure <NUMBER> drug therapies may act either host cells affecting specific receptor restoring innate immunity cells b virus blocking virus functions target acting virus structural proteins ii target primary drug target represented several nonstructural viral proteins nsps whose inhibition blocks viral rna synthesis replication <NUMBER> include papainlike protease plpro nsp<NUMBER> region main protease mpro also known clike protease <NUMBER>clpro rnadependent rna polymerase rdrp helicase structural spike protein viral envelope studied protein secondary ii drug targets <NUMBER> virus cannot bind host cell receptors fuse cell membranes enter cells spike protein inhibited thus also already solved electron microscopy <NUMBER> comprises receptor binding domain rbd mainly involved hostcell interaction incorporating subdomain called receptor binding motif rbm believed bind similarly sarscov mainly human angiotensinconverting enzyme <NUMBER> ace<NUMBER> cell receptor gain entry inside cells <NUMBER> ace<NUMBER> receptor discovered <NUMBER> expressed lungs heart kidneys gastrointestinal tract testis tissues organs <NUMBER> drugs sarscov<NUMBER> investigated today therefore target complex rbdace<NUMBER> <NUMBER> <NUMBER> <NUMBER> solved sarscov<NUMBER> molecular structures used setup docking analyses molecular dynamics simulations predict affinity chemical binding structures known compounds silico modeling technique used intensely drug screening virtual libraries table <NUMBER> shows latest published results terms drugs predicted bind sarscov<NUMBER> targets worth noting silico drug docking analyses listed table <NUMBER> use homology modelling strategy predict structures target proteins yet experimentally resolved <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> homology modelling approach predicts atomicresolution model target protein based structure protein chosen template according genome sequence identity <NUMBER> genome sarscov<NUMBER> showed high homology sars virus makes reliable template <NUMBER> sequence alignment previous sarslike viruses also applied perform virus evolutionary analysis <NUMBER> highlight particular features sarscov<NUMBER> virus table <NUMBER> several studies compared sarscov<NUMBER> sars terms interaction spike protein host cell receptor structuraland freebinding energybased analyses revealed accurate details sarscov<NUMBER> observations may explain aggressiveness sarscov<NUMBER> least part <NUMBER> <NUMBER> <NUMBER> <NUMBER> similar approach also taken explore efficiency binding proteins encoded different human ace<NUMBER> allelic variants sarscov<NUMBER> spike protein binding analysis two variants showed variations orientation amino acid side chain altering intramolecular interactions complex formation aspect may represent partial intrinsic susceptibility resistance sarscov<NUMBER> infection <NUMBER> <NUMBER> structure alignment sarscov<NUMBER> sarscov <NUMBER> sarscov<NUMBER> ace<NUMBER> complex modeling via single point mutation solved sarscov ace<NUMBER> <NUMBER> sarscov<NUMBER> sarscov interaction ace<NUMBER> hot spots residues mainly involved rbd binding comparison <NUMBER> comparison animals ace<NUMBER> two spike proteins quite similar therefore authors analyzed detail hot spots revealed sarscov <NUMBER> two virusbinding hot spots identified ace<NUMBER> hot spot <NUMBER>salt bridge lys<NUMBER>glu<NUMBER> hot spot <NUMBER> salt bridge lys<NUMBER>asp<NUMBER> <NUMBER> sarscov<NUMBER> q<NUMBER> vs sarscov n<NUMBER> compatible less affinity hotspot <NUMBER> b sarscov<NUMBER> q<NUMBER> vs sarscov t<NUMBER> less affinity hotspot <NUMBER> still compatible c sarscov<NUMBER> l<NUMBER> vs sarscov y<NUMBER> preferred interaction hotspot <NUMBER> sarscov<NUMBER> f<NUMBER> vs sarscov l<NUMBER> enhances interaction hotspot <NUMBER> e sarscov<NUMBER> s<NUMBER> vs sarscov d<NUMBER> made interaction weaker compatible hotspot <NUMBER> <NUMBER> mouse rat ace<NUMBER> contained hotspot <NUMBER> position fit rbd sarscov<NUMBER> instead recognized ace<NUMBER> pigs ferrets cats orangutans monkeys humans <NUMBER> receptor ace<NUMBER> sarscov<NUMBER> spike <NUMBER> genomic analysis <NUMBER> homology modeling sarscov<NUMBER> spike <NUMBER> structural superimposition sarscovace<NUMBER> model <NUMBER> binding free energy evaluation <NUMBER> low homology rbd domain sarscov<NUMBER> sarscov high similarity similar polarity <NUMBER> free energy binding authors observed even though weaker sarscov <NUMBER> kcal mol<NUMBER> sarscov<NUMBER> spike still showed high affinity ace<NUMBER> <NUMBER> kcal mol<NUMBER> <NUMBER> differences aa sequences alter protein conformation maintained similar van der waals electrostatic properties <NUMBER> receptor cd<NUMBER> sarscov<NUMBER> spike <NUMBER> homology modeling sarscov<NUMBER> spike s<NUMBER>s<NUMBER> using sarscov template pdb <NUMBER>acd obtain inactive configuration using sarscovace<NUMBER> complex structure template pdb<NUMBER>acg obtain active structure <NUMBER> analysis glycosylation sites via server <NUMBER> comparison sarscov<NUMBER> vs sarscov glycosylation shield structure obtained server <NUMBER> docking modeled trimeric spike human cd<NUMBER> pdb <NUMBER>qzv bat sarslike cov ratg<NUMBER> inner joint neighbor sarscov<NUMBER> <NUMBER> overall genome sequence identity fulllength sequence pangolin sarslike cov sarscov<NUMBER> seem little different sarscov<NUMBER> rbd sequence <NUMBER> <NUMBER> like cov higher <NUMBER> similarity bat sarslike cov pangolin sarslike cov higher probability cross host barriers infect humans infectioninvolved aa comparison identified pangolins turtles possible intermediate hosts <NUMBER> orf<NUMBER>ab <NUMBER> authors showed typical workflow homology modeling applied sarscov<NUMBER> orf<NUMBER>ab proteins <NUMBER> aa sequence comparison performed sequence alignment investigations <NUMBER> primary sequences sarscov<NUMBER> via blast swissmodel clustal omega <NUMBER> according blast analysis sequence identity orf<NUMBER>ab protein sarscov<NUMBER> sarscov <NUMBER> query cover <NUMBER> <NUMBER> authors showed typical workflow homology modeling applied sarscov<NUMBER> orf<NUMBER>ab proteins <NUMBER> spike ace<NUMBER> receptor study explores binding proteins encoded different human ace<NUMBER> allelic variants sarscov<NUMBER> spike protein <NUMBER> selected coding variants ace<NUMBER> predicted silico possible allelic variants <NUMBER> modelled <NUMBER> obtained coding variants ace<NUMBER> via homology modeling native structure superimposed structures comparison <NUMBER> superimposed obtained models native ace<NUMBER>spike protein complex <NUMBER> interresidual interaction maps <NUMBER> authors selected allelic structures involved ace<NUMBER>spike interaction <NUMBER> variants <NUMBER> protein architecture ace<NUMBER> allelic variants similar wild type spatial orientation substituting residues varied notably <NUMBER> ace<NUMBER> variants bind spike protein identical native complex intermolecular contacts sarscov<NUMBER> spike protein ace<NUMBER> variants comparable among differences rs<NUMBER> s<NUMBER>p rs<NUMBER> e<NUMBER>g showed low binding affinity may confer resistance virus infection spike protein studied secondary ii potential drug target virus cannot bind cell receptors spike protein inhibited <NUMBER> spike protein studied solved electron microscopy em consists nter domain ntd receptor binding domain rbd consisting receptor binding motif rbm subdomain <NUMBER> sd<NUMBER> subdomain <NUMBER> sd<NUMBER> fusion peptide fp heptad repeat <NUMBER> hr<NUMBER> heptad repeat <NUMBER> hr<NUMBER> transmembrane region tm intracellular domain ic studied rbd domain rbm red domain mainly involved hostcell interaction <NUMBER> rbm believed bind mainly ace<NUMBER> human cell receptor therefore relevant pdb codes <NUMBER>m<NUMBER>j includes rbdace<NUMBER> complex complete amino acid sequence rbd shown bottom figure amino acids corresponding rbm red betasheet alphahelix structures inside dotted boxes contact residues rbdace<NUMBER> interface <NUMBER> shown bold squares httpswwwncbinlmnihgovgenbanksarscov<NUMBER>seqs discovered silico drug tested vitro vivo experimental models viral infection aim include advanced study model developed virology vaccinology since sars coronavirus outbreak <NUMBER> analyzed literature pertaining last two decades found <NUMBER> papers <NUMBER> published last five years <NUMBER>d cell models generally based cell aggregates organoids cultured within matrix scaffold provide <NUMBER>d environment cell growth figure <NUMBER> organoids usually obtained starting pluripotent stem cells frequently ips engineered tissues mainly derived multipotent unipotent cells date five recent studies addressed sarscov<NUMBER> innovative approach specifically replicate sarscov<NUMBER> infection models human airway epithelium <NUMBER> <NUMBER> <NUMBER> human liver organoids <NUMBER> engineered human kidney vessel organoids <NUMBER> addition three studies include therapeutic agents inhibit sarscov<NUMBER> infection clinicalgrade human recombinant soluble angiotensin converting enzyme <NUMBER> hrsace<NUMBER> <NUMBER> remdesivir also association diltiazdem <NUMBER> βdn<NUMBER>hydroxycytidine <NUMBER> table <NUMBER> reports findings published <NUMBER>d cell models used study viral infections table <NUMBER> reports also include effects antiviral therapy nichoid culture <NUMBER>dsubstrates produced via twophoton laser polymerization sz<NUMBER> negative photoresist nearinfrared exposure following cad geometry b possible microscopy configurations use nichoid culture substrates thanks devices versatility scaffold enables optical accessibility transmission reflection modality c immunofluorescence images obtained via confocal fluorescence microscopy gfap red βactin green dna blue human adipose derived stem cells hadscs <NUMBER>day expansion inside nichoid standard conditions <NUMBER>dcontrol images demonstrate nuclear morphology protein organization localization βactin gfap differed two culture systems cytoskeletal markers merge yellow signal cellular protrusions inside nichoids poor signal appears flat conditions realtime pcr analysis specific gene targets shows significant gene expression difference upregulated green downregulated red nichoid control conditions using standard culture medium also using culture medium induces adipogenic neural differentiation primary human epithelial cells airway epithelium epithelial cells isolated expanded transwells airliquidinterface ali model provided pseudostratified fullydifferentiated system showing basal ciliated goblet cells secreted mucus proteins primary human cholangiocytes primary bile ducts liver ductal organoids ldo embedded matrigel human testicular organoid hto ssc sc lc peritubular cells centrifugated seeded ultralow attachment plate maintained medium testis ecm <NUMBER> h selfassembled spheroids <NUMBER> respiratory syncytial virus rsv human ipscs fetal tissue lung bud organoid lbo hpscs embedded matrigel induced anterior foregut endoderm differentiation cd<NUMBER> cxcr<NUMBER>ckit airway branch formation <NUMBER> respiratory syncytial virus rsv primary epithelial cells isolated nonsmall cell lung cancer cells embedded basement membrane extract bme grown adult human epithelial airway organoids pseudostratified airway epithelium basal secretory multiciliated cells <NUMBER> avian influenza iav h<NUMBER>n<NUMBER>h<NUMBER>n<NUMBER> hsaepcs loaded onto <NUMBER>d chitosancollagen scaffold exposed airliquid interface ali upper part transwell alternatively cells totally covered media <NUMBER>d culture conditions performed seeding cells directly upper part transwell plate replicating ali immerged conditions <NUMBER>d one decellularized porcine small intestinal submucosa sis seeded apical side fbcs h<NUMBER>efluor<NUMBER> cells dcsgfp dcsgfpadded suspension basolateral side <NUMBER> hiv<NUMBER> virus primary human cd<NUMBER> tlymphocytes cells loaded custommade collagen type gels derived rat tail bovine <NUMBER> andeshantavirus andv human lung fibroblast mrc<NUMBER>hbronchial epithelial cells <NUMBER>hbe<NUMBER>o layered construct transwell system bottom bovine collageni mrc<NUMBER> bcolli top <NUMBER>hbe<NUMBER>oguarantee airliquid interface ali andv inoculated apical side construct studies viruses sarscov<NUMBER> consist modeling respiratory infections diffused engineered human pseudostratified airway epithelium <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> models cellular constructs based primary epithelial cells embedded matrix biological origin replicating basal membrane grown full differentiation preferably airliquid interface organoid basal secretory multiciliated cells studies also use specific control cell lines cultured monolayer example derived lung intestinal adenocarcinoma epithelial cells <NUMBER> <NUMBER> <NUMBER> lung primary fibroblasts epithelial cells <NUMBER> comparison results <NUMBER>d models monolayer cultures highlights following significant advantages <NUMBER>d cell models replicating conditions observed vivo parameters imaged replicated similarly invivo <NUMBER>d cell organoid models unlike cell monolayers example cells <NUMBER>d engineered airway epithelium infected sarscov<NUMBER> showed apicalapical polarity known restrict infection airway lumen vivo <NUMBER> reproduced infection peaks significant morphological alterations earlier nasal cells compared bronchial cells <NUMBER> cells liver organoids infected sarscov<NUMBER> <NUMBER> cells intestinal organoids infected merscov <NUMBER> syncytia membrane fusions observed mice vivo models infected respiratory syncytial virus rsv lung organoids morphological structure infection features matching human fetal lung tissue <NUMBER> airway epithelium organoids massive epithelial modifications mature tissue infection vivo <NUMBER> <NUMBER>d engineered airway epithelium cell morphology close invivo characteristics reorganization cytoskeletal components abundance ciliated cells <NUMBER> mucociliary layer <NUMBER> surfactant mucus often produced <NUMBER> h<NUMBER>n<NUMBER> influenza virus infected ciliated nonciliated cells causing cilia tight junction damage seen vivo <NUMBER> <NUMBER>d engineered liver model reproduced demonstrated greater physiological hepatocyte morphology polarity apicalbasal adhesion ecm compared classical cell monolayer <NUMBER> <NUMBER>d cell organoid models significantly permissive viral infection compared cell monolayers example infected sarscov<NUMBER> peak infection <NUMBER>dengineered human airway epithelium reached <NUMBER> faster <NUMBER> also infected avian influenza virus h<NUMBER>n<NUMBER> viral proliferation faster <NUMBER> addition propagation human rhinovirus c bocavirus two three orders magnitude greater respectively <NUMBER> airway epithelium organoids infected avian influenza virus h<NUMBER>n<NUMBER> viral proliferation faster timeorder equivalent vivo proliferation time <NUMBER> merscov shown infect intestinal organoids epithelial monolayers <NUMBER> model hiv<NUMBER> infection primary human cd<NUMBER> tlymphocytes <NUMBER>d collagen culture unlike suspension conditions promoted cellassociated hiv<NUMBER> transmission consistent spread mechanisms described vivo <NUMBER> human intestinal organoids infected rotavirus displayed <NUMBER>fold increase genomic viral rna cells infected monolayer <NUMBER> hepatitis b replicated one order magnitude faster <NUMBER>dengineered liver model compared cell monolayer <NUMBER> cells cultured airliquid interface mucilair culture medium <NUMBER>well plates <NUMBER>mm transwell inserts <NUMBER> syncytial virus rsv entryfusion inhibitors gs<NUMBER> tmc<NUMBER> nucleoside viral polymerase inhibitor two nonnucleoside replication inhibitors az<NUMBER> pc<NUMBER> fullydifferentiated human airway epithelium cells huaecs bronchial origin healthy donors huaecs bronchial origin seeded airliquid interface cell culture system mucilair medium <NUMBER> rotavirus interferonalpha ifnα ribavirin mouse human organoids resection small intestine mouse intestinal biopsies surgically resected intestinal tissues patients <NUMBER>d culture caco<NUMBER> cell line crypts obtained biopsies suspended growth factors reduced phenolred free matrigel placed center well <NUMBER>well plate subsequently incubated specific culture medium <NUMBER> hepatitis b hbv entecavir human decellularized liver scaffold healthy cirrhotic donors hdcshdlcs seeded phhs hepg<NUMBER>ntcp <NUMBER> herpes simplex virus <NUMBER> hsv<NUMBER> human fibroblast derived ipscs hff<NUMBER>s cell lines <NUMBER>d neural culture obtained hipscs seeded cultured neurobasal medium brain neurothrophic factor become neural progenitor cells npcs mature neurons <NUMBER>d brain organoids obtained via hipscs differentiation towards npcs selfassembled neurospheroids transwell maturing toroidal shape cultured lowattachment plates expression markers similar time space invivo values <NUMBER>d cell organoid models compared cell monolayers example <NUMBER>dengineered airway epithelium infected sarscov<NUMBER> showed different expression levels immuneresponse genes type type iii interferons subset genes associated nfkb tnfα pathways nasal cells strong upregulation <NUMBER> hours post infection bronchial cells low expression <NUMBER> cells liver organoids expressed ace<NUMBER> receptor thus enabling sarscov<NUMBER> infection unlike mouse model <NUMBER> infected respiratory syncytial virus rsv lung organoids gene marker expression primarily mesenchymal markers pdgfrα pdgfrβ αsma vimentin cd<NUMBER> matched infected human fetal lung tissue <NUMBER> airway epithelium organoids expressed levels genes involved migration krt<NUMBER> krt<NUMBER>b interferon signaling il<NUMBER>rn ifi<NUMBER>l viral response mx<NUMBER> oas<NUMBER> comparable vivo values <NUMBER> <NUMBER>dengineered airway epithelium expression inflammatory cytokines aquaporin<NUMBER> cytokeratin<NUMBER> twofold higher monolayers infected avian influenza viruses h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> <NUMBER> two orders magnitude higher il<NUMBER> il<NUMBER> infected human rhinovirus c human bocavirus <NUMBER> closely recapitulating immune response seen vivo model stratified airway epithelium infected andeshantavirus longterm culture seven days showed switch immune response antiviral transient interferon antinflammatory cytokines vegfa occurs invivo <NUMBER> hepatitis b induced twofold higher expression specific antigens hbsag <NUMBER>dengineered liver model compared cell monolayers <NUMBER> <NUMBER>d models sensitivity antiviral drugs significantly lower similar vivo cell monolayer observations example efficacy clinicalgrade soluble human ace<NUMBER> reducing sarscov<NUMBER> infection human capillary organoids kidney organoids one order magnitude lower monolayers <NUMBER> <NUMBER>dengineered airway epithelium infected h<NUMBER>n<NUMBER> influenza virus treated recombinant human interferons α<NUMBER>b λ<NUMBER> expression interferonstimulated antiviral genes significantly reduced level gene expression induced two agents reversed consistently data vivo compared monolayers <NUMBER> human intestinal organoids infected human rotavirus compared simple cell line model monolayers twice less sensitive interferon α ribavirin range effective doses comparable administered vivo models <NUMBER> response antiviral drug entecavir <NUMBER>d human engineered liver model infected hepatitis b similar vivo compared cell line model <NUMBER> conventional cell monolayers response herpes simplex infection antivirals unrealistically fast <NUMBER> reactivation herpes simplex <NUMBER> virus reactivation exposure interferon α reduced fivefold infected <NUMBER>d brain organoids compared cell monolayers reported animal models <NUMBER> addition hydrogels made acrylated hyaluronic acid loaded fibroblasts time cell recovery reaggregation infection exposure antiviral drug acyclovir threefold greater cell monolayers similarly vivo <NUMBER> evidence outlined shows <NUMBER>d cells organoid models consistently develop properties able determine vivolike dynamics infection pathogenic viruses thus may represent valuable tool towards rapid assessment infectivity humans emerging respiratory viruses sarscov<NUMBER> relevant drug responses technological point view two principal limitations previously analyzed <NUMBER>d models compared conventional monolayer models essentially related <NUMBER>d scaffolds current scaffolds mainly represented either hydrogels <NUMBER> <NUMBER> solid ecm analogues <NUMBER> placed bottom culture plates transwell inserts resulting constructs millimeters thick cannot examined optical microscopy second problem current <NUMBER>d scaffolds limited control culture time physical chemical properties known profoundly affect cell behavior biodegradation release various solutes mechanical properties stiffness influence cell adhesion migration <NUMBER> overcome limitations many groups researchers developing miniaturized <NUMBER>d scaffolds cuttingedge fabrication technique called twophoton laser polymerization <NUMBER> example group developed innovative <NUMBER>d microscaffold called nichoid figure <NUMBER> optically physically accessible cells cultured inside time existing biological assays nichoid miniaturized rigid transparent ultraprecise <NUMBER>d grid fabricated biocompatible resin <NUMBER> <NUMBER> <NUMBER> scaffold <NUMBER> microns thick thus truly <NUMBER>d cells <NUMBER> optically accessible highresolution fluorescence diagnostics mimicking <NUMBER>d stiffness physiological cell niche <NUMBER> nichoid guide selforganization several types stem progenitor cells <NUMBER> <NUMBER> including embryonic stem cells <NUMBER> mesenchymal stem cells msc <NUMBER> also maintains phenotype expansion culture regulating hundreds genes involved mechanotransduction processes cell migration cytoskeletal organization membrane plasticity <NUMBER> nichoid could thus provide effective culture environment test mechanobiological effects overexpression interferoninduced transmembrane proteins rigidify cell membrane thus markedly inhibiting viral membrane fusion entry could thus used screening candidate antiviral drugs vaccines based targeting coronavirus spike protein also observed nichoid potentiates therapeutic efficacy stem cells expanded inside <NUMBER> substrate powerful candidate maintain safety function expanded msc <NUMBER> new therapy already tested clinical trials treat postcovid<NUMBER> pulmonary fibrosis <NUMBER> bioreactor culture systems cellular constructs organoids hosted culture chambers connected hydraulic circuit perfuses culture medium pump figure <NUMBER> microfluidic systems miniaturized version bioreactors generally consisting thin transparent devices similar microscopy slides integrated microchannels host cellloaded hydrogels suspensions table <NUMBER> shows viral infection models developed using bioreactor devices literature reports pioneering model sarscov infection <NUMBER>d bioreactorengineered respiratory epithelium <NUMBER> <NUMBER> several recent models infection based different types viruses studies demonstrate following significant advantages perfused culture replicating conditions seen vivo compared nonperfused culture example <NUMBER>d bioreactorengineered respiratory epithelium infected sarscov found closely resemble normal human tissue terms cell apical polarity essential viral cellcell transport compared nonperfused culture <NUMBER> <NUMBER> bioreactorengineered liver model hepatitis b infection recapitulated functional hepatic microarchitecture complete cell polarization critical cells susceptibility infection compared nonperfused organoids show dedifferentiation <NUMBER> days <NUMBER> bioreactorengineered model neuronal tissue based neural progenitors showed features human trigeminal ganglia site latency varicellazoster virus seen nonperfused cultures <NUMBER> <NUMBER> primary human bronchialtracheal cells hbtcs used establish human lung tissuelike assembly tla overlay human bronchial epithelial beas<NUMBER>b cells <NUMBER>d control established beas<NUMBER>b monoculture <NUMBER>d tissue dynamic culture system established using rotating wall vessel rwv bioreactor static <NUMBER>d controls tissue culture flasks near confluent beas<NUMBER>b monocultures <NUMBER> hepatitis b virus hbv perfused <NUMBER>d bioreactor medium recirculated via pneumatically driven micropump collagencoated scaffolds used cell adherence plate consisted <NUMBER> individual bioreactors flow rate regulated <NUMBER>d perfused phh seeded <NUMBER>d scaffolds nonperfused controls <NUMBER>d spheroid static <NUMBER>d phh selfassembling cocultures sacc phh <NUMBER> <NUMBER> varicella zoster virus vzv normal human neural progenitor nhnp cells used establish human neuronal tissuelike assembly tla gene mutations infection study vzv genome maintenance performed tla validated <NUMBER>d control human melanoma mewo cells optimized <NUMBER>d tissue culture systems created using rotating wall vessel rwv bioreactor <NUMBER>d model compared <NUMBER>d control nhnp cells <NUMBER> adenovirus carrying enhanced green fluorescent protein adegfp mouse embryonic fibroblasts mefs human foreskin fibroblasts hffs microfluidic study static control microfluidic device composed supporting glass slide pdms slab carved accommodate cell culture coverslip membranebased vacuum system reversible sealing microfluidic channels delivering fluids cultured cells control performed static conditions <NUMBER> enhanced green fluorescent protein egfp plasmid <NUMBER>t<NUMBER> fibroblasts used <NUMBER>d control static dynamic conditions microfluidic perfused device dynamic cell culture virus infection micro channel control performed <NUMBER>d conventional culture microfluidic device evaluated static dynamic conditions <NUMBER>d bioreactorengineered respiratory epithelium infected sarscov remained viable threetimes longer nonperfused controls <NUMBER> <NUMBER> bioreactorengineered liver model hepatitis b infection metabolically functionally stable least <NUMBER> days ie four times longer conventional nonperfused cultures <NUMBER> bioreactorengineered model neuronal tissue infected varicellazoster virus successfully maintained culture <NUMBER> days compared limit days primary human ganglia nonperfused culture <NUMBER> <NUMBER> microfluidic model fibroblast infection adenovirus <NUMBER> higher infection efficiency maintained lower multiplicity infection minimum viruscell ratio able cause infection longer incubation times respect nonperfused controls <NUMBER> bioreactorengineered liver model hepatitis b infection led <NUMBER>fold lower multiplicity infection compared nonperfused culture <NUMBER> bioreactorengineered model neuronal tissue infected varicellazoster virus maintained persistent viral infection <NUMBER> days possible nonperfused culture <NUMBER> <NUMBER> <NUMBER>d bioreactorengineered respiratory epithelium infected sarscov antibody response sarscovspecific spike nucleocapsid glycoproteins twofold compared nonperfused culture <NUMBER> <NUMBER> bioreactorengineered liver model hepatitis b infection maintained stable expression levels receptors innate immune cells downstream effectors compared nonperfused cultures <NUMBER> evidence therefore shows perfused models enable infection studies extended even several months stable cell cultures highly differentiated cells higher infection efficiency lower multiplicity infection compared nonperfused models makes potentially feasible extend study life cycle genetic stability new viruses sarscov<NUMBER> vitro systems despite derived minimal doses patients test sequential antiviral drug treatments <NUMBER> importantly perfused cell models make feasible reproduce dynamic interactions tissueresident cells circulating cells including response pathogen innate adaptive immune cells thus extend testing vaccines vitro models first step forward regard recent microfluidicbased model lymph node <NUMBER> stroma modeled adherent murine tumor dendritic cells cd<NUMBER> cd<NUMBER> lymphocytes put suspension culture medium recirculated interstitially within engineered organ system selectively promoted adhesion antigenspecific cells affinity isolation serial cell contacts fluidinduced shear stresses maintained range <NUMBER> dyncm <NUMBER> contrast nonperfused cultures model able compare parallel real time effect cell adhesion dendritic cells different treatments inhibitors activators immunogens regard vaccine testing bioreactors host cmsized <NUMBER>d scaffolds rotating wall vessel able provide tens millions cells confirmation assays pcr facs required regulatory agencies technological limitation however thick accessed thoroughly real time optical inspection cell interactions <NUMBER> <NUMBER> microfluidic bioreactors instead <NUMBER>d micronsized channels also fully inspectable real time <NUMBER> <NUMBER> however host thousand cells difficult harvest case would sufficient robust confirmation assays <NUMBER> overcome limitations group developed millifluidic opticallyaccessible bioreactor moab compromise two categories mentioned moab figure <NUMBER> chambered microscope slide allowing culture fully <NUMBER>d cell models dimensions millimeters containing several million cells interstitial perfusion culture medium infusion cells suspension therapeutic agents tested culture chambers <NUMBER> microns thick enable fullthickness highresolution fluorescence diagnostics real time postcultivation <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vitro tests moab led comparable cell response biodrugs one seen experimental animals specific fields characterized slowlydeveloping diseases slowlydeveloping healing induced therapeutic agent stem cell therapy neurodegeneration <NUMBER> gene therapy muscular dystrophy <NUMBER> chemotherapy bone metastases <NUMBER> adding lymphocytes suspension perfused medium figure <NUMBER> moab easily extended <NUMBER>d microfluidic model lymphocytes instruction within lymph node <NUMBER> millifluidic bioreactors fact high potential speed discovery testing drugs new vaccines sarscov<NUMBER> limited interactions immune system example successfully maintain human primary neurons infected virus longterm culture <NUMBER> days compared limit days nonperfused culture <NUMBER> <NUMBER> millifluidic bioreactors even hydraulically connected multiple units reproduce transport neurotoxic agents multiple body barriers pertaining distant body compartments example gut endothelial barrier bloodbrainbarrier <NUMBER> method exploited assess neurotoxicity primary concern new antiviral drugs vaccines sarscov<NUMBER> addition sarscov<NUMBER> virus could hold neurotropic potential new observations loss smell taste patients later manifesting symptoms covid<NUMBER> together evidence showing coronaviruses sarscov merscov could target central nervous system open new window regard <NUMBER> fact longterm bioreactor coculture olfactory neurons ensheathing glial cells <NUMBER>d could confirm expression ace<NUMBER> human olfactory neurons thus role potential entry site sarscov<NUMBER> virus also could help clarify potential mechanism virus propagation brain neural cell populations ie olfactory neurons ensheathing glial cells model could verify whether sarscov<NUMBER> infection defense mechanism provided olfactory ensheathing cells present whether maintained aging experiment could add crucial insights unveiling possible contribution neurological tissue damage morbidity mortality caused covid<NUMBER> <NUMBER> also suggesting new prevention measures vaporization nasal disinfectants elderly population immunization addresses response innate adaptive immune cells pathogen complex slowlydeveloping phenomenon commonly studied vivo advanced study models immune response influenza viruses experimental animals directly accessed microscope intravital real time optical inspection organs including nasal cavity <NUMBER> trachea <NUMBER> lungs <NUMBER> <NUMBER> <NUMBER> table <NUMBER> shows examples intravital imaging models published field immunization elegant procedures generally consist surgically creating direct percutaneous access microscope objective often using metallic holders transgenic mice fluorescent cd<NUMBER> cells andor cell receptors visualizing interactions inoculated recombinant vaccine viruses also expressing fluorescent proteins <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> compared conventional postmortem histopathology several key advantages intravital imaging techniques highlighted speedingup preclinical evaluation vaccines novel antiviral therapies quantified real time resolution cellular scale example intravital imaging studies lungs quantified time recruitment cd<NUMBER> cells blood vessels response influenza virus <NUMBER> <NUMBER> recently recruitment neutrophils response pr<NUMBER>h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> influenza viruses <NUMBER> multiphoton intravital microscopy abdominal lymph nodes used quantify partial reduction motility hivinfected cells well tethering fusion cd<NUMBER> immune cells <NUMBER> <NUMBER> intravital imaging within vessels colon adenocarcinoma tumors used quantify timely evolution several oncolytic viruses binding intravascular leukocytes endothelial cells <NUMBER> <NUMBER> parameters greater vitro assays example immunization study using glycoprotein respiratory syncytial virus associated antiviral treatment specific monoclonal antibody live imaging used visualize capture virusinfected cells nasal cavity lungs experimental mice higher sensitivity compared vitro plaque assay <NUMBER> intravital imaging live mice sufficiently sensitive quantify vaccinia viruses ear blood vessels labial mucosa <NUMBER> single oncolytic virus particles interacting individual leukocytes endothelial cells within blood tumors visceral organs <NUMBER> <NUMBER> intravital imaging thus emerging key tool observe spatialtemporal dynamics complex phenomena even complex embryonic development cellular resolution <NUMBER> field immunology however intravital imaging models significant limitations temporary suction window chambers highly invasive always require animal euthanization end observation preventing repeated observations subsequent time points contrast implantable windows allow longterm repeated observations animal however currently invasive affected chronic inflammation surgical site thus interfering desired measurements <NUMBER> addition implanted imaging windows general retain lymphatic circulation thus preventing recruitment cells bone marrow lymphatic system <NUMBER> <NUMBER> <NUMBER> lower labial mucosa exposed steel stage <NUMBER> ear blood vessels <NUMBER> labial mucosa upper part window imaging respect control reported lower part second harmonic generation left tissue autofluorescence middle nuclear dyes right used examination realtime e graphical quantitative representation reaction occurring terms collagen fibers orientation differential neovascularization rate differential cellular density subsequent incremental timepoints scale bars <NUMBER> µm overcome limitations developed implantable miniaturized intravital imaging device called microatlas figure <NUMBER> minimally invasive device <NUMBER> mm diameter <NUMBER> mm thickness implantable chicken embryos subcutaneously mice quantify vivo aspects immune response biomaterials drugs <NUMBER> microatlas integrates microfabricated fluorescent <NUMBER>d scaffold guides hosts intravital regeneration vascularized tissue addition scaffold enables repositioning observation field view twophoton microscope necessary repeated quantitative intravital measurements immune cell recruitment neoangiogenesis fibrotic reaction animal different timepoints fluorescent grid currently designed provide beacons correct aberrations derived deep optical sectioning <NUMBER>d microscaffold repopulated cells ex ovo experiments expression human ace<NUMBER> receptor engineered transgenic mice contrast histopathology techniques imaging miniaturized intravital window used incremental time points within mouse vital conditions study localization distribution pharmacokinetics pharmacodynamics antiviral therapies vaccines seeking solutions covid<NUMBER> could significantly speedup preclinical testing experimental antiviral drugs vaccines eliminating need animal sacrifice various time points thus reducing <NUMBER> number animals required regulation ex vivo assessments intravital imaging could effective model also test therapeutic agents based engineered messenger rna mrna directs cells make protein could work drug vaccine sarscov<NUMBER> human safety trials already begun mrnabased vaccines two flu strains zika virus case mrna encodes viral proteins infected cells would physiologically present activate immune system infections succeed engineered mrna must hide dendritic cells enter cells avoid degradation translated efficiently efficiency stages could monitored measured intravital imaging fluorescentlylabeled mrna review discussed various cuttingedge bioengineering tools already available fields virology pharmacology based <NUMBER>d cocultures highly predictive vivo mechanisms ii highresolution intravital microscopy also discussed potential strategies aimed repurposing tools order significantly accelerate development therapeutics vaccines covid<NUMBER> although several academic institutions already adopted improved tools research basic immune biology drug discovery pharmaceutical companies still use conventional cell lines standardized animal models confirmatory studies requested standards passage new drugs preclinical steps regulatory approval despite limited predictive capability models particular urgency find clinical solutions sarscov<NUMBER> pandemic makes even evident adequate validation new tools could lead update current preclinical testing standards new ones based concepts <NUMBER>d culture perfused culture intravital imaging presented virology vaccinology well many pharmaceutical sectors new standards suggested review would improve efficiency effectiveness whole drug development process added benefit drastically reducing refining widely replacing animal testing supplementary figures tables httpwwwthnoorgv<NUMBER>p<NUMBER>s<NUMBER>pdf effective treatments covid<NUMBER> urgently needed large number investigational well approved repurposed drugs suggested utility treatment covid<NUMBER> preclinical data animal models guide focused search effective treatments humans ruling treatments without proven efficacy vivo remdesivir gs<NUMBER> nucleotide analog prodrug broad antiviral activity <NUMBER> including coronaviruses <NUMBER> currently investigated covid<NUMBER> clinical trials worldwide including china us europe summarized <NUMBER> animal models remdesivir treatment effective merscov sarscov infection <NUMBER> <NUMBER> <NUMBER> vitro remdesivir inhibited replication sarscov<NUMBER> <NUMBER> <NUMBER> moreover vitro experiments shown mutations conferring resistance remdesivir easily emerge coronaviruses <NUMBER> investigated efficacy remdesivir treatment recently established rhesus macaque model sarscov<NUMBER> infection model infected rhesus macaques develop mild moderate transient respiratory disease pulmonary infiltrates visible radiographs shedding pattern similar observed covid<NUMBER> patients <NUMBER> therapeutic treatment rhesus macaques remdesivir shortly peak virus replication resulted significant clinical improvement reduction pulmonary infiltrates reduction pulmonary pathology animals rhesus macaques housed adjacent individual primate cages allowing social interactions climatecontrolled room fixed lightdark cycle <NUMBER>hr light<NUMBER>hr dark animals monitored least twice daily throughout experiment commercial monkey chow treats fruit provided twice daily trained personnel water available ad libitum environmental enrichment consisted variety human interaction manipulanda commercial toys videos music institutional biosafety committee ibc approved work infectious sarscov<NUMBER> strains bsl<NUMBER> conditions sample inactivation performed according ibcapproved standard operating procedures removal specimens high containment evaluate effect remdesivir treatment sarscov<NUMBER> disease outcome used recently established rhesus macaque model sarscov<NUMBER> infection results transient lower respiratory tract disease <NUMBER> twelve animals randomly assigned two groups inoculated described previously total dose <NUMBER>x<NUMBER> <NUMBER> tcid<NUMBER> sarscov<NUMBER> strain ncovwa<NUMBER> via intranasal oral ocular intratracheal routes efficacy therapeutic remdesivir treatment tested two groups six adult rhesus macaques <NUMBER> males <NUMBER> females <NUMBER>kg due acute nature sarscov<NUMBER> model rhesus macaques therapeutic treatment initiated <NUMBER> hours inoculation sarscov<NUMBER> continued daily <NUMBER> days post inoculation dpi one group rhesus macaques treated loading dose <NUMBER>mgkg remdesivir followed daily maintenance dose <NUMBER> mgkg group six animals served infected controls administered equal dose volume ie <NUMBER> mlkg loading dose <NUMBER> mlkg thereafter vehicle solution <NUMBER> sulfobutyletherβcyclodextrin water hydrochloric acid ph<NUMBER> according treatment schedule dosing scheme rhesus macaques mimics daily dosing tested clinicals studies covid<NUMBER> patients results similar systemic drug exposure treatment delivered intravenous bolus injection total dose delivered approximately <NUMBER> minutes administered alternatingly left right cephalic saphenous veins animals observed twice daily clinical signs disease using standardized scoring sheet described previously <NUMBER> person blinded group assignment animals assessed animals throughout study predetermined endpoint experiment <NUMBER> dpi nose throat rectal swabs collected daily treatment administration clinical exams performed <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> dpi anaesthetized animals exam days clinical parameters bodyweight temperature pulse oximetry blood pressure respiration rate collected well dorsalventral lateral chest radiographs radiographs analyzed clinical veterinarian blinded group assignment animals <NUMBER> <NUMBER> <NUMBER> dpi bronchoalveolar lavage bal performed using <NUMBER>ml sterile saline euthanasia <NUMBER> dpi necropsies performed percentage gross lung lesions scored boardcertified veterinary pathologist blinded group assignment animals samples following tissues collected cervical lymph node conjunctiva nasal mucosa oropharynx tonsil trachea lung lobes mediastinal lymph node right left bronchus heart liver spleen kidney stomach duodenum jejunum ileum cecum colon urinary bladder histopathological analysis tissue slides performed boardcertified veterinary pathologist blinded group assignment animals sarscov<NUMBER> isolate ncovwa<NUMBER> mn<NUMBER> <NUMBER> vero passage <NUMBER> kindly provided cdc propagated vero e<NUMBER> cells dmem sigma supplemented <NUMBER> fetal bovine serum gibco <NUMBER> mm lglutamine gibco <NUMBER> uml penicillin <NUMBER> μgml streptomycin gibco virus isolation medium virus stock used <NUMBER> identical initial deposited genbank sequence mn<NUMBER> contaminants detected veroe<NUMBER> cells maintained dmem supplemented <NUMBER> fetal calf serum <NUMBER> mm lglutamine <NUMBER> uml penicillin <NUMBER> μgml streptomycin remdesivir rdv gs<NUMBER> manufactured gilead sciences department process chemistry alberta canada good manufacturing practice gmp conditions batch number <NUMBER>bc<NUMBER>p solubilized <NUMBER> sulfobutyletherβcyclodextrin water matching vehicle solution provided nih tributylamine purchased millipore sigma lcms grade water acetone methanol isopropanol acetic acid purchased fisher scientific synthetic standards molecular analysis provided gilead sciences inc serum cleared lung homogenates gammairradiated <NUMBER> mrad inactivate infectious virus potentially present samples prior analysis samples prepared small molecule analysis diluting <NUMBER> µl aliquot either serum clarified lung homogenate <NUMBER> µl <NUMBER> acetone <NUMBER> methanol <NUMBER> water vv ice samples incubated room temperature <NUMBER> min centrifuged <NUMBER>k xg <NUMBER> minutes clarified supernatants <NUMBER> µl recovered taken dryness savant™ dna<NUMBER> speedvac™ concentrator thermo fisher samples resuspended <NUMBER> µl <NUMBER> methanol <NUMBER> water vv centrifuged supernatant taken sample vial lcms analysis samples separated using ionpairing liquid chromatography strategy sciex exionlc™ ac system samples injected onto waters atlantis t<NUMBER> column <NUMBER> å <NUMBER> µm <NUMBER> mm x <NUMBER> mm eluted using binary gradient <NUMBER> mm tributylamine <NUMBER> mm acetic acid <NUMBER> isopropanol <NUMBER> methanol <NUMBER> water vv <NUMBER> isopropanol <NUMBER> minutes analytes measured using sciex <NUMBER> qtrap® mass spectrometer negative mode multiple reaction monitoring performed using two signal pairs analyte signal fidelity confirmed collecting triggered product ion spectra comparing back spectra synthetically pure standards analytes quantified <NUMBER>point calibration curve respective synthetic standard prepared target matrix ie serum cleared lung homogenate processed manner experimental samples limit quantification loq approximated signal noise <NUMBER> loqs measured molecules matrix <NUMBER> nm gs<NUMBER> lung homogenate serum <NUMBER> nm gs<NUMBER> lung homogenate serum <NUMBER> nm gs<NUMBER> serum instability gs<NUMBER> triphosphorylated nucleotide metabolite lung homogenate tissue lysis prevented detection metabolites lung tissue rna extracted swabs bal using qiaamp viral rna kit qiagen according manufacturers instructions tissues <NUMBER> mg homogenized rlt buffer rna extracted using rneasy kit qiagen according manufacturers instructions detection viral rna <NUMBER> µl rna used onestep realtime rtpcr e assay <NUMBER> using rotorgene probe kit qiagen according instructions manufacturer run standard dilutions rna standards counted droplet digital pcr run parallel calculate copy numbers samples virus titrations performed endpoint titration vero e<NUMBER> cells tissue homogenized <NUMBER>ml dmem using tissuelyser qiagen cells inoculated <NUMBER>fold serial dilutions swab bal samples virus isolation performed lung tissues homogenizing tissue <NUMBER>ml dmem inoculating vero e<NUMBER> cells <NUMBER> well plate <NUMBER> µl cleared homogenate <NUMBER> dilution thereof one hour inoculation cells inoculum removed replaced <NUMBER> µl virus titration <NUMBER> µl virus isolation medium six days inoculation cpe scored tcid<NUMBER> calculated histopathology immunohistochemistry performed rhesus macaque tissues fixation minimum <NUMBER> days <NUMBER> neutralbuffered formalin embedding paraffin tissue sections stained hematoxylin eosin detect sarscov<NUMBER> antigen immunohistochemistry performed using custommade rabbit antiserum sarscov<NUMBER> n <NUMBER> dilution stained slides analyzed boardcertified veterinary pathologist viral rna extracted described cdnas prepared according briese parameters local nomixed x <NUMBER> pcr duplicates removed using picard markduplicates broad institute variants called using gatk haplotypecaller version <NUMBER> <NUMBER> parameterploidy <NUMBER> variants filtered qual <NUMBER> dp <NUMBER> using bcftools statistical analyses performed using graphpad prism software version <NUMBER> data included manuscript deposited figshare httpsdoiorg<NUMBER>yhjc<NUMBER> two groups six rhesus macaques inoculated sarscov<NUMBER> strain ncovwa<NUMBER> twelve hours post inoculation one group administered <NUMBER>mgkg intravenous remdesivir group treated equal volume vehicle solution <NUMBER>mlkg treatment continued <NUMBER>hrs first treatment every <NUMBER> hrs thereafter dose <NUMBER> mgkg remdesivir equal volume vehicle solution <NUMBER>mlkg serum concentration remdesivir determined serum collected <NUMBER> hrs initial treatment <NUMBER> hrs subsequent treatments administered immediately next dose treatment administered detectable levels remdesivir inoculation sarscov<NUMBER> animals assigned daily clinical score based preestablished scoring sheet blinded fashion twelve hours first remdesivir treatment clinical scores remdesivirtreated animals significantly lower control animals receiving vehicle solution difference clinical score maintained throughout study fig <NUMBER>a one six remdesivirtreated animals showed mild dyspnea whereas tachypnea dyspnea observed vehicletreated controls table s<NUMBER> radiographic pulmonary infiltrates one hallmarks covid<NUMBER> humans radiographs taken <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> dpi showed significantly less lung lobe involvement less severe pulmonary infiltration animals treated remdesivir compared receiving vehicle fig <NUMBER>b c <NUMBER> <NUMBER> <NUMBER> dpi bal performed indicator virus replication lower respiratory tract although viral loads bal reduced remdesivirtreated animals difference statistically significant fig <NUMBER>a however <NUMBER> hours first remdesivir treatment administered infectious virus titer bal <NUMBER>fold lower remdesivirtreated animals controls <NUMBER> dpi infectious virus could longer detected bal remdesivirtreated animals whereas virus still detected bal four six control animals fig <NUMBER>b despite reduction virus replication lower respiratory tract neither viral loads infectious virus titers reduced nose throat rectal swabs collected remdesivirtreated animals except significant difference virus titer throat swabs collected <NUMBER> dpi viral loads throat swabs collected <NUMBER> dpi fig <NUMBER> animals euthanized <NUMBER> dpi tissue samples collected lung lobe compare virus replication remdesivirtreated vehicletreated control animals <NUMBER> <NUMBER> lung lobe samples collected remdesivirtreated animals viral rna could detected whereas case <NUMBER> <NUMBER> lung lobes collected control animals general comparison across individual lung lobes two groups showed lower geometric mean viral rna remdesivirtreated group fig <NUMBER>a taken together viral load significantly lower lungs remdesivirtreated animals vehicletreated controls fig <NUMBER>b virus could isolated lung lobes five six vehicletreated control animals none lung tissue collected remdesivirtreated animals positive virus isolation although fewer tissues positions respiratory tract positive qrtpcr remdesivirtreated animals differences statistically significant fig <NUMBER>c necropsy <NUMBER> dpi lungs assessed grossly presence lesions gross lung lesions observed one six remdesivirtreated animals contrast six vehicle controls visible lesions resulting statistically significantly difference area lungs affected lesions fig <NUMBER>a b fig <NUMBER>a b difference also evident calculating lung weight bodyweight ratio indicator pneumonia statistically significantly lower ratio observed remdesivirtreated compared vehicletreated animals fig <NUMBER>c histologically clear effect remdesivir treatment lung lesions fewer less severe lesions remdesivir animals vehicletreated controls histologic lung lesions absent three six remdesivirtreated animals three remaining animals developed minimal pulmonary pathology lesions animals characterized widely separated minimal interstitial pneumonia frequently located subpleural spaces fig <NUMBER>c e five six vehicletreated animals developed multifocal mild moderate interstitial pneumonia fig <NUMBER>d f viral antigen detected animals regardless treatment fig <NUMBER>g h deep sequencing successful samples remdesivirtreated animals vehicle controls known mutations rna dependent rna polymerase confer resistance remdesivir coronaviruses <NUMBER> detected samples tested table s<NUMBER> remdesivir first antiviral treatment proven efficacy sarscov<NUMBER> animal model covid<NUMBER> remdesivir treatment rhesus macaques infected sarscov<NUMBER> highly effective reducing clinical disease damage lungs remdesivir dosing used rhesus macaques equivalent used humans however due acute nature disease rhesus macaques hard directly translate timing treatment used corresponding disease stages humans study treatment administered close peak virus replication lungs indicated authors affiliated gilead sciences employees company company stock authors affiliated nih conflict interest report ventrodorsal lateral radiographs scored presence pulmonary infiltrates clinical veterinarian according standard scoring system <NUMBER> normal <NUMBER> mild interstitial pulmonary infiltrates <NUMBER> moderate pulmonary infiltrates perhaps partial cardiac border effacement small areas pulmonary consolidation <NUMBER> severe interstitial infiltrates large areas pulmonary consolidation alveolar patterns air bronchograms individual lobes scored scores per animal per day totaled displayed panel c shows ventrodorsal radiographs collected animal taken <NUMBER> dpi areas pulmonary infiltration marked circle statistical analysis performed using <NUMBER>way anova sidaks multiple comparisons test p<NUMBER> p <NUMBER> p <NUMBER> march <NUMBER> world health organization declared coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> pandemic <NUMBER> covid<NUMBER> outbreak originally identified wuhan china <NUMBER> december <NUMBER> spread rapidly around world within months severe acute <NUMBER> respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causative agent covid<NUMBER> belongs <NUMBER> coronaviridae family closely related sarscov emerged china <NUMBER> zhu et <NUMBER> al <NUMBER> incubation period <NUMBER> days disease onset usually begins influenza<NUMBER> like syndrome associated high virus replication respiratory tracts huang et al <NUMBER> et al <NUMBER> <NUMBER> patients late acute respiratory distress syndrome associated high levels <NUMBER> inflammatory proteins occurs within one two weeks huang et al <NUMBER> <NUMBER> july <NUMBER> <NUMBER> <NUMBER> million cases covid<NUMBER> resulted <NUMBER> deaths dong et al <NUMBER> <NUMBER> face ongoing pandemic unprecedented repercussions human health <NUMBER> also society ecology economy urgent need effective infection prevention <NUMBER> control measures <NUMBER> whilst hostdirected immunebased therapies could prove useful clinical management <NUMBER> critically ill patients availability safe effective antiviral molecules would represent <NUMBER> important step towards fighting current pandemic conventional drug development slow <NUMBER> process repurposing drugs already approved indication extensively explored led <NUMBER> implementation many clinical trials treatment covid<NUMBER> mercorelli et al <NUMBER> <NUMBER> however development effective antiviral drugs treatment covid<NUMBER> much <NUMBER> possible rely robust preclinical vivo data efficacy generated vitro accordingly <NUMBER> rapid implementation rodent nonhuman primate animal models help assess <NUMBER> finely potential safety efficacy drug candidates determine appropriated dose <NUMBER> regimens humans chan et al <NUMBER> rockx et al <NUMBER> <NUMBER> favipiravir <NUMBER>fluoro<NUMBER>hydroxypyrazine<NUMBER>carboxamine antiinfluenza drug approved japan <NUMBER> shown broadspectrum antiviral activity variety rna viruses guedj et al <NUMBER> <NUMBER> yamada et al <NUMBER> segura guerrero et al <NUMBER> tani et al <NUMBER> jochmans et al <NUMBER> <NUMBER> takahashi et al <NUMBER> rosenke et al <NUMBER> favipiravir prodrug metabolized intracellularly <NUMBER> active ribonucleoside <NUMBER>triphosphate form acts nucleotide analogue selectively <NUMBER> inhibit rnadependent rna polymerase induce lethal mutagenesis baranovich et al <NUMBER> <NUMBER> sangawa et al <NUMBER> recently several studies reported vitro inhibitory activity favipiravir <NUMBER> sarscov<NUMBER> <NUMBER> effective concentrations ec<NUMBER> ranging <NUMBER> <NUMBER>µm <NUMBER> <NUMBER>µgml <NUMBER> wang et al <NUMBER> jeon et al <NUMBER> shannon et al <NUMBER> based results <NUMBER> clinical <NUMBER> trials management covid<NUMBER> favipiravir progress httpsclinicaltrialsgov present study syrian hamster model mesocricetus auratus implemented explore vivo <NUMBER> safety efficacy pharmacokinetics pk several dosing regimens favipiravir <NUMBER> vitro efficacy favipiravir <NUMBER> using veroe<NUMBER> cells antiviral assay based reduction cytopathic effect cpe recorded <NUMBER> ec<NUMBER> ec<NUMBER> <NUMBER> <NUMBER> µgml using multiplicity infection moi <NUMBER> <NUMBER> <NUMBER>µgml <NUMBER> moi <NUMBER> figure s<NUMBER> accordance previous studies wang et al <NUMBER> jeon et al <NUMBER> <NUMBER> shannon et al <NUMBER> infectious titer reductions fold change comparison untreated cells <NUMBER> ≥<NUMBER> <NUMBER>µgml favipiravir ranged <NUMBER> <NUMBER> <NUMBER>µgml using caco<NUMBER> <NUMBER> cells exhibit cpe sarscov<NUMBER> bavpat<NUMBER> strain infectious titer reductions around <NUMBER> <NUMBER> <NUMBER>µgml favipiravir ranged <NUMBER> <NUMBER> <NUMBER>µgml drug <NUMBER> <NUMBER> cytotoxic concentrations cc<NUMBER> veroe<NUMBER> caco<NUMBER> cells <NUMBER>µgml <NUMBER> infection syrian hamsters sarscov<NUMBER> following chan et al implemented hamster model study efficacy antiviral compounds <NUMBER> chan et al <NUMBER> firstly intranasally infected fourweekold female syrian hamsters <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> virus groups two animals sacrificed <NUMBER> <NUMBER> <NUMBER> <NUMBER> days postinfection dpi viral <NUMBER> replication quantified sacrificed animals rtqpcr organs lungs brain liver smalllarge <NUMBER> bowel kidney spleen heart plasma viral loads lungs peaked <NUMBER> dpi remained elevated <NUMBER> <NUMBER> dpi dramatically decreased <NUMBER> dpi figure <NUMBER>a viral loads plasma peaked <NUMBER> dpi <NUMBER> viral replication detected large bowel <NUMBER> dpi figure <NUMBER>b table s<NUMBER> viral rna <NUMBER> detected almost samples tested table s<NUMBER> subsequently infected animals two <NUMBER> lower doses virus <NUMBER> <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> viral rna quantified lungs large bowel plasma <NUMBER> sacrificed animals <NUMBER> <NUMBER> <NUMBER> <NUMBER> dpi figure <NUMBER>a <NUMBER>b viral loads lungs peaked <NUMBER> <NUMBER> dpi <NUMBER> doses <NUMBER> <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> respectively maximum viral loads lungs animals infected <NUMBER> dose virus comparable viral rna yields plasma large bowel followed similar <NUMBER> trend variability two lower doses addition clinical monitoring animals <NUMBER> showed marked symptoms infection significant weight losses <NUMBER> dpi compared <NUMBER> animals intranasally inoculated sodium chloride <NUMBER> figure <NUMBER>c <NUMBER> <NUMBER> figure <NUMBER> implementation hamster model hamsters intranasally infected <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> virus viral replication quantified using <NUMBER> rtqpcr assay lung viral rna yields b plasmatic viral loads c clinical course disease normalized <NUMBER> weight day n calculated follows initial weight animal day nmean initial weight <NUMBER> mockinfected animals day n data represent mean ±sd details table s<NUMBER> vivo efficacy favipiravir <NUMBER> assess efficacy favipiravir hamsters received drug intraperitoneally three times day <NUMBER> tid used three doses favipiravir <NUMBER> <NUMBER> <NUMBER>mgday corresponding <NUMBER>±<NUMBER> <NUMBER>±<NUMBER> <NUMBER> <NUMBER>±<NUMBER> mgkgday respectively <NUMBER> first set experiments treatment initiated day infection preemptive antiviral therapy <NUMBER> ended <NUMBER> dpi infected groups <NUMBER> animals intranasally three doses virus <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> viral replication measured lungs plasma <NUMBER> dpi figure <NUMBER>a analysis <NUMBER> virus replication clarified lung homogenates based infectious titers measured using <NUMBER> tcid<NUMBER> assay inverse relationship observed infectious titers dose <NUMBER> favipiravir figure <NUMBER>b trend even important low doses virus used infect <NUMBER> animals dose virus mean infectious titers groups animals treated <NUMBER>mgday tid <NUMBER> significantly lower observed untreated groups p≤<NUMBER> reduction infectious <NUMBER> titers ranged <NUMBER> <NUMBER> log<NUMBER> animals infected <NUMBER> <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> significant <NUMBER> infectious titer reductions around <NUMBER> log<NUMBER> also observed dose <NUMBER>mgday tid <NUMBER> p≤<NUMBER> drug <NUMBER> <NUMBER> effective doses ed<NUMBER> ed<NUMBER> estimated based results <NUMBER> ranged <NUMBER>mgday <NUMBER>mgday respectively table <NUMBER> analysis virus <NUMBER> replication clarified lung homogenates assessed viral rna yields measured using <NUMBER> quantitative real time rtpcr assay significant differences groups untreated animals ranging <NUMBER> <NUMBER> <NUMBER> log<NUMBER> observed higher dose favipiravir p≤<NUMBER> <NUMBER> difference noticeable lower doses virus figure <NUMBER>b since found higher <NUMBER> reductions infectious titers observed viral rna yields estimated relative <NUMBER> infectivity viral particle ie ratio number infectious particles number viral <NUMBER> rna molecules decreased infectivity observed treated groups animals differences always significant higher dose favipiravir p≤<NUMBER> significant dose <NUMBER> <NUMBER>mgday tid animals infected <NUMBER> <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> virus p≤<NUMBER> measured <NUMBER> plasmatic viral loads using quantitative real time rtpcr assay found higher dose <NUMBER> favipiravir groups animals infected <NUMBER> <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> significant reductions <NUMBER> <NUMBER> <NUMBER> log<NUMBER> respectively p≤<NUMBER> figure <NUMBER>b <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> virus lung infectious titers measured using tcid<NUMBER> assay viral rna yields <NUMBER> measured using rtqpcr assay expressed tcid<NUMBER>copy ɣactine gene viral genome copiescopy ɣactine gene respectively relative lung viral particle infectivities calculated follows ratio lung <NUMBER> infectious titer viral rna yields plasmatic viral loads measured using rtqpcr assay expressed <NUMBER> viral genome copiesml plasma dotted line indicates detection threshold assay data represent <NUMBER> mean ±sd symbols indicate average value group significantly lower <NUMBER> untreated group pvalue <NUMBER> ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively details table s<NUMBER> s<NUMBER> doseresponse curves presented figure s<NUMBER> second set experiments assessed period <NUMBER> days impact treatment <NUMBER> clinical course disease using weight loss primary criterion figure <NUMBER>a beforehand <NUMBER> evaluated toxicity three doses favipiravir groups four noninfected animals treated <NUMBER> day <NUMBER> day <NUMBER> figure <NUMBER>b high toxicity observed dose <NUMBER>mgday tid <NUMBER> significant weight loss noticed first day treatment table s<NUMBER> also found constant <NUMBER> moderate toxicity dose <NUMBER>mgday tid significant day <NUMBER> <NUMBER> <NUMBER> toxicity detected lower dose favipiravir assess toxicity observed <NUMBER> highest dose favipiravir exacerbated infection compared weight losses infected <NUMBER> noninfected animals treated dose <NUMBER>mgday tid regardless dose virus <NUMBER> significant difference observed <NUMBER> <NUMBER> <NUMBER> dpi figure s<NUMBER> evaluation favipiravir <NUMBER> toxicity intranasally infected groups <NUMBER> animals two doses virus <NUMBER> <NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> <NUMBER> treatment dose <NUMBER>mgday tid initiated day infection preemptive antiviral <NUMBER> therapy ended <NUMBER> dpi figure <NUMBER>a doses virus treatment associated <NUMBER> clinical alleviation disease figure <NUMBER>c dose <NUMBER> <NUMBER> tcid<NUMBER> mean weights treated <NUMBER> animals significantly higher untreated animals <NUMBER> <NUMBER> dpi p≤<NUMBER> similar <NUMBER> observations made dose <NUMBER> <NUMBER> tcid<NUMBER> <NUMBER> <NUMBER> <NUMBER> dpi p<NUMBER> <NUMBER> normalized weight day n calculated follows initial weight animal day nmean <NUMBER> initial weight mockinfected animals day n data represent mean ±sd symbols indicate <NUMBER> significant difference treated untreated animals pvalue <NUMBER> ranging <NUMBER> <NUMBER> respectively details table s<NUMBER> s<NUMBER> third set experiments treatment started one day infection preventive antiviral <NUMBER> therapy ended <NUMBER> dpi intranasally infected groups <NUMBER> animals <NUMBER> <NUMBER> tcid<NUMBER> virus <NUMBER> viral replication measured lungs plasma <NUMBER> dpi figure <NUMBER>a inverse <NUMBER> relationship observed lung infectious titers dose favipiravir figure <NUMBER>b mean <NUMBER> infectious titers groups animals treated <NUMBER> <NUMBER>mgday tid significantly lower <NUMBER> observed untreated groups p≤<NUMBER> note undetectable infectious titers <NUMBER> found animals treated higher dose estimated ed<NUMBER> ed<NUMBER> <NUMBER> <NUMBER>mgday <NUMBER> respectively table <NUMBER> significant reductions viral rna yields <NUMBER> <NUMBER> log<NUMBER> observed <NUMBER> animals treated <NUMBER> <NUMBER>mgday tid respectively p≤<NUMBER> resulting infectivity viral <NUMBER> particle decreased significant reduction higher dose favipiravir p<NUMBER> <NUMBER> finally found significantly reduced plasmatic viral loads animals treated <NUMBER> <NUMBER> <NUMBER>mgday tid p≤<NUMBER> <NUMBER> <NUMBER> symbols indicate average value group significantly different <NUMBER> untreated group pvalue <NUMBER> ranging <NUMBER> <NUMBER> respectively details table <NUMBER> s<NUMBER> s<NUMBER> favipiravir pharmacokinetics pk hamster model <NUMBER> first assessed pk lung distribution favipiravir subgroup uninfected animals groups <NUMBER> animals treated respectively single dose favipiravir administrated intraperitoneally <NUMBER> <NUMBER>mg <NUMBER> mg <NUMBER> mg dose group sacrificed <NUMBER> animals specific time points post<NUMBER> treatment <NUMBER> <NUMBER> <NUMBER> <NUMBER> hours determination favipiravir plasma drug concentration lung <NUMBER> tissue determined <NUMBER> <NUMBER> hours posttreatment subsequently assessed favipiravir <NUMBER> concentration multiple dose animals intranasally infected <NUMBER> <NUMBER> tcid<NUMBER> virus groups <NUMBER> <NUMBER> animals received three doses evaluated <NUMBER> days figure <NUMBER>a <NUMBER>mgday <NUMBER>mgday <NUMBER> <NUMBER>mgday tid sacrificed <NUMBER>hours last treatment dose favipiravir quantified <NUMBER> plasma n<NUMBER> lung tissue n<NUMBER> <NUMBER> results presented table <NUMBER> figure s<NUMBER> single dose pk analysis showed maximum <NUMBER> concentration favipiravir observed <NUMBER> hour doses plasma drug concentrations <NUMBER> decreased exponentially reach concentrations <NUMBER> µgml <NUMBER> hours favipiravir pk exhibited <NUMBER> nonlinear increase concentration doses multiple doses trough concentrations <NUMBER> <NUMBER> hours favipiravir also exhibited nonlinear increase doses extrapolated <NUMBER> hours <NUMBER> posttreatment concentrations single dose calculated order determine accumulation ratio accumulation ratios respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> doses confirming <NUMBER> nonproportional increase doses average concentration single dose administration <NUMBER> <NUMBER> <NUMBER>hour intervals calculated respective values obtained <NUMBER> µgml <NUMBER> <NUMBER> µgml <NUMBER> µgml <NUMBER> favipiravir doses <NUMBER> favipiravir lung concentrations <NUMBER> <NUMBER>fold lower plasma administration <NUMBER> single multiple doses single dose mean lung plasma ratio ranged <NUMBER> <NUMBER> <NUMBER> according time posttreatment similar <NUMBER> doses favipiravir <NUMBER> hours <NUMBER> high ratio <NUMBER> hours posttreatment observed highest dose <NUMBER> mg increase <NUMBER> factor <NUMBER> <NUMBER> compared lower doses multiple doses lung penetration <NUMBER> favipiravir confirmed mean lung plasma ratio ranging <NUMBER> <NUMBER> favipiravir <NUMBER> detected lungs lowest dose <NUMBER> mgday <NUMBER> understand genomic modifications accompanied favipiravir treatment direct complete <NUMBER> genome sequencing clarified lung homogenates animals intranasally infected <NUMBER> <NUMBER> tcid<NUMBER> <NUMBER> virus treated two highest doses drug preemptive antiviral therapy figure <NUMBER> <NUMBER> performed data generated next generation sequencing lung samples four animals <NUMBER> per group untreated <NUMBER>mgday tid <NUMBER>mgday tid mean sequencing coverage <NUMBER> sample ranged <NUMBER> <NUMBER> reads per genomic position subjected substitutions <NUMBER> frequency ≥<NUMBER> analysis genetic variability virus stock also analyzed <NUMBER> <NUMBER> nucleotide polymorphisms detected <NUMBER> recorded mutation frequency higher <NUMBER> <NUMBER> table s<NUMBER> <NUMBER> order study mutagenic effect favipiravir used consensus sequence virus stock <NUMBER> reference mutations simultaneously detected lung sample virus stock <NUMBER> considered analysis <NUMBER> <NUMBER> mutations per sample see table s<NUMBER> overall majority <NUMBER> mutations detected mutation frequency <NUMBER> mutations distributed throughout <NUMBER> whole genome almost exhibited frequency lower <NUMBER> figure <NUMBER>a <NUMBER>b subpopulations detected two independent animals notably <NUMBER> shared mutations <NUMBER> detected treated animals <NUMBER> nonsynonymous table s<NUMBER> significantly different untreated group pvalue ranging <NUMBER> <NUMBER> <NUMBER> respectively details details table s<NUMBER> s<NUMBER> e association lung infectious titers measured <NUMBER> using tcid<NUMBER> assay frequency non synonymous synonymous g→a mutations dot represent <NUMBER> data given animal current study used hamster model assess efficacy favipiravir sarscov<NUMBER> <NUMBER> following infection viral rna mainly detected lungs blood lesser extent <NUMBER> large bowel peak viral replication observed <NUMBER> dpi followed observation significant <NUMBER> weight losses line recently reported investigations involved <NUMBER> weeks old hamsters <NUMBER> kaptein et al <NUMBER> chan et al <NUMBER> clinically main symptom weight loss observed <NUMBER> first day infection followed recovery <NUMBER>dpi confirmed vivo model <NUMBER> younger animals <NUMBER> weeksold suitable preclinical evaluation antiviral compounds <NUMBER> sarscov<NUMBER> <NUMBER> using preemptive strategy demonstrated doses favipiravir around <NUMBER>mgkgday <NUMBER> tid reduced viral replication lungs infected animals allowed clinical alleviation disease <NUMBER> reduction viral replication greater estimated basis infectious titers total <NUMBER> viral rna previously observed nonhuman primates treated remdesivir williamson et al <NUMBER> <NUMBER> however effective doses favipiravir higher usually used rodent models <NUMBER> ≈<NUMBER>mgkgday sidwell et al <NUMBER> smither et al <NUMBER> julander et al <NUMBER> tani et al <NUMBER> <NUMBER> oestereich et al <NUMBER> yamada et al <NUMBER> correlated high favipiravir ec<NUMBER> found <NUMBER> vitro sarscov<NUMBER> moreover effective doses associated significant toxicity <NUMBER> hamster model observed toxicity reflected adverse effects favipiravir <NUMBER> exacerbated sarscov<NUMBER> infection indeed similar weight losses measured among <NUMBER> infected noninfected animals treated highest dose favipiravir <NUMBER> <NUMBER> <NUMBER>dpi <NUMBER> present study reduction viral replication correlated dose favipiravir <NUMBER> administrated inversely correlated dose virus inoculated recent study favipiravir <NUMBER> administrated per os twice daily loading dose <NUMBER>mgkgday followed <NUMBER>mgkgday revealed <NUMBER> mild reduction lung viral rna yields using similar hamster model high doses virus <NUMBER>x<NUMBER> <NUMBER> <NUMBER> tcid<NUMBER> kaptein et al <NUMBER> results accordance lower dose favipiravir <NUMBER> around <NUMBER>mgkgday tid <NUMBER> characterizing dose response curve estimated dose required reduce <NUMBER> <NUMBER> ed<NUMBER> level infectious titers lungs range <NUMBER>mgkgday favourable <NUMBER> situation high doses used preemptive therapy favipiravir led undetectable viral <NUMBER> replication lung plasma results showed use high doses favipiravir could <NUMBER> expand vivo spectrum rna viruses <NUMBER> influenza viruses favipiravir acts nucleotide analogue metabolized intracellularly <NUMBER> active form incorporated nascent viral rna strands inhibits rna strand extension induces abnormal levels mutation accumulation viral genome baranovich et al <NUMBER> <NUMBER> sangawa et al <NUMBER> recently shown vitro favipiravir similar mechanism action <NUMBER> sarscov<NUMBER> combination chain termination reduced rna synthesis lethal <NUMBER> mutagenesis shannon et al <NUMBER> genomic analysis confirmed mutagenic effect favipiravir <NUMBER> vivo indeed found favipiravir treatment induced appearance large number g→a <NUMBER> c→u mutations viral genomes associated decrease viral infectivity probably <NUMBER> alteration genomic rna disturb replication capacity similar findings described <NUMBER> vitro vivo rna viruses baranovich et al <NUMBER> guedj et al <NUMBER> escribano<NUMBER> romero et al <NUMBER> arias et al <NUMBER> note also observed strong inverse association <NUMBER> infectious titers lungs proportion nonsynonymous mutations detected viral <NUMBER> populations random nonsynonymous mutations deleterious synonymous <NUMBER> mutations cuevas et al <NUMBER> suggests randomly distributed three <NUMBER> positions codons compensatory mechanism triggered virus eliminate <NUMBER> ie negative selection finally inverse correlation lung infections titers <NUMBER> frequency g→a substitutions showed increased proportion mutations beyond <NUMBER> error threshold might expected cause lethal mutagenesis <NUMBER> genomic analyses revealed <NUMBER> mutations detected viral subpopulations shared <NUMBER> treated animals two located nsp<NUMBER> coding region involved proofreading <NUMBER> activity viral rna polymerisation eckerle et al <NUMBER> ferron et al <NUMBER> however <NUMBER> located n<NUMBER> mtase domain involved viral rna capping chen et al <NUMBER> et al <NUMBER> <NUMBER> comparison resistance mutations selected remdesivir βcoronavirus murine hepatitis virus <NUMBER> model obtained rdrp nsp<NUMBER> coding sequence agostini et al <NUMBER> <NUMBER> investigations needed assess impact mutations antiviral effect favipiravir <NUMBER> favipiravir pk hamster model displayed nonlinear increase plasma exposure <NUMBER> doses already reported nonhuman primates madelain et al <NUMBER> observed favipiravir <NUMBER> concentration versus time profiles agreement previous results pk study performed <NUMBER> <NUMBER> weekold hamsters orally treated single dose <NUMBER>mgkg favipiravir gowen et al <NUMBER> <NUMBER> maximum plasma drug concentration occurred <NUMBER> h oral administration earlier <NUMBER> humans decreased rapidly agreement short halflife madelain et al <NUMBER> <NUMBER> repeated doses plasma exposure confirmed nonlinear pk entire range doses <NUMBER> emphasized accumulation ratios important accumulation observed highest dose could <NUMBER> explain part toxicity observed hamsters dose favipiravir undergoes important <NUMBER> hepatic metabolism mainly aldehyde oxidase producing inactive m<NUMBER> metabolite inhibits <NUMBER> aldehyde oxidase activity concentrationand timedependent manner properties explain selfinhibition metabolism observed study highest dose <NUMBER> favipiravir led greater increase favipiravir concentrations madelain et al <NUMBER> <NUMBER> good penetration favipiravir lungs observed lungplasma ratios ranging <NUMBER> <NUMBER> <NUMBER> repeated doses consistent physicochemical properties lung exposure also <NUMBER> accordance previous studies gowen et al <NUMBER> <NUMBER> clinically realistic results address question compared drug <NUMBER> concentrations obtained hamster model obtained patients <NUMBER> clinical trial <NUMBER> evaluated use favipiravir ebola infected patients sissoko et al <NUMBER> dose used ebola <NUMBER> infected patients <NUMBER>mg day <NUMBER> followed <NUMBER>mg bid <NUMBER> days median trough <NUMBER> concentrations favipiravir day <NUMBER> day <NUMBER> <NUMBER> <NUMBER>µgml respectively within <NUMBER> range observed hamsters treated highest dose around <NUMBER>mgkgday <NUMBER> mean trough concentration <NUMBER>µgml however additional investigations required <NUMBER> determine whether similar favipiravir plasma exposure sarscov<NUMBER> infected patients <NUMBER> associated antiviral activity major differences pk hamster humans <NUMBER> toxicity observed highest doses animal model limits extrapolation results <NUMBER> therefore whether safe dosing regimens humans may achieve similar plasma exposure <NUMBER> recapitulate profound effect viral replication unknown intracellular <NUMBER> concentration active metabolite determined parameter drug <NUMBER> pharmacokinetics best drives antiviral effect remains established <NUMBER> summary study establishes high doses favipiravir associated antiviral activity <NUMBER> sarscov<NUMBER> infection hamster model better antiviral efficacy observed using <NUMBER> preventive strategy suggesting favipiravir could appropriate prophylactic use <NUMBER> results interpreted caution high doses favipiravir associated signs <NUMBER> toxicity model required determine tolerable dosing regimen could generate similar <NUMBER> exposure nonhuman primates associated significant antiviral activity testing high <NUMBER> dose regimen covid<NUMBER> patients furthermore subsequent studies determine increased <NUMBER> antiviral efficacy reached using favipiravir association effective antiviral drugs <NUMBER> since strategy may enable reduce dosing regimen favipiravir finally work reinforces <NUMBER> need rapid development animal models confirm vivo efficacy antiviral compounds <NUMBER> accordingly determine appropriate dose regimens humans starting clinical trials thank laurence thirion uve marseille providing rtqpcr systems thank camille placidi <NUMBER> uve marseille technical contribution also thank pr ernest gould uve marseille <NUMBER> careful reading manuscript english language editing thank pr drosten pr drexler <NUMBER> providing sarscov<NUMBER> strain european research infrastructure eva global <NUMBER> work supported fondation de france call flash covid<NUMBER> project tamac institut <NUMBER> national de la santé et de la recherche médicale reacting research action targeting <NUMBER> emerging infectious diseases initiative preuve de concept pour la production rapide vitro determination ec<NUMBER> ec<NUMBER> cc<NUMBER> infectious titer reductions <NUMBER> one day prior infection <NUMBER>×<NUMBER> <NUMBER> veroe<NUMBER> cells seeded <NUMBER>well culture plates <NUMBER>×<NUMBER> <NUMBER> cellswell <NUMBER> <NUMBER>µl <NUMBER> fbs medium assay medium next day seven <NUMBER>fold serial dilutions favipiravir <NUMBER> courtesy toyamachemical <NUMBER>µgml <NUMBER>µgml triplicate added <NUMBER>µlwell assay <NUMBER> medium eight virus control wells supplemented <NUMBER>µl assay medium eight cell <NUMBER> controls supplemented <NUMBER>µl assay medium <NUMBER> min <NUMBER>µl virus suspension <NUMBER> diluted assay medium added wells moi <NUMBER> <NUMBER> except cell controls <NUMBER> three days infection cell supernatant media collected perform tcid<NUMBER> assay <NUMBER> concentration <NUMBER> <NUMBER> <NUMBER>µgml described order calculate infectious titer <NUMBER> reductions cell viability assessed using celltiterblue reagent promega following <NUMBER> manufacturers intructions fluorescence <NUMBER>nm recorded tecan infinite <NUMBER>pro <NUMBER> machine tecan <NUMBER> <NUMBER> effective concentrations ec<NUMBER> ec<NUMBER> determined using <NUMBER> logarithmic interpolation inhibition calculated follows odsampleodvirus controlodcell control<NUMBER> odvirus control evaluation cc<NUMBER> concentration induced <NUMBER> cytoxicity <NUMBER> culture conditions set determination ec<NUMBER> without addition virus <NUMBER> cell viability measured using celltiter blue promega cc<NUMBER> determined using logarithmic <NUMBER> interpolation <NUMBER> workbench software v<NUMBER> qiagen de novo contig also produced ensure consensus <NUMBER> sequence affected reference sequence mutation frequency position <NUMBER> calculated number reads mutation compared reference divided total <NUMBER> number reads site substitutions frequency least <NUMBER> taken account <NUMBER> analysis table s<NUMBER> <NUMBER> conducted nonlinear regression infectious viral load dose using emax model giving <NUMBER> <NUMBER> × <NUMBER> − <NUMBER> <NUMBER> infectious viral load untreated animals estimated <NUMBER> <NUMBER> dose required decrease viral load <NUMBER> using coefficient account high <NUMBER> sigmoidicity relation dose titers coefficient chosen one maximizing <NUMBER> likelihood model extrapolated <NUMBER> <NUMBER> using <NUMBER> √<NUMBER> × <NUMBER> <NUMBER> <NUMBER> √<NUMBER> × <NUMBER> well <NUMBER> confidence interval using delta method <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> novel coronavirus emerged towards end <NUMBER> responsible coronavirus disease <NUMBER> covid<NUMBER> global pandemic available data suggests sarscov<NUMBER> zoonotic source <NUMBER> closest sequence currently available deriving horseshoe bat <NUMBER> yet transmission route humans including intermediate host unknown far little work done assess animal reservoirs sarscov<NUMBER> potential virus spread species living close proximity humans domestic rural agricultural zoological settings coronaviruses including sarscov<NUMBER> major multihost pathogens infect wide range nonhuman animals <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> betacoronavirus genus includes viruses infect economically important livestock including cows <NUMBER> pigs <NUMBER> together mice <NUMBER> rats <NUMBER> rabbits <NUMBER> wildlife antelope giraffe <NUMBER> severe acute respiratory syndrome coronavirus sarscov betacoronavirus caused <NUMBER> sars outbreak <NUMBER> likely jumped humans original bat host via civets viruses genetically similar human sarscov isolated animals diverse racoon dogs ferretbadgers <NUMBER> pigs <NUMBER> suggesting existence large host reservoir therefore probable sarscov<NUMBER> also infect wide range species realworld sarscov<NUMBER> infections reported cats <NUMBER> tigers <NUMBER> dogs <NUMBER> <NUMBER> minks <NUMBER> <NUMBER> animal infection studies also identified cats <NUMBER> dogs <NUMBER> hosts well ferrets <NUMBER> macaques <NUMBER> marmosets <NUMBER> recent vitro studies also suggested even broader set animals may infected <NUMBER> <NUMBER> <NUMBER> understand potential host range sarscov<NUMBER> plausible extent zoonotic anthroponotic transmission guide surveillance efforts vital know species susceptible sarscov<NUMBER> infection receptor binding domain rbd sarscov<NUMBER> spike protein sprotein binds extracellular peptidase domain angiotensin converting enzyme <NUMBER> ace<NUMBER> mediating cell entry <NUMBER> sequence ace<NUMBER> highly conserved across vertebrates suggesting sarscov<NUMBER> could use orthologues ace<NUMBER> cell entry structure sarscov<NUMBER> sprotein rbd solved complex human ace<NUMBER> <NUMBER> identification critical binding residues structure provided valuable insights viral recognition host receptor <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> compared sarscov sarscov<NUMBER> sprotein <NUMBER>fold higher affinity human ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> thought caused three classes mutations sprotein <NUMBER> similarly variations human ace<NUMBER> also found increase affinity sprotein receptor binding <NUMBER> factors may contribute host range infectivity sarscov<NUMBER> sarscov<NUMBER> sarscov additionally require transmembrane serine protease tmprss<NUMBER> mediate cell entry together ace<NUMBER> tmprss<NUMBER> confer specificity host cell types virus enter <NUMBER> <NUMBER> upon binding ace<NUMBER> sprotein cleaved tmprss<NUMBER> two cleavage sites separate loops primes sprotein cell entry <NUMBER> tmprss<NUMBER> docked sarscov<NUMBER> sprotein revealed binding site adjacent two cleavage sites <NUMBER> approved tmprss<NUMBER> protease inhibitor drug able block sarscov<NUMBER> cell entry <NUMBER> demonstrates key role tmprss<NUMBER> alongside ace<NUMBER> <NUMBER> ace<NUMBER> tmprss<NUMBER> represent attractive therapeutic targets sarscov<NUMBER> <NUMBER> recent work predicted possible hosts sarscov<NUMBER> using structural interplay sprotein ace<NUMBER> studies proposed broad range hosts covering hundreds mammalian species including tens bat <NUMBER> primate <NUMBER> species comprehensive studies analysing classes vertebrates <NUMBER> <NUMBER> including agricultural species cow sheep goat bison water buffalo addition sites ace<NUMBER> identified positive selection bats particularly regions involved binding sprotein <NUMBER> <NUMBER> impacts mutations ace<NUMBER> orthologues also tested example structural modelling ace<NUMBER> <NUMBER> primate species <NUMBER> demonstrated apes african asian monkeys may also susceptible sarscov<NUMBER> however whilst cell entry necessary viral infection may sufficient alone cause disease example variations proteins may prevent downstream events required viral replication new host hence examples realworld infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> experimental data animal infection studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> required validate hosts predicted susceptible analysed effect known mutations orthologues ace<NUMBER> tmprss<NUMBER> broad range <NUMBER> vertebrate species including primates rodents placental mammals birds reptiles fish species generated <NUMBER>dimensional model ace<NUMBER> protein structure protein sequence calculated impacts known mutations ace<NUMBER> stability sproteinace<NUMBER> complex correlated changes energy complex changes structure ace<NUMBER> chemical properties residues binding interface experimental covid<NUMBER> infection phenotypes vivo vitro animal studies test predictions rationalise key sites contributing energy changes complex performed detailed manual structural analyses presented variety case studies different species unlike studies analyse interactions sprotein makes host also analyse impact mutations vertebrate orthologues tmprss<NUMBER> results suggest sarscov<NUMBER> could infect broad range vertebrates could serve reservoirs virus supporting future anthroponotic zoonotic transmission aligned protein sequences <NUMBER> vertebrate orthologues ace<NUMBER> orthologues <NUMBER> sequence identity human ace<NUMBER> supplementary fig <NUMBER>a orthologue generated <NUMBER>dimensional model protein structure protein sequence using funmod <NUMBER> <NUMBER> able build highquality models <NUMBER> vertebrate orthologues ndope scores <NUMBER> supplementary table <NUMBER> <NUMBER> lowquality models removed analysis ace<NUMBER> residues directly contacting sprotein dc residues identified structure complex pdb id <NUMBER>m<NUMBER>j fig <NUMBER>a supplementary results <NUMBER> supplementary fig <NUMBER> also identified extended set dc residues residues within <NUMBER>å dc residues likely influencing binding dcex residues analysing orthologue interfaces removed models missing <NUMBER> dcex residues <NUMBER> models removed analysis leaving <NUMBER> models take forward analysis observed high sequence <NUMBER> identity structure similarity score <NUMBER> <NUMBER> ace<NUMBER> proteins species supplementary results <NUMBER> used multiple methods assess relative change binding energy δδg sarscov<NUMBER> sproteinace<NUMBER> complex following mutations dc residues dcex residues likely influence binding found protocol <NUMBER> employing mcsmppi<NUMBER> henceforth referred p<NUMBER>ppi<NUMBER> calculated dcex residues correlated best phenotype data supplementary results <NUMBER> supplementary fig <NUMBER> table <NUMBER> justifying use animal models calculate δδg values context since protocol considers mutations animal human lower δδg values correspond stabilisation animal complex relative human complex therefore higher risk infection show residues p<NUMBER>ppi<NUMBER> reports stabilising destabilising sarscov<NUMBER> sproteinace<NUMBER> animal complex dc supplementary fig <NUMBER> dcex supplementary fig <NUMBER> residues consider δδg values evolutionary context annotated phylogenetic trees <NUMBER> vertebrate species analysed supplementary fig <NUMBER> subset animals humans come close contact domestic agricultural zoological settings fig <NUMBER> thresholds chosen agree well available experimental data fig <NUMBER> animal number residue changes compared human ace<NUMBER> sequence total chemical shift across dcex residues also shown tree contains subset animals supplementary fig <NUMBER> general see high infection risk mammals notable exception nonplacental mammals δδg values measured p<NUMBER>ppi<NUMBER> correlate well infection phenotypes table <NUMBER> δδg values significantly lower animals infected sarscov<NUMBER> animals evidence infection fig <NUMBER> mannwhitney onesided p <NUMBER> x <NUMBER> <NUMBER> two animals outliers infected boxplot corresponding horseshoe bat δδg <NUMBER> marmoset δδg <NUMBER> cautious since vivo experiments shown marmosets infected vitro experiments shown horseshoe bats infected <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> consider animals δδg values less equal δδg <NUMBER> horseshoe bat risk additionally clear sampling bias set animals far experimentally characterised chicken duck mammals nonmammals tested median δδg value noninfection likely increase fig <NUMBER> shown previous studies supported experimental data many primates predicted high risk <NUMBER> <NUMBER> <NUMBER> agricultural settings camels cows sheep goats horses also relatively low δδg values suggesting comparable binding affinities humans agreement experimental data <NUMBER> <NUMBER> domestic settings dogs <NUMBER> cats <NUMBER> hamsters <NUMBER> rabbits <NUMBER> <NUMBER> <NUMBER> also δδg values suggesting risk agreement experimental data table <NUMBER> whilst zoological animals come contact humans pandas leopards bears also risk infection shown experimentally <NUMBER> predicting susceptibility chosen thresholds supported vivo vitro experimental data previous work contrasted binding energy sprotein sarscov sarscov<NUMBER> human ace<NUMBER> protein <NUMBER> <NUMBER> <NUMBER> sarscov able infect humans despite <NUMBER>fold lower binding affinity <NUMBER> <NUMBER> <NUMBER> suggesting even mutations different animal species make interfaces less compatible sarscov<NUMBER> considerably decreased binding energy may still sufficient enable infection applying threshold correctly predict <NUMBER> animals dataset experimental evidence infection risk table <NUMBER> however animals predict risk using threshold vitro experimental studies date shown infection example donkeys risk infection δδg <NUMBER> infections observed vitro animals <NUMBER> however infection observed vitro horse <NUMBER> horse donkey identical dcex residues δδg amongst new world monkeys marmosets experimentally infected <NUMBER> predict closely related capuchin squirrel monkey also risk although shown infected using functional assays <NUMBER> performed detailed structural analyses characterise key residues contributing binding energy changes consider discrepancies analyses reveal interfaces capuchin squirrel monkey similar marmoset suggesting two new world monkeys also likely risk even though current experimental data supporting <NUMBER> supplementary results <NUMBER> furthermore monkeys high global sequence similarity human capuchin squirrel monkey <NUMBER> dcex residues identical human supporting risk marmoset experimental evidence infection global sequence identity <NUMBER> <NUMBER> dcex residues additionally compared changes energy sproteinace<NUMBER> complex sarscov<NUMBER> sarscov found similar changes suggesting range animals susceptible virus likely similar sarscov<NUMBER> sarscov supplementary results <NUMBER> ace<NUMBER> tmprss<NUMBER> key factors sarscov<NUMBER> infection process highly coexpressed susceptible cell types type ii pneumocytes lungs ileal absorptive enterocytes gut nasal goblet secretory cells <NUMBER> since proteins required infection host cells since analyses clearly support suggestions conserved binding sproteinace<NUMBER> across animal species decided analyse whether tmprss<NUMBER> similarly conserved known structure tmprss<NUMBER> built highquality model template structure pdb id <NUMBER>i<NUMBER> since tmprss<NUMBER> serine protease key catalytic residues known used funfams identify highly conserved residues active site cleavage site likely involved substrate binding resulted two sets residues analysed active site cleavage site residues ascs active site cleavage site residues plus residues within <NUMBER>å catalytic residues highly conserved funfam ascsex sum grantham scores mutations active site cleavage site tmprss<NUMBER> zero consistently lower ace<NUMBER> organisms consideration ascs ascsex residues fig <NUMBER> means mutations tmprss<NUMBER> involve conservative changes mutations dcex residues seem disruptive effect ace<NUMBER> tmprss<NUMBER> whilst expect orthologues organisms close humans conserved lower grantham scores observed residue substitutions high grantham scores primates capuchin marmoset mouse lemur addition primates coquerel sifaka greater bamboo lemur bolivian squirrel monkey mutations dcex residues high grantham scores mutations tmprss<NUMBER> may render animals less susceptible infection sarscov<NUMBER> smallscale phylogenetic analysis performed subset sarscov<NUMBER> assemblies conjunction broader range sarslike betacoronaviruses supplementary table <NUMBER> including sarscov isolated humans civets phylogeny consistent previous work <NUMBER> identified virus isolated horseshoe bats ratg<NUMBER> epiisl<NUMBER> closest genome sarscov<NUMBER> strains currently available fig <NUMBER> aided large community effort thousands humanassociated sarscov<NUMBER> genome assemblies accessible gisaid <NUMBER> <NUMBER> time writing also include one assembly generated virus infecting domestic dog epiisl<NUMBER> one obtained zoo tiger epiisl<NUMBER> one obtained mink epiisl<NUMBER> sarscov<NUMBER> strains animal infections fall within phylogenetic diversity observed human lineages fig <NUMBER>a receptor binding domain completely conserved fig <NUMBER>bc across human animal sarscov<NUMBER> replacements spike protein dog sprotein v<NUMBER>l tiger sprotein d<NUMBER>g mink sprotein d<NUMBER>g strains relative wuhanhu<NUMBER> also observed humanassociated lineages <NUMBER> consistent circulation nonhuman hosts note whilst genomewide data indicates closer phylogenetic relationship sarscov<NUMBER> strains ratg<NUMBER> receptor binding domain alignment instead supports closer relationship virus isolated pangolins <NUMBER> epiisl<NUMBER> fig <NUMBER>c line previous reports <NUMBER> highlights importance considering variations protein structure may determine host range ongoing covid<NUMBER> global pandemic zoonotic origin necessitating investigations sarscov<NUMBER> infects animals virus transmitted across species given role stability complex formed sprotein receptors could contribute viral host range zoonosis anthroponosis clear need study interactions however relative changes energies sproteinace<NUMBER> complex explored experimentally silico number recent studies <NUMBER> <NUMBER> <NUMBER> suggested due high conservation ace<NUMBER> animals vulnerable infection sarscov<NUMBER> concerningly animals could theory serve reservoirs virus increasing risk future zoonotic events though transmission rates across species currently known therefore important try predict animals could potentially infected sarscov<NUMBER> plausible extent transmission estimated surveillance efforts guided appropriately animal susceptibility infection sarscov<NUMBER> studied vivo <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vitro <NUMBER> <NUMBER> <NUMBER> course pandemic parallel silico work made use protein structure sproteinace<NUMBER> complex computationally predict breadth possible viral hosts studies simply considered number residues mutated relative human ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> although also analyse effect mutations interface stability <NUMBER> <NUMBER> <NUMBER> comprehensive studies analysed number locations mutated residues ace<NUMBER> orthologues <NUMBER> species <NUMBER> perform detailed energy calculations done also assessment tmprss<NUMBER> made furthermore work study far explored changes energy sproteinace<NUMBER> complex large scale study performed comprehensive analysis major proteins sarscov<NUMBER> uses cell entry predicted structures ace<NUMBER> tmprss<NUMBER> orthologues <NUMBER> vertebrate species modelled sproteinace<NUMBER> complexes calculated relative changes energy δδg sproteinace<NUMBER> complexes silico following mutations animal residues human predictions suggest whilst many mammals susceptible infection sarscov<NUMBER> birds fish reptiles likely however exceptions manually analysed residues sproteinace<NUMBER> interface including dc residues directly contacted protein dcex residues also included residues within <NUMBER>å binding residues may affect binding clearly showed advantage performing sophisticated studies changes energy complex simple measuressuch number chemical nature mutated residuesused studies furthermore wider set dcex residues identified near binding interface higher correlation phenotype data dc residues addition ace<NUMBER> also analysed mutations tmprss<NUMBER> impact binding sprotein found mutations tmprss<NUMBER> less disruptive mutations ace<NUMBER> indicating binding interactions sproteintmprss<NUMBER> complex different species affected increase confidence assessing changes energy complex developed multiple protocols using different established methods correlated stability measures experimental infection phenotypes literature vivo <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vitro <NUMBER> <NUMBER> <NUMBER> studies animals protocol <NUMBER> using mcsmppi<NUMBER> p<NUMBER>ppi<NUMBER> correlated best number mutations chemical changes induced mutations infection phenotypes chose focus analysis employing protocol method cannot determine relative changes energy associated risk instead used experimental vivo vitro infection data gold standard identify animals risk note horseshoe bats heavily advocated putative reservoir host predicted infected vitro experiments despite considerable disruption interface detailed structural analysis shows found predicted δδg values animals infected sarscov<NUMBER> significantly lower animals showed infection tested experimentally fig <NUMBER> table <NUMBER> δδg values horseshoe bat marmoset outliers infected animals δδg values higher median δδg value animals infected approximately value median δδg <NUMBER> animals included study however may result biased sampling animals tested experimentally mammals date going forward distantly related animals experimentally characterised plausible nonplacental animals many δδg <NUMBER> value obtained horseshoe bat would found infected therefore difference δδg values animals cannot infected sarscov<NUMBER> increase humans likely come contact <NUMBER> species domestic agricultural zoological settings fig <NUMBER> particular concern sheep change energy sproteinace<NUMBER> complex animals farmed come close contact humans also provide phylogenetic evidence human sarscov<NUMBER> also present tigers <NUMBER> dogs <NUMBER> <NUMBER> minks <NUMBER> <NUMBER> fig <NUMBER> consistent reports humantoanimal transmission latter measurements change energy complex sarscov sprotein highly correlated sarscov<NUMBER> findings also applicable sarscov gain better understanding nature sproteinace<NUMBER> interface performed detailed structural analyses subset species cases found discrepancies energy calculations experimental phenotypes namely predicting risk animals invitro experiments showed infection table <NUMBER> test predictions manually analysed shape chemistry residues may impact complex stability dc residues selection dcex residues agreement studies <NUMBER> identified number locations ace<NUMBER> important binding sprotein locations namely hydrophobic cluster near nterminus two hotspot locations near residues <NUMBER> <NUMBER> stabilise binding interface sarscov<NUMBER> better able exploit hydrophobic pocket sarscov increased flexibility rbd loop mutation l<NUMBER>f <NUMBER> structural analysis showed sarscov<NUMBER> utilise pocket binding interface species examined including current experimental test data suggest risk hotspot <NUMBER> shows structural variability agreement calculations large changes energy sproteinace<NUMBER> complex horseshoe bat structural studies show variant d<NUMBER>n causes loss salt bridge hbonding interactions ace<NUMBER> sprotein hotspot <NUMBER> detailed structural analyses supported high grantham score calculated total δδg change energy complex dog cat physicochemically similar variant hotspot d<NUMBER>e although disrupting salt bridge still permits alternative hbonding interactions spike rbd ace<NUMBER> marmosets new world monkeys capuchin squirrel monkey structural analyses revealed similarity human hotspot <NUMBER> ace<NUMBER> interface fact capuchin resembled human ace<NUMBER> interface even closely marmoset infected <NUMBER> even though vitro experiments reported infection capuchin <NUMBER> δδg value capuchin δδg <NUMBER> suggests risk infection also squirrel monkey δδg <NUMBER> despite fact squirrel monkey also failed show risk vitro experimental studies note fact marmoset showed infection vitro studies <NUMBER> whilst recent vivo experiments <NUMBER> shown risk perhaps suggesting difficult detect infection vitro monkeys alternatively lack infection may suggest additional factors influencing infection indicate animals primates closely related human may useful models studying immune factors related resistance finally structural analyses showed dcex residues likely allosteric sites may represent promising drug targets <NUMBER> value study determining absolute δδg threshold risk rather providing information relative changes binding energy allow host range virus accurately gauged experimental work conducted believe false positive predictions acceptable false negatives within context possible transmission events species particularly human consider animal infected experimental evidence infection applied protocols enabled comprehensive study host range within reasonable time identifying species risk infection sarscov<NUMBER> becoming reservoirs virus although felt faster methods justified need timely answers questions clearly caveats work taken account whilst use state art modelling tool <NUMBER> endorsed method calculating changes energy complex <NUMBER> molecular dynamics may give accurate picture energy changes sampling rotamer space comprehensively however approach would prohibitively expensive time clearly important identify animals risk quickly possible animal could take orders magnitude longer analyse using molecular dynamics caveats include fact although animals highlight risk changes binding energy calculations correlate well experimental data small amount data currently available many experimental papers reporting data yet peer reviewed finally restricted analyses one strain sarscov<NUMBER> strains may evolved mutations give complementary interfaces example recent work suggests sarscov<NUMBER> readily adapt infect mice following serial passages <NUMBER> summary work aiming provide absolute measure risk infection rather considered efficient method screen large number animals suggest possible susceptibility thereby guide studies predictions possible risk confirmed experimental studies computationally expensive robust methods like molecular dynamics ability sarscov<NUMBER> infect host cells cause covid<NUMBER> sometimes resulting severe disease ultimately depends multitude hostvirus protein interactions <NUMBER> investigate study results suggest sarscov<NUMBER> could indeed infect broad range mammals possibility creating new reservoirs virus consider identify transmission early mitigate risks particular farm animals animals living close contact humans could monitored protected possible managed accordingly <NUMBER> ace<NUMBER> protein sequences <NUMBER> vertebrates including humans obtained ensembl <NUMBER> version <NUMBER> eight sequences uniprot release <NUMBER> supplementary table <NUMBER> tmprss<NUMBER> protein sequences <NUMBER> vertebrate sequences including human sequence obtained ensembl supplementary table <NUMBER> phylogenetic tree species indicate evolutionary relationships animals downloaded ensembl <NUMBER> structure <NUMBER> sarscov<NUMBER> sprotein bound human ace<NUMBER> <NUMBER>å used throughout pdb id <NUMBER>m<NUMBER>j used standard methods analyse sequence similarity human ace<NUMBER> vertebrate species supplementary methods <NUMBER> also mapped ace<NUMBER> tmprss<NUMBER> sequences cath functional families detect residues highly conserved across species supplementary methods <NUMBER> addition residues ace<NUMBER> contact sprotein directly various studies also considered residues second shell buried could influence binding <NUMBER> therefore analyses built approaches extended compile following sets study <NUMBER> direct contact dc residues includes total <NUMBER> residues involved direct contact sprotein <NUMBER> identified pdbe <NUMBER> pdbsum <NUMBER> <NUMBER> direct contact extended dcex residues dataset includes residues within <NUMBER>å dc residues likely important binding selected detailed manual inspection complex also considering following criteria reported evidence deep mutagenesis <NUMBER> ii silico alanine scanning using mcsmppi <NUMBER> iii residues high evolutionary conservation patterns identified funfamsbased protocol described ie residues identified dops ≥ <NUMBER> scorecons score ≥ <NUMBER> iv allosteric site prediction supplementary methods <NUMBER> v sites positive selection supplementary methods <NUMBER> selected residues shown supplementary fig <NUMBER> residues close dc residues ie within <NUMBER>å annotated also included residues identified related structural analyses reported literature supplementary methods <NUMBER> using ace<NUMBER> protein sequence species structural models generated sproteinace<NUMBER> complex <NUMBER> animals using funmod modelling pipeline <NUMBER> <NUMBER> based modeller <NUMBER> supplementary methods <NUMBER> models refined modeller optimise geometry complex interface highquality models used analysis ndope<NUMBER> score <NUMBER> <NUMBER> dcex residues missing gave final dataset <NUMBER> animals analysis modelled structures ace<NUMBER> compared human structure pdb id <NUMBER>m<NUMBER>j pairwise using ssap <NUMBER> ssap returns score range <NUMBER> identical structures scoring <NUMBER> also built models tmprss<NUMBER> proteins available species identified residues likely involved protein function supplementary methods <NUMBER> calculated changes binding energy sarscov<NUMBER> sproteinace<NUMBER> complex sarscov sproteinace<NUMBER> complex different species compared human following two different protocols <NUMBER> protocol <NUMBER> using human complex mutating residues ace<NUMBER> interface found given animal sequence calculating δδg complex using mcsmppi<NUMBER> <NUMBER> mcsmppi<NUMBER> <NUMBER> supplementary methods <NUMBER> gave measure destabilisation complex given animal relative human complex δδg values <NUMBER> associated destabilising mutations whilst values ≥ <NUMBER> associated stabilising mutations <NUMBER> protocol <NUMBER> repeated analysis mcsmppi<NUMBER> mcsmppi<NUMBER> protocol <NUMBER> using animal <NUMBER>dimensional models instead human ace<NUMBER> structure calculating δδg complex mutating animal ace<NUMBER> interface residue appropriate residue human ace<NUMBER> structure gave measure destabilisation complex human complex relative given animal values ≤ <NUMBER> associated destabilisation human complex ie animal complexes stable whilst values <NUMBER> associated stabilisation human complex ie animal complexes less stable subsequently correlated δδg values available vivo vitro experimental data covid<NUMBER> infection data mammals protocol <NUMBER> mcsmppi<NUMBER> correlated best data measure degree chemical change associated mutations occurring dc dcex residues computed grantham score <NUMBER> vertebrate compared human sequence supplementary methods <NUMBER> performed phylogenetic analyses subset sarscov n <NUMBER> sarslike n <NUMBER> sarscov<NUMBER> n <NUMBER> viruses publicly available data ncbi <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> gisaid <NUMBER> <NUMBER> supplementary methods <NUMBER> paper investigates narratives varying likely cause covid<NUMBER> pandemic influence peoples support prowildlife conservation policies well prowildlife behaviours behavioural intentions understanding cause outbreak important choosing contain mitigate risk future ones yet coronavirus originated still remains mystery much uncertainty characterises debates origin coronavirus evident various sometimes conflicting narratives concurrently circulating online news social media three popular narratives proposing different causal explanations coronavirus outbreak particularly pertinent peoples engagement wildlife environmental conservation first narrative sarscov<NUMBER> virus causing covid<NUMBER> outbreak originated animals may jumped humans via intermediary animal hosts market wuhan sold wildlife animalcause ac narrative proximate cause pandemic causal explanation based growing scientific consensus virus likely zoonotic pandemic instance zoonotic spillover ie animal pathogens transmitted humans similar past infectious epidemics like swine flu ebola andersen et al <NUMBER> mallapaty <NUMBER> cyranoski <NUMBER> second narrative takes reasoning suggesting ongoing human destruction nature via depletion wild animals habitats escalates risks zoonotic spillovers since increases humananimal interactions animal humancause ahc narrative distal cause pandemic compatible first narrative frames increased risk zoonotic pandemics unintended consequence anthropogenic mass animal extinction climate change put forward leading biologists like jane goodall thompson <NUMBER> environmental policymakers like uns environment chief inger andersen carrington <NUMBER>a third narrative often simultaneously shared alongside two suggests virus came biosecurity lab wuhan studying bat coronaviruses animal human labcause ahlc narrative provides alternate proximate cause proposed prominent political figures like president trump recently former uk intelligence head richard dearlove gardener <NUMBER> virus could accidentally escaped lab eg infected lab worker possible scientists lab might tweaked viruss genome research purposes escaped unlike two narratives publicly available scientific evidence cause present <NUMBER> story locates pandemics cause ongoing geopolitical rather anthropogenic environmental change context since proposes alternate explanation diverges first two stories conceptualised counternarrative increase uncertainty cause appears alongside stories estimate types covid<NUMBER> origin narratives affect proconservation outcomes ran preregistered online experiment uk n <NUMBER> subjects randomly allocated either control group read neutral article unrelated pandemic one three narrative treatment groups presenting different likely cause covid<NUMBER> outbreak animal cause ac animal human cause ahc animal human lab cause ahlc fig <NUMBER> subjects asked number prowildlife conservation outcomes donations nature conservation incentivised charitable giving task stated intentions undertake proconservation behaviours stated support policies prowildlife conservation best knowledge first ever effort estimate causal impact types covid<NUMBER> origin narratives prowildlife conservation outcomes controlled setting add number new insights literature firstly providing causal evidence types narratives affects proconservation outcomes eg bénabou et al <NUMBER> secondly estimating effect varying cause public health challenges ie covid<NUMBER> support conservation policies eg kahneman et al <NUMBER> thirdly examining impact inserting alternate causal explanations narratives eg van der linden <NUMBER> found ahc narrative elicited significantly greater support conservation policies especially commercial wildlife trade bans compared control treatment groups adding lab story ahlc group removing humancause component ac group attenuated effect explored possible mechanisms found ahc narratives less familiar elicited greater mental emotional engagement induced stronger feelings firms governments responsible mitigating wildlife extinction ahc narrative increased likelihood making donation default amount £<NUMBER> neither ac treatment narratives influenced donation amount proconservation intentions setting overall results suggest narratives causally linking human destruction nature covid<NUMBER> increase support wildlife conservation policies section two reviews literature narratives causal information shift beliefs preferences behaviour section three presents experimental design materials section four results section five concludes discussion narratives according bruner <NUMBER> deal human humanlike intention action vicissitudes consequences mark course stories people tell share others make sense human experience ie organize explain justify predict sometimes influence course bruner <NUMBER> chater loewenstein <NUMBER> bénabou et al <NUMBER> insights economics psychology suggest narrativesand causal explanations providecan shift support policies behaviour consistent stories told economics instance bénabou et al <NUMBER> formalise narratives rationales justifications one situations actions moral social implications involving externalities also see shiller <NUMBER> dolan <NUMBER> differentiate responsibilizing absolving narratives former creates pressure behave morally instance emphasizing persons actions impact others moral responsibility responsibilizing narratives therefore increase prosocial beliefs preferences behaviour conversely absolving narratives employ strategies like blaming victims appealing alternate facts denying responsibility used justify antisocial selfish shortsighted actions responsibilizing absolving narratives operate changing beliefs externality choices responsible people feel negative externalities long perceived recipients containing enough grain truth similarly eliaz spiegler <NUMBER> consider narratives causal models world map action variables onto consequences model lever narratives provide causal explanations levers trigger specific outcomes therefore shape policy preferences narrative persuasion discourse psychology scholars also conceptualise narratives type communication format specifying causeeffect relationship time using specific characters kreuter et al <NUMBER> dahlstrom <NUMBER> examine information placed within narratives eg protagonists plot emotional valence elicit responses compared factbased persuasive messages green et al <NUMBER> kreuter et al <NUMBER> moyergusé <NUMBER> dahlstrom <NUMBER> braddock dillard <NUMBER> apart altering beliefs strand research suggests narratives operate via specific psychological mechanisms reducing counterarguing changing norms selfefficacy outcome expectancies moyergusé <NUMBER> particularly important channel narrative engagement ie narratives work enabling greater mental emotional attentional absorption transportation story green brock <NUMBER> appel et al <NUMBER> van laer et al <NUMBER> work therefore suggests exposure narratives impact multiple outcomes like beliefs preferences intentions behaviours via several psychological mechanisms yet inconsistent results empirical research suggest effect narratives fully understood studies operationalise narratives numerous ways tend expose subjects different narratives formats eg fictionnonfiction videostext measure stated beliefs behavioural intentions rely small convenience samples eg students many lack control groups winterbottom et al <NUMBER> dahlstrom <NUMBER> greitemeyer <NUMBER> shen et al <NUMBER> van der linden et al <NUMBER> braddock dillard <NUMBER> cooper nisbet <NUMBER> moezzi et al <NUMBER> recent metaanalyses point positive associations narrative exposure narrativeconsistent beliefs intentions behaviour braddock dillard <NUMBER> shen et al <NUMBER> highlight effectiveness may depend issue handthey found narrativeformat health interventions advocating detection prevention behaviours led significant effects whereas advocating cessation environmental domain greitemeyer <NUMBER> found watching climate change sceptic film decreased environmental concern relative neutral film condition whereas exposure climate change affirming film similarly van der linden <NUMBER> found exposure anticlimate change conspiracy narratives reduced peoples proclimate behavioural intentions signing petitions donating volunteering compared control condition participants solved word puzzle studies largely focus impact public health environmental narratives behaviours respective domains aware studies investigate effects narratives connecting health anthropogenic wildlife extinction especially coronavirus context moreover although causal information considered crucial attribute narratives less evidence varying cause affects outcomes economists psychologists demonstrated causal information type cause matters environmental valuation studies example people willing pay address environmental problems caused humans rather nature kahneman et al <NUMBER> kahneman et al <NUMBER> kahneman ritov <NUMBER> brown et al <NUMBER> bulte et al <NUMBER> böhm pfister <NUMBER> kahneman et al <NUMBER> termed outrage effect found people reported humancaused harm upsetting unintentional harm recently shreedhar mourato <NUMBER> found evidence outrage effect wildlife conservation donations found subjects increased donations exposure audiovisual narratives causally linking wildlife loss human causes like poaching habitat loss compared control group omitting causal information narrative apart outrage feelings responsibility another mechanism varying type causehuman versus naturalcan influence willingness address environmental problems walker et al <NUMBER> brown et al <NUMBER> bulte et al <NUMBER> contrast outrage effect responsibility effect implies willingness pay humancaused environmental problems lower natural ones people dont feel responsible damages likely situations people attribute responsibility third parties like negligent polluting firms walker et al <NUMBER> bulte et al <NUMBER> related literature also highlights felt responsibility important psychological mechanism causally links beliefs humancaused climate change proenvironmental climate change mitigation engagement behaviour kaiser shimoda <NUMBER> gifford nilsson <NUMBER> bateman oconnor <NUMBER> bénabou et al <NUMBER> framework also supports notion denying feeling moral responsibility via absolving responsibilizing narratives respectively affects prosocial behaviour contribute connect distinct strands literature studying impacts narratives causal information investigating different causal explanations offered narratives public health challenge covid<NUMBER> influences prowildlife conservation outcomes instead comparing narratives vary human versus naturecauses environmental problems main focus past studies studied effect adding distal human causes proximate naturecauses covid<NUMBER> narrative addition study inclusion alternative causal explanation via absolving narrative ie lab story affects outcomes motivate predictions drawing bénabou et al <NUMBER> framework responsibilizing absolving narratives outrage versus responsibility effect conduct exploratory analysis whether effects driven two important psychological mechanisms highlighted literature namely narrative engagement felt responsibility also make modest contribution addressing previous methodological limitations literature since conduct controlled preregistered online experiment using comparatively larger sample uk residents attempt elicit stated behaviour intentions policy support revealed behaviour incentivised charitable giving task study main objective examine whether different types narratives cause origin covid<NUMBER> namely ac ahc ahlc narratives impact prowildlife conservation behaviours intentions policy preferences collectively called proconservation outcomes since three narratives raise issue covid<NUMBER> originating wild animals expect elicit higher proconservation outcomes compared control group line past studies showing narrative exposure increase narrative consistent beliefs preferences intentions behaviours eg braddock dillard <NUMBER> first hypothesis ac ahc ahlc narratives increase proconservation outcomes compared control narrative second objective investigate differences ac ahc ahlc narratives ahc narrative seen responsibilizing narrative bénabou et al <NUMBER> framework creates moral pressure increase prosocial proconservation outcomes making plight wildlife nature salient via trade wild animals depletion habitats identifying human behaviour distal cause negative externality current trade production consumption systems outrage effect also predicts human causes may elicit greater proconservation outcomes kahneman et al <NUMBER> ac narrative hand make causal link humancaused mass extinction covid<NUMBER> explicit second hypothesis ahc narrative increase proconservation outcomes compared ac narrative lab counternarrative seen absolving narrative adding ahc narrative ahlc narrative people might likely justify engaging personally effortful costly proconservation outcomes line responsibility effect people may deny responsibility covid<NUMBER> attributing blame biosecurity lab turn may dampen increase proconservation outcomes walker et al <NUMBER> bénabou et al <NUMBER> said since ahlc treatment group also contains information animal human causes unclear effect dominate third fourth hypotheses ahc narratives increase proconservation outcomes magnitude ahlc narrative ac narrative increase proconservation outcomes magnitude ahlc narrative respectively also undertake analysis examining impact different types narratives based past behaviour beliefs humancaused mass extinction particular expect people believe strongly anthropogenic mass extinction happening undertaken proconservation behaviours past may likely respond increasing proconservation outcomes hold weaker beliefs undertaken fewer relevant behaviours past addition also explored treatment effects depended past beliefs animal cause covid<NUMBER> outbreak finally undertake exploratory analysis investigating two possible psychological mechanisms namely felt responsibility narrative engagement could affect outcomes considered first exploratory hypothesis ac ahc ahlc narratives increase felt responsibility wildlife conservation compared control narrative second exploratory hypothesis ac ahc ahlc narratives increase narrative engagement compared control narrative conducted online survey experiment study preregistered open science framework <NUMBER> survey programmed qualtrics implemented <NUMBER> june <NUMBER> prolific academic platform advertised study daily life views covid<NUMBER> outbreak participation open uk residents ten subjects previously took part pilot participant pool excluded addition survey restricted using laptops computers ensure questions correctly displayed survey interface determine sample size per treatment group power analysis conducted gpower using nonparametric test difference means wilcoxonmannwhitney test two independent groups faul et al <NUMBER> effect size <NUMBER> alpha <NUMBER> power <NUMBER> assumed <NUMBER> yielded <NUMBER> subjects per treatment group subjects excluded failed seriousness check could indicate take part survey seriously aust et al <NUMBER> recruited <NUMBER> subjects total account possible reductions final sample size subjects consent take survey dropped taking survey failed seriousness check final usable sample consisted <NUMBER> subjects average <NUMBER> subjects per treatment group participants paid £<NUMBER> apart earnings donation task explained sect <NUMBER> average completion time around <NUMBER> min subjects consented participate answered introductory sociodemographic questions followed questions coronavirus proconservation behaviours beliefs participant randomly allocated read one four narrative stimuli explained sect <NUMBER> could choose donate money environmental charity answered questions intentions undertake proconservation behaviours support different wildlife conservation policies followed questions feelings responsibility narrative engagement survey concluded exploratory sociodemographic questions attempted mitigate possibility bias arising order effects number ways day et al <NUMBER> firstly embedding belief past behaviour questions amongst filler questions peoples daily behaviours experiences secondly randomising order questions thirdly randomising item order within questions relevant eg multiplechoice questions finally designing questions short simple order tire participants subjects asked imagine came across article social media feed please read carefully randomly assigned one articles containing narrative treatments control three narrative treatment articles shown fig <NUMBER> panels bd ac treatment article stated scientists believe coronavirus may jumped wild animals humans market wuhan narrative links proximate animal cause covid<NUMBER> pandemic ahc treatment exactly added causal information explaining human destruction nature may responsible animal viruses spreading humans narrative links two types compatible causes namely proximate animal distal human cause covid<NUMBER> pandemic ahlc treatment exactly ahc added alternate causal explanation stating president trump suggested coronavirus came lab wuhan narrative presented alternate explanation cause covid<NUMBER> pandemic still making link proximate animal distal human causes content treatment articles adapted real online narrativeformat articles bbc briggs <NUMBER> guardian carrington <NUMBER>b beaumont <NUMBER> daily mail boyd <NUMBER> pleasance <NUMBER> journal nature mallapaty <NUMBER> cyranoski <NUMBER> commonly seen real articles treatment articles also contain one picture placed text greater realism another reason chose place pictures narratives previous studies pointed enable effective communication pictures enable us retain information via picture superiority effect compared plain text hockley bancroft <NUMBER> schwabish <NUMBER> clarify implicit unclear relations text eitel scheiter <NUMBER> facilitate deeper learning via multimedia effect mayer <NUMBER> green brock <NUMBER> also suggest narratives visual images engaging persuasive pictures enable greater transportation narrative followed three criteria selection final photo use real photo good quality explicitly distressing visceral people picture selected single caged animal reflect animal source virus also nearly identical appearing bbc articles source coronavirus eg briggs <NUMBER> animal source one common causal explanation across treatment groups kept photo constant across treatment groups minimise differences balance experimental control realism although cannot isolate effect picture inclusion treatment could make narrative engaging memorable realistic similarly designed text treatment articles closely aligned real online narrativeformat articles used neutral words effort keep people focused arguments presented text <NUMBER> moreover articles carefully designed systematically add different types causal information way generates greater complexity uncertainty move ac ahlc treatments since used addon design addition new causal explanations increased word count article <NUMBER> ac group <NUMBER> words ahc group <NUMBER> words ahlc group way attempted mirror real covid<NUMBER> origin stories online news social media often contain multiple causal explanations within narrativeformat article cannot isolate effects word length per se approach arguably reflects multilayered complex causal connections environmental health systems covid<NUMBER> context finally ensure treatments realistic similar possible presented participants snapshot online bbc article using logo formatting font type colouring main message paragraph text narrative underlined bold nearly identical format online bbc articles help clarify main message enable greater comprehension account variations reading ability amongst participants bbc chosen recent surveys indicate widely used trusted source online offline news uk across political spectrum including conservative labour voters brexit leave remain voters control narrative scottish heritage monument adapted recent online bbc article act realistic placebo article actually circulation bbc <NUMBER> similar length ac narrative <NUMBER> words identically formatted one picture fig <NUMBER> panel proconservation outcomes included charitable donations revealed behaviour via incentivised task behavioural intentions support different wildlife conservation policies donations elicited modified charitable giving task start experiment subjects informed <NUMBER> chance win £<NUMBER> successfully completing survey exposed narrative asked much amount anything wanted allocate conservation charity preselected list nature conservation animal charities <NUMBER> remaining amount would sent directly donation receipt draw subjects used slider choose desired donation amount could take value £<NUMBER> £<NUMBER> £<NUMBER> increments default amount set £<NUMBER> chose format including default reflect practices reallife charities <NUMBER> four selfassessment items used measure subjects willing take relevant proconservation behaviours future especially lifestyle civic actions included intentions avoid eating meat attend protest civic actions engage conservation organisation instance donating money time follow sustainable lifestyle example using renewable energy response options raged definitely <NUMBER> definitely yes <NUMBER> three selfassessment items measured support three conservation policies including stricter regulation trade farming wild animals tax red processed meat ban commercial trade wild animals response options ranged definitely <NUMBER> definitely yes <NUMBER> measure past proconservation behaviours asked subjects indicate whether engaged animal wildlife organisation taken civic action past <NUMBER> years could indicate undertaken following six actions conservation organisation membership donating volunteering captured engagement attended protest signed petition written mp captured civic action responses summed participant denote many actions undertook values ranged <NUMBER> actions <NUMBER> six actions also asked subjects describe diet selecting one option list following omnivore pescatarian flexitarian vegetarian vegan restricted diets coded dummy variable <NUMBER> vegetarian vegan diet <NUMBER> measure past proconservation beliefs asked subjects indicate extent agreed three items examined anthropogenic mass extinction environmental change statements included climate change mostly caused human activities mass extinction wild animals happening mass extinction wild animals mostly caused human activities items adapted leiserowitz et al <NUMBER> response options ranged strongly disagree <NUMBER> strongly agree <NUMBER> three items averaged form pastproconservation belief score cronbach alpha <NUMBER> measure past animal cause beliefs origin coronavirus asked subjects indicate extent agreed one item stating coronavirus came animals market wuhan response options ranged strongly disagree <NUMBER> strongly agree <NUMBER> order check balance across observables analyses collected basic sociodemographic data including age gender education selfidentified ethnicity annual income also elicited whether people identified leavers remainers neither regards brexit <NUMBER> feelings responsibility mitigating wildlife extinction measured asking subjects much agreed two items one measuring personal responsibility another measuring whether felt firms governments responsibility help mitigate wildlife extinction response options ranged strongly disagree <NUMBER> strongly agree <NUMBER> adapted bateman oconnor <NUMBER> narrative engagement familiarity measured using three items modified appel et al <NUMBER> narrative transportation scale subjects asked indicate extent felt mentally emotionally engaged reading articles whether already familiar narrative responses ranged <NUMBER> extremely <NUMBER> assessed participants recalled information narratives asking indicate remembered following firstly article suggested cause covid<NUMBER> outbreak humans due either destruction nature lab wild animals none dont remember secondly zoonotic diseases swine flu diabetes none dont remember another item asked subjects remembered article source options included bbc itv cnn also asked subjects typically used bbc source online news whether trusted bbc response options yes maybe finally measured amount time subjects spent survey page containing articles check differences time spent reading narratives groups used filler questions throughout neutral title directed people daily life address concerns experimenter demand better understand people chose donate asked subset nondonors select reasons decision list common responses eg would rather keep money need save money dont know charities etc estimate causal effect narratives donations used cragghurdle regression model allowed us jointly estimate amount donated well probability making donation treating £<NUMBER> observed lower bound donations <NUMBER> also explored narrative exposure increased likelihood subjects donating £<NUMBER> ie default donation amount using logistic regression dependent variable categorical variable taking value <NUMBER> donations £<NUMBER> greater proconservation outcomes including prowildlife behavioural intentions policy support used ordered logistic regressions since ordinal variables <NUMBER> wald tests differences treatment categories used examine <NUMBER> cragg hurdle model estimated using churdle command stata <NUMBER> treatment effect probability donating estimated using probit regression model lower hurdle £<NUMBER> decision donate amount truncatedlinear regression model used estimated effects amount donated conditional decided make donation <NUMBER> ordered logistic model estimated using ologit command stata <NUMBER> postestimation tests using brant test parallel regression assumption via brant command revealed proportional odds assumption violated difference treatment effects policy support heterogeneous effects past behaviour beliefs explored interacting treatment dummy variable consideration significant effect main analysis statistical models estimated robust standard errors main analyses estimate average treatment effect undertaken without covariates entire sample <NUMBER> subjects covariates added additional exploratory analysis sample <NUMBER> subjects chose disclose sociodemographic data table <NUMBER> presents summary statistics around <NUMBER> subjects identified female <NUMBER> <NUMBER> years age <NUMBER> <NUMBER> years old almost <NUMBER> identified white <NUMBER> completed undergraduate degree attended college <NUMBER> annual income £<NUMBER> sample also contained people identifying remainers <NUMBER> leavers <NUMBER> terms past proconservation behaviours <NUMBER> sample follow vegetarian vegan diet terms civic actions like attending protest donating moneytime etc <NUMBER> taken actions <NUMBER> taken least one action <NUMBER> taken least two actions figure <NUMBER> appendix shows distribution responses across groups people found hold proconservation beliefs <NUMBER> least somewhat agreeing <NUMBER> agreeing strongly agreeing mass wildlife extinction climate change happening caused mostly humans relatively less agreement whether coronavirus originated animals <NUMBER> sample least somewhat agreeing animal origin story <NUMBER> agreeing strongly agreeing figures <NUMBER> <NUMBER> appendix show distribution responses across groups since treatment randomly allocated observable characteristics evenly spread across treatment groups noted p values table <NUMBER> summary statistics past proconservation behaviour dont seem show much difference across groups p value kruskalwallis balance tests indicates difference across groups smaller share ahlc group relative control group reported undertaking actions noted sect <NUMBER> preregistration plan first conduct main analysis without covariates add covariates subsequent analysis address issue turning proconservation outcomes table <NUMBER> average donation £<NUMBER> median mode £<NUMBER> likely reflecting fact default donation starting point mean donation control group slightly lower £<NUMBER> compared around £<NUMBER> treatment groups overall <NUMBER> subjects chose donate <NUMBER> donated amount examined distribution donation responses across groups see fig <NUMBER> appendix found slightly higher share subjects donated £<NUMBER> ie default amount donations task treatment groups <NUMBER> ac narrative <NUMBER> ahc narrative <NUMBER> ahlc narrative compared <NUMBER> control group terms proconservation behavioural intentions found generally low average scores suggesting people relatively weak intentions act specified proconservation ways future average score intentions engage future social action avoid eating meat engage conservation organisations <NUMBER> <NUMBER> <NUMBER> respectively score intentions follow sustainable lifestyles higher averaging <NUMBER> average scores slightly higher treated groups relative control figures <NUMBER> <NUMBER> <NUMBER> <NUMBER> appendix present distribution responses across groups support three wildlife conservation policies presented survey relatively higher gaining average scores around <NUMBER> <NUMBER> <NUMBER> support stricter regulation wildlife trade farming meat tax banning commercial trade wildlife respectively scores slightly higher treated groups figures <NUMBER> <NUMBER> <NUMBER> <NUMBER> appendix present distribution responses across groups regressed narrative treatment variable donations found treatment coefficients positive difference statistically significant compared control group results presented table <NUMBER> appendix table <NUMBER> model <NUMBER> presents results effect treatment narratives likelihood donating default £<NUMBER> amount without covariates treatment coefficients positive difference statistically significant <NUMBER> ahc narrative relative control group result suggests exposed ahc narrative subjects <NUMBER> likely make donation £<NUMBER> higher compared control group <NUMBER> table <NUMBER> effect narratives support conservation policies regression models without covariates robust standard errors parentheses ii p <NUMBER> p <NUMBER> p <NUMBER> iii model <NUMBER> presents logodds coefficient logistic regression model interpretation increase predicted log odds outcome <NUMBER> due oneunit increase predictor holding everything else constant models <NUMBER> <NUMBER> present ordered logodds logit regression coefficients interpretation oneunit increase predictor response variable level expected change respective regression coefficient ordered logodds scale holding everything else constant iv control group omitted category <NUMBER> wald tests show differences treatment indicators statistically significant ahc narrative remains positive statistically significant <NUMBER> level added covariates regression model shown table <NUMBER> appendix amongst covariates past proconservation behaviour beliefs female positively predicted likelihood subjects donating £<NUMBER> <NUMBER> <NUMBER> level considered intentions act proconservation ways regression results revealed narrative treatment coefficients positive significant compared control table <NUMBER> appendix presents results given lack robust treatment effects focus rest analysis effect narratives support different wildlife conservation policies table <NUMBER> models <NUMBER> presents main results narrative dummy regressed policy support outcomes without covariates relative control group ahc narrative group elicited higher support policies difference significant <NUMBER> level stricter regulation meat tax <NUMBER> level wildlife trade ban aggregate conservation policies variable specifically relative control group exposed ahc narrative increased odds subject reporting higher support one point stricter regulation meat tax ban <NUMBER> <NUMBER> <NUMBER> respectively exposure ahlc narrative significantly increased support trade ban <NUMBER> level compared control group translated increase odds subject reporting higher support one point ban <NUMBER> results indicate exposure ahc narrative significantly increased prowildlife conservation policy support line possible existence outrage effect removing human cause narrative ac narrative adding alternate causal explanation ahlc narrative removes effect overall also considering effects donations behavioural intentions results lend partial support first hypothesis wald tests show difference ac ahc coefficients significant positive since ahc higher effect <NUMBER> level meat tax trade ban chi <NUMBER> <NUMBER> p value <NUMBER> chi <NUMBER> <NUMBER> p value <NUMBER> respectively difference ac ahc coefficients significant <NUMBER> level outcome aggregated support conservation policies variable chi <NUMBER> <NUMBER> p value <NUMBER> difference ac ahlc coefficients ahc ahlc coefficients models results suggest adding distal human cause ahc narrative increased proconservation policy support relative narrative omits distal human cause ie ac narrative lends support hypothesis two context wildlife policy outcome also found difference ahc ahlc narratives ac ahlc narratives lending support hypothesis three four difference narratives terms effect wildlife policy outcome find heterogeneous effects policy support interacted dummy narrative treatments past proconservation behaviour past proconservation beliefs past beliefs whether virus originated animals exception positive significant interaction effect ahlc past beliefs animal cause virus significant <NUMBER> see table <NUMBER> appendix figure <NUMBER> plots coefficients ordered logistic regression narrative dummy regressed policy support outcomes past conservation behaviour past beliefs sociodemographic covariates results consistent terms effect size significance level main results treatment effect presented table <NUMBER> exception coefficient ahc narrative longer significant <NUMBER> level stricter regulation policy support following vegetarian vegan diet relative dont past conservation behaviour beliefs strongest predictors policy support respective coefficients positive statistically significant <NUMBER> level support wildlife trade bans stricter regulations meat tax positively associated age compared identifying leavers remainers likely support meat tax significant <NUMBER> table <NUMBER> presents results effect narrative treatments felt responsibility narrative engagement exposure treatment narratives increased feelings personal responsibility difference significant model <NUMBER> ahc narrative however increased feeling firms governments responsible difference positive significant <NUMBER> level model <NUMBER> terms covariates stronger past proconservation beliefs behaviours following vegetarianvegan diet positively associated higher feelings personal firms government responsibility significant mostly <NUMBER> level remainers felt firms governments responsible compared leavers significant <NUMBER> treatment narratives increased feelings emotional mental involvement article compared control group significant <NUMBER> level models <NUMBER> <NUMBER> turning whether effects different treatments found ahc narrative elicited higher mental emotional involvement ac narrative fig <NUMBER> effect narratives policy support ordered logistic regression coefficients covariates notes p <NUMBER> p <NUMBER> p <NUMBER> ii figure presents ordered logodds logit regression coefficients estimated confidence intervals <NUMBER> level coefficient interpretation one unit increase predictor response variable level expected change respective regression coefficient ordered logodds scale holding everything else constant iii omitted categories control group nonvegetarianvegan diet female white leaver iv model estimated robust se available table <NUMBER> appendix chi <NUMBER> <NUMBER> p value <NUMBER> chi <NUMBER> <NUMBER> p value <NUMBER> respectively ahc narrative also elicited higher mental emotional involvement ahlc narrative chi <NUMBER> <NUMBER> p value <NUMBER> chi <NUMBER> <NUMBER> p value <NUMBER> respectively terms covariates stronger past proconservation beliefs behaviours reported feeling engaged significant <NUMBER> level finally unsurprisingly subjects reported familiarity treatment narratives relative control narrative scottish castle subjects reported less familiarity ahc narrative compared ac narrative chi <NUMBER> <NUMBER> table <NUMBER> effect felt responsibility narrative engagement ordered logistic regressions covariates robust standard errors parentheses ii p <NUMBER> p <NUMBER> p <NUMBER> iii table presents ordered logodds logit regression coefficients interpretation one unit increase predictor response variable level expected change respective regression coefficient ordered logodds scale holding everything else constant iv omitted categories control group nonvegetarianvegan diet female white leaver p value <NUMBER> also marginally less familiarity ahlc narrative chi <NUMBER> <NUMBER> p value <NUMBER> ensure controlled imbalance across groups observable characteristics repeated main analysis addition covariates find similar results ie ahc narrative increased likelihood donating £<NUMBER> significant <NUMBER> level well support conservation policies significant <NUMBER> level especially meat taxes significant <NUMBER> level wildlife trade ban significant <NUMBER> level fig <NUMBER> tables <NUMBER> <NUMBER> appendix results also similar using ordinary least squares regressions instead logistic ordered logit models outcome donations ≥ £<NUMBER> policy support variables respectively check subjects read narratives asked remembered source article ie bbc also asked questions regarding narrative content namely whether article discussed cause covid<NUMBER> mentioned zoonotic diseases like swine flu reassuringly <NUMBER> subjects remembered content source narrative removing sample remember reducing sample size <NUMBER> significantly alter results regression analysis policy support outcomes likelihood donating £<NUMBER> showed results table <NUMBER> appendix also checked results driven prior attitudes choices towards bbc around <NUMBER> subjects used bbc obtain news online share evenly distributed across treatment groups chi <NUMBER> <NUMBER> p value <NUMBER> <NUMBER> reported trusting bbc proportion spread evenly across groups chi <NUMBER> <NUMBER> p value <NUMBER> results policy support qualitatively similar omitting subjects table <NUMBER> appendix addition checked positive effect ahc narrative support stricter regulation meat taxes wildlife trade bans aggregate conservation policies ie outcome averaging three policies likelihood donation ≥ £<NUMBER> compared control group replicated adjusting hypothesis testing multiple outcomes following list et al <NUMBER> differences means ahc control group remained significant <NUMBER> level donation ≥ £<NUMBER> dummy <NUMBER> level commercial wildlife trade ban overall conservation policy variables adjusted p value fell <NUMBER> <NUMBER> level stricter regulation meat taxes main regression results table <NUMBER> table <NUMBER> appendix overall suggests effect aggregated policy support variable commercial wildlife trade bans robust also explored whether differences groups time people spent reading narratives summary statistics similar across groups namely <NUMBER> control group sd <NUMBER> <NUMBER> ac group sd <NUMBER> <NUMBER> ahc group sd <NUMBER> <NUMBER> ahlc group sd <NUMBER> groups pooled average <NUMBER> sd <NUMBER> ran ols regression model test whether differences significant see table <NUMBER> appendix time spent marginally lower <NUMBER> ac group significant <NUMBER> results wald tests showed differences ac ahc group significantly different <NUMBER> level chi <NUMBER> <NUMBER> p value <NUMBER> differences ac ahlc ahc ahlc significant sum participants conformed expectations spending marginally less time shorter ac narrative checked people chose donate commonly cited reason need save money family <NUMBER> choosing donate followed already donate enough <NUMBER> id rather keep money <NUMBER> reasons evenly distributed across groups <NUMBER> <NUMBER> subjects around <NUMBER> <NUMBER> people reported liking knowing charities list spread evenly across groups well despite effort offer people wide choice environmental charities upon examining written comments found subjects preferred donate health causes may reflect current preoccupations health covid<NUMBER> context another concern subjects might guessed true objective experiment might changed responses one hand social desirability bias predicts subjects may increase proconservation outcomes think causal information articles designed purpose hand subjects perceive intent manipulate narrativeformat communications induce reactance effects may reduced escalas <NUMBER> clear effects dominate study attempted address using filler questions framing title survey experiment neutral way lastly observe higher share people donating default £<NUMBER> ahc narrative otherwise observe robust effects donations intentions act proconservation ways one explanation may narratives tested strong enough eg compared videos exposure long enough eg repeated many ways long period effect behaviour even affected policy preferences another possibility sample size large enough detect true effects donation intentions may smaller also possible effects smaller point time broader covid<NUMBER> context may shifted peoples focus inclination take prosocial actions improve health rather environmental outcomes said believe study first step right direction since higherpowered experiment comparable active control group compared existing research future work examine impact narratives larger representative sample address limitations study examined effects three alternative narratives currently circulation proposing different causal explanations covid<NUMBER> prowildlife conservation outcomes ac narrative points origins amongst wild animals ahc narrative includes causal link human depletion nature ahlc narrative adds possibility blame biosecurity lab found ahc narrative influenced peoples willingness support conservation policies especially commercial wildlife trade bans line outrage effect kahneman et al <NUMBER> bulte et al <NUMBER> shreedhar mourato <NUMBER> predicted impact responsibilizing narratives bénabou et al <NUMBER> found ahc narrative increased feeling firms governments responsible significant effect personal responsibility partially line responsibility effect walker et al <NUMBER> one possible explanation people may feel burden personal responsibility solely responsible outcome multiple parties also responsible cryder loewenstein <NUMBER> may give moral wiggle room dana et al <NUMBER> necessarily dampen outrage others perceive guilty increased feeling firms governments responsible may explain subjects supported policies ostensibly affected parties eg bans findings also suggest effect narrative exposure fragile either removing information human cause ac group conversely adding counternarrative ahlc group attenuate effects ac less effective ahc compatible explanation naturalcauses elicit lower responses humancaused problems brown et al <NUMBER> bulte et al <NUMBER> ahlc less effective ahc compatible prediction absolving narratives dampen prosocial behaviour bénabou et al <NUMBER> also supports findings even brief exposure climate conspiracy theories dampen proclimate actions greitemeyer <NUMBER> van der linden <NUMBER> moreover aligns literature suggesting articles presenting duelling experts without sense weight evidence distributed generates greater climate scepticism barrier engagement corbett durfee <NUMBER> lorenzoni et al <NUMBER> corner et al <NUMBER> understanding impact narratives shared online news social media crucial since people increasingly get information public health environmental issues dahlstrom <NUMBER> pearson et al <NUMBER> also important route forming preferences policy issues found ahc narrative linking human destruction nature covid<NUMBER> increases support wildlife conservation policies interestingly narrative rated least familiar subjects although story favoured environmental policymakers results experiment suggest scope use narrative grow public engagement extinction public support key craft durable legitimate longterm policy response covid<NUMBER> concurrently addresses anthropogenic mass wildlife extinction <NUMBER> <NUMBER> table <NUMBER> interaction effect narratives past beliefs origin coronavirus animals ordered logistic models without covariates robust standard errors parentheses ii p <NUMBER> p <NUMBER> p <NUMBER> iii table presents ordered logodds logit regression coefficients interpretation one unit increase predictor response variable level expected change respective regression coefficient ordered logodds scale holding everything else constant iv omitted category control group table <NUMBER> effect narrative outcomes sample didnt forget information treatments robust standard errors parentheses ii p <NUMBER> p <NUMBER> p <NUMBER> iii model <NUMBER> presents logodds coefficient logistic regression model interpretation increase predicted log odds outcome <NUMBER> due oneunit increase predictor holding everything else constant models <NUMBER> <NUMBER> present ordered logodds logit regression coefficients interpretation oneunit increase predictor response variable level expected change respective regression coefficient ordered logodds scale holding everything else constant iv control group omitted category table <NUMBER> effect narrative outcomes subsample trusting bbc robust standard errors parentheses ii p <NUMBER> p <NUMBER> p <NUMBER> iii model <NUMBER> presents logodds coefficient logistic regression model interpretation increase predicted log odds outcome <NUMBER> due oneunit increase predictor holding everything else constant models <NUMBER> <NUMBER> present ordered logodds logit regression coefficients interpretation oneunit increase predictor response variable level expected change respective regression coefficient ordered logodds scale holding everything else constant iv subsample includes reporting yes maybe trusting bbc v control group omitted category covid<NUMBER> respiratory support devices significant logistical challenges providing respiratory support devices beyond simple oxygen flow centres run supplies devices low resource settings peak covid<NUMBER> crisis extremely difficult import medical equipment supplies countries prohibited medical industry selling outside countries consequence engineering teams worldwide volunteered develop emergency devices medical experts mechanical ventilation helped guide design evaluation prototypes although regulations vary among countries given emergency situation regulatory agencies facilitated expedited procedures however laboratory animal model testing crucial minimize potential risk patients treated device may worsen clinical outcome poorly designed misused reader appreciate  reallocation resources needed supply essential medical equipment epidemic outbreak development use emergency devices respiratory support complex interaction healthcare providers patients respiratory support devices essential implement appropriate procedures rapidly evaluate new medical devices including testing training using animal models replicate human disease  lowmiddle income countries due scarcity cpap devices ventilators conducting clinical studies novel covid<NUMBER> emergency devices could contribute saving lives <NUMBER> reassess management respiratory failure affordable straightforward devices provide noninvasive invasive support evaluate effective efficient ways train healthcare providers diverse settings understand correctly use novel devices experience caring hospitalized children covid<NUMBER> barcelona like many places fortunately limited allowed us support initiate projects developing respiratory support devices region beginning outbreak alarming message regarding potential need thousands ventilators areas highest impact outbreak number intensive care unit icu beds multiplied threefold article shares strategies implemented catalonia spain provide respiratory support vast number adult patients admitted hospitals respiratory failure initially many hospitals able convert operating rooms general wards icus using anaesthetic ventilators transport ventilators older ventilators coming laboratories teaching simulation areas noninvasive ventilators also used transiently invasive ventilators pressurecontrolled modes however hospitals resources rapidly exhausted spain national government provides healthcare resources regional authorities regulate use catalonia situated north east corner country barcelona capital local government undertook several key initiatives listed tables <NUMBER> <NUMBER> significant logistical challenges providing respiratory support devices even though devices may become available guarantee provide optimal ventilation especially invasive ventilation need appropriate environment trained staff crucial good outcomes indeed clinical experience bangladesh <NUMBER> mortality pneumonia patients mechanically ventilated picu prompted rct <NUMBER> showed superior results using simplicity safety bubble cpap device built locally low cost <NUMBER> teams engineers biomedical backgrounds concentrated developing simple respiratory devices based resuscitation bags requiring positive endexpiratory pressure peep valves companies medical device experience academic centres developed respiratory devices fulfilling requirements device properly called ventilator mechanical ventilator university centres companies italy canada usa <NUMBER> important stress new devices initially evaluated physiology laboratory using lung simulator case evaluated external peep valve found condensed humidity induced respiration affected behaviour peep valve phenomenon could compromise patient oxygenation moreover inappropriate settings generate rebreathing auto peep problem missed laboratory easily identified blood gas measurements animal vivo testing procedure importantly new emergency device also require troubleshooting checklist likely different used conventional ventilators available hospitals therefore crucial clinicians guidance based problems observed laboratory simulation animals matter acute anxiety generated lack ventilators connecting patient insufficiently tested device may lead morbidity could worse using device additionally certification laboratory assess safety issues electromagnetic compatibility similar required get ce label fortunately even peak epidemic newly developed ventilators required clinical use hence checking clinical performance spain possible ethical reason justify unique opportunity learn whether relatively inexpensive simpler covid<NUMBER> inspired devices could play role lowmiddle income countries mechanical ventilators short supply simply unavailable mentioned ventilator support matter devices available formula<NUMBER> racing possible finish race one car driver nevertheless compete world championship requires seasoned driver replacement cars support team trained engineers mechanics maintenance availability spare parts repairs providing effective mechanical ventilation therapy also requires multidisciplinary welltrained team including health care staff technical support people able service equipment time offer oxygen concentrator lowcost devices improve outcome respiratory failure developing countries open source technology publication <NUMBER> cocreation design approaches involving local partners <NUMBER> training modules onsite healthcare workers technicians engineers needed make difference sufficient commitment globally could finally bring longterm improvements future lowmiddle income countries moving beyond oxygen coronavirus one major pathogens targets primarily human respiratory system earlier coronaviral outbreaks covs include middle east respiratory syndrome merscov severe acute respiratory syndrome sarscov significantly caused great threat human beings december <NUMBER> number patients admitted hospitals initial diagnosis pneumonia patients found epidemiological links wet animal seafood wholesale market wuhan hubei province china <NUMBER> <NUMBER> early studies predicted onset possible coronavirus outbreak <NUMBER>th february <NUMBER> estimated reproduction number covid<NUMBER> significantly largely ranging <NUMBER> <NUMBER> <NUMBER> december <NUMBER> first cases covid<NUMBER> infections reported <NUMBER> <NUMBER>th december <NUMBER> <NUMBER>th december <NUMBER> <NUMBER> patients acute respiratory distress syndrome hospitalized among one patient died <NUMBER> upto <NUMBER> january <NUMBER> <NUMBER> patients identified possess laboratory confirmed covid<NUMBER> infection almost half patients underlying diseases particularly cardiovascular diseases hypertension diabetes <NUMBER> believed patients infected hospital possibly due nosocomial infection thus concluded covid<NUMBER> superhot spreading virus spread many others one patient likely spread many patients get infected unknown mechanisms different locations hospital furthermore patients tested clinically sick probably several patients infected january <NUMBER> <NUMBER> total <NUMBER> covid<NUMBER> infection cases reported <NUMBER> provinces china <NUMBER> upto <NUMBER> january <NUMBER> china national health commission reported details first <NUMBER> deaths <NUMBER>th january <NUMBER> total <NUMBER> covid<NUMBER> infection cases confirmed along <NUMBER> deaths mainland china <NUMBER> another report <NUMBER>th january <NUMBER> estimated <NUMBER> covid<NUMBER> infections china <NUMBER> <NUMBER> first covid<NUMBER> infection case reported <NUMBER>th january <NUMBER> led identification description clinical diagnosis management case included initial mild symptoms patient leaded pneumonia <NUMBER>th day illness <NUMBER> moreover <NUMBER> january <NUMBER> first case covid<NUMBER> humantohuman transmission reported us httpswwwcdc govmediareleases<NUMBER>p<NUMBER> <NUMBER>th april <NUMBER> total number covid <NUMBER> fig <NUMBER> covid<NUMBER> infection symptoms starts appear incubation period <NUMBER> days <NUMBER> wang et al <NUMBER> reported time period onset covid<NUMBER> symptoms death ranges <NUMBER> days <NUMBER>day median time period depends patients immune system age patient found shorter among patients <NUMBER> years age relative <NUMBER> years patients <NUMBER> common symptoms onset infection fatigue cough fever symptoms include lymphopenia haemoptysis headache sputum production diarrhea <NUMBER> chest ct scan reveals pneumonia nevertheless clinical features like acute cardiac injury acute respiratory distress syndrome rnaaemia incidence grandglass opacities leads death <NUMBER> certain cases several peripheral groundglass opacities identified subpleural regions lungs likely induce localized systemic immune response leading increased inflammation <NUMBER> unfortunately interferon inhalation therapy showed therapeutic benefit instead aggravated disorder worsening pulmonary opacity <NUMBER> pertinent mention symptoms earlier betacoronavirus infections covid<NUMBER> bilateral groundglass opacity ct scans dry cough dyspnea fever similar <NUMBER> importantly covid<NUMBER> showed unique clinical features like targeting lower airway evident symptoms like sore throat rhinorrhoea sneezing <NUMBER> <NUMBER> additionally basis chest radiographs results cases found possess infiltrate upper lobe lung associated increasing dyspnea hypoxemia <NUMBER> although covid<NUMBER>infected patients reported gastrointestinal gi symptoms like diarrhoea small percentage sarscov merscov patients experienced similar gi distress hence analyzing faecal urine samples necessary eliminate possible alternative route transmission specifically health care staff patients etc <NUMBER> <NUMBER> therefore development methods identifying different modes transmission feacal urine samples urgently needed establish strategies inhibiting andor reducing transmission developing therapeutics manage disease first four cases acute respiratory syndrome unknown etiology identified among people linked local seafood market wet market wuhan city china <NUMBER> december <NUMBER> <NUMBER> research progress learn covid<NUMBER>related transmissibility frequency features <NUMBER> observed early detected cases kind history interaction seafood market <NUMBER> eventually humantohuman transmission close contact found secondary cause covid<NUMBER> infection rise frequency infected individuals history wildlife exposure visiting wuhan several cases infection identified among medical professionals well <NUMBER> become apparent covid<NUMBER> infection occurs upon exposure virus normal immunosuppressed population seem susceptible adult patients <NUMBER> <NUMBER> years age fewer cases found among children infants <NUMBER> <NUMBER> research dynamics early transmission virus reported median age patients <NUMBER> years ranging <NUMBER> <NUMBER> years majority males <NUMBER> <NUMBER> people low immune function particularly old aged people renal hepatic dysfunction considered high risk group <NUMBER> covid<NUMBER> found higher rates transmissibility pandemic risk sarscov covid<NUMBER>s effective reproductive number r <NUMBER> much higher recorded effective reproductive number r sars <NUMBER> different covid<NUMBER> studies estimated basic reproduction r <NUMBER> ranges <NUMBER> <NUMBER> covid<NUMBER> average incubation duration estimated <NUMBER> ± <NUMBER> ranging <NUMBER> days <NUMBER> chinese health authorities recently reported average incubation <NUMBER> days ranging <NUMBER> days findings epidemiological studies based important indicators summarized table <NUMBER> coronaviruses singlestranded zoonotic rna viruses cause symptoms ranging common cold extreme respiratory enteric hepatic neurological symptoms <NUMBER> <NUMBER> besides sarscov<NUMBER> six coronaviruses reported humans hcovoc<NUMBER> hcov<NUMBER>e sarscov hcovhku<NUMBER> merscov hcovnl<NUMBER> <NUMBER> <NUMBER> last two decades coronavirus caused two major pandemics sars <NUMBER> mers <NUMBER> order find source covid<NUMBER> outbreak cdc researchers china collected <NUMBER> environmental samples huanan seafood market wuhan hubei province found <NUMBER> samples sarscov<NUMBER> suggested came wild animals sold market <NUMBER> researchers also used lung fluid blood throat swab samples <NUMBER> patients laboratory elderly people <NUMBER> people poor immune function people chronic comorbidities <NUMBER> surgery history admission <NUMBER> research laboratory studies revealed virusspecific nucleic acid sequences sample vary known human coronavirus species laboratory findings also showed sars cov<NUMBER> identical beta β coronaviruses genera found bats located sarssarslike cov groups <NUMBER> conduction nextgeneration sequencing cultured isolates bronchoalveolar lavage fluid nine inpatients enrolled researchers wuhan viral pneumonia without common respiratory pathogens results indicated sarscov<NUMBER> distinct merscov approximately <NUMBER> sequence identity sarscov approximately <NUMBER> sequence identity two batderived sarslike coronaviruses batslcovzxc<NUMBER> <NUMBER> sequence identity batslcovzc<NUMBER> <NUMBER> sequence identity <NUMBER> studies also showed covid<NUMBER> sprotein strongly interacted human ace<NUMBER> molecules spite dissimilarity sequence sarscov <NUMBER> <NUMBER> case fatality rate cfr disease fixed varies location time reported cfr covid<NUMBER> varies widely countries ranging <NUMBER> germany <NUMBER> italy may accurate comparison true likelihood particularly like covid<NUMBER> since aware weather criterion testing applied countries many cases symptomatic vs asymptomatic better decision making understand differences cfr need better data however careful acknowledge limitations cfr help us understand pandemic better done combat itthe countries small number confirmed cases till left cfr small sample size significant look towards trajectory case iran <NUMBER>th february <NUMBER> <NUMBER> confirmed cases <NUMBER> deaths implausible cfr <NUMBER> number cases increased hundreds time cfr dropped level seen countries cfr ongoing covid<NUMBER> pandemic represented fig <NUMBER> anticipated probable zoonotic origin covid<NUMBER> based large number infected people exposed wet animal market wuhan city live animals routinely sold efforts made look host reservoir intermediate carriers infection could spread humans <NUMBER> two snake species identified thought possible covid<NUMBER> reservoirs however clear cut evidence reservoirs coronavirus mammals birds till date covid<NUMBER> genomic sequence analysis showed <NUMBER> identity two batderived severe acute respiratory syndrome sarslike coronaviruses suggesting bats likely link covid<NUMBER> humans <NUMBER> several studies indicated transmission person person possible way covid<NUMBER> infection spread observed covid<NUMBER> infection occurred many people even visited wuhans wet animal market <NUMBER> transmission disease person person occurs mainly direct contact droplets released infected person coughing sneezing fig <NUMBER> quickly disease spread country since <NUMBER>th confirmed case study conducted covid<NUMBER> infected women third trimester evidence analyze confirm transmission occur mother child nevertheless pregnant mothers underwent cesarean sections remains uncertain transmission occur vaginal delivery study important pregnant womens comparatively vulnerable respiratory infections extreme pneumonia <NUMBER> first step covid<NUMBER> viral infection binding receptor expressed host cells followed fusion cell membrane lung epithelial cells primary target virus stated humantohuman transmissions sarscov occurs binding cellular receptor known angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor receptorbinding domain virus spikes <NUMBER> important mention receptor binding domain sequence covid<NUMBER> similar sarscov results indicate likely entry host cells ace<NUMBER> receptor <NUMBER> covid<NUMBER> classified β cov group <NUMBER>b world health organization <NUMBER> covid<NUMBER> genome sequencing nine patients showed <NUMBER> sequence identity <NUMBER> another study five patients showed <NUMBER> nucleotide identity sequencing studies revealed presence new betacov strain <NUMBER> covid<NUMBER> genetic sequence showed <NUMBER> identity merscov <NUMBER> sarscov <NUMBER> merscov sarscov originate bats <NUMBER> covid<NUMBER> seventh member coronavirus family infects humans categorized subfamily orthocoronavirinae clade within subgenus sarbecovirus <NUMBER> basis phylogenetic reports genetic sequence studies covid<NUMBER> varies significantly sarscov thus regarded new betacoronavirus infects humans covid<NUMBER> likely developed bat origin coronaviruses another evidence supports covid<NUMBER> bat origin high homology ace<NUMBER> receptor diversity animal species implicating animal species possible intermediate hosts animal models covid<NUMBER> infections <NUMBER> additionally viruses single intact open reading frame gene <NUMBER> another sign batorigin covs nevertheless amino acid sequence receptorbinding domain resembles sarscov indicating viruses might use receptor <NUMBER> complete clinical manifestation yet clear symptoms recorded far vary mild extreme cases even leading death <NUMBER> frequently reported symptoms include coughproducing phlegm runny nose myalgia fever pneumonia complicated dyspnea less widely documented symptoms include headache vomiting hemoptysis <NUMBER> <NUMBER> patients mild symptoms usually recover within week severe cases reported suffer progressive respiratory failure due alveolar damage lead death well <NUMBER> usually elderly patients middle aged patients preexisting diseases coronary heart disease parkinsons disease diabetes hypertension tumor surgery cirrhosis seen prone death <NUMBER> case definition guidelines mentioned following symptoms decrease lymphocytes white blood cells fever new pulmonary infiltrates chest radiography improvement symptoms <NUMBER> days antibiotic treatment <NUMBER> patients suspected infection following techniques diagnosis suggested conducting realtime fluorescence rtpcr detect sarscov<NUMBER> positive nucleic acid sputum throat swabs lower respiratory tract sample secretions <NUMBER> vaccine currently available covid<NUMBER> neither specific antiviral treatment recommended far treatment symptomatic patients severe infection given oxygen therapy cases respiratory failure mechanical ventilation required whereas hemodynamic support important septic shock management <NUMBER>th january <NUMBER> released document summarizing guidelines clinical data obtained treatment previous hcovs epidemics document address steps identification sorting patients serious acute respiratory disease guidelines laboratory diagnosis early supportive therapy monitoring management septic shock respiratory failure methods treatment pregnant patients amongst recommendations focus approaches tackle respiratory failure including safe mechanical ventilation noninvasive ventilation niv highflow nasal oxygen hfno intubation special precautions required professional operator uses personal protective equipments ppe protective goggles disposable double socks disposable gloves ffp <NUMBER> n <NUMBER> mask disposable gown long sleeve raincoat conduct operation rapid sequence intubation rsi performed possible preoxygenation <NUMBER> <NUMBER> performed <NUMBER> minutes using method continuous positive airway pressure cpap heat moisture exchanger hme must located circuit fan mask ventilation balloon mask case mechanical ventilation lower inspiratory pressures reaching plateau pressure pplat <NUMBER> <NUMBER> cm h <NUMBER> lower tidal volumes <NUMBER> <NUMBER> mlkg predicted body weight pbw kept positive end expiratory pressure peep kept high possible maintain driving pressure pplatpeep low possible <NUMBER> cm h <NUMBER> furthermore prevent atelectasis loss peep disconnections ventilator must avoided paralytics recommended pao <NUMBER> fio <NUMBER> <NUMBER> mm hg use conservative fluid management strategy prone ventilation <NUMBER> hours per day patients suffering acute respiratory distress syndrome strongly recommended regard high flow nasal oxygen hfno noninvasive ventilation niv panel experts points approaches performed systems good interface fitting cause widespread dispersion exhaled air use considered low risk airborne transmission <NUMBER> practical sense noninvasive ventilation used non severe forms respiratory failure nevertheless patient improve even worsen within limited period time <NUMBER> hours mechanical ventilation must preferred first broadspectrum antibiotics interferonsα nebulization antiviral drugs used reduce viral load <NUMBER> remdesivir shown promising viral impact <NUMBER> remdesivir alone combination chloroquine βinterferon significantly blocked sarscov<NUMBER> replication patients found recover clinically <NUMBER> several antivirals drugs currently evaluated infection moderate results exhibited favipiravir nitazoxanide ribavirin baricitinib penciclovir ritonavir arbidol tested infection vitro clinical isolates patients <NUMBER> many formulations also tested covid<NUMBER> infections humans mice combinations antibiotic antivral drugs traditional chinese medicines <NUMBER> convalescent plasma therapy also tested doctors shanghai china usa well blood plasma isolated clinically treated covid<NUMBER> patients injected infected patients showed positive results rapid recovery <NUMBER> currently vaccine available covid<NUMBER> infection however vaccines strategies used develop vaccine sarscov effective recombinant dna urbani strain sarscov ay<NUMBER> administered hamsters mice leaded production neutralizing antibodies protection sarscov <NUMBER> <NUMBER> dna found inactivate whole virus livevectored strain sarscov ay<NUMBER> significantly reduced viral infection animal models <NUMBER> <NUMBER> <NUMBER> numerous sarscov strains also used develop inactivated livevectored vaccines effectively reduced viral load animal models strains include bj<NUMBER> ay<NUMBER> <NUMBER> <NUMBER> tor<NUMBER> ay<NUMBER> <NUMBER> <NUMBER> fra ay<NUMBER> <NUMBER> ns<NUMBER> ay<NUMBER> <NUMBER> zj<NUMBER> ay<NUMBER> <NUMBER> gz<NUMBER> ay<NUMBER> <NUMBER> utah ay<NUMBER> <NUMBER> gd<NUMBER> ay<NUMBER> <NUMBER> moreover vaccines sarscov<NUMBER> pipeline chinese centre disease control prevention cdc focusing creating inactivated vaccine viruses <NUMBER> sample mrna based vaccine prepared stermirna therapeutics available soon <NUMBER> geovax bravovax <NUMBER> working formation modified vaccina ankara mva based vaccine clover biopharmaceuticals developing recombinant <NUMBER>ncov protein subunittrimer based vaccine <NUMBER> although research teams around world working explore key characteristics pathogenesis combating disease appropriate attention drawn therapeutic options crossresistance vaccines instance vaccines diseases like measles rubella create crossresistance sarscov<NUMBER> concept cross resistance based findings children found less vulnerable infection compared elder population children predominantly vaccinated measles strategies prevention control reported three levels national level caserelated population level general population level case national level chinas national health commission issued no<NUMBER> announcement officially included covid<NUMBER> management legally infectious diseases class b allowed class infectious disease preventive control measures implemented <NUMBER> policy medical institutes adopt observation protocols isolation treatment prevent control spread covid<NUMBER> china national health commission issued national guidelines prevention control covid<NUMBER> infection <NUMBER> january <NUMBER> medical institutes prevent nosocomial infection <NUMBER> <NUMBER> january <NUMBER> chinese spring festival national health commission released guidelines rapid prevention control measures effectively contain spread disease major isolation great disinfection program <NUMBER> nationallevel policies targeted measures elderly population published <NUMBER> january <NUMBER> rural areas released <NUMBER> january <NUMBER> also released <NUMBER> several public health interventions implemented avoid delay covid<NUMBER> transmission include case isolation identification surveillance contacts environmental disinfection use personal protective equipments <NUMBER> specific antiviral therapy confirmed covid<NUMBER> infection regard patients diagnosed covid<NUMBER> recommended appropriate symptomatic treatment supportive care applied <NUMBER> studies also reported prevention psychological health issues nosocomial infection associated covid series measures suggested minimize nosocomial infection including awareness training prevention control isolation disinfection protection different levels infection areas protection reported cases <NUMBER> respect psychological health suggested psychological interventions set medical staff suspected cases confirmed cases <NUMBER> since vaccine preventing covid<NUMBER> moment best prevention general population avoid exposure virus <NUMBER> airborne measures protections discussed suggested protection infection prevention control measures minimize risk exposure include use face masks covering coughs sneezes tissues safely disposed regular hand wash soap disinfection hand sanitizer <NUMBER> alcohol maintaining appropriate distance much possible avoidance contact infected people refraining touching nose mouth eyes unwashed hands <NUMBER> also released detailed recommendations use face masks within population home care covid<NUMBER> health care settings <NUMBER> health care staff advised use particulate respirators licensed n <NUMBER> ffp <NUMBER> conducting aerosolgenerating procedures use surgical masks providing treatment suspected confirmed cases per guidelines individual without respiratory symptoms public required wear medical mask avoid increase risk transmission proper use disposal masks important <NUMBER> addition papers published scientific journals china cdc provided guidelines raise awareness among general public prevention control covid<NUMBER> guidelines main messages include causes choose wear face masks proper hand washing practices preventive measures different locations eg home public transportation public space methods disinfection home medical monitoring <NUMBER> addition scientific knowledge treat outbreak covid<NUMBER> guidelines also recommends ways reducing fear among general population <NUMBER> animal models play crucial role uncovering mechanisms viral pathogenicity entrance transmission scheming therapeutic strategies previously various animal models used examining replication sarscov showed symptoms severe infection <NUMBER> case merscov pathogenesis observed small animals seen case sarscov mice found susceptible merscoronavirus infection noncompatibility dpp <NUMBER> receptor <NUMBER> entire genome covid<NUMBER> <NUMBER> similar previous human sarslike bat cov hence animal models previously used sarscov may useful study pathogenicity covid<NUMBER> novel coronaviruses sars recognize human ace <NUMBER> cell receptor conclusively talen crisprmediated genetically modified hamsters small animals may used test pathogenicity novel coronaviruses observed sarscov mutation spike glycoprotein replicate cause severe disease rats f<NUMBER> <NUMBER> thus spike glycoprotein targeting therapeutics suitable option coronaviruses recent studies formulate therapeutic strategy covid<NUMBER> clinical isolates mice models used <NUMBER> artificial intelligence prediction also used similar studies investigate inhibitory role drug sarscov<NUMBER> <NUMBER> randomized clinical trials also used covid<NUMBER> patients <NUMBER> essential scientists worldwide collaborate design effective model investigate vivo mechanisms associated covid<NUMBER> pathogenesis combating current outbreak requires rigorous steps reduce transmission covid<NUMBER> infection person person special attention efforts applied protecting reducing transmission vulnerable populations including infants health care providers elderly medical personnel health care professionals public health individuals researchers involved <NUMBER>ncov guidelines follow published <NUMBER> early death cases covid<NUMBER> outbreak occurred mainly elderly possibly due poor immune system allows rapid progression viral infection <NUMBER> decontaminating regents provided public services facilities regularly physical contact contaminated things particularly urine facecal samples considered dealing virus potentially serve alternative route transmission <NUMBER> countries around world particularly us china india uae etc implemented major control prevention measures like implementing state wise country wise lockdown travel screenings control virus spread epidemiological changes occurring covid<NUMBER> infection monitored carefully taking account potential transmission routes subclinical infections well adaptation evolution possible intermediate animals reservoir spread virus among humans large number issues still remain addressed many tested percentage came positive weather rate remains constant varies proposition people tested positive covid<NUMBER> showed clinical symptoms far paediatric cases reported real lack susceptibility due inadequate testing coronavirus one major pathogens targets primarily human respiratory system earlier coronaviral outbreaks covs include middle east respiratory syndrome merscov severe acute respiratory syndrome sarscov significantly caused great threat human beings december <NUMBER> number patients admitted hospitals initial diagnosis pneumonia patients found epidemiological links wet animal seafood wholesale market wuhan hubei province china <NUMBER> <NUMBER> early studies predicted onset possible coronavirus outbreak <NUMBER>th february <NUMBER> estimated reproduction number covid<NUMBER> significantly largely ranging <NUMBER> <NUMBER> <NUMBER> december <NUMBER> first cases covid<NUMBER> infections reported <NUMBER> <NUMBER>th december <NUMBER> <NUMBER>th december <NUMBER> <NUMBER> patients acute respiratory distress syndrome hospitalized among one patient died <NUMBER> upto <NUMBER> january <NUMBER> <NUMBER> patients identified possess laboratory confirmed covid<NUMBER> infection almost half patients underlying diseases particularly cardiovascular diseases hypertension diabetes <NUMBER> believed patients infected hospital possibly due nosocomial infection thus concluded covid<NUMBER> superhot spreading virus spread many others one patient likely spread many patients get infected unknown mechanisms different locations hospital furthermore patients tested clinically sick probably several patients infected january <NUMBER> <NUMBER> total <NUMBER> covid<NUMBER> infection cases reported <NUMBER> provinces china <NUMBER> upto <NUMBER> january <NUMBER> china national health commission reported details first <NUMBER> deaths <NUMBER>th january <NUMBER> total <NUMBER> covid<NUMBER> infection cases confirmed along <NUMBER> deaths mainland china <NUMBER> another report <NUMBER>th january <NUMBER> estimated <NUMBER> covid<NUMBER> infections china <NUMBER> <NUMBER> first covid<NUMBER> infection case reported <NUMBER>th january <NUMBER> led identification description clinical diagnosis management case included initial mild symptoms patient leaded pneumonia <NUMBER>th day illness <NUMBER> moreover <NUMBER> january <NUMBER> first case covid<NUMBER> humantohuman transmission reported us httpswwwcdc govmediareleases<NUMBER>p<NUMBER> <NUMBER>th april <NUMBER> total number covid <NUMBER> fig <NUMBER> covid<NUMBER> infection symptoms starts appear incubation period <NUMBER> days <NUMBER> wang et al <NUMBER> reported time period onset covid<NUMBER> symptoms death ranges <NUMBER> days <NUMBER>day median time period depends patients immune system age patient found shorter among patients <NUMBER> years age relative <NUMBER> years patients <NUMBER> common symptoms onset infection fatigue cough fever symptoms include lymphopenia haemoptysis headache sputum production diarrhea <NUMBER> chest ct scan reveals pneumonia nevertheless clinical features like acute cardiac injury acute respiratory distress syndrome rnaaemia incidence grandglass opacities leads death <NUMBER> certain cases several peripheral groundglass opacities identified subpleural regions lungs likely induce localized systemic immune response leading increased inflammation <NUMBER> unfortunately interferon inhalation therapy showed therapeutic benefit instead aggravated disorder worsening pulmonary opacity <NUMBER> pertinent mention symptoms earlier betacoronavirus infections covid<NUMBER> bilateral groundglass opacity ct scans dry cough dyspnea fever similar <NUMBER> importantly covid<NUMBER> showed unique clinical features like targeting lower airway evident symptoms like sore throat rhinorrhoea sneezing <NUMBER> <NUMBER> additionally basis chest radiographs results cases found possess infiltrate upper lobe lung associated increasing dyspnea hypoxemia <NUMBER> although covid<NUMBER>infected patients reported gastrointestinal gi symptoms like diarrhoea small percentage sarscov merscov patients experienced similar gi distress hence analyzing faecal urine samples necessary eliminate possible alternative route transmission specifically health care staff patients etc <NUMBER> <NUMBER> therefore development methods identifying different modes transmission feacal urine samples urgently needed establish strategies inhibiting andor reducing transmission developing therapeutics manage disease first four cases acute respiratory syndrome unknown etiology identified among people linked local seafood market wet market wuhan city china <NUMBER> december <NUMBER> <NUMBER> research progress learn covid<NUMBER>related transmissibility frequency features <NUMBER> observed early detected cases kind history interaction seafood market <NUMBER> eventually humantohuman transmission close contact found secondary cause covid<NUMBER> infection rise frequency infected individuals history wildlife exposure visiting wuhan several cases infection identified among medical professionals well <NUMBER> become apparent covid<NUMBER> infection occurs upon exposure virus normal immunosuppressed population seem susceptible adult patients <NUMBER> <NUMBER> years age fewer cases found among children infants <NUMBER> <NUMBER> research dynamics early transmission virus reported median age patients <NUMBER> years ranging <NUMBER> <NUMBER> years majority males <NUMBER> <NUMBER> people low immune function particularly old aged people renal hepatic dysfunction considered high risk group <NUMBER> covid<NUMBER> found higher rates transmissibility pandemic risk sarscov covid<NUMBER>s effective reproductive number r <NUMBER> much higher recorded effective reproductive number r sars <NUMBER> different covid<NUMBER> studies estimated basic reproduction r <NUMBER> ranges <NUMBER> <NUMBER> covid<NUMBER> average incubation duration estimated <NUMBER> ± <NUMBER> ranging <NUMBER> days <NUMBER> chinese health authorities recently reported average incubation <NUMBER> days ranging <NUMBER> days findings epidemiological studies based important indicators summarized table <NUMBER> coronaviruses singlestranded zoonotic rna viruses cause symptoms ranging common cold extreme respiratory enteric hepatic neurological symptoms <NUMBER> <NUMBER> besides sarscov<NUMBER> six coronaviruses reported humans hcovoc<NUMBER> hcov<NUMBER>e sarscov hcovhku<NUMBER> merscov hcovnl<NUMBER> <NUMBER> <NUMBER> last two decades coronavirus caused two major pandemics sars <NUMBER> mers <NUMBER> order find source covid<NUMBER> outbreak cdc researchers china collected <NUMBER> environmental samples huanan seafood market wuhan hubei province found <NUMBER> samples sarscov<NUMBER> suggested came wild animals sold market <NUMBER> researchers also used lung fluid blood throat swab samples <NUMBER> patients laboratory elderly people <NUMBER> people poor immune function people chronic comorbidities <NUMBER> surgery history admission <NUMBER> research laboratory studies revealed virusspecific nucleic acid sequences sample vary known human coronavirus species laboratory findings also showed sars cov<NUMBER> identical beta β coronaviruses genera found bats located sarssarslike cov groups <NUMBER> conduction nextgeneration sequencing cultured isolates bronchoalveolar lavage fluid nine inpatients enrolled researchers wuhan viral pneumonia without common respiratory pathogens results indicated sarscov<NUMBER> distinct merscov approximately <NUMBER> sequence identity sarscov approximately <NUMBER> sequence identity two batderived sarslike coronaviruses batslcovzxc<NUMBER> <NUMBER> sequence identity batslcovzc<NUMBER> <NUMBER> sequence identity <NUMBER> studies also showed covid<NUMBER> sprotein strongly interacted human ace<NUMBER> molecules spite dissimilarity sequence sarscov <NUMBER> <NUMBER> case fatality rate cfr disease fixed varies location time reported cfr covid<NUMBER> varies widely countries ranging <NUMBER> germany <NUMBER> italy may accurate comparison true likelihood particularly like covid<NUMBER> since aware weather criterion testing applied countries many cases symptomatic vs asymptomatic better decision making understand differences cfr need better data however careful acknowledge limitations cfr help us understand pandemic better done combat itthe countries small number confirmed cases till left cfr small sample size significant look towards trajectory case iran <NUMBER>th february <NUMBER> <NUMBER> confirmed cases <NUMBER> deaths implausible cfr <NUMBER> number cases increased hundreds time cfr dropped level seen countries cfr ongoing covid<NUMBER> pandemic represented fig <NUMBER> anticipated probable zoonotic origin covid<NUMBER> based large number infected people exposed wet animal market wuhan city live animals routinely sold efforts made look host reservoir intermediate carriers infection could spread humans <NUMBER> two snake species identified thought possible covid<NUMBER> reservoirs however clear cut evidence reservoirs coronavirus mammals birds till date covid<NUMBER> genomic sequence analysis showed <NUMBER> identity two batderived severe acute respiratory syndrome sarslike coronaviruses suggesting bats likely link covid<NUMBER> humans <NUMBER> several studies indicated transmission person person possible way covid<NUMBER> infection spread observed covid<NUMBER> infection occurred many people even visited wuhans wet animal market <NUMBER> transmission disease person person occurs mainly direct contact droplets released infected person coughing sneezing fig <NUMBER> quickly disease spread country since <NUMBER>th confirmed case study conducted covid<NUMBER> infected women third trimester evidence analyze confirm transmission occur mother child nevertheless pregnant mothers underwent cesarean sections remains uncertain transmission occur vaginal delivery study important pregnant womens comparatively vulnerable respiratory infections extreme pneumonia <NUMBER> first step covid<NUMBER> viral infection binding receptor expressed host cells followed fusion cell membrane lung epithelial cells primary target virus stated humantohuman transmissions sarscov occurs binding cellular receptor known angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor receptorbinding domain virus spikes <NUMBER> important mention receptor binding domain sequence covid<NUMBER> similar sarscov results indicate likely entry host cells ace<NUMBER> receptor <NUMBER> covid<NUMBER> classified β cov group <NUMBER>b world health organization <NUMBER> covid<NUMBER> genome sequencing nine patients showed <NUMBER> sequence identity <NUMBER> another study five patients showed <NUMBER> nucleotide identity sequencing studies revealed presence new betacov strain <NUMBER> covid<NUMBER> genetic sequence showed <NUMBER> identity merscov <NUMBER> sarscov <NUMBER> merscov sarscov originate bats <NUMBER> covid<NUMBER> seventh member coronavirus family infects humans categorized subfamily orthocoronavirinae clade within subgenus sarbecovirus <NUMBER> basis phylogenetic reports genetic sequence studies covid<NUMBER> varies significantly sarscov thus regarded new betacoronavirus infects humans covid<NUMBER> likely developed bat origin coronaviruses another evidence supports covid<NUMBER> bat origin high homology ace<NUMBER> receptor diversity animal species implicating animal species possible intermediate hosts animal models covid<NUMBER> infections <NUMBER> additionally viruses single intact open reading frame gene <NUMBER> another sign batorigin covs nevertheless amino acid sequence receptorbinding domain resembles sarscov indicating viruses might use receptor <NUMBER> complete clinical manifestation yet clear symptoms recorded far vary mild extreme cases even leading death <NUMBER> frequently reported symptoms include coughproducing phlegm runny nose myalgia fever pneumonia complicated dyspnea less widely documented symptoms include headache vomiting hemoptysis <NUMBER> <NUMBER> patients mild symptoms usually recover within week severe cases reported suffer progressive respiratory failure due alveolar damage lead death well <NUMBER> usually elderly patients middle aged patients preexisting diseases coronary heart disease parkinsons disease diabetes hypertension tumor surgery cirrhosis seen prone death <NUMBER> case definition guidelines mentioned following symptoms decrease lymphocytes white blood cells fever new pulmonary infiltrates chest radiography improvement symptoms <NUMBER> days antibiotic treatment <NUMBER> patients suspected infection following techniques diagnosis suggested conducting realtime fluorescence rtpcr detect sarscov<NUMBER> positive nucleic acid sputum throat swabs lower respiratory tract sample secretions <NUMBER> vaccine currently available covid<NUMBER> neither specific antiviral treatment recommended far treatment symptomatic patients severe infection given oxygen therapy cases respiratory failure mechanical ventilation required whereas hemodynamic support important septic shock management <NUMBER>th january <NUMBER> released document summarizing guidelines clinical data obtained treatment previous hcovs epidemics document address steps identification sorting patients serious acute respiratory disease guidelines laboratory diagnosis early supportive therapy monitoring management septic shock respiratory failure methods treatment pregnant patients amongst recommendations focus approaches tackle respiratory failure including safe mechanical ventilation noninvasive ventilation niv highflow nasal oxygen hfno intubation special precautions required professional operator uses personal protective equipments ppe protective goggles disposable double socks disposable gloves ffp <NUMBER> n <NUMBER> mask disposable gown long sleeve raincoat conduct operation rapid sequence intubation rsi performed possible preoxygenation <NUMBER> <NUMBER> performed <NUMBER> minutes using method continuous positive airway pressure cpap heat moisture exchanger hme must located circuit fan mask ventilation balloon mask case mechanical ventilation lower inspiratory pressures reaching plateau pressure pplat <NUMBER> <NUMBER> cm h <NUMBER> lower tidal volumes <NUMBER> <NUMBER> mlkg predicted body weight pbw kept positive end expiratory pressure peep kept high possible maintain driving pressure pplatpeep low possible <NUMBER> cm h <NUMBER> furthermore prevent atelectasis loss peep disconnections ventilator must avoided paralytics recommended pao <NUMBER> fio <NUMBER> <NUMBER> mm hg use conservative fluid management strategy prone ventilation <NUMBER> hours per day patients suffering acute respiratory distress syndrome strongly recommended regard high flow nasal oxygen hfno noninvasive ventilation niv panel experts points approaches performed systems good interface fitting cause widespread dispersion exhaled air use considered low risk airborne transmission <NUMBER> practical sense noninvasive ventilation used non severe forms respiratory failure nevertheless patient improve even worsen within limited period time <NUMBER> hours mechanical ventilation must preferred first broadspectrum antibiotics interferonsα nebulization antiviral drugs used reduce viral load <NUMBER> remdesivir shown promising viral impact <NUMBER> remdesivir alone combination chloroquine βinterferon significantly blocked sarscov<NUMBER> replication patients found recover clinically <NUMBER> several antivirals drugs currently evaluated infection moderate results exhibited favipiravir nitazoxanide ribavirin baricitinib penciclovir ritonavir arbidol tested infection vitro clinical isolates patients <NUMBER> many formulations also tested covid<NUMBER> infections humans mice combinations antibiotic antivral drugs traditional chinese medicines <NUMBER> convalescent plasma therapy also tested doctors shanghai china usa well blood plasma isolated clinically treated covid<NUMBER> patients injected infected patients showed positive results rapid recovery <NUMBER> currently vaccine available covid<NUMBER> infection however vaccines strategies used develop vaccine sarscov effective recombinant dna urbani strain sarscov ay<NUMBER> administered hamsters mice leaded production neutralizing antibodies protection sarscov <NUMBER> <NUMBER> dna found inactivate whole virus livevectored strain sarscov ay<NUMBER> significantly reduced viral infection animal models <NUMBER> <NUMBER> <NUMBER> numerous sarscov strains also used develop inactivated livevectored vaccines effectively reduced viral load animal models strains include bj<NUMBER> ay<NUMBER> <NUMBER> <NUMBER> tor<NUMBER> ay<NUMBER> <NUMBER> <NUMBER> fra ay<NUMBER> <NUMBER> ns<NUMBER> ay<NUMBER> <NUMBER> zj<NUMBER> ay<NUMBER> <NUMBER> gz<NUMBER> ay<NUMBER> <NUMBER> utah ay<NUMBER> <NUMBER> gd<NUMBER> ay<NUMBER> <NUMBER> moreover vaccines sarscov<NUMBER> pipeline chinese centre disease control prevention cdc focusing creating inactivated vaccine viruses <NUMBER> sample mrna based vaccine prepared stermirna therapeutics available soon <NUMBER> geovax bravovax <NUMBER> working formation modified vaccina ankara mva based vaccine clover biopharmaceuticals developing recombinant <NUMBER>ncov protein subunittrimer based vaccine <NUMBER> although research teams around world working explore key characteristics pathogenesis combating disease appropriate attention drawn therapeutic options crossresistance vaccines instance vaccines diseases like measles rubella create crossresistance sarscov<NUMBER> concept cross resistance based findings children found less vulnerable infection compared elder population children predominantly vaccinated measles strategies prevention control reported three levels national level caserelated population level general population level case national level chinas national health commission issued no<NUMBER> announcement officially included covid<NUMBER> management legally infectious diseases class b allowed class infectious disease preventive control measures implemented <NUMBER> policy medical institutes adopt observation protocols isolation treatment prevent control spread covid<NUMBER> china national health commission issued national guidelines prevention control covid<NUMBER> infection <NUMBER> january <NUMBER> medical institutes prevent nosocomial infection <NUMBER> <NUMBER> january <NUMBER> chinese spring festival national health commission released guidelines rapid prevention control measures effectively contain spread disease major isolation great disinfection program <NUMBER> nationallevel policies targeted measures elderly population published <NUMBER> january <NUMBER> rural areas released <NUMBER> january <NUMBER> also released <NUMBER> several public health interventions implemented avoid delay covid<NUMBER> transmission include case isolation identification surveillance contacts environmental disinfection use personal protective equipments <NUMBER> specific antiviral therapy confirmed covid<NUMBER> infection regard patients diagnosed covid<NUMBER> recommended appropriate symptomatic treatment supportive care applied <NUMBER> studies also reported prevention psychological health issues nosocomial infection associated covid series measures suggested minimize nosocomial infection including awareness training prevention control isolation disinfection protection different levels infection areas protection reported cases <NUMBER> respect psychological health suggested psychological interventions set medical staff suspected cases confirmed cases <NUMBER> since vaccine preventing covid<NUMBER> moment best prevention general population avoid exposure virus <NUMBER> airborne measures protections discussed suggested protection infection prevention control measures minimize risk exposure include use face masks covering coughs sneezes tissues safely disposed regular hand wash soap disinfection hand sanitizer <NUMBER> alcohol maintaining appropriate distance much possible avoidance contact infected people refraining touching nose mouth eyes unwashed hands <NUMBER> also released detailed recommendations use face masks within population home care covid<NUMBER> health care settings <NUMBER> health care staff advised use particulate respirators licensed n <NUMBER> ffp <NUMBER> conducting aerosolgenerating procedures use surgical masks providing treatment suspected confirmed cases per guidelines individual without respiratory symptoms public required wear medical mask avoid increase risk transmission proper use disposal masks important <NUMBER> addition papers published scientific journals china cdc provided guidelines raise awareness among general public prevention control covid<NUMBER> guidelines main messages include causes choose wear face masks proper hand washing practices preventive measures different locations eg home public transportation public space methods disinfection home medical monitoring <NUMBER> addition scientific knowledge treat outbreak covid<NUMBER> guidelines also recommends ways reducing fear among general population <NUMBER> animal models play crucial role uncovering mechanisms viral pathogenicity entrance transmission scheming therapeutic strategies previously various animal models used examining replication sarscov showed symptoms severe infection <NUMBER> case merscov pathogenesis observed small animals seen case sarscov mice found susceptible merscoronavirus infection noncompatibility dpp <NUMBER> receptor <NUMBER> entire genome covid<NUMBER> <NUMBER> similar previous human sarslike bat cov hence animal models previously used sarscov may useful study pathogenicity covid<NUMBER> novel coronaviruses sars recognize human ace <NUMBER> cell receptor conclusively talen crisprmediated genetically modified hamsters small animals may used test pathogenicity novel coronaviruses observed sarscov mutation spike glycoprotein replicate cause severe disease rats f<NUMBER> <NUMBER> thus spike glycoprotein targeting therapeutics suitable option coronaviruses recent studies formulate therapeutic strategy covid<NUMBER> clinical isolates mice models used <NUMBER> artificial intelligence prediction also used similar studies investigate inhibitory role drug sarscov<NUMBER> <NUMBER> randomized clinical trials also used covid<NUMBER> patients <NUMBER> essential scientists worldwide collaborate design effective model investigate vivo mechanisms associated covid<NUMBER> pathogenesis combating current outbreak requires rigorous steps reduce transmission covid<NUMBER> infection person person special attention efforts applied protecting reducing transmission vulnerable populations including infants health care providers elderly medical personnel health care professionals public health individuals researchers involved <NUMBER>ncov guidelines follow published <NUMBER> early death cases covid<NUMBER> outbreak occurred mainly elderly possibly due poor immune system allows rapid progression viral infection <NUMBER> decontaminating regents provided public services facilities regularly physical contact contaminated things particularly urine facecal samples considered dealing virus potentially serve alternative route transmission <NUMBER> countries around world particularly us china india uae etc implemented major control prevention measures like implementing state wise country wise lockdown travel screenings control virus spread epidemiological changes occurring covid<NUMBER> infection monitored carefully taking account potential transmission routes subclinical infections well adaptation evolution possible intermediate animals reservoir spread virus among humans large number issues still remain addressed many tested percentage came positive weather rate remains constant varies proposition people tested positive covid<NUMBER> showed clinical symptoms far paediatric cases reported real lack susceptibility due inadequate testing n u c r p <NUMBER> source <NUMBER> severe acute respiratory syndrome sars epidemic traced civets live animal markets ultimately chinese horseshoe bats wild <NUMBER> <NUMBER> <NUMBER> epidemiological significance large number bat sarsrelated coronaviruses subsequently found horseshoe bat species fully appreciated last <NUMBER> years <NUMBER> <NUMBER> late <NUMBER> infection due novel betacoronavirus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> phylogenetically close bat sarsrelated coronaviruses reported patients epidemiological link market wild mammal trade wuhan china <NUMBER> <NUMBER> <NUMBER> disease <NUMBER> covid<NUMBER> initially recognized acute febrile pneumonia lymphopenia multifocal peripheral ground glass changes thoracic computerized tomography <NUMBER> <NUMBER> covid<NUMBER> often selflimiting may severe manifestations silent asymptomatic sudden collapse hypoxia acute respiratory distress syndrome ards thrombocytopenia disseminated intravascular coagulation diffuse microvascular thrombosis deep venous thrombosis pulmonary embolism andor multiorgan failure <NUMBER> <NUMBER> <NUMBER> <NUMBER> gastrointestinal manifestations diarrhea neurological manifestations meningoencephalitis guillainbarré syndrome kawasaki syndromelike multisystemic inflammatory disorder children also reported <NUMBER> <NUMBER> <NUMBER> however symptomatic patients mild moderate respiratory illness manifestations rhinorrhea sore throat cough conjunctivitis anosmia ageusia <NUMBER> <NUMBER> furthermore high proportion patients covid<NUMBER> subclinical infections believed enable efficient persontoperson transmission community hospital settings renders symptom screening borders ineffective entails extensive testing isolation infected individuals require laborintensive contact tracing measures necessitates social distancing lockdowns result ongoing c c e p e n u c r p <NUMBER> pandemic already affected <NUMBER> million patients <NUMBER> deaths <NUMBER> months <NUMBER> although covid<NUMBER> believed transmitted respiratory droplet direct indirect contact clear experimental evidence reported based silico estimates binding affinity angiotensinconverting enzyme <NUMBER> ace<NUMBER> common laboratory mammals receptorbinding domain surface spike protein sarscov<NUMBER> recently established golden syrian hamster model covid<NUMBER> <NUMBER> sarscov<NUMBER>infected hamsters developed clinical signs rapid breathing weight loss histopathological changes ards <NUMBER> using animal model showed sarscov<NUMBER>challenged index hamsters consistently infected cohoused naïve hamsters confirming virus transmission direct indirect contact <NUMBER> however controversies whether transmission respiratory droplets airborne droplet nuclei whether wearing surgical mask virus shedder susceptible individual useful prevention transmission still unsettled study using hamster model covid<NUMBER> confirmed noncontact transmission sarscov<NUMBER> could potentially prevented surgical mask worn infected susceptible host sarscov<NUMBER> isolated nasopharyngeal aspirate specimen laboratoryconfirmed covid<NUMBER> patient hong kong <NUMBER> plaque purified viral isolate amplified one additional passage veroe<NUMBER> cells make working stocks virus described previously <NUMBER> experiments involving live sarscov<NUMBER> followed approved standard operating procedures biosafety level bsl<NUMBER> facility university hong kong hku <NUMBER> <NUMBER> c c e p e n u c r p <NUMBER> approval obtained hku committee use live animals teaching research male female syrian hamsters aged <NUMBER> weeks old obtained chinese university hong kong laboratory animal service centre hku laboratory animal unit animals kept bsl<NUMBER> housing given access standard pellet feed water ad libitum virus challenge bsl<NUMBER> animal facility animal rooms kept <NUMBER>°c <NUMBER> humidity study transmissibility sarscov<NUMBER> among hamsters noncontact transmission housed sarscov<NUMBER>challenged index hamsters naïve hamsters together closed systems closed systems kept isolators tecniplast spa varese italy prevent leakage contaminated air external environment figure <NUMBER>a three sets experiments conducted using isolator noncontact transmission model first experiment mask partition placed two cages system investigate whether noncontact transmission occurred among hamsters figure <NUMBER> total five systems housing <NUMBER> hamsters included first experiment second experiment simulate situation surgical masks worn sarscov<NUMBER>infected person fully knitted partition layer using surgical mask placed polyvinyl chloride air porous partition cages outer fluidrepellent layer blue side facing exposednaïve hamsters prevent emitted respiratory droplets containing sarscov<NUMBER> challenged index hamster reaching exposed naïve hamsters figure <NUMBER>a total four systems housing <NUMBER> hamsters included second experiment third experiment simulate situation close contacts sarscov<NUMBER>infected person wear surgical masks surgical mask partition outer fluidrepellent layer blue side facing challenged index hamsters placed polyvinyl chloride air porous partition cages prevent droplets containing sarscov<NUMBER> emitted challenged index hamster reaching exposed naïve hamsters figure <NUMBER>b total four systems housing <NUMBER> hamsters included third experiment air velocities challenged index hamsters cage expose naïve hamsters cage three experiments shown table <NUMBER> day <NUMBER> challenge dose <NUMBER>µl dulbeccos modified eagle medium dmem containing <NUMBER> <NUMBER> plaqueforming units sarscov<NUMBER> intranasally inoculated index hamster system intraperitoneal ketamine <NUMBER>mgkg xylazine <NUMBER>mgkg anaesthesia described previously <NUMBER> twentyfour hours later three naïve hamsters transferred cage adjacent exposed cage housing viruschallenged index hamster per system animals monitored daily clinical signs disease two c c e p e n u c r p <NUMBER> three exposed naïve hamsters system sacrificed <NUMBER> days postinoculation dpi <NUMBER> days exposure challenged index animal remaining exposed naïve animal system sacrificed <NUMBER>dpi animals organ tissues necropsy separated two parts one immediately fixed <NUMBER> pbsbuffered formalin histopathological analysis immediately frozen <NUMBER>°c use viral load studies described previously <NUMBER> <NUMBER> <NUMBER> serum samples used neutralizing antibody detection described previously <NUMBER> compare histopathological changes <NUMBER>dpi additional control sarscov<NUMBER>challenged hamster sacrificed <NUMBER>dpi data analysed graphpad prism software graphpad softwareinc fishers exact test used compare rate infection different groups hamsters without surgical mask partition students ttest used determine significant differences clinical scores virus loads different groups <NUMBER> p<NUMBER> considered statistically significant consistent previous findings <NUMBER> n<NUMBER> <NUMBER> <NUMBER> experiments <NUMBER> <NUMBER> <NUMBER> respectively sarscov<NUMBER>challenged index hamsters developed clinical signs lethargy ruffled furs hunched back posture rapid breathing starting <NUMBER>dpi virological histological evidence infection <NUMBER> first experiment six ten <NUMBER> exposed naïve hamsters sacrificed <NUMBER>dpi <NUMBER> days exposure also developed similar clinical signs overall mean clinical score <NUMBER> exposed naïve hamsters <NUMBER>±<NUMBER> table <NUMBER> <NUMBER> naïve hamsters developed clinical signs confirmed infected c c e p e n u c r p <NUMBER> sarscov<NUMBER> evidenced positive rtpcr results table <NUMBER> viral loads ranged around <NUMBER> <NUMBER> genome copiesβactin nasal turbinate <NUMBER> <NUMBER> genome copiesβactin trachea <NUMBER> <NUMBER> genome copiesβactin lung figure <NUMBER>a <NUMBER> dpi <NUMBER> days exposure remaining <NUMBER> naïve hamsters mean clinical score <NUMBER>±<NUMBER> four five <NUMBER> exposed naïve hamsters found infected viral loads around <NUMBER> <NUMBER> genome copiesβactin nasal turbinate <NUMBER> <NUMBER> genome copiesβactin trachea <NUMBER> <NUMBER> genome copiesβactin lung figure <NUMBER>b none index naïve hamsters died demonstrated noncontact transmission sarscov<NUMBER> occurred among hamsters model next investigated effectiveness surgical mask partition reduce risk noncontact transmission surgical mask partition cages installed external fluidrepelling surface facing exposed naïve hamsters challenged index hamsters mimic situation mask worn index hamsters exposed naïve contact hamsters respectively second experiment external surface mask facing naïve hamsters <NUMBER> dpi <NUMBER> days exposure two three naïve hamsters system n<NUMBER> sacrificed <NUMBER> <NUMBER> <NUMBER> naïve hamsters sarscov<NUMBER> rtpcrpositive table <NUMBER> viral loads hamster <NUMBER> nasal turbinate <NUMBER> trachea <NUMBER> lung genome copiesβactin figure <NUMBER>a <NUMBER> dpi remaining exposed naïve hamster n<NUMBER> sarscov<NUMBER>challenged index hamster n<NUMBER> system also sacrificed one four <NUMBER> remaining naïve hamsters rtpcrpositive viral loads around <NUMBER> lung <NUMBER> nasal turbinate genome copiesβactin c c e p e n u c r p <NUMBER> figure <NUMBER>b transmission rate <NUMBER> significantly p<NUMBER> lower exposed naïve hamsters without surgical mask partition <NUMBER> third experiment external surface mask facing challenged index hamsters <NUMBER> dpi <NUMBER> days exposure two three naïve hamsters system n<NUMBER> sacrificed three <NUMBER> <NUMBER> exposed naïve hamsters developed clinical signs sarscov<NUMBER> rtpcr positive table <NUMBER> viral loads ranged around <NUMBER> <NUMBER> genome copiesβactin nasal turbinate <NUMBER> <NUMBER> trachea genome copiesβactin <NUMBER> <NUMBER> genome copiesβactin lung figure <NUMBER>a <NUMBER> dpi remaining exposed naïve hamster n<NUMBER> challenged index hamster n<NUMBER> system also sacrificed one four <NUMBER> remaining naïve hamsters rtpcr positive viral loads around <NUMBER> lung <NUMBER> nasal turbinate genome copiesβactin figure <NUMBER>b transmission rate <NUMBER> also lower exposed naïve hamsters without surgical mask partition <NUMBER> although reaching statistical significance p<NUMBER> <NUMBER> dpi <NUMBER> days exposure naïve hamsters challenged index hamsters challenged index hamsters n<NUMBER> exhibited high titers serum neutralizing antibodies ranging <NUMBER> ≥<NUMBER> consistent previous observation figure <NUMBER> interestingly three five exposed <NUMBER> naïve hamsters without surgical mask partition sacrificed <NUMBER> dpi also developed serum neutralizing antibody titers <NUMBER> <NUMBER> suggested three rtpcrpositive infected naive hamsters likely acquired virus early exposure challenged index hamsters required <NUMBER> <NUMBER> days serum neutralizing antibodies detectable animal model contrast none <NUMBER> c c e p e n u c r p <NUMBER> exposed naïve hamsters surgical mask partition facing either side sacrificed <NUMBER> dpi including two rtpcrpositive hamsters developed detectable serum neutralizing antibody <NUMBER> results suggested even though two exposed naïve hamsters infected likely acquired virus much later infected naïve hamsters without protection surgical mask partition representative histological immunofluorescent staining findings infected naïve hamsters shown figure <NUMBER> <NUMBER>dpi <NUMBER> days exposure histopathological changes infected naïve hamsters experiments <NUMBER> <NUMBER> <NUMBER> generally milder challenged control hamster figure <NUMBER>a use surgical mask partition protect naïve hamsters reduced transmission rate <NUMBER> although reach statistical significance likely relatively small number animals p<NUMBER> expected histopathological changes amount respiratory tract viral n antigen expression protected naïve hamsters also significantly lower challenged index hamsters finding sarscov<NUMBER> transmitted noncontact route respiratory droplets airborne droplet nuclei unexpected case respiratory viruses seasonal influenza viruses similar transmission demonstrated syrian hamster ferret guinea pig models <NUMBER> <NUMBER> <NUMBER> seasonal influenza viruses could isolated plaque assay naïve hamsters day <NUMBER> postexposure whereas sarscov<NUMBER> could detected rtpcr infected naïve hamsters early day <NUMBER> postexposure <NUMBER> however case nipah virus neurotropic amongst lowest world timing writing <NUMBER> although could differentiate whether transmission occurred respiratory droplets airborne aerosols study types noncontact transmission might happened surgical masks efficient filtering large respiratory droplets <NUMBER>µm airborne aerosol particles less <NUMBER>µm therefore noncontact transmission still occurred hamster model despite reduction transmission naïve hamsters protected mask partitioning alternatively filtration efficiency masks might declined time study period interestingly c c e p e n u c r p <NUMBER> transmission exposed naïve hamsters significantly reduced surgical mask partition placed prevent emission challenged index hamsters completely unexpected masking infectious patients multidrugresistant tuberculosis hospital ward south africa reduced airborne transmission <NUMBER> patients guinea pigs breathing ward air compared percentage transmission guinea pigs periods masks worn <NUMBER> report clearly showed surgical masks could partially effective reducing however presence significant proportion asymptomatically infected patients aware need testing wearing mask isolation markedly impaired control measures case princess diamond cruise outbreak <NUMBER> <NUMBER> returnees found asymptomatically infected <NUMBER> days quarantine serial virological monitoring returning hong kong <NUMBER> findings use surgical mask partition protection noncontact transmission hamster model supported use communitywide masking reduce amount virus shedding asymptomatically infected patients protect susceptible individuals reasonable approach epidemic control densely populated city like hong kong without resorting city lockdown important measure stepwise loosening social distancing measures days ahead study limitations speed unidirectional airflow could unified surgical mask partitions installed would also apply surgical masks worn different individuals real life could indeed mechanism protection mask usage could determine exact timing acquisition c c e p e n u c r p <NUMBER> sarscov<NUMBER> exposed naïve hamsters started sampling <NUMBER> days exposure moreover could determine contact transmission occurred among exposed naïve hamsters housed cage might resulted underestimation protective efficacy masks would otherwise even significant studies relative importance large respiratory droplets small airborne aerosols warranted hamsters exposed naïve hamsters without surgical mask partition cages experiment <NUMBER> sarscov<NUMBER> intranasally inoculated index hamsters n<NUMBER> day <NUMBER> twentyfour hours later three naïve hamsters transferred adjacent cage exposed cage housing viruschallenged index hamster two exposed naïve hamsters system sacrificed day <NUMBER> postinoculation <NUMBER> days exposure challenged index animal remaining exposed naïve animal system sacrificed <NUMBER> dpi total <NUMBER> systems n<NUMBER> included experiment <NUMBER> n<NUMBER> orange diamonds naïve hamsters exposed challenged index hamsters without surgical mask partition experiment <NUMBER> n<NUMBER> red squares naïve hamsters exposed masked challenged index hamsters experiment <NUMBER> n<NUMBER> black circles masked naïve hamsters exposed challenged index hamsters experiment <NUMBER> n<NUMBER> blue novel coronavirus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> discovered december <NUMBER> wuhan china ongoing pandemic coronavirus disease <NUMBER> covid<NUMBER> spreading around world early april <NUMBER> clinical spectrum covid<NUMBER> ranges asymptomatic upper respiratory infection critically ill pneumonia associated acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> initial reports china prevalence older age hypertension diabetes mellitus cardiovascular disease cvd high covid<NUMBER> patients individuals comorbidities tended greater case fatality rates <NUMBER> <NUMBER> addition shown angiotensinconverting enzyme <NUMBER> ace<NUMBER> functional receptor sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> given experimental studies suggested angiotensin receptor blockers arbs ace inhibitor acei could increase ace<NUMBER> expression cardiovascular renal systems <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> concerns may raised regarding whether arbs aceis would augment infection sarscov<NUMBER> severity covid<NUMBER> hypertension cvd patients receiving drugs <NUMBER> contrast arbs potential benefits prevention treatment lung injury caused covid<NUMBER> <NUMBER> conflicting views appear arise based results experimental studies especially severe acute respiratory syndrome coronavirus sarscov direct clinical data covid<NUMBER> lacking present sarscov caused sars epidemic china <NUMBER> <NUMBER> virological characteristics closely related sarscov<NUMBER> <NUMBER> <NUMBER> available investigations association reninangiotensin system ras particularly ace<NUMBER> angiotensin ii sarscovinduced lung injury latest information covid<NUMBER> reviewed early april <NUMBER> would provide insight covid<NUMBER> direction future research covid<NUMBER> ace<NUMBER> receptor sarscov sarscov<NUMBER> ace<NUMBER> belongs membranebound carboxydipeptidase family widely distributed human body including heart kidney small intestine lesser extent lung lung ace<NUMBER> expression concentrated mainly type ii alveolar cells macrophages modestly bronchial tracheal epithelial cells <NUMBER> ace<NUMBER> degrades angiotensin ii generate angiotensin <NUMBER> activates mas oncogene receptor negatively regulates variety angiotensin ii actions mediated angiotensin ii type <NUMBER> receptor at<NUMBER>r <NUMBER> therefore thought ace<NUMBER>angiotensin <NUMBER>mas receptor axis counteracting effects excessively activated aceangiotensin iiat<NUMBER>r axis seen hypertension cardiac hypertrophy heart failure cvds <NUMBER> hand human ace<NUMBER> established functional receptor sarscov enters host target cells fig <NUMBER> <NUMBER> <NUMBER> transmembrane spike glycoprotein protein sarscov binds cellular membrane ace<NUMBER> sarscov attaches target cells followed sarscovs protein priming cellular surface proteases transmembrane protease serine <NUMBER> tmprss<NUMBER> allowing fusion viral cellular membranes resulting sarscov entry replication target cells <NUMBER> moreover ace<NUMBER> knockout greatly reduces viral infection replication mice experimental sarscov infection <NUMBER> thus suggested binding sarscovs protein ace<NUMBER> crucial sarscov infection recently shown sarscov<NUMBER>s protein shares nearly <NUMBER> amino acid identity sarscovs protein binding affinity sarscov<NUMBER>s protein human ace<NUMBER> similar sarscovs protein <NUMBER> <NUMBER> <NUMBER> antihuman ace<NUMBER> antibodies antisera inhibit sarscov<NUMBER>s proteinmediated entry cultured cells vitro <NUMBER> <NUMBER> <NUMBER> accordingly sarscov<NUMBER> utilizes ace<NUMBER> target cell entry well however still clear whether ace<NUMBER> sole receptor sarscov<NUMBER> infection cd<NUMBER>l glycoprotein ctype lectin also called lsign identified possible secondary receptor sarscov cultured chinese hamster ovary cells <NUMBER> experimental sarscov infection induces acute respiratory failure lung parenchymal injury characterized alveolar wall thickening pulmonary vascular hyperpermeability inflammatory cell infiltration mice <NUMBER> sarscov infection mice lung ace<NUMBER> fig <NUMBER> possible scheme association ace<NUMBER> angiotensin ii at<NUMBER>r acute lung injury sars covid<NUMBER> ang ii angiotensin ii ace angiotensinconverting enzyme ace<NUMBER> angiotensinconverting enzyme <NUMBER> acei angiotensinconverting enzyme inhibitor at<NUMBER>r angiotensin ii type<NUMBER> receptor arb angiotensin ii type<NUMBER> receptor blocker sarscov severe acute respiratory syndrome coronavirus sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sprotein spikeglycoprotein protein levels greatly reduced ace levels changed <NUMBER> findings consistent previous observation coronaviruses specifically downregulate ace<NUMBER> expression host cells depending virus replication <NUMBER> addition sarscovinduced acute lung injury remarkably attenuated ace<NUMBER> knockout mice compared wildtype mice <NUMBER> lung angiotensin ii levels increase wildtype mice sarscov infection <NUMBER> acid aspiration mice ards model show functional pathological changes mimicking sarscovinduced lung injury <NUMBER> lung angiotensin ii levels increase acid aspiration sarscovs protein treatment elicits angiotensin ii increase <NUMBER> interestingly exogenous recombinant ace<NUMBER> treatment rescues acid aspirationinduced acute lung injury <NUMBER> taking evidence together following hypothesis raised mechanism underlying sarscovinduced lung injury sarscov infection downregulates lung ace<NUMBER> turn shifts balance toward dominance ace angiotensin iiat<NUMBER>r system ace<NUMBER>angiotensin <NUMBER>mas receptor system lung result noncompeting angiotensin ii accumulation occurs resulting acute lung injury at<NUMBER>r activation <NUMBER> noted similar mechanism proposed severe lung injury caused avian influenza virus h<NUMBER>n<NUMBER> spread worldwide humans high mortality rate h<NUMBER>n<NUMBER> virus infection mice lung ace<NUMBER> expression downregulated serum angiotensin ii levels increase <NUMBER> acute lung injury augmented ace<NUMBER> knockout h<NUMBER>n<NUMBER>infected mice administration recombinant human ace<NUMBER> ameliorates h<NUMBER>n<NUMBER>induced lung injury mice <NUMBER> moreover mouse models acute lung injury ards acid aspiration sepsis druginduced lung fibrosis shown ace<NUMBER> expression downregulated response noxious stimuli acute lung injury aggravated ace<NUMBER> knockout rescued exogenous ace<NUMBER> administration at<NUMBER>r knockout <NUMBER> <NUMBER> accordingly suggested angiotensin ii at<NUMBER>rinduced aggravation resulting ace<NUMBER> downregulation protective effects ace<NUMBER> specific lung injury sars rather may common acute lung injuryards induced various viral infections lung diseases several kinds arbs eg olmesartan telmisartan losartan azilsartan shown increase mrna protein levels ace<NUMBER> animal models heart diseases hypertensive hypertrophy autoimmune myocarditis dilated cardiomyopathy myocardial infarction diabetic cardiomyopathy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> chronic kidney disease hypertensive nephropathy diabetic nephropathy <NUMBER> <NUMBER> well normal rat heart renal vasculature <NUMBER> <NUMBER> hypertensive rat aorta carotid artery <NUMBER> <NUMBER> acei inhibit ace<NUMBER> pharmacological property normal rats lisinopril shown modestly increase cardiac ace<NUMBER> mrna levels c effects losartan <NUMBER> mgkg lung edema wetdry weight ratio acid plus spikefc proteintreated mice n <NUMBER> per group p <NUMBER> vs vehicletreated wildtype mice acid injury at<NUMBER> angiotensin ii type<NUMBER> receptor cited ref <NUMBER> changing cardiac ace<NUMBER> activity <NUMBER> myocardial infarction model valsartan ramipril combination effects cardiac ace<NUMBER> expression <NUMBER> noted doses arbs aceis used animal studies much greater clinical practice observed effects drugs ace<NUMBER> expression activity could extrapolated clinical situations humans importantly clinical data exist regarding effects arbs aceis human tissue ace<NUMBER> expression activity vivo although several clinical studies investigating changes plasma urine levels soluble form ace<NUMBER> hypertension cvd patients receiving arbs aceis soluble form ace<NUMBER> plasma urine reliable indicator activity tissue ace<NUMBER> namely membranebound ace<NUMBER> <NUMBER> importantly data effects arbs aceis lung ace<NUMBER> expression either animal models humans still unknown whether changes ace<NUMBER> levels example arbinduced upregulation actually facilitate greater engagement entry sarscov viruses even animal models hand shown pretreatment losartan arb ameliorates acute pulmonary edema lung injury sarscovs proteintreated mice acid aspiration fig <NUMBER> <NUMBER> taken together lung angiotensin ii level elevation <NUMBER> evidence suggested even considering speculation viral load would enhanced ace<NUMBER> upregulation net effects arbs would favorable prevent sarscovinduced acute lung injury model addition another possibility arb pretreatmentinduced baseline ace<NUMBER> increase prior sarscov infection would result higher ace<NUMBER> levels remained sarscovinduced downregulation consequently conferred protection lung injury model <NUMBER> <NUMBER> however interpreting results study noted effects losartan observed merely mice treated sarscovs protein addition acid aspiration mice treated sarscovs protein alone additionally data lung ace<NUMBER> levels treatment sarscovs protein acid aspiration lacking mice pretreated without losartan earlier studies reported case fatality rate high covid<NUMBER> patients comorbidities older age hypertension diabetes mellitus cvd chronic pulmonary disease malignancy <NUMBER> <NUMBER> patients hypertension cvd likely treated aceis arbs concern raised regarding whether use aceis arbs may aggravate morbidity mortality covid<NUMBER> <NUMBER> however possible observed phenomenon would result reverse causality older patients highest risk covid<NUMBER> concurrently tend multiple comorbidities including hypertension cvd adjustments age possible confounding factors performed earlier studies <NUMBER> <NUMBER> <NUMBER> indeed recent retrospective multicenter cohort study enrolling <NUMBER> confirmed covid<NUMBER> patients wuhan china multivariable regression analysis revealed independent risk factors inhospital death older age higher sequential organ failure assessment score higher ddimer levels early stage covid<NUMBER> although hypertension diabetes coronary artery disease included <NUMBER> small case study reported plasma angiotensin ii levels markedly elevated linearly associated viral load lung injury severity covid<NUMBER> pneumonia patients <NUMBER> given remarkable elevation circulating levels also documented various kinds cytokines il<NUMBER> il<NUMBER> tnfalpha etc unknown whether findings angiotensin ii cause result systemic cytokine storm covid<NUMBER> patients <NUMBER> context effects arbs aecis retrospective singlecenter analysis enrolling <NUMBER> covid<NUMBER> patients showed use arbs aceis effects morbidity mortality covid<NUMBER> patients cvd <NUMBER> currently casecontrol study underway clarify effects aceis arbs severity covid<NUMBER> italy nct<NUMBER> importantly present largescale study convincing evidence determine whether arbs aceis play neutral beneficial harmful role susceptibility sarscov<NUMBER> severity outcomes covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition vaccine development antiviral agents modulation ras especially ace<NUMBER> angiotensin ii highlighted potential therapeutic target covid<NUMBER> based animal study suggesting beneficial net effects arb sarscovinfected acute lung injury mice <NUMBER> multicenter doubleblinded placebocontrolled randomized trials rcts currently conducted investigate effects losartan mortality hospital admission covid<NUMBER> patients requiring hospital admission nct<NUMBER> requiring hospital admission nct<NUMBER> respectively recombinant ace<NUMBER> another candidate prevent covid<NUMBER> pneumonia described efficacy exogenous recombinant ace<NUMBER> shown animal models acute lung injuryards <NUMBER> <NUMBER> also possible circulating soluble form ace<NUMBER> may act decoy receptor binds sarscov<NUMBER> competitively inhibits virus entry host target cells mediated membranebound ace<NUMBER> investigate efficacy human recombinant ace<NUMBER> treatment covid<NUMBER> patients randomized controlled pilot clinical study planned nct<NUMBER> however study withdrawn march <NUMBER> <NUMBER> tmprss<NUMBER> membrane protease ace<NUMBER> priming crucial step fusion sarscov<NUMBER> target cell membranes resultant viral entry cells <NUMBER> nafamostat mesylate camostat mesylate tmprss<NUMBER> inhibitors used treatment acute pancreatitis japan currently clinical trial evaluating efficacy nafamostat camostat treating covid<NUMBER> underway japan httpswwwutokyoacjpfocusenarticlesz<NUMBER>html concern regarding whether arbs aceis may harmful effects morbidity mortality covid<NUMBER> patients based speculation drugs would upregulate ace<NUMBER> receptor sarscov<NUMBER> would increase viral load augment lung injury however evidence ace<NUMBER> upregulation limited animal studies using relatively high namely pharmacological doses several arbs one acei additionally remains unclear whether arb aceinduced ace<NUMBER> increase actually enhances susceptibility sarscov<NUMBER> sarcov importantly clinical studies exist supporting arbs aceis augment susceptibility infection worsen improve allcause cardiovascular outcomes covid<NUMBER> patients also sars patients present therefore hypothesis underlying concern would readily extrapolated humans particularly covid<NUMBER> patients patients heart failure prior myocardial infarction cvds cerebrovascular disease benefit arbs aceis established improvement quality life survival outcomes discontinuation leads new onset exacerbation heart failure cvd stroke worsening prognosis <NUMBER> thus ras inhibitors continued highrisk patients received guidelinedirected medical therapy gdmt general switching one another class antihypertensive agents infrequently result destabilization blood pressure control requires frequent visits drug titration achieve appropriate stable blood pressure control avoid adverse effects blood pressure destabilization increases incidence heart failure stroke cvds addition frequent visits clinic hospital expose patients greater risk infection covid<NUMBER> pandemic situation accordingly even stably controlled hypertension patients without compelling indications thought simple discontinuation also switching arb acei antihypertensive agents avoided unless physicians make decision based specific considerations cardiovascular comorbidities common covid<NUMBER> patients patients great risk morbidity mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> myocardial damage ranging silent troponin elevation fulminant myocarditis documented covid<NUMBER> patients <NUMBER> confirmed suspected covid<NUMBER> patients acei arb medications recommended treatment heart failure cvd according gdmt based available evidence time <NUMBER> conclusion present use arbs aecis withheld established standard therapy highrisk patients heart failure prior myocardial infarction cvd cerebrovascular disease also patients hypertension stable condition according recent statements released european society hypertension european society cardiology american heart association heart failure society americaamerican college cardiology <NUMBER> <NUMBER> <NUMBER> evidence covid<NUMBER> accumulated day largescale clinical studies convincing evidence rcts also realworld big data analyses well experimental studies awaited solve question whether arbs aceis neutral favorable harmful effects susceptibility sarscov<NUMBER> severity outcomes covid<NUMBER> finally learn lessons covid<NUMBER> without bound common sense antecovid<NUMBER> era addition reconstruct novel strategy treatment hypertension cvd postcovid<NUMBER> era funding work supported part jsps kakenhi grant <NUMBER>k<NUMBER> conflict interest authors declare conflict interest publishers note springer nature remains neutral regard jurisdictional claims published maps institutional affiliations much recent debate regarding use angiotensin converting enzyme inhibitors aceis angiotensin receptor blockers arbs patients coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> thus prompting concern among patients health care providers basis concern involves whether aceisarbs increase expression ace<NUMBER> primary cellular receptor severe acute respiratory syndromecoronavirus <NUMBER> sarscov<NUMBER> thereby possibly increasing severity infection published correspondencesletters cited typically make assertions relationship aceiarb use ace<NUMBER> expression levels lack detailed comprehensive breakdown available data humans animals strength experimental data thus unclear regarding aceiarb use ace<NUMBER> protein expression address issue reviewed key literature assessing studies conducted experimental animals primarily rats humans order obtain comprehensive picture available data convey focus discussion studies ace<NUMBER> protein data available either via direct measurement inferred ace<NUMBER> activity assays tissue ace<NUMBER> mrna expression seems weakly correlate protein expression shown data human protein atlas <NUMBER> proteinatlasorg results human renal samples <NUMBER> studies experimental animals discussed refs <NUMBER> <NUMBER> identified relevant studies searches pubmed google scholar available literature combinations search terms used maximize identification relevant studies search terms included ace inhibitor angiotensin receptor blocker ace inhibition ace<NUMBER> ace<NUMBER> expression ace<NUMBER> protein expression ace<NUMBER> activity humans patients lung heart kidney imposed limits studies performed manually curated relevant hit ensure data articles original research andor metaanalysis included quantitativenormalized ace<NUMBER> protein expression activity involved studies tissues relevant covid<NUMBER> sarscov<NUMBER> infection focused assessment studies evaluated ace<NUMBER> levels tissuescells involved infection sarscov<NUMBER> sarscov<NUMBER> data <NUMBER> animal studies summarized table <NUMBER> shows effect aceiarb use ace<NUMBER> protein expressionactivity animals primarily rats used conversion factors based principles allometric scaling evaluate doses animals relative use humans <NUMBER> studies relevant used human equivalent dose assuming <NUMBER> kg human <NUMBER> doses aceiarbs conversion factor rats <NUMBER> ie doses mgkg divided <NUMBER> multiplied <NUMBER> kg human equivalent dose <NUMBER> pigs obtained recommended doses humans using approved labeling us food drug administration fda website fdagov recommended human doses provided table <NUMBER> drugs maximum doses indicated table <NUMBER> generally administered humans treatment animals equivalent larger doses especially models acute dosing refs <NUMBER> <NUMBER> discussed table <NUMBER> raise concern relevance aceiarb administration patients summary three studies <NUMBER> <NUMBER> <NUMBER> animals reported increase treatment groups ace<NUMBER> protein expressionactivity aceiarb treatment one study <NUMBER> combined arb acei treatment show effect two studies reported relatively small effects <NUMBER> increase ace<NUMBER> protein expression controlsham animals studies used high doses aceisarbs noted contrast six studies <NUMBER> found little change ace<NUMBER> expression aceiarb treatment three studies <NUMBER> treatment aceiarb effect decrease ace<NUMBER> protein expressionactivity controlsham animals increased ace<NUMBER> expression observed following experimental exposure ferrario et al <NUMBER> lewis rats treated losartan arb lisinopril acei <NUMBER> mgkgday hed <NUMBER> mgday <NUMBER> days ace<NUMBER> activity measured membranes renal cortex lisinopril losartan treatment associated increases ace<NUMBER> activity used combination produce effect ocaranza et al <NUMBER> sprague dawley rats used myocardial infarction model via coronary ligation acei enalapril <NUMBER> mgkg day hed <NUMBER> mgday administered <NUMBER> weeks postsurgery plasma ace<NUMBER> activity measured enalapril increased plasma ace<NUMBER> <NUMBER> <NUMBER> sham mi animals respectively hamming et al <NUMBER> renal ace<NUMBER> activity assayed wistar rats controls low sodium diet along lisinopril <NUMBER> gl drinking water <NUMBER> weeks renal ace<NUMBER> activity unchanged acei treatment either group velkoska et al <NUMBER> ace<NUMBER> activity assessed kidneys sprague dawley rats subtotal nephrectomy given ramipril acei <NUMBER> mg kgday hed <NUMBER> mgday <NUMBER> days ace<NUMBER> activity renal cortex medulla unchanged acei treatment control rats increased <NUMBER> nephrectomy han et al <NUMBER> ace<NUMBER> protein expression lungs measured sprague dawley rats cigarette smokeinduced lung damage rats treated losartan <NUMBER> <NUMBER> mgkgday hed <NUMBER> <NUMBER> mgday <NUMBER> months ace<NUMBER> expression unchanged control rats either dose losartan animals exposed cigarette smoke reduced ace<NUMBER> losartan treatment restored asperen et al <NUMBER> sprague dawley rats used lpsinduced model ards rats given losartan <NUMBER> mgkgh <NUMBER> hours ventilation hed <NUMBER> mg ace<NUMBER> protein expression lung measured <NUMBER> hours inducing ards lps losartan administration decreased ace<NUMBER> activity control animals unclear ifhow statistics performed induction ards ace<NUMBER> levels decreased restored normal losartan burrell et al <NUMBER> ace<NUMBER> activity protein expression assayed tissues sd rats <NUMBER> days subtotal nephrectomy received ramipril acei <NUMBER> mgkgday hed <NUMBER> mgday ramipril effect ace<NUMBER> cardiac renal cortex medullary tissue ace<NUMBER> activity reduced nephrectomy ramipril restored ace<NUMBER> activity control levels renal cortex medullary cardiac tissue burchill et al <NUMBER> ace<NUMBER> protein expression assessed cardiac tissue mi model sd rats ramipril <NUMBER> mgkgday hed <NUMBER> mg day valsartan arb <NUMBER> mgkgday hed <NUMBER> mgday given <NUMBER> days postcoronary artery ligation ace<NUMBER> expression altered may decreased viable myocardium border infarct zones unclear statistical analysis yang et al <NUMBER> spontaneously hypertensive rats treated enalapril <NUMBER> mgkgday hed <NUMBER> mgday <NUMBER> weeks cardiac ace<NUMBER> protein expression measured ace<NUMBER> mrna expression increased ace<NUMBER> protein expression change acei treatment zhang et al <NUMBER> cardiac ace<NUMBER> protein assayed sd rats cardiac remodeling aortic constriction treated losartan <NUMBER> mgkgday hed <NUMBER> mgday enalapril <NUMBER> mgkg day hed <NUMBER> mgday <NUMBER> days starting <NUMBER> days surgery ace<NUMBER> cardiac protein expression increased <NUMBER>fold drugs rats cardiac remodeling data provided animals sham surgery li et al <NUMBER> sd rats underwent lpsstimulated lung injury simultaneous intravenous injection lps animals administered captopril <NUMBER> mgkg hed <NUMBER> mg <NUMBER> hours samples collected ace<NUMBER> protein expression measured lungs ace<NUMBER> protein expression elevated lungs control rats <NUMBER> lpsinduced lung injury <NUMBER>fold wang et al <NUMBER> pigs used study effects aceis cardiac arrest resuscitation enalapril <NUMBER> mgkg hed <NUMBER> mg perfused <NUMBER> minutes followed surgery myocardial ace<NUMBER> protein expression assayed samples collected <NUMBER> hours postsurgery compared salineinfused controls enalapril increase ace<NUMBER> levels enalapril administered sham rats acei angiotensin converting enzyme inhibitor arb angiotensin receptor blocker ards acute respiratory distress syndrome hed human equivalent dose lps lipopolysaccharide mi myocardial infarction sd sprague dawley lung injury myocardial infarction etc nearly studies reported increase ace<NUMBER> doses aceisarbs used greater equivalent doses typically administered patients identified one study <NUMBER> aceiarb use increased ace<NUMBER> protein expression doses typically used treat patients albeit changes occurred exposure acute injury subtotal nephrectomy overall studies experimental animals provide consistent evidence effect arbacei administration ace<NUMBER> protein expression especially contexts model drug administration humans challenge assessing animal studies table <NUMBER> although doses provided drugs pharmacokinetic studies performed ascertain peak serum concentration c max area curve auc would allow precision evaluating translational relevance findings however data studies provide insight pharmacokinetics rats doses comparable used studies table <NUMBER> table <NUMBER> shows estimates c max drugs used studies table <NUMBER> humans therapeutic doses indicated rats doses comparable table <NUMBER> differences auc drugs humans rats mirror differences c max refer readers indicated references details exception study nephrectomy model <NUMBER> animal data including data control animals show relationship ace<NUMBER> expression use aceis arbs involved drug treatments associated plasma concentrations far excess often one order magnitude values normally seen patients absent exposureresponse studies clinically appropriate drug concentrations conclude bulk animal data regarding ace<NUMBER> expression aceiarb administration dubious translational relevance evidence changes ace<NUMBER> protein human subjectspatients table <NUMBER> derived studies assessed ace<NUMBER> protein concentration enzymatic activity urine serumplasma <NUMBER> studies summarized table <NUMBER> seven showed effect arbacei use ace<NUMBER> protein levels conditionpatient grouping one study <NUMBER> documented small increase serum ace<NUMBER> attributable use aceis among patients type<NUMBER> diabetes found effect use arbs another study <NUMBER> found slightly larger proportional decrease urinary ace<NUMBER> patients type<NUMBER> diabetes using aceisarbs distinguish effects use aceis arbs one study <NUMBER> investigators observed subjects using arb olmesartan increased ace<NUMBER> levels several arbs aceis effect one study <NUMBER> acei use effect control patients stage <NUMBER> chronic kidney disease dialysis arb small effect patients dialysis besides quantitative data table <NUMBER> another study used immunohistochemical analysis assess ace<NUMBER> protein expression kidneys found aceidependent effect <NUMBER> together <NUMBER> studies humans imply lack association ace<NUMBER> protein expression use arbs aceis support idea aceisarbs unlikely raise ace<NUMBER> harmful context covid<NUMBER> infection would constitute strong supportive evidence hypothesis aceiarb usage risk factor setting sarscov<NUMBER> infection findings help support hypothesis would include replication prominent effect multiple animal studies models ii evidence tissues low expression ace<NUMBER> prominent increases expression activity following aceiarb treatment iii data documenting increases ace<NUMBER> expression response aceiarb treatment enhance ability sarscov<NUMBER> virus infect cells iv findings human studies statistically significant relationships aceiarb usage ace<NUMBER> expression activity v epidemiological data showing patients covid<NUMBER> administered aceisarbs increased morbidity mortality ideally doseresponse relationship outcomes acei angiotensin converting enzyme inhibitor arb angiotensin receptor blocker auc <NUMBER>∞ area concentrationtime curve zero infinity auc <NUMBER>h <NUMBER>hour area concentrationtime curve c max peak serum concentrations hed human equivalent dose well available data provide evidence hypothesis ace<NUMBER> expression increases aceiarb use supported plurality available data animal studies ii available evidence de novo expression ace<NUMBER> expression response aceisarbs tissues low expression iii affinity sarscov<NUMBER> ace<NUMBER> high approximately fourfold greater sarscov<NUMBER> <NUMBER> higher studies suggest orderofmagnitude higher affinity sarscov<NUMBER> <NUMBER> unclear small modest perturbations ace<NUMBER> expression impact infectivity sarscov<NUMBER> moreover ace<NUMBER> levels may decrease age <NUMBER> diabetes <NUMBER> yet elderlydiabetic subjects vulnerable younger individuals covid<NUMBER> <NUMBER> modest changes ace<NUMBER> expression <NUMBER>fold preclinical data discussed may meaningfully impact high infectivity sarscov<NUMBER> host tissues iv data human studies suggest treatment aceisarbs produces little effect urinary circulating ace<NUMBER> levels caveat changes ace<NUMBER> levels serum urine may reflect changes tissue v epidemiological studies slowly becoming available matched groups patients infected sarscov<NUMBER> taking aceisarbs one preliminary study <NUMBER> examined <NUMBER> patients severe covid<NUMBER> <NUMBER> patients mild disease also hypertension arb use associated reduction risk severe covid<NUMBER> disease morbidity mortality result contradicts hypothesis arbacei use harmful however small numbers patients assessed larger retrospective study <NUMBER> patients covid<NUMBER> china hypertension found <NUMBER>fold reduction mortality patients administered aceisarbs compared patients receiving drugs <NUMBER> additional smaller retrospective study also noted hypertensive patients covid<NUMBER> receiving aceiarb treatment lower rate severe covid<NUMBER> disease trend toward reduced blood levels interleukin<NUMBER> plus reduced viral load increased counts cytotoxic cells <NUMBER> none three retrospective studies found elevation risk aceiarb use based data summarized conclude current evidence especially human studies table <NUMBER> support idea treatment aceis arbs produces <NUMBER> urinary ace<NUMBER> protein levels measured via elisa <NUMBER> patients type<NUMBER> diabetes use arbs aceis effect urinary ace<NUMBER> levels epelman et al <NUMBER> plasma ace<NUMBER> activity assayed <NUMBER> patients heart failure association found aceiarb use ace<NUMBER> levels soropaavonen et al <NUMBER> serum ace<NUMBER> activity measured <NUMBER> patients type<NUMBER> diabetes <NUMBER> healthy control subjects ace<NUMBER> increased <NUMBER> <NUMBER> higher women patients diabetes using aceis association found arb usage ace<NUMBER> levels ortizperez et al <NUMBER> serum ace<NUMBER> activity assayed <NUMBER> patients stelevation myocardial infarction <NUMBER> control subjects association found acei use ace<NUMBER> levels arb usage discussed anguiano et al <NUMBER> plasma ace<NUMBER> activity measured n <NUMBER> control subjects n <NUMBER> stage <NUMBER> chronic kidney disease n <NUMBER> patients dialysis multivariate regression analysis performed identify factors influenced ace<NUMBER> acei use effect ace<NUMBER> group arb use predict ace<NUMBER> activity control stage <NUMBER> patients patients dialysis arb use small effect raising ace<NUMBER> activity uri et al <NUMBER> serum ace<NUMBER> activity assayed <NUMBER> healthy subjects <NUMBER> hypertensive patients <NUMBER> patients heart failure different types logistic regression analysis showed acei arb usage association ace<NUMBER> levels walters et al <NUMBER> plasma ace<NUMBER> activity assessed <NUMBER> control subjects <NUMBER> patients atrial fibrillation association found ace<NUMBER> levels aceiarb use ramchand et al <NUMBER> plasma ace<NUMBER> activity measured <NUMBER> patients obstructive coronary artery disease ace<NUMBER> levels association use aceis arbs entries ordered chronologically first studies urine studies circulating ace<NUMBER> acei angiotensin converting enzyme inhibitor arb angiotensin receptor blocker elisa enzymelinked immunosorbent assay pathophysiologically relevant increases ace<NUMBER> protein abundance hypothesis use drugs increases sarscov<NUMBER> virus infectivity andor severity covid<NUMBER> therefore supported available evidence would thus seem prudent patients continue receiving medications recently recommended multiple health associations <NUMBER> publications <NUMBER> sarscov<NUMBER> strain betacovwuhanivdchb<NUMBER> ctanhb<NUMBER> gisaid accession epiisl<NUMBER> formally designated sarscov<NUMBER>ctanhuman<NUMBER>wuhan ctanh study isolated human patient <NUMBER> sarscov<NUMBER> strain betacovwuhanivdchbenvf<NUMBER> f<NUMBER> gisaid accession epiisl<NUMBER> formally designated sarscov<NUMBER>f<NUMBER>environment<NUMBER>wuhanf<NUMBER>e study isolated environmental sample collected huanan seafood market wuhan two viruses differ two nucleotides noncoding region ctanh bears <NUMBER>c <NUMBER>c whereas f<NUMBER>e bears <NUMBER>t <NUMBER>a viral stocks prepared vero e<NUMBER> cells dmem containing <NUMBER> fbs <NUMBER> ugml tpcktrypsin <NUMBER> mmoll mgcl<NUMBER> viruses harvested titers determined means plaque assay vero e<NUMBER> cells qpcr quantitate viral rna copies samples collected animals viral rna extracted using qiaamp vrna minikit qiagen hilden germany reverse transcription performed using hiscript® ii q rt supermix qpcr vazyme nanjing china qpcr conducted using applied biosystems® quantstudio® <NUMBER> realtime pcr system thermo fisher scientific waltham usa premix ex taq™ probe qpcr bulk taraka dalian china n genespecific primers forward <NUMBER>ggggaacttctcctgctagaat<NUMBER> reverse <NUMBER>cagacattttgctctcaagctg<NUMBER> probe <NUMBER>famttgctgctgcttgacagatttamra<NUMBER> utilized according information provided national institute viral disease control prevention china httpnmdccnncov amount vrna target sarscov<NUMBER> n gene normalized standard curve obtained using plasmid pbluescriptⅱskn <NUMBER> bp containing fulllength cdna sarscov<NUMBER> n gene antibodies sarscov<NUMBER> detected using double antigen sandwich elisa kit prottech luoyang china according manufacturers instructions briefly <NUMBER> μl sera added antigenprecoated microtiter plate incubated <NUMBER> °c <NUMBER> min plates washed <NUMBER> times pbst incubated hrpconjugated antigen <NUMBER> °c <NUMBER> min plates washed <NUMBER> times pbst <NUMBER> μl substrate solution added enable colorimetric analysis reaction stopped adding <NUMBER> μl stop buffer optical density od measured <NUMBER> nm od<NUMBER> value greater <NUMBER> considered positive seroconversion according manufacturers instructions randomization blinding used allocation animals experimental groups number animals used study similar reported previous publications <NUMBER> <NUMBER> <NUMBER> <NUMBER> determined following minimumquantityprinciple protocol animal studies performed one time biological replicates number animals used experiment indicated detail threeto fourmonthold female ferrets wuxi cay ferret farm wuxi china used study groups five ferrets anesthetized zoletil <NUMBER> virbac carros france inoculated intranasally <NUMBER> <NUMBER> plaque forming unit pfu sarscov<NUMBER> ctanh f<NUMBER>e volume <NUMBER> ml ferret housed separate cage inside isolator <NUMBER> <NUMBER> <NUMBER> <NUMBER> two ferrets group euthanized day <NUMBER> postinoculation pi organs tissues including lungs tracheas nasal turbinates soft palates brains hearts tonsils kidneys spleens livers pancreas small intestines collected viral rna virus detection nasal washes rectal swabs collected three ferrets days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi viral rna virus detection body weights body temperature monitored every day ferrets scheduled euthanized day <NUMBER> pi assess antibodies sarscov<NUMBER> using double antigen sandwich elisa kit prottech luoyang china use neutralization assay eight ferrets also inoculated intratracheally <NUMBER> <NUMBER> pfu ctanh days <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi two ferrets euthanized organs collected virus detection malefemale mixed ten outbred domestic juvenile cats aged <NUMBER> days ten outbred subadult cats aged <NUMBER> months obtained national engineering research center veterinary biologics corp harbin china used study evaluate replication sarscov<NUMBER> four juvenile cats four subadult cats intranasally inoculated <NUMBER> <NUMBER> pfu ctanh two cats age group euthanized day <NUMBER> pi day <NUMBER> pi respectively organs tissues collected viral rna detection virus titration vero e<NUMBER> cells histological studies investigate transmissibility sarscov<NUMBER> cats six cats three subadult three juvenile anesthetized zoletil <NUMBER> inoculated intranasally <NUMBER> <NUMBER> pfu ctanh animal housed specially designed cage inside isolator <NUMBER> <NUMBER> <NUMBER> <NUMBER> schematic presentation isolator cages shown figure s<NUMBER> twentyfour hours later similaraged naive cat placed adjacent cage <NUMBER> cm away separated doublelayered net divider fig s<NUMBER>c ambient conditions set <NUMBER>℃and <NUMBER> relative humidity airflow isolator horizontal speed <NUMBER> ms airflow direction inoculated animals exposed animals feces collected days <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi subadult cats nasal washes collected juvenile cats days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi viral rna detection one pair two pairs subadult cats euthanized days <NUMBER> <NUMBER> pi respectively organs including lungs tracheas nasal turbinates soft palates tonsils brains hearts submaxillary lymph nodes kidneys spleens livers pancreas small intestines collected viral rna detection animals anesthetized process nasal wash blood collection exposed animals always handled first sera collected subadult cats days euthanized sera collected juvenile cats days <NUMBER> <NUMBER> pi antibodies sarscov<NUMBER> detected using double antigen sandwich elisa kit prottech luoyang china neutralization assay dog pig chicken duck study access susceptibility dogs pigs chickens ducks sarscov<NUMBER> threemonthold beagles kangping institute shenyang china malefemale mixed <NUMBER>dayold specificpathogenfree spf landrace large white pigs hvri harbin china <NUMBER>weekold specificpathogenfree spf white leghorn chickens hvri harbin china <NUMBER>weekold spf ducks shaoxin ducks local bred hvri harbin china used study five animals species intranasally inoculated <NUMBER> <NUMBER> pfu dogs pigs <NUMBER> <NUMBER> pfu chickens ducks ctanh two dogs three pigs chickens ducks uninfected animals housed room infected counterparts monitor transmission ctanh oropharyngeal rectal swabs animals collected every day viral rna detection one beagle viral rna positive rectal swab day <NUMBER> pi euthanized day <NUMBER> pi organs including nasal turbinates soft palates tonsils tracheas lungs brains hearts kidneys spleens livers pancreas small intestines collected viral rna detection qpcr sera collected remaining animals day <NUMBER> pi antibodies sarscov<NUMBER> detected using double antigen sandwich elisa kit prottech luoyang china plaque reduction neutralization test sarscov<NUMBER> ctanh strain <NUMBER> pfu incubated twofold serial dilutions sera <NUMBER> h <NUMBER>°c plaque assay performed vero e<NUMBER> cells neutralization mixtures neutralizing antibody titers calculated maximum serum dilution yielding <NUMBER> reduction number plaques relative control serum prepared uninfected animals tissues animals fixed <NUMBER> neutralbuffered formalin embedded paraffin cut <NUMBER>µm sections sections stained hematoxylineosin used immunohistochemical ihc assays sections used immunohistochemistry dewaxed xylene hydrated series descending concentrations alcohol water viral antigen retrieval sections immersed citric acidsodium citrate solution <NUMBER> °c <NUMBER> minutes cooling sections treated <NUMBER> hydrogen peroxide <NUMBER> minutes remove endogenous peroxidase activity blocked <NUMBER> skim milk reduce nonspecific binding three <NUMBER>minute washes tbs sections incubated rabbit antisarscov<NUMBER> nucleoprotein monoclonal antibody <NUMBER> frdbio wuhan china catalog number ncovnrmab <NUMBER> skim milk <NUMBER> °c overnight sections washed tbs incubated antirabbit igg whole moleculehrp <NUMBER> sigmaaldrich catalog number a<NUMBER> room temperature <NUMBER> minutes immunostaining visualized dab counterstained hematoxylin attachment sarscov<NUMBER> virus lung tissues ferrets tested described previously h<NUMBER>n<NUMBER> influenza virus <NUMBER> slight modification neutral buffered formalinfixed health ferret lungs processed paraffinembedded tissue sections dewaxing xylene hydrating alcohol βpropiolactone inactivated sarscov<NUMBER> concentration <NUMBER>×<NUMBER> <NUMBER> pfuml added sections incubated <NUMBER> °c overnight extensive washing triethanolaminebuffered saline tbs buffer sections incubated mouse serum anti recombinant sarscov<NUMBER> protein hrpconjugated goat antimouse igg hl secondary antibody <NUMBER> invitrogen catalog number <NUMBER> room temperature <NUMBER> hour immunostaining visualized diaminobenzidine dab counterstained hematoxylin omission incubation inactivated virus used negative control histopathologic immunohistochemical studies performed samples virusinoculated juvenile cats died euthanized day <NUMBER> pi nasal respiratory mucosa epithelium exhibited abnormal arrangement loss cilia accompanied lymphocyte infiltration lamina propria fig s<NUMBER>a tonsils surface epithelium covered abundant neutrophils cellular debris epithelial cells showed varying degrees degeneration necrosis fig s<NUMBER>b tracheal mucosa covered cellular debris mucous material altered polarity degeneration necrosis observed epithelial cells fig s<NUMBER>c researchers wear powered airpurifying respirators filter air disposable coveralls culture virus handle animals ferrets cats isolators b researchers wear full body airsupplied positive pressure suits perform studies involving use dogs pigs chickens ducks kept room isolators c transmission cages specifically designed allow transmission experiments conducted negatively pressurized isolators <NUMBER> cm x <NUMBER> cm x <NUMBER> cm absl<NUMBER> facility animals housed clear solid steel cage <NUMBER> cm x <NUMBER> cm x <NUMBER> cm divided <NUMBER> small cages <NUMBER> cm x <NUMBER> cm x <NUMBER> cm doublelayered net divider neighboring cages <NUMBER> cm apart twentyfour hours three inoculated animals placed cages three naï animals placed adjacent cages negative pressure within isolator cage used direct modest <NUMBER>msec flow hepafiltered air inoculated naï animals outlet airflow b hepafiltered prevent continuous circulation infectious influenza virus particles table s<NUMBER> amino acids sarscov<NUMBER> spikecontacting positions ace<NUMBER> protein amino acid residues sarscov<NUMBER> spikecontacting positions ace<NUMBER> protein <NUMBER> late december <NUMBER> unusual pneumonia emerged humans wuhan china rapidly spread internationally raising global public health concerns causative pathogen identified novel coronavirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> basis phylogenetic analysis related coronaviruses coronavirus study group international committee virus taxonomy <NUMBER> disease causes subsequently designated covid<NUMBER> world health organization despite tremendous efforts control covid<NUMBER> outbreak disease still spreading march <NUMBER> <NUMBER> sarscov<NUMBER> infections reported <NUMBER> countries <NUMBER> human cases confirmed <NUMBER> fatalities <NUMBER> covid<NUMBER> announced pandemic although sarscov<NUMBER> shares <NUMBER> identity nucleotide level coronavirus ratg<NUMBER> detected horseshoe bats rhinolophus spp yunnan province <NUMBER> <NUMBER> previously detected humans animals emerging situation raises many urgent questions could widely disseminated viruses transmit animal species become reservoirs infection sarscov<NUMBER> infection wide clinical spectrum humans mild infection death virus behave animals efforts made vaccine antiviral drug development animals used precisely model efficacy control measures humans address questions evaluated susceptibility different model laboratory animals well companion domestic animals sarscov<NUMBER> experiments infectious sarscov<NUMBER> performed biosafety level <NUMBER> animal biosafety level <NUMBER> facilities harbin veterinary research institute hvri chinese academy agricultural sciences caas approved use ministry agriculture rural affairs china details biosafety biosecurity measures taken provided supplementary materials <NUMBER> protocols animal study animal welfare reviewed approved committee ethics animal experiments hvri caas approval number <NUMBER>jipi ferrets commonly used animal model respiratory viruses infected humans <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore tested susceptibility sarscov<NUMBER> ferrets two viruses sarscov<NUMBER>f<NUMBER>environment<NUMBER>wuhan isolated environmental sample collected huanan seafood market wuhan f<NUMBER>e sarscov<NUMBER>ctanhuman<NUMBER>wuhan ctanh isolated human patient used study pairs ferrets inoculated intranasally <NUMBER> <NUMBER> plaque forming unit pfu f<NUMBER>e ctanh respectively euthanized day <NUMBER> postinoculation pi nasal turbinate soft palate tonsils susceptibility ferrets cats dogs domesticated animals sarscoronavirus <NUMBER> trachea lung heart liver spleen kidneys pancreas small intestine brain ferret collected viral rna quantification qpcr virus titration vero e<NUMBER> cells viral rna fig <NUMBER> b infectious virus detected nasal turbinate soft palate tonsils four ferrets inoculated two viruses detected organs tested fig <NUMBER> c results indicate sarscov<NUMBER> replicate upper respiratory tract ferrets replication organs undetectable investigate replication dynamics viruses ferrets groups three animals inoculated intranasally <NUMBER> <NUMBER> pfu f<NUMBER>e ctanh placed three separate cages within isolator nasal washes rectal swabs collected days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi ferrets viral rna detection virus titration body temperatures signs disease monitored two weeks shown fig <NUMBER> viral rna detected nasal washes days <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi six ferrets inoculated two viruses fig <NUMBER> e f viral rna also detected rectal swabs virusinoculated ferrets although copy numbers notably lower nasal washes ferrets fig s<NUMBER> c infectious virus detected nasal washes ferrets fig <NUMBER> g h rectal swabs ferrets fig s<NUMBER> b one ferret virusinoculated group developed fever loss appetite days <NUMBER> <NUMBER> pi respectively investigate whether symptoms caused virus replication lower respiratory tract euthanized two ferrets day <NUMBER> pi collected organs viral rna detection however viral rna detected tissues organs either ferret except low copy number <NUMBER> <NUMBER> copiesg turbinate ferret inoculated ctanh fig s<NUMBER> pathological studies revealed severe lymphoplasmacytic perivasculitis vasculitis increased numbers type ii pneumocytes macrophages neutrophils alveolar septa alveolar lumen mild peribronchitis lungs two ferrets euthanized day <NUMBER> pi fig s<NUMBER> antibodies sarscov<NUMBER> detected ferrets elisa neutralization assay although antibody titers two ferrets euthanized day <NUMBER> pi notably lower ferrets euthanized day <NUMBER> pi fig <NUMBER> l virus attachment assay indicated sarscov<NUMBER> could attach bronchiolar epithelial cells fig s<NUMBER>a type ii pneumocytes fig s<NUMBER>b ferret lung investigate whether sarscov<NUMBER> replicates lungs ferrets intratracheally inoculated eight ferrets <NUMBER> <NUMBER> pfu ctanh euthanized two animals days <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi look viral rna tissues organs viral rna detected nasal turbinate soft palate one two ferrets euthanized days <NUMBER> <NUMBER> pi soft palate one ferret nasal turbinate soft palate tonsil trachea ferret euthanized day <NUMBER> pi detected either two ferrets euthanized day <NUMBER> pi fig s<NUMBER> results indicate sarscov<NUMBER> replicate upper respiratory tract ferrets eight days without causing severe disease death cats dogs close contact humans therefore important understand susceptibility sarscov<NUMBER> covid<NUMBER> control first investigated replication sarscov<NUMBER> cats seven subadult cats aged <NUMBER> months outbred domestic cats intranasally inoculated <NUMBER> <NUMBER> pfu ctanh two animals scheduled euthanized days <NUMBER> pi <NUMBER> pi respectively evaluate viral replication organs three subadult cats placed separate cages within isolator monitor respiratory droplet transmission uninfected cat placed cage adjacent infected cats difficult perform regular nasal wash collection subadult cats aggressive avoid possible injury collected feces cats checked viral rna organs euthanasia viral rna detected nasal turbinate one animal soft palates tonsils tracheas lungs small intestine animals euthanized day <NUMBER> pi fig <NUMBER>a animals euthanized day <NUMBER> pi viral rna detected nasal turbinates soft palates tonsils animals trachea one animal small intestine however viral rna detected lung samples either animals fig <NUMBER>c infectious virus detected viral rnapositive nasal turbinates soft palates tonsils tracheas lungs cats recovered viral rnapositive small intestine fig <NUMBER> transmission study viral rna detected feces two virusinoculated subadult cats day <NUMBER> pi three virusinoculated subadult cats day <NUMBER> pi fig <NUMBER>a viral rna detected feces one exposed cat day <NUMBER> pi fig <NUMBER>a pair subadult cats viral rnapositive feces euthanized day <NUMBER> pi viral rna detected soft palate tonsils virusinoculated animal nasal turbinate soft palate tonsils trachea exposed animal fig <NUMBER>b indicating respiratory droplet transmission occurred pair cats euthanized pairs animals day <NUMBER> pi viral rna detected tonsils one virusinoculated subadult cat nasal turbinate soft palate tonsils trachea virusinoculated subadult cat detected organs tissues two exposed subadult cats fig <NUMBER>b antibodies sarscov<NUMBER> detected three virusinoculated subadult cats one exposed cat use elisa neutralization assay fig <NUMBER> c replicated replication transmission studies juvenile cats aged <NUMBER> days figs <NUMBER> e h <NUMBER> e g fig s<NUMBER> histopathologic studies performed samples virusinoculated juvenile cats died euthanized day <NUMBER> pi revealed massive lesions nasal tracheal mucosa epitheliums lungs fig s<NUMBER> results indicate sarscov<NUMBER> replicate efficiently cats younger cats permissive perhaps importantly virus transmit cats via airborne route next investigated replication transmission sarscov<NUMBER> dogs five <NUMBER>monthold beagles intranasally inoculated <NUMBER> <NUMBER> pfu ctanh housed two uninoculated beagles room oropharyngeal rectal swabs beagle collected days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pi viral rna detection virus titration vero e<NUMBER> cells viral rna detected rectal swabs two virusinoculated dogs day <NUMBER> pi rectal swab one dog day <NUMBER> pi table <NUMBER> one dog viral rna positive rectal swab day <NUMBER> pi euthanized day <NUMBER> pi viral rna detected organs tissues collected dog fig s<NUMBER> infectious virus detected swabs collected dogs sera collected dogs day <NUMBER> pi antibody detection use elisa two virusinoculated dogs seroconverted two virusinoculated dogs two contact dogs seronegative sarscov<NUMBER> according elisa table <NUMBER> fig s<NUMBER> results indicate dogs low susceptibility sarscov<NUMBER> also investigated susceptibility pigs chickens ducks sarscov<NUMBER> using strategy used assess dogs however viral rna detected swabs collected virusinoculated animals naïve contact animals table <NUMBER> animals seronegative sarscov<NUMBER> tested using elisa sera collected day <NUMBER> pi table <NUMBER> results indicate pigs chickens ducks susceptible sarscov<NUMBER> summary found ferrets cats highly susceptible sarscov<NUMBER> dogs low susceptibility livestock including pigs chickens ducks susceptible virus ferrets frequently used animal model study human respiratory viruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> unlike influenza viruses human sarscoronavirus replicate upper lower respiratory tract ferrets <NUMBER> <NUMBER> <NUMBER> <NUMBER> found sarscov<NUMBER> replicates nasal turbinate soft palate tonsils ferrets may also replicate digestive tract viral rna detected rectal swabs virusinfected ferrets virus detected lung lobes even ferrets intratracheally inoculated virus remains unclear whether virus causes severe disease male ferrets female ferrets observed among humans <NUMBER> <NUMBER> several studies reported sarscov<NUMBER> uses angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor enter cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> mainly expressed type ii pneumocytes serous epithelial cells tracheobronchial submucosal glands ferrets <NUMBER> ferrets cats two amino acid differences sarscov<NUMBER> spikecontacting regions ace<NUMBER> table s<NUMBER> therefore underlying mechanism prevents replication sarscov<NUMBER> lower respiratory tract ferrets remains investigated fact sarscov<NUMBER> replicates efficiently upper respiratory tract ferrets makes candidate animal model evaluating antiviral drugs vaccine candidates covid<NUMBER> cats used study outbred susceptible sarscov<NUMBER> replicated efficiently transmitted naïve cats cats wuhan reported seropositive sarscov<NUMBER> <NUMBER> surveillance sarscov<NUMBER> cats considered adjunct elimination covid<NUMBER> humans international cc <NUMBER> license permits unrestricted use distribution reproduction medium provided original work properly cited view copy license visit httpscreativecommonsorglicensesby<NUMBER> license apply figuresphotosartwork content included article credited third party obtain authorization rights holder using material sciencesciencemagorgcgicontentfullscienceabb<NUMBER>dc<NUMBER> materials methods supplementary text figs s<NUMBER> s<NUMBER> table s<NUMBER> references notes <NUMBER> <NUMBER> <NUMBER> mdar reproducibility checklist viewrequest protocol paper bioprotocol others viral negative organs including brain heart submaxillary lymph nodes kidneys spleen liver pancreas color bar represents value individual animal horizontal dashed lines indicate lower limit detection one virusinoculated beagle euthanized day <NUMBER> pi viral rna detected collected organs included lung trachea nasal turbinate soft palate brain heart tonsil kidneys spleen liver pancreas small intestine fig s<NUMBER> c sera collected animals day <NUMBER> pi antibodies sarscov<NUMBER> detected using double antigen sandwich elisa kit prottech luoyang china theoretical analysis quantitative analysis simulation needed prediction various infectious diseases analysis cannot carried without models established various infectious diseases infectious disease transmission complicated diffusion process occurring crowd models established process analyze study transmission process infectious diseases theoretically <NUMBER> accurately predict future development trend infectious diseases <NUMBER> therefore order control reduce harm infectious diseases research analysis infectious disease prediction models become hot research topic <NUMBER> traditional infectious disease prediction models mainly include differential equation prediction models time series prediction models based statistics random processes differential equation prediction models establish differential equation reflect dynamic characteristics infectious diseases according characteristics population growth occurrence diseases laws transmission within population qualitative quantitative analysis numerical simulation model dynamics occurrence process diseases displayed transmission laws revealed change development trends predicted causes key factors disease transmission analyzed optimal strategies prevention control sought theoretical basis quantitative basis provided people make prevention control decisions common models predicting infectious disease dynamics differential equations ordinary differential systems directly reflect relationship instantaneous rate change individuals compartment corresponding time compartments partial differential system common model system considering age structure delay differential system kind differential system appears structure stage considered eg infected person definite infectious period latent person definite incubation period immunized person definite immune period etc currently widely studied applied models include si model sis model sir model seir model etc <NUMBER> system individuals divided different categories category state respectively susceptible eexposed infected r remove classical differential equation prediction model assumes total number people certain area constant prompt natural transmission process infectious diseases describe evolution relationship different types nodes time reveal overall information transmission law however practice population changing time always form interaction populations terms food resources living space connection individuals random difference spreading individuals ignored thus limiting application scope model infectious disease prediction model established method relies curve fitting parameter estimation available time series data difficult apply large number irregular data infectious disease surveillance research based internet begun rise since mid<NUMBER>s <NUMBER> provide information services public health management institutions medical workers public analyzing processing provide users early warning situational awareness information infectious diseases <NUMBER> early research traditional web page web information example related news topics authoritative organizations etc main data source however development internet research begun expand data sources social media twitter facebook microblog etc multimedia information recent years due global spread internet people use internet search engines social networks online map tools track frequency location information query keywords strengthen integration information social public focus hot issues realize disease monitoring based search engines social media predict incidence infectious diseases provide important reference decision management infectious disease prevention control <NUMBER> theory internet search tracking efficient reflect realtime status infectious diseases therefore infectious disease prediction models based internet search engine good supplement traditional infectious disease prediction models <NUMBER> compared traditional prediction models internetbased infectious disease prediction models advantages realtime fast predict incidence trend infectious diseases early possible suitable data analysis large number people however sensitivity spatial resolution accuracy prediction need improved internetbased infectious disease prediction models cannot replace traditional prediction models used extension traditional infectious disease prediction model <NUMBER> paper use <NUMBER> sars data verify three mathematical models logistic model bertalanffy model gompertz model predict development trend virus use three models fit analyze epidemic trend covid<NUMBER> wuhan mainland china nonhubei areas including total number confirmed cases number deaths end time epidemic short machine learning learn useful information large amount data using algorithm model specific problems machine learning spans variety fields medicine computer science statistics engineering technology psychology etc <NUMBER> example neural network relatively mature machine learning algorithm simulate highdimensional nonlinear optimal mapping input output imitating processing function biological brains nervous system faced complex data relations traditional statistical method effective may receive accurate results neural network <NUMBER> since new infectious diseases occurring human beings animal origin animal infectious diseases effective prerequisite predict diseases determining common intrinsic characteristics species environmental conditions lead overflow new infections analyzing intrinsic characteristics wild species machine learning new reservoirs mammals carriers insects zoonotic diseases accurately predicted <NUMBER> overall goal machine learningbased approach extend causal inference theory machine learning identify quantify important factors cause zoonotic disease outbreaks generate visual tools illustrate complex causal relationships animal infectious diseases correlation zoonotic diseases <NUMBER> however highly nonlinear complex problems analyzed early prediction model infectious diseases based machine learning usually lead local minima global minima leading limitations machine learning model infectious disease prediction models mainly include differential equation prediction models based dynamics time series prediction models based statistics random processes internetbased infectious disease prediction model machine learning methods models complicated many factors considered often leads overfitting paper logistic model bertalanffy model gompertz model relatively simple accord statistical law epidemiology selected predict epidemic situation covid<NUMBER> model selected least square method used curve fitting least square method mathematical optimization technique finds best function match data minimizing sum squareed errors using least square method unknown data easily obtained sum squares errors obtained data actual data minimized <NUMBER> logistic model logistic model mainly used epidemiology commonly explore risk factors certain disease predict probability occurrence certain disease according risk factors roughly predict development transmission law epidemiology logistic regression analysis qt cumulative confirmed cases deaths predicted maximum confirmed cases deaths b c fitting coefficients number days since first case t<NUMBER> time first case occurred <NUMBER> bertalanffy model bertalanffy model often used growth model mainly used study factors control affect growth used describe growth characteristics fish species also used describe growth animals pigs horses cattle sheep etc infectious diseases development infectious diseases similar growth individuals populations paper bertalanffy model selected describe spread law infectious diseases study factors control affect spread covid<NUMBER> qt cumulative confirmed cases deaths predicted maximum confirmed cases deaths b c fitting coefficients number days since first case t<NUMBER> time first case occurred <NUMBER> gompertz model model originally proposed gomperts gompertz<NUMBER> animal population growth model describe extinction law population development infectious diseases similar growth individuals populations paper gompertz model selected describe spread law infectious diseases study factors control affect spread covid<NUMBER> qt cumulative confirmed cases deaths predicted maximum confirmed cases deaths b c fitting coefficients number days since first case t<NUMBER> time first case occurred regression coefficient r <NUMBER> used evaluate fitting ability various methods obtained following equation actual cumulative confirmed covid<NUMBER> cases � predicted cumulative confirmed covid<NUMBER> cases � average actual cumulative confirmed covid<NUMBER> cases closer fitting coefficient <NUMBER> accurate prediction covid<NUMBER> sars virus coronaviruses infection pattern may similar firstly used sars data verify rationality model  cumulative number confirmed cases novel coronavirus hereinafter referred covid figure <NUMBER> number confirmed cases dramatically increased china since first case confirmed epidemic spreads parts hubei whole country wuhan center since main confirmed cases wuhan development trend new confirmed cases whole country basically wuhan judging prediction results three models predict epidemic situation covid<NUMBER> well later stage epidemic among logistic model better two models fitting data wuhan gompertz model better fitting data outside wuhan due various reasons worth noting number confirmed cases suddenly increased <NUMBER> february <NUMBER> <NUMBER>obviously mutation data originate mechanism virus treatment method remove impact part data mutation <NUMBER> <NUMBER> peoplethen impact sudden increase confirmed cases considered later fitting analysis according daily realtime updated data covid<NUMBER> used three mathematical models logistic model bertalanffy model gompertz model carry fitting analysis epidemic covid<NUMBER> prediction results shown table <NUMBER> prediction cumulative confirmed number final predicted cumulative confirmed number a<NUMBER> b c fitting coefficients number days since first case r <NUMBER> c means fitting goodness cumulative confirmed cases r <NUMBER> n means fitting goodness new confirmed cases c three models predicting covid<NUMBER> cases nonhubei areas since january <NUMBER> order predict turning point use three models compare new confirmed cases wuhan china mainland nonhubei areas seen figure <NUMBER> turning points w wuhan china mainland nonhubei areas february <NUMBER> february <NUMBER> february <NUMBER> <NUMBER> respectively results prediction newly confirmed cases three models predict covid<NUMBER> epidemic well early late stages epidemic among logistic model better two models fitting data fitting parameters model seen table <NUMBER> prediction death toll b c fitting coefficients number days since first case r <NUMBER> dc means fitting goodness cumulative deaths according available data death toll predicted three models wuhan <NUMBER> non stronger support various resources across country getting stronger ability refine management treatment getting stronger factors likely rapidly reduce mortality rate covid<NUMBER> factors may also influence cumulative number confirmed cases due large number confirmed cases influence favorable human factors cumulative number confirmed cases may small present papers prediction covid<NUMBER> epidemic collected covid<NUMBER> epidemic predictions researchers shown table <NUMBER> seen table <NUMBER> coronaviruses belong coronaviridae family nidovirales order corona represents crownlike spikes outer surface virus thus named coronavirus <NUMBER> chinese population infected virus causing severe acute respiratory syndrome sars guangdong province virus confirmed member betacoronavirus subgroup named sarscov <NUMBER> <NUMBER> infected patients exhibited pneumonia symptoms diffused alveolar injury lead acute respiratory distress syndrome ards sars initially emerged guangdong china spread rapidly around globe <NUMBER> infected persons <NUMBER> deceases decade later <NUMBER> couple saudi arabian nationals diagnosed infected another coronavirus detected virus confirmed member coronaviruses named middle east respiratory syndrome coronavirus merscov world health organization reported merscoronavirus infected <NUMBER> individuals <NUMBER> deaths <NUMBER> merscov member betacoronavirus subgroup phylogenetically diverse humancov infection merscov initiates mild upper respiratory injury progression leads severe respiratory disease similar sarscoronavirus patients infected merscoronavirus suffer pneumonia followed ards renal failure <NUMBER> recently end <NUMBER> informed chinese government several cases pneumonia unfamiliar etiology outbreak initiated hunan seafood market wuhan city china rapidly infected <NUMBER> peoples live animals frequently sold hunan seafood market bats frogs snakes birds marmots rabbits <NUMBER> <NUMBER> january <NUMBER> national health commission china released details epidemic suggested viral pneumonia <NUMBER> sequencebased analysis isolates patients virus identified novel coronavirus moreover genetic sequence also provided diagnosis viral infection initially suggested patients infected wuhan coronavirus induced pneumonia china may visited seafood market live animals sold may used infected animals birds source food however investigations revealed individuals contracted infection even record visiting seafood market observations indicated human human spreading capability virus subsequently reported <NUMBER> countries world human human spreading virus occurs due close contact infected person exposed coughing sneezing respiratory droplets aerosols aerosols penetrate human body lungs via inhalation nose mouth fig <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> source origination transmission important determined order develop preventive strategies contain infection case sarscov researchers initially focused raccoon dogs palm civets key reservoir infection however samples isolated civets food market showed positive results viral rna detection suggesting civet palm might secondary hosts <NUMBER> <NUMBER> samples isolated healthy persons hongkong molecular assessment showed <NUMBER> frequency rate antibodies sarscoronavirus indications suggested sarscoronavirus may circulating humans causing outbreak <NUMBER> <NUMBER> later rhinolophus bats also found antisarscov antibodies suggesting bats source viral replication <NUMBER> middle east respiratory syndrome mers coronavirus first emerged <NUMBER> saudi arabia <NUMBER> merscoronavirus also pertains betacoronavirus camels zoonotic source primary host <NUMBER> recent study merscoronavirus also detected pipistrellus perimyotis bats <NUMBER> proffering bats key host transmitting medium virus <NUMBER> <NUMBER> initially group researchers suggested snakes possible host however genomic similarity findings novel coronavirus sarslike bat viruses supported statement snakes bats could key reservoirs table <NUMBER> <NUMBER> <NUMBER> analysis homologous recombination revealed receptor binding spike glycoprotein novel coronavirus developed sarscov covzxc<NUMBER> covzc<NUMBER> yet unknown betacov <NUMBER> nonetheless eradicate virus work required done aspects identification intermediate zoonotic source caused transmission virus humans coronaviruses contain specific genes orf<NUMBER> downstream regions encode proteins viral replication nucleocapsid spikes formation <NUMBER> glycoprotein spikes outer surface coronaviruses responsible attachment entry virus host cells fig <NUMBER> receptorbinding domain rbd loosely attached among virus therefore virus may infect multiple hosts <NUMBER> <NUMBER> coronaviruses mostly recognize aminopeptidases carbohydrates key receptor entry human cells sarscov merscov recognize exopeptidases <NUMBER> entry mechanism coronavirus depends upon cellular proteases include human airway trypsinlike protease hat cathepsins transmembrane protease serine <NUMBER> tmprss<NUMBER> split spike protein establish penetration changes <NUMBER> <NUMBER> merscoronavirus employs dipeptidyl peptidase <NUMBER> dpp<NUMBER> hcovnl<NUMBER> sarscoronavirus require angiotensinconverting enzyme <NUMBER> ace<NUMBER> key receptor <NUMBER> <NUMBER> sarscov<NUMBER> possesses typical coronavirus structure spike protein also expressed polyproteins nucleoproteins membrane proteins rna polymerase <NUMBER>chymotrypsinlike protease papainlike protease helicase glycoprotein accessory proteins <NUMBER> <NUMBER> spike protein sarscov<NUMBER> contains <NUMBER>d structure rbd region maintain van der waals forces <NUMBER> <NUMBER> glutamine residue rbd region sarscov<NUMBER> recognized critical lysine <NUMBER> residue human ace<NUMBER> receptor <NUMBER> entire mechanism pathogenicity sarscov<NUMBER> attachment replication well mentioned fig <NUMBER> genome sarscov<NUMBER> reported <NUMBER> identical previous human coronavirus sarslike bat cov <NUMBER> structural proteins encoded four structural genes including spike envelope e membrane nucleocapsid n genes orf<NUMBER>ab largest gene sarscov<NUMBER> encodes pp<NUMBER>ab protein <NUMBER> nsps orf<NUMBER>a gene encodes pp<NUMBER>a protein also contains <NUMBER> nsps <NUMBER> <NUMBER> <NUMBER> according evolutionary tree sarscov<NUMBER> lies close group sarscoronaviruses <NUMBER> <NUMBER> fig <NUMBER> recent studies indicated notable variations sarscov sarscov<NUMBER> absence <NUMBER>a protein fluctuation number amino acids <NUMBER>b <NUMBER>c protein sarscov<NUMBER> <NUMBER> fig <NUMBER> also reported spike glycoprotein wuhan coronavirus modified via homologous recombination spike glycoprotein sarscov<NUMBER> mixture bat sarscov known betacov <NUMBER> fluorescent study confirmed sarscov<NUMBER> also uses ace<NUMBER> angiotensinconverting enzyme <NUMBER> cell receptor mechanism entry host cell previously used sarscov <NUMBER> <NUMBER> single n<NUMBER>t mutation sarscov<NUMBER>s spike protein may significantly enhanced binding affinity ace<NUMBER> <NUMBER> animal models play vital role uncover mechanisms viral pathogenicity entrance transmission designing therapeutic strategies previously examine replication sarscov various animal models used showed symptoms severe infection <NUMBER> contrast sarscov merscov pathogenesis observed small animals mice vulnerable infection merscoronavirus due noncompatibility dpp<NUMBER> receptor <NUMBER> entire genome <NUMBER>novel coronavirus <NUMBER> similar previous human sarslike bat cov previously used animal models sarscov utilized study infectious pathogenicity sarscov<NUMBER> human ace<NUMBER> cell receptor recognized sars novel coronaviruses conclusively talen crisprmediated genetically modified hamsters small animals utilized study pathogenicity novel coronaviruses sarscov reported replicate cause severe disease rats f<NUMBER> sequence analysis revealed mutation spike glycoprotein <NUMBER> thus could another suitable option develop spike glycoprotein targeting therapeutics novel coronaviruses recently mice models clinical isolates used develop therapeutic strategy sarscov<NUMBER> induced covid<NUMBER> <NUMBER> <NUMBER> similar study artificial intelligence prediction used investigate inhibitory role drug sarscov<NUMBER> <NUMBER> sarscov<NUMBER> infected patients also used conduct randomized clinical trials <NUMBER> <NUMBER> <NUMBER> important scientists worldwide collaborate design suitable model investigate vivo mechanisms associated pathogenesis sarscov<NUMBER> initially interferonsa nebulization broadspectrum antibiotics antiviral drugs used reduce viral load <NUMBER> <NUMBER> <NUMBER> however remdesivir shown promising impact virus <NUMBER> remdesivir combination chloroquine interferon beta significantly blocked sarscov<NUMBER> replication patients declared clinically recovered <NUMBER> <NUMBER> <NUMBER> various antivirals currently evaluated infection nafamostat nitazoxanide ribavirin penciclovir favipiravir ritonavir aak<NUMBER> baricitinib arbidol exhibited moderate results tested infection patients invitro clinical isolates <NUMBER> <NUMBER> <NUMBER> <NUMBER> several combinations combining antiviral antibiotics traditional chinese medicines also evaluated sarscov<NUMBER> induced infection humans mice <NUMBER> recently shanghai doctors isolated blood plasma clinically recovered patients covid<NUMBER> injected infected patients showed positive results rapid recovery <NUMBER> recent study identified monoclonal antibody cr<NUMBER> bindswith spike rbd sarscov<NUMBER> likely due antibodys epitope overlapping divergent ace<NUMBER> receptorbinding motif cr<NUMBER> potential developed therapeutic candidate alone combination neutralizing antibodies prevention treatment covid<NUMBER> infection <NUMBER> subgroup clusters labeled <NUMBER>a <NUMBER>b alphacoronavirus <NUMBER>a <NUMBER>b <NUMBER>c <NUMBER>d betacoronavirus tree based published trees coronavirinae <NUMBER> <NUMBER> reconstructed sequences complete rnadependent rna polymerasecoding region representative novel coronaviruses maximum likelihood method using mega <NUMBER> software severe acute respiratory syndrome coronavirus sarscov sarsrelated coronavirus sarsrcov middle east respiratory syndrome coronavirus merscov porcine enteric diarrhea virus pedv wuhan seafood market pneumonia wuhanhu<NUMBER> bat cov ratg<NUMBER> showed high sequence identity sarscov<NUMBER> <NUMBER> interpretation references colour figure legend reader referred web version article available vaccine covid<NUMBER> previous vaccines strategies used develop vaccine sarscov effective recombinant protein urbani ay<NUMBER> strain sarscov administered mice hamsters resulted production neutralizing antibodies protection sarscov <NUMBER> <NUMBER> dna fragment inactivated whole virus livevectored strain sarscov ay<NUMBER> significantly reduced viral infection various animal models <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> different strains sarscov also used produce inactivated livevectored vaccines efficiently reduced viral load animal models strains include tor<NUMBER> ay<NUMBER> <NUMBER> <NUMBER> utah ay<NUMBER> <NUMBER> fra ay<NUMBER> <NUMBER> hku<NUMBER> ay<NUMBER> <NUMBER> <NUMBER> bj<NUMBER> ay<NUMBER> <NUMBER> <NUMBER> ns<NUMBER> ay<NUMBER> <NUMBER> zj<NUMBER> ay<NUMBER> <NUMBER> gd<NUMBER> ay<NUMBER> <NUMBER> gz<NUMBER> ay<NUMBER> <NUMBER> however vaccines pipeline sarscov<NUMBER> mrna based vaccine prepared us national institute allergy infectious diseases sarscov<NUMBER> phase <NUMBER> trial <NUMBER> ino<NUMBER>dna based vaccine soon available human testing <NUMBER> chinese centre disease control prevention cdc working development inactivated virus vaccine <NUMBER> <NUMBER> soon mrna based vaccines sample prepared stermirna therapeutics available <NUMBER> geovaxbravovax working develop modified vaccina ankara mva based vaccine <NUMBER> clover biopharmaceuticals developing recombinant <NUMBER>ncov protein subunittrimer based vaccine <NUMBER> although research teams world working investigate key features pathogenesis treatment options deemed necessary focus competitive therapeutic options crossresistance vaccines instance possibility vaccines diseases rubella measles create crossresistance sarscov<NUMBER> statement crossresistance based observations children china found less vulnerable infection compared elder population children largely vaccinated measles china novel coronavirus originated hunan seafood market wuhan china bats snakes raccoon dogs palm civets animals sold rapidly spread <NUMBER> countries zoonotic source sarscov<NUMBER> confirmed however sequencebased analysis suggested bats key reservoir dna recombination found involved spike glycoprotein assorted sarscov covzxc<NUMBER> covzc<NUMBER> rbd another beta cov thus could reason crossspecies transmission rapid infection according phylogenetic trees sarscov closer sarslike bat covs promising clinical treatments prevention strategies developed human coronaviruses however researchers working develop efficient therapeutic strategies cope novel coronaviruses various broadspectrum antivirals previously used influenza sars mers coronaviruses evaluated either alone combinations treat covid<NUMBER> patients mice models clinical isolates remdesivir lopinavir ritonavir oseltamivir significantly blocked covid<NUMBER> infection infected patients cocluded homologus recombination event protein rbd region enhanced transmission ability virus decision bring back nationals infected area various countries poor screening passengers become leading cause spreading virus others countries importantly human coronaviruses targeting vaccines antiviral drugs designed could used current well future epidemics many companies working development effective sarscov<NUMBER> vaccines moderna therapeutics inovio pharmaceuticals novavax vir biotechnology stermirna therapeutics johnson johnson vidointervac geovaxbravovax clover biopharmaceuticals curevac codagenix need rapid human animalbased trails vaccines still require <NUMBER> months commercialization must complete ban utilizing wild animals birds source food beside development efficient drug strategy rapidly diagnose sarscov<NUMBER> suspected patient also required signs symptoms sarscov<NUMBER> induced covid<NUMBER> bit similar influenza seasonal allergies pollen allergies person suffering influenza seasonal allergy may also exhibit temprature detected thermoscanners hence person become suspected therefore accurate rapid diagnostic kit meter detection sarscov<NUMBER> suspected patients required pcr based testing expensive time consuming different teams chinese doctors immediately sent eurpean countries especially spain italy control spread covid<NUMBER> chinese doctors efficiently controlled outbreak china limited mortality rate less <NUMBER> therapeutic strategies used chinese also followed countries coronaviruses belong coronaviridae family nidovirales order corona represents crownlike spikes outer surface virus thus named coronavirus <NUMBER> chinese population infected virus causing severe acute respiratory syndrome sars guangdong province virus confirmed member betacoronavirus subgroup named sarscov <NUMBER> <NUMBER> infected patients exhibited pneumonia symptoms diffused alveolar injury lead acute respiratory distress syndrome ards sars initially emerged guangdong china spread rapidly around globe <NUMBER> infected persons <NUMBER> deceases decade later <NUMBER> couple saudi arabian nationals diagnosed infected another coronavirus detected virus confirmed member coronaviruses named middle east respiratory syndrome coronavirus merscov world health organization reported merscoronavirus infected <NUMBER> individuals <NUMBER> deaths <NUMBER> merscov member betacoronavirus subgroup phylogenetically diverse humancov infection merscov initiates mild upper respiratory injury progression leads severe respiratory disease similar sarscoronavirus patients infected merscoronavirus suffer pneumonia followed ards renal failure <NUMBER> recently end <NUMBER> informed chinese government several cases pneumonia unfamiliar etiology outbreak initiated hunan seafood market wuhan city china rapidly infected <NUMBER> peoples live animals frequently sold hunan seafood market bats frogs snakes birds marmots rabbits <NUMBER> <NUMBER> january <NUMBER> national health commission china released details epidemic suggested viral pneumonia <NUMBER> sequencebased analysis isolates patients virus identified novel coronavirus moreover genetic sequence also provided diagnosis viral infection initially suggested patients infected wuhan coronavirus induced pneumonia china may visited seafood market live animals sold may used infected animals birds source food however investigations revealed individuals contracted infection even record visiting seafood market observations indicated human human spreading capability virus subsequently reported <NUMBER> countries world human human spreading virus occurs due close contact infected person exposed coughing sneezing respiratory droplets aerosols aerosols penetrate human body lungs via inhalation nose mouth fig <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> source origination transmission important determined order develop preventive strategies contain infection case sarscov researchers initially focused raccoon dogs palm civets key reservoir infection however samples isolated civets food market showed positive results viral rna detection suggesting civet palm might secondary hosts <NUMBER> <NUMBER> samples isolated healthy persons hongkong molecular assessment showed <NUMBER> frequency rate antibodies sarscoronavirus indications suggested sarscoronavirus may circulating humans causing outbreak <NUMBER> <NUMBER> later rhinolophus bats also found antisarscov antibodies suggesting bats source viral replication <NUMBER> middle east respiratory syndrome mers coronavirus first emerged <NUMBER> saudi arabia <NUMBER> merscoronavirus also pertains betacoronavirus camels zoonotic source primary host <NUMBER> recent study merscoronavirus also detected pipistrellus perimyotis bats <NUMBER> proffering bats key host transmitting medium virus <NUMBER> <NUMBER> initially group researchers suggested snakes possible host however genomic similarity findings novel coronavirus sarslike bat viruses supported statement snakes bats could key reservoirs table <NUMBER> <NUMBER> <NUMBER> analysis homologous recombination revealed receptor binding spike glycoprotein novel coronavirus developed sarscov covzxc<NUMBER> covzc<NUMBER> yet unknown betacov <NUMBER> nonetheless eradicate virus work required done aspects identification intermediate zoonotic source caused transmission virus humans coronaviruses contain specific genes orf<NUMBER> downstream regions encode proteins viral replication nucleocapsid spikes formation <NUMBER> glycoprotein spikes outer surface coronaviruses responsible attachment entry virus host cells fig <NUMBER> receptorbinding domain rbd loosely attached among virus therefore virus may infect multiple hosts <NUMBER> <NUMBER> coronaviruses mostly recognize aminopeptidases carbohydrates key receptor entry human cells sarscov merscov recognize exopeptidases <NUMBER> entry mechanism coronavirus depends upon cellular proteases include human airway trypsinlike protease hat cathepsins transmembrane protease serine <NUMBER> tmprss<NUMBER> split spike protein establish penetration changes <NUMBER> <NUMBER> merscoronavirus employs dipeptidyl peptidase <NUMBER> dpp<NUMBER> hcovnl<NUMBER> sarscoronavirus require angiotensinconverting enzyme <NUMBER> ace<NUMBER> key receptor <NUMBER> <NUMBER> sarscov<NUMBER> possesses typical coronavirus structure spike protein also expressed polyproteins nucleoproteins membrane proteins rna polymerase <NUMBER>chymotrypsinlike protease papainlike protease helicase glycoprotein accessory proteins <NUMBER> <NUMBER> spike protein sarscov<NUMBER> contains <NUMBER>d structure rbd region maintain van der waals forces <NUMBER> <NUMBER> glutamine residue rbd region sarscov<NUMBER> recognized critical lysine <NUMBER> residue human ace<NUMBER> receptor <NUMBER> entire mechanism pathogenicity sarscov<NUMBER> attachment replication well mentioned fig <NUMBER> genome sarscov<NUMBER> reported <NUMBER> identical previous human coronavirus sarslike bat cov <NUMBER> structural proteins encoded four structural genes including spike envelope e membrane nucleocapsid n genes orf<NUMBER>ab largest gene sarscov<NUMBER> encodes pp<NUMBER>ab protein <NUMBER> nsps orf<NUMBER>a gene encodes pp<NUMBER>a protein also contains <NUMBER> nsps <NUMBER> <NUMBER> <NUMBER> according evolutionary tree sarscov<NUMBER> lies close group sarscoronaviruses <NUMBER> <NUMBER> fig <NUMBER> recent studies indicated notable variations sarscov sarscov<NUMBER> absence <NUMBER>a protein fluctuation number amino acids <NUMBER>b <NUMBER>c protein sarscov<NUMBER> <NUMBER> fig <NUMBER> also reported spike glycoprotein wuhan coronavirus modified via homologous recombination spike glycoprotein sarscov<NUMBER> mixture bat sarscov known betacov <NUMBER> fluorescent study confirmed sarscov<NUMBER> also uses ace<NUMBER> angiotensinconverting enzyme <NUMBER> cell receptor mechanism entry host cell previously used sarscov <NUMBER> <NUMBER> single n<NUMBER>t mutation sarscov<NUMBER>s spike protein may significantly enhanced binding affinity ace<NUMBER> <NUMBER> animal models play vital role uncover mechanisms viral pathogenicity entrance transmission designing therapeutic strategies previously examine replication sarscov various animal models used showed symptoms severe infection <NUMBER> contrast sarscov merscov pathogenesis observed small animals mice vulnerable infection merscoronavirus due noncompatibility dpp<NUMBER> receptor <NUMBER> entire genome <NUMBER>novel coronavirus <NUMBER> similar previous human sarslike bat cov previously used animal models sarscov utilized study infectious pathogenicity sarscov<NUMBER> human ace<NUMBER> cell receptor recognized sars novel coronaviruses conclusively talen crisprmediated genetically modified hamsters small animals utilized study pathogenicity novel coronaviruses sarscov reported replicate cause severe disease rats f<NUMBER> sequence analysis revealed mutation spike glycoprotein <NUMBER> thus could another suitable option develop spike glycoprotein targeting therapeutics novel coronaviruses recently mice models clinical isolates used develop therapeutic strategy sarscov<NUMBER> induced covid<NUMBER> <NUMBER> <NUMBER> similar study artificial intelligence prediction used investigate inhibitory role drug sarscov<NUMBER> <NUMBER> sarscov<NUMBER> infected patients also used conduct randomized clinical trials <NUMBER> <NUMBER> <NUMBER> important scientists worldwide collaborate design suitable model investigate vivo mechanisms associated pathogenesis sarscov<NUMBER> initially interferonsa nebulization broadspectrum antibiotics antiviral drugs used reduce viral load <NUMBER> <NUMBER> <NUMBER> however remdesivir shown promising impact virus <NUMBER> remdesivir combination chloroquine interferon beta significantly blocked sarscov<NUMBER> replication patients declared clinically recovered <NUMBER> <NUMBER> <NUMBER> various antivirals currently evaluated infection nafamostat nitazoxanide ribavirin penciclovir favipiravir ritonavir aak<NUMBER> baricitinib arbidol exhibited moderate results tested infection patients invitro clinical isolates <NUMBER> <NUMBER> <NUMBER> <NUMBER> several combinations combining antiviral antibiotics traditional chinese medicines also evaluated sarscov<NUMBER> induced infection humans mice <NUMBER> recently shanghai doctors isolated blood plasma clinically recovered patients covid<NUMBER> injected infected patients showed positive results rapid recovery <NUMBER> recent study identified monoclonal antibody cr<NUMBER> bindswith spike rbd sarscov<NUMBER> likely due antibodys epitope overlapping divergent ace<NUMBER> receptorbinding motif cr<NUMBER> potential developed therapeutic candidate alone combination neutralizing antibodies prevention treatment covid<NUMBER> infection <NUMBER> subgroup clusters labeled <NUMBER>a <NUMBER>b alphacoronavirus <NUMBER>a <NUMBER>b <NUMBER>c <NUMBER>d betacoronavirus tree based published trees coronavirinae <NUMBER> <NUMBER> reconstructed sequences complete rnadependent rna polymerasecoding region representative novel coronaviruses maximum likelihood method using mega <NUMBER> software severe acute respiratory syndrome coronavirus sarscov sarsrelated coronavirus sarsrcov middle east respiratory syndrome coronavirus merscov porcine enteric diarrhea virus pedv wuhan seafood market pneumonia wuhanhu<NUMBER> bat cov ratg<NUMBER> showed high sequence identity sarscov<NUMBER> <NUMBER> interpretation references colour figure legend reader referred web version article available vaccine covid<NUMBER> previous vaccines strategies used develop vaccine sarscov effective recombinant protein urbani ay<NUMBER> strain sarscov administered mice hamsters resulted production neutralizing antibodies protection sarscov <NUMBER> <NUMBER> dna fragment inactivated whole virus livevectored strain sarscov ay<NUMBER> significantly reduced viral infection various animal models <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> different strains sarscov also used produce inactivated livevectored vaccines efficiently reduced viral load animal models strains include tor<NUMBER> ay<NUMBER> <NUMBER> <NUMBER> utah ay<NUMBER> <NUMBER> fra ay<NUMBER> <NUMBER> hku<NUMBER> ay<NUMBER> <NUMBER> <NUMBER> bj<NUMBER> ay<NUMBER> <NUMBER> <NUMBER> ns<NUMBER> ay<NUMBER> <NUMBER> zj<NUMBER> ay<NUMBER> <NUMBER> gd<NUMBER> ay<NUMBER> <NUMBER> gz<NUMBER> ay<NUMBER> <NUMBER> however vaccines pipeline sarscov<NUMBER> mrna based vaccine prepared us national institute allergy infectious diseases sarscov<NUMBER> phase <NUMBER> trial <NUMBER> ino<NUMBER>dna based vaccine soon available human testing <NUMBER> chinese centre disease control prevention cdc working development inactivated virus vaccine <NUMBER> <NUMBER> soon mrna based vaccines sample prepared stermirna therapeutics available <NUMBER> geovaxbravovax working develop modified vaccina ankara mva based vaccine <NUMBER> clover biopharmaceuticals developing recombinant <NUMBER>ncov protein subunittrimer based vaccine <NUMBER> although research teams world working investigate key features pathogenesis treatment options deemed necessary focus competitive therapeutic options crossresistance vaccines instance possibility vaccines diseases rubella measles create crossresistance sarscov<NUMBER> statement crossresistance based observations children china found less vulnerable infection compared elder population children largely vaccinated measles china novel coronavirus originated hunan seafood market wuhan china bats snakes raccoon dogs palm civets animals sold rapidly spread <NUMBER> countries zoonotic source sarscov<NUMBER> confirmed however sequencebased analysis suggested bats key reservoir dna recombination found involved spike glycoprotein assorted sarscov covzxc<NUMBER> covzc<NUMBER> rbd another beta cov thus could reason crossspecies transmission rapid infection according phylogenetic trees sarscov closer sarslike bat covs promising clinical treatments prevention strategies developed human coronaviruses however researchers working develop efficient therapeutic strategies cope novel coronaviruses various broadspectrum antivirals previously used influenza sars mers coronaviruses evaluated either alone combinations treat covid<NUMBER> patients mice models clinical isolates remdesivir lopinavir ritonavir oseltamivir significantly blocked covid<NUMBER> infection infected patients cocluded homologus recombination event protein rbd region enhanced transmission ability virus decision bring back nationals infected area various countries poor screening passengers become leading cause spreading virus others countries importantly human coronaviruses targeting vaccines antiviral drugs designed could used current well future epidemics many companies working development effective sarscov<NUMBER> vaccines moderna therapeutics inovio pharmaceuticals novavax vir biotechnology stermirna therapeutics johnson johnson vidointervac geovaxbravovax clover biopharmaceuticals curevac codagenix need rapid human animalbased trails vaccines still require <NUMBER> months commercialization must complete ban utilizing wild animals birds source food beside development efficient drug strategy rapidly diagnose sarscov<NUMBER> suspected patient also required signs symptoms sarscov<NUMBER> induced covid<NUMBER> bit similar influenza seasonal allergies pollen allergies person suffering influenza seasonal allergy may also exhibit temprature detected thermoscanners hence person become suspected therefore accurate rapid diagnostic kit meter detection sarscov<NUMBER> suspected patients required pcr based testing expensive time consuming different teams chinese doctors immediately sent eurpean countries especially spain italy control spread covid<NUMBER> chinese doctors efficiently controlled outbreak china limited mortality rate less <NUMBER> therapeutic strategies used chinese also followed countries covid<NUMBER> become one biggest health concern along huge economic burden clear remedies treat disease doctors repurposing drugs like chloroquine remdesivir treat covid<NUMBER> patients parallel research institutes collaboration biotech companies identified strategies use viral proteins vaccine candidates covid<NUMBER> although looks promising still need pass test challenge studies animal models various models sarscov<NUMBER> testing phase biotech companies bypassed animal studies moved phase clinical trials view present outbreak looks justified approach problem absence animal studies never predict outcomes humans since animal models critical vaccine development sarscov<NUMBER> different transmission dynamics review compare different animal models sarscov<NUMBER> humans pathogenic immune response transmission dynamics make ideal models vaccine testing covid<NUMBER> another issue using animal model ethics using animals research thus also discuss pros cons using animals vaccine development studies current global vaccine drug efforts covid<NUMBER> pros cons bypassing animal trials desperate need treatments sars cov<NUMBER> virus causes covid <NUMBER> <NUMBER> disease <NUMBER> one unmet need antiviral therapy development identification virologic surrogates <NUMBER> clinically meaningful endpoints death need hospitalization case sarscov<NUMBER> infected people viral load routinely measured nasal samples saliva <NUMBER> however primary <NUMBER> site disease lung tissue therefore bronchoalveolar lavage bal lungs would ideal <NUMBER> sample however bal usually necessary diagnosis represents infection risk medical <NUMBER> personnel rarely performed care covid<NUMBER> patients bal occur often <NUMBER> late disease critically ill patients rather early clinical presentation thus natural <NUMBER> kinetics sars cov<NUMBER> lungs unknown humans <NUMBER> humans doubleblind randomized placebocontrolled trial showed nucleoside <NUMBER> analog remdesivir limited duration illness approached statistical significance reduction <NUMBER> mortality given later disease <NUMBER> separate study overall later time treatment <NUMBER> initiation remdesivir effect viral load clinical outcome <NUMBER> recent preprint demonstrated <NUMBER> remdesivir highly effective initiated <NUMBER> hours infection rhesus macaques <NUMBER> <NUMBER> context remdesivir prevented pneumonia limited extent clinical illness effect <NUMBER> viral shedding serial bal specimens viral load nasal passage unchanged relative <NUMBER> animals treated vehicle first several days infection higher starting day <NUMBER> <NUMBER> critical question whether nasal viral loads potentially useful surrogate extent lung <NUMBER> disease covid<NUMBER> infection <NUMBER> develop mathematical models recapitulate viral load trajectories anatomic <NUMBER> compartments infected rhesus macaques models explain differences according <NUMBER> different underlying viral kinetics therapy compartments well differential drug potency <NUMBER> nasal passage versus lung infiltrates chest radiograph lower viral load nucleic acid viral titer measurement <NUMBER> bronchoalveolar lavage fluid days <NUMBER> <NUMBER> <NUMBER> decreased volume lung lesions lung weight <NUMBER> inflammation histologic postmortem exam <NUMBER> <NUMBER> reexamined viral loads bal nasal specimens noted days <NUMBER> <NUMBER> <NUMBER> post<NUMBER> infection bal viral loads lower remdesivir arm relative vehicle arm approximately <NUMBER> single order magnitude fig <NUMBER>a similar results observed viral load measured using <NUMBER> viral culture <NUMBER> nasal specimens observed difference viral loads days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> day <NUMBER> trend towards higher viral loads remdesivir treated arm day <NUMBER> <NUMBER> nasal <NUMBER> viral loads statistically higher treated arm relative vehicle fig <NUMBER>b <NUMBER> nasal viral loads compared longitudinally bal viral loads vehicle treated <NUMBER> animals viral loads generally higher bal nasal passages days <NUMBER> <NUMBER> <NUMBER> fig <NUMBER>c <NUMBER> remdesivirtreated animals viral loads equivalent days <NUMBER> <NUMBER> higher nasal <NUMBER> passages bal day <NUMBER> fig <NUMBER>d overall results suggest remdesivir lowered viral load <NUMBER> lung appeared opposite effect nasal passages rhesus macaques late timepoints molecule achieve active triphosphate form ntp well distribution metabolites <NUMBER> plasma tissue <NUMBER> singledose pk fit model data healthy rhesus macaques various <NUMBER> intermediate metabolites measured time following single injection <NUMBER> mgkg including <NUMBER> levels ntp pbmcs <NUMBER> <NUMBER> also simultaneously fit model multidose drug metabolite <NUMBER> trough levels infected rhesus macaques <NUMBER> mgkg day <NUMBER> thereafter <NUMBER> mgkg daily <NUMBER> days <NUMBER> till <NUMBER> postinfection including day <NUMBER> level nuc tissue time necropsy day <NUMBER> <NUMBER> fig <NUMBER>b <NUMBER> rdv pk parameters listed table <NUMBER> pd models assumes ec<NUMBER> concentration <NUMBER> active metabolite ntp replication inhibited <NUMBER> <NUMBER> model able recapitulate levels remdesivir metabolites healthy fig <NUMBER>a <NUMBER> infected rhesus macaques fig <NUMBER>b <NUMBER> lung nasal mathematical model sars cov<NUMBER> rhesus macaques developed model <NUMBER> viral replication nasal passage lungs includes multiple mechanisms may occur <NUMBER> following infection lungs nasal passages fig <NUMBER>a model adaptation previous <NUMBER> model human covid<NUMBER> infection includes densitydependent death infected cells proxy <NUMBER> intensifying innate response higher burden infection proliferation susceptible epithelial <NUMBER> cells conversion susceptible andor infected cells infection refractory state movement <NUMBER> virus nasal passages lung <NUMBER> fit different versions model viral loads <NUMBER> nasal passages lung <NUMBER> infected remdesivirtreated animals <NUMBER> using model selection theory found model minimal complexity necessary <NUMBER> explain observed data one fig <NUMBER>b model infected cell death viral production <NUMBER> different rates lung compared nasal passage table <NUMBER> furthermore selected model <NUMBER> susceptible lung cells proliferate become refractory infection cells nasal passages <NUMBER> table <NUMBER> interestingly model lacked viral interchange lung nasal passages <NUMBER> <NUMBER> model fit viral load data untreated rhesus macaques best model fit recapitulated <NUMBER> frequently observed trend higher viral loads bal late timepoints relative nasal passage <NUMBER> untreated macaques fig <NUMBER>a model also closely captured viral dynamics bal untreated <NUMBER> animals mostly captured nasal viral loads well though outlier datapoints compromised model fit <NUMBER> somewhat several animals <NUMBER> infected cell death rates generally higher viral replication rates uniformly lower <NUMBER> nasal passages relative lungs untreated animals table <NUMBER> densitydependent exponent <NUMBER> similar value compartments k<NUMBER> similar predicted humans <NUMBER> led suppressed viral replication varied somewhat across animals course treatment day <NUMBER> day <NUMBER> mean efficacy rdv treatment nasal mucosa estimated <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rm<NUMBER> rm<NUMBER> rm<NUMBER> rm<NUMBER> rm<NUMBER> rm<NUMBER> respectively similarly <NUMBER> course treatment day <NUMBER> day <NUMBER> mean efficacy rdv treatment lung <NUMBER> estimated <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rm<NUMBER> rm<NUMBER> rm<NUMBER> rm<NUMBER> rm<NUMBER> <NUMBER> rm<NUMBER> respectively fig <NUMBER> brief reductions rdv drug concentrations doses related lower <NUMBER> active metabolite levels cells associated viral reexpansion dose fig <NUMBER>b <NUMBER> antiviral potency remdesivir estimated using vivo ec<NUMBER> whereas vitro ic<NUMBER> <NUMBER> estimate antiviral concentration needed inhibit <NUMBER> viral replication based vitro <NUMBER> experiments estimate ec<NUMBER> based viral loads measured vivo animal human experiments <NUMBER> <NUMBER> estimates ivio ec<NUMBER> roughly <NUMBER>fold higher <NUMBER>fold lower potency lung relative <NUMBER> nasal passages table <NUMBER> variability nasal viral load peak contemporaneous viral loads <NUMBER> treated animals generally related difference vivo ec<NUMBER> rather viral replication rate rm<NUMBER> <NUMBER> complex kinetics low peak viral load followed viral rebound captured <NUMBER> model may represent drug resistant variant <NUMBER> found lowest ec<NUMBER> one animal <NUMBER> accelerated viral elimination lung rm<NUMBER> found higher infected cell death rate <NUMBER> lung similar ec<NUMBER> relative <NUMBER> treated animals table <NUMBER> <NUMBER> <NUMBER> next performed counterfactual simulations six treated animals assumed <NUMBER> received treatment ϵ <NUMBER> ϵ <NUMBER> viral load trajectories simulations fig <NUMBER> appear <NUMBER> similar untreated animals bal viral loads often exceeding nasal viral loads later <NUMBER> timepoints fig <NUMBER>a comparisons counterfactual viral load tracings treated animals suggests <NUMBER> majority viral load decrease lungs achieved following first dose carried <NUMBER> forward throughout duration therapy unchanged decay slopes hand nasal <NUMBER> passages viral load decreased initially therapy stabilizes even increases leading <NUMBER> higher viral loads counterfactual projections fig <NUMBER> nasal cavity somewhere day <NUMBER> <NUMBER> therapy tracings cross viral loads <NUMBER> treated animals predicted exceed counterfactual simulations animals <NUMBER> therapy fig <NUMBER> model projects early treatment reduces viral load thereby decreasing new early <NUMBER> infection preventing depletion susceptible cells nasal passages fig <NUMBER> even without <NUMBER> assuming susceptible cell proliferation adequate population cells establish steady <NUMBER> state viral replication fig <NUMBER> lung remdesivir less potent initially susceptible cells <NUMBER> become refractory infection treatment leads slower depletion susceptible cells cells <NUMBER> nevertheless depleted linear fashion convert refractory state fig <NUMBER> inclusion <NUMBER> refractory cell compartment therefore necessary allow linear elimination virus serial bal <NUMBER> decreased cell death lungs remdesivir treated animals informal assessment lung <NUMBER> damage longitudinally assessed cell death time counterfactual simulations case <NUMBER> therapy decreased degree peak cell death least <NUMBER> fig <NUMBER> lung damage multi<NUMBER> factorial covid<NUMBER> finding qualitatively compatible observation early <NUMBER> remdesivir spared <NUMBER> animals severe clinical disease abnormal lung histopathology <NUMBER> <NUMBER> projected nasal lung viral load trajectories higher drug potency next performed sensitivity <NUMBER> analyses assumed potent antiviral effect could arise either different <NUMBER> dosing remdesivir drug potent drug nasal passages fig <NUMBER>a lungs fig <NUMBER> <NUMBER>b impact first dose profound higher potency leading abrupt decline <NUMBER> viral load <NUMBER> estimate minimum drug efficacies <NUMBER> <NUMBER> would required eliminate <NUMBER> virus nasal passages lungs within <NUMBER> days drug given <NUMBER> hours infection <NUMBER> need high potency reflects lack concurrent immune response early stage <NUMBER> infection modeling human infection antiviral treatment moderate potency would clear viral <NUMBER> infection nasal passage sputum dosed prior peak viral load would clear infection <NUMBER> dose several days later <NUMBER> simulations rhesus macaque data arrive similar conclusion <NUMBER> nasal passage paradoxically later treatment moderate potency drug results lower viral <NUMBER> loads whereas treatment started peak results increased late viral loads fig <NUMBER>a contrast <NUMBER> lungs later treatment days <NUMBER> <NUMBER> leads subsequent viral load trajectory similar <NUMBER> earlier treated animals later stages infection fig <NUMBER>b <NUMBER> estimate minimum drug efficacies <NUMBER> <NUMBER> would required eliminate <NUMBER> virus nasal passages lungs within <NUMBER> days drug given <NUMBER> days infection <NUMBER> result due higher remaining viral load lungs animals first untreated <NUMBER> days <NUMBER> infection viral load valid surrogate endpoint treatment efficacy several viruses including hiv <NUMBER> hepatitis b hepatitis c cytomegalovirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> plausible sars cov<NUMBER> lung viral load also <NUMBER> predictive disease severity humans viral loads swabs infected tissue provide <NUMBER> approximation number infected cells given point time therefore surface area <NUMBER> infected tissue <NUMBER> <NUMBER> unfortunately less certain whether viral load measurements leveraged <NUMBER> sars cov<NUMBER> treatment response humans bal required measure lung viral loads <NUMBER> never performed longitudinally infected people part routine clinical care experience <NUMBER> respiratory viruses suggests viral load measures upper airway nasal swab <NUMBER> saliva may may representative lung <NUMBER> <NUMBER> apply mathematical models remdesivir treatment data rhesus macaques <NUMBER> lung nasal viral load measured identify relationship lung nasal hand rhesus macaques extensive lung damage clinic illness observed <NUMBER> within two days infection keeping severe illness humans emerges least <NUMBER> week initial phase illness <NUMBER> <NUMBER> hypothesize direct intratracheal inoculation <NUMBER> macaques high viral titer results immediate infection lung humans common <NUMBER> pattern respiratory viruses start replicating upper airway transmit lungs <NUMBER> second stage infection <NUMBER> alternative mutually exclusive explanation degree <NUMBER> viral replication lung also established extremely early humans extensive <NUMBER> immunemediated damage may correlated extent early viral replication occurs <NUMBER> <NUMBER> weeks later rhesus macaques highest lung viral loads followed longer period <NUMBER> time possible severe pneumonia would developed later timepoints <NUMBER> counterintuitive result predicted model remdesivir slightly potent <NUMBER> nasal cavity lung per cell level assuming drug levels indeed equivalent two <NUMBER> compartments nevertheless sars cov<NUMBER> cleared nasal passages effectively lungs <NUMBER> treatment effectiveness antiviral therapies never independent concurrent <NUMBER> intensity immune response infection <NUMBER> <NUMBER> previously predicted potent therapy <NUMBER> needed <NUMBER> days sars cov<NUMBER> infection relative <NUMBER> days infection little <NUMBER> innate immune pressure virus early expansion phase <NUMBER> result despite slight <NUMBER> blunting initial viral loads virus rebound stabilize end higher viral level nose <NUMBER> absence treatment <NUMBER> recapitulate finding nasal passages also predict occur <NUMBER> lungs macaques lung nasal cavity assume density dependent killing proxy intensifying innate response higher burden infection however model also <NUMBER> suggests ongoing infection drives percentage lung cells become temporarily refractory <NUMBER> infection inclusion assumption required recapitulate lung viral load data explain <NUMBER> observation lung damage severely blunted animals receiving treatment assumption <NUMBER> supported modeling influenza infection <NUMBER> several limitations approach first approximation lung damage <NUMBER> relatively coarse based complexity postviral inflammatory process may mediated <NUMBER> factors number infected cells therefore qualitative target modeling <NUMBER> second fits nasal viral load imperfect may due imprecision viral load <NUMBER> measurements well missed components within model case rm<NUMBER> substantial <NUMBER> viral rebound may due incomplete innate responses first pulse infection de novo <NUMBER> drug resistance third model early infection therefore neglect critical impact late <NUMBER> acquired immune response <NUMBER> <NUMBER> conclusion demonstrate rhesus macaques nonlinear forces governing sars <NUMBER> cov<NUMBER> viral load trajectories lung nasal passages differ substantially presence <NUMBER> partially effective antiviral therapy extent rhesus macaque model approximates human <NUMBER> infection nasal viral load remains promising surrogate endpoint marker perhaps context <NUMBER> highly potent antiviral therapy experimental data analyzed viral load observations nasal passages bal remdesivir <NUMBER> metabolites plasma concentrations <NUMBER> sarscov<NUMBER>infected rhesus macaques <NUMBER> <NUMBER> treated remdesivir <NUMBER> received vehicle control <NUMBER> remdesivir infused <NUMBER> hours infection <NUMBER> dose <NUMBER>mgkg subsequent daily doses <NUMBER> mgkg <NUMBER> day also added viral loads nasal <NUMBER> passages bal <NUMBER> additional untreated animals muster et al <NUMBER> <NUMBER> studies rhesus <NUMBER> macaques infected <NUMBER>x<NUMBER> <NUMBER> tcid<NUMBER> sarscov<NUMBER> strain details infection <NUMBER> treatment protocol found two preprints <NUMBER> also analyzed frequently sampled observations remdesivir metabolites averaged <NUMBER> three healthy animals single iv infusion <NUMBER>mgkg remdesivir <NUMBER> <NUMBER> <NUMBER> remdesivir pharmakinetics model used compartmental metabolism pharmacokinetics pk <NUMBER> model remdesivir goal model recapitulate sparse data remdesivir <NUMBER> metabolites several doses sarscov<NUMBER>infected animals <NUMBER> along frequently <NUMBER> sampled data single dose healthy animals <NUMBER> pk model depicted fig <NUMBER> <NUMBER> produced rate π <NUMBER> cleared rate γ <NUMBER> <NUMBER> free virus exchanged lungs nasal <NUMBER> passages rates <NUMBER> <NUMBER> <NUMBER> also considered possibility emergence refractory cells due antiviral actions <NUMBER> cytokines interferon experimentally demonstrated uninfected lung airway cells may <NUMBER> become refractory rate <NUMBER> infected cells may convert directly refractory cells <NUMBER> rate refractory cells may lose refractory state become susceptible rate <NUMBER> since interested viral dynamics short span <NUMBER> days without treatment ignored <NUMBER> death rate uninfected refractory cells lung usually longlived <NUMBER> also included possibility regeneration susceptible cells infection innate <NUMBER> immune cells eliminate virus also induce pulmonary tissue damage endothelium damage part <NUMBER> process <NUMBER> <NUMBER> restoration respiratory epithelial barrier injury important may <NUMBER> happens within days viral clearance <NUMBER> depending severity infection extent <NUMBER> lung involvement indeed proliferation epithetical cells progenitor stem cells distal airway <NUMBER> stem cells dascs critical barrier repair following inflammatory insult following lung injury <NUMBER> tissue repair process promoted immune cells including innate lymphoid cells ilciis <NUMBER> macrophages <NUMBER> epithelial restoration initiated locally proliferating alveolar type ii at<NUMBER> cells <NUMBER> <NUMBER> modeled restoration adding logistic proliferation susceptible refractory infected <NUMBER> <NUMBER> epithetical cells maximum rate previous mechanisms modeled following <NUMBER> taking derivative sides obtain <NUMBER> notice definition <NUMBER> equivalent <NUMBER> <NUMBER> − <NUMBER> − <NUMBER> − <NUMBER> assumption <NUMBER> fraction lung covered dead cells would table <NUMBER> <NUMBER> next fit models viral load lung lesion observations treated untreated animals <NUMBER> explored different competing models listed table <NUMBER> described explored models <NUMBER> included cell proliferation refractory cells lungs fixing <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> explored possibility at<NUMBER> cells proliferate maximum rate <NUMBER> delay <NUMBER> ie <NUMBER> <NUMBER> <NUMBER> also included models assuming antiviral activity remdesivir nasal passages occurs <NUMBER> activity lungs delay comprehensiveness checked two models refractory <NUMBER> <NUMBER> rate <NUMBER> rate notice latter <NUMBER> compartment since estimating <NUMBER> <NUMBER> together explored fixing standard deviation random effects <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> finally estimated fixed effects <NUMBER> applicable also <NUMBER> assumed <NUMBER> time infection initial values fixed parameters <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> estimated remaining parameters depending model assumptions <NUMBER> determine best parsimonious model among instances computed <NUMBER> loglikelihood log l akaike information criteria aic<NUMBER>log l<NUMBER>m number <NUMBER> parameters estimated assumed model similar support data difference <NUMBER> aic best model lowest aic less two <NUMBER> <NUMBER> assuming treatment case lung bal specimens therapy projected lead consistently <NUMBER> lower viral loads case nasal viral load therapy temporarily lowers viral load viral load <NUMBER> predicted ultimately persist higher levels absence treatment simulations based <NUMBER> data rm<NUMBER> time days infection <NUMBER> end december <NUMBER> novel coronavirus <NUMBER>ncov later renamed sarscov<NUMBER> identified wuhan city china’s hubei province <NUMBER> <NUMBER> severe pneumonic patients admitted intensive care unit icu wuhan jin yintan hospital <NUMBER> metagenomics sequencing analysis patients’ bronchoalveolar lavage fluid samples de novo sequence assembly revealed <NUMBER>kb genomes shared <NUMBER> <NUMBER> <NUMBER> sequence identity sarscov<NUMBER> bj strain bat cov ratg<NUMBER> strain respectively <NUMBER> phylogenetic analysis fulllength genomes revealed identity sarscov<NUMBER> newly emerged strain betacoronavirus formed distinct lineage sarsrelated covs sarsrcovs bats closely related ratg<NUMBER> <NUMBER> since identification virus quickly spread within china subsequently <NUMBER> countries around world within <NUMBER> months march <NUMBER> declared disease caused sarscov<NUMBER> termed cov disease <NUMBER> covid<NUMBER> pandemic <NUMBER> may <NUMBER> <NUMBER> million cases <NUMBER> deaths reported globally numbers still rise many countries united states alone rapid community transmission resulted <NUMBER> million cases <NUMBER> deaths source johns hopkins coronavirus resource center httpscoronavirusjhuedu sarscov<NUMBER> member coronavirinae subfamily family coronaviridae order nidovirales based genetic phylogenetic relationships subfamily classified four genera α β γ δcov members α βcov genera infect mammals <NUMBER> members γ δcov genera primarily infect birds also mammals <NUMBER> covs named crownlike morphology observed electron microscope em afforded surface glycoproteins virus enveloped positivesense singlestranded rna viruses cause wide range respiratory enteric hepatic renal neurologic diseases birds mammals <NUMBER> currently circulating covs humans include two αcovs <NUMBER>e nl<NUMBER> two βcovs oc<NUMBER> hku<NUMBER> cause common cold highly pathogenic human βcovs emerged past two decades include sarscov<NUMBER> middle eastern respiratory syndrome coronavirus merscov recent sarscov<NUMBER> <NUMBER> bats considered natural hosts progenitors highly pathogenic covs whose spill humans known involve intermediate animal hosts <NUMBER> domestic civets dromedary camels known intermediate hosts sarscov<NUMBER> merscov respectively role intermediary host sarscov<NUMBER> spillover presently unknown pangolincov closely related ratg<NUMBER> <NUMBER> genome identity sarscov<NUMBER> <NUMBER> genome identity identified dead malayan pangolin considered possible intermediary host <NUMBER> humantohuman transmission via direct indirect contact inhalation respiratory droplets main modes global spread highly pathogenic covs sarscov<NUMBER> virions spherical diameter <NUMBER> nm conforming typical cov diameter <NUMBER> nm <NUMBER> virion surface displays characteristic clubshaped projections <NUMBER> sarscov<NUMBER> highly stable <NUMBER> °c <NUMBER> weeks whereas room temperature remain stable day without significant loss infectivity <NUMBER> sensitive uv inactivation heat treatment <NUMBER> °c <NUMBER> min <NUMBER> °c temperature reducing virus inactivation time <NUMBER> min stability printing paper tissue paper <NUMBER> hr limited compared wood cloth <NUMBER> days <NUMBER> contrast higher stability <NUMBER>–<NUMBER> days smooth surfaces banknotes stainless steel plastic layers mask <NUMBER> stability halflife sarscov<NUMBER> stainless steel plastic comparable sarscov<NUMBER> <NUMBER> viruses similar halflives aerosols well median estimate <NUMBER>–<NUMBER> hrs <NUMBER> sarscov<NUMBER> remains sensitive disinfectants including household bleach povidoneiodine chlorhexidine chloroxylenol benzalkonium chloride diethyl ether ethanol <NUMBER>–<NUMBER> chlorine peracetic acid chloroform <NUMBER> like sarscov<NUMBER> sarscov<NUMBER> also utilizes human angiotenisinconverting enzyme <NUMBER> ace<NUMBER> receptor cellular entry <NUMBER> ace<NUMBER> type membrane glycoprotein expressed lungs heart intestines kidneys <NUMBER> physiologically ace<NUMBER> promotes cleavage maturation peptide hormones involved regulation blood pressure angiotenisin ang ii ace<NUMBER> cleaves ang ang<NUMBER> gets processed enzymes generate ang<NUMBER> ace<NUMBER> also directly process ang ii generate ang<NUMBER> <NUMBER> ace<NUMBER>ang<NUMBER> forms another arm renin–angiotensin system ras cardiovascular protective effects including antiheart failure antithrombosis antimyocardial hypertrophy antifibrosis antiarrhythmia antiatherogenesis <NUMBER> furthermore ace<NUMBER> also protects lung injury downregulated upon sarscov<NUMBER> infection <NUMBER> findings ignited interest ace inhibitors andor angiotensin receptor blockers potential treatment covid<NUMBER> hand upregulation ace<NUMBER> agents likely enhances viral entry leads worse disease outcomes <NUMBER> conflicting vitro data exist regarding benefit agents sarscov<NUMBER> clinical practice guidelines recommend agents covid<NUMBER> therapy <NUMBER> fulllength ace<NUMBER> protein consists nterminal peptidase domain pd cterminal collectrinlike domain cld followed single transmembrane helix <NUMBER>residue intracellular segment <NUMBER> cryoem structure sarscov<NUMBER> spike trimer revealed metastable prefusion conformation upon ace<NUMBER> binding undergoes substantial rearrangement promote fusion viral cell membranes <NUMBER> unlike sarscov<NUMBER>s sarscov<NUMBER>s harbors multibasic furin cleavage site rrarsv canonical s<NUMBER>s<NUMBER> site aytm allows efficient proteolytic processing viral egress prior subsequent round entry <NUMBER> processing critical separation receptorbinding domain rbd fusion domain harbored s<NUMBER> s<NUMBER> subunits respectively figure <NUMBER> stochastic movement rbd s<NUMBER> transiently exposes binding determinants “up” conformation permits receptor binding sarscov<NUMBER>s binds ace<NUMBER> <NUMBER>–<NUMBER>fold higher affinity sarscov<NUMBER>s <NUMBER> receptor binding destabilizes prefusion conformation resulting shedding s<NUMBER> subunit transition s<NUMBER> subunit highly stable postfusion conformation <NUMBER> following binding endocytosis efficient proteolytic priming s<NUMBER> site proximal fusion peptide essential exposing fusion peptide <NUMBER> like sarscov<NUMBER>s sarscov<NUMBER>s either use endosomal cysteine proteases cathepsin b l catbl serine protease tmprss<NUMBER> protein priming <NUMBER> proteases therefore attractive drug targets example inhibitors catbl e<NUMBER>d tmprss<NUMBER> camostat mesylate nafamostat mesylate efficiently inhibit viral entry <NUMBER> vero e<NUMBER> cell line engineered overexpress tmprss<NUMBER> produces higher yields sarscov<NUMBER> compared parent vero e<NUMBER> cell line <NUMBER> however tmprss<NUMBER> catbl known essential sarscov<NUMBER> entry primary target cells efficient viral replication spread infected mice <NUMBER> tmprss<NUMBER> coexpressed ace<NUMBER> receptor multiple cells tissues likely targets sarscov<NUMBER> including nasal goblet ciliated cells esophagus ileum colon cornea <NUMBER> relative importance proteases sarscov<NUMBER>s priming viral pathogenesis target cell tropism need investigated patient tissues animal models acidified endosomes exposed fusion peptide inserts cell membrane followed joining two heptad repeats s<NUMBER>′ antiparallel sixhelix bundle facilitates mixing viral cellular membranes resulting fusion <NUMBER> upon fusion genome released cytoplasm sarscov<NUMBER> genomic rna contains <NUMBER>′ cap <NUMBER>′ polya tail allow immediate translation produce two coterminal replicase polyproteins pp<NUMBER>a pp<NUMBER>ab utilizing ribosomal frameshifting mechanism replicase polyproteins encoded within twothirds genome orf<NUMBER>a orf<NUMBER>b figure <NUMBER> <NUMBER> polyproteins subsequently cleaved action two viral proteases nsp<NUMBER>plpro nsp<NUMBER>mpro individual nonstructural proteins nsps nsp<NUMBER> nsp<NUMBER> respectively <NUMBER> remaining third codes structural spike envelope e membrane nucleoprotein n accessory proteins orf<NUMBER>a <NUMBER>b <NUMBER> <NUMBER>a <NUMBER>b <NUMBER> <NUMBER>a <NUMBER>b <NUMBER> figure <NUMBER> <NUMBER> nsps assembled replicase–transcriptase complex begins generate antisense genomic subgenomic rnas serve templates positivesense genome subgenomic mrna synthesis respectively subgenomic mrnas <NUMBER>′ coterminal viral genome form nested set rnas due discontinuous extension antisense rna nsps also promote membrane rearrangement rough endoplasmic reticulum er membranes doublemembrane vesicles replication transcription processes occur <NUMBER> structural proteins translated subgenomic mrnas inserted er pass along secretory pathway ergolgi intermediate compartment ergic <NUMBER> along pathway protein cleaved two subunits s<NUMBER> s<NUMBER> furinlike proteases <NUMBER> newly synthesized genome forms complex n proteinand bud ergic generate virions assembly virions transported cell surface vesicles exocytosed <NUMBER> accessory proteins also translated subgenomic mrnas carry accessory functions likely important pathogenesis innate immune evasion <NUMBER> accessory protein functions sarscov<NUMBER> yet characterized following transmission droplets contact modes virus replicates cells respiratory upper lower gastrointestinal tracts clinical spectrum covid<NUMBER> vary asymptomatic mild symptomatic adverse clinical condition characterized severe respiratory failure requiring mechanical ventilation hospitalization critically ill condition <NUMBER> critically ill patients systemic features characterized sepsis septic shock multiple organ dysfunction syndromes mods <NUMBER> mild covid<NUMBER> illness symptoms typical upper respiratory tract viral infection including mild fever cough dry sore throat nasal congestion malaise headache muscle pain dyspnea <NUMBER> infrequently digestive symptoms nausea vomiting abdominal pain diarrhea may present patients moderate pneumonia display symptoms cough shortness breath tachypnea patients clinically diagnosed severe pneumonia display symptoms without fever severe dyspnea respiratory distress tachypnea <NUMBER> breathsmin hypoxia spo<NUMBER> <NUMBER> room air <NUMBER> patients sudden onset respiratory failure worsening already impaired lung function diagnosed acute respiratory distress syndrome ards require mechanical ventilation <NUMBER> different ards forms include mild moderate severe chest computerized tomography ct scans reveal bilateral ground glass opacities subsegmental areas consolidation <NUMBER> clinical features covid<NUMBER> patients sepsis particularly critical wide range signs symptoms involving multiple organs <NUMBER> signs symptoms include respiratory manifestations severe dyspnea hypoxemia kidney impairment reduced urine output tachycardia altered mental status coagulation dysfunction functional alteration multiple tissues reflected laboratory findings include lymphopenia hyperbilirubinemia increased ddimers acidosis high lactate coagulopathy thrombocytopenia physiologically patients severe disease significantly lower counts cells cd<NUMBER> cells nk cells compared mild disease <NUMBER> overall covid<NUMBER> patients fewer cd<NUMBER> cells nk cells compared healthy controls addition nk cd<NUMBER> tcell populations covid<NUMBER> patients functionally exhausted nkg<NUMBER>a whereas convalescing patients recover functionality <NUMBER> <NUMBER> sarscov<NUMBER>positive pneumonic patients admitted jin yintan hospital <NUMBER> patients progressed ards therefore placed icu care <NUMBER> icu nonicu patients higher initial plasma concentrations il<NUMBER>b il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> basic fgf gcsf gmcsf ifnγ ip<NUMBER> mcp<NUMBER> mip<NUMBER>a mip<NUMBER>b pdgf tnfα vegf compared healthy adult controls whereas il<NUMBER> il<NUMBER>p<NUMBER> il<NUMBER> eotaxin regulated activation normal cell expressed secreted rantes similar <NUMBER> comparison icu nonicu patients showed higher plasma concentrations il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα icu patients nonicu patients substantiating association “cytokine storm” severe disease <NUMBER> separate study also reported decreased counts cells monocytes covid<NUMBER> patients compared healthy controls <NUMBER> cd<NUMBER> cells displayed remarkable decrease icu nonicu patients decrease cd<NUMBER> cells noted icu patients covid<NUMBER> patient cd<NUMBER> cd<NUMBER> cells displayed activated phenotype higher expression cd<NUMBER> cd<NUMBER> cd<NUMBER> <NUMBER> cd<NUMBER> cells icu patients severe pneumonia showed higher percentage gmcsf il<NUMBER> cells compared nonicu patients healthy adults higher percentage cd<NUMBER>cd<NUMBER> inflammatory monocytes peripheral blood covid<NUMBER> patients much higher percentage icu patients noted <NUMBER> notably inflammatory monocytes gmcsf il<NUMBER> higher percentages activated cd<NUMBER> cells inflammatory monocytes severe patients accompanied gmcsf il<NUMBER> production likely contribute cytokine storm pulmonary immune pathology patients interestingly differences granulocyte b cell nk cell counts noted covid<NUMBER> healthy patients study <NUMBER> separate study <NUMBER> patients admitted tongji hospital china also reported higher leukocyte counts neutrophil counts lower lymphocyte counts higher neutrophiltolymphocyte ratio well lower percentage monocytes eosinophils basophils severe patients compared nonsevere ones <NUMBER> severe patients also higher levels il<NUMBER>r il<NUMBER> il<NUMBER> il<NUMBER> tnfα differences iga igg complement proteins c<NUMBER> c<NUMBER> percentage reduction cd<NUMBER> cytotoxic suppressor cells cd<NUMBER>cd<NUMBER>cd<NUMBER> regulatory cells cd<NUMBER>cd<NUMBER>cd<NUMBER>cd<NUMBER>low observed severe cases <NUMBER> overall immune dysregulation exuberant inflammatory response severe patients due higher neutrophils activated monocytes andor cells reduced suppressor regulatory cells <NUMBER> robust animal models faithfully recapitulate sarscov<NUMBER> pathogenesis humans exist widely used laboratory mice less susceptible sarscov<NUMBER> infection likely due mouse ace<NUMBER> receptor incompatibility glycoprotein however research tools mouseadapted sarscov<NUMBER> strain human ace<NUMBER> hace<NUMBER> transgenic mice may overcome incompatibility issue nevertheless c<NUMBER>bl<NUMBER> balbc mice infected sarscov<NUMBER> displayed transient infection viral replication limited induction innate immune response <NUMBER> however sarscov<NUMBER> underwent efficient replication lower respiratory tract hace<NUMBER>transgenic mice caused mild moderate interstitial pneumonia major clinical symptoms <NUMBER> another group recently demonstrated altered viral tropism pathogenesis sarscov<NUMBER>infected hace<NUMBER> transgenic mice although hace<NUMBER> transgenic mice displayed active viral replication lungs <NUMBER> mice mortality observed <NUMBER> days post infection dpi due brain tropism <NUMBER> overcome altered tropism accurately model respiratory disease observed humans authors adapted rbd interaction mouse ace<NUMBER> directed evolution rbd interaction residues q<NUMBER>tp<NUMBER>y <NUMBER> sarscov<NUMBER> displayed replication upper lower respiratory tracts caused mortality agedependent pathogenesis humans seen infected <NUMBER>weekold <NUMBER>yearold female balbc mice displaying mild moderate severe disease respectively <NUMBER> model successfully used sarscov<NUMBER> prophylaxis therapy employing venezuelan equine encephalitis virus veevreplicon pegylated ifnλ <NUMBER> contrast sarscov<NUMBER>infected syrian hamsters displayed early active virus replication lungs marked lung pathology characterized necrotizing bronchiolitis massive leukocyte infiltration edema recapitulating pathological changes sarscov<NUMBER>infected syrian hamsters severe pneumonic patients <NUMBER> addition doubleedged role stat<NUMBER> demonstrated sarscov<NUMBER> hamster model <NUMBER> stat<NUMBER> knockout ko hamsters displayed higher lung titers viremia systemic spread compared wildtype ones indicating role stat<NUMBER> limiting systemic spread <NUMBER> hand limited leukocyte infiltration attenuated lung pathology pneumonia observed stat<NUMBER> ko hamsters ferrets successfully used model respiratory disease transmission several respiratory viruses including influenza respiratory syncytial virus parainfluenza viruses sarscov<NUMBER> <NUMBER> similarities tissue architecture anatomy ferret respiratory system human respect receptor distribution submucosal gland density bronchial wall number terminal bronchioles made attractive models study susceptibility various laboratory companion domestic animals sarscov<NUMBER> tested model pathogenic mechanisms efficacy control interventions several animal models tested sarscov<NUMBER> susceptibility include <NUMBER>monthold female ferrets <NUMBER>monthold mixed sex ferrets subadult juvenile cats <NUMBER>monthold beagles <NUMBER>dayold mixed sex specificpathogenfree spf landrace large white pigs <NUMBER>weekold specificpathogenfree spf white leghorn chickens <NUMBER>weekold spf ducks <NUMBER> sarscov<NUMBER> also underwent efficient viral replication organs upper respiratory tract <NUMBER>monthold infected contact ferrets including nasal turbinate soft palate tonsils neither virus viral replication detected trachea lungs heart kidneys spleen pancreas small intestine brain <NUMBER> contrast <NUMBER>monthold mixed sex ferrets infected contactexposed sarscov<NUMBER> efficient replication observed organs upper lower respiratory tract along viral rna detection trachea kidneys intestines <NUMBER> furthermore efficient viral shedding noticed biological fluids saliva urine nasal washes feces infectedcontact ferrets observed humans <NUMBER> apart agerelated difference pathogenesis one limitation sarscov<NUMBER>infected ferrets lower lung virus titers severe disease mortality compared animal models sarscov<NUMBER>infected merscovinfected hace<NUMBER> hdpp<NUMBER> transgenic mice <NUMBER> agerelated difference viral replication also noted among cats juvenile cats permissive compared subadult cats <NUMBER> efficient viral replication noted organs tested juvenile cats whereas subadult cats viral replication limited organs upper respiratory tract <NUMBER> companion cats large cats zoos reported positive due humantocat transmission former displaying respiratory signs <NUMBER> among sarscov<NUMBER> infected animals dogs displayed minor susceptibility whereas livestock including pigs chickens ducks displayed susceptibility <NUMBER> line two companion dogs covid<NUMBER> patients one old age pomeranian several preexisting conditions adult german shepherd tested positive viral rna nasal oral swabs latter demonstrating higher viral rna loads <NUMBER> dog viral genomic rna matched respective patient transmitters potential reservoir onward transmission cats dogs presently unknown requires investigation <NUMBER> recently nonhuman primate models including young aged cynomolgus macaques young rhesus macaques investigated potential animal models covid<NUMBER> <NUMBER> sarscov<NUMBER>infected macaques displayed productive infection clinical signs ranging asymptomatic cynomolgus macaques moderate disease rhesus macaques <NUMBER> rhesus macaques displayed transient respiratory disease weight loss <NUMBER> peak early viral replication respiratory tissues followed rapid decline although aged cynomolgus young rhesus macaques continued shed virus prolonged periods viral antigen detected nasal epithelium ciliated epithelial cells type type ii pneumocytes bronchial bronchiolar epithelial cells macrophages <NUMBER> injury cell types correlated diffuse alveolar damage alveolar bronchiolar epithelial necrosis alveolar edema hyaline membrane formation infiltration neutrophils macrophages lymphocytes interstitial pneumonia <NUMBER> nonhuman primate models fail recapitulate severe disease critical condition observed covid<NUMBER> patients may useful evaluation licensure preventive therapeutic strategies <NUMBER> dna immunogen expressing fulllength immunogen provided optimal protection sarscov<NUMBER> rhesus macaque challenge model compared soluble constructs smaller fragments immunogens <NUMBER> protection efficacy correlated reduced viral replication upper lower respiratory tracts neutralization antibody titers nonhuman primate models however come increased expense <NUMBER> nhc orally available prodrug eidd<NUMBER> ribonucleoside analogs broad spectrum antiviral activity multiple rna viruses including current sarscov<NUMBER> sarscov<NUMBER> merscov venezuelan equine encephalitis virus veev influenza ab ebola ebov chikungunya chikv viruses <NUMBER> vitro low micromolar concentrations nhc induced potent antiviral effect towards sarscov<NUMBER> ec<NUMBER> <NUMBER> μm mers ec<NUMBER> <NUMBER> μm sarscov<NUMBER> ec<NUMBER> <NUMBER> μm propagated calu<NUMBER> cell lines primary human airway epithelial cultures <NUMBER> vivo prophylactic therapeutic treatment eidd<NUMBER> significantly reduced lung viral loads improved pulmonary function sars merscov mouse models however therapeutic improvement diminished delay treatment initiation time <NUMBER> thus early intervention eidd<NUMBER> may significantly improve clinical outcome covid<NUMBER> patients deserves future investigation mechanism action moa nhceidd<NUMBER> targeting viral rnadependent rna polymerase vrdrp induce error catastrophe beyond error threshold allowed sustain rna virus quasispecies <NUMBER> nhc incorporation c u antisense genome positivestrand genomicsubgenomic mrna results increased nucleotide transitions g g c u u c therefore nonsynonymous substitutions positive correlation increased transition rate frequency nonsynonymous mutations therapeutic efficacy observed mice moa remdesivir rdv via chain termination generate resistance see resistant mutants rdv still inhibited nhc <NUMBER> remdesivir rdv prodrug cadenosine nucleoside analog <NUMBER>cyano <NUMBER>aza<NUMBER>dideazaadenosine cnucleoside broad spectrum antiviral activity filoviruses paramyxoviruses pneumoviruses covs including sarscov merscov mouse hepatitis virus mhv oc<NUMBER> <NUMBER>e porcine bat cov strains <NUMBER> rdv similar nucleoside analogs favipiravir ribavirin eidd<NUMBER> converted proform active triphosphate form inhibits vrdrp nonobligate rna chain termination <NUMBER> rdv incorporated nascent viral rna chains vrdrp result chain termination <NUMBER> displayed potent vitro antiviral activity towards sarscov<NUMBER> ec<NUMBER> <NUMBER> μm vero e<NUMBER> cells <NUMBER> vitro remdesivir also displayed potent antiviral activity towards sarscov<NUMBER> ec<NUMBER> <NUMBER> μm merscov ec<NUMBER> <NUMBER> μm low micromolar concentrations <NUMBER> nonhuman primate nhp model ebov disease intravenous iv administration <NUMBER> mgkg rdv resulted persistent active concentration <NUMBER> μm blood conferred <NUMBER> protection ebov infection effective serum concentration rdv therefore likely achieved nhp human models mouse model sarscov<NUMBER> disease prophylactic early therapeutic treatment <NUMBER> dpi caused reduction lung viral replication defects pulmonary function <NUMBER> therapeutic treatment <NUMBER> dpi also reduced lung viral replication although improve pulmonary function <NUMBER> similarly humanized dpp<NUMBER> transgenic mouse improved pharmacokinetics nucleotide prodrugs ces<NUMBER>c−− hdpp<NUMBER> prophylactic therapeutic treatment rdv reduced lung viral replication weight loss improved pulmonary function <NUMBER> furthermore mouse model rdv provided superior antiviral activity merscov compared lpvrtvifnβ combination see <NUMBER> sars merscov disease models although therapeutic treatment initiated peak lung viral replication lung damage led reduced viral loads failed reduce lung pathology clinical disease macaque model merscov disease prophylactic treatment successfully reduced viral loads lung pathology whereas therapeutic treatment peak viral loads reduced viral loads lung pathology <NUMBER> <NUMBER> animals <NUMBER> hence clinical benefit rdv likely limited prophylaxis early therapy viral loads reach high titers <NUMBER> resistant variants rdv identified serial passage mhv presence increasing concentration rdv bore two mutations vrdrp f<NUMBER>lv<NUMBER>l <NUMBER> mutations also conferred resistance sarscov<NUMBER> indicative conserved mechanism action moa towards covs however sarscov<NUMBER> resistance rdv came fitness cost vivo resulting attenuated pathogenesis mouse model <NUMBER> case reports describing successful use rdv covid<NUMBER> treatment exist rdv promising drug far covid treatment <NUMBER> many randomized clinical trials rcts presently evaluating safety antiviral activity rdv patients mild moderate severe covid<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> <NUMBER> rdv currently fdaapproved must procured compassionate use children <NUMBER> yo pregnant women expanded access clinical trial enrollment <NUMBER> however fda recently issued emergency use authorization eua emergency use rdv treatment hospitalized covid<NUMBER> patients upon review data gileadsponsored openlabel trial nct<NUMBER> rct carried niaid nct<NUMBER> <NUMBER> ivermectin fdaapproved antiparasitic drug known exhibit broad spectrum antiviral activity hiv veev <NUMBER> dengue virus denv <NUMBER> yellow fever virus yfv japanese encephalitis virus jev west nile virus wnv tick borne encephalitis virus tbev <NUMBER> influenza <NUMBER> ivermectin targets viral host factors instance ivermectin known inhibit classical nuclear transport viral proteins eg denv ns<NUMBER> relying importin αβ heterodimer <NUMBER> viruses usurp host nuclear transport machinery transport viral cellular factors targeting host machinery attractive antiviral approach genetic barrier resistance much higher host compared virus <NUMBER> hand ivermectin also acted uncompetitive helicase inhibitor flavivirus ns<NUMBER> helicase exhibited antiviral effect flaviviruses tested <NUMBER> recently ivermectin found exhibit antiviral activity sarscov<NUMBER> ec<NUMBER> <NUMBER> μm low micromolar concentration vitro cytotoxic effects <NUMBER> although specifically inhibited viral genome replication potential moa finding remains investigated structurebased ab initio drug design combined virtual screening highthroughput screening drugs including fdaapproved drugs clinical trial drugs others two compounds namely n<NUMBER> ebselen identified antiviral activity towards sarscov<NUMBER> <NUMBER> ebselen n<NUMBER> displayed vitro antiviral activity inhibiting sarscov<NUMBER> main protease mpro ec<NUMBER> values <NUMBER> μm <NUMBER> μm respectively <NUMBER> noncovalent binding irreversible covalent modification mpro proposed moa ebselen n<NUMBER> respectively therapeutic efficacy n<NUMBER> ebselen sarscov<NUMBER> needs investigated animal models either alone combination therapy lopinavir lpv ritonavir rtv fdaapproved hiv<NUMBER> protease inhibitors also appear inhibit <NUMBER>clpro activity vitro <NUMBER> lopinavir poor bioavailability potent inhibiting hiv<NUMBER> ritonavir <NUMBER> part hiv medication lopinavir used combination ritonavir inhibits lopinavir metabolizing enzyme cytochrome p<NUMBER> <NUMBER>a<NUMBER> improves bioavailability <NUMBER> lpv rtv shown antiviral effect towards sarscov merscov <NUMBER>egfp ec<NUMBER> concentrations <NUMBER> μm <NUMBER> μm <NUMBER> μm respectively however lpv displayed effect towards merscov vero cells huh<NUMBER> cells <NUMBER> similarly lpv rtv also demonstrated antiviral effect towards sarscov<NUMBER> logec<NUMBER> <NUMBER> μm vitro furthermore lpvrtv combination ifnβ displayed synergistic antiviral activity merscov compared ifnβ alone ec<NUMBER> <NUMBER> vs <NUMBER> iuml respectively calu<NUMBER> cells study also demonstrated near similar ec<NUMBER> lpvrtv ec<NUMBER> <NUMBER> μm lpv <NUMBER> μm suggesting similar activity observed sarscov<NUMBER> despite vitro antiviral activity merscov prophylactic therapeutic administration lpvrtv ifnβ mouse model failed reduce virus titer prevent body weight loss pulmonary function inflammatory lung disease contrast common marmoset model severe merscov disease lpvrtv treatment resulted reduced lung extrapulmonary tissue viral loads improved clinical radiological pathological features compared untreated mycophenolate mofetiltreated marmosets miracle trial merscov infection treated combination lopinavirritonavir interferonβ<NUMBER>b presently investigating efficacy combination therapy lpvrtv ifnβ compared placebo mersconfirmed hospitalized patients provided standard supportive care <NUMBER> nonrct comprising sarscov<NUMBER> patients efficacy lpvrtv combination ribavirin compared ribavirin steroids lpvrtv without ribavirin treatment induced milder disease course terms diarrhea fever chest radiographs reduction number patients undergoing ards death <NUMBER> notably clinical benefit lpvrtv demonstrated patients received initial treatment lpvrtv treatment initiated time sarscov<NUMBER> diagnosis currently efficacy lpvrtv without ribavirin also evaluated sarscov<NUMBER> patients randomized control trials <NUMBER> although minimum attainable serum concentration lpvrtv less minimum vitro ec<NUMBER> sarscov<NUMBER> lpvrtv without ribavirin <NUMBER> mg <NUMBER> mg twice daily part recommended treatment covid<NUMBER> patients china <NUMBER> openlabel rct reported significant benefit lopinavirritonavir <NUMBER> mg twice daily sarscov<NUMBER> patients standard care terms time clinical improvement mortality <NUMBER> days throat swab viral loads various time points <NUMBER> furthermore gastrointestinal adverse events nausea vomiting diarrhea appeared common lpvrtv group standard care group <NUMBER> although delayed treatment initiation may partially explain lack clinical benefit lpvrtv subgroup analysis find reduced time clinical improvement patients received lpvrtv within <NUMBER> days singapore <NUMBER> <NUMBER> earlier sarscov<NUMBER> patients supplemental oxygen treated lpvrtv fever resolved supplemental oxygen requirement reduced within <NUMBER> days <NUMBER> <NUMBER> patients whereas <NUMBER> patients developed progressive respiratory failure four <NUMBER> patients developed nausea vomiting andor diarrhea <NUMBER> abnormal liver function <NUMBER> korea one patient treated lpvrtv starting day <NUMBER> illness reduced viral loads eventually remained undetectable <NUMBER> two case studies comprising chinese patients also reported improved clinical outcomes upon combination therapy lpvrtv arbidol shufengjiedu capsule sfjdc traditional chinese medicine lpvrtv <NUMBER> mg daily methylprednisolone <NUMBER> mg daily ifnα<NUMBER>b <NUMBER> million iu daily ambroxol hcl <NUMBER> difficult interpret outcomes studies due additional drug therapies varied time points initial therapy varied degree severity illnesses lack control placebo treatment given significant drug–drug interactions potential adverse effects hepatotoxicity cautious review coadministered drugs monitoring required prior use lpvrtv <NUMBER> data lpvrtv limited advantage standard care sarscov<NUMBER> patients <NUMBER> importantly whether early therapy initiation leads improved clinical outcomes compared rescue andor salvage therapy warrants investigation <NUMBER> another secondgeneration hiv<NUMBER> protease inhibitor darunavir demonstrated vitro antiviral activity sarscov<NUMBER> ec<NUMBER> <NUMBER> μm <NUMBER> darunavir treatment inhibited sarscov<NUMBER> replication <NUMBER>fold compared nontreated control <NUMBER> rct darunavircobicistat currently underway china <NUMBER> chloroquine antimalarial drug antiinflammatory immunomodulatory properties investigated potential therapeutic sarscov<NUMBER>infected patients <NUMBER> chloroquine prevents endosomal acidification required protein conformational changes thereby blocks fusion viral cellular membranes <NUMBER> addition chloroquine also interferes glycosylation viral entry receptors chloroquine demonstrated potent vitro activity sarscov<NUMBER> ec<NUMBER> <NUMBER> μm low micromolar concentration vero e<NUMBER> cells <NUMBER> concentration within ec<NUMBER> range reported sarscov<NUMBER> ec<NUMBER> <NUMBER>–<NUMBER> μm merscov ec<NUMBER> <NUMBER> μm vero e<NUMBER> huh<NUMBER> cell lines respectively <NUMBER> findings prompted use chloroquine numerous clinical trials covid<NUMBER> patients gao et al reported “thus far results <NUMBER> patients demonstrated chloroquine phosphate superior control treatment inhibiting exacerbation pneumonia improving lung imaging findings promoting virusnegative conversion shortening disease course according news briefing <NUMBER> severe adverse reactions chloroquine phosphate noted aforementioned patients” although preliminary results promising drug supply issues cardiotoxicity concerns limited use chloroquine us <NUMBER> alternative chloroquine known hydroxychloroquine pursued effective treatment covid<NUMBER> patients hydroxychloroquine ec<NUMBER> <NUMBER> μm exhibited <NUMBER>fold greater potency chloroquine ec<NUMBER> <NUMBER> μm sarscov<NUMBER>infected vero cells <NUMBER> contrast chloroquine ec<NUMBER> <NUMBER> ± <NUMBER> μm exhibited approximately <NUMBER>fold greater potency compared hydroxychloroquine ec<NUMBER> <NUMBER> ± <NUMBER> μm sarscov<NUMBER>infected vero cells <NUMBER> nonrandomized clinical trial comprising <NUMBER> patients <NUMBER> hydroxychloroquine <NUMBER> control aged <NUMBER> pcr sarscov<NUMBER> conducted evaluate therapeutic efficacy hydroxychloroquine viral clearance nasopharyngeal swabs considered primary endpoint day <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hydroxychloroquine control patients respectively viral clearance <NUMBER> study addition azithromycin hydroxychloroquine <NUMBER> patients resulted superior viral clearance <NUMBER> <NUMBER> compared hydroxychloroquine alone <NUMBER> <NUMBER> <NUMBER> another prospective trial <NUMBER> randomized patients split <NUMBER> fashion treated hydroxychloroquine daily <NUMBER> days standard care supportive care ifn antivirals standard care alone <NUMBER> difference virological clearance noted <NUMBER> <NUMBER> clearance observed hydroxychloroquine standard care group standard care group respectively limited sample size cardiotoxicity concerns call additional studies adopting regimen therapy observational study effectiveness chloroquine hydroxychloroquine reported lack higher lower risk intubation death among patients <NUMBER> several rcts presently examining efficacy chloroquine hydroxychloroquine covid<NUMBER> patients <NUMBER> cov infections typically associated attenuated innate interferon induction delayed proinflammatory response hae cultures sarscov<NUMBER> merscov hcov<NUMBER>e infections resulted earlier transcriptional induction interferons proinflammatory cytokines <NUMBER> <NUMBER> <NUMBER> hours post infection hpi <NUMBER> calu<NUMBER> cells unlike merscov sarscov<NUMBER> <NUMBER>e infection caused slightly higher induction ifnβ <NUMBER> hpi <NUMBER> merscov however highly sensitive antiviral effects ifn unlike sarscov<NUMBER> vitro antiviral activity ifnβ ec<NUMBER> <NUMBER> unitsml <NUMBER> <NUMBER> <NUMBER> <NUMBER>fold higher ifn α<NUMBER>b ifnγ ifnuniversal type <NUMBER> ifnα<NUMBER>a respectively <NUMBER> like merscov sarscov<NUMBER> highly sensitive antiviral effects recombinant type ifn vero cells <NUMBER>–<NUMBER>fold reduction viral titers <NUMBER> although sarscov<NUMBER> blocked early induction type ifn significant induction ifn downstream stat<NUMBER> phosphorylation noticed <NUMBER> hpi calu<NUMBER> cells <NUMBER> reduced capacity sarscov<NUMBER> interfere induction action type ifn attributed loss orf<NUMBER>b truncationchanges orf<NUMBER> respectively <NUMBER> sarscov<NUMBER> orf<NUMBER>b orf<NUMBER> disrupt irf<NUMBER> phosphorylation karyopherin function respectively resulting attenuated induction type ifn blocked nuclear transport stat<NUMBER> <NUMBER> common marmosets infected merscov clinical improvements ifnβ similar lpvrtv ones described <NUMBER> similar vitro findings loss type ifn signaling significant impact sarscov<NUMBER> disease vivo indicative insensitivity antiviral effects type ifn <NUMBER> interventional study evaluate efficacy safety lpvrtv adult hospitalized patients sarscov<NUMBER> infection pursued china <NUMBER> due lack clinical trial data conflicting vitro vivo data interferons currently recommended sarscov<NUMBER> treatment <NUMBER> arbidol umifenovir promising repurposed drug targets proteinace<NUMBER> interaction thereby inhibiting viral fusion entry <NUMBER> although fdaapproved currently approved russia china treatment prophylaxis influenza vitro antiviral activity sarscov<NUMBER> ec<NUMBER> <NUMBER>–<NUMBER> μm <NUMBER> nonrandomized study <NUMBER> covid<NUMBER> patients indicated treatment arbidol median duration <NUMBER> days associated lower mortality <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> higher discharge rate compared patients receive <NUMBER> ongoing rcts currently evaluating arbidol covid<NUMBER> treatment china ribavirin guanosine analog antiviral effects several viral infections including respiratory syncitial virus rsv hepatitis c virus hcv herpes simplex virus hsv<NUMBER> ribavirin displayed antiviral effect towards merscov sarscov<NUMBER> vitro concentrations <NUMBER> µm vero e<NUMBER> cells <NUMBER> another study reported conflicting findings ribavirin displayed antiviral effects logec<NUMBER> <NUMBER> μm towards merscov replication vero e<NUMBER> cells <NUMBER> vero cells comparably inefficient converting ribavirin mono triphosphate forms therefore relevant cell line study antiviral effects nucleoside analogs including ribavirin <NUMBER> separate study identified better responsiveness merscovinfected llcmk<NUMBER> cells antiviral effects ribavirin ec<NUMBER> <NUMBER> μgml compared vero cells ec<NUMBER> <NUMBER> μgml <NUMBER> similarly sensitivity sarscov<NUMBER> ribavirin also appears cell linedependent higher concentration ec<NUMBER> <NUMBER> μgml reported effective vero cells <NUMBER> however concentrations exceeded attainable serum concentrations humans therefore ribavirin use may effective towards cov infections human <NUMBER> combination ifnα ribavirin previously reported synergistic additive effect towards sars merscov infections respectively combination also reduced virus replication downregulated host inflammatory response improved clinical outcome merscovinfected macaques <NUMBER> however smallscale clinical trial comprising <NUMBER> critically ill mers patients multiple comorbidities delayed initiation combination therapy <NUMBER>th day admission resulted fatal outcome patients <NUMBER> addition ribavirin usage limited patients respiratory disorders lead marked fall hemoglobin levels anemia <NUMBER> line metaanalysis sarscov<NUMBER> merscov patient case studies found limited efficacy ribavirin outcomes patients highly pathogenic coronavirus respiratory syndromes due lack vitro efficacy toxicity profile poor clinical outcomes ribavirin considered promising candidate evaluation research development plan sarscov<NUMBER> <NUMBER> nitazoxanide <NUMBER>acetyloxyn<NUMBER>nitro<NUMBER>thiazolyl benzamide fdaapproved broadspectrum antiparasitic compound effective intestinal protozoal helminthic infections specifically giardia lamblia cryptosporidium parvum <NUMBER> recently compound shown broad spectrum antiviral activity multiple viruses including influenza virus <NUMBER> rotavirus <NUMBER> astrovirus <NUMBER> norovirus <NUMBER> japanese encephalitis virus jev <NUMBER> rubella virus <NUMBER> zika virus zikv <NUMBER> hepatitis c virus hcv <NUMBER> hepatitis b virus hbv <NUMBER> nitazoxanide displayed potent antiviral activity towards covs mhva<NUMBER> bovine coronavirus strain l<NUMBER> bcovl<NUMBER> human enteric coronavirus <NUMBER> hecov<NUMBER> propagated mouse astrocytoma dbt fibroblast <NUMBER>cl<NUMBER> cells low micromolar concentration ec<NUMBER> <NUMBER> µgml <NUMBER> similarly llcmk<NUMBER> cells nitazoxanide active metabolite tizoxanide displayed potent antiviral activity merscov ec<NUMBER> <NUMBER> <NUMBER> µgml respectively <NUMBER> effective concentration nitazoxanide sars cov<NUMBER> grown vero e<NUMBER> cells within range observed viruses ec<NUMBER> <NUMBER> μm <NUMBER> current research indicates potential mechanism antiviral activity induction interferon response via activation protein kinase r disruption unfolded protein response <NUMBER> clinical trials successfully demonstrated effectiveness treating influenza virus norovirus rotavirus hepatitis b virus hepatitis c virus phase <NUMBER>b<NUMBER> study outpatient management influenza treatment dose <NUMBER> mg nitazoxanide mouth bid associated <NUMBER>·<NUMBER>hr reduction time alleviation symptoms compared placebo <NUMBER> phase <NUMBER> rct comprising hospitalized patients severe acute respiratory illnesses mainly caused respiratory viruses nitazoxanide failed reduce time hospital discharge time symptom alleviation <NUMBER> although nitazoxanide displayed vitro antiviral activity towards sarscov<NUMBER> prophylactic therapeutic efficacy studies sarscov<NUMBER> animal models necessary determine benefit clinic homoharringtonine plant alkaloid known exhibit potent antiviral effects herpesviruses varicella zoster virus vzv hsv<NUMBER> pseudorabies virus prv coronaviruses porcine epidemic diarrhea virus pedv mhv rhabdoviruses vesicular stomatitis virus vsv rabies virus viruses hepatitis virus newcastle disease virus echovirus <NUMBER> <NUMBER> omacetaxine semisynthetic form homoharringtonine fdaapproved treatment chronic myeloid leukemia targets phosphorylated form eif<NUMBER>e s<NUMBER> resulting degradation phosphorylated eif<NUMBER>e inhibit protein translation resulting loss proteins mcl<NUMBER> cmyc required survival leukemia cells <NUMBER> interestingly homoharringtonine displayed antiviral effects towards sarscov<NUMBER> vero e<NUMBER> cells much lower effective concentration ec<NUMBER> <NUMBER> μm remdesivir lpv <NUMBER> antiviral effect hht viral infections presumably associated action phosphorylated eif<NUMBER>e repurposing hht sarscov<NUMBER> treatment may represent attractive strategy deserves investigation emetine alkaloid derived ipecac fdaapproved treatment ameobiasis emetine demonstrated antiviral effects towards wide range dna rna viruses including bovine herpes virus<NUMBER> hsv<NUMBER> human cytomegalovirus buffalo poxvirus zikv ebov hiv<NUMBER> newcastle’s disease virus ndv pestes des petits ruminants virus rift valley fever virus influenza rabies virus <NUMBER> particular antiviral effects towards hcovoc<NUMBER> hcovnl<NUMBER> sarscov<NUMBER> sarscov<NUMBER> merscov mhva<NUMBER> vitro low micromolar concentrations <NUMBER> emetine therefore broad spectrum cov inhibitor emetine inhibits viral protein translation blocking <NUMBER>s ribosomal protein s<NUMBER> host cells additional mechanisms emetine include blocking hiv reverse transcriptase inhibiting viral polymerases trypanosomes killing dna intercalation lysosomal malfunction emetine inhibited merscov entry dpp<NUMBER>expressing huh<NUMBER> cells possibly affecting lysosomal function <NUMBER> corticosteroids used mitigate host inflammatory response contributes acute lung injury acute respiratory distress syndrome ards severe pneumonia cases however benefit agents outweighs adverse effects include delayed viral clearance enhanced risk secondary infection <NUMBER> presently data corticosteroid use sarscov<NUMBER> merscov sarscov<NUMBER> patients inconclusive confounding data rcts uncontrolled nonrandomized study <NUMBER> <NUMBER> sarscov<NUMBER> patients treated highdose methylprednisolone recovered progressive lung disease first week illness <NUMBER> two studies documented evidence possible adverse effects corticosteroids use sarscov<NUMBER> patients <NUMBER> randomized doubleblind placebocontrolled trial patients received corticosteroids within first week illness documented delayed viral clearance significantly higher viral rna loads plasma second third week illness <NUMBER> another retrospective casecontrolled study patients psychosis also familial history psychosis received higher cumulative doses steroids patients without psychosis <NUMBER> one report documented increase composite endpoint icu admission death <NUMBER> another report demonstrated decreased mortality critically ill patients <NUMBER> among merscov icu patients received corticosteroid therapy n <NUMBER> documented delayed clearance viral rna difference <NUMBER>day mortality accounting timevarying exposure <NUMBER> finally recent observational study indicated reduced risk mortality receipt corticosteroids sarscov<NUMBER> patients ards <NUMBER> given adverse effects lack consistent proven benefit clinicians must carefully weigh risks benefits corticosteroid use individual patient level <NUMBER> tocilizumab fdaapproved humanized monoclonal antibody inhibits il<NUMBER> receptor membranebound soluble form originally approved treatment rheumatoid arthritis ra used patient therapy cytokinerelease syndrome crs following chimeric antigen receptor cell cart therapy <NUMBER> il<NUMBER> key driver dysregulated inflammation contributes pulmonary pathology organ damage observed covid<NUMBER> patients <NUMBER> theoretically antibodies targeting receptor could dampen il<NUMBER> signal transduction downstream inflammation thus improving clinical outcomes limited cohort <NUMBER> covid<NUMBER> patients receipt tocilizumab resulted clinical improvement <NUMBER> patients assessed fever resolution chest tightness relief lung opacity resolution ct improved respiratory function drug reactions <NUMBER> <NUMBER> patients lymphocyte creactive protein crp levels returned normal within <NUMBER> days <NUMBER> recent study conducted single cell rnaseq patient blood cell populations isolated longitudinally various stages beginning tocilizumab treatment <NUMBER> hr <NUMBER>th <NUMBER>th day two severe patients <NUMBER> monocytic subpopulation significant downregulation processes contributing inflammatory storm noted upon tocilizumab treatment <NUMBER> like tocilizumab sarilumab another il<NUMBER> receptor antagonist fdaapproved ra treatment currently rcts tocilizumab combination favipiravir nct<NUMBER> sarilumab nct<NUMBER> tested rcts use convalescent plasma cp patients recovered viral infections practice <NUMBER> years used successfully sarscov<NUMBER> merscov ebov h<NUMBER>n<NUMBER> influenza <NUMBER> theoretically cp obtained recovered patients contain large quantity neutralizing antibodies nabs capable clearing virus virusinfected cells <NUMBER> regard nab titer cp cp therapy initiation time critical factors needs considered <NUMBER> firstly sars merscov patients duration nabs shortlived decline within <NUMBER> months disease process therefore plasma recently recovered patients remains effective cp therapy secondly sarscov patients improved outcome observed upon cp therapy <NUMBER> days post onset illness dpoi compared rescue andor salvage recent pilot clinical trial comprising <NUMBER> severe covid<NUMBER> patients given maximal supportive care antiviral agents one dose cp <NUMBER> ml transfusion median time transfusion <NUMBER> dpoi resulted negative viral rna levels improvement clinical symptoms pulmonary function paraclinical criteria increased lymphocyte counts oxygen saturation decreased crp <NUMBER> serious adverse reactions noted among cp treated patients <NUMBER> findings also point inflammation overreaction immune system contribute ards ali severe patients alleviated cp therapy <NUMBER> summary sarscov<NUMBER> highly transmissible cov led current pandemic disruption human activity presently limited understanding sarscov<NUMBER> pathogenesis mostly extrapolated sarscov<NUMBER> merscov studies studies useful development animal model faithfully recapitulates sarscov<NUMBER> pathogenesis humans allow identification viral host factors critical covid<NUMBER> furthermore animal model allows researchers carry immediate task developing testing antiviral interventions eventually control covid<NUMBER> humans present summary detailed current understanding sarscov<NUMBER> result incredible efforts researchers worldwide manifestation caused sarscov<NUMBER> infection known covid<NUMBER> since first case sarscov<NUMBER> infection reported wuhan china five months causes pandemic three million confirmed cases nearly <NUMBER> thousand deaths addition huge economic losses world <NUMBER> nevertheless widely considered controllable according experiences china countries however still critical aspects need investigated patients cytokine storm immunopathogenic damages tropism sarscov<NUMBER> sources sarscov<NUMBER> infection besides bat pangolin regarded origin sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> points view studies animals become essentially important fact several animal models covid<NUMBER> recently reported murine <NUMBER> hamster <NUMBER> ferret <NUMBER> nonhuman primate <NUMBER> <NUMBER> <NUMBER> <NUMBER> recapitulate covid<NUMBER> different aspects terms susceptibility sarscov<NUMBER> addition experimental animals domestic animals pets also investigated <NUMBER> cats popular pet could important source sarscov<NUMBER> infection due close relationship human beings tree shrew also known tupaia belangeris genetically demonstrated close primates <NUMBER> <NUMBER> <NUMBER> therefore developed experimental animal could alternative primates biomedical research due unique characteristics <NUMBER> fact tree shrew used several animal models virus infections including hepatitis b <NUMBER> influenza virus <NUMBER> <NUMBER> <NUMBER> zika virus <NUMBER> however tupaia model high pathogenic viruses reported yet including sarscov<NUMBER> several reports show sarscov<NUMBER> may originate wild animals <NUMBER> <NUMBER> <NUMBER> replication sarscov<NUMBER> tree shrews still unknown study order determine possibility tree shrew covid<NUMBER> model tested susceptibility tree shrew sarscov<NUMBER> infection found sarscov<NUMBER> limited replication shedding tree shrew cause mild histopathology typical symptom observed infected tree shrew reported covid<NUMBER> patients tree shew tupaia belangeri chinensis bred institute medical biology chinese academy medical sciences quarantine infection animals transferred absl<NUMBER> facility housed isolated ventilation cages <NUMBER>hour light <NUMBER>hour dark animal procedures approved institutional animal care use committee institute procedures study outlined figure <NUMBER> total <NUMBER> tree shrews used study divided three groups consideration gender age including young <NUMBER> months <NUMBER> months adult <NUMBER> years <NUMBER> years old <NUMBER> years <NUMBER> years groups group contains half male half female animals baseline data samples collected right virus inoculation tree shrew inoculated <NUMBER> ml <NUMBER> <NUMBER> pfu sarscov<NUMBER> nasally <NUMBER>uleach nostril clinical signs recorded daily including behavior drinking eating breathing feces body temperature also monitored every day post viral inoculation time points nasal throat anal swab blood samples collected viral genomic rna samples quantified rtqpcr using virusspecific primers probes day <NUMBER> post viral inoculation six animals anesthetized bled necropsied gross lesions recorded tissue samples harvested analysis viral loads histopathology rnasednasefree h<NUMBER>o used elute rna column <NUMBER> µl rna analyzed well <NUMBER>well plate onestep rtqpcr using genespecific primers probe described <NUMBER> tissue samples heart liver spleen lung kidney weasand stomach small intestine rectum pancreas brain spinal cord uterus penis testis cecum harvested fixed <NUMBER> neutral buffered formalin paraffinembedded tissues cut <NUMBER> µm sections followed haematoxylin eosin staining slides scanned <NUMBER>dhistech inspected experienced pathologist using manufacture provided software caseviewer period study couldnt observe clinical sign besides change body temperature sarscov<NUMBER> inoculation body temperature tree shrew monitored every day among three ages virusinoculated tree shrews young tree shrews except ts<NUMBER> showed increasing body temperature <NUMBER> young tree shrews <NUMBER> males <NUMBER> females peak body temperature <NUMBER> <NUMBER>day post inoculation dpi followed gradual decline peaks body temperatures two female ts<NUMBER> ts<NUMBER> one male ts<NUMBER> young tree shrews <NUMBER> figure <NUMBER>a addition among old tree shrews one male ts<NUMBER> three female ts<NUMBER> ts<NUMBER> ts<NUMBER> peak body temperature <NUMBER> <NUMBER> <NUMBER> dpi however one adult female ts<NUMBER> showed peak body temperature <NUMBER> <NUMBER> dpi figure <NUMBER>b c results indicated youngold tree shrews female tree shrews showed higher sensitivity sarscov<NUMBER> infection compared adult male tree shrews <NUMBER> dpi could detect genomic rna sarscov<NUMBER> <NUMBER> nasal swabs <NUMBER> throat swabs <NUMBER> anal swabs one serum sample young tree shrews <NUMBER> nasal swabs adult tree shrews <NUMBER> nasal swabs <NUMBER> anal swab old tree shrew table <NUMBER> notably four samples nasal throat anal swabs blood collected young tree shrew ts<NUMBER> showed virus rna positive highest copy number viral genomic rna <NUMBER> <NUMBER> ml nasal swab young tree shrew ts<NUMBER> <NUMBER> dpi four young three adult four old tree shrew viral rna positive samples highest level virus shedding still young tree shrew ts<NUMBER> <NUMBER> dpi young tree shrews showed decreasing virus shedding animal ts<NUMBER> rnapositive throat swab contrast increasing number old tree shrews detectable viral rna nasal throat anal swabs table <NUMBER> findings deduced young tree shrew susceptible sarscov<NUMBER> infection adult old tree shrew however old tree shrew adult tree shrews gave longer duration virus shedding young tree shrews moreover noticed male animals adult old tree shrews showed virus shedding females order determine viral load tissue samples necropsied <NUMBER> animals <NUMBER> ages tree shrews <NUMBER> dpi sixteen major tissues collected animal viral genomic rna quantified described methods three young tree shrews ts<NUMBER> ts<NUMBER> ts<NUMBER> could detect viral rna lungs ts<NUMBER> ts<NUMBER> tissue ts<NUMBER> although animal higher number viral genomic copy numbers earlier stage sarscov<NUMBER> infection contrast adult tree shrew ts<NUMBER> six tissues rna positive highest number <NUMBER> <NUMBER> ml pancreas female adult tree shrew ts<NUMBER> viral rnapositive uterus addition lung pancreas four necropsied tree shrews showed viral rnanegative results <NUMBER> tissues table s<NUMBER> determine host response sarscov<NUMBER> infection examined sixteen tissues <NUMBER> tree shrews necropsied <NUMBER> dpi <NUMBER> dpi clinically reported old covid<NUMBER> patients show high morbidity mortality thought associated comorbidities <NUMBER> firstly young old tree shrews showed increasing body temperature adult tree shrews figure <NUMBER> secondly young tree shrews severe virus shedding early stage virus infection animals old tree shrews longer duration virus shedding others table <NUMBER> one young male tree shrew ts<NUMBER> didnt significant increasing body temperature virus shedding nasal throat anal serum detected <NUMBER> dpi results indicated asymptomatic infection sarscov<NUMBER> young tree shrews although sarscov<NUMBER> infection didnt cause severe disease three ages tree shrews viral replication mild histopathological changes still observed study particularly found severe lung abnormality histology one adult tree shrew may caused immunopathological responses cytokine storm <NUMBER> table <NUMBER> results confirmed via nucleic acid situ hybridization immunohistochemistry immunofluorescent staining conclusion tree shrew susceptible sarscov<NUMBER> infection reported animal models covid<NUMBER> though limited replication sarscov<NUMBER> mild histopathology detected observed tissues addition commercial reagents completely domesticated tree shrews limited therefore tree shrew suitable experimental animal covid<NUMBER> related studies however important investigate whether wild tree shrews nature infected asymptomatic carrier sarscov<NUMBER> none declared total <NUMBER> tree shrews tupaia belangeris divided three groups young adult old according ages group included half male half female tree shrew inoculated <NUMBER>ml <NUMBER> <NUMBER> pfu sarscov<NUMBER> nasally <NUMBER>uleach <NUMBER> dpi every day body temperature monitored time nasal throat anal blood samples collected analysis viral loads <NUMBER> <NUMBER> dpi animals euthanatized necropsied gross lesions recorded tissue samples collected analysis b every day indicated body temperature tree shrew monitored recorded software graphpad utilized data processing plotting rainbow heat map x represents data collected body temperature beyond <NUMBER> shown white boxes young old adult <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> histopathological examination affected tissues sarscov<NUMBER> infected tree shrews <NUMBER> <NUMBER> dpi tree shrews euthanized necropsied seventeen tissues collected animal histopathological analysis eight old tree shrews eleven tissues various degrade pathological changes representatively shown green arrows indicate pathological changes described text histopathology tree shrews summarized table <NUMBER> table <NUMBER> summary histopathological examination tissues <NUMBER> tree shrews age group sixteen tissues collected examined histopathogically six tissues showed histopathological change therefore eleven tissues shown table age group contained <NUMBER> tree shrews number animals histopathological changes total <NUMBER> animals age group table s<NUMBER> viral load tissues collected sarscov<NUMBER> infected tree shrews density green color proportional copy number viral genomic rna animal code copy number viral genomic rna expressed log <NUMBER> ml means undetectable much recent debate regarding use ace inhibitors aceis angiotensin receptor blockers arbs covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus prompting concern among patients health care providers basis concern involves whether aceisarbs increase expression ace<NUMBER> primary cellular receptor sarscov<NUMBER> virus thereby may increase severity infection review key literature regarding possibility assessing studies conducted experimental animals primarily rats humans focus discussion studies ace<NUMBER> protein data available tissue ace<NUMBER> mrna expression appears weakly correlate protein expression shown data human protein atlas <NUMBER> proteinatlasorg results human renal samples <NUMBER> animal studies discussed eg <NUMBER> <NUMBER> focused assessment studies evaluated ace<NUMBER> levels tissuescells involved infection sarscov<NUMBER> sarscov<NUMBER> data <NUMBER> animal studies summarized table <NUMBER> shows effect aceiarb use ace<NUMBER> protein expressionactivity animals primarily rats used conversion factors based principles allometric scaling evaluate doses animals relative use humans <NUMBER> studies relevant used hed human equivalent dose assuming <NUMBER> kg human <NUMBER> doses aceiarbs obtained recommended doses humans using approved labelling food drug administration fda website fdagov recommended human doses provided table <NUMBER> drugs maximum doses indicated table <NUMBER> seldom achieved humans treatment animals equivalent larger doses especially models acute dosing refs <NUMBER> <NUMBER> discussed table <NUMBER> raise concern relevance aceiarb administration patients including setting covid<NUMBER> summary <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> animals reported increase treatment groups ace<NUMBER> protein expressionactivity aceiarb treatment one study <NUMBER> combined arbacei treatment show effect two studies reported relatively small effects <NUMBER> increase ace<NUMBER> protein expression controlsham animals studies used high doses aceisarbs noted contrast <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> found little change ace<NUMBER> expression aceiarb treatment <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> treatment aceiarb effect decrease ace<NUMBER> protein expressionactivity controlsham animals increased ace<NUMBER> expression observed following experimental exposure lung injury mi etc nearly studies reported increase ace<NUMBER> doses aceisarbs used greater equivalent doses typically administered patients identified one study <NUMBER> aceiarb use increased ace<NUMBER> protein expression doses typical human use albeit changes occurred exposure acute injury subtotal nephrectomy overall studies experimental animals provide consistent evidence effect arbacei administration ace<NUMBER> protein expression especially contexts model drug administration humans evidence changes ace<NUMBER> protein human subjectspatients table <NUMBER> derived studies assessed ace<NUMBER> protein concentration enzymatic activity urine serumplasma <NUMBER> studies summarized table <NUMBER> <NUMBER> showed effect arbacei use ace<NUMBER> protein levels one study <NUMBER> documented small increase serum ace<NUMBER> attributable use aceis among type<NUMBER> diabetic patients found effect use arbs another study <NUMBER> found slightly larger proportional decrease urinary ace<NUMBER> patients type<NUMBER> diabetes using aceisarbs distinguish effects use aceis arbs one study <NUMBER> investigators observed subjects using arb olmesartan increased ace<NUMBER> levels several arbs aceis effect besides quantitative data results regarding ace<NUMBER> protein expression generated immunohistochemical analysis kidneys <NUMBER> indicated aceidependent effect together results imply lack association ace<NUMBER> protein expression use arbs aceis support idea aceisarbs unlikely raise ace<NUMBER> harmful context covid<NUMBER> infection would constitute strong supportive evidence hypothesis aceiarb usage risk factor setting sarscov<NUMBER> infection findings help support hypothesis would include <NUMBER> replication prominent effect multiple animal studies models <NUMBER> evidence tissues low expression ace<NUMBER> prominent increases expression activity following aceiarb treatment <NUMBER> data documenting increases ace<NUMBER> expression response aceiarb treatment enhance ability sarscov<NUMBER> virus infect cells <NUMBER> findings human studies statistically significant relationships aceiarb usage ace<NUMBER> expressionactivity <NUMBER> epidemiological data showing covid<NUMBER> patients administered aceisarbs increased morbidity mortality ideally doseresponse relationship outcomes well available data provide evidence <NUMBER> hypothesis ace<NUMBER> expression increases aceiarb use supported plurality available data animal studies <NUMBER> available evidence de novo expression ace<NUMBER> expression response aceisarbs tissues low expression <NUMBER> affinity sarscov<NUMBER> ace<NUMBER> high <NUMBER>fold greater sarscov<NUMBER> <NUMBER> unclear small modest perturbations ace<NUMBER> expression impact infectivity sarscov<NUMBER> moreover ace<NUMBER> levels may decrease age <NUMBER> diabetes <NUMBER> yet elderlydiabetic subjects vulnerable younger individuals covid<NUMBER> <NUMBER> modest changes ace<NUMBER> expression may meaningfully impact high infectivity sarscov<NUMBER> host tissues <NUMBER> data human studies suggest treatment aceisarbs produces little effect urinary circulating ace<NUMBER> levels caveat changes ace<NUMBER> levels serum urine may reflect changes tissue <NUMBER> epidemiological studies assessed outcomes matched groups patients infected sarscov<NUMBER> taking aceisarbs based data summarized conclude current evidence especially human studies table <NUMBER> support idea treatment aceis arbs produces pathophysiologically relevant increases ace<NUMBER> protein abundance hypothesis use drugs increases sarscov<NUMBER> virus infectivity andor severity covid<NUMBER> therefore supported available evidence would thus seem prudent patients continue receiving medications recently recommended multiple health associations <NUMBER> <NUMBER> words without <NUMBER> including abstract ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity ferrario et al <NUMBER> lewis rats treated losartan arb lisinopril acei <NUMBER> mgkgday hed <NUMBER> mgday <NUMBER> days ace<NUMBER> activity measured membranes renal cortex lisinopril losartan treatment associated increases ace<NUMBER> activity used combination produce effect ocaranza et al <NUMBER> sprague dawley sd rats used myocardial infarction model via coronary ligation acei enalapril <NUMBER> mgkgday hed <NUMBER> mgday administered <NUMBER> weeks postsurgery plasma ace<NUMBER> activity measured enalapril increased plasma ace<NUMBER> <NUMBER> <NUMBER> sham mi animals respectively hamming et al <NUMBER> renal ace<NUMBER> activity assayed wistar rats controls low sodium diet along lisinopril <NUMBER> gl drinking water <NUMBER> weeks renal ace<NUMBER> activity unchanged acei treatment either group velkoska et al <NUMBER> ace<NUMBER> activity assessed kidneys sd rats subtotal nephrectomy given ramipril ace <NUMBER> mgkgday hed <NUMBER> mgday <NUMBER> days ace<NUMBER> activity renal cortex medulla unchanged acei treatment control rats increased <NUMBER> nephrectomy han et al <NUMBER> ace<NUMBER> protein expression lungs measured sd rats cigarette smokeinduced lung damage rats treated losartan <NUMBER> <NUMBER>mgkgday hed <NUMBER> <NUMBER> mgday <NUMBER> months ace<NUMBER> expression unchanged control rats either dose losartan animals exposed cigarette smoke reduced ace<NUMBER> losartan treatment restored wöstenvan asperen et al <NUMBER> sd rats used lpsinduced model acute respiratory distress syndrome ards rats given losartan <NUMBER> mgkgh <NUMBER>h ventilation hed <NUMBER> mg ace<NUMBER> protein expression lung measured <NUMBER>h inducing ards lps losartan administration decreased ace<NUMBER> activity control animals unclear ifhow statistics performed induction ards ace<NUMBER> levels decreased restored normal losartan burrell et al <NUMBER> ace<NUMBER> activity protein expression assayed tissues sd rats <NUMBER> days subtotal nephrectomy received ramipril acei <NUMBER> mgkgday hed <NUMBER> mgday ramipril effect ace<NUMBER> cardiac renal cortex medullary tissue ace<NUMBER> activity reduced renal cortex nephrectomy ramipril restored ace<NUMBER> activity control levels burchill et al <NUMBER> ace<NUMBER> protein expression assessed cardiac tissue myocardial infarction mi model sd rats ramipril <NUMBER> mgkgday hed <NUMBER> mgday valsartan arb <NUMBER> mgkgday hed <NUMBER> mgday given <NUMBER> days postcoronary artery ligation ace<NUMBER> expression altered may decreased viable myocardium border infarct zones unclear statistical analysis yang et al <NUMBER> spontaneously hypertensive rats treated enalapril <NUMBER> mgkgday hed <NUMBER> mgday <NUMBER> weeks cardiac ace<NUMBER> protein expression measured ace<NUMBER> mrna expression increased ace<NUMBER> protein expression change acei treatment zhang et al <NUMBER> cardiac ace<NUMBER> protein assayed sd rats cardiac remodeling aortic constriction treated losartan <NUMBER> mgkgday hed <NUMBER> mgday enalapril <NUMBER> mgkgday hed <NUMBER> mgday <NUMBER> days starting <NUMBER> days surgery ace<NUMBER> cardiac protein expression increased <NUMBER>fold drugs rats cardiac remodeling data provided animals sham surgery sd rats underwent lpsstimulated lung injury simultaneous intravenous injection lps animals administered captopril <NUMBER> mgkg hed <NUMBER> mg <NUMBER>h samples collected ace<NUMBER> protein expression measured lung ace<NUMBER> protein expression elevated lung control rats <NUMBER> lpsinduced lung injury <NUMBER>fold wang et al <NUMBER> pigs used study effects aceis cardiac arrest resuscitation enalapril <NUMBER> mgkg hed <NUMBER> mg perfused <NUMBER> min followed surgery myocardial ace<NUMBER> protein expression assayed samples collected <NUMBER>h postsurgery compared salineinfused controls enalapril increase ace<NUMBER> levels enalapril administered sham rats ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted march <NUMBER> <NUMBER> use arbs aceis effect urinary ace<NUMBER> levels epelman et al <NUMBER> plasma ace<NUMBER> activity assayed <NUMBER> patients heart failure association found aceiarb use ace<NUMBER> levels soropaavonen et al <NUMBER> serum ace<NUMBER> activity measured <NUMBER> patients type<NUMBER> diabetes <NUMBER> healthy control subjects ace<NUMBER> increased <NUMBER> <NUMBER> higher women diabetics using aceis association found arb usage ace<NUMBER> levels serum ace<NUMBER> activity assayed <NUMBER> patients stelevation myocardial infarction <NUMBER> control subjects association found acei use ace<NUMBER> levels arb usage discussed serum ace<NUMBER> activity assayed <NUMBER> healthy subjects <NUMBER> hypertensive patients <NUMBER> patients heart failure different types logistic regression analysis showed acei arb usage association ace<NUMBER> levels walters et al <NUMBER> plasma ace<NUMBER> activity assessed <NUMBER> control subjects <NUMBER> patients atrial fibrillation association found ace<NUMBER> levels aceiarb use plasma ace<NUMBER> activity measured <NUMBER> patients obstructive coronary artery disease ace<NUMBER> levels association use aceis arbs ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint respiratory viruses common worldwide impact human animal health important economic consequences although symptoms respiratory virus infection related airway inflammation focused respiratory tract extra respiratory organs also targeted viruses including central nervous system bohmwald et al <NUMBER> recent pandemic coronavirus disease emerging december <NUMBER> accompanied prevalence olfaction alteration indeed approximately <NUMBER> patients infected severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> cause covid<NUMBER> suffered mild hyposmia total loss olfactory capacities anosmia spinato et al <NUMBER> origin alterations remains established olfaction starts olfactory sensory neurons osn located olfactory epithelium oe present dorsal part nasal cavity oe along underlying lamina propria constitutes olfactory mucosa osns cilia direct contact environment order detect odorants therefore accessible respiratory viruses viruses able infect osn reach central nervous system following olfactory nerves project olfactory bulbs bryche et al <NUMBER>b forrester et al <NUMBER> interestingly sarscov<NUMBER> netland et al <NUMBER> described virus able use olfactory pathway ace<NUMBER> angiotensinconverting enzyme <NUMBER> characterized main entrance receptor sarscov<NUMBER> letko et al <NUMBER> similarly sarscov<NUMBER> sarscov<NUMBER> described able enter central nervous system mice transgenic human ace<NUMBER> netland et al <NUMBER> model brain infection starts olfactory bulbs authors look potential infection olfactory mucosa may sarscov<NUMBER> could infect olfactory sensory neurons reaching brain olfactory bulbs neurons project forrester et al <NUMBER> sarscov<NUMBER> infection follows pathway anosmia following sarscov<NUMBER> infection may correlate encephalopathies observed covid<NUMBER> patients roe <NUMBER> highlights need unravel cellular basis observed anosmia golden syrian hamsters successfully used model sarscov<NUMBER> infection roberts et al <NUMBER> also recently shown good model sarscov<NUMBER> well sia et al <NUMBER> indeed expression profile ace<NUMBER> entry receptor sarscov<NUMBER> similar hamsters humans luan et al <NUMBER> anosmia covid<NUMBER> patients provided impetus study expression profile ace<NUMBER> nasal cavity several studies show ace<NUMBER> present oe expressed sustentacular cells supporting cells surrounding olfactory neurons rather olfactory neurons bilinska et al <NUMBER> fodoulian et al <NUMBER> however recent study suggested sarscov<NUMBER> could infect olfactory sensory neurons hamsters sia et al <NUMBER> present work focused pathological impact two different sarscov<NUMBER> strains nasal cavity central nervous system golden syrian hamster viral strains isolated nasopharyngeal swabs obtained patients suffering respiratory infection suspected covid<NUMBER> submitted molecular diagnosis nasopharyngeal flocked swabs suspended utm media copan italy kept <NUMBER>°c less <NUMBER> hours volume <NUMBER> µl homogenized microfiltered <NUMBER> µm previous inoculation vero cells ccl<NUMBER> passage <NUMBER> atcc usa grown <NUMBER> confluence bsl<NUMBER> virology laboratory virology unit chu de caen france supernatants harvested day <NUMBER> inoculation immediately used subsequent passage one p<NUMBER> virus following protocol p<NUMBER> used stock production stock aliquoted conserved <NUMBER>°c titration genomic quantification two strains used model ucn<NUMBER> ucn<NUMBER> isolated one week interval course active epidemic normandy france end march animal experiments carried animalbiosafety level <NUMBER> absl<NUMBER> facility animal experimental platform anses laboratoire de lyon protocol animal use approved french ministère de la recherche et de lenseignement supérieur number apafis n°<NUMBER> twelve female golden syrian hamsters eight weeks old purchased janviers breeding centre le genest st isle france infection done nasal instillation <NUMBER>µl nostril anaesthetised animals vetflurane five animals infected <NUMBER> <NUMBER> <NUMBER> plaque forming units pfu sarscov<NUMBER> strain ucn<NUMBER> five animals infected <NUMBER> <NUMBER> <NUMBER> pfu sarscov<NUMBER> strain ucn<NUMBER> two mockinfected animals received dulbeccos minimal essential medium dmem sarscov<NUMBER>infected hamsters euthanized general anaesthesia vetflurane <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> days infection postmortem lungs harvested weighed homogenized <NUMBER> ml dmem stainless steel beads qiagen <NUMBER>s <NUMBER> hz using tissuelyserii qiagen lung homogenates clarified centrifugation <NUMBER> × g <NUMBER>°c <NUMBER> min aliquoted stored −<NUMBER>°c rna extraction rna extraction done qiaamp viral rna minikit qiagen following manufacturers instructions real time quantitative pcr performed e gene described recently corman et al <NUMBER> lightcycler lc<NUMBER> roche immunohistochemistry analysis olfactory mucosa tissue sections performed described previously mice bryche et al <NUMBER>b briefly whole animal head fixed <NUMBER> days room temperature <NUMBER> paraformaldehyde pbs decalcified one week <NUMBER> edta ph <NUMBER> <NUMBER>°c nasal septum endoturbinates removed block postfixed overnight <NUMBER>°c <NUMBER> paraformaldehyde pbs decalcified <NUMBER> days procedure applied cortex brainstem without decalcification blocks tissues cryoprotected sucrose <NUMBER> cryosectioning <NUMBER> μm performed median transversal sections nasal cavity perpendicular hard palate order highlight vomeronasal organ olfactory mucosa stenos gland olfactory bulb brain cryosectioned <NUMBER> µm coronal plane sections stored <NUMBER>°c use nonspecific staining blocked incubation <NUMBER> bovine histology sections rehydrated stained hematoxylin h<NUMBER> vector laboratories <NUMBER>s washed water slides transferred acidalcohol solution <NUMBER> hcl <NUMBER> ethanol <NUMBER>s washed water immersed eosin sigma ht<NUMBER> <NUMBER>s washed water finally slides gradually dehydrated mounted eukitt sigma <NUMBER> nissl staining performed sections following conventional histological procedures including immersion <NUMBER> cresyl violet solution <NUMBER> minutes images taken x<NUMBER> magnification using dmbr leica microscope equipped olympus dp<NUMBER> ccd camera using cell f software olympus soft imaging solutions gmbh osis munster germany measured oe thickness osn cilia quality based golf staining immune cell infiltration olfactory mucosa based iba<NUMBER> staining <NUMBER> images per animal taken <NUMBER> different slides spread along nasal cavity oe thickness <NUMBER> measurements along oe septum performed image previously described francois et al <NUMBER> percentage apical oe preserved g olf staining percentage iba<NUMBER> cells infiltration oe measured using imagej threshold specific staining values averaged per animal also globally estimated impact sarscov<NUMBER> oe parameters comparing mockinfected animals sarscov<NUMBER> infected animals evaluated <NUMBER> integrity structure oe using staining <NUMBER> preservation osn cilia using g olf signal apical part oe <NUMBER> presence shape iba<NUMBER> cells oe underneath lamina propria ramified iba<NUMBER> cells considered representative resting state amoeboid shape linked activated state oe mori et al <NUMBER> parameter used scale ranging <NUMBER> <NUMBER> scored three sections olfactory mucosa spread along nasal cavity per animal evaluation performed three experienced investigators blinded animal treatment scores averaged per animal investigators used cohort <NUMBER> hamsters examine impact two different isolates sarscov<NUMBER> ucn<NUMBER> ucn<NUMBER> nasal cavity <NUMBER> <NUMBER> day post infection dpi nasal instillation olfactory epithelium well preserved control animals observed massive damage olfactory epithelium sarscov<NUMBER>infected animals early <NUMBER> dpi fig <NUMBER>a nasal cavity lumen filled cellular aggregates olfactory epithelium strongly disorganized affected oe zones axon bundles olfactory sensory neurons olfactory epithelium almost direct contact environment fig <NUMBER>b objective measure olfactory mucosa damage first measured septal olfactory epithelium thickness fig <NUMBER>c scored overall lesions oe fig <NUMBER>d oe disappeared <NUMBER> dpi point started recover reached preinfection thickness <NUMBER> dpi measurements stopped results similar viruses examined cellular localisation sarscov<NUMBER> nasal cavity immunohistochemistry using antibody raised nucleocapsid protein virus observed large proportion oe infected <NUMBER> dpi decreased <NUMBER> dpi subsequently disappeared fig <NUMBER>a supp fig <NUMBER>a b virus also present vomeronasal organ supp fig <NUMBER>a stenos gland supp fig <NUMBER>b <NUMBER> dpi <NUMBER> dpi also examined various areas brain could find presence virus olfactory bulbs supp fig <NUMBER>a olfactory cortex piriform cortex olfactory tubercle hypothalamus hippocampus brainstem mainly focused respiratory control centres ventral respiratory column nucleus solitary tract supp fig <NUMBER>b virus presence nasal cavity followed kinetic similar presence lungs supp fig <NUMBER>c order identify cells infected sarscov<NUMBER> oe performed double staining olfactory mucosa omp ck<NUMBER> specific markers mature osns sustentacular cells respectively cells infected sarscov<NUMBER> expressed ck<NUMBER> well able find viral antigen omp expressing cells results show sarscov<NUMBER> infects sustentacular cells osns fig <NUMBER> interestingly observed staining omp ck<NUMBER> sarscov<NUMBER> well hoechst lumen nasal cavity indicating part oe containing infected noninfected cells desquamated response sarscov<NUMBER> infection order understand extent damage osns following sarscov<NUMBER> infection examined preservation osn cilia layer contains transduction complex allowing detection odours dibattista et al <NUMBER> performed immunohistochemistry g olf fig <NUMBER>a b specific g protein complex jones reed <NUMBER> quantified percentage septal olfactory epithelium containing g olf staining apical part oe fig <NUMBER>c scored globally quantity g olf staining oe fig <NUMBER>d g olf signal completely preserved control animals quickly diminished sarscov<NUMBER>infected animals without clear improvement <NUMBER> dpi <NUMBER> dpi observed small recovery g olf signal septal part oe <NUMBER> dpi ucn<NUMBER> virus finally examined presence immune cells olfactory mucosa using iba<NUMBER> specific marker monocytemacrophage lineage bryche et al <NUMBER>a fig <NUMBER>a control animals iba<NUMBER> cells mainly localized lamina propria exhibited ramified morphology many processes fig <NUMBER>b typical resting phenotype mori et al <NUMBER> measured presence iba<NUMBER> cell fig <NUMBER>c scored presence shape iba<NUMBER> cells oe lamina propria separately fig <NUMBER>d iba<NUMBER> cells mostly absent oe moderately present lamina propria control animals presence drastically increased <NUMBER> dpi infected animals oe lamina propria fig <NUMBER>a b furthermore iba<NUMBER> cells mostly amoeboid shape typical activated state <NUMBER> <NUMBER> dpi fig <NUMBER>b also observed iba<NUMBER> cells lumen nasal cavity cellular aggregates containing sarscov<NUMBER> fig <NUMBER>a immune cell infiltration gradually diminished reduction first observed <NUMBER> dpi oe seen lamina propria <NUMBER> dpi <NUMBER> dpi reached mock level oe lamina propria virus strains fig <NUMBER>c present study focused impact sarscov<NUMBER> nasal cavity central nervous system using golden syrian hamster model chose work <NUMBER> different isolates sarscov<NUMBER> potential obtain slightly different strain behaviour explored kinetic impact two different isolates due difficulty designing experiments covid<NUMBER> pandemic examined one animal per virus strain per time point overall results globally consistent viruses kinetics different measured parameters always following consistent evolution <NUMBER> dpi <NUMBER> dpi results require confirmation larger animal groups provide qualitative overview impact sarscov<NUMBER> nasal cavity could explain anosmia observed covid<NUMBER> patients indeed according results sustentacular cells rapidly infected sarscov<NUMBER> infection associated massive recruitment immune cells oe lamina propria could induce rapid disorganization oe structure causing immunopathology hypothesis consistent elevated level tnfα observed oe samples covid<NUMBER> suffering patients torabi et al <NUMBER> however experiments required identify importance damage directly induce virus replication disorganization followed massive destruction oe released lumen nasal cavity taking away cilia layer osns absence cilia olfactory transduction functional thus olfactory capacity animals impaired oe regenerates supplementary behavioural experiments would required demonstrate anosmia infected hamsters however odours recognition behavioural tasks rely hungry thirsty animals witt et al <NUMBER> thus may biased impact sarscov<NUMBER> animal feeding behaviour <NUMBER> dpi thickness oe already recovering approximately <NUMBER> mock condition functional cilia reappear kinetics consistent observed recovery anosmia covid<NUMBER> patients indeed recent studies highlight relatively fast recovery <NUMBER> days dellera et al <NUMBER> meini et al <NUMBER> compatible observed partial recovery oe hamsters <NUMBER> dpi sarscov<NUMBER> deadly men women clear yet anosmia affects gender equally dellera et al <NUMBER> meini et al <NUMBER> however recovery olfaction seems longer women dellera et al <NUMBER> meini et al <NUMBER> studied female hamsters experiments needed decipher gender impact sarscov<NUMBER> oe identify sustentacular cells main target cells sarscov<NUMBER> oe observation consistent expression pattern ace<NUMBER> mainly present cells along facilitating protease tmprss<NUMBER> bilinska et al <NUMBER> fodoulian et al <NUMBER> two recent reports indicate olfactory neurons hamster sia et al <NUMBER> respiratory cells ferret ryan et al <NUMBER> may target sarscov<NUMBER> studies focus nasal cavity use double staining clearly identify infected cells oe observed sarscov<NUMBER> infect nonneuronal cells nasal cavity notably epithelium covering lumen stenos gland however poorly described literature bryche et al <NUMBER>b studies required clearly identify nonneuronal cells infected sarscov<NUMBER> nasal cavity may facilitate systemic infection cell types tissues lower respiratory airways double staining colocalize ace<NUMBER> sarscov<NUMBER> presence would also improve understanding importance ace<NUMBER> sarscov<NUMBER> cellular susceptibility observe presence virus brain notably olfactory bulbs osns projects piriform cortex olfactory signal integrated also focused hypothalamus contains ace<NUMBER> expressing neurons mukerjee et al <NUMBER> well respiratory centres brainstem latter suspected infected covid<NUMBER> patients suffering heavy respiratory disorders gandhi et al <NUMBER> lack virus detection central nervous system may due low number animal examined nevertheless rule systematic important infection brain following sarscov<NUMBER> infection hamster consistent recent review literature failed indicate central nervous manifestation sarscov<NUMBER> presence human central nervous system romoli et al <NUMBER> however neurotropic ability sarscov<NUMBER> remains controversial wang et al <NUMBER> interestingly sarscov<NUMBER> shown neurotropic using ace<NUMBER> humanized mice osns mice must also express ace<NUMBER> control k<NUMBER> ubiquitous promoter netland et al <NUMBER> sarscov<NUMBER> may thus infect osns expressing ectopic ace<NUMBER> observation presence virus brain may relevant physiological model model observed fast desquamation oe following sarscov<NUMBER> infection sustentacular cells studies required decipher whether could antiviral strategy limit access virus brain olfactory pathway extent recruitment immune cells contributes process immunopathological mechanisms globally present first data focusing impact sarscov<NUMBER> nasal cavity results could explain high prevalence anosmia observed covid<NUMBER> patients need confirmed analysis human oe low sn titers resulting prolonged infection several fdaapproved repurposed drugs tested antiviral candidates clinics without sufficient information rapid preclinical animal studies proceed identify therapeutic drug candidates strong antiviral potential high safety prior human efficacy trial keywords covid<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> antiviral therapeutics immunosuppression serum neutralization ferrets n december <NUMBER> novel coronavirus cov disease identified wuhan hubei province china patients pneumonia found caused previously unknown betacoronavirus outbreak rapidly spread provinces mainland china despite great efforts epidemic continued spread china europe north america asian countries world health organization announced severe acute respiratory syndrome cov <NUMBER> sarscov<NUMBER> epidemic public health emergency international concern <NUMBER> january <NUMBER> <NUMBER> march <NUMBER> director general characterized covid<NUMBER> pandemic httpwwweurowhointenhealthtopicshealth emergenciescoronaviruscovid<NUMBER>newsnews<NUMBER>ncovoutbreakisan emergencyofinternationalconcern httpswwwwhointdgspeechesdetailwho directorgeneralsopeningremarksatthemediabriefingoncovid<NUMBER>march <NUMBER> currently number people diagnosed sarscov<NUMBER> infection increasing approximately <NUMBER> cases day <NUMBER> april <NUMBER> approximately <NUMBER> cases diagnosed covid<NUMBER> <NUMBER> deaths occurred <NUMBER> recent studies reported detection sarscov<NUMBER> rna various clinical specimens suggesting transmission routes virus besides respiratory secretions <NUMBER> <NUMBER> <NUMBER> unfortunately date vaccines antiviral drugs approved treatment sarscov<NUMBER> infection regulatory agencies researchers fervently working develop vaccines specifically virus well potential treatments covid<NUMBER> although many clinical trials ongoing specific therapeutic agents approved covid<NUMBER> developing sarscov<NUMBER>specific antiviral drugs scratch could take years drugs already approved us food drug administration fda potential reach patients quickly sars outbreak <NUMBER> screening approved drugs identified lopinavirritonavir human immunodeficiency virus type <NUMBER> hiv<NUMBER> aspartate protease inhibitor effective sarscov replication <NUMBER> antiviral activity lopinavirritonavir middle east respiratory syndrome coronavirus merscov vitro <NUMBER> animal model <NUMBER> reported case reports suggest combination lopinavirritonavir ribavirin interferon alpha results virologic clearance survival <NUMBER> <NUMBER> chloroquine cq widely used antimalarial immunomodulatory effects <NUMBER> found recent study inhibit growth sarscov<NUMBER> vitro <NUMBER> however finding strongly supported clinical studies approximately <NUMBER> sarscov<NUMBER>infected patients <NUMBER> <NUMBER> derivative chloroquine hydroxychloroquine hcq sulfate first synthesized <NUMBER> adding hydroxyl group cq resulting compound found much less toxic cq animal study <NUMBER> autoimmune diseases hcq sulfate works reducing inflammation <NUMBER> however recent reports also shown heart risk concerns use cq hcq sulfate covid<NUMBER> treatment emtricitabinetenofovir truvada prescription medicine hiv approved us fda preexposure prophylaxis reduce risk hiv infection adults adolescents nucleotide analogue reported active triphosphate form tenofovir diphosphate inhibits activity rnadependent rna polymerase rdrp hiv hepatitis b virus hbv <NUMBER> <NUMBER> still even existing drugs need rigorous testing efficacy safety ultimately rampedup production deployed widely covid<NUMBER> generally immunocompromised patients susceptible bacterial fungal viral parasitic infections healthy persons due inability mount successful immune responses caused impairment weakening immune system number conditions including diseases eg diabetes hiv infection malnutrition use certain medications become apparent sarscov<NUMBER> infection also affects immunocompromised individuals severely majority covid<NUMBER> patients clinically diagnosed older ϳ<NUMBER> years underlying complications including heart disease diabetes hypertension cancer indicating age reduced immune activity critical risk factors determinants covid<NUMBER> morbidity mortality recently established ferret model sarscov<NUMBER> infection transmission highly recapitulates aspects human infection <NUMBER> elevated body temperatures virus replication readily detected sarscov<NUMBER>infected ferrets sarscov<NUMBER>infected ferrets shed virus nasal washes saliva urine fecal specimens sarscov<NUMBER> transmitted readily naive directcontact ferrets less efficiently naive indirectcontact ferrets <NUMBER> acute bronchiolitis observed infected lungs report evaluated efficacy oral administration lopinavirritonavir hcq sulfate emtricitabinetenofovir sarscov<NUMBER> infection ferret infection models also treated ferrets azathioprine immunosuppressive drug evaluated replication kinetics sarscov<NUMBER> drug treatments reduced clinical symptoms cs none led significant reduction vivo virus titers ferrets thus drug candidate study robust preclinical animal model greatly facilitate testing efficacies safety therapeutic treatments covid<NUMBER> patients clinical features sarscov<NUMBER>inoculated ferrets treated antivirals order determine antiviral efficacies lopinavirritonavir hydroxychloroquine hcq sulfate emtricitabinetenofovir treatment sarscov<NUMBER> infection sarscov<NUMBER> antibodyfree ferrets <NUMBER>group inoculated <NUMBER> <NUMBER> <NUMBER> tissue culture infective doses tcid <NUMBER> ml nmcncov<NUMBER> strain intranasal route fig <NUMBER> <NUMBER> day postinfection dpi sarscov<NUMBER> ferrets administered lopinavir <NUMBER> mgkg body weightritonavir <NUMBER> mgkg hydroxychloroquine sulfate <NUMBER> mgkg emtricitabine <NUMBER> mgkgtenofovir <NUMBER> mgkg daily via oral gavage <NUMBER> days fig <NUMBER> addition test effect immunosuppression viral infection clinical outcome group n ϭ <NUMBER> ferrets also treated phosphatebuffered saline pbs control azathioprine immunosuppressive drug <NUMBER> mgkg <NUMBER> days prior sarscov<NUMBER> infection fig <NUMBER> groups sarscov<NUMBER>infected ferrets showed elevated temperatures <NUMBER> <NUMBER> dpi lopinavirritonaviror emtricitabinetenofovirtreated group exhibited mild fever compared pbstreated group fig <NUMBER>a pbstreated group hydroxychloroquine sulfateor azathioprinetreated group showed ϳ<NUMBER> body weight loss <NUMBER> dpi lopinavirritonaviror emtricitabinetenofovirtreated group showed ͻ<NUMBER> change body weight average fig <NUMBER>b compare clinical features sarscov<NUMBER> infection following treatment drug developed arbitrary scoring method generate clinical symptom values based <NUMBER>min observations cough rhinorrhea reduced activity compared cs values among ferret groups described table <NUMBER> average cs value pbstreated control ferrets <NUMBER> <NUMBER> dpi remained relatively high ͼ<NUMBER> <NUMBER> <NUMBER> dpi returned normal less <NUMBER> <NUMBER> dpi table <NUMBER> lopinavirritonavirtreated ferrets showed reduced overall cs values less <NUMBER> peaked <NUMBER> <NUMBER> dpi resolved <NUMBER> dpi table <NUMBER> hcq sulfatetreated ferrets also showed reduced cs values <NUMBER> <NUMBER> dpi compared pbstreated group overall clinical symptoms similar pbstreated control group table <NUMBER> although emtricitabinetenofovirtreated ferrets initially demonstrated clinical symptoms similar pbstreated control group overall cs values relatively low <NUMBER> <NUMBER> dpi clinical symptoms ultimately resolved <NUMBER> dpi finally azathioprinetreated immunosuppressed ferrets also showed cs values similar pbstreated control group groups clinical symptoms lasted slightly longer pbstreated control group table <NUMBER> results collectively showed lopinavirritonavir hcq sulfate emtricitabinetenofovirtreated group exhibited lower overall clinical scores pbstreated control group overall clinical symptoms immunosuppressed ferrets similar persisted slightly longer pbstreated control ferrets comparisons virus titers shedding periods antiviraldrugtreated ferrets evaluate antiviral activity drug sarscov<NUMBER> measured infectious virus titers nasal washes drugtreated ferrets fig <NUMBER>c sarscov<NUMBER> isolated infected ferrets regardless drug treatment <NUMBER> dpi <NUMBER> dpi similar virus titers <NUMBER> <NUMBER> log <NUMBER> tcid <NUMBER> ml <NUMBER> dpi emtricitabinetenofovirtreated ferrets exhibited reduced virus titers compared pbstreated control group although infectious virus detected ferrets pbsor antiviraldrugtreated groups <NUMBER> dpi three four azathioprinetreated ferrets positive virus even <NUMBER> dpi fig <NUMBER>c suggesting delayed virus clearance upper respiratory tracts immunocompromised ferrets gastrointestinal involvement documented coronavirus infections animals humans <NUMBER> also collected fecal specimens performed quantitative realtime pcr qrtpcr determine whether drug treatments affected sarscov<NUMBER> shedding gastrointestinal system fig <NUMBER>d results showed viral rna present fecal specimens groups <NUMBER> <NUMBER> dpi peak viral rna copy numbers observed <NUMBER> <NUMBER> dpi however statistical difference viral rna copy numbers among groups experimental period <NUMBER> dpi viral rna copy numbers declined drugtreated ferrets evaluate virus titers tissues three ferrets group euthanized <NUMBER> <NUMBER> dpi virus titers measured nasal turbinate lungs <NUMBER> dpi groups ferrets showed high virus titers <NUMBER> log <NUMBER> tcid <NUMBER> g nasal turbinate tissues virus also isolated lung tissues fig <NUMBER> <NUMBER> dpi nasal turbinate tissues positive virus azathioprinetreated group showed much higher virus titer ϳ<NUMBER> log <NUMBER> tcid <NUMBER> g groups fig <NUMBER>a <NUMBER> dpi azathioprinetreated group still detectable virus titers lung tissues whereas rest groups negative virus fig <NUMBER>b compare serum neutralization sn antibody titers among drugtreated groups blood collected group ferrets <NUMBER> <NUMBER> <NUMBER> dpi <NUMBER> dpi pbstreated control drugtreated groups demonstrated sn titers greater <NUMBER> fig <NUMBER> antiviraltreated groups showed sn titers similar pbstreated control group <NUMBER> dpi exhibited lower sn titers <NUMBER> dpi pbstreated control group fig <NUMBER> noteworthy azathioprinetreated immunosuppression group showed geometric mean sn titers <NUMBER> <NUMBER> <NUMBER> <NUMBER> dpi respectively suggesting continuously reduced sn antibody response immunosuppressed group study evaluated antiviral efficacies three fdaapproved drug candidates sarscov<NUMBER> infection using ferret infection model previously proven highly susceptible sarscov<NUMBER> infection <NUMBER> <NUMBER> although several clinical trials continue evaluate drug candidates enrolled patient populations considered heterogeneous regard duration severity illness enrollment given rapid spread covid<NUMBER> around efficacies fdaapproved drugs sarscov<NUMBER> ® world relatively higher mortality rates regions certain age groups therefore use highly susceptible animal models controlled experimental settings effective approach prior human clinical trials evaluate vivo antiviral effects potential therapeutics ferrets treated antivirals showed relatively reduced overall clinical scores compared pbstreated control group displayed high overall clinical scores three drugs emtricitabinetenofovirtreated group showed noticeable reduction overall clinical scores յ<NUMBER> shorter duration <NUMBER> dpi clinical symptoms although attenuation overall clinical scores observed lopinavirritonavirand hcqtreated groups time points clinical durations comparable pbstreated control group results suggest treatment emtricitabinetenofovir nucleotide analogue inhibits rnadependent rna polymerase activity may likely candidate reduce clinical symptoms including cough morbidity sarscov<NUMBER>infected hosts lopinavirritonavir protease inhibitor cqhcq sulfate autophagy inhibitor shown effective sarscov merscov sarscov<NUMBER> vitro culture <NUMBER> several reports already described benefit clinical improvement covid<NUMBER> patients furthermore hqc reported associated number side effects including heart rhythm problem severely low blood pressure muscle nerve damage thus existing fdaapproved drugs still need rigorous testing efficacy safety animal model prior clinical trials covid<NUMBER> patients since emergence sarscov<NUMBER> china december <NUMBER> number cases rapidly increased disease spread globally increase number cases alarming specially compounded possibility viral transmission asymptomatic individuals several studies indicate asymptomatic patients transmit virus persons close contact <NUMBER> <NUMBER> therefore although clinical symptoms attenuated ferret groups treated antiviral candidates also evaluated virus titers respiratory gastrointestinal tracts using nasal washes stool samples respectively sarscov<NUMBER>infected ferrets regardless antiviral candidate treatment sarscov<NUMBER> detected <NUMBER> log <NUMBER> tcid <NUMBER> ml <NUMBER> dpi statistical difference pbstreated control group antiviraldrugtreated groups however emtricitabinetenofovirtreated group showed relatively low virus tiers shortened periods virus shedding nasal wash specimens compared groups currently role sn antibody pathogenesis disease clearance sarscov<NUMBER> unclear wu et al <NUMBER> recently reported sn antibody levels covid<NUMBER> patients variable depending immune status patient <NUMBER> patients failed develop high sn titers sarscov<NUMBER> infection although disease durations patients comparable others suggests sn antibody titer may closely associated immune activity rather virus titer disease duration patients interestingly found antiviraltreated groups showed lower sn antibody titers pbstreated control group possible antiviral treatment reduced overall clinical symptoms sarscov<NUMBER>infected ferrets might evoke weak immune responses thereby lead reduced neutralizing antibody responses nevertheless immunological studies needed understand detailed mechanisms low sn antibody titers antiviraltreated ferrets efficacies fdaapproved drugs sarscov<NUMBER> ® covid<NUMBER> typically characterized respiratory symptoms gastrointestinal symptoms reported cases moreover evidence viral rna stools sarscov<NUMBER> patients emtricitabinetenofovir reportedly shown antiviral efficacy gastrointestinal tract well respiratory tract <NUMBER> however qrtpcr analysis stools revealed statistical difference virus titers stools among pbstreated control antiviraltreated groups suggesting none tested antiviral candidates significantly diminished gastrointestinal sarscov<NUMBER> replication infected ferrets conclusion although may discrepancies drug efficacy animals humans results preclinical ferret infection study aid selection antiviral treatments covid<NUMBER> patients also suggests robust preclinical animal model sarscov<NUMBER> infection valuable order identify antiviral drugs future human efficacy trials sarscov<NUMBER> strain nmcncov<NUMBER> propagated vero cells dulbeccos modified eagle medium dmem gibco grand island ny supplemented <NUMBER> penicillinstreptomycin gibco tpck tosylsulfonyl phenylalanyl chloromethyl ketonetreated trypsin <NUMBER> gml worthington biochemical lakewood nj <NUMBER>°c incubator supplemented <NUMBER> co <NUMBER> <NUMBER> h propagated virus stored ϫ<NUMBER>°c working virus stock animal studies <NUMBER> tissue culture infective dose tcid <NUMBER> determined fixation crystal violet staining immunosuppression antiviraldrug candidate treatments ten ferrets treated orally azathioprine <NUMBER> mgkg celltrion daily <NUMBER> days prior sarscov<NUMBER> infection treatment continued <NUMBER> days postinfection dpi reduce immune response control pbs volume administered <NUMBER> ferrets confirm immunosuppressed status ferrets blood samples collected azathioprinetreated ferrets percentage lymphocytes assessed <NUMBER> <NUMBER> days preinfection <NUMBER> <NUMBER> <NUMBER> dpi reduction lymphocyte numbers azathioprinetreated ferrets compared lymphocyte numbers pbs control group confirmed see fig s<NUMBER> supplemental material treatment candidate antiviral drugs groups ferrets <NUMBER>group administered lopinavir <NUMBER> mgkgritonavir <NUMBER> mgkg abbott hydroxychloroquine sulfate <NUMBER> mgkg elyson emtricitabine <NUMBER> mgkgtenofovir <NUMBER> mgkg gilead daily via oral gavage starting <NUMBER> dpi sarscov<NUMBER> infection continuing <NUMBER> dpi experimental infection ferrets groups <NUMBER>to <NUMBER>monthold female ferrets <NUMBER>group seronegative sarscov<NUMBER> sarscov<NUMBER> intranasally inoculated <NUMBER> <NUMBER> tcid <NUMBER> ml nmcncov<NUMBER> anesthesia body weights temperatures infected ferrets monitored every day <NUMBER> dpi nasal washes stool specimens collected every day inoculated ferrets blood collected <NUMBER> <NUMBER> <NUMBER> dpi measure serum neutralization titer three ferrets per group euthanized <NUMBER> <NUMBER> dpi nasal turbinate lungs collected measure tissue virus titers examine lung histopathology virus titers nasal washes tissues determined <NUMBER> tcid <NUMBER> assessment vero cells virus titers stool specimens measured quantitative realtime pcr qrtpcr briefly total rna extracted using trizol reagent thermo fisher scientific rneasy kit qiagen cdnas generated sarscov<NUMBER>specific primer reverse transcription using quantitect reverse transcription qiagen qrtpcrs performed using sybr green supermix biorad cfx<NUMBER> touch realtime pcr detection system biorad spike genebased sarscov<NUMBER>specific primer set previously described <NUMBER> virus rna copy numbers calculated ratio respect standard control clinical scoring methods sarscov<NUMBER>infected ferrets ferrets monitored daily <NUMBER>day period temperature change weight loss clinical symptom movement activity change briefly frequency cough rhinorrhea assessed group ferrets scored basis following criteria evidence cough score <NUMBER> occasional cough score <NUMBER> frequent cough score <NUMBER> nasal rattling sneezing score <NUMBER> moderate nasal discharge external nares score <NUMBER> severe nasal discharge external nares score <NUMBER> change ferrets activity assessed scored basis following criteria normal movement activity score <NUMBER> mildly reduced movement activity score <NUMBER> considerably reduced movement activity score <NUMBER> least <NUMBER> min neutralizing assay sera collected group ferrets detect serum neutralization titer heatinactivated <NUMBER>folddiluted serum samples serially diluted <NUMBER>fold equal volume sarscov<NUMBER> <NUMBER> tcid <NUMBER> added diluted samples mixture serum virus incubated <NUMBER>°c <NUMBER> h added vero cells <NUMBER>well tissue culture plate <NUMBER> min mixture serum virus removed followed two washes cold pbs fresh medium added infected cells cells incubated <NUMBER>°c <NUMBER> co <NUMBER> <NUMBER> days supernatants removed fixed <NUMBER> formalin solution stained crystal violet determine titer statistical analysis assess significant differences values weight loss temperature viral titers serum neutralization titers statistical analyses done asterisks indicate statistical significance pbsadministered treated ferrets determined twoway analysis variance anova subsequent dunnett test p ͻ <NUMBER> p ͻ <NUMBER> p ͻ <NUMBER> statistical analyses performed using graphpad prism version <NUMBER> windows graphpad software la jolla ca park et al coronavirus disease <NUMBER> caused novel coronavirus sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> abruptly reached pandemic proportions sarscov<NUMBER> member betacoronavirus family well sarscov severe acute respiratory syndrome coronavirus merscov middle east respiratory syndromerelated coronavirus since beginning <NUMBER> number confirmed cases covid<NUMBER> dramatically increased worldwide leaping million march <NUMBER> <NUMBER> although majority covid<NUMBER> patients develop mild moderate clinical features <NUMBER> severe pneumonia acute respiratory distress syndrome ards multiorgan failure leading high death rate may develop notably marked sex differences emerged covid<NUMBER> prevalence prognosis particular agespecific risk disease reported significantly higher males females except age <NUMBER> years moreover agespecific risks death hospitalization least two fold higher males females among age ranges <NUMBER> furthermore patients advanced age underlying pathologies mainly hypertension diabetes cardiovascular disease cvd prone experience severe form disease <NUMBER> even though overall mortality considerably varies among countries fatalityrate age groups displays similar patterns rising consistently <NUMBER>year age group <NUMBER> importantly presence comorbidities increases mortality sample <NUMBER> patients died covid<NUMBER> italy prevalence diabetes <NUMBER> <NUMBER> differently covid<NUMBER> spread diabetes known boundaries number affected people reached nearly half billion worldwide <NUMBER> number deaths attributed diabetes complications around <NUMBER> million <NUMBER> <NUMBER> notably <NUMBER> diabetic patients <NUMBER> years old <NUMBER> thus although extremely different connotations covid<NUMBER> diabetes two pandemics share burden wide diffusion elderly population dramatic impact global mortality economic health resources short review focused open questions emerging effort fully understand link covid<NUMBER> diabetes mainly context possible harmful beneficial effects commonly used drugs patients diabetes course covid<NUMBER> infection diabetes reportedly major cause mortality morbidity worldwide conceivable link diabetes infectious diseases postulated particular lower respiratory tract infections known rather common severe elderly type <NUMBER> diabetes t<NUMBER>d <NUMBER> although evidence suggests diabetes unlikely significantly increase susceptibility sarscov<NUMBER> infection higher risk worse covid<NUMBER> progression outcomes observed <NUMBER> mechanisms underlying association completely clear yet exacerbated proinflammatory cascade impaired immune response diabetic patients covid<NUMBER> suspected crucially involved particular increased levels proinflammatory markers leukocyte neutrophil count procalcitonin creactive protein ferritin circulating cytokines trigger cytokine storm namely il<NUMBER> il<NUMBER> il<NUMBER> receptor tnfα detected diabetic patients severe covid<NUMBER> compared patients without diabetes <NUMBER> furthermore altered immune response diabetic patients possibly due impaired lymphocyte neutrophil monocytemacrophage function long hypothesised especially presence poorly controlled glycaemia <NUMBER> <NUMBER> higher concentrations ddimer fibrinogen hallmarks severe forms covid<NUMBER> also reported patients diabetes compared patients without diabetes suggesting patients might prone develop coagulation abnormalities course infection known significantly associated worse prognosis <NUMBER> <NUMBER> recent retrospective study involving chinese patients n <NUMBER> moderate severe critical disease major risk factors mortality poor outcomes evaluated among enrolled patients <NUMBER> n <NUMBER> diabetes including t<NUMBER>d type <NUMBER> diabetes gestational diabetes overall diabetes increased odds inhospital death poor prognosis diabetic patients older significant alterations several laboratory parameters associated poor prognosis compared patients without diabetes particular higher levels ddimer female diabetic patients increased ldh neutrophil count compared nondiabetic patients cvd common men diabetes nondiabetic men notably multivariable regression analysis insulin therapy independently associated poor prognosis creactive protein independent risk factor either mortality poor prognosis patients covid<NUMBER> diabetes <NUMBER> besides research also needed clarify whether hypoglycaemia might also contribute adverse outcomes increased mortality covid<NUMBER> patients diabetes <NUMBER> patients diabetes high prevalence high blood pressure increased risk cvd <NUMBER> hence treatment hypertension largely includes drug classes demonstrated reduce cardiovascular events angiotensinconverting enzyme ace inhibitors angiotensin receptor blockers arbs <NUMBER> since ace converts angiotensin angiotensin ii potent vasoconstrictor sodiumretentive agent blockage reninangiotensinaldosterone system raas leads effective reduction blood pressure ace shows homology angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor transmembrane spike glycoprotein surface sarscov sarscov<NUMBER> binds allowing internalization virus alveolar cells cell types <NUMBER> ace<NUMBER> clearly direct target ace inhibitors ubiquitous monocarboxypeptidase converts angiotensin ii antiinflammatory antifibrotic angiotensin<NUMBER> contrasting potent vasoconstrictor sodiumretentive proinflammatory profibrotic effects indeed angiotensin<NUMBER> binding mas receptor induces nitric oxide release protecting tissue injury <NUMBER> another known substrate ace<NUMBER> angiotensin converted angiotensin<NUMBER> <NUMBER> <NUMBER> latter turn converted angiotensin<NUMBER> ace therefore competing angiotensin ii binding <NUMBER> limited animal vitro studies reported upregulation ace<NUMBER> induced arbs far lesser extent ace inhibitors predominantly heart kidney effect partly explained increase local levels angiotensin ii induced arbs ace inhibitors <NUMBER> indeed arbs block angiotensin ii type <NUMBER> at<NUMBER> receptors consequently increase availability substrate angiotensin ii upregulates ace<NUMBER> <NUMBER> based assumption speculated treatment arbs ace inhibitors might favour entry sarscov<NUMBER> lung cells therefore increasing risk adverse outcomes severe forms covid<NUMBER> infection conversely beneficial effect background therapy arb course disease supposed two complex mechanisms might support hypothesis firstly angiotensin ii binding receptor at<NUMBER> might enhance shedding transmembrane ace<NUMBER> promoted adam<NUMBER> disintegrin metalloprotease therefore releasing soluble ace<NUMBER> locally soluble form ace<NUMBER> unable mediate sarscov<NUMBER> internalization longer annexed cell membrane <NUMBER> secondly upregulation ace<NUMBER> probably induced arbs might necessarily negative effects sarscov<NUMBER> internalization lung cells inevitably induces downregulation ace<NUMBER> increase substrate angiotensin ii potent vasoconstrictor proinflammatory agent might contribute exacerbation lung injury indeed animal models lung injury clear association activation angiotensin iiat<NUMBER> signalling severity lung damage observed detrimental effects cascade counterbalanced activation ace<NUMBER>angiotensin<NUMBER>mas receptor axis <NUMBER> specifically models sepsis acid aspiration frequently cause acute lung injury ards ace<NUMBER> knockout mice experienced severe tissue damage characterized marked inflammatory cell infiltration increased vascular permeability lung oedema bleeding compared wildtype mice similarly angiotensin ii type <NUMBER> at<NUMBER> receptors knockout mice marked lung damage models injection recombinant human ace<NUMBER> protein ace<NUMBER> knockout mice considerably decreased severity lung injury <NUMBER> line findings pretreatment recombinant human ace<NUMBER> able reduce inflammatory cell infiltration tissue injury mouse model respiratory syncytial virus infection <NUMBER> evidence clinical studies still rather limited patients ards recombinant human ace<NUMBER> increased angiotensin<NUMBER> decreased angiotensinii concentrations even though study prematurely discontinued lack clinical improvement <NUMBER> overall evidence animal models suggests conceivable pneumoprotective role ace<NUMBER> at<NUMBER> receptor context lung injury loss pulmonary ace<NUMBER> might therefore harmful effects exacerbating inflammation promoting respiratory distress fibrosis way activation ace angiotensin ii at<NUMBER> receptor axis might exert detrimental effects worsening lung damage rationale raas inhibition therefore counterbalancing effects reducing angiotensin ii increasing ace<NUMBER> notably arb ace inhibitors attenuated lpsinduced lung injury several preclinical studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently milne et al analysed gene expression ace<NUMBER> ace agtr<NUMBER> encoding at<NUMBER> tmprss<NUMBER> transmembrane protease serine <NUMBER> requested cofactor internalization sarscov<NUMBER> adam<NUMBER> large number healthy lung tissue samples collected patients undergoing lung resection cancer significant association use ace inhibitors reduced ace<NUMBER> gene expression observed differently use arbs linked relevant changes ace<NUMBER> expression significantly correlated increased ace decreased agtr<NUMBER> expression <NUMBER> although findings quite contrast data animal studies highlighted gene expression rather protein concentration analysed collected tissue samples exhibit lung injury ards covid<NUMBER> results severe lung damage imbalance raas system context cannot excluded recently pilot study covid<NUMBER> patients found higher levels circulating angiotensin ii compared healthy subjects correlation angiotensin ii concentration severity disease observed well <NUMBER> thus effects ace inhibitors arbs might different extremely damaged context therefore explored animal models covid<NUMBER> mounting evidence recent clinical studies suggests raas inhibitor use related increased risk covid<NUMBER> infection poor outcomes retrospective cohort study <NUMBER> patients screened covid<NUMBER> test positivity significantly associated ace inhibitor arb therapy <NUMBER> similarly us study relationship emerged prior ace inhibitor arb use increased likelihood positive sarscov<NUMBER> test result adjusting relevant confounding factors <NUMBER> italian communitybased casecontrol study association found ace inhibitor arb treatment covid<NUMBER> infection although use drugs rather frequent due high prevalence cvd <NUMBER> overall findings excluded increased risk covid<NUMBER> infection patients already treated raas inhibitors studies evaluated link covid<NUMBER> progression raas inhibitor therapy recent korean populationbased cohort study involving <NUMBER> covid<NUMBER> patients use ace inhibitors arbs associated higher mortality risk adjustment confounders <NUMBER> recent systematic review including total n <NUMBER> covid<NUMBER> patients different countries ace inhibitor arb use associated increased severity covid<NUMBER> illness <NUMBER> interestingly metaanalysis <NUMBER> covid<NUMBER> patients seven cohort studies five casecontrol studies use raas inhibitors linked higher risk covid<NUMBER> infection severity mortality whereas mortality risk significantly lower patients treated ace inhibitors arbs compared treated antihypertensive drugs <NUMBER> taking together data observational studies indicates raas inhibitor therapy unlikely negative impact course infection however whether patients covid<NUMBER> might take advantage initiating drugs terms disease progression outcomes explored clinical trials still ongoing cvd wellknown major complications diabetes risk developing cvd <NUMBER>to fivefold higher patients t<NUMBER>d nondiabetic patients mainly due diabetesrelated coronary atherosclerosis <NUMBER> addition diabetic cardiomyopathy may occur independently coronary artery disease likely developing helper <NUMBER> driven responses within cardiomyocyte <NUMBER> <NUMBER> besides common clinical features covid<NUMBER> cardiovascular damage may occur nearly <NUMBER> patients <NUMBER> cause major concern due high related mortality mechanisms underlying complication largely unknown direct viral damage destabilization coronary plaques reportedly suspected play consistent role notably sample <NUMBER> patients covid<NUMBER> guo et al observed presence background coronary heart disease cardiomyopathy associated frequent occurrence myocardial damage highlighted marked increase serum troponin course disease <NUMBER> accordingly mortality considerably higher among patients myocardial injury concomitant cvd <NUMBER> patients without cvd <NUMBER> remarkably considerable percentage patients displaying myocardial injury diabetes <NUMBER> compared patients without myocardial injury <NUMBER> myocardial injury may therefore contribute poorer outcomes observed diabetic patients covid<NUMBER> <NUMBER> note patients myocardial injury prone develop malignant arrhythmias ards coagulopathy acute kidney injury explained high mortality <NUMBER> importantly ace inhibitors arbs broadly used patients myocardial injury mortality significantly differ treated nontreated patients although consistent evidence excluding harms suggesting benefits raas inhibitors covid<NUMBER> patients hearth injury lacking arbs able increase ace<NUMBER> expression hearts animal models arterial hypertension <NUMBER> even pathological context possible effects drugs elucidated downregulation ace<NUMBER> cardiomyocytes blood vessels induced sarscov<NUMBER> internalization might exacerbate myocardial injury endothelial dysfunction compromising heart function patients diabetes underlying cvd <NUMBER> <NUMBER> addition patients t<NUMBER>d high rate lipid alterations statins first line therapy dyslipidaemia remarkably evidence preclinical studies suggests statins might modulate ace<NUMBER> expression several tissues including heart observed atorvastatin increased ace<NUMBER> protein expression heart kidney rabbits atherosclerosis <NUMBER> another study diabetic rats displayed significantly lower expression ace<NUMBER> impaired systolic diastolic function compared control rats combined treatment insulin fluvastatin associated higher levels ace<NUMBER> compared nontreated diabetic rats <NUMBER> ace<NUMBER> multisubstrate enzyme targeted several molecules although extremely limited evidence animal studies peroxisome proliferatoractivated receptor gamma pparγ agonists insulinsensitizer drugs treatment type <NUMBER> diabetes t<NUMBER>d might increase expression ace<NUMBER> different tissues animal model hypertension insulinsensitizer rosiglitazone modulated ace<NUMBER>angiotensin<NUMBER>angiotensin ii axis aortic tissue lowered blood pressure increasing expression ace<NUMBER> <NUMBER> similarly high fat diet fed rats animal model obesity pioglitazone increased expression ace<NUMBER> insulinsensitive tissues liver adipose tissue skeletal muscle likely modulation reninangiotensin system <NUMBER> ace<NUMBER> widely distributed human tissues remarkably expression found even lower lung sites <NUMBER> hence mediators thought play role facilitating sarscov<NUMBER> infection priming serine protease tmprss<NUMBER> requested binding ace<NUMBER> internalization sarscov<NUMBER> tmprss<NUMBER> cleaves protein s<NUMBER> s<NUMBER> subunits necessary step membrane fusion viral internalization contextually drags ace<NUMBER> alveolar cells <NUMBER> light antibodies targeting sprotein tmprss<NUMBER> inhibitors might prevent sarscov<NUMBER> entry lung cell <NUMBER> individuating possible candidate coreceptors therefore great importance development new therapeutic strategies contrast infection dpp<NUMBER> ubiquitously expressed cell surface exopeptidase important metabolic functions mainly regulates bioactivity gutderived hormones glucagonlike peptide<NUMBER> glp<NUMBER> glucosedependent insulinotropic polypeptide gip stimulate insulin secretion response oral glucose administration known incretin effect <NUMBER> dpp<NUMBER> inhibitors dpp<NUMBER>i commonly used drugs treatment t<NUMBER>d prevent degradation incretins inhibiting catalytic activity dpp<NUMBER> result ßcell insulin secretion potentiated glycaemia significantly reduced independently catalytic function dpp<NUMBER> displays inflammatory immune functions <NUMBER> indeed expressed mainly tlymphocytes involved activation proliferation <NUMBER> interestingly proinflammatory factors significantly increase dpp<NUMBER> expression circulating immune cells <NUMBER> unlike sarscov sarscov<NUMBER> binds ace<NUMBER> entry lung cells dpp<NUMBER> functional receptor merscov <NUMBER> hence several mouse human monoclonal antibodies preventing protein binding dpp<NUMBER> given promising results treatment mers <NUMBER> note recently reported dpp<NUMBER> shares patterns expression ace<NUMBER> lung precisely alveolar type <NUMBER> cells main target sarscov<NUMBER> <NUMBER> vankadari et al recently set docking model dpp<NUMBER> sarscov<NUMBER> spike glycoprotein <NUMBER> predicted several dpp<NUMBER> residues might involved interaction sarscov<NUMBER> s<NUMBER> domain spike protein also targeted coronaviruses enter host cells functional receptor dpp<NUMBER> however validation needed draw conclusions establish whether possible adhesion dpp<NUMBER> spike protein may play role sarscov<NUMBER> infection consequently important issues addressed claiming possible beneficial effects dpp<NUMBER> modulation covid <NUMBER> <NUMBER> according data chen et al patients diabetes moderatesevere covid<NUMBER> use dpp<NUMBER>i significantly impact mortality clinical outcomes <NUMBER> presence diabetes considerably influences course covid<NUMBER> infection risk factor poor outcomes limited preclinical studies ace<NUMBER> expression found modulated several players different tissues largely employed treatment diabetes antihypertensive considerably lesser extent insulinsensitizers statins light potential harmful protective effects treatments covid<NUMBER> infection might interesting soil research date data supporting drugs clearly interfere sarscov<NUMBER> access lung cells tissues completely lacking stressed absence evidence consistent clinical studies discontinuation adoption therapies attempt influence course infection strongly discouraged december <NUMBER> pneumonia unknown etiology confirmed china <NUMBER> chinese center disease control prevention ccdc identified novel coronavirus infection cause pneumonia <NUMBER> world health organization named disease <NUMBER>new coronavirus disease international committee taxonomy viruses ictv named virus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> ii soon declared covid<NUMBER> fastevolving pandemic iii may <NUMBER> <NUMBER> estimated <NUMBER> people infected covid<NUMBER> <NUMBER> people died globally iii multiple clinical trials currently underway prevention intervention disease progression <NUMBER> parallel also equally essential carry basic research sarscov<NUMBER> support efficient development therapeutic agents models faithfully reproduce behavior virus reproduce pathology covid<NUMBER> required briefly review relevant cell lines organoids animal model animals vitro cell model sarscov<NUMBER> research essential understanding viral life cycle amplifying isolating virus research preclinical evaluation therapeutic molecules section lays cell lines used replicate isolate sarscov<NUMBER> well organoids used examine effects sarscov<NUMBER> infection specific human tissues table <NUMBER>a figure <NUMBER> humans airway epithelial cells highly express putative sarscov<NUMBER> entry receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> transmembrane serine <NUMBER> reported viral rna copies culture supernatants cells <NUMBER> times higher vero e<NUMBER> cells suggesting would possible isolate higher titer virus using tmprss<NUMBER>overexpressing vero e<NUMBER> cells organoids composed multiple cell types model physiological conditions human organs organoids ability selfreplicate also suitable models largescale screening drug discovery disease research <NUMBER> besides lung damage caused pneumonia sarscov<NUMBER> affects several organs like kidney <NUMBER> liver <NUMBER> cardiovascular system <NUMBER> suzuki et al han et al generated human bronchial organoids <NUMBER> human lung organoids <NUMBER> respectively sarscov<NUMBER> research showed organoids permissive sarscov<NUMBER> infection could evaluate antiviral effects covid<NUMBER> candidate therapeutic compounds including camostat <NUMBER> besides lung damage caused pneumonia sarscov<NUMBER> affects several organs like kidney <NUMBER> liver <NUMBER> cardiovascular system <NUMBER> monteil infection support replication <NUMBER> interestingly virus infection impaired bile acid transporting functions cholangiocytes <NUMBER> effect might reason furthermore expected intestine another viral target organ <NUMBER> lamers complex pathophysiology disease understood figure <NUMBER> one works set pace discovery animal models zhou et al conducted sarscov<NUMBER> infection experiments using hela cells expressed ace<NUMBER> proteins taken multiple animal species mice humans <NUMBER> interestingly sarscov<NUMBER> could use ace<NUMBER> proteins except mouse ace<NUMBER> therefore bao et al used transgenic mice express human ace<NUMBER> <NUMBER> team found mice sarscov<NUMBER> infection showed weight loss virus replication lungs interstitial pneumonia <NUMBER> search alternative small animal models molecular docking studies performed binding ace<NUMBER> various mammals protein sarscov<NUMBER> finding syrian hamster might suitable <NUMBER> infection hamsters show rapid breathing weight loss alveolar damage extensive apoptosis <NUMBER> j u r n l p r e p r f figure <NUMBER> help assess advantages disadvantages towards discovery better models j u r n l p r e p r f manuscript also thank dr eiri ono kyoto university creating figure author conflict interests human ace<NUMBER> transgenic mice sarscov<NUMBER> infection mice show weight loss virus replication lungs interstitial pneumonia <NUMBER> syrian hamster sarscov<NUMBER> infection hamsters show rapid breathing weight loss diffuse alveolar damage extensive apoptosis <NUMBER> ferrets sarscov<NUMBER> infection acute bronchiolitis observed lungs <NUMBER> cats sarscov<NUMBER> infection intraalveolar edema congestion interalveolar septa observed abnormal arrangement epithelium loss cilia lymphocytic infiltration lamina propria also observed coronavirus disease <NUMBER> covid <NUMBER> infectious disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> june <NUMBER> <NUMBER> million cases recorded resulting <NUMBER> deaths <NUMBER> sudden global outbreak covid<NUMBER> made millions people quarantined due social distancing measures additionally covid<NUMBER> pandemic caused historic rise mental health problems depression posttraumatic stress disorder suicide due statewise quarantine people isolated stressed may develop longterm psychological consequences beyond quarantine period <NUMBER> <NUMBER> <NUMBER> therefore time people rely online webbased resources getting news updates concerning covid<NUMBER> given currently many web sources hold accurate information pandemic misinformation campaigns running rampant <NUMBER> critically important people patients receive accurate uptodate useful information regarding covid<NUMBER> online communities forums social media provide potential venues search relevant questions answers post questions seek answers members however due nature sites always limited number relevant questions responses search posted questions rarely answered immediately address issues propose develop chatbot enhanced neural language models able automatically answer questions related covid<NUMBER> conversational interactions conversational chatbot software able conduct conversation via text andor means different taxonomies type conversational chatbot based natural language conversations generated two main categories script chatbot intelligent chatbot entire interaction script chatbot based predetermined model determines chatbot cannot script usually decision tree manually crafted domain experts determine specific path take given response one question task usually laborexpensive nongeneralizable develop conversation decision trees intelligent chatbot built using artificial intelligence ai natural language processing nlp techniques automatically generate natural language back end advancements ai nlp functionality performance modern chatbots dramatically improved however techniques rarely applied evaluated healthcare domain meet information needs accurate uptodate interactive healthcare information outbreak covid<NUMBER> motivated us develop chatbot advanced nlp techniques evaluate approach automatically answering questions related covid<NUMBER> best knowledge first study kind contributions • applied compared performance four embedding generation approaches namely tfidf term frequency inverse document frequency <NUMBER> bidirectional encoder representations transformers bert <NUMBER> biobert bidirectional encoder representations transformers biomedical text mining <NUMBER> universal sentence encoder use <NUMBER> refining automatically generated answers • proposed qualitative evaluation guideline automatic questionanswering covid<NUMBER> • assessed performance proposed hybrid approach automatic questionanswering covid<NUMBER> • built webbased chatbot using language models facilitate questionanswering users paper organized follows proceed discussing related work efforts section <NUMBER> section <NUMBER> dedicated materials section <NUMBER> proposed approach report chatbot evaluation strategy experimental results sections <NUMBER> <NUMBER> respectively finally also discuss webbased chatbot proposed model future work section <NUMBER> conclude work section <NUMBER> recent neural language models dialogue generation offer great promise generating responses intelligent chatbots lstm long shortterm memory sequencetosequence seq<NUMBER>seq model one type neural generation model maximizes probability generating response given previous dialogue turn <NUMBER> <NUMBER> <NUMBER> xlnet uses context word predicting next word context word constrained two directions backward forward <NUMBER> sam technique selfattentive associative memory two memories wired single sequential model capable memorization relational reasoning <NUMBER> gpt<NUMBER> domain lee hsiang <NUMBER> finetuned gpt<NUMBER> generating patent claims klein nabi <NUMBER> applied gpt<NUMBER> conjunction bert automatic question generation purposes zhang sun et al developed large tunable neural conversational model dialogpt using gpt<NUMBER> <NUMBER> lee shu et al developed recipegpt automatic generation cooking recipes finetuning gpt<NUMBER> large cooking recipe dataset <NUMBER> unaware work applied gpt<NUMBER> model transfer learning purposes cord<NUMBER> regard work related comparing pretrained ai models jin et al made efforts conducting probing experiments comparing bert elmo <NUMBER> biobert sharma daniel <NUMBER> compared performance bert networks flair <NUMBER> general aibased chatbot domain serbal et al <NUMBER> applied deep reinforcement learning building conversational ai chatbot adiwardana et al <NUMBER> developed multiturn opendomain chatbot trained endtoend data mined social media conversations yin et al <NUMBER> developed deep learning based chatbot psychological therapy purposes semantic similarity texts hand studied long time recent breakthroughs allowed development new models bert biobert universal sentence encoder use today one stateofthe art conversational ai models gpt<NUMBER> gpt<NUMBER> pretrained model applied transfer learning utilizing cord<NUMBER> retraining purposes resulted chatbot gave irregularly long responses would typical human therefore decided filter responses via applying embedding generation algorithms models tfidf bert biobert use using semantic similarity approaches cosine similarity inner product words first let human ask question make gpt<NUMBER> come answer processed response additional filters ultimately applied embedding generation model finding sentences relevant question cosine similarity one commonly used approaches calculating semantic similarity texts therefore naturally employed nlp tasks many nlp applications need compute semantic similarity two short texts flexibility allows one apply virtually settings long documents represented vectors besides finding cosine similarity usually timeconsuming task done really quickly therefore also commonly used benchmarking purposes <NUMBER> study produced chatbot performant extensible additional layer filters shown success classifying sentences chatbot also able retrained readjusted new data case new discoveries scientific achievements related covid<NUMBER> furthermore chatbot responses annotated medical experts results consistent across annotators white house office science technology policy alongside coalition leading research groups released covid<NUMBER> machine readable dataset covid<NUMBER> open research dataset cord <NUMBER> <NUMBER> consisted <NUMBER> scholarly articles regarding covid<NUMBER> sarscov<NUMBER> related coronaviruses including <NUMBER> full text called researchers globally develop text data mining tools finding answers questions within content support ongoing covid<NUMBER> response efforts worldwide <NUMBER> used cord<NUMBER> train language model would automatically answer questions related covid<NUMBER> chatbot would help improve information acquisition also serve knowledge base covid<NUMBER> harvested data initial commercial use subset cord<NUMBER> containing <NUMBER> scholarly articles form json files extracted abstract main body article every json file combined together used corpus retraining language model applied hybrid approach generating responses gpt<NUMBER> used generate answer question additional filtering step applied pruning irrelevant sentences answer subsequently semantic similarity methods employed retain sentences semantically similar question hybrid approach response generation produced high quality answers covid<NUMBER>related questions figure <NUMBER> illustrates pipeline proposed approach gpt<NUMBER> transformerbased <NUMBER> architecture many ways similar open ai gpt model <NUMBER> <NUMBER> total <NUMBER> different gpt<NUMBER> models released openai <NUMBER> million <NUMBER>m <NUMBER> million <NUMBER>m <NUMBER> million <NUMBER>m <NUMBER> billion <NUMBER>b parameters <NUMBER> models model <NUMBER> billion parameters showed best results original paper <NUMBER> experiments found difficult finetune use transfer learning purposes besides training unbearably slow even run tpus tensor processing unit provided google colaboratory <NUMBER> used training ground therefore utilized <NUMBER>m model ran transfer learning <NUMBER> iterations batch size <NUMBER> <NUMBER> iterations loss decreasing let language model train additional <NUMBER> iterations stopped training batch size <NUMBER> chosen due memory limitations google colaboratory optimizer used adam <NUMBER> set learning rate <NUMBER> <NUMBER>e<NUMBER> adam algorithm firstorder gradientbased optimization stochastic objective functions based adaptive estimates lowerorder moments <NUMBER> highly memoryefficient shown good results retraining chatbot also tried sgd <NUMBER> yet adam shown better performance hence released adambased retrained model original gpt<NUMBER> written tensorflow <NUMBER> version used said retraining purposes applied tputrainable version gpt<NUMBER> <NUMBER> hardware google colaboratory provided us cloud tpus training capabilities came <NUMBER> gb ram since connected colab google drive <NUMBER> enough storage transfer learning link downloading model available github page <NUMBER> gpt<NUMBER> responses usually lengthy part answer relevant question prune responses generated gpt<NUMBER> first chunked answer list sentences using pythons builtin module dealing regular expressions <NUMBER> answer list answers performed following regexstring operations <NUMBER> eliminated redundant spaces <NUMBER> eliminated extra punctuation marks specifically <NUMBER> removed redundant parentheses square brackets <NUMBER> split sentence separate sentences contained period steps <NUMBER> <NUMBER> employed module steps <NUMBER> <NUMBER> builtin string operations sufficient hence builtin external module used operations significantly improved quality answer allowed us directly passing pretrained models generating embeddings semantic similarity metric quantifies degree two texts text documents similar two approaches used include cosine similarity inner product difference two cosine similarity pays attention angle vectors inner product cares angle magnitude said one normalized data approaches nearly equivalent put sentence vector representation tested applied four different approaches generating embeddings • tfidf <NUMBER> simple tfidf based embeddinggeneration method cases similar strategy applied filtering sentences following equation defines embedding generation process <NUMBER> <NUMBER> n q denotes list sentences obtained performing split based regexstring manipulation plus question emb denotes one embedding generation approaches ie tfidf bert biobert use q denotes question asked e denotes embeddings generated list sentences words list sentences passed embedding generation function feature matrix returned embeddings generated applied cosine similarity inner product ranking sentences inner product used use since embeddings approximately normalized following equation shows ranking process e <NUMBER> e <NUMBER> e n e q ∈ e sim function finds cosine similarity inner product two embeddings every sentence embedding e <NUMBER> e <NUMBER> e n approach calculates cosine similarity question embedding e q similarity matrix every column denotes similarity vector particular sentence similarity vector contains similarity values particular sentence respect sentences including last columnsimilarity vector matrix similarity measures respect question embedding finally ranked sentences based similarity scores selected top five similar sentences using pythons numpy <NUMBER> package concatenated single unified answer show example responses form humanbot conversation generated gpt<NUMBER> language model follows know vaccines therapeutics covid<NUMBER> critical role viral pathogenesis host defense infections several drugs developed covid<NUMBER> mind present evidence drugs inhibit proinflammatory responses eg il<NUMBER> potential inhibit covid<NUMBER> infection viral replication nonhuman primates administration <NUMBER> days following infection critical role viral pathogenesis host defense infections several drugs developed covid<NUMBER> know covid<NUMBER> risk factors however covid<NUMBER> threat global health security according latest world health organization report large number travel seen one major causes covid<NUMBER> spread known transmission incubation environmental stability covid<NUMBER>  example number reports suggested animal human hosts may provided necessary environment transmission covid<NUMBER> people poultry fact known animal hosts associated animaltohuman transmission covid<NUMBER> wild birds including chickens geese mule deer herons turkey fact known animal hosts associated animaltohuman transmission covid<NUMBER> wild birds including chickens geese mule deer herons turkey dialogue shows consistent pattern generating responses response first question regarding vaccines therapeutics states several drugs developed covid<NUMBER> furthermore says drugs inhibit proinflammatory responses eg il<NUMBER> potential inhibit covid<NUMBER> infection viral replication nonhuman primates regarding response second question concerning risk factors addressed question directly stating large number travel seen one major causes covid<NUMBER> spread third question transmission incubation environmental stability covid<NUMBER> mentioned large number travel seen one major causes covid<NUMBER> spread additionally talks animaltohuman transmission cases sentences highly readable understandable said cases sentences repeated due hybrid approach implemented avoided discuss section <NUMBER> order evaluate performance proposed approaches well overall performance chatbot crucial question dataset frequently asked related covid<NUMBER> purpose decided use <NUMBER> questions kaggles covid<NUMBER> open research dataset challenge cord<NUMBER> <NUMBER> questions included term covid<NUMBER> others case appended term end question table <NUMBER> presents <NUMBER> questions every one <NUMBER> questions generated five different answers applying four different embedding generation techniques resulting total <NUMBER> answers therefore response every question generated exactly <NUMBER> times using technique ensured fair consistent distribution questions approaches across dataset made answers publicly available github <NUMBER> asked two experienced medical experts evaluate quality responses assigning different relevance scores according categories table <NUMBER> <NUMBER> categories allowed flexibility diversity opinionsjudgements well broad range scores ultimately gave us better way evaluate approaches evaluation done primarily averaging scores particular approach published information sharing intersectoral collaboration covid<NUMBER> know vaccines therapeutics covid<NUMBER> know nonpharmaceutical interventions covid<NUMBER> annotation process two phases first phase let annotators evaluate test subset responses generated language model test subset comprised <NUMBER> questions computed iaa inner annotator agreement approximately equal <NUMBER> due <NUMBER> categories used pearson correlation coefficient computing iaa opposed cohens kappa etc low correlation value led us meeting annotators discussed different scores particular responses questions finally annotators reached agreement gave scores every question test subset <NUMBER> agreement reached let annotators evaluate remaining <NUMBER> questions note evaluated model based <NUMBER> responses included initial subset annotators agreed judgement done sake fairness consistency description points answer partially fully answers question andor makes clear attempts related question <NUMBER> wellformed answer makes logical sense somewhat related question covid<NUMBER> yet partially fully answer question <NUMBER> informative answer related question provides information covid<NUMBER> makes logical sense <NUMBER> acceptable answer makes logical sense weakly related question covid<NUMBER> mostly difficult understand <NUMBER> poor answer totally unrelated question covid<NUMBER> andor make logical sense <NUMBER> <NUMBER> empirical results <NUMBER> performance approach table <NUMBER> lists evaluation results different approaches shows approach average scores based approach annotator overall average across annotators first annotator rated bert best approach average score <NUMBER> biobert shows slightly worse performance score <NUMBER> bert tfidf approach performs well score <NUMBER> yet could outperform either bert biobert use worst performance embedding generation techniques score <NUMBER> <NUMBER> second annotator similarly gave highest average score bert <NUMBER> use second best score <NUMBER> followed biobert approximately score <NUMBER> tfidf approach yielded worst results rated <NUMBER> general results consistent two annotators inner annotator agreement score <NUMBER> calculated using pearson correlation models bert family showed best performance automatically answering covid<NUMBER> questions bert slightly outperforming biobert <NUMBER> vs <NUMBER> average scores best tfidf approach use show roughly similar performance <NUMBER> vs <NUMBER> yet inferior bert biobert four approaches average considered wellformed category bert biobert close relevant category overall average <NUMBER> wellformed noted <NUMBER> questions seem rather short length responses question <NUMBER> hand worst average score interestingly annotators given score <NUMBER> said question also one shortest questions length therefore length seem always correlation score hence performance analyze responses question <NUMBER> lowest average score determined whether terms question present dataset terms intersectoral collaboration information sharing present cord<NUMBER> therefore likely issue stems model dataset according scores also find terms question correlation score example questions featured words strongly linked covid<NUMBER> virus question <NUMBER> vaccine question <NUMBER> risk question <NUMBER> higher average response scores eg question <NUMBER> project several limitations first due hardware constraints difficulty finetuining used larger <NUMBER>b gpt<NUMBER> model could potentially yield better results generating responses second question pool also limited comprised <NUMBER> questions additionally tried <NUMBER> specific embedding generation approaches might fair representation techniques domains ai nlp order make language model accessible general audience automating response generation built webbased chatbot using trained gpt<NUMBER> options tfidf bert biobert use approaches please find released code github application powered pythons flask <NUMBER> package gives simple userfriendly interface interactive communication chatbot please note health information generated chatbot general research purposes diagnostic tool substitute medical advice treatment specific conditions although work demonstrated feasiblity using language models automatically answering covid<NUMBER> questions much done research first would like explore certain questions higher scores others secondly approaches generating embeddings sentences biowordvec <NUMBER> could potentially improve performance chatbot another avenue exploration dialogue presented section <NUMBER> clear gpt<NUMBER> could generate duplicate sentences may irrelevant question case sentence might repeated final answer one could incorporate additional simple step eliminating duplicate sentences could potentially improve quality answers adding additional third layer filtering also tested checked whether improves quality responses additionally gpt<NUMBER> model always retrained new corpus could potentially improve result <NUMBER>b gpt<NUMBER> model could also applied retraining purposes finally given larger gpt language model gpt<NUMBER> recently released <NUMBER> believe feasible chatbot capable hardware explore realm possibilities model could also evolve interesting future work paper applied gpt<NUMBER> language model automatically answer questions related covid<NUMBER> quantitatively evaluate proposed approach refine responses generated gpt<NUMBER> compared four different embedding generation techniques namely tfidf bert biobert use utilized collected corpus cord<NUMBER> task pretrain gpt<NUMBER> model evaluated automatically generated answers twelve questions cord<NUMBER> results evaluated two medical experts general results consistent two annotators empirical results show bert achieved best performance automatically answering covid<NUMBER> questions also built webbased chatbot using trained gpt<NUMBER> model opensoured code work supported nih grant r<NUMBER>lm<NUMBER> mayo clinic center health equity community engagement research award mayo clinic office patient education funders role design study collection analysis interpretation data preparation manuscript views presented report necessarily representative funders views belong solely authors since december <NUMBER> humanity deal emergence severe acute respiratory coronavirus disease caused strain coronavirus referred severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> respiratory problems caused pathogen well known ophthalmological implications syndrome yet well described coronavirus disease new pathology three human coronaviruses known exist since mid<NUMBER>s human coronavirus <NUMBER>e hcov<NUMBER>e human coronavirus oc<NUMBER> hcovoc<NUMBER> severe acute respiratory syndrome sarsassociated coronavirus sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> human coronavirus nl<NUMBER> hcovnl<NUMBER> novel human coronavirus date reported <NUMBER>monthold child suffering bronchiolitis conjunctivitis <NUMBER> <NUMBER> coronaviridae family viruses consist enveloped viruses large plusstrand rna genome <NUMBER> kb capped polyadenylated serology type characterized specific host range genome sequence pathogenic four types coronaviruses sarscov causes lifethreatening pneumonia <NUMBER> <NUMBER> <NUMBER> virus likely reside animals affect humans zoonotic transmission <NUMBER> <NUMBER> coronaviruses identified mice rats chickens turkeys swine dogs horses rabbits cats humans cause variety health problems humans including gastroenteritis respiratory tract problems <NUMBER> <NUMBER> conjunctivitis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> authors recent study concluded onethird patients covid<NUMBER> ocular abnormalities frequent manisfestation patients severe disease although low prevalence sarscov<NUMBER> tears possible transmit disease ocular secretions <NUMBER> therefore taking consideration reports literature associating coronavirus ophthalmic problems aim narrative review summarize ophthalmological perspective pathogeny portal entry implantation virus conjunctiva ophthalmic implications ocular complications prevention ophthalmology context possible treatment ocular disease relationship covid<NUMBER> ocular surface conjunctiva corneal epithelium tear film potencial portal entry transmission mechanism currently discussion due high transmission rate disease article based previously conducted studies contain studies human participants animals performed authors general coronaviruses able cause wide range upper respiratory infections common cold alphacoronavirus hcov<NUMBER>e alphacoronavirus hcovnl<NUMBER> betacoronavirus hcovoc<NUMBER> hcovhku<NUMBER> whereas betacoronaviruses sarscov middle east respiratory syndrome coronavirus merscov responsible aggressive lower respiratory problems considered atypical pneumonias different infection sites likely related presence viral surface spike composed dipeptidyl peptidase <NUMBER> glycoprotein human receptor lower respiratory tract known angiotensin converting enzyme <NUMBER> ace<NUMBER> sarscov merscov surface spike glycoprotein <NUMBER> <NUMBER> <NUMBER> genetic point view sarscov<NUMBER> <NUMBER> similar sarscov therefore capable using cell entry receptor ace<NUMBER> infect human cells <NUMBER> <NUMBER> however sarscov<NUMBER> glycoprotein spike binds ace<NUMBER> human receptors <NUMBER>to <NUMBER>fold higher affinity sarscov <NUMBER> sarscov<NUMBER> enters alveolar epithelial cells fast replication rate triggers strong immune response causing cytokine storm syndrome hypercytokinemia subsequence pulmonary tissue damage general hypercytokinemias consist group disorders produce elevation proinflammatory cytokines cytokines important cause acute respiratory distress syndrome ards multiple organ failure <NUMBER> <NUMBER> <NUMBER> one analysis first <NUMBER> cases sarscov<NUMBER> revealed cytokine storm occurred patients severe covid<NUMBER> <NUMBER> ards among latter patients <NUMBER> deteriorated rapidly died multiple organ failure <NUMBER> addition number cells cd<NUMBER> cd<NUMBER> decreased patients infected sarscov<NUMBER> suggesting decreased immune function subsequently allows secondary infection could worsen respiratory failure <NUMBER> viral diseases immune problems lead ocular manifestations conjunctivitis uveitis retinitis among others difficult determine pathogeny ophthalmic involvement however since virus cultured conjunctival secretions <NUMBER> covid<NUMBER> ophthalmopathy likely related virus infestation rather secondary immune reaction infection may cause known sarscov<NUMBER> transmitted direct indirect contact mucous membranes eyes mouth nose <NUMBER> <NUMBER> <NUMBER> respiratory tract considered route transmission fact recent studies associate enteric symptoms covid<NUMBER> diarrhea nausea vomiting <NUMBER> <NUMBER> invaded ace<NUMBER>expressing enterocytes <NUMBER> oralfecal route another potential portal entry additional studies required test different portal entries proposed theories include <NUMBER> analysis studies included narrative review see table <NUMBER> revealed common ophthalmologic sign related coronavirus infection inflammation conjunctiva conjunctivitis among studies reviewed six performed animals feline murine canine bird experimental models <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> humans <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> first time conjunctivitis associated human coronavirus <NUMBER> <NUMBER>monthold child <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> due great interest understanding clinical manifestations coronavirus first sarscov crisis however new <NUMBER> outbreak conjunctivitis associated coronavirus outbreak taken sign covid<NUMBER> retrospective study vabret et al investigated hcovnl<NUMBER> infection hospitalized <NUMBER> tear conjunctival secretions collected reversetranscription pcr rtpcr assay authors demonstrated sarscov<NUMBER> present tears conjunctival secretions coronavirus pneumonia patients conjunctivitis however virus detected tears conjunctival secretions patients without conjunctivitis results could possibly indicate tear conjunctival secretions common route coronavirus transmission given majority covid<NUMBER> patients manifest conjunctivitis nevertheless route transmission could completely eliminated patients <NUMBER> ophthalmologists aware finding sign conjunctivitis clinical setting considered possible coronavirus conjunctivitis especially accompanied respiratory tract problems fever study carried loon et al <NUMBER> demonstrated presence sarscov rna tears <NUMBER> tear samples collected <NUMBER> suspected sarscov patients sent rtpcr analysis presence sarscov sarscov rna identified three patients <NUMBER> contrast studies assessed tears conjunctival scrapes <NUMBER> patients confirmed sarscov infection positive results rtpcr analysis <NUMBER> <NUMBER> authors propose three explanations results <NUMBER> low sensitivity rtpcr ocular surface secretions <NUMBER> viral shedding ocular tissue window period may last short period time <NUMBER> possibility sarscov exist ocular tissues regarding severity covid<NUMBER> disease patients ocular symptoms likely higher white blood cell neutrophil counts higher levels another interesting detail regarding ocular implication infection human eye actually intraocular reninangiotensin system ace<NUMBER> receptors found aqueous humor <NUMBER> previously explained main receptor sarscov<NUMBER> ace<NUMBER> receptor indicates aqueous humor could target covid<NUMBER> infection studies exploring hypothesis sarscov<NUMBER> ocular manifestation ace<NUMBER> receptor need performed study ocular manifestations animals could improve current understanding eye disease humans therefore following section ocular manifestations associated coronavirus infections animals discussed earlier studies reported association coronaviruses ocular problems animal models example feline infectious peritonitis fip caused feline coronavirus fcov vasculitis common feature fip ocular manifestations include pyogranulomatous anterior uveitis coroiditis retinal detachment retina vasculitis perivascular cuffing inflammatory cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> manifestations common noneffusive dry form effusive wet form disease also present without systemic signs fip <NUMBER> treatment uveitis associated fip described large fibrin clots anterior chamber treated intracameral injections <NUMBER> lg tissue plasminogen activator however cats mild uveitis responded topical therapy <NUMBER> murine coronavirus mouse hepatitis virus mhv shown involvement posterior pole eye mhv neurotropic strains particular importance animal model studies ophthalmology field two main strains jhm jhmv a<NUMBER> mhva<NUMBER> isolated paralyzed mouse result extensive demyelination encephalomyelitis <NUMBER> jhmvinfected mice subsequently utilized intravitreal inoculation study mechanisms virusinduced retinal degeneration <NUMBER> model known experimental cov retinopathy ecor model used examine genetic host immune responses may contribute retinal disease <NUMBER> ecor model infection two phases namely inflammation early phase retinal degeneration late phase following inoculation presence virus retina retina pigment epithelium result infiltration immune cells release proinflammatory mediators first week infection viral clearance achieved however retinal retinal pigment epithelial cell autoantibodies subsequently produced resulting progressive loss photoreceptors ganglion cells well thinning neuroretina <NUMBER> case autoimmune process cause majority retinal damage mhva<NUMBER> models hand used create viralinduced optic neuritis line research based increasingly popular hypothesis viralinduced inflammation likely etiology multiple sclerosis shindler et al inoculated mhva<NUMBER> intracranially mice inducing meningitis focal acute encephalitis importantly optic neuritis <NUMBER> inflammation optic nerve detected early <NUMBER> days inoculation peak incidence <NUMBER> days axonal loss highlighted significant decrease axonal staining compared control optic nerves <NUMBER> days inoculation <NUMBER> important note animal models coronaviruses affect anterior surface eye thus careful ophthalmologists prevent possible ocular transmission disease important learn transmission mechanism eye try understand pathogeny virus ocular tissues clear knowledge retinal optic nerve problems related coronavirus animals implications thereof consequently meticulous examining patients tested positive covid<NUMBER> nevertheless best knowledge evidence human coronaviruses causing intraocular ophthalmic problems uveitis retinitis optic neuritis observed animals according number authors ophthalmologists could higher risk contracting sarscov<NUMBER> infection due facetoface communication patients frequent exposure tears ocular discharge unavoidable use equipment slit lamp tonometer laser etc <NUMBER> <NUMBER> ssome guidelines recently published minimize risk infection number patients visiting clinic strictly limited strict timetable appointments prevent agglomeration patients clinic waiting room <NUMBER> <NUMBER> online platforms hospitals official website used telephone assistance could useful helping patient distinguish urgent noturgent ocular problems recommending treatments nonurgent diseases reminding patients use personal protection equipment ppe coming clinic answering questions possible symptoms relative covid<NUMBER> <NUMBER> triage system also important identify patients fever respiratory symptoms andor acute conjunctivitis recently traveled outbreak areas online ordering delivery prescribed medication especially chronic medication chronic eye diseases glaucoma also recommended <NUMBER> number accessible entry points hospitalclinic reduced checkpoints set hospital entrance temperature patients controlled patients screening covid<NUMBER> symptoms contact history confirmed suspected covid<NUMBER> patients within past <NUMBER> days patients provided mask bring one home social distancing registration waiting area practiced patients conjunctivitis similar infections seen separate clinic separate waiting area patients tested two times sarscov<NUMBER> rna conjunctival sac tears inside clinical examination room number people limited <NUMBER> doctor <NUMBER> patient per room exception visually impaired patients patients communicationmobility difficulties small children room well ventilated instruments used disinfected immediately patient visit infection control training provided clinical staff installation protective shields slit lamps frequent disinfection equipment provision eye protection staff implemented clinics universal masking hand hygiene correct use ppe promoted <NUMBER> direct ophthalmoscope examination recommended could replaced slit light lenses optical coherence tomography oct fundus photography <NUMBER> preoperative infection screening inpatients recommended especially surgical procedure general anesthesia avoided local anesthesia preferable avoid contamination emergency operation covid<NUMBER>positive patient performed negative pressure operating room surgical area available patient referred another qualified hospital equipped operating room operations healthy patients performed space positive pressure laminar flow standard practice <NUMBER> infection control training staff necessary taking temperature queryandquestionnaire procedure entering hospital also applies staff strict hand hygiene required gloves changed regularly one pair latex gloves used long periods time <NUMBER> according current evidence human coronavirus remain infectious inanimate surfaces <NUMBER> days <NUMBER> therefore reducing viral load surfaces disinfection important world health organization recommends cleaning environmental surfaces water detergent applying commonly used disinfectants sodium hypochlorite <NUMBER> bleach typically used dilution <NUMBER> <NUMBER> sodium hypochlorite resulting final concentration <NUMBER> <NUMBER> also suggested concentration <NUMBER> effective <NUMBER> min therefore seems appropriate recommend dilution <NUMBER> standard bleach coronavirus setting case small surface desinfection ethanol <NUMBER> shown efficacy coronavirus <NUMBER> <NUMBER> biocidal agents <NUMBER> benzalkonium chloride <NUMBER> chlorhexidine digluconate less effective <NUMBER> duan et al found irradiation ultraviolet light <NUMBER> min several coronaviruses culture medium resulted undetectable levels viral infectivity speculate ocular spray disinfectants contain hypochlorous acid usually applied treat blefaritis order reduce bacterial viral load skin eyelashes could used measurement prevention facial area many chemical agents cannot applied little evidence exists treatment viral conjunctivitis associated covid<NUMBER> antiviral systemic drugs used outbreak umefenovir lopinavir ritonavir <NUMBER> specifically ocular problem chen et al reported possibility ribavirin eyedrops could help ocular symptom treatment <NUMBER> cheema et al recently treated one patient presented pseudodendritic keratoconjunctivitis oral valacyclovir <NUMBER> mg orally three times per day moxifloxacin <NUMBER> drop daily right eye based presumed diagnosis herpetic keratoconjunctivitis patient however turned positive sarscov<NUMBER> conjunctival swab result <NUMBER> common cause infectious conjunctivitis human adenovirus hadv accounting <NUMBER> conjunctivitis cases affecting people ages demographics coronavirus also cause systemic infections form gastroenteritis respiratory disease hadv causes lytic infection mucoepithelial cells conjunctiva cornea well latent infection lymphoid adenoid cells despite common ophthalmological viral infection us food drug administrationapproved antiviral treating hadv keratoconjunctivitis therefore managing viral persistance dissemination constitute challenge treatment modalities investigated systemic topical antivirals inoffice povidoneiodine irrigation immunoglobulinbased therapy antiinflammatory therapy immunotherapy posible therapeutic options sialic acid analogs cold atmospheric plasma nchlorotaurine benzalkonium chloride <NUMBER> although viral conjunctivitis cause discomfort patients lifethreatening condition therefore treatment efforts patients testing positive sarscov<NUMBER> destined vital problems rather serious threats eye treatment viral conjunctivitis mostly supportive majority cases selflimited nonetheless important ophthalmologists decrease possible viral load conjunctiva decrease potential transmission tear eye secretions general ophthalmic recommendations viral conjunctivitis could apply covid<NUMBER> patients terms reducing transmission rate possible complications include hygienic measures frequent hand washing especially eye drops need applied contact lens worn avoiding touching rubbing eyes changing pillowcases sheets towels regularly sharing personal items etc studies conducted establish specific antiviral ocular treatment aimed reducing viral load present conjunctiva patients reducing transmission rate ophthalmological perspective however difficult determine treatment many doubts still remain regarding ophthalmic implications sarscov<NUMBER> infection <NUMBER> <NUMBER> review literature reveal studies suggest ocular symptoms commonly appear patients severe covid pneumonia possible detect viral rna conjunctival sac patients apparently conjunctivitis frequent manifestation coronavirus disease patients nonsevere covid<NUMBER> despite conjunctivitis generally selflimited benign condition important route viral transmission therefore prevention important aspect remember ophthalmologists protect patients new coronavirus cov known severe acute respiratory syndrome sarscov<NUMBER> currently spreading around world lead respiratory illness exacerbated novel <NUMBER> disease known cov diseases<NUMBER> covid<NUMBER> appears induce mortality rate less <NUMBER> lesser epidemics ever become global headlines pan et al <NUMBER> covs similar influenza viruses show almost identical symptoms heymann shindo <NUMBER> rothan byrareddy <NUMBER> two recent outbreaks new cov including severe acute respiratory syndrome sars middle east respiratory syndrome mers originated animals gretebeck subbarao <NUMBER> song et al <NUMBER> yao et al <NUMBER> diseases caused viruses extremely fatal humans cases reported mild asymptomatic however reported mortality rate covid<NUMBER> sars mers mahase <NUMBER> peeri et al <NUMBER> past days repeatedly reported vaccine sarscov<NUMBER> discovered vaccines like medicines require lengthy testing process approved medical applications ahmed et al <NUMBER> prompetchara et al <NUMBER> one strategy date replication piece virus rna could one day serve vaccine enayatkhani et al <NUMBER> although welldeveloped dna sequencing devises let rapid genetic sequencing vaccine development costly complex time intensive plotkin et al <NUMBER> includes finding viral sequence providing memory immune system lead acute inflammatory reaction achieving goal requires laboratory experimentation animal models subjecting humans addition vaccine discovered possible dispatch sample quickly easily worldwide therefore pharmaceutical companies generally found profitable invest drugs used chronic medical conditions cov case influenza may undertake mutations therefore would require continuous vaccine development considerable number people worldwide infected covid<NUMBER> scientists identified number cases broadspectrum antiviral agents bsaas could serve potential candidates treatment viral diseases andersen et al <NUMBER> ianevski et al <NUMBER> indeed repurposing current approved antiviral drugs could solution treat new viral infections guo <NUMBER> kouznetsova et al <NUMBER> mercorelli et al <NUMBER> xu et al <NUMBER> drug repurposing means examining existing drugs find therapeutic effects new diseases aggarwal et al <NUMBER> khan jha et al <NUMBER> senathilake et al <NUMBER> bsaas small molecules inhibit different infections blocking viral replication pant et al <NUMBER> xiong et al <NUMBER> drugs block virus hostrelated factors thus prevent virus proliferating lowering level virus body extent immune system inhibit infection cui et al <NUMBER> ji li <NUMBER> bsaa received special attention emergence numerous new viral diseases repurposing existing drugs even rejected drugs viral diseases increases possibility market success well reducing costs time required launch benefit drug repurposing drug details stages chemical synthesis mass production processes various stages clinical trials many identified beforehand aanouz et al <NUMBER> gupta et al <NUMBER> currently drug vaccine prevent sarscov<NUMBER> infection use widespread antivirals effective prophylaxis virus boopathi et al <NUMBER> elmezayen et al <NUMBER> example chloroquine remdesivir rdv gs<NUMBER> two drugs vitro studies suggested inhibit viral replication teicoplanin oritavancin dalbavancin monensin antibiotics also prevent viral replication andersen et al <NUMBER> currently bsaas treatment pyrophylaxis candidates sarscov<NUMBER> senanayake <NUMBER> furthermore combination bsaas applied wider range viruses yet well recognized drugresistant viruses potential clinical trials currently conducted drugs results published soon li de clercq <NUMBER> senanayake <NUMBER> perhaps near future bsaas used treat covid<NUMBER> patients although number bs reported date review focused rdv potential compound assessed animal models reaches clinical phase mers cov sarscov sarscov<NUMBER> covs large family viruses ranging common cold virus cause sars cascella et al <NUMBER> paules et al <NUMBER> structure cov common rna genome classified enveloped viruses mackie <NUMBER> sarscov<NUMBER> originating china city wuhan believed member corona family infected many people date despite emergence virus china spreading rapidly parts world zhu et al <NUMBER> similar cases reported countries thailand south korea japan taiwan australia united states even recently iran velavan meyer <NUMBER> zhu et al <NUMBER> disease spread close contact infected person handling contaminated equipment airborne outbreaks velavan meyer <NUMBER> people hypertension diabetes respiratory problems weak immune systems higher risk infection likely death fang et al <NUMBER> covs four types proteins including spike envelope e membrane nucleocapsid n hasan et al <NUMBER> protein attached virus membrane play important role binding entry host cell hence targeting protein various drugs inhibitors one potential approach combat types viruses chatterjee <NUMBER> lai cavanagh <NUMBER> woo et al <NUMBER> sarscov<NUMBER> proteins surface mediate viral infection binding angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor batlle et al <NUMBER> chen hao <NUMBER> therefore one promising way stop infection sarscov<NUMBER> find compound blocks receptor consequently prevent infection preventing interaction protein ace<NUMBER> receptor andersen et al <NUMBER> joshi et al <NUMBER> cov also <NUMBER> unstructured protein nsp <NUMBER> encoded orf<NUMBER>a<NUMBER>b act important cofactors activation viral replication enzymes figure <NUMBER> although recent research china suggests bat potential source virus ongoing researches clarify exact origin virus guo et al <NUMBER> figure <NUMBER> researches origin sars outbreaks led discovery many bat viruses sarscov<NUMBER> belongs category sarsrelated viruses fung et al <NUMBER> two genome sequences rhinolophus sinicus show <NUMBER> similarity sarscov<NUMBER> third genome rhinolophus affinis virus ratg<NUMBER> resembles <NUMBER> similarity sarscov<NUMBER> andersen et al <NUMBER> better sense variation similar rate mutation observed ten years human h<NUMBER>n<NUMBER> influenza virus strain rdv gs<NUMBER> nucleotide analogue originally developed treat ebola tchesnokov et al <NUMBER> laboratory assessments shown rdv effective sarscov ju et al <NUMBER> merscov gordon et al <NUMBER> viruses therefore used potential antiviral agent sarscov<NUMBER> mechanism rdvs antiviral function based blockage viral rna transcription revealed molecular examinations using different recombinant viral polymerases sarma et al <NUMBER> tchesnokov et al <NUMBER> warren et al <NUMBER> siegel et al <NUMBER> reported gs<NUMBER> used potential candidate treatment ebola emerging cov agostini et al <NUMBER> reported cov susceptible rdv targeting viral polymerase nsp<NUMBER> exoribonuclease exon compared sensitivity wt exon virus rdv exon virus showed greater decrease viral titer presence gs<NUMBER> relative wt virus determined ec <NUMBER> value exon virus around <NUMBER> whereas ec <NUMBER> value wt determined <NUMBER> figure <NUMBER>ai increased inhibition exon virus gs<NUMBER> figure <NUMBER>a ii indicated gs<NUMBER> integrated viral genome excluded exon agostini et al <NUMBER> also shown type cov concentration antiviral drug type antiviral drug incubation time play important role inhibition virus infection figure <NUMBER>b figure <NUMBER> furthermore found rdv therapeutic agent remarkably decreased pulmonary infection furthermore gordon et al <NUMBER> de wit et al <NUMBER> revealed rdv derives antiviral effects merscov though inhibition rna polymerase sarscov investigations treated rdv similar outcomes observed merscov along limited weight loss increased pulmonary activity decreased virus replication sheahan et al <NUMBER> kinetics sarsor merscov proliferation animal models significantly different compared humans animal sarscov merscov proliferation lung tissue reaches maximum <NUMBER> dpi mortality stimulated <NUMBER> dpi douglas et al <NUMBER> sheahan et al <NUMBER> thus therapeutic window control infected animal model prior peak cov proliferation less <NUMBER> days human merscov replication lung tissue reaches maximum <NUMBER> days onset infections disease severity increases death within <NUMBER> days oh et al <NUMBER> thus time therapeutic handling substantially divergent humans experimentally infected animal models although applying rdv led reduction merscov pathogenesis pronounced decrease viral dose therapeutic handling thoroughly reduce infection furthermore high levels cov rdv unable sustain viral viability pulmonary cells functionality despite remarkable decrease viral loads outcomes reported sarscov therapeutic platforms launched peak virus titer lung injury show progress resultant outcomes sheahan et al <NUMBER> since sarsand merscov infections controlled covs host immune system modulators therefore early handling antiviral therapeutics either solely combination therapeutic drugs based stage disorder progression inhibit virus proliferation immunopathology switch repairing systems control pulmonary homeostasis arising viral disorders resulted meaningful catastrophic pandemics genetic exploration animal models shown pronounced mutation viral genome case cov even pointed viruses indistinguishable ongoing past pathogenic strains animals ge et al <NUMBER> woo et al <NUMBER> therefore absence fdaapproved therapeutics reducing human cov infection useful broadspectrum therapeutic platforms wellknown epidemic zoonotic strains probably pave way diminishing current epidemic diseases case cov patients received offlabel antiviral drugs well immunomodulators either solely combined reduce severe disease symptoms zumla et al <NUMBER> however due lack patient therapeutic consistency verified standard efficiency measurement complicated process although interferon result improved clinical consequence merscov patients morra et al <NUMBER> showed rdv stimulated superior antiviral function merscov vitro vivo comparison lopinavirritonavirinterferon b nucleosidenucleotide analogues inhibit virus replication blocking activity polymerase enzyme virus chhikara et al <NUMBER> men endezarias et al <NUMBER> usage nucleosidenucleotide analogues major step treatment patients infected covs due appropriate antiviral response chhikara et al <NUMBER> however application drugs may lead genetic variation subsequent mutation emergence hence safety rdv broadspectrum antiviral activity considered suggesting potential alternative candidates clinical development recent years animal model progression rdv seems orient primarily cov respiratory infections sheahan et al <NUMBER> clinical trials selective patient populations cov covlike diseases needed examine efficacy developed drugs regarding safety data rdv necessary studies covid<NUMBER> patients conducted proceed clinical trials studies covlike diseases probably require enrollment large number infected patients currently approved antiviral drug sarscov<NUMBER> treat hospitalized patients moreover clinical trials covid<NUMBER> patients seems complicated due several factors inability apply placebo underlying diseases evaluating antiviral drug efficiency synergistic activity rdv antiviral agents cell cultures approved current phase <NUMBER> clinical trials patients sarscov<NUMBER> outcome may propose way developing performing clinical trials relative integration rdv monotherapy antiviral drug monotherapy treating patients hospitalized covid<NUMBER> ongoing future perspectives trying determine resistance different covs rdv vitro vivo elucidate whether mutational strains behave way wild types due emergence new respiratory infections sarscov<NUMBER> progression animal studies subsequent preclinical clinical trials required explore activity rdv preclinical explorations ongoing examine potential rdv sarscov<NUMBER> given application history rdv treating wide range infections well outcomes clinical trials patients sarsand merscov reinforces rationale additional trials rdv wider range infectious including covid<NUMBER> ongoing studies sarscov<NUMBER> supported expected furnish potential data corresponding rdv application treating covid<NUMBER> similar investigations may envisioned respect increasing identifications importance covs driving force covid<NUMBER> apart potential progression rdv treating sarsand merscovs emergence viral illnesses may pave way clinical trials rdv derivatives authors declare conflict interest sheahan et al <NUMBER> covid<NUMBER> predicted overwhelm healthcare capacity us worldwide interventions could prevent clinical decompensation respiratory compromise infected patients desperately needed excessive cytokine release activation coagulation appear key drivers covid<NUMBER> pneumonia associated mortality contact activation linked pathologic upregulation inflammatory mediators coagulation accumulating preclinical clinical data suggest rational therapeutic target covid<NUMBER> patients pharmacological inhibition interaction coagulation factors xi xii shown prevent consumptive coagulopathy pathologic systemic inflammatory response mortality least <NUMBER> types experimental sepsis importantly inhibition contact activation also prevented death aureusinduced lethal systemic inflammatory response syndrome nonhuman primates contact system likely dispensable hemostasis may needed host immunity suggesting reasonably safe target result immunosuppression bleeding drugs targeting contact activation already clinical development immediate clinical trials use covid<NUMBER> patients potentially feasible prevention treatment respiratory distress contact activation system potential therapeutic target patients covid<NUMBER> covid<NUMBER> predicted overwhelm healthcare capacity us worldwide interventions could prevent clinical decompensation respiratory compromise infected patients desperately needed excessive cytokine release activation coagulation appear key drivers covid<NUMBER> pneumonia associated mortality contact activation linked pathologic upregulation inflammatory mediators coagulation accumulating preclinical clinical data suggest rational therapeutic target covid<NUMBER> patients pharmacological inhibition interaction coagulation factors xi xii shown prevent consumptive coagulopathy pathologic systemic inflammatory response mortality least <NUMBER> types experimental sepsis importantly inhibition contact activation also prevented death aureusinduced lethal systemic inflammatory response syndrome nonhuman primates contact system likely dispensable hemostasis may needed host immunity suggesting reasonably safe target result immunosuppression bleeding drugs targeting contact activation already clinical development immediate clinical trials use covid<NUMBER> patients potentially feasible prevention treatment respiratory distress contact activation system potential therapeutic target patients covid<NUMBER> tion linked pathologic upregulation inflammatory mediators coagulation accumulating preclinical clinical data suggest rational therapeutic target patients covid<NUMBER> pharmacologic inhibition interaction coagulation factors xi xii shown prevent consumptive coagulopathy pathologic systemic inflammatory response mortality least <NUMBER> types experimental sepsis importantly inhibition contact activation also prevented death staphylococcus aureusinduced lethal systemic inflammatory response syndrome nonhuman primates contact system likely dispensable hemostasis may needed host immunity suggesting reasonably safe target result immunosuppression bleeding drugs targeting contact activation already clinical development immediate clinical trials use patients covid<NUMBER> potentially feasible prevention treatment respiratory distress • patients coronavirus disease <NUMBER> covid <NUMBER> severe infection suffer inflammatory thrombotic complications • contact activation supports inflammation thrombin generation • inhibiting contact activation infection models reduces inflammation death • contact activation inhibitors clinical development could tested patients covid<NUMBER> patients coronavirus disease <NUMBER> covid<NUMBER> may succumb systemic cytokine release syndrome prompted therapeutic trials biologic agents targeting interleukin il<NUMBER> tocilizumab sarilumab inflammatory mediators singlearm study tocilizumab <NUMBER> patients severe critical covid<NUMBER>related pneumonia undertaken outbreak china reported reduction oxygen requirements improvement pulmonary imaging <NUMBER> <NUMBER> patients respectively <NUMBER> autopsy reports patients died severe covid<NUMBER>related respiratory failure note intraalveolar fibrin accumulation suggesting loss vascular integrity <NUMBER> pathologic upregulation inflammation coagulation response sarscov<NUMBER> infection led significant enthusiasm mobilizing clinical trials targeting either pathway <NUMBER> paper propose targeting contact activation rational target clinical trials patients covid<NUMBER> risk respiratory compromise based animal models showing inhibiting contact activation prevents pathologic host inflammatory responses certain infections bacterial challenge ii clinical rationale inhibiting contact activation may safe critically ill patients unlikely provoke significant bleeding compromise immune system iii several contact activation inhibitors clinical development potentially available rapid clinical trial implementation molecular complex contact activation composed factor xii fxii factor xi fxi prekallikrein highmolecularweight kininogen serves central node linking coagulation inflammation pathways figure <NUMBER> contact activation leads thrombin generation also upregulation kallikrein several studies evaluated effects fxi knockout murine models bacterial challenge fxi knockout mice develop less severe coagulopathy lower serum cytokine levels wildtype mice challenged listeria monocytogenes plasma inflammatory markers including il<NUMBER> hepatic mrna encoding il<NUMBER> il<NUMBER> significantly attenuated correlating improved survival <NUMBER> vs <NUMBER> <NUMBER> likewise cecal ligation puncture model designed mimic polymicrobial peritoneal sepsis fxi knockout mice experienced less consumptive coagulopathy wildtype mice <NUMBER> prothrombin times increased significantly wildtype mice remained unchanged fxideficient animals mice lacked fxi clearly developed less pronounced coagulopathy relatively attenuated inflammatory response compared wildtype controls translated directly significant survival advantage <NUMBER> vs <NUMBER> experimental model later replicated define changes inflammatory cytokine levels coagulation profiles fxi knockout mice compared wildtype mice fxideficient mice demonstrated significantly lower plasma levels il<NUMBER>β il<NUMBER> il<NUMBER> tumor necrosis factorα tnfα infection survival <NUMBER> days also significantly higher fxi knockout mice <NUMBER> vs <NUMBER> <NUMBER> however pharmacologicl inhibition fxia deficiency fxi potential impair hemostasis may already compromised infections therefore inhibition components contact activation complex evaluated murine monoclonal antibody <NUMBER>e<NUMBER> binds a<NUMBER> domain fxi selectively disrupts reciprocal activation fxi fxii without affecting activation fxi thrombin fix activation fxia beneficial effects cecal ligation puncture model described including significantly improved survival <NUMBER> vs <NUMBER> postmortem organ evaluation <NUMBER> <NUMBER>e<NUMBER>treated mice evidence hepatic vascular microthrombi compared <NUMBER> control group levels inflammatory cytokines including tnfα il<NUMBER> significantly lower <NUMBER>e<NUMBER>treated mice <NUMBER> administration <NUMBER>e<NUMBER> l monocytogenesinfected mice also improved survival <NUMBER> similarly preclinical studies evaluated role fxii health disease fxii knockout mice protected experimentally induced thrombosis numerous models displaying normal hemostatic capacity <NUMBER> upregulated fxii activation cause certain forms hereditary angioedema leads excess bradykinin generation complement activation increased vascular permeability edema monoclonal antibody <NUMBER>f<NUMBER> inhibits activity fxiia shown protective bradykinin generation edema mouse models hereditary angioedema prevent bradykinin generation plasma humans hereditary angioedema <NUMBER> recombinant version antibody csl<NUMBER> currently clinical development treatment prevention hereditary angioedema <NUMBER> finally ixodes ricinus contact phase inhibitor dual inhibitor fxia fxiia isolated saliva ricinus ticks shown attenuate thrombosis animal models without apparent detriment hemostasis <NUMBER> effect simultaneous inhibition fxia fxiia humans remains unknown contact activation system coagulation leads thrombin generation appears contribute development thrombosis seems mostly dispensable hemostasis epidemiologic data suggest individuals congenital fxi deficiency largely protected venous arterial thrombosis usually mild bleeding diathesis little spontaneous bleeding bleeding hemostatic challenge trauma major surgery often require treatment importantly congenital fxii deficiency rare associated abnormal bleeding <NUMBER> relative safety reducing fxi activity humans demonstrated prospective clinical trial antisense oligonucleotide reduced plasma fxi levels surgical patients partial reduction fxi levels effective method prevention postoperative venous thromboembolism patients undergoing elective knee arthroplasty associated trend less bleeding traditional anticoagulation <NUMBER> similarly antibodymediated inhibition fxia associated trend less bleeding observed lowmolecularweight heparin large prospective trial thromboprophylaxis patients undergoing elective knee arthroplasty <NUMBER> phase <NUMBER> trial ab<NUMBER> appeared safe without notable drugrelated adverse effects healthy volunteers <NUMBER> recent retrospective analyses suggested anticoagulation heparin products may improve clinical outcomes patients covid<NUMBER> <NUMBER> selective targeting contact activation may offer refined approach impact hemostasis would likely associated fewer bleeding complications however safety inhibiting contact activation system patients bacterial viral infections assessed innate immunity appear compromised humans congenital fxi fxii deficiency although fxi deficiency associated nasal infections holstein cattle <NUMBER> epidemiologic studies humans fxi deficiency reported identical rates hospitalization pneumonia pneumoniarelated outcomes controls normal fxi levels knowledge reports linking human fxi deficiency immunocompromised phenotype <NUMBER> thus contact activation appears contribute proinflammatory procoagulant pathways humans absence fxi seem significantly compromise host defense hemostasis noted results study mouse model pneumonia conflict premise thus stroo colleagues <NUMBER> <NUMBER> showed administering streptococcus pneumoniae klebsiella lungs resulted inflammation higher mortality fxideficient mice wildtype mice raising cautionary note findings may represent speciesspecific effect like observed holstein cattle reassuring aforementioned epidemiologic study found increase frequency pneumonia fxideficient humans compared normal fxi levels furthermore pneumonia significant difference severity shortterm mortality <NUMBER> posit strategy directly targeting fxii targeting link fxii fxi produce effect complete deficiency fxi importantly leave hemostatic function fxi intact however important monitor response directly targeting eliminating function kks patients pneumonia world midst pandemic time course resolution unclear times responsibility scientific medical community quickly develop welldesigned clinical trials rationally based preclinical clinical data propose fxii ↔ fxi axis rational therapeutic target potential clinical trial could include prophylaxis decompensation covid<NUMBER> patients severe disease evidenced reduction need ventilator treatment shorter time ventilator weaning reduced progression extracorporeal membrane oxygenation hemostatic safety potential effects innate immune response need monitored part novel approach addition clinically relevant end points may free vital resources available preclinical data suggest inhibition contact activation potential improve survival patients sarscov<NUMBER> infectioninduced severe covid<NUMBER> autopsy reports patients died severe covid<NUMBER>related respiratory failure note intraalveolar fibrin accumulation suggesting loss vascular integrity <NUMBER> pathologic upregulation inflammation coagulation response sarscov<NUMBER> infection led significant enthusiasm mobilizing clinical trials targeting either pathway <NUMBER> paper propose targeting contact activation rational target clinical trials patients covid<NUMBER> risk respiratory compromise based animal models showing inhibiting contact activation prevents pathologic host inflammatory responses certain infections bacterial challenge ii clinical rationale inhibiting contact activation may safe critically ill patients unlikely provoke significant bleeding compromise immune system iii several contact activation inhibitors clinical development potentially available rapid clinical trial implementation molecular complex contact activation composed factor xii fxii factor xi fxi prekallikrein highmolecularweight kininogen serves central node linking coagulation inflammation pathways figure <NUMBER> contact activation leads thrombin generation also upregulation kallikreinkinin system kks thrombin generation may also upregulate kks feedback activation fxii via thrombininduced several studies evaluated effects fxi knockout murine models bacterial challenge fxi knockout mice develop less severe coagulopathy lower serum cytokine levels wildtype mice challenged listeria monocytogenes plasma inflammatory markers including il<NUMBER> hepatic mrna encoding il<NUMBER> il<NUMBER> significantly attenuated correlating improved survival <NUMBER> vs <NUMBER> <NUMBER> likewise cecal ligation puncture model designed mimic polymicrobial peritoneal sepsis fxi knockout mice experienced less consumptive coagulopathy wildtype mice <NUMBER> prothrombin times increased significantly wildtype mice remained unchanged fxideficient animals mice lacked fxi clearly developed less pronounced coagulopathy relatively attenuated inflammatory response compared wildtype controls translated directly significant survival advantage <NUMBER> vs <NUMBER> experimental model later replicated define changes inflammatory cytokine levels coagulation profiles fxi knockout mice compared wildtype mice fxideficient mice demonstrated significantly lower plasma levels il<NUMBER>β il<NUMBER> il<NUMBER> tumor necrosis factorα tnfα infection survival <NUMBER> days also significantly higher fxi knockout mice <NUMBER> vs <NUMBER> <NUMBER> however pharmacologicl inhibition fxia deficiency fxi potential impair hemostasis may already compromised infections therefore inhibition components contact activation complex evaluated murine monoclonal antibody <NUMBER>e<NUMBER> binds a<NUMBER> domain fxi selectively disrupts reciprocal activation fxi fxii without affecting activation fxi thrombin fix activation fxia beneficial effects cecal ligation puncture model described including significantly improved survival <NUMBER> vs <NUMBER> postmortem organ evaluation <NUMBER> <NUMBER>e<NUMBER>treated mice evidence hepatic vascular microthrombi compared <NUMBER> control group levels inflammatory cytokines including tnfα il<NUMBER> significantly lower <NUMBER>e<NUMBER>treated mice <NUMBER> administration <NUMBER>e<NUMBER> l monocytogenesinfected mice also improved survival <NUMBER> similarly preclinical studies evaluated role fxii health disease fxii knockout mice protected experimentally induced thrombosis numerous models displaying normal hemostatic capacity <NUMBER> upregulated fxii activation cause certain forms hereditary angioedema leads excess bradykinin generation complement activation increased vascular permeability edema monoclonal antibody <NUMBER>f<NUMBER> inhibits activity fxiia shown protective bradykinin generation edema mouse models hereditary angioedema prevent bradykinin generation plasma humans hereditary angioedema <NUMBER> recombinant version antibody csl<NUMBER> currently clinical development treatment prevention hereditary angioedema <NUMBER> finally ixodes ricinus contact phase inhibitor dual inhibitor fxia fxiia isolated saliva ricinus ticks shown attenuate thrombosis animal models without apparent detriment hemostasis <NUMBER> effect simultaneous inhibition fxia fxiia humans remains unknown contact activation system coagulation leads thrombin generation appears contribute development thrombosis seems mostly dispensable hemostasis epidemiologic data suggest individuals congenital fxi deficiency largely protected venous arterial thrombosis usually mild bleeding diathesis little spontaneous bleeding bleeding hemostatic challenge trauma major surgery often require treatment importantly congenital fxii deficiency rare associated abnormal bleeding <NUMBER> relative safety reducing fxi activity humans demonstrated prospective clinical trial antisense oligonucleotide reduced plasma fxi levels surgical patients partial reduction fxi levels effective method prevention postoperative venous thromboembolism patients undergoing elective knee arthroplasty associated trend less bleeding traditional anticoagulation <NUMBER> similarly antibodymediated inhibition fxia associated trend less bleeding observed lowmolecularweight heparin large prospective trial thromboprophylaxis patients undergoing elective knee arthroplasty <NUMBER> phase <NUMBER> trial ab<NUMBER> appeared safe without notable drugrelated adverse effects healthy volunteers <NUMBER> recent retrospective analyses suggested anticoagulation heparin products may improve clinical outcomes patients covid<NUMBER> <NUMBER> selective targeting contact activation may offer refined approach impact hemostasis would likely associated fewer bleeding complications however safety inhibiting contact activation system patients bacterial viral infections assessed innate immunity appear compromised humans congenital fxi fxii deficiency although fxi deficiency associated nasal infections holstein cattle <NUMBER> epidemiologic studies humans fxi deficiency reported identical rates hospitalization pneumonia pneumoniarelated outcomes controls normal fxi levels knowledge reports linking human fxi deficiency immunocompromised phenotype <NUMBER> thus contact activation appears contribute proinflammatory procoagulant pathways humans absence fxi seem significantly compromise host defense hemostasis noted results study mouse model pneumonia conflict premise thus stroo colleagues <NUMBER> <NUMBER> showed administering streptococcus pneumoniae klebsiella lungs resulted inflammation higher mortality fxideficient mice wildtype mice raising cautionary note findings may represent speciesspecific effect like observed holstein cattle reassuring aforementioned epidemiologic study found increase frequency pneumonia fxideficient humans compared normal fxi levels furthermore pneumonia significant difference severity shortterm mortality <NUMBER> posit strategy directly targeting fxii targeting link fxii fxi produce effect complete deficiency fxi importantly leave hemostatic function fxi intact however important monitor response directly targeting eliminating function kks patients pneumonia world midst pandemic time course resolution unclear times responsibility december <NUMBER> new pneumonia today known coronavirus disease <NUMBER> shorlty covid<NUMBER> locally started chinese city wuhan <NUMBER> may <NUMBER> world recorded almost <NUMBER> million cases covid <NUMBER> reported worldwide <NUMBER> <NUMBER> note number infections keep rising meaning pandemic far countries nations territories among reported cases almost <NUMBER> people succumbed disease fig <NUMBER> fig <NUMBER> fortunately almost <NUMBER> million people recovered <NUMBER> march <NUMBER> world health organization declared covid<NUMBER> pandemic maybe unprecedented situation since <NUMBER> spanish flu pandemic <NUMBER> would different alert call li wenliang <NUMBER> taken consideration time chinese authorities hence worldwide epicenter disease since hit several countries china usa via italy spain uk fig <NUMBER> fig <NUMBER> fig <NUMBER> moved southern hemisphere country brazil winter season fig <NUMBER> highly contagious covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> proven spread easily cold winter conditions met fact research made recently <NUMBER> shown sarscov<NUMBER> easily spread communities live places temperature relatively low around <NUMBER> <NUMBER> degrees celsius associated low specific around <NUMBER> <NUMBER> gkg absolute humidity around <NUMBER> <NUMBER> gm <NUMBER> southern hemisphere moves winter season worries feel two particular countries whose number deaths keeps rising chile south africa fig <NUMBER> fig <NUMBER> worries south africa country stands current covid<NUMBER> affected country africa also hiv affected country moreover alarming situation brazil huge concern south africa countries face similar precarious social issues shown table <NUMBER> recent statistics <NUMBER> <NUMBER> show covid<NUMBER> mostly kills people preexisting diseases diabetes high blood pressure tuberculosis also hiv hence motivated us study paper combined hivcovid<NUMBER> model order start another alert call concerned countries risk <NUMBER> note number infections kept rising peak reached decrease rise china quickly contained around <NUMBER> feb italy took epicenter status around <NUMBER> mar <NUMBER> <NUMBER> note number infections kept rising peak reached decrease rise spain contained around <NUMBER> april <NUMBER> uk took epicenter status around <NUMBER> april <NUMBER> <NUMBER> shows number new infections keeps rising countries chile south africa next one enter winter season brazil south africa approximative population <NUMBER> million <NUMBER> <NUMBER> million <NUMBER> total population mainly african descents mainly africans poverty sanitation water poverty infrastructure garbage collection problemswater supply problem promiscuity densely populated affected latin america affected africa countrys president countrys president chose go chose easy lockdown hard lockdown despite despite increasing increasing number deaths number deaths note global numbers still relatively low chile south africa upfront alerts need heard late commonly done mathematical epidemiology type diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> start formulating model clarifying assumptions used throughout section simple system modeling temporal dynamics corona virus <NUMBER>ncov combined hiv within human population described dont yet answers real dynamics spread new <NUMBER>ncov focus people already covid<NUMBER> infectious symptomatic asymptomatic individuals assume people population n p constant divide four different compartments according status respect diseases hence denote p p fraction people population susceptible c c fraction people population covid<NUMBER> infectious h h fraction people population hiv infectious hc hc fraction people population dually infectious hiv covid<NUMBER> assume covid<NUMBER> infection process originates reservoir source infection called ξ animals pangolin bats etc total population n r n r divided two different compartments susceptible covid<NUMBER> r r covid<NUMBER> infectious r r assume individuals susceptible compartment recruited people population rate λ p constant infections covid<NUMBER> individuals happen rate λ c due sufficient contact infected animals ξ move compartment covid<NUMBER> infectious individuals c moreover infections hiv happen rate λ h due sufficient contact infected individuals therefore susceptible individuals move compartment hiv infectious individuals <NUMBER> note number deaths peaked times around <NUMBER> april <NUMBER> remain significant around world exactly <NUMBER> reported <NUMBER> may h people infected covid<NUMBER> either recover thanks immunity moved rate γ compartment susceptible individuals infected hiv due sufficient contact infected individuals fraction rate ελ h ε ∈ <NUMBER> <NUMBER> recall <NUMBER> ε taken expect eventual drop sexual intercourse principal known cause hiv transmission people infected covid<NUMBER> due disease move compartment hc dually infectious hiv covid<NUMBER> disease covid<NUMBER> kills people rate κ c people infected hiv either die due disease get infection corona virus rate θλ h due sufficient contact infected source move compartment hc dually infectious hiv covid<NUMBER> take θ <NUMBER> since people infected hiv lower immune system therefore highly susceptible catch covid<NUMBER> individuals hiv covid<NUMBER> recover covid<NUMBER> thanks immunity moved rate compartment individuals infected hiv die covid<NUMBER> rate τ κ c take τ <NUMBER> high probability mortality within people hc hiv covid<NUMBER> compared individuals infected covid<NUMBER> furthermore individuals hiv covid<NUMBER> also die hiv rate νκ h take ν ≥ <NUMBER> high probability mortality within people hc hiv covid<NUMBER> compared individuals infected hiv denote µ h rate death due natural causes occurs assume susceptible animals ξ recruited population n r rate λ r constant assume animals die rate µ c become infected covid<NUMBER> rate λ r due sufficient contact infected animals move compartment covid<NUMBER> infectious r based setting dynamics system given transfer diagram depicted fig <NUMBER> expressed following differential equations λ c λ h λ r respectively forces infection reading β h representing hiv infection effective contact rate ξ hc ≥ <NUMBER> representing regularization parameter modeling relative infectiousness people hiv covid<NUMBER> hc compared individuals infected hiv h new corona virus <NUMBER>ncov σ per capita vectortohost contact rate animals reservoir β c parameter accounting people transmission probability per vectortohost contact β r accounts probability animals <NUMBER> submodels analysis wellposedness feasibility region stability section start analyzing two submodels hiv covid<NUMBER> contained model <NUMBER> <NUMBER> establish hiv submodel model <NUMBER> force infection λ h reading order analyze hiv system <NUMBER> human population consider region biological feasibility given following results hiv system <NUMBER> remains nonnegative time <NUMBER> corresponding initial condition nonnegative <NUMBER> region ω h positively invariant hiv system <NUMBER> nonnegative initial conditions taken r <NUMBER> fact attracting absorbing compact set system <NUMBER> <NUMBER> moreover proceeding standard comparison integration give conclusion also shows attractiveness absorbing results ω hiv system <NUMBER> therefore treated dynamical system ω wellposed diseasefree equilibrium dfe hiv system <NUMBER> reads exploiting next generation operator f v −<NUMBER> detailed <NUMBER> leads hiv system <NUMBER> written matrix formẋ fx−vx matrices f v respectively given evaluated dfe e <NUMBER> jacobian matrices yields hence basic reproduction number r h spectral radius using linearization hiv system <NUMBER> around dfe e <NUMBER> obtain jacobian matrix reading easily obtain eigenvalues j e <NUMBER> reads λ <NUMBER> −µ h negative thus proven following result <NUMBER> proposition <NUMBER> dfe e <NUMBER> model <NUMBER> locallyasymptotically stable r h <NUMBER> unstable r h <NUMBER> establishment global asymptotical stability dfe e <NUMBER> use method lyapunovlasalle considering lyapunov function ls p h µ h κ h h timederivative along solution p h reads used fact h np ≤ <NUMBER> hence knowing system parameters nonnegative dl dt ≤ <NUMBER> r h ≤ <NUMBER> moreover happens dl dt <NUMBER> ⇐⇒ h <NUMBER> therefore l lyapunov function ω h lasalles invariance principle <NUMBER> implies limit points solutions model <NUMBER> belong largest compact invariance set p h ∈ ω h dl dt <NUMBER> set h <NUMBER> dsp dt λ p −µ h p thus p −→ λp µ h −→ ∞ thus therefore every solution p h taking initial conditions ω h approaches dfe e <NUMBER> λp µ h <NUMBER> −→ ∞ r h ≤ <NUMBER> henceforth proven following result <NUMBER> globallyasymptotically stable whenever r h ≤ <NUMBER> yields force infection simple transformation <NUMBER> <NUMBER> leads following polynomial λ h shown results establish covid<NUMBER> submodel model <NUMBER> putting h <NUMBER> hc <NUMBER> yields force infection λ c λ r reading respectively λ c β c σi r n p λ r β r σi r n r diseasefree equilibrium dfe covid<NUMBER> system <NUMBER> reads exploiting next generation operator f v −<NUMBER> detailed <NUMBER> leads covid<NUMBER> system <NUMBER> written matrix formẋ fx−vx matrices f v respectively given evaluated dfe e <NUMBER> jacobian matrices yields hence basic reproduction number r c spectral radius following approach proposition <NUMBER> easily show <NUMBER> locallyasymptotically stable r c <NUMBER> unstable r c <NUMBER> aim section look conditions exists backward bifurcation model <NUMBER> recall type bifurcation happens stable dfe stable endemic equilibrium exist together values basic <NUMBER> reproduction number r c less one hence find conditions endemic equilibrium e p c r r pose yields simple transformation <NUMBER> <NUMBER> leads following polynomial λ c  many endemic equilibrium points solutions λ c solution λ c <NUMBER> related def let following results proposition <NUMBER> • necessary condition existence backward subcritical bifurcation model <NUMBER> σ σ furthermore <NUMBER> r c <NUMBER> model <NUMBER> one one endemic equilibrium point ifr c r c model <NUMBER> two endemic equilibrium points r c ∈ r c <NUMBER> model <NUMBER> one endemic equilibrium point r c ≥ <NUMBER> model <NUMBER> endemic equilibrium point r c r c • necessary condition existence transcritical bifurcation model <NUMBER> σ ≥σ prove use equivalence relation <NUMBER> <NUMBER> obvious see <NUMBER> <NUMBER> σ σ hence r c ≥ <NUMBER> q <NUMBER> ≤ <NUMBER> meaning r c ≥ <NUMBER> q <NUMBER> ≤ <NUMBER> equation <NUMBER> one one positive root however equation <NUMBER> positive root r c ≤ <NUMBER> meaning q <NUMBER> ≥ <NUMBER> q <NUMBER> <NUMBER> case <NUMBER> ≥ r c also q <NUMBER> <NUMBER> q <NUMBER> ≥ <NUMBER> ∆ f r c q <NUMBER> <NUMBER> − <NUMBER>q <NUMBER> q <NUMBER> denotes discriminant <NUMBER> functional r c r c ∈ <NUMBER> f strictly increasing <NUMBER> f −<NUMBER>q <NUMBER> q <NUMBER> <NUMBER> f <NUMBER> q <NUMBER> <NUMBER> <NUMBER> therefore isr c ∈ <NUMBER> f r c <NUMBER> f <NUMBER> tr c f <NUMBER> r c <NUMBER> hence r c ∈ r c <NUMBER> equation <NUMBER> two real positive roots since q <NUMBER> <NUMBER> q <NUMBER> <NUMBER> leads model <NUMBER> also two endemic equilibrium points similarly equation <NUMBER> one positive root r c r c equation <NUMBER> positive root r c r c concludes proof conditions existence subcritical bifurcation covid<NUMBER> model let us look full model note according definition σ β c clear δ σβ c represents covid<NUMBER> transmission rate per vectortohost contact per unit time state following result proof let r <NUMBER> maxr h r c let e <NUMBER> <NUMBER> p <NUMBER> c <NUMBER> h <NUMBER> hc <NUMBER> r <NUMBER> r denotes diseasefree equilibrium point investigate stability dfe e <NUMBER> analyzing eigenvalues jacobian matrix j e <NUMBER> evaluated e <NUMBER> linearizing model <NUMBER> set <NUMBER> hc − <NUMBER> hc <NUMBER> r − <NUMBER> r <NUMBER> r − <NUMBER> r assuming solutions <NUMBER> take exponential <NUMBER> c <NUMBER> e λt <NUMBER> c <NUMBER> e λt <NUMBER> c <NUMBER> e λt <NUMBER> c <NUMBER> e λt <NUMBER> c <NUMBER> e λt <NUMBER> c <NUMBER> e λt substitution <NUMBER> canceling term e λt yields system characteristic equation given equivalently fig <NUMBER> existence globally stable diseasefree equilibrium e <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> system <NUMBER> β r <NUMBER> σ <NUMBER> r c <NUMBER> hence <NUMBER> eigenvalues j e <NUMBER> given negative fourth eigenvalue root z <NUMBER> r h <NUMBER> reads obviously λ <NUMBER> <NUMBER> r h <NUMBER> λ <NUMBER> <NUMBER> r h <NUMBER> previous section def covid<NUMBER> model analyzed z <NUMBER> r c <NUMBER> refers corresponding characteristic equations hence showed proposition <NUMBER> z <NUMBER> r c <NUMBER> roots negative real parts r c <NUMBER> moreover z <NUMBER> r c <NUMBER> least root positive real part r c <NUMBER> finally r <NUMBER> maxr h r c <NUMBER> equation <NUMBER> roots negative real parts least root positive real part r <NUMBER> <NUMBER> bifurcation analysis depicted fig <NUMBER> fig <NUMBER> showing condition model forward backward bifurcations respectively show model contains backward bifurcation certain conditions also study different scenarios stability unstability state equilibrium points dfe e <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> endemic equilibrium point shown fig <NUMBER>fig <NUMBER> globally stable dfe e <NUMBER> illustrated fig <NUMBER> fig <NUMBER> β r <NUMBER> σ <NUMBER> r c <NUMBER> fig <NUMBER> shows exists globally stable endemic equilibrium e <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> system <NUMBER> unstable dfe e <NUMBER> β r <NUMBER> σ <NUMBER>×<NUMBER> −<NUMBER> r c <NUMBER> shown fig <NUMBER> fig <NUMBER> fig <NUMBER> numbers victims fatalities due hiv new coronavirus remain fateful scourge around world combination certainly explosive affected countries especially think southern hemisphere countries getting summer moving winter season urgent countries like south africa chile alerted still time react efficiently indeed world ignored first alert made pandemic young late chinese doctor li wenliang paper serves covid<NUMBER> alert southern hemisphere countries like chile south africa moving winter season seeing heavily hit pandemic winter moved southern hemisphere also observed epicenter new coronavirus shifting brazil shares similar features favellas townships poverty promiscuity south africa chile used generalized simple mathematical model hivcovid<NUMBER> together graphs curves tables compare pandemic situation countries epicenter disease china italy spain united kingdom united states america managed show conditions existence stable equilibria different bifurcation forward backward scenarios model fractional generalized covid<NUMBER> model solved numerically predicted prevalence covid<NUMBER> provided ground concerned southern hemisphere countries since happens countries epicenter winter season status epicenter covid<NUMBER> opted ease lockdown peak disease reached epicenter brazil full winter season observe health system emergency services overcrowded large number covid<NUMBER> patients deaths recent data show increasing number infections chile south africa combination hiv cannot help moreover still far seeing disease reaching peak country south africa enter winter season opted reopen countrys activities schools exactly opposite observed western countries recall south africa stands covid<NUMBER> affected country africa going next epicenter weeks come winter conditions favorable spread new coronavirus comfily installed answer certainly affirmative seeing social conditions townships country country however started imposing social distanciation wearing face mask public services hiring health workers targeted community tests enough country chose reopen economic sectors <NUMBER> june <NUMBER> coincides beginning winter season ask whether lockdown started <NUMBER> march <NUMBER> right moment coming months tell us lastly another worrying alert fact winter still going move europe may see epicenter shifting towards north unless cure vaccine found future months <NUMBER> fig <NUMBER> predicted covid<NUMBER> prevalence using generalized model <NUMBER> certain values α following first reports outbreak acute respiratory syndrome <NUMBER> coronavirus disease china december <NUMBER> novel coronavirus sarscov<NUMBER> identified <NUMBER> <NUMBER> march <NUMBER> <NUMBER> <NUMBER> cases reported worldwide <NUMBER> <NUMBER> deaths surpassing combined number cases deaths two previously emerging coronaviruses sarscov merscov <NUMBER> covid<NUMBER> characterized range symptoms including fever cough dyspnoea myalgia cases <NUMBER> severe cases bilateral lung involvement groundglass opacity common chest ct finding <NUMBER> similar <NUMBER> outbreak sars severity covid<NUMBER> disease associated <NUMBER> increased age andor comorbidity although severe disease limited risk groups <NUMBER> however despite large number cases deaths limited information available pathogenesis virus infection two reports histological examination lungs three patients showed bilateral diffuse alveolar damage dad pulmonary oedema hyaline membrane formation indicative acute respiratory distress syndrome ards well <NUMBER> characteristic syncytial cells alveolar lumen <NUMBER> <NUMBER> similar findings <NUMBER> outbreak sarscov <NUMBER> pathogenesis sarscov infection previously studied nonhuman primate model aged animals likely develop disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> current study sarscov<NUMBER> infection characterized animal model using cynomolgus macaques compared infection merscov historical data <NUMBER> sarscov <NUMBER> <NUMBER> <NUMBER> first two groups four cynomolgus macaques young adult <NUMBER> years age aged <NUMBER> years age inoculated via combined intratracheal intranasal route sarscov<NUMBER> strain german traveller returning china overt clinical signs observed infected animals exception serous nasal discharge one aged <NUMBER> animal day <NUMBER> post inoculation pi significant weight loss observed animals study day <NUMBER> pi remaining animals seroconverted revealed presence sarscov<NUMBER> specific antibodies s<NUMBER> domain nucleocapsid proteins sera fig s<NUMBER> measure virus shedding nasal throat rectal swabs assayed virus rtqpcr virus culture nasal swabs detection sarscov<NUMBER> rna peaked day <NUMBER> pi young adult animals day <NUMBER> pi aged animals detected least day <NUMBER> pi two <NUMBER> four animals day <NUMBER> pi one four animals fig <NUMBER>a overall higher levels sarscov<NUMBER> rna detected nasal swabs aged animals compared young adult animals sarscov<NUMBER> rna detection throat swabs peaked day <NUMBER> pi young adult day <NUMBER> pi aged animals decreased rapidly time compared nasal swabs could still detected intermittently day <NUMBER> pi fig <NUMBER>b low levels infectious virus could <NUMBER> cultured nasal throat swabs day <NUMBER> <NUMBER> respectively table s<NUMBER> sarscov<NUMBER> rna could detected rectal swab <NUMBER> animal day <NUMBER> pi viral rna could detected whole blood time point throughout study upon autopsy four macaques day <NUMBER> pi two foci pulmonary consolidation lungs fig <NUMBER>a one animal aged <NUMBER> years right middle lobe representing less <NUMBER> <NUMBER> lung tissue second animal young adult <NUMBER> years two foci left lower lobe representing <NUMBER> lung tissue fig <NUMBER>a consolidated lung tissue wellcircumscribed redpurple level less buoyant normal organs two macaques well respiratory tract organs two animals normal virus replication assessed rtqpcr day <NUMBER> pi tissues respiratory digestive <NUMBER> urinary cardiovascular tracts endocrine central nervous systems well various lymphoid tissues virus replication primarily restricted respiratory tract nasal cavity trachea bronchi lung lobes highest levels sarscov<NUMBER> rna lungs fig <NUMBER>c interestingly three four animals sarscovrna also detected ileum tracheobronchial lymph nodes fig <NUMBER>c <NUMBER> main histological lesion consolidated pulmonary tissue involved alveoli bronchioles consisted areas acute advanced dad fig <NUMBER>b areas lumina alveoli bronchioles variably filled proteinrich oedema fluid fibrin cellular debris moderate number alveolar macrophages fewer neutrophils lymphocytes fig <NUMBER>c e epithelial necrosis extensive loss epithelium <NUMBER> alveolar bronchiolar walls hyaline membranes present damaged alveoli areas advanced lesions alveolar walls moderately thickened lined cuboidal epithelial cells type ii pneumocyte hyperplasia alveolar lumina empty alveolar bronchiolar walls thickened oedema fluid mononuclear cells neutrophils aggregates lymphocytes around small pulmonary vessels moderate <NUMBER> numbers lymphocytes macrophages present lamina propria submucosa bronchial walls neutrophils bronchial epithelium regeneration epithelium seen bronchioles visible irregular layer squamous high cuboidal epithelial cells hyperchromatic nuclei occasional multinucleated giant cells syncytia free lumina bronchioles alveoli fig <NUMBER>f based positive pankeratin staining <NUMBER> negative cd<NUMBER> staining originated epithelial cells fig <NUMBER>f inset sarscov<NUMBER> antigen expression detected moderate numbers type pneumocytes type ii pneumocytes foci dad fig <NUMBER>g fig s<NUMBER> pattern staining similar lung tissue sarscovinfected macaques positive control sarscov<NUMBER> antigen expression observed syncytia upper respiratory tract focal locally extensive sarscov<NUMBER> antigen expression epithelial cells mucous glands <NUMBER> nasal cavity septum concha four macaques without associated histological lesions fig <NUMBER>i order assess severity infection sarscov<NUMBER> compared previously emerged merscov young adult cynomolgus macaques <NUMBER> years age inoculated merscov via route animals remained free clinical signs day <NUMBER> pi <NUMBER> remaining animals n<NUMBER> seroconverted revealed presence merscov specific antibodies sera elisa merscov rna detected nasal fig <NUMBER>a throat swabs fig <NUMBER>b days <NUMBER> <NUMBER> pi peaks days <NUMBER> <NUMBER> pi respectively low levels merscov rna detected rectal swabs days <NUMBER> <NUMBER> pi data shown <NUMBER> upon autopsy four macaques day <NUMBER> pi three four macaques foci pulmonary consolidation characterized slightly depressed areas lungs representing less <NUMBER> lung tissue table <NUMBER> similar sarscov<NUMBER> day <NUMBER> pi merscov rna primarily detected respiratory tract inoculated animals fig <NUMBER>c infectious virus titres comparable sarscov<NUMBER> lower compared sarscov infection young adult <NUMBER> macaques table <NUMBER> addition merscov rna detected spleen table <NUMBER> consistent presence virus lower respiratory tract day <NUMBER> pi histopathological changes characteristic dad observed lungs inoculated animals fig <NUMBER>d alveolar septa thickened due infiltration neutrophils macrophages moderate type ii pneumocyte hyperplasia hypertrophy alveolar lumina <NUMBER> increased numbers alveolar macrophages occasionally small amounts oedema fluid fibrin neutrophils fig <NUMBER>d syncytial cells seen alveolar lumina interestingly merscov antigen detected tissues day <NUMBER> pi part respiratory tract therefore four young adult macaques included earlier time point day <NUMBER> pi day <NUMBER> pi multifocal expression viral antigen predominantly type ii <NUMBER> pneumocytes occasionally type pneumocytes bronchiolar bronchial epithelial cells macrophages fig <NUMBER>d summary inoculated young adult aged cynomolgus macaques low passage clinical isolates sarscov<NUMBER> resulted productive infection absence overt clinical signs increased age affect disease outcome prolonged viral shedding <NUMBER> upper respiratory tract aged animals prolonged shedding observed sarscov<NUMBER> sarscov patients <NUMBER> <NUMBER> interestingly sarscov<NUMBER> model peaked early course infection similar seen patients <NUMBER> earlier peak virus shedding sarscov<NUMBER> similar influenza virus shedding <NUMBER> sarscov shedding peaked around day <NUMBER> post onset symptoms <NUMBER> may explain case <NUMBER> detection isolation may effective sarscov<NUMBER> control sarscov <NUMBER> also four macaques expressed sarscov<NUMBER> antigen mucous glands nasal cavity day <NUMBER> pi seen sarscov <NUMBER> <NUMBER> <NUMBER> merscov infections manuscript animal model viral tropism nasal mucosa fits efficient respiratory transmission seen influenza virus <NUMBER> sarscov<NUMBER> primarily detected tissues respiratory tract however sarscov<NUMBER> rna also detectable tissues intestines line recent report <NUMBER> <NUMBER> two four animals foci dad day <NUMBER> pi colocalisation sarscov<NUMBER>antigen expression dad provides strong evidence sarscov<NUMBER> infection caused lesion histological character dad including alveolar bronchiolar epithelial necrosis alveolar oedema hyaline membrane formation accumulation neutrophils macrophages lymphocytes corresponds limited pathological analyses human covid<NUMBER> cases <NUMBER> <NUMBER> <NUMBER> particular presence syncytia lung lesions characteristic respiratory coronavirus infections whereas merscov primarily infects type ii pneumocytes cynomolgus macaques sarscov sarscov<NUMBER> also infect type pneumocytes injury type pneumocytes result pulmonary oedema formation hyaline membranes <NUMBER> may explain hyaline membrane formation hallmark sars covid<NUMBER> <NUMBER> <NUMBER> c ovid<NUMBER> known previously <NUMBER>ncov pneumonia disease emerged global public health crisis joining severe acute respiratory syndrome sars middle east respiratory syndrome mers growing number coronavirusassociated illnesses jumped animals people least seven identified coronaviruses infect humans december <NUMBER> city wuhan china became epicenter outbreak novel coronavirus sarscov<NUMBER> sarscov<NUMBER> isolated sequenced human airway epithelial cells infected patients <NUMBER> <NUMBER> disease symptoms range mild flulike severe cases lifethreatening pneumonia <NUMBER> global situation dynamically evolving <NUMBER> january <NUMBER> world health organization declared covid<NUMBER> public health emergency international concern pheic <NUMBER> march <NUMBER> declared global pandemic <NUMBER> may <NUMBER> <NUMBER> people confirmed infected <NUMBER> deaths <NUMBER> infections spread multiple continents humantohuman transmission observed multiple countries shortage disposable personal protective equipment <NUMBER> prolonged survival times coronaviruses inanimate surfaces <NUMBER> compounded already delicate situation heightened risk nosocomial infections advanced research activities must pursued parallel push forward protective modalities effort protect billions vulnerable individuals worldwide currently licensed preventative vaccine available covid<NUMBER> address urgent need medical countermeasure prevent dissemination sarscov<NUMBER> employed synthetic dnabased vaccine approach synthetic dna vaccines amenable accelerated developmental timelines due ability quickly design multiple candidates preclinical testing scalable manufacturing large quantities drug product possibility leverage established regulatory pathways clinic synthetic dna temperaturestable coldchain free important features delivery resourcelimited settings <NUMBER> specifically development covid<NUMBER> vaccine candidate leveraged prior experiences developing vaccine approaches sarscov <NUMBER> experience developing merscov vaccine ino<NUMBER> <NUMBER> <NUMBER> well taking advantage vaccine design manufacturing pathway previously utilized zika vaccine candidate gls<NUMBER> <NUMBER> advanced clinic <NUMBER> months ino<NUMBER> gls<NUMBER> vaccines currently clinical testing prior work demonstrated dna approach sars mers drive neutralizing antibody nab responses provide protection challenge models <NUMBER> <NUMBER> previous studies indicated immunization small large animal models dna vaccines encoding merscov spike protein provided protection disease challenge matched virus subjects immunized ino<NUMBER> merscov protein dna vaccine durable neutralizing antibodies nabs cell immune responses measured seroconversion rate <NUMBER> observed immunity followed <NUMBER> weeks study volunteers <NUMBER> ino<NUMBER> phase <NUMBER>a testing continuing south korea larger phase <NUMBER> study planned begin middle east areas affected mers infections sarscov<NUMBER> spike similar sequence structure sarscov spike protein <NUMBER> shares global protein fold architecture merscov spike protein fig <NUMBER> allowing us build prior vaccine construct design <NUMBER> unlike glycoproteins hiv influenza prefusion form coronavirus trimeric spike conformationally dynamic fully exposing receptorbinding site infrequently <NUMBER> receptorbinding site vulnerable target nabs fact mers nabs targeted receptorbinding domain rbd tend greater neutralizing potency epitopes <NUMBER> recent report demonstrated antisars antibody could crossreact rbd sarscov<NUMBER> <NUMBER> data suggest sarscov<NUMBER> rbd important target vaccine development recent data revealed sarscov<NUMBER> protein binds host receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> sarscov protein <NUMBER> describe design initial preclinical testing covid<NUMBER> synthetic dna vaccine candidates show expression sarscov<NUMBER> antigen rna protein vitro transfection cos<NUMBER> <NUMBER>t cells respectively vaccine candidates followed induction immunity selected immunogen mice guinea pigs measuring sarscov<NUMBER> proteinspecific antibody levels serum lung fluid antibody functionality competitive inhibition ace<NUMBER> binding pseudovirus live virus neutralization ino<NUMBER> vaccine induces cellular humoral host immune responses observed within days following single immunization including crossreactive responses sarscov data demonstrate immunogenicity covid<NUMBER> synthetic dna vaccine candidate targeting sarscov<NUMBER> protein supporting translational studies advance development candidate response current global health crisis design synthesis covid<NUMBER> dna vaccine constructs four spike protein sequences retrieved first four available sarscov<NUMBER> full genome sequences published gisaid global initiative sharing influenza data three spike sequences <NUMBER> matched one considered outlier <NUMBER> sequence identity sequences performing sequence alignment sarscov<NUMBER> spike glycoprotein sequence generated nterminal ige leader sequence added highly optimized dna sequence encoding sarscov<NUMBER> igespike created using inovios proprietary silico gene optimization algorithm enhance expression immunogenicity optimized dna sequence synthesized digested bamhi xhoi cloned expression vector pgx<NUMBER> control human cytomegalovirus immediateearly promoter bovine growth hormone polyadenylation signal resulting plasmids designated pgx<NUMBER> pgx<NUMBER> designed encode sarscov<NUMBER> protein threematched sequences outlier sequence respectively fig <NUMBER>a vitro characterization covid<NUMBER> dna vaccine constructs measured expression encoded sarscov<NUMBER> spike transgene rna level cos<NUMBER> cells transfected pgx<NUMBER> pgx<NUMBER> using total rna extracted transfected cos<NUMBER> cells confirmed expression spike transgene rtpcr fig <NUMBER>b vitro spike protein expression hek<NUMBER>t cells measured western blot analysis using crossreactive antibody sarscov protein cell lysates western blots lysates hek<NUMBER>t cells transfected pgx<NUMBER> pgx<NUMBER> constructs revealed bands approximate predicted protein molecular weight <NUMBER> kda slight shifts likely due <NUMBER> potential nlinked glycans protein fig <NUMBER>c immunofluorescent studies protein detected <NUMBER>t cells transfected pgx<NUMBER> pgx<NUMBER> fig <NUMBER>d summary vitro studies revealed expression spike protein rna protein level transfection cell lines candidate vaccine constructs humoral immune responses mice since candidate design observed newly published sarscov<NUMBER> spike protein sequences match pgx<NUMBER> <NUMBER> amino acid sequence identity supplementary data <NUMBER> pgx<NUMBER> therefore selected vaccine construct advance immunogenicity studies due broader coverage would likely provide compared outlier pgx<NUMBER> pgx<NUMBER> subsequently termed ino<NUMBER> immunogenicity ino<NUMBER> evaluated balbc mice postadministration tibialis anterior muscle using cellectra® delivery device <NUMBER> reactivity sera group mice immunized ino<NUMBER> measured panel sarscov<NUMBER> sarscov antigens fig <NUMBER>a analysis revealed igg binding sarscov<NUMBER> protein antigens limited crossreactivity sarscov protein antigens sera ino<NUMBER> immunized mice measured serum igg binding endpoint titers epts mice immunized pdna recombinant sarscov<NUMBER> spike protein s<NUMBER> s<NUMBER> regions fig <NUMBER>b c recombinant sarscov<NUMBER> spike protein receptor binding domain rbd fig <NUMBER>d e epts observed sera mice day <NUMBER> immunization single dose ino<NUMBER> fig <NUMBER>c e developed neutralization assay pnl<NUMBER>lucrebased pseudovirus displaying sarscov<NUMBER> spike protein neutralization titers detected reduction relative luciferase units rlu compared controls decrease rlu signal balbc mice immunized twice ino<NUMBER> days <NUMBER> <NUMBER> sera collected day <NUMBER> postsecond immunization pseudovirus incubated serial dilutions mouse sera seravirus mixture added <NUMBER>t cells stably expressing human ace<NUMBER> receptor ace<NUMBER>t <NUMBER> h neutralization id<NUMBER> average titers <NUMBER> observed ino<NUMBER> immunized mice fig <NUMBER>a b reduction rlu observed control animals neutralizing titers additionally measured two wildtype sarscov<NUMBER> virus strains prnt assay sera ino<NUMBER> immunized balbc mice neutralized sarscov<NUMBER>wh<NUMBER>human<NUMBER> sarscov<NUMBER>australiavic<NUMBER> virus strains average nd<NUMBER> titers <NUMBER> <NUMBER> respectively table <NUMBER> live virus neutralizing titers also evaluated c<NUMBER>bl<NUMBER> mice following ino<NUMBER> immunization regimen sera ino<NUMBER> immunized c<NUMBER>bl<NUMBER> mice neutralized wildtype sarscov<NUMBER> virus average nd<NUMBER> titer <NUMBER> table <NUMBER> humoral immune responses guinea pigs assessed immunogenicity ino<NUMBER> hartley guinea pig model established model intradermal vaccine delivery <NUMBER> <NUMBER> one hundred micrograms pdna administered mantoux injection skin followed cellectra® delivery device day <NUMBER> described methods section day <NUMBER> antispike protein binding serum antibodies measured elisa immunization ino<NUMBER> revealed immune response respect sarscov<NUMBER> s<NUMBER> <NUMBER> protein binding igg levels sera fig <NUMBER>a b endpoint sarscov<NUMBER> protein binding titer day <NUMBER> <NUMBER> <NUMBER> guinea pigs treated <NUMBER> µg ino<NUMBER> pvax control respectively fig <NUMBER>b next evaluated antibody neutralizing activity following intradermal ino<NUMBER> immunization guinea pig model guinea pigs treated days <NUMBER> <NUMBER> <NUMBER> pvax ino<NUMBER> sera samples collected days <NUMBER> <NUMBER> measure sera neutralizing activity pseudovirus wildtype virus respectively sarscov<NUMBER> pseudovirus neutralizing activity average nd<NUMBER> titers <NUMBER> observed ino<NUMBER> immunized guinea pigs table <NUMBER> wildtype sarscov<NUMBER> virus activity also observed ino<NUMBER> immunized guinea pigs nd<NUMBER> titers <NUMBER> prnt assay observed animals table <NUMBER> inhibition sarscov<NUMBER> protein binding ace<NUMBER> receptor induction antibodies capable inhibiting spike protein engagement host receptor considered relevant sarscov<NUMBER> vaccine development therefore examined receptor inhibiting functionality ino<NUMBER>induced antibody responses recently developed elisabased ace<NUMBER> inhibition assay surrogate neutralization assay similar principle surrogate neutralization assays validated coronaviruses <NUMBER> control assay show ace<NUMBER> bind sarscov<NUMBER> spike protein ec <NUMBER> <NUMBER> µgml fig <NUMBER>a balbc mice immunized days <NUMBER> day <NUMBER> <NUMBER> µg ino<NUMBER> serum igg purified day <NUMBER> postimmunization ensure inhibition antibodymediated compared inhibition spikeace<NUMBER> interaction using serum igg naïve mouse ino<NUMBER> pgx<NUMBER> outlier ol containing ige leader sequence sarscov<NUMBER> spike protein insert b rtpcr assay rna extracts cos<NUMBER> cells transfected duplicate pgx<NUMBER> pgx<NUMBER> extracted rna analyzed rtpcr using pcr assays designed target cos<NUMBER> βactin mrna used internal expression normalization gene delta c δ c calculated c target minus c βactin transfection concentration plotted log mass pdna transfected plotted mean ± sd c analysis vitro expression spike protein transfection <NUMBER>t cells pgx<NUMBER> pgx<NUMBER> mock plasmid western blot <NUMBER>t cell lysates resolved gel probed polyclonal antisars spike protein blots stripped probed antiβactin loading control vitro immunofluorescent staining <NUMBER>t cells transfected <NUMBER> µgwell pgx<NUMBER> pgx<NUMBER> pvax empty control vector expression spike protein measured polyclonal antisars spike protein igg antiigg secondary green cell nuclei counterstained dapi blue images captured using imagexpress pico automated cell imaging system scale bars <NUMBER> µm left <NUMBER> µm middle <NUMBER> µm right vaccinated mouse fig <NUMBER>b repeated receptor inhibition assay group five immunized mice demonstrating ino<NUMBER>induced antibodies competed ace<NUMBER> binding sarscov<NUMBER> spike protein fig <NUMBER>c supplementary fig <NUMBER> ace<NUMBER> binding inhibition evaluated guinea pig model sera collected ino<NUMBER> immunized guinea pigs inhibited binding sarscov<NUMBER> spike protein range concentrations ace<NUMBER> <NUMBER> µgml <NUMBER> µgml fig <NUMBER>d furthermore serum dilution curves revealed sera collected ino<NUMBER> immunized guinea pigs blocked binding ace<NUMBER> sarscov<NUMBER> dilutiondependent manner fig <NUMBER>e sera collected pvaxtreated animals displayed negligible activity inhibition ace<NUMBER> binding virus protein decrease od signal highest concentration serum considered matrix effect assay ace<NUMBER> considered primary receptor sarscov<NUMBER> cellular entry blocking interaction suggests ino<NUMBER>induced antibodies believed important prevent host infection summary humoral immunogenicity testing mice guinea pigs revealed covid<NUMBER> vaccine candidate ino<NUMBER> capable eliciting functional blocking antibody responses sarscov<NUMBER> spike protein biodistribution sarscov<NUMBER> reactive igg lung lower respiratory disease lrd associated severe cases covid<NUMBER> presence antibodies lung mucosa targeting sarscov<NUMBER> could potentially mediate protection lrd therefore evaluated presence sarscov<NUMBER> specific antibody lungs immunized mice guinea pigs balbc mice hartley guinea pigs immunized days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively ino<NUMBER> pvax control pdna bronchoalveolar lavage bal fluid collected following sacrifice sarscov<NUMBER> protein elisas performed balbc hartley guinea pigs received ino<NUMBER> measured statistically significant increase sarscov<NUMBER> protein binding igg bal fluid compared animals receiving pvax control fig <NUMBER>ad taken together data demonstrate presence antisarscov<NUMBER> specific antibody lungs following immunization ino<NUMBER> fig <NUMBER> balbc mouse sarscov<NUMBER> epitope mapping performed epitope mapping splenocytes balbc mice receiving <NUMBER> µg ino<NUMBER> dose thirty matrix mapping pools used stimulate splenocytes <NUMBER> h immunodominant responses detected multiple peptide pools fig <NUMBER>a responses deconvoluted identify several epitopes h<NUMBER>k clustering receptor binding domain s<NUMBER> domain fig <NUMBER>b interestingly one sarscov<NUMBER> h<NUMBER>k epitope phgvvflhv observed overlapping adjacent sarscov human hlaa<NUMBER> restricted epitope vvflhvtyv <NUMBER> summary cell responses sarscov<NUMBER> protein epitopes detected mice immunized ino<NUMBER> novel coronavirus sarscov<NUMBER> associated covid<NUMBER> disease become global pandemic significant morbidity mortality toll currently covid<NUMBER> vaccines available global dissemination sarscov<NUMBER> may continue high level herd immunity within human population described preclinical development synthetic dnabased covid<NUMBER> vaccine ino<NUMBER> combat emerging infectious disease synthetic dna vaccine design synthesis immediately initiated upon public release sarscov<NUMBER> genome sequences <NUMBER> january <NUMBER> data support expression immunogenicity ino<NUMBER> synthetic dna vaccine candidate multiple animal models humoral cell responses observed mice guinea pigs employed clinical delivery parameters observed sarscov<NUMBER> protein binding antibody titers blocking ace<NUMBER>sarscov<NUMBER> protein interaction serum samples ino<NUMBER>treated animals nabs also measured species halting rapidly emerging infectious disease requires orchestrated response global health community requires improved strategies accelerate vaccine development response <NUMBER> coronavirus outbreak employed synthetic dna medicine platform design manufacture synthetic dna vaccine represents plug play process insert target antigen sequence highly characterized clinically tested plasmid vector backbone pgx<NUMBER> construct design engineering parameters optimized vivo gene expression previously applied mers ebov zika lassa dna vaccine constructs undergoing clinical testing <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> based upon previous experience developing vaccine mers coronavirus previous published studies sars vaccines sarscov<NUMBER> protein chosen antigen target sarscov<NUMBER> protein class membrane fusion protein major envelope protein surface coronaviruses initial studies already performed indicate sarscov<NUMBER> interaction host receptor ace<NUMBER> blocked antibodies <NUMBER> vivo immunogenicity studies mouse guinea pig models revealed levels proteinreactive igg serum ino<NUMBER> immunized animals addition fulllength s<NUMBER> s<NUMBER> s<NUMBER> ino<NUMBER> immunization induced rbd binding antibodies fig <NUMBER> domain known target nabs sarscov convalescent patients <NUMBER> <NUMBER> demonstrate functionality antibodies neutralization sarscov<NUMBER> wildtype virus pseudovirus table <NUMBER> competitive inhibition sarscov<NUMBER> spike protein binding ace<NUMBER> receptor presence sera ino<NUMBER> immunized animals fig <NUMBER> importantly antisarscov<NUMBER> binding antibodies detected lung washes ino<NUMBER>immunized mice guinea pigs fig <NUMBER> presence antibodies lungs potential protect infection tissues prevent lrd associated severe cases covid<NUMBER> addition humoral responses cellular immune responses shown associated favorable recovery merscov infection <NUMBER> likely important sarscov infection <NUMBER> showed induction cell responses sarscov<NUMBER> early day <NUMBER> postvaccine delivery rapid cellular responses potential lower viral load could potentially reduce spread sarscov<NUMBER> associated covid<NUMBER> illness believe synthetic dna medicine platform several synergistic characteristics position well respond disease outbreaks covid<NUMBER> mentioned previously ability design immediately synthesize candidate vaccine constructs means vitro vivo testing potentially begin within days receiving viral sequence dna plasmid manufacture process allows scalable manufacture drug product potential circumvent complexities conventional vaccine production eggs cell culture additionally published stability profile afforded products use optimized dna formulation <NUMBER> stability characteristics mean dna drug product nonfrozen stored <NUMBER> years <NUMBER>°c room temperature rt <NUMBER> year <NUMBER> month <NUMBER>°c maintaining potency temperatures upwards <NUMBER>°c context pandemic outbreak stability profile vaccine plays directly ability deployed stockpiled efficient executable manner study observed seroconversion single intradermal administration ino<NUMBER> guinea pigs fig <NUMBER> whether single immunization sufficient humans investigated clinical trials although vaccineinduced immunopathology raised potential concern sars mers vaccine candidates possibly sarscov<NUMBER> vaccines concerns likely vaccineplatform dependent todate evidence immune pathogenesis reported mers dna vaccines mice nonhuman primate models <NUMBER> sars dna vaccines mice <NUMBER> lung immunopathology characterized th<NUMBER>related eosinophilia reported whole inactivated virus iv recombinant protein peptide andor recombinant viral vector vaccines following sarscov challenge <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently merscov challenge model <NUMBER> however majority studies protective efficacy without lung immunopathology reported sarscov merscov vaccines <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> important note majority studies demonstrating cov vaccineinduced immunopathology utilized balbc mouse model known preferentially develop th<NUMBER>type responses dna vaccine platform induces th<NUMBER>type immune responses demonstrated efficacy without immunopathology models respiratory infection including sarscov <NUMBER> merscov <NUMBER> rsv <NUMBER> sarscov<NUMBER> animal challenge studies assess ino<NUMBER>mediated protection disease vaccineenhanced disease report functional neutralization ino<NUMBER> immune sera using sarscov<NUMBER> pseudovirus assay fig <NUMBER> table <NUMBER> prnt assay two wildtype sarscov<NUMBER> strains table <NUMBER> well show ino<NUMBER> induced antibodies block sarscov<NUMBER> spike binding host receptor ace<NUMBER> using surrogate neutralization assay fig <NUMBER> study highlights immunogenicity ino<NUMBER> animal studies test protection infection summary initial results describing immunogenicity covid<NUMBER> vaccine candidate ino<NUMBER> promising particularly encouraging measure functional antibodies cell responses multiple animal models study supports evaluation ino<NUMBER> vaccine candidate covid<NUMBER> cell lines hek<NUMBER>t atcc® crl<NUMBER>™ african green monkey kidney cos<NUMBER> atcc® crl<NUMBER>™ cell lines obtained atcc old town manassas va cell lines maintained dmem supplemented <NUMBER> fetal bovine serum fbs penicillinstreptomycin vitro rna expression qrtpcr vitro mrna expression plasmid demonstrated transfection cos<NUMBER> serially diluted plasmids followed analysis total rna extracted cells using reverse transcription pcr transfections four concentrations plasmid performed using fugene® <NUMBER> transfection reagent promega resulted final masses ranging <NUMBER> <NUMBER> ng per well transfections performed duplicate following <NUMBER> <NUMBER> h incubation cells lysed rlt buffer qiagen total rna isolated well using qiagen rneasy kit following kit instructions resulting rna concentration determined od <NUMBER> samples rna diluted <NUMBER> ng per µl one hundred nanograms rna converted cdna using high capacity cdna reverse transcription revt kit applied biosystems following kit instructions revt reactions containing rna reverse transcriptase minus rt included controls plasmid dna cellular genomic dna sample contamination eight microliters sample cdna subjected pcr using primers probes specific target sequence pgx<NUMBER> forward caggac aagaacacacaggaa pgx<NUMBER> reverse caggcaggatttgggagaaa pgx<NUMBER> probe acccatcaaggactttggagg pgx<NUMBER> forward aggacaagaacacacaggaag pgx<NUMBER> reverse caggatctggga gaagttgaag pgx<NUMBER> probe acaccacccatcaaggactttgga separate reaction quantity sample cdna subjected pcr using primers probe designed βactin forward gtgacgtggacatccgta aa βactin reverse cagggcagtaatctccttctg βactin probe tac cctggcattgctgacaggatg cos<NUMBER> cell line βactin sequences primers probes synthesized integrated dna technologies inc probes labeled <NUMBER>fam black hole quencher <NUMBER> reaction used abi fast advance <NUMBER>×cat <NUMBER> final forward reverse primer concentrations <NUMBER> µm probe concentrations <NUMBER> µm using quantstudio <NUMBER> flex real time pcr studio system applied biosystems samples first subjected hold <NUMBER> min <NUMBER>°c <NUMBER> cycles pcr cycle consisting <NUMBER> <NUMBER>°c <NUMBER> <NUMBER>°c following pcr amplifications results analyzed follows negative transfection controls minus revt controls ntc scrutinized respective indications threshold cycle c transfection concentration ino<NUMBER> covid<NUMBER> target mrna βactin mrna generated quantstudio software using automatic threshold setting plasmid considered active mrna expression expression plasmid transfected wells compared negative transfection controls greater <NUMBER> c vitro protein expression western blot human embryonic kidney cells <NUMBER>t cultured transfected described previously <NUMBER> <NUMBER>t cells transfected pdna using turbofectin<NUMBER> origene transfection reagent following manufacturers protocol fortyeight hours later cell lysates harvested using modified ripa cell lysis buffer proteins separated <NUMBER> bistris gel thermofisher scientific following transfer blots incubated antisarscov spike protein polyclonal antibody novus biologicals visualized horseradish peroxidase hrpconjugated antimouse igg ge amersham immunofluorescence transfected <NUMBER>t cells vitro staining spike protein expression <NUMBER>t cells cultured <NUMBER>well glass slides labtek transfected <NUMBER> µg per well pdna using turbofectin<NUMBER> origene transfection reagent following manufacturers protocol cells fixed <NUMBER> h transfection <NUMBER> neutralbuffered formalin bbc biochemical washington state <NUMBER> min rt washed pbs staining chamber slides blocked <NUMBER> vv tritonx sigma <NUMBER> vv donkey serum pbs <NUMBER> h rt cells stained rabbit antisarscov spike protein polyclonal antibody novus biologicals diluted <NUMBER> wv bsa sigma <NUMBER> vv donkey serum <NUMBER> vv tritonx sigma <NUMBER> vv <NUMBER> g ml −<NUMBER> sodium azide sigma pbs <NUMBER> h rt slides washed three times <NUMBER> min pbs stained donkey antirabbit igg af<NUMBER> lifetechnologies a<NUMBER> <NUMBER> h rt slides washed mounted covered dapifluoromount southernbiotech antigen binding elisa elisas performed determine sera antibody binding titers nunc elisa plates coated <NUMBER> µg ml −<NUMBER> recombinant protein antigens dulbeccos phosphatebuffered saline dpbs overnight <NUMBER>°c plates washed three times blocked <NUMBER> bovine serum albumin bsa dpbs <NUMBER> tween <NUMBER> <NUMBER> h <NUMBER>°c plates washed incubated serial dilutions mouse guinea pig sera incubated <NUMBER> h <NUMBER>°c plates washed incubated <NUMBER> dilution horse radish peroxidase hrp conjugated antiguinea pig igg secondary antibody sigmaaldrich cat a<NUMBER> hrp conjugated antimouse igg secondary antibody sigmaaldrich incubated <NUMBER> h rt final wash plates developed using sureblue tm tmb <NUMBER>component peroxidase substrate kpl cat <NUMBER> reaction stopped tmb stop solution kpl cat <NUMBER> plates read <NUMBER> nm wavelength within <NUMBER> min using synergy htx biotek instruments highland park vt binding antibody epts calculated previously described <NUMBER> binding antigens tested included sarscov<NUMBER> antigens s<NUMBER> spike protein sino biological <NUMBER>v<NUMBER>h s<NUMBER> s<NUMBER> ecd spike protein sino biological <NUMBER>v<NUMBER>b<NUMBER> rbd university texas austin mclellan lab sarscov antigens spike s<NUMBER> protein sino biological <NUMBER>v<NUMBER>b<NUMBER> <NUMBER> immune tech it<NUMBER>p spike cterminal meridian life science r<NUMBER> ace<NUMBER> competition elisa mouse studies elisas performed determine sera igg antibody competition human ace<NUMBER> human fc tag nunc elisa plates coated <NUMBER> µg ml −<NUMBER> rabbit antihis<NUMBER>x <NUMBER>× pbs <NUMBER> h rt washed four times washing buffer <NUMBER>× pbs <NUMBER> tween <NUMBER> plates blocked overnight <NUMBER>°c blocking buffer <NUMBER>× pbs <NUMBER> tween <NUMBER> <NUMBER> evaporated milk <NUMBER> fbs plates washed four times washing buffer incubated full length s<NUMBER> s<NUMBER> spike protein containing cterminal tag sino biologics cat <NUMBER>v<NUMBER>b<NUMBER> <NUMBER> µg ml −<NUMBER> <NUMBER> h rt plates washed serial dilutions purified mouse igg mixed <NUMBER> µg ml −<NUMBER> recombinant human ace<NUMBER> human fc tag ace<NUMBER>ighu incubated <NUMBER> h rt plates washed incubated <NUMBER> dilution hrp conjugated antihuman igg secondary antibody bethyl cat a<NUMBER>p incubated <NUMBER> h rt final wash plates developed using <NUMBER>step ultra tmbelisa substrate thermo cat <NUMBER> reaction stopped <NUMBER> sulfuric acid plates read <NUMBER> nm wavelength within <NUMBER> min using spectramax plus <NUMBER> microplate reader molecular devices sunnyvale ca competition curves plotted area curve auc calculated using prism <NUMBER> analysis software multiple ttests determine statistical significance guinea pig studies <NUMBER>well half area assay plates costar coated <NUMBER> µl per well <NUMBER> µg ml −<NUMBER> sarscov<NUMBER> spike s<NUMBER> s<NUMBER> protein sino biological diluted <NUMBER>× dpbs thermofisher overnight <NUMBER>°c plates washed <NUMBER>× pbs buffer <NUMBER> tween sigma hundred microliters per well <NUMBER> wv bsa sigma <NUMBER>× pbs <NUMBER> tween added incubated <NUMBER> h <NUMBER>°c serum samples diluted <NUMBER> <NUMBER> wv bsa <NUMBER>× pbs <NUMBER> tween washing assay plate <NUMBER> µlwell diluted serum added incubated <NUMBER> h <NUMBER>°c human recombinant ace<NUMBER>fctag sinobiological added directly diluted serum followed <NUMBER> h incubation <NUMBER>°c plates washed <NUMBER> µl per well <NUMBER> diluted goat antihu fc fragment antibody hrp bethyl a<NUMBER>p added assay plate plates incubated <NUMBER> h rt development surebluetmb stop solution kpl md used od recorded <NUMBER> nm sarscov<NUMBER> pseudovirus neutralization assay sarscov<NUMBER> pseudotyped viruses produced using hek<NUMBER>t cells transfected genejammer agilent using igesarscov<NUMBER> plasmid genscript pnl<NUMBER>lucreplasmid nih aids reagent <NUMBER> ratio fortyeight hours post transfection transfection supernatant collected enriched fbs <NUMBER> final volume sterifiltered millipore sigma aliquoted storage −<NUMBER>°c sarscov<NUMBER> pseudotyped viruses titered yielding <NUMBER> times relative luminescence units rlu cells alone <NUMBER> h infection mouse sera ino<NUMBER> vaccinated naive groups heat inactivated <NUMBER> min <NUMBER>°c serially diluted threefold starting <NUMBER> dilution assay sera incubated fixed amount sarscov<NUMBER> pseudotyped virus <NUMBER> min hek<NUMBER>t cells stably expressing ace<NUMBER> added <NUMBER> min allowed incubate standard incubator <NUMBER> humidity <NUMBER> co <NUMBER> <NUMBER> h post infection cells lysed using britelite plus luminescence reporter gene assay system perkin elmer catalog <NUMBER> rlu measured using biotek plate reader neutralization titers id <NUMBER> calculated serum dilution rlu reduced <NUMBER> compared rlu virus control wells subtraction background rlu cell control wells sarscov<NUMBER> wildtype virus neutralization assays sarscov<NUMBER>australia vic<NUMBER> isolate neutralization assays performed public health england porton uk neutralizing virus titers measured serum samples heatinactivated <NUMBER>°c <NUMBER> min sarscov<NUMBER> australiavic<NUMBER> isolate <NUMBER> diluted concentration <NUMBER> pfu ml −<NUMBER> mixed <NUMBER> <NUMBER> fcsmem containing <NUMBER> mm hepes buffer doubling serum dilutions <NUMBER> <NUMBER> <NUMBER>well vbottomed plate plate incubated <NUMBER>°c humidified box <NUMBER> h virus transferred wells twice dpbswashed <NUMBER>well plate seeded previous day <NUMBER> × <NUMBER> <NUMBER> vero e<NUMBER> cells per well <NUMBER> fcsmem virus allowed adsorb <NUMBER>°c hour overlaid plaque assay overlay media <NUMBER>× mem<NUMBER> cmc <NUMBER> fcs final <NUMBER> days incubation <NUMBER>°c humidified box plates fixed stained plaques counted median neutralizing titers nd<NUMBER> determined using spearmankarber formula relative virus control wells sarscov<NUMBER>wh<NUMBER>human<NUMBER> isolate neutralization assays performed institute laboratory animal science chinese academy medical sciences cams approved national health commission peoples republic china seed sarscov<NUMBER> sarscov<NUMBER>wh<NUMBER>human <NUMBER> stocks virus isolation studies performed vero e<NUMBER> cells maintained dulbeccos modified eagles medium dmem invitrogen carlsbad usa supplemented <NUMBER> fetal bovine serum fbs <NUMBER> iu ml −<NUMBER> penicillin <NUMBER> µg ml −<NUMBER> streptomycin incubated <NUMBER>°c <NUMBER> co <NUMBER> virus titer determined using standard <NUMBER> tissue culture infection dose tcid<NUMBER> assay serum samples collected immunized animals inactivated <NUMBER>°c <NUMBER> min serially diluted cell culture medium twofold steps diluted samples mixed virus suspension <NUMBER> tcid <NUMBER> <NUMBER>well plates ratio <NUMBER> followed <NUMBER> h incubation <NUMBER>°c <NUMBER> co <NUMBER> incubator <NUMBER> × <NUMBER> <NUMBER> vero cells added serumvirus mixture plates incubated <NUMBER> days <NUMBER>°c <NUMBER> co <NUMBER> incubator cytopathic effect cpe well recorded microscopes neutralizing titer calculated dilution number <NUMBER> protective condition bal collection bal fluid collected washing lungs euthanized exsanguinated mice <NUMBER> μl icecold pbs containing <NUMBER> μm edta <NUMBER> sodium azide <NUMBER> tween<NUMBER> <NUMBER>× protease inhibitor pierce mucosal prep solutions mps bluntended needle guinea pig lungs washed <NUMBER> ml mps via <NUMBER> g catheter inserted trachea collected bal fluid stored −<NUMBER>c time assay ifnγ elispot spleens mice collected individually rpmi<NUMBER> media supplemented <NUMBER> fbs r<NUMBER> penicillinstreptomycin processed single cell suspensions cell pellets resuspended <NUMBER> ml ack lysis buffer life technologies carlsbad ca <NUMBER> min rt pbs added stop reaction samples centrifuged <NUMBER> × g <NUMBER> min cell pellets resuspended r<NUMBER> passed <NUMBER> µm nylon filter use elispot assay elispot assays performed using mouse ifnγ elispot plus plates mabtech <NUMBER>well elispot plates precoated capture antibody blocked r<NUMBER> medium overnight <NUMBER>°c <NUMBER> mouse splenocytes plated well stimulated <NUMBER> h pools <NUMBER>mer peptides overlapping nine amino acid sarscov<NUMBER> sarscov merscov spike proteins five peptide pools per protein additionally matrix mapping performed using peptide pools matrix designed identify immunodominant responses cells stimulated final concentration <NUMBER> μl peptide per well rpmi <NUMBER> fbs r<NUMBER> spots developed based manufacturers instructions r<NUMBER> cell stimulation cocktails invitrogen used negative positive controls respectively spots scanned quantified immunospot ctl reader spotforming unit sfu per million cells calculated subtracting negative control wells flow cytometry intracellular cytokine staining performed splenocytes harvested balbc c<NUMBER>bl<NUMBER> mice stimulated overlapping peptides spanning sarscov<NUMBER> protein <NUMBER> h <NUMBER>°c <NUMBER> co <NUMBER> cells stained following antibodies bd biosciences unless stated dilutions stated parentheses fitc antimouse cd<NUMBER>a <NUMBER> percpcy<NUMBER> antimouse cd<NUMBER> <NUMBER> apc antimouse cd<NUMBER>a <NUMBER> vivid dye <NUMBER> livedead® fixable violet dead cell stain kit invitrogen l<NUMBER> apccy<NUMBER> antimouse cd<NUMBER>e <NUMBER> bv<NUMBER> antimouse ifnγ <NUMBER> ebiosciences phorbol myristate acetate pma used positive control complete medium negative control cells washed fixed cell events acquired using facs canto bd biosciences followed flowjo software flowjo llc ashland analysis structural modeling structural models sarscov merscov constructed pdb ids <NUMBER>acc <NUMBER>×<NUMBER> order assemble prefusion model three rbds conformation sarscov<NUMBER> structural model built using sarscov structure pdb id<NUMBER>acc template rosetta remodel simulations employed make appropriate amino acid mutations build de novo models sarscov<NUMBER> loops structurally defined sarscov structure <NUMBER> amino acid positions neighboring loops allowed change backbone conformation accommodate new loops structural figures made using pymol statistics statistical analyses performed using graphpad prism <NUMBER> <NUMBER> software la jolla ca data considered significant p <NUMBER> lines graphs represent mean value error bars represent standard deviation samples animals excluded analysis randomization performed animal studies samples animals blinded performing experiment reporting summary information research design available nature research reporting summary linked article postmortem pm confirmation infection mycobacterium bovis extensively studied cattle herds including presence pathology visible lesions culturing pathogen milne et al <NUMBER> shittu et al <NUMBER> murray et al <NUMBER> part bovine tuberculosis control programs postmortem data important confirming quality antemortem testing occurring large scale control programs oleapopelka et al <NUMBER> frankena et al <NUMBER> lahuertamarin et al <NUMBER> furthermore slaughterhouse surveillance data population level gives good independent indicator underlying trends infection time especially times changes application use type antemortem tests employed abernethy et al <NUMBER> et al <NUMBER> presence lesions used additional metric infection estimate performance antemortem tb tests used disclose infected cattle mccallan et al <NUMBER> karolemeas et al <NUMBER> lahuertamarin et al <NUMBER> possibly importantly pm surveillance discloses cases may otherwise missed via antemortem testing programs humphrey et al <NUMBER> garciasaenz et al <NUMBER> lahuertamarin et al <NUMBER> pascuallinaza et al <NUMBER> willeberg et al <NUMBER> animals confirmed lesions found routine slaughter lrs also known factory lesion cases result herd restrictions disease breakdowns significant impact farmers lesion found herds trading status immediately suspended lesions confirmed via laboratory means histology culture herds trading status move withdrawn normal trading cannot returned two clear tests achieved good et al <NUMBER> limited work assess variation followup testing following disclosure lesion antemortem test negative animal variation followup disclosure skin test positive animals see oleapopelka et al <NUMBER> important epidemiological policy disease control program perspective understand followup disclosure infection might vary across different herd enterprise types sizes policy changes could tailored differing contexts events use dataset herd breakdowns ireland <NUMBER> <NUMBER> explore variation risk followup skin test reactor disclosure herd breakdown initiated due finding lesion slaughter paper developed need rapid response changing resource laboratory capacity ireland extraordinary event pandemic covid<NUMBER> requirement laboratory capacity testing sarscov<NUMBER> virus causative agent covid<NUMBER> acute impact bovis confirmation rates reduced capacity direct effect policy restrictionsderestrictions therefore interim policy required based risk profile herdlevel work highlights timely epidemiological data analytics capacity heart government policy making help inform decision making extraordinary events data collated animal health computer system ahcs restructured line within dataset represented discrete breakdown bd event initiation test whether herd entered breakdown due presence lesion detected routine slaughter lrs derived bd herds flagged initiated factory slaughter case lrs retained denoted within dataset slaughter nonpermit animal antemortem testing data primarily reactor animals included animals removed part official test including standard reactors inconclusive reactors interferon gamma test positive animals also report descriptive statistics standard reactors modelled reactors attempt <NUMBER> improve relative animallevel sensitivity antemortem testing regime <NUMBER> understand better patterns measured field within irish program derived herd size based testing history herd within dataset see supplementary material herd size modelled continuous log n transformed categorical variable small ≤<NUMBER> medium <NUMBER> large <NUMBER> large <NUMBER> herd type derived ahcs flag four categoriesbeef dairy suckler herd types outcome binary response reactors disclosed yes modelled using logit distribution temporal trend analysis undertaken modelling time continuous linear predictor categorical variable year study separate logistic models multiple observations per herds obs per group min <NUMBER> avg <NUMBER> max <NUMBER> random effects models fitted data herd identifier univariable models fitted assess unadjusted associations dependent independent variables fully saturated multivariable model fitted data ie herd temporal factors fitted explanatory variables compared simpler models covariates removed using akaikes information criterion aic model lowest aic presented dataset <NUMBER> <NUMBER> breakdowns collated overall <NUMBER> breakdowns initiated slaughter nonpermit animal cases index tests breakdowns <NUMBER> revealed <NUMBER> reactor animals <NUMBER> <NUMBER> standard reactors <NUMBER> <NUMBER> significant decline probability herds disclosing reactors followup time fig <NUMBER> univariable logistic trend model using year single continuous predictor suggested significant decline <NUMBER> per year p <NUMBER> <NUMBER>ci <NUMBER> herd size associated reactor disclosure followup index tests relationship curvilinear herdsize modelled log n transform unadjusted <NUMBER> <NUMBER>ci <NUMBER> fig s<NUMBER> small herds <NUMBER> animals <NUMBER> index tests disclosed <NUMBER> reactors <NUMBER> index tests large herds <NUMBER> disclosed <NUMBER> reactors table <NUMBER> univariable logit model results presented table s<NUMBER> significant variation proportion index tests disclosed reactors amongst herd types univariable logit model table <NUMBER> s<NUMBER> beef <NUMBER> <NUMBER> herd production types lower proportion index test reactors comparison dairy <NUMBER> suckler <NUMBER> herds dairy <NUMBER> suckler <NUMBER> significantly higher risk beef disclosing reactors followup significantly lower risk relative beef <NUMBER> dairy significantly higher risk suckler herds posthoc wald test χ <NUMBER> df <NUMBER> <NUMBER> prob χ <NUMBER> <NUMBER> overall <NUMBER> <NUMBER> observations within dataset <NUMBER>year histories truncated recorded early dataset number herds <NUMBER> overall <NUMBER> observations <NUMBER> associated breakdown preceding <NUMBER> years <NUMBER> herds experienced breakdown preceding <NUMBER> years <NUMBER> historic breakdowns <NUMBER> <NUMBER> initiated disclosure ≥<NUMBER> reactor index test <NUMBER> <NUMBER> single reactor breakdowns table <NUMBER> shows breakdown herd history types respective proportion disclosing skin test reactors lrs followup <NUMBER> herds without breakdown within <NUMBER> years reactors lrs followup whereas <NUMBER> herds bd <NUMBER> reactors disclosed reactors lrs followup significant increase risk herd disclosing reactors experienced breakdown previous <NUMBER>year window univariable logit model χ <NUMBER> df <NUMBER> <NUMBER> prob χ <NUMBER> <NUMBER> primarily driven larger previous bds table s<NUMBER> significant difference disclosure reactors followup test herds without previous breakdown within <NUMBER> years disclosed single reactor breakdowns previous bd vs single reactor bd <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> herds breakdown previous <NUMBER> years n <NUMBER> relationship time since last breakdown skin test reactor disclosure risk lrs followup test unadjusted <NUMBER> p <NUMBER> vet res commun final multivariable model presented table <NUMBER> variables presented model retained explained variation outcome parsimonious models greater aic values beef aor <NUMBER> suckler aor <NUMBER> aor <NUMBER> herds significantly lower risk disclosing reactors followup relative dairy herds risk disclosing reactors followup increased increasing herd size fig <NUMBER> bovine tuberculosis remains priority statutory disease cattle herds ireland requires rapid evaluation data inform policy decisions <NUMBER> present study demonstrated characteristics herds associated additional reactors disclosed antemortem negative animal found postmortem evidence bovis infection postmortem surveillance characteristics herd size herd type btb history readily available within national databases allowing refinement followup policy resource attribution near real time risk disclosure additional antemortem test positive animals increased larger herds dairy suckler herds relative beef herds herds history infection three variables identified important risk factors btb generally herdlevel allen et al <NUMBER> skuce et al <NUMBER> also reported associated increased recurrence risk eg wolfe et al <NUMBER> karolemeas et al <NUMBER> prolonged breakdown length milne et al <NUMBER> doyle et al <NUMBER> recurrence herds may related environmental exposure buying trade behaviour biosecurity practices palisson et al <NUMBER> milne et al <NUMBER> may also suggest clearance infection previous breakdowns might robust oleapopelka et al <NUMBER> studied herds attested clear disclosed reactors discovery factory lesion ireland <NUMBER>years prior current study percentage herds disclosing standard reactor across study <NUMBER> present study suggested <NUMBER> herd disclosed ≥<NUMBER> standard reactors furthermore evidence present study percentage declined <NUMBER> <NUMBER> fig <NUMBER> demonstrates proportion declined approximately<NUMBER> tõ <NUMBER> present study confirmed previous finding beef herds significantly lower risk disclosing additional reactors postlrs relative dairy suckler herds oleapopelka et al <NUMBER> dairy herds significantly higher risk either suckler beef herds herdsize could related intensity agriculture undertaken within farm may correlate inward movement animals depending enterprise type oleapopelka et al <NUMBER> skuce et al <NUMBER> herd history previous <NUMBER>years important previous breakdowns large present study <NUMBER> reactors oleapopelka et al <NUMBER> found number years herd tested negative associated reactor disclosure lrs lesioned animal present herd last breakdown interestingly present study found herds experienced breakdown caused lrs zeroreactor breakdowns within <NUMBER>years lower risk herds remained tb clear previous <NUMBER>years may suggest herds could greater risk repeating lrs breakdowns lrs presence found risk factor breakdown recurrence doyle et al <NUMBER> though aware data suggests repeated lrs breakdowns could cluster within herds animal level lrs presence associated older cattle moved herds residing herds recent breakdowns eg <NUMBER> yrs lahuertamarin et al <NUMBER> clegg et al <NUMBER> herd level lrs disclosure associated higher risk herds experience long duration breakdowns buy animals situated high risk geographic regions shittu et al <NUMBER> milne et al <NUMBER> limitation study animal level data animal movements introductions used model outcome limits amount variation explained model however deemed acceptable primary purpose model inform followup risk limited number herdlevel characteristics could informative policy makers period unprecedented challengethe covid<NUMBER> outbreak ireland griffin et al <NUMBER> present study undertaken response rapidly changing policy environment capacity undertake postmortem confirmation surveillance impacted major event covid<NUMBER> pandemic negatively affected laboratory capacity study demonstrated rapid response via epidemiological assessment key parameters could inform emergency policy response authors contributions pb er conceived study awb pb er designed study jm constructed breakdownlevel dataset awb undertook statistical analyses input jm awb drafted paper contributions authors authors read approved final manuscript funding information specific funding associated work data availability datasets analysed current study available department agriculture food marine subject data protection regulations limitations httpswww agriculturegoviedataprotection covid<NUMBER> pandemic high mortality rate affecting practically entire world population leading cause death severe acute respiratory syndrome consequence exacerbated inflammatory response accompanied uncontrolled oxidative stress well inflammatory reaction lung level specific definitive treatment pathology worries world population especially older adults constitute main risk group context results particular interest evaluation efficacy existing pharmacological agents may used overcoming attenuating severity pulmonary complication ended lives many people worldwide vitamin melatonin could good options achieving aim taking account many shared underlying mechanisms able modulate control immune adequately oxidative response covid<NUMBER> infection possibly even synergistic interaction reninangiotensin system exaltation consequent inflammatory response leading role physiopathology covid<NUMBER> infection may downregulated vitamin melatonin many organs therefore also essential analyze potential therapeutic association relation ras part new approach facing lack specific treatment lethal covid<NUMBER> pandemic rapid advance taking account adequate immune response crucial overcome viral infection need arises explore pharmacological existing known agents reinforce enhance immune system activity physiopathology covid<NUMBER> infection main cause death patients infected virus consist exacerbated inflammation infiltration immune cells necrosis hyperplasia affected tissue especially lung level results impaired pulmonary oxygen exchange causing severe pneumonia <NUMBER> <NUMBER> <NUMBER> systemic alterations also observed mainly patients <NUMBER> years include disturbance normal plasma levels lymphocytes thrombocytes creactive protein lactate dehydrogenase enzyme <NUMBER> particular interest older adults higher risk death <NUMBER> angiotensin ii plasma levels found significantly elevated infected patients directly proportional viral load lung damage observed <NUMBER> hence close connections covid<NUMBER> reninangiotensin system ras shown covid<NUMBER> binds angiotensinconverting enzyme <NUMBER> receptors ace<NUMBER>r invade human lung epithelial cells initiate infection time ace<NUMBER> produces antiinflammatory antioxidant antifibrotic antihyperplasia effects since cause degradation angiotensin ii ang ii lung level ace<NUMBER>ang<NUMBER>mas receptor signaling pathway counterregulatory ras axis actions opposite classical ras axis aceang iiat <NUMBER> receptor pathway increase degradation ang ii prevents toxic overaccumulation httpsdoiorg<NUMBER>jlfs<NUMBER> received <NUMBER> april <NUMBER> received revised form <NUMBER> may <NUMBER> accepted <NUMBER> may <NUMBER> would provoke acute respiratory distress syndrome often present covid<NUMBER> infection therefore ace<NUMBER> antagonistic dual action viral infection also expression ace<NUMBER> lower males females also lower older adults young people could influence susceptibility elderly males death covid<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> highlight group patients worse prognosis associated addition elderly condition comorbidities cardiovascular diseases diabetes hypertension obesity stimulated ras also reported ras involved regulation proliferation inflammation fibrosis lung tissues several pulmonary pathologies independently covid<NUMBER> infection acute lung injury asthma pulmonary arterial hypertension chronic obstructive pulmonary disease idiopathic pulmonary fibrosis among others <NUMBER> context known vitamin metabolites enhance immunity great variety respiratory pathogens vitro moreover many clinical trials demonstrated strong association vitamin deficiency increased risk developing respiratory infections supplementation reduces events related respiratory tract infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical trial results showed vitamin supplementation markedly reduces rate moderate severe chronic obstructive pulmonary cop disease exacerbations patients basal <NUMBER>hydroxyvitamin levels lower <NUMBER> nmoll patients higher levels <NUMBER> observed vitamin decreases risk respiratory tract infections three main mechanisms maintenance tight junctions prevent infiltration immune cells lungs respiratory tissues kill viruses stimulation antiviral mechanisms reduction synthesis proinflammatory cytokines modulation immune system avoiding development pneumonia <NUMBER> sense known vitamin metabolites modulate secretion expression several chemokines proinflammatory cytokines type <NUMBER> interferon ifn<NUMBER> cxcl<NUMBER> cxcl<NUMBER> tnfalfa il<NUMBER> different viral infections <NUMBER> antiviral effects vitamin modulation immune system also recently suggested fact vitamin deficiency may associated higher risk getting influenza respiratory viral infections dengue hepatitis herpesvirus even human immunodeficiency virus hiv infection cell culture studies vitamin antiviral efficacy especially facing enveloped viruses therefore would effective covid<NUMBER> although antiviral mechanisms vitamin completely established may related ability vitamin upregulate antimicrobial peptides human betadefensin <NUMBER> ll<NUMBER> cathelicidin <NUMBER> <NUMBER> also evidence shows melatonin influences directly indirectly immune system state <NUMBER> simultaneously melatonin also suggested antiviral hormone effects exerted different mechanisms related melatonins antioxidation immunomodulation antiinflammation actions <NUMBER> recent study proposed use melatonin treatment covid<NUMBER> using repurposed drugs represents attractive drug strategy using currently available drugs would reduce time costs comparison de novo drug development antioxidant properties melatonin would make appropriate candidate drug relieve clinical symptoms patients infected covid<NUMBER> although melatonin cannot interrupt replication transcription virus administration melatonin may prolong survival time infected patients indicates possibility immune system patients recovers due elimination virus since melatonin indirectly targets several human coronavirus cellular vital points ace<NUMBER> bcl<NUMBER>l<NUMBER> jun inhibitor nuclear factor kappa b kinase subunit beta ikbkb <NUMBER> melatonin also demonstrated antioxidant antiinflammatory effects mice infected respiratory syncytial virus reduced levels tnfalfa significantly nitric oxide malondialdehyde mda hydroxyl radical oh whereas increased glutathione peroxidase gsh superoxide dismutase sod activity therefore melatonin reversed altered inflammatory oxidative parameters respiratory viral infection suggests also may useful treatment covid<NUMBER> infection <NUMBER> additionally another study suggested use melatonin management covid<NUMBER> infection also highlighted high safety profile hormone encourages even clinical application <NUMBER> also known advancing age causes decline immunity also melatonin endogenous vitamin production therefore could also explain greater susceptibility older adults death covid<NUMBER> infection <NUMBER> could also hypothesized lower infection rate older women undergoing treatments bone diseases incorporate vitamin supplements although scientific evidence supports evidence supports beneficial effects vitamin melatonin helpful lung pathologies pulmonary infection covid<NUMBER> also exacerbated inflammation oxidation similar pathophysiologic mechanisms information suggests using analyzing natural compounds well possible synergism overcome pandemic affects many people around world searching definitive treatment vaccine continues additionally essential assess potential relationship compounds reninangiotensin system mechanism cell entry covid<NUMBER> establish potential treatments avoid first step viral infection suggested deficiency vitamin usually associated hyper responsiveness airways impaired pulmonary functions worse control asthma perhaps resistance steroids pulmonary epithelial cells high expression <NUMBER> alphahydroxylase level allows local synthesis <NUMBER>α <NUMBER>dihydroxy vitamin active form vitamin also called calcitriol lungs calcitriol inhibits production secretion many cytokines bronchial smooth muscle cells growth factor derived platelets rantes regulated activation normal cell expressed secreted matrix metalloproteinases leads reduction smooth muscle cell proliferation lung inflammation moreover vitamin stimulates synthesis interleukin <NUMBER> cd<NUMBER>cd<NUMBER>foxp<NUMBER> tregulatory cells dendritic cells time vitamin inhibits activation dendritic cells downregulating expression cd<NUMBER> cd<NUMBER> costimulatory molecules stimulates expression many antiinfective molecules <NUMBER> <NUMBER> <NUMBER>α <NUMBER>dihydroxy vitamin supplementation suppresses recruitment eosinophil lymphocyte airways decreases il<NUMBER> production cells inhibits migration cells attenuating inflammatory response <NUMBER> vitamin may also useful adjuvant therapies allergen immunotherapy whose beneficial effects improved simultaneous <NUMBER> <NUMBER>dihydroxy vitamin administration mouse model asthma <NUMBER> vitamin dexamethasone treatment administration cultured cd<NUMBER>þ regulatory cells steroidresistant asthmatic patients increased synthesis il<NUMBER> levels similar found steroidsensitive patients treated dexamethasone <NUMBER> similar vitro model steroid resistance observed vitamin caused inhibition cell proliferation dexamethasone alone could suppress cell proliferation <NUMBER> high serum levels ige eotaxin found asthmatic rat model also significantly reduced treatment vitamin <NUMBER> asthmatic mice vitamin treatment also decreased infiltration inflammatory cells airways serum levels il<NUMBER> tumor necrosis factor tnf α il <NUMBER>β expression bcl <NUMBER>associated x apoptotic protein caspase <NUMBER> casp<NUMBER> high mobility group vm martín giménez et al life sciences <NUMBER> <NUMBER> <NUMBER> box <NUMBER> protein hmgb<NUMBER> tlr<NUMBER> nf κb phosphorylated nf κb p<NUMBER> likewise vitamin elevated il<NUMBER> serum levels reducing inflammatory apoptotic response mice <NUMBER> human bronchial epithelial cells exposed pollutant particulate matter vitamin suppressed synthesis <NUMBER>isoprostane <NUMBER>iso il<NUMBER> granulocytemacrophage colonystimulating factorstimulated pollutant agent vitamin caused rise expression g<NUMBER>pd antioxidant pathway gene levels oxidized glutathione suggest vitamin protect lungs airways asthmatic pathology antiinflammatory antioxidant effects facing air pollutant exposure <NUMBER> murine model pulmonary inflammation induced bleomycin calcitriol reduced early lung inflammation attenuating immune cell infiltration repressing pulmonary inflammatory cytokines secretion blocking nuclear translocation nuclear factor kappa b nfκb p<NUMBER> inhibiting phosphorylation pulmonary p<NUMBER> mapk protein kinase b akt attenuating αsmooth muscle actin marker epithelialmesenchymal transition lungs promotes fibrosis decreased transforming growth factorbeta <NUMBER> tgfβ<NUMBER> upregulated smad phosphorylation <NUMBER> calcitriol also caused reduction approximately <NUMBER> neutrophil recruitment lungs animal model acute lung injury considerably inhibiting pathological condition antiinflammatory effect vitamin may mediated inhibition il<NUMBER> secretion lung level <NUMBER> administration vitamin neonatal rats lung injury induced hyperoxia model bronchopulmonary dysplasia caused attenuation lesion via several protective actions preserving pulmonary structure integrity decreasing inflammation downregulating tlr<NUMBER> activation reducing deposition extracellular matrix inhibiting lung cell apoptosis <NUMBER> vitamin also shown immunomodulatory antiinflammatory effects treatment airway cystic fibrosis since reduced expression cd<NUMBER> pd<NUMBER> cd<NUMBER> cd<NUMBER> cells moreover vitamin decreased frequency cd<NUMBER> mucosalassociated invariant cells coexpress cd<NUMBER> activation markers human leucocyte antigen drelated therefore vitamin treatment would prevent lung damage progression associated airway cystic fibrosis <NUMBER> oxidative stress causes tobacco smoke worsens progression chronic obstructive pulmonary disease sense vitamin also proposed natural antiinflammatory antioxidant able improve prognosis lung pathology smoking patients <NUMBER> fact observed patients chronic obstructive pulmonary disease lower plasma levels vitamin healthy patients suggesting possible correlation deficient antioxidant defense development pulmonary disease <NUMBER> central interest revision years ago group raised discussion world pandemic vitamin deficiency possible explanation cellular inflammatory response activity rasinduced <NUMBER> original discussion involved significant number pathologies mainly cardiovascularbut similar inflammatory basis present central focus acute pulmonary inflammation caused covid<NUMBER> irish longitudinal study ageing tilda <NUMBER> reinforces idea adequate supplementation vitamin especially older people may beneficial vulnerable population groups covid<NUMBER> pandemic outbreak <NUMBER> graphical abstract therapeutic potential melatonin respiratory system level mediated among mechanisms blockade nuclear factorκappa beta nfκβ overexpress cfos downregulate matrix metalloproteinases<NUMBER> mmp<NUMBER> modulates profibrotic proinflammatory cytokines <NUMBER> moreover protective role melatonin pulmonary hypertension due antioxidant antifibrotic vasodilator properties <NUMBER> also suggested pretreatment melatonin murine model asthma reduces accumulation collagen airways possibly inhibition matrix metalloproteinase<NUMBER> modulates tissue remodeling therefore melatonin would expected exert antiinflammatory effect level airway <NUMBER> melatonin also useful protection pulmonary tissue acute lung injury rats due ability eliminate free radicals block activation nfkappa b <NUMBER> <NUMBER>hydroxy<NUMBER>′isobutylstreptochlorin novel derivative melatonin enhanced antiinflammatory properties inhibits penetration immune cells lung secretion proinflammatory cytokines tnfα il<NUMBER> murine model acute lung injury antiinflammatory effects mediated modulation signaling pathwaydependent interferonβ tolllike receptors moreover inhibited secretion il<NUMBER>β blocking activation nlrp<NUMBER> inflammasome independent mitochondrial production reactive oxygen species <NUMBER> lung surfactant lipid peroxidation induced production oxygen radicals stimulated phagocytes responsible development progression acute lung injury sense melatonin alone combined antioxidants markedly reduced lipid peroxidation pulmonary surfactant <NUMBER> intratracheal administration melatonin provoked marked reduction lung lesions recruitment neutrophils macrophages lungs acute pulmonary injury furthermore melatonin inhibited nlrp<NUMBER> inflammasome activation suppression extracellular histone release <NUMBER> suggested melatonin inhibits pulmonary fibrosis animal models decrease migration fibroblasts consequence reduction activity chloride channels mediated protein kinase c <NUMBER> animal model pulmonary fibrosis induced bleomycin melatonin provoked significant reduction edema lesions lung level likewise melatonin treatment lowered expression cyclooxygenase <NUMBER> produces eicosanoids whose role crucial development pulmonary fibrosis besides melatonin caused decrease interstitial tissue percentage volume increase alveolar space percentage volume <NUMBER> melatonin attenuated pneumonitis lung fibrosis caused radiation exposure decrease inflammatory cell infiltration collagen deposition edema vascular alveolar thickening lungs <NUMBER> idiopathic pulmonary fibrosis causes progressive loss pulmonary function due tissue cicatrization interesting reported melatonin metabolites modulate many proinflammatory profibrogenic signaling pathways involved pathophysiology pulmonary fibrosis transforming growth factor β wntβ catenin interleukin <NUMBER>a vascular endothelial growth factor fibroblast growth factors plateletderived growth factor reninangiotensin system endothelin <NUMBER> impaired caveolin <NUMBER> function causing protective effects lungs <NUMBER> removing free radicals melatonin may adequately modulate autophagy pathways apoptosis key mechanism development idiopathic pulmonary fibrosis <NUMBER> additionally utilization melatonin treatment animals induced hepatopulmonary syndrome effective reduction lung fibrosis levels vasodilation oxidative stress <NUMBER> melatonin also ameliorates pulmonary lesions associated inflammation oxidative stress caused nitrogen mustard rodents since acts powerful antioxidant eliminates reactive nitrogen oxygen species potent antiinflammatory agent <NUMBER> <NUMBER> <NUMBER> pretreatment melatonin combined quercetin rats hypoxiainduced sodium nitrite considerably reduced plasma levels il<NUMBER> tnfα crp heat shock protein <NUMBER> extracellular hsp<NUMBER>e vegf additionally melatonin enhanced histopathological changes lungs animals also suggesting powerful protective effects melatonin pulmonary level <NUMBER> melatonin potent pulmonary protective effect rats lung injury induced phosgene protective mechanism associated elimination free radicals inhibition p<NUMBER> mapk activation inos expression <NUMBER> pretreatment melatonin effective reducing lung damage patients subjected chemotherapy melatonin cyclophosphamide decrease lipid peroxidation restoring glutathione levels superoxide dismutasecatalase activities furthermore mentioned association could reduce typical histological abnormalities lungs patients chemotherapy <NUMBER> melatonin also inhibited expression hypoxiainducible factor<NUMBER>α hif<NUMBER>α proliferating cell nuclear antigen pcna nuclear factorκb nfκb murine model hypoxic pulmonary hypertension molecule also suppressed proliferation pulmonary artery smooth muscle cells concentrations phosphorylated akt kinases <NUMBER> modulated extracellular signal provoked hypoxia vitro model results also suggest significant antiproliferative antiinflammatory effects melatonin pulmonary level <NUMBER> postnatal administration melatonin reduced pathological vascular remodeling cardiovascular response hypoxia neonatal lambs pulmonary hypertension hand melatonin increased angiogenesis animals effects enhance pulmonary vascular function structure neonatal period conditions chronic hypoxia <NUMBER> <NUMBER> melatonin also markedly inhibited pulmonary injury induced hepatic ischemiareperfusion rats antiinflammatory properties achieved reduction apoptosis lung cells blocking jnk p<NUMBER> nfƙb activation stimulating nrf<NUMBER> activation <NUMBER> mice induced lung ischemiareperfusion melatonin pretreatment achieved reduction damage lung parenchymal decrease expression inflammatory markers interleukin<NUMBER>β tnfα ikkγ apoptotic markers baxbcl<NUMBER> cleaved casp<NUMBER> tunel positive cells also inhibited addition melatonin pretreatment increased expression activity cellular antioxidant systems superoxide dismutase glutathione peroxidase glutathione reductase <NUMBER> animal model neurogenic pulmonary edema melatonin attenuated dysfunction alveolarcapillary barrier inhibiting disruption tight junction proteins zo<NUMBER> occludin furthermore caused downregulation myeloperoxidase interleukin il <NUMBER>β well provoked inhibition activation matrix metallopeptidase <NUMBER> addition melatonin treatment considerably decreased casp<NUMBER> activity number positive lung cells tunel assay therefore melatonin treatment enhanced prognosis neurogenic pulmonary edema due antiinflammatory antiapoptotic effects <NUMBER> melatonin also exerted antiinflammatory antioxidant antiapoptotic effects murine model lung aging significantly reducing expression apoptosis markers bax bad aif inflammatory markers il<NUMBER>β tnfα ho<NUMBER> nfκb<NUMBER> oxidative damage rna measured production <NUMBER>hydroxyguanosine <NUMBER> well documented melatonin prevents chronic obstructive pulmonary disease attenuating nlrp<NUMBER> inflammasome il<NUMBER>β responsible inflammation airways pathology additionally melatonin caused increase silent information regulator <NUMBER> sirt<NUMBER> expression mediates mentioned antiinflammatory effect additional protective mechanisms attenuation apoptosis endoplasmic reticulum stress <NUMBER> <NUMBER> melatonin caused decrease oxidative stress inflammation airways lungs reduced chronic cough induced particulate matter <NUMBER> μm pig model <NUMBER> additionally demonstrated environmental pollution form particulate matter <NUMBER> μm stimulated melatonin synthesis lung level order protect lung tissues damage provoked inhalation polluted air <NUMBER> administration ramelteon agonist melatonin receptor animal model lung injury induced ventilation notably decreased pulmonary edema malondialdehyde concentrations levels proinflammatory cytokines activation nfκb expression inos apoptosis lung cells moreover ramelteon treatment markedly elevated expression intracellular protective heat shock protein <NUMBER> hsp<NUMBER>i lung cells levels antiinflammatory cytokine il<NUMBER> bronchoalveolar lavage fluid results suggest protective effects melatonin lung disease mainly mediated melatonin receptor <NUMBER> documented exposure nicotine pregnant rats caused significant changes lungs offspring structural biochemical level regard melatonin treatment reduced altered parameters lowering number alveolar macrophages mast cells well levels malondialdehyde <NUMBER> melatonin also significantly reduced oxidative stress injury lungs exposed radiation suppression infiltration neutrophils cd<NUMBER>bly<NUMBER>g macrophages cd<NUMBER>bcd<NUMBER>c downregulation nlrp<NUMBER> inflammasome macrophages accompanied reduction release il<NUMBER>β activity caspase<NUMBER> casp<NUMBER> upregulation mir<NUMBER>e levels <NUMBER> melatonin treatment decreased lung injury rats exposed chromium upregulating sirt<NUMBER> promotes deacetylation transcriptional coactivator peroxisome proliferatoractivated receptorγ coactivator<NUMBER>α pgc<NUMBER>α time caused rise expression crucial antioxidant target genes transcription factor nuclear factor erythroid <NUMBER>related factor <NUMBER> nrf<NUMBER> findings indicate melatonin exerts antiinflammatory antioxidant antiapoptosis effects attenuation lung injury provoked chromium exposure sirt<NUMBER>pgc<NUMBER>αnrf<NUMBER> signaling pathway <NUMBER> also determined melatonin able mitigate lung damage induced carbon tetrachloride elimination free radicals increase antioxidant ability pulmonary tissues induction effective antiinflammatory response <NUMBER> melatonin also reduced increased levels malondialdehyde myeloperoxidase pulmonary tissue diabetic rats moreover attenuated bronchial hyperplasia reduced cleavedcaspase <NUMBER> expression significantly increased animals <NUMBER> graphical abstract special interest clinical trial use melatonin prophylaxis covid<NUMBER> infection among healthcare workers carrying clinicaltrialsgov identifier nct<NUMBER> moreover many human trials demonstrated efficacy melatonin reduction elevated levels circulating cytokines multiple inflammatory pathologies suggesting melatonin would also useful treatment covid<NUMBER> infection decreasing plasma levels proinflammatory cytokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore clinical trials showed melatonin effective chronic obstructive pulmonary disease <NUMBER> multiple newborn diseases associated increased oxidative stress lung levels many organs due important antioxidative properties <NUMBER> known strong interaction melatonin ras <NUMBER> <NUMBER> regard melatonin treatment caused reduction at<NUMBER> expression normalized ang ii levels model renal disease <NUMBER> also known local pineal ras modulates synthesis melatonin regard indicated ang ii acts at<NUMBER> receptors located pineal gland cells regulate expression activity tryptophan hydroxylase enzyme involved synthesis melatonin also demonstrated antioxidant antiinflammatory antiapoptosis effects melatonin opposite ang ii <NUMBER> reported patients chronic renal disease secrete lower nocturnal melatonin concentrations healthy patients altered secretion may related increased nocturnal intrarenal ras activation kidney damage patients renal disease fact reinforces existence close antagonistic interaction ras melatonin <NUMBER> regard known reactive oxygen species crucial activation intrarenal ras also shown antioxidant treatment melatonin ameliorates intrarenal ras overactivation renal injury <NUMBER> nephrectomized rat model chronic kidney disease <NUMBER> <NUMBER> despite lack studies specifically show relationship melatonin ras lung level existing evidence relationship organs kidney suggests possibility similar behavior respiratory level concerning vitamin dras interaction participation ace<NUMBER> ang<NUMBER>masr signaling pathway neuroprotective effects vitamin brain recently demonstrated hypertensive rats <NUMBER> found vitamin acts cofactor attenuation incident atrial fibrillation raas inhibition <NUMBER> furthermore reestablishment normal vitamin levels patients hypovitaminosis provokes blockade peripheral ras <NUMBER> exacerbated activation ras hepatic level causes liver dysfunction increases risk developing diabetes mellitus sense found calcitriol modulates altered upregulation liver ras conditions insulin resistance <NUMBER> vitamin potent suppressor renin production thus low plasma levels vitamin associated increase synthesis renin results overactivation ras increased production ang ii vice versa <NUMBER> <NUMBER> demonstrated vitamin deficiency also results overexpression angiotensinconverting enzymes ace ace<NUMBER> <NUMBER> also observed vitamin receptornull mice develop serious induced acute lung injury wildtype mice increased levels pulmonary ang ii renin pretreatment vitamin receptornull mice losartan reduced severity pulmonary injury indicating vitamin via receptors attenuates acute lung injury blocking ras <NUMBER> moreover vitamin deficiency chronic uncontrolled ras overactivation extended periods may induce pulmonary fibrosis exacerbated accelerated increase extracellular matrix deposition lung tissues <NUMBER> graphical abstract combined supplementation vitamin melatonin could offer attractive synergistic alternative prevention treatment pulmonary infection covid<NUMBER> molecules modulate signaling pathways relate antiinflammatory immunomodulatory antioxidant antifibrotic well antiapoptotic effects many tissues special focus lung level natural compounds highly safe clinical use many shared underlying mechanisms allow exert potentiating actions aimed strengthening immune system preparing body overcome severe pathological consequences covid<NUMBER> infection infection reduce high mortality rate exist many therapeutic objectives evaluating efficacy vitamin melatonin prevention treatment covid<NUMBER> infection however ras ends bottleneck central signaling pathway constitutes common meeting point triad ras stimulation consecutive inflammatory storm favors infection evolution outcome complex new pathologic entity previously suggested global deficiency vitamin result among others cultural changes could respond mechanistically least part higher inflammatory processes consequence lack brake vitamin exerts typically ras system healthy conditions <NUMBER> perspective would interest carry clinical trials evaluate therapeutic utility vitamin dmelatonin combination healthy patients infected covid<NUMBER> compare effects joint administration versus individual administration regard would specially interesting adequately define melatonin vitamin supplementation regime used taking account group individual features patients participate studies since considering aspects may lead obtain heterogeneous controversial results could affect general applicability <NUMBER> however central focus acute lung inflammation caused covid<NUMBER> longitudinal study suggest adequate vitamin levels vulnerable groups pandemic outbreak covid<NUMBER> <NUMBER> last findings showed degree protection infections increases vitamin levels increase relationship allowed establishing adequate cut level yet still observational study reported <NUMBER> ngml appropriate values decrease risk acute viral respiratory infections <NUMBER> hand authors suggest maintaining serum vitamin level least <NUMBER> ngml even maintaining range <NUMBER> <NUMBER> ngml reduce infectious processes moreover recently dr alipio provided substantial information physicians health policymakers specifically concluded vitamin supplementation improves clinical course patients infected covid<NUMBER> based increased probability mild result serum level vitamin increases serum decrease vitamin associated worse clinical evolution <NUMBER> recommendation reinforced grant colleagues suggested vitamin supplementation could reduce risk covid<NUMBER> infection <NUMBER> also rhodes collaborators proposed vitamin supplementation least northern hemisphere higher risk severe illness death <NUMBER> recommended united kingdom association dietitians <NUMBER> editorials international scientific rigors finally although controversies regarding effectiveness vitamin melatonin clinical studies contradictions consequence experimental designs many errors latest findings better designsbegin show robust evidence benefits melatonin one hand vitamin would complicit endogenous physiological responders exogenous drugs therapeutics treatment could alleviate pathological process even infection develops work supported grants research technology council cuyo university secyt mendoza argentina anpcyt foncyt awarded walter manucha grant pict <NUMBER> authors declared potential conflicts interest respect research authorship andor publication article j u r n l p r e p r f <NUMBER> respiratory pathogens vitro moreover many clinical trials demonstrated strong association vitamin deficiency increased risk developing respiratory infections supplementation reduces events related respiratory tract infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical trial results showed vitamin supplementation markedly reduces rate moderate severe chronic obstructive pulmonary cop disease exacerbations patients basal <NUMBER>hydroxyvitamin levels lower <NUMBER> nmoll patients higher levels <NUMBER> observed vitamin decreases risk respiratory tract infections three main mechanisms maintenance tight junctions prevent infiltration immune cells lungs respiratory tissues kill viruses stimulation antiviral mechanisms reduction synthesis proinflammatory cytokines modulation immune system avoiding development pneumonia <NUMBER> sense known vitamin metabolites modulate secretion expression several chemokines proinflammatory cytokines type <NUMBER> interferon ifn<NUMBER> cxcl<NUMBER> cxcl<NUMBER> tnfalfa il<NUMBER> different viral infections <NUMBER> antiviral effects vitamin modulation immune system also recently suggested fact vitamin deficiency may associated higher risk getting influenza respiratory viral infections dengue hepatitis herpesvirus even human immunodeficiency virus hiv infection cell culture studies vitamin antiviral efficacy especially facing enveloped viruses therefore would effective covid<NUMBER> although antiviral mechanisms vitamin completely established may related ability vitamin upregulate antimicrobial peptides human betadefensin <NUMBER> ll<NUMBER> cathelicidin <NUMBER> <NUMBER> also evidence shows melatonin influences directly indirectly immune system state <NUMBER> simultaneously melatonin also suggested antiviral hormone effects exerted different mechanisms related melatonins antioxidation immunomodulation antiinflammation actions <NUMBER> recent study proposed use melatonin treatment covid<NUMBER> using repurposed drugs represents attractive drug strategy using currently available drugs would reduce time costs comparison de novo drug development antioxidant properties melatonin would make appropriate candidate drug relieve clinical symptoms patients infected covid<NUMBER> although melatonin cannot interrupt replication transcription virus administration melatonin may prolong survival time infected patients indicates possibility immune system patients recovers due elimination virus since melatonin indirectly targets several human coronavirus cellular vital points journal preproof j u r n l p r e p r f <NUMBER> ace<NUMBER> bcl<NUMBER>l<NUMBER> jun inhibitor nuclear factor kappa b kinase subunit beta ikbkb <NUMBER> melatonin also demonstrated antioxidant antiinflammatory effects mice infected respiratory syncytial virus reduced levels tnfalfa significantly nitric oxide malondialdehyde mda hydroxyl radical oh whereas increased glutathione peroxidase gsh superoxide dismutase sod activity therefore melatonin reversed altered inflammatory oxidative parameters respiratory viral infection suggests also may useful treatment covid<NUMBER> infection <NUMBER> additionally another study suggested use melatonin management covid<NUMBER> infection also highlighted high safety profile hormone encourages even clinical application <NUMBER> also known advancing age causes decline immunity also melatonin endogenous vitamin production therefore could also explain greater susceptibility older adults death covid<NUMBER> infection <NUMBER> could also hypothesized lower infection rate older women undergoing treatments bone diseases incorporate vitamin supplements although scientific evidence supports evidence supports beneficial effects vitamin melatonin helpful lung pathologies pulmonary infection covid<NUMBER> also exacerbated inflammation oxidation similar pathophysiologic mechanisms information suggests using analyzing natural compounds well possible synergism overcome pandemic affects many people around world searching definitive treatment vaccine continues additionally essential assess potential relationship compounds reninangiotensin system mechanism cell entry covid<NUMBER> establish potential treatments avoid first step viral infection j u r n l p r e p r f <NUMBER> regulated activation normal cell expressed secreted matrix metalloproteinases leads reduction smooth muscle cell proliferation lung inflammation moreover vitamin stimulates synthesis interleukin <NUMBER> cd<NUMBER>cd<NUMBER>foxp<NUMBER> tregulatory cells dendritic cells time vitamin inhibits activation dendritic cells downregulating expression cd<NUMBER> cd<NUMBER> costimulatory molecules stimulates expression many antiinfective molecules <NUMBER> <NUMBER> <NUMBER>α <NUMBER>dihydroxy vitamin supplementation suppresses recruitment eosinophil lymphocyte airways decreases il<NUMBER> production cells inhibits migration cells attenuating inflammatory response <NUMBER> vitamin may also useful adjuvant therapies allergen immunotherapy whose beneficial effects improved simultaneous <NUMBER> <NUMBER>dihydroxy vitamin administration mouse model asthma <NUMBER> vitamin dexamethasone treatment administration cultured cd<NUMBER>þ regulatory cells steroidresistant asthmatic patients increased synthesis il<NUMBER> levels similar found steroidsensitive patients treated dexamethasone <NUMBER> similar vitro model steroid resistance observed vitamin caused inhibition cell proliferation dexamethasone alone could suppress cell proliferation <NUMBER> high serum levels ige eotaxin found asthmatic rat model also significantly reduced treatment vitamin <NUMBER> asthmatic mice vitamin treatment also decreased infiltration inflammatory cells airways serum levels il<NUMBER> tumor necrosis factor tnf α il <NUMBER>β expression bcl <NUMBER>associated x apoptotic protein caspase <NUMBER> casp<NUMBER> high mobility group box <NUMBER> protein hmgb<NUMBER> tlr<NUMBER> nf κb phosphorylated nf κb p<NUMBER> likewise vitamin elevated il<NUMBER> serum levels reducing inflammatory apoptotic response mice <NUMBER> human bronchial epithelial cells exposed pollutant particulate matter vitamin suppressed synthesis <NUMBER>isoprostane <NUMBER>iso il<NUMBER> granulocytemacrophage colonystimulating factorstimulated pollutant agent vitamin caused rise expression g<NUMBER>pd antioxidant pathway gene levels oxidized glutathione suggest vitamin protect lungs airways asthmatic pathology antiinflammatory antioxidant effects facing air pollutant exposure <NUMBER> murine model pulmonary inflammation induced bleomycin calcitriol reduced early lung inflammation attenuating immune cell infiltration repressing pulmonary inflammatory cytokines secretion blocking nuclear translocation nuclear factor kappa b nfκb p<NUMBER> inhibiting phosphorylation pulmonary p<NUMBER> mapk protein kinase b akt attenuating αsmooth muscle actin marker epithelialmesenchymal transition lungs promotes j u r n l p r e p r f <NUMBER> fibrosis decreased transforming growth factorbeta <NUMBER> tgfβ<NUMBER> upregulated smad phosphorylation <NUMBER> calcitriol also caused reduction approximately <NUMBER> neutrophil recruitment lungs animal model acute lung injury considerably inhibiting pathological condition antiinflammatory effect vitamin may mediated inhibition il<NUMBER> secretion lung level <NUMBER> administration vitamin neonatal rats lung injury induced hyperoxia model bronchopulmonary dysplasia caused attenuation lesion via several protective actions preserving pulmonary structure integrity decreasing inflammation downregulating tlr<NUMBER> activation reducing deposition extracellular matrix inhibiting lung cell apoptosis <NUMBER> vitamin also shown immunomodulatory antiinflammatory effects treatment airway cystic fibrosis since reduced expression cd<NUMBER> pd<NUMBER> cd<NUMBER> cd<NUMBER> cells moreover vitamin decreased frequency cd<NUMBER> mucosalassociated invariant cells coexpress cd<NUMBER> activation markers human leucocyte antigen drelated therefore vitamin treatment would prevent lung damage progression associated airway cystic fibrosis <NUMBER> oxidative stress causes tobacco smoke worsens progression chronic obstructive pulmonary disease sense vitamin also proposed natural antiinflammatory antioxidant able improve prognosis lung pathology smoking patients <NUMBER> fact observed patients chronic obstructive pulmonary disease lower plasma levels vitamin healthy patients suggesting possible correlation deficient antioxidant defense development pulmonary disease <NUMBER> central interest revision years ago group raised discussion world pandemic vitamin deficiency possible explanation cellular inflammatory response activity rasinduced <NUMBER> original discussion involved significant number pathologies mainly cardiovascularbut similar inflammatory basis present central focus acute pulmonary inflammation caused covid<NUMBER> irish longitudinal study ageing tilda <NUMBER> reinforces idea adequate supplementation vitamin especially older people may beneficial vulnerable population groups covid<NUMBER> pandemic outbreak <NUMBER> graphical abstract j u r n l p r e p r f inflammatory cytokines <NUMBER> moreover protective role melatonin pulmonary hypertension due antioxidant antifibrotic vasodilator properties <NUMBER> also suggested pretreatment melatonin murine model asthma reduces accumulation collagen airways possibly inhibition matrix metalloproteinase<NUMBER> modulates tissue remodeling therefore melatonin would expected exert antiinflammatory effect level airway <NUMBER> melatonin also useful protection pulmonary tissue acute lung injury rats due ability eliminate free radicals block activation nfkappa b <NUMBER> <NUMBER>hydroxy<NUMBER>isobutylstreptochlorin novel derivative melatonin enhanced antiinflammatory properties inhibits penetration immune cells lung secretion proinflammatory cytokines tnfα il<NUMBER> murine model acute lung injury antiinflammatory effects mediated modulation signaling pathwaydependent interferonβ tolllike receptors moreover inhibited secretion il<NUMBER>β blocking activation nlrp<NUMBER> inflammasome independent mitochondrial production reactive oxygen species <NUMBER> lung surfactant lipid peroxidation induced production oxygen radicals stimulated phagocytes responsible development progression acute lung injury sense melatonin alone combined antioxidants markedly reduced lipid peroxidation pulmonary surfactant <NUMBER> intratracheal administration melatonin provoked marked reduction lung lesions recruitment neutrophils macrophages lungs acute pulmonary injury furthermore melatonin inhibited nlrp<NUMBER> inflammasome activation suppression extracellular histone release <NUMBER> suggested melatonin inhibits pulmonary fibrosis animal models decrease migration fibroblasts consequence reduction activity chloride channels mediated protein kinase c <NUMBER> animal model pulmonary fibrosis induced bleomycin melatonin provoked significant reduction edema lesions lung level likewise melatonin treatment lowered expression cyclooxygenase <NUMBER> produces eicosanoids whose role crucial development pulmonary fibrosis besides melatonin caused decrease interstitial tissue percentage volume increase alveolar space percentage volume <NUMBER> melatonin attenuated pneumonitis lung fibrosis caused radiation exposure decrease inflammatory cell infiltration collagen deposition edema vascular alveolar thickening lungs <NUMBER> idiopathic pulmonary fibrosis causes progressive loss pulmonary function due tissue cicatrization interesting reported j u r n l p r e p r f <NUMBER> melatonin metabolites modulate many proinflammatory profibrogenic signaling pathways involved pathophysiology pulmonary fibrosis transforming growth factor β wntβ catenin interleukin <NUMBER>a vascular endothelial growth factor fibroblast growth factors plateletderived growth factor reninangiotensin system endothelin <NUMBER> impaired caveolin <NUMBER> function causing protective effects lungs <NUMBER> removing free radicals melatonin may adequately modulate autophagy pathways apoptosis key mechanism development idiopathic pulmonary fibrosis <NUMBER> additionally utilization melatonin treatment animals induced hepatopulmonary syndrome effective reduction lung fibrosis levels vasodilation oxidative stress <NUMBER> melatonin also ameliorates pulmonary lesions associated inflammation oxidative stress caused nitrogen mustard rodents since acts powerful antioxidant eliminates reactive nitrogen oxygen species potent antiinflammatory agent <NUMBER> <NUMBER> <NUMBER> pretreatment melatonin combined quercetin rats hypoxiainduced sodium nitrite considerably reduced plasma levels il<NUMBER> tnfα crp heat shock protein <NUMBER> extracellular hsp<NUMBER>e vegf additionally melatonin enhanced histopathological changes lungs animals also suggesting powerful protective effects melatonin pulmonary level <NUMBER> melatonin potent pulmonary protective effect rats lung injury induced phosgene protective mechanism associated elimination free radicals inhibition p<NUMBER> mapk activation inos expression <NUMBER> pretreatment melatonin effective reducing lung damage patients subjected chemotherapy melatonin cyclophosphamide decrease lipid peroxidation restoring glutathione levels superoxide dismutasecatalase activities furthermore mentioned association could reduce typical histological abnormalities lungs patients chemotherapy <NUMBER> melatonin also inhibited expression hypoxiainducible factor<NUMBER>α hif<NUMBER>α melatonin also markedly inhibited pulmonary injury induced hepatic ischemiareperfusion rats antiinflammatory properties achieved reduction apoptosis lung cells blocking jnk p<NUMBER> nfƙb activation stimulating nrf<NUMBER> activation <NUMBER> mice induced lung ischemiareperfusion melatonin pretreatment achieved reduction damage lung parenchymal decrease expression inflammatory markers interleukin<NUMBER>β tnfα ikkγ apoptotic markers baxbcl<NUMBER> cleaved casp<NUMBER> tunel positive cells also inhibited addition melatonin pretreatment increased expression activity cellular antioxidant systems superoxide dismutase glutathione peroxidase glutathione reductase <NUMBER> animal model neurogenic pulmonary edema melatonin attenuated dysfunction alveolarcapillary barrier inhibiting disruption tight junction proteins zo<NUMBER> occludin furthermore caused downregulation myeloperoxidase interleukin il <NUMBER>β well provoked inhibition activation matrix metallopeptidase <NUMBER> addition melatonin treatment considerably decreased casp<NUMBER> activity number positive lung cells tunel assay therefore melatonin treatment enhanced prognosis neurogenic pulmonary edema due antiinflammatory antiapoptotic effects <NUMBER> melatonin also exerted antiinflammatory antioxidant antiapoptotic effects murine model lung aging significantly reducing expression apoptosis markers bax bad aif inflammatory markers il<NUMBER>β tnfα ho<NUMBER> nfκb<NUMBER> oxidative damage rna measured production <NUMBER>hydroxyguanosine <NUMBER> well documented melatonin prevents chronic obstructive pulmonary disease attenuating nlrp<NUMBER> inflammasome il<NUMBER>β responsible inflammation airways documented exposure nicotine pregnant rats caused significant changes lungs offspring structural biochemical level regard melatonin treatment reduced altered parameters lowering number alveolar macrophages mast cells well levels malondialdehyde <NUMBER> melatonin also significantly reduced oxidative stress injury lungs exposed radiation suppression infiltration neutrophils cd<NUMBER>bly<NUMBER>g macrophages cd<NUMBER>bcd<NUMBER>c downregulation nlrp<NUMBER> inflammasome macrophages accompanied reduction release il<NUMBER>β activity caspase<NUMBER> casp<NUMBER> upregulation mir<NUMBER>e levels <NUMBER> melatonin treatment decreased lung injury rats exposed chromium upregulating sirt<NUMBER> promotes deacetylation transcriptional coactivator peroxisome proliferatoractivated receptorγ coactivator<NUMBER>α pgc<NUMBER>α time caused rise expression crucial antioxidant target genes transcription factor nuclear factor erythroid <NUMBER>related factor <NUMBER> nrf<NUMBER> findings indicate melatonin exerts antiinflammatory antioxidant antiapoptosis effects attenuation lung injury provoked chromium exposure sirt<NUMBER>pgc<NUMBER>αnrf<NUMBER> signaling pathway <NUMBER> also determined melatonin able mitigate lung damage induced carbon tetrachloride elimination free radicals increase antioxidant ability pulmonary tissues induction effective antiinflammatory response <NUMBER> melatonin also reduced increased levels malondialdehyde myeloperoxidase pulmonary tissue diabetic rats moreover attenuated bronchial hyperplasia reduced cleavedcaspase <NUMBER> expression significantly increased animals <NUMBER> suggesting melatonin would also useful treatment covid<NUMBER> infection decreasing plasma levels proinflammatory cytokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore clinical trials showed melatonin effective chronic obstructive pulmonary disease <NUMBER> multiple newborn diseases associated increased oxidative stress lung levels many organs due important antioxidative properties <NUMBER> known strong interaction melatonin ras <NUMBER> <NUMBER> regard melatonin treatment caused reduction at<NUMBER> expression normalized ang ii levels model renal disease <NUMBER> also known local pineal ras modulates synthesis melatonin regard indicated ang ii acts at<NUMBER> receptors located pineal gland cells regulate expression activity tryptophan hydroxylase enzyme involved synthesis melatonin also demonstrated antioxidant antiinflammatory antiapoptosis effects melatonin opposite ang ii <NUMBER> reported patients chronic renal disease secrete lower nocturnal melatonin concentrations healthy patients altered secretion may related increased nocturnal intrarenal ras activation kidney damage patients renal disease fact reinforces existence close antagonistic interaction ras melatonin <NUMBER> regard known reactive oxygen species crucial activation intrarenal ras also shown antioxidant treatment melatonin ameliorates intrarenal ras overactivation renal injury <NUMBER> nephrectomized rat model chronic kidney disease <NUMBER> <NUMBER> despite lack studies specifically show relationship melatonin ras lung level existing evidence relationship organs kidney suggests possibility similar behavior respiratory level concerning vitamin dras interaction participation ace<NUMBER>ang<NUMBER>masr signaling pathway neuroprotective effects vitamin brain recently demonstrated hypertensive rats <NUMBER> found vitamin acts cofactor attenuation incident atrial fibrillation raas inhibition <NUMBER> furthermore reestablishment normal j u r n l p r e p r f vitamin levels patients hypovitaminosis provokes blockade peripheral ras <NUMBER> exacerbated activation ras hepatic level causes liver dysfunction increases risk developing diabetes mellitus sense found calcitriol modulates altered upregulation liver ras conditions insulin resistance <NUMBER> vitamin potent suppressor renin production thus low plasma levels vitamin associated increase synthesis renin results overactivation ras increased production ang ii vice versa <NUMBER> <NUMBER> demonstrated vitamin deficiency also results overexpression angiotensinconverting enzymes ace ace<NUMBER> <NUMBER> also observed vitamin receptornull mice develop serious induced acute lung injury wildtype mice increased levels pulmonary ang ii renin pretreatment vitamin receptornull mice losartan reduced severity pulmonary injury indicating vitamin via receptors attenuates acute lung injury blocking ras <NUMBER> moreover vitamin deficiency chronic uncontrolled ras overactivation extended periods may induce pulmonary fibrosis exacerbated accelerated increase extracellular matrix deposition lung tissues <NUMBER> graphical abstract combined supplementation vitamin melatonin could offer attractive synergistic alternative prevention treatment pulmonary infection covid<NUMBER> molecules modulate signaling pathways relate antiinflammatory immunomodulatory antioxidant antifibrotic well antiapoptotic effects many tissues special focus lung level natural compounds highly safe clinical use many shared underlying mechanisms allow exert potentiating actions aimed strengthening immune system preparing body overcome severe pathological part higher inflammatory processes consequence lack brake vitamin exerts typically ras system healthy conditions <NUMBER> perspective would interest carry clinical trials evaluate therapeutic utility vitamin dmelatonin combination healthy patients infected covid<NUMBER> compare effects joint administration versus individual administration regard would specially interesting adequately define melatonin vitamin supplementation regime used taking account group individual features patients participate studies since considering aspects may lead obtain heterogeneous controversial results could affect general applicability <NUMBER> <NUMBER> also rhodes collaborators proposed vitamin supplementation least northern hemisphere higher risk severe illness death <NUMBER> recommended united kingdom association dietitians <NUMBER> editorials international scientific rigors respiratory viruses common worldwide impact human animal health important economic consequences although symptoms respiratory virus infection related airway inflammation focused respiratory tract extra respiratory organs also targeted viruses including central nervous system bohmwald et al <NUMBER> recent pandemic coronavirus disease emerging december <NUMBER> accompanied prevalence olfaction alteration indeed approximately <NUMBER> patients infected severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> cause covid<NUMBER> suffered mild hyposmia total loss olfactory capacities anosmia spinato et al <NUMBER> origin alterations remains established olfaction starts olfactory sensory neurons osn located olfactory epithelium oe present dorsal part nasal cavity oe along underlying lamina propria constitutes olfactory mucosa osns cilia direct contact environment order detect odorants therefore accessible respiratory viruses viruses able infect osn reach central nervous system following olfactory nerves project olfactory bulbs forrester et al <NUMBER> bryche et al <NUMBER>a interestingly sarscov<NUMBER> netland et al <NUMBER> described virus able use olfactory pathway ace<NUMBER> angiotensinconverting enzyme <NUMBER> characterized main entrance receptor sarscov<NUMBER> letko et al <NUMBER> similarly sarscov<NUMBER> sarscov<NUMBER> described able enter central nervous system mice transgenic human ace<NUMBER> netland et al <NUMBER> model brain infection starts olfactory bulbs authors look potential infection olfactory mucosa may sarscov<NUMBER> could infect olfactory sensory neurons reaching brain olfactory bulbs neurons project forrester et al <NUMBER> sarscov<NUMBER> infection follows pathway anosmia following sarscov<NUMBER> infection may correlate encephalopathies observed covid<NUMBER> patients roe <NUMBER> highlights need unravel cellular basis observed anosmia golden syrian hamsters successfully used model sarscov<NUMBER> infection roberts et al <NUMBER> also recently shown good model sarscov<NUMBER> well sia et al <NUMBER> indeed expression profile ace<NUMBER> entry receptor sarscov<NUMBER> similar hamsters humans luan et al <NUMBER> anosmia covid<NUMBER> patients provided impetus study expression profile ace<NUMBER> nasal cavity several studies show ace<NUMBER> present oe expressed sustentacular cells supporting cells surrounding olfactory neurons rather olfactory neurons bilinska et al <NUMBER> fodoulian et al <NUMBER> however recent study suggested sarscov<NUMBER> could infect olfactory sensory neurons hamsters sia et al <NUMBER> present work focused pathological impact two different sarscov<NUMBER> strains nasal cavity central nervous system golden syrian hamster viral strains isolated nasopharyngeal swabs obtained patients suffering respiratory infection suspected covid<NUMBER> submitted molecular diagnosis nasopharyngeal flocked swabs suspended utm media copan italy kept <NUMBER>°c less <NUMBER> hours volume <NUMBER> µl homogenized microfiltered <NUMBER> µm previous inoculation vero cells ccl<NUMBER> passage <NUMBER> atcc usa grown <NUMBER> confluence bsl<NUMBER> virology laboratory virology unit chu de caen france supernatants harvested day <NUMBER> inoculation immediately used subsequent passage one p<NUMBER> virus following protocol p<NUMBER> used stock production stock aliquoted conserved <NUMBER>°c titration genomic quantification two strains used model ucn<NUMBER> ucn<NUMBER> isolated one week interval course active epidemic normandy france end march animal experiments carried animalbiosafety level <NUMBER> absl<NUMBER> facility animal experimental platform anses laboratoire de lyon protocol animal use approved french ministère de la recherche et de lenseignement supérieur number apafis n°<NUMBER> twelve female golden syrian hamsters eight weeks old purchased janviers breeding centre le genest st isle france infection done nasal instillation <NUMBER>µl nostril anaesthetised animals vetflurane five animals infected <NUMBER> <NUMBER> <NUMBER> plaque forming units pfu sarscov<NUMBER> strain ucn<NUMBER> five animals infected <NUMBER> <NUMBER> <NUMBER> pfu sarscov<NUMBER> strain ucn<NUMBER> two mockinfected animals received dulbeccos minimal essential medium dmem sarscov<NUMBER>infected hamsters euthanized general anaesthesia vetflurane <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> days infection postmortem lungs harvested weighed homogenized <NUMBER> ml dmem stainless steel beads qiagen <NUMBER>s <NUMBER> hz using tissuelyserii qiagen lung homogenates clarified centrifugation <NUMBER> × g <NUMBER>°c <NUMBER> min aliquoted stored −<NUMBER>°c rna extraction rna extraction done qiaamp viral rna minikit qiagen following manufacturers instructions real time quantitative pcr performed e gene described recently corman et al <NUMBER> lightcycler lc<NUMBER> roche immunohistochemistry analysis olfactory mucosa tissue sections performed described previously mice bryche et al <NUMBER>a briefly whole animal head fixed <NUMBER> days room temperature <NUMBER> paraformaldehyde pbs decalcified one week <NUMBER> edta ph <NUMBER> <NUMBER>°c nasal septum endoturbinates removed block postfixed overnight <NUMBER>°c <NUMBER> paraformaldehyde pbs decalcified <NUMBER> days procedure applied cortex brainstem without decalcification blocks tissues cryoprotected sucrose <NUMBER> cryosectioning <NUMBER> μm performed median transversal sections nasal cavity perpendicular hard palate order highlight vomeronasal organ olfactory mucosa stenos gland olfactory bulb brain cryosectioned <NUMBER> µm coronal plane sections stored <NUMBER>°c use nonspecific staining blocked incubation <NUMBER> bovine histology sections rehydrated stained hematoxylin h<NUMBER> vector laboratories <NUMBER>s washed water slides transferred acidalcohol solution <NUMBER> hcl <NUMBER> ethanol <NUMBER>s washed water immersed eosin sigma ht<NUMBER> <NUMBER>s washed water finally slides gradually dehydrated mounted eukitt sigma <NUMBER> nissl staining performed sections following conventional histological procedures including immersion <NUMBER> cresyl violet solution <NUMBER> minutes images taken x<NUMBER> magnification using dmbr leica microscope equipped olympus dp<NUMBER> ccd camera using cell f software olympus soft imaging solutions gmbh osis munster germany measured oe thickness osn cilia quality based golf staining immune cell infiltration olfactory mucosa based iba<NUMBER> staining <NUMBER> images per animal taken <NUMBER> different slides spread along nasal cavity oe thickness <NUMBER> measurements along oe septum performed image previously described francois et al <NUMBER> percentage apical oe preserved g olf staining percentage iba<NUMBER> cells infiltration oe measured using imagej threshold specific staining values averaged per animal also globally estimated impact sarscov<NUMBER> oe parameters comparing mockinfected animals sarscov<NUMBER> infected animals evaluated <NUMBER> integrity structure oe using staining <NUMBER> preservation osn cilia using g olf signal apical part oe <NUMBER> presence shape iba<NUMBER> cells oe underneath lamina propria ramified iba<NUMBER> cells considered representative resting state amoeboid shape linked activated state oe mori et al <NUMBER> parameter used scale ranging <NUMBER> <NUMBER> scored three sections olfactory mucosa spread along nasal cavity per animal evaluation performed three experienced investigators blinded animal treatment scores averaged per animal investigators used cohort <NUMBER> hamsters examine impact two different isolates sarscov<NUMBER> ucn<NUMBER> ucn<NUMBER> nasal cavity <NUMBER> <NUMBER> day post infection dpi nasal instillation olfactory epithelium well preserved control animals observed massive damage olfactory epithelium sarscov<NUMBER>infected animals early <NUMBER> dpi fig <NUMBER>a nasal cavity lumen filled cellular aggregates olfactory epithelium strongly disorganized affected oe zones axon bundles olfactory sensory neurons olfactory epithelium almost direct contact environment fig <NUMBER>b objective measure olfactory mucosa damage first measured septal olfactory epithelium thickness fig <NUMBER>c scored overall lesions oe fig <NUMBER>d oe disappeared <NUMBER> dpi point started recover reached preinfection thickness <NUMBER> dpi measurements stopped results similar viruses examined cellular localisation sarscov<NUMBER> nasal cavity immunohistochemistry using antibody raised nucleocapsid protein virus observed large proportion oe infected <NUMBER> dpi decreased <NUMBER> dpi subsequently disappeared fig <NUMBER>a supp fig <NUMBER>a b virus also present vomeronasal organ supp fig <NUMBER>a stenos gland supp fig <NUMBER>b <NUMBER> dpi <NUMBER> dpi also examined various areas brain could find presence virus olfactory bulbs supp fig <NUMBER>a olfactory cortex piriform cortex olfactory tubercle hypothalamus hippocampus brainstem mainly focused respiratory control centres ventral respiratory column nucleus solitary tract supp fig <NUMBER>b virus presence nasal cavity followed kinetic similar presence lungs supp fig <NUMBER>c order identify cells infected sarscov<NUMBER> oe performed double staining olfactory mucosa omp ck<NUMBER> specific markers mature osns sustentacular cells respectively cells infected sarscov<NUMBER> expressed ck<NUMBER> well able find viral antigen omp expressing cells results show sarscov<NUMBER> infects sustentacular cells osns fig <NUMBER> interestingly observed staining omp ck<NUMBER> sarscov<NUMBER> well hoechst lumen nasal cavity indicating part oe containing infected noninfected cells desquamated response sarscov<NUMBER> infection order understand extent damage osns following sarscov<NUMBER> infection examined preservation osn cilia layer contains transduction complex allowing detection odours dibattista et al <NUMBER> performed immunohistochemistry g olf fig <NUMBER>a b specific g protein complex jones reed <NUMBER> quantified percentage septal olfactory epithelium containing g olf staining apical part oe fig <NUMBER>c scored globally quantity g olf staining oe fig <NUMBER>d g olf signal completely preserved control animals quickly diminished sarscov<NUMBER>infected animals without clear improvement <NUMBER> dpi <NUMBER> dpi observed small recovery g olf signal septal part oe <NUMBER> dpi ucn<NUMBER> virus finally examined presence immune cells olfactory mucosa using iba<NUMBER> specific marker monocytemacrophage lineage bryche et al <NUMBER>b fig <NUMBER>a control animals iba<NUMBER> cells mainly localized lamina propria exhibited ramified morphology many processes fig <NUMBER>b typical resting phenotype mori et al <NUMBER> measured presence iba<NUMBER> cell fig <NUMBER>c scored presence shape iba<NUMBER> cells oe lamina propria separately fig <NUMBER>d iba<NUMBER> cells mostly absent oe moderately present lamina propria control animals presence drastically increased <NUMBER> dpi infected animals oe lamina propria fig <NUMBER>a b furthermore iba<NUMBER> cells mostly amoeboid shape typical activated state <NUMBER> <NUMBER> dpi fig <NUMBER>b also observed iba<NUMBER> cells lumen nasal cavity cellular aggregates containing sarscov<NUMBER> fig <NUMBER>a immune cell infiltration gradually diminished reduction first observed <NUMBER> dpi oe seen lamina propria <NUMBER> dpi <NUMBER> dpi reached mock level oe lamina propria virus strains fig <NUMBER>c  present study focused impact sarscov<NUMBER> nasal cavity central nervous system using golden syrian hamster model chose work <NUMBER> different isolates sarscov<NUMBER> potential obtain slightly different strain behaviour explored kinetic impact two different isolates identify sustentacular cells main target cells sarscov<NUMBER> oe observation consistent expression pattern ace<NUMBER> mainly present cells along facilitating protease tmprss<NUMBER> bilinska et al <NUMBER> fodoulian et al <NUMBER> two recent reports indicate olfactory neurons hamster sia et al <NUMBER> respiratory cells ferret ryan et al <NUMBER> may target sarscov<NUMBER> studies focus nasal cavity use double staining clearly identify infected cells oe observed sarscov<NUMBER> infect nonneuronal cells nasal cavity notably epithelium covering lumen stenos gland however poorly described literature bryche et al <NUMBER>b studies required clearly identify nonneuronal cells infected sarscov<NUMBER> nasal cavity may facilitate systemic infection cell types tissues lower respiratory airways observe presence virus brain notably olfactory bulbs osns projects piriform cortex olfactory signal integrated also focused hypothalamus contains ace<NUMBER> expressing neurons mukerjee et al <NUMBER> well respiratory centres brainstem latter suspected infected covid<NUMBER> patients suffering heavy respiratory disorders gandhi et al <NUMBER> lack virus detection central nervous system may due low number animal examined nevertheless rule systematic important infection brain following sarscov<NUMBER> infection hamster consistent recent review literature failed indicate central nervous manifestation sarscov<NUMBER> presence human central nervous system romoli et al <NUMBER> however neurotropic ability sarscov<NUMBER> remains controversial wang et al <NUMBER> interestingly sarscov<NUMBER> shown neurotropic using ace<NUMBER> humanized mice osns mice must also express ace<NUMBER> control k<NUMBER> ubiquitous promoter netland et al <NUMBER> sarscov<NUMBER> may thus infect osns expressing ectopic ace<NUMBER> observation presence virus brain may relevant physiological model model observed fast desquamation oe following sarscov<NUMBER> infection sustentacular cells studies required decipher whether could antiviral strategy limit access virus brain olfactory pathway extent recruitment immune cells contributes process immunopathological mechanisms globally present first data focusing impact sarscov<NUMBER> nasal cavity results could explain high prevalence anosmia observed covid<NUMBER> patients need confirmed analysis human oe coronavirus cov belongs subfamily coronavirinae family coronavirdiae order nidovirales repeatedly crossed species barriers become important human pathogens <NUMBER> december <NUMBER> highly pathogenic novel coronavirus severe acute respiratory syndromeassociated coronavirus<NUMBER> sarscov<NUMBER> emerged cause coronavirus disease <NUMBER> virus likely originated bats transmitted intoamong humans <NUMBER> affected <NUMBER> countries territories around world causing <NUMBER> million confirmed cases human infection <NUMBER> deaths short months <NUMBER> known species specificity host tropism transmission capacity virus determined viral envelope spike protein mediating receptorbinding affinity host receptor therefore elucidate pathogenesis sarscov<NUMBER> develop vaccines treatments covid<NUMBER> appropriate preclinical animal models express human angiotensinconverting enzyme ace<NUMBER> functional receptor sarscov<NUMBER> also recapitulate symptoms immediately required <NUMBER> <NUMBER> describe role ace<NUMBER> covid<NUMBER> urgent need translational research using human h ace<NUMBER> transgenic tg mice susceptible covid<NUMBER> infection varying degrees also demonstrate symptoms observed human patients infected pandemic disease angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace<NUMBER> known acerelated carboxypeptidase angiotensinconverting enzyme homologue aceh monocarboxypeptidase expressed lung arteries heart kidney brain intestines <NUMBER> <NUMBER> essential component reninangiotensinaldosterone system raas <NUMBER> raas hormone system leading regulation blood pressure water balance electrolytic homeostasis vascular resistance heart remodeling <NUMBER> classical pathway raas initiated circulating blood volume decreased juxtaglomerular cells lining afferent arterioles located proximal renal glomeruli recognize change secrete renin blood circulation renin cleaves angiotensinogen angiotensin ang liver circulating ang hydrolyzed ang ii ace primarily located pulmonary renal vessels ang ii activates angiotensin type receptor at<NUMBER>r initiate vasoconstrictor response stimulate aldosterone synthesis adrenal gland circulating blood volume blood pressure increased aldosterone induces renal tubes initiate sodium water retention <NUMBER> <NUMBER> raas ace<NUMBER> directly hydrolyzes ang ii yield ang<NUMBER> converts ang ang<NUMBER> eventually creating vasodilator ang<NUMBER> crucial product ace<NUMBER> ang<NUMBER> binds g proteincoupled mas receptor masr leads cellular signaling opposite vasoconstrictor effects ang ii stimulate aldosterone secretion fig <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recognized raas far complicated initial understanding classical function <NUMBER> imbalance levels ang ang ii ang cleavage peptides ang<NUMBER> leads vasoconstriction impairs vascular reactivity key enzyme controlling balance players raas ace<NUMBER> plays critical role cardiorenal pulmonary disease <NUMBER> <NUMBER> role ace<NUMBER> receptor pathogenesis sarscov<NUMBER> ace<NUMBER> implicated functional cellular receptor sarscov pathogen sars caused <NUMBER> cases infection <NUMBER> deaths <NUMBER> countries <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> <NUMBER> abundant studies conducted prove essential role ace<NUMBER> pathogenesis severity sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> leveraging rich fig <NUMBER> role ace<NUMBER> adverse effect sarscov raas renin cleaves angiotensinogen angiotensin ang circulating ang hydrolyzed ang ii ace ang ii activates at<NUMBER>r lead proatrophy profibrosis proinflammation prooxidant vasoconstrictor response increase aldosterone synthesis ace<NUMBER> directly hydrolyzes ang ang ii generate ang<NUMBER> ang<NUMBER> respectively ang<NUMBER> binds masr leads cellular signaling opposite tissue injury effects ang ii stimulate aldosterone secretion sarscov destroys balance raas downregulating ace<NUMBER> expression levels conclusively disproportion at<NUMBER>r masr axes sarscov infected patients contributes development tissue injury severe inflammatory reactions knowledge highly beneficial useful elucidate uses ace<NUMBER> sarscov<NUMBER> infection considering similarity viral structure pathogenesis two viruses <NUMBER> viral binding ability sarscov ace<NUMBER> known crucial factor supports viral replication host determines infection efficiency different species including human mice rats palm civets <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although species responsible transmission remains unclear <NUMBER> <NUMBER> several studies shown sarscov sarscov<NUMBER> also originated bat may also contain partial genes another intermediate species pangolin scale anteater high conservation genome encode spike proteins receptorbinding motif rbm receptorbinding domain rbd sarscov<NUMBER> nearly identical one virus isolated pangolin <NUMBER> <NUMBER> <NUMBER> aligning sequence amino acids aas viral rbd aas ace<NUMBER> five residues hace<NUMBER> including k<NUMBER> e<NUMBER> d<NUMBER> m<NUMBER> k<NUMBER> identified key aas interacting viral rbm sarscov sarscov<NUMBER> <NUMBER> <NUMBER> mainly k<NUMBER> k<NUMBER> virus binding hot spots play critical roles crossspecies human human transmissions <NUMBER> <NUMBER> <NUMBER> recently ace<NUMBER> binding affinity rbd sarscov sarscov<NUMBER> evaluated fortytwo mammals based hot spot aas ace<NUMBER> species protein complex structure simulation study supported possibility pangolin ace<NUMBER> might better affinity sarscov<NUMBER> n<NUMBER> pangolin ace<NUMBER> could contact closer viral rbd m<NUMBER> hace<NUMBER> <NUMBER> major clinical characteristics sarscov sarscov<NUMBER> patients deterioration lung function apparent loss lung repair capacity <NUMBER> <NUMBER> ace<NUMBER> expressed primarily alveolar epithelial type ii cells produce surfactant prevent collapse alveoli order maintain normal gas exchange lung <NUMBER> <NUMBER> interaction ace<NUMBER> rbd viral spike protein leads endocytosis virus particles internalization ace<NUMBER> establishes sarscov infection <NUMBER> leading cell damage <NUMBER> <NUMBER> although catalytic pocket ace<NUMBER> blocked binding rbd sarscov infection notably downregulated ace<NUMBER> expression transcriptional posttranslational level <NUMBER> <NUMBER> <NUMBER> <NUMBER> validated vitro vivo studies challenged recombinant spike protein sarscov cell culture downregulated ace<NUMBER> expression levels <NUMBER> injection sarscov spike mice decreased ace<NUMBER> expression levels leading worsened lung injury fig <NUMBER> <NUMBER> <NUMBER> furthermore inflammation excessively produced infections sarscov<NUMBER> <NUMBER> sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> suppress ace<NUMBER> transcription <NUMBER> <NUMBER> resulting raas activation activation contributes development severe acute respiratory distress syndrome ards acute lung injury severe inflammatory reactions <NUMBER> suggests direct viral interaction subsequent inflammation contribute ace<NUMBER> downregulation thusly ace<NUMBER> potentially could serve protect lung injury <NUMBER> however concerns normalization upregulation ace<NUMBER> expression levels patients would enable heightened level infectivity sarscov<NUMBER> well clinical illness severity <NUMBER> indeed pathogenic events caused viral infections recognized highly complex fully understood <NUMBER> solely targeting ace<NUMBER>mediated pathways alone may able fully answer questions regarding diversity symptoms studies elucidating pathogenesis evaluating efficacy potential therapeutics vaccines must immediately conducted utilizing appropriate preclinical model relevant animal models essential understanding pathogenesis sars <NUMBER> covid<NUMBER> <NUMBER> several animal models shown susceptible sarscov infection ferrets hamsters mice nonhuman primates include macaques african green monkeys marmosets <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> animals exhibited viral replication limited degree histopathology clinical illness none displayed consistent disease symptoms immunological response profile mortality <NUMBER> spike protein sarscov much higher binding affinity hace<NUMBER> mice rats animal species correlates much lower level permissiveness virus animals <NUMBER> therefore tg mouse models expressing hace<NUMBER> developed used elucidate complex ace<NUMBER>mediated responses sarscov infection <NUMBER> <NUMBER> hace<NUMBER> tg mice provide significant findings discover pathogenesis sarscov<NUMBER> support development covid<NUMBER> therapeutics vaccines human cytokeratin <NUMBER> k<NUMBER>hace<NUMBER> tg mouse models k<NUMBER>hace<NUMBER> tg mice also known b<NUMBER>cgtgk<NUMBER>ace<NUMBER>prlmnj developed mccray et al <NUMBER> <NUMBER> <NUMBER> purified dna fragment containing hace<NUMBER> coding sequence <NUMBER>′ <NUMBER>′ genomic regions human k<NUMBER> gene shown required driving highlevel epithelial cellspecific expression injected pronuclei zygotes intercross c<NUMBER>bl<NUMBER>j × sjlj f <NUMBER> parents generate transgenic embryos table <NUMBER> mice backcrossed onto c<NUMBER>bl<NUMBER> background hace<NUMBER> mrna expression detected several tissues including lung liver kidney colon low measurable mrna level hace<NUMBER> found brain <NUMBER> intranasal inoculation sarscov caused development rapidly fatal disease outcome correlated copy number hace<NUMBER> mrna level mice high hace<NUMBER> expression level tg lines <NUMBER> <NUMBER> succumbed day <NUMBER> <NUMBER> postinfection pi whereas tg line <NUMBER> showed lower hace<NUMBER> expression died <NUMBER> <NUMBER> days pi viral replication found lungs k<NUMBER>hace<NUMBER> tg nontg mice however viral titers lower clearance much faster nontg mice k<NUMBER>hace<NUMBER> tg mice began lose weight <NUMBER> <NUMBER> days following sarscov infection becoming lethargic labored breathing died within <NUMBER> days table <NUMBER> <NUMBER> similar patients symptoms lung obviously organ majorly affected sarscov infection k<NUMBER>hace<NUMBER> tg mice showing significant inflammatory reactions ifngamma cxcl<NUMBER> cxcl<NUMBER> il<NUMBER> il<NUMBER>beta etc hemorrhage epithelial cell damage congestion alveolar septum fig <NUMBER> <NUMBER> <NUMBER> one interesting findings regarding mice heavy viral infection brain increased inflammatory cytokines cxcl<NUMBER> cxcl<NUMBER> il<NUMBER> il<NUMBER>beta etc fig <NUMBER> postulated major factor aspiration pneumonia observed k<NUMBER>hace<NUMBER> tg mice occasionally infected patients well <NUMBER> fact several studies detected virus brain patients infected sarscov <NUMBER> <NUMBER> <NUMBER> patients survived viral disease displayed neurologicalpsychological sequelae presumed side effects either corticosteroid therapy severe lung infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> intensive investigation sarscovinduced neurological disease challenge due difficulty obtaining infected brain tissues derived patients <NUMBER> therefore k<NUMBER>hace<NUMBER> tg mouse used discover pathogenic mechanism sarscov including viral entry central nervous system cns spread neuronal infection cause lethality <NUMBER> detecting viral antigens different regions mouse brain observing timedependently neuronal infection sarscov revealed initiate olfactory bulb spreading brain thoroughly <NUMBER> <NUMBER> days intranasal inoculation virus induced neuronal loss <NUMBER> brain patient infected sarscov exhibited neuronal necrosis glial hyperplasia edema viral infection mainly affected neurons <NUMBER> <NUMBER> <NUMBER> consistent studies showing distinguished neuronal tropism sarscov infected k<NUMBER>hace<NUMBER> tg mice <NUMBER> <NUMBER> based sars studies utilized k<NUMBER>hace<NUMBER> tg mice possible mechanisms including high regional infection cardiorespiratory center medulla oblongata extreme inflammatory reactions resulted cytokine storm also suggested <NUMBER> vectors <NUMBER> plasmid containing hace<NUMBER> cdna coding sequence injected pronuclei zygotes c<NUMBER>bl<NUMBER>j × c<NUMBER>hhej f<NUMBER> table <NUMBER> either c<NUMBER>bl<NUMBER> balbc mice used backcrossing mouse line showed different expression levels hace<NUMBER> mrna ac<NUMBER> tg line supremely susceptible sarscov infection expressed high level hace<NUMBER> mrna overall organs ie spleen stomach heart muscle brain kidney lung intestine liver showed clinical illness including lethargy labored breathing persistent weight loss leading immobility <NUMBER> mortality within <NUMBER> <NUMBER> days following infection table <NUMBER> <NUMBER> <NUMBER> among tissues examined lung brain primarily affected organs infected ac<NUMBER> tg mice viral replication lung brain showed notably different kinetics viral titers reached maximum level lung <NUMBER> <NUMBER> days pi gradually decreased viral titers brain first detected day <NUMBER> rapidly increased day <NUMBER> remained high levels death host inflammatory cytokine levels correlated level viral replication lung brain following intraperitoneal injection caused lowlevel viremia ac<NUMBER> tg mice virus detected brain lung suggesting sarscov could disseminate cns mechanism independent one lung infection <NUMBER> tg mice lines ac<NUMBER> ac<NUMBER> used investigate resistance lethality following sarscov infection compared ac<NUMBER> infected ac<NUMBER> ac<NUMBER> tg mice recovered even though mice suffered severe clinical illness progression disease <NUMBER> <NUMBER> although hace<NUMBER> expression levels lung brain lower ac<NUMBER> ac<NUMBER> pattern viral yield pulmonary pathologies lung following sarscov infection showed subtle dissimilarity two lines however viral replication inflammatory response brain infected ac<NUMBER> significantly lower ac<NUMBER> another finding comparison study showed cell loss ac<NUMBER> tg mice much distinct ac<NUMBER> tg mice similar severity cell loss correlated poor outcome sarscov sarscov<NUMBER> infected patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hepatocyte nuclear factor<NUMBER>forkhead homologue <NUMBER>hfh<NUMBER>ace<NUMBER> tg mouse models hfh<NUMBER>ace<NUMBER> tg mice also known b<NUMBER>jcgtg foxj<NUMBER>ace<NUMBER>rbammnc airwaytargeted overexpression human ace<NUMBER> generated menachery et al <NUMBER> expression cassette consisting hfh<NUMBER> foxj<NUMBER> lung ciliated epithelial cellspecific promoter elements coding region ace<NUMBER> cdna ptg<NUMBER> vector injected pronuclei zygotes c<NUMBER>h × c<NUMBER>bl<NUMBER> f<NUMBER> c<NUMBER>b<NUMBER>f<NUMBER> table <NUMBER> founder mice crossed c<NUMBER>b<NUMBER> hace<NUMBER> expression mouse confirmed pcr hfh<NUMBER>ace<NUMBER> mice expressed hace<NUMBER> lung also brain liver kidney gastrointestinal tract indicating broader organ distribution hfh<NUMBER>mediated expressions expected initially sarscov urbani strain challenge hfh<NUMBER>hace<NUMBER> mice rapidly lost <NUMBER> bodyweight died within <NUMBER> <NUMBER> days robust viral replication lung brain found endpoint table <NUMBER> antisars human antibody <NUMBER> protected hfh<NUMBER>hace<NUMBER> mice death sarscov infection mice used evaluate possibility human infection transmission wiv<NUMBER>cov sarslike virus identified metagenomics studies isolated replication virus horseshoe bat known animal reservoir sarscov <NUMBER> previous research wiv<NUMBER>cov revealed broad species tropism use ace<NUMBER> orthologs also could replicate low level a<NUMBER> human lung cancer cell line <NUMBER> furthermore robust wiv<NUMBER>cov infection confirmed welldifferentiated primary human airway epithelial hae cell meaning sarslike viruses yet found well wiv<NUMBER>cov might need intermediate species infect humans therefore critical investigate pathogenesis observe symptoms wiv<NUMBER>cov infection animal models expressing hace<NUMBER> compared sarscov infection hfh<NUMBER>hace<NUMBER> mice wiv<NUMBER>cov infection showed attenuated symptoms lesser amount weight loss delayed death limited mice well lower viral titer contrasts finding similar titer level following infection primary hae cell culture suggests wiv<NUMBER>cov spike protein bind hace<NUMBER> additional adaptations possibly required cause epidemic disease <NUMBER> example demonstrates additional use hace<NUMBER> tg mice validation potential epidemical viral strains showing beneficial impact hace<NUMBER> tg mice provide knowledge needed prevention management future cov outbreaks hace<NUMBER> tg mouse hace<NUMBER> gene introduced mouse genome developed yang et al <NUMBER> <NUMBER> hace<NUMBER> cdna inserted pegfpn<NUMBER> plasmid hace<NUMBER> expression mediated mouse ace<NUMBER> promotor resulting likelihood mimicking human condition closely verification hace<NUMBER> expression fragment containing mouse ace<NUMBER> driving hace<NUMBER> coding sequencing injected pronuclei zygote icr mice table <NUMBER> hace<NUMBER> expression observed lung heart kidney intestinal tracts hace<NUMBER> tg model contrast previous hace<NUMBER> tg mice models including k<NUMBER>hace<NUMBER> a<NUMBER> hfh<NUMBER>ace<NUMBER> although severe diffuse interstitial pneumonia broad extrapulmonary organ damage seen <NUMBER> similar observed patients infected sarscov <NUMBER> <NUMBER> <NUMBER> mice die sarscov infection table <NUMBER> reason milder disease progression recovery could due lower hace<NUMBER> expression levels since death rate sars <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> <NUMBER> <NUMBER> resistant hace<NUMBER> tg mice still significant pathologic symptoms useful understanding pathogenesis sarscov sarscov<NUMBER> potential contributions hace<NUMBER> tg mouse models battle covid<NUMBER> several vaccine candidates sarscov shown induce neutralizing antibodies well effective protecting young mice hamsters viral challenge <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hace<NUMBER> tg mouse k<NUMBER>hace<NUMBER> used test protective ability recombinant sarscov deleted envelope e protein rsarscovδe deleted e several groupspecific protein genes rsarscovδe<NUMBER>b sarscovmediated fatal respiratory disease rsarscovs showed protective effects challenge sarscov inducing antivirus cell antibody responses improved survival rate <NUMBER> recently sarscov<NUMBER> mrna<NUMBER> inactivated recombinantspike protein sarscov<NUMBER> undergoing testing clinical phase openlabel doseranging clinical trial nct<NUMBER> mainly determine safety efficacy <NUMBER> since virus generate subclasses efficacy safety host immunization potential deter viral replication sarscov<NUMBER> evaluated vaccine candidates accomplish desperate need use hace<NUMBER> tg mouse model help discover potential vaccines desirable properties move toward next phase vaccine development several strong therapeutic candidates previously used treatment viral disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> rapidly applied clinical trials covid<NUMBER> based antiviral effects validated cultured cells <NUMBER> <NUMBER> instance remdesivir gs<NUMBER> recognized broadspectrum antiviral drug rna viruses <NUMBER> sars merscov <NUMBER> shown inhibit sarscov<NUMBER> viral infection human liver cancer cell line huh<NUMBER> <NUMBER> remdesivir recently approved fda emergency use severe covid<NUMBER> patients <NUMBER> evaluated efficacy given patients earlier disease course currently eight clinical trials progress usa nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> china nct<NUMBER> nct<NUMBER> france nct<NUMBER> nct<NUMBER> assess expanded treatment approaches potential combinational treatments remdesivir get approval fda considering complicated hidden pathogenic mechanisms evolution sarscov<NUMBER> vivo study simultaneously immediately conducted provide comprehensive data predict therapeutic adverse responses sarscov<NUMBER> infected patients hace<NUMBER> tg mice may provide highly beneficial data particularly associated severity covid<NUMBER> clinical illness mortality cannot investigated using cultured cells nontransgenic mice moreover hace<NUMBER> tg mice facilitate developing evaluating potential therapeutic strategy targeting hace<NUMBER>mediated pathogenic pathways soluble recombinant human ace<NUMBER> rhace<NUMBER> attracting attention competitive interceptor bind rbd sarscov sarscov<NUMBER> viral rbds attach fulllength hace<NUMBER> bound cell membrane <NUMBER> several vitro studies shown soluble form ace<NUMBER> blocked sarscov replication veroe<NUMBER> cells <NUMBER> <NUMBER> extracellular domain human ace<NUMBER> fused human igg<NUMBER>fc could neutralize sarscov<NUMBER> <NUMBER> appropriate form rhace<NUMBER> provided would new therapeutic compound used inhibit sarscov<NUMBER> binding ace<NUMBER> diminish viral infection viral replication host <NUMBER> however beneficial effect rhace<NUMBER> yet tested animal studies human clinical studies therefore hace<NUMBER> tg mice would useful animal model expedite process developing new approach subsequent migration mutation sarscov<NUMBER> evolving subclasses tang et al reported two major lineages ltype stype sarscov<NUMBER> coexist phylogenetic analysis <NUMBER> genomes sarscov<NUMBER> stype indicated ancestral subclass ltype characterized higher frequency stype <NUMBER> coinfection two subclasses observed one patient usa<NUMBER>a gisaid id epiisl<NUMBER> clear whether coinfection increased severity <NUMBER> recently three subclasses ie b c subclasses identified based distinguishable aa changes characterbased phylogenetic network analysis <NUMBER> sarscov<NUMBER> genomes <NUMBER> understanding pathogenesis viral subclass consisting special residues determining host affinity disease severity important developing vaccines treatment described clinical symptoms hace<NUMBER> tg mice following sarscov infection quite similar patients hace<NUMBER> tg mice potentially provide significant knowledge viral dissemination pathogenic impact sarscov<NUMBER> subclasses infected hosts also lead essential knowledge supports transgenic animal models enhancing investigating permissiveness infection sarscov<NUMBER> <NUMBER> validation risk factors associated severe symptoms covid<NUMBER> previous study using mouse models aged mice shown severe pathological lesions higher mortality rate young mice following sarscov infection young mice required mutations passages aged mice produce mouseadapted sarscov strains <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> age known one factors determine disease severity sars covid<NUMBER> <NUMBER> <NUMBER> therefore investigating pathologic severity sarscov<NUMBER> associated age young old hace<NUMBER> tg mice immediately required understand difference symptoms infected patients establish diseasecontrol strategy also covid<NUMBER> patients lethal symptoms revealed preexisting medical comorbidities pulmonary disease chronic kidney disease diabetes mellitus obesity body mass index ≥ <NUMBER> cardiovascular disease hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> various animal models developed investigating diseases including inbred strains mice genetic manipulations predispose disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> manipulations environmental exposures used study effects comorbidities cigarette smokeor drug ie bleomycininduced pulmonary disease <NUMBER> <NUMBER> paraquatinduced acute renal failure <NUMBER> repeated lowdose cisplatin treatmentinduced chronic renal failure <NUMBER> streptozotocindeveloped type diabetes mellitus <NUMBER> high fatsucrose ditesinduced insulin resistance closely linked type ii diabetes melilitus obesity cardiovascular disease <NUMBER> <NUMBER> chemicaldietinduced disease methods applied hace<NUMBER> tg mouse models infecting sarscov<NUMBER> elucidate association comorbidity symptoms pathogenesis covid<NUMBER> moreover development breeding together tg mice develop comorbidities express hace<NUMBER> facilitate discovery impact mechanism comorbidity severity symptoms covid<NUMBER> knowledge help us ready prevent protect people undesirable pandemic disaster like covid<NUMBER> sarscov<NUMBER> higher binding affinity hace<NUMBER> species recent cryoelectron microscopy studies demonstrate showed even higher affinity sarscov <NUMBER> transgenic mouse model expresses hace<NUMBER> proven mimic symptoms human disease sars infection comprehensively reviewed currently established hace<NUMBER> tg mouse models studies utilizing mice also arguments presented show urgent demand investigations covid<NUMBER> treatments prevention significantly require use hace<NUMBER> tg mice conclusion along efforts medical scientific fields hace<NUMBER> tg mice critical translational animal model would greatly facilitate deciphering pandemic disease development therapeutics vaccines covid<NUMBER> abbreviations aas amino acids ace angiotensinconverting enzyme ace<NUMBER> angiotensinconverting enzyme <NUMBER> aceh angiotensinconverting enzyme homologue ang angiotensin ang ii angiotensin ii ang<NUMBER> angiotensin <NUMBER> ang<NUMBER> angiotensin <NUMBER> ards acute respiratory distress syndrome at<NUMBER>r angiotensin type receptor cns coronavirus disease <NUMBER> covid<NUMBER> pandemic caused sarscov<NUMBER> infections led substantial unmet need treatments many require testing appropriate animal models disease vaccine trials already underway remains urgent need find therapeutic approaches either target sarscov<NUMBER> complications arising viral infection particularly dysregulated immune response systemic complications associated progression severe covid<NUMBER> time writing vivo studies sarscov<NUMBER> infection described using macaques cats ferrets hamsters transgenic mice expressing human angiotensin converting enzyme <NUMBER> ace<NUMBER> infection models already useful studies transmission immunity date partially model mechanisms implicated human severe covid<NUMBER> therefore urgent need development animal models improved evaluation efficacy drugs identified potential treatment severe covid<NUMBER> models need recapitulate key mechanisms covid<NUMBER> severe acute respiratory distress syndrome reproduce immunopathology systemic sequelae associated disease review current models sarscov<NUMBER> infection covid<NUMBER>related disease mechanisms suggest ways animal models adapted increase usefulness research covid<NUMBER> pathogenesis assessing potential treatments animal models mechanisms sarscov<NUMBER> infection covid<NUMBER> pathology coronavirus disease <NUMBER> covid<NUMBER> pandemic caused sarscov<NUMBER> infections led substantial unmet need treatments many require testing appropriate animal models disease vaccine trials already underway remains urgent need find therapeutic approaches either target sarscov<NUMBER> complications arising viral infection particularly dysregulated immune response systemic complications associated progression severe covid<NUMBER> time writing vivo studies sarscov<NUMBER> infection described using macaques cats ferrets hamsters transgenic mice expressing human angiotensin converting enzyme <NUMBER> ace<NUMBER> infection models already useful studies transmission immunity date partially model mechanisms implicated human severe covid<NUMBER> therefore urgent need development animal models improved evaluation efficacy drugs identified potential treatment severe covid<NUMBER> models need recapitulate key mechanisms covid<NUMBER> severe acute respiratory distress syndrome reproduce immunopathology systemic sequelae associated disease review current models sarscov<NUMBER> infection covid<NUMBER>related disease mechanisms suggest ways animal models adapted increase usefulness research covid<NUMBER> pathogenesis assessing potential treatments animal models mechanisms sarscov<NUMBER> infection covid<NUMBER> pathology severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first emerged wuhan <NUMBER> china december <NUMBER> <NUMBER> virus rapidly spread around globe infecting <NUMBER> <NUMBER> million people far june <NUMBER> httpscovid<NUMBER>whoint sarscov<NUMBER> <NUMBER> causative agent coronavirus disease <NUMBER> common clinical manifestations <NUMBER> covid<NUMBER> fever dry cough paired minority patients difficult breathing muscle <NUMBER> andor joint pain headachedizziness decreased sense taste smell diarrhea <NUMBER> nausea <NUMBER> small subset patients develop acute respiratory distress syndrome <NUMBER> ards characterized difficult breathing low blood oxygen levels may directly <NUMBER> result respiratory failure <NUMBER> addition overreaction hosts immune <NUMBER> inflammatory responses result vast release cytokines cytokine storm inducing <NUMBER> sepsis multiorgan damage may lead organ failure <NUMBER> date <NUMBER> <NUMBER> patients worldwide succumbed covid<NUMBER> hence response ongoing pandemic <NUMBER> desperate need therapeutic prophylactic options <NUMBER> present specific antiviral drugs developed approved treat infections <NUMBER> human coronaviruses nonetheless antiviral drugs could fulfill important role <NUMBER> treatment covid<NUMBER> patients slowing replication sarscov<NUMBER> antiviral <NUMBER> treatment could beneficial prevent alleviate symptoms addition antiviral drugs <NUMBER> could used prophylaxis protect health care workers highrisk groups however <NUMBER> specific highly potent antiviral drug sarscov<NUMBER> take years develop evaluate <NUMBER> clinical studies therefore main focus covid<NUMBER> treatment short term <NUMBER> hamsters treated daily <NUMBER> consecutive days either hydroxychloroquine <NUMBER> favipiravir starting <NUMBER> day prior exposure index hamster <NUMBER> study contribution fecaloral route overall transmission sarscov<NUMBER> <NUMBER> index hamsters inoculated described earlier day <NUMBER> <NUMBER> pi index hamsters <NUMBER> sacrificed sentinel hamsters placed dirty cages index <NUMBER> hamsters food grids water bottles replaced clean ones minimize virus <NUMBER> transmission via food water day <NUMBER> post exposure sentinels sacrificed tissues <NUMBER> lung ileum stool collected index sentinel hamsters processed <NUMBER> detection viral rna infectious virus <NUMBER> hydroxychloroquine hcq active metabolite desethylhydroxychloroquine dhcq <NUMBER> quantified edtaplasma samples total <NUMBER> µl sample ii <NUMBER> µl internal <NUMBER> standard solution hydroxychloroquined<NUMBER> <NUMBER> ngml water added tube <NUMBER> mixed addition <NUMBER> µl <NUMBER> perchloric acid samples shaken <NUMBER> min <NUMBER> centrifuged <NUMBER> min <NUMBER> g five µl supernatant injected onto hplc<NUMBER> column <NUMBER> hplc analysis performed using shimadzu prominence system shimadzu kioto <NUMBER> japan equipped kinetex c<NUMBER> column <NUMBER>mm length x <NUMBER>mm id <NUMBER> µm particle size <NUMBER> <NUMBER>x weighting dhcq quadratic <NUMBER>x² weighting <NUMBER> <NUMBER> ngml betweenrun imprecision qc levels <NUMBER> <NUMBER> <NUMBER> <NUMBER> ngml ranged <NUMBER> <NUMBER> <NUMBER> hcq <NUMBER> <NUMBER> dhcq <NUMBER> starting measured total trough plasma concentrations measured sacrifice <NUMBER> <NUMBER> <NUMBER> days hcq treatment total lung cytosolic concentrations hcq calculated first <NUMBER> mean trough total plasma concentration hcq used starting point estimate <NUMBER> whole blood concentrations considering blood plasma ratio <NUMBER> reported tett <NUMBER> coworkers <NUMBER> subsequently hcq efficacy target intracellular cytosolic total hcq <NUMBER> concentration ratio estimated based relative lysosomal lung tissue volume well <NUMBER> contributions interstitial intracellular volumes total lung volume ii ph <NUMBER> partition theory applying pka value hcq <NUMBER> based calculations data <NUMBER> shown lung cytosolic hcq concentrations corresponding <NUMBER> total lung tissue <NUMBER> total cytosolic lung tissue concentrationtotal lung tissue concentration ×<NUMBER> <NUMBER> calculated total cytosolic lung concentration compared ec<NUMBER> concentrations <NUMBER> previously reported literature ranging <NUMBER> µm <NUMBER> µm <NUMBER> <NUMBER> hamster tissues collected sacrifice homogenized using bead disruption <NUMBER> precellys <NUMBER> µl rlt buffer rneasy mini kit qiagen centrifuged <NUMBER> rpm <NUMBER> min <NUMBER> pellet cell debris rna extracted according manufacturers instructions <NUMBER> extract rna serum nucleospin kit machereynagel used <NUMBER> μl eluate <NUMBER> <NUMBER> μl used template rtqpcr reactions rtqpcr performed <NUMBER> lightcycler<NUMBER> platform roche using itaq universal probes onestep rtqpcr kit <NUMBER> biorad n<NUMBER> primers probes targeting nucleocapsid <NUMBER> standards sarscov<NUMBER> <NUMBER> cdna idt used express viral genome copies per mg tissue per ml serum <NUMBER> lung tissues homogenized using bead disruption precellys <NUMBER> µl minimal essential <NUMBER> medium centrifuged <NUMBER> rpm <NUMBER>min <NUMBER>°c pellet cell debris quantify infectious <NUMBER> sarscov<NUMBER> particles endpoint titrations performed confluent vero e<NUMBER> cells <NUMBER> well plates viral titers calculated reed muench method using lindenbach <NUMBER> calculator <NUMBER> expressed <NUMBER> tissue culture infectious dose tcid<NUMBER> per mg tissue <NUMBER> histological examination lungs fixed overnight <NUMBER> formaldehyde <NUMBER> embedded paraffin tissue sections <NUMBER> μm analyzed staining hematoxylin <NUMBER> eosin scored blindly lung damage expert pathologist scored <NUMBER> parameters cumulative score <NUMBER> <NUMBER> attributed following <NUMBER> congestion intralalveolar hemorrhagic apoptotic bodies bronchus wall necrotizing <NUMBER> bronchiolitis perivascular edema bronchopneumonia perivascular inflammation <NUMBER> peribronchial inflammation vasculitis microct data hamster lungs acquired vivo using dedicated small animal microct <NUMBER> scanners either using xcube molecubes ghent belgium skyscan <NUMBER> bruker <NUMBER> belgium kontich belgium brief hamsters anaesthetized using isoflurane <NUMBER> <NUMBER> oxygen installed prone position xcube scanner using dedicated imaging <NUMBER> bed scout view acquired lung selected nongated helical ct <NUMBER> acquisition using highresolution ct protocol following parameters <NUMBER> kvp <NUMBER> visualization quantification reconstructed microct data performed <NUMBER> dataviewer ctan software bruker belgium primary outcome measure semi<NUMBER> quantitative scoring microct data performed previously described <NUMBER> visual <NUMBER> observations blindly scored <NUMBER> <NUMBER> depending severity parenchymal <NUMBER> airway disease <NUMBER> different predefined transversal tomographic sections throughout <NUMBER> entire lung image lung airway disease two independent observers <NUMBER> averaged scores <NUMBER> sections summed obtain score <NUMBER> <NUMBER> reflecting <NUMBER> severity lung airway abnormalities compared scans healthy wt control hamsters <NUMBER> secondary measures imagingderived biomarkers nonaerated lung volume aerated lung <NUMBER> volume total lung volume respective densities within volumes quantified <NUMBER> previously <NUMBER> manually delineated volume interest covering lung avoiding heart main blood vessels threshold used distinguish aerated nonaerated <NUMBER> lung volume manually defined kept constant data sets <NUMBER> <NUMBER> <NUMBER> graphpad prism graphpad software inc used perform statistical analysis <NUMBER> statistical significance determined using nonparametric mann whitney utest p <NUMBER> values ≤<NUMBER> considered significant <NUMBER> characterized sarscov<NUMBER> infection readouts disease hamsters <NUMBER> replicates lungs hamsters viral rna detected lungs day <NUMBER> <NUMBER> pi reaching maximum level <NUMBER> log<NUMBER> rna copiesmg tissue <NUMBER> days pi fig <NUMBER>a <NUMBER> similar kinetic profile found ileum stool samples albeit lower levels <NUMBER> <NUMBER> log<NUMBER> rna copiesmg tissue titrations homogenized lung tissue contained infectious <NUMBER> particles <NUMBER> day pi reached levels <NUMBER> log<NUMBER> tcid<NUMBER>mg tissue day <NUMBER> pi onwards <NUMBER> fig <NUMBER>b line viral rna levels infected animals displayed slight weight <NUMBER> loss <NUMBER> day <NUMBER> pi completely resolved day <NUMBER> pi fig <NUMBER>c infiltrates lung consolidation day <NUMBER> pi fig <NUMBER>d analysis staining lungs <NUMBER> infected hamsters day <NUMBER> pi showed signs bronchopneumonia peribronchial <NUMBER> inflammation present day inoculation fig <NUMBER>e <NUMBER> next treated hamsters antiviral molecules four consecutive days starting one hour <NUMBER> intranasal infection sarscov<NUMBER> day <NUMBER> pi microct scan performed <NUMBER> animals sacrificed organs collected quantification viral <NUMBER> rna infectious virus titers lung histopathology fig <NUMBER>a twicedaily treatment <NUMBER> favipiravir done orally loading dose <NUMBER> mgkgday day <NUMBER> pi <NUMBER> mgkgday <NUMBER> day <NUMBER> pi onwards favipiravirtreated hamsters presented decrease <NUMBER> log<NUMBER> rna <NUMBER> copiesmg lung tissue compared untreated infected hamsters fig <NUMBER>b lesser effect <NUMBER> observed ileum stool treated animals fig <NUMBER>b modest reduction infectious <NUMBER> titers <NUMBER> log<NUMBER> tcid<NUMBER>mg observed lungs favipiravirtreated animals fig <NUMBER>c <NUMBER> treatment favipiravir caused <NUMBER> weight loss day <NUMBER> <NUMBER> pi slightly <NUMBER> untreated animals fig <NUMBER>d could due effect administering <NUMBER> relatively high volume compound per os limit <NUMBER> mlkg day due <NUMBER> toxicity molecule despite modest reduction viral load obvious <NUMBER> change improvement worsening rather subtle radiological histological lung <NUMBER> pathology could observed favipiravirtreated hamsters fig <NUMBER>eg quantification <NUMBER> microctderived biomarkers support observations quantify relatively small <NUMBER> burden radiological lung consolidation upon infection change favipiravir <NUMBER> treatment fig <NUMBER>f <NUMBER> hcq sulphate tested alone combination azithromycin dose <NUMBER> mgkgday <NUMBER> equivalent <NUMBER> mgkg hcq base administered intraperitoneally daily <NUMBER> combination azithromycin given orally daily dose <NUMBER> mgkgday treatment <NUMBER> hcq alone resulted modest reduction <NUMBER> log<NUMBER> viral rna copiesmg lung <NUMBER> reduction viral rna load ileum stool compared untreated infected hamsters <NUMBER> fig <NUMBER>b combined azithromycin additional reduction viral rna observed <NUMBER> organs infected animals fig <NUMBER>b virus titrations lungs also revealed <NUMBER> significant reduction treatment hcq alone combination azithromycin fig <NUMBER> <NUMBER>c weight loss animals treated hcq follows along lines untreated <NUMBER> animals <NUMBER> weight loss whole experiment combination treatment <NUMBER> azithromycin caused slightly greater weight loss day <NUMBER> <NUMBER> pi animals could partially recover fig <NUMBER>d similarly radiological improvement observed <NUMBER> nontreated animals animals treated hcq hcq combination <NUMBER> azithromycin confirmed quantification microctderived biomarkers lung <NUMBER> pathology fig <NUMBER>eg fig <NUMBER> indicates <NUMBER> fecaloral route marginally contributes transmission sarscov<NUMBER> <NUMBER> hamsters thereby confirming results previous study <NUMBER> therefore continued <NUMBER> focusing transmission virus via direct contact <NUMBER> using transmission model investigated prophylactic potential hcq favipiravir <NUMBER> sarscov<NUMBER> sentinel hamsters received daily dosage <NUMBER> consecutive days <NUMBER> either hcq favipiravir starting <NUMBER> hours prior exposure individual sentinel hamster <NUMBER> cohoused index hamster intranasally inoculated sarscov<NUMBER> <NUMBER> day fig <NUMBER>a index hamsters sacrificed <NUMBER> days pi sentinels <NUMBER> days post <NUMBER> exposure viral loads lung ileum stool determined index hamsters <NUMBER> <NUMBER> log<NUMBER> viral rna copiesmg lungs whereas untreated sentinel hamsters <NUMBER> log<NUMBER> viral rna copiesmg lungs fig <NUMBER>b even though variability <NUMBER> individual hamsters sentinel groups pronounced index groups <NUMBER> reduction viral rna observed either favipiraviror hcqtreated sentinel hamsters <NUMBER> also ileum stool viral rna levels reduced compound treatment <NUMBER> infectious viral loads lungs also reduced treatment either compound <NUMBER> fig <NUMBER>c line viral rna data contrast index hamsters sentinel <NUMBER> hamsters lose weight gained around <NUMBER> body weight day <NUMBER> pi sentinels <NUMBER> received hcq favipiravir treatment gained less body weight untreated sentinels <NUMBER> <NUMBER> <NUMBER> respectively fig <NUMBER>d pathology scores derived microct scans <NUMBER> hamsters revealed multifocal pulmonary infiltrates consolidations <NUMBER> hamsters fig <NUMBER>e <NUMBER>f also microctderived biomarkers showed difference lung <NUMBER> pathology untreated treated sentinel hamsters fig <NUMBER>g confirming <NUMBER> hydroxychloroquine favipiravir failed prevent sarscov<NUMBER> infection transmission <NUMBER> model <NUMBER> based measurement trough concentrations hcq sacrifice n<NUMBER> mean ± sd <NUMBER> trough plasma concentration <NUMBER> <NUMBER> ngml <NUMBER> ± <NUMBER> µm found fig <NUMBER>a <NUMBER> comparable plasma trough concentrations detected cynomolgus macaques <NUMBER> treated dosing regimen <NUMBER> mgkg day <NUMBER> pi loading dose followed daily <NUMBER> maintenance dose <NUMBER> mgkg <NUMBER> patients <NUMBER> days starting treatment <NUMBER> <NUMBER> mg three times daily <NUMBER> peak viral load lungs significantly associated <NUMBER> plasma hcq concentrations individual hamsters fig <NUMBER>b suggesting higher hcq <NUMBER> exposure result pronounced reduction viral infection <NUMBER> according equation <NUMBER> whole blood concentration <NUMBER> ± <NUMBER> µm calculated fig <NUMBER> <NUMBER>c subsequently applying equation <NUMBER> resulted total lung concentration <NUMBER> ± <NUMBER> <NUMBER> µm indicating lung tissues achieved hcq concentrations reported <NUMBER> vitro ec<NUMBER> values ranging <NUMBER> <NUMBER> µm median value <NUMBER> µm interquartile range <NUMBER> <NUMBER> <NUMBER> estimate <NUMBER> inhibition viral replication ec<NUMBER> <NUMBER> ec<NUMBER> equated <NUMBER> times ec<NUMBER> resulting target lung concentration <NUMBER> ± <NUMBER> <NUMBER> µm case efficacy target trough would reached applying <NUMBER> dosing regimen ie <NUMBER> mg hcq sulphatekgday however important note <NUMBER> total lung tissue concentrations described consist intracellular interstitial <NUMBER> hcq concentrations vivo antiviral mechanisms action hcq sars<NUMBER> cov<NUMBER> clarified yet might exclusively inhibition endosome <NUMBER> acidification <NUMBER> hcq concentrations calculated cytosolic lung tissue endosomal<NUMBER> lysosomal compartment cells interstitial compartment assuming cytosolic <NUMBER> hcq concentrations <NUMBER> total tissue concentrations total cytosolic lung tissue <NUMBER> concentration <NUMBER> ± <NUMBER> µm calculated value line median vitro <NUMBER> ec<NUMBER> value well estimated ec<NUMBER> value also interstitial concentration <NUMBER> calculated <NUMBER> µm contrast endosomallysosomal hcq concentration <NUMBER> calculated <NUMBER> mm much higher estimated ec<NUMBER> previous study showed wildtype syrian hamsters highly susceptible sars<NUMBER> cov<NUMBER> infections <NUMBER> characterized hamster infection model allow use <NUMBER> model antiviral drug evaluation agreement previous studies upon intranasal <NUMBER> inoculation observed virus replicates efficiently peak levels <NUMBER> log<NUMBER> tcid<NUMBER>mg <NUMBER> lungs day <NUMBER> pi supported radiological pathological evidence <NUMBER> although virus also present ileum stool infected hamsters levels <NUMBER> significantly lower <NUMBER> log<NUMBER> copiesmg besides serving efficient replication reservoirs <NUMBER> sarscov<NUMBER> hamsters also efficiently transmit virus cohoused sentinels <NUMBER> <NUMBER> <NUMBER> demonstrated virus mainly transmitted via direct contact limited <NUMBER> extent via fecaloral route variability observed virus titers lungs <NUMBER> sentinels probably due differences infection stage animals <NUMBER> besides hamsters variety animals tested permissiveness <NUMBER> sarscov<NUMBER> ferrets nonhuman primates sensitive ones <NUMBER> <NUMBER> ferrets infectious sarscov<NUMBER> detected nasal turbinate lesser extent <NUMBER> soft palate tonsils lungs <NUMBER> although different study infectious <NUMBER> virus lungs ferrets detected levels remained close limit detection <NUMBER> <NUMBER> indicates ferrets support sarscov<NUMBER> replication albeit lesser extent hamsters <NUMBER> sarscov<NUMBER>infected macaques rhesus cynomolgus virus levels <NUMBER> highest nasal swabs lungs <NUMBER> sarscov<NUMBER> infection resulted moderate transient <NUMBER> disease rhesus macaques whereas cynomolgus macaques remained asymptomatic <NUMBER> develop lung pathology seen covid<NUMBER> <NUMBER> although aged macaque models may <NUMBER> represent best models studying severe covid<NUMBER> disease <NUMBER> high costs severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER>the virus causes coronavirus disease covid<NUMBER>has detected domestic dogs cats raising concerns transmission animals late march <NUMBER> report hong kong indicated two nineteen dogs one nine cats households confirmed human covid<NUMBER> cases persons close contact confirmed patients tested positive virus <NUMBER> <NUMBER> belgium cat household confirmed covid<NUMBER> case determined infected <NUMBER> april beginning may additional six cases covid<NUMBER> among domestic cats confirmed belgium france spain united states <NUMBER> currently indication felineor caninetohuman transmission occur evidence possible humantofeline humantocanine transmission <NUMBER> <NUMBER> animaltoanimal transmission also appears plausible recently published preprint <NUMBER> infections cats original epicenter covid<NUMBER>wuhan chinaresearchers examined serological samples domestic stray cats samples collected january february <NUMBER> among <NUMBER> positive positive samples cats cared human covid<NUMBER> cases cats pet hospital samples stray cats known link human covid<NUMBER> cases also positive indicating possibility sustained felinetofeline transmission among stray cats domestic animals ones affected early april <NUMBER>yearold female malayan tiger cub tested positive sarscov<NUMBER> new york six tigers lions zoo symptoms consistent illness considered presumptive positive cases virus likely transmitted cats asymptomatic zookeeper though whether cats infected human keeper felinetofeline transmission occurred initial introduction virus cats uncertain addition late april dutch ministry agriculture nature food quality notified world organisation animal health oie outbreak covid<NUMBER> four mink farms used fur production three farms epidemiologically linked fourth farm connection previous outbreaks two infected farms reported early may although humantomink transmission considered probable source outbreaks transmission minks indicated main driver <NUMBER> contrast infected domestic dogs cats typically asymptomatic mild course disease following infection infected minks suffered severe course involving pneumonia death <NUMBER> experimental evidence <NUMBER> <NUMBER> classified mustalids mink ferrets felids cats domestic exotic rabbits highly susceptible covid<NUMBER> canids domesticated birds pigs less likely become infected transmit disease experiments <NUMBER> authors inoculated infected animals high viral loads however majority serological samples collected stray domestic cats showed relatively weak viral titer <NUMBER> similarly viral titers infected dog hong kong also weak dog never considered contagious dogs humans <NUMBER> light information rampant transmission sarscov<NUMBER> among stray cats wuhan seems unlikely however sustained transmission among domesticated animals possible sarscov<NUMBER> may pose substantial threat animal communities also risk animals act reservoir virus <NUMBER> paper attempt resolve uncertainty around sarscov<NUMBER> transmission potential animals quantify transmission strength mathematical terms <NUMBER> aggregated publicly available records confirmed cases covid<NUMBER> among animals <NUMBER> estimated basic reproduction number r<NUMBER>the average number secondary cases generated single primary caseamong cats using results serological study zhang et al <NUMBER> modeling framework data analysis draw inferences transmissibility discuss implications current covid<NUMBER> pandemic retrieved information confirmed sarscov<NUMBER> animal cases publicly available immediate notifications followup reports world animal health information system wahis published world organization animal health oie httpswwwoieintwahis<NUMBER>publicwahidphpwahidhomehome information infected captive felids bronx zoo new york usa additionally verified press releases wildlife conservation society nonprofit organization runs bronx zoo httpsnewsroomwcsorg order avoid missing possible reports also scanned promedmailing list httppromedmailorg using query covid animals modeling framework possible sustained chain transmission among domestic stray cats wuhan china <NUMBER> assumed homogeneous mixing random independent sampling process collection serological samples employed formula final size epidemic estimate basic reproduction number given number positive tests taken among total n samples fraction positives entire population estimated using binomial likelihood ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint basic reproduction number linked value follows knowing value also estimated probability major outbreak according formula derivation relies assumption infectious period follows exponential distribution <NUMBER> statistical inference done bayesian framework running markov chain monte carlo mcmc simulations stan cmdstan version <NUMBER> code available httpgithubcomaakhmetzcovid<NUMBER>catsstory table <NUMBER> presents aggregated list <NUMBER> animal cases confirmed sarscov<NUMBER> infection cases recovered disease except two first case dog hong kong d<NUMBER>the first reported case covid<NUMBER> animalsdied two days release quarantine death linked sarscov<NUMBER> infection second case cat spain c<NUMBER> euthanatized veterinary clinic due severe heart problems three animals hong kong d<NUMBER> c<NUMBER> exhibit clinical signs infection six cat cases europe united states c<NUMBER> <NUMBER> <NUMBER> showed mild respiratory digestive symptoms captive felids bronx zoo new york f<NUMBER> exhibited dry cough wheezing shown respiratory distress though one animal lost appetite ◎ indicates positive test shown red positive sample nasal andor oral swab symbol black virus detected fecal sample case cat belgium virus also sampled vomit × mark indicates negative test 〇 indicates positive antibody test sera upright black triangle ▼ indicates date quarantine start lower black triangle ▲ date release quarantine black square ■ indicates death animal unless otherwise indicated animal recovered disease dates specified reports data samples taken animal shown last column question mark na indicates information viral titer available links individual reports case found supplementary materials note cases among domestic animals except one linked households sarscov<NUMBER> infected owners one unlinked case cat new york c<NUMBER> lived healthy household allowed walk outside likely infected neighborhood interested whether transmission within cat populations could occurring turned attention study zhang et al <NUMBER> serological samples domestic stray cats wuhan china serological samples collected january february <NUMBER> <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint positive positive samples cats cared human covid<NUMBER> cases pet hospital stray cats known link human covid<NUMBER> cases tested positive well following modeling framework <NUMBER> estimated basic reproduction number <NUMBER> <NUMBER> confidence interval ci <NUMBER> <NUMBER> suggested probability major outbreak around <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> given low probability likelihood sustained transmission among domestic stray cats occurred wuhan china low hong kong pets human covid<NUMBER> cases generally quarantined tested <NUMBER> favors detection mild asymptomatic cases however countries symptomatic pets likely detected typically testing done unless animals symptomatic line logic three cases hong kong show specific symptoms covid<NUMBER> cases reported elsewhere exhibited respiratory digestive symptoms observed difference severity disease animals may additionally explained difference prevalence covid<NUMBER> human casesas <NUMBER> may hong kong reported one thousand cases countries domestic animal cases reported <NUMBER> human cases secondary attack rate sarscov<NUMBER> human pets appears low may also driven infectiousness profile owners government hong kong reported <NUMBER> animals including <NUMBER> hamsters tested <NUMBER> april <NUMBER> however count confirmed cases remained compared earlier numbers <NUMBER> recent preprint <NUMBER> reported absence sarscov<NUMBER> infections among <NUMBER> cats <NUMBER> dogs whose ownersveterinary students <NUMBER>yearold age groupformed cluster covid<NUMBER> cases france among <NUMBER> infected individuals <NUMBER> confirmed pcr testing <NUMBER> presumptive cases <NUMBER> asymptomatic <NUMBER> one hand may suggest lower infectiousness <NUMBER>yearold individuals compared pet owners heterogenous age profile hand presence asymptomatic human carriers could also play role studies shown highlighted lack secondary infections households asymptomatic index cases <NUMBER> <NUMBER> historical records closely related virus sarscov<NUMBER> reveal similar story <NUMBER> outbreak sars cats ferrets experimentally infected sarscov<NUMBER> <NUMBER> community transmission humans domestic animals documented oncein amoy gardens complex hong kong two blocks high level contamination eight cats one dog tested positive rectal swabs <NUMBER> transmission animals animals humans affected areas speculated <NUMBER> contrast animals infected even lethally seasonal influenza virus transmitted owner <NUMBER> humantoanimal transmission potential sarscov<NUMBER> likely lies somewhere sarscov<NUMBER> influenza <NUMBER> estimate <NUMBER> transmission cats much lower estimate <NUMBER> humans area <NUMBER> however results subject limitations first data shared <NUMBER> allow us distinguish negative serological tests domestic cats stray cats therefore assumed domestic cats part chain transmission among cats also assumed stray cats unlikely close contact humans however stray cats could fed humans chance virus could transmitted infected human stray cat contaminated feeder fomite second assumed interventions implemented chinese government halt epidemic wuhan februarymarch <NUMBER> affect transmission dynamics virus among cats third calculation probability major outbreakestimated <NUMBER>relied assumption homogeneous contact pattern stray domestic cats imposed exponentially distributed infectious period use heterogeneous contact pattern example gamma distribution infectious period would provide precise results <NUMBER> <NUMBER> <NUMBER> however incorporation factors requires detailed data serological tests cat population wuhan available preprint zhang et al ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint conclusion current evidence supports advice veterinary authorities worldwide pet owners persons covid<NUMBER> close contact animals pay special attention way interact clear evidence virus minimally transmissible among domestic animals sporadic detections found likely weakly positive therefore infections domestic cats dogs likely came directly infected humans time scientific evidence continues indicate probability sarscov<NUMBER> transmission domestic animals humans extremely low u ntil end <NUMBER> six coronaviruses known cause disease humans four result little common cold endemic around world viruses known human coronavirus hcov<NUMBER>e hcovhku<NUMBER> hcovnl<NUMBER> hcovoc<NUMBER> little concern global public health level two however caused widespread concern <NUMBER> severe acute respiratory syndrome coronavirus sarscov emerged human population matter months virus bat transmitted via palm civet infect human guangdong province china infected <NUMBER> people killing roughly <NUMBER> <NUMBER> <NUMBER> sarscov infections stopped virus seen since second epidemic coronavirus known middle east respiratory syndrome coronavirus merscov emerged <NUMBER> like sarscov outbreak merscov started patient suffering pneumonia came zoonotic event time bat via camel human <NUMBER> however merscov shown far limited humantohuman transmission sarscov since <NUMBER> roughly <NUMBER> cases merscov mostly confined regions middle east case numbers low merscov high case fatality ratio cfr approximately <NUMBER> making virus one deadliest human pathogens coronaviruses infect humans appear respiratory transmission making pathogens pandemic potential end <NUMBER> saw emergence novel human coronavirus rapidly spreading around global higher degree lethality endemic coronaviruses though level sarscov merscov virus initially named <NUMBER>ncov termed sarscov<NUMBER> causes disease covid<NUMBER> coronavirus disease <NUMBER> time writing <NUMBER> cases <NUMBER> deaths first case covid<NUMBER> reported chinese authorities <NUMBER> december <NUMBER> result patient suffering pneumonia wuhan city hubei province china following days patients suspected suffering disease <NUMBER> january novel coronavirus detected sequence published online shortly thereafter <NUMBER> <NUMBER> months since emergence sarscov<NUMBER> demonstrated rapid pace virus spread science develop initial lag phase cases covid<NUMBER> followed closely exponential curve vast majority cases time writing still mainland china however <NUMBER> countries reported cases cases outside china associated travel country clusters cases detected without travel history article discuss already learned virus outline <NUMBER> key questions directions study novel coronavirus sarscov<NUMBER> virology novel virus coronaviridae family therefore shares common features family coronaviruses large ϳ<NUMBER>kb singlestranded positivesense rna genomes genome roughly divided <NUMBER> twothirds <NUMBER> third first twothirds genome code two large polyproteins pp<NUMBER>a pp<NUMBER>ab orf<NUMBER>a orf<NUMBER>b proteolytically cleaved nonstructural proteins nsp<NUMBER> <NUMBER> essential production new viral genetic material remainder genome codes structural proteins carries accessory genes produce virions alter host response respectively <NUMBER> naming may suggest newly emerged coronavirus closely related sarscov sharing roughly <NUMBER> identity nucleotide level closest relative sarscov<NUMBER> appears virus found bats known ratg<NUMBER> <NUMBER> identity suggesting similarly sarscov virus entered human population spillover event either directly bat animal intermediate <NUMBER> early studies sarscov<NUMBER> shown similarities namesake virus spike protein utilizes ace<NUMBER> cell surface receptor <NUMBER> <NUMBER> ace<NUMBER> found ciliated epithelial cells human lungs receptor utilization influences tropism viruses based speed outbreak covid<NUMBER> developed sarscov<NUMBER> appears spread easily human population many health care workers infected clusters cases detected passing day reproductive number r <NUMBER> virus currently thought around <NUMBER> <NUMBER> suggesting potential sustained humantohuman transmission appears respiratory droplets potentially fecaloral route <NUMBER> much gleaned general understanding coronavirus biology early studies sarscov<NUMBER> many pertinent questions exist outline <NUMBER> animal reservoirintermediate host bat virus termed ratg<NUMBER> <NUMBER> identity sarscov<NUMBER> <NUMBER> strongly pointing toward shared common ancestor suggesting novel human pathogen originated bats zoonoses first occurred remains interesting question sarscov merscov also common ancestry viruses found bats viruses intermediate host transmission humans palm civets camels sarsand merscov respectively <NUMBER> suggestion pangolins may intermediate host sarscov<NUMBER> <NUMBER> remains established knowing intermediate host important step understanding sarscov<NUMBER> became human virus potentially curtail spillover events knowing merscov transmits humans via dromedary camels allowed development camel vaccine potentially limit spread humans <NUMBER> <NUMBER> approval novel vaccines animal hosts far easier humans moreover knowing intermediate host allows measures taken limit human contact animal eg selling meat animals wet food markets help reduce chances future spillover events however spread sarscov<NUMBER> extensive whether measures would effective limiting human cases covid<NUMBER> may unlikely ii true case count mild symptomsasymptomatic carriers lethality since early stages covid<NUMBER> outbreak case fatality ratio cfr around <NUMBER> <NUMBER> much lower cfr seen sars mers around <NUMBER> <NUMBER> respectively however many people remain severe conditions hospitals result covid<NUMBER> could see cfr increase said true burden disease human population currently unknown recent report approximately <NUMBER> chinese patients showed <NUMBER> develop mild symptoms <NUMBER> develop severe symptoms <NUMBER> become critically ill <NUMBER> study suggests even among people symptoms severe enough tested sarscov<NUMBER> still mild symptoms may suggest many people symptoms mild enough require testing would make true case count far larger extension cfr lower early estimates suggested true case count may much <NUMBER> times higher reported <NUMBER> establishing true disease burden human population take time retrospective serological survey secondary aspect relation controlling current disease outbreak remains interesting question determined moving forward iii comorbidities associated severe disease outcome affect viral pathogenesis cases covid<NUMBER> occur becoming established severe cases mortality associated underlying health conditions common associated comorbidities pulmonary disease diabetes old age <NUMBER> interesting questions comorbidities impact viral pathogenesis open investigation severe sars cases also associated age work mice demonstrated <NUMBER> <NUMBER> <NUMBER> severe mers associated diabetes underlying health conditions <NUMBER> <NUMBER> work mice shown diabetes impact immune response infection leading increased pathogenesis <NUMBER> interesting see whether sarscov<NUMBER> infection similarly impacted iv spread sarscov<NUMBER> containedwill virus persist human population four seven human coronaviruses endemic around world cause little common cold currently sarscov<NUMBER> global epidemic potential considered pandemic one scenario outbreak may contained virus never seen like sarscov alternatively virus may become endemic virus seasonality like influenza human coronaviruses however early know whether sarscov<NUMBER> spread affected changing weather conditions nearly cases covid<NUMBER> china winter whether cases decrease temperatures increase northern hemisphere seen influenza remains seen v vitro vivo systems used research important question understanding sarscov<NUMBER> infection systems used study early studies sarscov<NUMBER> determined cellular receptor virus ace<NUMBER> similarly sarscov <NUMBER> knowledge helps develop understanding susceptibility certain vitro cell lines infection novel virus likelihood cells permissive growth sarscov probably support growth sarscov<NUMBER> labs around world start researching new virus better understanding permissive cell lines developed important step testing therapeutic options developing better understanding basic aspects sarscov<NUMBER> virology challenging aspect labbased research novel human coronavirus developing smallanimal models early research receptor usage suggests virus able infect cells expressing mouse ace<NUMBER> <NUMBER> thus making mouse model potentially challenging whether expression human ace<NUMBER> mouse lungs using adenovirus mouse adaptation sarscov<NUMBER> develop appropriate models done sarscov <NUMBER> pressing question whether smallanimal models used also needs investigated models essential thoroughly testing therapeutic candidates vaccine strategies understanding pathology disease vi find therapeutic options case count death toll epidemic continue increase becomes imperative identify therapeutic options covid<NUMBER> vitro vivo systems established tests proceed drug repurposing may prove best strategy quick development novel therapeutic options novel therapeutic tested remdesivir <NUMBER> <NUMBER> combination chloroquine found inhibit sarscov<NUMBER> growth vitro <NUMBER> recently announced nih remdesivir would entering phase <NUMBER> clinical trials humans chloroquine also reported effective patients china <NUMBER> combination lopinavir ritonavir also investigation human cases covid<NUMBER> china many people need treated drugs determine true efficacy promising leads vii vaccination strategy developed effective strategy contain virus spread vaccination sarscov merscov outbreaks much research went developing vaccine strategies <NUMBER> however cessation sars epidemic minimal humantohuman transmission merscov curtailed testing interventions humans emergence sarscov<NUMBER> new impetus development coronavirus vaccines generated several platforms used develop vaccines sarscov<NUMBER> including spike subunit dna rna wholevirion nanoparticle vaccines future testing cells animal models determine likely successful humans viii host response sarscov<NUMBER> pathology covid<NUMBER> initial push look therapeutic vaccine options help treat prevent covid<NUMBER> important better understand host response infection pathology disease prerequisite step course development appropriate animal models better understanding sarscov<NUMBER> causes pathology way host responds may help direct therapeutic avenues understanding comorbidities diabetes impact host response infection also important better understand covid<NUMBER> ix sarscov<NUMBER> appear spread rapidly sarscov merscov human population compared two highly pathogenic coronaviruses emerged <NUMBER>st century sarscov<NUMBER> appears spread well human population case interesting understand sarscov sarscov<NUMBER> appear use cell receptor ace<NUMBER> suggesting similar tropism yet novel coronavirus appears spread much efficiently simply based number cases speed emerged whether proteolytic cleavage sites furin site spike protein sarscov<NUMBER> influence important determine outbreak next many coronaviruses found bats potential spread human population <NUMBER> <NUMBER> <NUMBER> developing understanding difference dynamics spread sarscov<NUMBER> coronaviruses provide insights understand viruses may pose threat zoonotic transmission mass spread human population leading final question x next coronavirus enter human population past <NUMBER> years seen emergence three novel coronaviruses caused significant morbidity mortality human population continued surveillance viruses animal populations understanding factors influence zoonotic events essential attempts limit future outbreaks conclusion year <NUMBER> started rapid global epidemic virus sarscov<NUMBER> causing disease covid<NUMBER> virus appears transmitted humans zoonotic event bats many questions investigate regarding aspects sarscov<NUMBER> virology epidemiology questions range virus emerged spreads disease manifests pressingly global outbreak continues grow develop effective vaccine therapeutic strategies treat epidemic future coronavirus spillover events reninangiotensin system ras maintains homeostasis blood pressure balance fluid salts <NUMBER> homeostasis ras critical physiological pathological regulation various organs including heart kidneys lungs <NUMBER> angiotensinconverting enzyme ace <NUMBER> potent negative regulator ras critical maintaining homeostasis ras <NUMBER> <NUMBER> human ace<NUMBER> gene located chromosome xp<NUMBER> includes <NUMBER> exons functioning typical zinc metallopeptidase ace<NUMBER> protein contains <NUMBER> amino acids type integral membrane glycoprotein containing single catalytic domain <NUMBER> ras ace<NUMBER> degrades angiotensin ang ii potent vasoconstriction proinflammation profibrosis converts ang <NUMBER> vasodialatic antiproliferative apoptotic <NUMBER> besides systemic effect blood pressure regulation ace<NUMBER> local regulatory effects pathological changes several organs including heart kidneys lungs <NUMBER> ace<NUMBER> also regulates amino acid absorption kidney gut modulates expression transporters amino acid <NUMBER> ace<NUMBER> identified receptor severe acute respiratory syndrome coronavirus sarscov could rapidly cause acute lung failure humans <NUMBER> hence ace<NUMBER> vital viral entry host cells sarscov infection coronavirus disease <NUMBER> covid<NUMBER> pandemic declared world health organization <NUMBER> march <NUMBER> <NUMBER> accumulated one million confirmed cases globally early april <NUMBER> <NUMBER> epidemiological study revealed covid<NUMBER> infected people ages <NUMBER> elderly comorbid patients higher risk poor clinical outcomes prognosis <NUMBER> <NUMBER> highthroughput sequencing identified pathogen covid<NUMBER> novel betacoronavirus <NUMBER> named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> international committee taxonomy viruses <NUMBER> comparing sarscov sarscov<NUMBER> infective causing <NUMBER> times infections globally <NUMBER> confirmed cases covid<NUMBER> <NUMBER> april <NUMBER> <NUMBER> vs <NUMBER> sars patients <NUMBER> seems less virulent parts patients showed similar severity sarscov infection <NUMBER> also global case fatality rate covid<NUMBER> <NUMBER> <NUMBER> according data <NUMBER> april <NUMBER> <NUMBER> lower sarscov infection <NUMBER> <NUMBER> <NUMBER> similar sarscov sarscov<NUMBER> mainly transmits respiratory droplets direct contact according reported cases <NUMBER> <NUMBER> also entry sarscov<NUMBER> host cells requires binding receptor via sspike surface virus <NUMBER> computational modeling <NUMBER> <NUMBER> viral infection experiments using hela cells express ace<NUMBER> protein humans chinese horseshoe bats civets pigs mice <NUMBER> provided evidence ace<NUMBER> receptor sarscov<NUMBER> results cryoem experiments demonstrated sarscov<NUMBER> ten times higher affinity ace<NUMBER> comparing sarscov consistent higher efficiency infection sarscov<NUMBER> <NUMBER> findings indicated ace<NUMBER> might crucial human infection sarscov<NUMBER> progression prognosis covid<NUMBER> understanding expression activity ace<NUMBER> different physiological pathological conditions may help predict susceptibility sarscov<NUMBER> different cohorts people clinical outcomes prognosis covid<NUMBER> patients present review summarize regulation function ace<NUMBER> different physiological pathological states discuss potential implication sarscov<NUMBER> infectioninduced covid<NUMBER> organs express higher level ace<NUMBER> potential targets sarscov<NUMBER> infection therefore distribution abundance ace<NUMBER> organs may closely related clinical symptoms covid<NUMBER> known ace<NUMBER> enriched heart kidneys testes also broadly distributed lungs liver intestine brain <NUMBER> lung primary target organ sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> hospitalized patients infected sarscov<NUMBER> developed pneumonia typically characterized groundglass opacity bilateral patchy shadowing chest computed tomography <NUMBER> <NUMBER> pathological examination biopsy samples obtained deceased covid<NUMBER> patient revealed diffused alveolar damage cellular fibromyxoid exudates lungs <NUMBER> analysis singlecell rna sequencing data obtained <NUMBER> human lung cells revealed <NUMBER> cells lungs expressed ace<NUMBER> <NUMBER> ace<NUMBER> expressed type ii apical surface epithelial cells at<NUMBER> <NUMBER> types cells including type apical epithelial cells airway epithelial cells fibroblasts endothelial cells macrophages also express ace<NUMBER> lower levels at<NUMBER> <NUMBER> results indicated at<NUMBER> likely primary target sarscov<NUMBER> lungs <NUMBER> addition respiratory symptoms common complications found patients infected sarscov<NUMBER> include acute cardiac injury acute kidney injury <NUMBER> <NUMBER> rectal swabs stool urine saliva sampled covid<NUMBER> patients positive sarscov<NUMBER> virus <NUMBER> findings demonstrated broad distribution sarscov<NUMBER> humans whose pattern similar distribution ace<NUMBER> analysis singlecell rna sequencing data human organs revealed cells express ace<NUMBER> included <NUMBER> cardiomyocyte <NUMBER> proximal tubular epithelial cells <NUMBER> bladder urothelial cells <NUMBER> ileum epithelial cells <NUMBER> esophageal epithelial cell <NUMBER> respiratory tract epithelial cells <NUMBER> sarscov<NUMBER> may attack cells binding ace<NUMBER> tissue damage inflammation may cause severe complications may worsen clinical outcomes moreover positive detection rna sarscov<NUMBER> samples gastrointestinal tissues stool covid<NUMBER> patients suggested fecaloral transmission might possible <NUMBER> noteworthy placental villi uterus also express ace<NUMBER> <NUMBER> <NUMBER> indicating possibility vertical maternalfetal transmission current reports clinical observations indicated transmission route possible <NUMBER> <NUMBER> <NUMBER> may low risk <NUMBER> <NUMBER> sex hormones affect homeostasis ras although ace<NUMBER> activity showed difference male female <NUMBER> males higher expression levels ace<NUMBER> lungs compared females <NUMBER> moreover least five types cells lungs males express ace<NUMBER> two four types females lungs <NUMBER> consistent findings sarscov<NUMBER> infected males slightly statistically significantly higher females <NUMBER> vs <NUMBER> survey included <NUMBER> patients <NUMBER> female sex hormones may affect ace<NUMBER> <NUMBER> aceace<NUMBER> activity ratio male serum higher females may partially attribute activation effect estrogen ace<NUMBER> activity <NUMBER> pregnancy fluctuation hormones may drastically change expression ace<NUMBER> reproductive system organs <NUMBER> ace<NUMBER> mrna expression uterus pregnant rats significantly higher one unpregnant rats <NUMBER> indicating implication progesterone regulation ace<NUMBER> expression <NUMBER> similar upregulation ace<NUMBER> expression also found kidneys pregnant rats <NUMBER> results suggested pregnant women infected sarscov<NUMBER> watched severe complications rapid progression according data collected <NUMBER> patients laboratoryconfirmed covid<NUMBER> <NUMBER> hospitals mainland china average age severe patients n <NUMBER> significantly older nonsevere ones n <NUMBER> seven years <NUMBER> among critically ill covid<NUMBER> patients nonsurvivors <NUMBER> years older survivors <NUMBER> years <NUMBER> data indicated aging might correlated pathological progression poor prognosis covid<NUMBER> results obtained genetic knockout mice model demonstrated ace<NUMBER> depletion caused physiological early aging independent ang <NUMBER> indicating regulatory role ace<NUMBER> aging <NUMBER> ace<NUMBER> expression lungs may decrease aging according results aged rats <NUMBER> humans ace<NUMBER> activity differ young aged males showed significant difference young aged females <NUMBER> <NUMBER> finding indicated effect aging ace<NUMBER> activity might gender difference <NUMBER> <NUMBER> study included <NUMBER> healthy chinese volunteers young chinese females showed significantly higher ace<NUMBER> activity aged females <NUMBER> however activity ace<NUMBER> women aging controversial spanish group reported lower ace<NUMBER> activity young females comparing aged females <NUMBER> controversy may due sample numberinduced deviation race requires validation investigation although children ages susceptible covid<NUMBER> accumulating clinical data indicated lower infection rates better clinical outcomes children compared adults <NUMBER> <NUMBER> recently retrospective study analyzed clinical data <NUMBER> pediatric cases covid<NUMBER> found <NUMBER> pediatric patients asymptomatic mild moderate cases <NUMBER> although currently lacks explanation phenomenon authors speculated potential implication ace<NUMBER> <NUMBER> results animal studies implied ace<NUMBER> expression adults might higher children sheep could used animal model studying development ras <NUMBER> expression ace<NUMBER> significantly lower neonatal sheep comparing li et al pharmacological research <NUMBER> <NUMBER> <NUMBER> adult ones <NUMBER> finding seems indicate lower ace<NUMBER> expression might correlated lower susceptibility children sarscov<NUMBER> however expression activity ace<NUMBER> development human children teenagers largely unclear <NUMBER> according latest study covid<NUMBER> <NUMBER> current smokers <NUMBER> patients severe neversmokers indicated severe rate smoker <NUMBER> <NUMBER> vs neversmoker <NUMBER> <NUMBER> <NUMBER> data suggested cigarette smoking may affect pathogenesis progression covid<NUMBER> ace<NUMBER> content blood healthy male volunteers decreased long term smoking experience <NUMBER> effect cigarette smoking may attribute nicotine could suppress activity ace<NUMBER>ang <NUMBER>mas receptor axis upregulate aceang ii ang ii type <NUMBER> receptor <NUMBER> decreased ace<NUMBER> level accompanied imbalance aceace<NUMBER> hence disturbance ras homeostasis animal experiments demonstrated downregulation ace<NUMBER> contributes pathogenesis cigarette smokinginduced pulmonary arterial hypertension pah <NUMBER> expression activity ace<NUMBER> may promptly modulated diets especially salt glucose fat high salt diet increased activity ace<NUMBER> urine mice low salt intake decreased <NUMBER> activity ace<NUMBER> urine may reflect ace<NUMBER> kidneys <NUMBER> indeed found high salt diet increased aceace<NUMBER> ratio glomeruli resulted renal dysfunction via inducing oxidative stress <NUMBER> ace<NUMBER> also implicated hypertension whose pathogenesis closely correlated high salt intake high salt intake increased prevalence hypertension human ace<NUMBER> rs<NUMBER> tt rs<NUMBER> gg genes <NUMBER> spontaneous hypertension rat model high salt diet profoundly worsened symptoms hypertension impaired kidneys via decreasing ace<NUMBER> <NUMBER> high glucose diet could also upregulate ace downregulate ace<NUMBER> leading imbalance aceace<NUMBER> heart <NUMBER> strikingly effect diet could affect offspring animal experiments using high salt dietfed pregnant sheep revealed suppress effect high salt diet ace<NUMBER> may affect embryo last post natal <NUMBER> western diet could decrease methylation ace<NUMBER> gene kidneys brain stem perinatal mice resulted autonomic dysfunctions male offspring <NUMBER> findings collectively demonstrated impact diet ace<NUMBER> may involved pathogenesis several chronic diseases may even affect offspring covid<NUMBER> patients comorbidities likely progress critically ill patients compared without comorbidities <NUMBER> <NUMBER> found patients coexisting disorders including chronic obstructive pulmonary disease copd hypertension coronary heart disease chronic kidney disease diabetes significantly severe patients without existing disorders table <NUMBER> <NUMBER> likely patients chronic diseases usually aged weak immunity poor respiratory tract function including weakened movement respiratory mucosal cilia cells reduced ability excrete cough reflexes several complications reported covid<NUMBER> patients closely correlated severity disease table <NUMBER> studying implication regulation ace<NUMBER> diseased status would help understanding progression covid<NUMBER> prognosis since sarscov<NUMBER> mainly transmits via respiratory droplets ace<NUMBER> mostly distributed at<NUMBER> cells lung preliminary target organ sarscov<NUMBER> infection pneumonia common complication seen covid<NUMBER> patients occurrence <NUMBER> <NUMBER> acute respiratory distress syndrome ards one severe complications covid<NUMBER> patients severity rate ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> wellestablished protective effects lungs <NUMBER> ace<NUMBER> polymorphism correlated severity ards <NUMBER> ace<NUMBER> knockout mice showed severe ardslike injury pathology lungs comparing wild type controls <NUMBER> symptoms alleviated treatment catalytically active enzymatically inactive recombinant ace<NUMBER> race<NUMBER> protein <NUMBER> moreover ace<NUMBER> also protective sarsinfection induced acute lung disease <NUMBER> expression ace<NUMBER> lungs mice infected sarscov greatly reduced aggravated lung failure <NUMBER> results convincingly proved ace<NUMBER> protective lung injury may therapeutic target ards shown covid<NUMBER> ace<NUMBER> mrna expression decreased lungs copd rats model comparing controls <NUMBER> reduction ace<NUMBER> copd lungs revealed dysregulation ras may attribute upregulation et<NUMBER> et<NUMBER> increased sputum serum samples copd patients <NUMBER> et<NUMBER> doseand timedependently decreased expression activity ace<NUMBER> cell culture human bronchial epithelial cells <NUMBER> recent data showed covid<NUMBER> patients copd coexisting disorder likely progress severe cases <NUMBER> may partially attribute decrease ace<NUMBER> many pulmonary diseases copd accompanied hypoxia <NUMBER> early phase hypoxia ace<NUMBER> expression profoundly elevated pulmonary artery smooth muscle cells later elevation hypoxiainducible factor<NUMBER>α hif<NUMBER>α expression ace target gene hif<NUMBER>α increased accompanied decrease ace<NUMBER> <NUMBER> animal experiments demonstrated similar regulation hif<NUMBER>α ace<NUMBER> level possibly via mirna let<NUMBER>b hypoxia rats <NUMBER> results indicated hypoxia cellular adaptation hypoxia could profoundly induce fluctuation ace<NUMBER> lungs ras dysregulation primarily implicated pathogenesis progression hypertension <NUMBER> negative regulator ras ace<NUMBER> decreases blood pressure animal models hypertension <NUMBER> decrease ace<NUMBER> reported lungs patients idiopathic pah <NUMBER> similarly ace<NUMBER> also decreased blood vessel kidneys brain hypertension models <NUMBER> <NUMBER> since ace<NUMBER> protective tissue injuries lungs <NUMBER> heart <NUMBER> results suggested covid<NUMBER> patients hypertension may likely develop complications progress severe cases indeed data table <NUMBER> showed covid<NUMBER> patients hypertension high severity rate <NUMBER> besides severe cases covid<NUMBER> significantly higher systolic pressure comparing nonsevere cases <NUMBER> mmhg vs <NUMBER> mmhg <NUMBER> phenomenon may due deprivation ace<NUMBER> sarscov<NUMBER> leading drastic decrease ace<NUMBER> ace<NUMBER> enriched heart known essential regulator heart function <NUMBER> suggesting heart may one primary target organs sarscov<NUMBER> infection patients infected sarscov<NUMBER> higher risk progressing severe cases coronal heart disease comorbidity <NUMBER> <NUMBER> acute cardiac injury one common complications found covid<NUMBER> patients <NUMBER> <NUMBER> according retrospective study published lancet included <NUMBER> covid<NUMBER> patients <NUMBER> developed acute cardiac injury <NUMBER> cases diagnosed severe cases <NUMBER> therefore coronal heart disease covid<NUMBER> patients closely watched baseline comorbidity complications pathogenesis progression cardiac injury one preliminary factors determined clinical outcomes prognosis covid<NUMBER> patients <NUMBER> <NUMBER> cardiac injury found covid<NUMBER> patients may least partially attributed fluctuation ace<NUMBER> rat model myocardial infarction infarcted periinfarcted regions showed increased ace<NUMBER> expression comparing surviving myocardial tissue three days infarction <NUMBER> <NUMBER> days infarction surviving tissue also showed elevated ace<NUMBER> expression comparing normal control <NUMBER> upregulation ace<NUMBER> heart myocardial infarction may triggered compensatory protective mechanism <NUMBER> however lungs patients pah ace<NUMBER> expression phosphorylation drastically decreased <NUMBER> therefore pulmonary function covid<NUMBER> may progressively deteriorate upon occurrence cardiac complications kidneys may major target organ sarscov<NUMBER> infection laboratory examinations demonstrated urine samples covid<NUMBER> patients found positive virus <NUMBER> acute kidney injury one severe complications covid<NUMBER> patients sarscov<NUMBER> may infect renal intrinsic cells proximal tubular epithelial cells directly induce renal dysfunction occurrence acute kidney injury complication covid<NUMBER> <NUMBER> <NUMBER> cases reported lancet developed severe cases <NUMBER> cohort <NUMBER> covid<NUMBER> patients occurrence acute kidney injury <NUMBER> severity rate <NUMBER> <NUMBER> consecutive cohort study included <NUMBER> covid<NUMBER> patients renal dysfunction characterized elevation serum creatine blood urea nitrogen appearance proteinuria hematuria showed significantly higher risk mortality compared normal renal function <NUMBER> renal dysfunction independent risk factor mortality hospitalized patients <NUMBER> studies demonstrated acute kidney injury one critical complications occurred covid<NUMBER> patients ace<NUMBER> enriched kidneys <NUMBER> activity ace<NUMBER> renal cortex even higher heart <NUMBER> expression level ace<NUMBER> decreased acute kidney injury <NUMBER> several models chronic kidney disease induced hypertension diabetes nephrectomy <NUMBER> disrupted homeostasis ras kidneys worsened pathological changes kidneys <NUMBER> <NUMBER> accumulating evidence also demonstrated ace<NUMBER> played crucial role pathogenesis progression renal diseases reviewed <NUMBER> ace<NUMBER> knockout could worsen renal dysfunction modeled ischemiareperfusion <NUMBER> aggravate fibrotic pathologies obstructive renal diseases <NUMBER> investigation implication ace<NUMBER> renal dysfunction occurred covid<NUMBER> patients clinical outcome covid<NUMBER> patients chronic kidney diseases comorbidity required ace<NUMBER> modulates expression neutral amino acid transporters cell surface epithelial cells including insulin secretion pancreatic βcells andor growth pancreatic islet cells <NUMBER> ace<NUMBER> knockout mice showed impairments islet dysfunction abnormality glucose tolerance <NUMBER> diabetic mice model infected adenovirus expressing human ace<NUMBER> showed increase production insulin reduction cellular apoptosis pancreatic islet <NUMBER> moreover ace<NUMBER> could improve endothelial function pancreatic islet microvascular unit <NUMBER> findings demonstrated ace<NUMBER> prevented pancreatic dysfunction diabetes ace<NUMBER> implicated diabetic nephrology human kidneys diabetic nephropathy ace<NUMBER> profoundly suppressed ace increased <NUMBER> ratio aceace<NUMBER> positively correlated systolic pressure fasting blood glucose level serum creatine proteinuria patients <NUMBER> race<NUMBER> showed promising prevention diabetic nephrology <NUMBER> covid<NUMBER> patients diabetes coexisting disorders worse clinical outcome phenomena may partially attribute deprivation ace<NUMBER> sarscov<NUMBER> infection sarscov<NUMBER> binds ace<NUMBER> enter host cells leading systematic deprivation ace<NUMBER> race<NUMBER> shown therapeutic effect pulmonary injury <NUMBER> diabetic nephrology hypertension <NUMBER> recently found human recombinant soluble ace<NUMBER> hrsace<NUMBER> already tested phase <NUMBER> phase <NUMBER> clinical trials effectively reduced recovery sarscov<NUMBER> vero cells prevented infection sarscov<NUMBER> engineered human blood vessel organoids human kidney organoids <NUMBER> progress suggested therapeutic potential hrsace<NUMBER> covid<NUMBER> since ace<NUMBER> activation demonstrated protective effect pulmonary injury including ards developing ace<NUMBER> activator potential therapy may promising approach covid<NUMBER> diminazene aceturate <NUMBER> resorcinolnaphthalein xanthenone <NUMBER> found activate ace<NUMBER> drug screening test showed potential candidate therapy covid<NUMBER> acei arb commonlyused treatments hypertension safety effect using drugs covid<NUMBER> patients hypertension still unclear animal experiments revealed drugs might decrease systolic pressure normal rats upregulate ace<NUMBER> <NUMBER> since ace<NUMBER> expression suppressed hypertension <NUMBER> may deprived sarscov<NUMBER> virus upon infection application arb may protective pulmonary injury careful blood pressure management ace<NUMBER> currently intensive investigation receptor sarscov<NUMBER> novel coronavirus causes covid<NUMBER> pandemic summarized increasingly emerging findings covid<NUMBER> discussed potential role ace<NUMBER> pathogenesis progression prognosis covid<NUMBER> susceptibility sarscov<NUMBER> different cohorts seemed correlate ace<NUMBER> level distribution target organs susceptible sarscov<NUMBER> infection complications covid<NUMBER> similar one ace<NUMBER> three functions ace<NUMBER> peptidase negatively modulates ras regulator amino acid transport kidneys receptor virus including sarscov<NUMBER> sarscov together local protective effect tissue injury implicated progression prognosis covid<NUMBER> findings indicated targeting ace<NUMBER> using hrsace<NUMBER> ace<NUMBER> activator may potential therapeutic strategy covid<NUMBER> prescription drugs may affect ace<NUMBER> acei arb covid<NUMBER> patients requires close observation blood pressure progression covid<NUMBER> authors declare known competing financial interests personal relationships could appeared influence work reported paper cytokine release syndrome crs hypercytokinemia often referred cytokine storm postulated drive mortality severe respiratory viral infections influenza <NUMBER> including <NUMBER> spanish flu epidemic <NUMBER> h<NUMBER>n<NUMBER> bird flu <NUMBER> well severe acute respiratory syndrome coronavirus epidemic <NUMBER> sarscov<NUMBER> <NUMBER> increasing evidence supports notion mortality infections sarscov<NUMBER> causes coronavirus disease <NUMBER> driven exacerbated immune response virus leading cascade events involving cytokine storm acute respiratory distress syndrome ards often accompanied myocardial damage multiple organ failure <NUMBER> <NUMBER> pathological cascade resembles observed lethal viral lung infections immune response virus triggers primary wave cytokines including type type iii interferons ifns followed infiltration activation diverse immune cells production secondary cytokines chemokines including type ii ifn ifng accelerated immune activation progressive decline respiratory function <NUMBER> importantly many cytokines chemokines involved cytokine storm employ janus protein kinases jaks signal transduction cytokine analysis covid<NUMBER> patients indicate important role magnitude cytokine storm prognosis clinical outcome levels creactive protein crp il<NUMBER> time hospitalization reported significantly higher patients eventually died versus survived <NUMBER> different study patients admitted intensive care units icus showed significantly higher levels il<NUMBER> il<NUMBER> il<NUMBER> ip<NUMBER> mcp<NUMBER> mip<NUMBER>α gcsf tnfα relative nonicu patients <NUMBER> using artificial intelligence methods high levels circulating alanine aminotransferase alt marker liver inflammation associated progression toward ards <NUMBER> altogether findings support rationale combining antiviral treatment targeted immunosuppression therapeutic approach covid<NUMBER> <NUMBER> accordingly several clinical trials currently testing safety efficacy inhibitors il<NUMBER> signaling jakstat signaling furthermore hydroxychloroquine molecule shown attenuate tolllike receptor signaling cytokine production approved treatment rheumatoid arthritis systemic lupus erythematosus <NUMBER> <NUMBER> also testing many clinical trials covid<NUMBER> within context report relevant results obtained studies hyperactive immune response mouse model syndrome ds recently discovered trisomy <NUMBER> t<NUMBER> genetic cause ds causes consistent activation ifn transcriptional response multiple cell types <NUMBER> <NUMBER> <NUMBER> <NUMBER> explained fact four six ifn receptors encoded chromosome <NUMBER> ifnar<NUMBER> ifnar<NUMBER> ifngr<NUMBER> il<NUMBER>rb additional investigations proteome <NUMBER> metabolome <NUMBER> immune cell lineages <NUMBER> <NUMBER> people ds demonstrated t<NUMBER> causes <NUMBER> changes circulating proteome indicative chronic autoinflammation clear dysregulation ifninducible cytokines <NUMBER> <NUMBER> activation ifninducible kynurenine pathway leading elevated production neurotoxic tryptophan catabolites <NUMBER> <NUMBER> widespread hypersensitivity ifn stimulation across human immune system <NUMBER> <NUMBER> altogether results support notion ds understood good measure interferonopathy whereby increased ifn signaling could account many developmental clinical impacts t<NUMBER> report results generated investigation immune responses dp<NUMBER>yey mouse strain referred hereto dp<NUMBER> <NUMBER> widely used mouse model ds dp<NUMBER> strain carries segmental duplication murine chromosome <NUMBER> syntenic human chromosome <NUMBER> encoding <NUMBER> genes including four ifnrs found dp<NUMBER> mice overexpress ifnrs immune cell types tested display hypersensitivity type type ii ifn stimulation overproduce key cytokines display increased liver inflammation remarkably dp<NUMBER> mice display lethal immune responses upon challenge viral mimetic molecules tlr<NUMBER> agonist polyic pic tlr<NUMBER> agonist imiquimod phenotype observed wild type wt littermates mouse strains carrying triplications genomic regions syntenic chromosome <NUMBER> strikingly lethal immune phenotype associated cytokine storm blocked treatment small molecule inhibitor jak<NUMBER> kinase also decreases liver pathology overall results potential farreaching significance treatment covid<NUMBER> justifying deeper study jak inhibitors therapeutic strategy attenuate cytokine storm downstream organ failure condition also indicating individuals ds considered highrisk population covid<NUMBER> pandemic order model impact t<NUMBER> chronic innate immune responses mice employed dp<NUMBER> mouse strain harbors triplication region syntenic human chromosome <NUMBER> including four ifnrs figure <NUMBER>a <NUMBER> define relationship gene copy number ifnr protein expression evaluated surface expression ifnar<NUMBER> peripheral immune cells dp<NUMBER> mice flow cytometry dp<NUMBER>yey dp<NUMBER>yey mice hereafter referred dp<NUMBER> dp<NUMBER> three copies genes syntenic chromosome <NUMBER> disomic ifnrs <NUMBER> included controls figure <NUMBER>a expression ifnar<NUMBER> surface cd<NUMBER> white blood cells significantly higher dp<NUMBER> mice dp<NUMBER> dp<NUMBER> animals relative wt littermates figure <NUMBER>b different immune cell types analyzed flow cytometry ifnar<NUMBER> expression significantly higher cell types tested figure <NUMBER>c results consistent previous reports mrna overexpression ifnrs gene cluster various tissues dp<NUMBER> mice <NUMBER> <NUMBER> test whether upregulation ifnrs conferred stronger responses ifn ligands stimulated wt dp<NUMBER> blood samples ifna evaluated downstream phosphorylation stat<NUMBER> pstat<NUMBER> flow cytometry dp<NUMBER> cells responded strongly ifna defined significantly higher levels pstat<NUMBER> relative wt cells immune lineages examined figure <NUMBER>d widespread heightened response ifna observed dp<NUMBER> dp<NUMBER> cells however cell subsets dp<NUMBER> strain exhibited robust pstat<NUMBER> figure <NUMBER>ef although dp<NUMBER> mice two copies ifnr genes result suggests aspect triplication region chromosome <NUMBER> syntenic human chromosome <NUMBER> leads differential regulation type ifn signaling cells given one type ii ifn receptor subunits ifngr<NUMBER> also encoded murine chromosome <NUMBER> triplicated dp<NUMBER> mice next investigated response ifng stimulation indeed dp<NUMBER> cells responded strongly ifng stimulation cell types examined figure <NUMBER>g overall results suggest elevated expression ifnrs dp<NUMBER> mouse strain confers increased sensitivity type type ii ifns since dp<NUMBER> cells mount enhanced responses ifn ligands next investigated response dp<NUMBER> mice innate immune stimuli known trigger ifn response chronic systemic induction ifn signaling elicited repeated administration tlr<NUMBER> agonist polyinosinicpolycytidylic acid pic known produce acute spike type ifn production <NUMBER> days followed low persistent expression type ifn ligands robust cytokine response chronic phase <NUMBER> days <NUMBER> wt dp<NUMBER> mice given intraperitoneal injections <NUMBER> mgkg pic equivalent volume vehicle sham every day <NUMBER> days experiment completed day <NUMBER> remarkably dp<NUMBER> mice profoundly sensitive treatment largely tolerated wt mice figure <NUMBER>a body weight measurements course experiment revealed rapid weight loss dp<NUMBER> mice upon treatment figure <NUMBER>b eventually one twelve dp<NUMBER> mice removed study excessive weight loss <NUMBER> contrast wt animals lose much weight three nine survived end experiment figure <NUMBER>a b dp<NUMBER> dp<NUMBER> mice also tolerated chronic immune stimulation pic figure <NUMBER>cf although pic treatment caused weight loss dp<NUMBER> dp<NUMBER> mice percentage lost comparable wt levels picinduced weight loss clearly dosedependent mice receiving half lethal dose <NUMBER> mgkg displayed minor weight loss observable differences dp<NUMBER> wt mice figure s<NUMBER> order determine whether hypersensitivity restricted tlr<NUMBER> agonists broadly observed across activation pattern recognition receptors treated mice tlr<NUMBER> agonist imiquimod topical administration imiquimod causes ifn production acute skin inflammation systemic inflammation dehydration commonly employed model psoriasis <NUMBER> imiquimod treatment caused significant weight loss dp<NUMBER> mice despite daily administration supportive fluids led rapid termination study observation humane endpoint figure <NUMBER>gh contrast wt animals receiving identical treatment maintained weight figure <NUMBER>gh altogether results indicate hypersensitivity ifn stimulation observed cellular level dp<NUMBER> mice associates increased sensitivity lethality ifninducing viral mimetic agents organismal level next compared immune response dp<NUMBER> mice relative wild type littermates acute chronic responses pic first measured levels circulating ifna <NUMBER> hours first injection pic sham ifna levels induced pic stronger response dp<NUMBER> mice figure <NUMBER>a elevated ifn ligand production dp<NUMBER> mice consistent predicted fastforward loop driven increased ifnr expression ds <NUMBER> measured mrna expression several ifnstimulated genes isgs spleen wt dp<NUMBER> mice <NUMBER> hours single injection pic sham experiment revealed strong induction isg expression upon pic treatment several isgs significantly elevated dp<NUMBER> mice wt animals figure <NUMBER>b next measured levels several cytokines chemokines bloodstream <NUMBER> hours single pic injection expectedly pictreated animals showed increased levels many proinflammatory factors regardless genotype figure <NUMBER>c figure s<NUMBER>a acute phase significantly elevated inflammatory markers ip<NUMBER> cxcl<NUMBER> mcp<NUMBER> rantes ccl<NUMBER> kcgro cxcl<NUMBER> figure <NUMBER>c average dp<NUMBER> mice show significant differences expression cytokines relative wt littermates measured circulating cytokines chemokines chronic response compared serum levels dp<NUMBER> mice taken time harvest due reaching humane endpoint <NUMBER> weight loss levels wt littermates survived end <NUMBER>day experiment later stages chronic inflammation several inflammatory markers significantly elevated dp<NUMBER> animals mcp<NUMBER> mip<NUMBER>a wt littermates figure <NUMBER>d altogether results indicate activation tlr signaling leads strong induction key cytokine chemokines experimental paradigm several inflammatory markers elevated dp<NUMBER> mice although single cytokine chemokine stands sole driver phenotypes dp<NUMBER> mice mild overproduction several cytokines could potentially contribute exacerbated immune sensitivity next investigated markers liver inflammation injury serum levels enzymes alanine transaminase alt aspartate transaminase ast two commonly used markers hepatocyte injury significantly elevated upon pic treatment dp<NUMBER> mice reaching concentrations nearly order magnitude higher observed wt littermates figure <NUMBER>a prompted results investigated liver pathology liver tissue sections stained hematoxylin eosin evaluated trained histologist blinded treatment group genotype scoring liver pathology done procedures adapted mice <NUMBER> using validated histological scoring system <NUMBER> included parameters cell injury inflammation reactive changes leading overall liver pathology score analysis revealed dp<NUMBER> mice increased liver pathology even pic treatment demonstrated significantly higher levels cell injury inflammation reactive changes relative wt littermates figure <NUMBER>bc basal level liver pathology observed dp<NUMBER> dp<NUMBER> mice figure <NUMBER>de importantly upon treatment pic livers wt animals developed pathology scores comparable greater observed baseline dp<NUMBER> mice including signs strong recruitment andor expansion inflammatory cells pic administered dp<NUMBER> mice metrics liver pathology increased leading significantly higher overall pathology scores relative dp<NUMBER> sham treatment wt upon pic treatment figure <NUMBER>bc livers dp<NUMBER> dp<NUMBER> mice received pic also experienced increases liver pathology changes differ wt mice figure <NUMBER>de overall results indicate dp<NUMBER> mice display increased liver inflammation pathology baseline upon immune activation could potentially contribute heightened sensitivity ifninducing agents three types ifn signaling employ jak<NUMBER> kinase signal transduction combination either jak<NUMBER> tyk<NUMBER> figure <NUMBER>a therefore sought determine whether inhibiting jak<NUMBER> specifically would block lethality pathology caused pic treatment dp<NUMBER> mice end used jak<NUMBER>specific inhibitor incb<NUMBER> animals received dose <NUMBER> mgkg incb<NUMBER> equivalent volume methylcellulose used vehicle twice daily via oral gavage beginning <NUMBER> hours prior first pic injection every day course experiment remarkably dp<NUMBER> mice received jak<NUMBER> inhibitor survived pic treatment dp<NUMBER> animals received vehicle pic experienced weight loss euthanized figure <NUMBER>a analyzed impact jak<NUMBER> inhibition cytokine production comparing dp<NUMBER> mice treated pic without cotreatment jak<NUMBER> inhibitor importantly cytokine production strongly abrogated jak<NUMBER> inhibition figure <NUMBER>b figure s<NUMBER> lastly evaluated impact jak<NUMBER> inhibition markers liver inflammation injury indeed jak<NUMBER> inhibitor led reduction circulating levels alt ast well decrease overall liver pathology scores figure <NUMBER>c altogether results indicate blocking catalytic activity jak<NUMBER> kinase prevents lethality associated rampant innate immune response dp<NUMBER> mouse model efficacy treatment likely relies combination interrelated effects reduced cytokine production improved liver function covid<NUMBER> pandemic rapidly progresses worldwide dire need identify new prophylactic therapeutic strategies based recent data analyses inflammatory markers covid<NUMBER> <NUMBER> <NUMBER> prior knowledge inflammatory responses lethal viral lung infections targeted immunesuppression appreciated potential strategy prevent ards fulminant myocarditis organ failure mortality advanced stages condition <NUMBER> accordingly clinical trials diverse immunesuppressants started around world including inhibitors il<NUMBER> jakstat signaling demonstrate key role jak<NUMBER> kinase driving cytokine storms accompanying mortality mouse model lethal antiviral immune responses jak<NUMBER> one several jak kinases required mediating inflammatory signaling downstream large number cytokines including three types ifn signaling il<NUMBER> <NUMBER> show eliciting innate antiviral immune response tlr agonists lethal sensitized mouse model carrying triplication four six ifn receptors within days dp<NUMBER> mice rapidly lose weight die unattended concurrent induction many prominent cytokines linked severity covid<NUMBER>driven pathology il<NUMBER> tnfα il<NUMBER> ip<NUMBER> mcp<NUMBER> mip<NUMBER>α <NUMBER> furthermore dp<NUMBER> mice display exacerbated liver inflammation pathology together stronger production cytokines may converge pathological cascade leading wasting death importantly phenotypes blocked jak<NUMBER> inhibition based results propose jak inhibitors valid therapeutic approach attenuating cytokine storm covid<NUMBER> four jak inhibitors currently fdaapproved treatment diverse medical conditions jakafiruxolitinib jak<NUMBER> inhibitor approved myelofibrosis polycythemia vera graftversushostdisease xeljanztofacitinib jak<NUMBER> inhibitor approved rheumatoid arthritis psoriatic arthritis ulcerative colitis olumiantbaricitinib jak<NUMBER> inhibitor approved rheumatoid arthritis rinvoqupadacitinib jak<NUMBER> inhibitor also approved rheumatoid arthritis many jak<NUMBER>specific inhibitors currently developed tested clinical trials diverse inflammatory autoimmune conditions including molecule used study hypothesize jak inhibitors could superior agents terms attenuating cytokine storm caused covid<NUMBER> relative existing antiil<NUMBER> agents consist injectable monoclonal antibodies inhibit interaction il<NUMBER> receptor il<NUMBER>r <NUMBER> contrast jak inhibitors available drugs administered orally well characterized pharmacodynamics pharmacokinetics may provide appropriate strategy transiently tone cytokine storm prevent ards fulminant myocarditis furthermore jak<NUMBER> inhibitors block il<NUMBER> signaling also inflammatory pathways involved cytokine storm <NUMBER> depending degree inhibition various jak kinases predicted available jak inhibitors block various aspects cytokine storm potential varying degrees therapeutic benefit regards relevance therapeutic strategies covid<NUMBER> conditions associated cytokine storms study several limitations first mouse model fully reproduce human conditions associated cytokine storms although pandemic studies dp<NUMBER> mice originally driven interest studying immune dysregulation ifn hyperactivity ds note results consistent studies sarscov<NUMBER> demonstrating type ifn signaling contributes sarsdriven pathology mortality mice <NUMBER> predict observed rsv <NUMBER> h<NUMBER>n<NUMBER> <NUMBER> infections people ds develop severe complications upon sarscov<NUMBER> infection including higher rates hospitalization mortality hope results encourage special attention individuals ds including closer monitoring hyperinflammation covid<NUMBER> inclusion clinical trials targeted immunesuppressants table s<NUMBER> qrtpcr qrtpcr performed using applied biosystems viia<NUMBER>™ <NUMBER>well block real time pcr system qrtpcr master mix prepared applied biosystems sybr select master mix cfx standard curves run every primer pair qrtpcr experiment ensure efficient amplification target transcripts within experimental tissues samples run triplicate averaged normalized <NUMBER>s rrna primer sequences provided table s<NUMBER> cytokine measurements blood cytokine levels measured using mesoscale discovery assays andor biolegend legend plex assays per manufacturers instructions samples analyzed duplicate average used statistical analysis missing values set lower limit detection liver histopathology formalinfixed paraffinembedded pieces liver sectioned <NUMBER> microns stained hematoxylin eosin scoring liver pathology used procedures adapted mice described <NUMBER> table s<NUMBER> primers qrtpcr primers used qrtpcr analysis interferonstimulated genes <NUMBER>s rrna including gene refseq id forward primer sequence reverse primer sequence severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> recently <NUMBER> emerged rna virus responsible coronavirus disease <NUMBER> covid <NUMBER> pandemic clinical <NUMBER> disease variable ranging asymptomatic infection multiorgan failure death <NUMBER> casefatality rate <NUMBER> binding sarscov<NUMBER> spike protein human angiotensini <NUMBER> converting enzyme<NUMBER> hace<NUMBER> targets virus type ii pneumocytes within lung resulting <NUMBER> injury inflammation subsequent respiratory distress <NUMBER> covid<NUMBER> manifestations <NUMBER> eg cardiac dysfunction coagulopathy gastrointestinal tract symptoms suggest extra<NUMBER> pulmonary sites infection contribute disease pathogenesis patients <NUMBER> <NUMBER> development countermeasures reduce covid<NUMBER> morbidity mortality <NUMBER> priority global research community animal models essential effort <NUMBER> although several animal species used laboratory research evaluated <NUMBER> susceptibility sarscov<NUMBER> infection none recapitulated severe disease seen <NUMBER> hospitalized human cases hamsters ferrets nonhuman primates develop mild moderate <NUMBER> viral disease recover spontaneously <NUMBER> conventional laboratory strains mice cannot <NUMBER> infected efficiently sarscov<NUMBER> hace<NUMBER> mouse ace<NUMBER> supports sarscov<NUMBER> <NUMBER> binding <NUMBER> multiple strategies introducing hace<NUMBER> mice developed including <NUMBER> <NUMBER> transient introduction hace<NUMBER> via adenoviral viral vectors <NUMBER> <NUMBER> expression hace<NUMBER> <NUMBER> transgene driven heterologous gene promoters <NUMBER> <NUMBER> expression hace<NUMBER> mouse <NUMBER> physiology course sarscov<NUMBER> infection k<NUMBER>hace<NUMBER> mice measured clinical <NUMBER> chemistry hematological parameters peripheral blood samples fig <NUMBER> plasma levels <NUMBER> sodium potassium chloride concentrations anion gap trended slightly downward <NUMBER> <NUMBER> dpi fig <NUMBER>ad whereas plasma bicarbonate noticeably increased fig <NUMBER>e possibly result <NUMBER> poor gas exchange resulting lung pathology decreased respiratory drive plasma <NUMBER> analytes including calcium glucose blood urea nitrogen unchanged fig <NUMBER>fh <NUMBER> hematocrit plasma hemoglobin levels increased later course infection possibly <NUMBER> reduced water intake hemoconcentration fig <NUMBER>ij also observed modest <NUMBER> prolongation prothrombin time <NUMBER> dpi preceded increase ddimer <NUMBER> concentrations <NUMBER> <NUMBER> dpi fig <NUMBER>kl <NUMBER> next examined impact sarscov<NUMBER> infection pulmonary cardiac function <NUMBER> using treadmill stresstest assess exercise tolerance fig <NUMBER>m compared mockinfected <NUMBER> controls <NUMBER> dpi subset sarscov<NUMBER>infected k<NUMBER>hace<NUMBER> mice began show reduced <NUMBER> exercise tolerance measured decreased distance travelled however <NUMBER> dpi infected <NUMBER> k<NUMBER>hace<NUMBER> mice substantially reduced exercise tolerance compared mockinfected <NUMBER> animals preinfection baseline performance fig <NUMBER>m <NUMBER> examine changes biophysical properties lung course sars<NUMBER> cov<NUMBER> infection mechanically ventilated mice via tracheostomy performed several forced<NUMBER> oscillation tests determine various respiratory mechanics parameters fig <NUMBER>nw infected <NUMBER> animals showed normal lung biomechanics <NUMBER> <NUMBER> dpi markedly abnormal values <NUMBER> parameters <NUMBER> dpi relative mockinfected controls abnormalities included <NUMBER> reduced inspiratory capacity well increased respiratory system resistance elastance <NUMBER> fig <NUMBER>np collectively changes resulted downward deflection pressurevolume <NUMBER> loop fig <NUMBER>r concomitant decreases static compliance fig <NUMBER>q shapedescribing k <NUMBER> parameter fig <NUMBER>s loop hysteresis fig <NUMBER>t together indicate reduced lung compliance <NUMBER> distensibility analysis using broadband forced oscillation maneuvers <NUMBER> revealed <NUMBER> sarscov<NUMBER> infected mice <NUMBER> dpi relatively normal newtonian resistance fig <NUMBER>u <NUMBER> primarily reflection resistance larger conducting airways contrast mice <NUMBER> dpi <NUMBER> marked increases tissue damping fig <NUMBER>v elastance fig <NUMBER>w parameters measure <NUMBER> dissipation storage oscillatory energy parenchymal tissue reflect tissue <NUMBER> peripheral airway resistance elastic recoil ie tissue stiffness respectively <NUMBER> measurements mechanical properties respiratory system suggest sarscov<NUMBER> <NUMBER> infection k<NUMBER>hace<NUMBER> mice predominantly causes disease alveoli lung parenchyma <NUMBER> conducting airways consistent histopathological analysis <NUMBER> mice measurements pulmonary function humans viral pneumonia respiratory <NUMBER> failure including covid<NUMBER> <NUMBER> <NUMBER> immune response sarscov<NUMBER> infection lungs excessive pro<NUMBER> inflammatory host response sarscov<NUMBER> infection hypothesized contribute pulmonary <NUMBER> pathology development respiratory distress covid<NUMBER> patients <NUMBER> evaluate <NUMBER> composition immune cell response sarscov<NUMBER>infected k<NUMBER>hace<NUMBER> mice <NUMBER> performed flow cytometric analysis lung homogenates bronchoalveolar lavage bal fluid <NUMBER> three time points intranasal virus inoculation fig <NUMBER>ab extended data fig <NUMBER> consistent <NUMBER> histopathological analysis observed increased numbers cd<NUMBER> immune cells <NUMBER> bal beginning <NUMBER> dpi lung <NUMBER> dpi cellular infiltrates <NUMBER> <NUMBER> dpi <NUMBER> lung composed principally myeloid cell subsets including ly<NUMBER>g neutrophils ly<NUMBER>c <NUMBER> monocytes cd<NUMBER>b cd<NUMBER>c dendritic cells bal fluid monocyte numbers peaked <NUMBER> <NUMBER> dpi levels neutrophils dendritic cells continued rise <NUMBER> dpi accumulation <NUMBER> monocytes bal fluid coincided decrease number tissueresident alveolar <NUMBER> macrophages observation consistent scrnaseq analysis bal fluid patients <NUMBER> severe covid<NUMBER> disease <NUMBER> <NUMBER> dpi also observed increase several lymphoid cell <NUMBER> subsets lung including nk<NUMBER> natural killer cells γδ cd<NUMBER> cells cd<NUMBER> cd<NUMBER> cells <NUMBER> cd<NUMBER> cd<NUMBER> cells activated cd<NUMBER> cd<NUMBER> cd<NUMBER> cells fig <NUMBER>a <NUMBER> extensive changes cytokine profiles associated covid<NUMBER> disease <NUMBER> progression <NUMBER> compared lungs uninfected k<NUMBER>hace<NUMBER> control mice observed <NUMBER> induction ifnb il<NUMBER> ifng cxcl<NUMBER> cxcl<NUMBER> ccl<NUMBER> mrna first week fig <NUMBER>c <NUMBER> highest expression occurring <NUMBER> dpi cytokines except ifng ccl<NUMBER> also measured <NUMBER> protein levels lungs using multiplex assay <NUMBER> different cytokines chemokines fig <NUMBER> <NUMBER>d extended data fig <NUMBER> although mrna expression highest <NUMBER> dpi almost up<NUMBER> regulated proinflammatory cytokines ifnβ il<NUMBER> cxcl<NUMBER> cxcl<NUMBER> ccl<NUMBER> ccl<NUMBER> timp<NUMBER> <NUMBER> tnfα gcsf cellassociated cytokines il<NUMBER> ifnγ il<NUMBER> myeloid cell revealed distinct transcriptional signatures associated <NUMBER> dpi fig <NUMBER>a overlapping <NUMBER> signatures <NUMBER> <NUMBER> dpi hundreds genes differentially expressed time points <NUMBER> compared mockinfected animals fig <NUMBER>b many associated ifn signaling nf<NUMBER> kbdependent cytokine responses leukocyte activation agreement pca <NUMBER> <NUMBER> differentially expressed genes shared time points compared mock contrast <NUMBER> <NUMBER> unique differentially expressed genes identified mock <NUMBER> dpi whereas <NUMBER> <NUMBER> <NUMBER> genes different mock <NUMBER> <NUMBER> dpi respectively fig <NUMBER>c gene <NUMBER> ontology analysis top upregulated genes time points showed enrichment gene <NUMBER> clusters cytokinemediated signaling type ii ifn signaling neutrophil activation <NUMBER> pathogen recognition receptor signaling fig <NUMBER>d upregulation gene sets involved cytokine<NUMBER> mediated signaling neutrophil activation cellular responses type ii ifn tolllike receptor <NUMBER> signaling pronounced <NUMBER> dpi fig <NUMBER>e ifit<NUMBER> versus <NUMBER> dpi eg ifnar<NUMBER> tyk<NUMBER> irf<NUMBER> certain isgs samhd<NUMBER> oas<NUMBER> ifitm<NUMBER> <NUMBER> suggests temporally distinct type ifn response fig <NUMBER>f described previously <NUMBER> ifna ifnb subtypes <NUMBER> alternatively differences ifn isg signatures early <NUMBER> late time points could reflect differential signaling contributions type iii ifns <NUMBER> study found sarscov<NUMBER> infection k<NUMBER>hace<NUMBER> transgenic mice causes <NUMBER> severe pulmonary disease intranasal sarscov<NUMBER> inoculation k<NUMBER>hace<NUMBER> mice rapidly <NUMBER> lost weight <NUMBER> dpi began succumb disease <NUMBER> dpi high levels viral rna <NUMBER> infectious virus detected lungs infected animals <NUMBER> <NUMBER> <NUMBER> dpi rtqpcr <NUMBER> situ hybridization plaque assay infection accompanied high levels pro mild disease feature sarscov<NUMBER> infection naturally susceptible animals including <NUMBER> hamsters ferrets cats nonhuman primates <NUMBER> perhaps unsurprising given <NUMBER> strongest risk factors developing severe covid<NUMBER> humans eg old age cardiovascular <NUMBER> disease diabetes absent many laboratory animals mild moderate disease seen <NUMBER> many rodent models sarscov<NUMBER> infection including expressing hace<NUMBER> via viral <NUMBER> vectors transgenes <NUMBER> thus severity disease observed following sarscov<NUMBER> <NUMBER> infection k<NUMBER>hace<NUMBER> mouse unique onset severe clinical disease k<NUMBER>hace<NUMBER> <NUMBER> mice occurs days peak viral infection associated high levels infiltrating immune <NUMBER> cells inflammatory mediators lung immune responses likely contribute pathogenesis <NUMBER> histopathological changes observed infected lungs k<NUMBER>hace<NUMBER> mice <NUMBER> correlate impaired pulmonary function pneumocytes become infected early led <NUMBER> recruitment leukocytes pulmonary interstitium production proinflammatory <NUMBER> cytokines injury parenchymal cells collapse alveolar space compromise gas <NUMBER> exchange could cause hypercapnia observed <NUMBER> dpi course <NUMBER> remarkably consistent human disease rapid early viral replication followed <NUMBER> inflammatory responses believed contribute pathology morbidity mortality <NUMBER> <NUMBER> fundamental understanding immunological processes influence covid<NUMBER> <NUMBER> disease needed select immunomodulatory interventions target key cell types <NUMBER> pathways saw substantial immune cell accumulation lungs k<NUMBER>hace<NUMBER> mice role type ifn sarscov<NUMBER> pathogenesis model warrants <NUMBER> investigation suggested dysregulated type ifn response contributes <NUMBER> excessive immunopathology indeed sarscov infection type ifn signaling appears pro<NUMBER> inflammatory antiviral <NUMBER> rna sequencing analysis revealed differences type <NUMBER> ifn gene signatures associated early late sarscov<NUMBER> infection given isgs <NUMBER> exert diverse functions apart antiviral activities including inflammatory metabolic <NUMBER> transcriptional effects <NUMBER> two early late isg modules may different functional <NUMBER> consequences following sarscov<NUMBER> infection furthermore temporally distinct <NUMBER> programs induced regulated remains uncertain may result celltype <NUMBER> specificity kinetics sensitivity different type iii ifn subtypes <NUMBER> development severe disease following sarscov<NUMBER> infection important <NUMBER> feature k<NUMBER>hace<NUMBER> model although precise reason susceptibility compared <NUMBER> hace<NUMBER> transgenic models remains unknown potential explanations include high number <NUMBER> hace<NUMBER> transgene insertions httpswwwjaxorgstrain<NUMBER> andor strength <NUMBER> cellular specificity k<NUMBER> promoter human ace<NUMBER> expressed multiple tissues k<NUMBER> hace<NUMBER> mouse <NUMBER> could allow sarscov<NUMBER> infection multiple organs <NUMBER> detected viral rna several tissues lung heavily infected showed <NUMBER> consistent severe histopathological changes findings anticipated given <NUMBER> known tropism sarscov<NUMBER> respiratory tract intranasal route infection <NUMBER> moderate levels viral rna also found heart kidney spleen peak titers <NUMBER> <NUMBER> <NUMBER> dpi whereas levels gastrointestinal tract tissues duodenum ileum colon <NUMBER> lower gastrointestinal tract k<NUMBER>hace<NUMBER> mice hace<NUMBER> expressed abundantly <NUMBER> colon correlated infection seen later time points although hace<NUMBER> <NUMBER> expressed gastrointestinal tract hace<NUMBER>expressing mice productive infection <NUMBER> observed upon intragastric inoculation early time points following intranasal <NUMBER> infection <NUMBER> <NUMBER> observed dichotomous sarscov<NUMBER> infection brain high virus levels <NUMBER> approximately <NUMBER> mice <NUMBER> dpi low levels remaining <NUMBER> animals infection <NUMBER> brain also observed k<NUMBER>hace<NUMBER> mice infected sarscov <NUMBER> occurred earlier <NUMBER> <NUMBER> <NUMBER> dpi uniformly similar experiments sarscov detect <NUMBER> sarscov<NUMBER> olfactory bulb suggests sarscov sarscov<NUMBER> cross <NUMBER> bloodbrain barrier instead traversing cribriform plate infecting neuronal processes <NUMBER> near site intranasal inoculation <NUMBER> notwithstanding data unlike sarscov <NUMBER> alterations smell taste features sarscov<NUMBER> infection humans <NUMBER> suggesting <NUMBER> cell types within olfactory system may susceptible infection injury study <NUMBER> needed clarify routes sarscov<NUMBER> dissemination throughout host particularly <NUMBER> accesses brain animals humans <NUMBER> sarscov<NUMBER> lung infection k<NUMBER>hace<NUMBER> mice provides model studying <NUMBER> severe infection recapitulates features covid<NUMBER> humans acknowledge several <NUMBER> limitations expression hace<NUMBER> transgene nonphysiological several respects <NUMBER> driven nonnative ie cytokeratin<NUMBER> promotor resulting tissue expression levels <NUMBER> distinct endogenouslyexpressed ace<NUMBER> ace<NUMBER> expression k<NUMBER>hace<NUMBER> mice <NUMBER> independent complex regulatory systems governs ace<NUMBER> levels <NUMBER> comorbid <NUMBER> conditions eg obesity hypertension diabetes alter ace<NUMBER> expression humans <NUMBER> likely <NUMBER> cannot modelled faithfully transgenic mouse <NUMBER> summary found sarscov<NUMBER> infection k<NUMBER>hace<NUMBER> transgenic mice supports <NUMBER> robust viral replication lung leads severe immune cell infiltration inflammation cytokine foldchange calculated compared mockinfected animals log<NUMBER>fold<NUMBER> change plotted corresponding heatmap two experiments n <NUMBER> per group <NUMBER> associated statistics reported extended data fig <NUMBER> <NUMBER> rna analysis right lung inflated <NUMBER> ml <NUMBER> neutral buffered formalin <NUMBER> using <NUMBER>ml syringe catheter inserted trachea harvesting brains fixation <NUMBER> mouse decapitated skull cap removed whole brain removed intact cut <NUMBER> midsagittally increase surface area fixation drop fixed <NUMBER> neutralbuffered formalin <NUMBER> nbf kidney spleen liver heart organs removed dropfixed <NUMBER> nbf <NUMBER> fixation infection organs kept <NUMBER>ml suspension nbf <NUMBER> days <NUMBER> processing tissues embedded paraffin sections stained hematoxylin <NUMBER> eosin rna situ hybridization performed using rnascope <NUMBER> hd assay brown kit <NUMBER> according manufacturers instructions advanced cell diagnostics briefly sections <NUMBER> deparaffinized treated h <NUMBER> <NUMBER> protease plus prior probe hybridization probes <NUMBER> specifically targeting hace<NUMBER> cat <NUMBER> sarscov<NUMBER> sequence cat <NUMBER> <NUMBER> hybridized followed proprietary signal amplification detection <NUMBER>diaminobenzidine <NUMBER> tissues counterstained gills hematoxylin uninfected mouse used <NUMBER> negative control stained parallel tissue sections visualized using nikon eclipse <NUMBER> microscope equipped olympus dp<NUMBER> camera leica dm<NUMBER>b microscope equipped <NUMBER> leica dfc<NUMBER>t camera olympus bx<NUMBER> microscope attached camera <NUMBER> clinical laboratory analysis testing performed fresh wholeblood samples <NUMBER> within biosafety cabinet using pointofcare instruments prothrombin time measured using <NUMBER> coagucheck roche meter electrolyte acidbase hematology parameters <NUMBER> assayed lithiumheparinized whole blood using istat<NUMBER> abbot chem<NUMBER> <NUMBER> cartridge <NUMBER> respiratory mechanics mice anesthetized ketaminexylazine <NUMBER> mgkg <NUMBER> <NUMBER> mgkg ip respectively trachea isolated via dissection neck area <NUMBER> cannulated using <NUMBER>gauge blunt metal cannula typical resistance <NUMBER> cmh <NUMBER> osml <NUMBER> secured place nylon suture mouse connected flexivent <NUMBER> computercontrolled piston ventilator scireq inc via cannula attached <NUMBER> fx adaptor ytubing mechanical ventilation initiated mice given additional <NUMBER> <NUMBER> mgkg ketamine <NUMBER> mgmouse paralytic pancuronium bromide via intraperitoneal <NUMBER> route prevent breathing efforts ventilator measurements mice <NUMBER> ventilated using default settings mice consisted positive end expiratory pressure <NUMBER> <NUMBER> cm h <NUMBER> <NUMBER> mlkg tidal volume vt respiratory rate <NUMBER> breaths per minute bpm <NUMBER> fraction inspired oxygen fio <NUMBER> <NUMBER> ie room air respiratory mechanics assessed <NUMBER> using forced oscillation technique previously described <NUMBER> using latest version <NUMBER> flexivent operating software flexiware v<NUMBER> pressurevolume loops measurements <NUMBER> inspiratory capacity also done <NUMBER> treadmill stress test sixlane mouse treadmill columbus instruments columbus oh <NUMBER> placed within biosafety cabinet within absl<NUMBER> laboratory mice introduced <NUMBER> treadmill test three times prior infection introductory session performed <NUMBER> increasingly faster rates general treadmill set ramp <NUMBER> maximum speed <NUMBER> course first minute maintain maximum speed <NUMBER> min failure maintain <NUMBER> adequate speed resulted delivery shock occurred animal reinguaged <NUMBER> treadmill maximum <NUMBER> failures sex identified speed <NUMBER> mice <NUMBER> successfully completed test prior infection <NUMBER> ms female <NUMBER> ms male <NUMBER> rna sequencing cdna libraries constructed starting <NUMBER> ng total rna <NUMBER> lung tissues sample extracted using magmax mirvana total rna isolation kit <NUMBER> thermo scientific cdna generated using seqplex kit sigmaaldrich amplification <NUMBER> <NUMBER> cycles library construction performed using <NUMBER> ng cdna undergoing end repair <NUMBER> tailing ligation universal truseq adapters amplification <NUMBER> cycles incorporate unique <NUMBER> dual index sequences libraries sequenced novaseq <NUMBER> illumina san diego ca <NUMBER> targeting <NUMBER> million read pairs extending <NUMBER> cycles paired end reads rnaseq reads <NUMBER> aligned mouse ensembl grch<NUMBER> primary assembly sarscov<NUMBER> ncbi <NUMBER> nc<NUMBER> wuhanhu<NUMBER> genome star program version <NUMBER>a <NUMBER> gene counts <NUMBER> derived number uniquely aligned unambiguous reads subreadfeaturecount <NUMBER> version <NUMBER>p<NUMBER> <NUMBER> ribosomal fraction known junction saturation read distribution <NUMBER> known gene models quantified rseqc version <NUMBER> <NUMBER> gene counts <NUMBER> preprocessed r package edger <NUMBER> adjust samples differences library size using <NUMBER> trimmed mean values tmm normalization procedure ribosomal genes genes <NUMBER> expressed level greater equal <NUMBER> count per million reads smallest group size <NUMBER> excluded analysis r package limma <NUMBER> voomwithqualityweights <NUMBER> function <NUMBER> utilized calculate weighted likelihoods samples based observed <NUMBER> meanvariance relationship every gene sample differentially expressed genes <NUMBER> defined least <NUMBER>fold difference two individual groups benjamini<NUMBER> hochberg falsediscovery rate fdr adjusted pvalue ie qvalue <NUMBER> <NUMBER> statistical analysis statistical significance assigned p values <NUMBER> <NUMBER> using prism version <NUMBER> graphpad specific tests indicated figure legends analysis <NUMBER> weight change determined twoway anova changes functional parameters <NUMBER> immune parameters compared mockinfected animals analyzed oneway <NUMBER> anova oneway anova dunnetts test <NUMBER> data availability data supporting findings study found within paper <NUMBER> extended data figures available corresponding author upon request <NUMBER> rna sequencing data sets generated study available geo gse<NUMBER> <NUMBER> <NUMBER> <NUMBER> two viruses h<NUMBER>n<NUMBER> sarscov<NUMBER> resulted pandemics within <NUMBER> years <NUMBER> sars outbreak <NUMBER> mers outbreaks since <NUMBER> current covid<NUMBER> outbreak since <NUMBER> demonstrate potential coronaviruses especially batderived betacoronaviruses zhou et al <NUMBER> cause pheics covid<NUMBER> escalated global pandemic viruses new host humans potential evolve rapidly present quasispecies diversity eigen mccaskill schuster <NUMBER> hallmark rna viruses exist cloud variants due low fidelity high polymorphism viral polymerases lacking capability correct errors drew <NUMBER> wilke wang ofria lenski adami <NUMBER> result variants random accumulation errors useful tracing aetiology typically without substantial functional change grubaugh petrone holmes <NUMBER> unlike rna viruses coronaviruses express <NUMBER>′to<NUMBER>′ exoribonuclease enables highfidelity replication relatively large <NUMBER> kb ssrna genome minskaia et al <NUMBER> snijder et al <NUMBER> coronaviruses moderate mutation rate <NUMBER> × <NUMBER> <NUMBER> nucleotide substitutions per site per year sarscov genome zhao et al <NUMBER> allowing wider evolutionary space explored deliberately complicate outbreak response terms rapid development evaluation diagnostics vaccines antivirals antibody therapies many diverse strains unknown functional differences exist figure <NUMBER> particularly exacerbated increased movement people enabled global air travel animals goods spreading new viruses across worlds population exposing huge variations environment demographics age structure socioeconomic status comorbidities equitable access health care sheer number interconnected influencing factors often makes unfolding situation hard comprehend fully challenges traditional virology public health disciplines rendering less effective coping spread virus bioinformatic approaches may able better inform epidemiology responses transboundary viruses synthesizing complex information effectively systematically enabled advances genomic sequencing technology eg oxford nanopore illumina willingness share sequenced information public domain eg genbank gisaid bioinformatic approaches developed human domain enabled comparative analysis emerging genomic diversity virus spreads throughout host population ongoing covid<NUMBER> outbreak illustrated figure <NUMBER> applying silico approaches rapidly provide answers questions like first sequenced sarscov<NUMBER> genome often called reference genome gisaid genbank etc closest original true reference strain entered humans may sequenced andor may still circulating minimal mutations combined epidemiological experimental evidence bioinformatics help address questions like one multiple circulating strains different virulent ones yes identify molecular basis finally f g u r e <NUMBER> illustration coronavirus spread accumulates mutations dark blue arrows represent main volume transmissions nucleic acid symbol illustrates mutations acquired different viral strains enter humans primaryreservoir host represented bat symbol intermediate host yet identified sarscov<NUMBER> first human sarscov<NUMBER> isolate sequenced orange pink mutation may original strain first infected humans grey possible strain sequenced later green may genetically closer original strain scenario original strain captured sequencing also shows may two currently circulating strains orangepinkpurple orangepinkbrown turn might different virulent one orangepinkblue absence clinical data correlated sarscov<NUMBER> genome isolates bioinformatic analysis represented computer symbol identify clusters consensus sequences investigate genetic diversity emerging sars answers questions academic interest help inform outbreak response development evaluation diagnostics vaccines countermeasures instance outbreak response efforts including vaccine evaluation focus prevalent circulating strain lest may end rejecting acceptable candidates raising efficacy threshold high would desirable evaluate therapeutics virulent strain however field yet using bioinformatic tools fullest potential current data collection practices capturing information necessary advanced analysis example pathogen sequences derived patients typically annotated deidentified disease progression clinically relevant information turn hampers identification virulent strain associating pathogen properties genomic modifications use bioinformatic analysis identify emerging trends among sarscov<NUMBER> isolates sought identify representative strains animal models preclinical research particular strains among emerging australian isolates good choices animal model development ones representative two australian isolates betacovaustraliavic<NUMBER> betacov australiasa<NUMBER> sequenced miseq platform illumina inc brief rna purified isolate using directzol rna miniprep kit zymo research purified rna reverse transcribed using taqman reverse transcription kit applied biosystems random octamers linked specific primer sequence followed secondstrand cdna synthesis using klenow dna polymerase promega complementary dna amplified using primers specific sequences added random octamers used reverse transcription kapa hifi hotstart kit roche resulting dna purified using dna clean concentrator kit zymo research fragmentation dualindex library preparation conducted using nextera xt dna library preparation kit illumina inc denatured libraries sequenced using <NUMBER>cycle miseq reagent kit v<NUMBER> illumina inc sequencing reads trimmed quality mapped published reference sequence betacovwuhanhu<NUMBER> genbank accession number nc<NUMBER> using geneious <NUMBER> consensus genome sequences isolates generated analysis available viral sequences downloaded gisaid <NUMBER> see appendix s<NUMBER> elbe bucklandmerrett <NUMBER> filtering complete sequences human origin <NUMBER> genomes total lowquality sequences defined sequences n content greater <NUMBER> filtered leaving <NUMBER> strains total also included one recently reported viral sequence european virus archive global refsku <NUMBER>v<NUMBER> two australian sequences full data set data set <NUMBER> sequences aligned using muscle v<NUMBER> madeira et al <NUMBER> based alignments could see significant variation ends sequences figure s<NUMBER> likely due sequencing artefacts errors preventing full viral genomes sequenced reduce impact potential sequencing errors wrote custom perl script trim sequences positions <NUMBER> coverage retained trimming entailed removing first <NUMBER> last <NUMBER> bp alignments trimmed converting u identified <NUMBER> sequences identical limit effect duplicate sequences subsequent analysis collapsed single entry collapsed sequences summarized table s<NUMBER> maximum likelihood phylogenetic tree generated alignments using raxmlng kozlov darriba flouri morel stamatakis <NUMBER> evolutionary model used general time reversable model gammadistributed rate heterogeneity invariant sites gtr g use mode since general model proposed produce equal trees optimally selected models abadi azouri pupko mayrose <NUMBER> tree visualized using itol letunic bork <NUMBER> midpoint rooted tree shows likely evolutionary relationships sampled strains every organism potentially isolate unique genomic signature based composition genomic sequence quantify signature determined kmer frequency counting possible strings length k sequence virus emerged alternative phylogenetic trees disciplines sims jun wu kim <NUMBER> conceptual distance isolates visualized running principal component analysis pca genomic signatures reduce highdimensional kmer frequency vector twodimensional space jolliffe cadima <NUMBER> please see appendix s<NUMBER> details method custom scripts used calculate kmer frequency sequence using k <NUMBER> sims et al <NUMBER> kmers containing ambiguous bases ie ns removed calculated relative proportion kmer resulting frequency vector used pca implementation python scikitlearn reduce genomic signatures containing <NUMBER> <NUMBER>mer proportions vector containing two principal components finally custom scripts used compare genomic signatures aforementioned coronavirus sequences evolutionary structure <NUMBER> isolates determined phylogenetic tree reveals three major clusters c<NUMBER>c<NUMBER> figure <NUMBER> c<NUMBER> cluster mainly represents wuhan isolates captured early c<NUMBER> c<NUMBER> contain later isolates sydney<NUMBER> australiavic<NUMBER> franceidf<NUMBER> c<NUMBER> australiansw<NUMBER> australiaqld<NUMBER> australiavic<NUMBER> usawa<NUMBER> c<NUMBER> three clusters separated distinct mutations table <NUMBER> contain substantial number unique mutations define diversity within cluster individual mutations outside established hotspots diversity shown figure s<NUMBER> predominantly concern pcr primer design rather aetiology may also three additional clusters emerging c<NUMBER> c<NUMBER> capturing suspected community spread lombardy narrative genomic analysis covid<NUMBER> spread nd c<NUMBER> regionally mixed asia north amerika c<NUMBER> australia asia notably australiansw<NUMBER> see fully annotated tree figure s<NUMBER> finding different tang et al <NUMBER> postulate two clusters l analysis <NUMBER> gisaid isolates includes betacoronaviruses bats roots tree differently merges c<NUMBER> c<NUMBER> however aetiology fully demonstrated especially intermediate vector yet unknown f g u r e <NUMBER> phylogenetic tree highlighting isolates interest branch points six clusters labelled indicate mature orange emerging yellow disease clusters full list identical sequences branch points table s<NUMBER> complete image figure s<NUMBER> j p n i<NUMBER> <NUMBER> <NUMBER> irrespective root placement trees allow assessment individual isolates part major branches genetically divergent offshoots example sydney<NUMBER> appears offshoot wuhanhu<NUMBER> upon inspection sydney<NUMBER> strand discovered <NUMBER>bp deletion overlaps infectious bronchitis virus ibv motif <NUMBER>′ end goebel cluster mutations common note table lists isolate note paper collects information tables s<NUMBER> s<NUMBER> easy access third column counts number differences wuhanhu<NUMBER> full core sequences condensed deletions count <NUMBER>and full way taylor masters <NUMBER> inspecting isolates australiavic<NUMBER> also <NUMBER>bp deletion within genomic location <NUMBER>bp deletion figure s<NUMBER> despite similarity australiavic<NUMBER> placed c<NUMBER> sydney<NUMBER> c<NUMBER> since australiavic<NUMBER> contains g<NUMBER>t mutation indicative c<NUMBER> sydney<NUMBER> lacks see table <NUMBER> list referenced isolates systematic sequence analysis revealed many isolates deletions core genome table s<NUMBER> deletions appear specific isolate figure s<NUMBER> effect virus structure function might pronounced example australia vic<NUMBER> sydney<NUMBER> may ibv motif disrupted implications replication usaca<NUMBER> japanai<NUMBER> may disruption nonstructural protein <NUMBER> nsp<NUMBER> implications host gene expression figure s<NUMBER> full impact genomic variations confirmed functional genomics experiments coronaviruses proofreading ability likely lifts random accumulation errors methodology able take deletions consideration calculating genomic distance desirable aiming overcome limitations phylogenetic tree approaches also investigated whether alignmentfree approach used understand genomic content different sarscov<NUMBER> isolates changes time respect also taking deletions account therefore calculated frequency possible <NUMBER>mers across viral genome followed principal component analysis pca reduce highdimensional kmer vector space twodimensional image visual comparison first demonstrate methods ability faithfully separate distant coronavirus strains comparing sarscov<NUMBER> <NUMBER> sars <NUMBER> mers isolates shown figure <NUMBER> c<NUMBER> g e rm n b v p h u n <NUMBER> <NUMBER> <NUMBER> <NUMBER> n c v phylogenetic results reflects fact sequences mutational changes core sequences compared wuhanhu<NUMBER> table s<NUMBER> however alignmentfree method positions isolates deletions viz australiavic<NUMBER> canadaonvido<NUMBER> away wuhanhu<NUMBER> phylogenetic tree demonstrating ability kmer method represent deletions accurately see supplemental table <NUMBER> <NUMBER> isolates found singapore<NUMBER> taiwanntu<NUMBER> finland<NUMBER> usail<NUMBER> shenzhenszth<NUMBER> among furthest wuhanhu<NUMBER> data shown singapore<NUMBER> taiwanntu<NUMBER> due shorter core sequences kmer fingerprint accurately reflects missing sequences meanwhile usail<NUMBER> finland<NUMBER> contained several ambiguous bases effectively shortening length similar sequence method correctly places isolates kmer approach suggestive phylogenetic trees respect visualizing potential transmission route eg lombardy may accurately reflect fluidity changes cloud variants capture recombination events graham baric <NUMBER> example italyinmi<NUMBER> mutations common sydney<NUMBER> c<NUMBER> cluster g<NUMBER>t chongqingivdccq<NUMBER> c<NUMBER> cluster g<NUMBER>t making impossible definitively place discrete phylogenetic tree placed c<NUMBER> cluster figure <NUMBER> pca plot shows fluid evolution placing italian australian isolate figure <NUMBER> generally phylogenetic analysis based presence shared mutations example two strains share snps likely closely related therefore exist neighbouring branches phylogenetic tree comparison alignmentfree method kmer signatures concerned global similarities difference example changes averaged across whole genome rather specific locations informative highlevel similarities genomes example evolution distinct genomic islands common functions recombination events create visually clear clades offers holistic representation pairwise distances isolates together clinical information could hence help determine virulent strains figure <NUMBER> currently process determining isolate use animal models less informed could due lack shared genomic information readily available bioinformatic methodologies especially towards beginning outbreak example china published genomic sequence sarscov<NUMBER> zhou et al <NUMBER> patient samples virus isolates made available reverse genetics large rna virus taking time thao et al <NUMBER> countries wait imported cases australias doherty institute first world isolate virus australiavic<NUMBER> made available preclinical animal models authors csiro <NUMBER> public health england etc practical consideration dictated initial choice however isolates choose subsequently informed approach taken figure <NUMBER> according phylogenetic tree shown figure <NUMBER>a main clusters represented current animal models c<NUMBER> represented germanybavpat<NUMBER> human <NUMBER>ncov whose core sequence identical though seem halfway c<NUMBER> cluster suspected lombardy cluster c<NUMBER> represented australiavic<NUMBER> franceidf<NUMBER> c<NUMBER> represented usawa<NUMBER> note scotlandcvr<NUMBER> removed due high n content <NUMBER> however phylogenetic methods focusing presence shared mutations rather overall genomic similarity eg shared evolved functionality assumption current animal models adequately cover evolutionary space actively circulating virus might misleading pca plot indicates figure <NUMBER>b topleft bottomright areas seem underrepresented join strainetiology phylogenetic approaches fluid distance measure alignmentfree methods created consensus sequences major emerging clusters appendix s<NUMBER> reran pca analysis find robust future relevant isolates figure <NUMBER>b callaway <NUMBER> moving away purely practical considerations towards deliberate approach assesses current future characteristics isolate choices lead better coverage actively circulating strains figure <NUMBER> sharing isolates internationally information collected patientdeidentified details case severity outcome sophisticated machine learning approaches generated assist triaging treatment choices additional information comorbidities socioeconomic smoking status may also help anticipating public health demand furthermore releasing full highthroughput sequencing data sets rather consensus sequences would allow detailed exploration existing quasispecies improve isolate selection two australian isolates yet gisaid kindly pro authors declare conflict interest ethical statement applicable data support findings study available gisaid httpswwwgisaidorg denis c bauer httpsorcidorg<NUMBER> seshadri vasan httpsorcidorg<NUMBER> finch et al <NUMBER> <NUMBER> however human disease animal models temporal mechanistic <NUMBER> relationship viral replication subsequent immunopathology <NUMBER> <NUMBER> clinical <NUMBER> disease remains uncertain furthermore available nhp models <NUMBER> sublethal markers clinical disease cageside scoring chest xray <NUMBER> limited sensitivity concerningly metrics subject observer bias <NUMBER> <NUMBER> reliable animal models needed rapid development evaluation candidate <NUMBER> medical countermeasures mcms require unbiased reproducible quantifiable <NUMBER> metric disease mirrors key aspects covid<NUMBER> based rather limited x<NUMBER> ray findings lungs reported nhp models sarscov<NUMBER> infection either <NUMBER> mild clinical signs <NUMBER> <NUMBER> <NUMBER> turned highresolution chest ct <NUMBER> petct characterize lung abnormalities infected nhps toward longitudinal <NUMBER> quantitative comparison <NUMBER> used direct bilateral primary intrabronchial instillation <NUMBER>dayapart <NUMBER> staggered design expose two groups three crabeating macaques macaca <NUMBER> fascicularis medium mock group macaques m<NUMBER> medium including <NUMBER>x<NUMBER> <NUMBER> <NUMBER> pfumacaque sarscov<NUMBER> virus group macaques v<NUMBER> supplementary table <NUMBER> <NUMBER> macaques observed daily <NUMBER> days prior exposure day <NUMBER> <NUMBER> <NUMBER> days postexposure physical examination scores blood conjunctival <NUMBER> nasopharyngeal oropharyngeal rectal fecal urine specimens collected <NUMBER> identical timepoints virusexposed macaques indistinguishable mock group <NUMBER> macaques preexposure time period two preexposure chest ct whole<NUMBER> previously published results <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> none macaques developed major <NUMBER> clinical abnormalities including cageside assessment clinical scoring physical <NUMBER> examination throughout study clinical laboratory results significantly <NUMBER> different mockexposed virusexposed groups supplementary tables <NUMBER> <NUMBER> sarscov<NUMBER> rna could detected rtqpcr sample mock<NUMBER> exposed macaques variably present early days postexposure <NUMBER> conjunctival fecal nasopharyngeal oral rectal swabs never plasma urine <NUMBER> figure <NUMBER>a antisarscov<NUMBER> igg antibodies detectable elisa mock<NUMBER> exposed macaques detectable d<NUMBER> postexposure continued rise <NUMBER> virusexposed macaques least d<NUMBER> figure <NUMBER>b consistent elisa results <NUMBER> fluorescent neutralization titers generated sera undetected d<NUMBER> <NUMBER> detected virusexposed macaques figure <NUMBER>c longitudinal measurement <NUMBER> selected peripheral cytokines revealed betweenand withingroup differences <NUMBER> marked abnormalities noted macaque v<NUMBER> also highest igg antibody <NUMBER> titers supplementary figure <NUMBER> <NUMBER> exception minor transient abnormalities baseline imaging ct <NUMBER> scans mockexposed macaques appeared generally normal entire study <NUMBER> period supplementary figure <NUMBER> however virus group macaques developed lung <NUMBER> abnormalities clearly visible chest ct early d<NUMBER> qualitatively distribution <NUMBER> morphology duration abnormalities described spectrum similar mild<NUMBER> moderately ill humans covid<NUMBER> characteristic ct findings virus group <NUMBER> macaques included bilateral peripheral ggos variably association intraor <NUMBER> interlobular septal prominence socalled crazy paving reticular reticulonodular <NUMBER> sarscov<NUMBER> pulmonary abnormalities macaques finch et al <NUMBER> opacities peribronchial thickening subpleural nodules one macaque dense <NUMBER> alveolar consolidation air bronchograms figures <NUMBER>a videos <NUMBER> increased fdg uptake detected pet figure <NUMBER> supplementary figures <NUMBER> <NUMBER> corresponded well structural changes lungs observed ct regional <NUMBER> lymph node uptake seen virus group macaques d<NUMBER> macaque v<NUMBER> fdg <NUMBER> uptake decreased lungs d<NUMBER> increased mediastinal lymph nodes new <NUMBER> fdg uptake identified spleen two macaques v<NUMBER> v<NUMBER> persistent <NUMBER> progressive structural abnormalities chest ct variable changes fdg uptake <NUMBER> associated structural abnormalities lungs markedly increased <NUMBER> improved accompanying marked increase fdg uptake regional lymph <NUMBER> nodes spleens d<NUMBER> pet scan d<NUMBER> revealed normalization previous areas <NUMBER> increased fdg uptake lung parenchyma three virusexposed macaques <NUMBER> persistent increased fdg update regional lymph nodes spleen mockexposed <NUMBER> macaques similar increased fdg uptake exception transient <NUMBER> increased uptake regional lymph nodes mockexposure single macaque m<NUMBER> <NUMBER> sarscov<NUMBER> pulmonary abnormalities macaques finch et al <NUMBER> quantification suvmax selected regions interest roi lung specific <NUMBER> regional lymph nodes spleen mapped well qualitative findings mock<NUMBER> exposed virusexposed macaques figure <NUMBER> <NUMBER> ct images used quantification lung abnormalities using measures <NUMBER> volume radiodensity ie total lung volume lv average radiodensity total <NUMBER> lung volume ld hyperdense volume hv volume lung radiodensity <NUMBER> hounsfield units hu predefined threshold average radiodensity <NUMBER> hyperdense volume hyperdensity hd normalized changes preexposure <NUMBER> baseline longitudinally measured percent change volume lung <NUMBER> hyperdensity pclh toward standardization across lung volumes pclh also <NUMBER> expressed percent total lung volume pclhlv increases pclh pclhlv <NUMBER> seen mockexposed macaques entire study figure <NUMBER>a key advantage quantifiable ct chest imaging readout serial euthanasia <NUMBER> studies addition potentially reduced experimental animal numbers ability <NUMBER> evaluate betweengroup differences also compare severity duration <NUMBER> disease higher resolution single animals even isolated parenchymal areas <NUMBER> sequentially approach reduce error inherent crosssectional sampling <NUMBER> individual animals single timepoints imaging however introduce <NUMBER> experimental complexities limitations aimed evaluate whether pclh <NUMBER> ct imaging readouts presented figure <NUMBER> could useful quantitative readout <NUMBER> radiographic progression sarscov<NUMBER> infected lung chose include <NUMBER> irradiated inactivated sarscov<NUMBER> mock inoculum avoid antigeninduced <NUMBER> inflammation related radiographic changes similar reasons avoid <NUMBER> artificial dissemination sarscov<NUMBER> specifically perform bronchoalveolar <NUMBER> lavage bal obtain lung samples downstream cellular molecular virologic <NUMBER> analysis <NUMBER> <NUMBER> perform lung biopsies frequency anesthesia <NUMBER> instrument availability pragmatically limit imaging carefully chosen timepoints <NUMBER> sarscov<NUMBER> pulmonary abnormalities macaques finch et al <NUMBER> study particular extended time required perform pet imaging resulted <NUMBER> logistical limitations number macaques could included study <NUMBER> finally complete resolution radiographic abnormalities end study <NUMBER> period opted euthanize macaques able perform reexposure <NUMBER> study future thus cannot correlate radiographic histopathologic findings <NUMBER> future studies extend initial findings several directions first <NUMBER> followup confirmation pilot results model mildmoderate covid<NUMBER> <NUMBER> needed establish quantifiable lung ct reliable disease readout <NUMBER> forge imagingpathologic correlates macaques euthanized peak radiographic <NUMBER> abnormality confirmation enable proofofconcept evaluation whether <NUMBER> candidate mcm indeed significantly decrease peak auc pclh pclhlv <NUMBER> compared untreated infected control macaques data additional macaques <NUMBER> used confirm sensitivity relevance auc<NUMBER> auc<NUMBER> pclh <NUMBER> pclhlv robust measures lung changes ct evaluation <NUMBER> parallel disease severity could possibly increased crabeating <NUMBER> macaque model optimizing delivery sarscov<NUMBER> vulnerable lung via <NUMBER> aerosol distal bronchoscopic delivery ultimate goal using ct<NUMBER> quantifiable volume radiodensity readouts model sick hospitalized human <NUMBER> groups already evaluating nhps diverse species possible covid<NUMBER> <NUMBER> models models serial chest ct imaging intrabronchial instillation <NUMBER> sarscov<NUMBER> could used establish meaningful quantifiable covid<NUMBER>like <NUMBER> disease readout enable objective evaluation medical countermeasures also <NUMBER> comparison sarscov<NUMBER>induced lung abnormalities different nhp models macaques split <NUMBER> groups <NUMBER> animals supplementary table <NUMBER> <NUMBER> mock group macaques received <NUMBER> ml dmem <NUMBER> heatinactivated fbs <NUMBER> bronchus direct bilateral primary postcarinal intrabronchial instillation followed <NUMBER> <NUMBER>ml normal saline flush <NUMBER> ml air virus group v macaques exposed sarscov<NUMBER> pulmonary abnormalities macaques finch et al <NUMBER> way <NUMBER>ml instillate containing <NUMBER>x<NUMBER> <NUMBER> pfuml ie total exposure dose <NUMBER> <NUMBER>x<NUMBER> <NUMBER> pfu sarscov<NUMBER> followed <NUMBER>ml saline flush <NUMBER> ml air <NUMBER> macaques sedated prior instillation prior administering anesthesia <NUMBER> glycopyrrolate <NUMBER> mgkg delivered intramuscularly reduce saliva secretions <NUMBER> next macaque received <NUMBER> mgkg ketamine <NUMBER> μgkg dexmedetomidine <NUMBER> intramuscularly reverse anesthesia <NUMBER> mgkg atipamezole administered <NUMBER> intravenously macaques evaluated daily health periodically <NUMBER> table <NUMBER> cageside physical exam scoring <NUMBER> criteria developed collaboration national primate research centers <NUMBER> nprcs standardize disease assessment compare disease outcomes nhp <NUMBER> models heart rate incorporated physical exam scores d<NUMBER> <NUMBER> heart rate score determined beats per minute baseline baseline heart rate <NUMBER> determined average three timepoints d<NUMBER> d<NUMBER>d<NUMBER> d<NUMBER> except <NUMBER> normalized baseline densityradiodensity difference baseline severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> etiologic agents human priming <NUMBER> <NUMBER> bats speculated natural reservoir sarscov<NUMBER> numerous <NUMBER> betacoronaviruses chiropteran origin <NUMBER> <NUMBER> however although covid<NUMBER> pandemic <NUMBER> may begun battohuman transmission event appears close human <NUMBER> infections trace back respiratory droplets produced infected people fomites respiratory <NUMBER> droplet landing sites <NUMBER> <NUMBER> human infections lead various degrees disease severity <NUMBER> ranging asymptomatic infection mild symptoms fatal pneumonia older patients <NUMBER> patients chronic medical conditions vulnerable becoming critically ill poor <NUMBER> prognosis <NUMBER> common symptoms clinical signs covid<NUMBER> fever cough <NUMBER> liu et al sarscov<NUMBER> detection ffpe specimens <NUMBER> dyspnea myalgia medium incubation period <NUMBER> days <NUMBER> groundglass opacity <NUMBER> common radiologic finding chest ct upon admission <NUMBER> bilateral diffuse <NUMBER> alveolar damage alveolar hemorrhage edema interstitial fibrosis inflammation type <NUMBER> ii pneumocyte hyperplasia observed postmortem human lungs <NUMBER> <NUMBER> <NUMBER> <NUMBER> time writing animal models truly mimic disease spectrum <NUMBER> pathogenesis covid<NUMBER> however small animals eg human ace<NUMBER> transgenic laboratory <NUMBER> mice <NUMBER> cats <NUMBER> domestic ferrets <NUMBER> <NUMBER> golden hamsters <NUMBER> nonhuman primates <NUMBER> eg rhesus monkeys <NUMBER> <NUMBER> crabeating macaques <NUMBER> used study sarscov<NUMBER> <NUMBER> infection alveolar damage interstitial inflammation viral shedding occur animal <NUMBER> models various degree hoped development animal models <NUMBER> help overcome current roadblock evaluating efficacy candidate medical <NUMBER> countermeasures mcms pathogenesis covid<NUMBER> detection viral antigen using ihc ifa techniques detection viral nucleic acids using <NUMBER> ish within infected inactivated human animal model tissues greatly facilitates detection <NUMBER> viral infection thereby pathogenesis mcm efficacy studies techniques become <NUMBER> paramount particular studies potential pathogen cause overt causes <NUMBER> mild disease sarscov<NUMBER> currently available animal models viral antigen<NUMBER> based immunostaining used detect sarscov<NUMBER> antigen postmortem human <NUMBER> animal tissues <NUMBER> <NUMBER> <NUMBER> <NUMBER> however antibodies used studies produced <NUMBER> inhouse therefore commonly available identification characterization <NUMBER> commercially available antisarscov<NUMBER> antibodies ish assays used detect <NUMBER> sarscov<NUMBER> ffpe tissues therefore critically needed <NUMBER> liu et al sarscov<NUMBER> detection ffpe specimens <NUMBER> describe evaluation rabbit polyclonal antisarscov antibody mouse <NUMBER> monoclonal antisarscov np antibody commercially available ihc ifa <NUMBER> recognized respective sarscov<NUMBER> proteins ffpe specimens also identify two <NUMBER> commercially available ish assays used efficiently detect sarscov<NUMBER> rna <NUMBER> specimens develop dual staining assay using ihc ish detect sarscov<NUMBER> <NUMBER> rna ffpe section cov np may cross react sarscov<NUMBER> supplemental table <NUMBER> additionally also <NUMBER> identified rabbit monoclonal antibody sarscov<NUMBER> supplemental table <NUMBER> table <NUMBER> <NUMBER> expected forty zz positivesense rna probe <NUMBER> binding sarscov<NUMBER> positivesense <NUMBER> rna resulted stronger signal twenty zz positivesense rna probe <NUMBER> figure <NUMBER>a <NUMBER> <NUMBER> <NUMBER> tested mfish <NUMBER> detect sarscov<NUMBER> replication ffpe specimens using positivesense rna probe <NUMBER> <NUMBER> negativesense rna probe <NUMBER> supplemental table <NUMBER> consistent rnascope ish identify antibodies binds targets ffpe tissues compared frozen section tissues ffpe specimencompatible rabbit mouse antisarscov<NUMBER> antibodies <NUMBER> characterized used map cellular targets sarscov<NUMBER> various organs <NUMBER> using multiplex ifa addition detecting viral infection rnascope ish relatively novel <NUMBER> ish platform highsensitivity lowbackground due unique zz probe design table <NUMBER> incubated room temperature <NUMBER> min subsequently sections <NUMBER> liu et al rinsed peroxidaselabeled polymer secondary antibody applied <NUMBER> min table <NUMBER> tissue sections deparaffinized xylene underwent series <NUMBER> ethanol washes peroxidase blocking heated kitprovided antigen retrieval <NUMBER> buffer digested kitprovided proteinase sections exposed ish target probe pairs table <NUMBER> overnight <NUMBER>°c <NUMBER> following fast red substrate ish procedure described using positivesense rna probe <NUMBER> <NUMBER> supplemental table <NUMBER> one day later sections rinsed peroxidaselabeled 